"#",Jurisdiction,Kind,Display Key,Lens ID,Publication Date,Publication Year,Application Number,Application Date,Priority Numbers,Earliest Priority Date,Title,Abstract,Applicants,Inventors,Owners,URL,Document Type,Has Full Text,Cites Patent Count,Cited by Patent Count,Simple Family Size,Extended Family Size,Sequence Count,CPC Classifications,IPCR Classifications,US Classifications,NPL Citation Count,NPL Resolved Citation Count,NPL Resolved Lens ID(s),NPL Resolved External ID(s),NPL Citations,Legal Status
1,US,B2,US 7732955 B2,094-847-463-493-301,2010-06-08,2010,US 19320608 A,2008-08-18,US 19320608 A,2008-08-18,Power tool with motor air flow path control,"In accordance with an aspect of the present disclosure, a power tool has an electric motor having a stator disposed in a field case. The stator has field coils having opposed axial ends that extend axially outwardly from opposed axial ends of a lamination stack of the stator. An armature is disposed in the stator and has a shaft on which a fan is disposed. There are gaps between the opposed axial ends of the respective field coils. The fan baffle includes an air direction member that extends into one of the gaps to direct air flow between the armature and the stator. In an aspect, the fan baffle includes a plurality of such members, one for each gap.",BLACK & DECKER INC,MILLER PHILLIP T;;FRIEDMAN BRIAN E,BLACK & DECKER INC (2008-09-03),https://lens.org/094-847-463-493-301,Granted Patent,yes,5,5,7,7,0,B23D53/12;;B23D55/00;;H02K7/145;;H02K9/06;;H02K5/207;;H02K9/06;;H02K7/145;;B23D55/00;;B23D53/12;;H02K5/207,H02K9/06,310/63;;310/62;;X310 60 R,1,0,,,"International Search Report and Written Opinion of the International Searching Authority for PCT/US2009/053986, Issued Apr. 5, 2010.",INACTIVE
2,WO,A3,WO 2001/025870 A3,116-642-471-725-755,2001-11-01,2001,US 0026882 W,2000-09-29,US 15747299 P;;US 20694700 P,1999-10-01,SYSTEM AND METHOD FOR PROVIDING DATA SECURITY,A system and method protects security of data. The data is packaged (14) together with one or more permissions that designate what actions are allowed with respect to the data. The package (14) can be opened when there is approval for doing so and the allowed permissions are maintained. The data is stored within a vault (520) and there are a number of available security procedures that prevent the unauthorized access of data.,INFRAWORKS CORP;;FRIEDMAN GEORGE;;STAREK ROBERT PHILLIP;;MURDOCK CARLOS,FRIEDMAN GEORGE;;STAREK ROBERT PHILLIP;;MURDOCK CARLOS,,https://lens.org/116-642-471-725-755,Search Report,yes,6,0,28,31,0,G06F21/52;;G06F21/62;;G06F21/6209;;G06F2221/2141;;G06F21/52;;G06F21/6209;;G06F2221/2141;;G06F21/6209;;G06F21/62;;G06F21/52;;G06F2221/2141,G06F1/00;;G06F12/14;;G06F12/00;;G06F21/00;;G06F21/24,,0,0,,,,PENDING
3,WO,A1,WO 2001/025925 A1,179-182-363-773-064,2001-04-12,2001,US 0026839 W,2000-09-29,US 15747299 P;;US 20694700 P,1999-10-01,PORT BLOCKING METHOD AND SYSTEM,"A port blocking method (220) particularly applicable to a system in which protected data is segregated from other data, which allows for ports to be opened only by processes which do not have access to secured data (250) in order to ensure that applications using secured data do not imperil the security of secure data. In a preferred embodiment, port blocking method (220) is implemented in an application resident on the kernel level which monitors port requests and allows limited access to the port based on whether requesting processes are secure (220).",INFRAWORKS CORP;;FRIEDMAN GEORGE;;STAREK ROBERT PHILLIP;;MURDOCK CARLOS,FRIEDMAN GEORGE;;STAREK ROBERT PHILLIP;;MURDOCK CARLOS,,https://lens.org/179-182-363-773-064,Patent Application,yes,3,2,28,31,0,G06F21/52;;G06F21/62;;G06F21/6209;;G06F2221/2141;;G06F21/52;;G06F21/6209;;G06F2221/2141;;G06F21/6209;;G06F21/62;;G06F21/52;;G06F2221/2141,G06F1/00;;G06F12/00;;G06F21/00;;G06F21/24;;G06F12/14,,0,0,,,,PENDING
4,WO,A1,WO 2001/025932 A1,052-271-266-185-980,2001-04-12,2001,US 0026896 W,2000-09-29,US 15747299 P;;US 20694700 P,1999-10-01,BACK-CHANNELING IN A MEMORY VAULT SYSTEM,"A file system security driver and vault method and system particularly applicable to a system in which protected data is segregated from other data, which allows for back-channeling of file data in order to ensure that files created by applications using secured data do not cause data leaks of secure data. In a preferred embodiment, a file system security driver (140) is a driver resident on the kernel level (130) which monitors files system requests and allows limited access to files resident on the vault (120) and creation of files within the vault (120) when necessary.",INFRAWORKS CORP;;FRIEDMAN GEORGE;;STAREK ROBERT PHILLIP;;MURDOCK CARLOS,FRIEDMAN GEORGE;;STAREK ROBERT PHILLIP;;MURDOCK CARLOS,,https://lens.org/052-271-266-185-980,Patent Application,yes,3,2,28,31,0,G06F21/52;;G06F21/62;;G06F21/6209;;G06F2221/2141;;G06F21/52;;G06F21/6209;;G06F2221/2141;;G06F21/6209;;G06F21/62;;G06F21/52;;G06F2221/2141,G06F1/00;;G06F12/00;;G06F21/00;;G06F12/14;;G06F21/24,,0,0,,,,PENDING
5,AU,A,AU 2000/078407 A,052-069-480-465-343,2001-05-10,2001,AU 2000/078407 A,2000-09-29,US 15747299 P;;US 20694700 P;;US 0026893 W,1999-10-01,Method and apparatus for packaging and transmitting data,,INFRAWORKS CORP,FRIEDMAN GEORGE;;STAREK ROBERT PHILLIP;;MURDOCK CARLOS,,https://lens.org/052-069-480-465-343,Patent Application,no,0,0,28,31,0,G06F21/52;;G06F21/62;;G06F21/6209;;G06F2221/2141;;G06F21/52;;G06F21/6209;;G06F2221/2141;;G06F21/6209;;G06F21/62;;G06F21/52;;G06F2221/2141,G06F12/14;;G06F1/00;;G06F12/00;;G06F21/00;;G06F21/24,,0,0,,,,DISCONTINUED
6,WO,A1,WO 2001/025953 A1,056-121-086-042-773,2001-04-12,2001,US 0026844 W,2000-09-29,US 15747299 P;;US 20694700 P,1999-10-01,REGISTRY MONITORING SYSTEM AND METHOD,"A registry monitoring method particularly applicable to a system (100) in which protected data is transmitted to a recipient computer. The method comprises requesting a handle for a registry key to a calling process, requesting a registry key value for the handle, modifying and deleting keys and values of protected data locations, and obtaining security clearance to complete the requests by checking secured process lists and rejection lists. Also included are a registry monitoring system, a secured data transmission system including registry monitorings, a machine-readable medium comprising a program to monitor a registry (110), and a computer configured to monitor a registry (110).",INFRAWORKS CORP;;FRIEDMAN GEORGE;;STAREK ROBERT PHILLIP;;MURDOCK CARLOS,FRIEDMAN GEORGE;;STAREK ROBERT PHILLIP;;MURDOCK CARLOS,,https://lens.org/056-121-086-042-773,Patent Application,yes,3,4,28,31,0,G06F21/52;;G06F21/62;;G06F21/6209;;G06F2221/2141;;G06F21/52;;G06F21/6209;;G06F2221/2141;;G06F21/6209;;G06F21/62;;G06F21/52;;G06F2221/2141,G06F1/00;;G06F12/00;;G06F12/14;;G06F21/00;;G06F21/24,,0,0,,,,PENDING
7,AU,A,AU 2000/077359 A,102-899-313-521-998,2001-05-10,2001,AU 2000/077359 A,2000-09-29,US 15747299 P;;US 20694700 P;;US 0026843 W,1999-10-01,Network/tdi blocking method and system,,INFRAWORKS CORP,FRIEDMAN GEORGE;;STAREK ROBERT PHILLIP;;MURDOCK CARLOS,,https://lens.org/102-899-313-521-998,Patent Application,no,0,0,28,31,0,G06F21/52;;G06F21/62;;G06F21/6209;;G06F2221/2141;;G06F21/52;;G06F21/6209;;G06F2221/2141;;G06F21/6209;;G06F21/62;;G06F21/52;;G06F2221/2141,G06F12/14;;G06F1/00;;G06F12/00;;G06F21/00;;G06F21/24,,0,0,,,,DISCONTINUED
8,WO,A1,WO 2001/026277 A1,184-339-837-168-485,2001-04-12,2001,US 0026893 W,2000-09-29,US 15747299 P;;US 20694700 P,1999-10-01,METHOD AND APPARATUS FOR PACKAGING AND TRANSMITTING DATA,"A system and method for communicating a package of information. The system comprises a machine readable medium having information packaging software that generates a computer executable file (Fig 1, 14) comprising a package of information. The packet information comprises the file of data and encryption software. The system communicates the package of information over a network (Fig 1, 16) that is in communication with a machine readable medium. A client computer system (Fig 1, 17) in communication with the network is adapted to receive the package of information and execute the computer executable file. The computer system has a client permissions database (Fig 1, 20) and a vault adapted to receive the package of information.",INFRAWORKS CORP;;FRIEDMAN GEORGE;;STAREK ROBERT PHILLIP;;MURDOCK CARLOS,FRIEDMAN GEORGE;;STAREK ROBERT PHILLIP;;MURDOCK CARLOS,,https://lens.org/184-339-837-168-485,Patent Application,yes,5,3,28,31,0,G06F21/52;;G06F21/62;;G06F21/6209;;G06F2221/2141;;G06F21/52;;G06F21/6209;;G06F2221/2141;;G06F21/6209;;G06F21/62;;G06F21/52;;G06F2221/2141,G06F1/00;;G06F12/00;;G06F21/00;;G06F21/24;;G06F12/14,,0,0,,,,PENDING
9,WO,A1,WO 2001/025922 A1,028-527-116-232-573,2001-04-12,2001,US 0026858 W,2000-09-29,US 15747299 P;;US 20694700 P,1999-10-01,METHOD AND SYSTEM FOR PROVIDING DATA SECURITY USING FILE SPOOFING,"A method for providing data security in a device for accessing data. The device driver detects a file system request (210), completes the file system request, and receives return information form the file system request. The device driver (211) further determines whether the file system request is for a tag file associated with a secured file; and if so, modifies (212) the return information to reflect a file attribute of the secured file.",INFRAWORKS CORP;;FRIEDMAN GEORGE;;STAREK ROBERT PHILLIP;;MURDOCK CARLOS,FRIEDMAN GEORGE;;STAREK ROBERT PHILLIP;;MURDOCK CARLOS,,https://lens.org/028-527-116-232-573,Patent Application,yes,3,0,28,31,0,G06F21/52;;G06F21/62;;G06F21/6209;;G06F2221/2141;;G06F21/52;;G06F21/6209;;G06F2221/2141;;G06F21/6209;;G06F21/62;;G06F21/52;;G06F2221/2141,G06F1/00;;G06F12/00;;G06F12/14;;G06F21/00;;G06F21/24,,0,0,,,,PENDING
10,WO,A1,WO 2001/025928 A1,029-706-458-503-492,2001-04-12,2001,US 0026840 W,2000-09-29,US 15747299 P;;US 20694700 P,1999-10-01,METHOD AND APPARATUS FOR MONITORING CLOCK-RELATED PERMISSION ON A COMPUTER TO PREVENT UNAUTHORIZED ACCESS,"To prevent unauthorized access on a computer, a clock monitoring system having a memory for storing a permission database having one or more permission fields, each field comprising one or more clock-related permissions, a time-value field comprising a stored time-value, and a clock-monitor in communication with the permission database. The clock-monitor reads a first time-value from a system clock, determines whether the permissions database is initialized, and if the permission database is initialized, compares the first time-value to the stored time-value. If the first time-value is later than the stored time-value, the clock-monitor stores the first time-value in the stored time-value field. If the first time-value is earlier than the stored time-value, the clock-monitor disables the one or more clock-related permissions, thereby preventing access to the data. If the permissions database is not initialized, the clock-monitor stores the first time-value in the stored time-value field.",INFRAWORKS CORP;;FRIEDMAN GEORGE;;STAREK ROBERT PHILLIP;;MURDOCK CARLOS,FRIEDMAN GEORGE;;STAREK ROBERT PHILLIP;;MURDOCK CARLOS,,https://lens.org/029-706-458-503-492,Patent Application,yes,4,3,28,31,0,G06F21/52;;G06F21/62;;G06F21/6209;;G06F2221/2141;;G06F21/52;;G06F21/6209;;G06F2221/2141;;G06F21/6209;;G06F21/62;;G06F21/52;;G06F2221/2141,G06F1/00;;G06F12/00;;G06F21/00;;G06F12/14;;G06F21/24,,0,0,,,,PENDING
11,WO,A9,WO 2001/025870 A9,062-002-837-430-300,2002-09-26,2002,US 0026882 W,2000-09-29,US 15747299 P;;US 20694700 P,1999-10-01,SYSTEM AND METHOD FOR PROVIDING DATA SECURITY,A system and method protects security of data. The data is packaged (14) together with one or more permissions that designate what actions are allowed with respect to the data. The package (14) can be opened when there is approval for doing so and the allowed permissions are maintained. The data is stored within a vault (520) and there are a number of available security procedures that prevent the unauthorized access of data.,INFRAWORKS CORP;;FRIEDMAN GEORGE;;STAREK ROBERT PHILLIP;;MURDOCK CARLOS,FRIEDMAN GEORGE;;STAREK ROBERT PHILLIP;;MURDOCK CARLOS,,https://lens.org/062-002-837-430-300,Patent Application,no,0,0,28,31,0,G06F21/52;;G06F21/62;;G06F21/6209;;G06F2221/2141;;G06F21/52;;G06F21/6209;;G06F2221/2141;;G06F21/6209;;G06F21/62;;G06F21/52;;G06F2221/2141,G06F1/00;;G06F12/14;;G06F12/00;;G06F21/00;;G06F21/24,,0,0,,,,PENDING
12,CA,A1,CA 2352948 A1,155-219-168-146-36X,2001-04-12,2001,CA 2352948 A,2000-09-29,US 15747299 P;;US 20694700 P;;US 0026882 W,1999-10-01,SYSTEM AND METHOD FOR PROVIDING DATA SECURITY,A system and method protects security of data. The data is packaged together with one or more permission that designate what actions are allowed with respect to the data. The package can be opened when there is approval for doing so and the allowed permissions are maintained. The data is stored with in a vault and there are a number of available security procedures that prevent the unauthorized access of the data.,INFRAWORKS CORP,FRIEDMAN GEORGE;;STAREK ROBERT PHILLIP;;MURDOCK CARLOS,,https://lens.org/155-219-168-146-36X,Patent Application,no,0,3,28,31,0,G06F21/52;;G06F21/62;;G06F21/6209;;G06F2221/2141;;G06F21/52;;G06F21/6209;;G06F2221/2141;;G06F21/6209;;G06F21/62;;G06F21/52;;G06F2221/2141,G06F12/14;;G06F1/00;;G06F12/00;;G06F21/00;;G06F21/24,,0,0,,,,DISCONTINUED
13,AU,A,AU 2000/077385 A,026-032-890-921-362,2001-05-10,2001,AU 2000/077385 A,2000-09-29,US 15747299 P;;US 20694700 P;;US 0026896 W,1999-10-01,Back-channeling in a memory vault system,,INFRAWORKS CORP,FRIEDMAN GEORGE;;STAREK ROBERT PHILLIP;;MURDOCK CARLOS,,https://lens.org/026-032-890-921-362,Patent Application,no,0,0,28,31,0,G06F21/52;;G06F21/62;;G06F21/6209;;G06F2221/2141;;G06F21/52;;G06F21/6209;;G06F2221/2141;;G06F21/6209;;G06F21/62;;G06F21/52;;G06F2221/2141,G06F12/14;;G06F1/00;;G06F12/00;;G06F21/00;;G06F21/24,,0,0,,,,DISCONTINUED
14,CN,A,CN 1345497 A,028-243-981-190-879,2002-04-17,2002,CN 00802532 A,2000-09-29,US 15747299 P;;US 20694700 P,1999-10-01,Method and apparatus for packaging and transmitting data,,INFRAWORKS CORP,FRIEDMAN GEORGE;;STAREK ROBERT PHILLIP;;MURDOCK CARLOS,,https://lens.org/028-243-981-190-879,Patent Application,no,0,20,28,31,0,G06F21/52;;G06F21/62;;G06F21/6209;;G06F2221/2141;;G06F21/52;;G06F21/6209;;G06F2221/2141;;G06F21/6209;;G06F21/62;;G06F21/52;;G06F2221/2141,G06F12/14;;G06F1/00;;G06F12/00;;G06F21/00;;G06F21/24,,0,0,,,,DISCONTINUED
15,AU,A,AU 2000/077383 A,080-955-186-852-424,2001-05-10,2001,AU 2000/077383 A,2000-09-29,US 15747299 P;;US 20694700 P;;US 0026894 W,1999-10-01,Shared memory blocking method and system,,INFRAWORKS CORP,FRIEDMAN GEORGE;;STAREK ROBERT PHILLIP;;MURDOCK CARLOS,,https://lens.org/080-955-186-852-424,Patent Application,no,0,0,28,31,0,G06F21/52;;G06F21/62;;G06F21/6209;;G06F2221/2141;;G06F21/52;;G06F21/6209;;G06F2221/2141;;G06F21/6209;;G06F21/62;;G06F21/52;;G06F2221/2141,G06F12/14;;G06F1/00;;G06F12/00;;G06F21/00;;G06F21/24,,0,0,,,,DISCONTINUED
16,AU,A,AU 2001/014309 A,194-462-358-110-813,2001-05-10,2001,AU 2001/014309 A,2000-09-29,US 15747299 P;;US 20694700 P;;US 0026858 W,1999-10-01,Method and system for providing data security using file spoofing,,INFRAWORKS CORP,FRIEDMAN GEORGE;;STAREK ROBERT PHILLIP;;MURDOCK CARLOS,,https://lens.org/194-462-358-110-813,Patent Application,no,0,0,28,31,0,G06F21/52;;G06F21/62;;G06F21/6209;;G06F2221/2141;;G06F21/52;;G06F21/6209;;G06F2221/2141;;G06F21/6209;;G06F21/62;;G06F21/52;;G06F2221/2141,G06F12/14;;G06F1/00;;G06F12/00;;G06F21/00;;G06F21/24,,0,0,,,,DISCONTINUED
17,AU,A,AU 2001/013296 A,019-956-109-129-315,2001-05-10,2001,AU 2001/013296 A,2000-09-29,US 15747299 P;;US 20694700 P;;US 0026882 W,1999-10-01,System and method for providing data security,,INFRAWORKS CORP,FRIEDMAN GEORGE;;STAREK ROBERT PHILLIP;;MURDOCK CARLOS,,https://lens.org/019-956-109-129-315,Patent Application,no,0,0,28,31,0,G06F21/52;;G06F21/62;;G06F21/6209;;G06F2221/2141;;G06F21/52;;G06F21/6209;;G06F2221/2141;;G06F21/6209;;G06F21/62;;G06F21/52;;G06F2221/2141,G06F12/14;;G06F1/00;;G06F12/00;;G06F21/00;;G06F21/24,,0,0,,,,DISCONTINUED
18,WO,A1,WO 2001/025930 A1,022-196-376-932-419,2001-04-12,2001,US 0026894 W,2000-09-29,US 15747299 P;;US 20694700 P,1999-10-01,SHARED MEMORY BLOCKING METHOD AND SYSTEM,"A shared memory blocking method and particularly applicable to a system in which protected data is transmitted to a recipient computer. The method comprises reserving a memory page for a requesting application, committing a memory page to the requesting application's address space, which call may be made by the process providing the page reserve call or by a subsequent process, and providing security checks to complete the requests. The security checks include determining whether the process is secured by consulting a secured process list and determining whether the page is shared by consulting a shared memory list. Further disclosed are a computer readable medium and computer programmed to block shared memory, shared memory blocking system and secured data transmission system.",INFRAWORKS CORP;;FRIEDMAN GEORGE;;STAREK ROBERT PHILLIP;;MURDOCK CARLOS,FRIEDMAN GEORGE;;STAREK ROBERT PHILLIP;;MURDOCK CARLOS,,https://lens.org/022-196-376-932-419,Patent Application,yes,4,0,28,31,0,G06F21/52;;G06F21/62;;G06F21/6209;;G06F2221/2141;;G06F21/52;;G06F21/6209;;G06F2221/2141;;G06F21/6209;;G06F21/62;;G06F21/52;;G06F2221/2141,G06F1/00;;G06F12/14;;G06F12/00;;G06F21/00;;G06F21/24,,0,0,,,,PENDING
19,EP,A2,EP 1183585 A2,014-179-021-697-101,2002-03-06,2002,EP 00975215 A,2000-09-29,US 0026882 W;;US 15747299 P;;US 20694700 P,1999-10-01,SYSTEM AND METHOD FOR PROVIDING DATA SECURITY,,INFRAWORKS CORP,FRIEDMAN GEORGE;;STAREK ROBERT PHILLIP;;MURDOCK CARLOS,,https://lens.org/014-179-021-697-101,Patent Application,yes,0,1,28,31,0,G06F21/52;;G06F21/62;;G06F21/6209;;G06F2221/2141;;G06F21/52;;G06F21/6209;;G06F2221/2141;;G06F21/6209;;G06F21/62;;G06F21/52;;G06F2221/2141,G06F1/00;;G06F12/14;;G06F12/00;;G06F21/00;;G06F21/24,,0,0,,,,DISCONTINUED
20,WO,A1,WO 2001/025937 A1,101-725-000-568-668,2001-04-12,2001,US 0026843 W,2000-09-29,US 15747299 P;;US 20694700 P,1999-10-01,NETWORK/TDI BLOCKING METHOD AND SYSTEM,"A network blocking method particularly applicable to a system in which protected data is segregated from other data, which allows for a network connection to be opened only by processes which do not have access to secured data in order to ensure that applications using secured data do not imperil the security of that secure data. In a preferred embodiment, network blocking method is implemented in an application (110) residing on the level (120) which monitors network requests and allows limited access to the network (150) based on whether requesting processes are secure.",INFRAWORKS CORP;;FRIEDMAN GEORGE;;STAREK ROBERT PHILLIP;;MURDOCK CARLOS,FRIEDMAN GEORGE;;STAREK ROBERT PHILLIP;;MURDOCK CARLOS,,https://lens.org/101-725-000-568-668,Patent Application,yes,2,1,28,31,0,G06F21/52;;G06F21/62;;G06F21/6209;;G06F2221/2141;;G06F21/52;;G06F21/6209;;G06F2221/2141;;G06F21/6209;;G06F21/62;;G06F21/52;;G06F2221/2141,G06F1/00;;G06F12/14;;G06F12/00;;G06F21/00;;G06F21/24,,0,0,,,,PENDING
21,AU,A,AU 2000/076227 A,133-880-642-186-355,2001-05-10,2001,AU 2000/076227 A,2000-09-29,US 15747299 P;;US 20694700 P;;US 0026828 W,1999-10-01,Method and system for providing data security in a file system monitor with stack positioning,,INFRAWORKS CORP,FRIEDMAN GEORGE;;STAREK ROBERT PHILLIP;;MURDOCK CARLOS,,https://lens.org/133-880-642-186-355,Patent Application,no,0,0,28,31,0,G06F21/52;;G06F21/62;;G06F21/6209;;G06F2221/2141;;G06F21/52;;G06F21/6209;;G06F2221/2141;;G06F21/6209;;G06F21/62;;G06F21/52;;G06F2221/2141,G06F12/14;;G06F1/00;;G06F12/00;;G06F21/00;;G06F21/24,,0,0,,,,DISCONTINUED
22,AU,A,AU 2000/077356 A,072-202-608-182-939,2001-05-10,2001,AU 2000/077356 A,2000-09-29,US 15747299 P;;US 20694700 P;;US 0026839 W,1999-10-01,Port blocking method and system,,INFRAWORKS CORP,FRIEDMAN GEORGE;;STAREK ROBERT PHILLIP;;MURDOCK CARLOS,,https://lens.org/072-202-608-182-939,Patent Application,no,0,0,28,31,0,G06F21/52;;G06F21/62;;G06F21/6209;;G06F2221/2141;;G06F21/52;;G06F21/6209;;G06F2221/2141;;G06F21/6209;;G06F21/62;;G06F21/52;;G06F2221/2141,G06F12/14;;G06F1/00;;G06F12/00;;G06F21/00;;G06F21/24,,0,0,,,,DISCONTINUED
23,WO,A1,WO 2001/026276 A1,096-727-414-075-740,2001-04-12,2001,US 0026828 W,2000-09-29,US 15747299 P;;US 20694700 P,1999-10-01,METHOD AND SYSTEM FOR PROVIDING DATA SECURITY IN A FILE SYSTEM MONITOR WITH STACK POSITIONING,"A System for providing data security in a first device driver operably installed in a computer operating system having a layered plurality of device drivers (81, 82, 83, 84) for accessing data in a data storage device. The first device driver detects an I/O request, and determines whether the first device driver is functionally uppermost in the layered plurality of device drivers. If the first device driver is functionally uppermost in the layered plurality of device drivers, the method performs the I/O request (80) in the first device driver. If the device driver is not functionally uppermost in the layered plurality of device drivers, the method denies the I/O request in the first device driver, and allows the I/O request to be performed by the next lowest-level driver in the layered plurality of device drivers.",INFRAWORKS CORP;;FRIEDMAN GEORGE;;STAREK ROBERT PHILLIP;;MURDOCK CARLOS,FRIEDMAN GEORGE;;STAREK ROBERT PHILLIP;;MURDOCK CARLOS,,https://lens.org/096-727-414-075-740,Patent Application,yes,4,1,28,31,0,G06F21/52;;G06F21/62;;G06F21/6209;;G06F2221/2141;;G06F21/52;;G06F21/6209;;G06F2221/2141;;G06F21/6209;;G06F21/62;;G06F21/52;;G06F2221/2141,G06F1/00;;G06F12/14;;G06F12/00;;G06F21/00;;G06F21/24,,0,0,,,,PENDING
24,AU,A,AU 2000/077357 A,195-435-509-032-916,2001-05-10,2001,AU 2000/077357 A,2000-09-29,US 15747299 P;;US 20694700 P;;US 0026840 W,1999-10-01,Method and apparatus for monitoring clock-related permission on a computer to prevent unauthorized access,,INFRAWORKS CORP,FRIEDMAN GEORGE;;STAREK ROBERT PHILLIP;;MURDOCK CARLOS,,https://lens.org/195-435-509-032-916,Patent Application,no,0,0,28,31,0,G06F21/52;;G06F21/62;;G06F21/6209;;G06F2221/2141;;G06F21/52;;G06F21/6209;;G06F2221/2141;;G06F21/6209;;G06F21/62;;G06F21/52;;G06F2221/2141,G06F12/14;;G06F1/00;;G06F12/00;;G06F21/00;;G06F21/24,,0,0,,,,DISCONTINUED
25,AU,A,AU 2000/077360 A,099-660-427-875-769,2001-05-10,2001,AU 2000/077360 A,2000-09-29,US 15747299 P;;US 20694700 P;;US 0026844 W,1999-10-01,Registry monitoring system and method,,INFRAWORKS CORP,FRIEDMAN GEORGE;;STAREK ROBERT PHILLIP;;MURDOCK CARLOS,,https://lens.org/099-660-427-875-769,Patent Application,no,0,0,28,31,0,G06F21/52;;G06F21/62;;G06F21/6209;;G06F2221/2141;;G06F21/52;;G06F21/6209;;G06F2221/2141;;G06F21/6209;;G06F21/62;;G06F21/52;;G06F2221/2141,G06F12/14;;G06F1/00;;G06F12/00;;G06F21/00;;G06F21/24,,0,0,,,,DISCONTINUED
26,WO,A2,WO 2001/025870 A2,184-719-474-392-334,2001-04-12,2001,US 0026882 W,2000-09-29,US 15747299 P;;US 20694700 P,1999-10-01,SYSTEM AND METHOD FOR PROVIDING DATA SECURITY,A system and method protects security of data. The data is packaged (14) together with one or more permissions that designate what actions are allowed with respect to the data. The package (14) can be opened when there is approval for doing so and the allowed permissions are maintained. The data is stored within a vault (520) and there are a number of available security procedures that prevent the unauthorized access of data.,INFRAWORKS CORP;;FRIEDMAN GEORGE;;STAREK ROBERT PHILLIP;;MURDOCK CARLOS,FRIEDMAN GEORGE;;STAREK ROBERT PHILLIP;;MURDOCK CARLOS,,https://lens.org/184-719-474-392-334,Patent Application,yes,0,18,28,31,0,G06F21/52;;G06F21/62;;G06F21/6209;;G06F2221/2141;;G06F21/52;;G06F21/6209;;G06F2221/2141;;G06F21/6209;;G06F21/62;;G06F21/52;;G06F2221/2141,G06F1/00;;G06F12/14;;G06F12/00;;G06F21/00;;G06F21/24,,0,0,,,,PENDING
27,US,B1,US 7484245 B1,196-383-410-286-558,2009-01-27,2009,US 70115700 A,2000-09-29,US 0026882 W;;US 15747299 P;;US 20694700 P,1999-10-01,System and method for providing data security,A system and method protects security of data. The data is packaged together with one or more permissions that designate what actions are allowed with respect to the data. The package can be opened when there is approval for doing so and the allowed permissions are maintained. The data is stored within a vault and there are a number of available security procedures that prevent the unauthorized access of the data.,GIGATRUST,FRIEDMAN GEORGE;;STAREK ROBERT PHILLIP;;MURDOCK CARLOS A,GIGATRUST (2008-06-02);;GIGAMEDIA ACCESS CORPORATION (2019-07-31);;INFRAWORKS CORPORTATION (2000-11-15);;PINION SOFTWARE INC (2005-01-21),https://lens.org/196-383-410-286-558,Granted Patent,yes,10,198,28,31,0,G06F21/52;;G06F21/62;;G06F21/6209;;G06F2221/2141;;G06F21/52;;G06F21/6209;;G06F2221/2141;;G06F21/6209;;G06F21/62;;G06F21/52;;G06F2221/2141,G06F12/14;;G06F1/00;;G06F21/00;;G06F12/00;;G06F21/24,726/27;;726/28;;380/283;;713/165;;713/167;;705/51;;705/57,1,0,,,"International Search Report in connection with corresponding PCT application (PCT/US00/26882) mailed on Apr. 10, 2001.",INACTIVE
28,US,B1,US 6804784 B1,105-245-124-825-542,2004-10-12,2004,US 70145800 A,2000-11-22,US 70145800 A;;US 0026896 W,2000-09-29,Back-channeling in a memory vault system,"
    A file system security driver and vault method and system particularly applicable to a system in which protected data is segregated from other data, which allows for back-channeling of file data in order to ensure that files created by applications using secured data do not cause data leaks of secure data. In a preferred embodiment, a file system security driver is a driver resident on the kernel level which monitors file system requests and allows limited access to files resident on the vault and creation of files within the vault when necessary. 
",INFRAWORKS CORP,FRIEDMAN GEORGE;;STAREK ROBERT PHILLIP;;MURDOCK CARLOS A,GIGATRUST (2008-06-02);;GIGAMEDIA ACCESS CORPORATION (2019-07-31);;PINION SOFTWARE INC (2005-01-21),https://lens.org/105-245-124-825-542,Granted Patent,yes,9,10,1,1,0,G06F21/6281;;G06F21/6281,G06F21/00,713/200;;713/202;;709/227;;705/404;;705/60;;705/410;;380/51,0,0,,,,EXPIRED
29,AU,A,AU 2000/051531 A,045-582-690-085-158,2000-12-12,2000,AU 2000/051531 A,2000-05-18,US 31580299 A;;US 0014055 W,1999-05-21,Method and apparatus for securing files,,INFRAWORKS CORP,FRIEDMAN GEORGE;;STAREK ROBERT PHILLIP;;MOORMAN MICHAEL J,,https://lens.org/045-582-690-085-158,Patent Application,no,0,0,2,2,0,G06F21/6218;;G06F21/6281;;G06F2221/2141;;G06F2221/2149,G06F1/00;;G06F21/62,,0,0,,,,DISCONTINUED
30,US,B1,US 7103783 B1,002-807-212-152-672,2006-09-05,2006,US 70120100 A,2000-11-27,US 0026828 W;;US 70120100 A,2000-09-29,Method and system for providing data security in a file system monitor with stack positioning,"A System for providing data security in a first device driver operably installed in a computer operating system having a layered plurality of device drivers ( 81, 82, 83, 84 ) for accessing data in a data storage device. The first device driver detects an I/O request, and determines whether the first device driver is functionally uppermost in the layered plurality of device drivers. If the first device driver is functionally uppermost in the layered plurality of device drivers, the method performs the I/O request ( 80 ) in the first device driver. If the device driver is not functionally uppermost in the layered plurality of device drivers, the method denies the I/O request in the first device driver, and allows the I/O request to be performed by the next lowest-level driver in the layered plurality of device drivers.",PINION SOFTWARE INC,FRIEDMAN GEORGE;;STAREK ROBERT PHILLIP;;MURDOCK CARLOS A,GIGATRUST (2008-06-02);;GIGAMEDIA ACCESS CORPORATION (2019-07-31);;PINION SOFTWARE INC (2005-01-21),https://lens.org/002-807-212-152-672,Granted Patent,yes,15,11,1,1,0,G06F21/6281;;G06F21/6281,H04L9/00;;G06F3/02;;G06F11/30;;G06F13/28;;G06F15/16;;G06F15/173,713/200;;713/164;;713/165;;713/166;;713/201;;713/202;;710/26;;710/28;;710/43;;709/223;;709/226;;709/229,1,0,,,"Parker, May 1989, Computer Language, v6, n5, p. 49(6), p. 1-5.",EXPIRED
31,WO,A1,WO 2000/072200 A1,147-091-328-105-605,2000-11-30,2000,US 0014055 W,2000-05-18,US 31580299 A,1999-05-21,METHOD AND APPARATUS FOR SECURING FILES,"A method and apparatus are provided for securing computer files by cloaking or hiding files from the user. A virtual device driver (22) monitors calls from and returns to the file manager to identify any references to files which have been previously stored in the drivers (22) database or lookup table, the driver (22) modifies the calls or returns effectively to render the file invisible. The user thus is not able to open the file or manipulate it in any way, and is not able to see the file in a directory listing. Thus, the user is not able to learn of the existence of the cloaked file (16). Selection of files for storage in the driver (22) database or lookup table is password protected to ensure that the authorized user may de-select and de-cloak the files at a later time as desired. The method and apparatus also permits restrictive use of files by monitoring the type of process identified in the call and by the type of action or procedure within the process that is to be performed. Thus, only selected application programs (19) may access a file stored in the driver (22) database and only certain procedures within the selected applications (19) may be performed. In one example, a word processing program may have access to a file (12) but may not be permitted to perform a delete function.",INFRAWORKS CORP,FRIEDMAN GEORGE;;STAREK ROBERT PHILLIP;;MOORMAN MICHAEL J,,https://lens.org/147-091-328-105-605,Patent Application,yes,3,16,2,2,0,G06F21/6218;;G06F21/6281;;G06F2221/2141;;G06F2221/2149,G06F1/00;;G06F21/62,,0,0,,,,PENDING
32,US,B1,US 6986058 B1,005-614-716-901-487,2006-01-10,2006,US 70115400 A,2000-11-22,US 70115400 A;;US 15747299 P;;US 20694700 P;;US 0026858 W,1999-10-01,Method and system for providing data security using file spoofing,"A method for providing data security in a device driver for accessing data. The device driver detects a file system request, completes the file system request, and receives return information from the file system request. The device driver further determines whether the file system request is for a tag file associated with a secured file; and if so, modifies the return information to reflect a file attribute of the secured file.",INFRAWORKS CORP,FRIEDMAN GEORGE;;STAREK ROBERT PHILLIP;;MURDOCK CARLOS A,GIGATRUST (2008-06-02);;GIGAMEDIA ACCESS CORPORATION (2019-07-31);;PINION SOFTWARE INC (2005-01-21),https://lens.org/005-614-716-901-487,Granted Patent,yes,8,8,1,31,0,G06F21/54;;G06F21/54,H04L9/00,713/200;;713/201,0,0,,,,EXPIRED
33,US,B1,US 6553466 B1,161-937-599-749-633,2003-04-22,2003,US 70120200 A,2000-11-27,US 70120200 A;;US 15747299 P;;US 0026894 W,1999-10-01,Shared memory blocking method and system,"
    A shared memory blocking method and particularly applicable to a system in which protected data is transmitted to a recipient computer. The method comprises reserving a memory page for a requesting application, committing a memory page to the requesting application's address space, which call may be made by the process providing the page reserve call or by a subsequent process, and providing security checks to complete the requests. The security checks include determining whether the process is secured by consulting a secured process list and determining whether the page is shared by consulting a shared memory list. Further disclosed are a computer readable medium and computer programmed to block shared memory, shared memory blocking system and secured data transmission system. 
",INFRAWORKS CORP,FRIEDMAN GEORGE;;STAREK ROBERT PHILLIP;;MURDOCK CARLOS A,GIGATRUST (2008-06-02);;GIGAMEDIA ACCESS CORPORATION (2019-07-31);;PINION SOFTWARE INC (2005-01-21),https://lens.org/161-937-599-749-633,Granted Patent,yes,7,19,1,31,0,G06F9/5016;;G06F12/1458;;G06F21/6281;;G06F9/5016;;G06F21/6281;;G06F12/1458;;Y10S707/99938,G06F9/50;;G06F12/10;;G06F12/14;;G06F21/00,711/152;;711/163;;707/8,0,0,,,,EXPIRED
34,US,B1,US 7096326 B1,179-122-268-247-993,2006-08-22,2006,US 70120000 A,2000-11-27,US 0026844 W;;US 70120000 A,2000-09-29,Registry monitoring system and method,"A registry monitoring method particularly applicable to a system ( 100 ) in which protected data is transmitted to a recipient computer. The method comprises requesting a handle for a registry key to a calling process, requesting a registry key value for the handle, modifying and deleting keys and values of protected data locations, and obtaining security clearance to complete the requests by checking secured process lists and rejection lists. Also included are a registry monitoring system, a secured data transmission system including registry monitorings, a machine-readable medium comprising a program to monitor a registry ( 110 ), and a computer configured to monitor a registry ( 110 ).",PINION SOFTWARE INC,FRIEDMAN GEORGE;;STAREK ROBERT PHILLIP;;MURDOCK CARLOS A,GIGATRUST (2008-06-02);;GIGAMEDIA ACCESS CORPORATION (2019-07-31);;PINION SOFTWARE INC (2005-01-21),https://lens.org/179-122-268-247-993,Granted Patent,yes,7,2,1,1,0,G06F21/52;;G06F21/62;;G06F21/6218;;G06F21/6281;;G06F2221/2101;;G06F21/6218;;G06F21/6281;;G06F21/62;;G06F2221/2101;;G06F21/52;;Y10S707/99933,G06F12/00;;G06F7/00;;G06F15/16,711/154;;709/201;;707/3,1,0,,,"David A. Solomon, Inside Windows NT 1998, Microsoft Press, second Edition, pp. 305-319.",EXPIRED
35,US,B1,US 7039806 B1,112-037-175-439-42X,2006-05-02,2006,US 70123000 A,2000-11-28,US 70123000 A;;US 15747299 P;;US 20694700 P;;US 0026893 W,1999-10-01,Method and apparatus for packaging and transmitting data,"A system and method for communicating a package of information. The system comprises a machine readable medium having information packaging software that generates a computer executable file (FIG. 1, 14 ) comprising a package of information. The packet information comprises the file of data and encryption software. The system communicates the package of information over a network (FIG. 1, 16 ) that is in communication with a machine readable medium. A client computer system (FIG. 1, 17 ) in communication with the network is adapted to receive the package of information and execute the computer executable. The computer system has a client permissions database (FIG. 1, 20 ) and a vault adapted to receive the package of information.",INFRAWORKS CORP,FRIEDMAN GEORGE;;STAREK ROBERT PHILLIP;;MURDOCK CARLOS A,GIGATRUST (2008-06-02);;GIGAMEDIA ACCESS CORPORATION (2019-07-31);;PINION SOFTWARE INC (2005-01-21),https://lens.org/112-037-175-439-42X,Granted Patent,yes,7,104,1,31,0,H04L63/0428;;H04L51/212;;H04L63/0428;;H04L51/212,G06F1/26,713/170;;713/182;;713/189;;713/200;;713/201,0,0,,,,EXPIRED
36,DE,D1,DE 69334254 D1,183-352-976-966-583,2009-02-12,2009,DE 69334254 T,1993-05-27,US 89329592 A;;US 89403992 A,1992-06-04,Verfahren zur Zellkultivierung in einer Monoschicht,"A process for culturing cells in monolayer which comprises : a. seeding a culture vessel with a cell stock in a minimal or rich medium and allowing the cells to plant for about 24-72 hours; b. removing the medium from the culture of step a. and replacing with fresh, rich medium, supplemented with an opitimized concentration of lipids and optionally also including a serum supplement; c. growing the culture of cells in rich medium supplemented with lipid; d . optionally replacing the medium of Step c. with fresh medium containing no lipid supplement, after about 24-72 hours growth.",MERCK & CO INC,PROVOST PHILLIP J;;KRAH DAVID L;;FRIEDMAN PAUL A,"MERCK SHARP & DOHME CORP., NEW JERSEY, N.J., US (2010-09-23);;SCHERING CORPORATION, US (2012-12-13)",https://lens.org/183-352-976-966-583,Granted Patent,no,0,0,58,60,0,A61K39/25;;C12N5/0018;;C12N2500/36;;A61K2039/5254;;C12N2710/16734;;A61K39/12;;A61P31/12;;A61P31/22;;Y02A50/30;;C12N5/0018;;A61K39/25;;C12N2500/36;;C12N2710/16734;;A61K2039/5254;;A61K39/12;;Y02A50/30,A61K39/00;;C12N5/00;;A61K39/12;;A61K39/25;;A61P31/12;;A61P31/22;;C12N1/38;;C12N5/02;;C12N5/071;;C12N5/10;;C12N7/04;;C12N7/08,,0,0,,,,EXPIRED
37,ES,T3,ES 2161702 T3,187-245-222-969-595,2001-12-16,2001,ES 93201521 T,1993-05-27,US 89329592 A;;US 89403992 A,1992-06-04,PROCEDIMIENTO PARA LA PRODUCCION DE UNA VACUNA DEL VIRUS DE VARICELA ZOSTER ATENUADO.,"A process for culturing cells in monolayer which comprises : a. seeding a culture vessel with a cell stock in a minimal or rich medium and allowing the cells to plant for about 24-72 hours; b. removing the medium from the culture of step a. and replacing with fresh, rich medium, supplemented with an opitimized concentration of lipids and optionally also including a serum supplement; c. growing the culture of cells in rich medium supplemented with lipid; d . optionally replacing the medium of Step c. with fresh medium containing no lipid supplement, after about 24-72 hours growth.",MERCK & CO INC,PROVOST PHILLIP J;;KRAH DAVID L;;FRIEDMAN PAUL A,,https://lens.org/187-245-222-969-595,Granted Patent,no,0,0,58,60,0,A61K39/25;;C12N5/0018;;C12N2500/36;;A61K2039/5254;;C12N2710/16734;;A61K39/12;;A61P31/12;;A61P31/22;;Y02A50/30;;C12N5/0018;;A61K39/25;;C12N2500/36;;C12N2710/16734;;A61K2039/5254;;A61K39/12;;Y02A50/30,A61K39/00;;A61K39/12;;A61K39/25;;A61P31/12;;A61P31/22;;C12N1/38;;C12N5/00;;C12N5/02;;C12N5/071;;C12N5/10;;C12N7/04;;C12N7/08,,0,0,,,,EXPIRED
38,ES,T3,ES 2317869 T3,131-336-833-013-797,2009-05-01,2009,ES 01200292 T,1993-05-27,US 89329592 A;;US 89403992 A,1992-06-04,PROCEDIMIENTO DE CULTIVO DE CELULAS EN UNA MONOCAPA.,"A process for culturing cells in monolayer which comprises : a. seeding a culture vessel with a cell stock in a minimal or rich medium and allowing the cells to plant for about 24-72 hours; b. removing the medium from the culture of step a. and replacing with fresh, rich medium, supplemented with an opitimized concentration of lipids and optionally also including a serum supplement; c. growing the culture of cells in rich medium supplemented with lipid; d . optionally replacing the medium of Step c. with fresh medium containing no lipid supplement, after about 24-72 hours growth.",MERCK & CO INC,PROVOST PHILLIP J;;KRAH DAVID L;;FRIEDMAN PAUL A,,https://lens.org/131-336-833-013-797,Granted Patent,no,0,0,58,60,0,A61K39/25;;C12N5/0018;;C12N2500/36;;A61K2039/5254;;C12N2710/16734;;A61K39/12;;A61P31/12;;A61P31/22;;Y02A50/30;;C12N5/0018;;A61K39/25;;C12N2500/36;;C12N2710/16734;;A61K2039/5254;;A61K39/12;;Y02A50/30,A61K39/00;;C12N5/00;;A61K39/12;;A61K39/25;;A61P31/12;;A61P31/22;;C12N1/38;;C12N5/02;;C12N5/071;;C12N5/10;;C12N7/04;;C12N7/08,,0,0,,,,EXPIRED
39,EP,B1,EP 0573107 B1,177-697-330-700-360,2001-10-04,2001,EP 93201521 A,1993-05-27,US 89329592 A;;US 89403992 A,1992-06-04,Process for attenuated varicella zoster virus vaccine production,"A process for culturing cells in monolayer which comprises : a. seeding a culture vessel with a cell stock in a minimal or rich medium and allowing the cells to plant for about 24-72 hours; b. removing the medium from the culture of step a. and replacing with fresh, rich medium, supplemented with an opitimized concentration of lipids and optionally also including a serum supplement; c. growing the culture of cells in rich medium supplemented with lipid; d . optionally replacing the medium of Step c. with fresh medium containing no lipid supplement, after about 24-72 hours growth.",MERCK & CO INC,PROVOST PHILLIP J;;KRAH DAVID L;;FRIEDMAN PAUL A,"MERCK SHARP & DOHME CORP., US (2013-05-14);;MERCK SHARP & DOHME CORP., RAHWAY, US (2013-05-14);;126 EAST LINCOLN AVENUE, RAHWAY NEW JERSEY 07065 (2012-08-02);;SCHERING CORPORATION, US (2013-03-18);;MERCK  SHARP & DOHME CORP. (2012-10-19);;MERCK & CO., INC. (2007-10-15)",https://lens.org/177-697-330-700-360,Granted Patent,yes,3,1,58,60,0,A61K39/25;;C12N5/0018;;C12N2500/36;;A61K2039/5254;;C12N2710/16734;;A61K39/12;;A61P31/12;;A61P31/22;;Y02A50/30;;C12N5/0018;;A61K39/25;;C12N2500/36;;C12N2710/16734;;A61K2039/5254;;A61K39/12;;Y02A50/30,A61K39/00;;A61K39/12;;A61K39/25;;A61P31/12;;A61P31/22;;C12N1/38;;C12N5/00;;C12N5/02;;C12N5/071;;C12N5/10;;C12N7/04;;C12N7/08,,7,0,,,"INTERVIROLOGY, vol.15, 1981 pages 154 - 160 GROSE ET AL 'CRYOPRESERVATION OF VARICELLA-ZOSTER VIRIONS WITHOUT LOSS OF STRUCTURAL INTEGRITY OR INFECTIVITY';;ACTA PATHOLOGICA,MICROBIOLOGICA ET IMMUNOLOGICA SCANDINAVICA, vol.92C, October 1984 pages 285 - 291 BUUS ET AL 'CHLOROQUINE INHIBITS ACCESSORY CELL PRESENTATION OF SOLUBLE NATURAL AND SYNTHETIC PROTEIN ANTIGENS';;THE EMBO JOURNAL, vol.5, no.12, 1986 pages 3103 - 3109 KIELIAN ET AL 'KINETICS OF ENDOSOME ACIDIFICATION DETECTED BY MUTANT AND WILD-TYPE SEMLIKI FOREST VIRUS';;EXPERIMENTAL CELL RESEARCH, vol.192, no.1, January 1991 pages 52 - 60 DECOURCY ET AL 'OSMOTIC SWELLING OF ENDOCYTOTIC COMPARTMENTS INDUCED BY INTERNALIZED SUCROSE IS RESTRICTED TO MATURE LYSOSOMES IN CULTURED MAMMALIAN CELLS';;THE JOURNAL OF EXPERIMENTAL MEDICINE, vol.147, no.3, 1 March 1978 pages 923 - 933 ISCOVE ET AL 'COMPLETE REPLACEMENT OF SERUM BY ALBUMIN,TRANSFERRIN,AND SOYBEAN LIPID IN CULTURES OF LIPOPOLYSACCHARIDE-REACTIVE B LYMPHOCYTES';;IN VITRO, vol.16, no.7, 1980 pages 616 - 628 WEISS ET AL 'CHEMICALLY DEFINED SERUM-FREE MEDIA FOR THE CULTIVATION OF PRIMARY CELLS AND THEIR SUSCEPTIBILITY TO VIRUSES';;EXPERIMENTAL CELL RESEARCH, vol.52, 1968 pages 469 - 489 LING ET AL 'CHEMICALLY CHARACTERIZED CONCENTRATED CORODIES FOR CONTINUOUS CELL CULTURE (THE 7C'S CULTURE MEDIA)'",EXPIRED
40,DE,D1,DE 69330850 D1,076-118-472-898-236,2001-11-08,2001,DE 69330850 T,1993-05-27,US 89329592 A;;US 89403992 A,1992-06-04,Verfahren zur Herstellung von Virusimpfstoff aus abgeschwächten Varicella Zoster Viren,"A process for culturing cells in monolayer which comprises : a. seeding a culture vessel with a cell stock in a minimal or rich medium and allowing the cells to plant for about 24-72 hours; b. removing the medium from the culture of step a. and replacing with fresh, rich medium, supplemented with an opitimized concentration of lipids and optionally also including a serum supplement; c. growing the culture of cells in rich medium supplemented with lipid; d . optionally replacing the medium of Step c. with fresh medium containing no lipid supplement, after about 24-72 hours growth.",MERCK & CO INC,PROVOST PHILLIP J;;KRAH DAVID L;;FRIEDMAN PAUL A,"MERCK SHARP & DOHME CORP., NEW JERSEY, N.J., US (2010-09-23);;SCHERING CORPORATION, US (2012-12-13)",https://lens.org/076-118-472-898-236,Granted Patent,no,0,0,58,60,0,A61K39/25;;C12N5/0018;;C12N2500/36;;A61K2039/5254;;C12N2710/16734;;A61K39/12;;A61P31/12;;A61P31/22;;Y02A50/30;;C12N5/0018;;A61K39/25;;C12N2500/36;;C12N2710/16734;;A61K2039/5254;;A61K39/12;;Y02A50/30,A61K39/00;;A61K39/12;;A61K39/25;;A61P31/12;;A61P31/22;;C12N1/38;;C12N5/00;;C12N5/02;;C12N5/071;;C12N5/10;;C12N7/04;;C12N7/08,,0,0,,,,EXPIRED
41,MX,A,MX 9303274 A,024-895-506-307-482,1994-01-31,1994,MX 9303274 A,1993-06-01,US 89329592 A;;US 89403992 A,1992-06-04,PROCESO PARA PRODUCCION DE VACUNA DE VIRUS VARICELA ZOSTER ATENUADO.,"A process for culturing cells in monolayer which comprises : a. seeding a culture vessel with a cell stock in a minimal or rich medium and allowing the cells to plant for about 24-72 hours; b. removing the medium from the culture of step a. and replacing with fresh, rich medium, supplemented with an opitimized concentration of lipids and optionally also including a serum supplement; c. growing the culture of cells in rich medium supplemented with lipid; d . optionally replacing the medium of Step c. with fresh medium containing no lipid supplement, after about 24-72 hours growth.",MERCK & CO INC,PROVOST PHILLIP J;;KRAH DAVID L;;FRIEDMAN PAUL A,,https://lens.org/024-895-506-307-482,Patent Application,no,0,0,58,60,0,A61K39/25;;C12N5/0018;;C12N2500/36;;A61K2039/5254;;C12N2710/16734;;A61K39/12;;A61P31/12;;A61P31/22;;Y02A50/30;;C12N5/0018;;A61K39/25;;C12N2500/36;;C12N2710/16734;;A61K2039/5254;;A61K39/12;;Y02A50/30,A61K39/00;;A61K39/12;;A61K39/25;;A61P31/12;;A61P31/22;;C12N1/38;;C12N5/00;;C12N5/02;;C12N5/071;;C12N5/10;;C12N7/04;;C12N7/08,,0,0,,,,PENDING
42,DK,T3,DK 0573107 T3,144-321-952-538-430,2001-11-12,2001,DK 93201521 T,1993-05-27,US 89329592 A;;US 89403992 A,1992-06-04,Fremgangsmåde til fremstilling af en vaccine med svækkede varicella zoster-virus,"A process for culturing cells in monolayer which comprises : a. seeding a culture vessel with a cell stock in a minimal or rich medium and allowing the cells to plant for about 24-72 hours; b. removing the medium from the culture of step a. and replacing with fresh, rich medium, supplemented with an opitimized concentration of lipids and optionally also including a serum supplement; c. growing the culture of cells in rich medium supplemented with lipid; d . optionally replacing the medium of Step c. with fresh medium containing no lipid supplement, after about 24-72 hours growth.",MERCK & CO INC,PROVOST PHILLIP J;;KRAH DAVID L;;FRIEDMAN PAUL A,,https://lens.org/144-321-952-538-430,Granted Patent,no,0,0,58,60,0,A61K39/25;;C12N5/0018;;C12N2500/36;;A61K2039/5254;;C12N2710/16734;;A61K39/12;;A61P31/12;;A61P31/22;;Y02A50/30;;C12N5/0018;;A61K39/25;;C12N2500/36;;C12N2710/16734;;A61K2039/5254;;A61K39/12;;Y02A50/30,A61K39/00;;A61K39/12;;A61K39/25;;A61P31/12;;A61P31/22;;C12N1/38;;C12N5/00;;C12N5/02;;C12N5/071;;C12N5/10;;C12N7/04;;C12N7/08,,0,0,,,,EXPIRED
43,PT,E,PT 1097988 E,155-155-612-815-938,2009-03-05,2009,PT 01200292 T,1993-05-27,US 89329592 A;;US 89403992 A,1992-06-04,PROCESS FOR CULTURING CELLS IN A MONOLAYER,"A process for culturing cells in monolayer which comprises : a. seeding a culture vessel with a cell stock in a minimal or rich medium and allowing the cells to plant for about 24-72 hours; b. removing the medium from the culture of step a. and replacing with fresh, rich medium, supplemented with an opitimized concentration of lipids and optionally also including a serum supplement; c. growing the culture of cells in rich medium supplemented with lipid; d . optionally replacing the medium of Step c. with fresh medium containing no lipid supplement, after about 24-72 hours growth.",MERCK & CO INC,KRAH DAVID L;;FRIEDMAN PAUL A;;PROVOST PHILLIP J,,https://lens.org/155-155-612-815-938,Granted Patent,no,0,0,58,60,0,A61K39/25;;C12N5/0018;;C12N2500/36;;A61K2039/5254;;C12N2710/16734;;A61K39/12;;A61P31/12;;A61P31/22;;Y02A50/30;;C12N5/0018;;A61K39/25;;C12N2500/36;;C12N2710/16734;;A61K2039/5254;;A61K39/12;;Y02A50/30,A61K39/00;;C12N5/00;;A61K39/12;;A61K39/245;;A61K39/25;;A61P31/12;;A61P31/22;;C12N1/38;;C12N5/02;;C12N5/071;;C12N5/10;;C12N7/04;;C12N7/08,,0,0,,,,EXPIRED
44,AT,T1,AT E419332 T1,173-296-643-466-648,2009-01-15,2009,AT 01200292 T,1993-05-27,US 89329592 A;;US 89403992 A,1992-06-04,VERFAHREN ZUR ZELLKULTIVIERUNG IN EINER MONOSCHICHT,"A process for culturing cells in monolayer which comprises : a. seeding a culture vessel with a cell stock in a minimal or rich medium and allowing the cells to plant for about 24-72 hours; b. removing the medium from the culture of step a. and replacing with fresh, rich medium, supplemented with an opitimized concentration of lipids and optionally also including a serum supplement; c. growing the culture of cells in rich medium supplemented with lipid; d . optionally replacing the medium of Step c. with fresh medium containing no lipid supplement, after about 24-72 hours growth.",MERCK & CO INC,PROVOST PHILLIP J;;KRAH DAVID L;;FRIEDMAN PAUL A,,https://lens.org/173-296-643-466-648,Granted Patent,no,0,0,58,60,0,A61K39/25;;C12N5/0018;;C12N2500/36;;A61K2039/5254;;C12N2710/16734;;A61K39/12;;A61P31/12;;A61P31/22;;Y02A50/30;;C12N5/0018;;A61K39/25;;C12N2500/36;;C12N2710/16734;;A61K2039/5254;;A61K39/12;;Y02A50/30,A61K39/00;;A61K39/12;;A61K39/25;;A61P31/12;;A61P31/22;;C12N1/38;;C12N5/00;;C12N5/02;;C12N5/071;;C12N5/10;;C12N7/04;;C12N7/08,,0,0,,,,EXPIRED
45,EP,A3,EP 0573107 A3,158-308-877-254-842,1995-04-26,1995,EP 93201521 A,1993-05-27,US 89329592 A;;US 89403992 A,1992-06-04,Process for attenuated varicella zoster virus vaccine production.,"A live, attenuated varicella zoster virus vaccine is produced with enhanced yield of VZV. The new process makes mass production of a live VZV vaccine more practical. In addition, optimized monolayer cell culture conditions provide a process for maximizing monolayer cell density which is useful for enhancing viral vaccine production. According to this process, cell densities approaching 500,000 cells/cm² are routinely achieved in conventional culture vessels.",MERCK & CO INC,PROVOST PHILLIP J;;KRAH DAVID L;;FRIEDMAN PAUL A,"MERCK SHARP & DOHME CORP., US (2013-05-14);;MERCK SHARP & DOHME CORP., RAHWAY, US (2013-05-14);;126 EAST LINCOLN AVENUE, RAHWAY NEW JERSEY 07065 (2012-08-02);;SCHERING CORPORATION, US (2013-03-18);;MERCK  SHARP & DOHME CORP. (2012-10-19);;MERCK & CO., INC. (2007-10-15)",https://lens.org/158-308-877-254-842,Search Report,yes,3,0,58,60,0,A61K39/25;;C12N5/0018;;C12N2500/36;;A61K2039/5254;;C12N2710/16734;;A61K39/12;;A61P31/12;;A61P31/22;;Y02A50/30;;C12N5/0018;;A61K39/25;;C12N2500/36;;C12N2710/16734;;A61K2039/5254;;A61K39/12;;Y02A50/30,A61K39/00;;A61K39/12;;A61K39/25;;A61P31/12;;A61P31/22;;C12N1/38;;C12N5/00;;C12N5/02;;C12N5/071;;C12N5/10;;C12N7/04;;C12N7/08,,7,7,041-595-536-860-563;;089-554-910-670-358;;082-791-388-121-018;;004-911-355-001-954;;059-221-147-655-387;;028-032-339-542-11X;;023-908-346-042-342,10.1159/000149225;;6270035;;10.1111/j.1699-0463.1984.tb00089.x;;6334972;;10.1002/j.1460-2075.1986.tb04616.x;;pmc1167299;;3816755;;10.1016/0014-4827(91)90156-o;;1845800;;pmc2184195;;10.1084/jem.147.3.923;;305462;;6997185;;10.1007/bf02618387;;10.1016/0014-4827(68)90489-8;;5693247,"GROSE ET AL: ""CRYOPRESERVATION OF VARICELLA-ZOSTER VIRIONS WITHOUT LOSS OF STRUCTURAL INTEGRITY OR INFECTIVITY"", INTERVIROLOGY, vol. 15, 1981, pages 154 - 160, XP009077239, DOI: doi:10.1159/000149225;;BUUS ET AL: ""CHLOROQUINE INHIBITS ACCESSORY CELL PRESENTATION OF SOLUBLE NATURAL AND SYNTHETIC PROTEIN ANTIGENS"", ACTA PATHOLOGICA,MICROBIOLOGICA ET IMMUNOLOGICA SCANDINAVICA, vol. 92C, October 1984 (1984-10-01), pages 285 - 291;;KIELIAN ET AL: ""KINETICS OF ENDOSOME ACIDIFICATION DETECTED BY MUTANT AND WILD-TYPE SEMLIKI FOREST VIRUS"", THE EMBO JOURNAL, vol. 5, no. 12, 1986, pages 3103 - 3109;;DECOURCY ET AL: ""OSMOTIC SWELLING OF ENDOCYTOTIC COMPARTMENTS INDUCED BY INTERNALIZED SUCROSE IS RESTRICTED TO MATURE LYSOSOMES IN CULTURED MAMMALIAN CELLS"", EXPERIMENTAL CELL RESEARCH, vol. 192, no. 1, January 1991 (1991-01-01), pages 52 - 60, XP024857715, DOI: doi:10.1016/0014-4827(91)90156-O;;ISCOVE ET AL: ""COMPLETE REPLACEMENT OF SERUM BY ALBUMIN,TRANSFERRIN,AND SOYBEAN LIPID IN CULTURES OF LIPOPOLYSACCHARIDE-REACTIVE B LYMPHOCYTES"", THE JOURNAL OF EXPERIMENTAL MEDICINE, vol. 147, no. 3, 1 March 1978 (1978-03-01), pages 923 - 933, XP000990205, DOI: doi:10.1084/jem.147.3.923;;WEISS ET AL: ""CHEMICALLY DEFINED SERUM-FREE MEDIA FOR THE CULTIVATION OF PRIMARY CELLS AND THEIR SUSCEPTIBILITY TO VIRUSES"", IN VITRO, vol. 16, no. 7, 1980, pages 616 - 628;;LING ET AL: ""CHEMICALLY CHARACTERIZED CONCENTRATED CORODIES FOR CONTINUOUS CELL CULTURE (THE 7C'S CULTURE MEDIA)"", EXPERIMENTAL CELL RESEARCH, vol. 52, 1968, pages 469 - 489, XP024792176, DOI: doi:10.1016/0014-4827(68)90489-8",EXPIRED
46,AT,T1,AT E206311 T1,151-789-438-973-330,2001-10-15,2001,AT 93201521 T,1993-05-27,US 89329592 A;;US 89403992 A,1992-06-04,VERFAHREN ZUR HERSTELLUNG VON VIRUSIMPFSTOFF AUS ABGESCHWÄCHTEN VARICELLA ZOSTER VIREN,"A process for culturing cells in monolayer which comprises : a. seeding a culture vessel with a cell stock in a minimal or rich medium and allowing the cells to plant for about 24-72 hours; b. removing the medium from the culture of step a. and replacing with fresh, rich medium, supplemented with an opitimized concentration of lipids and optionally also including a serum supplement; c. growing the culture of cells in rich medium supplemented with lipid; d . optionally replacing the medium of Step c. with fresh medium containing no lipid supplement, after about 24-72 hours growth.",MERCK & CO INC,PROVOST PHILLIP J;;KRAH DAVID L;;FRIEDMAN PAUL A,,https://lens.org/151-789-438-973-330,Granted Patent,no,0,0,58,60,0,A61K39/25;;C12N5/0018;;C12N2500/36;;A61K2039/5254;;C12N2710/16734;;A61K39/12;;A61P31/12;;A61P31/22;;Y02A50/30;;C12N5/0018;;A61K39/25;;C12N2500/36;;C12N2710/16734;;A61K2039/5254;;A61K39/12;;Y02A50/30,A61K39/00;;A61K39/12;;A61K39/25;;A61P31/12;;A61P31/22;;C12N1/38;;C12N5/00;;C12N5/02;;C12N5/071;;C12N5/10;;C12N7/04;;C12N7/08,,0,0,,,,PENDING
47,GR,T3,GR 3036812 T3,065-384-152-590-083,2002-01-31,2002,GR 20010401425 T,2001-10-05,US 89329592 A;;US 89403992 A,1992-06-04,Process for attenuated varicella zoster virus vaccine production.,"A process for culturing cells in monolayer which comprises : a. seeding a culture vessel with a cell stock in a minimal or rich medium and allowing the cells to plant for about 24-72 hours; b. removing the medium from the culture of step a. and replacing with fresh, rich medium, supplemented with an opitimized concentration of lipids and optionally also including a serum supplement; c. growing the culture of cells in rich medium supplemented with lipid; d . optionally replacing the medium of Step c. with fresh medium containing no lipid supplement, after about 24-72 hours growth.",MERCK & CO INC,PROVOST PHILLIP J;;KRAH DAVID L;;FRIEDMAN PAUL A,,https://lens.org/065-384-152-590-083,Granted Patent,no,0,0,58,60,0,A61K39/25;;C12N5/0018;;C12N2500/36;;A61K2039/5254;;C12N2710/16734;;A61K39/12;;A61P31/12;;A61P31/22;;Y02A50/30;;C12N5/0018;;A61K39/25;;C12N2500/36;;C12N2710/16734;;A61K2039/5254;;A61K39/12;;Y02A50/30,A61K39/00;;A61K39/12;;A61K39/25;;A61P31/12;;A61P31/22;;C12N1/38;;C12N5/00;;C12N5/02;;C12N5/071;;C12N5/10;;C12N7/04;;C12N7/08,,0,0,,,,EXPIRED
48,EP,B1,EP 1097988 B1,090-842-285-441-331,2008-12-31,2008,EP 01200292 A,1993-05-27,EP 93201521 A;;US 89329592 A;;US 89403992 A,1992-06-04,Process for culturing cells in a monolayer,"A process for culturing cells in monolayer which comprises : a. seeding a culture vessel with a cell stock in a minimal or rich medium and allowing the cells to plant for about 24-72 hours; b. removing the medium from the culture of step a. and replacing with fresh, rich medium, supplemented with an opitimized concentration of lipids and optionally also including a serum supplement; c. growing the culture of cells in rich medium supplemented with lipid; d . optionally replacing the medium of Step c. with fresh medium containing no lipid supplement, after about 24-72 hours growth.",MERCK & CO INC,PROVOST PHILLIP J;;KRAH DAVID L;;FRIEDMAN PAUL A,"MERCK SHARP & DOHME CORP., US (2013-05-14);;MERCK SHARP & DOHME CORP., RAHWAY, US (2013-05-14);;126 EAST LINCOLN AVENUE, RAHWAY NEW JERSEY 07065 (2012-08-02);;SCHERING CORPORATION, US (2013-03-18);;MERCK  SHARP & DOHME CORP. (2012-10-19)",https://lens.org/090-842-285-441-331,Granted Patent,yes,0,1,58,60,0,A61K39/25;;C12N5/0018;;C12N2500/36;;A61K2039/5254;;C12N2710/16734;;A61K39/12;;A61P31/12;;A61P31/22;;Y02A50/30;;C12N5/0018;;A61K39/25;;C12N2500/36;;C12N2710/16734;;A61K2039/5254;;A61K39/12;;Y02A50/30,A61K39/00;;C12N5/00;;A61K39/12;;A61K39/25;;A61P31/12;;A61P31/22;;C12N1/38;;C12N5/02;;C12N5/071;;C12N5/10;;C12N7/04;;C12N7/08,,1,0,,,"AUSUBEL ET AL, CURRENT PROTOCOLS IN MOLECULAR BIOLOGY, 1987, GREENE PUBLISHING ASSOCIATES AND WILEY-INTERSCIENCE, pages 1.0.3 - 1.0.5",EXPIRED
49,EP,A2,EP 0573107 A2,007-339-546-320-899,1993-12-08,1993,EP 93201521 A,1993-05-27,US 89329592 A;;US 89403992 A,1992-06-04,Process for attenuated varicella zoster virus vaccine production.,"A live, attenuated varicella zoster virus vaccine is produced with enhanced yield of VZV. The new process makes mass production of a live VZV vaccine more practical. In addition, optimized monolayer cell culture conditions provide a process for maximizing monolayer cell density which is useful for enhancing viral vaccine production. According to this process, cell densities approaching 500,000 cells/cm² are routinely achieved in conventional culture vessels.",MERCK & CO INC,PROVOST PHILLIP J;;KRAH DAVID L;;FRIEDMAN PAUL A,"MERCK SHARP & DOHME CORP., US (2013-05-14);;MERCK SHARP & DOHME CORP., RAHWAY, US (2013-05-14);;126 EAST LINCOLN AVENUE, RAHWAY NEW JERSEY 07065 (2012-08-02);;SCHERING CORPORATION, US (2013-03-18);;MERCK  SHARP & DOHME CORP. (2012-10-19);;MERCK & CO., INC. (2007-10-15)",https://lens.org/007-339-546-320-899,Patent Application,yes,0,13,58,60,0,A61K39/25;;C12N5/0018;;C12N2500/36;;A61K2039/5254;;C12N2710/16734;;A61K39/12;;A61P31/12;;A61P31/22;;Y02A50/30;;C12N5/0018;;A61K39/25;;C12N2500/36;;C12N2710/16734;;A61K2039/5254;;A61K39/12;;Y02A50/30,A61K39/00;;A61K39/12;;A61K39/25;;A61P31/12;;A61P31/22;;C12N1/38;;C12N5/00;;C12N5/02;;C12N5/071;;C12N5/10;;C12N7/04;;C12N7/08,,0,0,,,,EXPIRED
50,DK,T3,DK 1097988 T3,029-296-732-504-73X,2009-05-04,2009,DK 01200292 T,1993-05-27,US 89403992 A;;US 89329592 A,1992-06-04,Fremgangsmåde til celledyrkning i monolag,"A process for culturing cells in monolayer which comprises : a. seeding a culture vessel with a cell stock in a minimal or rich medium and allowing the cells to plant for about 24-72 hours; b. removing the medium from the culture of step a. and replacing with fresh, rich medium, supplemented with an opitimized concentration of lipids and optionally also including a serum supplement; c. growing the culture of cells in rich medium supplemented with lipid; d . optionally replacing the medium of Step c. with fresh medium containing no lipid supplement, after about 24-72 hours growth.",MERCK & CO INC,KRAH DAVID L;;FRIEDMAN PAUL A;;PROVOST PHILLIP J,,https://lens.org/029-296-732-504-73X,Granted Patent,no,0,0,58,60,0,A61K39/25;;C12N5/0018;;C12N2500/36;;A61K2039/5254;;C12N2710/16734;;A61K39/12;;A61P31/12;;A61P31/22;;Y02A50/30;;C12N5/0018;;A61K39/25;;C12N2500/36;;C12N2710/16734;;A61K2039/5254;;A61K39/12;;Y02A50/30,A61K39/00;;C12N5/00;;A61K39/12;;A61K39/25;;A61P31/12;;A61P31/22;;C12N1/38;;C12N5/02;;C12N5/071;;C12N5/10;;C12N7/04;;C12N7/08,,0,0,,,,EXPIRED
51,DE,T2,DE 69330850 T2,075-432-894-717-764,2002-04-11,2002,DE 69330850 T,1993-05-27,US 89329592 A;;US 89403992 A,1992-06-04,Verfahren zur Herstellung von Virusimpfstoff aus abgeschwächten Varicella Zoster Viren,"A process for culturing cells in monolayer which comprises : a. seeding a culture vessel with a cell stock in a minimal or rich medium and allowing the cells to plant for about 24-72 hours; b. removing the medium from the culture of step a. and replacing with fresh, rich medium, supplemented with an opitimized concentration of lipids and optionally also including a serum supplement; c. growing the culture of cells in rich medium supplemented with lipid; d . optionally replacing the medium of Step c. with fresh medium containing no lipid supplement, after about 24-72 hours growth.",MERCK & CO INC,PROVOST PHILLIP J;;KRAH DAVID L;;FRIEDMAN PAUL A,"MERCK SHARP & DOHME CORP., NEW JERSEY, N.J., US (2010-09-23);;SCHERING CORPORATION, US (2012-12-13)",https://lens.org/075-432-894-717-764,Granted Patent,no,0,0,58,60,0,A61K39/25;;C12N5/0018;;C12N2500/36;;A61K2039/5254;;C12N2710/16734;;A61K39/12;;A61P31/12;;A61P31/22;;Y02A50/30;;C12N5/0018;;A61K39/25;;C12N2500/36;;C12N2710/16734;;A61K2039/5254;;A61K39/12;;Y02A50/30,A61K39/00;;A61K39/12;;A61K39/25;;A61P31/12;;A61P31/22;;C12N1/38;;C12N5/00;;C12N5/02;;C12N5/071;;C12N5/10;;C12N7/04;;C12N7/08,,0,0,,,,EXPIRED
52,EP,A1,EP 1097988 A1,193-528-566-261-58X,2001-05-09,2001,EP 01200292 A,1993-05-27,EP 93201521 A;;US 89329592 A;;US 89403992 A,1992-06-04,Process for culturing cells in a monolayer,"A process for culturing cells in monolayer which comprises :
 a. seeding a culture vessel with a cell stock in a minimal or rich medium and allowing the cells to plant for about 24-72 hours; b. removing the medium from the culture of step a. and replacing with fresh, rich medium, supplemented with an opitimized concentration of lipids and optionally also including a serum supplement; c. growing the culture of cells in rich medium supplemented with lipid; d . optionally replacing the medium of Step c. with fresh medium containing no lipid supplement, after about 24-72 hours growth.",MERCK & CO INC,PROVOST PHILLIP J;;KRAH DAVID L;;FRIEDMAN PAUL A,"MERCK SHARP & DOHME CORP., US (2013-05-14);;MERCK SHARP & DOHME CORP., RAHWAY, US (2013-05-14);;126 EAST LINCOLN AVENUE, RAHWAY NEW JERSEY 07065 (2012-08-02);;SCHERING CORPORATION, US (2013-03-18);;MERCK  SHARP & DOHME CORP. (2012-10-19)",https://lens.org/193-528-566-261-58X,Patent Application,yes,2,0,58,60,0,A61K39/25;;C12N5/0018;;C12N2500/36;;A61K2039/5254;;C12N2710/16734;;A61K39/12;;A61P31/12;;A61P31/22;;Y02A50/30;;C12N5/0018;;A61K39/25;;C12N2500/36;;C12N2710/16734;;A61K2039/5254;;A61K39/12;;Y02A50/30,A61K39/00;;A61K39/12;;A61K39/25;;A61P31/12;;A61P31/22;;C12N1/38;;C12N5/00;;C12N5/02;;C12N5/071;;C12N5/10;;C12N7/04;;C12N7/08,,3,3,059-221-147-655-387;;028-032-339-542-11X;;023-908-346-042-342,pmc2184195;;10.1084/jem.147.3.923;;305462;;6997185;;10.1007/bf02618387;;10.1016/0014-4827(68)90489-8;;5693247,"ISCOVE ET AL: ""COMPLETE REPLACEMENT OF SERUM BY ALBUMIN,TRANSFERRIN,AND SOYBEAN LIPID IN CULTURES OF LIPOPOLYSACCHARIDE-REACTIVE B LYMPHOCYTES"", THE JOURNAL OF EXPERIMENTAL MEDICINE, vol. 147, no. 3, 1 March 1978 (1978-03-01), pages 923 - 933, XP000990205;;WEISS ET AL: ""CHEMICALLY DEFINED SERUM-FREE MEDIA FOR THE CULTIVATION OF PRIMARY CELLS AND THEIR SUSCEPTIBILITY TO VIRUSES"", IN VITRO, vol. 16, no. 7, 1980, pages 616 - 628, XP000990057;;LING ET AL: ""CHEMICALLY CHARACTERIZED CONCENTRATED CORODIES FOR CONTINUOUS CELL CULTURE (THE 7C'S CULTURE MEDIA)"", EXPERIMENTAL CELL RESEARCH, vol. 52, 1968, pages 469 - 489, XP000990215",EXPIRED
53,US,A1,US 2015/0105762 A1,149-024-468-164-028,2015-04-16,2015,US 201414576422 A,2014-12-19,US 201414576422 A;;US 70224210 A;;US 4818508 A;;US 90694407 P,2007-03-13,METHOD FOR PATTERNED PLASMA-MEDIATED MODIFICATION OF THE CRYSTALLINE LENS,"A method of treating a cataractous lens of a patient's eye includes generating a light beam, deflecting the light beam using a scanner to form a treatment pattern, delivering the treatment pattern to the lens of the patient's eye to create a plurality of cuts in the form two or more different incisions patterns within the lens to segment the lens tissue into a plurality of patterned pieces, and mechanically breaking the lens into a plurality of pieces along the cuts. A first incision pattern includes two or more crossing cut incision planes. A second incision pattern includes a plurality of laser incision each extending along a first length between a posterior and an anterior surface of the lens capsule.",OPTIMEDICA CORP,CULBERTSON WILLIAM;;SEIBEL BARRY;;FRIEDMAN NEIL;;SCHUELE GEORG;;GOODING PHILLIP,AMO DEVELOPMENT LLC (2019-12-30);;OPTIMEDICA CORPORATION (2008-09-13),https://lens.org/149-024-468-164-028,Patent Application,yes,6,0,136,136,0,A61F2009/00859;;A61F2009/00872;;A61F2009/0088;;A61F2009/00897;;A61F9/00825;;A61F2009/0087;;A61F9/00;;A61F2/16;;A61F2220/0016;;A61F2/1637;;A61F2/1648;;A61F9/00;;A61F9/00825;;A61F2009/00859;;A61F2009/0087;;A61F2009/00872;;A61F2009/0088;;A61F2009/00897;;A61F2/16;;A61F2/1613;;A61F2009/00887;;A61F2002/1683;;A61F2220/0016;;A61F2/1662;;A61F9/00754;;A61F9/008;;A61F9/009;;A61F2002/16901;;A61F9/00812,A61F9/008,606/6,0,0,,,,ACTIVE
54,US,B2,US 8968375 B2,079-768-737-441-180,2015-03-03,2015,US 70224210 A,2010-02-08,US 70224210 A;;US 4818508 A;;US 90694407 P,2007-03-13,Method for patterned plasma-mediated modification of the crystalline lens,"A method of treating a lens of a patient's eye includes generating a light beam, deflecting the light beam using a scanner to form a treatment pattern of the light beam, delivering the treatment pattern to the lens of a patient's eye to create a plurality of cuts in the lens in the form of the treatment pattern to break the lens up into a plurality of pieces, and removing the lens pieces from the patient's eye. The lens pieces can then be mechanically removed. The light beam can be used to create larger segmenting cuts into the lens, as well as smaller softening cuts that soften the lens for easier removal.",CULBERTSON WILLIAM;;SEIBEL BARRY;;FRIEDMAN NEIL;;SCHUELE GEORG;;GOODING PHILLIP;;OPTIMEDICA CORP,CULBERTSON WILLIAM;;SEIBEL BARRY;;FRIEDMAN NEIL;;SCHUELE GEORG;;GOODING PHILLIP,AMO DEVELOPMENT LLC (2019-12-30);;OPTIMEDICA CORPORATION (2008-09-13),https://lens.org/079-768-737-441-180,Granted Patent,yes,102,23,136,136,0,A61F2009/00859;;A61F2009/00872;;A61F2009/0088;;A61F2009/00897;;A61F9/00825;;A61F2009/0087;;A61F9/00;;A61F2/16;;A61F2220/0016;;A61F2/1637;;A61F2/1648;;A61F9/00;;A61F9/00825;;A61F2009/00859;;A61F2009/0087;;A61F2009/00872;;A61F2009/0088;;A61F2009/00897;;A61F2/16;;A61F2/1613;;A61F2009/00887;;A61F2002/1683;;A61F2220/0016;;A61F2/1662;;A61F9/00754;;A61F9/008;;A61F9/009;;A61F2002/16901;;A61F9/00812,A61N5/06;;A61F2/16;;A61F9/008;;A61F9/009,607/88;;607/89;;607/92,16,5,097-583-099-978-486;;026-530-457-942-21X;;078-796-045-460-497;;000-548-666-851-615;;054-672-478-733-301,2299571;;10.1016/s0886-3350(13)80870-x;;2005552;;10.1016/s0886-3350(13)81001-2;;9713056;;10.1136/bjo.82.5.504;;pmc1722590;;15342071;;10.1016/j.jcrs.2004.05.018;;7993214;;10.1001/archopht.1994.01090240090031,"Abstract of AU Publication No. 2007292491, Publication date Mar. 13, 2008, which is the AU counterpart of the WO 08/030718 A2 application.;;U.S. Appl. No. 12/510,128, filed Jul. 27, 2009, Blumenkranz et al.;;U.S. Appl. No. 12/048,186, filed Mar. 13, 2008, Culbertson et al.;;U.S. Appl. No. 12/048,182, filed Mar. 13, 2008, Culbertson et al.;;Gimbel. ""Principles of Nuclear Phaco Emulsification"", In Cataract Surgery Techniques Complications and Management, 2nd ed., Edited by Steinert et al., 2004, Ch. 15, pp. 153-181.;;Steinert & Richter. ""Neodymium:Yttrium-Aluminum-Garnet Laser Posterior Capsulotomy"", In Cataract Surgery Techniques Complications and Management, 2nd ed., Edited by Steinert et al., 2004, Ch. 44, pp. 531-544.;;Gimbel & Neuhann, ""Development Advantages and Methods of the Continuous Circular Capsulorhexis Technique"", Journal of Cataract and Refractive Surgery, 1990: 16:31-37.;;Gimbel & Neuhann, ""Continuous Curvilinear Capsulorhexis"", Journal of Cataract and Refractive Surgery, 1991: 17:110-111.;;Geerling, Gerd, et al., Initial Clinical Experience With the Picosecond Nd:YLF Laser for Intraocular Therapeutic Applications, Br F Ophthalmol, 1998, 82:504-509.;;U.S. Appl. No. 12/703,687, filed Feb. 10, 2010, Culbertson.;;U.S. Appl. No. 12/703,689, filed Feb. 10, 2010, Culbertson.;;U.S. Appl. No. 12/510,148, filed Jul. 2009, Blumenkranz et al.;;Georges Baikoff, MD; Eric Lutun, Jay Wei, Caroline Ferraz, MD; ""Contact Between 3 Phakic Intraocular Lens Models and the Crystalline Lens: An Anterior Chamber Optical Coherence Tomography Study""; J Cataract Refract Surg 2004; 30:2007-2012.;;Joseph A. Izatt, PhD; Michael R. Hee, MS; Eric A. Swanson, MS; Charles P. Lin, PhD. et al.; ""Micrometer-Scale Resolution Imaging of the anterior Eye In Vivo With Optical Coherence Tomography"" Arch Ophthalmol. 1994; 112:1584-1589.;;Supplementary European Search Report for Application No. EP08726822, mailed on Apr. 9, 2010, 6 pages.;;Supplementary European Search Report for Application No. EP08726825, mailed on Apr. 30, 2010, 8 pages.",ACTIVE
55,US,B2,US 9782253 B2,140-235-645-474-741,2017-10-10,2017,US 201414576422 A,2014-12-19,US 201414576422 A;;US 70224210 A;;US 4818508 A;;US 90694407 P,2007-03-13,Method for patterned plasma-mediated modification of the crystalline lens,"A method of treating a cataractous lens of a patient's eye includes generating a light beam, deflecting the light beam using a scanner to form a treatment pattern, delivering the treatment pattern to the lens of the patient's eye to create a plurality of cuts in the form two or more different incisions patterns within the lens to segment the lens tissue into a plurality of patterned pieces, and mechanically breaking the lens into a plurality of pieces along the cuts. A first incision pattern includes two or more crossing cut incision planes. A second incision pattern includes a plurality of laser incision each extending along a first length between a posterior and an anterior surface of the lens capsule.",OPTIMEDICA CORP,CULBERTSON WILLIAM;;SEIBEL BARRY;;FRIEDMAN NEIL;;SCHUELE GEORG;;GOODING PHILLIP,AMO DEVELOPMENT LLC (2019-12-30);;OPTIMEDICA CORPORATION (2008-09-13),https://lens.org/140-235-645-474-741,Granted Patent,yes,113,7,136,136,0,A61F2009/00859;;A61F2009/00872;;A61F2009/0088;;A61F2009/00897;;A61F9/00825;;A61F2009/0087;;A61F9/00;;A61F2/16;;A61F2220/0016;;A61F2/1637;;A61F2/1648;;A61F9/00;;A61F9/00825;;A61F2009/00859;;A61F2009/0087;;A61F2009/00872;;A61F2009/0088;;A61F2009/00897;;A61F2/16;;A61F2/1613;;A61F2009/00887;;A61F2002/1683;;A61F2220/0016;;A61F2/1662;;A61F9/00754;;A61F9/008;;A61F9/009;;A61F2002/16901;;A61F9/00812,A61F2/16;;A61F9/008,,10,5,000-548-666-851-615;;078-796-045-460-497;;026-530-457-942-21X;;097-583-099-978-486;;054-672-478-733-301,15342071;;10.1016/j.jcrs.2004.05.018;;9713056;;10.1136/bjo.82.5.504;;pmc1722590;;2005552;;10.1016/s0886-3350(13)81001-2;;2299571;;10.1016/s0886-3350(13)80870-x;;7993214;;10.1001/archopht.1994.01090240090031,"Abstract of AU Publication No. 2007292491, Publication Date Mar. 13, 2008, which is the AU counterpart of the WO08030718 A2 application.;;Baikoff G., et al., “Contact Between 3 Phakic Intraocular Lens Models and the Crystalline Lens: An Anterior Chamber Optical Coherence Tomography Study,” Journal of Cataract and Refractive Surgery, 2004, vol. 30 (9), pp. 2007-2012.;;Geerling G., et al., “Initial Clinical Experience with the Picosecond Nd:YLF Laser for Intraocular Therapeutic Applications,” British Journal of Ophthalmology, 1998, vol. 82 (5), pp. 504-509.;;Gimbel H.V., et al., “Continuous Curvilinear Capsulorhexis,” Journal of Cataract and Refractive Surgery, 1991, vol. 17 (1), pp. 110-111.;;Gimbel H.V., et al., “Development, Advantages and Methods of the Continuous Circular Capsulorhexis Technique,” Journal of Cataract and Refractive Surgery, 1990, vol. 16 (1), pp. 31-37.;;Gimbel H.V., et al., “Principles of Nuclear Phaco Emulsification” In: Cataract Surgery Techniques Complications and Management, 2nd edition., Steinert et al., 2004, Chap. 15, pp. 153-181.;;Izatt J.A., et al., “Micrometer-Scale Resolution Imaging of the Anterior Eye In Vivo With Optical Coherence Tomography,” Arch Ophthalmology, 1994, vol. 112 (12), pp. 1584-1589.;;Steinert et al., “Neodymium: Yttrium-Aluminum-Garnet Laser Posterior Capsulotomy,” in: Cataract Surgery Techniques Complications and Management, 2nd edition., Steinert et al., 2004, Chapter. 44, pp. 531-544.;;Supplementary European Search Report for Application No. EP08726822, mailed on Apr. 9, 2010, 6 pages.;;Supplementary European Search Report for Application No. EP08726825, mailed on Apr. 30, 2010, 8 pages.",ACTIVE
56,US,B2,US 11839536 B2,088-697-051-330-209,2023-12-12,2023,US 202016866362 A,2020-05-04,US 202016866362 A;;US 201715726289 A;;US 201414576422 A;;US 70224210 A;;US 4818508 A;;US 90694407 P,2007-03-13,Method for patterned plasma-mediated modification of the crystalline lens,"A method of treating a cataractous lens of a patient's eye includes generating a light beam, deflecting the light beam using a scanner to form a treatment pattern, delivering the treatment pattern to the lens of the patient's eye to create a plurality of cuts in the form two or more different incisions patterns within the lens to segment the lens tissue into a plurality of patterned pieces, and mechanically breaking the lens into a plurality of pieces along the cuts. A first incision pattern includes two or more crossing cut incision planes. A second incision pattern includes a plurality of laser incision each extending along a first length between a posterior and an anterior surface of the lens capsule.",AMO DEV LLC,CULBERTSON WILLIAM;;SIEBEL BARRY;;FRIEDMAN NEIL;;SCHUELE GEORG;;GOODING PHILLIP,AMO DEVELOPMENT LLC (2019-12-30);;OPTIMEDICA CORPORATION (2008-09-13),https://lens.org/088-697-051-330-209,Granted Patent,yes,124,0,136,136,0,A61F2009/00859;;A61F2009/00872;;A61F2009/0088;;A61F2009/00897;;A61F9/00825;;A61F2009/0087;;A61F9/00;;A61F2/16;;A61F2220/0016;;A61F2/1637;;A61F2/1648;;A61F9/00;;A61F9/00825;;A61F2009/00859;;A61F2009/0087;;A61F2009/00872;;A61F2009/0088;;A61F2009/00897;;A61F2/16;;A61F2/1613;;A61F2009/00887;;A61F2002/1683;;A61F2220/0016;;A61F2/1662;;A61F9/00754;;A61F9/008;;A61F9/009;;A61F2002/16901;;A61F9/00812,A61F9/007;;A61F2/16;;A61F9/00;;A61F9/008;;A61F9/009,,8,5,000-548-666-851-615;;078-796-045-460-497;;026-530-457-942-21X;;097-583-099-978-486;;054-672-478-733-301,15342071;;10.1016/j.jcrs.2004.05.018;;9713056;;10.1136/bjo.82.5.504;;pmc1722590;;2005552;;10.1016/s0886-3350(13)81001-2;;2299571;;10.1016/s0886-3350(13)80870-x;;7993214;;10.1001/archopht.1994.01090240090031,"Abstract of AU Publication No. 2007292491, Publication Date Mar. 13, 2008, which is the AU counterpart of the WO08030718 A2 application.;;Baikoff G., et al., “Contact Between 3 Phakic Intraocular Lens Models and the Crystalline Lens: An Anterior Chamber Optical Coherence Tomography Study,” Journal of Cataract and Refractive Surgery, Sep. 2004, vol. 30 (9), pp. 2007-2012.;;Geerling G., et al., “Initial Clinical Experience with the Picosecond Nd:YLF Laser for Intraocular Therapeutic Applications,” British Journal of Ophthalmology, May 1998, vol. 82 (5), pp. 504-509.;;Gimbel H.V., et al., “Continuous Curvilinear Capsulorhexis,” Journal of Cataract and Refractive Surgery, Jan. 1991, vol. 17 (1), pp. 110-111.;;Gimbel H.V., et al., “Development, Advantages and Methods of the Continuous Circular Capsulorhexis Technique,” Journal of Cataract and Refractive Surgery, Jan. 1990, vol. 16 (1), pp. 31-37.;;Gimbel H.V., et al., “Principles of Nuclear Phaco Emulsification” In: Cataract Surgery Techniques Complications and Management, 2nd edition., Steinert et al., Oct. 2003, Chap. 15, pp. 153-181.;;Izatt J.A., et al., “Micrometer-Scale Resolution Imaging Of The Anterior Eye In Vivo With Optical Coherence Tomography,” Arch Ophthalmology, Dec. 1994, vol. 112 (12), pp. 1584-1589.;;Steinert et al., “Neodymium: Yttrium-Aluminum-Garnet Laser Posterior Capsulotomy,” in: Cataract Surgery Techniques Complications and Management, 2nd edition., Steinert et al., Oct. 2003, Chapter. 44, pp. 531-544.",ACTIVE
57,US,B2,US 10639140 B2,124-451-943-872-285,2020-05-05,2020,US 201715726289 A,2017-10-05,US 201715726289 A;;US 201414576422 A;;US 70224210 A;;US 4818508 A;;US 90694407 P,2007-03-13,Method for patterned plasma-mediated modification of the crystalline lens,"A method of treating a cataractous lens of a patient's eye includes generating a light beam, deflecting the light beam using a scanner to form a treatment pattern, delivering the treatment pattern to the lens of the patient's eye to create a plurality of cuts in the form two or more different incisions patterns within the lens to segment the lens tissue into a plurality of patterned pieces, and mechanically breaking the lens into a plurality of pieces along the cuts. A first incision pattern includes two or more crossing cut incision planes. A second incision pattern includes a plurality of laser incision each extending along a first length between a posterior and an anterior surface of the lens capsule.",OPTIMEDICA CORP;;AMO DEV LLC,CULBERTSON WILLIAM;;SEIBEL BARRY;;FRIEDMAN NEIL;;SCHUELE GEORG;;GOODING PHILLIP,AMO DEVELOPMENT LLC (2019-12-30);;OPTIMEDICA CORPORATION (2008-09-13),https://lens.org/124-451-943-872-285,Granted Patent,yes,118,0,136,136,0,A61F2009/00859;;A61F2009/00872;;A61F2009/0088;;A61F2009/00897;;A61F9/00825;;A61F2009/0087;;A61F9/00;;A61F2/16;;A61F2220/0016;;A61F2/1637;;A61F2/1648;;A61F9/00;;A61F9/00825;;A61F2009/00859;;A61F2009/0087;;A61F2009/00872;;A61F2009/0088;;A61F2009/00897;;A61F2/16;;A61F2/1613;;A61F2009/00887;;A61F2002/1683;;A61F2220/0016;;A61F2/1662;;A61F9/00754;;A61F9/008;;A61F9/009;;A61F2002/16901;;A61F9/00812,A61F9/008;;A61F2/16;;A61F9/00;;A61F9/007;;A61F9/009,,10,5,000-548-666-851-615;;078-796-045-460-497;;026-530-457-942-21X;;097-583-099-978-486;;054-672-478-733-301,15342071;;10.1016/j.jcrs.2004.05.018;;9713056;;10.1136/bjo.82.5.504;;pmc1722590;;2005552;;10.1016/s0886-3350(13)81001-2;;2299571;;10.1016/s0886-3350(13)80870-x;;7993214;;10.1001/archopht.1994.01090240090031,"Abstract of AU Publication No. 2007292491, Publication Date Mar. 13, 2008, which is the AU counterpart of the WO08030718 A2 application.;;Baikoff G., et al., “Contact Between 3 Phakic Intraocular Lens Models and the Crystalline Lens: An Anterior Chamber Optical Coherence Tomography Study,” Journal of Cataract and Refractive Surgery, 2004, vol. 30 (9), pp. 2007-2012.;;Geerling G., et al., “Initial Clinical Experience with the Picosecond Nd:YLF Laser for Intraocular Therapeutic Applications,” British Journal of Ophthalmology, 1998, vol. 82 (5), pp. 504-509.;;Gimbel H.V., et al., “Continuous Curvilinear Capsulorhexis,” Journal of Cataract and Refractive Surgery, 1991, vol. 17 (1), pp. 110-111.;;Gimbel H.V., et al., “Development, Advantages and Methods of the Continuous Circular Capsulorhexis Technique,” Journal of Cataract and Refractive Surgery, 1990, vol. 16 (1), pp. 31-37.;;Gimbel H.V., et al., “Principles of Nuclear Phaco Emulsification” In: Cataract Surgery Techniques Complications and Management, 2nd edition., Steinert et al., 2004, Chap. 15, pp. 153-181.;;Izatt J.A., et al., “Micrometer-Scale Resolution Imaging of the Anterior Eye in Vivo With Optical Coherence Tomography,” Arch Ophthalmology, 1994, vol. 112 (12), pp. 1584-1589.;;Steinert et al., “Neodymium: Yttrium-Aluminum-Garnet Laser Posterior Capsulotomy,” in: Cataract Surgery Techniques Complications and Management, 2nd edition., Steinert et al., 2004, Chapter. 44, pp. 531-544.;;Supplementary European Search Report for Application No. EP08726822, dated Apr. 26, 2010, 6 pages.;;Supplementary European Search Report for Application No. EP08726825, dated Apr. 30, 2010, 8 pages.",ACTIVE
58,US,A1,US 2020/0360130 A1,173-070-290-642-260,2020-11-19,2020,US 202016944144 A,2020-07-30,US 202016944144 A;;US 201715726296 A;;US 201414576422 A;;US 70224210 A;;US 4818508 A;;US 90694407 P,2007-03-13,METHOD FOR PATTERNED PLASMA-MEDIATED MODIFICATION OF THE CRYSTALLINE LENS,"A method of treating a lens of a patient's eye includes generating a light beam, deflecting the light beam using a scanner to form a treatment pattern of the light beam, delivering the treatment pattern to the lens of a patient's eye to create a plurality of cuts in the lens in the form of the treatment pattern to break the lens up into a plurality of pieces, and removing the lens pieces from the patient's eye. The lens pieces can then be mechanically removed. The light beam can be used to create larger segmenting cuts into the lens, as well as smaller softening cuts that soften the lens for easier removal.",AMO DEV LLC,CULBERTSON WILLIAM;;SEIBEL BARRY;;FRIEDMAN NEIL;;SCHUELE GEORG;;GOODING PHILLIP,AMO DEVELOPMENT LLC (2019-12-30);;OPTIMEDICA CORPORATION (2008-09-13),https://lens.org/173-070-290-642-260,Patent Application,yes,0,0,136,136,0,A61F2009/00859;;A61F2009/00872;;A61F2009/0088;;A61F2009/00897;;A61F9/00825;;A61F2009/0087;;A61F9/00;;A61F2/16;;A61F2220/0016;;A61F2/1637;;A61F2/1648;;A61F9/00;;A61F9/00825;;A61F2009/00859;;A61F2009/0087;;A61F2009/00872;;A61F2009/0088;;A61F2009/00897;;A61F2/16;;A61F2/1613;;A61F2009/00887;;A61F2002/1683;;A61F2220/0016;;A61F2/1662;;A61F9/00754;;A61F9/008;;A61F9/009;;A61F2002/16901;;A61F9/00812,A61F2/16,,0,0,,,,ACTIVE
59,US,A1,US 2020/0261215 A1,029-126-488-539-882,2020-08-20,2020,US 202016866362 A,2020-05-04,US 202016866362 A;;US 201715726289 A;;US 201414576422 A;;US 70224210 A;;US 4818508 A;;US 90694407 P,2007-03-13,METHOD FOR PATTERNED PLASMA-MEDIATED MODIFICATION OF THE CRYSTALLINE LENS,"A method of treating a cataractous lens of a patient's eye includes generating a light beam, deflecting the light beam using a scanner to form a treatment pattern, delivering the treatment pattern to the lens of the patient's eye to create a plurality of cuts in the form two or more different incisions patterns within the lens to segment the lens tissue into a plurality of patterned pieces, and mechanically breaking the lens into a plurality of pieces along the cuts. A first incision pattern includes two or more crossing cut incision planes. A second incision pattern includes a plurality of laser incision each extending along a first length between a posterior and an anterior surface of the lens capsule.",AMO DEV LLC,CULBERTSON WILLIAM;;SIEBEL BARRY;;FRIEDMAN NEIL;;SCHUELE GEORG;;GOODING PHILLIP,AMO DEVELOPMENT LLC (2019-12-30);;OPTIMEDICA CORPORATION (2008-09-13),https://lens.org/029-126-488-539-882,Patent Application,yes,4,0,136,136,0,A61F2009/00859;;A61F2009/00872;;A61F2009/0088;;A61F2009/00897;;A61F9/00825;;A61F2009/0087;;A61F9/00;;A61F2/16;;A61F2220/0016;;A61F2/1637;;A61F2/1648;;A61F9/00;;A61F9/00825;;A61F2009/00859;;A61F2009/0087;;A61F2009/00872;;A61F2009/0088;;A61F2009/00897;;A61F2/16;;A61F2/1613;;A61F2009/00887;;A61F2002/1683;;A61F2220/0016;;A61F2/1662;;A61F9/00754;;A61F9/008;;A61F9/009;;A61F2002/16901;;A61F9/00812,A61F2/16,,0,0,,,,ACTIVE
60,US,A1,US 2018/0042715 A1,078-336-072-072-361,2018-02-15,2018,US 201715726289 A,2017-10-05,US 201715726289 A;;US 201414576422 A;;US 70224210 A;;US 4818508 A;;US 90694407 P,2007-03-13,METHOD FOR PATTERNED PLASMA-MEDIATED MODIFICATION OF THE CRYSTALLINE LENS,"A method of treating a cataractous lens of a patient's eye includes generating a light beam, deflecting the light beam using a scanner to form a treatment pattern, delivering the treatment pattern to the lens of the patient's eye to create a plurality of cuts in the form two or more different incisions patterns within the lens to segment the lens tissue into a plurality of patterned pieces, and mechanically breaking the lens into a plurality of pieces along the cuts. A first incision pattern includes two or more crossing cut incision planes. A second incision pattern includes a plurality of laser incision each extending along a first length between a posterior and an anterior surface of the lens capsule.",OPTIMEDICA CORP,CULBERTSON WILLIAM;;SEIBEL BARRY;;FRIEDMAN NEIL;;SCHUELE GEORG;;GOODING PHILLIP,AMO DEVELOPMENT LLC (2019-12-30);;OPTIMEDICA CORPORATION (2008-09-13),https://lens.org/078-336-072-072-361,Patent Application,yes,2,0,136,136,0,A61F2009/00859;;A61F2009/00872;;A61F2009/0088;;A61F2009/00897;;A61F9/00825;;A61F2009/0087;;A61F9/00;;A61F2/16;;A61F2220/0016;;A61F2/1637;;A61F2/1648;;A61F9/00;;A61F9/00825;;A61F2009/00859;;A61F2009/0087;;A61F2009/00872;;A61F2009/0088;;A61F2009/00897;;A61F2/16;;A61F2/1613;;A61F2009/00887;;A61F2002/1683;;A61F2220/0016;;A61F2/1662;;A61F9/00754;;A61F9/008;;A61F9/009;;A61F2002/16901;;A61F9/00812,A61F2/16;;A61F9/00;;A61F9/008,,0,0,,,,ACTIVE
61,US,B2,US 9968439 B2,149-203-663-364-694,2018-05-15,2018,US 201414576467 A,2014-12-19,US 201414576467 A;;US 70224210 A;;US 4818508 A;;US 90694407 P,2007-03-13,Method for patterned plasma-mediated modification of the crystalline lens,"A system for treating a cataractous lens of a patient's eye includes a laser source for generating a light beam, a scanning system for deflecting the light beam to form a treatment pattern of the light beam, and a controller operably coupled to the laser source and scanning system and configured to operate the scanner to form the treatment pattern. The treatment pattern is a plurality of cuts in the form two or more different incision patterns for segmenting the lens tissue into a plurality of patterned pieces. The incision pattern includes: a first incision pattern including two or more crossing cut incision planes; and a second incision pattern comprising one or more laser incision each extending along a first length between a posterior and an anterior surface of the lens capsule.",OPTIMEDICA CORP,CULBERTSON WILLIAM;;SEIBEL BARRY;;FRIEDMAN NEIL;;SCHUELE GEORG;;GOODING PHILLIP,AMO DEVELOPMENT LLC (2019-12-30);;OPTIMEDICA CORPORATION (2008-09-13),https://lens.org/149-203-663-364-694,Granted Patent,yes,113,4,136,136,0,A61F2009/00859;;A61F2009/00872;;A61F2009/0088;;A61F2009/00897;;A61F9/00825;;A61F2009/0087;;A61F9/00;;A61F2/16;;A61F2220/0016;;A61F2/1637;;A61F2/1648;;A61F9/00;;A61F9/00825;;A61F2009/00859;;A61F2009/0087;;A61F2009/00872;;A61F2009/0088;;A61F2009/00897;;A61F2/16;;A61F2/1613;;A61F2009/00887;;A61F2002/1683;;A61F2220/0016;;A61F2/1662;;A61F9/00754;;A61F9/008;;A61F9/009;;A61F2002/16901;;A61F9/00812,A61B18/20;;A61F2/16;;A61F9/00;;A61F9/008,,10,5,000-548-666-851-615;;078-796-045-460-497;;026-530-457-942-21X;;097-583-099-978-486;;054-672-478-733-301,15342071;;10.1016/j.jcrs.2004.05.018;;9713056;;10.1136/bjo.82.5.504;;pmc1722590;;2005552;;10.1016/s0886-3350(13)81001-2;;2299571;;10.1016/s0886-3350(13)80870-x;;7993214;;10.1001/archopht.1994.01090240090031,"Abstract of AU Publication No. 2007292491, Publication Date Mar. 13, 2008, which is the AU counterpart of the WO08030718 A2 application.;;Baikoff G., et al., “Contact Between 3 Phakic Intraocular Lens Models and the Crystalline Lens: An Anterior Chamber Optical Coherence Tomography Study,” Journal of Cataract and Refractive Surgery, 2004, vol. 30 (9), pp. 2007-2012.;;Geerling G., et al., “Initial Clinical Experience with the Picosecond Nd:YLF Laser for Intraocular Therapeutic Applications,” British Journal of Ophthalmology, 1998, vol. 82 (5), pp. 504-509.;;Gimbel H.V., et al., “Continuous Curvilinear Capsulorhexis,” Journal of Cataract and Refractive Surgery, 1991, vol. 17 (1), pp. 110-111.;;Gimbel H.V., et al., “Development, Advantages and Methods of the Continuous Circular Capsulorhexis Technique,” Journal of Cataract and Refractive Surgery, 1990, vol. 16 (1), pp. 31-37.;;Gimbel H.V., et al., “Principles of Nuclear Phaco Emulsification” In: Cataract Surgery Techniques Complications and Management, 2nd edition., Steinert et al., 2004, Chap. 15, pp. 153-181.;;Izatt J.A., et al., “Micrometer-Scale Resolution Imaging of the Anterior Eye In Vivo With Optical Coherence Tomography,” Arch Ophthalmology, 1994, vol. 112 (12), pp. 1584-1589.;;Steinert et al., “Neodymium: Yttrium-Aluminum-Garnet Laser Posterior Capsulotomy,” in: Cataract Surgery Techniques Complications and Management, 2nd edition., Steinert et al., 2004, Chapter. 44, pp. 531-544.;;Supplementary European Search Report for Application No. EP08726822, dated Apr. 9, 2010, 6 pages.;;Supplementary European Search Report for Application No. EP08726825, dated Apr. 30, 2010, 8 pages.",ACTIVE
62,US,B2,US 10729538 B2,175-406-119-068-755,2020-08-04,2020,US 201715726296 A,2017-10-05,US 201715726296 A;;US 201414576422 A;;US 70224210 A;;US 4818508 A;;US 90694407 P,2007-03-13,Method for patterned plasma-mediated modification of the crystalline lens,"A method of treating a lens of a patient's eye includes generating a light beam, deflecting the light beam using a scanner to form a treatment pattern of the light beam, delivering the treatment pattern to the lens of a patient's eye to create a plurality of cuts in the lens in the form of the treatment pattern to break the lens up into a plurality of pieces, and removing the lens pieces from the patient's eye. The lens pieces can then be mechanically removed. The light beam can be used to create larger segmenting cuts into the lens, as well as smaller softening cuts that soften the lens for easier removal.",AMO DEV LLC,CULBERTSON WILLIAM;;SEIBEL BARRY;;FRIEDMAN NEIL;;SCHUELE GEORG;;GOODING PHILLIP,AMO DEVELOPMENT LLC (2019-12-30);;OPTIMEDICA CORPORATION (2008-09-13),https://lens.org/175-406-119-068-755,Granted Patent,yes,119,2,136,136,0,A61F2009/00859;;A61F2009/00872;;A61F2009/0088;;A61F2009/00897;;A61F9/00825;;A61F2009/0087;;A61F9/00;;A61F2/16;;A61F2220/0016;;A61F2/1637;;A61F2/1648;;A61F9/00;;A61F9/00825;;A61F2009/00859;;A61F2009/0087;;A61F2009/00872;;A61F2009/0088;;A61F2009/00897;;A61F2/16;;A61F2/1613;;A61F2009/00887;;A61F2002/1683;;A61F2220/0016;;A61F2/1662;;A61F9/00754;;A61F9/008;;A61F9/009;;A61F2002/16901;;A61F9/00812,A61F9/008;;A61F2/16;;A61F9/00;;A61F9/007;;A61F9/009,,10,5,000-548-666-851-615;;078-796-045-460-497;;026-530-457-942-21X;;097-583-099-978-486;;054-672-478-733-301,15342071;;10.1016/j.jcrs.2004.05.018;;9713056;;10.1136/bjo.82.5.504;;pmc1722590;;2005552;;10.1016/s0886-3350(13)81001-2;;2299571;;10.1016/s0886-3350(13)80870-x;;7993214;;10.1001/archopht.1994.01090240090031,"Abstract of AU Publication No. 2007292491, Publication Date Mar. 13, 2008, which is the AU counterpart of the WO08030718 A2 application.;;Baikoff G., et al., “Contact Between 3 Phakic Intraocular Lens Models and the Crystalline Lens: An Anterior Chamber Optical Coherence Tomography Study,” Journal of Cataract and Refractive Surgery, 2004, vol. 30 (9), pp. 2007-2012.;;Geerling G., et al., “Initial Clinical Experience with the Picosecond Nd:YLF Laser for Intraocular Therapeutic Applications,” British Journal of Ophthalmology, 1998, vol. 82 (5), pp. 504-509.;;Gimbel H.V., et al., “Continuous Curvilinear Capsulorhexis,” Journal of Cataract and Refractive Surgery, 1991, vol. 17 (1), pp. 110-111.;;Gimbel H.V., et al., “Development, Advantages and Methods of the Continuous Circular Capsulorhexis Technique,” Journal of Cataract and Refractive Surgery, 1990, vol. 16 (1), pp. 31-37.;;Gimbel H.V., et al., “Principles of Nuclear Phaco Emulsification” In: Cataract Surgery Techniques Complications and Management, 2nd edition., Steinert et al., 2004, Chap. 15, pp. 153-181.;;Izatt J.A., et al., “Micrometer-Scale Resolution Imaging of the Anterior Eye in Vivo With Optical Coherence Tomography,” Arch Ophthalmology, 1994, vol. 112 (12), pp. 1584-1589.;;Steinert et al., “Neodymium: Yttrium-Aluminum-Garnet Laser Posterior Capsulotomy,” in: Cataract Surgery Techniques Complications and Management, 2nd edition., Steinert et al., 2004, Chapter. 44, pp. 531-544.;;Supplementary European Search Report for Application No. EP08726822, dated Apr. 26, 2010, 6 pages.;;Supplementary European Search Report for Application No. EP08726825, dated Apr. 30, 2010, 8 pages.",ACTIVE
63,US,A1,US 2018/0263758 A1,019-402-301-824-145,2018-09-20,2018,US 201815976751 A,2018-05-10,US 201815976751 A;;US 201414576467 A;;US 70224210 A;;US 4818508 A;;US 90694407 P,2007-03-13,METHOD FOR PATTERNED PLASMA-MEDIATED MODIFICATION OF THE CRYSTALLINE LENS,"A method of treating a lens of a patient's eye includes generating a light beam, deflecting the light beam using a scanner to form a treatment pattern of the light beam, delivering the treatment pattern to the lens of a patient's eye to create a plurality of cuts in the lens in the form of the treatment pattern to break the lens up into a plurality of pieces, and removing the lens pieces from the patient's eye. The lens pieces can then be mechanically removed. The light beam can be used to create larger segmenting cuts into the lens, as well as smaller softening cuts that soften the lens for easier removal.",OPTIMEDICA CORP,CULBERTSON WILLIAM;;SEIBEL BARRY;;FRIEDMAN NEIL;;SCHUELE GEORG;;GOODING PHILLIP,AMO DEVELOPMENT LLC (2019-12-30);;OPTIMEDICA CORPORATION (2008-09-13),https://lens.org/019-402-301-824-145,Patent Application,yes,3,2,136,136,0,A61F2009/00859;;A61F2009/00872;;A61F2009/0088;;A61F2009/00897;;A61F9/00825;;A61F2009/0087;;A61F9/00;;A61F2/16;;A61F2220/0016;;A61F2/1637;;A61F2/1648;;A61F9/00;;A61F9/00825;;A61F2009/00859;;A61F2009/0087;;A61F2009/00872;;A61F2009/0088;;A61F2009/00897;;A61F2/16;;A61F2/1613;;A61F2009/00887;;A61F2002/1683;;A61F2220/0016;;A61F2/1662;;A61F9/00754;;A61F9/008;;A61F9/009;;A61F2002/16901;;A61F9/00812,A61F2/16;;A61F9/00;;A61F9/008,,0,0,,,,ACTIVE
64,US,B2,US 10828149 B2,049-519-364-633-669,2020-11-10,2020,US 201815976751 A,2018-05-10,US 201815976751 A;;US 201414576467 A;;US 70224210 A;;US 4818508 A;;US 90694407 P,2007-03-13,Method for patterned plasma-mediated modification of the crystalline lens,"A method of treating a lens of a patient's eye includes generating a light beam, deflecting the light beam using a scanner to form a treatment pattern of the light beam, delivering the treatment pattern to the lens of a patient's eye to create a plurality of cuts in the lens in the form of the treatment pattern to break the lens up into a plurality of pieces, and removing the lens pieces from the patient's eye. The lens pieces can then be mechanically removed. The light beam can be used to create larger segmenting cuts into the lens, as well as smaller softening cuts that soften the lens for easier removal.",AMO DEV LLC,CULBERTSON WILLIAM;;SEIBEL BARRY;;FRIEDMAN NEIL;;SCHUELE GEORG;;GOODING PHILLIP,AMO DEVELOPMENT LLC (2019-12-30);;OPTIMEDICA CORPORATION (2008-09-13),https://lens.org/049-519-364-633-669,Granted Patent,yes,120,2,136,136,0,A61F2009/00859;;A61F2009/00872;;A61F2009/0088;;A61F2009/00897;;A61F9/00825;;A61F2009/0087;;A61F9/00;;A61F2/16;;A61F2220/0016;;A61F2/1637;;A61F2/1648;;A61F9/00;;A61F9/00825;;A61F2009/00859;;A61F2009/0087;;A61F2009/00872;;A61F2009/0088;;A61F2009/00897;;A61F2/16;;A61F2/1613;;A61F2009/00887;;A61F2002/1683;;A61F2220/0016;;A61F2/1662;;A61F9/00754;;A61F9/008;;A61F9/009;;A61F2002/16901;;A61F9/00812,A61F2/16;;A61F9/00;;A61F9/007;;A61F9/008;;A61F9/009,,10,5,000-548-666-851-615;;078-796-045-460-497;;026-530-457-942-21X;;097-583-099-978-486;;054-672-478-733-301,15342071;;10.1016/j.jcrs.2004.05.018;;9713056;;10.1136/bjo.82.5.504;;pmc1722590;;2005552;;10.1016/s0886-3350(13)81001-2;;2299571;;10.1016/s0886-3350(13)80870-x;;7993214;;10.1001/archopht.1994.01090240090031,"Abstract of AU Publication No. 2007292491, Publication Date Mar. 13, 2008, which is the AU counterpart of the WO08030718 A2 application.;;Baikoff G., et al., “Contact Between 3 Phakic Intraocular Lens Models and the Crystalline Lens: An Anterior Chamber Optical Coherence Tomography Study,” Journal of Cataract and Refractive Surgery, 2004, vol. 30 (9), pp. 2007-2012.;;Geerling G., et al., “Initial Clinical Experience with the Picosecond Nd:YLF Laser for Intraocular Therapeutic Applications,” British Journal of Ophthalmology, 1998, vol. 82 (5), pp. 504-509.;;Gimbel H.V., et al., “Continuous Curvilinear Capsulorhexis,” Journal of Cataract and Refractive Surgery, 1991, vol. 17 (1), pp. 110-111.;;Gimbel H.V., et al., “Development, Advantages and Methods of the Continuous Circular Capsulorhexis Technique,” Journal of Cataract and Refractive Surgery, 1990, vol. 16 (1), pp. 31-37.;;Gimbel H.V., et al., “Principles of Nuclear Phaco Emulsification” In: Cataract Surgery Techniques Complications and Management, 2nd edition., Steinert et al., 2004, Chap. 15, pp. 153-181.;;Izatt J.A., et al., “Micrometer-Scale Resolution Imaging of the Anterior Eye in Vivo With Optical Coherence Tomography,” Arch Ophthalmology, 1994, vol. 112 (12), pp. 1584-1589.;;Steinert et al., “Neodymium: Yttrium-Aluminum-Garnet Laser Posterior Capsulotomy,” in: Cataract Surgery Techniques Complications and Management, 2nd edition., Steinert et al., 2004, Chapter. 44, pp. 531-544.;;Supplementary European Search Report for Application No. EP08726822, dated Apr. 26, 2010, 6 pages.;;Supplementary European Search Report for Application No. EP08726825, dated Apr. 30, 2010, 8 pages.",ACTIVE
65,US,A1,US 2015/0105763 A1,140-391-304-849-650,2015-04-16,2015,US 201414576467 A,2014-12-19,US 201414576467 A;;US 70224210 A;;US 4818508 A;;US 90694407 P,2007-03-13,METHOD FOR PATTERNED PLASMA-MEDIATED MODIFICATION OF THE CRYSTALLINE LENS,"A system for treating a cataractous lens of a patient's eye includes a laser source for generating a light beam, a scanning system for deflecting the light beam to form a treatment pattern of the light beam, and a controller operably coupled to the laser source and scanning system and configured to operate the scanner to form the treatment pattern. The treatment pattern is a plurality of cuts in the form two or more different incision patterns for segmenting the lens tissue into a plurality of patterned pieces. The incision pattern includes: a first incision pattern including two or more crossing cut incision planes; and a second incision pattern comprising one or more laser incision each extending along a first length between a posterior and an anterior surface of the lens capsule.",OPTIMEDICA CORP,CULBERTSON WILLIAM;;SEIBEL BARRY;;FRIEDMAN NEIL;;SCHUELE GEORG;;GOODING PHILLIP,AMO DEVELOPMENT LLC (2019-12-30);;OPTIMEDICA CORPORATION (2008-09-13),https://lens.org/140-391-304-849-650,Patent Application,yes,1,7,136,136,0,A61F2009/00859;;A61F2009/00872;;A61F2009/0088;;A61F2009/00897;;A61F9/00825;;A61F2009/0087;;A61F9/00;;A61F2/16;;A61F2220/0016;;A61F2/1637;;A61F2/1648;;A61F9/00;;A61F9/00825;;A61F2009/00859;;A61F2009/0087;;A61F2009/00872;;A61F2009/0088;;A61F2009/00897;;A61F2/16;;A61F2/1613;;A61F2009/00887;;A61F2002/1683;;A61F2220/0016;;A61F2/1662;;A61F9/00754;;A61F9/008;;A61F9/009;;A61F2002/16901;;A61F9/00812,A61F9/008,606/6,0,0,,,,ACTIVE
66,US,B2,US 11826245 B2,001-050-006-140-103,2023-11-28,2023,US 202016944144 A,2020-07-30,US 202016944144 A;;US 201715726296 A;;US 201414576422 A;;US 70224210 A;;US 4818508 A;;US 90694407 P,2007-03-13,Method for patterned plasma-mediated modification of the crystalline lens,"A method of treating a lens of a patient's eye includes generating a light beam, deflecting the light beam using a scanner to form a treatment pattern of the light beam, delivering the treatment pattern to the lens of a patient's eye to create a plurality of cuts in the lens in the form of the treatment pattern to break the lens up into a plurality of pieces, and removing the lens pieces from the patient's eye. The lens pieces can then be mechanically removed. The light beam can be used to create larger segmenting cuts into the lens, as well as smaller softening cuts that soften the lens for easier removal.",AMO DEV LLC,CULBERTSON WILLIAM;;SEIBEL BARRY;;FRIEDMAN NEIL;;SCHUELE GEORG;;GOODING PHILLIP,AMO DEVELOPMENT LLC (2019-12-30);;OPTIMEDICA CORPORATION (2008-09-13),https://lens.org/001-050-006-140-103,Granted Patent,yes,117,0,136,136,0,A61F2009/00859;;A61F2009/00872;;A61F2009/0088;;A61F2009/00897;;A61F9/00825;;A61F2009/0087;;A61F9/00;;A61F2/16;;A61F2220/0016;;A61F2/1637;;A61F2/1648;;A61F9/00;;A61F9/00825;;A61F2009/00859;;A61F2009/0087;;A61F2009/00872;;A61F2009/0088;;A61F2009/00897;;A61F2/16;;A61F2/1613;;A61F2009/00887;;A61F2002/1683;;A61F2220/0016;;A61F2/1662;;A61F9/00754;;A61F9/008;;A61F9/009;;A61F2002/16901;;A61F9/00812,A61F9/008;;A61F2/16;;A61F9/00;;A61F9/007;;A61F9/009,,8,5,000-548-666-851-615;;078-796-045-460-497;;026-530-457-942-21X;;097-583-099-978-486;;054-672-478-733-301,15342071;;10.1016/j.jcrs.2004.05.018;;9713056;;10.1136/bjo.82.5.504;;pmc1722590;;2005552;;10.1016/s0886-3350(13)81001-2;;2299571;;10.1016/s0886-3350(13)80870-x;;7993214;;10.1001/archopht.1994.01090240090031,"Abstract of AU Publication No. 2007292491, Publication Date Mar. 13, 2008, which is the AU counterpart of the WO08030718 A2 application.;;Baikoff G., et al., “Contact Between 3 Phakic Intraocular Lens Models and the Crystalline Lens: An Anterior Chamber Optical Coherence Tomography Study,” Journal of Cataract and Refractive Surgery, Sep. 2004, vol. 30 (9), pp. 2007-2012.;;Geerling G., et al., “Initial Clinical Experience with the Picosecond Nd:YLF Laser for Intraocular Therapeutic Applications,” British Journal of Ophthalmology, May 1998, vol. 82 (5), pp. 504-509.;;Gimbel H.V., et al., “Continuous Curvilinear Capsulorhexis,” Journal of Cataract and Refractive Surgery, Jan. 1991, vol. 17 (1), pp. 110-111.;;Gimbel H.V., et al., “Development, Advantages and Methods of the Continuous Circular Capsulorhexis Technique,” Journal of Cataract and Refractive Surgery, Jan. 1990, vol. 16 (1), pp. 31-37.;;Gimbel H.V., et al., “Principles of Nuclear Phaco Emulsification”In: Cataract Surgery Techniques Complications and Management, 2nd edition., Steinert et al., Oct. 2003, Chap. 15, pp. 153-181.;;Izatt J.A., et al., “Micrometer-Scale Resolution Imaging of the Anterior Eye In Vivo With Optical Coherence Tomography,” Arch Ophthalmology, Dec. 1994, vol. 112 (12), pp. 1584-1589.;;Steinert et al., “Neodymium: Yttrium-Aluminum-Garnet Laser Posterior Capsulotomy,” in: Cataract Surgery Techniques Complications and Management, 2nd edition., Steinert et al., Oct. 2003, Chapter. 44, pp. 531-544.",ACTIVE
67,US,A1,US 2018/0042716 A1,114-410-840-955-447,2018-02-15,2018,US 201715726296 A,2017-10-05,US 201715726296 A;;US 201414576422 A;;US 70224210 A;;US 4818508 A;;US 90694407 P,2007-03-13,METHOD FOR PATTERNED PLASMA-MEDIATED MODIFICATION OF THE CRYSTALLINE LENS,"A method of treating a lens of a patient's eye includes generating a light beam, deflecting the light beam using a scanner to form a treatment pattern of the light beam, delivering the treatment pattern to the lens of a patient's eye to create a plurality of cuts in the lens in the form of the treatment pattern to break the lens up into a plurality of pieces, and removing the lens pieces from the patient's eye. The lens pieces can then be mechanically removed. The light beam can be used to create larger segmenting cuts into the lens, as well as smaller softening cuts that soften the lens for easier removal.",OPTIMEDICA CORP,CULBERTSON WILLIAM;;SEIBEL BARRY;;FRIEDMAN NEIL;;SCHUELE GEORG;;GOODING PHILLIP,AMO DEVELOPMENT LLC (2019-12-30);;OPTIMEDICA CORPORATION (2008-09-13),https://lens.org/114-410-840-955-447,Patent Application,yes,5,0,136,136,0,A61F2009/00859;;A61F2009/00872;;A61F2009/0088;;A61F2009/00897;;A61F9/00825;;A61F2009/0087;;A61F9/00;;A61F2/16;;A61F2220/0016;;A61F2/1637;;A61F2/1648;;A61F9/00;;A61F9/00825;;A61F2009/00859;;A61F2009/0087;;A61F2009/00872;;A61F2009/0088;;A61F2009/00897;;A61F2/16;;A61F2/1613;;A61F2009/00887;;A61F2002/1683;;A61F2220/0016;;A61F2/1662;;A61F9/00754;;A61F9/008;;A61F9/009;;A61F2002/16901;;A61F9/00812,A61F2/16;;A61F9/00;;A61F9/008,,0,0,,,,ACTIVE
68,US,A,US 5991778 A,159-381-714-250-916,1999-11-23,1999,US 94074697 A,1997-09-30,US 94074697 A,1997-09-30,Method and apparatus for real-time secure file deletion,"A method and apparatus are provided that enhance file system calls to a file system structure of an operating system. In particular, file system calls can be enhanced to provide real-time secure file deletion on an ongoing basis. A file system call that is intended to perform a function with respect to data stored on a storage device is intercepted. It is then determined whether the file system call is of a type that should be processed. If not, the original file system call is passed on through the file system. If the file system call should be processed, supplemental processing is performed to enhance the original file system call and the file system call is transparently returned to the calling system application. In embodiment, real-time secure file deletion is implemented using a vendor supplied driver (VSD) executing within the installable file system (IFS) of WINDOWS 95.",STRATFOR SYSTEMS INC,STAREK ROBERT PHILLIP;;FRIEDMAN GEORGE;;MARSHALL DAVID EARL;;CHAMBERS JASON LEE,GIGATRUST (2008-06-02);;GIGAMEDIA ACCESS CORPORATION (2019-07-31);;STRATEGIC FORECASTING L.L.C (1997-09-30);;PINION SOFTWARE INC (2005-01-21),https://lens.org/159-381-714-250-916,Granted Patent,yes,10,88,1,5,0,G06F16/162;;G06F16/162;;Y10S707/99956;;Y10S707/99953,G06F17/30,707/205;;707/206;;707/200,6,0,,,"Workplace: The Messy Business of Culling Computer Files, Alex Markels, The Wall Street Journal , May 22, 1997.;;Examining the Windows 95 Layered File System, by Mark Russinovich and Bryce Cogswell, Dr. Dobb s Journal , Dec. 1995.;;The Windows 95 File System, 1996 Knowles Consulting .;;Disk Partioning Under FAT File System Saves Disk Space and Aids in Organization, Sidney D. Peters, Peters Computer Services .;;Inside the Windows 95 File System, Stan Mitchell, O Reilly & Associates, Inc. , pp. 124 143;202 203.;;Snoop Proof Your PC , author unknown, (PC Computing vol. 11 No. 3) obtained via internet www.infowar.com, Jan. 3, 1998.",EXPIRED
69,AU,B2,AU 2017/308847 B2,055-491-341-468-889,2022-06-30,2022,AU 2017/308847 A,2017-08-09,US 201662372586 P;;US 2017/0046012 W,2016-08-09,Solid herbicidal concentrate compositions,"The present invention generally relates to solid herbicidal concentrate compositions comprising one or more herbicide salts, particularly salts of acidic herbicides such as glyphosate salts, glufosinate salts, and/or various auxin herbicide salts. The present invention further relates to various processes for preparing the solid herbicidal concentrate compositions as well as methods of using the solid herbicidal concentrate compositions to prepare herbicidal application mixtures.",MONSANTO TECHNOLOGY LLC,DYSZLEWSKI ANDREW D;;FRIEDMAN TODD C;;LEE PHILLIP K;;MACINNES ALISON,,https://lens.org/055-491-341-468-889,Granted Patent,no,2,0,16,16,0,A01N25/00;;A01N31/00;;A01N37/40;;A01N57/20;;A01N37/40;;A01N31/00;;A01N25/00;;A01N57/20;;A01N25/22,A01N25/00;;A01N31/00,,0,0,,,,ACTIVE
70,AR,A1,AR 109317 A1,099-413-887-712-217,2018-11-21,2018,AR P170102237 A,2017-08-09,US 201662372586 P,2016-08-09,COMPOSICIONES DE CONCENTRADOS HERBICIDAS SÓLIDOS,"Reivindicación 1: Una composición de un concentrado herbicida sólido caracterizada porque comprende un componente de sal de glifosato y una sal de ácido monocarboxílico, donde el componente de sal de glifosato comprende aniones de glifosato y un catión formador de sales monovalente, y donde la proporción molar entre el catión formador de sales monovalente y los aniones de glifosato totales es de entre aproximadamente 1,2:1 y aproximadamente 1,75:1 y la concentración del componente de sal de glifosato, sobre una base de equivalentes ácidos, es de al menos aproximadamente 20% en peso. Reivindicación 3: La composición de un concentrado herbicida sólido de la reivindicación 1 ó 2, caracterizado porque el catión formador de sales monovalente del componente de sal de glifosato se selecciona del grupo que consiste en potasio, sodio, amonio, isopropilamonio, monoetanolamonio, dietanolamonio, trietanolamonio, dimetilamonio y mezclas de estos. Reivindicación 11: La composición de un concentrado herbicida sólido de cualquiera de las reivindicaciones 1 a 10, caracterizada porque la sal de ácido monocarboxílico tiene la formula R¹-C(O)OM, donde R¹ es C₁₋₂₀ alquilo sustituido o no sustituido, C₂₋₂₀ alquenilo sustituido o no sustituido, arilo sustituido o no sustituido o arilalquilo sustituido o no sustituido y M es un catión aceptable para la agricultura. Reivindicación 14: La composición de un concentrado herbicida sólido de cualquiera de las reivindicaciones 11 a 13, caracterizada porque M es un catión metálico monovalente. Reivindicación 21: La composición de un concentrado herbicida sólido de cualquiera de las reivindicaciones 1 a 20, caracterizada porque también comprende un componente de sal de herbicida de auxina. Reivindicación 22: La composición de un concentrado herbicida sólido de la reivindicación 21, caracterizada porque el componente de sal de herbicida de auxina comprende una sal de uno más herbicidas de auxina seleccionados del grupo que consiste en ácido 3,6-dicloro-2-metoxibenzoico (dicamba), ácido 2,4-diclorofenoxiacético (2,4-D), ácido 4-(2,4-diclorofenoxi)butírico (2,4-DB), dicloroprop, ácido 2-metil-4-clorofenoxiacético (MCPA), ácido 4-(4-cloro-2-metilfenoxi)butanoico (MCPB), ácido 4-clorofenoxiacético, ácido 2,4,5-triclorofenoxiacético (2,4,5-T), aminopiralid, clopiralid, fluroxipir, triclopir, mecoprop, picloram, quinclorac, aminociclopiraclor y mezclas de estos. Reivindicación 60: Un método para preparar una mezcla herbicida acuosa caracterizado porque comprende mezclar una composición de un concentrado herbicida sólido de cualquiera de las reivindicaciones 1 a 59 con agua. Reivindicación 63: Un proceso para preparar una composición de un concentrado herbicida sólido, caracterizado porque comprende mezclar glifosato ácido, una base y agua para formar una masa de reacción, donde la base comprende un catión formador de sales monovalente y la proporción molar entre el catión formador de sales monovalente y el glifosato ácido en la masa de reacción es de entre aproximadamente 1,2 y aproximadamente 1,75; disminuir el contenido de agua de la masa de reacción para producir una pasta herbicida; mezclar una sal de ácido monocarboxílico con la pasta herbicida; procesar la pasta herbicida que comprende la sal de glifosato y la sal de ácido monocarboxílico para formar gránulos herbicidas; y secar los gránulos herbicidas para producir una composición de un concentrado herbicida sólido.",MONSANTO TECHNOLOGY LLC,LEE PHILLIP KEVIN;;FRIEDMAN TODD CHARLES;;MACINNES ALISON;;DYSZLEWSKI ANDREW DUNCAN,,https://lens.org/099-413-887-712-217,Patent Application,no,0,0,16,16,0,A01N25/00;;A01N31/00;;A01N37/40;;A01N57/20;;A01N37/40;;A01N31/00;;A01N25/00;;A01N57/20;;A01N25/22,A01N25/00;;A01N37/40;;A01N57/20;;A01P13/00,,0,0,,,,ACTIVE
71,UY,A,UY 37356 A,151-687-365-834-630,2018-03-23,2018,UY 37356 A,2017-08-09,US 201662372586 P,2016-08-09,COMPOSICIONES DE CONCENTRADOS HERBICIDAS SÓLIDOS,"Composiciones de concentrados herbicidas sólidos que comprenden una o más sales de herbicidas, particularmente sales de herbicidas ácidos, por ejemplo, sales de glifosato, sales de glufosinato y/o sales de diversos herbicidas de auxina. Procesos para preparar composiciones de concentrados herbicidas sólidos. Métodos para usar las composiciones de concentrados herbicidas sólidos en la preparación de mezclas para aplicaciones herbicidas.",MONSANTO TECHNOLOGY LLC,PHILLIP KEVIN LEE;;TODD CHARLES FRIEDMAN;;ANDREW DUNCAN DYSZLEWSKI;;MACLNNES ALISON,,https://lens.org/151-687-365-834-630,Patent Application,no,0,0,16,16,0,A01N25/00;;A01N31/00;;A01N37/40;;A01N57/20;;A01N37/40;;A01N31/00;;A01N25/00;;A01N57/20;;A01N25/22,A01N57/20;;A01N37/40;;C07C63/70;;C07F9/38,,0,0,,,,PENDING
72,CA,A1,CA 3033440 A1,150-108-875-544-101,2018-02-15,2018,CA 3033440 A,2017-08-09,US 201662372586 P;;US 2017/0046012 W,2016-08-09,HERBICIDAL COMPOSITIONS COMPRISING GLYPHOSATE AND A MONOCARBOXYLIC ACID SALT,"The present invention generally relates to solid herbicidal concentrate compositions comprising one or more herbicide salts, particularly salts of acidic herbicides such as glyphosate salts, glufosinate salts, and/or various auxin herbicide salts. The present invention further relates to various processes for preparing the solid herbicidal concentrate compositions as well as methods of using the solid herbicidal concentrate compositions to prepare herbicidal application mixtures.",MONSANTO TECHNOLOGY LLC,DYSZLEWSKI ANDREW D;;FRIEDMAN TODD C;;LEE PHILLIP K;;MACINNES ALISON,,https://lens.org/150-108-875-544-101,Patent Application,no,0,0,16,16,0,A01N25/00;;A01N31/00;;A01N37/40;;A01N57/20;;A01N37/40;;A01N31/00;;A01N25/00;;A01N57/20;;A01N25/22,A01N25/00;;A01N31/00,,0,0,,,,PENDING
73,BR,A2,BR 112019002613 A2,109-800-052-261-922,2019-05-28,2019,BR 112019002613 A,2017-08-09,US 2017/0046012 W;;US 201662372586 P,2016-08-09,composições sólidas de concentrado de herbicida,"a presente invenção refere-se, de forma geral, a composições sólidas de concentrado de herbicida que compreendem um ou mais sais de herbicida, particularmente, sais de herbicidas ácidos, tais como sais de glifosato, sais de glufosinato e/ou diversos sais de herbicida de auxina. a presente invenção refere-se ainda a diversos processos para a preparação das composições sólidas de concentrado de herbicida, bem como a métodos de uso das composições sólidas de concentrado de herbicida para preparar misturas de aplicação herbicida.",MONSANTO TECHNOLOGY LLC,ALISON MACINNES;;ANDREW D DYSZLEWSKI;;PHILLIP K LEE;;TODD C FRIEDMAN,,https://lens.org/109-800-052-261-922,Patent Application,no,0,0,16,16,0,A01N25/00;;A01N31/00;;A01N37/40;;A01N57/20;;A01N37/40;;A01N31/00;;A01N25/00;;A01N57/20;;A01N25/22,A01N25/00;;A01N31/00,,0,0,,,,ACTIVE
74,MX,A,MX 2019001649 A,182-412-252-656-593,2019-06-10,2019,MX 2019001649 A,2017-08-09,US 201662372586 P;;US 2017/0046012 W,2016-08-09,SOLID HERBICIDAL CONCENTRATE COMPOSITIONS.,"The present invention generally relates to solid herbicidal concentrate compositions comprising one or more herbicide salts, particularly salts of acidic herbicides such as glyphosate salts, glufosinate salts, and/or various auxin herbicide salts. The present invention further relates to various processes for preparing the solid herbicidal concentrate compositions as well as methods of using the solid herbicidal concentrate compositions to prepare herbicidal application mixtures.",MONSANTO TECHNOLOGY LLC,ALISON MACINNES;;ANDREW D DYSZLEWSKI;;TODD C FRIEDMAN;;PHILLIP K LEE,,https://lens.org/182-412-252-656-593,Patent Application,no,0,0,16,16,0,A01N25/00;;A01N31/00;;A01N37/40;;A01N57/20;;A01N37/40;;A01N31/00;;A01N25/00;;A01N57/20;;A01N25/22,A01N25/00;;A01N31/00,,0,0,,,,PENDING
75,US,B1,US 6212600 B1,017-077-032-450-093,2001-04-03,2001,US 1026298 A,1998-01-21,US 1026298 A,1998-01-21,Method and apparatus for sanitization of fixed storage devices,"A method and apparatus are disclosed for sanitization of a fixed storage device interfaced to a computer system. The computer system is booted from a removable storage device that holds a bootable disk operating system and program code that is executed within the disk operating system. The fixed storage device is detected. The writeable space of the fixed storage device is then overwritten with a plurality of overwrite layers. Further, a report can be printed listing information about the sanitization process contemporaneously upon the completion of sanitization. In one embodiment, sanitizing is accomplished using a plurality of patterns, each layer having an associated pattern, to ensure that data can not be recovered even by destructive analysis.",INFRAWORKS CORP,FRIEDMAN GEORGE;;MARSHALL DAVID EARL;;STAREK ROBERT PHILLIP;;NELSON JAY R,GIGATRUST (2008-06-02);;GIGAMEDIA ACCESS CORPORATION (2019-07-31);;INFRAWORKS CORPORATION A CORP. OF DELAWARE (1998-09-30);;PINION SOFTWARE INC (2005-01-21),https://lens.org/017-077-032-450-093,Granted Patent,yes,3,52,1,1,0,G06F3/0623;;G06F3/0623;;G06F3/0652;;G06F3/0652;;G06F3/0674;;G06F3/0674;;G06F2221/2143;;G06F2221/2143,G06F3/06,711/112;;360/60;;713/200,3,0,,,"Guttman, ""Secure Deletion of Data From Magnetic and Solid-State Memory,"" 6th Usenix Security Symposium Proceedings, Jul. 1996.;;""The Norton Utilities Advanced Edition, Version 4.5"", pp. 1, 208-211, 1988.*;;""The Norton Trouble-Shooting Guide For Disks"", pp. 4-7, 1988.*",EXPIRED
76,AU,A1,AU 2022/224806 A1,091-258-008-341-483,2022-09-29,2022,AU 2022/224806 A,2022-09-01,AU 2022/224806 A;;AU 2017/308847 A;;US 201662372586 P;;US 2017/0046012 W,2016-08-09,Solid herbicidal concentrate compositions,"The present invention generally relates to solid herbicidal concentrate compositions comprising one or more herbicide salts, particularly salts of acidic herbicides such as glyphosate salts, glufosinate salts, and/or various auxin herbicide salts. The present invention further relates to various processes for preparing the solid herbicidal concentrate compositions as well as methods of using the solid herbicidal concentrate compositions to prepare herbicidal application mixtures.",MONSANTO TECHNOLOGY LLC,LEE PHILLIP K;;FRIEDMAN TODD C;;DYSZLEWSKI ANDREW D;;MACINNES ALISON,,https://lens.org/091-258-008-341-483,Patent Application,no,0,0,16,16,0,A01N25/00;;A01N31/00;;A01N37/40;;A01N57/20;;A01N37/40;;A01N31/00;;A01N25/00;;A01N57/20;;A01N25/22,A01N25/00;;A01N31/00,,0,0,,,,PENDING
77,AU,A1,AU 2017/308847 A1,184-453-020-848-469,2019-02-21,2019,AU 2017/308847 A,2017-08-09,US 201662372586 P;;US 2017/0046012 W,2016-08-09,Solid herbicidal concentrate compositions,"The present invention generally relates to solid herbicidal concentrate compositions comprising one or more herbicide salts, particularly salts of acidic herbicides such as glyphosate salts, glufosinate salts, and/or various auxin herbicide salts. The present invention further relates to various processes for preparing the solid herbicidal concentrate compositions as well as methods of using the solid herbicidal concentrate compositions to prepare herbicidal application mixtures.",MONSANTO TECHNOLOGY LLC,DYSZLEWSKI ANDREW D;;FRIEDMAN TODD C;;LEE PHILLIP K;;MACINNES ALISON,,https://lens.org/184-453-020-848-469,Patent Application,no,0,0,16,16,0,A01N25/00;;A01N31/00;;A01N37/40;;A01N57/20;;A01N37/40;;A01N31/00;;A01N25/00;;A01N57/20;;A01N25/22,A01N25/00;;A01N31/00,,0,0,,,,ACTIVE
78,US,B2,US 11129388 B2,160-050-138-359-049,2021-09-28,2021,US 201716324440 A,2017-08-09,US 201716324440 A;;US 201662372586 P;;US 2017/0046012 W,2016-08-09,Solid herbicidal concentrate compositions,"The present invention generally relates to solid herbicidal concentrate compositions comprising one or more herbicide salts, particularly salts of acidic herbicides such as glyphosate salts, glufosinate salts, and/or various auxin herbicide salts. The present invention further relates to various processes for preparing the solid herbicidal concentrate compositions as well as methods of using the solid herbicidal concentrate compositions to prepare herbicidal application mixtures.",MONSANTO TECHNOLOGY LLC,DYSZLEWSKI ANDREW D;;FRIEDMAN TODD C;;LEE PHILLIP K;;MACINNES ALISON,MONSANTO TECHNOLOGY LLC (2017-04-17),https://lens.org/160-050-138-359-049,Granted Patent,yes,31,0,16,16,0,A01N25/00;;A01N31/00;;A01N37/40;;A01N57/20;;A01N37/40;;A01N31/00;;A01N25/00;;A01N57/20;;A01N25/22,A01N57/20;;A01N25/00;;A01N25/22;;A01N31/00;;A01N37/40,,4,1,033-023-266-198-931,19071724;;10.1016/j.talanta.2006.12.047,"Kim, M., et al., “A Simplified Approach to the Determination of N-Nitroso Glyphosate in Technical Glyphosate Using HPLC with Post-Derivatization and Colorimetric Detection,” 2007, Talanta, 72:1054-1058, 5 pages.;;Analysis of N-Nitroso Glyphosate in Glyphosate Samples, LCGA, Downloaded Oct. 1, 2015, http://webcache.googleusercontent.com/...ch?q=cache:8CUETWf31bgJ:www.chromatographyonline.com/analysis-n-nitroso-glyphosate-glyphosate-samples+&cd=2&hl=en&ct=clnk&gl=us, 3 pages.;;International Search Report and Written Opinion issued in PCT/US2017/46012, dated Oct. 27, 2017.;;R.E.D. Facts, “Glyphosate”, EPA-738-F-93-011, Sep. 1993, Prevention, Pesticides and Toxic Substances (7508W), U.S. Environmental Protection Agency, 7 pages.",ACTIVE
79,ZA,B,ZA 201900790 B,164-568-699-704-422,2023-04-26,2023,ZA 201900790 A,2019-02-07,US 201662372586 P;;US 2017/0046012 W,2016-08-09,SOLID HERBICIDAL CONCENTRATE COMPOSITIONS,,MONSANTO TECHNOLOGY LLC,DYSZLEWSKI ANDREW D;;FRIEDMAN TODD C;;LEE PHILLIP K;;MACINNES ALISON,,https://lens.org/164-568-699-704-422,Granted Patent,no,0,0,16,16,0,A01N25/00;;A01N31/00;;A01N37/40;;A01N57/20;;A01N37/40;;A01N31/00;;A01N25/00;;A01N57/20;;A01N25/22,,,0,0,,,,ACTIVE
80,MX,A,MX 2022000462 A,044-438-422-943-387,2022-02-03,2022,MX 2022000462 A,2019-02-08,US 201662372586 P,2016-08-09,SOLID HERBICIDAL CONCENTRATE COMPOSITIONS.,"The present invention generally relates to solid herbicidal concentrate compositions comprising one or more herbicide salts, particularly salts of acidic herbicides such as glyphosate salts, glufosinate salts, and/or various auxin herbicide salts. The present invention further relates to various processes for preparing the solid herbicidal concentrate compositions as well as methods of using the solid herbicidal concentrate compositions to prepare herbicidal application mixtures.",MONSANTO TECHNOLOGY LLC,MACINNES ALISON;;DYSZLEWSKI ANDREW D;;FRIEDMAN TODD C;;LEE PHILLIP K,,https://lens.org/044-438-422-943-387,Patent Application,no,0,0,16,16,0,A01N25/00;;A01N31/00;;A01N37/40;;A01N57/20;;A01N37/40;;A01N31/00;;A01N25/00;;A01N57/20;;A01N25/22,A01N25/00;;A01N25/22;;A01N31/00;;A01N37/40;;A01N57/20,,0,0,,,,PENDING
81,WO,A1,WO 2018/031610 A1,044-346-551-493-417,2018-02-15,2018,US 2017/0046012 W,2017-08-09,US 201662372586 P,2016-08-09,SOLID HERBICIDAL CONCENTRATE COMPOSITIONS,"The present invention generally relates to solid herbicidal concentrate compositions comprising one or more herbicide salts, particularly salts of acidic herbicides such as glyphosate salts, glufosinate salts, and/or various auxin herbicide salts. The present invention further relates to various processes for preparing the solid herbicidal concentrate compositions as well as methods of using the solid herbicidal concentrate compositions to prepare herbicidal application mixtures.",MONSANTO TECHNOLOGY LLC,DYSZLEWSKI ANDREW D;;FRIEDMAN TODD C;;LEE PHILLIP K;;MACINNES ALISON,,https://lens.org/044-346-551-493-417,Patent Application,yes,6,3,16,16,0,A01N25/00;;A01N31/00;;A01N37/40;;A01N57/20;;A01N37/40;;A01N31/00;;A01N25/00;;A01N57/20;;A01N25/22,A01N25/00;;A01N31/00,,0,0,,,,PENDING
82,BR,B1,BR 112019002613 B1,195-619-168-836-807,2023-03-07,2023,BR 112019002613 A,2017-08-09,US 2017/0046012 W;;US 201662372586 P,2016-08-09,"COMPOSIÇÕES SÓLIDAS DE CONCENTRADO DE HERBICIDA, SEUS PROCESSOS DE PREPARAÇÃO, E MÉTODO PARA PREPARAÇÃO DE UMA MISTURA AQUOSA DE HERBICIDA","A presente invenção refere-se, de forma geral, a composições sólidas de concentrado de herbicida que compreendem um ou mais sais de herbicida, particularmente, sais de herbicidas ácidos, tais como sais de glifosato, sais de glufosinato e/ou diversos sais de herbicida de auxina. A presente invenção refere-se ainda a diversos processos para a preparação das composições sólidas de concentrado de herbicida, bem como a métodos de uso das composições sólidas de concentrado de herbicida para preparar misturas de aplicação herbicida.",MONSANTO TECHNOLOGY LLC,ANDREW D DYSZLEWSKI;;TODD C FRIEDMAN;;PHILLIP K LEE;;ALISON MACINNES,,https://lens.org/195-619-168-836-807,Granted Patent,no,0,0,16,16,0,A01N25/00;;A01N31/00;;A01N37/40;;A01N57/20;;A01N37/40;;A01N31/00;;A01N25/00;;A01N57/20;;A01N25/22,A01N25/00;;A01N31/00,,0,0,,,,ACTIVE
83,US,A1,US 2019/0208787 A1,025-705-962-756-309,2019-07-11,2019,US 201716324440 A,2017-08-09,US 201716324440 A;;US 201662372586 P;;US 2017/0046012 W,2016-08-09,SOLID HERBICIDAL CONCENTRATE COMPOSITIONS,"The present invention generally relates to solid herbicidal concentrate compositions comprising one or more herbicide salts, particularly salts of acidic herbicides such as glyphosate salts, glufosinate salts, and/or various auxin herbicide salts. The present invention further relates to various processes for preparing the solid herbicidal concentrate compositions as well as methods of using the solid herbicidal concentrate compositions to prepare herbicidal application mixtures.",MONSANTO TECHNOLOGY LLC,DYSZLEWSKI ANDREW D;;FRIEDMAN TODD C;;LEE PHILLIP K;;MACINNES ALISON,MONSANTO TECHNOLOGY LLC (2017-04-17),https://lens.org/025-705-962-756-309,Patent Application,yes,0,0,16,16,0,A01N25/00;;A01N31/00;;A01N37/40;;A01N57/20;;A01N37/40;;A01N31/00;;A01N25/00;;A01N57/20;;A01N25/22,A01N57/20;;A01N25/22;;A01N37/40,,0,0,,,,ACTIVE
84,CL,A1,CL 2019000321 A1,027-701-727-958-001,2019-06-07,2019,CL 2019000321 A,2019-02-07,US 201662372586 P,2016-08-09,Composiciones de concentrados herbicidas sólidos.,"COMPOSICIONES DE CONCENTRADOS HERBICIDAS SÓLIDOS QUE COMPRENDEN UNA O MÁS SALES DE HERBICIDAS, PARTICULARMENTE SALES DE HERBICIDAS ÁCIDOS, POR EJEMPLO, SALES DE GLIFOSATO, SALES DE GLUFOSINATO Y/O SALES DE DIVERSOS HERBICIDAS DE AUXINA. PROCESOS PARA PREPARAR COMPOSICIONES DE CONCENTRADOS HERBICIDAS SÓLIDOS. MÉTODOS PARA USAR LAS COMPOSICIONES DE CONCENTRADOS HERBICIDAS SÓLIDOS EN LA PREPARACIÓN DE MEZCLAS PARA APLICACIONES HERBICIDAS.",MONSANTO TECHNOLOGY LLC,FRIEDMAN TODD C;;MACINNES ALISON;;LEE PHILLIP K;;DYSZLEWSKI ANDREW D,,https://lens.org/027-701-727-958-001,Patent Application,no,0,0,16,16,0,A01N25/00;;A01N31/00;;A01N37/40;;A01N57/20;;A01N37/40;;A01N31/00;;A01N25/00;;A01N57/20;;A01N25/22,A01N25/00;;A01N31/00,,0,0,,,,PENDING
85,US,B1,US 7579887 B1,008-583-440-640-406,2009-08-25,2009,US 2445708 A,2008-02-01,US 2445708 A,2008-02-01,Technique for efficiently managing both short-term and long-term frequency adjustments of an electronic circuit clock signal,"A control system for generating an electronic circuit clock signal that can optimize operating frequency margins by responding to short term effects by quickly varying the clock frequency and long term effects by finding an optimal frequency point. A sensor indicates frequency margins associated with safe use of the clock signal, and these frequency margins are input into a frequency compensator and used to determine whether the system is operating within acceptable margins, or alternatively to modify the operating clock frequency on a short-term basis in order to achieve acceptable operating margins. The requests for frequency adjustment by the frequency compensator are provided to a frequency filter, which combines such request with a maintained/accumulated history of previous short-term frequency requests that have previously been made in order to determine whether an update needs to be made to the target frequency to provide long-term frequency control.",INTERNAT BSUINESS MACHINES COR,FRIEDMAN DANIEL JOSEPH;;RESTIE PHILLIP JOHN;;RYLYAKOV ALEXANDER V;;TIERNO JOSE A,INTERNATIONAL BUSINESS MACHINES CORPORATION (2008-01-31),https://lens.org/008-583-440-640-406,Granted Patent,yes,9,5,2,2,0,H03L7/08;;H03L7/093;;H03L7/0991;;H03L2207/50;;H03L7/093;;H03L7/0991;;H03L2207/50;;H03L7/08,H03L7/00,327/156;;327/159,3,1,013-563-679-549-690,10.1109/tc.2005.34,"Uht, A.K., ""Uniprocessor Performance Enhancement Through Adaptive Clock Frequency Control"", IEEE Computer Society, vol. 54, No. 2, Feb. 2005. pp. 132-140.;;Liotta, ""Wide Range of Output Frequencies Differentiates Fully Integrated Clock"",retrieved Mar. 3, 2008, pp. 1-3. http://electronicdesign.com/Article/Index.cfm?AD=1&ArticleID=9611.;;Mahashin, ""Optimize Timing Margins For Your High-Speed Interface"", retrieved on Mar. 5, 2008, pp. 1-9. http://electronicdesign.com/Article/Index.cfm?AD=1&ArticleID=9611.",INACTIVE
86,US,A1,US 2009/0195275 A1,023-234-115-015-322,2009-08-06,2009,US 2445708 A,2008-02-01,US 2445708 A,2008-02-01,TECHNIQUE FOR EFFICIENTLY MANAGING BOTH SHORT-TERM AND LONG-TERM FREQUENCY ADJUSTMENTS OF AN ELECTRONIC CIRCUIT CLOCK SIGNAL,"A control system for generating an electronic circuit clock signal that can optimize operating frequency margins by responding to short term effects by quickly varying the clock frequency and long term effects by finding an optimal frequency point. A sensor indicates frequency margins associated with safe use of the clock signal, and these frequency margins are input into a frequency compensator and used to determine whether the system is operating within acceptable margins, or alternatively to modify the operating clock frequency on a short-term basis in order to achieve acceptable operating margins. The requests for frequency adjustment by the frequency compensator are provided to a frequency filter, which combines such request with a maintained/accumulated history of previous short-term frequency requests that have previously been made in order to determine whether an update needs to be made to the target frequency to provide long-term frequency control.",FRIEDMAN DANIEL JOSEPH;;RESTIE PHILLIP JOHN;;RYLYAKOV ALEXANDER V;;TIERNO JOSE A,FRIEDMAN DANIEL JOSEPH;;RESTIE PHILLIP JOHN;;RYLYAKOV ALEXANDER V;;TIERNO JOSE A,INTERNATIONAL BUSINESS MACHINES CORPORATION (2008-01-31),https://lens.org/023-234-115-015-322,Patent Application,yes,9,18,2,2,0,H03L7/08;;H03L7/093;;H03L7/0991;;H03L2207/50;;H03L7/093;;H03L7/0991;;H03L2207/50;;H03L7/08,H03L7/085,327/156,0,0,,,,INACTIVE
87,US,A1,US 2018/0189349 A1,045-007-240-249-345,2018-07-05,2018,US 201615396291 A,2016-12-30,US 201615396291 A,2016-12-30,TECHNIQUES AND ARCHITECTURES FOR PROVIDING AND OPERATING AN APPLICATION-AWARE DATABASE ENVIRONMENT WITH PREDICTIVE EXECUTION OF QUERIES AND QUERY FLOWS,Predictive execution of query flows in an application aware database environment. A repository of previously received and registered database queries along with at least corresponding metadata having information about database query flows generating the database queries is maintained. Application metadata corresponding to a subsequent database query is received. The repository is checked to determine if the application metadata matches one of the previously received and registered database query flows. One or more queries corresponding to the query flow from the repository is/are retrieved if a match is determined. Execution of the retrieved one or more database queries is started prior to receiving the query from outside the repository.,SALESFORCE COM INC,SIROHI ARJUN KUMAR;;TANEJA VIKAS;;LICHONG KIM PHILLIP;;FRIEDMAN MICHAEL ALLAN;;SHARMA VIDUSHI,SALESFORCE.COM INC (2017-01-04),https://lens.org/045-007-240-249-345,Patent Application,yes,6,7,2,2,0,G06F16/24539;;G06F16/24539,G06F17/30,,0,0,,,,ACTIVE
88,DK,B,DK 138092 B,180-590-225-253-325,1978-07-10,1978,DK 99076 A,1976-03-08,DK 99076 A,1976-03-08,Hjælpesalgsautomat.,,REYNOLDS TOBACCO CO R,ALLDRED CYRUS A;;KECSETI FRANK M;;JACOBS PHILLIP F;;FRIEDMAN EVELYN;;SOUTHALL PETER,,https://lens.org/180-590-225-253-325,Patent Application,no,0,0,3,3,0,,G07F11/04,,0,0,,,,EXPIRED
89,CA,A,CA 1030923 A,014-542-495-958-696,1978-05-09,1978,CA 247323 A,1976-03-08,CA 247323 A,1976-03-08,AUXILIARY VENDING MACHINE,,REYNOLDS TOBACCO CO R,ALLDRED CYRUS A;;KECSETI FRANK M;;JACOBS PHILLIP F;;FRIEDMAN EVELYN;;SOUTHALL PETER,,https://lens.org/014-542-495-958-696,Granted Patent,no,0,0,1,1,0,,,221-31,0,0,,,,EXPIRED
90,DE,A1,DE 2609581 A1,038-074-026-226-587,1977-09-22,1977,DE 2609581 A,1976-03-08,DE 2609581 A,1976-03-08,Extension unit for cigarette vending machine - offers further selection using coin mechanism of main machine,"The supplementary vending machine may be used in conjunction with a main machine, especially an automatic cigarette machine, to extend the range of goods offered without excessive complication of the machinery. Output units (28) of the supplementary machine are connected with those of the main machine (72) and its coin checker so that insertion of a correct coin in the main machine can release the output units of either machine. Withdrawal of a drawer in either machine by the purchaser locks all drawers of both machines until his purchase has been extracted.",REYNOLDS TOBACCO CO R,ALLDRED JUN CYRUS A;;KECSETI FRANK M;;JACOBS PHILLIP F;;FRIEDMAN EVELYN;;SOUTHALL OF WHITEHALL PETER,,https://lens.org/038-074-026-226-587,Patent Application,no,0,1,1,1,0,G07F5/18;;G07F5/18;;G07F9/002;;G07F9/002,G07F5/18,,0,0,,,,PENDING
91,US,B1,US 6314437 B1,043-254-423-231-848,2001-11-06,2001,US 57651800 A,2000-05-23,US 57651800 A;;US 11475698 A;;US 94074697 A,1997-09-30,Method and apparatus for real-time secure file deletion,"A method and apparatus are provided that enhance file system calls to a file system structure of an operating system. In particular, file system calls can be enhanced to provide real-time secure file deletion on an ongoing basis. A file system call that is intended to perform a function with respect to data stored on a storage device is intercepted. It is then determined whether the file system call is of a type that should be processed. If not, the original file system call is passed on through the file system. If the file system call should be processed, supplemental processing is performed to enhance the original file system call and the file system call is transparently returned to the calling system application. In embodiment, real-time secure file deletion is implemented using a vendor supplied driver (VSD) executing within the installable file system (IFS) of WINDOWS 95. Further, a method and system are disclosed for real-time secure data deletion in a system having an NTFS file system. Read calls are monitored using a read filter and pointers to NTFS metafiles and page files are recognized and stored. Write calls are monitored using a write filter and real-time secure data deletion of buffers is performed. File creation operations are monitored and real-time secure data deletion of user files is performed when the file is to be overwritten. Further, set information operations are monitored and real-time secure data deletion is performed for truncated, shrunk or deleted user files.",INFRAWORKS CORP,STAREK ROBERT PHILLIP;;FRIEDMAN GEORGE;;MARSHALL DAVID EARL;;CHAMBERS JASON LEE;;MOORMAN MICHAEL J;;NEWGARD TERRY S,GIGATRUST (2008-06-02);;GIGAMEDIA ACCESS CORPORATION (2019-07-31);;STRATFOR SYSTEMS INC (1998-07-28);;PINION SOFTWARE INC (2005-01-21),https://lens.org/043-254-423-231-848,Granted Patent,yes,17,69,4,5,0,G06F2221/2143;;G06F16/162;;G06F16/162;;G06F2221/2143;;Y10S707/99957;;Y10S707/99953,G06F17/30,707/206;;707/205;;707/200,7,0,,,"Russinovich et al., Examining the windows 95 Layered File System, http://www.ddj.com, Dec. 1995.*;;Inside the Windows NT File System, chapter 2 p. 11-23, Dec. 1995.*;;Examining the Windows 95 Layered File Systems, by Mark Russinovich and Bryce Cogswell, Dr. Dobb's Journal, Dec. 1995.;;Inside the Windows 95 File System, Stan Mitchell, O'Reilly & Associates, Inc., pp. 124-143; 202-203.;;Matlock et al., Microsoft Windows NT step by step, Microsoft Press, pp. 92-94, Jan. 1994.;;NTFS obtained via the Internet, http://fuhs.ropnorth.org/network/hardware/boot/NTFS.html, Jun. 1999.;;Snoop-Proof Your PC obtained from the Internet www.infowar.comp/p.sub.-and.sub.-s/p.sub.-and.sub.-s 022498c printed Dec. 30, 1998, two pages.",EXPIRED
92,AU,A,AU 1998/095884 A,101-071-156-275-896,1999-04-23,1999,AU 1998/095884 A,1998-09-29,US 94074697 A;;US 11475698 A;;US 9820334 W,1997-09-30,Method and apparatus for real-time secure file deletion,,STRATFOR SYSTEMS INC,STAREK ROBERT PHILLIP;;FRIEDMAN GEORGE;;MARSHALL DAVID EARL;;CHAMBERS JASON LEE;;MOORMAN MICHAEL J;;NEWGARD TERRY S,,https://lens.org/101-071-156-275-896,Patent Application,no,0,0,4,5,0,G06F2221/2143;;G06F16/162;;G06F16/162;;G06F2221/2143;;Y10S707/99957;;Y10S707/99953,G06F17/30,,0,0,,,,DISCONTINUED
93,WO,A1,WO 1999/017233 A1,167-425-147-301-685,1999-04-08,1999,US 9820334 W,1998-09-29,US 94074697 A;;US 11475698 A,1997-09-30,METHOD AND APPARATUS FOR REAL-TIME SECURE FILE DELETION,"A method and apparatus are provided that enhance file system calls to a file system structure of an operating system. In particular, file system calls can be enhanced to provide real-time secure file deletion on an ongoing basis. A file system call that is intended to perform a function with respect to data stored on a storage device is intercepted. It is then determined whether the file system call is of a type that should be processed. If not, the original file system call is passed on through the file system. If the file system call should be processed, supplemental processing is performed to enhance the original file system call and the file system call is transparently returned to the calling system application. In embodiment, real-time secure file deletion is implemented using a vendor supplied driver (VSD) executing within the installable file system (IFS) of WINDOWS 95. Further, a method and system are disclosed for real-time secure data deletion in a system having an NTFS file system. Read calls are monitored using a read filter and pointers to NTFS metafiles and page files are recognized and stored. Write calls are monitored using a write filter and real-time secure data deletion of buffers is performed. File creation operations are monitored and real-time secure data deletion of user files is performed when the file is to be overwritten. Further, set information operations are monitored and real-time secure data deletion is performed for truncated, shrunk or deleted user files.",STRATFOR SYSTEMS INC,STAREK ROBERT PHILLIP;;FRIEDMAN GEORGE;;MARSHALL DAVID EARL;;CHAMBERS JASON LEE;;MOORMAN MICHAEL J;;NEWGARD TERRY S,,https://lens.org/167-425-147-301-685,Patent Application,yes,3,2,4,5,0,G06F2221/2143;;G06F16/162;;G06F16/162;;G06F2221/2143;;Y10S707/99957;;Y10S707/99953,G06F17/30,,0,0,,,,PENDING
94,US,A,US 6070174 A,077-086-386-513-38X,2000-05-30,2000,US 11475698 A,1998-07-13,US 11475698 A;;US 94074697 A,1997-09-30,Method and apparatus for real-time secure file deletion,"A method and apparatus are provided that enhance file system calls to a file system structure of an operating system. In particular, file system calls can be enhanced to provide real-time secure file deletion on an ongoing basis. A file system call that is intended to perform a function with respect to data stored on a storage device is intercepted. It is then determined whether the file system call is of a type that should be processed. If not, the original file system call is passed on through the file system. If the file system call should be processed, supplemental processing is performed to enhance the original file system call and the file system call is transparently returned to the calling system application. In embodiment, real-time secure file deletion is implemented using a vendor supplied driver (VSD) executing within the installable file system (IFS) of WINDOWS 95. Further, a method and system are disclosed for real-time secure data deletion in a system having an NTFS file system. Read calls are monitored using a read filter and pointers to NTFS metafiles and page files are recognized and stored. Write calls are monitored using a write filter and real-time secure data deletion of buffers is performed. File creation operations are monitored and real-time secure data deletion of user files is performed when the file is to be overwritten. Further, set information operations are monitored and real-time secure data deletion is performed for truncated, shrunk or deleted user files.",INFRAWORKS CORP,STAREK ROBERT PHILLIP;;FRIEDMAN GEORGE;;MARSHALL DAVID EARL;;CHAMBERS JASON LEE;;MOORMAN MICHAEL J;;NEWGARD TERRY S,GIGATRUST (2008-06-02);;GIGAMEDIA ACCESS CORPORATION (2019-07-31);;PINION SOFTWARE INC (2005-01-21),https://lens.org/077-086-386-513-38X,Granted Patent,yes,13,139,4,5,0,G06F2221/2143;;G06F16/162;;G06F16/162;;G06F2221/2143;;Y10S707/99957;;Y10S707/99953,G06F17/30,707/206;;707/205;;707/200,8,0,,,"Workplace: The Messy Business of Culling Computer Files, Alex Markels, The Wall Street Journal , May 22, 1997.;;Examining the Windows 95 Layered File Systems, by Mark Russinovich and Bryce Cogswell, Dr. Dobb s Journal , Dec. 1995.;;The Windows 95 File Systems, 1996 Knowles Consulting .;;Disk Partitioning Under FAT File System Saves Disk Space and Aids in Organization, Sidney D. Peters, Peters Computer Services .;;Inside the Windows 95 File System, Stan Mitchell, O Reilly & Associates, Inc. , pp. 124 143; 202 203.;;Matlock et al., Microsoft Windows NT step by step, Microsoft Press, pp. 92 94, Jan. 1994.;;NTFS obtained via the internet, http://fuhs.ropnorth.org/network/hardware/boot/NTFS.html , Jun. 1999.;;SNOOP PROOF YOUR PC obtained from the Internet www.infowar.comp/p and s/p and s 022498c printed Dec. 30, 1998, two pages.",EXPIRED
95,US,A,US 5457736 A,015-906-220-044-263,1995-10-10,1995,US 22678994 A,1994-04-12,US 22678994 A,1994-04-12,System and method for providing microcellular personal communications services (PCS) utilizing embedded switches,"A system and method adapted to provide microcellular Personal Communications Services (PCS) through the use of an improved Distributed Radio Port Controller (DRPC) architecture. The architecture achieves the desired handover with minimal impact on the existing embedded base of switches by generating new calls from target Radio Port Controllers (RPCs) through the switches to anchor RPCs and internally bridging bearer channels without the knowledge of the switches. The system includes a Home Location Register (HLR) for storing and providing subscription data and keeping track of where the mobile terminals are registered in order to deliver calls. A PCS# database is also utilized for storing a list of Universal Personal Telephone (UPT) numbers which have been assigned to the PCS subscribers. The PCS# database is operable to map these UPT numbers to the locations of their corresponding HLR. The system further includes a Service Control Point (SCP) which is provided in electrical communication with the switch, the HLR, and the PCS# database and which is operable to query the HLR for routing information and provide the received response to the switch.",US WEST TECHNOLOGIES INC,CAIN MICHAEL E;;FRIEDMAN JO A;;KAMAT PURUSHOTTAM V;;REDDICK PHILLIP D;;REINIG PETER L;;SIROVICA DEJAN,U S WEST TECHNOLOGIES INC (1994-04-11);;COMCAST MO GROUP INC (2002-11-18);;QWEST COMMUNICATIONS INTERNATIONAL INC (2000-06-30);;MEDIAONE GROUP INC (1998-06-12),https://lens.org/015-906-220-044-263,Granted Patent,yes,7,145,1,2,0,H04L12/6418;;H04L2012/6421;;H04L2012/6443;;H04L2012/6472;;H04L2012/6475;;H04L2012/6486;;H04M7/006;;H04M2207/18;;H04Q3/005;;H04Q2213/13513;;H04Q2213/13517;;H04Q2213/13532;;H04Q2213/13547;;H04W8/02;;H04W8/12;;H04W92/02;;H04W92/24;;H04L9/40;;H04W8/02;;H04W8/12;;H04L2012/6421;;H04L2012/6472;;H04Q3/005;;H04Q2213/13547;;H04Q2213/13513;;H04Q2213/13517;;H04M7/006;;H04Q2213/13532;;H04W92/02;;H04L2012/6475;;H04L12/6418;;H04W92/24;;H04L2012/6443;;H04L2012/6486;;H04M2207/18;;H04L9/40,H04L12/56;;H04L12/64;;H04L29/06;;H04M7/00;;H04Q3/00;;H04W8/02;;H04W8/12;;H04W92/02;;H04W92/24,379/60;;455/33.2;;455/56.1,3,1,119-977-569-545-764,10.1109/35.127560,"Cellular Mobile Radio as on Intelligent Network Application M. Ballard, E. Issenmann, M. Moya Sanchez, Electrical Communication vol. 63 4, 1989.;;Intelligent Network Concepts in Mobile Communications Bijan Jabbari IEEE Communications Magazine, Feb. 1992.;;System 900: The ISDN Approach to Cellular Mobile Radio M. Wizgall, W. Weiss Electrical Communication vol. 63 4, 1989.",EXPIRED
96,US,B1,US 6175752 B1,171-204-547-472-999,2001-01-16,2001,US 7067798 A,1998-04-30,US 7067798 A,1998-04-30,Analyte monitoring device and methods of use,"An analyte monitor includes a sensor, a sensor control unit, and a display unit. The sensor has, for example, a substrate, a recessed channel formed in the substrate, and conductive material disposed in the recessed channel to form a working electrode. The sensor control unit typically has a housing adapted for placement on skin and is adapted to receive a portion of an electrochemical sensor. The sensor control unit also includes two or more conductive contacts disposed on the housing and configured for coupling to two or more contact pads on the sensor. A transmitter is disposed in the housing and coupled to the plurality of conductive contacts for transmitting data obtained using the sensor. The display unit has a receiver for receiving data transmitted by the transmitter of the sensor control unit and a display coupled to the receiver for displaying an indication of a level of an analyte. The analyte monitor may also be part of a drug delivery system to alter the level of the analyte based on the data obtained using the sensor.",THERASENSE INC,SAY JAMES;;TOMASCO MICHAEL F;;HELLER ADAM;;GAL YORAM;;HELLER EPHRAIM;;PLANTE PHILLIP JOHN;;VREEKE MARK S;;FRIEDMAN KEITH A,E. HELLER & CO (1998-07-02);;ABBOTT DIABETES CARE INC (2000-03-13),https://lens.org/171-204-547-472-999,Granted Patent,yes,117,2732,211,221,0,A61B5/14532;;A61B5/14532;;A61B5/0002;;A61B5/0002;;A61B5/002;;A61B5/01;;A61B5/14503;;A61B5/1451;;A61B5/14546;;A61B5/14546;;A61B5/1473;;A61B5/1473;;A61B5/1486;;A61B5/1486;;A61B5/14865;;A61B5/1495;;A61B5/4839;;A61B5/72;;A61B5/7278;;A61B5/7282;;A61B5/7405;;A61B5/743;;A61B5/7445;;A61B5/7445;;A61B5/7455;;A61B2560/0252;;A61B2560/0252;;A61M5/1723;;C12Q1/54;;G16H10/40;;G16H10/40;;G16H20/17;;G16H20/17;;H01L23/3107;;H01L23/3107;;H01L23/49548;;H01L23/49548;;H01L2924/0002;;H01L2924/0002;;H01L2924/19041;;H01L2924/19041;;H01L2924/3011;;H01L2924/3011;;Y10S128/903;;Y10S128/903;;Y10T29/49;;Y10T29/49;;Y10T29/49124;;Y10T29/49124,G01N27/30;;A61B5/00;;A61B5/145;;A61B5/1477;;A61B5/1495;;G01N27/416;;G06F19/00;;H01L23/31;;H01L23/495,600/345;;600/365;;128/903,99,89,062-360-289-025-864;;010-601-725-111-91X;;101-292-518-663-191;;014-700-576-603-812;;033-562-815-299-181;;058-476-824-396-350;;000-125-755-474-124;;015-985-399-299-132;;081-249-097-078-543;;089-612-747-111-646;;082-114-500-909-975;;004-239-090-971-580;;026-894-457-160-450;;077-128-610-778-669;;009-725-244-669-882;;007-500-825-916-378;;037-755-689-613-42X;;012-449-714-188-064;;031-517-704-996-130;;131-299-284-996-064;;049-133-049-742-708;;000-272-178-768-076;;070-797-683-833-124;;032-860-147-271-886;;132-460-374-211-421;;052-364-430-129-757;;037-898-018-686-909;;130-044-667-529-69X;;065-221-074-461-027;;017-934-465-161-477;;101-660-130-379-529;;056-662-192-844-472;;131-420-472-995-124;;000-292-848-642-076;;037-547-642-717-655;;011-361-512-574-415;;006-033-609-366-053;;045-087-287-424-000;;112-172-675-119-141;;012-348-107-238-223;;057-907-035-573-356;;056-088-679-719-231;;158-841-328-840-967;;096-846-866-019-020;;046-051-917-287-322;;132-477-256-994-251;;126-256-551-957-406;;107-031-219-451-407;;070-035-450-644-84X;;073-842-915-397-35X;;002-244-337-345-21X;;068-386-284-377-434;;084-058-419-754-426;;011-920-220-103-986;;186-568-798-241-628;;083-932-858-886-510;;017-237-987-892-02X;;077-944-356-331-559;;015-613-189-270-414;;041-852-924-917-140;;052-850-283-559-75X;;047-861-542-219-382;;062-540-858-075-06X;;054-358-164-375-163;;031-531-088-033-656;;051-006-667-298-94X;;047-733-435-485-371;;003-067-671-137-047;;007-135-567-040-648;;006-536-656-748-868;;077-626-976-841-740;;035-535-925-014-211;;072-940-861-593-031;;024-011-256-425-251;;025-030-453-190-842;;030-775-076-635-419;;061-539-442-167-302;;008-149-576-479-541;;014-861-759-005-556;;035-211-086-138-107;;138-961-462-563-877;;115-233-158-409-162;;101-078-880-152-485;;007-757-545-982-964;;065-365-061-588-814;;116-750-608-164-513;;176-190-698-353-230;;063-392-112-944-585;;017-293-343-302-991,10.1021/ja00391a001;;2889225;;10.1098/rstb.1987.0021;;10.1109/51.294001;;10.1016/0265-928x(87)80018-4;;3333622;;10.1021/ac00017a008;;1789439;;8277748;;10.1016/0141-5425(93)90058-7;;236018;;10.1016/0005-2795(75)90259-7;;505005;;10.1126/science.505005;;6721151;;10.1021/ac00268a018;;6733082;;10.1021/bi00305a016;;4500021;;10.1007/978-1-4684-3288-6_18;;14021529;;10.1111/j.1749-6632.1962.tb13623.x;;3196517;;10.2337/diacare.10.5.622;;3677983;;7978306;;10.1021/ac00091a022;;7733469;;10.1021/ac00103a015;;10.1007/bf01248238;;10.1016/0265-928x(85)80002-x;;10.1021/j100290a001;;10.1021/ja00216a040;;10.1021/ja00188a091;;10.1021/ja00406a011;;2624333;;10.1021/ac00250a038;;10.1021/ac00266a005;;10.1021/ja00415a014;;10.1016/0022-0728(85)87006-6;;10.1021/ja00434a018;;10.1039/f19868201259;;3245585;;10.1021/ac00173a008;;2889234;;10.1098/rstb.1987.0020;;10.1016/0003-2670(91)85072-z;;10.1021/ac00202a007;;2305956;;10.1021/j100168a046;;10.1021/ja00191a084;;10.1021/ac00170a003;;3239784;;4356378;;10.1016/0925-4005(93)85356-f;;10.1021/j100188a007;;10.1021/ar00173a002;;10.1021/ac00236a033;;10.1021/ac00244a019;;10.1271/bbb1961.49.541;;10.1021/ja00415a004;;10.1021/ac00245a028;;10.1016/0925-4005(91)80225-9;;3842604;;10.1016/0265-928x(85)80005-5;;10.1149/1.2095533;;10.1021/ja00087a065;;1590584;;10.1021/ac00033a009;;10.1039/ft9969204131;;10.1016/0956-5663(91)85005-h;;2049169;;10.1016/0302-4598(90)80030-m;;10.1055/s-2007-1001749;;7875647;;10.1039/ft9938900361;;10.1021/ac00047a003;;1463213;;2712293;;10.1021/ac00176a006;;10.1016/0304-4165(85)90250-8;;3967047;;10.1016/0956-5663(92)85030-e;;1632948;;7926347;;10.1007/s001250050155;;10.1007/bf00403381;;10.1007/bf00400921;;1373393;;6130453;;10.1016/0024-3205(82)90736-6;;10.1016/0005-2744(76)90084-x;;182278;;10.1021/ac00071a031;;8297033;;8092486;;10.1021/ac00087a008;;10.1007/bf00580834;;567324;;10.1016/0022-0728(89)87165-7;;3812989;;10.1016/0003-2697(86)90315-5;;10.1016/0022-0728(95)04020-o;;10.1021/ja00047a065;;7763951;;10.1016/0167-7799(93)90016-3;;10.1007/bf00265097;;2666212;;10.1016/0265-928x(89)80026-4;;2719726;;1759711;;10.1021/ac00020a014;;10.1007/bf00404077;;8359584;;1457093;;10.1016/0956-5663(92)85010-8;;1751159;;10.1021/ja00540a026;;10.1021/ac00030a001;;10.1021/ac00030a718;;1580356;;2673892;;10.1007/bf00285330;;10.1016/0925-4005(93)85391-m;;10.1021/ja00392a010;;10.1021/ac00210a004;;2889233;;10.1098/rstb.1987.0019;;10.1016/0368-1874(83)80336-0;;10.1007/bf00250158;;6341145;;10.1021/ac00260a039;;10.1002/elan.1140080608;;7875646;;10.1055/s-2007-1001748,"Abruna, H. D. et al., ""Rectifying Interfaces Using Two-Layer, Films of Electrochemically Polymerized Vinylpyridine and Vinylbipyridine Complexes of Ruthenium and Iron on Electrodes,"" J. Am. Chem. Soc., 103(1):1-5 (Jan. 14, 1981).;;Albery, W. J. et al., ""Amperometric enzyme electrodes. Part II. Conducting salts as electrode materials for the oxidation of glucose oxidase,"" J. Electroanal. Chem. Interfacial Electrochem., 194(2) (1 page-Abstract only) (1985).;;Albery, W. J. et al., ""Amperometric Enzyme Electrodes,"" Phil. Trans. R Soc. Lond. B316:107-119 (1987).;;Alcock, S. J. et al., ""Continuous Analyte Monitoring to Aid Clinical Practice,"" IEEE Engineering in Medicine and Biology, 319-325 (1994).;;Anderson, L. B. et al., ""Thin-Layer Electrochemistry: Steady-State Methods of Studying Rate Processes,"" J. Electroanal. Chem., 10:295-395 (1965).;;Bartlett, P. N. et al., ""Covalent Binding of Electron Relays to Glucose Oxidation,"" J. Chem. Soc. Chem. Commun., 1603-1604 (1987).;;Bartlett, P. N. et al., ""Modification of glucose oxidase by tetrathiafulvalene,"" J. Chem. Soc., Chem. Commun., 16 (1 page-Abstract only) (1990).;;Bartlett, P. N. et al., ""Strategies for the Development of Amperometric Enzyme Electrodes,"" Biosensors, 3:359-379 (1987/88).;;Bindra, D.S. et al., ""Design and in Vitro Studies of a Needle-Type Glucose Sensor for Subcutaneous Monitoring"", Anal. Chem., 63(17):1692-1696 (Sep. 1, 1991).;;Bobbioni-Harsch, E. et al., ""Lifespan of subcutaneous glucose sensors and their performances during dynamic glycaemia changes in rats,"" J. Biomed. Eng. 15:457-463 (1993).;;Brandt J. et al., ""Covalent attachment of proteins to polysaccharide carriers by means of benzoquinone,"" Biochim. Biophys. Acta, 386(1) (1 page Abstract only) (1975).;;Brownlee, M. et al., ""A Glucose-Controlled Insulin-Delivery System: Semisynthetic Insulin Bound to Lectin"", Science, 206(4423):1190-1191 (Dec. 7, 1979).;;Cass, A.E.G. et al., ""Ferricinum Ion As An Electron Acceptor for Oxido-Reductases,"" J. Electroanal. Chem., 190:117-127 (1985).;;Cass, A.E.G. et al., ""Ferrocene-Mediated Enzyme Electrode for Amperometric Determination of Glucose"", Anal. Chem., 56(4):667-671 (Apr. 1984).;;Castner, J. F. et al., ""Mass Transport and Reaction Kinetic Parameters Determined Electrochemically for Immobilized Glucose Oxidase,"" Biochemistry, 23(10):2203-2210 (1984).;;Claremont, D.J. et al., ""Biosensors for Continuous In Vivo Glucose Monitoring"", IEEE Engineering in Medicine and Biology Society 10th Annual International Conference, New Orleans, Louisiana, 3 pgs. (Nov. 4-7, 1988).;;Clark L.C. et al., ""Differential Anodic Enzyme Polarography for the Measurement of Glucose"", Oxygen Transport to Tissue: Instrumentation, Methods, and Physiology, 127-132 (1973).;;Clark, L.C., Jr. et al., ""Electrode Systems for Continuous Monitoring in Cardiovascular Surgery,"" Annals New York Academy of Sciences, pp. 29-45 (1962).;;Clark, L.C. et al., ""Long-term Stability of Electroenzymatic Glucose Sensors Implanted in Mice,"" Trans. Am. Soc. Artif. Intern. Organs, XXXIV:259-265 (1988).;;Clarke, W. L., et al., ""Evaluating Clinical Accuracy of Systems for Self-Monitoring of Blood Glucose,"" Diabetes Care, 10(5):622-628 (Sep.-Oct. 1987).;;Csöregi, E. et al., ""Design, Characterization, and One-Point in Vivo Calibration of a Subcutaneously Implanted Glucose Electrode,"" Anal. Chem. 66(19):3131-3138 (Oct. 1, 1994).;;Csöregi, E. et al., ""Design and Optimization of a Selective Subcutaneously Implantable Glucose Electrode Based on ""Wired"" Glucose Oxidase,"" Anal. Chem. 67(7):1240-1244 (Apr. 1, 1995).;;Csöregi, E. et al., ""On-Line Glucose Monitoring by Using Microdialysis Sampling and Amperometric Detection Based on ""Wired"" Glucose Oxidase in Carbon Paste,"" Mikrochim. Acta. 121:31-40 (1995).;;Davis, G., ""Electrochemical Techniques for the Development of Amperometric Biosensors"", Biosensors, 1:161-178 (1985).;;Degani, Y. et al., ""Direct Electrical Communication between Chemically Modified Enzymes and Metal Electrodes. 1. Electron Transfer from Glucose Oxidase to Metal Electrodes via Electron Relays, Bound Covalently to the Enzyme,"" J. Phys. Chem. 91(6):1285-1289 (1987).;;Degani, Y. et al., ""Direct Electrical Communication between Chemically Modified Enzymes and Metal Electrodes. 2. Methods for Bonding Electron-Transfer Relays to Glucose Oxidase and D-Amino-Acid Oxidase,"" J. Am. Chem. Soc., 110(8):2615-2620 (1988).;;Degani, Y. et al., ""Electrical Communication between Redox Centers of Glucose Oxidase and Electrodes via Electrostatically and Covalently Bound Redox Polymers,"" J. Am. Chem. Soc., 111:2357-2358 (1989).;;Denisevich, P. et al., ""Unidirectional Current Flow and Charge State Trapping at Redox Polymer Interfaces on Bilayer Electrodes: Principles, Experimental Demonstration, and Theory,"" J. Am. Chem. Soc., 103(16):4727-4737 (1981).;;Dicks, J. M., ""Ferrocene modified polypyrrole with immobilised glucose oxidase and its application in amperometric glucose microbiosensors,"" Ann. Biol. clin., 47:607-619 (1989).;;Engstrom, R.C., ""Electrochemical Pretreatment of Glassy Carbon Electrodes"", Anal. Chem., 54(13):2310-2314 (Nov. 1982).;;Engstrom, R.C. et al., ""Characterization of Electrochemically Pretreated Glassy Carbon Electrodes"", Anal. Chem., 56(2):136-141 (Feb. 1984).;;Ellis, C. D., ""Selectivity and Directed Charge Transfer through an Electroactive Metallopolymer Film,"" J. Am. Chem. Soc., 103(25):7480-7483 (1981).;;Feldman, B.J. et al., ""Electron Transfer Kinetics at Redox Polymer/Solution Interfaces Using Microelectrodes and Twin Electrode Thin Layer Cells"", J. Electroanal. Chem., 194(1):63-81 (Oct. 10, 1985).;;Fischer, H. et al., ""Intramolecular Electron Transfer Mediated by 4,4'-Bipyridine and Related Bridging Groups"", J. Am. Chem. Soc., 98(18):5512-5517 (Sep. 1, 1976).;;Foulds, N.C. et al., ""Enzyme Entrapment in Electrically Conducting Polymers,"" J. Chem. Soc., Faraday Trans 1., 82:1259-1264 (1986).;;Foulds, N.C. et al., ""Immobilization of Glucose Oxidase in Ferrocene-Modified Pyrrole Polymers,"" Anal. Chem., 60(22):2473-2478 (Nov. 15, 1988).;;Frew, J.E. et al., ""Electron-Transfer Biosensors"", Phil. Trans. R Soc. Lond., B316:95-106 (1987).;;Gorton, L. et al., ""Selective detection in flow analysis based on the combination of immobilized enzymes and chemically modified electrodes,"" Analytica Chimica Acta., 250:203-248 (1991).;;Gregg, B. A. et al., ""Cross-Linked Redox Gels Containing Glucose Oxidase for Amperometric Biosensor Applications,"" Analytical Chemistry, 62(3):258-263 (Feb. 1, 1990).;;Gregg, B. A. et al., ""Redox Polymer Films Containing Enzymes. 1. A Redox-Conducting Epoxy Cement: Synthesis, Characterization, and Electrocatalytic Oxidation of Hydroquinone,"" J. Phys. Chem., 95(15):5970-5975 (1991).;;Hale, P D et al., ""A New Class of Amperometric Biosensor Incorporating a Polymeric Electron-Transfer Mediator,"" J. Am. Chem. Soc., 111(9):3482-3484 (1989).;;Harrison, D.J. et al., ""Characterization of Perfluorosulfonic Acid Polymer Coated Enzyme Electrodes and a Miniaturized Integrated Potentiostat for Glucose Analysis in Whole Blood"", Anal. Chem., 60(19):2002-2007 (Oct. 1, 1988).;;Hawkridge, F. M. et al., ""Indirect Coulometric Titration of Biological Electron Transport Components,"" Analytical Chemistry, 45(7):1021-1027 (Jun. 1973).;;Heller, A., ""Amperometric biosensors based on three-dimensional hydrogel-forming epoxy networks,"" Sensors and Actuators B. 13-14:180-183 (1993).;;Heller, A., ""Electrical Connection of Enzyme Redox Centers to Electrodes,"" J. Phys. Chem., 96(9):3579-3587 (1992).;;Heller, A., ""Electrical Wiring of Redox Enzymes,"" Acc. Chem. Res., 23(5):129-134 (1990).;;Ianniello, R.M. et al. ""Immobilized Enzyme Chemically Modified Electrode as an Amperometric Sensor"", Anal. Chem., 53(13):2090-2095 (Nov. 1981).;;Ianniello, R.M. et al., ""Differential Pulse Voltammetric Study of Direct Electron Transfer in Glucose Oxidase Chemically Modified Graphite Electrodes"", Anal. Chem., 54(7):1098-1101 (Jun. 1981).;;Ikeda, T. et al., ""Glucose oxidase-immobilized benzoquinone-carbon paste electrode as a glucose sensor,"" Agric. Biol. Chem., 49(2) (1 page-Abstract only) (1985).;;Ikeda, T. et al., ""Kinetics of Outer-Sphere Electron Transfers Between Metal Complexes in Solutions and Polymeric Films on Modified Electrodes"", J. Am. Chem. Soc., 103(25):7422-7425 (Dec. 16, 1981).;;Johnson, J. M. et al., ""Potential-Dependent Enzymatic Activity in an Enzyme Thin-Layer Cell,"" Anal. Chem. 54:1377-1383 (1982).;;Johnson, K. W., ""Reproducible Electrodeposition of Biomolecules for the Fabrication of Miniature Electroenzymatic Biosensors"", Sensors and Actuators B Chemical, B5:85-89 (1991).;;Jonsson, G. et al., ""An Amperometric Glucose Sensor Made by Modification of a Graphite Electrode Surface With Immobilized Glucose Oxidase and Adsorbed Mediator"", Biosensors, 1:355-368 (1985).;;Josowicz, M. et al., ""Electrochemical Pretreatment of Thin Film Platinum Electrodes"", J. Elecrochem. Soc., 135(1):112-115 (Jan. 1988).;;Katakis, I. et al., ""Electrostatic Control of the Electron Transfer Enabling Binding of Recombinant Glucose Oxidase and Redox Polyelectrolytes,"" J. Am. Chem. Soc., 116(8):3617-3618 (1994).;;Katakis, I. et al., ""L-alpha-Glycerophosphate and L-Lactate Electrodes Based on the Electrochemical ""Wiring"" of Oxidases,"" Analytical Chemistry, 64(9):1008-1013 (May 1, 1992).;;Kenausis, G. et al., ""Wiring of glucose oxidase and lactate oxidase within a hydrogel made with poly(vinyl pyridine) complexed with [Os(4,4'-dimethoxy-2,2'-bipyridine)2C1]+/2+,"" J. Chem. Soc., Faraday Trans., 90(20):4131-4136 (1996).;;Koudelka, M. et al., ""In-Vivo Behaviour of Hypodermically Implanted Microfabricated Glucose Sensors"", Biosensors & Bioelectronics, 6(1):31-36 (1991).;;Kulys, J. et al., ""Mediatorless peroxidase electrode and preparation of bienzyme sensors,"" Bioelectrochemistry and Bioenergetics, 24:305-311 (1990).;;Lager, W. et al., ""Implantable Electrocatalytic Glucose Sensor,"" Horm. Metab. Res., 26:526-530 (Nov. 1994).;;Lindner, E. et al. ""Flexible (Kapton-Based) Microsensor Arrays of High Stability for Cardiovascular Applications"", J. Chem. Soc, Faraday Trans., 89(2):361-367 (Jan. 21, 1993).;;Maidan, R. et al., ""Elimination of Electrooxidizable Interferant-Produced Currents in Amperometric Biosensors,"" Analytical Chemistry, 64(23):2889-2896 (Dec. 1, 1992).;;Mastrototaro, J.J. et al., ""An Electroenzymatic Glucose Sensor Fabricated on a Flexible Substrate"", Sensors and Biosensors B Chemical, B5:139-144 (1991).;;McNeil, C. J. et al., ""Thermostable Reduced Nicotinamide Adenine Dinucleotide Oxidase: Application to Amperometric Enzyme Assay,"" Anal. Chem., 61(1):25-29 (Jan. 1, 1989).;;Miyawaki, O. et al., ""Electrochemical and Glucose Oxidase Coenzyme Activity of Flavin Adenine Dinucleotide Covalently Attached to Glassy Carbon at the Adenine Amino Group"", Biochimica et Biophysica Acta, 838:60-68 (1985).;;Moatti-Sirat, D. et al., ""Evaluating in vitro and in vivo the inteference of ascorbate and acetaminophen on glucose detection by a needle-type glucose sensor,"" Biosensors & Bioelectronics, 7(5):345-352 (1992).;;Moatti-Sirat, D. et al., ""Reduction of acetaminophen interference in glucose sensors by a composite Nafion membrane: demonstration in rats and man,"" Diabetologia, 37(6) (1 page-Abstract only) (Jun. 1994).;;Moatti-Sirat, D. et al., ""Towards continuous glucose monitoring: in vivo evaluation of a miniaturized glucose sensor implanted for several days in rat subcutaneous tissue,"" Diabetologia, 35(3) (1 page-Abstract only) (Mar. 1992).;;Nagy, G. et al., ""A New Type of Enzyme Electrode: The Ascorbic Acid Eliminator Electrode,"" Life Sciences, 31(23):2611-2616 (1982).;;Nakamura, S. et al., ""Effect of Periodate Oxidation on the Structure and Properties of Glucose Oxidase,"" Biochimica et Biophysica Acta., 445:294-308 (1976).;;Narazimhan, K. et al., ""p-Benzoquinone activation of metal oxide electrodes for attachment of enzymes,"" Enzyme Microb. Technol., 7(6) (1 page-Abstract only) (1985).;;Ohara, T. J. et al., ""Glucose Electrodes Based on Cross-Linked [Os(bpy)2C1]+/2+ Complexed Poly(1-vinylimadazole) Films,"" Analytical Chemistry, 65(23):3512-3516 (Dec. 1, 1993).;;Ohara, T. J., ""Osmium Bipyridyl Redox Polymers Used in Enzyme Electrodes,"" Platinum Metals Rev., 39(2):54-62 (Apr. 1995).;;Ohara, T. J. et al., """"Wired"" Enzyme Electrodes for Amperometric Determination of Glucose or Lactate in the Presence of Interfering Substances,"" Analytical Chemistry, 66(15):2451-2457 (Aug. 1, 1994).;;Olievier, C. N. et al., ""In vivo Measurement of Carbon Dioxide Tension with a Miniature Electrode,"" Pflugers Arch. 373:269-272 (1978).;;Paddock, R. et al., ""Electrocatalytic reduction of hydrogen peroxide via direct electron transfer from pyrolytic graphite electrodes to irreversibly adsorbed cytochrome c peroxidase,"" J. Electroanal. Chem., 260:487-494 (1989).;;Palleschi, G. et al., ""A Study of Interferences in Glucose Measurements in Blood by Hydrogen Peroxide Based Glucose Probes"", Anal. Biochem., 159:114-121 (1986).;;Pankramov, I. et al., ""Sol-gel derived renewable-surface biosensors,"" Journal of Electroanalytical Chemistry, 393:35-41 (1995).;;Pathak, C. P. et al., ""Rapid Photopolymerization of Immunoprotective Gels in Contact with Cells and Tissue,"" J. Am. Chem. Soc., 114(21):8311-8312 (1992).;;Pickup, J., ""Developing glucose sensors for in vivo use,"" Tibtech, 11:285-289 (Jul. 1993).;;Pickup, J. C. et al., ""In vivo molecular sensing in diabetes mellitus: an implantable glucose sensor with direct electron transfer,"" Diabetologia, 32(3):213-217 (1989).;;Pickup, J. et al., ""Potentially-implantable, amperometric glucose sensors with mediated electron transfer: improving the operating stability,"" Biosensors, 4(2) (1 page-Abstract only) (1989).;;Pishko, M.V. et al., ""Amperometric Glucose Microelectrodes Prepared Through Immobilization of Glucose Oxidase in Redox Hydrogels"", Anal. Chem., 63(20):2268-2272 (Oct. 15, 1991).;;Poitout, V. et al., ""A glucose monitoring system for on line estimation in man of blood glucose concentration using a miniaturized glucose sensor implanted in the subcutaneous tissue and a wearable control unit,"" Diabetologia, 36(7) (1 page-Abstract only) (Jul. 1993).;;Poitout, V. et al., ""Calibration in dogs of a subcutaneous miniaturized glucose sensor using a glucose meter for blood glucose determination,"" Biosensors & Bioelectronics, 7:587-592 (1992).;;Poitout, V. et al., ""In vitro and in vivo evaluation in dogs of a miniaturized glucose sensor,"" ASAIO Transactions, 37(3) (1 page-Abstract only) (Jul.-Sep. 1991).;;Pollak, A. et al., ""Enzyme immobilization by Condensation Copolymerization into Cross-Linked Polyacrylamide Gels,"" J. Am. Chem. Soc., 102(20):6324-6336 (1980).;;Reach, G. et al., ""Can Continuous Glucose Monitoring Be Used for the Treatment of Diabetes?"" Analytical Chemistry, 64(6):381-386 (Mar. 15, 1992).;;Rebrin, K. et al., ""Automated Feedback Control of subcutaneous Glucose Concentration in Diabetic Dogs"", Diabetologia, 32(8):573-576 (Aug. 1989).;;Sakakida, M. et al., ""Ferrocene-mediate needle-type glucose sensor covered with newly designed biocompatible membrane,"" Sensors and Actuators B, 13-14:319-322 (1993).;;Samuels, G. J. et al., ""An Electrode-Supported Oxidation Catalyst Based on Ruthenium (IV). pH ""Encapsulation"" in a Polymer Film,"" J. Am. Chem. Soc., 103(2):307-312 (1981).;;Sasso, S.V. et al., ""Electropolymerized 1,2-Diaminobenzene as a Means to Prevent Interferences and Fouling and to Stabilize Immobilized Enzyme in Electrochemical Biosensors"", Anal. Chem., 62(11):1111-1117 (Jun. 1, 1990).;;Scheller, F. et al., ""Enzyme electrodes and their application,"" Phil. Trans. R Soc. Lond., B 316:85-94 (1987).;;Schmehl, R.H. et al., ""The Effect of Redox Site Concentration on the Rate of Mediated Oxidation of Solution Substrates by a Redox Copolymer Film"", J. Electroanal. Chem., 152:97-109 (Aug. 25, 1983).;;Shichiri, M. et al., ""Glycaemic Control in Pancrearetomized Dogs with a Wearable Artificial Endocrine Pancreas"", Diabetologia, 24(3):179-184 (Mar. 1983).;;Sirtampalam, G. et al., ""Surface-Modified Electrochemical Detector for Liquid Chromatography"", Anal. Chem., 55(9):1608-1610 (Aug. 1983).;;Soegijoko, S. et al., Horm. Metabl. Res., Suppl. Ser. 12 (1 page-Abstract only) (1982).;;Sprules, S. D. et al., ""Evaluation of a New Disposable Screen-Printed Sensor Strip for the Measurement of NADH and Its Modification to Produce a Lactate Biosensor Employing Microliter Volumes,"" Electroanalysis, 8(6):539-543 (1996).;;Sternberg, F. et al., ""Calibration Problems of Subcutaneous Glucosensors when Applied ""In-Situ"" in Man,"" Horm. metabl. Res. 26:524-525 (1994).",EXPIRED
97,US,A1,US 2008/0319292 A1,030-347-493-737-474,2008-12-25,2008,US 20216908 A,2008-08-29,US 20216908 A;;US 42005703 A;;US 66719900 A;;US 7067798 A,1998-04-30,ANALYTE MONITORING DEVICE AND METHODS OF USE,"An analyte monitor includes a sensor, a sensor control unit, and a display unit. The sensor has, for example, a substrate, a recessed channel formed in the substrate, and conductive material disposed in the recessed channel to form a working electrode. The sensor control unit typically has a housing adapted for placement on skin and is adapted to receive a portion of an electrochemical sensor. The sensor control unit also includes two or more conductive contacts disposed on the housing and configured for coupling to two or more contact pads on the sensor. A transmitter is disposed in the housing and coupled to the plurality of conductive contacts for transmitting data obtained using the sensor. The display unit has a receiver for receiving data transmitted by the transmitter of the sensor control unit and a display coupled to the receiver for displaying an indication of a level of an analyte. The analyte monitor may also be part of a drug delivery system to alter the level of the analyte based on the data obtained using the sensor.",ABBOTT DIABETES CARE INC,SAY JAMES;;TOMASCO MICHAEL F;;HELLER ADAM;;GAL YORAM;;ARIA BEHRAD;;HELLER EPHRAIM;;PLANTE PHILLIP JOHN;;VREEKE MARK S;;FRIEDMAN KEITH A;;COLMAN FREDRIC C,,https://lens.org/030-347-493-737-474,Patent Application,yes,0,42,211,221,0,A61B5/14532;;A61B5/14532;;A61B5/0002;;A61B5/0002;;A61B5/002;;A61B5/01;;A61B5/14503;;A61B5/1451;;A61B5/14546;;A61B5/14546;;A61B5/1473;;A61B5/1473;;A61B5/1486;;A61B5/1486;;A61B5/14865;;A61B5/1495;;A61B5/4839;;A61B5/72;;A61B5/7278;;A61B5/7282;;A61B5/7405;;A61B5/743;;A61B5/7445;;A61B5/7445;;A61B5/7455;;A61B2560/0252;;A61B2560/0252;;A61M5/1723;;C12Q1/54;;G16H10/40;;G16H10/40;;G16H20/17;;G16H20/17;;H01L23/3107;;H01L23/3107;;H01L23/49548;;H01L23/49548;;H01L2924/0002;;H01L2924/0002;;H01L2924/19041;;H01L2924/19041;;H01L2924/3011;;H01L2924/3011;;Y10S128/903;;Y10S128/903;;Y10T29/49;;Y10T29/49;;Y10T29/49124;;Y10T29/49124,A61B5/055;;G01N27/30;;A61B5/00;;A61B5/145;;A61B5/1477;;A61B5/1495;;G01N27/416;;G06F19/00;;H01L23/31;;H01L23/495,600/347;;600/391,0,0,,,,DISCONTINUED
98,JP,A,JP 2010227601 A,042-884-744-211-311,2010-10-14,2010,JP 2010136362 A,2010-06-15,US 7067798 A,1998-04-30,ANALYTE MONITORING DEVICE AND METHODS OF USE,"<P>PROBLEM TO BE SOLVED: To provide an insertion kit for inserting an electrochemical sensor into a patient. <P>SOLUTION: The insertion kit includes: an inserter, a portion of the inserter has a sharp, rigid, and planer structure or a sharp and hard U- or V-shape structure adapted to support the sensor during insertion of the electrochemical sensor; and an insertion gun having a port configured to accept the electrochemical sensor and the inserter, a driving mechanism for driving the inserter and electrochemical sensor into the patient's body, and a retraction mechanism for removing the inserter from the patient's body while leaving the sensor within the patient's body. <P>COPYRIGHT: (C)2011,JPO&INPIT",ABBOTT DIABETES CARE INC,SAY JAMES;;TOMASCO MICHAEL F;;HELLER ADAM;;GAL YORAM;;ARIA BEHRAD;;HELLER EPHRAIM;;PLANTE PHILLIP J;;VREEKE MARK S;;FRIEDMAN KEITH A;;COLMAN FREDRIC C,,https://lens.org/042-884-744-211-311,Patent Application,no,3,3,211,221,0,A61B5/14532;;A61B5/14532;;A61B5/0002;;A61B5/0002;;A61B5/002;;A61B5/01;;A61B5/14503;;A61B5/1451;;A61B5/14546;;A61B5/14546;;A61B5/1473;;A61B5/1473;;A61B5/1486;;A61B5/1486;;A61B5/14865;;A61B5/1495;;A61B5/4839;;A61B5/72;;A61B5/7278;;A61B5/7282;;A61B5/7405;;A61B5/743;;A61B5/7445;;A61B5/7445;;A61B5/7455;;A61B2560/0252;;A61B2560/0252;;A61M5/1723;;C12Q1/54;;G16H10/40;;G16H10/40;;G16H20/17;;G16H20/17;;H01L23/3107;;H01L23/3107;;H01L23/49548;;H01L23/49548;;H01L2924/0002;;H01L2924/0002;;H01L2924/19041;;H01L2924/19041;;H01L2924/3011;;H01L2924/3011;;Y10S128/903;;Y10S128/903;;Y10T29/49;;Y10T29/49;;Y10T29/49124;;Y10T29/49124,A61B5/1473;;G01N27/30;;A61B5/00;;A61B5/145;;A61B5/1477;;A61B5/1495;;G01N27/416;;G06F19/00;;H01L23/31;;H01L23/495,,0,0,,,,INACTIVE
99,US,A1,US 2010/0100078 A1,045-071-667-986-076,2010-04-22,2010,US 64398609 A,2009-12-21,US 64398609 A;;US 42005703 A;;US 66719900 A;;US 7067798 A,1998-04-30,Analyte Monitoring Device and Methods of Use,"An analyte monitor includes a sensor, a sensor control unit, and a display unit. The sensor has, for example, a substrate, a recessed channel formed in the substrate, and conductive material disposed in the recessed channel to form a working electrode. The sensor control unit typically has a housing adapted for placement on skin and is adapted to receive a portion of an electrochemical sensor. The sensor control unit also includes two or more conductive contacts disposed on the housing and configured for coupling to two or more contact pads on the sensor. A transmitter is disposed in the housing and coupled to the plurality of conductive contacts for transmitting data obtained using the sensor. The display unit has a receiver for receiving data transmitted by the transmitter of the sensor control unit and a display coupled to the receiver for displaying an indication of a level of an analyte. The analyte monitor may also be part of a drug delivery system to alter the level of the analyte based on the data obtained using the sensor.",ABBOTT DIABETES CARE INC,SAY JAMES;;TOMASCO MICHAEL F;;HELLER ADAM;;GAL YORAM;;ARIA BEHRAD;;HELLER EPHRAIM;;PLANTE PHILLIP JOHN;;VREEKE MARK S;;FRIEDMAN KEITH A;;COLMAN FREDRIC C,E. HELLER & CO (1998-07-02);;ABBOTT DIABETES CARE INC (2000-03-13),https://lens.org/045-071-667-986-076,Patent Application,yes,85,50,211,221,0,A61B5/14532;;A61B5/14532;;A61B5/0002;;A61B5/0002;;A61B5/002;;A61B5/01;;A61B5/14503;;A61B5/1451;;A61B5/14546;;A61B5/14546;;A61B5/1473;;A61B5/1473;;A61B5/1486;;A61B5/1486;;A61B5/14865;;A61B5/1495;;A61B5/4839;;A61B5/72;;A61B5/7278;;A61B5/7282;;A61B5/7405;;A61B5/743;;A61B5/7445;;A61B5/7445;;A61B5/7455;;A61B2560/0252;;A61B2560/0252;;A61M5/1723;;C12Q1/54;;G16H10/40;;G16H10/40;;G16H20/17;;G16H20/17;;H01L23/3107;;H01L23/3107;;H01L23/49548;;H01L23/49548;;H01L2924/0002;;H01L2924/0002;;H01L2924/19041;;H01L2924/19041;;H01L2924/3011;;H01L2924/3011;;Y10S128/903;;Y10S128/903;;Y10T29/49;;Y10T29/49;;Y10T29/49124;;Y10T29/49124,A61M5/00;;G01N27/30;;A61B5/00;;A61B5/145;;A61B5/1468;;A61B5/1477;;A61B5/1495;;G01N27/416;;G06F19/00;;G08B1/08;;H01L23/31;;H01L23/495,604/890.1;;600/345;;340/539.12,0,0,,,,EXPIRED
100,US,A1,US 2010/0069729 A1,058-547-181-591-712,2010-03-18,2010,US 61506909 A,2009-11-09,US 61506909 A;;US 42005703 A;;US 66719900 A;;US 7067798 A,1998-04-30,Analyte Monitoring Device And Methods Of Use,"An analyte monitor includes a sensor, a sensor control unit, and a display unit. The sensor has, for example, a substrate, a recessed channel formed in the substrate, and conductive material disposed in the recessed channel to form a working electrode. The sensor control unit typically has a housing adapted for placement on skin and is adapted to receive a portion of an electrochemical sensor. The sensor control unit also includes two or more conductive contacts disposed on the housing and configured for coupling to two or more contact pads on the sensor. A transmitter is disposed in the housing and coupled to the plurality of conductive contacts for transmitting data obtained using the sensor. The display unit has a receiver for receiving data transmitted by the transmitter of the sensor control unit and a display coupled to the receiver for displaying an indication of a level of an analyte. The analyte monitor may also be part of a drug delivery system to alter the level of the analyte based on the data obtained using the sensor.",SAY JAMES;;TOMASCO MICHAEL F;;HELLER ADAM;;GAL YORAM;;ARIA BEHRAD;;HELLER EPHRAIM;;PLANTE PHILLIP JOHN;;VREEKE MARK S;;FRIEDMAN KEITH A;;COLMAN FREDRIC C,SAY JAMES;;TOMASCO MICHAEL F;;HELLER ADAM;;GAL YORAM;;ARIA BEHRAD;;HELLER EPHRAIM;;PLANTE PHILLIP JOHN;;VREEKE MARK S;;FRIEDMAN KEITH A;;COLMAN FREDRIC C,,https://lens.org/058-547-181-591-712,Patent Application,yes,99,1,211,221,0,A61B5/14532;;A61B5/14532;;A61B5/0002;;A61B5/0002;;A61B5/002;;A61B5/01;;A61B5/14503;;A61B5/1451;;A61B5/14546;;A61B5/14546;;A61B5/1473;;A61B5/1473;;A61B5/1486;;A61B5/1486;;A61B5/14865;;A61B5/1495;;A61B5/4839;;A61B5/72;;A61B5/7278;;A61B5/7282;;A61B5/7405;;A61B5/743;;A61B5/7445;;A61B5/7445;;A61B5/7455;;A61B2560/0252;;A61B2560/0252;;A61M5/1723;;C12Q1/54;;G16H10/40;;G16H10/40;;G16H20/17;;G16H20/17;;H01L23/3107;;H01L23/3107;;H01L23/49548;;H01L23/49548;;H01L2924/0002;;H01L2924/0002;;H01L2924/19041;;H01L2924/19041;;H01L2924/3011;;H01L2924/3011;;Y10S128/903;;Y10S128/903;;Y10T29/49;;Y10T29/49;;Y10T29/49124;;Y10T29/49124,A61B5/1468;;G01N27/30;;A61B5/00;;A61B5/145;;A61B5/1477;;A61B5/1495;;G01N27/416;;G06F19/00;;H01L23/31;;H01L23/495,600/345,0,0,,,,EXPIRED
101,WO,A3,WO 2004/089294 A3,135-579-208-600-904,2007-08-16,2007,US 2004/0010278 W,2004-04-02,US 46067803 P;;US 47249403 P;;US 53203003 P;;US 54898604 P,2003-04-04,"COMPOSITIONS, METHODS AND KITS RELATING TO HER-2 CLEAVAGE","The present invention relates to compositions, methods and kits based on the ADAM-mediated cleavage of Her-2. The present invention also relates to treatments for cancer, and in particular, breast cancer, by modulating the ADAM­mediated cleavage of Her-2. Further, the invention relates to compositions, methods and kits based on the surprising synergistic effect between inhibition of Her-2 cleavage by an ADAM and certain cytostatic (e.g., Herceptin) and cytotoxic (e.g., Taxol) compounds in, among other things, inhibiting tumor cell proliferation and inducing cell death. Additionally, the invention relates to novel variants of ADAM15, designated ADAM15 variant I and ADAM 15 variant 2, now identified and isolated.",INCYTE CORP;;FRIEDMAN STEVEN M;;SCHERLE PEGGY A;;LIU XIANGDONG;;BURN TIMOTHY C;;HUBER REID;;LIU PHILLIP C C;;HOLLIS GREGORY F;;VADDI KRISHNA;;FRIDMAN JORDAN S,FRIEDMAN STEVEN M;;SCHERLE PEGGY A;;LIU XIANGDONG;;BURN TIMOTHY C;;HUBER REID;;LIU PHILLIP C C;;HOLLIS GREGORY F;;VADDI KRISHNA;;FRIDMAN JORDAN S,,https://lens.org/135-579-208-600-904,Search Report,yes,0,0,10,10,0,A61K31/19;;A61K31/19;;A61K31/395;;A61K31/395;;A61P35/00;;A61P35/04,A61K39/395;;A61K/;;A61K31/19,,2,1,066-681-448-888-222,10.1002/ijc.20945;;15729716,"HANDSLEY M.H. ET AL: ""Metalloproteinases and their inhibitors in tumor angiogenesis"", INT. J. CANCER, vol. 115, 2005, pages 849 - 860, XP002993254;;See also references of EP 1613269A4",PENDING
102,US,A1,US 2009/0216102 A1,117-531-187-825-331,2009-08-27,2009,US 39388309 A,2009-02-26,US 39388309 A;;US 42005703 A;;US 66719900 A;;US 7067798 A,1998-04-30,Analyte Monitoring Device and Methods of Use,"An analyte monitor includes a sensor, a sensor control unit, and a display unit. The sensor has, for example, a substrate, a recessed channel formed in the substrate, and conductive material disposed in the recessed channel to form a working electrode. The sensor control unit typically has a housing adapted for placement on skin and is adapted to receive a portion of an electrochemical sensor. The sensor control unit also includes two or more conductive contacts disposed on the housing and configured for coupling to two or more contact pads on the sensor. A transmitter is disposed in the housing and coupled to the plurality of conductive contacts for transmitting data obtained using the sensor. The display unit has a receiver for receiving data transmitted by the transmitter of the sensor control unit and a display coupled to the receiver for displaying an indication of a level of an analyte. The analyte monitor may also be part of a drug delivery system to alter the level of the analyte based on the data obtained using the sensor.",SAY JAMES;;TOMASCO MICHAEL F;;HELLER ADAM;;GAL YORAM;;ARIA BEHRAD;;HELLER EPHRAIM;;PLANTE PHILLIP JOHN;;VREEKE MARK S;;FRIEDMAN KEITH A;;COLMAN FREDRIC C,SAY JAMES;;TOMASCO MICHAEL F;;HELLER ADAM;;GAL YORAM;;ARIA BEHRAD;;HELLER EPHRAIM;;PLANTE PHILLIP JOHN;;VREEKE MARK S;;FRIEDMAN KEITH A;;COLMAN FREDRIC C,E. HELLER & CO (1998-07-02);;ABBOTT DIABETES CARE INC (2000-03-13),https://lens.org/117-531-187-825-331,Patent Application,yes,100,70,211,221,0,A61B5/14532;;A61B5/14532;;A61B5/0002;;A61B5/0002;;A61B5/002;;A61B5/01;;A61B5/14503;;A61B5/1451;;A61B5/14546;;A61B5/14546;;A61B5/1473;;A61B5/1473;;A61B5/1486;;A61B5/1486;;A61B5/14865;;A61B5/1495;;A61B5/4839;;A61B5/72;;A61B5/7278;;A61B5/7282;;A61B5/7405;;A61B5/743;;A61B5/7445;;A61B5/7445;;A61B5/7455;;A61B2560/0252;;A61B2560/0252;;A61M5/1723;;C12Q1/54;;G16H10/40;;G16H10/40;;G16H20/17;;G16H20/17;;H01L23/3107;;H01L23/3107;;H01L23/49548;;H01L23/49548;;H01L2924/0002;;H01L2924/0002;;H01L2924/19041;;H01L2924/19041;;H01L2924/3011;;H01L2924/3011;;Y10S128/903;;Y10S128/903;;Y10T29/49;;Y10T29/49;;Y10T29/49124;;Y10T29/49124,A61B5/1468;;G01N27/30;;A61B5/00;;A61B5/145;;A61B5/1477;;A61B5/1495;;G01N27/416;;G06F19/00;;H01L23/31;;H01L23/495,600/347,0,0,,,,EXPIRED
103,US,A1,US 2009/0192375 A1,156-114-790-323-077,2009-07-30,2009,US 41804709 A,2009-04-03,US 41804709 A;;US 42005703 A;;US 66719900 A;;US 7067798 A,1998-04-30,Analyte Monitoring Device and Methods of Use,"An analyte monitor includes a sensor, a sensor control unit, and a display unit. The sensor has, for example, a substrate, a recessed channel formed in the substrate, and conductive material disposed in the recessed channel to form a working electrode. The sensor control unit typically has a housing adapted for placement on skin and is adapted to receive a portion of an electrochemical sensor. The sensor control unit also includes two or more conductive contacts disposed on the housing and configured for coupling to two or more contact pads on the sensor. A transmitter is disposed in the housing and coupled to the plurality of conductive contacts for transmitting data obtained using the sensor. The display unit has a receiver for receiving data transmitted by the transmitter of the sensor control unit and a display coupled to the receiver for displaying an indication of a level of an analyte. The analyte monitor may also be part of a drug delivery system to alter the level of the analyte based on the data obtained using the sensor.",ABBOTT DIABETES CARE INC,SAY JAMES;;TOMASCO MICHAEL F;;HELLER ADAM;;GAL YORAM;;ARIA BEHRAD;;HELLER EPHRAIM;;PLANTE PHILLIP JOHN;;VREEKE MARK S;;FRIEDMAN KEITH A;;COLMAN FREDRIC C,,https://lens.org/156-114-790-323-077,Patent Application,yes,1,57,211,221,0,A61B5/14532;;A61B5/14532;;A61B5/0002;;A61B5/0002;;A61B5/002;;A61B5/01;;A61B5/14503;;A61B5/1451;;A61B5/14546;;A61B5/14546;;A61B5/1473;;A61B5/1473;;A61B5/1486;;A61B5/1486;;A61B5/14865;;A61B5/1495;;A61B5/4839;;A61B5/72;;A61B5/7278;;A61B5/7282;;A61B5/7405;;A61B5/743;;A61B5/7445;;A61B5/7445;;A61B5/7455;;A61B2560/0252;;A61B2560/0252;;A61M5/1723;;C12Q1/54;;G16H10/40;;G16H10/40;;G16H20/17;;G16H20/17;;H01L23/3107;;H01L23/3107;;H01L23/49548;;H01L23/49548;;H01L2924/0002;;H01L2924/0002;;H01L2924/19041;;H01L2924/19041;;H01L2924/3011;;H01L2924/3011;;Y10S128/903;;Y10S128/903;;Y10T29/49;;Y10T29/49;;Y10T29/49124;;Y10T29/49124,A61B5/1468;;G01N27/30;;A61B5/00;;A61B5/145;;A61B5/1477;;A61B5/1495;;G01N27/416;;G06F19/00;;H01L23/31;;H01L23/495,600/345,0,0,,,,DISCONTINUED
104,US,A1,US 2009/0210164 A1,177-217-401-226-956,2009-08-20,2009,US 42882609 A,2009-04-23,US 42882609 A;;US 39388309 A;;US 42005703 A;;US 66719900 A;;US 7067798 A,1998-04-30,ANALYTE MONITORING DEVICE AND METHODS OF USE,"An analyte monitor includes a sensor, a sensor control unit, and a display unit. The sensor has, for example, a substrate, a recessed channel formed in the substrate, and conductive material disposed in the recessed channel to form a working electrode. The sensor control unit typically has a housing adapted for placement on skin and is adapted to receive a portion of an electrochemical sensor. The sensor control unit also includes two or more conductive contacts disposed on the housing and configured for coupling to two or more contact pads on the sensor. A transmitter is disposed in the housing and coupled to the plurality of conductive contacts for transmitting data obtained using the sensor. The display unit has a receiver for receiving data transmitted by the transmitter of the sensor control unit and a display coupled to the receiver for displaying an indication of a level of an analyte. The analyte monitor may also be part of a drug delivery system to alter the level of the analyte based on the data obtained using the sensor.",SAY JAMES;;TOMASCO MICHAEL F;;HELLER ADAM;;GAL YORAM;;ARIA BEHRAD;;HELLER EPHRAIM;;PLANTE PHILLIP JOHN;;VREEKE MARK S;;FRIEDMAN KEITH A;;COLMAN FREDRIC C,SAY JAMES;;TOMASCO MICHAEL F;;HELLER ADAM;;GAL YORAM;;ARIA BEHRAD;;HELLER EPHRAIM;;PLANTE PHILLIP JOHN;;VREEKE MARK S;;FRIEDMAN KEITH A;;COLMAN FREDRIC C,E. HELLER & CO (1998-07-02);;ABBOTT DIABETES CARE INC (2000-03-13),https://lens.org/177-217-401-226-956,Patent Application,yes,1,46,211,221,0,A61B5/14532;;A61B5/14532;;A61B5/0002;;A61B5/0002;;A61B5/002;;A61B5/01;;A61B5/14503;;A61B5/1451;;A61B5/14546;;A61B5/14546;;A61B5/1473;;A61B5/1473;;A61B5/1486;;A61B5/1486;;A61B5/14865;;A61B5/1495;;A61B5/4839;;A61B5/72;;A61B5/7278;;A61B5/7282;;A61B5/7405;;A61B5/743;;A61B5/7445;;A61B5/7445;;A61B5/7455;;A61B2560/0252;;A61B2560/0252;;A61M5/1723;;C12Q1/54;;G16H10/40;;G16H10/40;;G16H20/17;;G16H20/17;;H01L23/3107;;H01L23/3107;;H01L23/49548;;H01L23/49548;;H01L2924/0002;;H01L2924/0002;;H01L2924/19041;;H01L2924/19041;;H01L2924/3011;;H01L2924/3011;;Y10S128/903;;Y10S128/903;;Y10T29/49;;Y10T29/49;;Y10T29/49124;;Y10T29/49124,A61B5/1468;;G01N27/30;;A61B5/00;;A61B5/145;;A61B5/1477;;A61B5/1495;;G01N27/416;;G06F19/00;;H01L23/31;;H01L23/495,702/19;;600/347;;702/85,0,0,,,,DISCONTINUED
105,US,A1,US 2010/0179398 A1,194-627-405-995-590,2010-07-15,2010,US 72721310 A,2010-03-18,US 72721310 A;;US 69082607 A;;US 42005703 A;;US 66719900 A;;US 7067798 A,1998-04-30,Analyte Monitoring Device and Methods of Use,"An analyte monitor includes a sensor, a sensor control unit, and a display unit. The sensor has, for example, a substrate, a recessed channel formed in the substrate, and conductive material disposed in the recessed channel to form a working electrode. The sensor control unit typically has a housing adapted for placement on skin and is adapted to receive a portion of an electrochemical sensor. The sensor control unit also includes two or more conductive contacts disposed on the housing and configured for coupling to two or more contact pads on the sensor. A transmitter is disposed in the housing and coupled to the plurality of conductive contacts for transmitting data obtained using the sensor. The display unit has a receiver for receiving data transmitted by the transmitter of the sensor control unit and a display coupled to the receiver for displaying an indication of a level of an analyte. The analyte monitor may also be part of a drug delivery system to alter the level of the analyte based on the data obtained using the sensor.",ABBOTT DIABETES CARE INC,SAY JAMES;;TOMASCO MICHAEL F;;HELLER ADAM;;GAL YORAM;;ARIA BEHRAD;;HELLER EPHRAIM;;PLANTE PHILLIP JOHN;;VREEKE MARK S;;FRIEDMAN KEITH A;;COLMAN FREDRIC C,,https://lens.org/194-627-405-995-590,Patent Application,yes,1,46,211,221,0,A61B5/14532;;A61B5/14532;;A61B5/0002;;A61B5/0002;;A61B5/002;;A61B5/01;;A61B5/14503;;A61B5/1451;;A61B5/14546;;A61B5/14546;;A61B5/1473;;A61B5/1473;;A61B5/1486;;A61B5/1486;;A61B5/14865;;A61B5/1495;;A61B5/4839;;A61B5/72;;A61B5/7278;;A61B5/7282;;A61B5/7405;;A61B5/743;;A61B5/7445;;A61B5/7445;;A61B5/7455;;A61B2560/0252;;A61B2560/0252;;A61M5/1723;;C12Q1/54;;G16H10/40;;G16H10/40;;G16H20/17;;G16H20/17;;H01L23/3107;;H01L23/3107;;H01L23/49548;;H01L23/49548;;H01L2924/0002;;H01L2924/0002;;H01L2924/19041;;H01L2924/19041;;H01L2924/3011;;H01L2924/3011;;Y10S128/903;;Y10S128/903;;Y10T29/49;;Y10T29/49;;Y10T29/49124;;Y10T29/49124,A61B5/145;;G01N27/30;;A61B5/00;;A61B5/1477;;A61B5/1495;;G01N27/416;;G06F19/00;;H01L23/31;;H01L23/495,600/309,0,0,,,,DISCONTINUED
106,US,A1,US 2009/0062634 A1,023-018-868-683-265,2009-03-05,2009,US 19720008 A,2008-08-22,US 19720008 A;;US 42005703 A;;US 66719900 A;;US 7067798 A,1998-04-30,ANALYTE MONITORING DEVICE AND METHODS OF USE,"An analyte monitor includes a sensor, a sensor control unit, and a display unit. The sensor has, for example, a substrate, a recessed channel formed in the substrate, and conductive material disposed in the recessed channel to form a working electrode. The sensor control unit typically has a housing adapted for placement on skin and is adapted to receive a portion of an electrochemical sensor. The sensor control unit also includes two or more conductive contacts disposed on the housing and configured for coupling to two or more contact pads on the sensor. A transmitter is disposed in the housing and coupled to the plurality of conductive contacts for transmitting data obtained using the sensor. The display unit has a receiver for receiving data transmitted by the transmitter of the sensor control unit and a display coupled to the receiver for displaying an indication of a level of an analyte. The analyte monitor may also be part of a drug delivery system to alter the level of the analyte based on the data obtained using the sensor.",ABBOTT DIABETES CARE INC,SAY JAMES;;TOMASCO MICHAEL F;;HELLER ADAM;;GAL YORAM;;ARIA BEHRAD;;HELLER EPHRAIM;;PLANTE PHILLIP JOHN;;VREEKE MARK S;;FRIEDMAN KEITH A;;COLMAN FREDRIC C,,https://lens.org/023-018-868-683-265,Patent Application,yes,1,74,211,221,0,A61B5/14532;;A61B5/14532;;A61B5/0002;;A61B5/0002;;A61B5/002;;A61B5/01;;A61B5/14503;;A61B5/1451;;A61B5/14546;;A61B5/14546;;A61B5/1473;;A61B5/1473;;A61B5/1486;;A61B5/1486;;A61B5/14865;;A61B5/1495;;A61B5/4839;;A61B5/72;;A61B5/7278;;A61B5/7282;;A61B5/7405;;A61B5/743;;A61B5/7445;;A61B5/7445;;A61B5/7455;;A61B2560/0252;;A61B2560/0252;;A61M5/1723;;C12Q1/54;;G16H10/40;;G16H10/40;;G16H20/17;;G16H20/17;;H01L23/3107;;H01L23/3107;;H01L23/49548;;H01L23/49548;;H01L2924/0002;;H01L2924/0002;;H01L2924/19041;;H01L2924/19041;;H01L2924/3011;;H01L2924/3011;;Y10S128/903;;Y10S128/903;;Y10T29/49;;Y10T29/49;;Y10T29/49124;;Y10T29/49124,A61B5/05;;G01N27/30;;A61B5/00;;A61B5/145;;A61B5/1477;;A61B5/1495;;G01N27/416;;G06F19/00;;H01L23/31;;H01L23/495,600/347,0,0,,,,DISCONTINUED
107,US,A1,US 2009/0177064 A1,008-815-865-254-383,2009-07-09,2009,US 40598709 A,2009-03-17,US 40598709 A;;US 42005703 A;;US 66719900 A;;US 7067798 A,1998-04-30,Analyte Monitoring Device and Methods of Use,"An analyte monitor includes a sensor, a sensor control unit, and a display unit. The sensor has, for example, a substrate, a recessed channel formed in the substrate, and conductive material disposed in the recessed channel to form a working electrode. The sensor control unit typically has a housing adapted for placement on skin and is adapted to receive a portion of an electrochemical sensor. The sensor control unit also includes two or more conductive contacts disposed on the housing and configured for coupling to two or more contact pads on the sensor. A transmitter is disposed in the housing and coupled to the plurality of conductive contacts for transmitting data obtained using the sensor. The display unit has a receiver for receiving data transmitted by the transmitter of the sensor control unit and a display coupled to the receiver for displaying an indication of a level of an analyte. The analyte monitor may also be part of a drug delivery system to alter the level of the analyte based on the data obtained using the sensor.",ABBOTT DIABETES CARE INC,SAY JAMES;;TOMASCO MICHAEL F;;HELLER ADAM;;GAL YORAM;;ARIA BEHRAD;;HELLER EPHRAIM;;PLANTE PHILLIP JOHN;;VREEKE MARK S;;FRIEDMAN KEITH A;;COLMAN FREDRIC C,E. HELLER & CO (1998-07-02);;ABBOTT DIABETES CARE INC (2000-03-13),https://lens.org/008-815-865-254-383,Patent Application,yes,99,57,211,221,0,A61B5/14532;;A61B5/14532;;A61B5/0002;;A61B5/0002;;A61B5/002;;A61B5/01;;A61B5/14503;;A61B5/1451;;A61B5/14546;;A61B5/14546;;A61B5/1473;;A61B5/1473;;A61B5/1486;;A61B5/1486;;A61B5/14865;;A61B5/1495;;A61B5/4839;;A61B5/72;;A61B5/7278;;A61B5/7282;;A61B5/7405;;A61B5/743;;A61B5/7445;;A61B5/7445;;A61B5/7455;;A61B2560/0252;;A61B2560/0252;;A61M5/1723;;C12Q1/54;;G16H10/40;;G16H10/40;;G16H20/17;;G16H20/17;;H01L23/3107;;H01L23/3107;;H01L23/49548;;H01L23/49548;;H01L2924/0002;;H01L2924/0002;;H01L2924/19041;;H01L2924/19041;;H01L2924/3011;;H01L2924/3011;;Y10S128/903;;Y10S128/903;;Y10T29/49;;Y10T29/49;;Y10T29/49124;;Y10T29/49124,A61B5/1468;;G01N27/30;;A61B5/00;;A61B5/145;;A61B5/1477;;A61B5/1495;;G01N27/416;;G06F19/00;;H01L23/31;;H01L23/495,600/345,0,0,,,,EXPIRED
108,AU,A,AU 1999/023307 A,027-419-212-406-081,1999-11-23,1999,AU 1999/023307 A,1999-01-21,US 7067798 A;;US 9901229 W,1998-04-30,Analyte monitoring device and methods of use,,THERASENSE INC,SAY JAMES;;TOMASCO MICHAEL F;;HELLER ADAM;;GAL YORAM;;ARIA BEHRAD;;HELLER EPHRAIM;;PLANTE PHILLIP JOHN;;VREEKE MARK S;;FRIEDMAN KEITH A;;COLMAN FREDRIC C,,https://lens.org/027-419-212-406-081,Patent Application,no,0,0,211,221,0,A61B5/14532;;A61B5/14532;;A61B5/0002;;A61B5/0002;;A61B5/002;;A61B5/01;;A61B5/14503;;A61B5/1451;;A61B5/14546;;A61B5/14546;;A61B5/1473;;A61B5/1473;;A61B5/1486;;A61B5/1486;;A61B5/14865;;A61B5/1495;;A61B5/4839;;A61B5/72;;A61B5/7278;;A61B5/7282;;A61B5/7405;;A61B5/743;;A61B5/7445;;A61B5/7445;;A61B5/7455;;A61B2560/0252;;A61B2560/0252;;A61M5/1723;;C12Q1/54;;G16H10/40;;G16H10/40;;G16H20/17;;G16H20/17;;H01L23/3107;;H01L23/3107;;H01L23/49548;;H01L23/49548;;H01L2924/0002;;H01L2924/0002;;H01L2924/19041;;H01L2924/19041;;H01L2924/3011;;H01L2924/3011;;Y10S128/903;;Y10S128/903;;Y10T29/49;;Y10T29/49;;Y10T29/49124;;Y10T29/49124,G01N27/30;;A61B5/00;;A61B5/145;;A61B5/1477;;A61B5/1495;;G01N27/416;;G06F19/00;;H01L23/31;;H01L23/495,,0,0,,,,DISCONTINUED
109,US,A1,US 2005/0121322 A1,024-414-748-270-846,2005-06-09,2005,US 4140405 A,2005-01-24,US 4140405 A;;US 42005703 A;;US 66719900 A;;US 7067798 A,1998-04-30,Analyte monitoring device and methods of use,"An analyte monitor includes a sensor, a sensor control unit, and a display unit. The sensor has, for example, a substrate, a recessed channel formed in the substrate, and conductive material disposed in the recessed channel to form a working electrode. The sensor control unit typically has a housing adapted for placement on skin and is adapted to receive a portion of an electrochemical sensor. The sensor control unit also includes two or more conductive contacts disposed on the housing and configured for coupling to two or more contact pads on the sensor. A transmitter is disposed in the housing and coupled to the plurality of conductive contacts for transmitting data obtained using the sensor. The display unit has a receiver for receiving data transmitted by the transmitter of the sensor control unit and a display coupled to the receiver for displaying an indication of a level of an analyte. The analyte monitor may also be part of a drug delivery system to alter the level of the analyte based on the data obtained using the sensor.",THERASENSE INC,SAY JAMES;;TOMASCO MICHAEL F;;HELLER ADAM;;GAL YORAM;;ARIA BEHRAD;;HELLER EPHRAIM;;PLANTE PHILLIP JOHN;;VREEKE MARK S;;FRIEDMAN KEITH A;;COLMAN FREDRIC C,,https://lens.org/024-414-748-270-846,Patent Application,yes,99,545,211,221,0,A61B5/14532;;A61B5/14532;;A61B5/0002;;A61B5/0002;;A61B5/002;;A61B5/01;;A61B5/14503;;A61B5/1451;;A61B5/14546;;A61B5/14546;;A61B5/1473;;A61B5/1473;;A61B5/1486;;A61B5/1486;;A61B5/14865;;A61B5/1495;;A61B5/4839;;A61B5/72;;A61B5/7278;;A61B5/7282;;A61B5/7405;;A61B5/743;;A61B5/7445;;A61B5/7445;;A61B5/7455;;A61B2560/0252;;A61B2560/0252;;A61M5/1723;;C12Q1/54;;G16H10/40;;G16H10/40;;G16H20/17;;G16H20/17;;H01L23/3107;;H01L23/3107;;H01L23/49548;;H01L23/49548;;H01L2924/0002;;H01L2924/0002;;H01L2924/19041;;H01L2924/19041;;H01L2924/3011;;H01L2924/3011;;Y10S128/903;;Y10S128/903;;Y10T29/49;;Y10T29/49;;Y10T29/49124;;Y10T29/49124,G01N27/30;;A61B5/00;;A61B5/145;;A61B5/1477;;A61B5/1495;;G01N27/416;;G06F19/00;;H01L23/31;;H01L23/495,204/403.1;;600/345,0,0,,,,DISCONTINUED
110,US,A1,US 2010/0160761 A1,035-224-567-218-581,2010-06-24,2010,US 71793610 A,2010-03-04,US 71793610 A;;US 69082607 A;;US 42005703 A;;US 66719900 A;;US 7067798 A,1998-04-30,Analyte Monitoring Device and Methods of Use,"An analyte monitor includes a sensor, a sensor control unit, and a display unit. The sensor has, for example, a substrate, a recessed channel formed in the substrate, and conductive material disposed in the recessed channel to form a working electrode. The sensor control unit typically has a housing adapted for placement on skin and is adapted to receive a portion of an electrochemical sensor. The sensor control unit also includes two or more conductive contacts disposed on the housing and configured for coupling to two or more contact pads on the sensor. A transmitter is disposed in the housing and coupled to the plurality of conductive contacts for transmitting data obtained using the sensor. The display unit has a receiver for receiving data transmitted by the transmitter of the sensor control unit and a display coupled to the receiver for displaying an indication of a level of an analyte. The analyte monitor may also be part of a drug delivery system to alter the level of the analyte based on the data obtained using the sensor.",ABBOTT DIABETES CARE INC,SAY JAMES;;TOMASCO MICHAEL F;;HELLER ADAM;;GAL YORAM;;ARIA BEHRAD;;HELLER EPHRAIM;;PLANTE PHILLIP JOHN;;VREEKE MARK S;;FRIEDMAN KEITH A;;COLMAN FREDRIC C,,https://lens.org/035-224-567-218-581,Patent Application,yes,0,29,211,221,0,A61B5/14532;;A61B5/14532;;A61B5/0002;;A61B5/0002;;A61B5/002;;A61B5/01;;A61B5/14503;;A61B5/1451;;A61B5/14546;;A61B5/14546;;A61B5/1473;;A61B5/1473;;A61B5/1486;;A61B5/1486;;A61B5/14865;;A61B5/1495;;A61B5/4839;;A61B5/72;;A61B5/7278;;A61B5/7282;;A61B5/7405;;A61B5/743;;A61B5/7445;;A61B5/7445;;A61B5/7455;;A61B2560/0252;;A61B2560/0252;;A61M5/1723;;C12Q1/54;;G16H10/40;;G16H10/40;;G16H20/17;;G16H20/17;;H01L23/3107;;H01L23/3107;;H01L23/49548;;H01L23/49548;;H01L2924/0002;;H01L2924/0002;;H01L2924/19041;;H01L2924/19041;;H01L2924/3011;;H01L2924/3011;;Y10S128/903;;Y10S128/903;;Y10T29/49;;Y10T29/49;;Y10T29/49124;;Y10T29/49124,A61B5/145;;G01N27/30;;A61B5/00;;A61B5/1477;;A61B5/1495;;G01N27/416;;G06F19/00;;H01L23/31;;H01L23/495,600/365;;600/309,0,0,,,,DISCONTINUED
111,US,A1,US 2009/0177059 A1,043-284-716-012-056,2009-07-09,2009,US 40573909 A,2009-03-17,US 40573909 A;;US 42005703 A;;US 66719900 A;;US 7067798 A,1998-04-30,Analyte Monitoring Device and Methods of Use,"An analyte monitor includes a sensor, a sensor control unit, and a display unit. The sensor has, for example, a substrate, a recessed channel formed in the substrate, and conductive material disposed in the recessed channel to form a working electrode. The sensor control unit typically has a housing adapted for placement on skin and is adapted to receive a portion of an electrochemical sensor. The sensor control unit also includes two or more conductive contacts disposed on the housing and configured for coupling to two or more contact pads on the sensor. A transmitter is disposed in the housing and coupled to the plurality of conductive contacts for transmitting data obtained using the sensor. The display unit has a receiver for receiving data transmitted by the transmitter of the sensor control unit and a display coupled to the receiver for displaying an indication of a level of an analyte. The analyte monitor may also be part of a drug delivery system to alter the level of the analyte based on the data obtained using the sensor.",ABBOTT DIABETES CARE INC,SAY JAMES;;TOMASCO MICHAEL F;;HELLER ADAM;;GAL YORAM;;ARIA BEHRAD;;HELLER EPHRAIM;;PLANTE PHILLIP JOHN;;VREEKE MARK S;;FRIEDMAN KEITH A;;COLMAN FREDRIC C,,https://lens.org/043-284-716-012-056,Patent Application,yes,8,95,211,221,0,A61B5/14532;;A61B5/14532;;A61B5/0002;;A61B5/0002;;A61B5/002;;A61B5/01;;A61B5/14503;;A61B5/1451;;A61B5/14546;;A61B5/14546;;A61B5/1473;;A61B5/1473;;A61B5/1486;;A61B5/1486;;A61B5/14865;;A61B5/1495;;A61B5/4839;;A61B5/72;;A61B5/7278;;A61B5/7282;;A61B5/7405;;A61B5/743;;A61B5/7445;;A61B5/7445;;A61B5/7455;;A61B2560/0252;;A61B2560/0252;;A61M5/1723;;C12Q1/54;;G16H10/40;;G16H10/40;;G16H20/17;;G16H20/17;;H01L23/3107;;H01L23/3107;;H01L23/49548;;H01L23/49548;;H01L2924/0002;;H01L2924/0002;;H01L2924/19041;;H01L2924/19041;;H01L2924/3011;;H01L2924/3011;;Y10S128/903;;Y10S128/903;;Y10T29/49;;Y10T29/49;;Y10T29/49124;;Y10T29/49124,A61B5/1468;;G01N27/30;;A61B5/00;;A61B5/145;;A61B5/1477;;A61B5/1495;;G01N27/416;;G06F19/00;;H01L23/31;;H01L23/495,600/345,0,0,,,,DISCONTINUED
112,US,A1,US 2009/0312619 A1,052-838-465-532-425,2009-12-17,2009,US 24987908 A,2008-10-10,US 24987908 A;;US 42005703 A;;US 66719900 A;;US 7067798 A,1998-04-30,Analyte Monitoring Device And Methods Of Use,"An analyte monitor includes a sensor, a sensor control unit, and a display unit. The sensor has, for example, a substrate, a recessed channel formed in the substrate, and conductive material disposed in the recessed channel to form a working electrode. The sensor control unit typically has a housing adapted for placement on skin and is adapted to receive a portion of an electrochemical sensor. The sensor control unit also includes two or more conductive contacts disposed on the housing and configured for coupling to two or more contact pads on the sensor. A transmitter is disposed in the housing and coupled to the plurality of conductive contacts for transmitting data obtained using the sensor. The display unit has a receiver for receiving data transmitted by the transmitter of the sensor control unit and a display coupled to the receiver for displaying an indication of a level of an analyte. The analyte monitor may also be part of a drug delivery system to alter the level of the analyte based on the data obtained using the sensor.",ABBOTT DIABETES CARE INC,SAY JAMES;;TOMASCO MICHAEL F;;HELLER ADAM;;GAL YORAM;;ARIA BEHRAD;;HELLER EPHRAIM;;PLANTE PHILLIP JOHN;;VREEKE MARK S;;FRIEDMAN KEITH A;;COLMAN FREDRIC C,,https://lens.org/052-838-465-532-425,Patent Application,yes,1,46,211,221,0,A61B5/14532;;A61B5/14532;;A61B5/0002;;A61B5/0002;;A61B5/002;;A61B5/01;;A61B5/14503;;A61B5/1451;;A61B5/14546;;A61B5/14546;;A61B5/1473;;A61B5/1473;;A61B5/1486;;A61B5/1486;;A61B5/14865;;A61B5/1495;;A61B5/4839;;A61B5/72;;A61B5/7278;;A61B5/7282;;A61B5/7405;;A61B5/743;;A61B5/7445;;A61B5/7445;;A61B5/7455;;A61B2560/0252;;A61B2560/0252;;A61M5/1723;;C12Q1/54;;G16H10/40;;G16H10/40;;G16H20/17;;G16H20/17;;H01L23/3107;;H01L23/3107;;H01L23/49548;;H01L23/49548;;H01L2924/0002;;H01L2924/0002;;H01L2924/19041;;H01L2924/19041;;H01L2924/3011;;H01L2924/3011;;Y10S128/903;;Y10S128/903;;Y10T29/49;;Y10T29/49;;Y10T29/49124;;Y10T29/49124,A61B5/1473;;G01N27/30;;A61B5/00;;A61B5/145;;A61B5/1477;;A61B5/1495;;G01N27/416;;G06F19/00;;H01L23/31;;H01L23/495,600/347;;600/345,0,0,,,,DISCONTINUED
113,US,A1,US 2010/0292555 A1,060-299-594-439-446,2010-11-18,2010,US 84682110 A,2010-07-29,US 84682110 A;;US 69082607 A;;US 42005703 A;;US 66719900 A;;US 7067798 A,1998-04-30,Analyte Monitoring Device and Methods of Use,"An analyte monitor includes a sensor, a sensor control unit, and a display unit. The sensor has, for example, a substrate, a recessed channel formed in the substrate, and conductive material disposed in the recessed channel to form a working electrode. The sensor control unit typically has a housing adapted for placement on skin and is adapted to receive a portion of an electrochemical sensor. The sensor control unit also includes two or more conductive contacts disposed on the housing and configured for coupling to two or more contact pads on the sensor. A transmitter is disposed in the housing and coupled to the plurality of conductive contacts for transmitting data obtained using the sensor. The display unit has a receiver for receiving data transmitted by the transmitter of the sensor control unit and a display coupled to the receiver for displaying an indication of a level of an analyte. The analyte monitor may also be part of a drug delivery system to alter the level of the analyte based on the data obtained using the sensor.",ABBOTT DIABETES CARE INC,SAY JAMES;;TOMASCO MICHAEL F;;HELLER ADAM;;GAL YORAM;;ARIA BEHRAD;;HELLER EPHRAIM;;PLANTE PHILLIP JOHN;;VREEKE MARK S;;FRIEDMAN KEITH A;;COLMAN FREDRIC C,,https://lens.org/060-299-594-439-446,Patent Application,yes,1,1,211,221,0,A61B5/14532;;A61B5/14532;;A61B5/0002;;A61B5/0002;;A61B5/002;;A61B5/01;;A61B5/14503;;A61B5/1451;;A61B5/14546;;A61B5/14546;;A61B5/1473;;A61B5/1473;;A61B5/1486;;A61B5/1486;;A61B5/14865;;A61B5/1495;;A61B5/4839;;A61B5/72;;A61B5/7278;;A61B5/7282;;A61B5/7405;;A61B5/743;;A61B5/7445;;A61B5/7445;;A61B5/7455;;A61B2560/0252;;A61B2560/0252;;A61M5/1723;;C12Q1/54;;G16H10/40;;G16H10/40;;G16H20/17;;G16H20/17;;H01L23/3107;;H01L23/3107;;H01L23/49548;;H01L23/49548;;H01L2924/0002;;H01L2924/0002;;H01L2924/19041;;H01L2924/19041;;H01L2924/3011;;H01L2924/3011;;Y10S128/903;;Y10S128/903;;Y10T29/49;;Y10T29/49;;Y10T29/49124;;Y10T29/49124,A61B5/05;;G01N27/30;;A61B5/00;;A61B5/145;;A61B5/1477;;A61B5/1495;;G01N27/416;;G06F19/00;;H01L23/31;;H01L23/495,600/347,0,0,,,,DISCONTINUED
114,US,A1,US 2004/0171921 A1,069-755-367-883-049,2004-09-02,2004,US 78977604 A,2004-02-27,US 78977604 A;;US 42005403 A;;US 66719900 A;;US 7067798 A,1998-04-30,Analyte monitoring device and methods of use,"
   An analyte monitor includes a sensor, a sensor control unit, and a display unit. The sensor has, for example, a substrate, a recessed channel formed in the substrate, and conductive material disposed in the recessed channel to form a working electrode. The sensor control unit typically has a housing adapted for placement on skin and is adapted to receive a portion of an electrochemical sensor. The sensor control unit also includes two or more conductive contacts disposed on the housing and configured for coupling to two or more contact pads on the sensor. A transmitter is disposed in the housing and coupled to the plurality of conductive contacts for transmitting data obtained using the sensor. The display unit has a receiver for receiving data transmitted by the transmitter of the sensor control unit and a display coupled to the receiver for displaying an indication of a level of an analyte. The analyte monitor may also be part of a drug delivery system to alter the level of the analyte based on the data obtained using the sensor. 
",SAY JAMES;;TOMASCO MICHAEL F.;;HELLER ADAM;;GAL YORAM;;ARIA BEHRAD;;HELLER EPHRAIM;;PLANTE PHILLIP JOHN;;VREEKE MARK S.;;FRIEDMAN KEITH A.;;COLMAN FREDRIC C.,SAY JAMES;;TOMASCO MICHAEL F;;HELLER ADAM;;GAL YORAM;;ARIA BEHRAD;;HELLER EPHRAIM;;PLANTE PHILLIP JOHN;;VREEKE MARK S;;FRIEDMAN KEITH A;;COLMAN FREDRIC C,E. HELLER & CO (1998-07-02);;ABBOTT DIABETES CARE INC (2000-03-13),https://lens.org/069-755-367-883-049,Patent Application,yes,99,354,7,7,0,A61B5/14532;;A61B5/14532;;A61B5/0002;;A61B5/0002;;A61B5/14546;;A61B5/14546;;A61B5/7445;;A61B5/7445;;G16H15/00;;G16H15/00;;G16H40/67;;G16H40/67;;H01L23/3107;;H01L23/3107;;H01L23/49548;;H01L23/49548;;H01L24/48;;H01L24/48;;H01L2224/48091;;H01L2224/48091;;H01L2224/48247;;H01L2224/48247;;H01L2924/00014;;H01L2924/00014;;H01L2924/01012;;H01L2924/01012;;H01L2924/12042;;H01L2924/12042;;H01L2924/14;;H01L2924/14;;H01L2924/181;;H01L2924/181;;H01L2924/19041;;H01L2924/19041;;H01L2924/3011;;H01L2924/3011;;Y02A90/10;;Y02A90/10,G01N27/30;;A61B5/00;;A61B5/145;;A61B5/1477;;A61B5/1495;;G01N27/416;;H01L23/31;;H01L23/495,600/347;;600/365;;128/903,0,0,,,,EXPIRED
115,US,A1,US 2009/0173628 A1,083-636-658-954-842,2009-07-09,2009,US 40556809 A,2009-03-17,US 40556809 A;;US 42005703 A;;US 66719900 A;;US 7067798 A,1998-04-30,Analyte Monitoring Device and Methods of Use,"An analyte monitor includes a sensor, a sensor control unit, and a display unit. The sensor has, for example, a substrate, a recessed channel formed in the substrate, and conductive material disposed in the recessed channel to form a working electrode. The sensor control unit typically has a housing adapted for placement on skin and is adapted to receive a portion of an electrochemical sensor. The sensor control unit also includes two or more conductive contacts disposed on the housing and configured for coupling to two or more contact pads on the sensor. A transmitter is disposed in the housing and coupled to the plurality of conductive contacts for transmitting data obtained using the sensor. The display unit has a receiver for receiving data transmitted by the transmitter of the sensor control unit and a display coupled to the receiver for displaying an indication of a level of an analyte. The analyte monitor may also be part of a drug delivery system to alter the level of the analyte based on the data obtained using the sensor.",ABBOTT DIABETES CARE INC,SAY JAMES;;TOMASCO MICHAEL F;;HELLER ADAM;;GAL YORAM;;ARIA BEHRAD;;HELLER EPHRAIM;;PLANTE PHILLIP JOHN;;VREEKE MARK S;;FRIEDMAN KEITH A;;COLMAN FREDRIC C,,https://lens.org/083-636-658-954-842,Patent Application,yes,99,57,211,221,0,A61B5/14532;;A61B5/14532;;A61B5/0002;;A61B5/0002;;A61B5/002;;A61B5/01;;A61B5/14503;;A61B5/1451;;A61B5/14546;;A61B5/14546;;A61B5/1473;;A61B5/1473;;A61B5/1486;;A61B5/1486;;A61B5/14865;;A61B5/1495;;A61B5/4839;;A61B5/72;;A61B5/7278;;A61B5/7282;;A61B5/7405;;A61B5/743;;A61B5/7445;;A61B5/7445;;A61B5/7455;;A61B2560/0252;;A61B2560/0252;;A61M5/1723;;C12Q1/54;;G16H10/40;;G16H10/40;;G16H20/17;;G16H20/17;;H01L23/3107;;H01L23/3107;;H01L23/49548;;H01L23/49548;;H01L2924/0002;;H01L2924/0002;;H01L2924/19041;;H01L2924/19041;;H01L2924/3011;;H01L2924/3011;;Y10S128/903;;Y10S128/903;;Y10T29/49;;Y10T29/49;;Y10T29/49124;;Y10T29/49124,G01N27/26;;G01N27/30;;A61B5/00;;A61B5/145;;A61B5/1477;;A61B5/1495;;G01N27/416;;G06F19/00;;H01L23/31;;H01L23/495,204/400,0,0,,,,EXPIRED
116,US,A1,US 2009/0192368 A1,088-798-510-716-331,2009-07-30,2009,US 40685909 A,2009-03-18,US 40685909 A;;US 42005703 A;;US 66719900 A;;US 7067798 A,1998-04-30,Analyte Monitoring Device and Methods of Use,"An analyte monitor includes a sensor, a sensor control unit, and a display unit. The sensor has, for example, a substrate, a recessed channel formed in the substrate, and conductive material disposed in the recessed channel to form a working electrode. The sensor control unit typically has a housing adapted for placement on skin and is adapted to receive a portion of an electrochemical sensor. The sensor control unit also includes two or more conductive contacts disposed on the housing and configured for coupling to two or more contact pads on the sensor. A transmitter is disposed in the housing and coupled to the plurality of conductive contacts for transmitting data obtained using the sensor. The display unit has a receiver for receiving data transmitted by the transmitter of the sensor control unit and a display coupled to the receiver for displaying an indication of a level of an analyte. The analyte monitor may also be part of a drug delivery system to alter the level of the analyte based on the data obtained using the sensor.",ABBOTT DIABETES CARE INC,SAY JAMES;;TOMASCO MICHAEL F;;HELLER ADAM;;GAL YORAM;;ARIA BEHRAD;;HELLER EPHRAIM;;PLANTE PHILLIP JOHN;;VREEKE MARK S;;FRIEDMAN KEITH A;;COLMAN FREDRIC C,,https://lens.org/088-798-510-716-331,Patent Application,yes,8,57,211,221,0,A61B5/14532;;A61B5/14532;;A61B5/0002;;A61B5/0002;;A61B5/002;;A61B5/01;;A61B5/14503;;A61B5/1451;;A61B5/14546;;A61B5/14546;;A61B5/1473;;A61B5/1473;;A61B5/1486;;A61B5/1486;;A61B5/14865;;A61B5/1495;;A61B5/4839;;A61B5/72;;A61B5/7278;;A61B5/7282;;A61B5/7405;;A61B5/743;;A61B5/7445;;A61B5/7445;;A61B5/7455;;A61B2560/0252;;A61B2560/0252;;A61M5/1723;;C12Q1/54;;G16H10/40;;G16H10/40;;G16H20/17;;G16H20/17;;H01L23/3107;;H01L23/3107;;H01L23/49548;;H01L23/49548;;H01L2924/0002;;H01L2924/0002;;H01L2924/19041;;H01L2924/19041;;H01L2924/3011;;H01L2924/3011;;Y10S128/903;;Y10S128/903;;Y10T29/49;;Y10T29/49;;Y10T29/49124;;Y10T29/49124,A61B5/1468;;G01N27/30;;A61B5/00;;A61B5/145;;A61B5/1477;;A61B5/1495;;G01N27/416;;G06F19/00;;H01L23/31;;H01L23/495,600/345,0,0,,,,DISCONTINUED
117,US,A1,US 2008/0214914 A1,107-037-878-536-831,2008-09-04,2008,US 3956508 A,2008-02-28,US 3956508 A;;US 76674707 A;;US 42005703 A;;US 66719900 A;;US 7067798 A,1998-04-30,ANALYTE MONITORING DEVICE AND METHODS OF USE,"An analyte monitor includes a sensor, a sensor control unit, and a display unit. The sensor has, for example, a substrate, a recessed channel formed in the substrate, and conductive material disposed in the recessed channel to form a working electrode. The sensor control unit typically has a housing adapted for placement on skin and is adapted to receive a portion of an electrochemical sensor. The sensor control unit also includes two or more conductive contacts disposed on the housing and configured for coupling to two or more contact pads on the sensor. A transmitter is disposed in the housing and coupled to the plurality of conductive contacts for transmitting data obtained using the sensor. The display unit has a receiver for receiving data transmitted by the transmitter of the sensor control unit and a display coupled to the receiver for displaying an indication of a level of an analyte. The analyte monitor may also be part of a drug delivery system to alter the level of the analyte based on the data obtained using the sensor.",ABBOTT LAB,SAY JAMES;;TOMASCO MICHAEL F;;HELLER ADAM;;GAL YORAM;;ARIA BEHRAD;;HELLER EPHRAIM;;PLANTE PHILLIP JOHN;;VREEKE MARK S;;FRIEDMAN KEITH A;;COLMAN FREDRIC C,,https://lens.org/107-037-878-536-831,Patent Application,yes,10,17,211,221,0,A61B5/14532;;A61B5/14532;;A61B5/0002;;A61B5/0002;;A61B5/002;;A61B5/01;;A61B5/14503;;A61B5/1451;;A61B5/14546;;A61B5/14546;;A61B5/1473;;A61B5/1473;;A61B5/1486;;A61B5/1486;;A61B5/14865;;A61B5/1495;;A61B5/4839;;A61B5/72;;A61B5/7278;;A61B5/7282;;A61B5/7405;;A61B5/743;;A61B5/7445;;A61B5/7445;;A61B5/7455;;A61B2560/0252;;A61B2560/0252;;A61M5/1723;;C12Q1/54;;G16H10/40;;G16H10/40;;G16H20/17;;G16H20/17;;H01L23/3107;;H01L23/3107;;H01L23/49548;;H01L23/49548;;H01L2924/0002;;H01L2924/0002;;H01L2924/19041;;H01L2924/19041;;H01L2924/3011;;H01L2924/3011;;Y10S128/903;;Y10S128/903;;Y10T29/49;;Y10T29/49;;Y10T29/49124;;Y10T29/49124,A61B5/05;;G01N27/30;;A61B5/00;;A61B5/145;;A61B5/1477;;A61B5/1495;;A61L31/08;;G01N27/416;;G06F19/00;;H01L23/31;;H01L23/495,600/345;;427/2.12,0,0,,,,DISCONTINUED
118,US,A1,US 2009/0192378 A1,109-565-547-638-157,2009-07-30,2009,US 41846209 A,2009-04-03,US 41846209 A;;US 42005703 A;;US 66719900 A;;US 7067798 A,1998-04-30,Analyte Monitoring Device and Methods of Use,"An analyte monitor includes a sensor, a sensor control unit, and a display unit. The sensor has, for example, a substrate, a recessed channel formed in the substrate, and conductive material disposed in the recessed channel to form a working electrode. The sensor control unit typically has a housing adapted for placement on skin and is adapted to receive a portion of an electrochemical sensor. The sensor control unit also includes two or more conductive contacts disposed on the housing and configured for coupling to two or more contact pads on the sensor. A transmitter is disposed in the housing and coupled to the plurality of conductive contacts for transmitting data obtained using the sensor. The display unit has a receiver for receiving data transmitted by the transmitter of the sensor control unit and a display coupled to the receiver for displaying an indication of a level of an analyte. The analyte monitor may also be part of a drug delivery system to alter the level of the analyte based on the data obtained using the sensor.",ABBOTT DIABETES CARE INC,SAY JAMES;;TOMASCO MICHAEL F;;HELLER ADAM;;GAL YORAM;;ARIA BEHRAD;;HELLER EPHRAIM;;PLANTE PHILLIP JOHN;;VREEKE MARK S;;FRIEDMAN KEITH A;;COLMAN FREDRIC C,,https://lens.org/109-565-547-638-157,Patent Application,yes,1,57,211,221,0,A61B5/14532;;A61B5/14532;;A61B5/0002;;A61B5/0002;;A61B5/002;;A61B5/01;;A61B5/14503;;A61B5/1451;;A61B5/14546;;A61B5/14546;;A61B5/1473;;A61B5/1473;;A61B5/1486;;A61B5/1486;;A61B5/14865;;A61B5/1495;;A61B5/4839;;A61B5/72;;A61B5/7278;;A61B5/7282;;A61B5/7405;;A61B5/743;;A61B5/7445;;A61B5/7445;;A61B5/7455;;A61B2560/0252;;A61B2560/0252;;A61M5/1723;;C12Q1/54;;G16H10/40;;G16H10/40;;G16H20/17;;G16H20/17;;H01L23/3107;;H01L23/3107;;H01L23/49548;;H01L23/49548;;H01L2924/0002;;H01L2924/0002;;H01L2924/19041;;H01L2924/19041;;H01L2924/3011;;H01L2924/3011;;Y10S128/903;;Y10S128/903;;Y10T29/49;;Y10T29/49;;Y10T29/49124;;Y10T29/49124,A61B5/1468;;G01N27/30;;A61B5/00;;A61B5/145;;A61B5/1477;;A61B5/1495;;G01N27/416;;G06F19/00;;H01L23/31;;H01L23/495,600/345,0,0,,,,DISCONTINUED
119,US,A1,US 2010/0223021 A1,129-218-055-220-765,2010-09-02,2010,US 77994110 A,2010-05-13,US 77994110 A;;US 69082607 A;;US 42005703 A;;US 66719900 A;;US 7067798 A,1998-04-30,Analyte Monitoring Device and Methods of Use,"An analyte monitor includes a sensor, a sensor control unit, and a display unit. The sensor has, for example, a substrate, a recessed channel formed in the substrate, and conductive material disposed in the recessed channel to form a working electrode. The sensor control unit typically has a housing adapted for placement on skin and is adapted to receive a portion of an electrochemical sensor. The sensor control unit also includes two or more conductive contacts disposed on the housing and configured for coupling to two or more contact pads on the sensor. A transmitter is disposed in the housing and coupled to the plurality of conductive contacts for transmitting data obtained using the sensor. The display unit has a receiver for receiving data transmitted by the transmitter of the sensor control unit and a display coupled to the receiver for displaying an indication of a level of an analyte. The analyte monitor may also be part of a drug delivery system to alter the level of the analyte based on the data obtained using the sensor.",ABBOTT DIABETES CARE INC,SAY JAMES;;TOMASCO MICHAEL F;;HELLER ADAM;;GAL YORAM;;ARIA BEHRAD;;HELLER EPHRAIM;;PLANTE PHILLIP JOHN;;VREEKE MARK S;;FRIEDMAN KEITH A;;COLMAN FREDRIC C,,https://lens.org/129-218-055-220-765,Patent Application,yes,4,0,211,221,0,A61B5/14532;;A61B5/14532;;A61B5/0002;;A61B5/0002;;A61B5/002;;A61B5/01;;A61B5/14503;;A61B5/1451;;A61B5/14546;;A61B5/14546;;A61B5/1473;;A61B5/1473;;A61B5/1486;;A61B5/1486;;A61B5/14865;;A61B5/1495;;A61B5/4839;;A61B5/72;;A61B5/7278;;A61B5/7282;;A61B5/7405;;A61B5/743;;A61B5/7445;;A61B5/7445;;A61B5/7455;;A61B2560/0252;;A61B2560/0252;;A61M5/1723;;C12Q1/54;;G16H10/40;;G16H10/40;;G16H20/17;;G16H20/17;;H01L23/3107;;H01L23/3107;;H01L23/49548;;H01L23/49548;;H01L2924/0002;;H01L2924/0002;;H01L2924/19041;;H01L2924/19041;;H01L2924/3011;;H01L2924/3011;;Y10S128/903;;Y10S128/903;;Y10T29/49;;Y10T29/49;;Y10T29/49124;;Y10T29/49124,G01N27/30;;A61B5/00;;A61B5/145;;A61B5/1477;;A61B5/1495;;G01N27/416;;G06F19/00;;H01L23/31;;H01L23/495,702/104,0,0,,,,DISCONTINUED
120,US,A1,US 2009/0182214 A1,144-259-855-847-19X,2009-07-16,2009,US 40603109 A,2009-03-17,US 40603109 A;;US 42005703 A;;US 66719900 A;;US 7067798 A,1998-04-30,Analyte Monitoring Device and Methods of Use,"An analyte monitor includes a sensor, a sensor control unit, and a display unit. The sensor has, for example, a substrate, a recessed channel formed in the substrate, and conductive material disposed in the recessed channel to form a working electrode. The sensor control unit typically has a housing adapted for placement on skin and is adapted to receive a portion of an electrochemical sensor. The sensor control unit also includes two or more conductive contacts disposed on the housing and configured for coupling to two or more contact pads on the sensor. A transmitter is disposed in the housing and coupled to the plurality of conductive contacts for transmitting data obtained using the sensor. The display unit has a receiver for receiving data transmitted by the transmitter of the sensor control unit and a display coupled to the receiver for displaying an indication of a level of an analyte. The analyte monitor may also be part of a drug delivery system to alter the level of the analyte based on the data obtained using the sensor.",ABBOTT DIABETES CARE INC,SAY JAMES;;TOMASCO MICHAEL F;;HELLER ADAM;;GAL YORAM;;ARIA BEHRAD;;HELLER EPHRAIM;;PLANTE PHILLIP JOHN;;VREEKE MARK S;;FRIEDMAN KEITH A;;COLMAN FREDRIC C,,https://lens.org/144-259-855-847-19X,Patent Application,yes,1,57,211,221,0,A61B5/14532;;A61B5/14532;;A61B5/0002;;A61B5/0002;;A61B5/002;;A61B5/01;;A61B5/14503;;A61B5/1451;;A61B5/14546;;A61B5/14546;;A61B5/1473;;A61B5/1473;;A61B5/1486;;A61B5/1486;;A61B5/14865;;A61B5/1495;;A61B5/4839;;A61B5/72;;A61B5/7278;;A61B5/7282;;A61B5/7405;;A61B5/743;;A61B5/7445;;A61B5/7445;;A61B5/7455;;A61B2560/0252;;A61B2560/0252;;A61M5/1723;;C12Q1/54;;G16H10/40;;G16H10/40;;G16H20/17;;G16H20/17;;H01L23/3107;;H01L23/3107;;H01L23/49548;;H01L23/49548;;H01L2924/0002;;H01L2924/0002;;H01L2924/19041;;H01L2924/19041;;H01L2924/3011;;H01L2924/3011;;Y10S128/903;;Y10S128/903;;Y10T29/49;;Y10T29/49;;Y10T29/49124;;Y10T29/49124,A61B5/1468;;G01N27/30;;A61B5/00;;A61B5/145;;A61B5/1477;;A61B5/1495;;G01N27/416;;G06F19/00;;H01L23/31;;H01L23/495,600/345,0,0,,,,DISCONTINUED
121,US,A1,US 2007/0179370 A1,156-564-080-377-386,2007-08-02,2007,US 69560807 A,2007-04-03,US 69560807 A;;US 42005703 A;;US 66719900 A;;US 7067798 A,1998-04-30,Analyte Monitoring Device and Methods of Use,"An analyte monitor includes a sensor, a sensor control unit, and a display unit. The sensor has, for example, a substrate, a recessed channel formed in the substrate, and conductive material disposed in the recessed channel to form a working electrode. The sensor control unit typically has a housing adapted for placement on skin and is adapted to receive a portion of an electrochemical sensor. The sensor control unit also includes two or more conductive contacts disposed on the housing and configured for coupling to two or more contact pads on the sensor. A transmitter is disposed in the housing and coupled to the plurality of conductive contacts for transmitting data obtained using the sensor. The display unit has a receiver for receiving data transmitted by the transmitter of the sensor control unit and a display coupled to the receiver for displaying an indication of a level of an analyte. The analyte monitor may also be part of a drug delivery system to alter the level of the analyte based on the data obtained using the sensor.",ABBOTT DIABETES CARE INC,SAY JAMES;;TOMASCO MICHAEL F;;HELLER ADAM;;GAL YORAM;;ARIA BEHRAD;;HELLER EPHRAIM;;PLANTE PHILLIP J;;VREEKE MARK S;;FRIEDMAN KEITH A;;COLMAN FREDRIC C,E. HELLER & CO (1998-07-02);;ABBOTT DIABETES CARE INC (2000-03-13),https://lens.org/156-564-080-377-386,Patent Application,yes,99,44,211,221,0,A61B5/14532;;A61B5/14532;;A61B5/0002;;A61B5/0002;;A61B5/002;;A61B5/01;;A61B5/14503;;A61B5/1451;;A61B5/14546;;A61B5/14546;;A61B5/1473;;A61B5/1473;;A61B5/1486;;A61B5/1486;;A61B5/14865;;A61B5/1495;;A61B5/4839;;A61B5/72;;A61B5/7278;;A61B5/7282;;A61B5/7405;;A61B5/743;;A61B5/7445;;A61B5/7445;;A61B5/7455;;A61B2560/0252;;A61B2560/0252;;A61M5/1723;;C12Q1/54;;G16H10/40;;G16H10/40;;G16H20/17;;G16H20/17;;H01L23/3107;;H01L23/3107;;H01L23/49548;;H01L23/49548;;H01L2924/0002;;H01L2924/0002;;H01L2924/19041;;H01L2924/19041;;H01L2924/3011;;H01L2924/3011;;Y10S128/903;;Y10S128/903;;Y10T29/49;;Y10T29/49;;Y10T29/49124;;Y10T29/49124,A61B5/00;;G01N27/30;;A61B5/05;;A61B5/145;;A61B5/1477;;A61B5/1495;;G01N27/416;;G06F19/00;;H01L23/31;;H01L23/495,600/345;;600/365,0,0,,,,EXPIRED
122,US,A1,US 2009/0192377 A1,176-293-115-432-714,2009-07-30,2009,US 41842309 A,2009-04-03,US 41842309 A;;US 42005703 A;;US 66719900 A;;US 7067798 A,1998-04-30,Analyte Monitoring Device and Methods of Use,"An analyte monitor includes a sensor, a sensor control unit, and a display unit. The sensor has, for example, a substrate, a recessed channel formed in the substrate, and conductive material disposed in the recessed channel to form a working electrode. The sensor control unit typically has a housing adapted for placement on skin and is adapted to receive a portion of an electrochemical sensor. The sensor control unit also includes two or more conductive contacts disposed on the housing and configured for coupling to two or more contact pads on the sensor. A transmitter is disposed in the housing and coupled to the plurality of conductive contacts for transmitting data obtained using the sensor. The display unit has a receiver for receiving data transmitted by the transmitter of the sensor control unit and a display coupled to the receiver for displaying an indication of a level of an analyte. The analyte monitor may also be part of a drug delivery system to alter the level of the analyte based on the data obtained using the sensor.",ABBOTT DIABETES CARE INC,SAY JAMES;;TOMASCO MICHAEL F;;HELLER ADAM;;GAL YORAM;;ARIA BEHRAD;;HELLER EPHRAIM;;PLANTE PHILLIP JOHN;;VREEKE MARK S;;FRIEDMAN KEITH A;;COLMAN FREDRIC C,,https://lens.org/176-293-115-432-714,Patent Application,yes,1,57,211,221,0,A61B5/14532;;A61B5/14532;;A61B5/0002;;A61B5/0002;;A61B5/002;;A61B5/01;;A61B5/14503;;A61B5/1451;;A61B5/14546;;A61B5/14546;;A61B5/1473;;A61B5/1473;;A61B5/1486;;A61B5/1486;;A61B5/14865;;A61B5/1495;;A61B5/4839;;A61B5/72;;A61B5/7278;;A61B5/7282;;A61B5/7405;;A61B5/743;;A61B5/7445;;A61B5/7445;;A61B5/7455;;A61B2560/0252;;A61B2560/0252;;A61M5/1723;;C12Q1/54;;G16H10/40;;G16H10/40;;G16H20/17;;G16H20/17;;H01L23/3107;;H01L23/3107;;H01L23/49548;;H01L23/49548;;H01L2924/0002;;H01L2924/0002;;H01L2924/19041;;H01L2924/19041;;H01L2924/3011;;H01L2924/3011;;Y10S128/903;;Y10S128/903;;Y10T29/49;;Y10T29/49;;Y10T29/49124;;Y10T29/49124,A61B5/1468;;G01N27/30;;A61B5/00;;A61B5/145;;A61B5/1477;;A61B5/1495;;G01N27/416;;G06F19/00;;H01L23/31;;H01L23/495,600/345,0,0,,,,DISCONTINUED
123,US,A1,US 2010/0298681 A1,179-044-937-449-381,2010-11-25,2010,US 84680010 A,2010-07-29,US 84680010 A;;US 69082607 A;;US 42005703 A;;US 66719900 A;;US 7067798 A,1998-04-30,Analyte Monitoring Device and Methods of Use,"An analyte monitor includes a sensor, a sensor control unit, and a display unit. The sensor has, for example, a substrate, a recessed channel formed in the substrate, and conductive material disposed in the recessed channel to form a working electrode. The sensor control unit typically has a housing adapted for placement on skin and is adapted to receive a portion of an electrochemical sensor. The sensor control unit also includes two or more conductive contacts disposed on the housing and configured for coupling to two or more contact pads on the sensor. A transmitter is disposed in the housing and coupled to the plurality of conductive contacts for transmitting data obtained using the sensor. The display unit has a receiver for receiving data transmitted by the transmitter of the sensor control unit and a display coupled to the receiver for displaying an indication of a level of an analyte. The analyte monitor may also be part of a drug delivery system to alter the level of the analyte based on the data obtained using the sensor.",ABBOTT DIABETES CARE INC,SAY JAMES;;TOMASCO MICHAEL F;;HELLER ADAM;;GAL YORAM;;ARIA BEHRAD;;HELLER EPHRAIM;;PLANTE PHILLIP JOHN;;VREEKE MARK S;;FRIEDMAN KEITH A;;COLMAN FREDRIC C,,https://lens.org/179-044-937-449-381,Patent Application,yes,1,23,211,221,0,A61B5/14532;;A61B5/14532;;A61B5/0002;;A61B5/0002;;A61B5/002;;A61B5/01;;A61B5/14503;;A61B5/1451;;A61B5/14546;;A61B5/14546;;A61B5/1473;;A61B5/1473;;A61B5/1486;;A61B5/1486;;A61B5/14865;;A61B5/1495;;A61B5/4839;;A61B5/72;;A61B5/7278;;A61B5/7282;;A61B5/7405;;A61B5/743;;A61B5/7445;;A61B5/7445;;A61B5/7455;;A61B2560/0252;;A61B2560/0252;;A61M5/1723;;C12Q1/54;;G16H10/40;;G16H10/40;;G16H20/17;;G16H20/17;;H01L23/3107;;H01L23/3107;;H01L23/49548;;H01L23/49548;;H01L2924/0002;;H01L2924/0002;;H01L2924/19041;;H01L2924/19041;;H01L2924/3011;;H01L2924/3011;;Y10S128/903;;Y10S128/903;;Y10T29/49;;Y10T29/49;;Y10T29/49124;;Y10T29/49124,A61B5/05;;G01N27/30;;A61B5/00;;A61B5/145;;A61B5/1477;;A61B5/1495;;G01N27/416;;G06F19/00;;H01L23/31;;H01L23/495,600/347,0,0,,,,DISCONTINUED
124,US,A1,US 2009/0171179 A1,197-790-912-048-546,2009-07-02,2009,US 39729309 A,2009-03-03,US 39729309 A;;US 69082607 A;;US 42005703 A;;US 66719900 A;;US 7067798 A,1998-04-30,Analyte Monitoring Device and Methods of Use,"An analyte monitor includes a sensor, a sensor control unit, and a display unit. The sensor has, for example, a substrate, a recessed channel formed in the substrate, and conductive material disposed in the recessed channel to form a working electrode. The sensor control unit typically has a housing adapted for placement on skin and is adapted to receive a portion of an electrochemical sensor. The sensor control unit also includes two or more conductive contacts disposed on the housing and configured for coupling to two or more contact pads on the sensor. A transmitter is disposed in the housing and coupled to the plurality of conductive contacts for transmitting data obtained using the sensor. The display unit has a receiver for receiving data transmitted by the transmitter of the sensor control unit and a display coupled to the receiver for displaying an indication of a level of an analyte. The analyte monitor may also be part of a drug delivery system to alter the level of the analyte based on the data obtained using the sensor.",ABBOTT DIABETES CARE INC,SAY JAMES;;TOMASCO MICHAEL F;;HELLER ADAM;;GAL YORAM;;ARIA BEHRAD;;HELLER EPHRAIM;;PLANTE PHILLIP JOHN;;VREEKE MARK S;;FRIEDMAN KEITH A;;COLMAN FREDRIC C,E. HELLER & CO (1998-07-02);;ABBOTT DIABETES CARE INC (2000-03-13),https://lens.org/197-790-912-048-546,Patent Application,yes,102,11,211,221,0,A61B5/14532;;A61B5/14532;;A61B5/0002;;A61B5/0002;;A61B5/002;;A61B5/01;;A61B5/14503;;A61B5/1451;;A61B5/14546;;A61B5/14546;;A61B5/1473;;A61B5/1473;;A61B5/1486;;A61B5/1486;;A61B5/14865;;A61B5/1495;;A61B5/4839;;A61B5/72;;A61B5/7278;;A61B5/7282;;A61B5/7405;;A61B5/743;;A61B5/7445;;A61B5/7445;;A61B5/7455;;A61B2560/0252;;A61B2560/0252;;A61M5/1723;;C12Q1/54;;G16H10/40;;G16H10/40;;G16H20/17;;G16H20/17;;H01L23/3107;;H01L23/3107;;H01L23/49548;;H01L23/49548;;H01L2924/0002;;H01L2924/0002;;H01L2924/19041;;H01L2924/19041;;H01L2924/3011;;H01L2924/3011;;Y10S128/903;;Y10S128/903;;Y10T29/49;;Y10T29/49;;Y10T29/49124;;Y10T29/49124,A61B5/1468;;G01N27/30;;A61B5/00;;A61B5/145;;A61B5/1477;;A61B5/1495;;G01N27/416;;G06F19/00;;H01L23/31;;H01L23/495,600/365,0,0,,,,EXPIRED
125,US,A1,US 2007/0179372 A1,012-610-058-572-807,2007-08-02,2007,US 69560707 A,2007-04-03,US 69560707 A;;US 42005703 A;;US 66719900 A;;US 7067798 A,1998-04-30,Analyte Monitoring Device and Methods of Use,"An analyte monitor includes a sensor, a sensor control unit, and a display unit. The sensor has, for example, a substrate, a recessed channel formed in the substrate, and conductive material disposed in the recessed channel to form a working electrode. The sensor control unit typically has a housing adapted for placement on skin and is adapted to receive a portion of an electrochemical sensor. The sensor control unit also includes two or more conductive contacts disposed on the housing and configured for coupling to two or more contact pads on the sensor. A transmitter is disposed in the housing and coupled to the plurality of conductive contacts for transmitting data obtained using the sensor. The display unit has a receiver for receiving data transmitted by the transmitter of the sensor control unit and a display coupled to the receiver for displaying an indication of a level of an analyte. The analyte monitor may also be part of a drug delivery system to alter the level of the analyte based on the data obtained using the sensor.",ABBOTT DIABETES CARE INC,SAY JAMES;;TOMASCO MICHAEL F;;HELLER ADAM;;GAL YORAM;;ARIA BEHRAD;;HELLER EPHRAIM;;PLANTE PHILLIP J;;VREEKE MARK S;;FRIEDMAN KEITH A;;COLMAN FREDRIC C,E. HELLER & CO (1998-07-02);;ABBOTT DIABETES CARE INC (2000-03-13),https://lens.org/012-610-058-572-807,Patent Application,yes,99,42,211,221,0,A61B5/14532;;A61B5/14532;;A61B5/0002;;A61B5/0002;;A61B5/002;;A61B5/01;;A61B5/14503;;A61B5/1451;;A61B5/14546;;A61B5/14546;;A61B5/1473;;A61B5/1473;;A61B5/1486;;A61B5/1486;;A61B5/14865;;A61B5/1495;;A61B5/4839;;A61B5/72;;A61B5/7278;;A61B5/7282;;A61B5/7405;;A61B5/743;;A61B5/7445;;A61B5/7445;;A61B5/7455;;A61B2560/0252;;A61B2560/0252;;A61M5/1723;;C12Q1/54;;G16H10/40;;G16H10/40;;G16H20/17;;G16H20/17;;H01L23/3107;;H01L23/3107;;H01L23/49548;;H01L23/49548;;H01L2924/0002;;H01L2924/0002;;H01L2924/19041;;H01L2924/19041;;H01L2924/3011;;H01L2924/3011;;Y10S128/903;;Y10S128/903;;Y10T29/49;;Y10T29/49;;Y10T29/49124;;Y10T29/49124,A61B5/05;;G01N27/30;;A61B5/00;;A61B5/145;;A61B5/1477;;A61B5/1495;;G01N27/416;;G06F19/00;;H01L23/31;;H01L23/495,600/347;;600/365;;128/903,0,0,,,,EXPIRED
126,US,A1,US 2010/0099969 A1,000-375-826-887-543,2010-04-22,2010,US 64814309 A,2009-12-28,US 64814309 A;;US 42005703 A;;US 66719900 A;;US 7067798 A,1998-04-30,Analyte Monitoring Device and Methods of Use,"An analyte monitor includes a sensor, a sensor control unit, and a display unit. The sensor has, for example, a substrate, a recessed channel formed in the substrate, and conductive material disposed in the recessed channel to form a working electrode. The sensor control unit typically has a housing adapted for placement on skin and is adapted to receive a portion of an electrochemical sensor. The sensor control unit also includes two or more conductive contacts disposed on the housing and configured for coupling to two or more contact pads on the sensor. A transmitter is disposed in the housing and coupled to the plurality of conductive contacts for transmitting data obtained using the sensor. The display unit has a receiver for receiving data transmitted by the transmitter of the sensor control unit and a display coupled to the receiver for displaying an indication of a level of an analyte. The analyte monitor may also be part of a drug delivery system to alter the level of the analyte based on the data obtained using the sensor.",ABBOTT DIABETES CARE INC,SAY JAMES;;TOMASCO MICHAEL F;;HELLER ADAM;;GAL YORAM;;ARIA BEHRAD;;HELLER EPHRAIM;;PLANTE PHILLIP JOHN;;VREEKE MARK S;;FRIEDMAN KEITH A;;COLMAN FREDRIC C,ABBOTT DIABETES CARE INC (2005-07-25);;THERASENSE INC (2000-03-13);;E. HELLER & COMPANY (1998-07-02),https://lens.org/000-375-826-887-543,Patent Application,yes,79,45,211,221,0,A61B5/14532;;A61B5/14532;;A61B5/0002;;A61B5/0002;;A61B5/002;;A61B5/01;;A61B5/14503;;A61B5/1451;;A61B5/14546;;A61B5/14546;;A61B5/1473;;A61B5/1473;;A61B5/1486;;A61B5/1486;;A61B5/14865;;A61B5/1495;;A61B5/4839;;A61B5/72;;A61B5/7278;;A61B5/7282;;A61B5/7405;;A61B5/743;;A61B5/7445;;A61B5/7445;;A61B5/7455;;A61B2560/0252;;A61B2560/0252;;A61M5/1723;;C12Q1/54;;G16H10/40;;G16H10/40;;G16H20/17;;G16H20/17;;H01L23/3107;;H01L23/3107;;H01L23/49548;;H01L23/49548;;H01L2924/0002;;H01L2924/0002;;H01L2924/19041;;H01L2924/19041;;H01L2924/3011;;H01L2924/3011;;Y10S128/903;;Y10S128/903;;Y10T29/49;;Y10T29/49;;Y10T29/49124;;Y10T29/49124,A61B5/05;;G01N27/30;;A61B5/00;;A61B5/145;;A61B5/1477;;A61B5/1495;;G01N27/416;;G06F19/00;;H01L23/31;;H01L23/495,600/345;;600/308,0,0,,,,EXPIRED
127,US,B2,US 8612159 B2,031-956-198-819-311,2013-12-17,2013,US 78367504 A,2004-02-16,US 78367504 A;;US 42005403 A;;US 66719900 A;;US 7067798 A,1998-04-30,Analyte monitoring device and methods of use,"An analyte monitor includes a sensor, a sensor control unit, and a display unit. The sensor has, for example, a substrate, a recessed channel formed in the substrate, and conductive material disposed in the recessed channel to form a working electrode. The sensor control unit typically has a housing adapted for placement on skin and is adapted to receive a portion of an electrochemical sensor. The sensor control unit also includes two or more conductive contacts disposed on the housing and configured for coupling to two or more contact pads on the sensor. A transmitter is disposed in the housing and coupled to the plurality of conductive contacts for transmitting data obtained using the sensor. The display unit has a receiver for receiving data transmitted by the transmitter of the sensor control unit and a display coupled to the receiver for displaying an indication of a level of an analyte.",SAY JAMES;;TOMASCO MICHAEL F;;HELLER ADAM;;GAL YORAM;;ARIA BEHRAD;;HELLER EPHRAIM;;PLANTE PHILLIP JOHN;;VREEKE MARK S;;FRIEDMAN KEITH A;;COLMAN FREDRIC C;;ABBOTT DIABETES CARE INC,SAY JAMES;;TOMASCO MICHAEL F;;HELLER ADAM;;GAL YORAM;;ARIA BEHRAD;;HELLER EPHRAIM;;PLANTE PHILLIP JOHN;;VREEKE MARK S;;FRIEDMAN KEITH A;;COLMAN FREDRIC C,E. HELLER & CO (1998-07-02);;ABBOTT DIABETES CARE INC (2000-03-13),https://lens.org/031-956-198-819-311,Granted Patent,yes,103,4,7,7,0,A61B5/14532;;A61B5/14532;;A61B5/0002;;A61B5/0002;;A61B5/14546;;A61B5/14546;;A61B5/7445;;A61B5/7445;;G16H15/00;;G16H15/00;;G16H40/67;;G16H40/67;;H01L23/3107;;H01L23/3107;;H01L23/49548;;H01L23/49548;;H01L24/48;;H01L24/48;;H01L2224/48091;;H01L2224/48091;;H01L2224/48247;;H01L2224/48247;;H01L2924/00014;;H01L2924/00014;;H01L2924/01012;;H01L2924/01012;;H01L2924/12042;;H01L2924/12042;;H01L2924/14;;H01L2924/14;;H01L2924/181;;H01L2924/181;;H01L2924/19041;;H01L2924/19041;;H01L2924/3011;;H01L2924/3011;;Y02A90/10;;Y02A90/10,C23C28/00;;G01N27/30;;A61B5/00;;A61B5/145;;A61B5/1477;;A61B5/1495;;G01N27/416;;H01L23/31;;H01L23/495,702/19,101,5,044-807-213-528-815;;044-807-213-528-815;;173-901-776-852-06X;;010-716-634-556-075;;027-869-745-688-841,9451795;;10.1016/s0956-5663(97)00083-3;;9451795;;10.1016/s0956-5663(97)00083-3;;10.1142/9789810248628_0003;;1632949;;10.1016/0956-5663(92)85031-5;;10.1007/bf02221686;;1473620,"A user-friendly method for calibrating a subcutaneous glucose sensor-based hypoglycaemic alarm, B. Aussedat, Biosensors & Bioelectronics vol. 12. No. I I, pp. 1061-1071, 1997, 1997 Elsevier Science Limited.;;B. Aussedat, A user-friendly method for calibrating a subcutaneous glucose sensor-based hypoglycaemic alarm, Biosensors & Bioelectronics vol. 12. No. 11, pp. 1061-1071, Mar. 24, 1997.;;Japanese Patent Application No. 2007-270411, Office Action mailed Aug. 17, 2010.;;Japanese Patent Application No. 2007-270411, Office Action mailed Jun. 21, 2011.;;U.S. Appl. No. 11/681,730, Office Action mailed Apr. 27, 2011.;;U.S. Appl. No. 11/681,730, Office Action mailed Dec. 15, 2011.;;U.S. Appl. No. 11/683,396, Office Action mailed Sep. 8, 2011.;;U.S. Appl. No. 11/690,826, Office Action mailed Aug. 9, 2011.;;U.S. Appl. No. 11/695,607, Office Action mailed Mar. 2, 2011.;;U.S. Appl. No. 11/742,453, Office Action mailed Oct. 28, 2011.;;U.S. Appl. No. 11/742,507, Office Action mailed Apr. 13, 2011.;;U.S. Appl. No. 11/742,507, Office Action mailed Jun. 12, 2009.;;U.S. Appl. No. 11/928,795, Office Action mailed May 12, 2011.;;U.S. Appl. No. 11/941,078, Office Action mailed Apr. 22, 2011.;;U.S. Appl. No. 11/941,078, Office Action mailed Dec. 22, 2011.;;U.S. Appl. No. 12/135,937, Office Action mailed Dec. 19, 2011.;;U.S. Appl. No. 12/249,644, Office Action mailed Apr. 15, 2011.;;U.S. Appl. No. 12/249,644, Office Action mailed Nov. 17, 2011.;;U.S. Appl. No. 12/371,539, Office Action mailed Sep. 26, 2011.;;U.S. Appl. No. 12/397,281, Office Action mailed May 12, 2011.;;U.S. Appl. No. 12/397,293, Office Action mailed Aug. 5, 2011.;;U.S. Appl. No. 12/397,301, Office Action mailed Aug. 22, 2011.;;U.S. Appl. No. 12/405,515, Office Action mailed Apr. 29, 2011.;;U.S. Appl. No. 12/405,515, Office Action mailed Nov. 22, 2011.;;U.S. Appl. No. 12/405,568, Office Action mailed Sep. 16, 2011.;;U.S. Appl. No. 12/405,643, Office Action mailed Nov. 14, 2011.;;U.S. Appl. No. 12/405,987, Office Action mailed Nov. 16, 2010.;;U.S. Appl. No. 12/406,746, Office Action mailed Apr. 5, 2011.;;U.S. Appl. No. 12/406,746, Office Action mailed Jul. 23, 2010.;;U.S. Appl. No. 12/406,746, Office Action mailed Sep. 1, 2011.;;U.S. Appl. No. 12/406,800, Office Action mailed Apr. 20, 2011.;;U.S. Appl. No. 12/406,800, Office Action mailed Nov. 29, 2011.;;U.S. Appl. No. 12/414,456, Notice of Allowance mailed Dec. 19, 2011.;;U.S. Appl. No. 12/414,456, Office Action mailed Apr. 29, 2011.;;U.S. Appl. No. 12/414,487, Notice of Allowance mailed Dec. 20, 2011.;;U.S. Appl. No. 12/414,487, Office Action mailed Oct. 31, 2011.;;U.S. Appl. No. 12/414,542, Office Action mailed Apr. 13, 2011.;;U.S. Appl. No. 12/414,542, Office Action mailed Nov. 14, 2011.;;U.S. Appl. No. 12/414,558, Office Action mailed Apr. 4, 2011.;;U.S. Appl. No. 12/422,269, Office Action mailed Apr. 14, 2011.;;U.S. Appl. No. 12/422,269, Office Action mailed Nov. 18, 2011.;;U.S. Appl. No. 12/495,798, Office Action mailed Dec. 1, 2011.;;U.S. Appl. No. 12/495,798, Office Action mailed Jun. 30, 2011.;;U.S. Appl. No. 12/495,803, Office Action mailed Dec. 1, 2011.;;U.S. Appl. No. 12/495,803, Office Action mailed Jun. 30, 2011.;;U.S. Appl. No. 12/495,807, Office Action mailed Jul. 21, 2011.;;U.S. Appl. No. 12/495,807, Office Action mailed Nov. 25, 2011.;;U.S. Appl. No. 12/533,680, Office Action mailed Nov. 14, 2011.;;U.S. Appl. No. 12/614,974, Office Action mailed Apr. 12, 2011.;;U.S. Appl. No. 12/614,974, Office Action mailed Nov. 21, 2011.;;U.S. Appl. No. 12/614,990, Office Action mailed Apr. 14, 2011.;;U.S. Appl. No. 12/614,990, Office Action mailed Dec. 15, 2011.;;U.S. Appl. No. 12/615,069, Notice of Allowance mailed Dec. 29, 2011.;;U.S. Appl. No. 12/615,069, Office Action mailed Jun. 9, 2011.;;U.S. Appl. No. 12/615,128, Office Action mailed Aug. 19 2011.;;U.S. Appl. No. 12/615,128, Office Action mailed Dec. 20, 2011.;;U.S. Appl. No. 12/643,974, Office Action mailed May 4, 2011.;;U.S. Appl. No. 12/643,975, Advisory Action mailed Dec. 19, 2011.;;U.S. Appl. No. 12/643,975, Office Action mailed Sep. 22, 2011.;;U.S. Appl. No. 12/643,977, Office Action mailed Apr. 14, 2011.;;U.S. Appl. No. 12/643,977, Office Action mailed Oct. 19, 2011.;;U.S. Appl. No. 12/643,978, Office Action mailed Apr. 15, 2011.;;U.S. Appl. No. 12/643,978, Office Action mailed Oct. 18, 2011.;;U.S. Appl. No. 12/643,980, Office Action mailed Dec. 1, 2011.;;U.S. Appl. No. 12/643,980, Office Action mailed Jun. 24, 2011.;;U.S. Appl. No. 12/643,982, Office Action mailed Jun. 17, 2011.;;U.S. Appl. No. 12/643,982, Office Action mailed Nov. 23, 2011.;;U.S. Appl. No. 12/643,986, Office Action mailed Jun. 17, 2011.;;U.S. Appl. No. 12/643,986, Office Action mailed Nov. 23, 2011.;;U.S. Appl. No. 12/779,947, Office Action mailed Apr. 8, 2011.;;U.S. Appl. No. 12/825,186, Office Action mailed Mar. 31, 2011.;;U.S. Appl. No. 12/825,202 Office Action mailed Jun. 8, 2011.;;U.S. Appl. No. 12/859,054, Office Action mailed Dec. 29, 2011.;;U.S. Appl. No. 12/859,054, Office Action mailed Jul. 13, 2011.;;U.S. Appl. No. 12/902,138 Office Action mailed Jun. 7, 2011.;;U.S. Patent Reexamination Application No. 90/010,791, Notice of Intent to Issue Reexamination Certificate mailed May 17, 2011.;;U.S. Patent Reexamination Application No. 90/010,791, Office Action mailed Dec. 17, 2010.;;U.S. Patent Reexamination Application No. 90/010,791, Office Action mailed May 28, 2010.;;U.S. Patent Reexamination Application No. 90/011,730, Order Granting Request for Reexamination of U.S. Patent No. 6,990,366 mailed Aug. 24, 2011.;;U.S. Patent Reexamination Application No. 90/011,730, Request for Reexamination of U.S. Patent No. 6,990,366 filed Jun. 3, 2011.;;Gough, D. A., et al., ""The Implantable Glucose Sensor: An Example of Bioengineering Design"", Introduction to Bioengineering, Chapter 3, 2001, pp. 57-66.;;Gunasingham, et al., ""Electrochemically Modulated Optrode for Glucose"", Biosensors & Bioelectronics, vol. 7, 1992, pp. 353-359.;;Ikeda, T., et al., ""Artificial Pancreas-Investigation of the Stability of Glucose Sensors Using a Telemetry System"" (English language translation of abstract), Jpn. J. Artif. Organs, vol. 19, No. 2, 1990, 889-892.;;Meyerhoff, C., et al., ""On Line Continuous Monitoring of Subcutaneous Tissue Glucose in Men by Combining Portable Glucosensor with Microdialysis"", Diabetologia, vol. 35, 1992, pp. 1087-1092.;;Minimed Technologies, ""Tape Tips and Other Infusion Site Information"", 1995.;;Reach, G., et al., ""Continuous Glucose Sensing for the Treatment of Diabetes Mellitus"", Analysis Magazine, vol. 21, No. 2, 1993, pp. M35-M39.;;European Patent Application No. 09010614.7, Examination Report mailed Aug. 8, 2012.;;European Patent Application No. 10012409.8, Examination Report mailed Dec. 13, 2012.;;European Patent Application No. 10012414.8, Examination Report mailed Dec. 13, 2012.;;European Patent Application No. 10012960.0, Examination Report mailed Feb. 13, 2013.;;European Patent Application No. 10012961.8, Examination Report mailed Feb. 13, 2013.;;European Patent Application No. 99903239.4, Third Party Observation filed Oct. 15, 2012.;;PCT Application No. PCT/US2008/074469, International Preliminary Report on Patentability and Written Opinion of the International Searching Authority mailed Mar. 11, 2010.;;PCT Application No. PCT/US2010/040117, International Preliminary Report on Patentability and Written Opinion of the International Searching Authority mailed Jan. 12, 2012.;;PCT Application No. PCT/US2010/040118, International Preliminary Report on Patentability and Written Opinion of the International Searching Authority mailed Jan. 12, 2012.;;PCT Application No. PCT/US2010/040119, International Preliminary Report on Patentability and Written Opinion of the International Searching Authority mailed Jan. 12, 2012.;;U.S. Appl. No. 11/683,396, Notice of Allowance mailed Dec. 10, 2012.;;U.S. Appl. No. 11/683,396, Notice of Allowance mailed Feb. 20, 2013.;;U.S. Appl. No. 11/737,671, Notice of Allowance mailed Mar. 20, 2013.;;U.S. Appl. No. 11/737,671, Office Action mailed Oct. 16, 2012.;;U.S. Appl. No. 11/742,453, Notice of Allowance mailed Mar. 27, 2012.",EXPIRED
128,US,A1,US 2009/0177061 A1,029-947-884-251-096,2009-07-09,2009,US 40588309 A,2009-03-17,US 40588309 A;;US 42005703 A;;US 66719900 A;;US 7067798 A,1998-04-30,Analyte Monitoring Device and Methods of Use,"An analyte monitor includes a sensor, a sensor control unit, and a display unit. The sensor has, for example, a substrate, a recessed channel formed in the substrate, and conductive material disposed in the recessed channel to form a working electrode. The sensor control unit typically has a housing adapted for placement on skin and is adapted to receive a portion of an electrochemical sensor. The sensor control unit also includes two or more conductive contacts disposed on the housing and configured for coupling to two or more contact pads on the sensor. A transmitter is disposed in the housing and coupled to the plurality of conductive contacts for transmitting data obtained using the sensor. The display unit has a receiver for receiving data transmitted by the transmitter of the sensor control unit and a display coupled to the receiver for displaying an indication of a level of an analyte. The analyte monitor may also be part of a drug delivery system to alter the level of the analyte based on the data obtained using the sensor.",ABBOTT DIABETES CARE INC,SAY JAMES;;TOMASCO MICHAEL F;;HELLER ADAM;;GAL YORAM;;ARIA BEHRAD;;HELLER EPHRAIM;;PLANTE PHILLIP JOHN;;VREEKE MARK S;;FRIEDMAN KEITH A;;COLMAN FREDRIC C,,https://lens.org/029-947-884-251-096,Patent Application,yes,1,57,211,221,0,A61B5/14532;;A61B5/14532;;A61B5/0002;;A61B5/0002;;A61B5/002;;A61B5/01;;A61B5/14503;;A61B5/1451;;A61B5/14546;;A61B5/14546;;A61B5/1473;;A61B5/1473;;A61B5/1486;;A61B5/1486;;A61B5/14865;;A61B5/1495;;A61B5/4839;;A61B5/72;;A61B5/7278;;A61B5/7282;;A61B5/7405;;A61B5/743;;A61B5/7445;;A61B5/7445;;A61B5/7455;;A61B2560/0252;;A61B2560/0252;;A61M5/1723;;C12Q1/54;;G16H10/40;;G16H10/40;;G16H20/17;;G16H20/17;;H01L23/3107;;H01L23/3107;;H01L23/49548;;H01L23/49548;;H01L2924/0002;;H01L2924/0002;;H01L2924/19041;;H01L2924/19041;;H01L2924/3011;;H01L2924/3011;;Y10S128/903;;Y10S128/903;;Y10T29/49;;Y10T29/49;;Y10T29/49124;;Y10T29/49124,A61B5/1468;;G01N27/30;;A61B5/00;;A61B5/145;;A61B5/1477;;A61B5/1495;;G01N27/416;;G06F19/00;;H01L23/31;;H01L23/495,600/345,0,0,,,,DISCONTINUED
129,US,A1,US 2011/0077491 A1,049-854-507-061-556,2011-03-31,2011,US 89582610 A,2010-09-30,US 89582610 A;;US 69082607 A;;US 42005703 A;;US 66719900 A;;US 7067798 A,1998-04-30,Analyte Monitoring Device and Methods of Use,"An analyte monitor includes a sensor, a sensor control unit, and a display unit. The sensor has, for example, a substrate, a recessed channel formed in the substrate, and conductive material disposed in the recessed channel to form a working electrode. The sensor control unit typically has a housing adapted for placement on skin and is adapted to receive a portion of an electrochemical sensor. The sensor control unit also includes two or more conductive contacts disposed on the housing and configured for coupling to two or more contact pads on the sensor. A transmitter is disposed in the housing and coupled to the plurality of conductive contacts for transmitting data obtained using the sensor. The display unit has a receiver for receiving data transmitted by the transmitter of the sensor control unit and a display coupled to the receiver for displaying an indication of a level of an analyte. The analyte monitor may also be part of a drug delivery system to alter the level of the analyte based on the data obtained using the sensor.",ABBOTT DIABETES CARE INC,SAY JAMES;;TOMASCO MICHAEL F;;HELLER ADAM;;GAL YORAM;;ARIA BEHRAD;;HELLER EPHRAIM;;PLANTE PHILLIP JOHN;;VREEKE MARK S;;FRIEDMAN KEITH A;;COLMAN FREDRIC C,,https://lens.org/049-854-507-061-556,Patent Application,yes,9,7,211,221,0,A61B5/14532;;A61B5/14532;;A61B5/0002;;A61B5/0002;;A61B5/002;;A61B5/01;;A61B5/14503;;A61B5/1451;;A61B5/14546;;A61B5/14546;;A61B5/1473;;A61B5/1473;;A61B5/1486;;A61B5/1486;;A61B5/14865;;A61B5/1495;;A61B5/4839;;A61B5/72;;A61B5/7278;;A61B5/7282;;A61B5/7405;;A61B5/743;;A61B5/7445;;A61B5/7445;;A61B5/7455;;A61B2560/0252;;A61B2560/0252;;A61M5/1723;;C12Q1/54;;G16H10/40;;G16H10/40;;G16H20/17;;G16H20/17;;H01L23/3107;;H01L23/3107;;H01L23/49548;;H01L23/49548;;H01L2924/0002;;H01L2924/0002;;H01L2924/19041;;H01L2924/19041;;H01L2924/3011;;H01L2924/3011;;Y10S128/903;;Y10S128/903;;Y10T29/49;;Y10T29/49;;Y10T29/49124;;Y10T29/49124,A61B5/1473;;G01N27/30;;A61B5/00;;A61B5/145;;A61B5/1477;;A61B5/1495;;G01N27/416;;G06F19/00;;H01L23/31;;H01L23/495,600/347;;600/345,0,0,,,,DISCONTINUED
130,US,A1,US 2009/0182215 A1,061-259-204-219-799,2009-07-16,2009,US 40680009 A,2009-03-18,US 40680009 A;;US 42005703 A;;US 66719900 A;;US 7067798 A,1998-04-30,Analyte Monitoring Device and Methods of Use,"An analyte monitor includes a sensor, a sensor control unit, and a display unit. The sensor has, for example, a substrate, a recessed channel formed in the substrate, and conductive material disposed in the recessed channel to form a working electrode. The sensor control unit typically has a housing adapted for placement on skin and is adapted to receive a portion of an electrochemical sensor. The sensor control unit also includes two or more conductive contacts disposed on the housing and configured for coupling to two or more contact pads on the sensor. A transmitter is disposed in the housing and coupled to the plurality of conductive contacts for transmitting data obtained using the sensor. The display unit has a receiver for receiving data transmitted by the transmitter of the sensor control unit and a display coupled to the receiver for displaying an indication of a level of an analyte. The analyte monitor may also be part of a drug delivery system to alter the level of the analyte based on the data obtained using the sensor.",ABBOTT DIABETES CARE INC,SAY JAMES;;TOMASCO MICHAEL F;;HELLER ADAM;;GAL YORAM;;ARIA BEHRAD;;HELLER EPHRAIM;;PLANTE PHILLIP JOHN;;VREEKE MARK S;;FRIEDMAN KEITH A;;COLMAN FREDRIC C,E. HELLER & CO (1998-07-02);;ABBOTT DIABETES CARE INC (2000-03-13),https://lens.org/061-259-204-219-799,Patent Application,yes,106,64,211,221,0,A61B5/14532;;A61B5/14532;;A61B5/0002;;A61B5/0002;;A61B5/002;;A61B5/01;;A61B5/14503;;A61B5/1451;;A61B5/14546;;A61B5/14546;;A61B5/1473;;A61B5/1473;;A61B5/1486;;A61B5/1486;;A61B5/14865;;A61B5/1495;;A61B5/4839;;A61B5/72;;A61B5/7278;;A61B5/7282;;A61B5/7405;;A61B5/743;;A61B5/7445;;A61B5/7445;;A61B5/7455;;A61B2560/0252;;A61B2560/0252;;A61M5/1723;;C12Q1/54;;G16H10/40;;G16H10/40;;G16H20/17;;G16H20/17;;H01L23/3107;;H01L23/3107;;H01L23/49548;;H01L23/49548;;H01L2924/0002;;H01L2924/0002;;H01L2924/19041;;H01L2924/19041;;H01L2924/3011;;H01L2924/3011;;Y10S128/903;;Y10S128/903;;Y10T29/49;;Y10T29/49;;Y10T29/49124;;Y10T29/49124,A61B5/1468;;G01N27/30;;A61B5/00;;A61B5/145;;A61B5/1477;;A61B5/1495;;G01N27/416;;G06F19/00;;H01L23/31;;H01L23/495,600/345,0,0,,,,EXPIRED
131,US,B2,US 8275439 B2,131-896-204-279-133,2012-09-25,2012,US 61497409 A,2009-11-09,US 61497409 A;;US 42005703 A;;US 66719900 A;;US 7067798 A,1998-04-30,Analyte monitoring device and methods of use,"An analyte monitor includes a sensor, a sensor control unit, and a display unit. The sensor has, for example, a substrate, a recessed channel formed in the substrate, and conductive material disposed in the recessed channel to form a working electrode. The sensor control unit typically has a housing adapted for placement on skin and is adapted to receive a portion of an electrochemical sensor. The sensor control unit also includes two or more conductive contacts disposed on the housing and configured for coupling to two or more contact pads on the sensor. A transmitter is disposed in the housing and coupled to the plurality of conductive contacts for transmitting data obtained using the sensor. The display unit has a receiver for receiving data transmitted by the transmitter of the sensor control unit and a display coupled to the receiver for displaying an indication of a level of an analyte. The analyte monitor may also be part of a drug delivery system to alter the level of the analyte based on the data obtained using the sensor.",SAY JAMES;;TOMASCO MICHAEL F;;HELLER ADAM;;GAL YORAM;;ARIA BEHRAD;;HELLER EPHRAIM;;PLANTE PHILLIP JOHN;;VREEKE MARK S;;FRIEDMAN KEITH A;;COLMAN FREDRIC C;;ABBOTT DIABETES CARE INC,SAY JAMES;;TOMASCO MICHAEL F;;HELLER ADAM;;GAL YORAM;;ARIA BEHRAD;;HELLER EPHRAIM;;PLANTE PHILLIP JOHN;;VREEKE MARK S;;FRIEDMAN KEITH A;;COLMAN FREDRIC C,E. HELLER & CO (1998-07-02);;ABBOTT DIABETES CARE INC (2000-03-13),https://lens.org/131-896-204-279-133,Granted Patent,yes,109,3,211,221,0,A61B5/14532;;A61B5/14532;;A61B5/0002;;A61B5/0002;;A61B5/002;;A61B5/01;;A61B5/14503;;A61B5/1451;;A61B5/14546;;A61B5/14546;;A61B5/1473;;A61B5/1473;;A61B5/1486;;A61B5/1486;;A61B5/14865;;A61B5/1495;;A61B5/4839;;A61B5/72;;A61B5/7278;;A61B5/7282;;A61B5/7405;;A61B5/743;;A61B5/7445;;A61B5/7445;;A61B5/7455;;A61B2560/0252;;A61B2560/0252;;A61M5/1723;;C12Q1/54;;G16H10/40;;G16H10/40;;G16H20/17;;G16H20/17;;H01L23/3107;;H01L23/3107;;H01L23/49548;;H01L23/49548;;H01L2924/0002;;H01L2924/0002;;H01L2924/19041;;H01L2924/19041;;H01L2924/3011;;H01L2924/3011;;Y10S128/903;;Y10S128/903;;Y10T29/49;;Y10T29/49;;Y10T29/49124;;Y10T29/49124,A61B5/05;;G01N27/30;;A61B5/00;;A61B5/145;;A61B5/1477;;A61B5/1495;;G01N27/416;;G06F19/00;;H01L23/31;;H01L23/495,600/345;;600/347;;600/365,99,81,136-791-935-548-81X;;062-360-289-025-864;;010-601-725-111-91X;;101-292-518-663-191;;056-703-879-057-297;;030-155-762-644-019;;004-149-141-436-651;;016-731-054-793-457;;080-559-561-995-335;;044-807-213-528-815;;027-538-525-436-179;;015-020-161-517-40X;;025-919-454-564-785;;014-700-576-603-812;;004-851-060-590-788;;075-958-432-122-199;;052-356-140-149-389;;035-090-282-884-790;;033-562-815-299-181;;018-803-926-589-211;;008-505-762-041-402;;016-601-143-530-813;;019-502-772-562-215;;058-476-824-396-350;;006-498-707-073-30X;;054-091-551-638-293;;010-531-147-771-746;;054-827-198-877-419;;122-658-944-077-000;;017-261-560-469-37X;;000-125-755-474-124;;113-381-664-783-802;;082-626-907-191-554;;017-950-014-792-456;;090-348-305-613-628;;015-985-399-299-132;;171-049-047-164-618;;016-819-089-891-758;;081-249-097-078-543;;089-612-747-111-646;;031-706-897-890-035;;094-198-536-559-723;;003-690-143-043-420;;007-943-354-378-456;;082-114-500-909-975;;004-239-090-971-580;;026-894-457-160-450;;077-128-610-778-669;;022-466-506-956-898;;008-424-592-956-946;;007-500-825-916-378;;009-725-244-669-882;;037-755-689-613-42X;;153-411-506-517-475;;038-134-360-685-692;;012-449-714-188-064;;031-517-704-996-130;;131-299-284-996-064;;049-133-049-742-708;;000-272-178-768-076;;070-797-683-833-124;;043-870-224-178-49X;;025-574-914-238-550;;052-364-430-129-757;;004-434-167-910-115;;032-860-147-271-886;;132-460-374-211-421;;098-172-374-375-47X;;109-358-955-476-095;;014-988-634-483-130;;061-786-187-274-992;;037-898-018-686-909;;130-044-667-529-69X;;134-265-642-839-645;;065-221-074-461-027;;017-934-465-161-477;;101-660-130-379-529;;028-236-706-290-220;;087-333-189-994-274;;059-082-211-027-266;;057-977-752-782-568,10.1016/s0956-5663(02)00099-4;;12392956;;10.1021/ja00391a001;;2889225;;10.1098/rstb.1987.0021;;10.1109/51.294001;;10.1016/0022-0728(65)85063-x;;2245876;;10.2337/diabetes.39.12.1519;;10.2337/diab.39.12.1519;;10.1016/s0956-5663(03)00220-3;;14611755;;18615658;;10.1002/bit.260430310;;9366023;;10.1016/s0956-5663(97)00025-0;;9451795;;10.1016/s0956-5663(97)00083-3;;10.1016/0956-5663(93)80028-n;;8311939;;8651496;;10.1021/ac960030d;;10.1080/03091900210156797;;12487712;;10.1016/0265-928x(87)80018-4;;3333622;;10.1109/19.816143;;10.1007/bf01015979;;10.1089/15209150252924058;;12017416;;18473691;;10.1089/dia.2007.0281;;10.1021/ac00017a008;;1789439;;2817408;;10.1021/ac00197a022;;10.1016/0925-4005(95)01730-5;;10.1016/0010-4825(90)90013-f;;2257734;;2868172;;8277748;;10.1016/0141-5425(93)90058-7;;11469630;;10.1089/15209150050214104;;10624783;;10.1016/s0168-8227(99)00113-8;;10.1089/15209150050214113;;11469631;;10.1007/bf00401374;;1478372;;10.2337/diacare.20.1.64;;9028696;;10.1109/tbme.1986.325807;;3957374;;236018;;10.1016/0005-2795(75)90259-7;;10.1089/hum.1998.9.6-879;;9581910;;11762520;;10.1089/15209150152607196;;10.2337/diabetes.48.3.445;;10078542;;10.1016/0265-928x(87)80012-3;;505005;;10.1126/science.505005;;10.1021/ac0498516;;15253640;;10.1109/10.284922;;8026845;;6721151;;10.1021/ac00268a018;;6733082;;10.1021/bi00305a016;;10.1515/cclm.2002.135;;12392305;;10.1016/j.ecl.2003.12.001;;15053902;;12052350;;10.1016/s0956-5663(01)00304-9;;12052349;;10.1016/s0956-5663(01)00306-2;;4500021;;10.1007/978-1-4684-3288-6_18;;14021529;;10.1111/j.1749-6632.1962.tb13623.x;;3196517;;10.2337/diacare.10.5.622;;3677983;;10.2337/diacare.8.6.529;;4075939;;10.1002/elan.1140061103;;7733469;;10.1021/ac00103a015;;7978306;;10.1021/ac00091a022;;10.1007/bf01248238;;10.1016/s0376-7388(98)00330-5;;10.1016/0142-9612(92)90147-g;;1472593;;10.1016/0265-928x(85)80002-x;;10.1021/j100290a001;;10.1021/ja00216a040;;10.1021/ja00188a091;;10.1021/ja00406a011;;2624333;;12323417;;10.1016/s0165-0270(02)00170-x;;10.1177/193229680700100208;;pmc2771467;;19888405;;10.1021/ja00415a014;;10.1007/bf00575392;;10.1021/ac00250a038;;10.1021/ac00266a005;;10.1007/s00216-002-1284-0;;12194035;;10.1089/dia.2006.0030;;17705688;;9642777;;10.1016/s0956-5663(97)00091-2;;10.1089/152091503322526978;;14633342;;10.1016/0022-0728(85)87006-6;;10.1021/ja00434a018;;10.1016/0003-2697(92)90243-z;;1443528;;10.1039/f19868201259;;3245585;;10.1021/ac00173a008;;2889234;;10.1098/rstb.1987.0020;;11762521;;10.1089/15209150152607204;;12413548;;10.1016/s1367-5931(02)00371-x;;10526740;;10.2337/diacare.22.10.1708;;14988294;;10.2337/diacare.27.3.734,"""Poretics Polycarbonate Membrane"", Osmonics Filtration and Separation Group, 2002.;;Abel, P. U., et al., ""Biosensors for In Vivo Glucose Measurement: Can We Cross the Experimental Stage"", Biosensors and Bioelectronics, vol. 17, 2002, pp. 1059-1070.;;Abruna, H. D., et al., ""Rectifying Interfaces Using Two-Layer Films of Electrochemically Polymerized Vinylpyridine and Vinylbipyridine Complexes of Ruthenium and Iron on Electrodes"", Journal of the American Chemical Society, vol. 103, No. 1, 1981, pp. 1-5.;;Albery, W. J., et al., ""Amperometric Enzyme Electrodes Part II: Conducting Salts as Electrode Materials for the Oxidation of Glucose Oxidase"", Journal of ElectroAnalytical Chemistry, vol. 194, 1985, pp. 223-235.;;Albery, W. J., et al., ""Amperometric Enzyme Electrodes"", Philosophical Transactions of the Royal Society of London, vol. 316, 1987, pp. 107-119.;;Alcock, S. J., et al., ""Continuous Analyte Monitoring to Aid Clinical Practice"", IEEE Engineering in Medicine and Biology Magazine, 1994, pp. 319-325.;;Anderson, L. B., et al., ""Thin-Layer Electrochemistry: Steady-State Methods of Studying Rate Processes"", Journal of ElectroAnalytical Chemistry, vol. 10, 1965, pp. 295-305.;;Armour, J. C., et al., ""Application of Chronic Intravascular Blood Glucose Sensor in Dogs"", Diabetes, vol. 39, 1990, pp. 1519-1526.;;Asberg, P., et al., ""Hydrogels of a Conducting Conjugated Polymer as 3-D Enzyme Electrode"", Biosensors & Bioelectronics, vol. 19, 2003, pp. 199-207.;;Atanasov, P., et al., ""Biosensor for Continuous Glucose Bioengineering"", Biotechnology and Bioengineering, vol. 43, 1994, pp. 262-266.;;Atanasov, P., et al., ""Implantation of a Refillable Glucose Monitoring-Telemetry Device"", Biosensors & Bioelectronics, vol. 12, No. 7, 1997, pp. 669-680.;;Aussedat, B., et al., ""A User-Friendly Method for Calibrating a Subcutaneous Glucose Sensor-Based Hypoglycaemic Alarm"", Biosensors & Bioelectronics, vol. 12, No. 11, 1997, pp. 1061-1071.;;Baker, D. A., et al., ""Dynamic Concentration Challenges for Biosensor Characterization"", Biosensors & Bioelectronics, vol. 8, 1993, pp. 433-441.;;Baker, D. A., et al., ""Dynamic Delay and Maximal Dynamic Error in Continuous Biosensors"", Analytical Chemistry, vol. 68, No. 8, 1996, pp. 1292-1297.;;Bani Amer, M. M., ""An Accurate Amperometric Glucose Sensor Based Glucometer with Eliminated Cross-Sensitivity"", Journal of Medical Engineering & Technology, vol. 26, No. 5, 2002, pp. 208-213.;;Bard, A. J., et al., Electrochemical Methods, 1980, pp. 173-175.;;Bartlett, P. N., et al., ""Covalent Binding of Electron Relays to Glucose Oxidase"", Journal of the Chemical Society, Chemical Communications, 1987, pp. 1603-1604.;;Bartlett, P. N., et al., ""Modification of Glucose Oxidase by Tetrathiafulvalene"", Journal of the Chemical Society, Chemical Communications, 1990, pp. 1135-1136.;;Bartlett, P. N., et al., ""Strategies for the Development of Amperometric Enzyme Electrodes"", Biosensors, vol. 3, 1987/88, pp. 359-379.;;Beach, R. D., et al., ""Subminiature Implantable Potentiostat and Modified Commercial Telemetry Device for Remote Glucose Monitoring"", IEEE Transactions on Instrumentation and Measurement, vol. 28, No. 6, 1999, pp. 1239-1245.;;Beech, W. A., ""AX.25 Link Access Protocol for Amateur Packet Radio"", Tucson Amateur Packet Radio Corporation, 1998, pp. 1-133.;;Bellucci, F., et al., ""Electrochemical Behaviour of Graphite-Epoxy Composite Materials (GECM) in Aqueous Salt Solutions"", Journal of Applied Electrochemistry, vol. 16, 1986, pp. 15-22.;;Bennion, N., et al., ""Alternate Site Glucose Testing: A Crossover Design"", Diabetes Technology & Therapeutics, vol. 4, No. 1, 2002, pp. 25-33.;;Biermann, E., et al., ""How Would Patients Behave if They Were Continually Informed of Their Blood Glucose Levels? A Simulation Study Using a 'Virtual' Patient"", Diabetes Technology & Therapeutics, vol. 10, No. 3, 2008, pp. 178-187.;;Bindra, D. S., et al., ""Design and in Vitro Studies of a Needle-Type Glucose Sensor for Subcutaneous Monitoring"", Analytical Chemistry, vol. 63, No. 17, 1991, pp. 1692-1696.;;Bindra, D. S., et al., ""Pulsed Amperometric Detection of Glucose in Biological Fluids at a Surface-Modified Gold Electrode"", Analytical Chemistry, vol. 61, No. 22, 1989, pp. 2566-2570.;;Bisenberger, M., et al., ""A Triple-Step Potential Waveform at Enzyme Multisensors with Thick-Film Gold Electodes for Detection of Glucose and Sucrose"", Sensors and Actuators B, vol. 28, 1995, pp. 181-189.;;Bland, J. M., et al., ""A Note on the Use of the Intraclass Correlation Coefficient in the Evaluation of Agreement Between Two Methods of Measurement"", Computers in Biology and Medicine, vol. 20, No. 5, 1990, pp. 337-340.;;Bland, J. M., et al., ""Statistical Methods for Assessing Agreement Between Two Methods of Clinical Measurement"", The Lancet, 1986, pp. 307-310.;;Blank, T. B., et al., ""Clinical Results From a Non-Invasive Blood Glucose Monitor"", Optical Diagnostics and Sensing of Biological Fluids and Glucose and Cholesterol Monitoring II, Proceedings of SPIE, vol. 4624, 2002, pp. 1-10.;;Bobbioni-Harsch, E., et al., ""Lifespan of Subcutaneous Glucose Sensors and Their Performances During Dynamics Glycaemia Changes in Rats"", Journal of Biomedical Engineering, vol. 15, 1993, pp. 457-463.;;Bode, B. W., ""Clinical Utility of the Continuous Glucose Monitoring System"", Diabetes Technology & Therapeutics, vol. 2, Sup. 1, 2000, pp. S35-S41.;;Bode, B. W., et al., ""Continuous Glucose Monitoring Used to Adjust Diabetes Therapy Improves Glycoslyated Hemoglobin: A Pilot Study"", Diabetes Research and Clinical Practice, vol. 46, 1999, pp. 183-190.;;Bode, B. W., et al., ""Using the Continuous Glucose Monitoring System to Improve the Management of Type 1 Diabetes"", Diabetes Technology & Therapeutics, vol. 2, Sup. 1, 2000, pp. S43-S48.;;Boedeker Plastics, Inc., ""Polyethylene Specifications"", Web Page of Boedeker.com, 2007, pp. 1-3.;;Bolinder, J., et al., ""Microdialysis Measurement of the Absolute Glucose Concentration in Subcutaneous Adipose Tissue Allowing Glucose Monitoring in Diabetic Patients"", Diabetologia, vol. 35, 1992, pp. 1177-1180.;;Bolinder, J., et al., ""Self-Monitoring of Blood Glucose in Type I Diabetic Patients: Comparison with Continuous Microdialysis Measurements of Glucose in Subcutaneous Adipose Tissue During Ordinary Life Conditions"", Diabetes Care, vol. 20, No. 1, 1997, pp. 64-70.;;Bott, A. W., ""A Comparison of Cyclic Voltammetry and Cyclic Staircase Voltammetry"", Current Separations, vol. 16, No. 1, 1997, pp. 23-26.;;Bott, A. W., ""Electrochemical Methods for the Determination of Glucose"", Current Separations, vol. 17, No. 1, 1998, pp. 25-31.;;Bowman, L., et al., ""The Packaging of Implantable Integrated Sensors"", IEEE Transactions on Biomedical Engineering, vol. 33, No. 2, 1986, pp. 248-255.;;Brandt, J., et al., ""Covalent Attachment of Proteins to Polysaccharide Carriers by Means of Benzoquinone"", Biochimica et Biophysica Acta, vol. 386, 1975, pp. 196-202.;;Brauker, J., et al., ""Sustained Expression of High Levels of Human Factor IX from Human Cells Implanted Within an Immunoisolation Device into Athymic Rodents"", Human Gene Therapy, vol. 9, No. 6, 1998, pp. 879-888.;;Bremer, T. M., et al., ""Benchmark Data from the Literature for Evaluation of New Glucose Sensing Technologies"", Diabetes Technology & Therapeutics, vol. 3, No. 3, 2001, pp. 409-418.;;Bremer, T., et al., ""Is Blood Glucose Predictable from Previous Values?"", Diabetes, vol. 48, 1999, pp. 445-451.;;Brooks, S. L., et al., ""Development of an On-Line Glucose Sensor for Fermentation Monitoring"", Biosensors, vol. 3, 1987/88, pp. 45-56.;;Brownlee, M., et al., ""A Glucose-Controlled Insulin-Delivery System: Semisynthetic Insulin Bound to Lectin"", Science, vol. 206, 1979, 1190-1191.;;Cai, Q., et al., ""A Wireless, Remove Query Glucose Biosensor Based on a pH-Sensitive Polymer"", Analytical Chemistry, vol. 76, No. 14, 2004, pp. 4038-4043.;;Candas, B., et al., ""An Adaptive Plasma Glucose Controller Based on a Nonlinear Insulin/Glucose Model"", IEEE Transactions on Biomedical Engineering, vol. 41, No. 2, 1994, pp. 116-124.;;Cass, A. E., et al., ""Ferricinum Ion as an Electron Acceptor for Oxido-Reductases"", Journal of ElectroAnalytical Chemistry, vol. 190, 1985, pp. 117-127.;;Cass, A. E., et al., ""Ferrocene-Medicated Enzyme Electrode for Amperometric Determination of Glucose"", Analytical Chemistry, vol. 56, No. 4, 1984, 667-671.;;Castner, J. F., et al., ""Mass Transport and Reaction Kinetic Parameters Determined Electrochemically for Immobilized Glucose Oxidase"", Biochemistry, vol. 23 No. 10, 1984, 2203-2210.;;Chen, J. C., et al., ""A Comparison of MAC Protocols for Wireless Local Networks Based on battery Power Consumption"", IEEE, 1998, pp. 150-157.;;Chen, T., et al., ""Defining the Period of Recovery of the Glucose Concentration After its Local Perturbation by the Implantation of a Miniature Sensor"", Clinical Chemistry and Laboratory Medicine, vol. 40, No. 8, 2002, pp. 486-489.;;Chia, C. W., et al., ""Glucose Sensors: Toward Closed Loop Insulin Delivery"", Endocrinology and Metabolism Clinics of North America, vol. 33, 2004, pp. 175-195.;;Choleau, C., et al., ""Calibration of a Subcutaneous Amperometric Glucose Sensor Implanted for 7 Days in Diabetic Patients Part 2: Superiority of the One-Point Calibration Method"", Biosensors and Bioelectronics, vol. 17, 2002, pp. 647-654.;;Choleau, C., et al., ""Calibration of a Subcutaneous Amperometric Glucose Sensor Part 1: Effect of Measurement Uncertainties on the Determination of Sensor Sensitivity and Background Current"", Biosensors and Bioelectronics, vol. 17, 2002, pp. 641-646.;;Claremont, D. J., et al., ""Biosensors for Continuous In Vivo Glucose Monitoring"", Proceedings of the Annual International Conference of the IEEE Engineering in Medicine and Biology Society, vol. 10, 1988.;;Clark Jr., L. C., et al., ""Differential Anodic Enzyme Polarography for the Measurement of Glucose"", Oxygen Transport to Tissue: Instrumentation, Methods, and Physiology, 1973, pp. 127-133.;;Clark Jr., L. C., et al., ""Electrode Systems for Continuous Monitoring in Cardiovascular Surgery"", Annals New York Academy of Sciences, 1962, pp. 29-45.;;Clark Jr., L. C., et al., ""Long-term Stability of Electroenzymatic Glucose Sensors Implanted in Mice"", American Society of Artificial Internal Organs Transactions, vol. XXXIV, 1988, pp. 259-265.;;Clarke, W. L., et al., ""Evaluating Clinical Accuracy of Systems for Self-Monitoring of Blood Glucose"", Diabetes Care, vol. 10, No. 5, 1987, pp. 622-628.;;Complaint, ""Abbott Diabetes Care, Inc. v. Dexcom, Inc."", filed Aug. 11, 2005.;;Complaint, Amended, ""Abbott Diabetes Care, Inc. v. Dexcom, Inc."", filed Jun. 27, 2006.;;Cox, D. J., et al., ""Accuracy of Perceiving Blood Glucose in IDDM"", Diabetes Care, vol. 8, No. 6, 1985, pp. 529-536.;;Csoregi, E., et al., ""Amperometric Microbiosensors for Detection of Hydrogen Peroxide and Glucose Based on Peroxidase-Modified Carbon Fibers"", Electroanalysis, vol. 6, 1994, pp. 925-933.;;Csoregi, E., et al., ""Design and Optimization of a Selective Subcutaneously Implantable Glucose Electrode Based on 'Wired' Glucose Oxidase"", Analytical Chemistry, vol. 67, No. 7, 1995, pp. 1240-1244.;;Csoregi, E., et al., ""Design, Characterization, and One-Point in Vivo Calibration of a Subcutaneously Implanted Glucose Electrode"", Analytical Chemistry, vol. 66 No. 19, 1994, pp. 3131-3138.;;Csoregi, E., et al., ""On-Line Glucose Monitoring by Using Microdialysis Sampling and Amperometric Detection in Based on 'Wired' Glucose Oxidase in Carbon Paste"", Mikrochimica Acta, vol. 121, 1995, pp. 31-40.;;D'Arrigo, G., et al., ""Porous-Si Based Bio Reactors for Glucose Monitoring and Drugs Production"", Proceedings of SPIE: Microfluids, BioMEMS, and Medical Microsystems, vol. 4982, 2003, pp. 178-184.;;Dai, W. S., et al., ""Hydrogel Membranes with Mesh Size Asymmetry Based on the Gradient Crosslinking of Poly(vinyl alcohol),"" Journal of Membrane Science, vol. 156, 1999, pp. 67-79.;;Davies, M. L., et al., ""Polymer Membranes in Clinical Sensor Applications"", Biomaterials, vol. 13, No. 14, 1992, pp. 971-978.;;Davis, G., ""Electrochemical Techniques for the Development of Amperometric Biosensors"", Biosensors, vol. 1, 1985, pp. 161-178.;;Degani, Y., et al., ""Direct Electrical Communication Between Chemically Modified Enzymes and Metal Electrodes. 1. Electron Transfer from Glucose Oxidase to Metal Electrodes via Electron Relays, Bound Covalently to the Enzyme"", The Journal of Physical Chemistry, vol. 91, No. 6, 1987, pp. 1285-1289.;;Degani, Y., et al., ""Direct Electrical Communication Between Chemically Modified Enzymes and Metal Electrodes. 2. Methods for Bonding Electron-Transfer Relays to Glucose Oxidase and D-Amino-Acid Oxidase"", Journal of the American Chemical Society, vol. 110, No. 8, 1988, pp. 2615-2620.;;Degani, Y., et al., ""Electrical Communication Between Redox Centers of Glucose Oxidase and Electrodes via Electrostatically and Covalently Bound Redox Polymers"", Journal of the American Chemical Society, vol. 111, 1989, pp. 2357-2358.;;Denisevich, P., et al., ""Unidirectional Current Flow and Charge State Trapping at Redox Polymer Interfaces on Bilayer Electrodes: Principles, Experimental Demonstration, and Theory"", Journal of the American Chemical Society, vol. 103, 1981, pp. 4727-4737.;;Dicks, J. M., et al., ""Ferrocene Modified Polypyrrole with Immobilised Glucose Oxidase and its Application in Amperometric Glucose Microbiosensors"", Annales de Biologie Clinique, vol. 47, 1989, pp. 607-619.;;Dixon, B. M., et al., ""Characterization In Vitro and In Vivo of the Oxygen Dependence of an Enzyme/Polymer Biosensors for Monitoring Brain Glucose"", Journal of Neuroscience Methods, vol. 119, 2002, pp. 135-142.;;Eighth Annual Diabetes Technology Meeting Abstracts, Nov. 13-15, 2008, pp. A1-A182.;;El-Khatib, F. H, et al., ""Adaptive Closed-Loop Control Provides Blood-Glucose Regulation Using Subcutaneous Insulin and Glucagon Infusion in Diabetic Swine"", Journal of Diabetes Science and Technology, vol. 1, No. 2, 2007, pp. 181-192.;;Ellis, C. D., et al., ""Selectivity and Directed Charge Transfer through an Electroactive Metallopolymer Film"", Journal of the American Chemical Society, vol. 103, No. 25, 1981, pp. 7480-7483.;;El-Sa'ad, L., et al., ""Moisture Absorption by Epoxy Resins: The Reverse Thermal Effect"", Journal of Materials Science, vol. 25, No. 8, 1990, pp. 3577-3582.;;Engstrom, R. C., ""Electrochemical Pretreatment of Glassy Carbon Electrodes"", Analytical Chemistry, vol. 54, No. 13, 1982, pp. 2310-2314.;;Engstrom, R. C., et al., ""Characterization of Electrochemically Pretreated Glassy Carbon Electrodes"", Analytical Chemistry, vol. 56, No. 2, 1984, pp. 136-141.;;Ernst, H., et al., ""Reliable Glucose Monitoring Through the Use of Microsystem Technology"", Analytical and Bioanalytical Chemistry, vol. 373, 2002, pp. 758-761.;;Fabietti, P. G., et al. ""Clinical Validation of a New Control-Oriented Model of Insulin and Glucose Dynamics in Subjects with Type 1 Diabetes"", Diabetes Technology & Therapeutics, vol. 9, No. 4, 2007, pp. 327-338.;;Fare, T. L., et al., ""Functional Characterization of a Conducting Polymer-Based Immunoassay System"", Biosensors & Bioelectronics, vol. 13, No. 3-4, 1998, pp. 459-470.;;Feldman, B., et al., ""A Continuous Glucose Sensor Based on Wired Enzyme(TM) Technology-Results from a 3-Day Trial in Patients with Type 1 Diabetes"", Diabetes Technology & Therapuetics, vol. 5, No. 5, 2003, pp. 769-779.;;Feldman, B., et al., ""Correlation of Glucose Concentrations in Interstitial Fluid and Venous Blood During Periods of Rapid Glucose Change"", Abbott Diabetes Care, Inc. Freestyle Navigator Continuous Glucose Monitor Pamphlet, 2004.;;Feldman, B., et al., ""Electron Transfer Kinetics at Redox Polymer/Solution Interfaces Using Microelectrodes and Twin Electrode Thin Layer Cells"", Journal of ElectroAnalytical Chemistry, vol. 194, 1985, pp. 63-81.;;Fischer, H., et al., ""Intramolecular Electron Transfer Medicated by 4,4'-Bypyridine and Related Bridging Groups"", Journal of the American Chemical Society, vol. 98, No. 18, 1976, pp. 5512-5517.;;Flentge, F., et al., ""An Enzyme-Reactor for Electrochemical Monitoring of Choline and Acetylcholine: Applications in High-Performance Liquid Chromatography, Bran Tissue, Microdialysis and Cerebrospinal Fluid,"" Analytical Biochemistry, vol. 204, 1992, pp. 305-310.;;Foulds, N. C., et al., ""Enzyme Entrapment in Electrically Conducting Polymers: Immobilisation of Glucose Oxidase in Polypyrrole and its Application in Amperometric Glucose Sensors"", Journal of the Chemical Society, Faraday Transactions 1, vol. 82, 1986, pp. 1259-1264.;;Foulds, N. C., et al , ""Immobilization of Glucose Oxidase in Ferrocene-Modified Pyrrole Polymers"", Analytical Chemistry, vol. 60, No. 22, 1988, pp. 2473-2478.;;Frew, J. E., et al., ""Electron-Transfer Biosensors"", Philosophical Transactions of The Royal Society of London, vol. 316, 1987, pp. 95-106.;;Frohnauer, M. K., et al., ""Graphical Human Insulin Time-Activity Profiles Using Standardized Definitions"", Diabetes Technology & Therapeutics, vol. 3, No. 3, 2001, pp. 419-429.;;Frost, M. C., et al., ""Implantable Chemical Sensors for Real-Time Clinical Monitoring: Progress and Challenges"", Current Opinion in Chemical Biology, vol. 6, 2002, pp. 633-641.;;Garg, S. K., et al., ""Correlation of Fingerstick Blood Glucose Measurements with GlucoWatch Biographer Glucose Results in Young Subjects with Type 1 Diabetes"", Diabetes Care, vol. 22, No. 10, 1999, pp. 1708-1714.;;Garg, S. K., et al., ""Improved Glucose Excursions Using an Implantable Real-Time Continuous Glucose Sensor in Adults with Type 1 Diabetes"", Diabetes Care, vol. 27, No. 3, 2004, pp. 734-738.",EXPIRED
132,EP,B1,EP 1613269 B1,148-753-258-997-439,2015-02-25,2015,EP 04758815 A,2004-04-02,US 2004/0010278 W;;US 46067803 P;;US 47249403 P;;US 53203003 P;;US 54898604 P,2003-04-04,"COMPOSITIONS, METHODS AND KITS RELATING TO HER-2 CLEAVAGE",,INCYTE CORP,FRIEDMAN STEVEN M;;SCHERLE PEGGY A;;LIU XIANGDONG;;BURN TIMOTHY C;;HUBER REID;;LIU PHILLIP C C;;HOLLIS GREGORY F;;VADDI KRISHNA;;FRIDMAN JORDAN S,"INCYTE HOLDINGS CORPORATION (2015-12-09);;INCYTE CORPORATION (2015-02-11);;INCYTE HOLDINGS CORPORATION, US (2016-09-27);;INCYTE HOLDINGS CORPORATION, WILMINGTON, US (2016-02-24)",https://lens.org/148-753-258-997-439,Granted Patent,yes,1,0,10,10,0,A61K31/19;;A61K31/19;;A61K31/395;;A61K31/395;;A61P35/00;;A61P35/04,A61K39/395;;A61K/;;A61K31/19,,3,0,,,"JA LOW, MD JOHNSON, EA BONE, AND RB DICKSON: ""The matrix metalloproteinase inhibitor batimastat (BB-94) retards human breast cancer solid tumor growth but not ascites formation in nude mice"" CLINICAL CANCER RESEARCH, vol. 2, July 1996 (1996-07), pages 1207-1214, XP002542088;;SLEDGE ET AL: ""Angiogenesis and Antiangiogenic Therapy"" CURRENT PROBLEMS IN CANCER, MOSBY, ST LOUIS, MO, US, vol. 26, no. 1, 1 January 2002 (2002-01-01), pages 6-59, XP005139279 ISSN: 0147-0272;;HANDSLEY M.H. ET AL: 'Metalloproteinases and their inhibitors in tumor angiogenesis' INT. J. CANCER vol. 115, 2005, pages 849 - 860, XP002993254",ACTIVE
133,US,A1,US 2009/0177057 A1,155-386-098-341-394,2009-07-09,2009,US 40564309 A,2009-03-17,US 40564309 A;;US 42005703 A;;US 66719900 A;;US 7067798 A,1998-04-30,Analyte Monitoring Device and Methods of Use,"An analyte monitor includes a sensor, a sensor control unit, and a display unit. The sensor has, for example, a substrate, a recessed channel formed in the substrate, and conductive material disposed in the recessed channel to form a working electrode. The sensor control unit typically has a housing adapted for placement on skin and is adapted to receive a portion of an electrochemical sensor. The sensor control unit also includes two or more conductive contacts disposed on the housing and configured for coupling to two or more contact pads on the sensor. A transmitter is disposed in the housing and coupled to the plurality of conductive contacts for transmitting data obtained using the sensor. The display unit has a receiver for receiving data transmitted by the transmitter of the sensor control unit and a display coupled to the receiver for displaying an indication of a level of an analyte. The analyte monitor may also be part of a drug delivery system to alter the level of the analyte based on the data obtained using the sensor.",ABBOTT DIABETES CARE INC,SAY JAMES;;TOMASCO MICHAEL F;;HELLER ADAM;;GAL YORAM;;ARIA BEHRAD;;HELLER EPHRAIM;;PLANTE PHILLIP JOHN;;VREEKE MARK S;;FRIEDMAN KEITH A;;COLMAN FREDRIC C,E. HELLER & CO (1998-07-02);;ABBOTT DIABETES CARE INC (2000-03-13),https://lens.org/155-386-098-341-394,Patent Application,yes,99,58,211,221,0,A61B5/14532;;A61B5/14532;;A61B5/0002;;A61B5/0002;;A61B5/002;;A61B5/01;;A61B5/14503;;A61B5/1451;;A61B5/14546;;A61B5/14546;;A61B5/1473;;A61B5/1473;;A61B5/1486;;A61B5/1486;;A61B5/14865;;A61B5/1495;;A61B5/4839;;A61B5/72;;A61B5/7278;;A61B5/7282;;A61B5/7405;;A61B5/743;;A61B5/7445;;A61B5/7445;;A61B5/7455;;A61B2560/0252;;A61B2560/0252;;A61M5/1723;;C12Q1/54;;G16H10/40;;G16H10/40;;G16H20/17;;G16H20/17;;H01L23/3107;;H01L23/3107;;H01L23/49548;;H01L23/49548;;H01L2924/0002;;H01L2924/0002;;H01L2924/19041;;H01L2924/19041;;H01L2924/3011;;H01L2924/3011;;Y10S128/903;;Y10S128/903;;Y10T29/49;;Y10T29/49;;Y10T29/49124;;Y10T29/49124,A61B5/1468;;G01N27/30;;A61B5/00;;A61B5/145;;A61B5/1477;;A61B5/1495;;G01N27/416;;G06F19/00;;H01L23/31;;H01L23/495,600/345,0,0,,,,EXPIRED
134,US,A1,US 2009/0192374 A1,179-463-026-283-671,2009-07-30,2009,US 41800809 A,2009-04-03,US 41800809 A;;US 42005703 A;;US 66719900 A;;US 7067798 A,1998-04-30,Analyte Monitoring Device and Methods of Use,"An analyte monitor includes a sensor, a sensor control unit, and a display unit. The sensor has, for example, a substrate, a recessed channel formed in the substrate, and conductive material disposed in the recessed channel to form a working electrode. The sensor control unit typically has a housing adapted for placement on skin and is adapted to receive a portion of an electrochemical sensor. The sensor control unit also includes two or more conductive contacts disposed on the housing and configured for coupling to two or more contact pads on the sensor. A transmitter is disposed in the housing and coupled to the plurality of conductive contacts for transmitting data obtained using the sensor. The display unit has a receiver for receiving data transmitted by the transmitter of the sensor control unit and a display coupled to the receiver for displaying an indication of a level of an analyte. The analyte monitor may also be part of a drug delivery system to alter the level of the analyte based on the data obtained using the sensor.",ABBOTT DIABETES CARE INC,SAY JAMES;;TOMASCO MICHAEL F;;HELLER ADAM;;GAL YORAM;;ARIA BEHRAD;;HELLER EPHRAIM;;PLANTE PHILLIP JOHN;;VREEKE MARK S;;FRIEDMAN KEITH A;;COLMAN FREDRIC C,,https://lens.org/179-463-026-283-671,Patent Application,yes,1,57,211,221,0,A61B5/14532;;A61B5/14532;;A61B5/0002;;A61B5/0002;;A61B5/002;;A61B5/01;;A61B5/14503;;A61B5/1451;;A61B5/14546;;A61B5/14546;;A61B5/1473;;A61B5/1473;;A61B5/1486;;A61B5/1486;;A61B5/14865;;A61B5/1495;;A61B5/4839;;A61B5/72;;A61B5/7278;;A61B5/7282;;A61B5/7405;;A61B5/743;;A61B5/7445;;A61B5/7445;;A61B5/7455;;A61B2560/0252;;A61B2560/0252;;A61M5/1723;;C12Q1/54;;G16H10/40;;G16H10/40;;G16H20/17;;G16H20/17;;H01L23/3107;;H01L23/3107;;H01L23/49548;;H01L23/49548;;H01L2924/0002;;H01L2924/0002;;H01L2924/19041;;H01L2924/19041;;H01L2924/3011;;H01L2924/3011;;Y10S128/903;;Y10S128/903;;Y10T29/49;;Y10T29/49;;Y10T29/49124;;Y10T29/49124,A61B5/1468;;G01N27/30;;A61B5/00;;A61B5/145;;A61B5/1477;;A61B5/1495;;G01N27/416;;G06F19/00;;H01L23/31;;H01L23/495,600/345,0,0,,,,DISCONTINUED
135,US,A1,US 2009/0177066 A1,178-145-265-543-979,2009-07-09,2009,US 40683409 A,2009-03-18,US 40683409 A;;US 42005703 A;;US 66719900 A;;US 7067798 A,1998-04-30,Analyte Monitoring Device and Methods of Use,"An analyte monitor includes a sensor, a sensor control unit, and a display unit. The sensor has, for example, a substrate, a recessed channel formed in the substrate, and conductive material disposed in the recessed channel to form a working electrode. The sensor control unit typically has a housing adapted for placement on skin and is adapted to receive a portion of an electrochemical sensor. The sensor control unit also includes two or more conductive contacts disposed on the housing and configured for coupling to two or more contact pads on the sensor. A transmitter is disposed in the housing and coupled to the plurality of conductive contacts for transmitting data obtained using the sensor. The display unit has a receiver for receiving data transmitted by the transmitter of the sensor control unit and a display coupled to the receiver for displaying an indication of a level of an analyte. The analyte monitor may also be part of a drug delivery system to alter the level of the analyte based on the data obtained using the sensor.",ABBOTT DIABETES CARE INC,SAY JAMES;;TOMASCO MICHAEL F;;HELLER ADAM;;GAL YORAM;;ARIA BEHRAD;;HELLER EPHRAIM;;PLANTE PHILLIP JOHN;;VREEKE MARK S;;FRIEDMAN KEITH A;;COLMAN FREDRIC C,,https://lens.org/178-145-265-543-979,Patent Application,yes,1,57,211,221,0,A61B5/14532;;A61B5/14532;;A61B5/0002;;A61B5/0002;;A61B5/002;;A61B5/01;;A61B5/14503;;A61B5/1451;;A61B5/14546;;A61B5/14546;;A61B5/1473;;A61B5/1473;;A61B5/1486;;A61B5/1486;;A61B5/14865;;A61B5/1495;;A61B5/4839;;A61B5/72;;A61B5/7278;;A61B5/7282;;A61B5/7405;;A61B5/743;;A61B5/7445;;A61B5/7445;;A61B5/7455;;A61B2560/0252;;A61B2560/0252;;A61M5/1723;;C12Q1/54;;G16H10/40;;G16H10/40;;G16H20/17;;G16H20/17;;H01L23/3107;;H01L23/3107;;H01L23/49548;;H01L23/49548;;H01L2924/0002;;H01L2924/0002;;H01L2924/19041;;H01L2924/19041;;H01L2924/3011;;H01L2924/3011;;Y10S128/903;;Y10S128/903;;Y10T29/49;;Y10T29/49;;Y10T29/49124;;Y10T29/49124,A61B5/1468;;G01N27/30;;A61B5/00;;A61B5/145;;A61B5/1477;;A61B5/1495;;G01N27/416;;G06F19/00;;H01L23/31;;H01L23/495,600/345,0,0,,,,DISCONTINUED
136,US,A1,US 2010/0268044 A1,010-961-451-678-968,2010-10-21,2010,US 82518010 A,2010-06-28,US 82518010 A;;US 39388309 A;;US 42005703 A;;US 66719900 A;;US 7067798 A,1998-04-30,Analyte Monitoring Device and Methods of Use,"An analyte monitor includes a sensor, a sensor control unit, and a display unit. The sensor has, for example, a substrate, a recessed channel formed in the substrate, and conductive material disposed in the recessed channel to form a working electrode. The sensor control unit typically has a housing adapted for placement on skin and is adapted to receive a portion of an electrochemical sensor. The sensor control unit also includes two or more conductive contacts disposed on the housing and configured for coupling to two or more contact pads on the sensor. A transmitter is disposed in the housing and coupled to the plurality of conductive contacts for transmitting data obtained using the sensor. The display unit has a receiver for receiving data transmitted by the transmitter of the sensor control unit and a display coupled to the receiver for displaying an indication of a level of an analyte. The analyte monitor may also be part of a drug delivery system to alter the level of the analyte based on the data obtained using the sensor.",ABBOTT DIABETES CARE INC,SAY JAMES;;TOMASCO MICHAEL F;;HELLER ADAM;;GAL YORAM;;ARIA BEHRAD;;HELLER EPHRAIM;;PLANTE PHILLIP JOHN;;VREEKE MARK S;;FRIEDMAN KEITH A;;COLMAN FREDRIC C,E. HELLER & CO (1998-07-02);;ABBOTT DIABETES CARE INC (2000-03-13),https://lens.org/010-961-451-678-968,Patent Application,yes,99,1,211,221,0,A61B5/14532;;A61B5/14532;;A61B5/0002;;A61B5/0002;;A61B5/002;;A61B5/01;;A61B5/14503;;A61B5/1451;;A61B5/14546;;A61B5/14546;;A61B5/1473;;A61B5/1473;;A61B5/1486;;A61B5/1486;;A61B5/14865;;A61B5/1495;;A61B5/4839;;A61B5/72;;A61B5/7278;;A61B5/7282;;A61B5/7405;;A61B5/743;;A61B5/7445;;A61B5/7445;;A61B5/7455;;A61B2560/0252;;A61B2560/0252;;A61M5/1723;;C12Q1/54;;G16H10/40;;G16H10/40;;G16H20/17;;G16H20/17;;H01L23/3107;;H01L23/3107;;H01L23/49548;;H01L23/49548;;H01L2924/0002;;H01L2924/0002;;H01L2924/19041;;H01L2924/19041;;H01L2924/3011;;H01L2924/3011;;Y10S128/903;;Y10S128/903;;Y10T29/49;;Y10T29/49;;Y10T29/49124;;Y10T29/49124,A61B5/1468;;G01N27/30;;A61B5/00;;A61B5/145;;A61B5/1477;;A61B5/1495;;G01N27/416;;G06F19/00;;H01L23/31;;H01L23/495,600/345,0,0,,,,DISCONTINUED
137,US,A1,US 2007/0191699 A1,025-911-762-064-495,2007-08-16,2007,US 69560507 A,2007-04-03,US 69560507 A;;US 42005703 A;;US 66719900 A;;US 7067798 A,1998-04-30,Analyte Monitoring Device and Methods of Use,"An analyte monitor includes a sensor, a sensor control unit, and a display unit. The sensor has, for example, a substrate, a recessed channel formed in the substrate, and conductive material disposed in the recessed channel to form a working electrode. The sensor control unit typically has a housing adapted for placement on skin and is adapted to receive a portion of an electrochemical sensor. The sensor control unit also includes two or more conductive contacts disposed on the housing and configured for coupling to two or more contact pads on the sensor. A transmitter is disposed in the housing and coupled to the plurality of conductive contacts for transmitting data obtained using the sensor. The display unit has a receiver for receiving data transmitted by the transmitter of the sensor control unit and a display coupled to the receiver for displaying an indication of a level of an analyte. The analyte monitor may also be part of a drug delivery system to alter the level of the analyte based on the data obtained using the sensor.",ABBOTT DIABETES CARE INC,SAY JAMES;;TOMASCO MICHAEL F;;HELLER ADAM;;GAL YORAM;;ARIA BEHRAD;;HELLER EPHRAIM;;PLANTE PHILLIP J;;VREEKE MARK S;;FRIEDMAN KEITH A;;COLMAN FREDRIC C,E. HELLER & CO (1998-07-02);;ABBOTT DIABETES CARE INC (2000-03-13),https://lens.org/025-911-762-064-495,Patent Application,yes,101,37,211,221,0,A61B5/14532;;A61B5/14532;;A61B5/0002;;A61B5/0002;;A61B5/002;;A61B5/01;;A61B5/14503;;A61B5/1451;;A61B5/14546;;A61B5/14546;;A61B5/1473;;A61B5/1473;;A61B5/1486;;A61B5/1486;;A61B5/14865;;A61B5/1495;;A61B5/4839;;A61B5/72;;A61B5/7278;;A61B5/7282;;A61B5/7405;;A61B5/743;;A61B5/7445;;A61B5/7445;;A61B5/7455;;A61B2560/0252;;A61B2560/0252;;A61M5/1723;;C12Q1/54;;G16H10/40;;G16H10/40;;G16H20/17;;G16H20/17;;H01L23/3107;;H01L23/3107;;H01L23/49548;;H01L23/49548;;H01L2924/0002;;H01L2924/0002;;H01L2924/19041;;H01L2924/19041;;H01L2924/3011;;H01L2924/3011;;Y10S128/903;;Y10S128/903;;Y10T29/49;;Y10T29/49;;Y10T29/49124;;Y10T29/49124,A61B5/05;;G01N27/30;;A61B5/00;;A61B5/145;;A61B5/1477;;A61B5/1495;;G01N27/416;;G06F19/00;;H01L23/31;;H01L23/495,600/345,0,0,,,,DISCONTINUED
138,US,A1,US 2011/0077481 A1,059-649-871-048-155,2011-03-31,2011,US 95932910 A,2010-12-02,US 95932910 A;;US 69082607 A;;US 42005703 A;;US 66719900 A;;US 7067798 A,1998-04-30,Analyte Monitoring Device and Methods of Use,"An analyte monitor includes a sensor, a sensor control unit, and a display unit. The sensor has, for example, a substrate, a recessed channel formed in the substrate, and conductive material disposed in the recessed channel to form a working electrode. The sensor control unit typically has a housing adapted for placement on skin and is adapted to receive a portion of an electrochemical sensor. The sensor control unit also includes two or more conductive contacts disposed on the housing and configured for coupling to two or more contact pads on the sensor. A transmitter is disposed in the housing and coupled to the plurality of conductive contacts for transmitting data obtained using the sensor. The display unit has a receiver for receiving data transmitted by the transmitter of the sensor control unit and a display coupled to the receiver for displaying an indication of a level of an analyte. The analyte monitor may also be part of a drug delivery system to alter the level of the analyte based on the data obtained using the sensor.",ABBOTT DIABETES CARE INC,SAY JAMES;;TOMASCO MICHAEL F;;HELLER ADAM;;GAL YORAM;;ARIA BEHRAD;;HELLER EPHRAIM;;PLANTE PHILLIP JOHN;;VREEKE MARK S;;FRIEDMAN KEITH A;;COLMAN FREDRIC C,,https://lens.org/059-649-871-048-155,Patent Application,yes,39,21,211,221,0,A61B5/14532;;A61B5/14532;;A61B5/0002;;A61B5/0002;;A61B5/002;;A61B5/01;;A61B5/14503;;A61B5/1451;;A61B5/14546;;A61B5/14546;;A61B5/1473;;A61B5/1473;;A61B5/1486;;A61B5/1486;;A61B5/14865;;A61B5/1495;;A61B5/4839;;A61B5/72;;A61B5/7278;;A61B5/7282;;A61B5/7405;;A61B5/743;;A61B5/7445;;A61B5/7445;;A61B5/7455;;A61B2560/0252;;A61B2560/0252;;A61M5/1723;;C12Q1/54;;G16H10/40;;G16H10/40;;G16H20/17;;G16H20/17;;H01L23/3107;;H01L23/3107;;H01L23/49548;;H01L23/49548;;H01L2924/0002;;H01L2924/0002;;H01L2924/19041;;H01L2924/19041;;H01L2924/3011;;H01L2924/3011;;Y10S128/903;;Y10S128/903;;Y10T29/49;;Y10T29/49;;Y10T29/49124;;Y10T29/49124,A61B5/145;;G01N27/30;;A61B5/00;;A61B5/1477;;A61B5/1495;;G01N27/416;;G06F19/00;;H01L23/31;;H01L23/495,600/310,0,0,,,,DISCONTINUED
139,US,A1,US 2008/0269672 A1,066-129-400-175-267,2008-10-30,2008,US 11390708 A,2008-05-01,US 11390708 A;;US 42005703 A;;US 66719900 A;;US 7067798 A,1998-04-30,Analyte Monitoring Device and Methods of Use,"An analyte monitor includes a sensor, a sensor control unit, and a display unit. The sensor has, for example, a substrate, a recessed channel formed in the substrate, and conductive material disposed in the recessed channel to form a working electrode. The sensor control unit typically has a housing adapted for placement on skin and is adapted to receive a portion of an electrochemical sensor. The sensor control unit also includes two or more conductive contacts disposed on the housing and configured for coupling to two or more contact pads on the sensor. A transmitter is disposed in the housing and coupled to the plurality of conductive contacts for transmitting data obtained using the sensor. The display unit has a receiver for receiving data transmitted by the transmitter of the sensor control unit and a display coupled to the receiver for displaying an indication of a level of an analyte. The analyte monitor may also be part of a drug delivery system to alter the level of the analyte based on the data obtained using the sensor.",ABBOTT DIABETES CARE INC,SAY JAMES;;TOMASCO MICHAEL F;;HELLER ADAM;;GAL YORAM;;ARIA BEHRAD;;HELLER EPHRAIM;;PLANTE PHILLIP JOHN;;VREEKE MARK S;;FRIEDMAN KEITH A;;COLMAN FREDRIC C,,https://lens.org/066-129-400-175-267,Patent Application,yes,0,20,211,221,0,A61B5/14532;;A61B5/14532;;A61B5/0002;;A61B5/0002;;A61B5/002;;A61B5/01;;A61B5/14503;;A61B5/1451;;A61B5/14546;;A61B5/14546;;A61B5/1473;;A61B5/1473;;A61B5/1486;;A61B5/1486;;A61B5/14865;;A61B5/1495;;A61B5/4839;;A61B5/72;;A61B5/7278;;A61B5/7282;;A61B5/7405;;A61B5/743;;A61B5/7445;;A61B5/7445;;A61B5/7455;;A61B2560/0252;;A61B2560/0252;;A61M5/1723;;C12Q1/54;;G16H10/40;;G16H10/40;;G16H20/17;;G16H20/17;;H01L23/3107;;H01L23/3107;;H01L23/49548;;H01L23/49548;;H01L2924/0002;;H01L2924/0002;;H01L2924/19041;;H01L2924/19041;;H01L2924/3011;;H01L2924/3011;;Y10S128/903;;Y10S128/903;;Y10T29/49;;Y10T29/49;;Y10T29/49124;;Y10T29/49124,A61B5/055;;G01N27/30;;A61B5/00;;A61B5/145;;A61B5/1477;;A61B5/1495;;A61M31/00;;G01N27/416;;G06F19/00;;H01L23/31;;H01L23/495,604/66;;600/345,0,0,,,,DISCONTINUED
140,US,A1,US 2009/0177054 A1,065-118-078-581-100,2009-07-09,2009,US 39730109 A,2009-03-03,US 39730109 A;;US 69082607 A;;US 42005703 A;;US 66719900 A;;US 7067798 A,1998-04-30,Analyte Monitoring Device and Methods of Use,"An analyte monitor includes a sensor, a sensor control unit, and a display unit. The sensor has, for example, a substrate, a recessed channel formed in the substrate, and conductive material disposed in the recessed channel to form a working electrode. The sensor control unit typically has a housing adapted for placement on skin and is adapted to receive a portion of an electrochemical sensor. The sensor control unit also includes two or more conductive contacts disposed on the housing and configured for coupling to two or more contact pads on the sensor. A transmitter is disposed in the housing and coupled to the plurality of conductive contacts for transmitting data obtained using the sensor. The display unit has a receiver for receiving data transmitted by the transmitter of the sensor control unit and a display coupled to the receiver for displaying an indication of a level of an analyte. The analyte monitor may also be part of a drug delivery system to alter the level of the analyte based on the data obtained using the sensor.",ABBOTT DIABETES CARE INC,SAY JAMES;;TOMASCO MICHAEL F;;HELLER ADAM;;GAL YORAM;;ARIA BEHRAD;;HELLER EPHRAIM;;PLANTE PHILLIP JOHN;;VREEKE MARK S;;FRIEDMAN KEITH A;;COLMAN FREDRIC C,E. HELLER & CO (1998-07-02);;ABBOTT DIABETES CARE INC (2000-03-13),https://lens.org/065-118-078-581-100,Patent Application,yes,17,11,211,221,0,A61B5/14532;;A61B5/14532;;A61B5/0002;;A61B5/0002;;A61B5/002;;A61B5/01;;A61B5/14503;;A61B5/1451;;A61B5/14546;;A61B5/14546;;A61B5/1473;;A61B5/1473;;A61B5/1486;;A61B5/1486;;A61B5/14865;;A61B5/1495;;A61B5/4839;;A61B5/72;;A61B5/7278;;A61B5/7282;;A61B5/7405;;A61B5/743;;A61B5/7445;;A61B5/7445;;A61B5/7455;;A61B2560/0252;;A61B2560/0252;;A61M5/1723;;C12Q1/54;;G16H10/40;;G16H10/40;;G16H20/17;;G16H20/17;;H01L23/3107;;H01L23/3107;;H01L23/49548;;H01L23/49548;;H01L2924/0002;;H01L2924/0002;;H01L2924/19041;;H01L2924/19041;;H01L2924/3011;;H01L2924/3011;;Y10S128/903;;Y10S128/903;;Y10T29/49;;Y10T29/49;;Y10T29/49124;;Y10T29/49124,A61B5/1468;;G01N27/30;;A61B5/00;;A61B5/145;;A61B5/1477;;A61B5/1495;;G01N27/416;;G06F19/00;;H01L23/31;;H01L23/495,600/345,0,0,,,,EXPIRED
141,US,A1,US 2009/0187088 A1,081-022-411-252-217,2009-07-23,2009,US 40674609 A,2009-03-18,US 40674609 A;;US 42005703 A;;US 66719900 A;;US 7067798 A,1998-04-30,Analyte Monitoring Device and Methods of Use,"An analyte monitor includes a sensor, a sensor control unit, and a display unit. The sensor has, for example, a substrate, a recessed channel formed in the substrate, and conductive material disposed in the recessed channel to form a working electrode. The sensor control unit typically has a housing adapted for placement on skin and is adapted to receive a portion of an electrochemical sensor. The sensor control unit also includes two or more conductive contacts disposed on the housing and configured for coupling to two or more contact pads on the sensor. A transmitter is disposed in the housing and coupled to the plurality of conductive contacts for transmitting data obtained using the sensor. The display unit has a receiver for receiving data transmitted by the transmitter of the sensor control unit and a display coupled to the receiver for displaying an indication of a level of an analyte. The analyte monitor may also be part of a drug delivery system to alter the level of the analyte based on the data obtained using the sensor.",ABBOTT DIABETES CARE INC,SAY JAMES;;TOMASCO MICHAEL F;;HELLER ADAM;;GAL YORAM;;ARIA BEHRAD;;HILLER EPHRAIM;;PLANTE PHILLIP JOHN;;VREEKE MARK S;;FRIEDMAN KEITH A;;COLMAN FREDRIC C,,https://lens.org/081-022-411-252-217,Patent Application,yes,99,60,211,221,0,A61B5/14532;;A61B5/14532;;A61B5/0002;;A61B5/0002;;A61B5/002;;A61B5/01;;A61B5/14503;;A61B5/1451;;A61B5/14546;;A61B5/14546;;A61B5/1473;;A61B5/1473;;A61B5/1486;;A61B5/1486;;A61B5/14865;;A61B5/1495;;A61B5/4839;;A61B5/72;;A61B5/7278;;A61B5/7282;;A61B5/7405;;A61B5/743;;A61B5/7445;;A61B5/7445;;A61B5/7455;;A61B2560/0252;;A61B2560/0252;;A61M5/1723;;C12Q1/54;;G16H10/40;;G16H10/40;;G16H20/17;;G16H20/17;;H01L23/3107;;H01L23/3107;;H01L23/49548;;H01L23/49548;;H01L2924/0002;;H01L2924/0002;;H01L2924/19041;;H01L2924/19041;;H01L2924/3011;;H01L2924/3011;;Y10S128/903;;Y10S128/903;;Y10T29/49;;Y10T29/49;;Y10T29/49124;;Y10T29/49124,A61B5/1468;;G01N27/30;;A61B5/00;;A61B5/145;;A61B5/1477;;A61B5/1495;;G01N27/416;;G06F19/00;;H01L23/31;;H01L23/495,600/345,0,0,,,,EXPIRED
142,US,A1,US 2010/0324399 A1,103-536-800-483-953,2010-12-23,2010,US 85243610 A,2010-08-06,US 85243610 A;;US 69082607 A;;US 42005703 A;;US 66719900 A;;US 7067798 A,1998-04-30,ANALYTE MONITORING DEVICE AND METHODS OF USE,"An analyte monitor includes a sensor, a sensor control unit, and a display unit. The sensor has, for example, a substrate, a recessed channel formed in the substrate, and conductive material disposed in the recessed channel to form a working electrode. The sensor control unit typically has a housing adapted for placement on skin and is adapted to receive a portion of an electrochemical sensor. The sensor control unit also includes two or more conductive contacts disposed on the housing and configured for coupling to two or more contact pads on the sensor. A transmitter is disposed in the housing and coupled to the plurality of conductive contacts for transmitting data obtained using the sensor. The display unit has a receiver for receiving data transmitted by the transmitter of the sensor control unit and a display coupled to the receiver for displaying an indication of a level of an analyte. The analyte monitor may also be part of a drug delivery system to alter the level of the analyte based on the data obtained using the sensor.",ABBOTT DIABETES CARE INC,SAY JAMES;;TOMASCO MICHAEL F;;HELLER ADAM;;GAL YORAM;;ARIA BEHRAD;;HELLER EPHRAIM;;PLANTE PHILLIP JOHN;;VREEKE MARK S;;FRIEDMAN KEITH A;;COLMAN FREDRIC C,E. HELLER & CO (1998-07-02);;ABBOTT DIABETES CARE INC (2000-03-13),https://lens.org/103-536-800-483-953,Patent Application,yes,99,0,211,221,0,A61B5/14532;;A61B5/14532;;A61B5/0002;;A61B5/0002;;A61B5/002;;A61B5/01;;A61B5/14503;;A61B5/1451;;A61B5/14546;;A61B5/14546;;A61B5/1473;;A61B5/1473;;A61B5/1486;;A61B5/1486;;A61B5/14865;;A61B5/1495;;A61B5/4839;;A61B5/72;;A61B5/7278;;A61B5/7282;;A61B5/7405;;A61B5/743;;A61B5/7445;;A61B5/7445;;A61B5/7455;;A61B2560/0252;;A61B2560/0252;;A61M5/1723;;C12Q1/54;;G16H10/40;;G16H10/40;;G16H20/17;;G16H20/17;;H01L23/3107;;H01L23/3107;;H01L23/49548;;H01L23/49548;;H01L2924/0002;;H01L2924/0002;;H01L2924/19041;;H01L2924/19041;;H01L2924/3011;;H01L2924/3011;;Y10S128/903;;Y10S128/903;;Y10T29/49;;Y10T29/49;;Y10T29/49124;;Y10T29/49124,A61B5/05;;G01N27/30;;A61B5/00;;A61B5/145;;A61B5/1477;;A61B5/1495;;G01N27/416;;G06F19/00;;H01L23/31;;H01L23/495,600/365,0,0,,,,EXPIRED
143,US,B2,US 7860544 B2,108-420-329-833-815,2010-12-28,2010,US 68340807 A,2007-03-07,US 68340807 A;;US 42005703 A;;US 66719900 A;;US 7067798 A,1998-04-30,Analyte monitoring device and methods of use,"An analyte monitor includes a sensor, a sensor control unit, and a display unit. The sensor has, for example, a substrate, a recessed channel formed in the substrate, and conductive material disposed in the recessed channel to form a working electrode. The sensor control unit typically has a housing adapted for placement on skin and is adapted to receive a portion of an electrochemical sensor. The sensor control unit also includes two or more conductive contacts disposed on the housing and configured for coupling to two or more contact pads on the sensor. A transmitter is disposed in the housing and coupled to the plurality of conductive contacts for transmitting data obtained using the sensor. The display unit has a receiver for receiving data transmitted by the transmitter of the sensor control unit and a display coupled to the receiver for displaying an indication of a level of an analyte. The analyte monitor may also be part of a drug delivery system to alter the level of the analyte based on the data obtained using the sensor.",ABBOTT DIABETES CARE INC,SAY JAMES;;TOMASCO MICHAEL F;;HELLER ADAM;;GAL YORAM;;BEHRAD ARIA;;HELLER EPHRAIM;;PLANTE PHILLIP JOHN;;VREEKE MARK S;;FRIEDMAN KEITH A;;COLMAN FREDRIC C,E. HELLER & CO (1998-07-02);;ABBOTT DIABETES CARE INC (2000-03-13),https://lens.org/108-420-329-833-815,Granted Patent,yes,99,55,211,221,0,A61B5/14532;;A61B5/14532;;A61B5/0002;;A61B5/0002;;A61B5/002;;A61B5/01;;A61B5/14503;;A61B5/1451;;A61B5/14546;;A61B5/14546;;A61B5/1473;;A61B5/1473;;A61B5/1486;;A61B5/1486;;A61B5/14865;;A61B5/1495;;A61B5/4839;;A61B5/72;;A61B5/7278;;A61B5/7282;;A61B5/7405;;A61B5/743;;A61B5/7445;;A61B5/7445;;A61B5/7455;;A61B2560/0252;;A61B2560/0252;;A61M5/1723;;C12Q1/54;;G16H10/40;;G16H10/40;;G16H20/17;;G16H20/17;;H01L23/3107;;H01L23/3107;;H01L23/49548;;H01L23/49548;;H01L2924/0002;;H01L2924/0002;;H01L2924/19041;;H01L2924/19041;;H01L2924/3011;;H01L2924/3011;;Y10S128/903;;Y10S128/903;;Y10T29/49;;Y10T29/49;;Y10T29/49124;;Y10T29/49124,A61B5/05;;G01N27/30;;A61B5/00;;A61B5/145;;A61B5/1477;;A61B5/1495;;G01N27/416;;G06F19/00;;H01L23/31;;H01L23/495,600/347;;600/365;;600/345;;600/309,99,23,075-958-432-122-199;;035-090-282-884-790;;016-819-089-891-758;;038-134-360-685-692;;025-574-914-238-550;;109-358-955-476-095;;098-973-607-166-581;;029-493-512-369-495;;035-856-257-818-78X;;054-580-942-789-395;;024-691-508-279-134;;034-958-263-939-044;;074-053-786-843-062;;013-438-201-644-557;;062-066-135-131-958;;045-727-118-688-577;;089-659-640-648-249;;165-290-677-293-493;;034-397-061-963-129;;000-878-682-341-828;;114-397-952-341-999;;024-996-438-831-487;;080-674-869-523-362,10.1007/bf01015979;;18473691;;10.1089/dia.2007.0281;;10.1109/10.284922;;8026845;;10.1016/0142-9612(92)90147-g;;1472593;;10.1177/193229680700100208;;pmc2771467;;19888405;;10.1089/dia.2006.0030;;17705688;;10.2337/diacare.26.3.582;;12610005;;4064281;;10.1093/clinchem/31.12.1931;;10.1016/0003-2670(93)85008-8;;10.1016/s0967-0661(97)00046-4;;10.1016/s0967-0661(97)00053-1;;1789455;;10.1021/ac00024a029;;10.1016/s0169-7439(98)00146-4;;18473688;;10.1089/dia.2007.0293;;10.1016/0142-9612(92)90148-h;;1472594;;12706570;;10.1016/s0956-5663(03)00038-1;;10.1016/s0956-5663(02)00216-6;;12713912;;10.1016/0013-4686(81)90029-3;;10.1089/dia.2007.0273;;18473693;;5469118;;10.2337/diab.19.9.644;;10.1093/clinchem/26.1.0089;;7356580;;12713913;;10.1016/s0956-5663(02)00215-4;;8850596,"U.S. Appl. No. 09/447,227, Shults.;;U.S. Appl. No. 11/737,671, Wolpert et al.;;U.S. Appl. No. 11/766,747, Say et al.;;U.S. Appl. No. 11/849,200, Peyser et al.;;U.S. Appl. No. 11/928,574, Heller et al.;;U.S. Appl. No. 11/928,668, Heller et al.;;U.S. Appl. No. 11/928,743, Heller et al.;;U.S. Appl. No. 11/928,795, Heller et al.;;U.S. Appl. No. 11/928,891, Heller et al.;;U.S. Appl. No. 11/928,968, Heller et al.;;U.S. Appl. No. 11/941,078, Say et al.;;Bellucci, F., et al., ""Electrochemical Behaviour of Graphite-Epoxy Composite Materials (GECM) in Aqueous Salt Solutions"", Journal of Applied Electrochemistry, vol. 16, 1986, pp. 15-22.;;Biermann, E., et al., ""How Would Patients Behave if They Were Continually Informed of Their Blood Glucose Levels? A Simulation Study Using a 'Virtual' Patient"" Diabetes Technology & Therapeutics, vol. 10, No. 3, 2008, pp. 178-187.;;Candas, B., et al., ""An Adaptive Plasma Glucose Controller Based on a Nonlinear Insulin/Glucose Model"", IEEE Transactions on Biomedical Engineering, vol. 41, No. 2, 1994, pp. 116-124.;;Davies, M. L., et al., ""Polymer Membranes in Clinical Sensor Applications"", Biomaterials, vol. 13, No. 14, 1992, pp. 971-978.;;Eighth Annual Diabetes Technology Meeting Abstracts, Nov. 13-15, 2008, pp. A1-A182.;;El-Khatib, F. H, et al., ""Adaptive Closed-Loop Control Provides Blood-Glucose Regulation Using Subcutaneous Insulin and Glucagon Infusion in Diabetic Swine"", Journal of Diabetes Science and Technology, vol. 1, No. 2, 2007, pp. 181-192.;;Fabietti, P. G., et al. ""Clinical Validation of a New Control-Oriented Model of Insulin and Glucose Dynamics in Subjects with Type 1 Diabetes"", Diabetes Technology & Therapeutics, vol. 9, No. 4, 2007, pp. 327-338.;;Guerci, B., et al., ""Clinical Performance of CGMS in Type 1 Diabetic Patients Treated by Continuous Subcutaneous Insulin Infusion Using Insulin Analogs"", Diabetes Care, vol. 26, 2003, pp. 582-589.;;Hicks, J. M., ""In Situ Monitoring"", Clinical Chemistry, vol. 31, No. 12, 1985, pp. 1931-1935.;;Hu, Y., et al., ""A Needle-Type Enzyme-Based Lactate Sensor for In Vivo Monitoring"", Analytica Chimica Acta , vol. 281, 1993, pp. 503-511.;;Isermann, R., ""Supervision, Fault-Detection and Fault-Diagnosis Methods-An Introduction"", Control Engineering Practice, vol. 5, No. 5, 1997, pp. 639-652.;;Isermann, R., et al., ""Trends in the Application of Model-Based Fault Detection and Diagnosis of Technical Processes"", Control Engineering Practice, vol. 5, No. 5, 1997, pp. 709-719.;;Kamath, A., et al., ""Calibration of a Continuous Glucose Monitor: Effect of Glucose Rate of Change"", Eighth Annual Diabetes Technology Meeting Abstracts, Nov. 13-15, 2008, pp. A88.;;Kawagoe, J. L., et al., ""Enzyme-Modified Organic Conducting Salt Microelectrode"", Analytical Chemistry, vol. 63, No. 24, 1991, pp. 2961-2965.;;Lewis, R. J., ed., ""2-hydroxyethyl methacrylate"", Hawley's Condensed Chemical Dictionary, Twelfth Edition, 1993, pp. 596.;;Lohn, A., et al., ""A Knowledge-Based System for Real-Time Validation of Calibrations and Measurements"", Chemometrics and Intelligent Laboratory Systems, vol. 46, 1999, pp. 57-66.;;Mazze, R. S., et al., ""Characterizing Glucose Exposure for Individuals with Normal Glucose Tolerance Using Continuous Glucose Monitoring and Ambulatory Glucose Profile Analysis"", Diabetes Technology & Therapeutics, vol. 10, No. 3, 2008, pp. 149-159.;;Murphy, S. M., et al., ""Polymer Membranes in Clinical Sensor Applications"", Biomaterials, vol. 13, No. 14, 1992, pp. 979-990.;;Petrou, P. S., et al., ""Microdevice with Integrated Dialysis Probe and Biosensor Array for Continuous Multi-Analyte Monitoring"", Biosensors & Bioelectronics, vol. 18, 2003, pp. 613-619.;;Poscia, A., et al., ""A Microdialysis Technique for Continuous Subcutaneous Glucose Monitoring in Diabetic Patients (Part 1)"", Biosensors & Bioelectronics, vol. 18, 2003, pp. 891-898.;;Prabhu, V. G., et al., ""Electrochemical Studies of Hydrogen Peroxide at a Platinum Disc Electrode"", Electrochimica Acta, vol. 26, No. 6, 1981, pp. 725-729.;;Rigla, M, et al., ""Real-Time Continuous Glucose Monitoring Together with Telemedical Assistance Improves Glycemic Control and Glucose Stability in Pump-Treated Patients"", Diabetes Technology & Therapeutics, vol. 10, No. 3, 2008, pp. 194-199.;;Service, F. J., et al., ""Mean Amplitude of Glycemic Excursions, a Measure of Diabetic Instability"", Diabetes, vol. 19, No. 9, 1970, pp. 644-655.;;Sokol, L., et al , ""Immobilized-Enzyme Rate-Determination Method for Glucose Analysis"", Clinical Chemistry, vol. 26, No. 1, 1980, pp. 89-92.;;Varalli, M., et al., ""A Microdialysis Technique for Continuous Subcutaneous Glucose Monitoring in Diabetic Patients (Part 2)"", Biosensors & Bioelectronics, vol. 18, 2003, pp. 899-905.;;Yang, S., et al., ""A Glucose Biosensor Based on an Oxygen Electrode: In-Vitro Performances in Model Buffer Solution and in Blood Plasma"", Biomedical Instrumentation & Technology, vol. 30, No. 1, 1996, pp. 55-61.;;Canadian Patent Application No. 2,433,144, Examiner's Report mailed Sep. 8, 2008.;;Chinese Patent Application No. 01822786.4, Office Action mailed Feb. 2, 2007.;;Chinese Patent Application No. 01822786.4, Office Action mailed Sep. 21, 2007.;;European Patent Application No. 01 994 499.0, Examination Report mailed Dec. 7, 2006.;;European Patent Application No. 01 994 499.0, Examination Report mailed Feb. 10, 2009.;;European Patent Application No. 01 994 499.0, Examination Report mailed Oct. 11, 2007.;;European Patent Application No. 09 010 614.7, Extended European Search Report mailed Mar. 2, 2010.;;European Patent Application No. 99 903 239.4, Examination Report mailed Apr. 14, 2008.;;European Patent Application No. 99 903 239.4, Examination Report mailed Dec. 20, 2004.;;European Patent Application No. 99 903 239.4, Examination Report mailed Oct. 7, 2005.;;Japanese Patent Application No. 2000-546653, Office Action mailed Dec. 15, 2009.;;Japanese Patent Application No. 2000-546653, Office Action mailed Jan. 6, 2009.;;Japanese Patent Application No. 2002-558875, Office Action mailed Sep. 26, 2006.;;PCT Application No. PCT/US1999/001229, International Preliminary Examination Report mailed Aug. 1, 2000.;;PCT Application No. PCT/US1999/001229, International Search Report mailed May 6, 1999.;;PCT Application No. PCT/US1999/001229, Written Opinion of the International Preliminary Examining Authority mailed Feb. 7, 2000.;;PCT Application No. PCT/US2001/050832, International Preliminary Examination Report mailed Nov. 4, 2003.;;PCT Application No. PCT/US2001/050832, International Search Report mailed Dec. 17, 2002.;;PCT Application No. PCT/US2006/060400, International Preliminary Report on Patentability and Written Opinion of the International Searching Authority mailed May 15, 2008.;;PCT Application No. PCT/US2006/060400, International Search Report and Written Opinion of the International Searching Authority mailed Oct. 16, 2007.;;PCT Application No. PCT/US2008/074469, International Search Report and Written Opinion of the International Searching Authority mailed Nov. 3, 2008.;;U.S. Appl. No. 09/070,677, Notice of Allowance mailed Aug. 1, 2000.;;U.S. Appl. No. 09/070,677, Notice of Allowance mailed Jun. 6, 2000.;;U.S. Appl. No. 09/070,677, Office Action mailed Apr. 27, 1999.;;U.S. Appl. No. 09/070,677, Office Action mailed Nov. 15, 1999.;;U.S. Appl. No. 09/667,199, Notice of Allowance mailed Nov. 25, 2002.;;U.S. Appl. No. 09/667,199, Office Action mailed Jul. 24, 2002.;;U.S. Appl. No. 09/753,746, Notice of Allowance mailed Oct. 9, 2002.;;U.S. Appl. No. 09/753,746, Office Action mailed Jul. 3, 2002.;;U.S. Appl. No. 10/336,195, Office Action mailed Apr. 29, 2005.;;U.S. Appl. No. 10/336,195, Office Action mailed Dec. 28, 2007.;;U.S. Appl. No. 10/336,195, Office Action mailed Feb. 6, 2006.;;U.S. Appl. No. 10/336,195, Office Action mailed Jul. 16, 2008.;;U.S. Appl. No. 10/336,195, Office Action mailed Jun. 17, 2004.;;U.S. Appl. No. 10/336,195, Office Action mailed Mar. 25, 2009.;;U.S. Appl. No. 10/336,195, Office Action mailed Nov. 10, 2009.;;U.S. Appl. No. 10/336,195, Office Action mailed Oct. 26, 2006.;;U.S. Appl. No. 10/420,057, Advisory Action mailed Jan. 27, 2009.;;U.S. Appl. No. 10/420,057, Office Action mailed Apr. 4, 2006.;;U.S. Appl. No. 10/420,057, Office Action mailed Aug. 21, 2008.;;U.S. Appl. No. 10/420,057, Office Action mailed Jul. 25, 2007.;;U.S. Appl. No. 10/420,057, Office Action mailed Jun. 1, 2005.;;U.S. Appl. No. 10/420,057, Office Action mailed Jun. 24, 2010.;;U.S. Appl. No. 10/420,057, Office Action mailed Nov. 23, 2007.;;U.S. Appl. No. 10/420,057, Office Action mailed Oct. 17, 2006.;;U.S. Appl. No. 10/420,057, Office Action mailed Sep. 30, 2009.;;U.S. Appl. No. 10/722,246, Office Action mailed Dec. 28, 2005.;;U.S. Appl. No. 10/722,246, Office Action mailed Oct. 12, 2006.;;U.S. Appl. No. 10/722,251, Notice of Allowance mailed Jul. 22, 2005.;;U.S. Appl. No. 10/722,253, Notice of Allowance mailed Jul. 5, 2005.;;U.S. Appl. No. 10/722,264, Notice of Allowance mailed Jan. 26, 2005.;;U.S. Appl. No. 10/783,675, Office Action mailed Dec. 2, 2008.;;U.S. Appl. No. 10/783,675, Office Action mailed Mar. 24, 2010.;;U.S. Appl. No. 10/783,675, Office Action mailed Oct. 9, 2007.;;U.S. Appl. No. 10/783,675, Patent Office Communication mailed Apr. 15, 2009.;;U.S. Appl. No. 10/789,776, Office Action mailed Apr. 3, 2009.;;U.S. Appl. No. 10/789,776, Office Action mailed Aug. 13, 2008.;;U.S. Appl. No. 10/789,776, Office Action mailed Jan. 7, 2010.;;U.S. Appl. No. 10/789,776, Office Action mailed Nov. 1, 2007.;;U.S. Appl. No. 10/789,776, Office Action mailed Sep. 3, 2009.;;U.S. Appl. No. 11/027,423, Office Action mailed Feb. 20, 2009.;;U.S. Appl. No. 11/027,423, Office Action mailed Nov. 4, 2009.",EXPIRED
144,US,A1,US 2004/0106858 A1,113-567-114-492-096,2004-06-03,2004,US 72224603 A,2003-11-24,US 72224603 A;;US 42005403 A;;US 66719900 A;;US 7067798 A,1998-04-30,Analyte monitoring device and methods of use,"
   An analyte monitor includes a sensor, a sensor control unit, and a display unit. The sensor has, for example, a substrate, a recessed channel formed in the substrate, and conductive material disposed in the recessed channel to form a working electrode. The sensor control unit typically has a housing adapted for placement on skin and is adapted to receive a portion of an electrochemical sensor. The sensor control unit also includes two or more conductive contacts disposed on the housing and configured for coupling to two or more contact pads on the sensor. A transmitter is disposed in the housing and coupled to the plurality of conductive contacts for transmitting data obtained using the sensor. The display unit has a receiver for receiving data transmitted by the transmitter of the sensor control unit and a display coupled to the receiver for displaying an indication of a level of an analyte. The analyte monitor may also be part of a drug delivery system to alter the level of the analyte based on the data obtained using the sensor. 
",THERASENSE INC,SAY JAMES;;TOMASCO MICHAEL F;;HELLER ADAM;;GAL YORAM;;ARIA BEHRAD;;HELLER EPHRAIM;;PLANTE PHILLIP JOHN;;VREEKE MARK S;;FRIEDMAN KEITH A;;COLMAN FREDRIC C,,https://lens.org/113-567-114-492-096,Patent Application,yes,8,384,7,7,0,A61B5/14532;;A61B5/14532;;A61B5/0002;;A61B5/0002;;A61B5/14546;;A61B5/14546;;A61B5/7445;;A61B5/7445;;G16H15/00;;G16H15/00;;G16H40/67;;G16H40/67;;H01L23/3107;;H01L23/3107;;H01L23/49548;;H01L23/49548;;H01L24/48;;H01L24/48;;H01L2224/48091;;H01L2224/48091;;H01L2224/48247;;H01L2224/48247;;H01L2924/00014;;H01L2924/00014;;H01L2924/01012;;H01L2924/01012;;H01L2924/12042;;H01L2924/12042;;H01L2924/14;;H01L2924/14;;H01L2924/181;;H01L2924/181;;H01L2924/19041;;H01L2924/19041;;H01L2924/3011;;H01L2924/3011;;Y02A90/10;;Y02A90/10,G01N27/30;;A61B5/00;;A61B5/145;;A61B5/1477;;A61B5/1495;;G01N27/416;;H01L23/31;;H01L23/495,600/345;;600/365;;128/903,0,0,,,,DISCONTINUED
145,US,A1,US 2009/0192376 A1,121-280-142-728-168,2009-07-30,2009,US 41839409 A,2009-04-03,US 41839409 A;;US 42005703 A;;US 66719900 A;;US 7067798 A,1998-04-30,Analyte Monitoring Device and Methods of Use,"An analyte monitor includes a sensor, a sensor control unit, and a display unit. The sensor has, for example, a substrate, a recessed channel formed in the substrate, and conductive material disposed in the recessed channel to form a working electrode. The sensor control unit typically has a housing adapted for placement on skin and is adapted to receive a portion of an electrochemical sensor. The sensor control unit also includes two or more conductive contacts disposed on the housing and configured for coupling to two or more contact pads on the sensor. A transmitter is disposed in the housing and coupled to the plurality of conductive contacts for transmitting data obtained using the sensor. The display unit has a receiver for receiving data transmitted by the transmitter of the sensor control unit and a display coupled to the receiver for displaying an indication of a level of an analyte. The analyte monitor may also be part of a drug delivery system to alter the level of the analyte based on the data obtained using the sensor.",ABBOTT DIABETES CARE INC,SAY JAMES;;TOMASCO MICHAEL F;;HELLER ADAM;;GAL YORAM;;ARIA BEHRAD;;HELLER EPHRAIM;;PLANTE PHILLIP JOHN;;VREEKE MARK S;;FRIEDMAN KEITH A;;COLMAN FREDRIC C,,https://lens.org/121-280-142-728-168,Patent Application,yes,1,57,211,221,0,A61B5/14532;;A61B5/14532;;A61B5/0002;;A61B5/0002;;A61B5/002;;A61B5/01;;A61B5/14503;;A61B5/1451;;A61B5/14546;;A61B5/14546;;A61B5/1473;;A61B5/1473;;A61B5/1486;;A61B5/1486;;A61B5/14865;;A61B5/1495;;A61B5/4839;;A61B5/72;;A61B5/7278;;A61B5/7282;;A61B5/7405;;A61B5/743;;A61B5/7445;;A61B5/7445;;A61B5/7455;;A61B2560/0252;;A61B2560/0252;;A61M5/1723;;C12Q1/54;;G16H10/40;;G16H10/40;;G16H20/17;;G16H20/17;;H01L23/3107;;H01L23/3107;;H01L23/49548;;H01L23/49548;;H01L2924/0002;;H01L2924/0002;;H01L2924/19041;;H01L2924/19041;;H01L2924/3011;;H01L2924/3011;;Y10S128/903;;Y10S128/903;;Y10T29/49;;Y10T29/49;;Y10T29/49124;;Y10T29/49124,A61B5/1468;;G01N27/30;;A61B5/00;;A61B5/145;;A61B5/1477;;A61B5/1495;;G01N27/416;;G06F19/00;;H01L23/31;;H01L23/495,600/345,0,0,,,,DISCONTINUED
146,US,A1,US 2010/0324394 A1,157-435-880-259-72X,2010-12-23,2010,US 85568210 A,2010-08-12,US 85568210 A;;US 69082607 A;;US 42005703 A;;US 66719900 A;;US 7067798 A,1998-04-30,Analyte Monitoring Device and Methods of Use,"An analyte monitor includes a sensor, a sensor control unit, and a display unit. The sensor has, for example, a substrate, a recessed channel formed in the substrate, and conductive material disposed in the recessed channel to form a working electrode. The sensor control unit typically has a housing adapted for placement on skin and is adapted to receive a portion of an electrochemical sensor. The sensor control unit also includes two or more conductive contacts disposed on the housing and configured for coupling to two or more contact pads on the sensor. A transmitter is disposed in the housing and coupled to the plurality of conductive contacts for transmitting data obtained using the sensor. The display unit has a receiver for receiving data transmitted by the transmitter of the sensor control unit and a display coupled to the receiver for displaying an indication of a level of an analyte. The analyte monitor may also be part of a drug delivery system to alter the level of the analyte based on the data obtained using the sensor.",ABBOTT DIABETES CARE INC,SAY JAMES;;TOMASCO MICHAEL F;;HELLER ADAM;;GAL YORAM;;ARIA BEHRAD;;HELLER EPHRAIM;;PLANTE PHILLIP JOHN;;VREEKE MARK S;;FRIEDMAN KEITH A;;COLMAN FREDRIC C,,https://lens.org/157-435-880-259-72X,Patent Application,yes,2,4,211,221,0,A61B5/14532;;A61B5/14532;;A61B5/0002;;A61B5/0002;;A61B5/002;;A61B5/01;;A61B5/14503;;A61B5/1451;;A61B5/14546;;A61B5/14546;;A61B5/1473;;A61B5/1473;;A61B5/1486;;A61B5/1486;;A61B5/14865;;A61B5/1495;;A61B5/4839;;A61B5/72;;A61B5/7278;;A61B5/7282;;A61B5/7405;;A61B5/743;;A61B5/7445;;A61B5/7445;;A61B5/7455;;A61B2560/0252;;A61B2560/0252;;A61M5/1723;;C12Q1/54;;G16H10/40;;G16H10/40;;G16H20/17;;G16H20/17;;H01L23/3107;;H01L23/3107;;H01L23/49548;;H01L23/49548;;H01L2924/0002;;H01L2924/0002;;H01L2924/19041;;H01L2924/19041;;H01L2924/3011;;H01L2924/3011;;Y10S128/903;;Y10S128/903;;Y10T29/49;;Y10T29/49;;Y10T29/49124;;Y10T29/49124,A61B5/145;;G01N27/30;;A61B5/00;;A61B5/1477;;A61B5/1495;;G01N27/416;;G06F19/00;;H01L23/31;;H01L23/495,600/345,0,0,,,,DISCONTINUED
147,US,A1,US 2010/0324400 A1,180-100-733-316-076,2010-12-23,2010,US 85243910 A,2010-08-06,US 85243910 A;;US 69082607 A;;US 42005703 A;;US 66719900 A;;US 7067798 A,1998-04-30,ANALYTE MONITORING DEVICE AND METHODS OF USE,"An analyte monitor includes a sensor, a sensor control unit, and a display unit. The sensor has, for example, a substrate, a recessed channel formed in the substrate, and conductive material disposed in the recessed channel to form a working electrode. The sensor control unit typically has a housing adapted for placement on skin and is adapted to receive a portion of an electrochemical sensor. The sensor control unit also includes two or more conductive contacts disposed on the housing and configured for coupling to two or more contact pads on the sensor. A transmitter is disposed in the housing and coupled to the plurality of conductive contacts for transmitting data obtained using the sensor. The display unit has a receiver for receiving data transmitted by the transmitter of the sensor control unit and a display coupled to the receiver for displaying an indication of a level of an analyte. The analyte monitor may also be part of a drug delivery system to alter the level of the analyte based on the data obtained using the sensor.",ABBOTT DIABETES CARE INC,SAY JAMES;;TOMASCO MICHAEL F;;HELLER ADAM;;GAL YORAM;;ARIA BEHRAD;;HELLER EPHRAIM;;PLANTE PHILLIP JOHN;;VREEKE MARK S;;FRIEDMAN KEITH A;;COLMAN FREDRIC C,E. HELLER & CO (1998-07-02);;ABBOTT DIABETES CARE INC (2000-03-13),https://lens.org/180-100-733-316-076,Patent Application,yes,99,2,211,221,0,A61B5/14532;;A61B5/14532;;A61B5/0002;;A61B5/0002;;A61B5/002;;A61B5/01;;A61B5/14503;;A61B5/1451;;A61B5/14546;;A61B5/14546;;A61B5/1473;;A61B5/1473;;A61B5/1486;;A61B5/1486;;A61B5/14865;;A61B5/1495;;A61B5/4839;;A61B5/72;;A61B5/7278;;A61B5/7282;;A61B5/7405;;A61B5/743;;A61B5/7445;;A61B5/7445;;A61B5/7455;;A61B2560/0252;;A61B2560/0252;;A61M5/1723;;C12Q1/54;;G16H10/40;;G16H10/40;;G16H20/17;;G16H20/17;;H01L23/3107;;H01L23/3107;;H01L23/49548;;H01L23/49548;;H01L2924/0002;;H01L2924/0002;;H01L2924/19041;;H01L2924/19041;;H01L2924/3011;;H01L2924/3011;;Y10S128/903;;Y10S128/903;;Y10T29/49;;Y10T29/49;;Y10T29/49124;;Y10T29/49124,A61B5/00;;G01N27/30;;A61B5/145;;A61B5/1477;;A61B5/1495;;G01N27/416;;G06F19/00;;H01L23/31;;H01L23/495,600/365,0,0,,,,EXPIRED
148,US,A1,US 2010/0292553 A1,015-012-245-356-308,2010-11-18,2010,US 84680310 A,2010-07-29,US 84680310 A;;US 69082607 A;;US 42005703 A;;US 66719900 A;;US 7067798 A,1998-04-30,Analyte Monitoring Device and Methods of Use,"An analyte monitor includes a sensor, a sensor control unit, and a display unit. The sensor has, for example, a substrate, a recessed channel formed in the substrate, and conductive material disposed in the recessed channel to form a working electrode. The sensor control unit typically has a housing adapted for placement on skin and is adapted to receive a portion of an electrochemical sensor. The sensor control unit also includes two or more conductive contacts disposed on the housing and configured for coupling to two or more contact pads on the sensor. A transmitter is disposed in the housing and coupled to the plurality of conductive contacts for transmitting data obtained using the sensor. The display unit has a receiver for receiving data transmitted by the transmitter of the sensor control unit and a display coupled to the receiver for displaying an indication of a level of an analyte. The analyte monitor may also be part of a drug delivery system to alter the level of the analyte based on the data obtained using the sensor.",ABBOTT DIABETES CARE INC,SAY JAMES;;TOMASCO MICHAEL F;;HELLER ADAM;;GAL YORAM;;ARIA BEHRAD;;HELLER EPHRAIM;;PLANTE PHILLIP JOHN;;VREEKE MARK S;;FRIEDMAN KEITH A;;COLMAN FREDRIC C,,https://lens.org/015-012-245-356-308,Patent Application,yes,99,2,211,221,0,A61B5/14532;;A61B5/14532;;A61B5/0002;;A61B5/0002;;A61B5/002;;A61B5/01;;A61B5/14503;;A61B5/1451;;A61B5/14546;;A61B5/14546;;A61B5/1473;;A61B5/1473;;A61B5/1486;;A61B5/1486;;A61B5/14865;;A61B5/1495;;A61B5/4839;;A61B5/72;;A61B5/7278;;A61B5/7282;;A61B5/7405;;A61B5/743;;A61B5/7445;;A61B5/7445;;A61B5/7455;;A61B2560/0252;;A61B2560/0252;;A61M5/1723;;C12Q1/54;;G16H10/40;;G16H10/40;;G16H20/17;;G16H20/17;;H01L23/3107;;H01L23/3107;;H01L23/49548;;H01L23/49548;;H01L2924/0002;;H01L2924/0002;;H01L2924/19041;;H01L2924/19041;;H01L2924/3011;;H01L2924/3011;;Y10S128/903;;Y10S128/903;;Y10T29/49;;Y10T29/49;;Y10T29/49124;;Y10T29/49124,A61B5/05;;G01N27/30;;A61B5/00;;A61B5/145;;A61B5/1477;;A61B5/1495;;G01N27/416;;G06F19/00;;H01L23/31;;H01L23/495,600/347,0,0,,,,DISCONTINUED
149,US,A1,US 2007/0149874 A1,018-215-262-153-077,2007-06-28,2007,US 68340807 A,2007-03-07,US 68340807 A;;US 42005703 A;;US 66719900 A;;US 7067798 A,1998-04-30,Analyte Monitoring Device and Methods of Use,"An analyte monitor includes a sensor, a sensor control unit, and a display unit. The sensor has, for example, a substrate, a recessed channel formed in the substrate, and conductive material disposed in the recessed channel to form a working electrode. The sensor control unit typically has a housing adapted for placement on skin and is adapted to receive a portion of an electrochemical sensor. The sensor control unit also includes two or more conductive contacts disposed on the housing and configured for coupling to two or more contact pads on the sensor. A transmitter is disposed in the housing and coupled to the plurality of conductive contacts for transmitting data obtained using the sensor. The display unit has a receiver for receiving data transmitted by the transmitter of the sensor control unit and a display coupled to the receiver for displaying an indication of a level of an analyte. The analyte monitor may also be part of a drug delivery system to alter the level of the analyte based on the data obtained using the sensor.",ABBOTT DIABETES CARE INC,SAY JAMES;;TOMASCO MICHAEL F;;HELLER ADAM;;GAL YORAM;;ARIA BEHRAD;;HELLER EPHRAIM;;PLANTE PHILLIP J;;VREEKE MARK S;;FRIEDMAN KEITH A;;COLMAN FREDRIC C,E. HELLER & CO (1998-07-02);;ABBOTT DIABETES CARE INC (2000-03-13),https://lens.org/018-215-262-153-077,Patent Application,yes,99,79,211,221,0,A61B5/14532;;A61B5/14532;;A61B5/0002;;A61B5/0002;;A61B5/002;;A61B5/01;;A61B5/14503;;A61B5/1451;;A61B5/14546;;A61B5/14546;;A61B5/1473;;A61B5/1473;;A61B5/1486;;A61B5/1486;;A61B5/14865;;A61B5/1495;;A61B5/4839;;A61B5/72;;A61B5/7278;;A61B5/7282;;A61B5/7405;;A61B5/743;;A61B5/7445;;A61B5/7445;;A61B5/7455;;A61B2560/0252;;A61B2560/0252;;A61M5/1723;;C12Q1/54;;G16H10/40;;G16H10/40;;G16H20/17;;G16H20/17;;H01L23/3107;;H01L23/3107;;H01L23/49548;;H01L23/49548;;H01L2924/0002;;H01L2924/0002;;H01L2924/19041;;H01L2924/19041;;H01L2924/3011;;H01L2924/3011;;Y10S128/903;;Y10S128/903;;Y10T29/49;;Y10T29/49;;Y10T29/49124;;Y10T29/49124,A61B5/05;;G01N27/30;;A61B5/00;;A61B5/145;;A61B5/1477;;A61B5/1495;;G01N27/416;;G06F19/00;;H01L23/31;;H01L23/495,600/345;;600/347;;600/365,0,0,,,,EXPIRED
150,US,A1,US 2009/0089999 A1,034-591-163-326-381,2009-04-09,2009,US 24964408 A,2008-10-10,US 24964408 A;;US 42005703 A;;US 66719900 A;;US 7067798 A,1998-04-30,Analyte Monitoring Device and Methods of Use,"An analyte monitor includes a sensor, a sensor control unit, and a display unit. The sensor has, for example, a substrate, a recessed channel formed in the substrate, and conductive material disposed in the recessed channel to form a working electrode. The sensor control unit typically has a housing adapted for placement on skin and is adapted to receive a portion of an electrochemical sensor. The sensor control unit also includes two or more conductive contacts disposed on the housing and configured for coupling to two or more contact pads on the sensor. A transmitter is disposed in the housing and coupled to the plurality of conductive contacts for transmitting data obtained using the sensor. The display unit has a receiver for receiving data transmitted by the transmitter of the sensor control unit and a display coupled to the receiver for displaying an indication of a level of an analyte. The analyte monitor may also be part of a drug delivery system to alter the level of the analyte based on the data obtained using the sensor.",ABBOTT DIABETES CARE INC,SAY JAMES;;TOMASCO MICHAEL F;;HELLER ADAM;;GAL YORAM;;ARIA BEHRAD;;HELLER EPHRAIM;;PLANTE PHILLIP JOHN;;VREEKE MARK S;;FRIEDMAN KEITH A;;COLMAN FREDRIC C,E. HELLER & CO (1998-07-02);;ABBOTT DIABETES CARE INC (2000-03-13),https://lens.org/034-591-163-326-381,Patent Application,yes,12,17,211,221,0,A61B5/14532;;A61B5/14532;;A61B5/0002;;A61B5/0002;;A61B5/002;;A61B5/01;;A61B5/14503;;A61B5/1451;;A61B5/14546;;A61B5/14546;;A61B5/1473;;A61B5/1473;;A61B5/1486;;A61B5/1486;;A61B5/14865;;A61B5/1495;;A61B5/4839;;A61B5/72;;A61B5/7278;;A61B5/7282;;A61B5/7405;;A61B5/743;;A61B5/7445;;A61B5/7445;;A61B5/7455;;A61B2560/0252;;A61B2560/0252;;A61M5/1723;;C12Q1/54;;G16H10/40;;G16H10/40;;G16H20/17;;G16H20/17;;H01L23/3107;;H01L23/3107;;H01L23/49548;;H01L23/49548;;H01L2924/0002;;H01L2924/0002;;H01L2924/19041;;H01L2924/19041;;H01L2924/3011;;H01L2924/3011;;Y10S128/903;;Y10S128/903;;Y10T29/49;;Y10T29/49;;Y10T29/49124;;Y10T29/49124,G01N27/30;;H05K3/00;;A61B5/00;;A61B5/145;;A61B5/1477;;A61B5/1495;;G01N27/416;;G06F19/00;;H01L23/31;;H01L23/495,29/829,0,0,,,,EXPIRED
151,EP,B1,EP 2305107 B1,053-803-675-450-766,2015-04-29,2015,EP 10012960 A,1999-01-21,EP 99903239 A;;US 7067798 A,1998-04-30,Analyte monitoring device,,ABBOTT DIABETES CARE INC,SAY JAMES;;TOMASCO MICHAEL F;;HELLER ADAM;;GAL YORAM;;ARIA BEHRAD;;HELLER EPHRAIM;;PLANTE PHILLIP JOHN;;VREEKE MARK S;;FRIEDMAN KEITH A;;COLMAN FREDRIC C,,https://lens.org/053-803-675-450-766,Granted Patent,yes,4,0,211,221,0,A61B5/14532;;A61B5/14532;;A61B5/0002;;A61B5/0002;;A61B5/002;;A61B5/01;;A61B5/14503;;A61B5/1451;;A61B5/14546;;A61B5/14546;;A61B5/1473;;A61B5/1473;;A61B5/1486;;A61B5/1486;;A61B5/14865;;A61B5/1495;;A61B5/4839;;A61B5/72;;A61B5/7278;;A61B5/7282;;A61B5/7405;;A61B5/743;;A61B5/7445;;A61B5/7445;;A61B5/7455;;A61B2560/0252;;A61B2560/0252;;A61M5/1723;;C12Q1/54;;G16H10/40;;G16H10/40;;G16H20/17;;G16H20/17;;H01L23/3107;;H01L23/3107;;H01L23/49548;;H01L23/49548;;H01L2924/0002;;H01L2924/0002;;H01L2924/19041;;H01L2924/19041;;H01L2924/3011;;H01L2924/3011;;Y10S128/903;;Y10S128/903;;Y10T29/49;;Y10T29/49;;Y10T29/49124;;Y10T29/49124,A61B5/00;;G01N27/30;;A61B5/145;;A61B5/1468;;A61B5/1477;;A61B5/1495;;G01N27/416;;G06F19/00;;H01L23/31;;H01L23/495,,0,0,,,,EXPIRED
152,US,B2,US 8734348 B2,054-725-768-222-645,2014-05-27,2014,US 40598709 A,2009-03-17,US 40598709 A;;US 42005703 A;;US 66719900 A;;US 7067798 A,1998-04-30,Analyte monitoring device and methods of use,"An analyte monitor includes a sensor, a sensor control unit, and a display unit. The sensor has, for example, a substrate, a recessed channel formed in the substrate, and conductive material disposed in the recessed channel to form a working electrode. The sensor control unit typically has a housing adapted for placement on skin and is adapted to receive a portion of an electrochemical sensor. The sensor control unit also includes two or more conductive contacts disposed on the housing and configured for coupling to two or more contact pads on the sensor. A transmitter is disposed in the housing and coupled to the plurality of conductive contacts for transmitting data obtained using the sensor. The display unit has a receiver for receiving data transmitted by the transmitter of the sensor control unit and a display coupled to the receiver for displaying an indication of a level of an analyte. The analyte monitor may also be part of a drug delivery system to alter the level of the analyte based on the data obtained using the sensor.",SAY JAMES;;TOMASCO MICHAEL F;;HELLER ADAM;;GAL YORAM;;ARIA BEHRAD;;HELLER EPHRAIM;;PLANTE PHILLIP JOHN;;VREEKE MARK S;;FRIEDMAN KEITH A;;COLMAN FREDRIC C;;ABBOTT DIABETES CARE INC,SAY JAMES;;TOMASCO MICHAEL F;;HELLER ADAM;;GAL YORAM;;ARIA BEHRAD;;HELLER EPHRAIM;;PLANTE PHILLIP JOHN;;VREEKE MARK S;;FRIEDMAN KEITH A;;COLMAN FREDRIC C,E. HELLER & CO (1998-07-02);;ABBOTT DIABETES CARE INC (2000-03-13),https://lens.org/054-725-768-222-645,Granted Patent,yes,101,15,211,221,0,A61B5/14532;;A61B5/14532;;A61B5/0002;;A61B5/0002;;A61B5/002;;A61B5/01;;A61B5/14503;;A61B5/1451;;A61B5/14546;;A61B5/14546;;A61B5/1473;;A61B5/1473;;A61B5/1486;;A61B5/1486;;A61B5/14865;;A61B5/1495;;A61B5/4839;;A61B5/72;;A61B5/7278;;A61B5/7282;;A61B5/7405;;A61B5/743;;A61B5/7445;;A61B5/7445;;A61B5/7455;;A61B2560/0252;;A61B2560/0252;;A61M5/1723;;C12Q1/54;;G16H10/40;;G16H10/40;;G16H20/17;;G16H20/17;;H01L23/3107;;H01L23/3107;;H01L23/49548;;H01L23/49548;;H01L2924/0002;;H01L2924/0002;;H01L2924/19041;;H01L2924/19041;;H01L2924/3011;;H01L2924/3011;;Y10S128/903;;Y10S128/903;;Y10T29/49;;Y10T29/49;;Y10T29/49124;;Y10T29/49124,A61B5/05;;G01N27/30;;A61B5/00;;A61B5/145;;A61B5/1477;;A61B5/1495;;G01N27/416;;G06F19/00;;H01L23/31;;H01L23/495,600/365;;300/345;;300/347,99,80,061-539-442-167-302;;136-791-935-548-81X;;062-360-289-025-864;;010-601-725-111-91X;;101-292-518-663-191;;056-703-879-057-297;;030-155-762-644-019;;004-149-141-436-651;;016-731-054-793-457;;080-559-561-995-335;;044-807-213-528-815;;027-538-525-436-179;;015-020-161-517-40X;;025-919-454-564-785;;014-700-576-603-812;;004-851-060-590-788;;075-958-432-122-199;;052-356-140-149-389;;035-090-282-884-790;;033-562-815-299-181;;018-803-926-589-211;;008-505-762-041-402;;016-601-143-530-813;;019-502-772-562-215;;058-476-824-396-350;;006-498-707-073-30X;;054-091-551-638-293;;010-531-147-771-746;;054-827-198-877-419;;122-658-944-077-000;;017-261-560-469-37X;;000-125-755-474-124;;113-381-664-783-802;;082-626-907-191-554;;017-950-014-792-456;;090-348-305-613-628;;015-985-399-299-132;;171-049-047-164-618;;016-819-089-891-758;;081-249-097-078-543;;089-612-747-111-646;;031-706-897-890-035;;094-198-536-559-723;;003-690-143-043-420;;007-943-354-378-456;;082-114-500-909-975;;004-239-090-971-580;;026-894-457-160-450;;077-128-610-778-669;;022-466-506-956-898;;008-424-592-956-946;;007-500-825-916-378;;009-725-244-669-882;;037-755-689-613-42X;;153-411-506-517-475;;038-134-360-685-692;;012-449-714-188-064;;031-517-704-996-130;;131-299-284-996-064;;049-133-049-742-708;;000-272-178-768-076;;070-797-683-833-124;;043-870-224-178-49X;;025-574-914-238-550;;052-364-430-129-757;;004-434-167-910-115;;032-860-147-271-886;;132-460-374-211-421;;098-172-374-375-47X;;109-358-955-476-095;;014-988-634-483-130;;061-786-187-274-992;;037-898-018-686-909;;130-044-667-529-69X;;134-265-642-839-645;;065-221-074-461-027;;017-934-465-161-477;;101-660-130-379-529;;028-236-706-290-220;;087-333-189-994-274,1751159;;10.1016/s0956-5663(02)00099-4;;12392956;;10.1021/ja00391a001;;2889225;;10.1098/rstb.1987.0021;;10.1109/51.294001;;10.1016/0022-0728(65)85063-x;;2245876;;10.2337/diabetes.39.12.1519;;10.2337/diab.39.12.1519;;10.1016/s0956-5663(03)00220-3;;14611755;;18615658;;10.1002/bit.260430310;;9366023;;10.1016/s0956-5663(97)00025-0;;9451795;;10.1016/s0956-5663(97)00083-3;;10.1016/0956-5663(93)80028-n;;8311939;;8651496;;10.1021/ac960030d;;10.1080/03091900210156797;;12487712;;10.1016/0265-928x(87)80018-4;;3333622;;10.1109/19.816143;;10.1007/bf01015979;;10.1089/15209150252924058;;12017416;;18473691;;10.1089/dia.2007.0281;;10.1021/ac00017a008;;1789439;;2817408;;10.1021/ac00197a022;;10.1016/0925-4005(95)01730-5;;10.1016/0010-4825(90)90013-f;;2257734;;2868172;;8277748;;10.1016/0141-5425(93)90058-7;;11469630;;10.1089/15209150050214104;;10624783;;10.1016/s0168-8227(99)00113-8;;10.1089/15209150050214113;;11469631;;10.1007/bf00401374;;1478372;;10.2337/diacare.20.1.64;;9028696;;10.1109/tbme.1986.325807;;3957374;;236018;;10.1016/0005-2795(75)90259-7;;10.1089/hum.1998.9.6-879;;9581910;;11762520;;10.1089/15209150152607196;;10.2337/diabetes.48.3.445;;10078542;;10.1016/0265-928x(87)80012-3;;505005;;10.1126/science.505005;;10.1021/ac0498516;;15253640;;10.1109/10.284922;;8026845;;6721151;;10.1021/ac00268a018;;6733082;;10.1021/bi00305a016;;10.1515/cclm.2002.135;;12392305;;10.1016/j.ecl.2003.12.001;;15053902;;12052350;;10.1016/s0956-5663(01)00304-9;;12052349;;10.1016/s0956-5663(01)00306-2;;4500021;;10.1007/978-1-4684-3288-6_18;;14021529;;10.1111/j.1749-6632.1962.tb13623.x;;3196517;;10.2337/diacare.10.5.622;;3677983;;10.2337/diacare.8.6.529;;4075939;;10.1002/elan.1140061103;;7733469;;10.1021/ac00103a015;;7978306;;10.1021/ac00091a022;;10.1007/bf01248238;;10.1016/s0376-7388(98)00330-5;;10.1016/0142-9612(92)90147-g;;1472593;;10.1016/0265-928x(85)80002-x;;10.1021/j100290a001;;10.1021/ja00216a040;;10.1021/ja00188a091;;10.1021/ja00406a011;;2624333;;12323417;;10.1016/s0165-0270(02)00170-x;;10.1177/193229680700100208;;pmc2771467;;19888405;;10.1021/ja00415a014;;10.1007/bf00575392;;10.1021/ac00250a038;;10.1021/ac00266a005;;10.1007/s00216-002-1284-0;;12194035;;10.1089/dia.2006.0030;;17705688;;9642777;;10.1016/s0956-5663(97)00091-2;;10.1089/152091503322526978;;14633342;;10.1016/0022-0728(85)87006-6;;10.1021/ja00434a018;;10.1016/0003-2697(92)90243-z;;1443528;;10.1039/f19868201259;;3245585;;10.1021/ac00173a008;;2889234;;10.1098/rstb.1987.0020;;11762521;;10.1089/15209150152607204;;12413548;;10.1016/s1367-5931(02)00371-x,"U.S. Reexamination Appl. No. 90/010,988, Request for Reexamination of U.S. Patent No. 7,583,990 filed May 10, 2010.;;U.S. Reexamination Appl. No. 90/011,031, Request for Reexamination of U.S. Patent No. 7,599,726 filed Jun. 14, 2010.;;Poitout, V., et al., ""In Vitro and In Vivo Evaluation in Dogs of a Miniaturized Glucose Sensor"", ASAIO Transactions, vol. 37, No. 3, 1991, pp. M298-M300.;;Abel, P. U., et al., ""Biosensors for in Vivo Glucose Measurement: Can We Cross the Experimental Stage"", Biosensors and Bioelectronics, vol. 17, 2002, pp. 1059-1070.;;Abruna, H. D., et al., ""Rectifying Interfaces Using Two-Layer Films of Electrochemically Polymerized Vinylpyridine and Vinylbipyridine Complexes of Ruthenium and Iron on Electrodes"", Journal of the American Chemical Society, vol. 103, No. 1, 1981, pp. 1-5.;;Albery, W. J., et al., ""Amperometric Enzyme Electrodes Part II: Conducting Salts as Electrode Materials for the Oxidation of Glucose Oxidase"", Journal of ElectroAnalytical Chemistry, vol. 194, 1985, pp. 223-235.;;Albery, W. J., et al., ""Amperometric Enzyme Electrodes"", Philosophical Transactions of the Royal Society of London, vol. 316, 1987, pp. 107-119.;;Alcock, S. J., et al., ""Continuous Analyte Monitoring to Aid Clinical Practice"", IEEE Engineering in Medicine and Biology Magazine, 1994, pp. 319-325.;;Anderson, L. B., et al., ""Thin-Layer Electrochemistry: Steady-State Methods of Studying Rate Processes"", Journal of ElectroAnalytical Chemistry, vol. 10, 1965, pp. 295-305.;;Armour, J. C., et al., ""Application of Chronic Intravascular Blood Glucose Sensor in Dogs"", Diabetes, vol. 39, 1990, pp. 1519-1526.;;Asberg, P., et al., ""Hydrogels of a Conducting Conjugated Polymer as 3-D Enzyme Electrode"", Biosensors & Bioelectronics, vol. 19, 2003, pp. 199-207.;;Atanasov, P., et al., ""Biosensor for Continuous Glucose Monitoring"", Biotechnology and Bioengineering, vol. 43, 1994, pp. 262-266.;;Atanasov, P., et al., ""Implantation of a Refillable Glucose Monitoring-Telemetry Device"", Biosensors & Bioelectronics, vol. 12, No. 7, 1997, pp. 669-680.;;Aussedat, B., et al., ""A User-Friendly Method for Calibrating a Subcutaneous Glucose Sensor-Based Hypoglycaemic Alarm"", Biosensors & Bioelectronics, vol. 12, No. 11, 1997, pp. 1061-1071.;;Baker, D. A., et al., ""Dynamic Concentration Challenges for Biosensor Characterization"", Biosensors & Bioelectronics, vol. 8, 1993, pp. 433-441.;;Baker, D. A., et al., ""Dynamic Delay and Maximal Dynamic Error in Continuous Biosensors"", Analytical Chemistry, vol. 68, No. 8, 1996, pp. 1292-1297.;;Bani Amer, M. M., ""An Accurate Amperometric Glucose Sensor Based Glucometer with Eliminated Cross-Sensitivity"", Journal of Medical Engineering & Technology, vol. 26, No. 5, 2002, pp. 208-213.;;Bard, A. J., et al., Electrochemical Methods, 1980, pp. 173-175.;;Bartlett, P. N., et al., ""Covalent Binding of Electron Relays to Glucose Oxidase"", Journal of the Chemical Society, Chemical Communications, 1987, pp. 1603-1604.;;Bartlett, P. N., et al., ""Modification of Glucose Oxidase by Tetrathiafulvalene"", Journal of the Chemical Society, Chemical Communications, 1990, pp. 1135-1136.;;Bartlett, P. N., et al., ""Strategies for the Development of Amperometric Enzyme Electrodes"", Biosensors, vol. 3, 1987/88, pp. 359-379.;;Beach, R. D., et al., ""Subminiature Implantable Potentiostat and Modified Commercial Telemetry Device for Remote Glucose Monitoring"", IEEE Transactions on Instrumentation and Measurement, vol. 28, No. 6, 1999, pp. 1239-1245.;;Beech, W. A., ""AX.25 Link Access Protocol for Amateur packet Radio"", Tucson Amateur Packet Radio Corporation, 1998, pp. 1-133.;;Bellucci, F., et al., ""Electrochemical Behaviour of Graphite-Epoxy Composite Materials (GECM) in Aqueous Salt Solutions"", Journal of Applied Electrochemistry, vol. 16, 1986, pp. 15-22.;;Bennion, N., et al., ""Alternate Site Glucose Testing: A Crossover Design"", Diabetes Technology & Therapeutics, vol. 4, No. 1, 2002, pp. 25-33.;;Biermann, E., et al., ""How Would Patients Behave if They Were Continually Informed of Their Blood Glucose Levels? A Simulation Study Using a 'Virtual' Patient"", Diabetes Technology & Therapeutics, vol. 10, No. 3, 2008, pp. 178-187.;;Bindra, D. S., et al., ""Design and in Vitro Studies of a Needle-Type Glucose Sensor for Subcutaneous Monitoring"", Analytical Chemistry, vol. 63, No. 17, 1991, pp. 1692-1696.;;Bindra, D. S., et al., ""Pulsed Amperometric Detection of Glucose in Biological Fluids at a Surface-Modified Gold Electrode"", Analytical Chemistry, vol. 61, No. 22, 1989, pp. 2566-2570.;;Bisenberger, M., et al., ""A Triple-Step Potential Waveform at Enzyme Multisensors with Thick-Film Gold Electrodes for Detection of Glucose and Sucrose"", Sensors and Actuators B, vol. 28, 1995, pp. 181-189.;;Bland, J. M., et al., ""A Note on the Use of the Intraclass Correlation Coefficient in the Evaluation of Agreement Between Two Methods of Measurement"", Computers in Biology and Medicine, vol. 20, No. 5, 1990, pp. 337-340.;;Bland, J. M., et al., ""Statistical Methods for Assessing Agreement Between Two Methods of Clinical Measurement"", The Lancet, 1986, pp. 307-310.;;Blank, T. B., et al., ""Clinical Results From a Non-Invasive Blood Glucose Monitor"", Optical Diagnostics and Sensing of Biological Fluids and Glucose and Cholesterol Monitoring II, Proceedings of SPIE, vol. 4624, 2002, pp. 1-10.;;Bobbioni-Harsch, E., et al., ""Lifespan of Subcutaneous Glucose Sensors and Their Performances During Dynamic Glycaemia Changes in Rats"", Journal of Biomedical Engineering, vol. 15, 1993, pp. 457-463.;;Bode, B. W., ""Clinical Utility of the Continuous Glucose Monitoring System"", Diabetes Technology & Therapeutics, vol. 2, Sup. 1, 2000, pp. S35-S41.;;Bode, B. W., et al., ""Continuous Glucose Monitoring Used to Adjust Diabetes Therapy Improves Glycosylated Hemoglobin: A Pilot Study"", Diabetes Research and Clinical Practice, vol. 46, 1999, pp. 183-190.;;Bode, B. W., et al., ""Using the Continuous Glucose Monitoring System to Improve the Management of Type I Diabetes"", Diabetes Technology & Therapeutics, vol. 2, Sup. 1, 2000, pp. S43-S48.;;Boedeker Plastics, Inc., ""Polyethylene Specifications"", 2007, Web Page of Boedeker.com, 2007, pp. 1-3.;;Bolinder, J., et al., ""Microdialysis Measurement of the Absolute Glucose Concentration in Subcutaneous Adipose Tissue Allowing Glucose Monitoring in Diabetic Patients"", Diabetologia, vol. 35, 1992, pp. 1177-1180.;;Bolinder, J., et al., ""Self-Monitoring of Blood Glucose in Type I Diabetic Patients: Comparison with Continuous Microdialysis Measurements of Glucose in Subcutaneous Adipose Tissue During Ordinary Life Conditions"", Diabetes Care, vol. 20, No. 1, 1997, pp. 64-70.;;Bott, A. W., ""A Comparison of Cyclic Voltammetry and Cyclic Staircase Voltammetry"", Current Separations, vol. 16, No. 1, 1997, pp. 23-26.;;Bott, A. W., ""Electrochemical Methods for the Determination of Glucose"", Current Separations, vol. 17, No. 1, 1998, pp. 25-31.;;Bowman, L., et al., ""The Packaging of Implantable Integrated Sensors"", IEEE Transactions on Biomedical Engineering, vol. 33, No. 2, 1986, pp. 248-255.;;Brandt, J., et al., ""Covalent Attachment of Proteins to Polysaccharide Carriers by Means of Benzoquinone"", Biochimica et Biophysica Acta, vol. 386, 1975, pp. 196-202.;;Brauker, J., et al., ""Sustained Expression of High Levels Human Factor IX from Human Cells Implanted Within an Immunoisolation Device into Athymic Rodents"", Human Gene Therapy, vol. 9, No. 6, 1998, pp. 879-888.;;Bremer, T. M., et al., ""Benchmark Data from the Literature for Evaluation of New Glucose Sensing Technologies"", Diabetes Technology & Therapeutics, vol. 3, No. 3, 2001, pp. 409-418.;;Bremer, T., et al., ""Is Blood Glucose Predictable from Previous Values?"", Diabetes, vol. 48, 1999, pp. 445-451.;;Brooks, S. L., et al., ""Development of an On-Line Glucose Sensor for Fermentation Monitoring"", Biosensors, vol. 3, 1987/88, pp. 45-56.;;Brownlee, M., et al., ""A Glucose-Controlled Insulin-Delivery System: Semisynthetic Insulin Bound to Lectin"", Science, vol. 206, 1979, 1190-1191.;;Cai, Q., et al., ""A Wireless, Remove Query Glucose Biosensor Based on a pH-Sensitive Polymer"", Analytical Chemistry, vol. 76, No. 14, 2004, pp. 4038-4043.;;Candas, B., et al., ""An Adaptive Plasma Glucose Controller Based on a Nonlinear Insulin/Glucose Model"", IEEE Transactions on Biomedical Engineering, vol. 41, No. 2, 1994, pp. 116-124.;;Cass, A. E., et al., ""Ferricinum Ion As an Electron Acceptor for Oxido-Reductases"", Journal of ElectroAnalytical Chemistry, vol. 190, 1985, pp. 117-127.;;Cass, A. E., et al., ""Ferrocene-Medicated Enzyme Electrode for Amperometric Determination of Glucose"", Analytical Chemistry, vol. 56, No. 4, 1984, 667-671.;;Castner, J. F., et al., ""Mass Transport and Reaction Kinetic Parameters Determined Electrochemically for Immobilized Glucose Oxidase"", Biochemistry, vol. 23, No. 10, 1984, 2203-2010.;;Chen, J. C., et al., ""A Comparison of MAC Protocols for Wireless Local Networks Based on battery Power Consumption"", IEEE, 1998, pp. 150-157.;;Chen, T., et al., ""Defining the Period of Recovery of the Glucose Concentration After Its Local Perturbation by the Implantation of a Miniature Sensor"", Clinical Chemistry and Laboratory Medicine, vol. 40, No. 8, 2002, pp. 486-489.;;Chia, C. W., et al., ""Glucose Sensors: Toward Closed Loop Insulin Delivery"", Endocrinology and Metabolism Clinics of North America, vol. 33, 2004, pp. 175-195.;;Choleau, C., et al., ""Calibration of a Subcutaneous Amperometric Glucose Sensor Implanted for 7 Days in Diabetic Patients Part 2: Superiority of the One-Point Calibration Method"", Biosensors and Bioelectronics, vol. 17, 2002, pp. 647-654.;;Choleau, C., et al., ""Calibration of a Subcutaneous Amperometric Glucose Sensor Part 1: Effect of Measurement Uncertainties on the Determination of Sensor Sensitivity and Background Current"", Biosensors and Bioelectronics, vol. 17, 2002, pp. 641-646.;;Claremont, D. J., et al., ""Biosensors for Continuous In Vivo Glucose Monitoring"", Proceedings of the Annual International Conference of the IEEE Engineering in Medicine and Biology Society, vol. 10, 1988.;;Clark Jr., L. C., et al., ""Differential Anodic Enzyme Polarography for the Measurement of Glucose"", Oxygen Transport to Tissue: Instrumentation, Methods, and Physiology, 1973, pp. 127-133.;;Clark Jr., L. C., et al., ""Electrode Systems for Continuous Monitoring in Cardiovascular Surgery"", Annals New York Academy of Sciences, 1962, pp. 29-45.;;Clark Jr., L. C., et al., ""Long-term Stability of Electroenzymatic Glucose Sensors Implanted in Mice"", American Society of Artificial Internal Organs Transactions, vol. XXXIV, 1988, pp. 259-265.;;Clarke, W. L., et al., ""Evaluating Clinical Accuracy of Systems for Self-Monitoring of Blood Glucose"", Diabetes Care, vol. 10, No. 5, 1987, pp. 622-628.;;Complaint, ""Abbott Diabetes Care, Inc. v. Dexcom, Inc."", filed Aug. 11, 2005.;;Complaint, Amended, ""Abbott Diabetes Care, Inc. v. Dexcom, Inc."", filed Jun. 27, 2006.;;Cox, D. J., et al., ""Accuracy of Perceiving Blood Glucose in IDDM"", Diabetes Care, vol. 8, No. 6, 1985, pp. 529-536.;;Csoregi, E., et al., ""Amperometric Microbiosensors for Detection of Hydrogen Peroxide and Glucose Based on Peroxidase-Modified Carbon Fibers"", Electroanalysis, vol. 6, 1994, pp. 925-933.;;Csoregi, E., et al., ""Design and Optimization of a Selective Subcutaneously Implanatabe Glucose Electrode Based on 'Wired' Glucose Oxidase"", Analytical Chemistry, vol. 67, No. 7, 1995, pp. 1240-1244.;;Csoregi, E., et al., ""Design, Characterization, and One-Point in Vivo Calibration of a Subcutaneously Implanted Glucose Electrode"", Analytical Chemistry, vol. 66 No. 19, 1994, pp. 3131-3138.;;Csoregi, E., et al., ""On-Line Glucose Monitoring by Using Microdialysis Sampling and Amperometric Detection Based on 'Wired' Glucose Oxidase in Carbon Paste"", Mikrochimica Acta, vol. 121, 1995, pp. 31-40.;;D'Arrigo, G., et al., ""Porous-Si Based Bio Reactors for Glucose Monitoring and Drugs Production"", Proceedings of SPIE: Microfluids, BioMEMS, and Medical Microsystems, vol. 4982, 2003, pp. 178-184.;;Dai, W. S., et al., ""Hydrogel Membranes with Mesh Size Asymmetry Based on the Gradient Crosslinking of Poly(vinyl alcohol),"" Journal of Membrane Science, vol. 156, 1999, pp. 67-79.;;Davies, M. L., et al., ""Polymer Membranes in Clinical Sensor Applications"", Biomaterials, vol. 13, No. 14, 1992, pp. 971-978.;;Davis, G., ""Electrochemical Techniques for the Development of Amperometric Biosensors"", Biosensors, vol. 1, 1985, pp. 161-178.;;Degani, Y., et al., ""Direct Electrical Communication Between Chemically Modified Enzymes and Metal Electrodes. 1. Electron Transfer from Glucose Oxidase to Metal Electrodes via Electron Relays, Bound Covalently to the Enzyme"", The Journal of Physical Chemistry, vol. 91, No. 6, 1987, pp. 1285-1289.;;Degani, Y., et al., ""Direct Electrical Communication Between Chemically Modified Enzymes and Metal Electrodes. 2. Methods for Bonding Electron-Transfer Relays to Glucose Oxidase and D-Amino-Acid Oxidase"", Journal of the American Chemical Society, vol. 110, No. 8, 1988, pp. 2615-2620.;;Degani, Y., et al., ""Electrical Communication Between Redox Centers of Glucose Oxidase and Electrodes via Electrostatically and Covalently Bound Redox Polymers"", Journal of the American Chemical Society, vol. 111, 1989, pp. 2357-2358.;;Denisevich, P., et al., ""Unidirectional Current Flow and Charge State Trapping at Redox Polymer Interfaces on Bilayer Electrodes: Principles, Experimental Demonstration, and Theory"", Journal of the American Chemical Society, vol. 103, 1981, pp. 4727-4737.;;Dicks, J. M., et al., ""Ferrocene Modified Polypyrrole with Immobilised Glucose Oxidase and its Application in Amperometric Glucose Microbiosenses"", Annales de Biologie Clinique, vol. 47, 1989, pp. 607-619.;;Dixon, B. M., et al., ""Characterization In Vitro and In Vivo of the Oxygen Dependence of an Enzyme/Polymer Biosensors for Monitoring Brain Glucose"", Journal of Neuroscience Methods, vol. 119, 2002, pp. 135-142.;;Eighth Annual Diabetes Technology Meeting Abstracts, Nov. 13-15, 2008, pp. A1-A182.;;El-Khatib, F. H, et al., ""Adaptive Closed-Loop Control Provides Blood-Glucose Regulation Using Subcutaneous Insulin and Glucagon Infusion in Diabetic Swine"", Journal of Diabetes Science and Technology, vol. 1, No. 2, 2007, pp. 181-192.;;Ellis, C. D., et al., ""Selectivity and Directed Charge Transfer through an Electroactive Metallopolymer Film"", Journal of the American Chemical Society, vol. 103, No. 25, 1981, pp. 7480-7483.;;El-Sa'ad, L., et al., ""Moisture Absorption by Epoxy Resins: The Reverse Thermal Effect"", Journal of Materials Science, vol. 25, No. 8, 1990, pp. 3577-3582.;;Engstrom, R. C., ""Electrochemical Pretreatment of Glassy Carbon Electrodes"", Analytical Chemistry, vol. 54, No. 13, 1982, pp. 2310-2314.;;Engstrom, R. C., et al., ""Characterization of Electrochemically Pretreated Glassy Carbon Electrodes"", Analytical Chemistry, vol. 56, No. 2, 1984, pp. 136-141.;;Ernst, H., et al., ""Reliable Glucose Monitoring Through the Use of Microsystem Technology"", Analytical and Bioanalytical Chemistry, vol. 373, 2002, pp. 758-761.;;Fabietti, P. G., et al. ""Clinical Validation of a New Control-Oriented Model of Insulin and Glucose Dynamics in Subjects with Type 1 Diabetes"", Diabetes Technology & Therapeutics, vol. 9, No. 4, 2007, pp. 327-338.;;Fare, T. L., et al., ""Functional Characterization of a Conducting Polymer-Based Immunoassay System"", Biosensors & Bioelectronics, vol. 13, No. 3-4, 1998, pp. 459-470.;;Feldman, B., et al., ""A Continuous Glucose Sensor Based on Wired Enzyme(TM) Technology-Results from a 3-Day Trial in Patients with Type 1 Diabetes"", Diabetes Technology & Therapeutics, vol. 5, No. 5, 2003, pp. 769-779.;;Feldman, B., et al., ""Correlation of Glucose Concentrations in Interstitial Fluid and Venous Blood During Periods of Rapid Glucose Change"", Abbott Diabetes Care, Inc. Freestyle Navigator Continuous Glucose Monitor Pamphlet, 2004.;;Feldman, B., et al., ""Electron Transfer Kinetics at Redox Polymer/Solution Interfaces Using Microelectrodes and Twin Electrode Thin Layer Cells"", Joural of ElectroAnalytical Chemistry, vol. 194, 1985, pp. 63-81.;;Fischer, H., et al., ""Intramolecular Electron Transfer Medicated by 4,4'-Bypyridine and Related Bridging Groups"", Journal of the American Chemical Society, vol. 98, No. 18, 1976, pp. 5512-5517.;;Flentge, F., et al., ""An Enzyme-Reactor for Electrochemical Monitoring of Choline and Acetylcholine: Applications in High-Performance Liquid Chromatography, Bran Tissue, Microdialysis and Cerebrospinal Fluid,"" Analytical Biochemistry, vol. 204, 1992, pp. 305-310.;;Foulds, N. C., et al., ""Enzyme Entrapment in Electrically Conducting Polymers: Immobilisation of Glucose Oxidase in Polypyrrole and its Application in Amperometric Glucose Sensors"", Journal of the Chemical Society, Faraday Transactions 1, vol. 82, 1986, pp. 1259-1264.;;Foulds, N. C., et al., ""Immobilization of Glucose Oxidase in Ferrocene-Modified Pyrrole Polymers"", Analytical Chemistry, vol. 60, No. 22, 1988, pp. 2473-2478.;;Frew, J. E., et al., ""Electron-Transfer Biosensors"", Philosophical Transactions of The Royal Society of London, vol. 316, 1987, pp. 95-106.;;Frohnauer, M. K., et al., ""Graphical Human Insulin Time-Activity Profiles Using Standardized Definitions"", Diabetes Technology & Therapeutics, vol. 3, No. 3, 2001, pp. 419-429.;;Frost, M. C., et al., ""Implantable Chemical Sensors for Real-Time Clinical Monitoring: Progress and Challenges"", Current Opinion in Chemical Biology, vol. 6, 2002, pp. 633-641.",EXPIRED
153,US,A1,US 2004/0106860 A1,053-469-755-997-007,2004-06-03,2004,US 72226403 A,2003-11-24,US 72226403 A;;US 42005703 A;;US 66719900 A;;US 7067798 A,1998-04-30,Analyte monitoring device and methods of use,"
   An analyte monitor includes a sensor, a sensor control unit, and a display unit. The sensor has, for example, a substrate, a recessed channel formed in the substrate, and conductive material disposed in the recessed channel to form a working electrode. The sensor control unit typically has a housing adapted for placement on skin and is adapted to receive a portion of an electrochemical sensor. The sensor control unit also includes two or more conductive contacts disposed on the housing and configured for coupling to two or more contact pads on the sensor. A transmitter is disposed in the housing and coupled to the plurality of conductive contacts for transmitting data obtained using the sensor. The display unit has a receiver for receiving data transmitted by the transmitter of the sensor control unit and a display coupled to the receiver for displaying an indication of a level of an analyte. The analyte monitor may also be part of a drug delivery system to alter the level of the analyte based on the data obtained using the sensor. 
",SAY JAMES;;TOMASCO MICHAEL F.;;HELLER ADAM;;GAL YORAM;;ARIA BEHRAD;;HELLER EPHRAIM;;PLANTE PHILLIP JOHN;;VREEKE MARK S.;;FRIEDMAN KEITH A.;;COLMAN FREDRIC C.,SAY JAMES;;TOMASCO MICHAEL F;;HELLER ADAM;;GAL YORAM;;ARIA BEHRAD;;HELLER EPHRAIM;;PLANTE PHILLIP JOHN;;VREEKE MARK S;;FRIEDMAN KEITH A;;COLMAN FREDRIC C,ABBOTT DIABETES CARE INC (2005-07-25),https://lens.org/053-469-755-997-007,Patent Application,yes,1,81,211,221,0,A61B5/14532;;A61B5/14532;;A61B5/0002;;A61B5/0002;;A61B5/002;;A61B5/01;;A61B5/14503;;A61B5/1451;;A61B5/14546;;A61B5/14546;;A61B5/1473;;A61B5/1473;;A61B5/1486;;A61B5/1486;;A61B5/14865;;A61B5/1495;;A61B5/4839;;A61B5/72;;A61B5/7278;;A61B5/7282;;A61B5/7405;;A61B5/743;;A61B5/7445;;A61B5/7445;;A61B5/7455;;A61B2560/0252;;A61B2560/0252;;A61M5/1723;;C12Q1/54;;G16H10/40;;G16H10/40;;G16H20/17;;G16H20/17;;H01L23/3107;;H01L23/3107;;H01L23/49548;;H01L23/49548;;H01L2924/0002;;H01L2924/0002;;H01L2924/19041;;H01L2924/19041;;H01L2924/3011;;H01L2924/3011;;Y10S128/903;;Y10S128/903;;Y10T29/49;;Y10T29/49;;Y10T29/49124;;Y10T29/49124,G01N27/30;;A61B5/00;;A61B5/145;;A61B5/1477;;A61B5/1495;;G01N27/416;;G06F19/00;;H01L23/31;;H01L23/495,600/345;;600/365;;128/903,0,0,,,,EXPIRED
154,EP,A1,EP 2305108 A1,074-621-276-197-323,2011-04-06,2011,EP 10012961 A,1999-01-21,EP 99903239 A;;US 7067798 A,1998-04-30,Analyte monitoring device,"An analyte monitor includes a sensor, a sensor control unit, and a display unit. The sensor has, for example, a substrate, a recessed channel formed in the substrate, and conductive material disposed in the recessed channel to form a working electrode. The sensor control unit typically has a housing adapted for placement on skin and is adapted to receive a portion of an electrochemical sensor. The sensor control unit also includes two or more conductive contacts disposed on the housing and configured for coupling to two or more contact pads on the sensor. A transmitter is disposed in the housing and coupled to the plurality of conductive contacts for transmitting data obtained using the sensor. The display unit has a receiver for receiving data transmitted by the transmitter of the sensor control unit and a display coupled to the receiver for displaying an indication of a level of an analyte. The analyte monitor may also be part of a drug delivery system to alter the level of the analyte based on the data obtained using the sensor.
",ABBOTT DIABETES CARE INC,SAY JAMES;;TOMASCO MICHAEL F;;HELLER ADAM;;GAL YORAM;;ARIA BEHRAD;;HELLER EPHRAIM;;PLANTE PHILLIP JOHN;;VREEKE MARK S;;FRIEDMAN KEITH A;;COLMAN FREDRIC C,,https://lens.org/074-621-276-197-323,Patent Application,yes,17,5,211,221,0,A61B5/14532;;A61B5/14532;;A61B5/0002;;A61B5/0002;;A61B5/002;;A61B5/01;;A61B5/14503;;A61B5/1451;;A61B5/14546;;A61B5/14546;;A61B5/1473;;A61B5/1473;;A61B5/1486;;A61B5/1486;;A61B5/14865;;A61B5/1495;;A61B5/4839;;A61B5/72;;A61B5/7278;;A61B5/7282;;A61B5/7405;;A61B5/743;;A61B5/7445;;A61B5/7445;;A61B5/7455;;A61B2560/0252;;A61B2560/0252;;A61M5/1723;;C12Q1/54;;G16H10/40;;G16H10/40;;G16H20/17;;G16H20/17;;H01L23/3107;;H01L23/3107;;H01L23/49548;;H01L23/49548;;H01L2924/0002;;H01L2924/0002;;H01L2924/19041;;H01L2924/19041;;H01L2924/3011;;H01L2924/3011;;Y10S128/903;;Y10S128/903;;Y10T29/49;;Y10T29/49;;Y10T29/49124;;Y10T29/49124,A61B5/00;;G01N27/30;;A61B5/145;;A61B5/1468;;A61B5/1477;;A61B5/1495;;G01N27/416;;G06F19/00;;H01L23/31;;H01L23/495,,2,2,090-280-737-637-908;;101-236-266-667-666,10.1073/pnas.95.1.294;;9419369;;pmc18205;;10.1152/ajpendo.1995.269.1.e155;;7631771,"SCHMIDTKE ET AL.: ""Measurement and Modeling of the Transient Difference Between Blood and Subcutaneous Glucose Concentrations in the Rat after Injection of Insulin"", PROC. OF THE NAT'L ACAD. OF SCIENCE, vol. 95, 1998, pages 294 - 299, XP001203807, DOI: doi:10.1073/pnas.95.1.294;;QUINN ET AL.: ""Kinetics of Glucose Delivery to Subcutaneous Tissue in Rats Measured with 0.3mm Amperometric Microsensors"", AM. J. PHYSIOL., 269 (ENDOCRINOL. METAB. 32), vol. 269, no. 32, 1995, pages E155 - E161, XP009039648",EXPIRED
155,US,A1,US 2010/0298682 A1,064-809-361-807-503,2010-11-25,2010,US 84680210 A,2010-07-29,US 84680210 A;;US 69082607 A;;US 42005703 A;;US 66719900 A;;US 7067798 A,1998-04-30,Analyte Monitoring Device and Methods of Use,"An analyte monitor includes a sensor, a sensor control unit, and a display unit. The sensor has, for example, a substrate, a recessed channel formed in the substrate, and conductive material disposed in the recessed channel to form a working electrode. The sensor control unit typically has a housing adapted for placement on skin and is adapted to receive a portion of an electrochemical sensor. The sensor control unit also includes two or more conductive contacts disposed on the housing and configured for coupling to two or more contact pads on the sensor. A transmitter is disposed in the housing and coupled to the plurality of conductive contacts for transmitting data obtained using the sensor. The display unit has a receiver for receiving data transmitted by the transmitter of the sensor control unit and a display coupled to the receiver for displaying an indication of a level of an analyte. The analyte monitor may also be part of a drug delivery system to alter the level of the analyte based on the data obtained using the sensor.",ABBOTT DIABETES CARE INC,SAY JAMES;;TOMASCO MICHAEL F;;HELLER ADAM;;GAL YORAM;;ARIA BEHRAD;;HELLER EPHRAIM;;PLANTE PHILLIP JOHN;;VREEKE MARK S;;FRIEDMAN KEITH A;;COLMAN FREDRIC C,,https://lens.org/064-809-361-807-503,Patent Application,yes,0,1,211,221,0,A61B5/14532;;A61B5/14532;;A61B5/0002;;A61B5/0002;;A61B5/002;;A61B5/01;;A61B5/14503;;A61B5/1451;;A61B5/14546;;A61B5/14546;;A61B5/1473;;A61B5/1473;;A61B5/1486;;A61B5/1486;;A61B5/14865;;A61B5/1495;;A61B5/4839;;A61B5/72;;A61B5/7278;;A61B5/7282;;A61B5/7405;;A61B5/743;;A61B5/7445;;A61B5/7445;;A61B5/7455;;A61B2560/0252;;A61B2560/0252;;A61M5/1723;;C12Q1/54;;G16H10/40;;G16H10/40;;G16H20/17;;G16H20/17;;H01L23/3107;;H01L23/3107;;H01L23/49548;;H01L23/49548;;H01L2924/0002;;H01L2924/0002;;H01L2924/19041;;H01L2924/19041;;H01L2924/3011;;H01L2924/3011;;Y10S128/903;;Y10S128/903;;Y10T29/49;;Y10T29/49;;Y10T29/49124;;Y10T29/49124,A61B5/05;;G01N27/30;;A61B5/00;;A61B5/145;;A61B5/1477;;A61B5/1495;;G01N27/416;;G06F19/00;;H01L23/31;;H01L23/495,600/347,0,0,,,,DISCONTINUED
156,US,A1,US 2010/0288632 A1,078-481-085-155-618,2010-11-18,2010,US 84201510 A,2010-07-22,US 84201510 A;;US 78367504 A;;US 42005703 A;;US 66719900 A;;US 7067798 A,1998-04-30,Analyte Monitoring Device and Methods of Use,"An analyte monitor includes a sensor, a sensor control unit, and a display unit. The sensor has, for example, a substrate, a recessed channel formed in the substrate, and conductive material disposed in the recessed channel to form a working electrode. The sensor control unit typically has a housing adapted for placement on skin and is adapted to receive a portion of an electrochemical sensor. The sensor control unit also includes two or more conductive contacts disposed on the housing and configured for coupling to two or more contact pads on the sensor. A transmitter is disposed in the housing and coupled to the plurality of conductive contacts for transmitting data obtained using the sensor. The display unit has a receiver for receiving data transmitted by the transmitter of the sensor control unit and a display coupled to the receiver for displaying an indication of a level of an analyte. The analyte monitor may also be part of a drug delivery system to alter the level of the analyte based on the data obtained using the sensor.",ABBOTT DIABETES CARE INC,SAY JAMES;;TOMASCO MICHAEL F;;HELLER ADAM;;GAL YORAM;;ARIA BEHRAD;;HELLER EPHRAIM;;PLANTE PHILLIP JOHN;;VREEKE MARK S;;FRIEDMAN KEITH A;;COLMAN FREDRIC C,,https://lens.org/078-481-085-155-618,Patent Application,yes,14,9,1,221,0,A61B5/0002;;A61B5/14532;;A61B5/14546;;A61B5/7445;;H01L23/3107;;H01L23/49548;;H01L2924/19041;;H01L2924/3011;;H01L2924/0002;;H01L23/3107;;A61B5/14546;;H01L2924/3011;;A61B5/7445;;H01L23/49548;;A61B5/0002;;H01L2924/19041;;A61B5/14532;;H01L2924/0002,G01N27/30;;A61B5/00;;G01N33/50;;A61B5/145;;A61B5/1477;;A61B5/1495;;G01N27/416;;H01L23/31;;H01L23/495,204/403.01,0,0,,,,DISCONTINUED
157,US,B2,US 8353829 B2,089-720-600-080-468,2013-01-15,2013,US 64397509 A,2009-12-21,US 64397509 A;;US 42005703 A;;US 66719900 A;;US 7067798 A,1998-04-30,Analyte monitoring device and methods of use,"An analyte monitor includes a sensor, a sensor control unit, and a display unit. The sensor has, for example, a substrate, a recessed channel formed in the substrate, and conductive material disposed in the recessed channel to form a working electrode. The sensor control unit typically has a housing adapted for placement on skin and is adapted to receive a portion of an electrochemical sensor. The sensor control unit also includes two or more conductive contacts disposed on the housing and configured for coupling to two or more contact pads on the sensor. A transmitter is disposed in the housing and coupled to the plurality of conductive contacts for transmitting data obtained using the sensor. The display unit has a receiver for receiving data transmitted by the transmitter of the sensor control unit and a display coupled to the receiver for displaying an indication of a level of an analyte. The analyte monitor may also be part of a drug delivery system to alter the level of the analyte based on the data obtained using the sensor.",ABBOTT DIABETES CARE INC;;SAY JAMES;;TOMASCO MICHAEL F;;HELLER ADAM;;GAL YORAM;;ARIA BEHRAD;;HELLER EPHRAIM;;PLANTE PHILLIP JOHN;;VREEKE MARK S;;FRIEDMAN KEITH A;;COLMAN FREDRIC C,SAY JAMES;;TOMASCO MICHAEL F;;HELLER ADAM;;GAL YORAM;;ARIA BEHRAD;;HELLER EPHRAIM;;PLANTE PHILLIP JOHN;;VREEKE MARK S;;FRIEDMAN KEITH A;;COLMAN FREDRIC C,E. HELLER & CO (1998-07-02);;ABBOTT DIABETES CARE INC (2000-03-13),https://lens.org/089-720-600-080-468,Granted Patent,yes,114,311,211,221,0,A61B5/14532;;A61B5/14532;;A61B5/0002;;A61B5/0002;;A61B5/002;;A61B5/01;;A61B5/14503;;A61B5/1451;;A61B5/14546;;A61B5/14546;;A61B5/1473;;A61B5/1473;;A61B5/1486;;A61B5/1486;;A61B5/14865;;A61B5/1495;;A61B5/4839;;A61B5/72;;A61B5/7278;;A61B5/7282;;A61B5/7405;;A61B5/743;;A61B5/7445;;A61B5/7445;;A61B5/7455;;A61B2560/0252;;A61B2560/0252;;A61M5/1723;;C12Q1/54;;G16H10/40;;G16H10/40;;G16H20/17;;G16H20/17;;H01L23/3107;;H01L23/3107;;H01L23/49548;;H01L23/49548;;H01L2924/0002;;H01L2924/0002;;H01L2924/19041;;H01L2924/19041;;H01L2924/3011;;H01L2924/3011;;Y10S128/903;;Y10S128/903;;Y10T29/49;;Y10T29/49;;Y10T29/49124;;Y10T29/49124,A61B5/00;;G01N27/30;;A61B5/145;;A61B5/1477;;A61B5/1495;;G01N27/416;;G06F19/00;;H01L23/31;;H01L23/495,600/365,99,38,173-901-776-852-06X;;136-791-935-548-81X;;062-360-289-025-864;;010-601-725-111-91X;;101-292-518-663-191;;056-703-879-057-297;;030-155-762-644-019;;004-149-141-436-651;;016-731-054-793-457;;080-559-561-995-335;;044-807-213-528-815;;027-538-525-436-179;;015-020-161-517-40X;;025-919-454-564-785;;014-700-576-603-812;;004-851-060-590-788;;075-958-432-122-199;;052-356-140-149-389;;035-090-282-884-790;;033-562-815-299-181;;018-803-926-589-211;;008-505-762-041-402;;016-601-143-530-813;;019-502-772-562-215;;058-476-824-396-350;;006-498-707-073-30X;;054-091-551-638-293;;010-531-147-771-746;;054-827-198-877-419;;122-658-944-077-000;;017-261-560-469-37X;;000-125-755-474-124;;113-381-664-783-802;;082-626-907-191-554;;017-950-014-792-456;;090-348-305-613-628;;015-985-399-299-132;;171-049-047-164-618,10.1142/9789810248628_0003;;10.1016/s0956-5663(02)00099-4;;12392956;;10.1021/ja00391a001;;2889225;;10.1098/rstb.1987.0021;;10.1109/51.294001;;10.1016/0022-0728(65)85063-x;;2245876;;10.2337/diabetes.39.12.1519;;10.2337/diab.39.12.1519;;10.1016/s0956-5663(03)00220-3;;14611755;;18615658;;10.1002/bit.260430310;;9366023;;10.1016/s0956-5663(97)00025-0;;9451795;;10.1016/s0956-5663(97)00083-3;;10.1016/0956-5663(93)80028-n;;8311939;;8651496;;10.1021/ac960030d;;10.1080/03091900210156797;;12487712;;10.1016/0265-928x(87)80018-4;;3333622;;10.1109/19.816143;;10.1007/bf01015979;;10.1089/15209150252924058;;12017416;;18473691;;10.1089/dia.2007.0281;;10.1021/ac00017a008;;1789439;;2817408;;10.1021/ac00197a022;;10.1016/0925-4005(95)01730-5;;10.1016/0010-4825(90)90013-f;;2257734;;2868172;;8277748;;10.1016/0141-5425(93)90058-7;;11469630;;10.1089/15209150050214104;;10624783;;10.1016/s0168-8227(99)00113-8;;10.1089/15209150050214113;;11469631;;10.1007/bf00401374;;1478372;;10.2337/diacare.20.1.64;;9028696;;10.1109/tbme.1986.325807;;3957374;;236018;;10.1016/0005-2795(75)90259-7;;10.1089/hum.1998.9.6-879;;9581910;;11762520;;10.1089/15209150152607196;;10.2337/diabetes.48.3.445;;10078542;;10.1016/0265-928x(87)80012-3;;505005;;10.1126/science.505005;;10.1021/ac0498516;;15253640,"Gough, D. A., et al., ""The Implantable Glucose Sensor: An Example of Bioengineering Design"", Introduction to Bioengineering, Chapter 3, 2001, pp. 57-66.;;Japanese Patent Application No. 2007-270411, Office Action mailed Aug. 17, 2010.;;Japanese Patent Application No. 2007-270411, Office Action mailed Jun. 21, 2011.;;PCT Application No. PCT/US2008/074469, International Preliminary Report on Patentability and Written Opinion of the International Searching Authority mailed Mar. 11, 2010.;;PCT Application No. PCT/US2010/040117, International Preliminary Report on Patentability and Written Opinion of the International Searching Authority mailed Jan. 12, 2012.;;PCT Application No. PCT/US2010/040118, International Preliminary Report on Patentability and Written Opinion of the International Searching Authority mailed Jan. 12, 2012.;;PCT Application No. PCT/US2010/040119, International Preliminary Report on Patentability and Written Opinion of the International Searching Authority mailed Jan. 12, 2012.;;U.S. Appl. No. 11/681,730, Office Action mailed Dec. 15, 2011.;;U.S. Appl. No. 11/742,453, Office Action mailed Oct. 28, 2011.;;U.S. Appl. No. 11/941,078, Office Action mailed Dec. 22, 2011.;;U.S. Appl. No. 12/135,937, Office Action mailed Dec. 19, 2011.;;U.S. Appl. No. 12/249,644, Notice of Allowance mailed Mar. 14, 2012.;;U.S. Appl. No. 12/249,644, Office Action mailed Nov. 17, 2011.;;U.S. Appl. No. 12/371,539, Office Action mailed Sep. 26, 2011.;;U.S. Appl. No. 12/405,515, Office Action mailed Nov. 22, 2011.;;U.S. Appl. No. 12/405,568, Office Action mailed Sep. 16, 2011.;;U.S. Appl. No. 12/405,643, Advisory Action mailed Mar. 9, 2012.;;U.S. Appl. No. 12/405,643, Office Action mailed Nov. 14, 2011.;;U.S. Appl. No. 12/405,987, Office Action mailed Nov. 16, 2010.;;U.S. Appl. No. 12/406,800, Office Action mailed Nov. 29, 2011.;;U.S. Appl. No. 12/414,456, Notice of Allowance mailed Dec. 19, 2011.;;U.S. Appl. No. 12/414,487, Notice of Allowance mailed Dec. 20, 2011.;;U.S. Appl. No. 12/414,487, Office Action mailed Oct. 31, 2011.;;U.S. Appl. No. 12/414,542, Office Action mailed Nov. 14, 2011.;;U.S. Appl. No. 12/422,269, Office Action mailed Nov. 18, 2011.;;U.S. Appl. No. 12/495,798, Office Action mailed Dec. 1, 2011.;;U.S. Appl. No. 12/495,803, Office Action mailed Dec. 1, 2011.;;U.S. Appl. No. 12/495,807, Office Action mailed Nov. 25, 2011.;;U.S. Appl. No. 12/533,680, Advisory Action mailed Mar. 9, 2012.;;U.S. Appl. No. 12/533,680, Office Action mailed Nov. 14, 2011.;;U.S. Appl. No. 12/614,974, Office Action mailed Nov. 21, 2011.;;U.S. Appl. No. 12/614,990, Office Action mailed Dec. 15, 2011.;;U.S. Appl. No. 12/615,069, Notice of Allowance mailed Dec. 29, 2011.;;U.S. Appl. No. 12/615,128, Office Action mailed Dec. 20, 2011.;;U.S. Appl. No. 12/643,974, Notice of Allowance mailed Jan. 13, 2012.;;U.S. Appl. No. 12/643,977, Advisory Action mailed Mar. 9, 2012.;;U.S. Appl. No. 12/643,977, Office Action mailed Apr. 14, 2011.;;U.S. Appl. No. 12/643,977, Office Action mailed Oct. 19, 2011.;;U.S. Appl. No. 12/643,978, Advisory Action mailed Mar. 13, 2012.;;U.S. Appl. No. 12/643,978, Office Action mailed Oct. 18, 2011.;;U.S. Appl. No. 12/643,980, Office Action mailed Dec. 1, 2011.;;U.S. Appl. No. 12/643,982, Advisory Action mailed Mar. 13, 2012.;;U.S. Appl. No. 12/643,982, Office Action mailed Nov. 23, 2011.;;U.S. Appl. No. 12/643,986, Advisory Action mailed Mar. 13, 2012.;;U.S. Appl. No. 12/643,986, Office Action mailed Nov. 23, 2011.;;U.S. Appl. No. 12/859,054, Office Action mailed Dec. 29, 2011.;;U.S. Appl. No. 12/859,054, Office Action mailed Jul. 13, 2011.;;U.S. Appl. No. 12/902,138, Notice of Allowance, mailed Feb. 23, 2012.;;U.S. Appl. No. 12/902,138, Office Action mailed Jan. 27, 2012.;;U.S. Appl. No. 12/959,337, Office Action, mailed Mar. 5, 2012.;;U.S. Patent Reexamination Application No. 90/011,730, Office Action mailed Jan. 11, 2012.;;U.S. Patent Reexamination Application No. 90/011,730, Order Granting Request for Reexamination of U.S. Patent No. 6,990,366 mailed Aug. 24, 2011.;;""Poretics Polycarbonate Membrane"", Osmonics Filtration and Separation Group, 2002.;;Abel, P. U., et al., ""Biosensors for In Vivo Glucose Measurement: Can We Cross the Experimental Stage"", Biosensors and Bioelectronics, vol. 17, 2002, pp. 1059-1070.;;Abruna, H. D., et al., ""Rectifying Interfaces Using Two-Layer Films of Electrochemically Polymerized Vinylpyridine and Vinylbipyridine Complexes of Ruthenium and Iron on Electrodes"", Journal of the American Chemical Society, vol. 103, No. 1, 1981, pp. 1-5.;;Albery, W. J., et al., ""Amperometric Enzyme Electrodes Part II: Conducting Salts as Electrode Materials for the Oxidation of Glucose Oxidase"", Journal of ElectroAnalytical Chemistry, vol. 194, 1985, pp. 223-235.;;Albery, W. J., et al., ""Amperometric Enzyme Electrodes"", Philosophical Transactions of the Royal Society of London, vol. 316, 1987, pp. 107-119.;;Alcock, S. J., et al., ""Continuous Analyte Monitoring to Aid Clinical Practice"", IEEE Engineering in Medicine and Biology Magazine, 1994, pp. 319-325.;;Anderson, L. B., et al., ""Thin-Layer Electrochemistry: Steady-State Methods of Studying Rate Processes"", Journal of ElectroAnalytical Chemistry, vol. 10, 1965, pp. 295-305.;;Armour, J. C., et al., ""Application of Chronic Intravascular Blood Glucose Sensor in Dogs"", Diabetes, vol. 39, 1990, pp. 1519-1526.;;Asberg, P., et al., ""Hydrogels of a Conducting Conjugated Polymer as 3-D Enzyme Electrode"", Biosensors & Bioelectronics, vol. 19, 2003, pp. 199-207.;;Atanasov, P., et al., ""Biosensor for Continuous Glucose Monitoring"", Biotechnology and Bioengineering, vol. 43, 1994, pp. 262-266.;;Atanasov, P., et al., ""Implantation of a Refillable Glucose Monitoring-Telemetry Device"", Biosensors & Bioelectronics, vol. 12, No. 7, 1997, pp. 669-680.;;Aussedat, B., et al., ""A User-Friendly Method for Calibrating a Subcutaneous Glucose Sensor-Based Hypoglycaemic Alarm"", Biosensors & Bioelectronics, vol. 12, No. 11, 1997, pp. 1061-1071.;;Baker, D. A., et al., ""Dynamic Concentration Challenges for Biosensor Characterization"", Biosensors & Bioelectronics, vol. 8, 1993, pp. 433-441.;;Baker, D. A., et al., ""Dynamic Delay and Maximal Dynamic Error in Continuous Biosensors"", Analytical Chemistry, vol. 68, No. 8, 1996, pp. 1292-1297.;;Bani Amer, M. M., ""An Accurate Amperometric Glucose Sensor Based Glucometer with Eliminated Cross-Sensitivity"", Journal of Medical Engineering & Technology, vol. 26, No. 5, 2002, pp. 208-213.;;Bard, A. J., et al., Electrochemical Methods, 1980, pp. 173-175.;;Bartlett, P. N., et al., ""Covalent Binding of Electron Relays to Glucose Oxidase"", Journal of the Chemical Society, Chemical Communications, 1987, pp. 1603-1604.;;Bartlett, P. N., et al., ""Modification of Glucose Oxidase by Tetrathiafulvalene"", Journal of the Chemical Society, Chemical Communications, 1990, pp. 1135-1136.;;Bartlett, P. N., et al., ""Strategies for the Development of Amperometric Enzyme Electrodes"", Biosensors, vol. 3, 1987/88, pp. 359-379.;;Beach, R. D., et al., ""Subminiature Implantable Potentiostat and Modified Commercial Telemetry Device for Remote Glucose Monitoring"", IEEE Transactions on Instrumentation and Measurement, vol. 28, No. 6, 1999, pp. 1239-1245.;;Beech, W. A., ""AX.25 Link Access Protocol for Amateur packet Radio"", Tucson Amateur Packet Radio Corporation, 1998, pp. 1-133.;;Bellucci, F., et al., ""Electrochemical Behaviour of Graphite-Epoxy Composite Materials (GECM) in Aqueous Salt Solutions"", Journal of Applied Electrochemistry, vol. 16, 1986, pp. 15-22.;;Bennion, N., et al., ""Alternate Site Glucose Testing: A Crossover Design"", Diabetes Technology & Therapeutics, vol. 4, No. 1, 2002, pp. 25-33.;;Biermann, E., et al., ""How Would Patients Behave if They Were Continually Informed of Their Blood Glucose Levels? A Simulation Study Using a 'Virtual' Patient"", Diabetes Technology & Therapeutics, vol. 10, No. 3, 2008, pp. 178-187.;;Bindra, D. S., et al., ""Design and in Vitro Studies of a Needle-Type Glucose Sensor for Subcutaneous Monitoring"", Analytical Chemistry, vol. 63, No. 17, 1991, pp. 1692-1696.;;Bindra, D. S., et al., ""Pulsed Amperometric Detection of Glucose in Biological Fluids at a Surface-Modified Gold Electrode"", Analytical Chemistry, vol. 61, No. 22, 1989, pp. 2566-2570.;;Bisenberger, M., et al., ""A Triple-Step Potential Waveform at Enzyme Multisensors with Thick-Film Gold Electrodes for Detection of Glucose and Sucrose"", Sensors and Actuators B, vol. 28, 1995, pp. 181-189.;;Bland, J. M., et al., ""A Note on the Use of the Intraclass Correlation Coefficient in the Evaluation of Agreement Between Two Methods of Measurement"", Computers in Biology and Medicine, vol. 20, No. 5, 1990, pp. 337-340.;;Bland, J. M., et al., ""Statistical Methods for Assessing Agreement Between Two Methods of Clinical Measurement"", The Lancet, 1986, pp. 307-310.;;Blank, T. B., et al., ""Clinical Results From a Non-Invasive Blood Glucose Monitor"", Optical Diagnostics and Sensing of Biological Fluids and Glucose and Cholesterol Monitoring II, Proceedings of SPIE, vol. 4624, 2002, pp. 1-10.;;Bobbioni-Harsch, E., et al., ""Lifespan of Subcutaneous Glucose Sensors and Their Performances During Dynamic Glycaemia Changes in Rats"", Journal of Biomedical Engineering, vol. 15, 1993, pp. 457-463.;;Bode, B. W., ""Clinical Utility of the Continuous Glucose Monitoring System"", Diabetes Technology & Therapeutics, vol. 2, Sup. 1, 2000, pp. S35-S41.;;Bode, B. W., et al., ""Continuous Glucose Monitoring Used to Adjust Diabetes Therapy Improves Glycosylated Hemoglobin: A Pilot Study"", Diabetes Research and Clinical Practice, vol. 46, 1999, pp. 183-190.;;Bode, B. W., et al., ""Using the Continuous Glucose Monitoring System to Improve the Management of Type I Diabetes"", Diabetes Technology & Therapeutics, vol. 2, Sup. 1, 2000, pp. S43-S48.;;Boedeker Plastics, Inc., ""Polyethylene Specifications"", Web Page of Boedeker.com, 2007, pp. 1-3.;;Bolinder, J., et al., ""Microdialysis Measurement of the Absolute Glucose Concentration in Subcutaneous Adipose Tissue Allowing Glucose Monitoring in Diabetic Patients"", Diabetologia, vol. 35, 1992, pp. 1177-1180.;;Bolinder, J., et al., ""Self-Monitoring of Blood Glucose in Type I Diabetic Patients: Comparison with Continuous Microdialysis Measurements of Glucose in Subcutaneous Adipose Tissue During Ordinary Life Conditions"", Diabetes Care, vol. 20, No. 1, 1997, pp. 64-70.;;Bott, A. W., ""A Comparison of Cyclic Voltammetry and Cyclic Staircase Voltammetry"", Current Separations, vol. 16, No. 1, 1997, pp. 23-26.;;Bott, A. W., ""Electrochemical Methods for the Determination of Glucose"", Current Separations, vol. 17, No. 1, 1998, pp. 25-31.;;Bowman, L., et al., ""The Packaging of Implantable Integrated Sensors"", IEEE Transactions on Biomedical Engineering, vol. 33, No. 2, 1986, pp. 248-255.;;Brandt, J., et al., ""Covalent Attachment of Proteins to Polysaccharide Carriers by Means of Benzoquinone"", Biochimica et Biophysica Acta, vol. 386, 1975, pp. 196-202.;;Brauker, J., et al., ""Sustained Expression of High Levels of Human Factor IX from Human Cells Implanted Within an Immunoisolation Device into Athymic Rodents"", Human Gene Therapy, vol. 9, No. 6, 1998, pp. 879-888.;;Bremer, T. M., et al., ""Benchmark Data from the Literature for Evaluation of New Glucose Sensing Technologies"", Diabetes Technology & Therapeutics, vol. 3, No. 3, 2001, pp. 409-418.;;Bremer, T., et al., ""Is Blood Glucose Predictable from Previous Values?"", Diabetes, vol. 48, 1999, pp. 445-451.;;Brooks, S. L., et al., ""Development of an On-Line Glucose Sensor for Fermentation Monitoring"", Biosensors, vol. 3, 1987/88, pp. 45-56.;;Brownlee, M., et al., ""A Glucose-Controlled Insulin-Delivery System: Semisynthetic Insulin Bound to Lectin"", Science, vol. 206, 1979, 1190-1191.;;Cai, Q., et al., ""A Wireless, Remove Query Glucose Biosensor Based on a pH-Sensitive Polymer"", Analytical Chemistry, vol. 76, No. 14, 2004, pp. 4038-4043.",EXPIRED
158,US,A1,US 2009/0177055 A1,119-644-045-127-988,2009-07-09,2009,US 40542509 A,2009-03-17,US 40542509 A;;US 42005703 A;;US 66719900 A;;US 7067798 A,1998-04-30,Analyte Monitoring Device and Methods of Use,"An analyte monitor includes a sensor, a sensor control unit, and a display unit. The sensor has, for example, a substrate, a recessed channel formed in the substrate, and conductive material disposed in the recessed channel to form a working electrode. The sensor control unit typically has a housing adapted for placement on skin and is adapted to receive a portion of an electrochemical sensor. The sensor control unit also includes two or more conductive contacts disposed on the housing and configured for coupling to two or more contact pads on the sensor. A transmitter is disposed in the housing and coupled to the plurality of conductive contacts for transmitting data obtained using the sensor. The display unit has a receiver for receiving data transmitted by the transmitter of the sensor control unit and a display coupled to the receiver for displaying an indication of a level of an analyte. The analyte monitor may also be part of a drug delivery system to alter the level of the analyte based on the data obtained using the sensor.",ABBOTT DIABETES CARE INC,SAY JAMES;;TOMASCO MICHAEL F;;HELLER ADAM;;GAL YORAM;;ARIA BEHRAD;;HELLER EPHRAIM;;PLANTE PHILLIP JOHN;;VREEKE MARK S;;FRIEDMAN KEITH A;;COLMAN FEDRIC C,,https://lens.org/119-644-045-127-988,Patent Application,yes,1,57,211,221,0,A61B5/14532;;A61B5/14532;;A61B5/0002;;A61B5/0002;;A61B5/002;;A61B5/01;;A61B5/14503;;A61B5/1451;;A61B5/14546;;A61B5/14546;;A61B5/1473;;A61B5/1473;;A61B5/1486;;A61B5/1486;;A61B5/14865;;A61B5/1495;;A61B5/4839;;A61B5/72;;A61B5/7278;;A61B5/7282;;A61B5/7405;;A61B5/743;;A61B5/7445;;A61B5/7445;;A61B5/7455;;A61B2560/0252;;A61B2560/0252;;A61M5/1723;;C12Q1/54;;G16H10/40;;G16H10/40;;G16H20/17;;G16H20/17;;H01L23/3107;;H01L23/3107;;H01L23/49548;;H01L23/49548;;H01L2924/0002;;H01L2924/0002;;H01L2924/19041;;H01L2924/19041;;H01L2924/3011;;H01L2924/3011;;Y10S128/903;;Y10S128/903;;Y10T29/49;;Y10T29/49;;Y10T29/49124;;Y10T29/49124,A61B5/05;;G01N27/30;;A61B5/00;;A61B5/145;;A61B5/1477;;A61B5/1495;;G01N27/416;;G06F19/00;;H01L23/31;;H01L23/495,600/345,0,0,,,,DISCONTINUED
159,US,B2,US 8409131 B2,156-286-452-219-622,2013-04-02,2013,US 68339607 A,2007-03-07,US 68339607 A;;US 42005703 A;;US 66719900 A;;US 7067798 A,1998-04-30,Analyte monitoring device and methods of use,"An analyte monitor includes a sensor, a sensor control unit, and a display unit. The sensor has, for example, a substrate, a recessed channel formed in the substrate, and conductive material disposed in the recessed channel to form a working electrode. The sensor control unit typically has a housing adapted for placement on skin and is adapted to receive a portion of an electrochemical sensor. The sensor control unit also includes two or more conductive contacts disposed on the housing and configured for coupling to two or more contact pads on the sensor. A transmitter is disposed in the housing and coupled to the plurality of conductive contacts for transmitting data obtained using the sensor. The display unit has a receiver for receiving data transmitted by the transmitter of the sensor control unit and a display coupled to the receiver for displaying an indication of a level of an analyte. The analyte monitor may also be part of a drug delivery system to alter the level of the analyte based on the data obtained using the sensor.",SAY JAMES;;TOMASCO MICHAEL F;;HELLER ADAM;;GAL YORAM;;BEHRAD ARIA;;HELLER EPHRAIM;;PLANTE PHILLIP JOHN;;VREEKE MARK S;;FRIEDMAN KEITH A;;COLMAN FREDRIC C;;ABBOTT DIABETES CARE INC,SAY JAMES;;TOMASCO MICHAEL F;;HELLER ADAM;;GAL YORAM;;BEHRAD ARIA;;HELLER EPHRAIM;;PLANTE PHILLIP JOHN;;VREEKE MARK S;;FRIEDMAN KEITH A;;COLMAN FREDRIC C,E. HELLER & CO (1998-07-02);;ABBOTT DIABETES CARE INC (2000-03-13),https://lens.org/156-286-452-219-622,Granted Patent,yes,114,21,211,221,0,A61B5/14532;;A61B5/14532;;A61B5/0002;;A61B5/0002;;A61B5/002;;A61B5/01;;A61B5/14503;;A61B5/1451;;A61B5/14546;;A61B5/14546;;A61B5/1473;;A61B5/1473;;A61B5/1486;;A61B5/1486;;A61B5/14865;;A61B5/1495;;A61B5/4839;;A61B5/72;;A61B5/7278;;A61B5/7282;;A61B5/7405;;A61B5/743;;A61B5/7445;;A61B5/7445;;A61B5/7455;;A61B2560/0252;;A61B2560/0252;;A61M5/1723;;C12Q1/54;;G16H10/40;;G16H10/40;;G16H20/17;;G16H20/17;;H01L23/3107;;H01L23/3107;;H01L23/49548;;H01L23/49548;;H01L2924/0002;;H01L2924/0002;;H01L2924/19041;;H01L2924/19041;;H01L2924/3011;;H01L2924/3011;;Y10S128/903;;Y10S128/903;;Y10T29/49;;Y10T29/49;;Y10T29/49124;;Y10T29/49124,A61M31/00;;G01N27/30;;A61B5/00;;A61B5/145;;A61B5/1477;;A61B5/1495;;G01N27/416;;G06F19/00;;H01L23/31;;H01L23/495,604/65;;604/504;;600/365,99,83,136-791-935-548-81X;;062-360-289-025-864;;010-601-725-111-91X;;101-292-518-663-191;;056-703-879-057-297;;030-155-762-644-019;;004-149-141-436-651;;016-731-054-793-457;;080-559-561-995-335;;044-807-213-528-815;;027-538-525-436-179;;015-020-161-517-40X;;025-919-454-564-785;;014-700-576-603-812;;004-851-060-590-788;;052-356-140-149-389;;033-562-815-299-181;;018-803-926-589-211;;008-505-762-041-402;;016-601-143-530-813;;019-502-772-562-215;;058-476-824-396-350;;006-498-707-073-30X;;054-091-551-638-293;;010-531-147-771-746;;054-827-198-877-419;;122-658-944-077-000;;017-261-560-469-37X;;000-125-755-474-124;;113-381-664-783-802;;082-626-907-191-554;;017-950-014-792-456;;090-348-305-613-628;;015-985-399-299-132;;171-049-047-164-618;;081-249-097-078-543;;089-612-747-111-646;;031-706-897-890-035;;094-198-536-559-723;;003-690-143-043-420;;007-943-354-378-456;;082-114-500-909-975;;004-239-090-971-580;;026-894-457-160-450;;077-128-610-778-669;;022-466-506-956-898;;008-424-592-956-946;;007-500-825-916-378;;009-725-244-669-882;;037-755-689-613-42X;;153-411-506-517-475;;012-449-714-188-064;;031-517-704-996-130;;131-299-284-996-064;;049-133-049-742-708;;000-272-178-768-076;;070-797-683-833-124;;043-870-224-178-49X;;052-364-430-129-757;;004-434-167-910-115;;032-860-147-271-886;;132-460-374-211-421;;098-172-374-375-47X;;014-988-634-483-130;;061-786-187-274-992;;037-898-018-686-909;;130-044-667-529-69X;;134-265-642-839-645;;065-221-074-461-027;;017-934-465-161-477;;101-660-130-379-529;;028-236-706-290-220;;087-333-189-994-274;;059-082-211-027-266;;057-977-752-782-568;;022-511-780-866-588;;017-782-200-698-498;;031-911-801-211-572;;023-255-236-083-738;;047-840-238-307-748;;015-212-015-297-572;;091-416-302-291-908;;056-662-192-844-472,10.1016/s0956-5663(02)00099-4;;12392956;;10.1021/ja00391a001;;2889225;;10.1098/rstb.1987.0021;;10.1109/51.294001;;10.1016/0022-0728(65)85063-x;;2245876;;10.2337/diabetes.39.12.1519;;10.2337/diab.39.12.1519;;10.1016/s0956-5663(03)00220-3;;14611755;;18615658;;10.1002/bit.260430310;;9366023;;10.1016/s0956-5663(97)00025-0;;9451795;;10.1016/s0956-5663(97)00083-3;;10.1016/0956-5663(93)80028-n;;8311939;;8651496;;10.1021/ac960030d;;10.1080/03091900210156797;;12487712;;10.1016/0265-928x(87)80018-4;;3333622;;10.1109/19.816143;;10.1089/15209150252924058;;12017416;;10.1021/ac00017a008;;1789439;;2817408;;10.1021/ac00197a022;;10.1016/0925-4005(95)01730-5;;10.1016/0010-4825(90)90013-f;;2257734;;2868172;;8277748;;10.1016/0141-5425(93)90058-7;;11469630;;10.1089/15209150050214104;;10624783;;10.1016/s0168-8227(99)00113-8;;10.1089/15209150050214113;;11469631;;10.1007/bf00401374;;1478372;;10.2337/diacare.20.1.64;;9028696;;10.1109/tbme.1986.325807;;3957374;;236018;;10.1016/0005-2795(75)90259-7;;10.1089/hum.1998.9.6-879;;9581910;;11762520;;10.1089/15209150152607196;;10.2337/diabetes.48.3.445;;10078542;;10.1016/0265-928x(87)80012-3;;505005;;10.1126/science.505005;;10.1021/ac0498516;;15253640;;6721151;;10.1021/ac00268a018;;6733082;;10.1021/bi00305a016;;10.1515/cclm.2002.135;;12392305;;10.1016/j.ecl.2003.12.001;;15053902;;12052350;;10.1016/s0956-5663(01)00304-9;;12052349;;10.1016/s0956-5663(01)00306-2;;4500021;;10.1007/978-1-4684-3288-6_18;;14021529;;10.1111/j.1749-6632.1962.tb13623.x;;3196517;;10.2337/diacare.10.5.622;;3677983;;10.2337/diacare.8.6.529;;4075939;;10.1002/elan.1140061103;;7733469;;10.1021/ac00103a015;;7978306;;10.1021/ac00091a022;;10.1007/bf01248238;;10.1016/s0376-7388(98)00330-5;;10.1016/0265-928x(85)80002-x;;10.1021/j100290a001;;10.1021/ja00216a040;;10.1021/ja00188a091;;10.1021/ja00406a011;;2624333;;12323417;;10.1016/s0165-0270(02)00170-x;;10.1021/ja00415a014;;10.1007/bf00575392;;10.1021/ac00250a038;;10.1021/ac00266a005;;10.1007/s00216-002-1284-0;;12194035;;9642777;;10.1016/s0956-5663(97)00091-2;;10.1089/152091503322526978;;14633342;;10.1016/0022-0728(85)87006-6;;10.1021/ja00434a018;;10.1016/0003-2697(92)90243-z;;1443528;;10.1039/f19868201259;;3245585;;10.1021/ac00173a008;;2889234;;10.1098/rstb.1987.0020;;11762521;;10.1089/15209150152607204;;12413548;;10.1016/s1367-5931(02)00371-x;;10526740;;10.2337/diacare.22.10.1708;;14988294;;10.2337/diacare.27.3.734;;10.1111/j.1749-6632.1997.tb52216.x;;9616733;;10868819;;10.2337/diacare.23.2.143;;10.1002/1097-4636(200101)54:1<69::aid-jbm8>3.0.co;2-q;;11077404;;10.1002/1097-4636(200101)54:1<69::aid-jbm8>3.3.co;2-h;;10.1016/s0300-2977(99)00006-6;;10218387;;10.2337/diacare.17.8.882;;7956636;;15198842;;10.1089/152091504774198089;;10.1042/cs20000250;;10.1042/cs1010001;;11410108;;10.1016/0003-2670(91)85072-z,"Abel, P. U., et al., ""Biosensors for In Vivo Glucose Measurement: Can We Cross the Experimental Stage"", Biosensors and Bioelectronics, vol. 17, 2002, pp. 1059-1070.;;Abruna, H. D., et al., ""Rectifying Interfaces Using Two-Layer Films of Electrochemically Polymerized Vinylpyridine and Vinylbipyridine Complexes of Ruthenium and Iron on Electrodes"", Journal of the American Chemical Society, vol. 103, No. 1, 1981, pp. 1-5.;;Albery, W. J., et al., ""Amperometric Enzyme Electrodes Part II: Conducting Salts as Electrode Materials for the Oxidation of Glucose Oxidase"", Journal of ElectroAnalytical Chemistry, vol. 194, 1985, pp. 223-235.;;Albery, W. J., et al., ""Amperometric Enzyme Electrodes"", Philosophical Transactions of The Royal Society of London, vol. 316, 1987, pp. 107-119.;;Alcock, S. J., et al., ""Continuous Analyte Monitoring to Aid Clinical Practice"", IEEE Engineering in Medicine and Biology Magazine, 1994, pp. 319-325.;;Anderson, L. B., et al., ""Thin-Layer Electrochemistry: Steady-State Methods of Studying Rate Processes"", Journal of ElectroAnalytical Chemistry, vol. 10, 1965, pp. 295-305.;;Armour, J. C., et al., ""Application of Chronic Intravascular Blood Glucose Sensor in Dogs"", Diabetes, vol. 39, 1990, pp. 1519-1526.;;Asberg, P., et al., ""Hydrogels of a Conducting Conjugated Polymer as 3-D Enzyme Electrode"", Biosensors & Bioelectronics, vol. 19, 2003, pp. 199-207.;;Atanasov, P., et al., ""Biosensor for Continuous Glucose Monitoring"", Biotechnology and Bioengineering, vol. 43, 1994, pp. 262-266.;;Atanasov, P., et al., ""Implantation of a Refillable Glucose Monitoring-Telemetry Device"", Biosensors & Bioelectronics, vol. 12, No. 7, 1997, pp. 669-680.;;Aussedat, B., et al., ""A User-Friendly Method for Calibrating a Subcutaneous Glucose Sensor-Based Hypoglycaemic Alarm"", Biosensors & Bioelectronics, vol. 12, No. 11, 1997, pp. 1061-1071.;;Baker, D. A., et al., ""Dynamic Concentration Challenges for Biosensor Characterization"", Biosensors & Bioelectronics, vol. 8, 1993, pp. 433-441.;;Baker, D. A., et al., ""Dynamic Delay and Maximal Dynamic Error in Continuous Biosensors"", Analytical Chemistry, vol. 68, No. 8, 1996, pp. 1292-1297.;;Bani Amer, M. M., ""An Accurate Amperometric Glucose Sensor Based Glucometer with Eliminated Cross-Sensitivity"", Journal of Medical Engineering & Technology, vol. 26, No. 5, 2002, pp. 208-213.;;Bard, A. J., et al., Electrochemical Methods, 1980, pp. 173-175.;;Bartlett, P. N., et al., ""Covalent Binding of Electron Relays to Glucose Oxidase"", Journal of the Chemical Society, Chemical Communications, 1987, pp. 1603-1604.;;Bartlett, P. N., et al., ""Modification of Glucose Oxidase by Tetrathiqfulvalen"", Journal of the Chemical Society, Chemical Communications, 1990, pp. 1135-1136.;;Bartlett, P. N., et al., ""Strategies for the Development of Amperometric Enzyme Electrodes"", Biosensors, vol. 3, 1987/1988, pp. 359-379.;;Beach, R. D., et al., ""Subminiature Implantable Potentiostat and Modified Commercial Telemetry Device for Remote Glucose Monitoring"", IEEE Transactions on Instrumentation and Measurement, vol. 28, No. 28, No. 6, 1999, pp. 1239-1245.;;Beech, W. A., ""AX.25 Link Access Protocol for Amateur packet Radio"", Tucson Amateur Packet Radio Corporation, 1998, pp. 1-133.;;Bennion, N., et al., ""Alternate Site Glucose Testing: A Crossover Design"", Diabetes Technology & Therapeutics, vol. 4, No. 1, 2002, pp. 25-33.;;Bindra, D. S., et al., ""Design and in Vitro Studies of a Needle-Type Glucose Sensor for Subcutaneous Monitoring"", Analytical Chemistry, vol. 63, No. 17, 1991, pp. 1692-1696.;;Bindra, D. S., et al., ""Pulsed Amperometric Detection of Glucose in Biological Fluids at a Surface-Modified Gold Electrode"", Analytical Chemistry, vol. 61, No. 22, 1989, pp. 2566-2570.;;Bisenberger, M., et al., ""A Triple-Step Potential Waveform at Enzyme Multisensors with Thick-Film Gold Electrodes for Detection of Glucose and Sucrose"", Sensors and Actuators B9, vol. 28, 1995, pp. 181-189.;;Bland, J. M., et al., ""A Note on the Use of the Intraclass Correlation Coefficient in the Evaluation of Agreement Between Two Methods of Measurement"", Computers in Biology and Medicine, vol. 20, No. 5, 1990, pp. 337-340.;;Bland, J. M., et al., ""Statistical Methods for Assessing Agreement Between Two Methods of Clinical Measurement"", The Lancet, 1986, pp. 307-310.;;Blank, T. B., et al., ""Clinical Results From a Non-Invasive Blood Glucose Monitor"", Optical Diagnostics and Sensing of Biological Fluids and Glucose and Cholesterol Monitoring II, Proceedings of SPIE, vol. 4624, 2002, pp. 1-10.;;Bobbioni-Harsch, E., et al., ""Lifespan of Subcutaneous Glucose Sensors and Their Performances During Dynamic Glycaemia Changes in Rats"", Journal of Biomedical Engineering, vol. 15, 1993, pp. 457-463.;;Bode, B. W., ""Clinical Utility of the Continuous Glucose Monitoring System"", Diabetes Technology & Therapeutics, vol. 2, Sup. 1, 2000, pp. S35-S41.;;Bode, B. W., et al., ""Continuous Glucose Monitoring Used to Adjust Diabetes Therapy Improves Glycosylated Hemoglobin: A Pilot Study"", Diabetes Research and Clinical Practice, vol. 46, 1999, pp. 183-190.;;Bode, B. W., et al., ""Using the Continuous Glucose Monitoring System to Improve the Management of Type I Diabetes"", Diabetes Technology & Therapeutics, vol. 2, Sup. 1, 2000, pp. S43-S48.;;Boedeker Plastics, Inc., ""Polyethylene Specifications"", Web Page of Boedeker.com, 2007, pp. 1-3.;;Bolinder, J., et al., ""Microdialysis Measurement of the Absolute Glucose Concentration in Subcutaneous Adipose Tissue Allowing Glucose Monitoring in Diabetic Patients"", Diabetologia, vol. 35, 1992, pp. 1177-1180.;;Bolinder, J., et al., ""Self-Monitoring of Blood Glucose in Type I Diabetic Patients: Comparison with Continuous Microdialysis Measurements of Glucose in Subcutaneous Adipose Tissue During Ordinary Life Conditions"", Diabetes Care, vol. 20, No. 1, 1997, pp. 64-70.;;Bott, A. W., ""A Comparison of Cyclic Voltammetry and Cyclic Staircase Voltammetry"", Current Separations, vol. 16, No. 1, 1997, pp. 23-26.;;Bott, A. W., ""Electrochemical Methods for the Determination of Glucose"", Current Separations, vol. 17, No. 1, 1998, pp. 25-31.;;Bowman, L., et al., ""The Packaging of Implantable Integrated Sensors"", IEEE Transactions on Biomedical Engineering, vol. 33, No. 2, 1986, pp. 248-255.;;Brandt, J., et al., ""Covalent Attachment of Proteins to Polysaccharide Carriers by Means of Benzoquinone"", Biochimica et Biophysica Acta, vol. 386, 1975, pp. 196-202.;;Brauker, J., et al., ""Sustained Expression of High Levels of Human Factor IX from Human Cells Implanted Within an Immunoisolation Device into Athymic Rodents"", Human Gene Therapyvol. 9, No. 6, 1998, pp. 879-888.;;Bremer, T. M., et al., ""Benchmark Data from the Literature for Evaluation of New Glucose Sensing Technologies"", Diabetes Technology & Therapeutics, vol. 3, No. 3, 2001, pp. 409-418.;;Bremer, T., et al., ""Is Blood Glucose Predictable from Previous Values?"", Diabetes, vol. 48, 1999, pp. 445-451.;;Brooks, S. L., et al., ""Development of an On-Line Glucose Sensor for Fermentation Monitoring"", Biosensors, vol. 3, 1987/1988, pp. 45-56.;;Brownlee, M., et al., ""A Glucose-Controlled Insulin-Delivery System: Semisynthetic Insulin Bound to Lectin"", Science, vol. 206, 1979, 1190-1191.;;Cai, Q., et al., ""A Wireless, Remove Query Glucose Biosensor Based on a pH-Sensitive Polymer"", Analytical Chemistry, vol. 76, No. 14, 2004, pp. 4038-4043.;;Cass, A. E., et al., ""Ferricinum Ion As An Electron Acceptor for Oxido-Reductases"", Journal of ElectroAnalytical Chemistry, vol. 190, 1985, pp. 117-127.;;Cass, A. E., et al., ""Ferrocene-Medicated Enzyme Electrode for Amperometric Determination of Glucose"", Analytical Chemistry, vol. 56, No. 4, 1984, 667-671.;;Castner, J. F., et al., ""Mass Transport and Reaction Kinetic Parameters Determined Electrochemically for Immobilized Glucose Oxidase"", Biochemistry, vol. 23 No. 10, 1984, 2203-2210.;;Chen, J. C., et al., ""A Comparison of MAC Protocols for Wireless Local Networks Based on battery Power Consumption"", IEEE, 1998, pp. 150-157.;;Chen, T., et al., ""Defining the Period of Recovery of the Glucose Concentration After Its Local Perturbation by the Implantation of a Miniature Sensor"", Clinical Chemistry and Laboratory Medicine, vol. 40, No. 8, 2002, pp. 486-489.;;Chia, C. W., et al., ""Glucose Sensors: Toward Closed Loop Insulin Delivery"", Endocrinology and Metabolism Clinics of North America, vol. 33, 2004, pp. 175-195.;;Choleau, C., et al., ""Calibration of a Subcutaneous Amperometric Glucose Sensor Implanted for 7 Days in Diabetic Patients Part 2: Superiority of the One-Point Calibration Method"", Biosensors and Bioelectronics, vol. 17, 2002, pp. 647-654.;;Choleau, C., et al., ""Calibration of a Subcutaneous Amperometric Glucose Sensor Part 1: Effect of Measurement Uncertainties on the Determination of Sensor Sensitivity and Background Current"", Biosensors and Bioelectronics, vol. 17, 2002, pp. 641-646.;;Claremont, D. J., et al., ""Biosensors for Continuous In Vivo Glucose Monitoring"", Proceedings of the Annual International Conference of the IEEE Engineering in Medicine and Biology Society, vol. 10, 1988.;;Clark Jr., L. C., et al., ""Differential Anodic Enzyme Polarography for the Measurement of Glucose"", Oxygen Transport to Tissue: Instrumentation, Methods, and Physiology, 1973, pp. 127-133.;;Clark Jr., L. C., et al., ""Electrode Systems for Continuous Monitoring in Cardiovascular Surgery"", Annals New York Academy of Sciences, 1962, pp. 29-45.;;Clark Jr., L. C., et al., ""Long-term Stability of Electroenzymatic Glucose Sensors Implanted in Mice"", American Society of Artificial Internal Organs Transactions, vol. XXXIV, 1988, pp. 259-265.;;Clarke, W. L., et al., ""Evaluating Clinical Accuracy of Systems for Self-Monitoring of Blood Glucose"", Diabetes Care, vol. 10, No. 5, 1987, pp. 622-628.;;Complaint, ""Abbott Diabetes Care, Inc. v. Dexcom, Inc."", filed Aug. 11, 2005.;;Complaint, Amended, ""Abbott Diabetes Care, Inc. v. Dexcom, Inc."", filed Jun. 27, 2006.;;Cox, D. J., et al., ""Accuracy of Perceiving Blood Glucose in IDDM"", Diabetes Care, vol. 8, No. 6, 1985, pp. 529-536.;;Csoregi, E., et al., ""Amperometric Microbiosensors for Detection of Hydrogen Peroxide and Glucose Based on Peroxidase-Modified Carbon Fibers"", Electroanalysis, vol. 6, 1994, pp. 925-933.;;Csoregi, E., et al., ""Design and Optimization of a Selective Subcutaneously Implantable Glucose Electrode Based on 'Wired' Glucose Oxidase"", Analytical Chemistry, vol. 67, No. 7, 1995, pp. 1240-1244.;;Csoregi, E., et al., ""Design, Characterization, and One-Point in Vivo Calibration of a Subcutaneously Implanted Glucose Electrode"", Analytical Chemistry, vol. 66 No. 19, 1994, pp. 3131-3138.;;Csoregi, E., et al., ""On-Line Glucose Monitoring by Using Microdialysis Sampling and Amperometric Detection Based on 'Wired' Glucose Oxidase in Carbon Paste"", Mikrochimica Acta, vol. 121, 1995, pp. 31-40.;;D'Arrigo, G., et al., ""Porous-Si Based Bio Reactors for Glucose Monitoring and Drugs Production"", Proceedings of SPIE: Microfluids, BioMEMS, and Medical Microsystems, vol. 4982, 2003, pp. 178-184.;;Dai, W. S., et al., ""Hydrogel Membranes with Mesh Size Asymmetry Based on the Gradient Crosslinking of Poly(vinyl alcohol),"" Journal of Membrane Science, vol. 156, 1999, pp. 67-79.;;Davis, G., ""Electrochemical Techniques for the Development of Amperometric Biosensors"", Biosensors, vol. 1, 1985, pp. 161-178.;;Degani, Y., et al., ""Direct Electrical Communication Between Chemically Modified Enzymes and Metal Electrodes. 1. Electron Transfer from Glucose Oxidase to Metal Electrodes via Electron Relays, Bound Covalently to the Enzyme"", The Journal of Physical Chemistry, vol. 91, No. 6, 1987, pp. 1285-1289.;;Degani, Y., et al., ""Direct Electrical Communication Between Chemically Modified Enzymes and Metal Electrodes. 2. Methods for Bonding Electron-Transfer Relays to Glucose Oxidase and D-Amino-Acid Oxidase"", Journal of the American Chemical Society, vol. 110, No. 8, 1988, pp. 2615-2620.;;Degani, Y., et al., ""Electrical Communication Between Redox Centers of Glucose Oxidase and Electrodes via Electrostatically and Covalently Bound Redox Polymers"", Journal of the American Chemical Society, vol. 111, 1989, pp. 2357-2358.;;Denisevich, P., et al., ""Unidirectional Current Flow and Charge State Trapping at Redox Polymer Interfaces on Bilayer Electrodes: Principles, Experimental Demonstration, and Theory"", Journal of the American Chemical Society, vol. 103, 1981, pp. 4727-4737.;;Dicks, J. M., et al., ""Ferrocene Modified Polypyrrole with Immobilised Glucose Oxidase and its Application in Amperometric Glucose Microbiosensors"", Annales de Biologie Clinique, vol. 47, 1989, pp. 607-619.;;Dixon, B. M., et al., ""Characterization In Vitro and In Vivo of the Oxygen Dependence of an Enzyme/Polymer Biosensors for Monitoring Brain Glucose"", Journal of Neuroscience Methods, vol. 119, 2002, pp. 135-142.;;Ellis, C. D., et al., ""Selectivity and Directed Charge Transfer through an Electroactive Metallopolymer Film"", Journal of the American Chemical Society, vol. 103, No. 25, 1981, pp. 7480-7483.;;El-Sa'Ad, L., et al., ""Moisture Absorption by Epoxy Resins: The Reverse Thermal Effect"", Journal of Materials Science, vol. 25, No. 8, 1990, pp. 3577-3582.;;Engstrom, R. C., ""Electrochemical Pretreatment of Glassy Carbon Electrodes"", Analytical Chemistry, vol. 54, No. 13, 1982, pp. 2310-2314.;;Engstrom, R. C., et al., ""Characterization of Electrochemically Pretreated Glassy Carbon Electrodes"", Analytical Chemistry, vol. 56, No. 2, 1984, pp. 136-141.;;Ernst, H., et al., ""Reliable Glucose Monitoring Through the Use of Microsystem Technology"", Analytical and Bioanalytical Chemistry, vol. 373, 2002, pp. 758-761.;;Fare, T. L., et al., ""Functional Characterization of a Conducting Polymer-Based Immunoassay System"", Biosensors & Bioelectronics, vol. 13, No. 3-4, 1998, pp. 459-470.;;Feldman, B., et al., ""A Continuous Glucose Sensor Based on Wired Enzyme(TM) Technology-Results from a 3-Day Trial in Patients with Type 1 Diabetes"", Diabetes Technology & Therapeutics, vol. 5, No. 5, 2003, pp. 769-779.;;Feldman, B., et al., ""Correlation of Glucose Concentrations in Interstitial Fluid and Venous Blood During Periods of Rapid Glucose Change"", Abbott Diabetes Care, Inc. Freestyle Navigator Continuous Glucose Monitor Pamphlet.;;Feldman, B., et al., ""Electron Transfer Kinetics at Redox Polymer/Solution Interfaces Using Microelectrodes and Twin Electrode Thin Layer Cells"", Journal of ElectroAnalytical Chemistry, vol. 194, 1985, pp. 63-81.;;Fischer, H., et al., ""Intramolecular Electron Transfer Medicated by 4,4'-Bypyridine and Related Bridging Groups"", Journal of the American Chemical Society, vol. 98, No. 18, 1976, pp. 5512-5517.;;Flentge, F., et al., ""An Enzyme-Reactor for Electrochemical Monitoring of Choline and Acetylcholine: Applications in High-Performance Liquid Chromatography, Bran Tissue, Microdialysis and Cerebrospinal Fluid,"" Analytical Biochemistry, vol. 204, 1992, pp. 305-310.;;Foulds, N. C., et al., ""Enzyme Entrapment in Electrically Conducting Polymers: Immobilisation of Glucose Oxidase in Polypyrrole and its Application in Amperometric Glucose Sensors"", Journal of the Chemical Society, Faraday Transactions 1, vol. 82, 1986, pp. 1259-1264.;;Foulds, N. C., et al , ""Immobilization of Glucose Oxidase in Ferrocene-Modified Pyrrole Polymers"", Analytical Chemistry, vol. 60, No. 22, 1988, pp. 2473-2478.;;Frew, J. E., et al., ""Electron-Transfer Biosensors"", Philosophical Transactions of The Royal Society of London, vol. 316, 1987, pp. 95-106.;;Frohnauer, M. K., et al., ""Graphical Human Insulin Time-Activity Profiles Using Standardized Definitions"", Diabetes Technology & Therapeutics, vol. 3, No. 3, 2001, pp. 419-429.;;Frost, M. C., et al., ""Implantable Chemical Sensors for Real-Time Clinical Monitoring: Progress and Challenges"", Current Opinion in Chemical Biology, vol. 6, 2002, pp. 633-641.;;Garg, S. K., et al., ""Correlation of Fingerstick Blood Glucose Measurements with GlucoWatch Biographer Glucose Results in Young Subjects with Type 1 Diabetes"", Diabetes Care, vol. 22, No. 10, 1999, pp. 1708-1714.;;Garg, S. K., et al., ""Improved Glucose Excursions Using an Implantable Real-Time Continuous Glucose Sensor in Adults with Type 1 Diabetes"", Diabetes Care, vol. 27, No. 3, 2004, pp. 734-738.;;Geller, R. L., et al., ""Use of an Immunoisolation Device for Cell Transplantation and Tumor Immunotherapy"", Annals of the New York Academy of Sciences, vol. 831, 1997, pp. 438-451.;;Gerritsen, M., ""Problems Associated with Subcutaneously Implanted Glucose Sensors"", Diabetes Care, vol. 23, No. 2, 2000, pp. 143-145.;;Gerritsen, M., et al., ""Influence of Inflammatory Cells and Serum on the Performance of Implantable Glucose Sensors"", Journal of Biomedical materials Research, vol. 54, 2001, pp. 69-75.;;Gerritsen, M., et al., ""Performance of Subcutaneously Implanted glucose Sensors for Continuous Monitoring"", The Netherlands Journal of Medicine, vol. 54, 1999, pp. 167-179.;;Gilligan, B. J., ""et al., Evaluation of a Subcutaneous Glucose Sensor Out to 3 Months in a Dog Model"", Diabetes Care, vol. 17, No. 8, 1994, pp. 882-887.;;Gilligan, B. J., et al., ""Feasibility of Continuous Long-Term Glucose Monitoring from a Subcutaneous Glucose Sensor in Humans"", Diabetes Technology & Therapeutics, vol. 6, No. 3, 2004, pp. 378-386.;;Godsland, I. F., et al., ""Maximizing the Success Rate of Minimal Model Insulin Sensitivity Measurement in Humans: The Importance of Basal Glucose Levels,"" Clinical Science, vol. 101, 2001, pp. 1-9.;;Gorton, L., et al., ""Selective Detection in Flow Analysis Based on the Combination of Immobilized Enzymes and Chemically Modified Electrodes"", Analytica Chimica Acta, vol. 250, 1991, pp. 203-248.",EXPIRED
160,US,A1,US 2007/0161880 A1,148-239-117-368-581,2007-07-12,2007,US 69082607 A,2007-03-24,US 69082607 A;;US 42005703 A;;US 66719900 A;;US 7067798 A,1998-04-30,Analyte Monitoring Device and Methods of Use,"An analyte monitor includes a sensor, a sensor control unit, and a display unit. The sensor has, for example, a substrate, a recessed channel formed in the substrate, and conductive material disposed in the recessed channel to form a working electrode. The sensor control unit typically has a housing adapted for placement on skin and is adapted to receive a portion of an electrochemical sensor. The sensor control unit also includes two or more conductive contacts disposed on the housing and configured for coupling to two or more contact pads on the sensor. A transmitter is disposed in the housing and coupled to the plurality of conductive contacts for transmitting data obtained using the sensor. The display unit has a receiver for receiving data transmitted by the transmitter of the sensor control unit and a display coupled to the receiver for displaying an indication of a level of an analyte. The analyte monitor may also be part of a drug delivery system to alter the level of the analyte based on the data obtained using the sensor.",ABBOTT DIABETES CARE INC,SAY JAMES;;TOMASCO MICHAEL F;;HELLER ADAM;;GAL YORAM;;ARIA BEHRAD;;HELLER EPHRAIM;;PLANTE PHILLIP J;;VREEKE MARK S;;FRIEDMAN KEITH A;;COLMAN FREDRIC C,E. HELLER & CO (1998-07-02);;ABBOTT DIABETES CARE INC (2000-03-13),https://lens.org/148-239-117-368-581,Patent Application,yes,100,61,211,221,0,A61B5/14532;;A61B5/14532;;A61B5/0002;;A61B5/0002;;A61B5/002;;A61B5/01;;A61B5/14503;;A61B5/1451;;A61B5/14546;;A61B5/14546;;A61B5/1473;;A61B5/1473;;A61B5/1486;;A61B5/1486;;A61B5/14865;;A61B5/1495;;A61B5/4839;;A61B5/72;;A61B5/7278;;A61B5/7282;;A61B5/7405;;A61B5/743;;A61B5/7445;;A61B5/7445;;A61B5/7455;;A61B2560/0252;;A61B2560/0252;;A61M5/1723;;C12Q1/54;;G16H10/40;;G16H10/40;;G16H20/17;;G16H20/17;;H01L23/3107;;H01L23/3107;;H01L23/49548;;H01L23/49548;;H01L2924/0002;;H01L2924/0002;;H01L2924/19041;;H01L2924/19041;;H01L2924/3011;;H01L2924/3011;;Y10S128/903;;Y10S128/903;;Y10T29/49;;Y10T29/49;;Y10T29/49124;;Y10T29/49124,A61B5/05;;G01N27/30;;A61B5/00;;A61B5/145;;A61B5/1477;;A61B5/1495;;G01N27/416;;G06F19/00;;H01L23/31;;H01L23/495,600/345;;600/347,0,0,,,,EXPIRED
161,US,B2,US 8672844 B2,188-997-836-644-005,2014-03-18,2014,US 78977604 A,2004-02-27,US 78977604 A;;US 42005403 A;;US 66719900 A;;US 7067798 A,1998-04-30,Analyte monitoring device and methods of use,"An analyte monitor includes a sensor, a sensor control unit, and a display unit. The sensor has, for example, a substrate, a recessed channel formed in the substrate, and conductive material disposed in the recessed channel to form a working electrode. The sensor control unit typically has a housing adapted for placement on skin and is adapted to receive a portion of an electrochemical sensor. The sensor control unit also includes two or more conductive contacts disposed on the housing and configured for coupling to two or more contact pads on the sensor. A transmitter is disposed in the housing and coupled to the plurality of conductive contacts for transmitting data obtained using the sensor. The display unit has a receiver for receiving data transmitted by the transmitter of the sensor control unit and a display coupled to the receiver for displaying an indication of a level of an analyte. The analyte monitor may also be part of a drug delivery system to alter the level of the analyte based on the data obtained using the sensor.",SAY JAMES;;TOMASCO MICHAEL F;;HELLER ADAM;;GAL YORAM;;ARIA BEHRAD;;HELLER EPHRAIM;;PLANTE PHILLIP JOHN;;VREEKE MARK S;;FRIEDMAN KEITH A;;COLMAN FREDRIC C;;ABBOTT DIABETES CARE INC,SAY JAMES;;TOMASCO MICHAEL F;;HELLER ADAM;;GAL YORAM;;ARIA BEHRAD;;HELLER EPHRAIM;;PLANTE PHILLIP JOHN;;VREEKE MARK S;;FRIEDMAN KEITH A;;COLMAN FREDRIC C,E. HELLER & CO (1998-07-02);;ABBOTT DIABETES CARE INC (2000-03-13),https://lens.org/188-997-836-644-005,Granted Patent,yes,125,4,7,7,0,A61B5/14532;;A61B5/14532;;A61B5/0002;;A61B5/0002;;A61B5/14546;;A61B5/14546;;A61B5/7445;;A61B5/7445;;G16H15/00;;G16H15/00;;G16H40/67;;G16H40/67;;H01L23/3107;;H01L23/3107;;H01L23/49548;;H01L23/49548;;H01L24/48;;H01L24/48;;H01L2224/48091;;H01L2224/48091;;H01L2224/48247;;H01L2224/48247;;H01L2924/00014;;H01L2924/00014;;H01L2924/01012;;H01L2924/01012;;H01L2924/12042;;H01L2924/12042;;H01L2924/14;;H01L2924/14;;H01L2924/181;;H01L2924/181;;H01L2924/19041;;H01L2924/19041;;H01L2924/3011;;H01L2924/3011;;Y02A90/10;;Y02A90/10,A61B5/00;;G01N27/30;;A61B5/145;;A61B5/1477;;A61B5/1495;;G01N27/416;;H01L23/31;;H01L23/495,600/365,99,74,136-791-935-548-81X;;062-360-289-025-864;;010-601-725-111-91X;;101-292-518-663-191;;056-703-879-057-297;;030-155-762-644-019;;004-149-141-436-651;;016-731-054-793-457;;080-559-561-995-335;;044-807-213-528-815;;027-538-525-436-179;;015-020-161-517-40X;;025-919-454-564-785;;014-700-576-603-812;;004-851-060-590-788;;052-356-140-149-389;;033-562-815-299-181;;018-803-926-589-211;;008-505-762-041-402;;016-601-143-530-813;;019-502-772-562-215;;058-476-824-396-350;;006-498-707-073-30X;;054-091-551-638-293;;010-531-147-771-746;;054-827-198-877-419;;122-658-944-077-000;;017-261-560-469-37X;;000-125-755-474-124;;113-381-664-783-802;;082-626-907-191-554;;017-950-014-792-456;;090-348-305-613-628;;015-985-399-299-132;;171-049-047-164-618;;081-249-097-078-543;;089-612-747-111-646;;031-706-897-890-035;;094-198-536-559-723;;003-690-143-043-420;;007-943-354-378-456;;082-114-500-909-975;;004-239-090-971-580;;026-894-457-160-450;;077-128-610-778-669;;022-466-506-956-898;;008-424-592-956-946;;007-500-825-916-378;;009-725-244-669-882;;037-755-689-613-42X;;153-411-506-517-475;;012-449-714-188-064;;031-517-704-996-130;;131-299-284-996-064;;049-133-049-742-708;;000-272-178-768-076;;070-797-683-833-124;;043-870-224-178-49X;;052-364-430-129-757;;004-434-167-910-115;;032-860-147-271-886;;132-460-374-211-421;;098-172-374-375-47X;;014-988-634-483-130;;061-786-187-274-992;;037-898-018-686-909;;130-044-667-529-69X;;134-265-642-839-645;;065-221-074-461-027;;017-934-465-161-477;;101-660-130-379-529;;028-236-706-290-220;;087-333-189-994-274;;059-082-211-027-266,10.1016/s0956-5663(02)00099-4;;12392956;;10.1021/ja00391a001;;2889225;;10.1098/rstb.1987.0021;;10.1109/51.294001;;10.1016/0022-0728(65)85063-x;;2245876;;10.2337/diabetes.39.12.1519;;10.2337/diab.39.12.1519;;10.1016/s0956-5663(03)00220-3;;14611755;;18615658;;10.1002/bit.260430310;;9366023;;10.1016/s0956-5663(97)00025-0;;9451795;;10.1016/s0956-5663(97)00083-3;;10.1016/0956-5663(93)80028-n;;8311939;;8651496;;10.1021/ac960030d;;10.1080/03091900210156797;;12487712;;10.1016/0265-928x(87)80018-4;;3333622;;10.1109/19.816143;;10.1089/15209150252924058;;12017416;;10.1021/ac00017a008;;1789439;;2817408;;10.1021/ac00197a022;;10.1016/0925-4005(95)01730-5;;10.1016/0010-4825(90)90013-f;;2257734;;2868172;;8277748;;10.1016/0141-5425(93)90058-7;;11469630;;10.1089/15209150050214104;;10624783;;10.1016/s0168-8227(99)00113-8;;10.1089/15209150050214113;;11469631;;10.1007/bf00401374;;1478372;;10.2337/diacare.20.1.64;;9028696;;10.1109/tbme.1986.325807;;3957374;;236018;;10.1016/0005-2795(75)90259-7;;10.1089/hum.1998.9.6-879;;9581910;;11762520;;10.1089/15209150152607196;;10.2337/diabetes.48.3.445;;10078542;;10.1016/0265-928x(87)80012-3;;505005;;10.1126/science.505005;;10.1021/ac0498516;;15253640;;6721151;;10.1021/ac00268a018;;6733082;;10.1021/bi00305a016;;10.1515/cclm.2002.135;;12392305;;10.1016/j.ecl.2003.12.001;;15053902;;12052350;;10.1016/s0956-5663(01)00304-9;;12052349;;10.1016/s0956-5663(01)00306-2;;4500021;;10.1007/978-1-4684-3288-6_18;;14021529;;10.1111/j.1749-6632.1962.tb13623.x;;3196517;;10.2337/diacare.10.5.622;;3677983;;10.2337/diacare.8.6.529;;4075939;;10.1002/elan.1140061103;;7733469;;10.1021/ac00103a015;;7978306;;10.1021/ac00091a022;;10.1007/bf01248238;;10.1016/s0376-7388(98)00330-5;;10.1016/0265-928x(85)80002-x;;10.1021/j100290a001;;10.1021/ja00216a040;;10.1021/ja00188a091;;10.1021/ja00406a011;;2624333;;12323417;;10.1016/s0165-0270(02)00170-x;;10.1021/ja00415a014;;10.1007/bf00575392;;10.1021/ac00250a038;;10.1021/ac00266a005;;10.1007/s00216-002-1284-0;;12194035;;9642777;;10.1016/s0956-5663(97)00091-2;;10.1089/152091503322526978;;14633342;;10.1016/0022-0728(85)87006-6;;10.1021/ja00434a018;;10.1016/0003-2697(92)90243-z;;1443528;;10.1039/f19868201259;;3245585;;10.1021/ac00173a008;;2889234;;10.1098/rstb.1987.0020;;11762521;;10.1089/15209150152607204;;12413548;;10.1016/s1367-5931(02)00371-x;;10526740;;10.2337/diacare.22.10.1708,"U.S. Appl. No. 09/447,227, Shults.;;U.S. Appl. No. 11/928,574, Heller, et al.;;U.S. Appl. No. 11/928,668, Heller, et al.;;U.S. Appl. No. 11/928,743, Heller, et al.;;U.S. Appl. No. 11/928,795, Heller, et al.;;U.S. Appl. No. 11/928,891, Heller, et al.;;U.S. Appl. No. 11/928,968, Heller, et al.;;U.S. Appl. No. 11/941,078, Say, et al.;;U.S. Appl. No. 12/052,489, Say, et al.;;Abel, P. U., et al., ""Biosensors for in Vivo Glucose Measurement: Can We Cross the Experimental Stage"", Biosensors and Bioelectronics, vol. 17, 2002, pp. 1059-1070.;;Abruna, H. D., et al., ""Rectifying Interfaces Using Two-Layer Films of Electrochemically Polymerized Vinylpyridine and Vinylbipyridine Complexes of Ruthenium and Iron on Electrodes"", Journal of the American Chemical Society, vol. 103, No. 1, 1981, pp. 1-5.;;Albery, W. J., et al., ""Amperometric Enzyme Electrodes Part II: Conducting Salts as Electrode Materials for the Oxidation of Glucose Oxidase"", Journal of ElectroAnalytical Chemistry, vol. 194, 1985, pp. 223-235.;;Albery, W. J., et al., ""Amperometric Enzyme Electrodes"", Philosophical Transactions of the Royal Society of London, vol. 316, 1987, pp. 107-119.;;Alcock, S. J., et al., ""Continuous Analyte Monitoring to Aid Clinical Practice"", IEEE Engineering in Medicine and Biology Magazine, 1994, pp. 319-325.;;Anderson, L. B., et al., ""Thin-Layer Electrochemistry: Steady-State Methods of Studying Rate Processes"", Journal of ElectroAnalytical Chemistry, vol. 10, 1965, pp. 295-305.;;Armour, J. C., et al., ""Application of Chronic Intravascular Blood Glucose Sensor in Dogs"", Diabetes, vol. 39, 1990, pp. 1519-1526.;;Asberg, P., et al., ""Hydrogels of a Conducting Conjugated Polymer as 3-D Enzyme Electrode"", Biosensors & Bioelectronics, vol. 19, 2003, pp. 199-207.;;Atanasov, P., et al., ""Biosensor for Continuous Glucose Monitoring"", Biotechnology and Bioengineering, vol. 43, 1994, pp. 262-266.;;Atanasov, P., et al., ""Implantation of a Refillable Glucose Monitoring-Telemetry Device"", Biosensors & Bioelectronics, vol. 12, No. 7, 1997, pp. 669-680.;;Aussedat, B., et al., ""A User-Friendly Method for Calibrating a Subcutaneous Glucose Sensor-Based Hypoglycaemic Alarm"", Biosensors & Bioelectronics, vol. 12, No. 11, 1997, pp. 1061-1071.;;Baker, D. A., et al., ""Dynamic Concentration Challenges for Biosensor Characterization"", Biosensors & Bioelectronics, vol. 8, 1993, pp. 433-441.;;Baker, D. A., et al., ""Dynamic Delay and Maximal Dynamic Error in Continuous Biosensors"", Analytical Chemistry, vol. 68, No. 8, 1996, pp. 1292-1297.;;Bani Amer, M. M., ""An Accurate Amperometric Glucose Sensor Based Glucometer with Eliminated Cross-Sensitivity"", Journal of Medical Engineering & Technology, vol. 26, No. 5, 2002, pp. 208-213.;;Bard, A. J., et al., Electrochemical Methods, 1980, pp. 173-175.;;Bartlett, P. N., et al., ""Covalent Binding of Electron Relays to Glucose Oxidase"", Journal of the Chemical Society, Chemical Communications, 1987, pp. 1603-1604.;;Bartlett, P. N., et al., ""Modification of Glucose Oxidase by Tetrathiafulvalene"", Journal of the Chemical Society, Chemical Communications, 1990, pp. 1135-1136.;;Bartlett, P. N., et al., ""Strategies for the Development of Amperometric Enzyme Electrodes"", Biosensors, vol. 3, 1987/1988, pp. 359-379.;;Beach, R. D., et al., ""Subminiature Implantable Potentiostat and Modified Commercial Telemetry Device for Remote Glucose Monitoring"", IEEE Transactions on Instrumentation and Measurement, vol. 28, No. 6, 1999, pp. 1239-1245.;;Beech, W. A., ""AX.25 Link Access Protocol for Amateur packet Radio"", Tucson Amateur Packet Radio Corporation, 1998, pp. 1-133.;;Bennion, N., et al., ""Alternate Site Glucose Testing: A Crossover Design"", Diabetes Technology & Therapeutics, vol. 4, No. 1, 2002, pp. 25-33.;;Bindra, D. S., et al., ""Design and in Vitro Studies of a Needle-Type Glucose Sensor for Subcutaneous Monitoring"", Analytical Chemistry, vol. 63, No. 17, 1991, pp. 1692-1696.;;Bindra, D. S., et al., ""Pulsed Amperometric Detection of Glucose in Biological Fluids at a Surface-Modified Gold Electrode"", Analytical Chemistry, vol. 61, No. 22, 1989, pp. 2566-2570.;;Bisenberger, M., et al., ""A Triple-Step Potential Waveform at Enzyme Multisensors with Thick-Film Gold Electrodes for Detection of Glucose and Sucrose"", Sensors and Actuators B, vol. 28, 1995, pp. 181-189.;;Bland, J. M., et al., ""A Note on the Use of the Intraclass Correlation Coefficient in the Evaluation of Agreement Between Two Methods of Measurement"", Computers in Biology and Medicine, vol. 20, No. 5, 1990, pp. 337-340.;;Bland, J. M., et al., ""Statistical Methods for Assessing Agreement Between Two Methods of Clinical Measurement"", The Lancet, 1986, pp. 307-310.;;Blank, T. B., et al., ""Clinical Results From a Non-Invasive Blood Glucose Monitor"", Optical Diagnostics and Sensing of Biological Fluids and Glucose and Cholesterol Monitoring II, Proceedings of SPIE, vol. 4624, 2002, pp. 1-10.;;Bobbioni-Harsch, E., et al., ""Lifespan of Subcutaneous Glucose Sensors and Their Performances During Dynamic Glycaemia Changes in Rats"", Journal of Biomedical Engineering, vol. 15, 1993, pp. 457-463.;;Bode, B. W., ""Clinical Utility of the Continuous Glucose Monitoring System"", Diabetes Technology & Therapeutics, vol. 2, Sup. 1, 2000, pp. S35-S41.;;Bode, B. W., et al., ""Continuous Glucose Monitoring Used to Adjust Diabetes Therapy Improves Glycosylated Hemoglobin: A Pilot Study"", Diabetes Research and Clinical Practice, vol. 46, 1999, pp. 183-190.;;Bode, B. W., et al., ""Using the Continuous Glucose Monitoring System to Improve the Management of Type I Diabetes"", Diabetes Technology & Therapeutics, vol. 2, Sup. 1, 2000, pp. S43-S48.;;Boedeker Plastics, Inc., ""Polyethylene Specifications"", Web Page of Boedeker.com, 2007, pp. 1-3.;;Bolinder, J., et al., ""Microdialysis Measurement of the Absolute Glucose Concentration in Subcutaneous Adipose Tissue Allowing Glucose Monitoring in Diabetic Patients"", Diabetologia, vol. 35, 1992, pp. 1177-1180.;;Bolinder, J., et al., ""Self-Monitoring of Blood Glucose in Type I Diabetic Patients: Comparison with Continuous Microdialysis Measurements of Glucose in Subcutaneous Adipose Tissue During Ordinary Life Conditions"", Diabetes Care, vol. 20, No. 1, 1997, pp. 64-70.;;Bott, A. W., ""A Comparison of Cyclic Voltammetry and Cyclic Staircase Voltammetry"", Current Separations, vol. 16, No. 1, 1997, pp. 23-26.;;Bott, A. W., ""Electrochemical Methods for the Determination of Glucose"", Current Separations, vol. 17, No. 1, 1998, pp. 25-31.;;Bowman, L., et al., ""The Packaging of Implantable Integrated Sensors"", IEEE Transactions on Biomedical Engineering, vol. 33, No. 2, 1986, pp. 248-255.;;Brandt, J., et al., ""Covalent Attachment of Proteins to Polysaccharide Carriers by Means of Benzoquinone"", Biochimica et Biophysica Acta, vol. 386, 1975, pp. 196-202.;;Brauker, J., et al., ""Sustained Expression of High Levels of Human Factor IX from Human Cells Implanted Within an Immunoisolation Device into Athymic Rodents"", Human Gene Therapy, vol. 9, No. 6, 1998, pp. 879-888.;;Bremer, T. M., et al., ""Benchmark Data from the Literature for Evaluation of New Glucose Sensing Technologies"", Diabetes Technology & Therapeutics, vol. 3, No. 3, 2001, pp. 409-418.;;Bremer, T., et al., ""Is Blood Glucose Predictable from Previous Values?"", Diabetes, vol. 48, 1999, pp. 445-451.;;Brooks, S. L., et al., ""Development of an On-Line Glucose Sensor for Fermentation Monitoring"", Biosensors, vol. 3, 1987/1988, pp. 45-56.;;Brownlee, M., et al., ""A Glucose-Controlled Insulin-Delivery System: Semisynthetic Insulin Bound to Lectin"", Science, vol. 206, 1979, 1190-1191.;;Cai, Q., et al., ""A Wireless, Remove Query Glucose Biosensor Based on a pH-Sensitive Polymer"", Analytical Chemistry, vol. 76, No. 14, 2004, pp. 4038-4043.;;Cass, A. E., et al., ""Ferricinum Ion As an Electron Acceptor for Oxido-Reductases"", Journal of ElectroAnalytical Chemistry, vol. 190, 1985, pp. 117-127.;;Cass, A. E., et al., ""Ferrocene-Medicated Enzyme Electrode for Amperometric Determination of Glucose"", Analytical Chemistry, vol. 56, No. 4, 1984, 667-671.;;Castner, J. F., et al., ""Mass Transport and Reaction Kinetic Parameters Determined Electrochemically for Immobilized Glucose Oxidase"", Biochemistry, vol. 23 No. 10, 1984, 2203-2210.;;Chen, J. C., et al., ""A Comparison of MAC Protocols for Wireless Local Networks Based on battery Power Consumption"", IEEE, 1998, pp. 150-157.;;Chen, T., et al., ""Defining the Period of Recovery of the Glucose Concentration After Its Local Perturbation by the Implantation of a Miniature Sensor"", Clinical Chemistry and Laboratory Medicine, vol. 40, No. 8, 2002, pp. 486-489.;;Chia, C. W., et al., ""Glucose Sensors: Toward Closed Loop Insulin Delivery"", Endocrinology and Metabolism Clinics of North America, vol. 33, 2004, pp. 175-195.;;Choleau, C., et al., ""Calibration of a Subcutaneous Amperometric Glucose Sensor Implanted for 7 Days in Diabetic Patients Part 2: Superiority of the One-Point Calibration Method"", Biosensors and Bioelectronics, vol. 17, 2002, pp. 647-654.;;Choleau, C., et al., ""Calibration of a Subcutaneous Amperometric Glucose Sensor Part 1: Effect of Measurement Uncertainties on the Determination of Sensor Sensitivity and Background Current"", Biosensors and Bioelectronics, vol. 17, 2002, pp. 641-646.;;Claremont, D. J., et al., ""Biosensors for Continuous in Vivo Glucose Monitoring"", Proceedings of the Annual International Conference of the IEEE Engineering in Medicine and Biology Society, vol. 10, 1988.;;Clark Jr., L. C., et al., ""Differential Anodic Enzyme Polarography for the Measurement of Glucose"", Oxygen Transport to Tissue: Instrumentation, Methods, and Physiology, 1973, pp. 127-133.;;Clark Jr., L. C., et al., ""Electrode Systems for Continuous Monitoring in Cardiovascular Surgery"", Annals New York Academy of Sciences, 1962, pp. 29-45.;;Clark Jr., L. C., et al., ""Long-term Stability of Electroenzymatic Glucose Sensors Implanted in Mice"", American Society of Artificial Internal Organs Transactions, vol. XXXIV, 1988, pp. 259-265.;;Clarke, W. L., et al., ""Evaluating Clinical Accuracy of Systems for Self-Monitoring of Blood Glucose"", Diabetes Care, vol. 10, No. 5, 1987, pp. 622-628.;;Complaint, ""Abbott Diabetes Care, Inc. v. Dexcom, Inc."", filed Aug. 11, 2005.;;Complaint, Amended, ""Abbott Diabetes Care, Inc. v. Dexcom, Inc."", filed Jun. 27, 2006.;;Cox, D. J., et al., ""Accuracy of Perceiving Blood Glucose in IDDM"", Diabetes Care, vol. 8, No. 6, 1985, pp. 529-536.;;Csoregi, E., et al., ""Amperometric Microbiosensors for Detection of Hydrogen Peroxide and Glucose Based on Peroxidase-Modified Carbon Fibers"", Electroanalysis, vol. 6, 1994, pp. 925-933.;;Csoregi, E., et al., ""Design and Optimization of a Selective Subcutaneously Implantable Glucose Electrode Based on 'Wired' Glucose Oxidase"", Analytical Chemistry, vol. 67, No. 7, 1995, pp. 1240-1244.;;Csoregi, E., et al., ""Design, Characterization, and One-Point in Vivo Calibration of a Subcutaneously Implanted Glucose Electrode"", Analytical Chemistry, vol. 66 No. 19, 1994, pp. 3131-3138.;;Csoregi, E., et al., ""On-Line Glucose Monitoring by Using Microdialysis Sampling and Amperometric Detection Based on 'Wired' Glucose Oxidase in Carbon Paste"", Mikrochimica Acta, vol. 121, 1995, pp. 31-40.;;D'Arrigo, G., et al., ""Porous-Si Based Bio Reactors for Glucose Monitoring and Drugs Production"", Proceedings of SPIE: Microfluids, BioMEMS, and Medical Microsystems, vol. 4982, 2003, pp. 178-184.;;Dai, W. S., et al., ""Hydrogel Membranes with Mesh Size Asymmetry Based on the Gradient Crosslinking of Poly(vinyl alcohol),"" Journal of Membrane Science, vol. 156, 1999, pp. 67-79.;;Davis, G., ""Electrochemical Techniques for the Development of Amperometric Biosensors"", Biosensors, vol. 1, 1985, pp. 161-178.;;Degani, Y., et al., ""Direct Electrical Communication Between Chemically Modified Enzymes and Metal Electrodes. 1. Electron Transfer from Glucose Oxidase to Metal Electrodes via Electron Relays, Bound Covalently to the Enzyme"", The Journal of Physical Chemistry, vol. 91, No. 6, 1987, pp. 1285-1289.;;Degani, Y., et al., ""Direct Electrical Communication Between Chemically Modified Enzymes and Metal Electrodes. 2. Methods for Bonding Electron-Transfer Relays to Glucose Oxidase and D-Amino-Acid Oxidase"", Journal of the American Chemical Society, vol. 110, No. 8, 1988, pp. 2615-2620.;;Degani, Y., et al., ""Electrical Communication Between Redox Centers of Glucose Oxidase and Electrodes via Electrostatically and Covalently Bound Redox Polymers"", Journal of the American Chemical Society, vol. 111, 1989, pp. 2357-2358.;;Denisevich, P., et al., ""Unidirectional Current Flow and Charge State Trapping at Redox Polymer Interfaces on Bilayer Electrodes: Principles, Experimental Demonstration, and Theory"", Journal of the American Chemical Society, vol. 103, 1981, pp. 4727-4737.;;Dicks, J. M., et al., ""Ferrocene Modified Polypyrrole with Immobilised Glucose Oxidase and its Application in Amperometric Glucose Microbiosensors"", Annales de Biologie Clinique, vol. 47, 1989, pp. 607-619.;;Dixon, B. M., et al., ""Characterization in Vitro and in Vivo of the Oxygen Dependence of an Enzyme/Polymer Biosensors for Monitoring Brain Glucose"", Journal of Neuroscience Methods, vol. 119, 2002, pp. 135-142.;;Ellis, C. D., et al., ""Selectivity and Directed Charge Transfer through an Electroactive Metallopolymer Film"", Journal of the American Chemical Society, vol. 103, No. 25, 1981, pp. 7480-7483.;;El-Sa'Ad, L., et al., ""Moisture Absorption by Epoxy Resins: The Reverse Thermal Effect"", Journal of Materials Science, vol. 25, No. 8, 1990, pp. 3577-3582.;;Engstrom, R. C., ""Electrochemical Pretreatment of Glassy Carbon Electrodes"", Analytical Chemistry, vol. 54, No. 13, 1982, pp. 2310-2314.;;Engstrom, R. C., et al., ""Characterization of Electrochemically Pretreated Glassy Carbon Electrodes"", Analytical Chemistry, vol. 56, No. 2, 1984, pp. 136-141.;;Ernst, H., et al., ""Reliable Glucose Monitoring Through the Use of Microsystem Technology"", Analytical and Bioanalytical Chemistry, vol. 373, 2002, pp. 758-761.;;Fare, T. L., et al., ""Functional Characterization of a Conducting Polymer-Based Immunoassay System"", Biosensors & Bioelectronics, vol. 13, No. 3-4, 1998, pp. 459-470.;;Feldman, B., et al., ""A Continuous Glucose Sensor Based on Wired Enzyme(TM) Technology-Results from a 3-Day Trial in Patients with Type 1 Diabetes"", Diabetes Technology & Therapeutics, vol. 5, No. 5, 2003, pp. 769-779.;;Feldman, B., et al., ""Correlation of Glucose Concentrations in Interstitial Fluid and Venous Blood During Periods of Rapid Glucose Change"", Abbott Diabetes Care, Inc. Freestyle Navigator Continuous Glucose Monitor Pamphlet.;;Feldman, B., et al., ""Electron Transfer Kinetics at Redox Polymer/Solution Interfaces Using Microelectrodes and Twin Electrode Thin Layer Cells"", Journal of ElectroAnalytical Chemistry, vol. 194, 1985, pp. 63-81.;;Fischer, H., et al., ""Intramolecular Electron Transfer Medicated by 4,4'-Bypyridine and Related Bridging Groups"", Journal of the American Chemical Society, vol. 98, No. 18, 1976, pp. 5512-5517.;;Flentge, F., et al., ""An Enzyme-Reactor for Electrochemical Monitoring of Choline and Acetylcholine: Applications in High-Performance Liquid Chromatography, Bran Tissue, Microdialysis and Cerebrospinal Fluid,"" Analytical Biochemistry, vol. 204, 1992, pp. 305-310.;;Foulds, N. C., et al., ""Enzyme Entrapment in Electrically Conducting Polymers: Immobilisation of Glucose Oxidase in Polypyrrole and its Application in Amperometric Glucose Sensors"", Journal of the Chemical Society, Faraday Transactions 1, vol. 82, 1986, pp. 1259-1264.;;Foulds, N. C., et al , ""Immobilization of Glucose Oxidase in Ferrocene-Modified Pyrrole Polymers"", Analytical Chemistry, vol. 60, No. 22, 1988, pp. 2473-2478.;;Frew, J. E., et al., ""Electron-Transfer Biosensors"", Philosophical Transactions of The Royal Society of London, vol. 316, 1987, pp. 95-106.;;Frohnauer, M. K., et al., ""Graphical Human Insulin Time-Activity Profiles Using Standardized Definitions"", Diabetes Technology & Therapeutics, vol. 3, No. 3, 2001, pp. 419-429.;;Frost, M. C., et al., ""Implantable Chemical Sensors for Real-Time Clinical Monitoring: Progress and Challenges"", Current Opinion in Chemical Biology, vol. 6, 2002, pp. 633-641.;;Garg, S. K., et al., ""Correlation of Fingerstick Blood Glucose Measurements with GlucoWatch Biographer Glucose Results in Young Subjects with Type 1 Diabetes"", Diabetes Care, vol. 22, No. 10, 1999, pp. 1708-1714.",ACTIVE
162,US,A1,US 2007/0249919 A1,192-636-815-341-84X,2007-10-25,2007,US 76670807 A,2007-06-21,US 76670807 A;;US 42005703 A;;US 66719900 A;;US 7067798 A,1998-04-30,ANALYTE MONITORING DEVICE AND METHODS OF USE,"An analyte monitor includes a sensor, a sensor control unit, and a display unit. The sensor has, for example, a substrate, a recessed channel formed in the substrate, and conductive material disposed in the recessed channel to form a working electrode. The sensor control unit typically has a housing adapted for placement on skin and is adapted to receive a portion of an electrochemical sensor. The sensor control unit also includes two or more conductive contacts disposed on the housing and configured for coupling to two or more contact pads on the sensor. A transmitter is disposed in the housing and coupled to the plurality of conductive contacts for transmitting data obtained using the sensor. The display unit has a receiver for receiving data transmitted by the transmitter of the sensor control unit and a display coupled to the receiver for displaying an indication of a level of an analyte. The analyte monitor may also be part of a drug delivery system to alter the level of the analyte based on the data obtained using the sensor.",ABBOTT DIABETES CARE INC,SAY JAMES;;TOMASCO MICHAEL F;;HELLER ADAM;;GAL YORAM;;ARIA BEHRAD;;HELLER EPHRAIM;;PLANTE PHILLIP J;;VREEKE MARK S;;FRIEDMAN KEITH A;;COLMAN FREDRIC C,E. HELLER & CO (1998-07-02);;ABBOTT DIABETES CARE INC (2000-03-13),https://lens.org/192-636-815-341-84X,Patent Application,yes,101,38,211,221,0,A61B5/14532;;A61B5/14532;;A61B5/0002;;A61B5/0002;;A61B5/002;;A61B5/01;;A61B5/14503;;A61B5/1451;;A61B5/14546;;A61B5/14546;;A61B5/1473;;A61B5/1473;;A61B5/1486;;A61B5/1486;;A61B5/14865;;A61B5/1495;;A61B5/4839;;A61B5/72;;A61B5/7278;;A61B5/7282;;A61B5/7405;;A61B5/743;;A61B5/7445;;A61B5/7445;;A61B5/7455;;A61B2560/0252;;A61B2560/0252;;A61M5/1723;;C12Q1/54;;G16H10/40;;G16H10/40;;G16H20/17;;G16H20/17;;H01L23/3107;;H01L23/3107;;H01L23/49548;;H01L23/49548;;H01L2924/0002;;H01L2924/0002;;H01L2924/19041;;H01L2924/19041;;H01L2924/3011;;H01L2924/3011;;Y10S128/903;;Y10S128/903;;Y10T29/49;;Y10T29/49;;Y10T29/49124;;Y10T29/49124,A61B5/05;;G01N27/30;;A61B5/00;;A61B5/145;;A61B5/1477;;A61B5/1495;;G01N27/416;;G06F19/00;;H01L23/31;;H01L23/495,600/345,0,0,,,,EXPIRED
163,US,B2,US 8840553 B2,013-704-220-249-682,2014-09-23,2014,US 39388309 A,2009-02-26,US 39388309 A;;US 42005703 A;;US 66719900 A;;US 7067798 A,1998-04-30,Analyte monitoring device and methods of use,"An analyte monitor includes a sensor, a sensor control unit, and a display unit. The sensor has, for example, a substrate, a recessed channel formed in the substrate, and conductive material disposed in the recessed channel to form a working electrode. The sensor control unit typically has a housing adapted for placement on skin and is adapted to receive a portion of an electrochemical sensor. The sensor control unit also includes two or more conductive contacts disposed on the housing and configured for coupling to two or more contact pads on the sensor. A transmitter is disposed in the housing and coupled to the plurality of conductive contacts for transmitting data obtained using the sensor. The display unit has a receiver for receiving data transmitted by the transmitter of the sensor control unit and a display coupled to the receiver for displaying an indication of a level of an analyte. The analyte monitor may also be part of a drug delivery system to alter the level of the analyte based on the data obtained using the sensor.",SAY JAMES;;TOMASCO MICHAEL F;;HELLER ADAM;;GAL YORAM;;ARIA BEHRAD;;HELLER EPHRAIM;;PLANTE PHILLIP JOHN;;VREEKE MARK S;;FRIEDMAN KEITH A;;COLMAN FREDRIC C;;ABBOTT DIABETES CARE INC,SAY JAMES;;TOMASCO MICHAEL F;;HELLER ADAM;;GAL YORAM;;ARIA BEHRAD;;HELLER EPHRAIM;;PLANTE PHILLIP JOHN;;VREEKE MARK S;;FRIEDMAN KEITH A;;COLMAN FREDRIC C,E. HELLER & CO (1998-07-02);;ABBOTT DIABETES CARE INC (2000-03-13),https://lens.org/013-704-220-249-682,Granted Patent,yes,106,2,211,221,0,A61B5/14532;;A61B5/14532;;A61B5/0002;;A61B5/0002;;A61B5/002;;A61B5/01;;A61B5/14503;;A61B5/1451;;A61B5/14546;;A61B5/14546;;A61B5/1473;;A61B5/1473;;A61B5/1486;;A61B5/1486;;A61B5/14865;;A61B5/1495;;A61B5/4839;;A61B5/72;;A61B5/7278;;A61B5/7282;;A61B5/7405;;A61B5/743;;A61B5/7445;;A61B5/7445;;A61B5/7455;;A61B2560/0252;;A61B2560/0252;;A61M5/1723;;C12Q1/54;;G16H10/40;;G16H10/40;;G16H20/17;;G16H20/17;;H01L23/3107;;H01L23/3107;;H01L23/49548;;H01L23/49548;;H01L2924/0002;;H01L2924/0002;;H01L2924/19041;;H01L2924/19041;;H01L2924/3011;;H01L2924/3011;;Y10S128/903;;Y10S128/903;;Y10T29/49;;Y10T29/49;;Y10T29/49124;;Y10T29/49124,A61B5/145;;G01N27/30;;A61B5/00;;A61B5/1473;;A61B5/1477;;A61B5/1486;;A61B5/1495;;A61M31/00;;G01N27/416;;G06F19/00;;H01L23/31;;H01L23/495,600/365;;604/66;;604/504;;128/903,99,89,062-360-289-025-864;;010-601-725-111-91X;;101-292-518-663-191;;014-700-576-603-812;;033-562-815-299-181;;058-476-824-396-350;;000-125-755-474-124;;015-985-399-299-132;;081-249-097-078-543;;089-612-747-111-646;;082-114-500-909-975;;004-239-090-971-580;;026-894-457-160-450;;077-128-610-778-669;;009-725-244-669-882;;007-500-825-916-378;;037-755-689-613-42X;;012-449-714-188-064;;031-517-704-996-130;;131-299-284-996-064;;049-133-049-742-708;;000-272-178-768-076;;070-797-683-833-124;;032-860-147-271-886;;132-460-374-211-421;;052-364-430-129-757;;037-898-018-686-909;;130-044-667-529-69X;;065-221-074-461-027;;017-934-465-161-477;;101-660-130-379-529;;056-662-192-844-472;;131-420-472-995-124;;000-292-848-642-076;;037-547-642-717-655;;011-361-512-574-415;;006-033-609-366-053;;045-087-287-424-000;;112-172-675-119-141;;012-348-107-238-223;;057-907-035-573-356;;056-088-679-719-231;;158-841-328-840-967;;096-846-866-019-020;;046-051-917-287-322;;132-477-256-994-251;;126-256-551-957-406;;107-031-219-451-407;;070-035-450-644-84X;;073-842-915-397-35X;;002-244-337-345-21X;;068-386-284-377-434;;084-058-419-754-426;;011-920-220-103-986;;186-568-798-241-628;;083-932-858-886-510;;017-237-987-892-02X;;077-944-356-331-559;;015-613-189-270-414;;041-852-924-917-140;;052-850-283-559-75X;;047-861-542-219-382;;062-540-858-075-06X;;054-358-164-375-163;;031-531-088-033-656;;051-006-667-298-94X;;047-733-435-485-371;;003-067-671-137-047;;007-135-567-040-648;;006-536-656-748-868;;077-626-976-841-740;;035-535-925-014-211;;072-940-861-593-031;;024-011-256-425-251;;025-030-453-190-842;;030-775-076-635-419;;061-539-442-167-302;;008-149-576-479-541;;014-861-759-005-556;;035-211-086-138-107;;138-961-462-563-877;;115-233-158-409-162;;101-078-880-152-485;;007-757-545-982-964;;065-365-061-588-814;;116-750-608-164-513;;176-190-698-353-230;;063-392-112-944-585;;017-293-343-302-991,10.1021/ja00391a001;;2889225;;10.1098/rstb.1987.0021;;10.1109/51.294001;;10.1016/0265-928x(87)80018-4;;3333622;;10.1021/ac00017a008;;1789439;;8277748;;10.1016/0141-5425(93)90058-7;;236018;;10.1016/0005-2795(75)90259-7;;505005;;10.1126/science.505005;;6721151;;10.1021/ac00268a018;;6733082;;10.1021/bi00305a016;;4500021;;10.1007/978-1-4684-3288-6_18;;14021529;;10.1111/j.1749-6632.1962.tb13623.x;;3196517;;10.2337/diacare.10.5.622;;3677983;;7978306;;10.1021/ac00091a022;;7733469;;10.1021/ac00103a015;;10.1007/bf01248238;;10.1016/0265-928x(85)80002-x;;10.1021/j100290a001;;10.1021/ja00216a040;;10.1021/ja00188a091;;10.1021/ja00406a011;;2624333;;10.1021/ac00250a038;;10.1021/ac00266a005;;10.1021/ja00415a014;;10.1016/0022-0728(85)87006-6;;10.1021/ja00434a018;;10.1039/f19868201259;;3245585;;10.1021/ac00173a008;;2889234;;10.1098/rstb.1987.0020;;10.1016/0003-2670(91)85072-z;;10.1021/ac00202a007;;2305956;;10.1021/j100168a046;;10.1021/ja00191a084;;10.1021/ac00170a003;;3239784;;4356378;;10.1016/0925-4005(93)85356-f;;10.1021/j100188a007;;10.1021/ar00173a002;;10.1021/ac00236a033;;10.1021/ac00244a019;;10.1271/bbb1961.49.541;;10.1021/ja00415a004;;10.1021/ac00245a028;;10.1016/0925-4005(91)80225-9;;3842604;;10.1016/0265-928x(85)80005-5;;10.1149/1.2095533;;10.1021/ja00087a065;;1590584;;10.1021/ac00033a009;;10.1039/ft9969204131;;10.1016/0956-5663(91)85005-h;;2049169;;10.1016/0302-4598(90)80030-m;;10.1055/s-2007-1001749;;7875647;;10.1039/ft9938900361;;10.1021/ac00047a003;;1463213;;2712293;;10.1021/ac00176a006;;10.1016/0304-4165(85)90250-8;;3967047;;10.1016/0956-5663(92)85030-e;;1632948;;7926347;;10.1007/s001250050155;;10.1007/bf00403381;;10.1007/bf00400921;;1373393;;6130453;;10.1016/0024-3205(82)90736-6;;10.1016/0005-2744(76)90084-x;;182278;;10.1021/ac00071a031;;8297033;;8092486;;10.1021/ac00087a008;;10.1007/bf00580834;;567324;;10.1016/0022-0728(89)87165-7;;3812989;;10.1016/0003-2697(86)90315-5;;10.1016/0022-0728(95)04020-o;;10.1021/ja00047a065;;7763951;;10.1016/0167-7799(93)90016-3;;10.1007/bf00265097;;2666212;;10.1016/0265-928x(89)80026-4;;2719726;;1759711;;10.1021/ac00020a014;;10.1007/bf00404077;;8359584;;1457093;;10.1016/0956-5663(92)85010-8;;1751159;;10.1021/ja00540a026;;10.1021/ac00030a001;;10.1021/ac00030a718;;1580356;;2673892;;10.1007/bf00285330;;10.1016/0925-4005(93)85391-m;;10.1021/ja00392a010;;10.1021/ac00210a004;;2889233;;10.1098/rstb.1987.0019;;10.1016/0368-1874(83)80336-0;;10.1007/bf00250158;;6341145;;10.1021/ac00260a039;;10.1002/elan.1140080608;;7875646;;10.1055/s-2007-1001748,"Abruña, H. D. et al., ""Rectifying Interfaces Using Two-Layer Films of Electrochemically Polymerized Vinylpyridine and Vinylbipyridine Complexes of Ruthenium and Iron on Electrodes,"" J. Am. Chem. Soc., 103(1):1-5 (Jan. 14, 1981).;;Albery, W. J. et al., ""Amperometric enzyme electrodes. Part II. Conducting salts as electrode materials for the oxidation of glucose oxidase,"" J. Electroanal. Chem. Interfacial Electrochem., 194(2) (1 page-Abstract only) (1985).;;Albery, W. J. et al., ""Amperometric Enzyme Electrodes,"" Phil. Trans. R. Soc. Lond. B316:107-119 (1987).;;Alcock, S. J. et al., ""Continuous Analyte Monitoring to Aid Clinical Practice,"" IEEE Engineering in Medicine and Biology, 319-325 (1994).;;Anderson, L. B. et al., ""Thin-Layer Electrochemistry: Steady-State Methods of Studying Rate Processes,"" J. Electroanal. Chem., 10:295-395 (1965).;;Bartlett, P. N. et al., ""Covalent Binding of Electron Relays to Glucose Oxidation,"" J. Chem. Soc. Chem. Commun., 1603-1604 (1987).;;Bartlett, P. N. et al., ""Modification of glucose oxidase by tetrathiafulvalene,"" J. Chem. Soc., Chem. Commun., 16 (1 page-Abstract only) (1990).;;Bartlett, P. N. et al., ""Strategies for the Development of Amperometric Enzyme Electrodes,"" Biosensors, 3:359-379 (1987/88).;;Bindra, D.S. et al., ""Design and in Vitro Studies of a Needle-Type Glucose Sensor for Subcutaneous Monitoring"", Anal. Chem., 63(17):1692-1696 (Sep. 1, 1991).;;Bobbioni-Harsch, E. et al., ""Lifespan of subcutaneous glucose sensors and their performances during dynamic glycaemia changes in rats,"" J. Biomed. Eng. 15:457-463 (1993).;;Brandt, J. et al., ""Covalent attachment of proteins to polysaccharide carriers by means of benzoquinone,"" Biochim. Biophys. Acta, 386(1) (1 page Abstract only) (1975).;;Brownlee, M. et al., ""A Glucose-Controlled Insulin-Delivery System: Semisynthetic Insulin Bound to Lectin"", Science, 206(4423):1190-1191 (Dec. 7, 1979).;;Cass, A.E.G. et al., ""Ferricinum Ion as an Electron Acceptor for Oxido-Reductases,"" J. Electroanal. Chem., 190:117-127(1985).;;Cass, A.E.G. et al., ""Ferrocene-Mediated Enzyme Electrode for Amperometric Determination of Glucose"", Anal. Chem., 56(4):667-671 (Apr. 1984).;;Castner, J. F. et al., ""Mass Transport and Reaction Kinetic Parameters Determined Electrochemically for Immobilized Glucose Oxidase,"" Biochemisty, 23(10):2203-2210 (1984).;;Claremont, D.J. et al., ""Biosensors for Continuous In Vivo Glucose Monitoring"", IEEE Engineering in Medicine and Biology Society 10th Annual International Conference, New Orleans, Louisiana, 3 pgs. (Nov. 4-7, 1988).;;Clark, L.C. et al., ""Differential Anodic Enzyme Polarography for the Measurement of Glucose"", Oxygen Transport to Tissue: Instrumentation, Methods, and Physiology, 127-132 (1973).;;Clark, L.C., Jr. et al., ""Electrode Systems for Continuous Monitoring in Cardiovascular Surgery,"" Annals New York Academy of Sciences, pp. 29-45 (1962).;;Clark, L.C. et al., ""Long-term Stability of Electroenzymatic Glucose Sensors Implanted in Mice,"" Trans. Am. Soc. Artif. Intern. Organs, XXXIV:259-265 (1988).;;Clarke, W. L., et al., ""Evaluating Clinical Accuracy of Systems for Self-Monitoring of Blood Glucose,"" Diabetes Care, 10(5):622-628 (Sep.-Oct. 1987).;;Csöregi, E. et al., ""Design, Characterization, and One-Point in Vivo Calibration of a Subcutaneously Implanted Glucose Electrode,"" Anal. Chem. 66(19):3131-3138 (Oct. 1, 1994).;;Csöregi, E. et al., ""Design and Optimization of a Selective Subcutaneously Implantable Glucose Electrode Based on ""Wired"" Glucose Oxidase,"" Anal. Chem. 67(7):1240-1244 (Apr. 1, 1995).;;Csöregi, E. et al., ""On-Line Glucose Monitoring by Using Microdialysis Sampling and Amperometric Detection Based on ""Wired"" Glucose Oxidase in Carbon Paste,"" Mikrochim. Acta. 121:31-40 (1995).;;Davis, G., ""Electrochemical Techniques for the Development of Amperometric Biosensors"", Biosensors, 1:161-178 (1985).;;Degani, Y. et al., ""Direct Electrical Communication between Chemically Modified Enzymes and Metal Electrodes. 1. Electron Transfer from Glucose Oxidase to Metal Electrodes via Electron Relays, Bound Covalently to the Enzyme,"" J. Phys. Chem., 91(6):1285-1289 (1987).;;Degani, Y. et al., ""Direct Electrical Communication between Chemically Modified Enzymes and Metal Electrodes. 2. Methods for Bonding Electron-Transfer Relays to Glucose Oxidase and D-Amino-Acid Oxidase,"" J. Am. Chem. Soc., 110(8):2615-2620 (1988).;;Degani, Y. et al., ""Electrical Communication between Redox Centers of Glucose Oxidase and Electrodes via Electrostatically and Covalently Bound Redox Polymers,"" J. Am. Chem. Soc., 111:2357-2358 (1989).;;Denisevich, P. et al., ""Unidirectional Current Flow and Charge State Trapping at Redox Polymer Interfaces on Bilayer Electrodes: Principles, Experimental Demonstration, and Theory,"" J. Am. Chem. Soc., 103(16):4727-4737 (1981).;;Dicks, J. M., ""Ferrocene modified polypyrrole with immobilised glucose oxidase and its application in amperometric glucose microbiosensors,"" Ann. Biol. clin., 47:607-619 (1989).;;Engstrom, R.C., ""Electrochemical Pretreatment of Glassy Carbon Electrodes"", Anal. Chem., 54(13):2310-2314 (Nov. 1982).;;Engstrom, R.C. et al., ""Characterization of Electrochemically Pretreated Glassy Carbon Electrodes"", Anal. Chem., 56(2):136-141 (Feb. 1984).;;Ellis, C. D., ""Selectivity and Directed Charge Transfer through an Electroactive Metallopolymer Film,"" J. Am. Chem. Soc., 103(25):7480-7483 (1981).;;Feldman, B.J. et al., ""Electron Transfer Kinetics at Redox Polymer/Solution Interfaces Using Microelectrodes and Twin Electrode Thin Layer Cells"", J. Electroanal. Chem., 194(1):63-81 (Oct. 10, 1985).;;Fischer, H. et al., ""Intramolecular Electron Transfer Mediated by 4,4'-Bipyridine and Related Bridging Groups"", J. Am. Chem. Soc., 98(18):5512-5517 (Sep. 1, 1976).;;Foulds, N.C. et al., ""Enzyme Entrapment in Electrically Conducting Polymers,"" J. Chem. Soc., Faraday Trans 1., 82:1259-1264 (1986).;;Foulds, N.C. et al., ""Immobilization of Glucose Oxidase in Ferrocene-Modified Pyrrole Polymers,"" Anal. Chem., 60(22):2473-2478 (Nov. 15, 1988).;;Frew, J.E. et al., ""Electron-Transfer Biosensors"", Phil. Trans. R. Soc. Lond., B316:95-106 (1987).;;Gorton, L. et al., ""Selective detection in flow analysis based on the combination of immobilized enzymes and chemically modified electrodes,"" Analytica Chimica Acta., 250:203-248 (1991).;;Gregg, B. A. et al., ""Cross-Linked Redox Gels Containing Glucose Oxidase for Amperometric Biosensor Applications,"" Analytical Chemistry, 62(3):258-263 (Feb. 1, 1990).;;Gregg, B. A. et al., ""Redox Polymer Films Containing Enzymes. 1. A Redox-Conducting Epoxy Cement: Synthesis, Characterization, and Electrocatalytic Oxidation of Hydroquinone,"" J. Phys. Chem., 95(15):5970-5975 (1991).;;Hale, P.D. et al., ""A New Class of Amperometric Biosensor Incorporating a Polymeric Electron-Transfer Mediator,"" J. Am. Chem. Soc., 111(9):3482-3484 (1989).;;Harrison, D.J. et al., ""Characterization of Perfluorosulfonic Acid Polymer Coated Enzyme Electrodes and a Miniaturized Integrated Potentiostat for Glucose Analysis in Whole Blood"", Anal. Chem., 60(19):2002-2007 (Oct. 1, 1988).;;Hawkridge, F. M. et al., ""Indirect Coulometric Titration of Biological Electron Transport Components,"" Analytical Chemistry, 45(7):1021-1027 (Jun. 1973).;;Heller, A., ""Amperometric biosensors based on three-dimensional hydrogel-forming epoxy networks,"" Sensors and Actuators B, 13-14:180-183 (1993).;;Heller, A., ""Electrical Connection of Enzyme Redox Centers to Electrodes,"" J. Phys. Chem,, 96(9):3579-3587 (1992).;;Heller, A., ""Electrical Wiring of Redox Enzymes,"" Acc. Chem. Res., 23(5):129-134 (1990).;;Ianniello, R.M. et al. ""Immobilized Enzyme Chemically Modified Electrode as an Amperometric Sensor"", Anal. Chem., 53(13):2090-2095 (Nov. 1981).;;Ianniello, R.M. et al., ""Differential Pulse Voltammetric Study of Direct Electron Transfer in Glucose Oxidase Chemically Modified Graphite Electrodes"", Anal. Chem., 54:(7):1098-1101 (Jun. 1981).;;Ikeda, T. et al., ""Glucose oxidase-immobilized benzoquinone-carbon paste electrode as a glucose sensor,"" Agric. Biol. Chem., 49(2) (1 page-Abstract only) (1985).;;Ikeda, T. et al., ""Kinetics of Outer-Sphere Electron Transfers Between Metal Complexes in Solutions and Polymeric Films on Modified Electrodes"", J. Am. Chem. Soc., 103(25):7422-7425 (Dec. 16, 1981).;;Johnson, J. M. et al., ""Potential-Dependent Enzymatic Activity in an Enzyme Thin-Layer Cell,"" Anal. Chem. 54:1377-1383 (1982).;;Johnson, K.W., ""Reproducible Electrodeposition of Biomolecules for the Fabrication of Miniature Electroenzymatic Biosensors"", Sensors and Actuators B Chemical, B5:85-89 (1991).;;Jönsson, G. et al., ""An Amperometric Glucose Sensor Made by Modification of a Graphite Electrode Surface With Immobilized Glucose Oxidase and Adsorbed Mediator"", Biosensors, 1:355-368 (1985).;;Josowicz, M. et al., ""Electrochemical Pretreatment of Thin Film Platinum Electrodes"", J. Elecrochem. Soc., 135(1):112-115 (Jan. 1988).;;Katakis, I. et al., ""Electrostatic Control of the Electron Transfer Enabling Binding of Recombinant Glucose Oxidase and Redox Polyelectrolytes,"" J. Am. Chem. Soc., 116(8):3617-3618 (1994).;;Katakis, I. et al., ""L-alpha-Glycerophosphate and L-Lactate Electrodes Based on the Electrochemical ""Wiring"" of Oxidases,"" Analytical Chemistry, 64(9):1008-1013 (May 1, 1992).;;Kenausis, G. et al., ""'Wiring' of glucose oxidase and lactate oxidase within a hydrogel made with poly(vinyl pyridine) complexed with [Os(4,4'-dimethoxy-2,2'-bipyridine)2C1]+/2+,"" J. Chem. Soc., Faraday Trans., 92(20):4131-4136 (1996).;;Koudelka, M. et al., ""In-Vivo Behaviour of Hypodermically Implanted Microfabricated Glucose Sensors"", Biosensors & Bioelectronics, 6(1):31-36 (1991).;;Kulys, J. et al., ""Mediatorless peroxidase electrode and preparation of bienzyme sensors,"" Bioelectrochemistry and Bioenergetics, 24:305-311 (1990).;;Lager, W. et al., ""Implantable Electrocatalytic Glucose Sensor,"" Horm. Metab. Res., 26:526-530 (Nov. 1994).;;Lindner, E. et al. ""Flexible (Kapton-Based) Microsensor Arrays of High Stability for Cardiovascular Applications"", J. Chem. Soc.Faraday Trans., 89(2):361-367 (Jan. 21, 1993).;;Maidan, R. et al., ""Elimination of Electrooxidizable Interferant-Produced Currents in Amperometric Biosensors,"" Analytical Chemistry, 64(23):2889-2896 (Dec. 1, 1992).;;Mastrototaro, J.J. et al., ""An Electroenzymatic Glucose Sensor Fabricated on a Flexible Substrate"", Sensors and Biosensors B Chemical, B5:139-144 (1991).;;McNeil, C. J. et al., ""Thermostable Reduced Nicotinamide Adenine Dinucleotide Oxidase: Application to Amperometric Enzyme Assay,"" Anal. Chem., 61(1):25-29 (Jan. 1, 1989).;;Miyawaki, O. et al., ""Electrochemical and Glucose Oxidase Coenzyme Activity of Flavin Adenine Dinucleotide Covalently Attached to Glassy Carbon at the Adenine Amino Group"", Biochimica et Biophysica Acta, 838:60-68 (1985).;;Moatti-Sirat, D. et al., ""Evaluating in vitro and in vivo the inteference of ascorbate and acetaminophen on glucose detection by a needle-type glucose sensor,"" Biosensors & Bioelectronics, 7(5):345-352 (1992).;;Moatti-Sirat, D. et al., ""Reduction of acetaminophen interference in glucose sensors by a composite Nafion membrane: demonstration in rats and man,"" Diabetologia, 37(6) (1 page-Abstract only) (Jun. 1994).;;Moatti-Sirat, D. et al., ""Towards continuous glucose monitoring: in vivo evaluation of a miniaturized glucose sensor implanted for several days in rat subcutaneous tissue,"" Diabetologia, 35(3) (1 page-Abstract only) (Mar. 1992).;;Nagy, G. et al., ""A New Type of Enzyme Electrode: The Ascorbic Acid Eliminator Electrode,"" Life Sciences, 31(23):2611-2616 (1982).;;Nakamura, S. et al., ""Effect of Periodate Oxidation on the Structure and Properties of Glucose Oxidase,"" Biochimica et Biophysica Acta., 445:294-308 (1976).;;Narazimhan, K. et al., ""p-Benzoquinone activation of metal oxide electrodes for attachment of enzymes,"" Enzyme Microb. Technol., 7(6) (1 page-Abstract only) (1985).;;Ohara, T. J. et al., ""Glucose Electrodes Based on Cross-Linked [Os(bpy)2CI]+/2+ Complexed Poly(1-vinylimadazole) Films,"" Analytical Chemistry, 65(23):3512-3516 (Dec. 1, 1993).;;Ohara, T. J., ""Osmium Bipyridyl Redox Polymers Used in Enzyme Electrodes,"" Platinum Metals Rev., 39(2):54-62 (Apr. 1995).;;Ohara, T. J. et al., """"Wired"" Enzyme Electrodes for Amperometric Determination of Glucose or Lactate in the Presence of Interfering Substances,"" Analytical Chemistry, 66(15):2451-2457 (Aug. 1, 1994).;;Olievier, C. N. et al., ""In vivo Measurement of Carbon Dioxide Tension with a Miniature Electrode,"" Pflugers Arch. 373:269-272 (1978).;;Paddock, R. et al., ""Electrocatalytic reduction of hydrogen peroxide via direct electron transfer from pyrolytic graphite electrodes to irreversibly adsorbed cytochrome c peroxidase,"" J. Electroanal. Chem., 260:487-494 (1989).;;Palleschi, G. et al., ""A Study of Interferences in Glucose Measurements in Blood by Hydrogen Peroxide Based Glucose Probes"", Anal. Biochem., 159:114-121 (1986).;;Pankratov, I. et al., ""Sol-gel derived renewable-surface biosensors,"" Journal of Electroanalytical Chemistry, 393:35-41 (1995).;;Pathak, C. P. et al., ""Rapid Photopolymerization of Immunoprotective Gels in Contact with Cells and Tissue,"" J. Am. Chem. Soc., 114(21):8311-8312 (1992).;;Pickup, J., ""Developing glucose sensors for in vivo use,"" Tibtech, 11: 285-289 (Jul. 1993).;;Pickup, J. C. et al., ""In vivo molecular sensing in diabetes mellitus: an implantable glucose sensor with direct electron transfer,"" Diabetologia, 32(3):213-217 (1989).;;Pickup, J. et al., ""Potentially-implantable, amperometric glucose sensors with mediated electron transfer: improving the operating stability,"" Biosensors, 4(2) (1 page-Abstract only) (1989).;;Pishko, M.V. et al., ""Amperometric Glucose Microelectrodes Prepared Through Immobilization of Glucose Oxidase in Redox Hydrogels"", Anal. Chem., 63(20):2268-2272 (Oct. 15, 1991).;;Poitout, V. et al., ""A glucose monitoring system for on line estimation in man of blood glucose concentration using a miniaturized glucose sensor implanted in the subcutaneous tissue and a wearable control unit,"" Diabetolgia, 36(7) (1 page-Abstract only) (Jul. 1993).;;Poitout, V. et al., ""Calibration in dogs of a subcutaneous miniaturized glucose sensor using a glucose meter for blood glucose determination,"" Biosensors & Bioelectronics, 7:587-592 (1992).;;Poitout, V. et al., ""In vitro and in vivo evaluation in dogs of a miniaturized glucose sensor,"" ASAIO Transactions, 37(3) (1 page-Abstract only) (Jul.-Sep. 1991).;;Pollak, A. et al., ""Enzyme Immobilization by Condensation Copolymerization into Cross-Linked Polyacrylamide Gels,"" J. Am. Chem. Soc., 102(20):6324-6336 (1980).;;Reach, G. et al., ""Can Continuous Glucose Monitoring Be Used for the Treatment of Diabetes?"" Analytical Chemistry, 64(6):381-386 (Mar. 15, 1992).;;Rebrin, K. et al., ""Automated Feedback Control of Subcutaneous Glucose Concentration in Diabetic Dogs"", Diabetologia, 32(8):573-576 (Aug. 1989).;;Sakakida, M. et al., ""Ferrocene-mediate needle-type glucose sensor covered with newly designed biocompatible membrane,"" Sensors and Actuators B, 13-14:319-322 (1993).;;Samuels, G. J. et al., ""An Electrode-Supported Oxidation Catalyst Based on Ruthenium (IV). pH ""Encapsulation"" in a Polymer Film,"" J. Am. Chem. Soc., 103(2):307-312 (1981).;;Sasso, S.V. et al., ""Electropolymerized 1,2-Diaminobenzene as a Means to Prevent Interferences and Fouling and to Stabilize Immobilized Enzyme in Electrochemical Biosensors"", Anal. Chem., 62(11):1111-1117 (Jun. 1, 1990).;;Scheller, F. et al., ""Enzyme electrodes and their application,"" Phil. Trans. R. Soc. Lond., B 316:85-94 (1987).;;Schmehl, R.H. et al., ""The Effect of Redox Site Concentration on the Rate of Mediated Oxidation of Solution Substrates by a Redox Copolymer Film"", J. Electroanal. Chem., 152:97-109 (Aug. 25, 1983).;;Shichiri, M. et al., ""Glycaemic Control in Pancreatetomized Dogs with a Wearable Artificial Endocrine Pancreas"", Diabetologia, 24(3):179-184 (Mar. 1983).;;Sittampalam, G. et al., ""Surface-Modified Electrochemical Detector for Liquid Chromatography"", Anal. Chem., 55(9):1608-1610 (Aug. 1983).;;Soegijoko, S. et al., Horm. Metabl. Res., Suppl. Ser, 12 (1 page-Abstract only) (1982).;;Sprules, S. D. et al., ""Evaluation of a New Disposable Screen-Printed Sensor Strip for the Measurement of NADH and Its Modification to Produce a Lactate Biosensor Employing Microliter Volumes,"" Electroanalysis, 8(6):539-543 (1996).;;Sternberg, F. et al., ""Calibration Problems of Subcutaneous Glucosensors when Applied ""In-Situ"" in Man,"" Horm. metabl. Res, 26:524-525 (1994).",EXPIRED
164,WO,A1,WO 1999/056613 A1,055-636-371-601-796,1999-11-11,1999,US 9901229 W,1999-01-21,US 7067798 A,1998-04-30,ANALYTE MONITORING DEVICE AND METHODS OF USE,"An analyte monitor (40) includes a sensor (42), a sensor control unit (44), and a display unit (48). The sensor (42) has, for example, a substrate (50), a recessed channel (54) formed in the substrate, and conductive material (52) disposed in the recessed channel to form a working electrode (58). The sensor control unit (44) typically has a housing (45) adapted for placement on skin and is adapted to receive a portion of an electrochemical sensor (42). The sensor control unit (44) also includes two or more conductive contacts (80) disposed on the housing (45) and configured for coupling to two or more contact pads (49) on the sensor. A transmitter (98) is disposed in the housing and coupled to the plurality of conductive contacts for transmitting data obtained using the sensor. The display unit (48) has a receiver (150) for receiving data transmitted by the transmitter of the sensor control unit and a display (154) coupled to the receiver for displaying an indication of a level of an analyte. The analyte monitor (40) may also be part of a drug delivery system to alter the level of the analyte based on the data obtained using the sensor.",HELLER E & CO;;SAY JAMES;;TOMASCO MICHAEL F;;HELLER ADAM;;GAL YORAM;;ARIA BEHRAD;;HELLER EPHRAIM;;PLANTE PHILLIP J;;VREEKE MARK S;;FRIEDMAN KEITH A;;COLMAN FREDRIC C,SAY JAMES;;TOMASCO MICHAEL F;;HELLER ADAM;;GAL YORAM;;ARIA BEHRAD;;HELLER EPHRAIM;;PLANTE PHILLIP JOHN;;VREEKE MARK S;;FRIEDMAN KEITH A;;COLMAN FREDRIC C,,https://lens.org/055-636-371-601-796,Patent Application,yes,11,489,211,221,0,A61B5/14532;;A61B5/14532;;A61B5/0002;;A61B5/0002;;A61B5/002;;A61B5/01;;A61B5/14503;;A61B5/1451;;A61B5/14546;;A61B5/14546;;A61B5/1473;;A61B5/1473;;A61B5/1486;;A61B5/1486;;A61B5/14865;;A61B5/1495;;A61B5/4839;;A61B5/72;;A61B5/7278;;A61B5/7282;;A61B5/7405;;A61B5/743;;A61B5/7445;;A61B5/7445;;A61B5/7455;;A61B2560/0252;;A61B2560/0252;;A61M5/1723;;C12Q1/54;;G16H10/40;;G16H10/40;;G16H20/17;;G16H20/17;;H01L23/3107;;H01L23/3107;;H01L23/49548;;H01L23/49548;;H01L2924/0002;;H01L2924/0002;;H01L2924/19041;;H01L2924/19041;;H01L2924/3011;;H01L2924/3011;;Y10S128/903;;Y10S128/903;;Y10T29/49;;Y10T29/49;;Y10T29/49124;;Y10T29/49124,G01N27/30;;A61B5/00;;A61B5/145;;A61B5/1477;;A61B5/1495;;G01N27/416;;G06F19/00;;H01L23/31;;H01L23/495,,0,0,,,,PENDING
165,US,A1,US 2011/0015510 A1,048-024-398-090-139,2011-01-20,2011,US 89159210 A,2010-09-27,US 89159210 A;;US 39388309 A;;US 42005703 A;;US 66719900 A;;US 7067798 A,1998-04-30,Analyte Monitoring Device and Methods of Use,"An analyte monitor includes a sensor, a sensor control unit, and a display unit. The sensor has, for example, a substrate, a recessed channel formed in the substrate, and conductive material disposed in the recessed channel to form a working electrode. The sensor control unit typically has a housing adapted for placement on skin and is adapted to receive a portion of an electrochemical sensor. The sensor control unit also includes two or more conductive contacts disposed on the housing and configured for coupling to two or more contact pads on the sensor. A transmitter is disposed in the housing and coupled to the plurality of conductive contacts for transmitting data obtained using the sensor. The display unit has a receiver for receiving data transmitted by the transmitter of the sensor control unit and a display coupled to the receiver for displaying an indication of a level of an analyte. The analyte monitor may also be part of a drug delivery system to alter the level of the analyte based on the data obtained using the sensor.",ABBOTT DIABETES CARE INC,SAY JAMES;;TOMASCO MICHAEL F;;HELLER ADAM;;GAL YORAM;;ARIA BEHRAD;;HELLER EPHRAIM;;PLANTE PHILLIP JOHN;;VREEKE MARK S;;FRIEDMAN KEITH A;;COLMAN FREDRIC C,ABOTT DIABETES CARE INC (2000-03-13);;E. HELLER & CO (1998-07-02),https://lens.org/048-024-398-090-139,Patent Application,yes,99,10,211,221,0,A61B5/14532;;A61B5/14532;;A61B5/0002;;A61B5/0002;;A61B5/002;;A61B5/01;;A61B5/14503;;A61B5/1451;;A61B5/14546;;A61B5/14546;;A61B5/1473;;A61B5/1473;;A61B5/1486;;A61B5/1486;;A61B5/14865;;A61B5/1495;;A61B5/4839;;A61B5/72;;A61B5/7278;;A61B5/7282;;A61B5/7405;;A61B5/743;;A61B5/7445;;A61B5/7445;;A61B5/7455;;A61B2560/0252;;A61B2560/0252;;A61M5/1723;;C12Q1/54;;G16H10/40;;G16H10/40;;G16H20/17;;G16H20/17;;H01L23/3107;;H01L23/3107;;H01L23/49548;;H01L23/49548;;H01L2924/0002;;H01L2924/0002;;H01L2924/19041;;H01L2924/19041;;H01L2924/3011;;H01L2924/3011;;Y10S128/903;;Y10S128/903;;Y10T29/49;;Y10T29/49;;Y10T29/49124;;Y10T29/49124,A61B5/1468;;G01N27/30;;A61B5/00;;A61B5/145;;A61B5/1477;;A61B5/1495;;A61M5/00;;G01N27/416;;G06F19/00;;H01L23/31;;H01L23/495,600/347;;604/504,0,0,,,,EXPIRED
166,US,B2,US 8660627 B2,071-029-643-804-614,2014-02-25,2014,US 40551509 A,2009-03-17,US 40551509 A;;US 42005703 A;;US 66719900 A;;US 7067798 A,1998-04-30,Analyte monitoring device and methods of use,"An analyte monitor includes a sensor, a sensor control unit, and a display unit. The sensor has, for example, a substrate, a recessed channel formed in the substrate, and conductive material disposed in the recessed channel to form a working electrode. The sensor control unit typically has a housing adapted for placement on skin and is adapted to receive a portion of an electrochemical sensor. The sensor control unit also includes two or more conductive contacts disposed on the housing and configured for coupling to two or more contact pads on the sensor. A transmitter is disposed in the housing and coupled to the plurality of conductive contacts for transmitting data obtained using the sensor. The display unit has a receiver for receiving data transmitted by the transmitter of the sensor control unit and a display coupled to the receiver for displaying an indication of a level of an analyte. The analyte monitor may also be part of a drug delivery system to alter the level of the analyte based on the data obtained using the sensor.",SAY JAMES;;TOMASCO MICHAEL F;;HELLER ADAM;;GAL YORAM;;ARIA BEHRAD;;HELLER EPHRAIM;;PLANTE PHILLIP JOHN;;VREEKE MARK S;;FRIEDMAN KEITH A;;COLMAN FREDRIC C;;ABBOTT DIABETES CARE INC,SAY JAMES;;TOMASCO MICHAEL F;;HELLER ADAM;;GAL YORAM;;ARIA BEHRAD;;HELLER EPHRAIM;;PLANTE PHILLIP JOHN;;VREEKE MARK S;;FRIEDMAN KEITH A;;COLMAN FREDRIC C,E. HELLER & CO (1998-07-02);;ABBOTT DIABETES CARE INC (2000-03-13),https://lens.org/071-029-643-804-614,Granted Patent,yes,116,0,211,221,0,A61B5/14532;;A61B5/14532;;A61B5/0002;;A61B5/0002;;A61B5/002;;A61B5/01;;A61B5/14503;;A61B5/1451;;A61B5/14546;;A61B5/14546;;A61B5/1473;;A61B5/1473;;A61B5/1486;;A61B5/1486;;A61B5/14865;;A61B5/1495;;A61B5/4839;;A61B5/72;;A61B5/7278;;A61B5/7282;;A61B5/7405;;A61B5/743;;A61B5/7445;;A61B5/7445;;A61B5/7455;;A61B2560/0252;;A61B2560/0252;;A61M5/1723;;C12Q1/54;;G16H10/40;;G16H10/40;;G16H20/17;;G16H20/17;;H01L23/3107;;H01L23/3107;;H01L23/49548;;H01L23/49548;;H01L2924/0002;;H01L2924/0002;;H01L2924/19041;;H01L2924/19041;;H01L2924/3011;;H01L2924/3011;;Y10S128/903;;Y10S128/903;;Y10T29/49;;Y10T29/49;;Y10T29/49124;;Y10T29/49124,A61B5/05;;G01N27/30;;A61B5/00;;A61B5/145;;A61B5/1477;;A61B5/1495;;G01N27/416;;G06F19/00;;H01L23/31;;H01L23/495,600/345;;600/309;;600/365;;600/347,99,41,124-660-118-050-67X;;136-791-935-548-81X;;062-360-289-025-864;;010-601-725-111-91X;;101-292-518-663-191;;056-703-879-057-297;;030-155-762-644-019;;004-149-141-436-651;;016-731-054-793-457;;080-559-561-995-335;;044-807-213-528-815;;027-538-525-436-179;;015-020-161-517-40X;;025-919-454-564-785;;014-700-576-603-812;;004-851-060-590-788;;075-958-432-122-199;;052-356-140-149-389;;035-090-282-884-790;;033-562-815-299-181;;018-803-926-589-211;;008-505-762-041-402;;016-601-143-530-813;;019-502-772-562-215;;058-476-824-396-350;;006-498-707-073-30X;;054-091-551-638-293;;010-531-147-771-746;;054-827-198-877-419;;122-658-944-077-000;;017-261-560-469-37X;;000-125-755-474-124;;113-381-664-783-802;;082-626-907-191-554;;017-950-014-792-456;;090-348-305-613-628;;015-985-399-299-132;;171-049-047-164-618;;016-819-089-891-758;;081-249-097-078-543;;089-612-747-111-646,10.1016/0250-6874(89)87015-5;;10.1016/s0956-5663(02)00099-4;;12392956;;10.1021/ja00391a001;;2889225;;10.1098/rstb.1987.0021;;10.1109/51.294001;;10.1016/0022-0728(65)85063-x;;2245876;;10.2337/diabetes.39.12.1519;;10.2337/diab.39.12.1519;;10.1016/s0956-5663(03)00220-3;;14611755;;18615658;;10.1002/bit.260430310;;9366023;;10.1016/s0956-5663(97)00025-0;;9451795;;10.1016/s0956-5663(97)00083-3;;10.1016/0956-5663(93)80028-n;;8311939;;8651496;;10.1021/ac960030d;;10.1080/03091900210156797;;12487712;;10.1016/0265-928x(87)80018-4;;3333622;;10.1109/19.816143;;10.1007/bf01015979;;10.1089/15209150252924058;;12017416;;18473691;;10.1089/dia.2007.0281;;10.1021/ac00017a008;;1789439;;2817408;;10.1021/ac00197a022;;10.1016/0925-4005(95)01730-5;;10.1016/0010-4825(90)90013-f;;2257734;;2868172;;8277748;;10.1016/0141-5425(93)90058-7;;11469630;;10.1089/15209150050214104;;10624783;;10.1016/s0168-8227(99)00113-8;;10.1089/15209150050214113;;11469631;;10.1007/bf00401374;;1478372;;10.2337/diacare.20.1.64;;9028696;;10.1109/tbme.1986.325807;;3957374;;236018;;10.1016/0005-2795(75)90259-7;;10.1089/hum.1998.9.6-879;;9581910;;11762520;;10.1089/15209150152607196;;10.2337/diabetes.48.3.445;;10078542;;10.1016/0265-928x(87)80012-3;;505005;;10.1126/science.505005;;10.1021/ac0498516;;15253640;;10.1109/10.284922;;8026845;;6721151;;10.1021/ac00268a018;;6733082;;10.1021/bi00305a016,"Koudelka, M., et al., ""Planar Amperometric Enzyme-Based Glucose Microelectrode"", Sensors and Actuators, vol. 18, 1989, pp. 157-165.;;U.S. Appl. No. 10/783,675, Office Action mailed Dec. 14, 2010.;;U.S. Appl. No. 10/783,675, Office Action mailed Jun. 2, 2011.;;U.S. Appl. No. 11/681,730, Office Action mailed Apr. 27, 2011.;;U.S. Appl. No. 11/683,396, Office Action mailed Sep. 8, 2011.;;U.S. Appl. No. 11/690,826, Office Action mailed Aug. 9, 2011.;;U.S. Appl. No. 11/695,607, Office Action mailed Mar. 2, 2011.;;U.S. Appl. No. 11/742,507, Office Action mailed Apr. 13, 2011.;;U.S. Appl. No. 11/742,507, Office Action mailed Jun. 12, 2009.;;U.S. Appl. No. 11/928,795, Office Action mailed May 12, 2011.;;U.S. Appl. No. 11/941,078, Office Action mailed Apr. 22, 2011.;;U.S. Appl. No. 11/941,078, Office Action mailed Mar. 18, 2010.;;U.S. Appl. No. 12/249,644, Office Action mailed Apr. 15, 2011.;;U.S. Appl. No. 12/371,539, Office Action mailed Sep. 26, 2011.;;U.S. Appl. No. 12/397,281, Office Action mailed May 12, 2011.;;U.S. Appl. No. 12/397,293, Office Action mailed Aug. 5, 2011.;;U.S. Appl. No. 12/397,301, Office Action mailed Aug. 22, 2011.;;U.S. Appl. No. 12/405,568, Office Action mailed Sep. 16, 2011.;;U.S. Appl. No. 12/406,746, Office Action mailed Jul. 23, 2010.;;U.S. Appl. No. 12/406,746, Office Action mailed Apr. 5, 2011.;;U.S. Appl. No. 12/406,746, Office Action mailed Sep. 1, 2011.;;U.S. Appl. No. 12/406,800, Office Action mailed Apr. 20, 2011.;;U.S. Appl. No. 12/414,456, Office Action mailed Apr. 29, 2011.;;U.S. Appl. No. 12/414,542, Office Action mailed Apr. 13, 2011.;;U.S. Appl. No. 12/414,558, Office Action mailed Apr. 4, 2011.;;U.S. Appl. No. 12/422,269, Office Action mailed Apr. 14, 2011.;;U.S. Appl. No. 12/495,798, Office Action mailed Jun. 30, 2011.;;U.S. Appl. No. 12/495,803, Office Action mailed Jun. 30, 2011.;;U.S. Appl. No. 12/495,807, Office Action mailed Jul. 21, 2011.;;U.S. Appl. No. 12/614,974, Office Action mailed Apr. 12, 2011.;;U.S. Appl. No. 12/614,990, Office Action mailed Apr. 14, 2011.;;U.S. Appl. No. 12/615,069, Office Action mailed Jun. 9, 2011.;;U.S. Appl. No. 12/615,128, Office Action mailed Aug. 19 2011.;;U.S. Appl. No. 12/643,974, Office Action mailed May 4, 2011.;;U.S. Appl. No. 12/643,975, Office Action mailed Sep. 22, 2011.;;U.S. Appl. No. 12/643,978, Office Action mailed Apr. 15, 2011.;;U.S. Appl. No. 12/643,980, Office Action mailed Jun. 24, 2011.;;U.S. Appl. No. 12/643,982, Office Action mailed Jun. 17, 2011.;;U.S. Appl. No. 12/643,986, Office Action mailed Jun. 17, 2011.;;U.S. Appl. No. 12/779,947, Office Action mailed Apr. 8, 2011.;;U.S. Appl. No. 12/825,186, Office Action mailed Mar. 31, 2011.;;U.S. Appl. No. 12/825,202 Office Action mailed Jun. 8, 2011.;;U.S. Appl. No. 12/902,138 Office Action mailed Jun. 7, 2011.;;U.S. Patent Reexamination Application No. 90/010,791, Notice of Intent to Issue Reexamination Certificate mailed May 17, 2011.;;U.S. Patent Reexamination Application No. 90/010,791, Office Action mailed Dec. 17, 2010.;;U.S. Patent Reexamination Application No. 90/010,791, Office Action mailed May 28, 2010.;;U.S. Patent Reexamination Application No. 90/011,730, Request for Reexamination of U.S. Patent No. 6,990,366 filed Jun. 3, 2011.;;""Poretics Polycarbonate Membrane"", Osmonics Filtration and Separation Group, 2002.;;Abel, P. U., et al., ""Biosensors for In Vivo Glucose Measurement: Can We Cross the Experimental Stage"", Biosensors and Bioelectronics, vol. 17, 2002, pp. 1059-1070.;;Abruna, H. D., et al., ""Rectifying Interfaces Using Two-Layer Films of Electrochemically Polymerized Vinylpyridine and Vinylbipyridine Complexes of Ruthenium and Iron on Electrodes"", Journal of the American Chemical Society, vol. 103, No. 1, 1981, pp. 1-5.;;Albery, W. J., et al., ""Amperometric Enzyme Electrodes Part II: Conducting Salts as Electrode Materials for the Oxidation of Glucose Oxidase"", Journal of ElectroAnalytical Chemistry, vol. 194, 1985, pp. 223-235.;;Albery, W. J., et al., ""Amperometric Enzyme Electrodes"", Philosophical Transactions of The Royal Society of London, vol. 316, 1987, pp. 107-119.;;Alcock, S. J., et al., ""Continuous Analyte Monitoring to Aid Clinical Practice"", IEEE Engineering in Medicine and Biology Magazine, 1994, pp. 319-325.;;Anderson, L. B., et al., ""Thin-Layer Electrochemistry: Steady-State Methods of Studying Rate Processes"", Journal of ElectroAnalytical Chemistry, vol. 10, 1965, pp. 295-305.;;Armour, J. C., et al., ""Application of Chronic Intravascular Blood Glucose Sensor in Dogs"", Diabetes, vol. 39, 1990, pp. 1519-1526.;;Asberg, P., et al., ""Hydrogels of a Conducting Conjugated Polymer as 3-D Enzyme Electrode"", Biosensors & Bioelectronics, vol. 19, 2003, pp. 199-207.;;Atanasov, P., et al., ""Biosensor for Continuous Monitoring"", Biotechnology and Glucose Bioengineering, vol. 43, 1994, pp. 262-266.;;Atanasov, P., et al., ""Implantation of a Refillable Glucose Monitoring-Telemetry Device"", Biosensors & Bioelectronics, vol. 12, No. 7, 1997, pp. 669-680.;;Aussedat, B., et al., ""A User-Friendly Method for Calibrating a Subcutaneous Glucose Sensor-Based Hypoglycaemic Alarm"", Biosensors & Bioelectronics, vol. 12, No. 11, 1997, pp. 1061-1071.;;Baker, D. A., et al., ""Dynamic Concentration Challenges for Biosensor Characterization"", Biosensors & Bioelectronics, vol. 8, 1993, pp. 433-441.;;Baker, D. A., et al., ""Dynamic Delay and Maximal Dynamic Error in Continuous Biosensors"", Analytical Chemistry, vol. 68, No. 8, 1996, pp. 1292-1297.;;Bani Amer, M. M., ""An Accurate Amperometric Glucose Sensor Based Glucometer with Eliminated Cross-Sensitivity"", Journal of Medical Engineering & Technology, vol. 26, No. 5, 2002, pp. 208-213.;;Bard, A. J., et al., Electrochemical Methods, 1980, pp. 173-175.;;Bartlett, P. N., et al., ""Covalent Binding of Electron Relays to Glucose Oxidase"", Journal of the Chemical Society, Chemical Communications, 1987, pp. 1603-1604.;;Bartlett, P. N., et al., ""Modification of Glucose Oxidase by Tetrathiafulvalene"", Journal of the Chemical Society, Chemical Communications, 1990, pp. 1135-1136.;;Bartlett, P. N., et al., ""Strategies for the Development of Amperometric Enzyme Electrodes"", Biosensors, vol. 3, 1987/88, pp. 359-379.;;Beach, R. D., et al., ""Subminiature Implantable Potentiostat and Modified Commercial Telemetry Device for Remote Glucose Monitoring"", IEEE Transactions on Instrumentation and Measurement, vol. 28, No. 6, 1999, pp. 1239-1245.;;Beech, W. A., ""AX.25 Link Access Protocol for Amateur packet Radio"", Tucson Amateur Packet Radio Corporation, 1998, pp. 1-133.;;Bellucci, F., et al., ""Electrochemical Behaviour of Graphite-Epoxy Composite Materials (GECM) in Aqueous Salt Solutions"", Journal of Applied Electrochemistry, vol. 16, 1986, pp. 15-22.;;Bennion, N., et al., ""Alternate Site Glucose Testing: A Crossover Design"", Diabetes Technology & Therapeutics, vol. 4, No. 1, 2002, pp. 25-33.;;Biermann, E., et al., ""How Would Patients Behave if They Were Continually Informed of Their Blood Glucose Levels? A Simulation Study Using a 'Virtual' Patient"", Diabetes Technology & Therapeutics, vol. 10, No. 3, 2008, pp. 178-187.;;Bindra, D. S., et al., ""Design and in Vitro Studies of a Needle-Type Glucose Sensor for Subcutaneous Monitoring"", Analytical Chemistry, vol. 63, No. 17, 1991, pp. 1692-1696.;;Bindra, D. S., et al., ""Pulsed Amperometric Detection of Glucose in Biological Fluids at a Surface-Modified Gold Electrode"", Analytical Chemistry, vol. 61, No. 22, 1989, pp. 2566-2570.;;Bisenberger, M., et al., ""A Triple-Step Potential Waveform at Enzyme Multisensors with Thick-Film Gold Electrodes for Detection of Glucose and Sucrose"", Sensors and Actuators B, vol. 28, 1995, pp. 181-189.;;Bland, J. M., et al., ""A Note on the Use of the Intraclass Correlation Coefficient in the Evaluation of Agreement Between Two Methods of Measurement"", Computers in Biology and Medicine, vol. 20, No. 5, 1990, pp. 337-340.;;Bland, J. M., et al., ""Statistical Methods for Assessing Agreement Between Two Methods of Clinical Measurement"", The Lancet, 1986, pp. 307-310.;;Blank, T. B., et al., ""Clinical Results From a Non-Invasive Blood Glucose Monitor"", Optical Diagnostics and Sensing of Biological Fluids and Glucose and Cholesterol Monitoring II, Proceedings of SPIE, vol. 4624, 2002, pp. 1-10.;;Bobbioni-Harsch, E., et al., ""Lifespan of Subcutaneous Glucose Sensors and Their Performances During Dynamic Glycaemia Changes in Rats"", Journal of Biomedical Engineering, vol. 15, 1993, pp. 457-463.;;Bode, B. W., ""Clinical Utility of the Continuous Glucose Monitoring System"", Diabetes Technology & Therapeutics, vol. 2, Sup. 1, 2000, pp. S35-S41.;;Bode, B. W., et al., ""Continuous Glucose Monitoring Used to Adjust Diabetes Therapy Improves Glycosylated Hemoglobin: A Pilot Study"", Diabetes Research and Clinical Practice, vol. 46, 1999, pp. 183-190.;;Bode, B. W., et al., ""Using the Continuous Glucose Monitoring System to Improve the Management of Type I Diabetes"", Diabetes Technology & Therapeutics, vol. 2, Sup. 1, 2000, pp. S43-S48.;;Boedeker Plastics, Inc., ""Polyethylene Specifications"", Web Page of Boedeker.com, 2007, pp. 1-3.;;Bolinder, J., et al., ""Microdialysis Measurement of the Absolute Glucose Concentration in Subcutaneous Adipose Tissue Allowing Glucose Monitoring in Diabetic Patients"", Diabetologia, vol. 35, 1992, pp. 1177-1180.;;Bolinder, J., et al., ""Self-Monitoring of Blood Glucose in Type I Diabetic Patients: Comparison with Continuous Microdialysis Measurements of Glucose in Subcutaneous Adipose Tissue During Ordinary Life Conditions"", Diabetes Care, vol. 20, No. 1, 1997, pp. 64-70.;;Bott, A. W., ""A Comparison of Cyclic Voltammetry and Cyclic Staircase Voltammetry"", Current Separations, vol. 16, No. 1, 1997, pp. 23-26.;;Bott, A. W., ""Electrochemical Methods for the Determination of Glucose"", Current Separations, vol. 17, No. 1, 1998, pp. 25-31.;;Bowman, L., et al., ""The Packaging of Implantable Integrated Sensors"", IEEE Transactions on Biomedical Engineering, vol. 33, No. 2, 1986, pp. 248-255.;;Brandt, J., et al., ""Covalent Attachment of Proteins to Polysaccharide Carriers by Means of Benzoquinone"", Biochimica et Biophysica Acta, vol. 386, 1975, pp. 196-202.;;Brauker, J., et al., ""Sustained Expression of High Levels of Human Factor IX from Human Cells Implanted Within an Immunoisolation Device into Athymic Rodents"", Human Gene Therapy, vol. 9, No. 6, 1998, pp. 879-888.;;Bremer, T. M., et al., ""Benchmark Data from the Literature for Evaluation of New Glucose Sensing Technologies"", Diabetes Technology & Therapeutics, vol. 3, No. 3, 2001, pp. 409-418.;;Bremer, T., et al., ""Is Blood Glucose Predictable from Previous Values?"", Diabetes, vol. 48, 1999, pp. 445-451.;;Brooks, S. L., et al., ""Development of an On-Line Glucose Sensor for Fermentation Monitoring"", Biosensors, vol. 3, 1987/88, pp. 45-56.;;Brownlee, M., et al., ""A Glucose-Controlled Insulin-Delivery System: Semisynthetic Insulin Bound to Lectin"", Science, vol. 206, 1979, 1190-1191.;;Cai, Q., et al., ""A Wireless, Remove Query Glucose Biosensor Based on a pH-Sensitive Polymer"", Analytical Chemistry, vol. 76, No. 14, 2004, pp. 4038-4043.;;Candas, B., et al., ""An Adaptive Plasma Glucose Controller Based on a Nonlinear Insulin/Glucose Model"", IEEE Transactions on Biomedical Engineering, vol. 41, No. 2, 1994, pp. 116-124.;;Cass, A. E., et al., ""Ferricinum Ion As An Electron Acceptor for Oxido-Reductases"", Journal of ElectroAnalytical Chemistry, vol. 190, 1985, pp. 117-127.;;Cass, A. E., et al., ""Ferrocene-Medicated Enzyme Electrode for Amperometric Determination of Glucose"", Analytical Chemistry, vol. 56, No. 4, 1984, 667-671.;;Castner, J. F., et al., ""Mass Transport and Reaction Kinetic Parameters Determined Electrochemically for Immobilized Glucose Oxidase"", Biochemistry, vol. 23 No. 10, 1984, 2203-2210.;;Chen, J. C., et al., ""A Comparison of MAC Protocols for Wireless Local Networks Based on battery Power Consumption"", IEEE, 1998, pp. 150-157.",EXPIRED
167,US,A1,US 2009/0192369 A1,069-801-897-451-619,2009-07-30,2009,US 41445609 A,2009-03-30,US 41445609 A;;US 42005703 A;;US 66719900 A;;US 7067798 A,1998-04-30,Analyte Monitoring Device and Methods of Use,"An analyte monitor includes a sensor, a sensor control unit, and a display unit. The sensor has, for example, a substrate, a recessed channel formed in the substrate, and conductive material disposed in the recessed channel to form a working electrode. The sensor control unit typically has a housing adapted for placement on skin and is adapted to receive a portion of an electrochemical sensor. The sensor control unit also includes two or more conductive contacts disposed on the housing and configured for coupling to two or more contact pads on the sensor. A transmitter is disposed in the housing and coupled to the plurality of conductive contacts for transmitting data obtained using the sensor. The display unit has a receiver for receiving data transmitted by the transmitter of the sensor control unit and a display coupled to the receiver for displaying an indication of a level of an analyte. The analyte monitor may also be part of a drug delivery system to alter the level of the analyte based on the data obtained using the sensor.",ABBOTT DIABETES CARE INC,SAY JAMES;;TOMASCO MICHAEL F;;HELLER ADAM;;GAL YORAM;;ARIA BEHRAD;;HELLER EPHRAIM;;PLANTE PHILLIP JOHN;;VREEKE MARK S;;FRIEDMAN KEITH A;;COLMAN FREDRIC C,,https://lens.org/069-801-897-451-619,Patent Application,yes,15,66,211,221,0,A61B5/14532;;A61B5/14532;;A61B5/0002;;A61B5/0002;;A61B5/002;;A61B5/01;;A61B5/14503;;A61B5/1451;;A61B5/14546;;A61B5/14546;;A61B5/1473;;A61B5/1473;;A61B5/1486;;A61B5/1486;;A61B5/14865;;A61B5/1495;;A61B5/4839;;A61B5/72;;A61B5/7278;;A61B5/7282;;A61B5/7405;;A61B5/743;;A61B5/7445;;A61B5/7445;;A61B5/7455;;A61B2560/0252;;A61B2560/0252;;A61M5/1723;;C12Q1/54;;G16H10/40;;G16H10/40;;G16H20/17;;G16H20/17;;H01L23/3107;;H01L23/3107;;H01L23/49548;;H01L23/49548;;H01L2924/0002;;H01L2924/0002;;H01L2924/19041;;H01L2924/19041;;H01L2924/3011;;H01L2924/3011;;Y10S128/903;;Y10S128/903;;Y10T29/49;;Y10T29/49;;Y10T29/49124;;Y10T29/49124,A61B5/1468;;G01N27/30;;A61B5/00;;A61B5/145;;A61B5/1477;;A61B5/1495;;G01N27/416;;G06F19/00;;H01L23/31;;H01L23/495,600/345,0,0,,,,EXPIRED
168,US,A1,US 2012/0238833 A1,056-008-165-258-017,2012-09-20,2012,US 201213429294 A,2012-03-23,US 201213429294 A;;US 42005703 A;;US 66719900 A;;US 7067798 A,1998-04-30,Analyte Monitoring Device and Methods of Use,"An analyte monitor includes a sensor, a sensor control unit, and a display unit. The sensor has, for example, a substrate, a recessed channel formed in the substrate, and conductive material disposed in the recessed channel to form a working electrode. The sensor control unit typically has a housing adapted for placement on skin and is adapted to receive a portion of an electrochemical sensor. The sensor control unit also includes two or more conductive contacts disposed on the housing and configured for coupling to two or more contact pads on the sensor. A transmitter is disposed in the housing and coupled to the plurality of conductive contacts for transmitting data obtained using the sensor.",SAY JAMES;;TOMASCO MICHAEL F;;HELLER ADAM;;GAL YORAM;;ARIA BEHRAD;;HELLER EPHRAIM;;PLANTE PHILLIP JOHN;;VREEKE MARK S;;FRIEDMAN KEITH A;;COLMAN FREDRIC C;;ABBOTT DIABETES CARE INC,SAY JAMES;;TOMASCO MICHAEL F;;HELLER ADAM;;GAL YORAM;;ARIA BEHRAD;;HELLER EPHRAIM;;PLANTE PHILLIP JOHN;;VREEKE MARK S;;FRIEDMAN KEITH A;;COLMAN FREDRIC C,,https://lens.org/056-008-165-258-017,Patent Application,yes,1,15,211,221,0,A61B5/14532;;A61B5/14532;;A61B5/0002;;A61B5/0002;;A61B5/002;;A61B5/01;;A61B5/14503;;A61B5/1451;;A61B5/14546;;A61B5/14546;;A61B5/1473;;A61B5/1473;;A61B5/1486;;A61B5/1486;;A61B5/14865;;A61B5/1495;;A61B5/4839;;A61B5/72;;A61B5/7278;;A61B5/7282;;A61B5/7405;;A61B5/743;;A61B5/7445;;A61B5/7445;;A61B5/7455;;A61B2560/0252;;A61B2560/0252;;A61M5/1723;;C12Q1/54;;G16H10/40;;G16H10/40;;G16H20/17;;G16H20/17;;H01L23/3107;;H01L23/3107;;H01L23/49548;;H01L23/49548;;H01L2924/0002;;H01L2924/0002;;H01L2924/19041;;H01L2924/19041;;H01L2924/3011;;H01L2924/3011;;Y10S128/903;;Y10S128/903;;Y10T29/49;;Y10T29/49;;Y10T29/49124;;Y10T29/49124,A61B5/1473;;G01N27/30;;A61B5/00;;A61B5/01;;A61B5/145;;A61B5/1477;;A61B5/1495;;G01N27/416;;G06F19/00;;H01L23/31;;H01L23/495,600/301;;600/345;;600/355;;600/347,0,0,,,,DISCONTINUED
169,US,A1,US 2010/0240974 A1,058-960-027-781-971,2010-09-23,2010,US 79366510 A,2010-06-03,US 79366510 A;;US 69082607 A;;US 42005703 A;;US 66719900 A;;US 7067798 A,1998-04-30,Analyte Monitoring Device and Methods of Use,"An analyte monitor includes a sensor, a sensor control unit, and a display unit. The sensor has, for example, a substrate, a recessed channel formed in the substrate, and conductive material disposed in the recessed channel to form a working electrode. The sensor control unit typically has a housing adapted for placement on skin and is adapted to receive a portion of an electrochemical sensor. The sensor control unit also includes two or more conductive contacts disposed on the housing and configured for coupling to two or more contact pads on the sensor. A transmitter is disposed in the housing and coupled to the plurality of conductive contacts for transmitting data obtained using the sensor. The display unit has a receiver for receiving data transmitted by the transmitter of the sensor control unit and a display coupled to the receiver for displaying an indication of a level of an analyte. The analyte monitor may also be part of a drug delivery system to alter the level of the analyte based on the data obtained using the sensor.",ABBOTT DIABETES CARE INC,SAY JAMES;;TOMASCO MICHAEL F;;HELLER ADAM;;GAL YORAM;;ARIA BEHRAD;;HELLER EPHRAIM;;PLANTE PHILLIP JOHN;;VREEKE MARK S;;FRIEDMAN KEITH A;;COLMAN FREDRIC C,,https://lens.org/058-960-027-781-971,Patent Application,yes,0,2,211,221,0,A61B5/14532;;A61B5/14532;;A61B5/0002;;A61B5/0002;;A61B5/002;;A61B5/01;;A61B5/14503;;A61B5/1451;;A61B5/14546;;A61B5/14546;;A61B5/1473;;A61B5/1473;;A61B5/1486;;A61B5/1486;;A61B5/14865;;A61B5/1495;;A61B5/4839;;A61B5/72;;A61B5/7278;;A61B5/7282;;A61B5/7405;;A61B5/743;;A61B5/7445;;A61B5/7445;;A61B5/7455;;A61B2560/0252;;A61B2560/0252;;A61M5/1723;;C12Q1/54;;G16H10/40;;G16H10/40;;G16H20/17;;G16H20/17;;H01L23/3107;;H01L23/3107;;H01L23/49548;;H01L23/49548;;H01L2924/0002;;H01L2924/0002;;H01L2924/19041;;H01L2924/19041;;H01L2924/3011;;H01L2924/3011;;Y10S128/903;;Y10S128/903;;Y10T29/49;;Y10T29/49;;Y10T29/49124;;Y10T29/49124,A61B5/1468;;G01N27/30;;A61B5/00;;A61B5/145;;A61B5/1477;;A61B5/1495;;G01N27/416;;G06F19/00;;H01L23/31;;H01L23/495,600/345,0,0,,,,DISCONTINUED
170,US,A1,US 2004/0236200 A1,077-005-759-053-519,2004-11-25,2004,US 72225303 A,2003-11-24,US 72225303 A;;US 42005703 A;;US 66719900 A;;US 7067798 A,1998-04-30,Analyte monitoring device and methods of use,"
   An analyte monitor includes a sensor, a sensor control unit, and a display unit. The sensor has, for example, a substrate, a recessed channel formed in the substrate, and conductive material disposed in the recessed channel to form a working electrode. The sensor control unit typically has a housing adapted for placement on skin and is adapted to receive a portion of an electrochemical sensor. The sensor control unit also includes two or more conductive contacts disposed on the housing and configured for coupling to two or more contact pads on the sensor. A transmitter is disposed in the housing and coupled to the plurality of conductive contacts for transmitting data obtained using the sensor. The display unit has a receiver for receiving data transmitted by the transmitter of the sensor control unit and a display coupled to the receiver for displaying an indication of a level of an analyte. The analyte monitor may also be part of a drug delivery system to alter the level of the analyte based on the data obtained using the sensor. 
",SAY JAMES;;TOMASCO MICHAEL F.;;HELLER ADAM;;GAL YORAM;;ARIA BEHRAD;;HELLER EPHRAIM;;PLANTE PHILLIP JOHN;;VREEKE MARK S.;;FRIEDMAN KEITH A.;;COLMAN FREDRIC C.,SAY JAMES;;TOMASCO MICHAEL F;;HELLER ADAM;;GAL YORAM;;ARIA BEHRAD;;HELLER EPHRAIM;;PLANTE PHILLIP JOHN;;VREEKE MARK S;;FRIEDMAN KEITH A;;COLMAN FREDRIC C,SYNTHEON NEUROVASCULAR LLC (2021-05-07),https://lens.org/077-005-759-053-519,Patent Application,yes,2,407,211,221,0,A61B5/14532;;A61B5/14532;;A61B5/0002;;A61B5/0002;;A61B5/002;;A61B5/01;;A61B5/14503;;A61B5/1451;;A61B5/14546;;A61B5/14546;;A61B5/1473;;A61B5/1473;;A61B5/1486;;A61B5/1486;;A61B5/14865;;A61B5/1495;;A61B5/4839;;A61B5/72;;A61B5/7278;;A61B5/7282;;A61B5/7405;;A61B5/743;;A61B5/7445;;A61B5/7445;;A61B5/7455;;A61B2560/0252;;A61B2560/0252;;A61M5/1723;;C12Q1/54;;G16H10/40;;G16H10/40;;G16H20/17;;G16H20/17;;H01L23/3107;;H01L23/3107;;H01L23/49548;;H01L23/49548;;H01L2924/0002;;H01L2924/0002;;H01L2924/19041;;H01L2924/19041;;H01L2924/3011;;H01L2924/3011;;Y10S128/903;;Y10S128/903;;Y10T29/49;;Y10T29/49;;Y10T29/49124;;Y10T29/49124,G01N27/30;;A61B5/00;;A61B5/145;;A61B5/1477;;A61B5/1495;;G01N27/416;;G06F19/00;;H01L23/31;;H01L23/495,600/345;;600/347,0,0,,,,EXPIRED
171,US,A1,US 2010/0234709 A1,136-709-420-699-701,2010-09-16,2010,US 64398009 A,2009-12-21,US 64398009 A;;US 42005703 A;;US 66719900 A;;US 7067798 A,1998-04-30,Analyte Monitoring Device and Methods of Use,"An analyte monitor includes a sensor, a sensor control unit, and a display unit. The sensor has, for example, a substrate, a recessed channel formed in the substrate, and conductive material disposed in the recessed channel to form a working electrode. The sensor control unit typically has a housing adapted for placement on skin and is adapted to receive a portion of an electrochemical sensor. The sensor control unit also includes two or more conductive contacts disposed on the housing and configured for coupling to two or more contact pads on the sensor. A transmitter is disposed in the housing and coupled to the plurality of conductive contacts for transmitting data obtained using the sensor. The display unit has a receiver for receiving data transmitted by the transmitter of the sensor control unit and a display coupled to the receiver for displaying an indication of a level of an analyte. The analyte monitor may also be part of a drug delivery system to alter the level of the analyte based on the data obtained using the sensor.",ABBOTT DIABETES CARE INC,SAY JAMES;;TOMASCO MICHAEL F;;HELLER ADAM;;GAL YORAM;;ARIA BEHRAD;;HELLER EPHRAIM;;PLANTE PHILLIP JOHN;;VREEKE MARK S;;FRIEDMAN KEITH A;;COLMAN FREDRIC C,,https://lens.org/136-709-420-699-701,Patent Application,yes,99,23,211,221,0,A61B5/14532;;A61B5/14532;;A61B5/0002;;A61B5/0002;;A61B5/002;;A61B5/01;;A61B5/14503;;A61B5/1451;;A61B5/14546;;A61B5/14546;;A61B5/1473;;A61B5/1473;;A61B5/1486;;A61B5/1486;;A61B5/14865;;A61B5/1495;;A61B5/4839;;A61B5/72;;A61B5/7278;;A61B5/7282;;A61B5/7405;;A61B5/743;;A61B5/7445;;A61B5/7445;;A61B5/7455;;A61B2560/0252;;A61B2560/0252;;A61M5/1723;;C12Q1/54;;G16H10/40;;G16H10/40;;G16H20/17;;G16H20/17;;H01L23/3107;;H01L23/3107;;H01L23/49548;;H01L23/49548;;H01L2924/0002;;H01L2924/0002;;H01L2924/19041;;H01L2924/19041;;H01L2924/3011;;H01L2924/3011;;Y10S128/903;;Y10S128/903;;Y10T29/49;;Y10T29/49;;Y10T29/49124;;Y10T29/49124,A61B5/145;;G01N27/30;;A61B5/00;;A61B5/1477;;A61B5/1495;;G01N27/416;;G06F19/00;;H01L23/31;;H01L23/495,600/365,0,0,,,,EXPIRED
172,ES,T3,ES 2537514 T3,145-577-971-399-873,2015-06-09,2015,ES 04758815 T,2004-04-02,US 46067803 P;;US 47249403 P;;US 53203003 P;;US 54898604 P;;US 2004/0010278 W,2003-04-04,"Composiciones, métodos y kits relacionados con la escisión de HER-2","Un compuesto que es un inhibidor de ADAM o un anticuerpo anti-Her2 para su uso en un método para tratar cáncer, en el que dicho cáncer expresa en exceso Her-2, y en el que el tratamiento comprende administrar una cantidad terapéuticamente eficaz del anticuerpo anti-Her2 y el inhibidor de ADAM, en el que el inhibidor de ADAM es un inhibidor de metaloproteinasa que inhibe la escisión de Her-2 in vivo",INCYTE CORP,FRIEDMAN STEVEN M;;SCHERLE PEGGY A;;LIU XIANGDONG;;BURN TIMOTHY C;;HUBER REID;;LIU PHILLIP C C;;HOLLIS GREGORY F;;VADDI KRISHNA;;FRIDMAN JORDAN S,,https://lens.org/145-577-971-399-873,Granted Patent,no,0,0,10,10,0,A61K31/19;;A61K31/19;;A61K31/395;;A61K31/395;;A61P35/00;;A61P35/04,A61K39/395;;A61K/;;A61K31/19,,0,0,,,,ACTIVE
173,US,B2,US 8265726 B2,155-328-116-941-567,2012-09-11,2012,US 61499009 A,2009-11-09,US 61499009 A;;US 42005703 A;;US 66719900 A;;US 7067798 A,1998-04-30,Analyte monitoring device and methods of use,"An analyte monitor includes a sensor, a sensor control unit, and a display unit. The sensor has, for example, a substrate, a recessed channel formed in the substrate, and conductive material disposed in the recessed channel to form a working electrode. The sensor control unit typically has a housing adapted for placement on skin and is adapted to receive a portion of an electrochemical sensor. The sensor control unit also includes two or more conductive contacts disposed on the housing and configured for coupling to two or more contact pads on the sensor. A transmitter is disposed in the housing and coupled to the plurality of conductive contacts for transmitting data obtained using the sensor. The display unit has a receiver for receiving data transmitted by the transmitter of the sensor control unit and a display coupled to the receiver for displaying an indication of a level of an analyte. The analyte monitor may also be part of a drug delivery system to alter the level of the analyte based on the data obtained using the sensor.",SAY JAMES;;TOMASCO MICHAEL F;;HELLER ADAM;;GAL YORAM;;ARIA BEHRAD;;HELLER EPHRAIM;;PLANTE PHILLIP JOHN;;VREEKE MARK S;;FRIEDMAN KEITH A;;COLMAN FREDRIC C;;ABBOTT DIABETES CARE INC,SAY JAMES;;TOMASCO MICHAEL F;;HELLER ADAM;;GAL YORAM;;ARIA BEHRAD;;HELLER EPHRAIM;;PLANTE PHILLIP JOHN;;VREEKE MARK S;;FRIEDMAN KEITH A;;COLMAN FREDRIC C,E. HELLER & CO (1998-07-02);;ABBOTT DIABETES CARE INC (2000-03-13),https://lens.org/155-328-116-941-567,Granted Patent,yes,114,6,211,221,0,A61B5/14532;;A61B5/14532;;A61B5/0002;;A61B5/0002;;A61B5/002;;A61B5/01;;A61B5/14503;;A61B5/1451;;A61B5/14546;;A61B5/14546;;A61B5/1473;;A61B5/1473;;A61B5/1486;;A61B5/1486;;A61B5/14865;;A61B5/1495;;A61B5/4839;;A61B5/72;;A61B5/7278;;A61B5/7282;;A61B5/7405;;A61B5/743;;A61B5/7445;;A61B5/7445;;A61B5/7455;;A61B2560/0252;;A61B2560/0252;;A61M5/1723;;C12Q1/54;;G16H10/40;;G16H10/40;;G16H20/17;;G16H20/17;;H01L23/3107;;H01L23/3107;;H01L23/49548;;H01L23/49548;;H01L2924/0002;;H01L2924/0002;;H01L2924/19041;;H01L2924/19041;;H01L2924/3011;;H01L2924/3011;;Y10S128/903;;Y10S128/903;;Y10T29/49;;Y10T29/49;;Y10T29/49124;;Y10T29/49124,A61B5/05;;G01N27/30;;A61B5/00;;A61B5/145;;A61B5/1477;;A61B5/1495;;G01N27/416;;G06F19/00;;H01L23/31;;H01L23/495,600/345;;600/347;;600/365,99,81,136-791-935-548-81X;;062-360-289-025-864;;010-601-725-111-91X;;101-292-518-663-191;;056-703-879-057-297;;030-155-762-644-019;;004-149-141-436-651;;016-731-054-793-457;;080-559-561-995-335;;044-807-213-528-815;;027-538-525-436-179;;015-020-161-517-40X;;025-919-454-564-785;;014-700-576-603-812;;004-851-060-590-788;;075-958-432-122-199;;052-356-140-149-389;;035-090-282-884-790;;033-562-815-299-181;;018-803-926-589-211;;008-505-762-041-402;;016-601-143-530-813;;019-502-772-562-215;;058-476-824-396-350;;006-498-707-073-30X;;054-091-551-638-293;;010-531-147-771-746;;054-827-198-877-419;;122-658-944-077-000;;017-261-560-469-37X;;000-125-755-474-124;;113-381-664-783-802;;082-626-907-191-554;;017-950-014-792-456;;090-348-305-613-628;;015-985-399-299-132;;171-049-047-164-618;;016-819-089-891-758;;081-249-097-078-543;;089-612-747-111-646;;031-706-897-890-035;;094-198-536-559-723;;003-690-143-043-420;;007-943-354-378-456;;082-114-500-909-975;;004-239-090-971-580;;026-894-457-160-450;;077-128-610-778-669;;022-466-506-956-898;;008-424-592-956-946;;007-500-825-916-378;;009-725-244-669-882;;037-755-689-613-42X;;153-411-506-517-475;;038-134-360-685-692;;012-449-714-188-064;;031-517-704-996-130;;131-299-284-996-064;;049-133-049-742-708;;000-272-178-768-076;;070-797-683-833-124;;043-870-224-178-49X;;025-574-914-238-550;;052-364-430-129-757;;004-434-167-910-115;;032-860-147-271-886;;132-460-374-211-421;;098-172-374-375-47X;;109-358-955-476-095;;014-988-634-483-130;;061-786-187-274-992;;037-898-018-686-909;;130-044-667-529-69X;;134-265-642-839-645;;065-221-074-461-027;;017-934-465-161-477;;101-660-130-379-529;;028-236-706-290-220;;087-333-189-994-274;;059-082-211-027-266;;057-977-752-782-568,10.1016/s0956-5663(02)00099-4;;12392956;;10.1021/ja00391a001;;2889225;;10.1098/rstb.1987.0021;;10.1109/51.294001;;10.1016/0022-0728(65)85063-x;;2245876;;10.2337/diabetes.39.12.1519;;10.2337/diab.39.12.1519;;10.1016/s0956-5663(03)00220-3;;14611755;;18615658;;10.1002/bit.260430310;;9366023;;10.1016/s0956-5663(97)00025-0;;9451795;;10.1016/s0956-5663(97)00083-3;;10.1016/0956-5663(93)80028-n;;8311939;;8651496;;10.1021/ac960030d;;10.1080/03091900210156797;;12487712;;10.1016/0265-928x(87)80018-4;;3333622;;10.1109/19.816143;;10.1007/bf01015979;;10.1089/15209150252924058;;12017416;;18473691;;10.1089/dia.2007.0281;;10.1021/ac00017a008;;1789439;;2817408;;10.1021/ac00197a022;;10.1016/0925-4005(95)01730-5;;10.1016/0010-4825(90)90013-f;;2257734;;2868172;;8277748;;10.1016/0141-5425(93)90058-7;;11469630;;10.1089/15209150050214104;;10624783;;10.1016/s0168-8227(99)00113-8;;10.1089/15209150050214113;;11469631;;10.1007/bf00401374;;1478372;;10.2337/diacare.20.1.64;;9028696;;10.1109/tbme.1986.325807;;3957374;;236018;;10.1016/0005-2795(75)90259-7;;10.1089/hum.1998.9.6-879;;9581910;;11762520;;10.1089/15209150152607196;;10.2337/diabetes.48.3.445;;10078542;;10.1016/0265-928x(87)80012-3;;505005;;10.1126/science.505005;;10.1021/ac0498516;;15253640;;10.1109/10.284922;;8026845;;6721151;;10.1021/ac00268a018;;6733082;;10.1021/bi00305a016;;10.1515/cclm.2002.135;;12392305;;10.1016/j.ecl.2003.12.001;;15053902;;12052350;;10.1016/s0956-5663(01)00304-9;;12052349;;10.1016/s0956-5663(01)00306-2;;4500021;;10.1007/978-1-4684-3288-6_18;;14021529;;10.1111/j.1749-6632.1962.tb13623.x;;3196517;;10.2337/diacare.10.5.622;;3677983;;10.2337/diacare.8.6.529;;4075939;;10.1002/elan.1140061103;;7733469;;10.1021/ac00103a015;;7978306;;10.1021/ac00091a022;;10.1007/bf01248238;;10.1016/s0376-7388(98)00330-5;;10.1016/0142-9612(92)90147-g;;1472593;;10.1016/0265-928x(85)80002-x;;10.1021/j100290a001;;10.1021/ja00216a040;;10.1021/ja00188a091;;10.1021/ja00406a011;;2624333;;12323417;;10.1016/s0165-0270(02)00170-x;;10.1177/193229680700100208;;pmc2771467;;19888405;;10.1021/ja00415a014;;10.1007/bf00575392;;10.1021/ac00250a038;;10.1021/ac00266a005;;10.1007/s00216-002-1284-0;;12194035;;10.1089/dia.2006.0030;;17705688;;9642777;;10.1016/s0956-5663(97)00091-2;;10.1089/152091503322526978;;14633342;;10.1016/0022-0728(85)87006-6;;10.1021/ja00434a018;;10.1016/0003-2697(92)90243-z;;1443528;;10.1039/f19868201259;;3245585;;10.1021/ac00173a008;;2889234;;10.1098/rstb.1987.0020;;11762521;;10.1089/15209150152607204;;12413548;;10.1016/s1367-5931(02)00371-x;;10526740;;10.2337/diacare.22.10.1708;;14988294;;10.2337/diacare.27.3.734,"""Poretics Polycarbonate Membrane"", Osmonics Filtration and Separation Group, 2002.;;Abel, P. U., et al., ""Biosensors for In Vivo Glucose Measurement: Can We Cross the Experimental Stage"", Biosensors and Bioelectronics, vol. 17, 2002, pp. 1059-1070.;;Abruna, H. D., et al., ""Rectifying Interfaces Using Two-Layer Films of Electrochemically Polymerized Vinylpyridine and Vinylbipyridine Complexes of Ruthenium and Iron on Electrodes"", Journal of the American Chemical Society, vol. 103, No. 1, 1981, pp. 1-5.;;Albery, W. J., et al., ""Amperometric Enzyme Electrodes Part II: Conducting Salts as Electrode Materials for the Oxidation of Glucose Oxidase"", Journal of ElectroAnalytical Chemistry, vol. 194, 1985, pp. 223-235.;;Albery, W. J., et al., ""Amperometric Enzyme Electrodes"", Philosophical Transactions of The Royal Society of London, vol. 316, 1987, pp. 107-119.;;Alcock, S. J., et al., ""Continuous Analyte Monitoring to Aid Clinical Practice"", IEEE Engineering in Medicine and Biology Magazine, 1994, pp. 319-325.;;Anderson, L. B., et al., ""Thin-Layer Electrochemistry: Steady-State Methods of Studying Rate Processes"", Journal of ElectroAnalytical Chemistry, vol. 10, 1965, pp. 295-305.;;Armour, J. C., et al., ""Application of Chronic Intravascular Blood Glucose Sensor in Dogs"", Diabetes, vol. 39, 1990, pp. 1519-1526.;;Asberg, P., et al., ""Hydrogels of a Conducting Conjugated Polymer as 3-D Enzyme Electrode"", Biosensors & Bioelectronics, vol. 19, 2003, pp. 199-207.;;Atanasov, P., et al., ""Biosensor for Continuous Glucose Monitoring"", Biotechnology and Bioengineering, vol. 43, 1994, pp. 262-266.;;Atanasov, P., et al., ""Implantation of a Refillable Glucose Monitoring-Telemetry Device"", Biosensors & Bioelectronics, vol. 12, No. 7, 1997, pp. 669-680.;;Aussedat, B., et al., ""A User-Friendly Method for Calibrating a Subcutaneous Glucose Sensor-Based Hypoglycaemic Alarm"", Biosensors & Bioelectronics, vol. 12, No. 11, 1997, pp. 1061-1071.;;Baker, D. A., et al., ""Dynamic Concentration Challenges for Biosensor Characterization"", Biosensors & Bioelectronics, vol. 8, 1993, pp. 433-441.;;Baker, D. A., et al., ""Dynamic Delay and Maximal Dynamic Error in Continuous Biosensors"", Analytical Chemistry, vol. 68, No. 8, 1996, pp. 1292-1297.;;Bani Amer, M. M., ""An Accurate Amperometric Glucose Sensor Based Glucometer with Eliminated Cross-Sensitivity"", Journal of Medical Engineering & Technology, vol. 26, No. 5, 2002, pp. 208-213.;;Bard, A. J., et al., Electrochemical Methods, 1980, pp. 173-175.;;Bartlett, P. N., et al., ""Covalent Binding of Electron Relays to Glucose Oxidase"", Journal of the Chemical Society, Chemical Communications, 1987, pp. 1603-1604.;;Bartlett, P. N., et al., ""Modification of Glucose Oxidase by Tetrathiafulvalene"", Journal of the Chemical Society, Chemical Communications, 1990, pp. 1135-1136.;;Bartlett, P. N., et al., ""Strategies for the Development of Amperometric Enzyme Electrodes"", Biosensors, vol. 3, 1987/88, pp. 359-379.;;Beach, R. D., et al., ""Subminiature Implantable Potentiostat and Modified Commercial Telemetry Device for Remote Glucose Monitoring"", IEEE Transactions on Instrumentation and Measurement, vol. 28, No. 6, 1999, pp. 1239-1245.;;Beech, W. A., ""AX.25 Link Access Protocol for Amateur packet Radio"", Tucson Amateur Packet Radio Corporation, 1998, pp. 1-133.;;Bellucci, F., et al., ""Electrochemical Behaviour of Graphite-Epoxy Composite Materials (GECM) in Aqueous Salt Solutions"", Journal of Applied Electrochemistry, vol. 16, 1986, pp. 15-22.;;Bennion, N., et al., ""Alternate Site Glucose Testing: A Crossover Design"", Diabetes Technology & Therapeutics, vol. 4, No. 1, 2002, pp. 25-33.;;Biermann, E., et al., ""How Would Patients Behave if They Were Continually Informed of Their Blood Glucose Levels? A Simulation Study Using a 'Virtual' Patient"", Diabetes Technology & Therapeutics, vol. 10, No. 3, 2008, pp. 178-187.;;Bindra, D. S., et al., ""Design and in Vitro Studies of a Needle-Type Glucose Sensor for Subcutaneous Monitoring"", Analytical Chemistry, vol. 63, No. 17, 1991, pp. 1692-1696.;;Bindra, D. S., et al., ""Pulsed Amperometric Detection of Glucose in Biological Fluids at a Surface-Modified Gold Electrode"", Analytical Chemistry, vol. 61, No. 22, 1989, pp. 2566-2570.;;Bisenberger, M., et al., ""A Triple-Step Potential Waveform at Enzyme Multisensors with Thick-Film Gold Electrodes for Detection of Glucose and Sucrose"", Sensors and Actuators B, vol. 28, 1995, pp. 181-189.;;Bland, J. M., et al., ""A Note on the Use of the Intraclass Correlation Coefficient in the Evaluation of Agreement Between Two Methods of Measurement"", Computers in Biology and Medicine, vol. 20, No. 5, 1990, pp. 337-340.;;Bland, J. M., et al., ""Statistical Methods for Assessing Agreement Between Two Methods of Clinical Measurement"", The Lancet, 1986, pp. 307-310.;;Blank, T. B., et al., ""Clinical Results From a Non-Invasive Blood Glucose Monitor"", Optical Diagnostics and Sensing of Biological Fluids and Glucose and Cholesterol Monitoring II, Proceedings of SPIE, vol. 4624, 2002, pp. 1-10.;;Bobbioni-Harsch, E., et al., ""Lifespan of Subcutaneous Glucose Sensors and Their Performances During Dynamic Glycaemia Changes in Rats"", Journal of Biomedical Engineering, vol. 15, 1993, pp. 457-463.;;Bode, B. W., ""Clinical Utility of the Continuous Glucose Monitoring System"", Diabetes Technology & Therapeutics, vol. 2, Sup. 1, 2000, pp. S35-S41.;;Bode, B. W., et al., ""Continuous Glucose Monitoring Used to Adjust Diabetes Therapy Improves Glycosylated Hemoglobin: A Pilot Study"", Diabetes Research and Clinical Practice, vol. 46, 1999, pp. 183-190.;;Bode, B. W., et al., ""Using the Continuous Glucose Monitoring System to Improve the Management of Type I Diabetes"", Diabetes Technology & Therapeutics, vol. 2, Sup. 1, 2000, pp. S43-S48.;;Boedeker Plastics, Inc., ""Polyethylene Specifications"", Web Page of Boedeker.com, 2007, pp. 1-3.;;Bolinder, J., et al., ""Microdialysis Measurement of the Absolute Glucose Concentration in Subcutaneous Adipose Tissue Allowing Glucose Monitoring in Diabetic Patients"", Diabetologia, vol. 35, 1992, pp. 1177-1180.;;Bolinder, J., et al., ""Self-Monitoring of Blood Glucose in Type I Diabetic Patients: Comparison with Continuous Microdialysis Measurements of Glucose in Subcutaneous Adipose Tissue During Ordinary Life Conditions"", Diabetes Care, vol. 20, No. 1, 1997, pp. 64-70.;;Bott, A. W., ""A Comparison of Cyclic Voltammetry and Cyclic Staircase Voltammetry"", Current Separations, vol. 16, No. 1, 1997, pp. 23-26.;;Bott, A. W., ""Electrochemical Methods for the Determination of Glucose"", Current Separations, vol. 17, No. 1, 1998, pp. 25-31.;;Bowman, L., et al., ""The Packaging of Implantable Integrated Sensors"", IEEE Transactions on Biomedical Engineering, vol. 33, No. 2, 1986, pp. 248-255.;;Brandt, J., et al., ""Covalent Attachment of Proteins to Polysaccharide Carriers by Means of Benzoquinone"", Biochimica et Biophysica Acta, vol. 386, 1975, pp. 196-202.;;Brauker, J., et al., ""Sustained Expression of High Levels of Human Factor IX from Human Cells Implanted Within an Immunoisolation Device into Athymic Rodents"", Human Gene Therapy, vol. 9, No. 6, 1998, pp. 879-888.;;Bremer, T. M., et al., ""Benchmark Data from the Literature for Evaluation of New Glucose Sensing Technologies"", Diabetes Technology & Therapeutics, vol. 3, No. 3, 2001, pp. 409-418.;;Bremer, T., et al., ""Is Blood Glucose Predictable from Previous Values?"", Diabetes, vol. 48, 1999, pp. 445-451.;;Brooks, S. L., et al., ""Development of an On-Line Glucose Sensor for Fermentation Monitoring"", Biosensors, vol. 3, 1987/88, pp. 45-56.;;Brownlee, M., et al., ""A Glucose-Controlled Insulin-Delivery System: Semisynthetic Insulin Bound to Lectin"", Science, vol. 206, 1979, 1190-1191.;;Cai, Q., et al., ""A Wireless, Remove Query Glucose Biosensor Based on a pH-Sensitive Polymer"", Analytical Chemistry, vol. 76, No. 14, 2004, pp. 4038-4043.;;Candas, B., et al., ""An Adaptive Plasma Glucose Controller Based on a Nonlinear Insulin/Glucose Model"", IEEE Transactions on Biomedical Engineering, vol. 41, No. 2, 1994, pp. 116-124.;;Cass, A. E., et al., ""Ferricinum Ion as an Electron Acceptor for Oxido-Reductases"", Journal of ElectroAnalytical Chemistry, vol. 190, 1985, pp. 117-127.;;Cass, A. E., et al., ""Ferrocene-Medicated Enzyme Electrode for Amperometric Determination of Glucose"", Analytical Chemistry, vol. 56, No. 4, 1984, 667-671.;;Castner, J. F., et al., ""Mass Transport and Reaction Kinetic Parameters Determined Electrochemically for Immobilized Glucose Oxidase"", Biochemistry, vol. 23 No. 10, 1984, 2203-2210.;;Chen, J. C., et al., ""A Comparison of MAC Protocols for Wireless Local Networks Based on battery Power Consumption"", IEEE, 1998, pp. 150-157.;;Chen, T., et al., ""Defining the Period of Recovery of the Glucose Concentration After Its Local Perturbation by the Implantation of a Miniature Sensor"", Clinical Chemistry and Laboratory Medicine, vol. 40, No. 8, 2002, pp. 486-489.;;Chia, C. W., et al., ""Glucose Sensors: Toward Closed Loop Insulin Delivery"", Endocrinology and Metabolism Clinics of North America, vol. 33, 2004, pp. 175-195.;;Choleau, C., et al., ""Calibration of a Subcutaneous Amperometric Glucose Sensor Implanted for 7 Days in Diabetic Patients Part 2: Superiority of the One-Point Calibration Method"", Biosensors and Bioelectronics, vol. 17, 2002, pp. 647-654.;;Choleau, C., et al., ""Calibration of a Subcutaneous Amperometric Glucose Sensor Part 1: Effect of Measurement Uncertainties on the Determination of Sensor Sensitivity and Background Current"", Biosensors and Bioelectronics, vol. 17, 2002, pp. 641-646.;;Claremont, D. J., et al., ""Biosensors for Continuous In Vivo Glucose Monitoring"", Proceedings of the Annual International Conference of the IEEE Engineering in Medicine and Biology Society, vol. 10, 1988.;;Clark Jr., L. C., et al., ""Differential Anodic Enzyme Polarography for the Measurement of Glucose"", Oxygen Transport to Tissue: Instrumentation, Methods, and Physiology, 1973, pp. 127-133.;;Clark Jr., L. C., et al., ""Electrode Systems for Continuous Monitoring in Cardiovascular Surgery"", Annals New York Academy of Sciences, 1962, pp. 29-45.;;Clark Jr., L. C., et al., ""Long-term Stability of Electroenzymatic Glucose Sensors Implanted in Mice"", American Society of Artificial Internal Organs Transactions, vol. XXXIV, 1988, pp. 259-265.;;Clarke, W. L., et al., ""Evaluating Clinical Accuracy of Systems for Self-Monitoring of Blood Glucose"", Diabetes Care, vol. 10, No. 5, 1987, pp. 622-628.;;Complaint, ""Abbott Diabetes Care, Inc. v. Dexcom, Inc."", filed Aug. 11, 2005.;;Complaint, Amended, ""Abbott Diabetes Care, Inc. v. Dexcom, Inc."", filed Jun. 27, 2006.;;Cox, D. J., et al., ""Accuracy of Perceiving Blood Glucose in IDDM"", Diabetes Care, vol. 8, No. 6, 1985, pp. 529-536.;;Csoregi, E., et al., ""Amperometric Microbiosensors for Detection of Hydrogen Peroxide and Glucose Based on Peroxidase-Modified Carbon Fibers"", Electroanalysis, vol. 6, 1994, pp. 925-933.;;Csoregi, E., et al., ""Design and Optimization of a Selective Subcutaneously Implantable Glucose Electrode Based on 'Wired' Glucose Oxidase"", Analytical Chemistry, vol. 67, No. 7, 1995, pp. 1240-1244.;;Csoregi, E., et al., ""Design, Characterization, and One-Point in Vivo Calibration of a Subcutaneously Implanted Glucose Electrode"", Analytical Chemistry, vol. 66 No. 19, 1994, pp. 3131-3138.;;Csoregi, E., et al., ""On-Line Glucose Monitoring by Using Microdialysis Sampling and Amperometric Detection Based on 'Wired' Glucose Oxidase in Carbon Paste"", Mikrochimica Acta, vol. 121, 1995, pp. 31-40.;;D'Arrigo, G., et al., ""Porous-Si Based Bio Reactors for Glucose Monitoring and Drugs Production"", Proceedings of SPIE: Microfluids, BioMEMS, and Medical Microsystems, vol. 4982, 2003, pp. 178-184.;;Dai, W. S., et al., ""Hydrogel Membranes with Mesh Size Asymmetry Based on the Gradient Crosslinking of Poly(vinyl alcohol),"" Journal of Membrane Science, vol. 156, 1999, pp. 67-79.;;Davies, M. L., et al., ""Polymer Membranes in Clinical Sensor Applications"", Biomaterials, vol. 13, No. 14, 1992, pp. 971-978.;;Davis, G., ""Electrochemical Techniques for the Development of Amperometric Biosensors"", Biosensors, vol. 1, 1985, pp. 161-178.;;Degani, Y., et al., ""Direct Electrical Communication Between Chemically Modified Enzymes and Metal Electrodes. 1. Electron Transfer from Glucose Oxidase to Metal Electrodes via Electron Relays, Bound Covalently to the Enzyme"", The Journal of Physical Chemistry, vol. 91, No. 6, 1987, pp. 1285-1289.;;Degani, Y., et al., ""Direct Electrical Communication Between Chemically Modified Enzymes and Metal Electrodes. 2. Methods for Bonding Electron-Transfer Relays to Glucose Oxidase and D-Amino-Acid Oxidase"", Journal of the American Chemical Society, vol. 110, No. 8, 1988, pp. 2615-2620.;;Degani, Y., et al., ""Electrical Communication Between Redox Centers of Glucose Oxidase and Electrodes via Electrostatically and Covalently Bound Redox Polymers"", Journal of the American Chemical Society, vol. 111, 1989, pp. 2357-2358.;;Denisevich, P., et al., ""Unidirectional Current Flow and Charge State Trapping at Redox Polymer Interfaces on Bilayer Electrodes: Principles, Experimental Demonstration, and Theory"", Journal of the American Chemical Society, vol. 103, 1981, pp. 4727-4737.;;Dicks, J. M., et al., ""Ferrocene Modified Polypyrrole with Immobilised Glucose Oxidase and its Application in Amperometric Glucose Microbiosensors"", Annales de Biologie Clinique, vol. 47, 1989, pp. 607-619.;;Dixon, B. M., et al., ""Characterization In Vitro and In Vivo of the Oxygen Dependence of an Enzyme/Polymer Biosensors for Monitoring Brain Glucose"", Journal of Neuroscience Methods, vol. 119, 2002, pp. 135-142.;;Eighth Annual Diabetes Technology Meeting Abstracts, Nov. 13-15, 2008, pp. A1-A182.;;El-Khatib, F. H, et al., ""Adaptive Closed-Loop Control Provides Blood-Glucose Regulation Using Subcutaneous Insulin and Glucagon Infusion in Diabetic Swine"", Journal of Diabetes Science and Technology, vol. 1, No. 2, 2007, pp. 181-192.;;Ellis, C. D., et al., ""Selectivity and Directed Charge Transfer through an Electroactive Metallopolymer Film"", Journal of the American Chemical Society, vol. 103, No. 25, 1981, pp. 7480-7483.;;El-Sa'ad, L., et al., ""Moisture Absorption by Epoxy Resins: The Reverse Thermal Effect"", Journal of Materials Science, vol. 25, No. 8, 1990, pp. 3577-3582.;;Engstrom, R. C., ""Electrochemical Pretreatment of Glassy Carbon Electrodes"", Analytical Chemistry, vol. 54, No. 13, 1982, pp. 2310-2314.;;Engstrom, R. C., et al., ""Characterization of Electrochemically Pretreated Glassy Carbon Electrodes"", Analytical Chemistry, vol. 56, No. 2, 1984, pp. 136-141.;;Ernst, H., et al., ""Reliable Glucose Monitoring Through the Use of Microsystem Technology"", Analytical and Bioanalytical Chemistry, vol. 373, 2002, pp. 758-761.;;Fabietti, P. G., et al. ""Clinical Validation of a New Control-Oriented Model of Insulin and Glucose Dynamics in Subjects with Type 1 Diabetes"", Diabetes Technology & Therapeutics, vol. 9, No. 4, 2007, pp. 327-338.;;Fare, T. L., et al., ""Functional Characterization of a Conducting Polymer-Based Immunoassay System"", Biosensors & Bioelectronics, vol. 13, No. 3-4, 1998, pp. 459-470.;;Feldman, B., et al., ""A Continuous Glucose Sensor Based on Wired Enzyme(TM) Technology-Results from a 3-Day Trial in Patients with Type 1 Diabetes"", Diabetes Technology & Therapeutics, vol. 5, No. 5, 2003, pp. 769-779.;;Feldman, B., et al., ""Correlation of Glucose Concentrations in Interstitial Fluid and Venous Blood During Periods of Rapid Glucose Change"", Abbott Diabetes Care, Inc. Freestyle Navigator Continuous Glucose Monitor Pamphlet, 2004.;;Feldman, B., et al., ""Electron Transfer Kinetics at Redox Polymer/Solution Interfaces Using Microelectrodes and Twin Electrode Thin Layer Cells"", Journal of ElectroAnalytical Chemistry, vol. 194, 1985, pp. 63-81.;;Fischer, H., et al., ""Intramolecular Electron Transfer Medicated by 4,4'-Bypyridine and Related Bridging Groups"", Journal of the American Chemical Society, vol. 98, No. 18, 1976, pp. 5512-5517.;;Flentge, F., et al., ""An Enzyme-Reactor for Electrochemical Monitoring of Choline and Acetylcholine: Applications in High-Performance Liquid Chromatography, Bran Tissue, Microdialysis and Cerebrospinal Fluid,"" Analytical Biochemistry, vol. 204, 1992, pp. 305-310.;;Foulds, N. C., et al., ""Enzyme Entrapment in Electrically Conducting Polymers: Immobilisation of Glucose Oxidase in Polypyrrole and its Application in Amperometric Glucose Sensors"", Journal of the Chemical Society, Faraday Transactions 1, vol. 82, 1986, pp. 1259-1264.;;Foulds, N. C., et al., ""Immobilization of Glucose Oxidase in Ferrocene-Modified Pyrrole Polymers"", Analytical Chemistry, vol. 60, No. 22, 1988, pp. 2473-2478.;;Frew, J. E., et al., ""Electron-Transfer Biosensors"", Philosophical Transactions of The Royal Society of London, vol. 316, 1987, pp. 95-106.;;Frohnauer, M. K., et al., ""Graphical Human Insulin Time-Activity Profiles Using Standardized Definitions"", Diabetes Technology & Therapeutics, vol. 3, No. 3, 2001, pp. 419-429.;;Frost, M. C., et al., ""Implantable Chemical Sensors for Real-Time Clinical Monitoring: Progress and Challenges"", Current Opinion in Chemical Biology, vol. 6, 2002, pp. 633-641.;;Garg, S. K., et al., ""Correlation of Fingerstick Blood Glucose Measurements with GlucoWatch Biographer Glucose Results in Young Subjects with Type 1 Diabetes"", Diabetes Care, vol. 22, No. 10, 1999, pp. 1708-1714.;;Garg, S. K., et al., ""Improved Glucose Excursions Using an Implantable Real-Time Continuous Glucose Sensor in Adults with Type 1 Diabetes"", Diabetes Care, vol. 27, No. 3, 2004, pp. 734-738.",EXPIRED
174,US,A1,US 2010/0222660 A1,175-875-411-688-902,2010-09-02,2010,US 77994410 A,2010-05-13,US 77994410 A;;US 69082607 A;;US 42005703 A;;US 66719900 A;;US 7067798 A,1998-04-30,Analyte Monitoring Device and Methods of Use,"An analyte monitor includes a sensor, a sensor control unit, and a display unit. The sensor has, for example, a substrate, a recessed channel formed in the substrate, and conductive material disposed in the recessed channel to form a working electrode. The sensor control unit typically has a housing adapted for placement on skin and is adapted to receive a portion of an electrochemical sensor. The sensor control unit also includes two or more conductive contacts disposed on the housing and configured for coupling to two or more contact pads on the sensor. A transmitter is disposed in the housing and coupled to the plurality of conductive contacts for transmitting data obtained using the sensor. The display unit has a receiver for receiving data transmitted by the transmitter of the sensor control unit and a display coupled to the receiver for displaying an indication of a level of an analyte. The analyte monitor may also be part of a drug delivery system to alter the level of the analyte based on the data obtained using the sensor.",ABBOTT DIABETES CARE INC,SAY JAMES;;TOMASCO MICHAEL F;;HELLER ADAM;;GAL YORAM;;ARIA BEHRAD;;HELLER EPHRAIM;;PLANTE PHILLIP JOHN;;VREEKE MARK S;;FRIEDMAN KEITH A;;COLMAN FREDRIC C,,https://lens.org/175-875-411-688-902,Patent Application,yes,4,0,211,221,0,A61B5/14532;;A61B5/14532;;A61B5/0002;;A61B5/0002;;A61B5/002;;A61B5/01;;A61B5/14503;;A61B5/1451;;A61B5/14546;;A61B5/14546;;A61B5/1473;;A61B5/1473;;A61B5/1486;;A61B5/1486;;A61B5/14865;;A61B5/1495;;A61B5/4839;;A61B5/72;;A61B5/7278;;A61B5/7282;;A61B5/7405;;A61B5/743;;A61B5/7445;;A61B5/7445;;A61B5/7455;;A61B2560/0252;;A61B2560/0252;;A61M5/1723;;C12Q1/54;;G16H10/40;;G16H10/40;;G16H20/17;;G16H20/17;;H01L23/3107;;H01L23/3107;;H01L23/49548;;H01L23/49548;;H01L2924/0002;;H01L2924/0002;;H01L2924/19041;;H01L2924/19041;;H01L2924/3011;;H01L2924/3011;;Y10S128/903;;Y10S128/903;;Y10T29/49;;Y10T29/49;;Y10T29/49124;;Y10T29/49124,A61B5/145;;G01N27/30;;A61B5/00;;A61B5/1477;;A61B5/1495;;G01N27/416;;G06F19/00;;H01L23/31;;H01L23/495,600/365;;702/104,0,0,,,,DISCONTINUED
175,US,B2,US 9066695 B2,178-011-764-603-717,2015-06-30,2015,US 73478207 A,2007-04-12,US 73478207 A;;US 72224603 A;;US 42005703 A;;US 66719900 A;;US 7067798 A,1998-04-30,Analyte monitoring device and methods of use,"An analyte monitor includes a sensor, a sensor control unit, and a display unit. The sensor has, for example, a substrate, a recessed channel formed in the substrate, and conductive material disposed in the recessed channel to form a working electrode. The sensor control unit typically has a housing adapted for placement on skin and is adapted to receive a portion of an electrochemical sensor. The sensor control unit also includes two or more conductive contacts disposed on the housing and configured for coupling to two or more contact pads on the sensor. A transmitter is disposed in the housing and coupled to the plurality of conductive contacts for transmitting data obtained using the sensor. The display unit has a receiver for receiving data transmitted by the transmitter of the sensor control unit and a display coupled to the receiver for displaying an indication of a level of an analyte. The analyte monitor may also be part of a drug delivery system to alter the level of the analyte based on the data obtained using the sensor.",SAY JAMES;;TOMASCO MICHAEL F;;HELLER ADAM;;GAL YORAM;;ARIA BEHRAD;;HELLER EPHRAIM;;PLANTE PHILLIP JOHN;;VREEKE MARK S;;FRIEDMAN KEITH A;;COLMAN FREDRIC C;;ABBOTT DIABETES CARE INC,SAY JAMES;;TOMASCO MICHAEL F;;HELLER ADAM;;GAL YORAM;;ARIA BEHRAD;;HELLER EPHRAIM;;PLANTE PHILLIP JOHN;;VREEKE MARK S;;FRIEDMAN KEITH A;;COLMAN FREDRIC C,E. HELLER & CO (1998-07-02);;ABBOTT DIABETES CARE INC (2000-03-13),https://lens.org/178-011-764-603-717,Granted Patent,yes,110,8,2,221,0,A61B5/14865;;A61B5/14865;;A61B5/14532;;A61B5/14532;;A61B5/14546;;A61B5/14546;;A61B5/1495;;A61B5/1495;;A61B5/7445;;A61B5/7445;;A61M5/1723;;A61M5/1723,A61B5/1468;;A61B5/00;;A61B5/145;;A61B5/1473;;A61B5/1486;;A61B5/1495;;A61M5/172,,99,71,136-791-935-548-81X;;062-360-289-025-864;;010-601-725-111-91X;;101-292-518-663-191;;056-703-879-057-297;;030-155-762-644-019;;004-149-141-436-651;;016-731-054-793-457;;080-559-561-995-335;;044-807-213-528-815;;027-538-525-436-179;;015-020-161-517-40X;;025-919-454-564-785;;014-700-576-603-812;;004-851-060-590-788;;075-958-432-122-199;;052-356-140-149-389;;035-090-282-884-790;;033-562-815-299-181;;018-803-926-589-211;;008-505-762-041-402;;016-601-143-530-813;;019-502-772-562-215;;058-476-824-396-350;;006-498-707-073-30X;;054-091-551-638-293;;010-531-147-771-746;;054-827-198-877-419;;122-658-944-077-000;;017-261-560-469-37X;;000-125-755-474-124;;113-381-664-783-802;;082-626-907-191-554;;017-950-014-792-456;;090-348-305-613-628;;015-985-399-299-132;;171-049-047-164-618;;016-819-089-891-758;;081-249-097-078-543;;089-612-747-111-646;;031-706-897-890-035;;094-198-536-559-723;;003-690-143-043-420;;007-943-354-378-456;;082-114-500-909-975;;004-239-090-971-580;;026-894-457-160-450;;077-128-610-778-669;;022-466-506-956-898;;008-424-592-956-946;;007-500-825-916-378;;009-725-244-669-882;;037-755-689-613-42X;;153-411-506-517-475;;038-134-360-685-692;;012-449-714-188-064;;031-517-704-996-130;;131-299-284-996-064;;049-133-049-742-708;;000-272-178-768-076;;070-797-683-833-124;;043-870-224-178-49X;;025-574-914-238-550;;052-364-430-129-757;;004-434-167-910-115;;032-860-147-271-886;;132-460-374-211-421;;098-172-374-375-47X;;109-358-955-476-095;;014-988-634-483-130;;061-786-187-274-992,10.1016/s0956-5663(02)00099-4;;12392956;;10.1021/ja00391a001;;2889225;;10.1098/rstb.1987.0021;;10.1109/51.294001;;10.1016/0022-0728(65)85063-x;;2245876;;10.2337/diabetes.39.12.1519;;10.2337/diab.39.12.1519;;10.1016/s0956-5663(03)00220-3;;14611755;;18615658;;10.1002/bit.260430310;;9366023;;10.1016/s0956-5663(97)00025-0;;9451795;;10.1016/s0956-5663(97)00083-3;;10.1016/0956-5663(93)80028-n;;8311939;;8651496;;10.1021/ac960030d;;10.1080/03091900210156797;;12487712;;10.1016/0265-928x(87)80018-4;;3333622;;10.1109/19.816143;;10.1007/bf01015979;;10.1089/15209150252924058;;12017416;;18473691;;10.1089/dia.2007.0281;;10.1021/ac00017a008;;1789439;;2817408;;10.1021/ac00197a022;;10.1016/0925-4005(95)01730-5;;10.1016/0010-4825(90)90013-f;;2257734;;2868172;;8277748;;10.1016/0141-5425(93)90058-7;;11469630;;10.1089/15209150050214104;;10624783;;10.1016/s0168-8227(99)00113-8;;10.1089/15209150050214113;;11469631;;10.1007/bf00401374;;1478372;;10.2337/diacare.20.1.64;;9028696;;10.1109/tbme.1986.325807;;3957374;;236018;;10.1016/0005-2795(75)90259-7;;10.1089/hum.1998.9.6-879;;9581910;;11762520;;10.1089/15209150152607196;;10.2337/diabetes.48.3.445;;10078542;;10.1016/0265-928x(87)80012-3;;505005;;10.1126/science.505005;;10.1021/ac0498516;;15253640;;10.1109/10.284922;;8026845;;6721151;;10.1021/ac00268a018;;6733082;;10.1021/bi00305a016;;10.1515/cclm.2002.135;;12392305;;10.1016/j.ecl.2003.12.001;;15053902;;12052350;;10.1016/s0956-5663(01)00304-9;;12052349;;10.1016/s0956-5663(01)00306-2;;4500021;;10.1007/978-1-4684-3288-6_18;;14021529;;10.1111/j.1749-6632.1962.tb13623.x;;3196517;;10.2337/diacare.10.5.622;;3677983;;10.2337/diacare.8.6.529;;4075939;;10.1002/elan.1140061103;;7733469;;10.1021/ac00103a015;;7978306;;10.1021/ac00091a022;;10.1007/bf01248238;;10.1016/s0376-7388(98)00330-5;;10.1016/0142-9612(92)90147-g;;1472593;;10.1016/0265-928x(85)80002-x;;10.1021/j100290a001;;10.1021/ja00216a040;;10.1021/ja00188a091;;10.1021/ja00406a011;;2624333;;12323417;;10.1016/s0165-0270(02)00170-x;;10.1177/193229680700100208;;pmc2771467;;19888405;;10.1021/ja00415a014;;10.1007/bf00575392;;10.1021/ac00250a038;;10.1021/ac00266a005;;10.1007/s00216-002-1284-0;;12194035;;10.1089/dia.2006.0030;;17705688;;9642777;;10.1016/s0956-5663(97)00091-2;;10.1089/152091503322526978;;14633342,"U.S. Appl. No. 09/447,227, Shults.;;U.S. Appl. No. 11/737,671, Wolpert, et al.;;U.S. Appl. No. 11/766,747, Say, et al.;;U.S. Appl. No. 11/849,200, Peyser, et al.;;U.S. Appl. No. 11/928,574, Heller, et al.;;U.S. Appl. No. 11/928,668, Heller, et al.;;U.S. Appl. No. 11/928,743, Heller, et al.;;U.S. Appl. No. 11/928,795, Heller, et al.;;U.S. Appl. No. 11/928,891, Heller, et al.;;U.S. Appl. No. 11/928,968, Heller, et al.;;U.S. Appl. No. 11/941,078, Say, et al.;;Abel, P. U., et al., ""Biosensors for In Vivo Glucose Measurement: Can We Cross the Experimental Stage"", Biosensors and Bioelectronics, vol. 17, 2002, pp. 1059-1070.;;Abruna, H. D., et al., ""Rectifying Interfaces Using Two-Layer Films of Electrochemically Polymerized Vinylpyridine and Vinylbipyridine Complexes of Ruthenium and Iron on Electrodes"", Journal of the American Chemical Society, vol. 103, No. 1, 1981, pp. 1-5.;;Albery, W. J. et al., ""Amperometric Enzyme Electrodes Part II. Conducting Salts as Electrode Materials for the Oxidation of Glucose Oxidase"", Journal of ElectroAnalytical Chemistry, vol. 194, 1985, pp. 223-235.;;Albery, W. J. et al., ""Amperometric Enzyme Electrodes"", Philosophical Transactions of The Royal Society of London, vol. 316, 1987, pp. 107-119.;;Alcock, S. J. et al., ""Continuous Analyte Monitoring to Aid Clinical Practice"", IEEE Engineering in Medicine and Biology Magazine, 1994, pp. 319-325.;;Anderson, L. B., et al., ""Thin-Layer Electrochemistry: Steady-State Methods of Studying Rate Processes"", Journal of ElectroAnalytical Chemistry, vol. 10, 1965, pp. 295-305.;;Armour, J. C., et al., ""Application of Chronic Intravascular Blood Glucose Sensor in Dogs"", Diabetes, vol. 39, 1990, pp. 1519-1526.;;Asberg, P., et al., ""Hydrogels of a Conducting Conjugated Polymer as 3-D Enzyme Electrode"", Biosensors & Bioelectronics, vol. 19, 2003, pp. 199-207.;;Atanasov, P., et al., ""Biosensor for Continuous Glucose Monitoring"", Biotechnology and Bioengineering, vol. 43, 1994, pp. 262-266.;;Atanasov, P., et al., ""Implantation of a Refillable Glucose Monitoring-Telemetry Device"", Biosensors & Bioelectronics, vol. 12, No. 7, 1997, pp. 669-680.;;Aussedat, B., et al., ""A User-Friendly Method for Calibrating a Subcutaneous Glucose Sensor-Based Hypoglycaemic Alarm"", Biosensors & Bioelectronics, vol. 12, No. 11, 1997, pp. 1061-1071.;;Baker, D. A., et al., ""Dynamic Concentration Challenges for Biosensor Characterization"", Biosensors & Bioelectronics, vol. 8, 1993, pp. 433-441.;;Baker, D. A., et al., ""Dynamic Delay and Maximal Dynamic Error in Continuous Biosensors"", Analytical Chemistry, vol. 68, No. 8, 1996, pp. 1292-1297.;;Bani Amer, M. M., ""An Accurate Amperometric Glucose Sensor Based Glucometer with Eliminated Cross-Sensitivity"", Journal of Medical Engineering & Technology, vol. 26, No. 5, 2002, pp. 208-213.;;Bard, A. J., et al., Electrochemical Methods, 1980, pp. 173-175.;;Bartlett, P. N., et al., ""Covalent Binding of Electron Relays to Glucose Oxidase"", Journal of the Chemical Society, Chemical Communications, 1987, pp. 1603-1604.;;Bartlett, P. N., et al., ""Modification of Glucose Oxidase by the Tetrathiafulvalene"", Journal of Chemical Society, Chemical Communications, 1990, pp. 1135-1136.;;Bartlett, P. N., et al., ""Strategies for the Development of Amperometric Enzyme Electrodes"", Biosensors, vol. 3, 1987/88, pp. 359-379.;;Beach, R. D., et al., ""Subminiature Implantable Potentiostat and Modified Commercial Telemetry Device for Remote Glucose Monitoring"", IEEE Transactions on Instrumentation and Measurement, vol. 28, No. 6, 1999, pp. 1239-1245.;;Beech, W. A., ""AX.25 Link Access Protocol for Amateur packet Radio"", Tucson Amateur Packet Radio Corporation, 1998, pp. 1-133.;;Bellucci, F., et al., ""Electrochemical Behaviour of Graphite-Epoxy Composite Materials (GECM) in Aqueous Salt Solutions"", Journal of Applied Electrochemistry, vol. 16, 1986, pp. 15-22.;;Bennion, N., et al., ""Alternate Site Glucose Testing: A Crossover Design"", Diabetes Technology & Therapeutics, vol. 4, No. 1, 2002, pp. 25-33.;;Biermann, E., et al., ""How Would Patients Behave if They Were Continually Informed of Their Blood Glucose Levels? A Simulation Study Using a 'Virtual'Patient"", Diabetes Technology & Therapeutics, vol. 10, No. 3, 2008, pp. 178-187.;;Bindra, D. S., et al., ""Design and in Vitro Studies of a Needle-Type Glucose Sensor for Subcutaneous Monitoring"", Analytical Chemistry, vol. 63, No. 17, 1991, pp. 1692-1696.;;Bindra, D. S., et al., ""Pulsed Amperometric Detection of Glucose in Biological Fluids at a Surface-Modified Gold Electrode"", Analytical Chemistry, vol. 61, No. 22, 1989, pp. 2566-2570.;;Bisenberger, M., et al., ""A Triple-Step Potential Waveform at Enzyme Multisensors with Thick-Film Gold Electrodes for Detection of Glucose and Sucrose"", Sensors and Actuators B, vol. 28, 1995, pp. 181-189.;;Bland, J. M., et al., ""A Note on the Use of the Intraclass Correlation Coefficient in the Evaluation of Agreement Between Two Methods of Measurement"", Computers in Biology and Medicine, vol. 20, No. 5, 1990, pp. 337-340.;;Bland, J. M., et al., ""Statistical Methods for Assessing Agreement Between Two Methods of Clinical Measurement"", The Lancet, 1986, pp. 307-310.;;Blank, T. B., et al., ""Clinical Results From a Non-Invasive Blood Glucose Monitor"", Optical Diagnostics and Sensing of Biological Fluids and Glucose and Cholesterol Monitoring II, Proceedings of SPIE, vol. 4624, 2002, pp. 1-10.;;Bobbioni-Harsch, E., et al., ""Lifespan of Subcutaneous Glucose Sensors and Their Performances During Dynamic Glycaemia Changes in Rats"", Journal of Biomedical Engineering, vol. 15, 1993, pp. 457-463.;;Bode, B. W., ""Clinical Utility of the Continuous Glucose Monitoring System"", Diabetes Technology & Therapeutics, vol. 2, Sup. 1, 2000, pp. S35-S41.;;Bode, B. W., et al., ""Continuous Glucose Monitoring Used to Adjust Diabetes Therapy Improves Glycosylated Hemoglobin: A Pilot Study"", Diabetes Research and Clinical Practice, vol. 46, 1999, pp. 183-190.;;Bode, B. W., et al., ""Using the Continuous Glucose Monitoring System to Improve the Management of Type I Diabetes"", Diabetes Technology & Therapeutics, vol. 2, Sup. 1, 2000, pp. S43-S48.;;Boedeker Plastics, Inc., ""Polyethylene Specifications"", Web Page of Boedeker.com, 2007, pp. 1-3.;;Bolinder, J., et al., ""Microdialysis Measurement of the Absolute Glucose Concentration in Subcutaneous Adipose Tissue Allowing Glucose Monitoring in Diabetic Patients"", Diabetologia, vol. 35, 1992, pp. 1177-1180.;;Bolinder, J., et al., ""Self-Monitoring of Blood Glucose in Type I Diabetic Patients: Comparison with Continuous Microdialysis Measurements of Glucose in Subcutaneous Adipose Tissue During Ordinary Life Conditions"", Diabetes Care, vol. 20, No. 1, 1997, pp. 64-70.;;Bott, A. W., ""A Comparison of Cyclic Voltammetry and Cyclic Staircase Voltammetry"", Current Separations, vol. 16, No. 1, 1997, pp. 23-26.;;Bott, A. W., ""Electrochemical Methods for the Determination of Glucose"", Current Separations, vol. 17, No. 1, 1998, pp. 25-31.;;Bowman, L., et al., ""The Packaging of Implantable Integrated Sensors"", IEEE Transactions on Biomedical Engineering, vol. 33, No. 2, 1986, pp. 248-255.;;Brandt, J., et al., ""Covalent Attachment of Proteins to Polysaccharide Carriers by Means of Benzoquinone"", Biochimica et Biophysica Acta, vol. 386, 1975, pp. 196-202.;;Brauker, J., et al., ""Sustained Expression of High Levels of Human Factor IX from Human Cells Implanted Within an Immunoisolation Device into Athymic Rodents"", Human Gene Thrapy, vol. 9, No. 6, 1998, pp. 879-888.;;Bremer, T. M., et al., ""Benchmark Data from the Literature for Evaluation of New Glucose Sensing Technologies"", Diabetes Technology & Therapeutics, vol. 3, No. 3, 2001, pp. 409-418.;;Bremer, T., et al., ""Is Blood Glucose Predictable from Previous Values?"", Diabetes, vol. 48, 1999, pp. 445-451.;;Brooks, S. L., et al., ""Development of an On-Line Glucose Sensor for Fermentation Monitoring"", Biosensors, vol. 3, 1987/88, pp. 45-56.;;Brownlee, M., et al., ""A Glucose-Controlled Insulin-Delivery System: Semisynthetic Insulin Bound to Lectin"", Science, vol. 206, 1979, 1190-1191.;;Cai, Q., et al., ""A Wireless, Remove Query Glucose Biosensor Based on a pH-Sensitive Polymer"", Analytical Chemistry, vol. 76, No. 14, 2004, pp. 4038-4043.;;Candas, B., et al., ""An Adaptive Plasma Glucose Controller Based on a Nonlinear Insulin/Glucose Model"", IEEE Transactions on Biomedical Engineering, vol. 41, No. 2, 1994, pp. 116-124.;;Cass, A. E. et al., ""Ferricinum Ion as an Electron Acceptor for Oxido-Reductases"", Journal of ElectroAnalytical Chemistry, vol. 190, 1985, pp. 117-127.;;Cass, A. E. et al., ""Ferrocene-Mediated Enzyme Electrode for Amperometric Determination of Glucose"", Analytical Chemistry, vol. 56, No. 4, 1984, 667-671.;;Castner, J. F. et al., ""Mass Transport and Reaction Kinetic Parameters Determined Electrochemically for Immobilized Glucose Oxidase"", Biochemisty, vol. 23 No. 10, 1984, 2203-2210.;;Chen, J. C., et al., ""A Comparison of MAC Protocols for Wireless Local Networks Based on battery Power Consumption"", IEEE, 1998, pp. 150-157.;;Chen, T., et al., ""Defining the Period of Recovery of the Glucose Concentration After Its Local Perturbation by the Implantation of a Miniature Sensor"", Clinical Chemistry and Laboratory Medicine, vol. 40, No. 8, 2002, pp. 486-489.;;Chia, C. W., et al., ""Glucose Sensors: Toward Closed Loop Insulin Delivery"", Endocrinology and Metabolism Clinics of North America, vol. 33, 2004, pp. 175-195.;;Choleau, C., et al., ""Calibration of a Subcutaneous Amperometric Glucose Sensor Implanted for 7 Days in Diabetic Patients Part 2: Superiority of the One-Point Calibration Method"", Biosensors and Bioelectronics, vol. 17, 2002, pp. 647-654.;;Choleau, C., et al., ""Calibration of a Subcutaneous Amperometric Glucose Sensor Part 1: Effect of Measurement Uncertainties on the Determination of Sensor Sensitivity and Background Current"", Biosensors and Bioelectronics, vol. 17, 2002, pp. 641-646.;;Claremont, D. J., et al., ""Biosensors for Continuous In Vivo Glucose Monitoring"", Proceedings of the Annual International Conference of the IEEE Engineering in Medicine and Biology Society, vol. 10, 1988.;;Clark Jr., L. C., et al., ""Differential Anodic Enzyme Polarography for the Measurement of Glucose"", Oxygen Transport to Tissue: Instrumentation, Methods, and Physiology, 1973, pp. 127-133.;;Clark Jr., L. C., et al., ""Electrode Systems for Continuous Monitoring in Cardiovascular Surgery"", Annals New York Academy of Sciences, 1962, pp. 29-45.;;Clark Jr., L. C., et al., ""Long-term Stability of Electroenzymatic Glucose Sensors Implanted in Mice"", American Society of Artificial Internal Organs Transactions, vol. XXXIV, 1988, pp. 259-265.;;Clarke, W. L., et al., ""Evaluating Clinical Accuracy of Systems for Self-Monitoring of Blood Glucose"", Diabetes Care, vol. 10, No. 5, 1987, pp. 622-628.;;Complaint, ""Abbott Diabetes Care, Inc. v. Dexcom, Inc."", filed Aug. 11, 2005.;;Complaint, Amended, ""Abbott Diabetes Care, Inc. v. Dexcom, Inc."", filed Jun. 27, 2006.;;Cox, D. J., et al., ""Accuracy of Perceiving Blood Glucose in IDDM"", Diabetes Care, vol. 8, No. 6, 1985, pp. 529-536.;;Csoregi, E., et al., ""Amperometric Microbiosensors for Detection of Hydrogen Peroxide and Glucose Based on Peroxidase-Modified Carbon Fibers"", Electroanalysis, vol. 6, 1994, pp. 925-933.;;Csoregi, E. et al., ""Design and Optimization of a Selective Subcutaneously Implantable Glucose Electrode Based on 'Wired' Glucose Oxidase"", Analytical Chemistry, vol. 67, No. 7, 1995, pp. 1240-1244.;;Csoregi, E. et al., ""Design, Characterization, and One-Point in Vivo Calibration of a Subcutaneously Implanted Glucose Electrode"", Analytical Chemistry, vol. 66 No. 19, 1994, pp. 3131-3138.;;Csoregi, E. et al., ""On-Line Glucose Monitoring by Using Microdialysis Sampling and Amperometric Detection Based on 'Wired' Glucose Oxidase in Carbon Paste"", Mikrochimica Acta, vol. 121, 1995, pp. 31-40.;;D'Arrigo, G., et al., ""Porous-Si Based Bio Reactors for Glucose Monitoring and Drugs Production"", Proceedings of SPIE: Microfluids, BioMEMS, and Medical Microsystems, vol. 4982, 2003, pp. 178-184.;;Dai, W. S., et al., ""Hydrogel Membranes with Mesh Size Asymmetry Based on the Gradient Crosslinking of Poly(vinyl alcohol),"" Journal of Membrane Science, vol. 156, 1999, pp. 67-79.;;Davies, M. L., et al., ""Polymer Membranes in Clinical Sensor Applications"", Biomaterials, vol. 13, No. 14, 1992, pp. 971-978.;;Davis, G., ""Electrochemical Techniques for the Development of Amperometric Biosensors"", Biosensors, vol. 1, 1985, pp. 161-178.;;Degani, Y., et al., ""Direct Electrical Communication Between Chemically Modified Enzymes and Metal Electrodes. 1. Electron Transfer from Glucose Oxidase to Metal Electrodes via Electron Relays, Bound Covalently to the Enzyme"", The Journal of Physical Chemistry, vol. 91, No. 6, 1987, pp. 1285-1289.;;Degani, Y. et al., ""Direct Electrical Communication Between Chemically Modified Enzymes and Metal Electrodes. 2. Methods for Bonding Electron-Transfer Relays to Glucose Oxidase and D-Amino-Acid Oxidase"", Journal of the American Chemical Society, vol. 110, No. 8, 1988, pp. 2615-2620.;;Degani, Y., et al., ""Electrical Communication Between Redox Centers of Glucose Oxidase and Electrodes via Electrostatically and Covalently Bound Redox Polymers"", Journal of the American Chemical Society, vol. 111, 1989, pp. 2357-2358.;;Denisevich, P., et al., ""Unidirectional Current Flow and Charge State Trapping at Redox Polymer Interfaces on Bilayer Electrodes: Principles, Experimental Demonstration, and Theory"", Journal of the American Chemical Society, vol. 103, 1981, pp. 4727-4737.;;Dicks, J. M., ""Ferrocene Modified Polypyrrole with Immobilised Glucose Oxidase and its Application in Amperometric Glucose Microbiosensors"", Annales de Biologie Clinique, vol. 47, 1989, pp. 607-619.;;Dixon, B. M., et al., ""Characterization In Vitro and In Vivo of the Oxygen Dependence of an Enzyme/Polymer Biosensors for Monitoring Brain Glucose"", Journal of Neuroscience Methods, vol. 119, 2002, pp. 135-142.;;Eighth Annual Diabetes Technology Meeting Abstracts, Nov. 13-15, 2008, pp. A1-A182.;;El-Khatib, F. H, et al., ""Adaptive Closed-Loop Control Provides Blood-Glucose Regulation Using Subcutaneous Insulin and Glucagon Infusion in Diabetic Swine"", Journal of Diabetes Science and Technology, vol. 1, No. 2, 2007, pp. 181-192.;;Ellis, C. D., ""Selectivity and Directed Charge Transfer through an Electroactive Metallopolymer Film"", Journal of the American Chemical Society, vol. 103, No. 25, 1981, pp. 7480-7483.;;El-Sa'Ad, L., et al., ""Moisture Absorption by Epoxy Resins: The Reverse Thermal Effect"", Journal of Materials Science, vol. 25, No. 8, 1990, pp. 3577-3582.;;Engstrom, R. C., Electrochemical Pretreatment of Glassy Carbon Electrodes, Analytical Chemistry, vol. 54, No. 13, 1982, pp. 2310-2314.;;Engstrom, R. C. et al., ""Characterization of Electrochemically Pretreated Glassy Carbon Electrodes"", Analytical Chemistry, vol. 56, No. 2, 1984, pp. 136-141.;;Ernst, H., et al., ""Reliable Glucose Monitoring Through the Use of Microsystem Technology"", Analytical and Bioanalytical Chemistry, vol. 373, 2002, pp. 758-761.;;Fabietti, P. G., et al. ""Clinical Validation of a New Control-Oriented Model of Insulin and Glucose Dynamics in Subjects with Type 1 Diabetes"", Diabetes Technology & Therapeutics, vol. 9, No. 4, 2007, pp. 327-338.;;Fare, T. L., et al., ""Functional Characterization of a Conducting Polymer-Based Immunoassay System"", Biosensors & Bioelectronics, vol. 13, No. 3-4, 1998, pp. 459-470.;;Feldman, B., et al., ""A Continuous Glucose Sensor Based on Wired Enzyme(TM) Technology-Results from a 3-Day Trial in Patients with Type 1 Diabetes"", Diabetes Technology & Therapeutics, vol. 5, No. 5, 2003, pp. 769-779.;;Feldman, B., et al., ""Correlation of Glucose Concentrations in Interstitial Fluid and Venous Blood During Periods of Rapid Glucose Change"", Abbott Diabetes Care, Inc. Freestyle Navigator Continuous Glucose Monitor Pamphlet, 2004",EXPIRED
176,EP,B1,EP 1075209 B1,196-383-815-867-481,2014-10-29,2014,EP 99903239 A,1999-01-21,US 9901229 W;;US 7067798 A,1998-04-30,ANALYTE MONITORING DEVICE,,ABBOTT DIABETES CARE INC,SAY JAMES;;TOMASCO MICHAEL F;;HELLER ADAM;;GAL YORAM;;ARIA BEHRAD;;HELLER EPHRAIM;;PLANTE PHILLIP J;;VREEKE MARK S;;FRIEDMAN KEITH A;;COLMAN FREDRIC C,ABBOTT DIABETES CARE INC. (2008-06-04),https://lens.org/196-383-815-867-481,Granted Patent,yes,3,5,211,221,0,A61B5/14532;;A61B5/14532;;A61B5/0002;;A61B5/0002;;A61B5/002;;A61B5/01;;A61B5/14503;;A61B5/1451;;A61B5/14546;;A61B5/14546;;A61B5/1473;;A61B5/1473;;A61B5/1486;;A61B5/1486;;A61B5/14865;;A61B5/1495;;A61B5/4839;;A61B5/72;;A61B5/7278;;A61B5/7282;;A61B5/7405;;A61B5/743;;A61B5/7445;;A61B5/7445;;A61B5/7455;;A61B2560/0252;;A61B2560/0252;;A61M5/1723;;C12Q1/54;;G16H10/40;;G16H10/40;;G16H20/17;;G16H20/17;;H01L23/3107;;H01L23/3107;;H01L23/49548;;H01L23/49548;;H01L2924/0002;;H01L2924/0002;;H01L2924/19041;;H01L2924/19041;;H01L2924/3011;;H01L2924/3011;;Y10S128/903;;Y10S128/903;;Y10T29/49;;Y10T29/49;;Y10T29/49124;;Y10T29/49124,A61B5/00;;G01N27/30;;A61B5/145;;A61B5/1477;;A61B5/1495;;G01N27/416;;G06F19/00;;H01L23/31;;H01L23/495,,0,0,,,,EXPIRED
177,US,A1,US 2009/0198116 A1,010-973-698-811-167,2009-08-06,2009,US 41792409 A,2009-04-03,US 41792409 A;;US 42005703 A;;US 66719900 A;;US 7067798 A,1998-04-30,Analyte Monitoring Device and Methods of Use,"An analyte monitor includes a sensor, a sensor control unit, and a display unit. The sensor has, for example, a substrate, a recessed channel formed in the substrate, and conductive material disposed in the recessed channel to form a working electrode. The sensor control unit typically has a housing adapted for placement on skin and is adapted to receive a portion of an electrochemical sensor. The sensor control unit also includes two or more conductive contacts disposed on the housing and configured for coupling to two or more contact pads on the sensor. A transmitter is disposed in the housing and coupled to the plurality of conductive contacts for transmitting data obtained using the sensor. The display unit has a receiver for receiving data transmitted by the transmitter of the sensor control unit and a display coupled to the receiver for displaying an indication of a level of an analyte. The analyte monitor may also be part of a drug delivery system to alter the level of the analyte based on the data obtained using the sensor.",ABBOTT DIABETES CARE INC,SAY JAMES;;TOMASCO MICHAEL F;;HELLER ADAM;;GAL YORAM;;ARIA BEHRAD;;HELLER EPHRAIM;;PLANTE PHILLIP JOHN;;VREEKE MARK S;;FRIEDMAN KEITH A;;COLMAN FREDRIC C,,https://lens.org/010-973-698-811-167,Patent Application,yes,1,57,211,221,0,A61B5/14532;;A61B5/14532;;A61B5/0002;;A61B5/0002;;A61B5/002;;A61B5/01;;A61B5/14503;;A61B5/1451;;A61B5/14546;;A61B5/14546;;A61B5/1473;;A61B5/1473;;A61B5/1486;;A61B5/1486;;A61B5/14865;;A61B5/1495;;A61B5/4839;;A61B5/72;;A61B5/7278;;A61B5/7282;;A61B5/7405;;A61B5/743;;A61B5/7445;;A61B5/7445;;A61B5/7455;;A61B2560/0252;;A61B2560/0252;;A61M5/1723;;C12Q1/54;;G16H10/40;;G16H10/40;;G16H20/17;;G16H20/17;;H01L23/3107;;H01L23/3107;;H01L23/49548;;H01L23/49548;;H01L2924/0002;;H01L2924/0002;;H01L2924/19041;;H01L2924/19041;;H01L2924/3011;;H01L2924/3011;;Y10S128/903;;Y10S128/903;;Y10T29/49;;Y10T29/49;;Y10T29/49124;;Y10T29/49124,A61B5/1468;;G01N27/30;;A61B5/00;;A61B5/145;;A61B5/1477;;A61B5/1495;;G01N27/416;;G06F19/00;;H01L23/31;;H01L23/495,600/345,0,0,,,,DISCONTINUED
178,US,B2,US 8366614 B2,017-512-096-324-137,2013-02-05,2013,US 41448709 A,2009-03-30,US 41448709 A;;US 42005703 A;;US 66719900 A;;US 7067798 A,1998-04-30,Analyte monitoring device and methods of use,"An analyte monitor includes a sensor, a sensor control unit, and a display unit. The sensor has, for example, a substrate, a recessed channel formed in the substrate, and conductive material disposed in the recessed channel to form a working electrode. The sensor control unit typically has a housing adapted for placement on skin and is adapted to receive a portion of an electrochemical sensor. The sensor control unit also includes two or more conductive contacts disposed on the housing and configured for coupling to two or more contact pads on the sensor. A transmitter is disposed in the housing and coupled to the plurality of conductive contacts for transmitting data obtained using the sensor. The display unit has a receiver for receiving data transmitted by the transmitter of the sensor control unit and a display coupled to the receiver for displaying an indication of a level of an analyte. The analyte monitor may also be part of a drug delivery system to alter the level of the analyte based on the data obtained using the sensor.",ABBOTT DIABETES CARE INC;;SAY JAMES;;TOMASCO MICHAEL F;;HELLER ADAM;;GAL YORAM;;ARIA BEHRAD;;HELLER EPHRAIM;;PLANTE PHILLIP JOHN;;VREEKE MARK S;;FRIEDMAN KEITH A;;COLMAN FREDRIC C,SAY JAMES;;TOMASCO MICHAEL F;;HELLER ADAM;;GAL YORAM;;ARIA BEHRAD;;HELLER EPHRAIM;;PLANTE PHILLIP JOHN;;VREEKE MARK S;;FRIEDMAN KEITH A;;COLMAN FREDRIC C,E. HELLER & CO (1998-07-02);;ABBOTT DIABETES CARE INC (2000-03-13),https://lens.org/017-512-096-324-137,Granted Patent,yes,104,64,211,221,0,A61B5/14532;;A61B5/14532;;A61B5/0002;;A61B5/0002;;A61B5/002;;A61B5/01;;A61B5/14503;;A61B5/1451;;A61B5/14546;;A61B5/14546;;A61B5/1473;;A61B5/1473;;A61B5/1486;;A61B5/1486;;A61B5/14865;;A61B5/1495;;A61B5/4839;;A61B5/72;;A61B5/7278;;A61B5/7282;;A61B5/7405;;A61B5/743;;A61B5/7445;;A61B5/7445;;A61B5/7455;;A61B2560/0252;;A61B2560/0252;;A61M5/1723;;C12Q1/54;;G16H10/40;;G16H10/40;;G16H20/17;;G16H20/17;;H01L23/3107;;H01L23/3107;;H01L23/49548;;H01L23/49548;;H01L2924/0002;;H01L2924/0002;;H01L2924/19041;;H01L2924/19041;;H01L2924/3011;;H01L2924/3011;;Y10S128/903;;Y10S128/903;;Y10T29/49;;Y10T29/49;;Y10T29/49124;;Y10T29/49124,A61B5/145;;G01N27/30;;A61B5/00;;A61B5/1477;;A61B5/1495;;G01N27/416;;G06F19/00;;H01L23/31;;H01L23/495,600/365;;600/309;;600/347,99,81,136-791-935-548-81X;;062-360-289-025-864;;010-601-725-111-91X;;101-292-518-663-191;;056-703-879-057-297;;030-155-762-644-019;;004-149-141-436-651;;016-731-054-793-457;;080-559-561-995-335;;044-807-213-528-815;;027-538-525-436-179;;015-020-161-517-40X;;025-919-454-564-785;;014-700-576-603-812;;004-851-060-590-788;;075-958-432-122-199;;052-356-140-149-389;;035-090-282-884-790;;033-562-815-299-181;;018-803-926-589-211;;008-505-762-041-402;;016-601-143-530-813;;019-502-772-562-215;;058-476-824-396-350;;006-498-707-073-30X;;054-091-551-638-293;;010-531-147-771-746;;054-827-198-877-419;;122-658-944-077-000;;017-261-560-469-37X;;000-125-755-474-124;;113-381-664-783-802;;082-626-907-191-554;;017-950-014-792-456;;090-348-305-613-628;;015-985-399-299-132;;171-049-047-164-618;;016-819-089-891-758;;081-249-097-078-543;;089-612-747-111-646;;031-706-897-890-035;;094-198-536-559-723;;003-690-143-043-420;;007-943-354-378-456;;082-114-500-909-975;;004-239-090-971-580;;026-894-457-160-450;;077-128-610-778-669;;022-466-506-956-898;;008-424-592-956-946;;007-500-825-916-378;;009-725-244-669-882;;037-755-689-613-42X;;153-411-506-517-475;;038-134-360-685-692;;012-449-714-188-064;;031-517-704-996-130;;131-299-284-996-064;;049-133-049-742-708;;000-272-178-768-076;;070-797-683-833-124;;043-870-224-178-49X;;025-574-914-238-550;;052-364-430-129-757;;004-434-167-910-115;;032-860-147-271-886;;132-460-374-211-421;;098-172-374-375-47X;;109-358-955-476-095;;014-988-634-483-130;;061-786-187-274-992;;037-898-018-686-909;;130-044-667-529-69X;;134-265-642-839-645;;065-221-074-461-027;;017-934-465-161-477;;101-660-130-379-529;;028-236-706-290-220;;087-333-189-994-274;;059-082-211-027-266;;057-977-752-782-568,10.1016/s0956-5663(02)00099-4;;12392956;;10.1021/ja00391a001;;2889225;;10.1098/rstb.1987.0021;;10.1109/51.294001;;10.1016/0022-0728(65)85063-x;;2245876;;10.2337/diabetes.39.12.1519;;10.2337/diab.39.12.1519;;10.1016/s0956-5663(03)00220-3;;14611755;;18615658;;10.1002/bit.260430310;;9366023;;10.1016/s0956-5663(97)00025-0;;9451795;;10.1016/s0956-5663(97)00083-3;;10.1016/0956-5663(93)80028-n;;8311939;;8651496;;10.1021/ac960030d;;10.1080/03091900210156797;;12487712;;10.1016/0265-928x(87)80018-4;;3333622;;10.1109/19.816143;;10.1007/bf01015979;;10.1089/15209150252924058;;12017416;;18473691;;10.1089/dia.2007.0281;;10.1021/ac00017a008;;1789439;;2817408;;10.1021/ac00197a022;;10.1016/0925-4005(95)01730-5;;10.1016/0010-4825(90)90013-f;;2257734;;2868172;;8277748;;10.1016/0141-5425(93)90058-7;;11469630;;10.1089/15209150050214104;;10624783;;10.1016/s0168-8227(99)00113-8;;10.1089/15209150050214113;;11469631;;10.1007/bf00401374;;1478372;;10.2337/diacare.20.1.64;;9028696;;10.1109/tbme.1986.325807;;3957374;;236018;;10.1016/0005-2795(75)90259-7;;10.1089/hum.1998.9.6-879;;9581910;;11762520;;10.1089/15209150152607196;;10.2337/diabetes.48.3.445;;10078542;;10.1016/0265-928x(87)80012-3;;505005;;10.1126/science.505005;;10.1021/ac0498516;;15253640;;10.1109/10.284922;;8026845;;6721151;;10.1021/ac00268a018;;6733082;;10.1021/bi00305a016;;10.1515/cclm.2002.135;;12392305;;10.1016/j.ecl.2003.12.001;;15053902;;12052350;;10.1016/s0956-5663(01)00304-9;;12052349;;10.1016/s0956-5663(01)00306-2;;4500021;;10.1007/978-1-4684-3288-6_18;;14021529;;10.1111/j.1749-6632.1962.tb13623.x;;3196517;;10.2337/diacare.10.5.622;;3677983;;10.2337/diacare.8.6.529;;4075939;;10.1002/elan.1140061103;;7733469;;10.1021/ac00103a015;;7978306;;10.1021/ac00091a022;;10.1007/bf01248238;;10.1016/s0376-7388(98)00330-5;;10.1016/0142-9612(92)90147-g;;1472593;;10.1016/0265-928x(85)80002-x;;10.1021/j100290a001;;10.1021/ja00216a040;;10.1021/ja00188a091;;10.1021/ja00406a011;;2624333;;12323417;;10.1016/s0165-0270(02)00170-x;;10.1177/193229680700100208;;pmc2771467;;19888405;;10.1021/ja00415a014;;10.1007/bf00575392;;10.1021/ac00250a038;;10.1021/ac00266a005;;10.1007/s00216-002-1284-0;;12194035;;10.1089/dia.2006.0030;;17705688;;9642777;;10.1016/s0956-5663(97)00091-2;;10.1089/152091503322526978;;14633342;;10.1016/0022-0728(85)87006-6;;10.1021/ja00434a018;;10.1016/0003-2697(92)90243-z;;1443528;;10.1039/f19868201259;;3245585;;10.1021/ac00173a008;;2889234;;10.1098/rstb.1987.0020;;11762521;;10.1089/15209150152607204;;12413548;;10.1016/s1367-5931(02)00371-x;;10526740;;10.2337/diacare.22.10.1708;;14988294;;10.2337/diacare.27.3.734,"""Poretics Polycarbonate Membrane"", Osmonics Filtration and Separation Group, 2002.;;Abel, P. U., et al., ""Biosensors for In Vivo Glucose Measurement: Can We Cross the Experimental Stage"", Biosensors and Bioelectronics, vol. 17, 2002, pp. 1059-1070.;;Abruna, H. D., et al., ""Rectifying Interfaces Using Two-Layer Films of Electrochemically Polymerized Vinylpyridine and Vinylbipyridine Complexes of Ruthenium and Iron on Electrodes"", Journal of the American Chemical Society, vol. 103, No. 1, 1981, pp. 1-5.;;Albery, W. J., et al., ""Amperometric Enzyme Electrodes Part II: Conducting Salts as Electrode Materials for the Oxidation of Glucose Oxidase"", Journal of ElectroAnalytical Chemistry, vol. 194, 1985, pp. 223-235.;;Albery, W. J., et al., ""Amperometric Enzyme Electrodes"", Philosophical Transactions of the Royal Society of London, vol. 316, 1987, pp. 107-119.;;Alcock, S. J., et al., ""Continuous Analyte Monitoring to Aid Clinical Practice"", IEEE Engineering in Medicine and Biology Magazine, 1994, pp. 319-325.;;Anderson, L. B., et al., ""Thin-Layer Electrochemistry: Steady-State Methods of Studying Rate Processes"", Journal of ElectroAnalytical Chemistry, vol. 10, 1965, pp. 295-305.;;Armour, J. C., et al., ""Application of Chronic Intravascular Blood Glucose Sensor in Dogs"", Diabetes, vol. 39, 1990, pp. 1519-1526.;;Asberg, P., et al., ""Hydrogels of a Conducting Conjugated Polymer as 3-D Enzyme Electrode"", Biosensors & Bioelectronics, vol. 19, 2003, pp. 199-207.;;Atanasov, P., et al., ""Biosensor for Continuous Glucose Monitoring"", Biotechnology and Bioengineering, vol. 43, 1994, pp. 262-266.;;Atanasov, P., et al., ""Implantation of a Refillable Glucose Monitoring-Telemetry Device"", Biosensors & Bioelectronics, vol. 12, No. 7, 1997, pp. 669-680.;;Aussedat, B., et al., ""A User-Friendly Method for Calibrating a Subcutaneous Glucose Sensor-Based Hypoglycaemic Alarm"", Biosensors & Bioelectronics, vol. 12, No. 11, 1997, pp. 1061-1071.;;Baker, D. A., et al., ""Dynamic Concentration Challenges for Biosensor Characterization"", Biosensors & Bioelectronics, vol. 8, 1993, pp. 433-441.;;Baker, D. A., et al., ""Dynamic Delay and Maximal Dynamic Error in Continuous Biosensors"", Analytical Chemistry, vol. 68, No. 8, 1996, pp. 1292-1297.;;Bani Amer, M. M., ""An Accurate Amperometric Glucose Sensor Based Glucometer with Eliminated Cross-Sensitivity"", Journal of Medical Engineering & Technology, vol. 26, No. 5, 2002, pp. 208-213.;;Bard, A. J., et al., Electrochemical Methods, 1980, pp. 173-175.;;Bartlett, P. N., et al., ""Covalent Binding of Electron Relays to Glucose Oxidase"", Journal of the Chemical Society, Chemical Communications, 1987, pp. 1603-1604.;;Bartlett, P. N., et al., ""Modification of Glucose Oxidase by Tetrathiafulvalene"", Journal of the Chemical Society, Chemical Communications, 1990, pp. 1135-1136.;;Bartlett, P. N., et al., ""Strategies for the Development of Amperometric Enzyme Electrodes"", Biosensors, vol. 3, 1987/88, pp. 359-379.;;Beach, R. D., et al., ""Subminiature Implantable Potentiostat and Modified Commercial Telemetry Device for Remote Glucose Monitoring"", IEEE Transactions on Instrumentation and Measurement, vol. 28, No. 6, 1999, pp. 1239-1245.;;Beech, W. A., ""AX.25 Link Access Protocol for Amateur packet Radio"", Tucson Amateur Packet Radio Corporation, 1998, pp. 1-133.;;Bellucci, F., et al., ""Electrochemical Behaviour of Graphite-Epoxy Composite Materials (GECM) in Aqueous Salt Solutions"", Journal of Applied Electrochemistry, vol. 16, 1986, pp. 15-22.;;Bennion, N., et al., ""Alternate Site Glucose Testing: A Crossover Design"",Diabetes Technology & Therapeutics, vol. 4, No. 1, 2002, pp. 25-33.;;Biermann, E., et al., ""How Would Patients Behave if They Were Continually Informed of Their Blood Glucose Levels? A Simulation Study Using a 'Virtual' Patient"", Diabetes Technology & Therapeutics, vol. 10, No. 3, 2008, pp. 178-187.;;Bindra, D. S., et al., ""Design and in Vitro Studies of a Needle-Type Glucose Sensor for Subcutaneous Monitoring"", Analytical Chemistry, vol. 63, No. 17, 1991, pp. 1692-1696.;;Bindra, D. S., et al., ""Pulsed Amperometric Detection of Glucose in Biological Fluids at a Surface-Modified Gold Electrode"", Analytical Chemistry, vol. 61, No. 22, 1989, pp. 2566-2570.;;Bisenberger, M., et al., ""A Triple-Step Potential Waveform at Enzyme Multisensors with Thick-Film Gold Electrodes for Detection of Glucose and Sucrose"", Sensors and Actuators B, vol. 28, 1995, pp. 181-189.;;Bland, J. M., et al., ""A Note on the Use of the Intraclass Correlation Coefficient in the Evaluation of Agreement Between Two Methods of Measurement"", Computers in Biology and Medicine, vol. 20, No. 5, 1990, pp. 337-340.;;Bland, J. M., et al., ""Statistical Methods for Assessing Agreement Between Two Methods of Clinical Measurement"", The Lancet, 1986, pp. 307-310.;;Blank, T. B., et al., ""Clinical Results From a Non-Invasive Blood Glucose Monitor"", Optical Diagnostics and Sensing of Biological Fluids and Glucose and Cholesterol Monitoring II, Proceedings of SPIE, vol. 4624, 2002, pp. 1-10.;;Bobbioni-Harsch, E., et al., ""Lifespan of Subcutaneous Glucose Sensors and Their Performances During Dynamic Glycaemia Changes in Rats"", Journal of Biomedical Engineering, vol. 15, 1993, pp. 457-463.;;Bode, B. W., ""Clinical Utility of the Continuous Glucose Monitoring System"", Diabetes Technology & Therapeutics, vol. 2, Sup. 1, 2000, pp. S35-S41.;;Bode, B. W., et al., ""Continuous Glucose Monitoring Used to Adjust Diabetes Therapy Improves Glycosylated Hemoglobin: A Pilot Study"", Diabetes Research and Clinical Practice, vol. 46, 1999, pp. 183-190.;;Bode, B. W., et al., ""Using the Continuous Glucose Monitoring System to Improve the Management of Type I Diabetes"", Diabetes Technology & Therapeutics, vol. 2, Sup. 1, 2000, pp. S43-S48.;;Boedeker Plastics, Inc., ""Polyethylene Specifications"", Web Page of Boedeker.com, 2007, pp. 1-3.;;Bolinder, J., et al., ""Microdialysis Measurement of the Absolute Glucose Concentration in Subcutaneous Adipose Tissue Allowing Glucose Monitoring in Diabetic Patients"", Diabetologia, vol. 35, 1992, pp. 1177-1180.;;Bolinder, J., et al., ""Self-Monitoring of Blood Glucose in Type I Diabetic Patients: Comparison with Continuous Microdialysis Measurements of Glucose in Subcutaneous Adipose Tissue During Ordinary Life Conditions"", Diabetes Care, vol. 20, No. 1, 1997, pp. 64-70.;;Bott, A. W., ""A Comparison of Cyclic Voltammetry and Cyclic Staircase Voltammetry"", Current Separations, vol. 16, No. 1, 1997, pp. 23-26.;;Bott, A. W., ""Electrochemical Methods for the Determination of Glucose"", Current Separations, vol. 17, No. 1, 1998, pp. 25-31.;;Bowman, L., et al., ""The Packaging of Implantable Integrated Sensors"", IEEE Transactions on Biomedical Engineering, vol. 33, No. 2, 1986, pp. 248-255.;;Brandt, J., et al., ""Covalent Attachment of Proteins to Polysaccharide Carriers by Means of Benzoquinone"", Biochimica et Biophysica Acta, vol. 386, 1975, pp. 196-202.;;Brauker, J., et al., ""Sustained Expression of High Levels of Human Factor IX from Human Cells Implanted Within an Immunoisolation Device into Athymic Rodents"", Human Gene Therapy, vol. 9, No. 6, 1998, pp. 879-888.;;Bremer, T. M., et al., ""Benchmark Data from the Literature for Evaluation of New Glucose Sensing Technologies"", Diabetes Technology & Therapeutics, vol. 3, No. 3, 2001, pp. 409-418.;;Bremer, T., et al., ""Is Blood Glucose Predictable from Previous Values?"", Diabetes, vol. 48, 1999, pp. 445-451.;;Brooks, S. L., et al., ""Development of an On-Line Glucose Sensor for Fermentation Monitoring"", Biosensors, vol. 3, 1987/88, pp. 45-56.;;Brownlee, M., et al., ""A Glucose-Controlled Insulin-Delivery System: Semisynthetic Insulin Bound to Lectin"", Science, vol. 206, 1979, 1190-1191.;;Cai, Q., et al., ""A Wireless, Remove Query Glucose Biosensor Based on a pH-Sensitive Polymer"", Analytical Chemistry, vol. 76, No. 14, 2004, pp. 4038-4043.;;Candas, B., et al., ""An Adaptive Plasma Glucose Controller Based on a Nonlinear Insulin/Glucose Model"", IEEE Transactions on Biomedical Engineering, vol. 41, No. 2, 1994, pp. 116-124.;;Cass, A. E., et al., ""Ferricinum Ion As an Electron Acceptor for Oxido-Reductases"", Journal of ElectroAnalytical Chemistry, vol. 190, 1985, pp. 117-127.;;Cass, A. E., et al., ""Ferrocene-Medicated Enzyme Electrode for Amperometric Determination of Glucose"", Analytical Chemistry, vol. 56, No. 4, 1984, 667-671.;;Castner, J. F., et al., ""Mass Transport and Reaction Kinetic Parameters Determined Electrochemically for Immobilized Glucose Oxidase"", Biochemistry, vol. 23 No. 10, 1984, 2203-2210.;;Chen, J. C., et al., ""A Comparison of MAC Protocols for Wireless Local Networks Based on battery Power Consumption"", IEEE, 1998, pp. 150-157.;;Chen, T., et al., ""Defining the Period of Recovery of the Glucose Concentration After Its Local Perturbation by the Implementation of a Miniature Sensor"", Clinical Chemistry and Laboratory Medicine, vol. 40, No. 8, 2002, pp. 486-489.;;Chia, C. W., et al., ""Glucose Sensors: Toward Closed Loop Insulin Delivery"", Endocrinology and Metabolism Clinics of North America, vol. 33, 2004, pp. 175-195.;;Choleau, C., et al., ""Calibration of a Subcutaneous Amperometric Glucose Sensor Implanted for 7 Days in Diabetic Patients Part 2: Superiority of the One-Point Calibration Method"", Biosensors and Bioelectronics, vol. 17, 2002, pp. 647-654.;;Choleau, C., et al., ""Calibration of a Subcutaneous Amperometric Glucose Sensor Part 1: Effect of Measurement Uncertainties on the Determination of Sensor Sensitivity and Background Current"", Biosensors and Bioelectronics, vol. 17, 2002, pp. 641-646.;;Claremont, D. J., et al., ""Biosensors for Continuous In Vivo Glucose Monitoring"", Proceedings of the Annual International Conference of the IEEE Engineering in Medicine and Biology Society, vol. 10, 1988.;;Clark Jr., L. C., et al., ""Differential Anodic Enzyme Polarography for the Measurement of Glucose"",Oxygen Transport to Tissue: Instrumentation, Methods, and Physiology, 1973, pp. 127-133.;;Clark Jr., L. C., et al., ""Electrode Systems for Continuous Monitoring in Cardiovascular Surgery"", Annals New York Academy of Sciences, 1962, pp. 29-45.;;Clark Jr., L. C., et al., ""Long-term Stability of Electroenzymatic Glucose Sensors Implanted in Mice"", American Society of Artificial Internal Organs Transactions, vol. XXXIV, 1988, pp. 259-265.;;Clarke, W. L., et al., ""Evaluating Clinical Accuracy of Systems for Self-Monitoring of Blood Glucose"", Diabetes Care, vol. 10, No. 5, 1987, pp. 622-628.;;Complaint, ""Abbott Diabetes Care, Inc. v. Dexcom, Inc."", filed Aug. 11, 2005.;;Complaint, Amended, ""Abbott Diabetes Care, Inc. v. Dexcom, Inc."", filed Jun. 27, 2006.;;Cox, D. J., et al., ""Accuracy of Perceiving Blood Glucose in IDDM"", Diabetes Care, vol. 8, No. 6, 1985, pp. 529-536.;;Csoregi, E., et al., ""Amperometric Microbiosensors for Detection of Hydrogen Peroxide and Glucose Based on Peroxidase-Modified Carbon Fibers"", Electroanalysis, vol. 6, 1994, pp. 925-933.;;Csoregi, E., et al., ""Design and Optimization of a Selective Subcutaneously Implantable Glucose Electrode Based on 'Wired' Glucose Oxidase"", Analytical Chemistry, vol. 67, No. 7, 1995, pp. 1240-1244.;;Csoregi, E., et al., ""Design, Characterization, and One-Point in Vivo Calibration of a Subcutaneously Implanted Glucose Electrode"", Analytical Chemistry, vol. 66 No. 19, 1994, pp. 3131-3138.;;Csoregi, E., et al., ""On-Line Glucose Monitoring by Using Microdialysis Sampling and Amperometric Detection Based on 'Wired' Glucose Oxidase in Carbon Paste"", Mikrochimica Acta, vol. 121, 1995, pp. 31-40.;;D'Arrigo, G., et al., ""Porous-Si Based Bio Reactors for Glucose Monitoring and Drugs Production"", Proceedings of SPIE: Microfluids, BioMEMS, and Medical Microsystems, vol. 4982, 2003, pp. 178-184.;;Dai, W. S., et al., ""Hydrogel Membranes with Mesh Size Asymmetry Based on the Gradient Crosslinking of Poly(vinyl alcohol),"" Journal of Membrane Science, vol. 156, 1999, pp. 67-79.;;Davies, M. L., et al., ""Polymer Membranes in Clinical Sensor Applications"", Biomaterials, vol. 13, No. 14, 1992, pp. 971-978.;;Davis, G., ""Electrochemical Techniques for the Development of Amperometric Biosensors"", Biosensors, vol. 1, 1985, pp. 161-178.;;Degani, Y., et al., ""Direct Electrical Communication Between Chemically Modified Enzymes and Metal Electrodes. 1. Electron Transfer from Glucose Oxidase to Metal Electrodes via Electron Relays, Bound Covalently to the Enzyme"", The Journal of Physical Chemistry, vol. 91, No. 6, 1987, pp. 1285-1289.;;Degani, Y., et al., ""Direct Electrical Communication Between Chemically Modified Enzymes and Metal Electrodes. 2. Methods for Bonding Electron-Transfer Relays to Glucose Oxidase and D-Amino-Acid Oxidase"", Journal of the American Chemical Society, vol. 110, No. 8, 1988, pp. 2615-2620.;;Degani, Y., et al., ""Electrical Communication Between Redox Centers of Glucose Oxidase and Electrodes via Electrostatically and Covalently Bound Redox Polymers"", Journal of the American Chemical Society, vol. 111, 1989, pp. 2357-2358.;;Denisevich, P., et al., ""Unidirectional Current Flow and Charge State Trapping at Redox Polymer Interfaces on Bilayer Electrodes: Principles, Experimental Demonstration, and Theory"", Journal of the American Chemical Society, vol. 103, 1981, pp. 4727-4737.;;Dicks, J. M., et al., ""Ferrocene Modified Polypyrrole with Immobilised Glucose Oxidase and its Application in Amperometric Glucose Microbiosensors"",Annales de Biologie Clinique, vol. 47, 1989, pp. 607-619.;;Dixon, B. M., et al., ""Characterization In Vitro and In Vivo of the Oxygen Dependence of an Enzyme/Polymer Biosensors for Monitoring Brain Glucose"", Journal of Neuroscience Methods, vol. 119, 2002, pp. 135-142.;;Eighth Annual Diabetes Technology Meeting Abstracts, Nov. 13-15, 2008, pp. A1-A182.;;El-Khatib, F. H, et al., ""Adaptive Closed-Loop Control Provides Blood-Glucose Regulation Using Subcutaneous Insulin and Glucagon Infusion in Diabetic Swine"", Journal of Diabetes Science and Technology, vol. 1, No. 2, 2007, pp. 181-192.;;Ellis, C. D., et al., ""Selectivity and Directed Charge Transfer through an Electroactive Metallopolymer Film"", Journal of the American Chemical Society, vol. 103, No. 25, 1981, pp. 7480-7483.;;El-Sa'Ad, L., et al., ""Moisture Absorption by Epoxy Resins: The Reverse Thermal Effect"", Journal of Materials Science, vol. 25, No. 8, 1990, pp. 3577-3582.;;Engstrom, R. C., ""Electrochemical Pretreatment of Glassy Carbon Electrodes"", Analytical Chemistry, vol. 54, No. 13, 1982, pp. 2310-2314.;;Engstrom, R. C., et al., ""Characterization of Electrochemically Pretreated Glassy Carbon Electrodes"", Analytical Chemistry, vol. 56, No. 2, 1984, pp. 136-141.;;Ernst, H., et al., ""Reliable Glucose Monitoring Through the Use of Microsystem Technology"", Analytical and Bioanalytical Chemistry, vol. 373, 2002, pp. 758-761.;;Fabietti, P. G., et al. ""Clinical Validation of a New Control-Oriented Model of Insulin and Glucose Dynamics in Subjects with Type 1 Diabetes"", Diabetes Technology & Therapeutics, vol. 9, No. 4, 2007, pp. 327-338.;;Fare, T. L., et al., ""Functional Characterization of a Conducting Polymer-Based Immunoassay System"", Biosensors & Bioelectronics, vol. 13, No. 3-4, 1998, pp. 459-470.;;Feldman, B., et al., ""A Continuous Glucose Sensor Based on Wired Enzyme(TM) Technology-Results from a 3-Day Trial in Patients with Type 1 Diabetes"", Diabetes Technology & Therapeutics, vol. 5, No. 5, 2003, pp. 769-779.;;Feldman, B., et al., ""Correlation of Glucose Concentrations in Interstitial Fluid and Venous Blood During Periods of Rapid Glucose Change"", Abbott Diabetes Care, Inc. Freestyle Navigator Continuous Glucose Monitor Pamphlet, 2004.;;Feldman, B., et al., ""Electron Transfer Kinetics at Redox Polymer/Solution Interfaces Using Microelectrodes and Twin Electrode Thin Layer Cells"", Journal of ElectroAnalytical Chemistry, vol. 194, 1985, pp. 63-81.;;Fischer, H., et al., ""Intramolecular Electron Transfer Medicated by 4,4'-Bypyridine and Related Bridging Groups"", Journal of the American Chemical Society, vol. 98, No. 18, 1976, pp. 5512-5517.;;Flentge, F., et al., ""An Enzyme-Reactor for Electrochemical Monitoring of Choline and Acetylcholine: Applications in High-Performance Liquid Chromatography, Bran Tissue, Microdialysis and Cerebrospinal Fluid,"" Analytical Biochemistry, vol. 204, 1992, pp. 305-310.;;Foulds, N. C., et al., ""Enzyme Entrapment in Electrically Conducting Polymers: Immobilisation of Glucose Oxidase in Polypyrrole and its Application in Amperometric Glucose Sensors"", Journal of the Chemical Society, Faraday Transactions 1, vol. 82, 1986, pp. 1259-1264.;;Foulds, N. C., et al , ""Immobilization of Glucose Oxidase in Ferrocene-Modified Pyrrole Polymers"", Analytical Chemistry, vol. 60, No. 22, 1988, pp. 2473-2478.;;Frew, J. E., et al., ""Electron-Transfer Biosensors"", Philosophical Transactions of The Royal Society of London, vol. 316, 1987, pp. 95-106.;;Frohnauer, M. K., et al., ""Graphical Human Insulin Time-Activity Profiles Using Standardized Definitions"", Diabetes Technology & Therapeutics, vol. 3, No. 3, 2001, pp. 419-429.;;Frost, M. C., et al., ""Implantable Chemical Sensors for Real-Time Clinical Monitoring: Progress and Challenges"", Current Opinion in Chemical Biology, vol. 6, 2002, pp. 633-641.;;Garg, S. K., et al., ""Correlation of Fingerstick Blood Glucose Measurements with GlucoWatch Biographer Glucose Results in Young Subjects with Type 1 Diabetes"", Diabetes Care, vol. 22, No. 10, 1999, pp. 1708-1714.;;Garg, S. K., et al., ""Improved Glucose Excursions Using an Implantable Real-Time Continuous Glucose Sensor in Adults with Type 1 Diabetes"", Diabetes Care, vol. 27, No. 3, 2004, pp. 734-738.",EXPIRED
179,US,B2,US 8357091 B2,029-268-791-186-956,2013-01-22,2013,US 64398609 A,2009-12-21,US 64398609 A;;US 42005703 A;;US 66719900 A;;US 7067798 A,1998-04-30,Analyte monitoring device and methods of use,"An analyte monitor includes a sensor, a sensor control unit, and a display unit. The sensor has, for example, a substrate, a recessed channel formed in the substrate, and conductive material disposed in the recessed channel to form a working electrode. The sensor control unit typically has a housing adapted for placement on skin and is adapted to receive a portion of an electrochemical sensor. The sensor control unit also includes two or more conductive contacts disposed on the housing and configured for coupling to two or more contact pads on the sensor. A transmitter is disposed in the housing and coupled to the plurality of conductive contacts for transmitting data obtained using the sensor. The display unit has a receiver for receiving data transmitted by the transmitter of the sensor control unit and a display coupled to the receiver for displaying an indication of a level of an analyte. The analyte monitor may also be part of a drug delivery system to alter the level of the analyte based on the data obtained using the sensor.",ABBOTT DIABETES CARE INC;;SAY JAMES;;TOMASCO MICHAEL F;;HELLER ADAM;;GAL YORAM;;ARIA BEHRAD;;HELLER EPHRAIM;;PLANTE PHILLIP JOHN;;VREEKE MARK S;;FRIEDMAN KEITH A;;COLMAN FREDRIC C,SAY JAMES;;TOMASCO MICHAEL F;;HELLER ADAM;;GAL YORAM;;ARIA BEHRAD;;HELLER EPHRAIM;;PLANTE PHILLIP JOHN;;VREEKE MARK S;;FRIEDMAN KEITH A;;COLMAN FREDRIC C,E. HELLER & CO (1998-07-02);;ABBOTT DIABETES CARE INC (2000-03-13),https://lens.org/029-268-791-186-956,Granted Patent,yes,117,44,211,221,0,A61B5/14532;;A61B5/14532;;A61B5/0002;;A61B5/0002;;A61B5/002;;A61B5/01;;A61B5/14503;;A61B5/1451;;A61B5/14546;;A61B5/14546;;A61B5/1473;;A61B5/1473;;A61B5/1486;;A61B5/1486;;A61B5/14865;;A61B5/1495;;A61B5/4839;;A61B5/72;;A61B5/7278;;A61B5/7282;;A61B5/7405;;A61B5/743;;A61B5/7445;;A61B5/7445;;A61B5/7455;;A61B2560/0252;;A61B2560/0252;;A61M5/1723;;C12Q1/54;;G16H10/40;;G16H10/40;;G16H20/17;;G16H20/17;;H01L23/3107;;H01L23/3107;;H01L23/49548;;H01L23/49548;;H01L2924/0002;;H01L2924/0002;;H01L2924/19041;;H01L2924/19041;;H01L2924/3011;;H01L2924/3011;;Y10S128/903;;Y10S128/903;;Y10T29/49;;Y10T29/49;;Y10T29/49124;;Y10T29/49124,A61B5/00;;G01N27/30;;A61B5/05;;A61B5/145;;A61B5/1477;;A61B5/1495;;G01N27/416;;G06F19/00;;H01L23/31;;H01L23/495,600/365;;600/347;;600/345;;600/309,99,82,136-791-935-548-81X;;062-360-289-025-864;;010-601-725-111-91X;;101-292-518-663-191;;056-703-879-057-297;;030-155-762-644-019;;004-149-141-436-651;;016-731-054-793-457;;080-559-561-995-335;;044-807-213-528-815;;027-538-525-436-179;;015-020-161-517-40X;;025-919-454-564-785;;014-700-576-603-812;;004-851-060-590-788;;075-958-432-122-199;;052-356-140-149-389;;035-090-282-884-790;;033-562-815-299-181;;018-803-926-589-211;;008-505-762-041-402;;016-601-143-530-813;;019-502-772-562-215;;058-476-824-396-350;;006-498-707-073-30X;;054-091-551-638-293;;010-531-147-771-746;;054-827-198-877-419;;122-658-944-077-000;;017-261-560-469-37X;;000-125-755-474-124;;113-381-664-783-802;;082-626-907-191-554;;017-950-014-792-456;;090-348-305-613-628;;015-985-399-299-132;;171-049-047-164-618;;016-819-089-891-758;;081-249-097-078-543;;089-612-747-111-646;;031-706-897-890-035;;094-198-536-559-723;;003-690-143-043-420;;007-943-354-378-456;;082-114-500-909-975;;004-239-090-971-580;;026-894-457-160-450;;077-128-610-778-669;;022-466-506-956-898;;008-424-592-956-946;;007-500-825-916-378;;009-725-244-669-882;;037-755-689-613-42X;;153-411-506-517-475;;038-134-360-685-692;;012-449-714-188-064;;031-517-704-996-130;;131-299-284-996-064;;049-133-049-742-708;;000-272-178-768-076;;070-797-683-833-124;;043-870-224-178-49X;;025-574-914-238-550;;052-364-430-129-757;;004-434-167-910-115;;032-860-147-271-886;;132-460-374-211-421;;098-172-374-375-47X;;109-358-955-476-095;;014-988-634-483-130;;061-786-187-274-992;;037-898-018-686-909;;130-044-667-529-69X;;134-265-642-839-645;;065-221-074-461-027;;017-934-465-161-477;;101-660-130-379-529;;028-236-706-290-220;;087-333-189-994-274;;059-082-211-027-266;;057-977-752-782-568;;022-511-780-866-588,10.1016/s0956-5663(02)00099-4;;12392956;;10.1021/ja00391a001;;2889225;;10.1098/rstb.1987.0021;;10.1109/51.294001;;10.1016/0022-0728(65)85063-x;;2245876;;10.2337/diabetes.39.12.1519;;10.2337/diab.39.12.1519;;10.1016/s0956-5663(03)00220-3;;14611755;;18615658;;10.1002/bit.260430310;;9366023;;10.1016/s0956-5663(97)00025-0;;9451795;;10.1016/s0956-5663(97)00083-3;;10.1016/0956-5663(93)80028-n;;8311939;;8651496;;10.1021/ac960030d;;10.1080/03091900210156797;;12487712;;10.1016/0265-928x(87)80018-4;;3333622;;10.1109/19.816143;;10.1007/bf01015979;;10.1089/15209150252924058;;12017416;;18473691;;10.1089/dia.2007.0281;;10.1021/ac00017a008;;1789439;;2817408;;10.1021/ac00197a022;;10.1016/0925-4005(95)01730-5;;10.1016/0010-4825(90)90013-f;;2257734;;2868172;;8277748;;10.1016/0141-5425(93)90058-7;;11469630;;10.1089/15209150050214104;;10624783;;10.1016/s0168-8227(99)00113-8;;10.1089/15209150050214113;;11469631;;10.1007/bf00401374;;1478372;;10.2337/diacare.20.1.64;;9028696;;10.1109/tbme.1986.325807;;3957374;;236018;;10.1016/0005-2795(75)90259-7;;10.1089/hum.1998.9.6-879;;9581910;;11762520;;10.1089/15209150152607196;;10.2337/diabetes.48.3.445;;10078542;;10.1016/0265-928x(87)80012-3;;505005;;10.1126/science.505005;;10.1021/ac0498516;;15253640;;10.1109/10.284922;;8026845;;6721151;;10.1021/ac00268a018;;6733082;;10.1021/bi00305a016;;10.1515/cclm.2002.135;;12392305;;10.1016/j.ecl.2003.12.001;;15053902;;12052350;;10.1016/s0956-5663(01)00304-9;;12052349;;10.1016/s0956-5663(01)00306-2;;4500021;;10.1007/978-1-4684-3288-6_18;;14021529;;10.1111/j.1749-6632.1962.tb13623.x;;3196517;;10.2337/diacare.10.5.622;;3677983;;10.2337/diacare.8.6.529;;4075939;;10.1002/elan.1140061103;;7733469;;10.1021/ac00103a015;;7978306;;10.1021/ac00091a022;;10.1007/bf01248238;;10.1016/s0376-7388(98)00330-5;;10.1016/0142-9612(92)90147-g;;1472593;;10.1016/0265-928x(85)80002-x;;10.1021/j100290a001;;10.1021/ja00216a040;;10.1021/ja00188a091;;10.1021/ja00406a011;;2624333;;12323417;;10.1016/s0165-0270(02)00170-x;;10.1177/193229680700100208;;pmc2771467;;19888405;;10.1021/ja00415a014;;10.1007/bf00575392;;10.1021/ac00250a038;;10.1021/ac00266a005;;10.1007/s00216-002-1284-0;;12194035;;10.1089/dia.2006.0030;;17705688;;9642777;;10.1016/s0956-5663(97)00091-2;;10.1089/152091503322526978;;14633342;;10.1016/0022-0728(85)87006-6;;10.1021/ja00434a018;;10.1016/0003-2697(92)90243-z;;1443528;;10.1039/f19868201259;;3245585;;10.1021/ac00173a008;;2889234;;10.1098/rstb.1987.0020;;11762521;;10.1089/15209150152607204;;12413548;;10.1016/s1367-5931(02)00371-x;;10526740;;10.2337/diacare.22.10.1708;;14988294;;10.2337/diacare.27.3.734;;10.1111/j.1749-6632.1997.tb52216.x;;9616733,"""Poretics Polycarbonate Membrane"", Osmonics Filtration and Separation Group, 2002.;;Abel, P. U., et al., ""Biosensors for In Vivo Glucose Measurement: Can We Cross the Experimental Stage"", Biosensors and Bioelectronics, vol. 17, 2002, pp. 1059-1070.;;Abruna, H. D., et al., ""Rectifying Interfaces Using Two-Layer Films of Electrochemically Polymerized Vinylpyridine and Vinylbipyridine Complexes of Ruthenium and Iron on Electrodes"", Journal of the American Chemical Society, vol. 103, No. 1, 1981, pp. 1-5.;;Albery, W. J., et al., ""Amperometric Enzyme Electrodes"", Philosophical Transactions of The Royal Society of London, vol. 316, 1987, pp. 107-119.;;Alcock, S. J., et al., ""Continuous Analyte Monitoring to Aid Clinical Practice "", IEEE Engineering in Medicine and Biology Magazine, 1994, pp. 319-325.;;Anderson, L. B., et al., ""Thin-Layer Electrochemistry: Steady-State Methods of Studying Rate Processes"", Journal of ElectroAnalytical Chemistry, vol. 10, 1965, pp. 295-305.;;Armour, J. C., et al., ""Application of Chronic Intravascular Blood Glucose Sensor in Dogs"", Diabetes, vol. 39, 1990, pp. 1519-1526.;;Asberg, P., et al., ""Hydrogels of a Conducting Conjugated Polymer as 3-D Enzyme Electrode"", Biosensors & Bioelectronics, vol. 19, 2003, pp. 199-207.;;Atanasov, P., et al., ""Biosensor for Continuous Glucose Monitoring"", Biotechnology and Bioengineering, vol. 43, 1994, pp. 262-266.;;Atanasov, P., et al., ""Implantation of a Refillable Glucose Monitoring-Telemetry Device"", Biosensors & Bioelectronics, vol. 12, No. 7, 1997, pp. 669-680.;;Aussedat, B., et al., ""A User-Friendly Method for Calibrating a Subcutaneous Glucose Sensor-Based Hypoglycaemic Alarm"", Biosensors & Bioelectronics, vol. 12, No. 11, 1997, pp. 1061-1071.;;Baker, D. A., et al., ""Dynamic Concentration Challenges for Biosensor Characterization"", Biosensors & Bioelectronics, vol. 8, 1993, pp. 433-441.;;Baker, D. A., et al., ""Dynamic Delay and Maximal Dynamic Error in Continuous Biosensors"", Analytical Chemistry, vol. 68, No. 8, 1996, pp. 1292-1297.;;Bani Amer, M. M., ""An Accurate Amperometric Glucose Sensor Based Glucometer with Eliminated Cross-Sensitivity"", Journal of Medical Engineering & Technology, vol. 26, No. 5, 2002, pp. 208-213.;;Bard, A. J., et al., Electrochemical Methods, 1980, pp. 173-175.;;Bartlett, P. N., et al., ""Covalent Binding of Electron Relays to Glucose Oxidase"", Journal of the Chemical Society, Chemical Communications, 1987, pp. 1603-1604.;;Bartlett, P. N., et al., ""Modification of Glucose Oxidase by Tetrathiafulvalene"", Journal of the Chemical Society, Chemical Communications, 1990, pp. 1135-1136.;;Bartlett, P. N., et al., ""Strategies for the Development of Amperometric Enzyme Electrodes"", Biosensors, vol. 3, 1987/88, pp. 359-379.;;Beach, R. D., et al., ""Subminiature Implantable Potentiostat and Modified Commercial Telemetry Device for Remote Glucose Monitoring"", IEEE Transactions on Instrumentation and Measurement, vol. 28, No. 6, 1999, pp. 1239-1245.;;Beech, W. A., ""AX.25 Link Access Protocol for Amateur Packet Radio"", Tucson Amateur Packet Radio Corporation, 1998, pp. 1-133.;;Bellucci, F., et al., ""Electrochemical Behaviour of Graphite-Epoxy Composite Materials (GECM) in Aqueous Salt Solutions"", Journal of Applied Electrochemistry, vol. 16, 1986, pp. 15-22.;;Bennion, N., et al., ""Alternate Site Glucose Testing: A Crossover Design"", Diabetes Technology & Therapeutics, vol. 4, No. 1, 2002, pp. 25-33.;;Biermann, E., et al., ""How Would Patients Behave if They Were Continually Informed of Their Blood Glucose Levels? A Simulation Study Using a 'Virtual' Patient"", Diabetes Technology & Therapeutics, vol. 10, No. 3, 2008, pp. 178-187.;;Bindra, D. S., et al., ""Design and in Vitro Studies of a Needle-Type Glucose Sensor for Subcutaneous Monitoring"", Analytical Chemistry, vol. 63, No. 17, 1991, pp. 1692-1696.;;Bindra, D. S., et al., ""Pulsed Amperometric Detection of Glucose in Biological Fluids at a Surface-Modified Gold Electrode"", Analytical Chemistry, vol. 61, No. 22, 1989, pp. 2566-2570.;;Bisenberger, M., et al., ""A Triple-Step Potential Waveform at Enzyme Multisensors with Thick-Film Gold Electrodes for Detection of Glucose and Sucrose"", Sensors and Actuators B, vol. 28, 1995, pp. 181-189.;;Bland, J. M., et al., ""A Note on the Use of the Intraclass Correlation Coefficient in the Evaluation of Agreement Between Two Methods of Measurement"", Computers in Biology and Medicine, vol. 20, No. 5, 1990, pp. 337-340.;;Bland, J. M., et al., ""Statistical Methods for Assessing Agreement Between Two Methods of Clinical Measurement"", The Lancet, 1986, pp. 307-310.;;Blank, T. B., et al., ""Clinical Results From a Non-Invasive Blood Glucose Monitor"", Optical Diagnostics and Sensing of Biological Fluids and Glucose and Cholesterol Monitoring II, Proceedings of SPIE, vol. 2624, 2002, pp. 1-10.;;Bobbioni-Harsch, E., et al., ""Lifespan of Subcutaneous Glucose Sensors and Their Performances During Dynamic Glycaemia Changes in Rats"", Journal of Biomedical Engineering, vol. 15, 1993, pp. 457-463.;;Bode, B. W., ""Clinical Utility of the Continuous Glucose Monitoring System"", Diabetes Technology & Therapeutics, vol. 2, Sup. 1, 2000, pp. S35-S41.;;Bode, B. W., et al., ""Continuous Glucose Monitoring Used to Adjust Diabetes Therapy Improves Glycosylated Hemoglobin: A Pilot Study"", Diabetes Research and Clinical Practice, vol. 46, 1999, pp. 183-190.;;Bode, B. W., et al., ""Using the Continuous Glucose Monitoring System to Improve the Management of Type I Diabetes"", Diabetes Technology & Therapeutics, vol. 2, Sup. 1, 2000, pp. S43-S48.;;Boedeker Plastics, Inc., ""Polyethylene Specifications"", Web Page of Boedeker.com, 2007, pp. 1-3.;;Bolinder, J., et al., ""Microdialysis Measurement of the Absolute Glucose Concentration in Subcutaneous Adipose Tissue Allowing Glucose Monitoring in Diabetic Patients"", Diabetologia, vol. 35, 1992, pp. 1177-1180.;;Bolinder, J., et al., ""Self-Monitoring of Blood Glucose in Type I Diabetic Patients: Comparison with Continuous Microdialysis Measurements of Glucose in Subcutaneous Adipose Tissue During Ordinary Life Conditions"", Diabetes Care, vol. 20, No. 1, 1997, pp. 64-70.;;Bott, A. W., ""A Comparison of Cyclic Voltammetry and Cyclic Staircase Voltammetry"", Current Separations, vol. 16, No. 1, 1997, pp. 23-26.;;Bott, A. W., ""Electrochemical Methods for the Determination of Glucose"", Current Separations, vol. 17, No. 1, 1998, pp. 25-31.;;Bowman, L., et al., ""The Packaging of Implantable Integrated Sensors"", IEEE Transactions on Biomedical Engineering, vol. 33, No. 2, 1986, pp. 248-255.;;Brandt, J., et al., ""Covalent Attachment of Proteins to Polysaccharide Carriers by Means of Benzoquinone"", Biochimica et Biophysica Acta, vol. 386, 1975, pp. 196-202.;;Brauker, J., et al., ""Sustained Expression of High Levels of Human Factor IX from Human Cells Implanted Within an Immunoisolation Device into Athymic Rodents"", Human Gene Therapy, vol. 9, No. 6, 1998, pp. 879-888.;;Bremer, T. M., et al., ""Benchmark Data from the Literature for Evaluation of New Glucose Sensing Technologies"", Diabetes Technology & Therapeutics, vol. 3, No. 3, 2001, pp. 409-418.;;Bremer, T., et al., ""Is Blood Glucose Predictable from Previous Values?"", Diabetes, vol. 48, 1999, pp. 445-451.;;Brooks, S. L., et al., ""Development of an On-Line Glucose Sensor for Fermentation Monitoring"", Biosensors, vol. 3, 1987/88, pp. 45-56.;;Brownlee, M., et al., ""A Glucose-Controlled Insulin-Delivery System: Semisynthetic Insulin Bound to Lectin"", Science, vol. 206, 1979, 1190-1191.;;Cai, Q., et al., ""A Wireless, Remove Query Glucose Biosensor Based on a pH-Sensitive Polymer"", Analytical Chemistry, vol. 76, No. 14, 2004, pp. 4038-4043.;;Candas, B., et al., ""An Adaptive Plasma Glucose Controller Based on a Nonlinear Insulin/Glucose Model"", IEEE Transactions on Biomedical Engineering, vol. 41, No. 2, 1994, pp. 116-124.;;Cass, A. E., et al., ""Ferricinum Ion as an Electron Acceptor for Oxido-Reductases"", Journal of ElectroAnalytical Chemistry, vol. 190, 1985, pp. 117-127.;;Cass, A. E., et al., ""Ferrocene-Medicated Enzyme Electrode for Amperometric Determination of Glucose"", Analytical Chemistry, vol. 56, No. 4, 1984, 667-671.;;Castner, J. F., et al., ""Mass Electrochemically for Immobilized Transport and Reaction Kinetic Parameters Determined Glucose Oxidase"", Biochemistry, vol. 23 No. 10, 1984, 2203-2210.;;Chen, J. C., et al., ""A Comparison of MAC Protocols for Wireless Local Networks Based on battery Power Consumption"", IEEE, 1998, pp. 150-157.;;Chen, T., et al., ""Defining the Period of Recovery of the Glucose Concentration After Its Local Perturbation by the Implantation of a Miniature Sensor"", Clinical Chemistry and Laboratory Medicine, vol. 40, No. 8, 2002, pp. 486-489.;;Chia, C. W., et al., ""Glucose Sensors: Toward Closed Loop Insulin Delivery"", Endocrinology and Metabolism Clinics of North America, vol. 33, 2004, pp. 175-195.;;Choleau, C., et al., ""Calibration of a Subcutaneous Amperometric Glucose Sensor Implanted for 7 Days in Diabetic Patients Part 2: Superiority of the One-Point Calibration Method"", Biosensors and Bioelectronics, vol. 17, 2002, pp. 647-654.;;Choleau, C., et al., ""Calibration of a Subcutaneous Amperometric Glucose Sensor Part 1: Effect of Measurement Uncertainties on the Determination of Sensor Sensitivity and Background Current"", Biosensors and Bioelectronics, vol. 17, 2002, pp. 641-646.;;Claremont, D. J., et al., ""Biosensors for Continuous in Vivo Glucose Monitoring"", Proceedings of the Annual International Conference of the IEEE Engineering in Medicine and.Biology Society, vol. 10, 1988.;;Clark Jr., L. C., et al., ""Differential Anodic Enzyme Polarography for the Measurement of Glucose"", Oxygen Transport to Tissue: Instrumentation, Methods, and Physiology, 1973, pp. 127-133.;;Clark Jr., L. C., et al., ""Electrode Systems for Continuous Monitoring in Cardiovascular Surgery"", Annals New York Academy of Sciences, 1962, pp. 29-45.;;Clark Jr., L. C., et al., ""Long-term Stability of Electroenzymatic Glucose Sensors Implanted in Mice"", American Society of Artificial Internal Organs Transactions, vol. XXXIV, 1988, pp. 259-265.;;Clarke, W. L., et al., ""Evaluating Clinical Accuracy of Systems for Self-Monitoring of Blood Glucose"", Diabetes Care, vol. 10, No. 5, 1987, pp. 622-628.;;Complaint, ""Abbott Diabetes Care, Inc. v. Dexcom, Inc."", filed Aug. 11, 2005.;;Complaint, Amended, ""Abbott Diabetes Care, Inc. v. Dexcom, Inc."", filed Jun. 27, 2006.;;Cox, D. J., et al., ""Accuracy of Perceiving Blood Glucose in IDDM"", Diabetes Care, vol. 8, No. 6, 1985, pp. 529-536.;;Csoregi, E., et al., ""Amperometric Microbiosensors for Detection of Hydrogen Peroxide and Glucose Based on Peroxidase-Modified Carbon Fibers"", Electroanalysis, vol. 6, 1994, pp. 925-933.;;Csoregi, E., et al., ""Design and Optimization of a Selective Subcutaneously Implantable Glucose Electrode Based on 'Wired' Glucose Oxidase"", Analytical Chemistry, vol. 67, No. 7, 1995, pp. 1240-1244.;;Csoregi, E., et al., ""Design, Subcutaneously Implanted Characterization, and One-Point in Vivo Calibration of a Glucose Electrode"", Analytical Chemistry, vol. 66 No. 19, 1994, pp. 3131-3138.;;Csoregi, E., et al., ""On-Line Glucose Monitoring by Using Microdialysis Sampling and Amperometric Detection Based on 'Wired' Glucose Oxidase in Carbon Paste"", Mikrochimica Acta, vol. 121, 1995, pp. 31-40.;;D'Arrigo, G., et al., ""Porous-Si Based Bio Reactors for Glucose Monitoring and Drugs Production"", Proceedings of SPIE: Microfluids, BioMEMS, and Medical Microsystems, vol.4982, 2003, pp. 178-184.;;Dai, W. S., et al., ""Hydrogel Membranes with Mesh Size Asymmetry Based on the Gradient Crosslinking of Poly(vinyl alcohol),"" Journal of Membrane Science, vol. 156, 1999, pp. 67-79.;;Davies, M. L., et al., ""Polymer Membranes in Clinical Sensor Applications"", Biomaterials, vol. 13 No. 14, 1992, pp. 971-978.;;Davis, G., ""Electrochemical Techniques for the Development of Amperometric Biosensors"", Biosensors, vol. 1, 1985, pp. 161-178.;;Degani, Y., et al., ""Direct Electrical Communication Between Chemically Modified Enzymes and Metal Electrodes. 1. Electron Transfer from Glucose Oxidase to Metal Electrodes via Electron Relays, Bound Covalently to the Enzyme"", The Journal of Physical Chemistry, vol. 91, No. 6, 1987, pp. 1285-1289.;;Degani, Y., et al., ""Direct Electrical Communication Between Chemically Modified Enzymes and Metal Electrodes. 2. Methods for Bonding Electron-Transfer Relays to Glucose Oxidase and D-Amino-Acid Oxidase"", Journal of the American Chemical Society, vol. 110, No. 8, 1988, pp. 2615-2620.;;Degani, Y., et al., ""Electrical Communication Between Redox Centers of Glucose Oxidase and Electrodes via Electrostatically and Covalently Bound Redox Polymers"", Journal of the American Chemical Society, vol. 111, 1989, pp. 2357-2358.;;Denisevich, P., et al., ""Unidirectional Current Flow and Charge State Trapping at Redox Polymer Interfaces on Bilayer Electrodes: Principles, Experimental Demonstration, and Theory"", Journal of the American Chemical Society, vol. 103, 1981, pp. 4727-4737.;;Dicks, J. M., et al., ""Ferrocene Application in Amperometric Modified Polypyrrole with Immobilised Glucose Oxidase and its Glucose Microbiosensors"", Annales de Biologie Clinique, vol. 47, 1989, pp. 607-619.;;Dixon, B. M., et al., ""Characterization in Vitro and in Vivo of the Oxygen Dependence of an Enzyme/Polymer Biosensors for Monitoring Brain Glucose"", Journal of Neuroscience Methods, vol. 119, 2002, pp. 135-142.;;Eighth Annual Diabetes Technology Meeting Abstracts, Nov. 13-15, 2008, pp. A1-A182.;;El-Khatib, F. H, et al., ""Adaptive Closed-Loop Control Provides Blood-Glucose Regulation Using Subcutaneous Insulin and Glucagon Infusion in Diabetic Swine"", Journal of Diabetes Science and Technology, vol. 1, No. 2, 2007, pp. 181-192.;;Ellis, C. D., et al., ""Selectivity and Directed Charge Transfer through an Electroactive Metallopolymer Film"", Journal of the American Chemical Society, vol. 103, No. 25, 1981, pp. 7480-7483.;;El-Sa'Ad, L., et al., ""Moisture Absorption by Epoxy Resins: The Reverse Thermal Effect"", Journal of Materials Science, vol. 25, No. 8, 1990, pp. 3577-3582.;;Engstrom, R. C., ""Electrochemical Pretreatment of Glassy Carbon Electrodes"", Analytical Chemistry, vol. 54, No. 13, 1982, pp. 2310-2314.;;Engstrom, R. C., et al., ""Characterization of Electrochemically Pretreated Glassy Carbon Electrodes"", Analytical Chemistry, vol. 56, No. 2, 1984, pp. 136-141.;;Ernst, H., et al., ""Reliable Glucose Monitoring Through the Use of Microsystem Technology"", Analytical and Bioanalytical Chemistry, vol. 373, 2002, pp. 758-761.;;Fabietti, P. G., et al. ""Clinical Validation of a New Control-Oriented Model of Insulin and Glucose Dynamics in Subjects with Type 1 Diabetes"", Diabetes Technology & Therapeutics, vol. 9 No. 4, 2007, pp. 327-338.;;Fare, T. L., et al., ""Functional Characterization of a Conducting Polymer-Based Immunoassay System"", Biosensors & Bioelectronics, vol. 13, No. 3-4, 1998, pp. 459-470.;;Feldman, B., et al., ""A Continuous Glucose Sensor Based Results on Wired Enzyme(TM) Technology-from a 3-Day Trial in Patients with Type 1 Diabetes"", Diabetes Technology & Therapeutics, vol. 5, No. 5, 2003, pp. 769-779.;;Feldman, B., et al., ""Correlation Blood During Periods of Rapid Continuous Glucose Monitor of Glucose Concentrations in Interstitial Fluid and Venous Glucose Change"", Abbott Diabetes Care, Inc. Freestyle Navigator.Pamphlet, 2004.;;Feldman, B., et al., ""Electron Transfer Kinetics at Redox Polymer/Solution Interfaces Using Microelectrodes and Twin Electrode Thin Layer Cells"", Journal of ElectroAnalytical Chemistry, vol. 194, 1985, pp. 63-81.;;Fischer, H., et al., ""Intramolecular Electron Transfer Medicated by 4,4'-Bypyridine and Related Bridging Groups"", Journal of the American Chemical Society, vol. 98, No. 18, 1976, pp. 5512-5517.;;Flentge, F., et al., ""An Enzyme-Reactor for Electrochemical Monitoring of Choline and Acetylcholine: Applications in High-Performance Liquid Chromatography, Bran Tissue, Microdialysis and Cerebrospinal Fluid,"" Analytical Biochemistry, vol. 204, 1992, pp. 305-310.;;Foulds, N. C., et al., ""Enzyme Entrapment in Electrically Conducting Polymers: Immobilisation of Glucose Oxidase in Polypyrrole and its Application in Amperometric Glucose Sensors"", Journal of the Chemical Society, Faraday Transactions 1, vol. 82, 1986, pp. 1259-1264.;;Foulds, N. C., et al , ""Immobilization of Glucose Oxidase in Ferrocene-Modified Pyrrole Polymers"", Analytical Chemistry, vol. 60, No. 22, 1988, pp. 2473-2478.;;Frew, J. E., et al., ""Electron-Transfer Biosensors"", Philosophical Transactions of the Royal Society of London, vol. 316, 1987, pp. 95-106.;;Frohnauer, M. K., et al., ""Graphical Human Insulin Time-Activity Profiles Using Standardized Definitions"", Diabetes Technology & Therapeutics, vol. 3, No. 3, 2001, pp. 419-429.;;Frost, M. C., et al., ""Implantable Chemical Sensors for Real-Time Clinical Monitoring: Progress and Challenges"", Current Opinion in Chemical Biology, vol. 6, 2002, pp. 633-641.;;Garg, S. K., et al., ""Correlation of Fingerstick Blood Glucose Measurements with GlucoWatch Biographer Glucose Results in Young Subjects with Type 1 Diabetes"", Diabetes Care, vol. 22, No. 10, 1999, pp. 1708-1714.;;Garg, S. K., et al., ""Improved Glucose Excursions Using an Implantable Real-Time Continuous Glucose Sensor in Adults with Type 1 Diabetes"", Diabetes Care, vol. 27, No. 3, 2004, pp. 734-738.;;Geller, R. L., et al., ""Use of an Immunoisolation Device for Cell Transplantation and Tumor Immunotherapy"", Annals of the New York Academy of Sciences, vol. 831, 1997, pp. 438-451.",EXPIRED
180,US,A1,US 2009/0177056 A1,048-506-854-725-305,2009-07-09,2009,US 40543909 A,2009-03-17,US 40543909 A;;US 42005703 A;;US 66719900 A;;US 7067798 A,1998-04-30,Analyte Monitoring Device and Methods of Use,"An analyte monitor includes a sensor, a sensor control unit, and a display unit. The sensor has, for example, a substrate, a recessed channel formed in the substrate, and conductive material disposed in the recessed channel to form a working electrode. The sensor control unit typically has a housing adapted for placement on skin and is adapted to receive a portion of an electrochemical sensor. The sensor control unit also includes two or more conductive contacts disposed on the housing and configured for coupling to two or more contact pads on the sensor. A transmitter is disposed in the housing and coupled to the plurality of conductive contacts for transmitting data obtained using the sensor. The display unit has a receiver for receiving data transmitted by the transmitter of the sensor control unit and a display coupled to the receiver for displaying an indication of a level of an analyte. The analyte monitor may also be part of a drug delivery system to alter the level of the analyte based on the data obtained using the sensor.",ABBOTT DIABETES CARE INC,SAY JAMES;;TOMASCO MICHAEL F;;HELLER ADAM;;GAL YORAM;;ARIA BEHRAD;;HELLER EPHRAIM;;PLANTE PHILLIP JOHN;;VREEKE MARK S;;FRIEDMAN KEITH A;;COLMAN FREDRIC C,,https://lens.org/048-506-854-725-305,Patent Application,yes,1,61,211,221,0,A61B5/14532;;A61B5/14532;;A61B5/0002;;A61B5/0002;;A61B5/002;;A61B5/01;;A61B5/14503;;A61B5/1451;;A61B5/14546;;A61B5/14546;;A61B5/1473;;A61B5/1473;;A61B5/1486;;A61B5/1486;;A61B5/14865;;A61B5/1495;;A61B5/4839;;A61B5/72;;A61B5/7278;;A61B5/7282;;A61B5/7405;;A61B5/743;;A61B5/7445;;A61B5/7445;;A61B5/7455;;A61B2560/0252;;A61B2560/0252;;A61M5/1723;;C12Q1/54;;G16H10/40;;G16H10/40;;G16H20/17;;G16H20/17;;H01L23/3107;;H01L23/3107;;H01L23/49548;;H01L23/49548;;H01L2924/0002;;H01L2924/0002;;H01L2924/19041;;H01L2924/19041;;H01L2924/3011;;H01L2924/3011;;Y10S128/903;;Y10S128/903;;Y10T29/49;;Y10T29/49;;Y10T29/49124;;Y10T29/49124,A61B5/1468;;G01N27/30;;A61B5/00;;A61B5/145;;A61B5/1477;;A61B5/1495;;G01N27/416;;G06F19/00;;H01L23/31;;H01L23/495,600/345,0,0,,,,DISCONTINUED
181,US,A1,US 2011/0112389 A1,065-160-931-218-018,2011-05-12,2011,US 201113006406 A,2011-01-13,US 201113006406 A;;US 69082607 A;;US 42005703 A;;US 66719900 A;;US 7067798 A,1998-04-30,Analyte Monitoring Device and Methods of Use,"An analyte monitor includes a sensor, a sensor control unit, and a display unit. The sensor has, for example, a substrate, a recessed channel formed in the substrate, and conductive material disposed in the recessed channel to form a working electrode. The sensor control unit typically has a housing adapted for placement on skin and is adapted to receive a portion of an electrochemical sensor. The sensor control unit also includes two or more conductive contacts disposed on the housing and configured for coupling to two or more contact pads on the sensor. A transmitter is disposed in the housing and coupled to the plurality of conductive contacts for transmitting data obtained using the sensor. The display unit has a receiver for receiving data transmitted by the transmitter of the sensor control unit and a display coupled to the receiver for displaying an indication of a level of an analyte. The analyte monitor may also be part of a drug delivery system to alter the level of the analyte based on the data obtained using the sensor.",ABBOTT DIABETES CARE INC,SAY JAMES;;TOMASCO MICHAEL F;;HELLER ADAM;;GAL YORAM;;ARIA BEHRAD;;HELLER EPHRAIM;;PLANTE PHILLIP JOHN;;VREEKE MARK S;;FRIEDMAN KEITH A;;COLMAN FREDRIC C,,https://lens.org/065-160-931-218-018,Patent Application,yes,1,4,211,221,0,A61B5/14532;;A61B5/14532;;A61B5/0002;;A61B5/0002;;A61B5/002;;A61B5/01;;A61B5/14503;;A61B5/1451;;A61B5/14546;;A61B5/14546;;A61B5/1473;;A61B5/1473;;A61B5/1486;;A61B5/1486;;A61B5/14865;;A61B5/1495;;A61B5/4839;;A61B5/72;;A61B5/7278;;A61B5/7282;;A61B5/7405;;A61B5/743;;A61B5/7445;;A61B5/7445;;A61B5/7455;;A61B2560/0252;;A61B2560/0252;;A61M5/1723;;C12Q1/54;;G16H10/40;;G16H10/40;;G16H20/17;;G16H20/17;;H01L23/3107;;H01L23/3107;;H01L23/49548;;H01L23/49548;;H01L2924/0002;;H01L2924/0002;;H01L2924/19041;;H01L2924/19041;;H01L2924/3011;;H01L2924/3011;;Y10S128/903;;Y10S128/903;;Y10T29/49;;Y10T29/49;;Y10T29/49124;;Y10T29/49124,A61B5/1473;;G01N27/30;;A61B5/00;;A61B5/145;;A61B5/1477;;A61B5/1495;;G01N27/416;;G06F19/00;;H01L23/31;;H01L23/495,600/347;;600/345,0,0,,,,DISCONTINUED
182,US,B2,US 8380273 B2,072-553-648-720-214,2013-02-19,2013,US 42226909 A,2009-04-11,US 42226909 A;;US 4140405 A;;US 42005703 A;;US 66719900 A;;US 7067798 A,1998-04-30,Analyte monitoring device and methods of use,"An analyte monitor includes a sensor, a sensor control unit, and a display unit. The sensor has, for example, a substrate, a recessed channel formed in the substrate, and conductive material disposed in the recessed channel to form a working electrode. The sensor control unit typically has a housing adapted for placement on skin and is adapted to receive a portion of an electrochemical sensor. The sensor control unit also includes two or more conductive contacts disposed on the housing and configured for coupling to two or more contact pads on the sensor. A transmitter is disposed in the housing and coupled to the plurality of conductive contacts for transmitting data obtained using the sensor. The display unit has a receiver for receiving data transmitted by the transmitter of the sensor control unit and a display coupled to the receiver for displaying an indication of a level of an analyte. The analyte monitor may also be part of a drug delivery system to alter the level of the analyte based on the data obtained using the sensor.",ABBOTT DIABETES CARE INC;;SAY JAMES;;TOMASCO MICHAEL F;;HELLER ADAM;;GAL YORAM;;ARIA BEHRAD;;HELLER EPHRAIM;;PLANTE PHILLIP JOHN;;VREEKE MARK S;;FRIEDMAN KEITH A;;COLMAN FREDRIC C,SAY JAMES;;TOMASCO MICHAEL F;;HELLER ADAM;;GAL YORAM;;ARIA BEHRAD;;HELLER EPHRAIM;;PLANTE PHILLIP JOHN;;VREEKE MARK S;;FRIEDMAN KEITH A;;COLMAN FREDRIC C,E. HELLER & CO (1998-07-02);;ABBOTT DIABETES CARE INC (2000-03-13),https://lens.org/072-553-648-720-214,Granted Patent,yes,115,21,211,221,0,A61B5/14532;;A61B5/14532;;A61B5/0002;;A61B5/0002;;A61B5/002;;A61B5/01;;A61B5/14503;;A61B5/1451;;A61B5/14546;;A61B5/14546;;A61B5/1473;;A61B5/1473;;A61B5/1486;;A61B5/1486;;A61B5/14865;;A61B5/1495;;A61B5/4839;;A61B5/72;;A61B5/7278;;A61B5/7282;;A61B5/7405;;A61B5/743;;A61B5/7445;;A61B5/7445;;A61B5/7455;;A61B2560/0252;;A61B2560/0252;;A61M5/1723;;C12Q1/54;;G16H10/40;;G16H10/40;;G16H20/17;;G16H20/17;;H01L23/3107;;H01L23/3107;;H01L23/49548;;H01L23/49548;;H01L2924/0002;;H01L2924/0002;;H01L2924/19041;;H01L2924/19041;;H01L2924/3011;;H01L2924/3011;;Y10S128/903;;Y10S128/903;;Y10T29/49;;Y10T29/49;;Y10T29/49124;;Y10T29/49124,A61B5/05;;G01N27/30;;A61B5/00;;A61B5/145;;A61B5/1477;;A61B5/1495;;G01N27/416;;G06F19/00;;H01L23/31;;H01L23/495,600/345;;600/347;;600/365,99,39,136-791-935-548-81X;;062-360-289-025-864;;010-601-725-111-91X;;101-292-518-663-191;;056-703-879-057-297;;030-155-762-644-019;;004-149-141-436-651;;016-731-054-793-457;;080-559-561-995-335;;044-807-213-528-815;;027-538-525-436-179;;015-020-161-517-40X;;025-919-454-564-785;;014-700-576-603-812;;004-851-060-590-788;;075-958-432-122-199;;052-356-140-149-389;;035-090-282-884-790;;033-562-815-299-181;;018-803-926-589-211;;008-505-762-041-402;;016-601-143-530-813;;019-502-772-562-215;;058-476-824-396-350;;006-498-707-073-30X;;054-091-551-638-293;;010-531-147-771-746;;054-827-198-877-419;;122-658-944-077-000;;017-261-560-469-37X;;000-125-755-474-124;;113-381-664-783-802;;082-626-907-191-554;;017-950-014-792-456;;090-348-305-613-628;;015-985-399-299-132;;171-049-047-164-618;;016-819-089-891-758;;081-249-097-078-543,10.1016/s0956-5663(02)00099-4;;12392956;;10.1021/ja00391a001;;2889225;;10.1098/rstb.1987.0021;;10.1109/51.294001;;10.1016/0022-0728(65)85063-x;;2245876;;10.2337/diabetes.39.12.1519;;10.2337/diab.39.12.1519;;10.1016/s0956-5663(03)00220-3;;14611755;;18615658;;10.1002/bit.260430310;;9366023;;10.1016/s0956-5663(97)00025-0;;9451795;;10.1016/s0956-5663(97)00083-3;;10.1016/0956-5663(93)80028-n;;8311939;;8651496;;10.1021/ac960030d;;10.1080/03091900210156797;;12487712;;10.1016/0265-928x(87)80018-4;;3333622;;10.1109/19.816143;;10.1007/bf01015979;;10.1089/15209150252924058;;12017416;;18473691;;10.1089/dia.2007.0281;;10.1021/ac00017a008;;1789439;;2817408;;10.1021/ac00197a022;;10.1016/0925-4005(95)01730-5;;10.1016/0010-4825(90)90013-f;;2257734;;2868172;;8277748;;10.1016/0141-5425(93)90058-7;;11469630;;10.1089/15209150050214104;;10624783;;10.1016/s0168-8227(99)00113-8;;10.1089/15209150050214113;;11469631;;10.1007/bf00401374;;1478372;;10.2337/diacare.20.1.64;;9028696;;10.1109/tbme.1986.325807;;3957374;;236018;;10.1016/0005-2795(75)90259-7;;10.1089/hum.1998.9.6-879;;9581910;;11762520;;10.1089/15209150152607196;;10.2337/diabetes.48.3.445;;10078542;;10.1016/0265-928x(87)80012-3;;505005;;10.1126/science.505005;;10.1021/ac0498516;;15253640;;10.1109/10.284922;;8026845;;6721151;;10.1021/ac00268a018,"Japanese Patent Application No. 2007-270411, Office Action mailed Aug. 17, 2010.;;Japanese Patent Application No. 2007-270411, Office Action mailed Jun. 21, 2011.;;U.S. Appl. No. 10/783,675, Office Action mailed Dec. 14, 2010.;;U.S. Appl. No. 10/783,675, Office Action mailed Jun. 2, 2011.;;U.S. Appl. No. 11/681,730, Office Action mailed Apr. 27, 2011.;;U.S. Appl. No. 11/683,396, Office Action mailed Sep. 8, 2011.;;U.S. Appl. No. 11/690,826, Office Action mailed Aug. 9, 2011.;;U.S. Appl. No. 11/695,607, Office Action mailed Mar. 2, 2011.;;U.S. Appl. No. 11/742,507, Office Action mailed Apr. 13, 2011.;;U.S. Appl. No. 11/742,507, Office Action mailed Jun. 12, 2009.;;U.S. Appl. No. 11/928,795, Office Action mailed May 12, 2011.;;U.S. Appl. No. 11/941,078, Office Action mailed Apr. 22, 2011.;;U.S. Appl. No. 11/941,078, Office Action mailed Mar. 18, 2010.;;U.S. Appl. No. 12/249,644, Office Action mailed Apr. 15, 2011.;;U.S. Appl. No. 12/371,539, Office Action mailed Sep. 26, 2011.;;U.S. Appl. No. 12/397,281, Office Action mailed May 12, 2011.;;U.S. Appl. No. 12/397,293, Office Action mailed Aug. 5, 2011.;;U.S. Appl. No. 12/397,301, Office Action mailed Aug. 22, 2011.;;U.S. Appl. No. 12/405,515, Office Action mailed Apr. 29, 2011.;;U.S. Appl. No. 12/405,568, Office Action mailed Sep. 16, 2011.;;U.S. Appl. No. 12/405,987, Office Action mailed Nov. 16, 2010.;;U.S. Appl. No. 12/406,746, Office Action mailed Apr. 5, 2011.;;U.S. Appl. No. 12/406,746, Office Action mailed Jul. 23, 2010.;;U.S. Appl. No. 12/406,746, Office Action mailed Sep. 1, 2011.;;U.S. Appl. No. 12/406,800, Office Action mailed Apr. 20, 2011.;;U.S. Appl. No. 12/414,456, Office Action mailed Apr. 29, 2011.;;U.S. Appl. No. 12/414,542, Office Action mailed Apr. 13, 2011.;;U.S. Appl. No. 12/414,558, Office Action mailed Apr. 4, 2011.;;U.S. Appl. No. 12/495,798, Office Action mailed Jun. 30, 2011.;;U.S. Appl. No. 12/495,803, Office Action mailed Jun. 30, 2011.;;U.S. Appl. No. 12/495,807, Office Action mailed Jul. 21, 2011.;;U.S. Appl. No. 12/614,974, Office Action mailed Apr. 12, 2011.;;U.S. Appl. No. 12/614,990, Office Action mailed Apr. 14, 2011.;;U.S. Appl. No. 12/615,069, Office Action mailed Jun. 9, 2011.;;U.S. Appl. No. 12/615,128, Office Action mailed Aug. 19 2011.;;U.S. Appl. No. 12/643,974, Office Action mailed May 4, 2011.;;U.S. Appl. No. 12/643,975, Office Action mailed Sep. 22, 2011.;;U.S. Appl. No. 12/643,978, Office Action mailed Apr. 15, 2011.;;U.S. Appl. No. 12/643,980, Office Action mailed Jun. 24, 2011.;;U.S. Appl. No. 12/643,982, Office Action mailed Jun. 17, 2011.;;U.S. Appl. No. 12/643,986, Office Action mailed Jun. 17, 2011.;;U.S. Appl. No. 12/779,947, Office Action mailed Apr. 8, 2011.;;U.S. Appl. No. 12/825,186, Office Action mailed Mar. 31, 2011.;;U.S. Appl. No. 12/825,202 Office Action mailed Jun. 8, 2011.;;U.S. Appl. No. 12/902,138 Office Action mailed Jun. 7, 2011.;;U.S. Appl. No. 90/010,791, Notice of Intent to Issue Reexamination Certificate mailed May 17, 2011.;;U.S. Appl. No. 90/010,791, Office Action mailed Dec. 17, 2010.;;U.S. Appl. No. 90/010,791, Office Action mailed May 28, 2010.;;U.S. Appl. No. 90/011,730, Request for Reexamination of U.S. Patent No. 6,990,366 filed Jun. 3, 2011.;;""Poretics Polycarbonate Membrane"", Osmonics Filtration and Separation Group, 2002.;;Abel, P. U., et al., ""Biosensors for in Vivo Glucose Measurement: Can We Cross the Experimental Stage"", Biosensors and Bioelectronics, vol. 17, 2002, pp. 1059-1070.;;Abruna, H. D., et al., ""Rectifying Interfaces Using Two-Layer Films of Electrochemically Polymerized Vinylpyridine and Vinylbipyridine Complexes of Ruthenium and Iron on Electrodes"", Journal of the American Chemical Society, vol. 103, No. 1, 1981, pp. 1-5.;;Albery, W. J., et al., ""Amperometric Enzyme Electrodes Part II: Conducting Salts as Electrode Materials for the Oxidation of Glucose Oxidase"", Journal of ElectroAnalytical Chemistry, vol. 194, 1985, pp. 223-235.;;Albery, W. J., et al., ""Amperometric Enzyme Electrodes"", Philosophical Transactions of the Royal Society of London, vol. 316, 1987, pp. 107-119.;;Alcock, S. J., et al., ""Continuous Analyte Monitoring to Aid Clinical Practive"", IEEE Engineering in Medicine and Biology Magazine, 1994, pp. 319-325.;;Anderson, L. B., et al., ""Thin-Layer Electrochemistry: Steady-State Methods of Studying Rate Processes"", Journal of ElectroAnalytical Chemistry, vol. 10, 1965, pp. 295-305.;;Armour, J. C., et al., ""Application of Chronic Intravascular Blood Glucose Sensor in Dogs"", Diabetes, vol. 39, 1990, pp. 1519-1526.;;Asberg, P., et al., ""Hydrogels of a Conducting Conjugated Polymer as 3-D Enzyme Electrode"", Biosensors & Bioelectronics, vol. 19, 2003, pp. 199-207.;;Atanasov, P., et al., ""Biosensor for Continuous Glucose Monitoring"", Biotechnology and Bioengineering, vol. 43, 1994, pp. 262-266.;;Atanasov, P., et al., ""Implantation of a Refillable Glucose Monitoring-Telemetry Device"", Biosensors & Bioelectronics, vol. 12, No. 7, 1997, pp. 669-680.;;Aussedat, B., et al., ""A User-Friendly Method for Calibrating a Subcutaneous Glucose Sensor-Based Hypoglycaemic Alarm"", Biosensors & Bioelectronics, vol. 12, No. 11, 1997, pp. 1061-1071.;;Baker, D. A., et al., ""Dynamic Concentration Challenges for Biosensor Characterization"", Biosensors & Bioelectronics, vol. 8, 1993, pp. 433-441.;;Baker, D. A., et al., ""Dynamic Delay and Maximal Dynamic Error in Continuous Biosensors"", Analytical Chemistry, vol. 68, No. 8, 1996, pp. 1292-1297.;;Bani Amer, M. M., ""An Accurate Amperometric Glucose Sensor Based Glucometer with Eliminated Cross-Sensitivity"", Journal of Medical Engineering & Technology, vol. 26, No. 5, 2002, pp. 208-213.;;Bard, A. J., et al., Electrochemical Methods, 1980, pp. 173-175.;;Bartlett, P. N., et al., ""Covalent Binding of Electron Relays to Glucose Oxidase"", Journal of the Chemical Society, Chemical Communications, 1987, pp. 1603-1604.;;Bartlett, P. N., et al., ""Modification of Glucose Oxidase by Tetrathiafulvalene"", Journal of the Chemical Society, Chemical Communications, 1990, pp. 1135-1136.;;Bartlett, P. N., et al., ""Strategies for the Development of Amperometric Enzyme Electrodes"", Biosensors, vol. 3, 1987/88, pp. 359-379.;;Beach, R. D., et al., ""Subminiature Implantable Potentiostat and Modified Commecial Telemetry Device for Remote Glucose Monitoring"", IEEE Transactions on Instrumentation and Measurement, vol. 28, No. 6, 1999, pp. 1239-1245.;;Beech, W. A., ""AX.25 Link Access Protocol for Amateur Packet Radio"", Tucson Amateur Packet Radio Corporation, 1998, pp. 1-133.;;Bellucci, F., et al., ""Electrochemical Behavior of Graphite-Epoxy Composite Materials (GECM) in Aqueous Salt Solutions"", Journal of Applied Electrochemistry, vol. 16, 1986, pp. 15-22.;;Bennion, N., et al., ""Alternate Site Glucose Testing: A Crossover Design"", Diabetes Technology & Therapeutics, vol. 4, No. 1, 2002, pp. 25-33.;;Biermann, E., et al., ""How Would Patients Behave if They Were Continually Informed of Their Blood Glucose Levels? A Simulation Study Using a 'Virtual' Patient"", Diabetes Technology & Therapeutics, vol. 10, No. 3, 2008, pp. 178-187.;;Bindra, D. S., et al., ""Design and in Vitro Studies of a Needle-Type Glucose Sensor for Subcutaneous Monitoring"", Analytical Chemistry, vol. 63, No. 17, 1991, pp. 1692-1696.;;Bindra, D. S., et al., ""Pulsed Amperometric Detection of Glucose in Biological Fluids at a Surface-Modified Gold Electrode"", Analytical Chemistry, vol. 61, No. 22, 1989, pp. 2566-2570.;;Bisenberger, M., et al., ""A Triple-Step Potential Waveform at Enzyme Multisensors with Thick-Film Gold Electodes for Detection of Glucose and Sucrose"", Sensors and Actuators B, vol. 28, 1998, pp. 181-189.;;Bland, J. M., et al., ""A Note on the Use of the Intraclass Correlation Coefficient in the Evaluation of Agreement Between Two Methods of Measurement"", Computers in Biology and Medicine, vol. 20, No. 5, 1990, pp. 337-340.;;Bland, J. M., et al., ""Statistical Methods for Assessing Agreement Between Two Methods of Clinical Measurement"", The Lancet, 1986, pp. 307-310.;;Blank, T. B., et al., ""Clinical Results From a Non-Invasive Blood Glucose Monitor"", Optical Diagnostics and Sensing of Biological Fluids and Glucose and Cholesterol Monitoring II, Proceedings of SPIE, vol. 4624, 2002, pp. 1-10.;;Bobbioni-Harsch, E., et al., ""Lifespan of Subcutaneous Glucose Sensors and Their Performances During Dynamic Glycaemia Changes in Rats"", Jouranl of Biomedical Engineering, vol. 15, 1993, pp. 457-463.;;Bode, B. W., ""Clinical Utility of the Continuous Glucose Monitoring System"", Diabetes Technology & Therapeutics, vol. 2, Sup. 1, 2000, pp. S35-S41.;;Bode, B. W., et al., ""Continuous Glucose Monitoring Used to Adjuest Diabetes Therapy Improves Glycosylated Hemoglobin: A Pilot Study"", Diabetes Research and Clinical Practice, vol. 46, 1999, pp. 183-190.;;Bode, B. W., et al., ""Using Management of the Continuous Glucose Monitoring System to Improve the Type I Diabetes"", Diabetes Technology & Therapeutics, vol. 2, Sup. 1, 2000, pp. S43-S48.;;Boedeker Plastics, Inc., ""Polyethylene Specifications"", Web Page of Boedeker.com, 2007, pp. 1-3.;;Bolinder, J., et al., ""Microdialysis Measurement of the Absolute Glucose Concentration in Subcutaneous Adipose Tissue Allowing Glucose Monitoring in Diabetic Patients"", Diabetologia, vol. 35, 1992, pp. 1177-1180.;;Bolinder, J., et al., ""Self-Monitoring of Blood Glucose in Type I Diabetic Patients: Comparison with Continuous Microdialysis Measurements of Glucose in Subcutaneous Adipose Tissue During Ordinary Life Conditions"", Diabetes Care, vol. 20, No. 1, 1997, pp. 64-70.;;Bott, A. W., ""A Comparison of Cyclic Voltammetry and Cyclic Staircase Voltammetry"", Current Separations, vol. 16, No. 1, 1997, pp. 23-26.;;Bott, A. W., ""Electrochemical Methods for the Determination of Glucose"", Current Separations, vol. 17, No. 1, 1998, pp. 25-31.;;Bowman, L., et al., ""The Packaging of Implantable Integrated Sensors"", IEEE Transactions on Biomedical Engineering, vol. 33, No. 2, 1986, pp. 248-255.;;Brandt, J., et al., ""Covalent Attachment of Proteins to Polysaccharide Carriers by Means of Benzoquinone"", Biochimica et Biophysica Acta, vol. 386, 1975, pp. 196-202.;;Brauker, J., et al., ""Sustained Expression of High Levels of Human Factor IX from Human Cells Implanted Within an Immunoisolation Device into Athymic Rodents"", Human Gene Therapy, vol. 9, No. 6, 1998, pp. 879-888.;;Bremer, T. M., et al., ""Benchmark Data from the Literature for Evaluation of New Glucose Sensing Technologies"", Diabetes Technology & Therapeutics, vol. 3, No. 3, 2001, pp. 409-418.;;Bremer, T., et al., ""Is Blood Glucose Predictable from Previous Values?"", Diabetes, vol. 48, 1999, pp. 445-451.;;Brooks, S. L., et al., ""Development of an On-Line Glucose Sensor for Fermentation Monitoring"", Biosensors, vol. 3, 1987/88, pp. 45-56.;;Brownlee, M., et al., ""A Glucose-Controlled Insulin-Delivery System: Semisynthetic Insulin Bound to Lectin"", Science, vol. 206, 1979, 1190-1191.;;Cai, Q., et al., ""A Wireless, Remove Query Glucose Biosensor Based on a pH-Sensitive Polymer"", Analytical Chemistry, vol. 76, No. 14, 2004, pp. 4038-4043.;;Candas, B., et al., ""An Adaptive Plasma Glucose Controller Based on a Nonlinear Insulin/Glucose Model"", IEEE Transactions on Biomedical Engineering, vol. 41, No. 2, 1994, pp. 116-124.;;Cass, A. E., et al., ""Ferricinum Ion as an Electron Acceptor for Oxido-Reductases"", Journal of ElectroAnalytical Chemistry, vol. 190, 1985, pp. 117-127.;;Cass, A. E., et al., ""Ferrocene-Medicated Enzyme Electrode for Amperometric Determination of Glucose"", Analytical Chemistry, vol. 56, No. 4, 1984, 667-671.",EXPIRED
183,US,A1,US 2007/0203410 A1,087-811-442-993-202,2007-08-30,2007,US 74250707 A,2007-04-30,US 74250707 A;;US 42005703 A;;US 66719900 A;;US 7067798 A,1998-04-30,Analyte Monitoring Device and Methods of Use,"An analyte monitor includes a sensor, a sensor control unit, and a display unit. The sensor has, for example, a substrate, a recessed channel formed in the substrate, and conductive material disposed in the recessed channel to form a working electrode. The sensor control unit typically has a housing adapted for placement on skin and is adapted to receive a portion of an electrochemical sensor. The sensor control unit also includes two or more conductive contacts disposed on the housing and configured for coupling to two or more contact pads on the sensor. A transmitter is disposed in the housing and coupled to the plurality of conductive contacts for transmitting data obtained using the sensor. The display unit has a receiver for receiving data transmitted by the transmitter of the sensor control unit and a display coupled to the receiver for displaying an indication of a level of an analyte. The analyte monitor may also be part of a drug delivery system to alter the level of the analyte based on the data obtained using the sensor.",ABBOTT DIABETES CARE INC,SAY JAMES;;TOMASCO MICHAEL F;;HELLER ADAM;;GAL YORAM;;ARIA BEHRAD;;HELLER EPHRAIM;;PLANTE PHILLIP J;;VREEKE MARK S;;FRIEDMAN KEITH A;;COLMAN FREDRIC C,E. HELLER & CO (1998-07-02);;ABBOTT DIABETES CARE INC (2000-03-13),https://lens.org/087-811-442-993-202,Patent Application,yes,99,131,211,221,0,A61B5/14532;;A61B5/14532;;A61B5/0002;;A61B5/0002;;A61B5/002;;A61B5/01;;A61B5/14503;;A61B5/1451;;A61B5/14546;;A61B5/14546;;A61B5/1473;;A61B5/1473;;A61B5/1486;;A61B5/1486;;A61B5/14865;;A61B5/1495;;A61B5/4839;;A61B5/72;;A61B5/7278;;A61B5/7282;;A61B5/7405;;A61B5/743;;A61B5/7445;;A61B5/7445;;A61B5/7455;;A61B2560/0252;;A61B2560/0252;;A61M5/1723;;C12Q1/54;;G16H10/40;;G16H10/40;;G16H20/17;;G16H20/17;;H01L23/3107;;H01L23/3107;;H01L23/49548;;H01L23/49548;;H01L2924/0002;;H01L2924/0002;;H01L2924/19041;;H01L2924/19041;;H01L2924/3011;;H01L2924/3011;;Y10S128/903;;Y10S128/903;;Y10T29/49;;Y10T29/49;;Y10T29/49124;;Y10T29/49124,A61F2/44;;G01N27/30;;A61B5/00;;A61B5/05;;A61B5/145;;A61B5/1477;;A61B5/1495;;G01N27/416;;G06F19/00;;H01L23/31;;H01L23/495,600/365;;600/345;;600/347,0,0,,,,EXPIRED
184,US,A1,US 2007/0203411 A1,123-608-986-076-859,2007-08-30,2007,US 74257107 A,2007-04-30,US 74257107 A;;US 42005703 A;;US 66719900 A;;US 7067798 A,1998-04-30,Analyte Monitoring Device and Methods of Use,"An analyte monitor includes a sensor, a sensor control unit, and a display unit. The sensor has, for example, a substrate, a recessed channel formed in the substrate, and conductive material disposed in the recessed channel to form a working electrode. The sensor control unit typically has a housing adapted for placement on skin and is adapted to receive a portion of an electrochemical sensor. The sensor control unit also includes two or more conductive contacts disposed on the housing and configured for coupling to two or more contact pads on the sensor. A transmitter is disposed in the housing and coupled to the plurality of conductive contacts for transmitting data obtained using the sensor. The display unit has a receiver for receiving data transmitted by the transmitter of the sensor control unit and a display coupled to the receiver for displaying an indication of a level of an analyte. The analyte monitor may also be part of a drug delivery system to alter the level of the analyte based on the data obtained using the sensor.",ABBOTT DIABETES CARE INC,SAY JAMES;;TOMASCO MICHAEL F;;HELLER ADAM;;GAL YORAM;;ARIA BEHRAD;;HELLER EPHRAIM;;PLANTE PHILLIP J;;VREEKE MARK S;;FRIEDMAN KEITH A;;COLMAN FREDRIC C,E. HELLER & CO (1998-07-02);;ABBOTT DIABETES CARE INC (2000-03-13),https://lens.org/123-608-986-076-859,Patent Application,yes,99,39,211,221,0,A61B5/14532;;A61B5/14532;;A61B5/0002;;A61B5/0002;;A61B5/002;;A61B5/01;;A61B5/14503;;A61B5/1451;;A61B5/14546;;A61B5/14546;;A61B5/1473;;A61B5/1473;;A61B5/1486;;A61B5/1486;;A61B5/14865;;A61B5/1495;;A61B5/4839;;A61B5/72;;A61B5/7278;;A61B5/7282;;A61B5/7405;;A61B5/743;;A61B5/7445;;A61B5/7445;;A61B5/7455;;A61B2560/0252;;A61B2560/0252;;A61M5/1723;;C12Q1/54;;G16H10/40;;G16H10/40;;G16H20/17;;G16H20/17;;H01L23/3107;;H01L23/3107;;H01L23/49548;;H01L23/49548;;H01L2924/0002;;H01L2924/0002;;H01L2924/19041;;H01L2924/19041;;H01L2924/3011;;H01L2924/3011;;Y10S128/903;;Y10S128/903;;Y10T29/49;;Y10T29/49;;Y10T29/49124;;Y10T29/49124,A61B5/1468;;G01N27/30;;A61B5/00;;A61B5/145;;A61B5/1477;;A61B5/1495;;G01N27/416;;G06F19/00;;H01L23/31;;H01L23/495,600/365,0,0,,,,EXPIRED
185,US,A1,US 2009/0192370 A1,124-920-260-373-400,2009-07-30,2009,US 41454209 A,2009-03-30,US 41454209 A;;US 42005703 A;;US 66719900 A;;US 7067798 A,1998-04-30,Analyte Monitoring Device and Methods of Use,"An analyte monitor includes a sensor, a sensor control unit, and a display unit. The sensor has, for example, a substrate, a recessed channel formed in the substrate, and conductive material disposed in the recessed channel to form a working electrode. The sensor control unit typically has a housing adapted for placement on skin and is adapted to receive a portion of an electrochemical sensor. The sensor control unit also includes two or more conductive contacts disposed on the housing and configured for coupling to two or more contact pads on the sensor. A transmitter is disposed in the housing and coupled to the plurality of conductive contacts for transmitting data obtained using the sensor. The display unit has a receiver for receiving data transmitted by the transmitter of the sensor control unit and a display coupled to the receiver for displaying an indication of a level of an analyte. The analyte monitor may also be part of a drug delivery system to alter the level of the analyte based on the data obtained using the sensor.",ABBOTT DIABETES CARE INC,SAY JAMES;;TOMASCO MICHAEL F;;HELLER ADAM;;GAL YORAM;;ARIA BEHRAD;;HELLER EPHRAIM;;PLANTE PHILLIP JOHN;;VREEKE MARK S;;FRIEDMAN KEITH A;;COLMAN FREDRIC C,,https://lens.org/124-920-260-373-400,Patent Application,yes,86,57,211,221,0,A61B5/14532;;A61B5/14532;;A61B5/0002;;A61B5/0002;;A61B5/002;;A61B5/01;;A61B5/14503;;A61B5/1451;;A61B5/14546;;A61B5/14546;;A61B5/1473;;A61B5/1473;;A61B5/1486;;A61B5/1486;;A61B5/14865;;A61B5/1495;;A61B5/4839;;A61B5/72;;A61B5/7278;;A61B5/7282;;A61B5/7405;;A61B5/743;;A61B5/7445;;A61B5/7445;;A61B5/7455;;A61B2560/0252;;A61B2560/0252;;A61M5/1723;;C12Q1/54;;G16H10/40;;G16H10/40;;G16H20/17;;G16H20/17;;H01L23/3107;;H01L23/3107;;H01L23/49548;;H01L23/49548;;H01L2924/0002;;H01L2924/0002;;H01L2924/19041;;H01L2924/19041;;H01L2924/3011;;H01L2924/3011;;Y10S128/903;;Y10S128/903;;Y10T29/49;;Y10T29/49;;Y10T29/49124;;Y10T29/49124,A61B5/1468;;G01N27/30;;A61B5/00;;A61B5/145;;A61B5/1477;;A61B5/1495;;G01N27/416;;G06F19/00;;H01L23/31;;H01L23/495,600/345,0,0,,,,DISCONTINUED
186,US,B2,US 8088737 B2,142-162-697-373-078,2012-01-03,2012,US 81771804 A,2004-04-02,US 81771804 A;;US 46067803 P;;US 47249403 P;;US 53203003 P;;US 54898604 P,2003-04-04,"Compositions, methods and kits relating to Her-2 cleavage","The present invention relates to compositions, methods and kits based on the ADAM-mediated cleavage of Her-2. The present invention also relates to treatments for cancer, and in particular, breast cancer, by modulating the ADAM-mediated cleavage of Her-2. Further, the invention relates to compositions, methods and kits based on the surprising synergistic effect between inhibition of Her-2 cleavage by an ADAM and certain cytostatic (e.g., Herceptin) and cytotoxic (e.g., Taxol) compounds in, among other things, inhibiting tumor cell proliferation and inducing cell death. Additionally, the invention relates to novel variants of ADAM15, designated ADAM15 variant 1 and ADAM15 variant 2, now identified and isolated.",FRIEDMAN STEVEN M;;SCHERLE PEGGY A;;LIU XIANGDONG;;BURN TIMOTHY C;;HUBER REID;;LIU PHILLIP C C;;HOLLIS GREGORY F;;VADDI KRISHNA;;FRIDMAN JORDAN S;;INCYTE CORP,FRIEDMAN STEVEN M;;SCHERLE PEGGY A;;LIU XIANGDONG;;BURN TIMOTHY C;;HUBER REID;;LIU PHILLIP C C;;HOLLIS GREGORY F;;VADDI KRISHNA;;FRIDMAN JORDAN S,INCYTE CORPORATION (2015-01-07);;INCYTE HOLDINGS CORPORATION (2015-01-07),https://lens.org/142-162-697-373-078,Granted Patent,yes,11,1,10,10,48,A61K31/19;;A61K31/19;;A61K31/395;;A61K31/395;;A61P35/00;;A61P35/04,A01N61/00;;A61K/;;A61K31/00;;A61K31/19;;A61K38/00;;A61K39/395;;G01N33/48,514/19.3;;424/130.1;;424/138.1;;436/64;;514/1;;514/1.1;;514/19.2;;514/19.4;;514/19.8;;514/20.1,52,45,063-623-385-354-885;;065-101-026-798-331;;028-732-734-943-455;;029-103-493-263-129;;026-281-375-851-686;;021-316-782-102-370;;075-486-391-274-109;;051-267-534-567-793;;000-587-586-475-455;;015-109-139-416-304;;029-210-017-016-26X;;001-062-898-610-817;;063-623-385-354-885;;046-400-909-933-163;;013-287-140-011-848;;030-344-740-353-643;;067-971-124-171-323;;001-764-793-874-679;;071-558-543-118-418;;004-675-612-587-983;;117-317-443-906-345;;042-168-263-345-282;;002-876-797-810-149;;030-904-589-650-719;;090-927-413-030-362;;066-681-448-888-222;;011-511-872-956-274;;118-356-954-617-105;;002-054-426-713-97X;;021-965-682-531-266;;020-671-742-059-726;;070-111-309-658-320;;069-525-088-009-873;;012-537-122-971-864;;051-267-534-567-793;;013-929-223-888-954;;031-397-073-411-701;;062-641-269-720-14X;;030-592-157-732-358;;082-669-654-793-134;;112-836-061-494-317;;071-879-473-575-281;;001-736-540-004-87X;;100-874-294-784-309;;051-826-302-349-824,10.1200/jco.1996.14.3.737;;8622019;;pmc4451119;;16843264;;10.1016/j.ccr.2006.05.024;;9704716;;10.1200/jco.1998.16.8.2659;;10.1023/a:1011163824080;;10.1093/annonc/12.suppl_1.s35;;11521720;;10.1016/s0093-7754(01)90276-3;;10.1053/sonc.2001.28544;;11706390;;pmc166329;;10.1128/mcb.23.16.5614-5624.2003;;12897135;;9823322;;11839648;;pmc360661;;2342466;;10.1128/mcb.10.6.2973;;10.1128/mcb.10.6.2973-2982.1990;;10.1128/mcb.13.4.2247-2257.1993;;8096058;;10.1128/mcb.13.4.2247;;pmc359545;;10.1038/sj.onc.1201866;;9681822;;1355522;;10.1200/jco.1992.10.9.1436;;10.1200/jco.1996.14.3.737;;8622019;;9399669;;10.1002/(sici)1097-0215(19971210)73:6<875::aid-ijc19>3.0.co;2-3;;12142389;;10.1093/clinchem/48.8.1314;;10.1038/319230a0;;3003577;;10.1128/mcb.9.2.671-677.1989;;pmc362644;;10.1128/mcb.9.2.671;;2785240;;pmc364322;;10.1128/mcb.12.2.883;;1732751;;10.1128/mcb.12.2.883-893.1992;;pmc17975;;10.1073/pnas.96.19.10869;;10485918;;11526509;;10.1038/sj.onc.1204555;;11934884;;10.1074/jbc.m111359200;;10.1042/bse0380141;;12463167;;10.1016/s0962-8924(01)02122-5;;pmc2788992;;11684441;;10.1101/gad.1039703;;12514095;;11406546;;10.1002/ijc.20945;;15729716;;10818225;;10.1016/s0014-5793(00)01528-3;;10.1021/cr010202t;;12475204;;11851455;;10.1021/cr960370z;;14500583;;10.1373/49.10.1579;;10.1016/0304-3940(95)12173-0;;8786845;;10096547;;10.1126/science.1067100;;11923519;;10.1021/jm00011a014;;7783126;;11839648;;10.1074/jbc.272.39.24588;;9305925;;10.1016/s0021-9258(18)68705-8;;3360803;;2167156;;10.1002/chin.200414160;;10.1002/chin.200414161;;10.1016/j.bmcl.2003.09.057;;14643313;;12517439;;10.1016/s0968-0896(02)00426-1;;16627988;;10.4161/cbt.5.6.2707;;10.1517/13543784.14.6.591;;16004590;;9816289;;11961506;;10.1016/s0147-0272(02)70005-6,"Shepherd, Frances A. Targeted therapy for lung cancer at the clinical level. Proceedings of the American Association for Cancer Research 43: 1167 and 1168, Mar. 2002.;;Baselga et al. Phase II Study of weekly intravenous recombinant humanized anti-p185 Her2 monoclonal antibody in patients with HER2/neu-overexpressing metastatic breast cancer. Journal of Clinical Oncology 14(3): 737-744, Mar. 1996.;;Zhou et al. Targeting ADAM-mediated ligand cleavage to inhibit HER3 and EGFR pathways in non-small cell lung cancer (Cancer Cell 10(1): 39-50, Jul. 2006.;;Pegram, et al., ""Phase-2 study of receptor-enhanced chemosensitivity using recombinant humanized anti-p185 her2/neu monoclonal antibody plus cisplatin in patients with HER2/neu overexpressing metastatic breast cancer refractory to chemotherapy treatment,"" J. Clin. Oncol. (1998) 16:2659-2671.;;Baselga and Albanell, ""Mechanism of action of anti-HER2 monoclonal antibodies,"" Ann Oncol. (2001) 12 (Supp 1): S35-S41.;;Baselga, et al., ""Mechanism of action of trastuzumab and scientific update,"" Sem. Oncol. (2001) 28 (Supp16):4-11.;;Horiuchi, et al., ""Potential role for ADAM15 in pathological neovascularization in mice,"" Mol. Cell. Biol. (2003) 23:5614-5624.;;Christianson, et al., ""NH2-terminally truncated HER-2/neu protein: relationship with shedding of the extracellular domain and wth prognostic factors in breast cancer,"" Cancer Res. (1998) 58:5123-5129.;;Molina, et al., ""NH2-terminal truncated HER-2 protein but not full-length receptor is associated with nodal metastasis in human breast cancer,"" Clin. Cancer Res. (2002) 8:347-353.;;Petch, et al., ""A truncated, secreted form of the epidermal growth factor receptor is encoded by an alternatively spliced transcript in normal rat tissue,"" Mol. Cell. Biol. (1990) 10:2973-2982.;;Scott, et al., ""A truncated intracellular HER2/neu receptor produced by alternative RNA processing affects growth of human carcinoma cells,"" Mol. Cell. Biol. (1993) 13:2247-2257.;;Lee and Maihle, ""Isolation and characterization of four alternate c-erbB3 transcripts expressed in ovarian carcinoma-derived cell lines and normal human tissues,"" Oncogene (1998) 16:3243-3252.;;Leitzel, et al.,""Elevated soluble c-erbB-2 antigen levels in the serum and effusions of a proportion of breast cancer patients,"" J. Clin. Oncol. (1992) 10:1438-1443.;;Baselga, et al., ""Phase II study of weekly Intravenous recombinant humanized anti-p185-HER2 monoclonal antibody in patients with HER2/neu-overexpressing metastatic breast cancer,"" J. Clin. Oncol. (1997) 14:737-744.;;Brodowicz, et al., ""Soluble HER-2/neu neutralizes biologic effects of anti-HER-2/neu antibody on breast cancer cells in vitro,"" Int. J. Cancer (1997) 73:8750879.;;Ali, et al., ""Relationship of serum HER2/neu and serum CA 15-3 in patients with metastatic breast cancer,"" Clin. Chem. (2002) 48:1314-1320.;;Yamamoto, et al., ""Similarity of protein encoded by the human c-erb-B-2 gene to epidermal growth factor receptor,"" Nature (1986) 319:230-234.;;Basu, et al., ""Inhibition of tyrosine kinase activity of the epidermal growth factor (EGF) receptor by a truncated receptor form that binds to EGF: role for interreceptor interaction in kinase regulation,"" Mel. Cell. Biol. (1989) 9:871-877.;;Flickinger, et al., ""An alternatively processed mRNA from the avian c-erbB gene encodes a soluble, truncated form of the receptor that can block ligand-dependent transformation,"" Mol. Cell. Bid. (1992) 12:883-893.;;Doherty, et al., ""The HER2/neu receptor tyrosine kinase gene encodes a secreted autoinhibitor,"" Proc. Natl. Acad. Sci. USA (1999) 96:10869-10874.;;Azios, et al., ""Expression of heratatin, an autoinhibitor of HER-2/neu, inhibits transactivation of HER-3 by HER-2 and blocks EGF activation of the EGF receptor,"" Oncogene (2001) 20:5199-5209.;;Justman and Clinton, ""Herstatin, an autoinhibitor of the human epidermal growth factor receptor 2 tyrosine kinas, modulates epidermal growth factor signalling pathways resulting in growth arrest,"" J. Biol. Chem. (2002) 277:20618-20624.;;Moss and Lambert, ""Shedding of membrane proteins by ADAM family proteases,"" Essays in Biochemistry (2002) 38:141-153.;;Chang and Werb, ""The many faces of metalloproteases: cell growth, invasion, angiogenesis and metastasis,"" Trends Cell Bid. (2001) 11:537-543.;;Seals and Courtneidge, ""The ADAMs family of metalloproteases: multidomain proteins with multiple functions,"" Genes Dev. (2003) 17:7-30.;;Molina, et al., ""Trastuzumab (herceptin), a humanized anti-HER2 receptor monoclonal antibody, inhibits basal and activated HER2 ectodomain devage in breast cancer cells,"" Cancer Res. (2001) 61:4744-4739.;;Handsley et al., ""Metalloproteinases and their inhibitors in tumor angiogenesis,"" Int. J. Cancer (2005) 115:849-860.;;Amour et al., ""The in vitro activity of ADAM-10 is inhibited by TIMP-1 and TIMP-3,"" FEBS Letters (2000) 473(3):275-279.;;Arribas et al., ""Protein ectodomain shedding,"" Chem Rev. (2002) 102(12):4627-4638.;;Babine et al., ""Molecular Recognition of Proteinminus signLigand Complexes: Applications to Drug Design,"" Chem. Rev. (1997) 97(5):1359-1472.;;Carney et al., ""Potential clinical utility of serum HER-2/neu oncoprotein concentrations in patients with breast cancer,"" Clinical Chemistry (2003) 49(10):1579-1598.;;Chandler et al., ""Matrix metalloproteinases degrade myelin basic protein,"" Neuroscience Lett. (1995) 201(3):223-226.;;Codony-Servat et al., ""Cleavage of the HER2 ectodomain is a pervanadate-activable process that is inhibited by the tissue inhibitor of metalloproteases-1 in breast cancer cells,"" Cancer Research (1999) 59(6):1196-1201.;;Coussens et al., ""Matrix metalloproteinase inhibitors and cancer: trials and tribulations,"" Science (2002) 295:2387-2392.;;Kuipers et al., ""N4-unsubstituted N1-arylpiperazines as high-affinity 5-HT1A receptor ligands,"" J. Med. Chem. (1995) 38(11):1942-1954.;;Molina et al., ""NH(2)-terminal truncated HER-2 protein but not full-length receptor is associated with nodal metastasis in human breast cancer,"" Clinical Cancer Research (2002) 8(2)347-353.;;Rosendahl et al., ""Identification and characterization of a pro-tumor necrosis factor-alpha-processing enzyme from the ADAM family of zinc metalloproteases,"" Biol. Chem. (1997) 272(39):24588-24593.;;Saus et al., ""The complete primary structure of human matrix metalloproteinase-3. Identity with stromelysin,"" J. Biol. Chem. (1988) 263(14):6742-6745.;;Templeton et al., ""Cloning and characterization of human tumor cell interstitial collagenase,"" Cancer Research (1990) 50(17):5431-5437.;;Xue et al., ""Rational design, synthesis and structure-activity relationships of a cyclic succinate series of TNF-alpha converting enzyme inhibitors. Part 1: lead identification,"" Biorg Med. Chem. Lett. (2003) 13(24):4293-4297.;;Xue et al., ""Rational design, synthesis and structure-activity relationships of a cyclic succinate series of TNF-alpha converting enzyme inhibitors. Part 2: lead optimization,"" Biorg. Med. Chem. Lett. (2003) 13(24):4299-4304.;;Yoshiizumi et al., ""Synthesis and structure-activity relationships of 5,6,7,8-tetrahydropyrido[3,4-b]pyrazine-based hydroxamic acids as HB-EGF shedding inhibitors,"" Biorg. Med. Chem. (2003) 11(3):433-450.;;Liu, P.C.C. et al., Cancer Bio. Ther. 5(6):www.landesbioscience.com/journals/cbt/abstract.php?id=2708 (2006).;;Liu, X. et al., ""Selective inhibition of ADAM metalloproteases blocks HER-2 extracellular domain (ECD) cleavage and potentiates the anti-tumor effects of trastuzumab"", Cancer Biology & Therapy 5(6):648-656 (2006).;;Zhou, B.B. et al., Expert Opin. Incestig. Drugs 14(6):591-606 (2005).;;Alana M. Harris, Ph.D. (Authorized Officer); International Search Report for Application PCT/US04/10278 (WO2004/089294); Dec. 2, 2005.;;Alana M. Harris, Ph.D. (Authorized Officer); Written Opinion for Application PCT/US04/10278 (WO2004/089294); Dec. 2, 2005.;;Alana M. Harris, Ph.D. (Authorized Officer); International Preliminary Report on Patentability for Application PCT/US04/10278 (WO2004/089294); May 8, 2006.;;Friedman et al., ""Clinical Benefit of INCB7839, a Potent and Selective Inhibitor of ADAM10 and ADAM17, in Combination with Trastuzumab in Metastatic HER2 Positive Breast Cancer Patients."" Abstract and slide presentation from the 32nd Annual San Antonio Breast Cancer Symposium; Dec. 9-13, 2009, San Antonio, Texas; Incyte Corporation; 20 pgs.;;Low, et al., ""The matrix metalloproteinase inhibitor batimastat (BB-94) retards human breast cancer solid tumor growth but not ascites formation in nude mice"", Clinical Cancer Research, vol. 2, Jul. 1996; pp. 1207-1214.;;Sledge et al., ""Angiogenesis and Antiangiogenic Therapy""; Current Problems in Cancer, Mosby, St. Louis, MO, US, vol. 26, No. 1, Jan. 1, 2002, pp. 6-59.;;Supplementary Partial European Search Report dated Aug. 19, 2009 for European Appln. No. EP04758815 (8 pgs.).",ACTIVE
187,US,A1,US 2010/0256472 A1,147-324-326-898-87X,2010-10-07,2010,US 81814010 A,2010-06-17,US 81814010 A;;US 69082607 A;;US 42005703 A;;US 66719900 A;;US 7067798 A,1998-04-30,Analyte Monitoring Device and Methods of Use,"An analyte monitor includes a sensor, a sensor control unit, and a display unit. The sensor has, for example, a substrate, a recessed channel formed in the substrate, and conductive material disposed in the recessed channel to form a working electrode. The sensor control unit typically has a housing adapted for placement on skin and is adapted to receive a portion of an electrochemical sensor. The sensor control unit also includes two or more conductive contacts disposed on the housing and configured for coupling to two or more contact pads on the sensor. A transmitter is disposed in the housing and coupled to the plurality of conductive contacts for transmitting data obtained using the sensor. The display unit has a receiver for receiving data transmitted by the transmitter of the sensor control unit and a display coupled to the receiver for displaying an indication of a level of an analyte. The analyte monitor may also be part of a drug delivery system to alter the level of the analyte based on the data obtained using the sensor.",ABBOTT DIABETES CARE INC,SAY JAMES;;TOMASCO MICHAEL F;;HELLER ADAM;;GAL YORAM;;ARIA BEHRAD;;HELLER EPHRAIM;;PLANTE PHILLIP JOHN;;VREEKE MARK S;;FRIEDMAN KEITH A;;COLMAN FREDRIC C,,https://lens.org/147-324-326-898-87X,Patent Application,yes,0,0,211,221,0,A61B5/14532;;A61B5/14532;;A61B5/0002;;A61B5/0002;;A61B5/002;;A61B5/01;;A61B5/14503;;A61B5/1451;;A61B5/14546;;A61B5/14546;;A61B5/1473;;A61B5/1473;;A61B5/1486;;A61B5/1486;;A61B5/14865;;A61B5/1495;;A61B5/4839;;A61B5/72;;A61B5/7278;;A61B5/7282;;A61B5/7405;;A61B5/743;;A61B5/7445;;A61B5/7445;;A61B5/7455;;A61B2560/0252;;A61B2560/0252;;A61M5/1723;;C12Q1/54;;G16H10/40;;G16H10/40;;G16H20/17;;G16H20/17;;H01L23/3107;;H01L23/3107;;H01L23/49548;;H01L23/49548;;H01L2924/0002;;H01L2924/0002;;H01L2924/19041;;H01L2924/19041;;H01L2924/3011;;H01L2924/3011;;Y10S128/903;;Y10S128/903;;Y10T29/49;;Y10T29/49;;Y10T29/49124;;Y10T29/49124,A61B5/1468;;G01N27/30;;A61B5/00;;A61B5/145;;A61B5/1477;;A61B5/1495;;G01N27/416;;G06F19/00;;H01L23/31;;H01L23/495,600/345,0,0,,,,DISCONTINUED
188,US,A1,US 2011/0077489 A1,166-331-617-455-23X,2011-03-31,2011,US 89582910 A,2010-09-30,US 89582910 A;;US 69082607 A;;US 42005703 A;;US 66719900 A;;US 7067798 A,1998-04-30,Analyte Monitoring Device and Methods of Use,"An analyte monitor includes a sensor, a sensor control unit, and a display unit. The sensor has, for example, a substrate, a recessed channel formed in the substrate, and conductive material disposed in the recessed channel to form a working electrode. The sensor control unit typically has a housing adapted for placement on skin and is adapted to receive a portion of an electrochemical sensor. The sensor control unit also includes two or more conductive contacts disposed on the housing and configured for coupling to two or more contact pads on the sensor. A transmitter is disposed in the housing and coupled to the plurality of conductive contacts for transmitting data obtained using the sensor. The display unit has a receiver for receiving data transmitted by the transmitter of the sensor control unit and a display coupled to the receiver for displaying an indication of a level of an analyte. The analyte monitor may also be part of a drug delivery system to alter the level of the analyte based on the data obtained using the sensor.",ABBOTT DIABETES CARE INC,SAY JAMES;;TOMASCO MICHAEL F;;HELLER ADAM;;GAL YORAM;;ARIA BEHRAD;;HELLER EPHRAIM;;PLANTE PHILLIP JOHN;;VREEKE MARK S;;FRIEDMAN KEITH A;;COLMAN FREDRIC C,,https://lens.org/166-331-617-455-23X,Patent Application,yes,2,5,211,221,0,A61B5/14532;;A61B5/14532;;A61B5/0002;;A61B5/0002;;A61B5/002;;A61B5/01;;A61B5/14503;;A61B5/1451;;A61B5/14546;;A61B5/14546;;A61B5/1473;;A61B5/1473;;A61B5/1486;;A61B5/1486;;A61B5/14865;;A61B5/1495;;A61B5/4839;;A61B5/72;;A61B5/7278;;A61B5/7282;;A61B5/7405;;A61B5/743;;A61B5/7445;;A61B5/7445;;A61B5/7455;;A61B2560/0252;;A61B2560/0252;;A61M5/1723;;C12Q1/54;;G16H10/40;;G16H10/40;;G16H20/17;;G16H20/17;;H01L23/3107;;H01L23/3107;;H01L23/49548;;H01L23/49548;;H01L2924/0002;;H01L2924/0002;;H01L2924/19041;;H01L2924/19041;;H01L2924/3011;;H01L2924/3011;;Y10S128/903;;Y10S128/903;;Y10T29/49;;Y10T29/49;;Y10T29/49124;;Y10T29/49124,A61B5/1473;;G01N27/30;;A61B5/00;;A61B5/145;;A61B5/1459;;A61B5/1477;;A61B5/1495;;G01N27/416;;G06F19/00;;H01L23/31;;H01L23/495,600/341;;600/345;;600/347,0,0,,,,DISCONTINUED
189,US,A1,US 2009/0069657 A1,157-565-921-566-386,2009-03-12,2009,US 20579808 A,2008-09-05,US 20579808 A;;US 42005703 A;;US 66719900 A;;US 7067798 A,1998-04-30,Analyte Monitoring Device and Methods of Use,"An analyte monitor includes a sensor, a sensor control unit, and a display unit. The sensor has, for example, a substrate, a recessed channel formed in the substrate, and conductive material disposed in the recessed channel to form a working electrode. The sensor control unit typically has a housing adapted for placement on skin and is adapted to receive a portion of an electrochemical sensor. The sensor control unit also includes two or more conductive contacts disposed on the housing and configured for coupling to two or more contact pads on the sensor. A transmitter is disposed in the housing and coupled to the plurality of conductive contacts for transmitting data obtained using the sensor. The display unit has a receiver for receiving data transmitted by the transmitter of the sensor control unit and a display coupled to the receiver for displaying an indication of a level of an analyte. The analyte monitor may also be part of a drug delivery system to alter the level of the analyte based on the data obtained using the sensor.",ABBOTT DIABETES CARE INC,SAY JAMES;;TOMASCO MICHAEL F;;HELLER ADAM;;GAL YORAM;;ARIA BEHRAD;;HELLER EPHRAIM;;PLANTE PHILLIP JOHN;;VREEKE MARK S;;FRIEDMAN KEITH A;;COLMAN FREDRIC C,,https://lens.org/157-565-921-566-386,Patent Application,yes,10,61,211,221,0,A61B5/14532;;A61B5/14532;;A61B5/0002;;A61B5/0002;;A61B5/002;;A61B5/01;;A61B5/14503;;A61B5/1451;;A61B5/14546;;A61B5/14546;;A61B5/1473;;A61B5/1473;;A61B5/1486;;A61B5/1486;;A61B5/14865;;A61B5/1495;;A61B5/4839;;A61B5/72;;A61B5/7278;;A61B5/7282;;A61B5/7405;;A61B5/743;;A61B5/7445;;A61B5/7445;;A61B5/7455;;A61B2560/0252;;A61B2560/0252;;A61M5/1723;;C12Q1/54;;G16H10/40;;G16H10/40;;G16H20/17;;G16H20/17;;H01L23/3107;;H01L23/3107;;H01L23/49548;;H01L23/49548;;H01L2924/0002;;H01L2924/0002;;H01L2924/19041;;H01L2924/19041;;H01L2924/3011;;H01L2924/3011;;Y10S128/903;;Y10S128/903;;Y10T29/49;;Y10T29/49;;Y10T29/49124;;Y10T29/49124,A61B5/1468;;G01N27/30;;A61B5/00;;A61B5/145;;A61B5/1477;;A61B5/1495;;G01N27/416;;G06F19/00;;H01L23/31;;H01L23/495,600/347;;600/365,0,0,,,,DISCONTINUED
190,EP,A2,EP 1613269 A2,169-519-893-751-944,2006-01-11,2006,EP 04758815 A,2004-04-02,US 2004/0010278 W;;US 46067803 P;;US 47249403 P;;US 53203003 P;;US 54898604 P,2003-04-04,"COMPOSITIONS, METHODS AND KITS RELATING TO HER-2 CLEAVAGE",,INCYTE CORP,FRIEDMAN STEVEN M;;SCHERLE PEGGY A;;LIU XIANGDONG;;BURN TIMOTHY C;;HUBER REID;;LIU PHILLIP C C;;HOLLIS GREGORY F;;VADDI KRISHNA;;FRIDMAN JORDAN S,"INCYTE HOLDINGS CORPORATION (2015-12-09);;INCYTE CORPORATION (2015-02-11);;INCYTE HOLDINGS CORPORATION, US (2016-09-27);;INCYTE HOLDINGS CORPORATION, WILMINGTON, US (2016-02-24)",https://lens.org/169-519-893-751-944,Patent Application,yes,0,0,10,10,48,A61K31/19;;A61K31/19;;A61K31/395;;A61K31/395;;A61P35/00;;A61P35/04,A61K39/395;;A61K/;;A61K31/19,,0,0,,,,ACTIVE
191,US,B2,US 6990366 B2,194-242-277-426-475,2006-01-24,2006,US 72226403 A,2003-11-24,US 72226403 A;;US 42005703 A;;US 66719900 A;;US 7067798 A,1998-04-30,Analyte monitoring device and methods of use,"An analyte monitor includes a sensor, a sensor control unit, and a display unit. The sensor has, for example, a substrate, a recessed channel formed in the substrate, and conductive material disposed in the recessed channel to form a working electrode. The sensor control unit typically has a housing adapted for placement on skin and is adapted to receive a portion of an electrochemical sensor. The sensor control unit also includes two or more conductive contacts disposed on the housing and configured for coupling to two or more contact pads on the sensor. A transmitter is disposed in the housing and coupled to the plurality of conductive contacts for transmitting data obtained using the sensor. The display unit has a receiver for receiving data transmitted by the transmitter of the sensor control unit and a display coupled to the receiver for displaying an indication of a level of an analyte. The analyte monitor may also be part of a drug delivery system to alter the level of the analyte based on the data obtained using the sensor.",THERASENSE INC,SAY JAMES;;TOMASCO MICHAEL F;;HELLER ADAM;;GAL YORAM;;ARIA BEHRAD;;HELLER EPHRAIM;;PLANTE PHILLIP JOHN;;VREEKE MARK S;;FRIEDMAN KEITH A;;COLMAN FREDRIC C,ABBOTT DIABETES CARE INC (2005-07-25),https://lens.org/194-242-277-426-475,Granted Patent,yes,1,634,211,221,0,A61B5/14532;;A61B5/14532;;A61B5/0002;;A61B5/0002;;A61B5/002;;A61B5/01;;A61B5/14503;;A61B5/1451;;A61B5/14546;;A61B5/14546;;A61B5/1473;;A61B5/1473;;A61B5/1486;;A61B5/1486;;A61B5/14865;;A61B5/1495;;A61B5/4839;;A61B5/72;;A61B5/7278;;A61B5/7282;;A61B5/7405;;A61B5/743;;A61B5/7445;;A61B5/7445;;A61B5/7455;;A61B2560/0252;;A61B2560/0252;;A61M5/1723;;C12Q1/54;;G16H10/40;;G16H10/40;;G16H20/17;;G16H20/17;;H01L23/3107;;H01L23/3107;;H01L23/49548;;H01L23/49548;;H01L2924/0002;;H01L2924/0002;;H01L2924/19041;;H01L2924/19041;;H01L2924/3011;;H01L2924/3011;;Y10S128/903;;Y10S128/903;;Y10T29/49;;Y10T29/49;;Y10T29/49124;;Y10T29/49124,A61B5/05;;G01N27/30;;A61B5/00;;A61B5/145;;A61B5/1477;;A61B5/1495;;G01N27/416;;G06F19/00;;H01L23/31;;H01L23/495,600/345;;600/347;;600/360;;600/357,0,0,,,,EXPIRED
192,US,B2,US 8649841 B2,015-701-123-051-77X,2014-02-11,2014,US 69560707 A,2007-04-03,US 69560707 A;;US 42005703 A;;US 66719900 A;;US 7067798 A,1998-04-30,Analyte monitoring device and methods of use,"An analyte monitor includes a sensor, a sensor control unit, and a display unit. The sensor has, for example, a substrate, a recessed channel formed in the substrate, and conductive material disposed in the recessed channel to form a working electrode. The sensor control unit typically has a housing adapted for placement on skin and is adapted to receive a portion of an electrochemical sensor. The sensor control unit also includes two or more conductive contacts disposed on the housing and configured for coupling to two or more contact pads on the sensor. A transmitter is disposed in the housing and coupled to the plurality of conductive contacts for transmitting data obtained using the sensor. The display unit has a receiver for receiving data transmitted by the transmitter of the sensor control unit and a display coupled to the receiver for displaying an indication of a level of an analyte. The analyte monitor may also be part of a drug delivery system to alter the level of the analyte based on the data obtained using the sensor.",SAY JAMES;;TOMASCO MICHAEL F;;HELLER ADAM;;GAL YORAM;;ARIA BEHRAD;;HELLER EPHRAIM;;PLANTE PHILLIP JOHN;;VREEKE MARK S;;FRIEDMAN KEITH A;;COLMAN FREDRIC C;;ABBOTT DIABETES CARE INC,SAY JAMES;;TOMASCO MICHAEL F;;HELLER ADAM;;GAL YORAM;;ARIA BEHRAD;;HELLER EPHRAIM;;PLANTE PHILLIP JOHN;;VREEKE MARK S;;FRIEDMAN KEITH A;;COLMAN FREDRIC C,E. HELLER & CO (1998-07-02);;ABBOTT DIABETES CARE INC (2000-03-13),https://lens.org/015-701-123-051-77X,Granted Patent,yes,100,0,211,221,0,A61B5/14532;;A61B5/14532;;A61B5/0002;;A61B5/0002;;A61B5/002;;A61B5/01;;A61B5/14503;;A61B5/1451;;A61B5/14546;;A61B5/14546;;A61B5/1473;;A61B5/1473;;A61B5/1486;;A61B5/1486;;A61B5/14865;;A61B5/1495;;A61B5/4839;;A61B5/72;;A61B5/7278;;A61B5/7282;;A61B5/7405;;A61B5/743;;A61B5/7445;;A61B5/7445;;A61B5/7455;;A61B2560/0252;;A61B2560/0252;;A61M5/1723;;C12Q1/54;;G16H10/40;;G16H10/40;;G16H20/17;;G16H20/17;;H01L23/3107;;H01L23/3107;;H01L23/49548;;H01L23/49548;;H01L2924/0002;;H01L2924/0002;;H01L2924/19041;;H01L2924/19041;;H01L2924/3011;;H01L2924/3011;;Y10S128/903;;Y10S128/903;;Y10T29/49;;Y10T29/49;;Y10T29/49124;;Y10T29/49124,A61B5/05;;G01N27/30;;A61B5/00;;A61B5/145;;A61B5/1477;;A61B5/1495;;G01N27/416;;G06F19/00;;H01L23/31;;H01L23/495,600/347;;600/365;;600/345,99,21,077-077-959-101-880;;098-973-607-166-581;;037-547-642-717-655;;072-065-897-572-037;;006-718-162-225-167;;016-274-887-563-137;;023-842-759-049-105;;080-901-539-399-829;;011-361-512-574-415;;006-033-609-366-053;;048-047-377-331-791;;112-172-675-119-141;;012-348-107-238-223;;027-927-639-674-836;;013-669-597-676-472;;045-087-287-424-000;;029-493-512-369-495;;017-843-532-202-598;;124-660-118-050-67X;;129-974-218-261-531;;115-480-299-312-274,11467320;;10.1089/152091500316737;;10.2337/diacare.26.3.582;;12610005;;10.1021/ja00191a084;;10.1016/s0013-4686(97)00125-4;;10.1016/s0013-4686(97)10116-5;;10.1016/s0013-4686(98)00369-7;;10.1016/s0013-4686(99)00183-8;;10.1016/s0013-4686(00)00481-3;;10.1021/ac00170a003;;3239784;;4356378;;14511411;;10.1089/152091503322250587;;10.1021/j100188a007;;10.1021/ar00173a002;;11701486;;10.1146/annurev.bioeng.1.1.153;;10.1038/nbt0603-631;;12776149;;10.1016/0925-4005(93)85356-f;;4064281;;10.1093/clinchem/31.12.1931;;8797377;;10.1021/ac950630x;;10.1016/0250-6874(89)87015-5;;2714056;;10.1088/0143-0815/10/1/001;;10.1039/ac9963300271,"U.S. Appl. No. 09/447,227, Shults.;;U.S. Appl. No. 11/737,671, Wolpert, et al.;;U.S. Appl. No. 11/766,747, Say, et al.;;U.S. Appl. No. 11/849,200, Peyser, et al.;;U.S. Appl. No. 11/928,574, Heller, et al.;;U.S. Appl. No. 11/928,668, Heller, et al.;;U.S. Appl. No. 11/928,743, Heller, et al.;;U.S. Appl. No. 11/928,795 Heller, et al.;;U.S. Appl. No. 11/928,891, Heller, et al.;;U.S. Appl. No. 11/928,968, Heller, et al.;;U.S. Appl. No. 11/941,078, Say, et al.;;Gross, T. M., et al., ""Performance Evaluation of the MiniMed® Continuous Glucose Monitoring System During Patient Home Use"", Diabetes Technology & Therapeutics, vol. 2, No. 1, 2000, pp. 49-56.;;Guerci, B., et al., ""Clinical Performance of CGMS in Type 1 Diabetic Patients Treated by Continuous Subcutaneous Insulin Infusion Using Insulin Analogs"", Diabetes Care, vol. 26, 2003, pp. 582-589.;;Hale, P. D., et al., ""A New Class of Amperometric Biosensor Incorporating a Polymeric Electron-Transfer Mediator"", Journal of the American Chemical Society, vol. 111, No. 9, 1989, pp. 3482-3484.;;Hall, S. B., et al., ""Electrochemical Oxidation of Hydrogen Peroxide at Platinum Electrodes: Part I: An Absorption-Controlled Mechanism"", Electrochimica Acta, vol. 43, No. 14-15, 1998, pp. 579-588.;;Hall, S. B., et al., ""Electrochemical Oxidation of Hydrogen Peroxide at Platinum Electrodes: Part II: Effect of Potential"", Electrochimica Acta, vol. 43, No. 14-15, 1998, pp. 2015-2024.;;Hall, S. B., et al., ""Electrochemical Oxidation of Hydrogen Peroxide at Platinum Electrodes: Part III: Effect of Temperature"", Electrochimica Acta, vol. 44, 1999, pp. 2455-2462.;;Hall, S. B., et al., ""Electrochemical Oxidation of Hydrogen Peroxide at Platinum Electrodes: Part IV: Phosphate Buffer Dependence"", Electrochimica Acta, vol. 44, 1999, pp. 4573-4582.;;Hall, S. B., et al., ""Electrochemical Oxidation of Hydrogen Peroxide at Platinum Electrodes: Part V: Inhibition by Chloride"", Electrochimica Acta, vol. 45, 2000, pp. 3573-3579.;;Hamilton, ""Hamilton Needle Gauge Index"", www.hamiltoncompany.com.;;Harrison, D. J., et al., ""Characterization of Perfluorosulfonic Acid Polymer Coated Enzyme Electrodes and a Miniatureized Integrated Potentiostat for Glucose Analysis in Whole Blood"", Analytical Chemistry, vol. 60, No. 19, 1988, pp. 2002-2007.;;Hawkridge, F. M., et al., ""Indirect Coulometric Titration of Biological Electron Transport Components"", Analytical Chemistry, vol. 45, No. 7, 1973, pp. 1021-1027.;;Heise, T., et al., ""Hypoglycemia Warning Signal and Glucose Sensors: Requirements and Concepts"", Diabetes Technology & Therapeutics, vol. 5, No. 4, 2003, pp. 563-571.;;Heller, A., ""Electrical Connection Enzyme Redox Centers to Electrodes"", Journal of Physical Chemistry, vol. 96, No. 9, 1990, pp. 3579-3587.;;Heller, A., ""Electrical Wiring of Redox Enzymes"", Accounts of Chemical Research vol. 23, No. 5, 1990, 128-134.;;Heller, A., ""Implanted Electrochemical Glucose Sensors for the Management of Diabetes"", Annual Review of Biomedical Engineering, vol. 1, 1999, pp. 153-175.;;Heller, A., ""Plugging Metal Connectors into Enzymes"", Nature Biotechnology, vol. 21, No. 6, 2003, pp. 631-632.;;Heller, A., et al., ""Amperometric Biosensors Based on Three-Dimensional Hydrogel-Forming Epoxy Networks"", Sensors and Actuators B, vol. 13-14, 1993, pp. 180-183.;;Hicks, J. M., ""In Situ Monitoring"", Clinical Chemistry, vol. 31, No. 12, 1985, pp. 1931-1935.;;""Poretics Polycarbonate Membrane"", Osmonics Filtration and Separation Group, 2002.;;Jobst, G., et al., ""Thin-Film Microbiosensors for Glucose-Lactate Monitoring"", Analytical Chemistry, vol. 68, No. 18, 1996, pp. 3173-3179.;;Koudelka, M., et al., ""Planar Amperometric Enzyme-Based Glucose Microelectrode"", Sensors and Actuators, vol. 18, 1989, pp. 157-165.;;Kusano, H., ""Glucose Enzyme Electrode with Percutaneous Interface Which Operates Independently of Dissolved Oxygen"", Clinical Physics and Physiological Measurement, vol. 10, No. 1, 1989, pp. 1-9.;;Park, T., et al., ""Sol-Gel-based Amperometric Glucose Biosensor Incorporating an Osmium Redox Polymer as Mediator"", Analytical Communications, vol. 33, 1996, pp. 271-273.;;Stedman's Medical Dictionary, 26th Edition, 1995, pp. 665.;;Canadian Patent Application No. 2,433,144, Examiner's Report mailed Nov. 2, 2010.;;European Patent Application No. 06 839 640.7, Extended European Search Report mailed Oct. 21, 2010.;;European Patent Application No. 10012409.8, Extended European Search Report mailed Mar. 15, 2011.;;European Patent Application No. 10012414.8, Extended European Search Report mailed Mar. 15, 2011.;;European Patent Application No. 10012960.0, Extended European Search Report mailed Mar. 2, 2011.;;European Patent Application No. 10012961.8, Extended European Search Report mailed Mar. 2, 2011.;;European Patent Application No. 99 903 239.4, Invitation Pursuant to Article 94(3) and Rule 71(1) EPC mailed Dec. 15, 2010.;;PCT Application No. PCT/US2010/040117, International Search Report and Written Opinion of the International Searching Authority mailed Sep. 1, 2010.;;PCT Application No. PCT/US2010/040118, International Search Report and Written Opinion of the International Searching Authority mailed Sep. 17, 2010.;;PCT Application No. PCT/US2010/040119, International Search Report and Written Opinion of the International Searching Authority mailed Sep. 17, 2010.;;U.S. Appl. No. 10/420,057, Office Action mailed Jun. 24, 2010.;;U.S. Appl. No. 10/783,675, Office Action mailed Dec. 14, 2010.;;U.S. Appl. No. 10/783,675, Office Action mailed Jun. 2, 2011.;;U.S. Appl. No. 11/265,787, Office Action mailed Aug. 4, 2010.;;U.S. Appl. No. 11/681,730, Office Action mailed Apr. 27, 2011.;;U.S. Appl. No. 11/681,730, Office Action mailed Oct. 15, 2010.;;U.S. Appl. No. 11/683,371, Office Action mailed Aug. 13, 2010.;;U.S. Appl. No. 11/683,371, Office Action mailed Jun. 24, 2010.;;U.S. Appl. No. 11/683,371, Office Action mailed Mar. 8, 2011.;;U.S. Appl. No. 11/683,396, Office Action mailed Jan. 18, 2011.;;U.S. Appl. No. 11/683,408, Notice of Allowance mailed Oct. 19, 2010.;;U.S. Appl. No. 11/683,408, Office Action mailed Jul. 12, 2010.;;U.S. Appl. No. 11/690,826, Office Action mailed Aug. 9, 2011.;;U.S. Appl. No. 11/695,608, Office Action mailed Jul. 22, 2010.;;U.S. Appl. No. 11/695,608, Office Action mailed Mar. 29, 2011.;;U.S. Appl. No. 11/734,782, Office Action mailed Jul. 19, 2010.;;U.S. Appl. No. 11/742,507, Office Action mailed Apr. 13, 2011.;;U.S. Appl. No. 11/742,507, Office Action mailed Jun. 12, 2009.;;U.S. Appl. No. 11/766,686, Office Action mailed Jun. 25, 2010.;;U.S. Appl. No. 11/766,708, Office Action mailed Jul. 9, 2010.;;U.S. Appl. No. 11/766,708, Office Action mailed Mar. 3, 2011.;;U.S. Appl. No. 11/928,574, Office Action mailed Jul. 21, 2010.;;U.S. Appl. No. 11/928,668, Office Action mailed Dec. 23, 2010.;;U.S. Appl. No. 11/928,795, Office Action mailed May 12, 2011.;;U.S. Appl. No. 11/928,795, Office Action mailed Sep. 15, 2010.;;U.S. Appl. No. 11/941,078, Office Action mailed Apr. 22, 2011.;;U.S. Appl. No. 11/941,078, Office Action mailed Dec. 22, 2010.;;U.S. Appl. No. 11/941,078, Office Action mailed Mar. 18, 2010.;;U.S. Appl. No. 12/109,049, Office Action mailed Mar. 4, 2011.;;U.S. Appl. No. 12/249,644, Office Action mailed Apr. 15, 2011.;;U.S. Appl. No. 12/371,539, Office Action mailed Mar. 7, 2011.;;U.S. Appl. No. 12/397,281, Office Action mailed May 12, 2011.;;U.S. Appl. No. 12/397,281, Office Action mailed Oct. 15, 2010.;;U.S. Appl. No. 12/397,293, Office Action mailed Aug. 5, 2011.;;U.S. Appl. No. 12/397,293, Office Action mailed Dec. 1, 2010.;;U.S. Appl. No. 12/397,301, Office Action mailed Aug. 22, 2011.;;U.S. Appl. No. 12/397,301, Office Action mailed Dec. 1, 2010.;;U.S. Appl. No. 12/405,515, Office Action mailed Apr. 29, 2011.;;U.S. Appl. No. 12/405,515, Office Action mailed Sep. 23, 2010.;;U.S. Appl. No. 12/405,568, Office Action mailed Jan. 25, 2011.;;U.S. Appl. No. 12/405,643, Office Action mailed Mar. 30, 2011.;;U.S. Appl. No. 12/405,690, Office Action mailed Mar. 10, 2011.;;U.S. Appl. No. 12/405,739, Office Action mailed Mar. 15, 2011.;;U.S. Appl. No. 12/405,843, Office Action mailed Mar. 24, 2011.;;U.S. Appl. No. 12/406,746, Office Action mailed Apr. 5, 2011.;;U.S. Appl. No. 12/406,746, Office Action mailed Jul. 23, 2010.;;U.S. Appl. No. 12/406,746, Office Action mailed Sep. 1, 2011.;;U.S. Appl. No. 12/406,800, Office Action mailed Apr. 20, 2011.;;U.S. Appl. No. 12/406,800, Office Action mailed Jul. 20, 2010.;;U.S. Appl. No. 12/414,456, Office Action mailed Apr. 29, 2011.;;U.S. Appl. No. 12/414,456, Office Action mailed Sep. 17, 2010.;;U.S. Appl. No. 12/414,474, Office Action mailed Mar. 15, 2011.;;U.S. Appl. No. 12/414,487, Office Action mailed Mar. 3, 2011.;;U.S. Appl. No. 12/414,531, Office Action mailed Mar. 22, 2011.",EXPIRED
193,US,A1,US 2010/0268045 A1,024-405-587-157-599,2010-10-21,2010,US 82519410 A,2010-06-28,US 82519410 A;;US 39388309 A;;US 42005703 A;;US 66719900 A;;US 7067798 A,1998-04-30,Analyte Monitoring Device and Methods of Use,"An analyte monitor includes a sensor, a sensor control unit, and a display unit. The sensor has, for example, a substrate, a recessed channel formed in the substrate, and conductive material disposed in the recessed channel to form a working electrode. The sensor control unit typically has a housing adapted for placement on skin and is adapted to receive a portion of an electrochemical sensor. The sensor control unit also includes two or more conductive contacts disposed on the housing and configured for coupling to two or more contact pads on the sensor. A transmitter is disposed in the housing and coupled to the plurality of conductive contacts for transmitting data obtained using the sensor. The display unit has a receiver for receiving data transmitted by the transmitter of the sensor control unit and a display coupled to the receiver for displaying an indication of a level of an analyte. The analyte monitor may also be part of a drug delivery system to alter the level of the analyte based on the data obtained using the sensor.",ABBOTT DIABETES CARE INC,SAY JAMES;;TOMASCO MICHAEL F;;HELLER ADAM;;GAL YORAM;;ARIA BEHRAD;;HELLER EPHRAIM;;PLANTE PHILLIP JOHN;;VREEKE MARK S;;FRIEDMAN KEITH A;;COLMAN FREDRIC C,E. HELLER & CO (1998-07-02);;ABBOTT DIABETES CARE INC (2000-03-13),https://lens.org/024-405-587-157-599,Patent Application,yes,99,0,211,221,0,A61B5/14532;;A61B5/14532;;A61B5/0002;;A61B5/0002;;A61B5/002;;A61B5/01;;A61B5/14503;;A61B5/1451;;A61B5/14546;;A61B5/14546;;A61B5/1473;;A61B5/1473;;A61B5/1486;;A61B5/1486;;A61B5/14865;;A61B5/1495;;A61B5/4839;;A61B5/72;;A61B5/7278;;A61B5/7282;;A61B5/7405;;A61B5/743;;A61B5/7445;;A61B5/7445;;A61B5/7455;;A61B2560/0252;;A61B2560/0252;;A61M5/1723;;C12Q1/54;;G16H10/40;;G16H10/40;;G16H20/17;;G16H20/17;;H01L23/3107;;H01L23/3107;;H01L23/49548;;H01L23/49548;;H01L2924/0002;;H01L2924/0002;;H01L2924/19041;;H01L2924/19041;;H01L2924/3011;;H01L2924/3011;;Y10S128/903;;Y10S128/903;;Y10T29/49;;Y10T29/49;;Y10T29/49124;;Y10T29/49124,A61B5/05;;G01N27/30;;A61B5/00;;A61B5/145;;A61B5/1477;;A61B5/1495;;G01N27/416;;G06F19/00;;H01L23/31;;H01L23/495,600/345,0,0,,,,DISCONTINUED
194,US,A1,US 2007/0203408 A1,065-717-958-204-076,2007-08-30,2007,US 74254607 A,2007-04-30,US 74254607 A;;US 42005703 A;;US 66719900 A;;US 7067798 A,1998-04-30,Analyte Monitoring Device and Methods of Use,"An analyte monitor includes a sensor, a sensor control unit, and a display unit. The sensor has, for example, a substrate, a recessed channel formed in the substrate, and conductive material disposed in the recessed channel to form a working electrode. The sensor control unit typically has a housing adapted for placement on skin and is adapted to receive a portion of an electrochemical sensor. The sensor control unit also includes two or more conductive contacts disposed on the housing and configured for coupling to two or more contact pads on the sensor. A transmitter is disposed in the housing and coupled to the plurality of conductive contacts for transmitting data obtained using the sensor. The display unit has a receiver for receiving data transmitted by the transmitter of the sensor control unit and a display coupled to the receiver for displaying an indication of a level of an analyte. The analyte monitor may also be part of a drug delivery system to alter the level of the analyte based on the data obtained using the sensor.",ABBOTT DIABETES CARE INC,SAY JAMES;;TOMASCO MICHAEL F;;HELLER ADAM;;GAL YORAM;;ARIA BEHRAD;;HELLER EPHRAIM;;PLANTE PHILLIP J;;VREEKE MARK S;;FRIEDMAN KEITH A;;COLMAN FREDRIC C,E. HELLER & CO (1998-07-02);;ABBOTT DIABETES CARE INC (2000-03-13),https://lens.org/065-717-958-204-076,Patent Application,yes,99,43,211,221,0,A61B5/14532;;A61B5/14532;;A61B5/0002;;A61B5/0002;;A61B5/002;;A61B5/01;;A61B5/14503;;A61B5/1451;;A61B5/14546;;A61B5/14546;;A61B5/1473;;A61B5/1473;;A61B5/1486;;A61B5/1486;;A61B5/14865;;A61B5/1495;;A61B5/4839;;A61B5/72;;A61B5/7278;;A61B5/7282;;A61B5/7405;;A61B5/743;;A61B5/7445;;A61B5/7445;;A61B5/7455;;A61B2560/0252;;A61B2560/0252;;A61M5/1723;;C12Q1/54;;G16H10/40;;G16H10/40;;G16H20/17;;G16H20/17;;H01L23/3107;;H01L23/3107;;H01L23/49548;;H01L23/49548;;H01L2924/0002;;H01L2924/0002;;H01L2924/19041;;H01L2924/19041;;H01L2924/3011;;H01L2924/3011;;Y10S128/903;;Y10S128/903;;Y10T29/49;;Y10T29/49;;Y10T29/49124;;Y10T29/49124,A61B5/1477;;G01N27/30;;A61B5/00;;A61B5/05;;A61B5/145;;A61B5/1495;;G01N27/416;;G06F19/00;;H01L23/31;;H01L23/495,600/347,0,0,,,,DISCONTINUED
195,US,B2,US 8224413 B2,073-135-913-441-860,2012-07-17,2012,US 24964408 A,2008-10-10,US 24964408 A;;US 42005703 A;;US 66719900 A;;US 7067798 A,1998-04-30,Analyte monitoring device and methods of use,"An analyte monitor includes a sensor, a sensor control unit, and a display unit. The sensor has, for example, a substrate, a recessed channel formed in the substrate, and conductive material disposed in the recessed channel to form a working electrode. The sensor control unit typically has a housing adapted for placement on skin and is adapted to receive a portion of an electrochemical sensor. The sensor control unit also includes two or more conductive contacts disposed on the housing and configured for coupling to two or more contact pads on the sensor. A transmitter is disposed in the housing and coupled to the plurality of conductive contacts for transmitting data obtained using the sensor. The display unit has a receiver for receiving data transmitted by the transmitter of the sensor control unit and a display coupled to the receiver for displaying an indication of a level of an analyte. The analyte monitor may also be part of a drug delivery system to alter the level of the analyte based on the data obtained using the sensor.",SAY JAMES;;TOMASCO MICHAEL F;;HELLER ADAM;;GAL YORAM;;ARIA BEHRAD;;HELLER EPHRAIM;;PLANTE PHILLIP JOHN;;VREEKE MARK S;;FRIEDMAN KEITH A;;COLMAN FREDRIC C;;ABBOTT DIABETES CARE INC,SAY JAMES;;TOMASCO MICHAEL F;;HELLER ADAM;;GAL YORAM;;ARIA BEHRAD;;HELLER EPHRAIM;;PLANTE PHILLIP JOHN;;VREEKE MARK S;;FRIEDMAN KEITH A;;COLMAN FREDRIC C,E. HELLER & CO (1998-07-02);;ABBOTT DIABETES CARE INC (2000-03-13),https://lens.org/073-135-913-441-860,Granted Patent,yes,111,2,211,221,0,A61B5/14532;;A61B5/14532;;A61B5/0002;;A61B5/0002;;A61B5/002;;A61B5/01;;A61B5/14503;;A61B5/1451;;A61B5/14546;;A61B5/14546;;A61B5/1473;;A61B5/1473;;A61B5/1486;;A61B5/1486;;A61B5/14865;;A61B5/1495;;A61B5/4839;;A61B5/72;;A61B5/7278;;A61B5/7282;;A61B5/7405;;A61B5/743;;A61B5/7445;;A61B5/7445;;A61B5/7455;;A61B2560/0252;;A61B2560/0252;;A61M5/1723;;C12Q1/54;;G16H10/40;;G16H10/40;;G16H20/17;;G16H20/17;;H01L23/3107;;H01L23/3107;;H01L23/49548;;H01L23/49548;;H01L2924/0002;;H01L2924/0002;;H01L2924/19041;;H01L2924/19041;;H01L2924/3011;;H01L2924/3011;;Y10S128/903;;Y10S128/903;;Y10T29/49;;Y10T29/49;;Y10T29/49124;;Y10T29/49124,A61B5/05;;G01N27/30;;A61B5/00;;A61B5/145;;A61B5/1477;;A61B5/1495;;B23P17/04;;G01N27/416;;G06F19/00;;H01L23/31;;H01L23/495,600/345;;600/347;;29/592,99,81,136-791-935-548-81X;;062-360-289-025-864;;010-601-725-111-91X;;101-292-518-663-191;;056-703-879-057-297;;030-155-762-644-019;;004-149-141-436-651;;016-731-054-793-457;;080-559-561-995-335;;044-807-213-528-815;;027-538-525-436-179;;015-020-161-517-40X;;025-919-454-564-785;;014-700-576-603-812;;004-851-060-590-788;;075-958-432-122-199;;052-356-140-149-389;;035-090-282-884-790;;033-562-815-299-181;;018-803-926-589-211;;008-505-762-041-402;;016-601-143-530-813;;019-502-772-562-215;;058-476-824-396-350;;006-498-707-073-30X;;054-091-551-638-293;;010-531-147-771-746;;054-827-198-877-419;;122-658-944-077-000;;017-261-560-469-37X;;000-125-755-474-124;;113-381-664-783-802;;082-626-907-191-554;;017-950-014-792-456;;090-348-305-613-628;;015-985-399-299-132;;171-049-047-164-618;;016-819-089-891-758;;081-249-097-078-543;;089-612-747-111-646;;031-706-897-890-035;;094-198-536-559-723;;003-690-143-043-420;;007-943-354-378-456;;082-114-500-909-975;;004-239-090-971-580;;026-894-457-160-450;;077-128-610-778-669;;022-466-506-956-898;;008-424-592-956-946;;007-500-825-916-378;;009-725-244-669-882;;037-755-689-613-42X;;153-411-506-517-475;;038-134-360-685-692;;012-449-714-188-064;;031-517-704-996-130;;131-299-284-996-064;;049-133-049-742-708;;000-272-178-768-076;;070-797-683-833-124;;043-870-224-178-49X;;025-574-914-238-550;;052-364-430-129-757;;004-434-167-910-115;;032-860-147-271-886;;132-460-374-211-421;;098-172-374-375-47X;;109-358-955-476-095;;014-988-634-483-130;;061-786-187-274-992;;037-898-018-686-909;;130-044-667-529-69X;;134-265-642-839-645;;065-221-074-461-027;;017-934-465-161-477;;101-660-130-379-529;;028-236-706-290-220;;087-333-189-994-274;;059-082-211-027-266;;057-977-752-782-568,10.1016/s0956-5663(02)00099-4;;12392956;;10.1021/ja00391a001;;2889225;;10.1098/rstb.1987.0021;;10.1109/51.294001;;10.1016/0022-0728(65)85063-x;;2245876;;10.2337/diabetes.39.12.1519;;10.2337/diab.39.12.1519;;10.1016/s0956-5663(03)00220-3;;14611755;;18615658;;10.1002/bit.260430310;;9366023;;10.1016/s0956-5663(97)00025-0;;9451795;;10.1016/s0956-5663(97)00083-3;;10.1016/0956-5663(93)80028-n;;8311939;;8651496;;10.1021/ac960030d;;10.1080/03091900210156797;;12487712;;10.1016/0265-928x(87)80018-4;;3333622;;10.1109/19.816143;;10.1007/bf01015979;;10.1089/15209150252924058;;12017416;;18473691;;10.1089/dia.2007.0281;;10.1021/ac00017a008;;1789439;;2817408;;10.1021/ac00197a022;;10.1016/0925-4005(95)01730-5;;10.1016/0010-4825(90)90013-f;;2257734;;2868172;;8277748;;10.1016/0141-5425(93)90058-7;;11469630;;10.1089/15209150050214104;;10624783;;10.1016/s0168-8227(99)00113-8;;10.1089/15209150050214113;;11469631;;10.1007/bf00401374;;1478372;;10.2337/diacare.20.1.64;;9028696;;10.1109/tbme.1986.325807;;3957374;;236018;;10.1016/0005-2795(75)90259-7;;10.1089/hum.1998.9.6-879;;9581910;;11762520;;10.1089/15209150152607196;;10.2337/diabetes.48.3.445;;10078542;;10.1016/0265-928x(87)80012-3;;505005;;10.1126/science.505005;;10.1021/ac0498516;;15253640;;10.1109/10.284922;;8026845;;6721151;;10.1021/ac00268a018;;6733082;;10.1021/bi00305a016;;10.1515/cclm.2002.135;;12392305;;10.1016/j.ecl.2003.12.001;;15053902;;12052350;;10.1016/s0956-5663(01)00304-9;;12052349;;10.1016/s0956-5663(01)00306-2;;4500021;;10.1007/978-1-4684-3288-6_18;;14021529;;10.1111/j.1749-6632.1962.tb13623.x;;3196517;;10.2337/diacare.10.5.622;;3677983;;10.2337/diacare.8.6.529;;4075939;;10.1002/elan.1140061103;;7733469;;10.1021/ac00103a015;;7978306;;10.1021/ac00091a022;;10.1007/bf01248238;;10.1016/s0376-7388(98)00330-5;;10.1016/0142-9612(92)90147-g;;1472593;;10.1016/0265-928x(85)80002-x;;10.1021/j100290a001;;10.1021/ja00216a040;;10.1021/ja00188a091;;10.1021/ja00406a011;;2624333;;12323417;;10.1016/s0165-0270(02)00170-x;;10.1177/193229680700100208;;pmc2771467;;19888405;;10.1021/ja00415a014;;10.1007/bf00575392;;10.1021/ac00250a038;;10.1021/ac00266a005;;10.1007/s00216-002-1284-0;;12194035;;10.1089/dia.2006.0030;;17705688;;9642777;;10.1016/s0956-5663(97)00091-2;;10.1089/152091503322526978;;14633342;;10.1016/0022-0728(85)87006-6;;10.1021/ja00434a018;;10.1016/0003-2697(92)90243-z;;1443528;;10.1039/f19868201259;;3245585;;10.1021/ac00173a008;;2889234;;10.1098/rstb.1987.0020;;11762521;;10.1089/15209150152607204;;12413548;;10.1016/s1367-5931(02)00371-x;;10526740;;10.2337/diacare.22.10.1708;;14988294;;10.2337/diacare.27.3.734,"""Poretics Polycarbonate Membrane"", Osmonics Filtration and Separation Group, 2002.;;Abel, P. U., et al., ""Biosensors for In Vivo Glucose Measurement: Can We Cross the Experimental Stage"", Biosensors and Bioelectronics, vol. 17, 2002, pp. 1059-1070.;;Abruna, H. D., et al., ""Rectifying Interfaces Using Two-Layer Films of Electrochemically Polymerized Vinylpyridine and Vinylbipyridine Complexes of Ruthenium and Iron on Electrodes"", Journal of the American Chemical Society, vol. 103, No. 1, 1981, pp. 1-5.;;Albery, W. J., et al., ""Amperometric Enzyme Electrodes Part II: Conducting Salts as Electrode Materials for the Oxidation of Gluose Oxidase"", Journal of ElectroAnalytical Chemistry, vol. 194, 1985, pp. 223-235.;;Albery, W. J., et al., ""Amperometric Enzyme Electrodes"", Philosophical Transactions of the Royal Society of London, vol. 316, 1987, pp. 107-119.;;Alcock, S. J., et al., ""Continuous Analyte Monitoring to Aid Clinical Practice"", IEEE Engineering in Medicine and Biology Magazine, 1994, pp. 319-325.;;Anderson, L. B., et al., ""Thin-Layer Electrochemistry: Steady-State Methods of Studying Rate Processes"", Journal of ElectroAnalytical Chemistry, vol. 10, 1965, pp. 295-305.;;Armour, J. C., et al., ""Application of Chronic Intravascular Blood Glucose Sensor in Dogs"", Diabetes, vol. 39, 1990, pp. 1519-1526.;;Asberg, P., et al., ""Hydrogels of a Conducting Conjugated Polymer as 3-D Enzyme Electrode"", Biosensors & Bioelectronics, vol. 19, 2003, pp. 199-207.;;Atanasov, P., et al., ""Biosensor for Continuous Glucose Monitoring"", Biotechnology and Bioengineering, vol. 43, 1994, pp. 262-266.;;Atanasov, P., et al., ""Implantation of a Refillable Glucose Monitoring-Telemetry Device"", Biosensors & Bioelectronics, vol. 12, No. 7, 1997, pp. 669-680.;;Aussedat, B., et al., ""A User-Friendly Method for Calibrating a Subcutaneous Glucose Sensor-Based Hypoglycaemic Alarm"", Biosensors & Bioelectronics, vol. 12, No. 11, 1997, pp. 1061-1071.;;Baker, D. A., et al., ""Dynamic Concentration Challenges for Biosensor Characterization"", Biosensors & Bioelectronics, vol. 8, 1993, pp. 433-441.;;Baker, D. A., et al., ""Dynamic Delay and Maximal Dynamic Error in Continuous Biosensors"", Analytical Chemistry, vol. 68, No. 8, 1996, pp. 1292-1297.;;Bani Amer, M. M., ""An Accurate Amperometric Glucose Sensor Based Glucometer with Eliminated Cross-Sensitivity"", Journal of Medical Engineering & Technology, vol. 26, No. 5, 2002, pp. 208-213.;;Bard, A. J., et al., Electrochemical Methods, 1980, pp. 173-175.;;Bartlett, P. N., et al., ""Covalent Binding of Electron Relays to Glucose Oxidase"", Journal of the Chemical Society, Chemical Communications, 1987, pp. 1603-1604.;;Bartlett, P. N., et al., ""Modification of Glucose Oxidase by Tetrathiafulvalene"", Journal of the Chemical Society, Chemical Communications, 1990, pp. 1135-1136.;;Bartlett, P. N., et al., ""Strategies for the Development of Amperometric Enzyme Electrodes"", Biosensors, vol. 3, 1987/88, pp. 359-379.;;Beach, R. D., et al., ""Subminiature Implantable Potentiostat and Modified Commercial Telemetry Device for Remote Glucose Monitoring"", IEEE Transactions on Instrumentation and Measurement, vol. 28, No. 6, 1999, pp. 1239-1245.;;Beech, W. A., ""AX.25 Link Access Protocol for Amateur Packet packet Radio"", Tucson Amateur Radio Corporation, 1998, pp. 1-133.;;Bellucci, F., et al., ""Electrochemical Behaviour of Graphite-Epoxy Composite Materials (GECM) in Aqueous Salt Solutions"", Journal of Applied Electrochemistry, vol. 16, 1986, pp. 15-22.;;Bennion, N., et al., ""Alternate Site Glucose Testing: A Crossover Design"", Diabetes Technology & Therapeutics, vol. 4, No. 1, 2002, pp. 25-33.;;Biermann, E., et al., ""How Would Patients Behave if They were Continually Informed of Their Blood Glucose Levels? A Simulation Study Using a 'Virtual' Patient"" Diabetes Technology & Therapeutics, vol. 10, No. 3, 2008, pp. 178-187.;;Bindra, D. S., et al., ""Design and in Vitro Studies of a Needle-Type Glucose Sensor for Subcutaneous Monitoring"", Analytical Chemistry, vol. 63, No. 17, 1991, pp. 1692-1696.;;Bindra, D. S., et al., ""Pulsed Amperometric Detection of Glucose in Biological Fluids at a Surface-Modified Gold Electrode"", Analytical Chemistry, vol. 61, No. 22, 1989, pp. 2566-2570.;;Bisenberger, M., et al., ""A Triple-Step Potential Waveform at Enzyme Multisensors with Thick-Film Gold Electrodes for Detection of Glucose Sucrose"", Sensors and Actuators B, and vol. 28, 1995, pp. 181-189.;;Bland, J. M., et al., ""A Note on the Use of the Intraclass Correlation Coefficient in the Evaluation of Agreement Between Two Methods of Measurement"", Computers in Biology and Medicine, vol. 20, No. 5, 1990, pp. 337-340.;;Bland, J. M., et al., ""Statistical Methods for Assessing Agreement Between Two Methods of Clinical Measurement"", The Lancet, 1986, pp. 307-310.;;Blank, T. B., et al., ""Clinical Results From a Non-Invasive Blood Glucose Monitor"", Optical Diagnostics and Sensing of Biological Fluids and Glucose and Cholesterol Monitoring II, Proceedings of SPIE, vol. 4624, 2002, pp. 1-10.;;Bobbioni-Harsch, E., et al., ""Lifespan of Subcutaneous Glucose Sensors and Their Performances During Dynamic Glycaemia Changes in Rats"", Journal of Biomedical Engineering, vol. 15, 1993, pp. 457-463.;;Bode, B. W., ""Clinical Utility of the Continuous Glucose Monitoring System"", Diabetes Technology & Therapeutics, vol. 2, Sup. 1, 2000, pp. S35-S41.;;Bode, B. W., et al., ""Continuous Glucose Monitoring Used to Adjust Diabetes Therapy Improves Glycosylated Hemoglobin: A Pilot Study"", Diabetes Research and Clinical Practice, vol. 46, 1999, pp. 183-190.;;Bode, B. W., et al., ""Using the Continuous Glucose Monitoring System to Improve the Management of Type I Diabetes"", Diabetes Technology & Therapeutics, vol. 2, Sup. 1, 2000, pp. S43-S48.;;Boedeker Plastics, Inc., ""Polyethylene Specifications"", Web Page of Boedeker.com, 2007, pp. 1-3.;;Bolinder, J., et al., ""Microdialysis Measurement of the Absolute Glucose Concentration in Subcutaneous Adipose Tissue Allowing Glucose Monitoring in Diabetic Patients"", Diabetologia, vol. 35, 1992, pp. 1177-1180.;;Bolinder, J., et al., ""Self-Monitoring of Blood Glucose in Type I Diabetic Patients: Comparison with Continuous Microdialysis Measurements of Glucose in Subcutaneous Adipose Tissue During Ordinary Life Conditions"", Diabetes Care, vol. 20, No. 1, 1997, pp. 64-70.;;Bott, A. W., ""A Comparison of Cyclic Voltammetry and Cyclic Staircase Voltammetry"", Current Separations, vol. 16, No. 1, 1997, pp. 23-26.;;Bott, A. W., ""Electrochemical Methods for the Determination of Glucose"", Current Separations, vol. 17, No. 1, 1998, pp. 25-31.;;Bowman, L., et al., ""The Packaging of Implantable Integrated Sensors"", IEEE Transactions on Biomedical Engineering, vol. 33, No. 2, 1986, pp. 248-255.;;Brandt, J., et al., ""Covalent Attachment of Proteins to Polysaccharide Carriers by Means of Benzoquinone"", Biochimica et Biophysica Acta, vol. 386, 1975, pp. 196-202.;;Brauker, J., et al., ""Sustained Expression of High Levels of Human Factor IX from Human Cells Implanted Within an Immunoisolation Device into Athymic Rodents"", Human Gene Therapy, vol. 9, No. 6, 1998, pp. 879-888.;;Bremer, T. M., et al., ""Benchmark Data from the Literature for Evaluation of New Glucose Sensing Technologies"", Diabetes Technology & Therapeutics, vol. 3, No. 3, 2001, pp. 409-418.;;Bremer, T., et al., ""Is Blood Glucose Predictable from Previous Values?"", Diabetes, vol. 48, 1999, pp. 445-451.;;Brooks, S. L., et al., ""Development of an On-Line Glucose Sensor for Fermentation Monitoring"", Biosensors, vol. 3, 1987/88, pp. 45-56.;;Brownlee, M., et al., ""A Glucose-Controlled Insulin-Delivery System: Semisynthetic Insulin Bound to Lectin"", Science, vol. 206, 1979, 1190-1191.;;Cai, Q., et al., ""A Wireless, Remove Query Glucose Biosensor Based on a pH-Sensitive Polymer"", Analytical Chemistry, vol. 76, No. 14, 2004, pp. 4038-4043.;;Candas, B., et al., ""An Adaptive Plasma Glucose Controller Based on a Nonlinear Insulin/Glucose Model"", IEEE Transactions on Biomedical Engineering, vol. 41, No. 2, 1994, pp. 116-124.;;Cass, A. E., et al., ""Ferricinum Ion as an Electron Acceptor for Oxido-Reductases"", Journal of ElectroAnalytical Chemistry, vol. 190, 1985, pp. 117-127.;;Cass, A. E., et al., ""Ferrocene-Medicated Enzyme Electrode for Amperometric Determination of Glucose"",Analytical Chemistry, vol. 56, No. 4, 1984, 667-671.;;Castner, J. F., et al., ""Mass Transport and Reaction Kinetic Parameters Determined Electrochemically for Immobilized Glucose Oxidase"", Biochemistry, vol. 23 No. 10, 1984, 2203-2210.;;Chen, J. C., et al., ""A Comparison of MAC Protocols for Wireless Local Networks Based on battery Power Consumption"", IEEE, 1998, pp. 150-157.;;Chen, T., et al., ""Defining the Period of Recovery of the Glucose Concentration After Its Local Perturbation by the Implantation of a Miniature Sensor"", Clinical Chemistry and Laboratory Medicine, vol. 40, No. 8, 2002, pp. 486-489.;;Chia, C. W., et al., ""Glucose Sensors: Toward Closed Loop Insulin Delivery"", Endocrinology and Metabolism Clinics of North America, vol. 33, 2004, pp. 175-195.;;Choleau, C., et al., ""Calibration of a Subcutaneous Amperometric Glucose Sensor Implanted for 7 Days in Diabetic Patients Part 2: Superiority of the One-Point Calibration Method"", Biosensors and Bioelectronics, vol. 17, 2002, pp. 647-654.;;Choleau, C., et al., ""Calibration of a Subcutaneous Amperometric Glucose Sensor Part 1: Effect of Measurement Uncertainties on the Determination of Sensor Sensitivity and Background Current"", Biosensors and Bioelectronics, vol. 17, 2002, pp. 641-646.;;Claremont, D. J., et al., ""Biosensors for Continuous In Vivo Glucose Monitoring"", Proceedings of the Annual International Conference of the IEEE Engineering in Medicine and Biology Society, vol. 10, 1988.;;Clark Jr., L. C., et al., ""Differential Anodic Enzyme Polarography for the Measurement of Glucose"", Oxygen Transport to Tissue: Instrumentation, Methods, and Physiology, 1973, pp. 127-133.;;Clark Jr., L. C., et al., ""Electrode Systems for Continuous Monitoring in Cardiovascular Surgery"", Annals New York Academy of Sciences, 1962, pp. 29-45.;;Clark Jr., L. C., et al., ""Long-term Stability of Electroenzymatic Glucose Sensors Implanted in Mice"", American Society of Artificial Internal Organs Transactions, vol. XXXIV, 1988, pp. 259-265.;;Clarke, W. L., et al., ""Evaluating Clinical Accuracy of Systems for Self-Monitoring of Blood Glucose"", Diabetes Care, vol. 10, No. 5, 1987, pp. 622-628.;;Complaint, ""Abbott Diabetes Care, Inc. v. Dexcom, Inc."", filed Aug. 11, 2005.;;Complaint, Amended, ""Abbott Diabetes Care, Inc. v. Dexcom, Inc."", filed Jun. 27, 2006.;;Cox, D. J., et al., ""Accuracy of Perceiving Blood Glucose in IDDM"", Diabetes Care, vol. 8, No. 6, 1985, pp. 529-536.;;Csoregi, E., et al., ""Amperometric Microbiosensors for Detection of Hydrogen Peroxide and Glucose Based on Peroxidase-Modified Carbon Fibers"", Electroanalysis, vol. 6, 1994, pp. 925-933.;;Csoregi, E., et al., ""Design and Optimization of a Selective Subcutaneously Implantable Glucose Electrode Based on 'Wired' Glucose Oxidase"", Analytical Chemistry, vol. 67, No. 7, 1995, pp. 1240-1244.;;Csoregi, E., et al., ""Design, Characterization, and One-Point in Vivo Calibration of a Subcutaneously Implanted Glucose Electrode"", Analytical Chemistry, vol. 66 No. 19, 1994, pp. 3131-3138.;;Csoregi, E., et al., ""On-Line Glucose Monitoring by Using Microdialysis Sampling and Amperometric Detection Based on 'Wired' Glucose Oxidase in Carbon Paste"", Mikrochimica Acta, vol. 121, 1995, pp. 31-40.;;D'Arrigo, G., et al., ""Porous-Si Based Bio Reactors for Glucose Monitoring and Drugs Production"", Proceedings of SPIE: Microfluids, BioMEMS, and Medical Microsystems, vol. 4982, 2003, pp. 178-184;;Dai, W. S., et al., ""Hydrogel Membranes with Mesh Size Asymmetry Based on the Gradient Crosslinking of Poly(vinyl alcohol),"" Journal of Membrane Science, vol. 156, 1999, pp. 67-79.;;Davies, M. L., et al., ""Polymer Membranes in Clinical Sensor Applications"", Biomaterials, vol. 13, No. 14, 1992, pp. 971-978.;;Davis, G., ""Electrochemical Techniques for the Development of Amperometric Biosensors"", Biosensors, vol. 1, 1985, pp. 161-178.;;Degani, Y., et al., ""Direct Electrical Communication Between Chemically Modified Enzymes and Metal Electrodes. 1. Electron Transfer from Glucose Oxidase to Metal Electrodes via Electron Relays, Bound Covalently to the Enzyme"", The Journal of Physical Chemistry, vol. 91, No. 6, 1987, pp. 1285-1289.;;Degani, Y., et al., ""Direct Electrical Communication Between Chemically Modified Enzymes and Metal Electrodes. 2. Methods for Bonding Electron-Transfer Relays to Glucose Oxidase and D-Amino-Acid Oxidase"", Journal of the American Chemical Society, vol. 110, No. 8, 1988, pp. 2615-2620.;;Degani, Y., et al., ""Electrical Communication Between Redox Centers of Glucose Oxidase and Electrodes via Electrostatically and Covalently Bound Redox Polymers"", Journal of the American Chemical Society, vol. 111, 1989, pp. 2357-2358.;;Denisevich, P., et al., ""Unidirectional Current Flow and Charge State Trapping at Redox Polymer Interfaces on Bilayer Electrodes: Principles, Experimental Demonstration, and Theory"", Journal of the American Chemical Society, vol. 103, 1981, pp. 4727-4737.;;Dicks, J. M., et al., ""Ferrocene Modified Polypyrrole with Immobilised Glucose Oxidase and its Application in Amperometric Glucose Microbiosensors"", Annales de Biologie Clinique, vol. 47, 1989, pp. 607-619.;;Dixon, B. M., et al., ""Characterization In Vitro and In Vivo of the Oxygen Dependence of an Enzyme/Polymer Biosensors for Monitoring Brain Glucose"", Journal of Neuroscience Methods, vol. 119, 2002, pp. 135-142.;;Eighth Annual Diabetes Technology Meeting Abstracts, Nov. 13-15, 2008, pp. A1-A182.;;El-Khatib, F. H, et al., ""Adaptive Closed-Loop Control Provides Blood-Glucose Regulation Using Subcutaneous Insulin and Glucagon Infusion in Diabetic Swine"", Journal of Diabetes Science and Technology, vol. 1, No. 2, 2007, pp. 181-192.;;Ellis, C. D., et al., ""Selectivity and Directed Charge Transfer through an Electroactive Metallopolymer Film"", Journal of the American Chemical Society, vol. 103, No. 25, 1981, pp. 7480-7483.;;El-Sa'ad, L., et al., ""Moisture Absorption by Epoxy Resins: The Reverse Thermal Effect"", Journal of Materials Science, vol. 25, No. 8, 1990, pp. 3577-3582.;;Engstrom, R. C., ""Electrochemical Pretreatment of Glassy Carbon Electrodes"", Analytical Chemistry, vol. 54, No. 13, 1982, pp. 2310-2314.;;Engstrom, R. C., et al., ""Characterization of Electrochemically Pretreated Glassy Carbon Electrodes"", Analytical Chemistry, vol. 56, No. 2, 1984, pp. 136-141.;;Ernst, H., et al., ""Reliable Glucose Monitoring Through the Use of Microsystem Technology"", Analytical and Bioanalytical Chemistry, vol. 373, 2002, pp. 758-761.;;Fabietti, P. G., et al. ""Clinical Validation of a New Control-Oriented Model of Insulin and Glucose Dynamics in Subjects with Type 1 Diabetes"", Diabetes Technology & Therapeutics, vol. 9, No. 4, 2007, pp. 327-338.;;Fare, T. L., et al., ""Functional Characterization of a Conducting Polymer-Based Immunoassay System"", Biosensors & Bioelectronics, vol. 13, No. 3-4, 1998, pp. 459-470.;;Feldman, B., et al., ""A Continuous Glucose Sensor Based on Wired Enzyme(TM) Technology-Results from a 3-Day Trial in Patients with Type 1 Diabetes"", Diabetes Technology & Therapeutics, vol. 5, No. 5, 2003, pp. 769-779.;;Feldman, B., et al., ""Correlation of Glucose Concentrations in Interstitial Fluid and Venous Blood During Periods of Rapid Glucose Change"", Abbott Diabetes Care, Inc. Freestyle Navigator Continuous Glucose Monitor Pamphlet, 2004.;;Feldman, B., et al., ""Electron Transfer Kinetics at Redox Polymer/Solution Interfaces Using Microelectrodes and Twin Electrode Thin Layer Cells"", Journal of ElectroAnalytical Chemistry, vol. 194, 1985, pp. 63-81.;;Fischer, H., et al., ""Intramolecular Electron Transfer Medicated by 4,4'-Bypyridine and Related Bridging Groups"", Journal of the American Chemical Society, vol. 98, No. 18, 1976, pp. 5512-5517.;;Flentge, F., et al., ""An Enzyme-Reactor for Electrochemical Monitoring of Choline and Acetylcholine: Applications in High-Performance Liquid Chromatography, Bran Tissue, Microdialysis and Cerebrospinal Fluid,"" Analytical Biochemistry, vol. 204, 1992, pp. 305-310.;;Foulds, N. C., et al., ""Enzyme Entrapment in Electrically Conducting Polymers: Immobilisation of Glucose Oxidase in Polypyrrole and its Application in Amperometric Glucose Sensors"", Journal of the Chemical Society, Faraday Transactions 1, vol. 82, 1986, pp. 1259-1264.;;Foulds, N. C., et al., ""Immobilization of Glucose Oxidase in Ferrocene-Modified Pyrrole Polymers"", Analytical Chemistry, vol. 60, No. 22, 1988, pp. 2473-2478.;;Frew, J. E., et al., ""Electron-Transfer Biosensors"", Philosophical Transactions of the Royal Society of London, vol. 316, 1987, pp. 95-106.;;Frohnauer, M. K., et al., ""Graphical Human Insulin Time-Activity Profiles Using Standardized Definitions"", Diabetes Technology & Therapeutics, vol. 3, No. 3, 2001, pp. 419-429.;;Frost, M. C., et al., ""Implantable Chemical Sensors for Real-Time Clinical Monitoring: Progress and Challenges"", Current Opinion in Chemical Biology, vol. 6, 2002, pp. 633-641.;;Garg, S. K., et al., ""Correlation of Fingerstick Blood Glucose Measurements with GlucoWatch Biographer Glucose Results in Young Subjects with Type 1 Diabetes"", Diabetes Care, vol. 22, No. 10, 1999, pp. 1708-1714.;;Garg, S. K., et al., ""Improved Glucose Excursions Using an Implantable Real-Time Continuous Glucose Sensor in Adults with Type 1 Diabetes"", Diabetes Care, vol. 27, No. 3, 2004, pp. 734-738.",EXPIRED
196,US,A1,US 2009/0192379 A1,074-935-011-258-84X,2009-07-30,2009,US 41848509 A,2009-04-03,US 41848509 A;;US 42005703 A;;US 66719900 A;;US 7067798 A,1998-04-30,Analyte Monitoring Device and Methods of Use,"An analyte monitor includes a sensor, a sensor control unit, and a display unit. The sensor has, for example, a substrate, a recessed channel formed in the substrate, and conductive material disposed in the recessed channel to form a working electrode. The sensor control unit typically has a housing adapted for placement on skin and is adapted to receive a portion of an electrochemical sensor. The sensor control unit also includes two or more conductive contacts disposed on the housing and configured for coupling to two or more contact pads on the sensor. A transmitter is disposed in the housing and coupled to the plurality of conductive contacts for transmitting data obtained using the sensor. The display unit has a receiver for receiving data transmitted by the transmitter of the sensor control unit and a display coupled to the receiver for displaying an indication of a level of an analyte. The analyte monitor may also be part of a drug delivery system to alter the level of the analyte based on the data obtained using the sensor.",ABBOTT DIABETES CARE INC,SAY JAMES;;TOMASCO MICHAEL F;;HELLER ADAM;;GAL YORAM;;ARIA BEHRAD;;HELLER EPHRAIM;;PLANTE PHILLIP JOHN;;VREEKE MARK S;;FRIEDMAN KEITH A;;COLMAN FREDRIC C,,https://lens.org/074-935-011-258-84X,Patent Application,yes,1,57,211,221,0,A61B5/14532;;A61B5/14532;;A61B5/0002;;A61B5/0002;;A61B5/002;;A61B5/01;;A61B5/14503;;A61B5/1451;;A61B5/14546;;A61B5/14546;;A61B5/1473;;A61B5/1473;;A61B5/1486;;A61B5/1486;;A61B5/14865;;A61B5/1495;;A61B5/4839;;A61B5/72;;A61B5/7278;;A61B5/7282;;A61B5/7405;;A61B5/743;;A61B5/7445;;A61B5/7445;;A61B5/7455;;A61B2560/0252;;A61B2560/0252;;A61M5/1723;;C12Q1/54;;G16H10/40;;G16H10/40;;G16H20/17;;G16H20/17;;H01L23/3107;;H01L23/3107;;H01L23/49548;;H01L23/49548;;H01L2924/0002;;H01L2924/0002;;H01L2924/19041;;H01L2924/19041;;H01L2924/3011;;H01L2924/3011;;Y10S128/903;;Y10S128/903;;Y10T29/49;;Y10T29/49;;Y10T29/49124;;Y10T29/49124,A61B5/1468;;G01N27/30;;A61B5/00;;A61B5/145;;A61B5/1477;;A61B5/1495;;G01N27/416;;G06F19/00;;H01L23/31;;H01L23/495,600/345,0,0,,,,DISCONTINUED
197,US,A1,US 2010/0280345 A1,091-648-904-506-200,2010-11-04,2010,US 83745810 A,2010-07-15,US 83745810 A;;US 69082607 A;;US 42005703 A;;US 66719900 A;;US 7067798 A,1998-04-30,Analyte Monitoring Device and Methods of Use,"An analyte monitor includes a sensor, a sensor control unit, and a display unit. The sensor has, for example, a substrate, a recessed channel formed in the substrate, and conductive material disposed in the recessed channel to form a working electrode. The sensor control unit typically has a housing adapted for placement on skin and is adapted to receive a portion of an electrochemical sensor. The sensor control unit also includes two or more conductive contacts disposed on the housing and configured for coupling to two or more contact pads on the sensor. A transmitter is disposed in the housing and coupled to the plurality of conductive contacts for transmitting data obtained using the sensor. The display unit has a receiver for receiving data transmitted by the transmitter of the sensor control unit and a display coupled to the receiver for displaying an indication of a level of an analyte. The analyte monitor may also be part of a drug delivery system to alter the level of the analyte based on the data obtained using the sensor.",ABBOTT DIABETES CARE INC,SAY JAMES;;TOMASCO MICHAEL F;;HELLER ADAM;;GAL YORAM;;ARIA BEHRAD;;HELLER EPHRAIM;;PLANTE PHILLIP JOHN;;VREEKE MARK S;;FRIEDMAN KEITH A;;COLMAN FREDRIC C,,https://lens.org/091-648-904-506-200,Patent Application,yes,1,48,211,221,0,A61B5/14532;;A61B5/14532;;A61B5/0002;;A61B5/0002;;A61B5/002;;A61B5/01;;A61B5/14503;;A61B5/1451;;A61B5/14546;;A61B5/14546;;A61B5/1473;;A61B5/1473;;A61B5/1486;;A61B5/1486;;A61B5/14865;;A61B5/1495;;A61B5/4839;;A61B5/72;;A61B5/7278;;A61B5/7282;;A61B5/7405;;A61B5/743;;A61B5/7445;;A61B5/7445;;A61B5/7455;;A61B2560/0252;;A61B2560/0252;;A61M5/1723;;C12Q1/54;;G16H10/40;;G16H10/40;;G16H20/17;;G16H20/17;;H01L23/3107;;H01L23/3107;;H01L23/49548;;H01L23/49548;;H01L2924/0002;;H01L2924/0002;;H01L2924/19041;;H01L2924/19041;;H01L2924/3011;;H01L2924/3011;;Y10S128/903;;Y10S128/903;;Y10T29/49;;Y10T29/49;;Y10T29/49124;;Y10T29/49124,A61B5/05;;G01N27/30;;A61B5/00;;A61B5/145;;A61B5/1477;;A61B5/1495;;G01N27/416;;G06F19/00;;H01L23/31;;H01L23/495,600/345,0,0,,,,DISCONTINUED
198,US,B1,US 7869853 B1,124-611-905-737-744,2011-01-11,2011,US 85243610 A,2010-08-06,US 85243610 A;;US 69082607 A;;US 42005703 A;;US 66719900 A;;US 7067798 A,1998-04-30,Analyte monitoring device and methods of use,"An analyte monitor includes a sensor, a sensor control unit, and a display unit. The sensor has, for example, a substrate, a recessed channel formed in the substrate, and conductive material disposed in the recessed channel to form a working electrode. The sensor control unit typically has a housing adapted for placement on skin and is adapted to receive a portion of an electrochemical sensor. The sensor control unit also includes two or more conductive contacts disposed on the housing and configured for coupling to two or more contact pads on the sensor. A transmitter is disposed in the housing and coupled to the plurality of conductive contacts for transmitting data obtained using the sensor. The display unit has a receiver for receiving data transmitted by the transmitter of the sensor control unit and a display coupled to the receiver for displaying an indication of a level of an analyte. The analyte monitor may also be part of a drug delivery system to alter the level of the analyte based on the data obtained using the sensor.",ABBOTT DIABETES CARE INC,SAY JAMES;;TOMASCO MICHAEL F;;HELLER ADAM;;GAL YORAM;;ARIA BEHRAD;;HELLER EPHRAIM;;PLANTE PHILLIP JOHN;;VREEKE MARK S;;FRIEDMAN KEITH A;;COLMAN FREDRIC C,E. HELLER & CO (1998-07-02);;ABBOTT DIABETES CARE INC (2000-03-13),https://lens.org/124-611-905-737-744,Granted Patent,yes,100,45,211,221,0,A61B5/14532;;A61B5/14532;;A61B5/0002;;A61B5/0002;;A61B5/002;;A61B5/01;;A61B5/14503;;A61B5/1451;;A61B5/14546;;A61B5/14546;;A61B5/1473;;A61B5/1473;;A61B5/1486;;A61B5/1486;;A61B5/14865;;A61B5/1495;;A61B5/4839;;A61B5/72;;A61B5/7278;;A61B5/7282;;A61B5/7405;;A61B5/743;;A61B5/7445;;A61B5/7445;;A61B5/7455;;A61B2560/0252;;A61B2560/0252;;A61M5/1723;;C12Q1/54;;G16H10/40;;G16H10/40;;G16H20/17;;G16H20/17;;H01L23/3107;;H01L23/3107;;H01L23/49548;;H01L23/49548;;H01L2924/0002;;H01L2924/0002;;H01L2924/19041;;H01L2924/19041;;H01L2924/3011;;H01L2924/3011;;Y10S128/903;;Y10S128/903;;Y10T29/49;;Y10T29/49;;Y10T29/49124;;Y10T29/49124,A61B5/00;;G01N27/30;;A61B5/145;;A61B5/1477;;A61B5/1495;;G01N27/416;;G06F19/00;;H01L23/31;;H01L23/495,600/347;;600/365,99,82,136-791-935-548-81X;;062-360-289-025-864;;010-601-725-111-91X;;101-292-518-663-191;;056-703-879-057-297;;030-155-762-644-019;;004-149-141-436-651;;016-731-054-793-457;;080-559-561-995-335;;044-807-213-528-815;;027-538-525-436-179;;015-020-161-517-40X;;025-919-454-564-785;;014-700-576-603-812;;004-851-060-590-788;;075-958-432-122-199;;052-356-140-149-389;;035-090-282-884-790;;033-562-815-299-181;;018-803-926-589-211;;008-505-762-041-402;;016-601-143-530-813;;019-502-772-562-215;;058-476-824-396-350;;006-498-707-073-30X;;054-091-551-638-293;;010-531-147-771-746;;054-827-198-877-419;;122-658-944-077-000;;017-261-560-469-37X;;000-125-755-474-124;;113-381-664-783-802;;082-626-907-191-554;;017-950-014-792-456;;090-348-305-613-628;;015-985-399-299-132;;171-049-047-164-618;;016-819-089-891-758;;081-249-097-078-543;;089-612-747-111-646;;031-706-897-890-035;;094-198-536-559-723;;003-690-143-043-420;;007-943-354-378-456;;082-114-500-909-975;;004-239-090-971-580;;026-894-457-160-450;;077-128-610-778-669;;022-466-506-956-898;;008-424-592-956-946;;007-500-825-916-378;;009-725-244-669-882;;037-755-689-613-42X;;153-411-506-517-475;;038-134-360-685-692;;012-449-714-188-064;;031-517-704-996-130;;131-299-284-996-064;;049-133-049-742-708;;000-272-178-768-076;;070-797-683-833-124;;043-870-224-178-49X;;025-574-914-238-550;;052-364-430-129-757;;004-434-167-910-115;;032-860-147-271-886;;132-460-374-211-421;;098-172-374-375-47X;;109-358-955-476-095;;014-988-634-483-130;;061-786-187-274-992;;037-898-018-686-909;;130-044-667-529-69X;;134-265-642-839-645;;065-221-074-461-027;;017-934-465-161-477;;101-660-130-379-529;;028-236-706-290-220;;087-333-189-994-274;;059-082-211-027-266;;057-977-752-782-568;;022-511-780-866-588,10.1016/s0956-5663(02)00099-4;;12392956;;10.1021/ja00391a001;;2889225;;10.1098/rstb.1987.0021;;10.1109/51.294001;;10.1016/0022-0728(65)85063-x;;2245876;;10.2337/diabetes.39.12.1519;;10.2337/diab.39.12.1519;;10.1016/s0956-5663(03)00220-3;;14611755;;18615658;;10.1002/bit.260430310;;9366023;;10.1016/s0956-5663(97)00025-0;;9451795;;10.1016/s0956-5663(97)00083-3;;10.1016/0956-5663(93)80028-n;;8311939;;8651496;;10.1021/ac960030d;;10.1080/03091900210156797;;12487712;;10.1016/0265-928x(87)80018-4;;3333622;;10.1109/19.816143;;10.1007/bf01015979;;10.1089/15209150252924058;;12017416;;18473691;;10.1089/dia.2007.0281;;10.1021/ac00017a008;;1789439;;2817408;;10.1021/ac00197a022;;10.1016/0925-4005(95)01730-5;;10.1016/0010-4825(90)90013-f;;2257734;;2868172;;8277748;;10.1016/0141-5425(93)90058-7;;11469630;;10.1089/15209150050214104;;10624783;;10.1016/s0168-8227(99)00113-8;;10.1089/15209150050214113;;11469631;;10.1007/bf00401374;;1478372;;10.2337/diacare.20.1.64;;9028696;;10.1109/tbme.1986.325807;;3957374;;236018;;10.1016/0005-2795(75)90259-7;;10.1089/hum.1998.9.6-879;;9581910;;11762520;;10.1089/15209150152607196;;10.2337/diabetes.48.3.445;;10078542;;10.1016/0265-928x(87)80012-3;;505005;;10.1126/science.505005;;10.1021/ac0498516;;15253640;;10.1109/10.284922;;8026845;;6721151;;10.1021/ac00268a018;;6733082;;10.1021/bi00305a016;;10.1515/cclm.2002.135;;12392305;;10.1016/j.ecl.2003.12.001;;15053902;;12052350;;10.1016/s0956-5663(01)00304-9;;12052349;;10.1016/s0956-5663(01)00306-2;;4500021;;10.1007/978-1-4684-3288-6_18;;14021529;;10.1111/j.1749-6632.1962.tb13623.x;;3196517;;10.2337/diacare.10.5.622;;3677983;;10.2337/diacare.8.6.529;;4075939;;10.1002/elan.1140061103;;7733469;;10.1021/ac00103a015;;7978306;;10.1021/ac00091a022;;10.1007/bf01248238;;10.1016/s0376-7388(98)00330-5;;10.1016/0142-9612(92)90147-g;;1472593;;10.1016/0265-928x(85)80002-x;;10.1021/j100290a001;;10.1021/ja00216a040;;10.1021/ja00188a091;;10.1021/ja00406a011;;2624333;;12323417;;10.1016/s0165-0270(02)00170-x;;10.1177/193229680700100208;;pmc2771467;;19888405;;10.1021/ja00415a014;;10.1007/bf00575392;;10.1021/ac00250a038;;10.1021/ac00266a005;;10.1007/s00216-002-1284-0;;12194035;;10.1089/dia.2006.0030;;17705688;;9642777;;10.1016/s0956-5663(97)00091-2;;10.1089/152091503322526978;;14633342;;10.1016/0022-0728(85)87006-6;;10.1021/ja00434a018;;10.1016/0003-2697(92)90243-z;;1443528;;10.1039/f19868201259;;3245585;;10.1021/ac00173a008;;2889234;;10.1098/rstb.1987.0020;;11762521;;10.1089/15209150152607204;;12413548;;10.1016/s1367-5931(02)00371-x;;10526740;;10.2337/diacare.22.10.1708;;14988294;;10.2337/diacare.27.3.734;;10.1111/j.1749-6632.1997.tb52216.x;;9616733,"Abel, P. U., et al., ""Biosensors for In Vivo Glucose Measurement: Can We Cross the Experimental Stage"", Biosensors and Bioelectronics, vol. 17, 2002, pp. 1059-1070.;;Abruna, H. D., et al., ""Rectifying Interfaces Using Two-Layer Films of Electrochemically Polymerized Vinylpyridine and Vinylbipyridine Complexes of Ruthenium and Iron on Electrodes"", Journal of the American Chemical Society, vol. 103, No. 1, 1981, pp. 1-5.;;Albery, W. J., et al., ""Amperometric Enzyme Electrodes Part II: Conducting Salts as Electrode Materials for the Oxidation of Glucose Oxidase"", Journal of ElectroAnalytical Chemistry, vol. 194, 1985, pp. 223-235.;;Albery, W. J., et al., ""Amperometric Enzyme Electrodes"", Philosophical Transactions of The Royal Society of London, vol. 316, 1987, pp. 107-119.;;Alcock, S. J., et al., ""Continuous Analyte Monitoring to Aid Clinical Practice"", IEEE Engineering in Medicine and Biology Magazine, 1994, pp. 319-325.;;Anderson, L. B., et al., ""Thin-Layer Electrochemistry: Steady-State Methods of Studying Rate Processes"", Journal of ElectroAnalytical Chemistry, vol. 10, 1965, pp. 295-305.;;Armour, J. C., et al., ""Application of Chronic Intravascular Blood Glucose Sensor in Dogs"", Diabetes, vol. 39, 1990, pp. 1519-1526.;;Asberg, P., et al., ""Hydrogels of a Conducting Conjugated Polymer as 3-D Enzyme Electrode"", Biosensors & Bioelectronics, vol. 19, 2003, pp. 199-207.;;Atanasov, P., et al., ""Biosensor for Continuous Glucose Monitoring"", Biotechnology and Bioengineering, vol. 43, 1994, pp. 262-266.;;Atanasov, P., et al., ""Implantation of a Refillable Glucose Monitoring-Telemetry Device"", Biosensors & Bioelectronics, vol. 12, No. 7, 1997, pp. 669-680.;;Aussedat, B., et al., ""A User Friendly Method for Calibrating a Subcutaneos Glucose Sensor-Based Hypoglycaemic Alarm"", Biosensors & Bioelectronics, vol. 12, No. 11, 1997, pp. 1061-1071.;;Baker, D. A., et al., ""Dynamic Concentration Challenges for Biosensor Characterization"", Biosensors & Bioelectronics, vol. 8, 1993, pp. 433-441.;;Baker, D. A., et al., ""Dynamic Delay and Maximal Dynamic Error in Continuous Biosensors"", Analytical Chemistry, vol. 68, No. 8, 1996, pp. 1292-1297.;;Bani Amer, M. M., ""An Accurate Amperometric Glucose Sensor Based Glucometer with Eliminated Cross-Sensitivity"", Journal of Medical Engineering & Technology, vol. 26, No. 5, 2002, pp. 208-213.;;Bard, A. J., et al., Electrochemical Methods, 1980, pp. 173-175.;;Bartlett, P. N., et al., ""Covalent Binding of Electron Relays to Glucose Oxidase"", Journal of the Chemical Society, Chemical Communications, 1987, pp. 1603-1604.;;Bartlett, P. N., et al., ""Modification of Glucose Oxidase by Tetrathiafulvalene"", Journal of the Chemical Society, Chemical Communications, 1990, pp. 1135-1136.;;Bartlett, P. N., et al., ""Strategies for the Development of Amperometric Enzyme Electrodes"", Biosensors, vol. 3, 1987/1988, pp. 359-379.;;Beach, R. D., et al., ""Subminiature Implantable Potentiostat and Modified Commerical Telemetry Device for Remote Glucose Monitoring"", IEEE Transactions on Instrumentation and Measurement, vol. 28, No. 6, 1999, pp. 1239-1245.;;Beech, W. A., ""AX.25 Link Access Protocol for Amateur Packet Radio"", Tucson Amateur Packet Radio Corporation, 1998, pp. 1-133.;;Bellucci, F., et al., ""Electrochemical Behavior of Graphite-Epoxy Composite Materials (GECM) in Aqueous Salt Solutions"", Journal of Applied Electrochemistry, vol. 16, 1986, pp. 15-22.;;Bennion, N., et al., ""Alternate Site Glucose Testing: A Crossover Design"", Diabetes Technology & Therapeutics, vol. 4, No. 1, 2002, pp. 25-33.;;Biermann, E., et al., ""How Would Patients Behave if They were Continually Informed of Their Blood Glucose Levels? A Simulation Study Using a 'Virutal' Patient"", Diabetes Technology & Therapeutics, vol. 10, No. 3, 2008, pp. 178-187.;;Bindra, D. S., et al., ""Design and in Vitro Studies of a Needle-Type Glucose Sensor for Subcutaneous Monitoring"", Analytical Chemistry, vol. 63, No. 17, 1991, pp. 1692-1696.;;Bindra, D. S., et al., ""Pulsed Amperometric Detection of Glucose in Biological Fluids at a Surface-Modified Gold Electrode"", Analytical Chemistry, vol. 61, No. 22, 1989, pp. 2566-2570.;;Bisenberger, M., et al., ""A Triple-Step Potential Waveform at Enzyme Multisensors with Thick-Film Gold Electrodes for Detection of Glucose and Sucrose"", Sensors and Actuators B, vol. 28, 1995, pp. 181-189.;;Bland, J. M., et al., ""A Note on the Use of the Intraclass Correlation Coefficient in the Evaluation of Agreement Between Two Methods of Measurement"", Computers in Biology and Medicine, vol. 20, No. 5, 1990, pp. 337-340.;;Bland, J. M., et al., ""Statistical Methods for Assessing Agreement Between Two Methods of Clinical Measurement"", The Lancet, 1986, pp. 307-310.;;Blank, T. B., et al., ""Clinical Results From a Non-Invasive Blood Glucose Monitor"", Optical Diagnostics and Sensing of Biological Fluids and Glucose and Cholesterol Monitoring II, Proceedings of SPIE, vol. 4624, 2002, pp. 1-10.;;Bobbioni-Harsch, E., et al., ""Lifespan of Subcutaneous Glucose Sensors and Their Performances During Dynamic Glycaemia Changes in Rats"", Journal of Biomedical Engineering, vol. 15, 1993, pp. 457-463.;;Bode, B. W., ""Clinical Utility of the Continuous Glucose Monitoring System"", Diabetes Technology & Therapeutics, vol. 2, Sup. 1, 2000, pp. S35-S41.;;Bode, B. W., et al., ""Continuous Glucose Monitoring Used to Adjust Diabetes Therapy Improves Glycosylated Hemoglobin: A Pilot Study"", Diabetes Research and Clinical Practice, vol. 46, 1999, pp. 183-190.;;Bode, B. W., et al., ""Using The Continuous Glucose Monitoring System to Improve the Management of Type I Diabetes"", Diabetes Technology & Therapeutics, vol. 2, Sup. 1, 2000, pp. S43-S48.;;Boedeker Plastics, Inc., ""Polyethylene Specifications"", Web Page of Boedeker.com, 2007, pp. 1-3.;;Bolinder, J., et al., ""Microdialysis Measurement of the Absolute Glucose Concentration in Subcutaneous Adipose Tissue Allowing Glucose Monitoring in Diabetic Patients"", Diabetologia, vol. 35, 1992, pp. 1177-1180.;;Bolinder, J., et al., ""Self-Monitoring of Blood Glucose in Type I Diabetic Patients: Comparison with Continuous Microdialysis Measurements of Glucose in Subcutaneous Adipose Tissue During Ordinary Life Conditions"", Diabetes Care, vol. 20, No. 1, 1997, pp. 64-70.;;Bott, A. W., ""A Comparison of Cyclic Voltammetry and Cyclic Staircase Voltammetry"", Current Separations, vol. 16, No. 1, 1997, pp. 23-26.;;Bott, A. W., ""Electrochemical Methods for the Determination of Glucose"", Current Seperations, vol. 17, No. 1, 1998, pp. 25-31.;;Bowman, L., et al., ""The Packaging of Implantable Integrated Sensors"", IEEE Transactions on Biomedical Engineering, vol. 33, No. 2, 1986, pp. 248-255.;;Brandt, J., et al., ""Covalent Attachment of Proteins to Polysaccharide Carriers by Means of Benzoquinone"", Biochimica et Biophysica Acta, vol. 386, 1975, pp. 196-202.;;Brauker, J., et al., ""Sustained Expression of High Levels of Human Factor IX from Human Cells Implanted Within an Immunoisolation Device into Athymic Rodents""Human Gene Therapy, vol. 9, No. 6, 1998, pp. 879-888.;;Bremer, T. M., et al., ""Benchmark Data from the Literature for Evaluation of New Glucose Sensing Technologies"", Diabetes Technology & Therapeutics, vol. 3, No. 3, 2001, pp. 409-418.;;Bremer, T., et al., ""Is Blood Glucose Predictable from Previous Values?"", Diabetes, vol. 48, 1999, pp. 445-451.;;Brooks, S. L., et al., ""Development of an On-Line Glucose Sensor for Fermentation Monitoring"", Biosensors, vol. 3, 1987/1988, pp. 45-56.;;Brownlee, M., et al., ""A Glucose-Controlled Insulin-Delivery System: Semisynthetic Insulin Bound to Lectin"", Science, vol. 206, 1979, 1190-1191.;;Cai, Q., et al., ""A Wireless, Remove Query Glucose Biosensor Based on a pH-Sensitive Polymer"", Analytical Chemistry, vol. 76, No. 14, 2004, pp. 4038-4043.;;Candas, B., et al., ""An Adaptive Plasma Glucose Controller Based on a Nonlinear Insulin/Glucose Model"", IEEE Transactions on Biomedical Engineering, vol. 41, No. 2, 1994, pp. 116-124.;;Cass, A. E., et al., ""Ferricinum Ion as an Electron Acceptor for Oxido-Reductases"", Journal of ElectroAnalytical Chemistry, vol. 190, 1985, pp. 117-127.;;Cass, A. E., et al., ""Ferrocene-Medicated Enzyme Electrode for Amperometric Determination of Glucose"", Analytical Chemistry, vol. 56, No. 4, 1984, 667-671.;;Castner, J. F., et al., ""Mass Transport and Reduction Kinetic Parameters Determines Electrochemically for Immobilized Glucose Oxidase"", Biochemistry, vol. 23 No. 10, 1984, 2203-2210.;;Chen, J. C., et al., ""A Comparison of MAC Protocols for Wireless Local Networks Based on battery Power Consumption"", IEEE, 1998, pp. 150-157.;;Chen, T., et al., ""Defining the Period of Recovery of the Glucose Concentration After its Local Perturbation by the Implantation of a Miniature Sensor"", Clincal Chemistry and Laboratory Medicine, vol. 40, No. 8, 2002, pp. 486-489.;;Chia, C. W., et al., ""Glucose Sensors: Toward Closed Loop Insulin Delivery"", Endocrinology and Metabolism Clinics of North America, vol. 33, 2004, pp. 175-195.;;Choleau, C., et al., ""Calibration of a Subcutaneous Amperometric Glucose Sensor Implanted for 7 Days in Diabetic Patients Part 2: Superiority of the One-Point Calibration Method"", Biosensors and Bioelectronics, vol. 17, 2002, pp. 647-654.;;Choleau, C., et al., ""Calibration of a Subcutaneous Amperometric Glucose Sensor Part 1: Effect of Measurement Uncertainties on the Determination of Sensor Sensitivity and Background Current"", Biosensors and Bioelectronics, vol. 17, 2002, pp. 641-646.;;Claremont, D. J., et al., ""Biosensors for Continuous in Vivo Glucose Monitoring"", Proceedings of the Annual International Conference of the IEEE Engineering in Medicine and Biology Society, vol. 10, 1988.;;Clark Jr., L. C., et al., ""Differential Anodic Enzyme Polarography for the Measurement of Glucose"", Oxygen Transport to Tissue: Instrumentation, Methods, and Physiology, 1973, pp. 127-133.;;Clark Jr., L. C., et al., ""Electrode Systems for Continuous Monitoring in Cardiovascular Surgery"", Annals New York Academy of Sciences, 1962, pp. 29-45.;;Clark Jr., L. C., et al., ""Long-term Stability of Electroenzymatic Glucose Sensors Implanted in Mice"", American Society of Artificial Internal Organs Transactions, vol. XXXIV, 1988, pp. 259-265.;;Clarke, W. L., et al., ""Evaluating Clinical Accuracy of Systems for Self-Monitoring of Blood Glucose"", Diabetes Care, vol. 10, No. 5, 1987, pp. 622-628.;;Complaint, ""Abbott Diabetes Care, Inc. v. Dexcom, Inc."", filed Aug. 11, 2005.;;Complaint, Amended, ""Abbott Diabetes Care, Inc. v. Dexcom, Inc."", filed Jun. 27, 2006.;;Cox, D. J., et al., ""Accuracy of Perceiving Blood Glucose in IDDM"", Diabetes Care, vol. 8, No. 6, 1985, pp. 529-536.;;Csoregi, E., et al., ""Amperometric Microbiosenesors for Detection of Hydrogen Peroxide and Glucose Based on Peroxidase-Modified Carbon Fibers"", Electroanalysis, vol. 6, 1994, pp. 925-933.;;Csoregi, E., et al., ""Design and Optimization of a Selective Subcutaneously Implantable Glucose Electrode Based on 'Wired' Glucose Oxidase"", Analytical Chemistry, vol. 67, No. 7, 1995, pp. 1240-1244.;;Csoregi, E., et al., ""Design, Characterization, and One-Point in Vivo Calibration of a Subcutaneously Implanted Glucose Electrode"", Analytical Chemistry, vol. 66 No. 19, 1994, pp. 3131-3138.;;Csoregi, E., et al., ""On-Line Glucose Monitoring by Using Microdialysis Sampling and Amperometric Detection Based on 'Wired' Glucose Oxidase in Carbon Paste"", Mikochimica Acta, vol. 121, 1995, pp. 31-40.;;D'Arrigo, G., et al., ""Porous-Si Based Bio Reactors for Glucose Monitoring and Drugs Production"", Proceedings of SPIE: Microfluids, BioMEMS, and Medical Microsystems, vol. 4982, 2003, pp. 178-184.;;Dai, W. S., et al., ""Hydrogel Membranes with Mesh Size Asymmetry Based on the Gradient Crosslinking of Poly(vinyl alcohol),"" Journal of Membrane Science, vol. 156, 1999, pp. 67-79.;;Davies, M. L., et al., ""Polymer Membranes in Clinical Sensor Applications"", Biomaterials, vol. 13 No. 14, 1992, pp. 971-978.;;Davis, G., ""Electrochemical Techniques for the Development of Amperometric Biosensors"", Biosensors, vol. 1, 1985, pp. 161-178.;;Degani, Y., et al., ""Direct Electrical Communication Between Chemically Modified Enzymes and Metal Electrodes. 1. Electron Transfer from Glucose Oxidase to Metal Electrodes via Electron Relays, Bound Covalently to the Enzyme"", The Journal of Physical Chemistry, vol. 91, No. 6, 1987, pp. 1285-1289.;;Degani, Y., et al., ""Direct Electrical Communication Between Chemically Modified Enzymes and Metal Electrodes. 2. Methods for Bonding Electron-Transfer Relays to Glucose Oxidase and D-Amino-Acid Oxidase"", Journal of the American Chemical Society, vol. 110, No. 8, 1988, pp. 2615-2620.;;Degani, Y., et al., ""Electrical Communication Between Redox Centers of Glucose Oxidase and Electrodes via Electrostatically and Covalently Bound Redox Polymers"", Journal of the American Chemical Society, vol. 111, 1989, pp. 2357-2358.;;Denisevich, P., et al., ""Unidirectional Current Flow and Charge State Trapping at Redox Polymer Interfaces on Bilayer Electrodes: Principles, Experimental Demonstration, and Theory"", Journal of the American Chemical Society, vol. 103, 1981, pp. 4727-4737.;;Dicks, J. M., et al., ""Ferrocene Modified Polypyrrole with Immobilised Glucose Oxidase and its Application in Amperometric Glucose Microbiosensors"", Annales de Biologie Clinique, vol. 47, 1989, pp. 607-619.;;Dixon, B. M., et al., ""Characterization in Vitro and in Vivo of the Oxygen Dependence of an Enzyme/Polymer Biosensors for Monitoring Brain Glucose"", Journal of Neuroscience Methods, vol. 119, 2002, pp. 135-142.;;Eighth Annual Diabetes Technology Meeting Abstracts, Nov. 13-15, 2008, pp. A1-A182.;;El-Khatib, F. H, et al., ""Adaptive Closed-Loop Control Provides Blood-Glucose Regulation Using Subcutaneous Insulin and Glucagon Infusion in Diabetic Swine"", Journal of Diabetes Science and Technology, vol. 1, No. 2, 2007, pp. 181-192.;;Ellis, C. D., et al., ""Selectivity and Directed Charge Transfer through an Electroactive Metallopolymer Film"", Journal of the American Chemical Society, vol. 103, No. 25, 1981, pp. 7480-7483.;;El-Sa'ad, L., et al., ""Moisture Absorption by Epoxy Resins: The Reverse Thermal Effect"", Journal of Materials Science, vol. 25, No. 8, 1990, pp. 3577-3582.;;Engstrom, R. C., ""Electrochemical Pretreatment of Glassy Carbon Electrodes"", Analytical Chemistry, vol. 54, No. 13, 1982, pp. 2310-2314.;;Engstrom, R. C., et al., ""Characterization of Electrochemically Pretreated Glassy Carbon Electrodes"", Analytical Chemistry, vol. 56, No. 2, 1984, pp. 136-141.;;Ernst, H., et al., ""Reliable Glucose Monitoring Through the Use of Microsystem Technology"", Analytical and Bioanalytical Chemistry, vol. 373, 2002, pp. 758-761.;;Fabietti, P. G., et al. ""Clinical Validation of a New Control-Oriented Model of Insulin and Glucose Dynamics in Subjects with Type 1 Diabetes"", Diabetes Technology & Therapeutics, vol. 9 No. 4, 2007, pp. 327-338.;;Fare, T. L., et al., ""Functional Characterization of a Conducting Polymer-Based Immunoassay System"", Biosensors & Bioelectronics, vol. 13, No. 3-4, 1998, pp. 459-470.;;Feldman, B., et al., ""A Continuous Glucose Sensor Based on Wired Enzyme(TM) Technolgy-Results from a 3-Day Trial in Patients with Type 1 Diabetes"", Diabetes Technology & Therapeutics, vol. 5, No. 5, 2003, pp. 769-779.;;Feldman, B., et al., ""Correlation of Glucose Concentrations in Interstitial Fluid and Venous Blood During Periods of Rapid Continuous Glucose Change"", Abbott Diabetes Care, Inc. Freestyle Navigator Continous Glucose Monitor Pamphlet, 2004.;;Feldman, B., et al., ""Electron Transfer Kinetics at Redox Polymer/Solution Interfaces Using Microelectrodes and Twin Electrode Thin Layer Cells"", Journal of ElectroAnalytical Chemistry, vol. 194, 1985, pp. 63-81.;;Fischer, H., et al., ""Intramolecular Electron Transfer Medicated by 4,4'-Bypyridine and Related Bridging Groups"", Journal of the American Chemical Society, vol. 98, No. 18, 1976, pp. 5512-5517.;;Flentge, F., et al., ""An Enzyme-Reactor for Electrochemical Monitoring of Choline and Acetylcholine: Applications in High-Performance Liquid Chromatography, Bran Tissue, Microdialysis and Cerebrospinal Fluid,"" Analytical Biochemistry, vol. 204, 1992, pp. 305-310.;;Foulds, N. C., et al., ""Enzyme Entrapment in Electrically Conducting Polymers: Immobilisation of Glucose Oxidase in Polypyrrole and its Application in Amperometric Glucose Sensors"", Journal of the Chemical Society, Faraday Transactions 1, vol. 82, 1986, pp. 1259-1264.;;Foulds, N. C., et al , ""Immobilization of Glucose Oxidase in Ferrocene-Modified Pyrrole Polymers"", Analytical Chemistry, vol. 60, No. 22, 1988, pp. 2473-2478.;;Frew, J. E., et al., ""Electron-Transfer Biosensors"", Philosophical Transactions of The Royal Society of London, vol. 316, 1987, pp. 95-106.;;Frohnauer, M. K., et al., ""Graphical Human Insulin Time-Activity Profiles Using Standardized Definitions"", Diabetes Technology & Therapeutics, vol. 3, No. 3, 2001, pp. 419-429.;;Frost, M. C., et al., ""Implantable Chemical Sensors for Real-Time Clinical Monitoring: Progress and Challenges"", Current Opinion in Chemical Biology, vol. 6, 2002, pp. 633-641.;;Garg, S. K., et al., ""Correlation of Fingerstick Blood Glucose Measurements with GlucoWatch Biographer Glucose Results in Young Subjects with Type 1 Diabetes"", Diabetes Care, vol. 22, No. 10, 1999, pp. 1708-1714.;;Garg, S. K., et al., ""Improved Glucose Excursions Using an Implantable Real-Time Continous Glucose Sensor in Adults with Type 1 Diabetes"", Diabetes Care, vol. 27, No. 3, 2004, pp. 734-738.;;Geller, R. L., et al., ""Use of an Immunoisolation Device for Cell Transplantation and Tumor Immunotherapy"", Annals of the New York Academy of Sciences, vol. 831, 1997, pp. 438-451.",EXPIRED
199,US,B2,US 8255031 B2,131-717-694-988-349,2012-08-28,2012,US 40556809 A,2009-03-17,US 40556809 A;;US 42005703 A;;US 66719900 A;;US 7067798 A,1998-04-30,Analyte monitoring device and methods of use,"An analyte monitor includes a sensor, a sensor control unit, and a display unit. The sensor has, for example, a substrate, a recessed channel formed in the substrate, and conductive material disposed in the recessed channel to form a working electrode. The sensor control unit typically has a housing adapted for placement on skin and is adapted to receive a portion of an electrochemical sensor. The sensor control unit also includes two or more conductive contacts disposed on the housing and configured for coupling to two or more contact pads on the sensor. A transmitter is disposed in the housing and coupled to the plurality of conductive contacts for transmitting data obtained using the sensor. The display unit has a receiver for receiving data transmitted by the transmitter of the sensor control unit and a display coupled to the receiver for displaying an indication of a level of an analyte. The analyte monitor may also be part of a drug delivery system to alter the level of the analyte based on the data obtained using the sensor.",SAY JAMES;;TOMASCO MICHAEL F;;HELLER ADAM;;GAL YORAM;;ARIA BEHRAD;;HELLER EPHRAIM;;PLANTE PHILLIP JOHN;;VREEKE MARK S;;FRIEDMAN KEITH A;;COLMAN FREDRIC C;;ABBOTT DIABETES CARE INC,SAY JAMES;;TOMASCO MICHAEL F;;HELLER ADAM;;GAL YORAM;;ARIA BEHRAD;;HELLER EPHRAIM;;PLANTE PHILLIP JOHN;;VREEKE MARK S;;FRIEDMAN KEITH A;;COLMAN FREDRIC C,,https://lens.org/131-717-694-988-349,Granted Patent,yes,112,0,211,221,0,A61B5/14532;;A61B5/14532;;A61B5/0002;;A61B5/0002;;A61B5/002;;A61B5/01;;A61B5/14503;;A61B5/1451;;A61B5/14546;;A61B5/14546;;A61B5/1473;;A61B5/1473;;A61B5/1486;;A61B5/1486;;A61B5/14865;;A61B5/1495;;A61B5/4839;;A61B5/72;;A61B5/7278;;A61B5/7282;;A61B5/7405;;A61B5/743;;A61B5/7445;;A61B5/7445;;A61B5/7455;;A61B2560/0252;;A61B2560/0252;;A61M5/1723;;C12Q1/54;;G16H10/40;;G16H10/40;;G16H20/17;;G16H20/17;;H01L23/3107;;H01L23/3107;;H01L23/49548;;H01L23/49548;;H01L2924/0002;;H01L2924/0002;;H01L2924/19041;;H01L2924/19041;;H01L2924/3011;;H01L2924/3011;;Y10S128/903;;Y10S128/903;;Y10T29/49;;Y10T29/49;;Y10T29/49124;;Y10T29/49124,A61B5/05;;G01N27/30;;A61B5/00;;A61B5/145;;A61B5/1477;;A61B5/1495;;G01N27/416;;G06F19/00;;H01L23/31;;H01L23/495,600/345;;600/347;;600/365,99,81,136-791-935-548-81X;;062-360-289-025-864;;010-601-725-111-91X;;101-292-518-663-191;;056-703-879-057-297;;030-155-762-644-019;;004-149-141-436-651;;016-731-054-793-457;;080-559-561-995-335;;044-807-213-528-815;;027-538-525-436-179;;015-020-161-517-40X;;025-919-454-564-785;;014-700-576-603-812;;004-851-060-590-788;;075-958-432-122-199;;052-356-140-149-389;;035-090-282-884-790;;033-562-815-299-181;;018-803-926-589-211;;008-505-762-041-402;;016-601-143-530-813;;019-502-772-562-215;;058-476-824-396-350;;006-498-707-073-30X;;054-091-551-638-293;;010-531-147-771-746;;054-827-198-877-419;;122-658-944-077-000;;017-261-560-469-37X;;000-125-755-474-124;;113-381-664-783-802;;082-626-907-191-554;;017-950-014-792-456;;090-348-305-613-628;;015-985-399-299-132;;171-049-047-164-618;;016-819-089-891-758;;081-249-097-078-543;;089-612-747-111-646;;031-706-897-890-035;;094-198-536-559-723;;003-690-143-043-420;;007-943-354-378-456;;082-114-500-909-975;;004-239-090-971-580;;026-894-457-160-450;;077-128-610-778-669;;022-466-506-956-898;;008-424-592-956-946;;007-500-825-916-378;;009-725-244-669-882;;037-755-689-613-42X;;153-411-506-517-475;;038-134-360-685-692;;012-449-714-188-064;;031-517-704-996-130;;131-299-284-996-064;;049-133-049-742-708;;000-272-178-768-076;;070-797-683-833-124;;043-870-224-178-49X;;025-574-914-238-550;;052-364-430-129-757;;004-434-167-910-115;;032-860-147-271-886;;132-460-374-211-421;;098-172-374-375-47X;;109-358-955-476-095;;014-988-634-483-130;;061-786-187-274-992;;037-898-018-686-909;;130-044-667-529-69X;;134-265-642-839-645;;065-221-074-461-027;;017-934-465-161-477;;101-660-130-379-529;;028-236-706-290-220;;087-333-189-994-274;;059-082-211-027-266;;057-977-752-782-568,10.1016/s0956-5663(02)00099-4;;12392956;;10.1021/ja00391a001;;2889225;;10.1098/rstb.1987.0021;;10.1109/51.294001;;10.1016/0022-0728(65)85063-x;;2245876;;10.2337/diabetes.39.12.1519;;10.2337/diab.39.12.1519;;10.1016/s0956-5663(03)00220-3;;14611755;;18615658;;10.1002/bit.260430310;;9366023;;10.1016/s0956-5663(97)00025-0;;9451795;;10.1016/s0956-5663(97)00083-3;;10.1016/0956-5663(93)80028-n;;8311939;;8651496;;10.1021/ac960030d;;10.1080/03091900210156797;;12487712;;10.1016/0265-928x(87)80018-4;;3333622;;10.1109/19.816143;;10.1007/bf01015979;;10.1089/15209150252924058;;12017416;;18473691;;10.1089/dia.2007.0281;;10.1021/ac00017a008;;1789439;;2817408;;10.1021/ac00197a022;;10.1016/0925-4005(95)01730-5;;10.1016/0010-4825(90)90013-f;;2257734;;2868172;;8277748;;10.1016/0141-5425(93)90058-7;;11469630;;10.1089/15209150050214104;;10624783;;10.1016/s0168-8227(99)00113-8;;10.1089/15209150050214113;;11469631;;10.1007/bf00401374;;1478372;;10.2337/diacare.20.1.64;;9028696;;10.1109/tbme.1986.325807;;3957374;;236018;;10.1016/0005-2795(75)90259-7;;10.1089/hum.1998.9.6-879;;9581910;;11762520;;10.1089/15209150152607196;;10.2337/diabetes.48.3.445;;10078542;;10.1016/0265-928x(87)80012-3;;505005;;10.1126/science.505005;;10.1021/ac0498516;;15253640;;10.1109/10.284922;;8026845;;6721151;;10.1021/ac00268a018;;6733082;;10.1021/bi00305a016;;10.1515/cclm.2002.135;;12392305;;10.1016/j.ecl.2003.12.001;;15053902;;12052350;;10.1016/s0956-5663(01)00304-9;;12052349;;10.1016/s0956-5663(01)00306-2;;4500021;;10.1007/978-1-4684-3288-6_18;;14021529;;10.1111/j.1749-6632.1962.tb13623.x;;3196517;;10.2337/diacare.10.5.622;;3677983;;10.2337/diacare.8.6.529;;4075939;;10.1002/elan.1140061103;;7733469;;10.1021/ac00103a015;;7978306;;10.1021/ac00091a022;;10.1007/bf01248238;;10.1016/s0376-7388(98)00330-5;;10.1016/0142-9612(92)90147-g;;1472593;;10.1016/0265-928x(85)80002-x;;10.1021/j100290a001;;10.1021/ja00216a040;;10.1021/ja00188a091;;10.1021/ja00406a011;;2624333;;12323417;;10.1016/s0165-0270(02)00170-x;;10.1177/193229680700100208;;pmc2771467;;19888405;;10.1021/ja00415a014;;10.1007/bf00575392;;10.1021/ac00250a038;;10.1021/ac00266a005;;10.1007/s00216-002-1284-0;;12194035;;10.1089/dia.2006.0030;;17705688;;9642777;;10.1016/s0956-5663(97)00091-2;;10.1089/152091503322526978;;14633342;;10.1016/0022-0728(85)87006-6;;10.1021/ja00434a018;;10.1016/0003-2697(92)90243-z;;1443528;;10.1039/f19868201259;;3245585;;10.1021/ac00173a008;;2889234;;10.1098/rstb.1987.0020;;11762521;;10.1089/15209150152607204;;12413548;;10.1016/s1367-5931(02)00371-x;;10526740;;10.2337/diacare.22.10.1708;;14988294;;10.2337/diacare.27.3.734,"""Poretics Polycarbonate Membrane"", Osmonics Filtration and Separation Group, 2002.;;Abel, P. U., et al., ""Biosensors for In Vivo Glucose Measurement: Can We Cross the Experimental Stage"", Biosensors and Bioelectronics, vol. 17, 2002, pp. 1059-1070.;;Abruna, H. D., et al., ""Rectifying Interfaces Using Two-Layer Films of Electrochemically Polymerized Vinylpyridine and Vinylbipyridine Complexes of Ruthenium and Iron on Electrodes"", Journal of the American Chemical Society, vol. 103, No. 1, 1981, pp. 1-5.;;Albery, W. J., et al., ""Amperometric Enzyme Electrodes Part II: Conducting Salts as Electrode Materials for the Oxidation of Glucose Oxidase"", Journal of ElectroAnalytical Chemistry, vol. 194, 1985, pp. 223-235.;;Albery, W. J., et al., ""Amperometric Enzyme Electrodes"", Philosophical Transactions of The Royal Society of London, vol. 316, 1987, pp. 107-119.;;Alcock, S. J., et al., ""Continuous Analyte Monitoring to Aid Clinical Practice"", IEEE Engineering in Medicine and Biology Magazine, 1994, pp. 319-325.;;Anderson, L. B., et al., ""Thin-Layer Electrochemistry: Steady-State Methods of Studying Rate Processes"", Journal of ElectroAnalytical Chemistry, vol. 10, 1965, pp. 295-305.;;Armour, J. C., et al., ""Application of Chronic Intravascular Blood Glucose Sensor in Dogs"", Diabetes, vol. 39, 1990, pp. 1519-1526.;;Asberg, P., et al., ""Hydrogels of a Conducting Conjugated Polymer as 3-D Enzyme Electrode"", Biosensors & Bioelectronics, vol. 19, 2003, pp. 199-207.;;Atanasov, P., et al., ""Biosensor for Continuous Glucose Monitoring"", Biotechnology and Bioengineering, vol. 43, 1994, pp. 262-266.;;Atanasov, P., et al., ""Implantation of a Refillable Glucose Monitoring-Telemetry Device"", Biosensors & Bioelectronics, vol. 12, No. 7, 1997, pp. 669-680.;;Aussedat, B., et al., ""A User-Friendly Method for Calibrating a Subcutaneous Glucose Sensor-Based Hypoglycaemic Alarm"", Biosensors & Bioelectronics, vol. 12, No. 11, 1997, pp. 1061-1071.;;Baker, D. A., et al., ""Dynamic Concentration Challenges for Biosensor Characterization"", Biosensors & Bioelectronics, vol. 8, 1993, pp. 433-441.;;Baker, D. A., et al., ""Dynamic Delay and Maximal Dynamic Error in Continuous Biosensors"", Analytical Chemistry, vol. 68, No. 8, 1996, pp. 1292-1297.;;Bani Amer, M. M., ""An Accurate Amperometric Glucose Sensor Based Glucometer with Eliminated Cross-Sensitivity"", Journal of Medical Engineering & Technology, vol. 26, No. 5, 2002, pp. 208-213.;;Bard, A. J., et al., Electrochemical Methods, 1980, pp. 173-175.;;Bartlett, P. N., et al., ""Covalent Binding of Electron Relays to Glucose Oxidase"", Journal of the Chemical Society, Chemical Communications, 1987, pp. 1603-1604.;;Bartlett, P. N., et al., ""Modification of Glucose Oxidase by Tetrathiafulvalene"", Journal of the Chemical Society, Chemical Communications, 1990, pp. 1135-1136.;;Bartlett, P. N., et al., ""Strategies for the Development of Amperometric Enzyme Electrodes"", Biosensors, vol. 3, 1987/88, pp. 359-379.;;Beach, R. D., et al., ""Subminiature Implantable Potentiostat and Modified Commercial Telemetry Device for Remote Glucose Monitoring"", IEEE Transactions on Instrumentation and Measurement, vol. 28, No. 6, 1999, pp. 1239-1245.;;Beech, W. A., ""AX.25 Link Access Protocol for Amateur packet Radio"", Tucson Amateur Packet Radio Corporation, 1998, pp. 1-133.;;Bellucci, F., et al., ""Electrochemical Behaviour of Graphite-Epoxy Composite Materials (GECM) in Aqueous Salt Solutions"", Journal of Applied Electrochemistry, vol. 16, 1986, pp. 15-22.;;Bennion, N., et al., ""Alternate Site Glucose Testing: A Crossover Design"", Diabetes Technology & Therapeutics, vol. 4, No. 1, 2002, pp. 25-33.;;Biermann, E., et al., ""How Would Patients Behave if They Were Continually Informed of Their Blood Glucose Levels? A Simulation Study Using a 'Virtual' Patient"", Diabetes Technology & Therapeutics, vol. 10, No. 3, 2008, pp. 178-187.;;Bindra, D. S., et al., ""Design and in Vitro Studies of a Needle-Type Glucose Sensor for Subcutaneous Monitoring"", Analytical Chemistry, vol. 63, No. 17, 1991, pp. 1692-1696.;;Bindra, D. S., et al., ""Pulsed Amperometric Detection of Glucose in Biological Fluids at a Surface-Modified Gold Electrode"", Analytical Chemistry, vol. 61, No. 22, 1989, pp. 2566-2570.;;Bisenberger, M., et al., ""A Triple-Step Potential Waveform at Enzyme Multisensors with Thick-Film Gold Electrodes for Detection of Glucose and Sucrose"", Sensors and Actuators B, vol. 28, 1995, pp. 181-189.;;Bland, J. M., et al., ""A Note on the Use of the Intraclass Correlation Coefficient in the Evaluation of Agreement Between Two Methods of Measurement"", Computers in Biology and Medicine, vol. 20, No. 5, 1990, pp. 337-340.;;Bland, J. M., et al., ""Statistical Methods for Assessing Agreement Between Two Methods of Clinical Measurement"", The Lancet, 1986, pp. 307-310.;;Blank, T. B., et al., ""Clinical Results From a Non-Invasive Blood Glucose Monitor"", Optical Diagnostics and Sensing of Biological Fluids and Glucose and Cholesterol Monitoring II, Proceedings of SPIE, vol. 4624, 2002, pp. 1-10.;;Bobbioni-Harsch, E., et al., ""Lifespan of Subcutaneous Glucose Sensors and Their Performances During Dynamic Glycaemia Changes in Rats"", Journal of Biomedical Engineering, vol. 15, 1993, pp. 457-463.;;Bode, B. W., ""Clinical Utility of the Continuous Glucose Monitoring System"", Diabetes Technology & Therapeutics, vol. 2, Sup. 1, 2000, pp. S35-S41.;;Bode, B. W., et al., ""Continuous Glucose Monitoring Used to Adjust Diabetes Therapy Improves Glycosylated Hemoglobin: A Pilot Study"", Diabetes Research and Clinical Practice, vol. 46, 1999, pp. 183-190.;;Bode, B. W., et al., ""Using the Continuous Glucose Monitoring System to Improve the Management of Type I Diabetes"", Diabetes Technology & Therapeutics, vol. 2, Sup. 1, 2000, pp. S43-S48.;;Boedeker Plastics, Inc., ""Polyethylene Specifications"", Web Page of Boedeker.com, 2007, pp. 1-3.;;Bolinder, J., et al., ""Microdialysis Measurement of the Absolute Glucose Concentration in Subcutaneous Adipose Tissue Allowing Glucose Monitoring in Diabetic Patients"", Diabetologia, vol. 35, 1992, pp. 1177-1180.;;Bolinder, J., et al., ""Self-Monitoring of Blood Glucose in Type I Diabetic Patients: Comparison with Continuous Microdialysis Measurements of Glucose in Subcutaneous Adipose Tissue During Ordinary Life Conditions"", Diabetes Care, vol. 20, No. 1, 1997, pp. 64-70.;;Bott, A. W., ""A Comparison of Cyclic Voltammetry and Cyclic Staircase Voltammetry"", Current Separations, vol. 16, No. 1, 1997, pp. 23-26.;;Bott, A. W., ""Electrochemical Methods for the Determination of Glucose"", Current Separations, vol. 17, No. 1, 1998, pp. 25-31.;;Bowman, L., et al., ""The Packaging of Implantable Integrated Sensors"", IEEE Transactions on Biomedical Engineering, vol. 33, No. 2, 1986, pp. 248-255.;;Brandt, J., et al., ""Covalent Attachment of Proteins to Polysaccharide Carriers by Means of Benzoquinone"", Biochimica et Biophysica Acta, vol. 386, 1975, pp. 196-202.;;Brauker, J., et al., ""Sustained Expression of High Levels of Human Factor IX from Human Cells Implanted Within an Immunoisolation Device into Athymic Rodents"", Human Gene Therapy, vol. 9, No. 6, 1998, pp. 879-888.;;Bremer, T. M., et al., ""Benchmark Data from the Literature for Evaluation of New Glucose Sensing Technologies"", Diabetes Technology & Therapeutics, vol. 3, No. 3, 2001, pp. 409-418.;;Bremer, T., et al., ""Is Blood Glucose Predictable from Previous Values?"", Diabetes, vol. 48, 1999, pp. 445-451.;;Brooks, S. L., et al., ""Development of an On-Line Glucose Sensor for Fermentation Monitoring"", Biosensors, vol. 3, 1987/88, pp. 45-56.;;Brownlee, M., et al., ""A Glucose-Controlled Insulin-Delivery System: Semisynthetic Insulin Bound to Lectin"", Science, vol. 206, 1979, 1190-1191.;;Cai, Q., et al., ""A Wireless, Remove Query Glucose Biosensor Based on a pH-Sensitive Polymer"", Analytical Chemistry, vol. 76, No. 14, 2004, pp. 4038-4043.;;Candas, B., et al., ""An Adaptive Plasma Glucose Controller Based on a Nonlinear Insulin/Glucose Model"", IEEE Transactions on Biomedical Engineering, vol. 41, No. 2, 1994, pp. 116-124.;;Cass, A. E., et al., ""Ferricinum Ion As an Electron Acceptor for Oxido-Reductases"", Journal of ElectroAnalytical Chemistry, vol. 190, 1985, pp. 117-127.;;Cass, A. E., et al., ""Ferrocene-Medicated Enzyme Electrode for Amperometric Determination of Glucose"", Analytical Chemistry, vol. 56, No. 4, 1984, 667-671.;;Castner, J. F., et al., ""Mass Transport and Reaction Kinetic Parameters Determined Electrochemically for Immobilized Glucose Oxidase"", Biochemistry, vol. 23 No. 10, 1984, 2203-2210.;;Chen, J. C., et al., ""A Comparison of MAC Protocols for Wireless Local Networks Based on battery Power Consumption"", IEEE, 1998, pp. 150-157.;;Chen, T., et al., ""Defining the Period of Recovery of the Glucose Concentration After Its Local Perturbation by the Implantation of a Miniature Sensor"", Clinical Chemistry and Laboratory Medicine, vol. 40, No. 8, 2002, pp. 486-489.;;Chia, C. W., et al., ""Glucose Sensors: Toward Closed Loop Insulin Delivery"", Endocrinology and Metabolism Clinics of North America, vol. 33, 2004, pp. 175-195.;;Choleau, C., et al., ""Calibration of a Subcutaneous Amperometric Glucose Sensor Implanted for 7 Days in Diabetic Patients Part 2: Superiority of the One-Point Calibration Method"", Biosensors and Bioelectronics, vol. 17, 2002, pp. 647-654.;;Choleau, C., et al., ""Calibration of a Subcutaneous Amperometric Glucose Sensor Part 1: Effect of Measurement Uncertainties on the Determination of Sensor Sensitivity and Background Current"", Biosensors and Bioelectronics, vol. 17, 2002, pp. 641-646.;;Claremont, D. J., et al., ""Biosensors for Continuous In Vivo Glucose Monitoring"", Proceedings of the Annual International Conference of the IEEE Engineering in Medicine and Biology Society, vol. 10, 1988.;;Clark Jr., L. C., et al., ""Differential Anodic Enzyme Polarography for the Measurement of Glucose"", Oxygen Transport to Tissue: Instrumentation, Methods, and Physiology, 1973, pp. 127-133.;;Clark Jr., L. C., et al., ""Electrode Systems for Continuous Monitoring in Cardiovascular Surgery"", Annals New York Academy of Sciences, 1962, pp. 29-45.;;Clark Jr., L. C., et al., ""Long-term Stability of Electroenzymatic Glucose Sensors Implanted in Mice"", American Society of Artificial Internal Organs Transactions, vol. XXXIV, 1988, pp. 259-265.;;Clarke, W. L., et al., ""Evaluating Clinical Accuracy of Systems for Self-Monitoring of Blood Glucose"", Diabetes Care, vol. 10, No. 5, 1987, pp. 622-628.;;Complaint, ""Abbott Diabetes Care, Inc. v. Dexcom, Inc."", filed Aug. 11, 2005.;;Complaint, Amended, ""Abbott Diabetes Care, Inc. v. Dexcom, Inc."", filed Jun. 27, 2006.;;Cox, D. J., et al., ""Accuracy of Perceiving Blood Glucose in IDDM"", Diabetes Care, vol. 8, No. 6, 1985, pp. 529-536.;;Csoregi, E., et al., ""Amperometric Microbiosensors for Detection of Hydrogen Peroxide and Glucose Based on Peroxidase-Modified Carbon Fibers"", Electroanalysis, vol. 6, 1994, pp. 925-933.;;Csoregi, E., et al., ""Design and Optimization of a Selective Subcutaneously Implantable Glucose Electrode Based on 'Wired' Glucose Oxidase"", Analytical Chemistry, vol. 67, No. 7, 1995, pp. 1240-1244.;;Csoregi, E., et al., ""Design, Characterization, and One-Point in Vivo Calibration of a Subcutaneously Implanted Glucose Electrode"", Analytical Chemistry, vol. 66 No. 19, 1994, pp. 3131-3138.;;Csoregi, E., et al., ""On-Line Glucose Monitoring by Using Microdialysis Sampling and Amperometric Detection Based on 'Wired' Glucose Oxidase in Carbon Paste"", Mikrochimica Acta, vol. 121, 1995, pp. 31-40.;;D'Arrigo, G., et al., ""Porous-Si Based Bio Reactors for Glucose Monitoring and Drugs Production"", Proceedings of SPIE: Microfluids, BioMEMS, and Medical Microsystems, vol. 4982, 2003, pp. 178-184.;;Dai, W. S., et al., ""Hydrogel Membranes with Mesh Size Asymmetry Based on the Gradient Crosslinking of Poly(vinyl alcohol),"" Journal of Membrane Science, vol. 156, 1999, pp. 67-79.;;Davies, M. L., et al., ""Polymer Membranes in Clinical Sensor Applications"", Biomaterials, vol. 13, No. 14, 1992, pp. 971-978.;;Davis, G., ""Electrochemical Techniques for the Development of Amperometric Biosensors"", Biosensors, vol. 1, 1985, pp. 161-178.;;Degani, Y., et al., ""Direct Electrical Communication Between Chemically Modified Enzymes and Metal Electrodes. 1. Electron Transfer from Glucose Oxidase to Metal Electrodes via Electron Relays, Bound Covalently to the Enzyme"", The Journal of Physical Chemistry, vol. 91, No. 6, 1987, pp. 1285-1289.;;Degani, Y., et al., ""Direct Electrical Communication Between Chemically Modified Enzymes and Metal Electrodes. 2. Methods for Bonding Electron-Transfer Relays to Glucose Oxidase and D-Amino-Acid Oxidase"", Journal of the American Chemical Society, vol. 110, No. 8, 1988, pp. 2615-2620.;;Degani, Y., et al., ""Electrical Communication Between Redox Centers of Glucose Oxidase and Electrodes via Electrostatically and Covalently Bound Redox Polymers"", Journal of the American Chemical Society, vol. 111, 1989, pp. 2357-2358.;;Denisevich, P., et al., ""Unidirectional Current Flow and Charge State Trapping at Redox Polymer Interfaces on Bilayer Electrodes: Principles, Experimental Demonstration, and Theory"", Journal of the American Chemical Society, vol. 103, 1981, pp. 4727-4737.;;Dicks, J. M., et al., ""Ferrocene Modified Polypyrrole with Immobilised Glucose Oxidase and its Application in Amperometric Glucose Microbiosensors"", Annales de Biologie Clinique, vol. 47, 1989, pp. 607-619.;;Dixon, B. M., et al., ""Characterization In Vitro and In Vivo of the Oxygen Dependence of an Enzyme/Polymer Biosensors for Monitoring Brain Glucose"", Journal of Neuroscience Methods, vol. 119, 2002, pp. 135-142.;;Eighth Annual Diabetes Technology Meeting Abstracts, Nov. 13-15, 2008, pp. A1-A182.;;El-Khatib, F. H, et al., ""Adaptive Closed-Loop Control Provides Blood-Glucose Regulation Using Subcutaneous Insulin and Glucagon Infusion in Diabetic Swine"", Journal of Diabetes Science and Technology, vol. 1, No. 2, 2007, pp. 181-192.;;Ellis, C. D., et al., ""Selectivity and Directed Charge Transfer through an Electroactive Metallopolymer Film"", Journal of the American Chemical Society, vol. 103, No. 25, 1981, pp. 7480-7483.;;El-Sa'Ad, L., et al., ""Moisture Absorption by Epoxy Resins: The Reverse Thermal Effect"", Journal of Materials Science, vol. 25, No. 8, 1990, pp. 3577-3582.;;Engstrom, R. C., ""Electrochemical Pretreatment of Glassy Carbon Electrodes"", Analytical Chemistry, vol. 54, No. 13, 1982, pp. 2310-2314.;;Engstrom, R. C., et al., ""Characterization of Electrochemically Pretreated Glassy Carbon Electrodes"", Analytical Chemistry, vol. 56, No. 2, 1984, pp. 136-141.;;Ernst, H., et al., ""Reliable Glucose Monitoring Through the Use of Microsystem Technology"", Analytical and Bioanalytical Chemistry, vol. 373, 2002, pp. 758-761.;;Fabietti, P. G., et al. ""Clinical Validation of a New Control-Oriented Model of Insulin and Glucose Dynamics in Subjects with Type 1 Diabetes"", Diabetes Technology & Therapeutics, vol. 9 No. 4, 2007, pp. 327-338.;;Fare, T. L., et al., ""Functional Characterization of a Conducting Polymer-Based Immunoassay System"", Biosensors & Bioelectronics, vol. 13, No. 3-4, 1998, pp. 459-470.;;Feldman, B., et al., ""A Continuous Glucose Sensor Based on Wired Enzyme(TM) Technology-Results from a 3-Day Trial in Patients with Type 1 Diabetes"", Diabetes Technology & Therapeutics, vol. 5, No. 5, 2003, pp. 769-779.;;Feldman, B., et al., ""Correlation of Glucose Concentrations in Interstitial Fluid and Venous Blood During Periods of Rapid Glucose Change"", Abbott Diabetes Care, Inc. Freestyle Navigator Continuous Glucose Monitor Pamphlet, 2004.;;Feldman, B., et al., ""Electron Transfer Kinetics at Redox Polymer/Solution Interfaces Using Microelectrodes and Twin Electrode Thin Layer Cells"", Journal of ElectroAnalytical Chemistry, vol. 194, 1985, pp. 63-81.;;Fischer, H., et al., ""Intramolecular Electron Transfer Medicated by 4,4'-Bypyridine and Related Bridging Groups"", Journal of the American Chemical Society, vol. 98, No. 18, 1976, pp. 5512-5517.;;Flentge, F., et al., ""An Enzyme-Reactor for Electrochemical Monitoring of Choline and Acetylcholine: Applications in High-Performance Liquid Chromatography, Bran Tissue, Microdialysis and Cerebrospinal Fluid,"" Analytical Biochemistry, vol. 204, 1992, pp. 305-310.;;Foulds, N. C., et al., ""Enzyme Entrapment in Electrically Conducting Polymers: Immobilisation of Glucose Oxidase in Polypyrrole and its Application in Amperometric Glucose Sensors"", Journal of the Chemical Society, Faraday Transactions 1, vol. 82, 1986, pp. 1259-1264.;;Foulds, N. C., et al , ""Immobilization of Glucose Oxidase in Ferrocene-Modified Pyrrole Polymers"", Analytical Chemistry, vol. 60, No. 22, 1988, pp. 2473-2478.;;Frew, J. E., et al., ""Electron-Transfer Biosensors"", Philosophical Transactions of The Royal Society of London, vol. 316, 1987, pp. 95-106.;;Frohnauer, M. K., et al., ""Graphical Human Insulin Time-Activity Profiles Using Standardized Definitions"", Diabetes Technology & Therapeutics, vol. 3, No. 3, 2001, pp. 419-429.;;Frost, M. C., et al., ""Implantable Chemical Sensors for Real-Time Clinical Monitoring: Progress and Challenges"", Current Opinion in Chemical Biology, vol. 6, 2002, pp. 633-641.;;Garg, S. K., et al., ""Correlation of Fingerstick Blood Glucose Measurements with GlucoWatch Biographer Glucose Results in Young Subjects with Type 1 Diabetes"", Diabetes Care, vol. 22, No. 10, 1999, pp. 1708-1714.;;Garg, S. K., et al., ""Improved Glucose Excursions Using an Implantable Real-Time Continuous Glucose Sensor in Adults with Type 1 Diabetes"", Diabetes Care, vol. 27, No. 3, 2004, pp. 734-738.",EXPIRED
200,US,B2,US 8641619 B2,165-670-933-617-894,2014-02-04,2014,US 64397709 A,2009-12-21,US 64397709 A;;US 42005703 A;;US 66719900 A;;US 7067798 A,1998-04-30,Analyte monitoring device and methods of use,"An analyte monitor includes a sensor, a sensor control unit, and a display unit. The sensor has, for example, a substrate, a recessed channel formed in the substrate, and conductive material disposed in the recessed channel to form a working electrode. The sensor control unit typically has a housing adapted for placement on skin and is adapted to receive a portion of an electrochemical sensor. The sensor control unit also includes two or more conductive contacts disposed on the housing and configured for coupling to two or more contact pads on the sensor. A transmitter is disposed in the housing and coupled to the plurality of conductive contacts for transmitting data obtained using the sensor. The display unit has a receiver for receiving data transmitted by the transmitter of the sensor control unit and a display coupled to the receiver for displaying an indication of a level of an analyte. The analyte monitor may also be part of a drug delivery system to alter the level of the analyte based on the data obtained using the sensor.",SAY JAMES;;TOMASCO MICHAEL F;;HELLER ADAM;;GAL YORAM;;ARIA BEHRAD;;HELLER EPHRAIM;;PLANTE PHILLIP JOHN;;VREEKE MARK S;;FRIEDMAN KEITH A;;COLMAN FREDRIC C;;ABBOTT DIABETES CARE INC,SAY JAMES;;TOMASCO MICHAEL F;;HELLER ADAM;;GAL YORAM;;ARIA BEHRAD;;HELLER EPHRAIM;;PLANTE PHILLIP JOHN;;VREEKE MARK S;;FRIEDMAN KEITH A;;COLMAN FREDRIC C,E. HELLER & CO (1998-07-02);;ABBOTT DIABETES CARE INC (2000-03-13),https://lens.org/165-670-933-617-894,Granted Patent,yes,108,0,211,221,0,A61B5/14532;;A61B5/14532;;A61B5/0002;;A61B5/0002;;A61B5/002;;A61B5/01;;A61B5/14503;;A61B5/1451;;A61B5/14546;;A61B5/14546;;A61B5/1473;;A61B5/1473;;A61B5/1486;;A61B5/1486;;A61B5/14865;;A61B5/1495;;A61B5/4839;;A61B5/72;;A61B5/7278;;A61B5/7282;;A61B5/7405;;A61B5/743;;A61B5/7445;;A61B5/7445;;A61B5/7455;;A61B2560/0252;;A61B2560/0252;;A61M5/1723;;C12Q1/54;;G16H10/40;;G16H10/40;;G16H20/17;;G16H20/17;;H01L23/3107;;H01L23/3107;;H01L23/49548;;H01L23/49548;;H01L2924/0002;;H01L2924/0002;;H01L2924/19041;;H01L2924/19041;;H01L2924/3011;;H01L2924/3011;;Y10S128/903;;Y10S128/903;;Y10T29/49;;Y10T29/49;;Y10T29/49124;;Y10T29/49124,A61B5/00;;G01N27/30;;A61B5/05;;A61B5/145;;A61B5/1477;;A61B5/1495;;C12Q1/54;;G01N27/416;;G06F19/00;;H01L23/31;;H01L23/495,600/365;;600/347;;422/50,99,81,136-791-935-548-81X;;062-360-289-025-864;;010-601-725-111-91X;;101-292-518-663-191;;056-703-879-057-297;;030-155-762-644-019;;004-149-141-436-651;;016-731-054-793-457;;080-559-561-995-335;;044-807-213-528-815;;027-538-525-436-179;;015-020-161-517-40X;;025-919-454-564-785;;014-700-576-603-812;;004-851-060-590-788;;075-958-432-122-199;;052-356-140-149-389;;035-090-282-884-790;;033-562-815-299-181;;018-803-926-589-211;;008-505-762-041-402;;016-601-143-530-813;;019-502-772-562-215;;058-476-824-396-350;;006-498-707-073-30X;;054-091-551-638-293;;010-531-147-771-746;;054-827-198-877-419;;122-658-944-077-000;;017-261-560-469-37X;;000-125-755-474-124;;113-381-664-783-802;;082-626-907-191-554;;017-950-014-792-456;;090-348-305-613-628;;015-985-399-299-132;;171-049-047-164-618;;016-819-089-891-758;;081-249-097-078-543;;089-612-747-111-646;;031-706-897-890-035;;094-198-536-559-723;;003-690-143-043-420;;007-943-354-378-456;;082-114-500-909-975;;004-239-090-971-580;;026-894-457-160-450;;077-128-610-778-669;;022-466-506-956-898;;008-424-592-956-946;;007-500-825-916-378;;009-725-244-669-882;;037-755-689-613-42X;;153-411-506-517-475;;038-134-360-685-692;;012-449-714-188-064;;031-517-704-996-130;;131-299-284-996-064;;049-133-049-742-708;;000-272-178-768-076;;070-797-683-833-124;;043-870-224-178-49X;;025-574-914-238-550;;052-364-430-129-757;;004-434-167-910-115;;032-860-147-271-886;;132-460-374-211-421;;098-172-374-375-47X;;109-358-955-476-095;;014-988-634-483-130;;061-786-187-274-992;;037-898-018-686-909;;130-044-667-529-69X;;134-265-642-839-645;;065-221-074-461-027;;017-934-465-161-477;;101-660-130-379-529;;028-236-706-290-220;;087-333-189-994-274;;059-082-211-027-266;;057-977-752-782-568,10.1016/s0956-5663(02)00099-4;;12392956;;10.1021/ja00391a001;;2889225;;10.1098/rstb.1987.0021;;10.1109/51.294001;;10.1016/0022-0728(65)85063-x;;2245876;;10.2337/diabetes.39.12.1519;;10.2337/diab.39.12.1519;;10.1016/s0956-5663(03)00220-3;;14611755;;18615658;;10.1002/bit.260430310;;9366023;;10.1016/s0956-5663(97)00025-0;;9451795;;10.1016/s0956-5663(97)00083-3;;10.1016/0956-5663(93)80028-n;;8311939;;8651496;;10.1021/ac960030d;;10.1080/03091900210156797;;12487712;;10.1016/0265-928x(87)80018-4;;3333622;;10.1109/19.816143;;10.1007/bf01015979;;10.1089/15209150252924058;;12017416;;18473691;;10.1089/dia.2007.0281;;10.1021/ac00017a008;;1789439;;2817408;;10.1021/ac00197a022;;10.1016/0925-4005(95)01730-5;;10.1016/0010-4825(90)90013-f;;2257734;;2868172;;8277748;;10.1016/0141-5425(93)90058-7;;11469630;;10.1089/15209150050214104;;10624783;;10.1016/s0168-8227(99)00113-8;;10.1089/15209150050214113;;11469631;;10.1007/bf00401374;;1478372;;10.2337/diacare.20.1.64;;9028696;;10.1109/tbme.1986.325807;;3957374;;236018;;10.1016/0005-2795(75)90259-7;;10.1089/hum.1998.9.6-879;;9581910;;11762520;;10.1089/15209150152607196;;10.2337/diabetes.48.3.445;;10078542;;10.1016/0265-928x(87)80012-3;;505005;;10.1126/science.505005;;10.1021/ac0498516;;15253640;;10.1109/10.284922;;8026845;;6721151;;10.1021/ac00268a018;;6733082;;10.1021/bi00305a016;;10.1515/cclm.2002.135;;12392305;;10.1016/j.ecl.2003.12.001;;15053902;;12052350;;10.1016/s0956-5663(01)00304-9;;12052349;;10.1016/s0956-5663(01)00306-2;;4500021;;10.1007/978-1-4684-3288-6_18;;14021529;;10.1111/j.1749-6632.1962.tb13623.x;;3196517;;10.2337/diacare.10.5.622;;3677983;;10.2337/diacare.8.6.529;;4075939;;10.1002/elan.1140061103;;7733469;;10.1021/ac00103a015;;7978306;;10.1021/ac00091a022;;10.1007/bf01248238;;10.1016/s0376-7388(98)00330-5;;10.1016/0142-9612(92)90147-g;;1472593;;10.1016/0265-928x(85)80002-x;;10.1021/j100290a001;;10.1021/ja00216a040;;10.1021/ja00188a091;;10.1021/ja00406a011;;2624333;;12323417;;10.1016/s0165-0270(02)00170-x;;10.1177/193229680700100208;;pmc2771467;;19888405;;10.1021/ja00415a014;;10.1007/bf00575392;;10.1021/ac00250a038;;10.1021/ac00266a005;;10.1007/s00216-002-1284-0;;12194035;;10.1089/dia.2006.0030;;17705688;;9642777;;10.1016/s0956-5663(97)00091-2;;10.1089/152091503322526978;;14633342;;10.1016/0022-0728(85)87006-6;;10.1021/ja00434a018;;10.1016/0003-2697(92)90243-z;;1443528;;10.1039/f19868201259;;3245585;;10.1021/ac00173a008;;2889234;;10.1098/rstb.1987.0020;;11762521;;10.1089/15209150152607204;;12413548;;10.1016/s1367-5931(02)00371-x;;10526740;;10.2337/diacare.22.10.1708;;14988294;;10.2337/diacare.27.3.734,"""Poretics Polycarbonate Membrane"", Osmonics Filtration and Separation Group, 2002.;;Abel, P. U., et al., ""Biosensors for In Vivo Glucose Measurement: Can We Cross the Experimental Stage"", Biosensors and Bioelectronics, vol. 17, 2002, pp. 1059-1070.;;Abruna, H. D., et al., ""Rectifying Interfaces Using Two-Layer Films of Electrochemically Polymerized Vinylpyridine and Vinylbipyridine Complexes of Ruthenium and Iron on Electrodes"", Journal of the American Chemical Society, vol. 103, No. 1, 1981, pp. 1-5.;;Albery, W. J., et al., ""Amperometric Enzyme Electrodes Part II: Conducting Salts as Electrode Materials for the Oxidation of Glucose Oxidase"", Journal of ElectroAnalytical Chemistry, vol. 194, 1985, pp. 223-235.;;Albery, W. J., et al., ""Amperometric Enzyme Electrodes"", Philosophical Transactions of the Royal Society of London, vol. 316, 1987, pp. 107-119.;;Alcock, S. J., et al., ""Continuous Analyte Monitoring to Aid Clinical Practice"", IEEE Engineering in Medicine and Biology Magazine, 1994, pp. 319-325.;;Anderson, L. B., et al., ""Thin-Layer Electrochemistry: Steady-State Methods of Studying Rate Processes"", Journal of ElectroAnalytical Chemistry, vol. 10, 1965, pp. 295-305.;;Armour, J. C., et al., ""Application of Chronic Intravascular Blood Glucose Sensor in Dogs"", Diabetes, vol. 39, 1990, pp. 1519-1526.;;Asberg, P., et al., ""Hydrogels of a Conducting Conjugated Polymer as 3-D Enzyme Electrode"", Biosensors & Bioelectronics, vol. 19, 2003, pp. 199-207.;;Atanasov, P., et al., ""Biosensor for Continuous Glucose Monitoring"", Biotechnology and Bioengineering, vol. 43, 1994, pp. 262-266.;;Atanasov, P., et al., ""Implantation of a Refillable Glucose Monitoring-Telemetry Device"", Biosensors & Bioelectronics, vol. 12, No. 7, 1997, pp. 669-680.;;Aussedat, B., et al., ""A User-Friendly Method for Calibrating a Subcutaneous Glucose Sensor-Based Hypoglycaemic Alarm"", Biosensors & Bioelectronics, vol. 12, No. 11, 1997, pp. 1061-1071.;;Baker, D. A., et al., ""Dynamic Concentration Challenges for Biosensor Characterization"", Biosensors & Bioelectronics, vol. 8, 1993, pp. 433-441.;;Baker, D. A., et al., ""Dynamic Delay and Maximal Dynamic Error in Continuous Biosensors"", Analytical Chemistry, vol. 68, No. 8, 1996, pp. 1292-1297.;;Bani Amer, M. M., ""An Accurate Amperometric Glucose Sensor Based Glucometer with Eliminated Cross-Sensitivity"", Journal of Medical Engineering & Technology, vol. 26, No. 5, 2002, pp. 208-213.;;Bard, A. J., et al., Electrochemical Methods, 1980, pp. 173-175.;;Bartlett, P. N., et al., ""Covalent Binding of Electron Relays to Glucose Oxidase"", Journal of the Chemical Society, Chemical Communications, 1987, pp. 1603-1604.;;Bartlett, P. N., et al., ""Modification of Glucose Oxidase by Tetrathiafulvalene"", Journal of the Chemical Society, Chemical Communications, 1990, pp. 1135-1136.;;Bartlett, P. N., et al., ""Strategies for the Development of Amperometric Enzyme Electrodes"", Biosensors, vol. 3, 1987/88, pp. 359-379.;;Beach, R. D., et al., ""Subminiature Implantable Potentiostat and Modified Commercial Telemetry Device for Remote Monitoring"", IEEE Transactions on Instrumentation and Measurement, vol. 28, No. 6, 1999, pp. 1239-1245.;;Beech, W. A., ""AX.25 Link Access Protocol for Amateur packet Radio"", Tucson Amateur Packet Radio Corporation, 1998, pp. 1-133.;;Bellucci, F., et al., ""Electrochemical Behaviour of Graphite-Epoxy Composite Materials (GECM) in Aqueous Salt Solutions"", Journal of Applied Electrochemistry, vol. 16, 1986, pp. 15-22.;;Bennion, N., et al., ""Alternate Site Glucose Testing: A Crossover Design"", Diabetes Technology & Therapeutics, vol. 4, No. 1, 2002, pp. 25-33.;;Biermann, E., et al., ""How Would Patients Behave if They Were Continually Informed of Their Blood Glucose Levels? A Simulation Study Using a 'Virtual' Patient"", Diabetes Technology & Therapeutics, vol. 10, No. 3, 2008, pp. 178-187.;;Bindra, D. S., et al., ""Design and in Vitro Studies of a Needle-Type Glucose Sensor for Subcutaneous Monitoring"", Analytical Chemistry, vol. 63, No. 17, 1991, pp. 1692-1696.;;Bindra, D. S., et al., ""Pulsed Amperometric Detection of Glucose in Biological Fluids at a Surface-Modified Gold Electrode"", Analytical Chemistry, vol. 61, No. 22, 1989, pp. 2566-2570.;;Bisenberger, M., et al., ""A Triple-Step Potential Waveform at Enzyme Multisensors with Thick-Film Gold Electrodes for Detection of Glucose and Sucrose"", Sensors and Actuators B, vol. 28, 1995, pp. 181-189.;;Bland, J. M., et al., ""A Note on the Use of the Intraclass Correlation Coefficient in the Evaluation of Agreement Between Two Methods of Measurement"", Computers in Biology and Medicine, vol. 20, No. 5, 1990, pp. 337-340.;;Bland, J. M., et al., ""Statistical Methods for Assessing Agreement Between Two Methods of Clinical Measurement"", The Lancet, 1986, pp. 307-310.;;Blank, T. B., et al., ""Clinical Results From a Non-Invasive Blood Glucose Monitor"", Optical Diagnostics and Sensing of Biological Fluids and Glucose and Cholesterol Monitoring II, Proceedings of SPIE, vo. 4624, 2002, pp. 1-10.;;Bobbioni-Harsch, E., et al., ""Lifespan of Subcutaneous Glucose Sensors and Their Performance During Dynamic Glycaemia Changes in Rats"", Journal of Biomedical Engineering, vol. 15, 1993, pp. 457-463.;;Bode, B. W., ""Clinical Utility of the Continuous Glucose Monitoring System"", Diabetes Technology & Therpeutics, vol. 2, Sup. 1, 2000, pp. S35-S41.;;Bode, B. W., et al., ""Continuous Glucose Monitoring Used to Adjust Diabetes Therapy Improves Glycosylated Hemoglobin: A Pilot Study"", Diabetes Research and Clinical Practice, vol. 46, 1999, pp. 183-190.;;Bode, B. W., et al., ""Using the Continuous Glucose Monitoring System to Improve Management of Type I Diabetes"", The Diabetes Technology & Therapeutics, vol. 2, Sup. 1, 2000, pp. S43-S48.;;Boedeker Plastics, Inc., ""Polyethylene Specifications"", Web Page of Boedeker.com, 2007, pp. 1-3.;;Bolinder, J., et al., ""Microdialysis Measurement of the Absolute Glucose Concentration in Subcutaneous Adipose Tissue Allowing Glucose Monitoringin Diabetic Patients"", Diabetologia, vol. 35, 1992, pp. 1177-1180.;;Bolinder, J., et al., ""Self-Monitoring of Blood Glucose in Type I Diabetic Patients: Comparison with Continuous Microdialysis Measurements of Glucose in Subcutaneous Adipose Tissue During Ordinary Life Conditions"", Diabetes Care, vol. 20, No. 1, 1997, pp. 64-70.;;Bott, A. W., ""A Comparison of Cyclic Voltammetry and Cyclic Staircase Voltammetry"", Current Separations, vol. 16, No. 1, 1997, pp. 23-26.;;Bott, A. W., ""Electrochemical Methods for the Determination of Glucose"", Current Separations, vol. 17, No. 1, 1998, pp. 25-31.;;Bowman, L., et al., ""The Packaging of Implantable Integrated Sensors"", IEEE Transactions on Biomedical Engineering, vol. 33, No. 2, 1986, pp. 248-255.;;Brandt, J., et al., ""Covalent Attachment of Proteins to Polysaccharide Carriers by Means of Benzoquinone"", Biochimica et Biophysica Acta, vol. 386, 1975, pp. 196-202.;;Brauker, J., et al., ""Sustained Expression of High Levels of Human Factor IX from Human Cells Implanted Within an Immunoisolation Device into Athymic Rodents"", Human Gene Therapy, vol. 9, No. 6, 1998, pp. 879-888.;;Bremer, T. M., et al., ""Benchmark Data from the Literature for Evaluation of New Glucose Sensing Technologies"", Diabetes Technology & Therapeutics, vol. 3, No. 3, 2001, pp. 409-418.;;Bremer, T., et al., ""Is Blood Glucose Predictable from Previous Values?"", Diabetes, vol. 48, 1999, pp. 445-451.;;Brooks, S. L., et al., ""Development of an On-Line Glucose Sensor for Fermentation Monitoring"", Biosensors, vol. 3, 1987/88, pp. 45-56.;;Brownlee, M., et al., ""A Glucose-Controlled Insulin-Delivery System: Semisynthetic Insulin Bound to Lectin"", Science, vol. 206, 1979, 1190-1191.;;Cai, Q., et al., ""A Wireless, Remove Query Glucose Biosensor Based on a pH-Sensitive Polymer"", Analytical Chemistry, vol. 76, No. 14, 2004, pp. 4038-4043.;;Candas, B., et al., ""An Adaptive Plasma Glucose Controller Based on a Nonlinear Insulin/Glucose Model"", IEEE Transactions on Biomedical Engineering, vol. 41, No. 2, 1994, pp. 116-124.;;Cass, A. E., et al., ""Ferricinum Ion as an Electron Acceptor for Oxido-Reductases"", Journal of ElectroAnalytical Chemistry, vol. 190, 1985, pp. 117-127.;;Cass, A. E., et al., ""Ferrocene-Medicated Enzyme Electrode for Amperometric Determination of Glucose"", Analytical Chemistry, vol. 56, No. 4, 1984, 667-671.;;Castner, J. F., et al., ""Mass Transport and Reaction Kinetic Parameters Determined Electrochemically for Immobilized Glucose Oxidase"", Biochemistry, vol. 23 No. 10, 1984, 2203-2210.;;Chen, J. C., et al., ""A Comparison of MAC Protocols for Wireless Local Networks Based on battery Power Consumption"", IEEE, 1998, pp. 150-157.;;Chen, T., et al., ""Defining the Period of Recovery of the Glucose Concentration After Its Local Perturbation by the Implantation of a Miniature Sensor"", Clinical Chemistry and Laboratory, vol. 40, No. 8, 2002, pp. 486-489.;;Chia, C. W., et al., ""Glucose Sensors: Toward Closed Loop Insulin Delivery"", Endocrinology and Metabolism Clinics of North America, vol. 33, 2004, pp. 175-195.;;Choleau, C., et al., ""Calibration of a Subcutaneous Amperometric Glucose Sensor Implanted for 7 Days in Diabetic Patients Part 2: Superiority of the One-Point Calibration Method"", Biosensors and Bioelectronics, vol. 17, 2002, pp. 647-654.;;Choleau, C., et al., ""Calibration of a Subcutaneous Amperometric Glucose Sensor Part 1: Effect of Measurement Uncertainties on the Determination of Sensor Sensitivity and Background Current"", Biosensors and Bioelectronics, vol. 17, 2002, pp. 641-646.;;Claremont, D. J., et al., ""Biosensors for Continuous In Vivo Glucose Monitoring"", Proceedings of the Annual International Conference of the IEEE Engineering in Medicine and Biology Society, vol. 10, 1988.;;Clark Jr., L. C., et al., ""Differential Anodic Enzyme Polarography for the Measurement of Glucose"", Oxygen Transport to Tissue: Instrumentation, Methods, and Physiology, 1973, pp. 127-133.;;Clark Jr., L. C., et al., ""Electrode Systems for Continuous Monitoring in Cardiovascular Surgery"", Annals New York Academy of Sciences, 1962, pp. 29-45.;;Clark Jr., L. C., et al., ""Long-term Stability of Electroenzymatic Glucose Sensors Implanted in Mice"", American Society of Artificial Internal Organs Transactions, vol. XXXIV, 1988, pp. 259-265.;;Clarke, W. L., et al., ""Evaluating Clinical Accuracy of Systems for Self-Monitoring of Blood Glucose"", Diabetes Care, vol. 10, No. 5, 1987, pp. 622-628.;;Complaint, ""Abbott Diabetes Care, Inc. v. Dexcom, Inc."", filed Aug. 11, 2005.;;Complaint, Amended, ""Abbott Diabetes Care, Inc. v. Dexcom, Inc."", filed Jun. 27, 2006.;;Cox, D. J., et al., ""Accuracy of Perceiving Blood Glucose in IDDM"", Diabetes Care, vol. 8, No. 6, 1985, pp. 529-536.;;Csoregi, E., et al., ""Amperometric Microbiosensors for Detection of Hydrogen Peroxide and Glucose Based on Peroxidase-Modified Carbon Fibers"", Electroanalysis, vol. 6, 1994, pp. 925-933.;;Csoregi, E., et al., ""Design and Optimization of a Selective Subcutaneously Implantable Glucose Electrode Based on 'Wired' Glucose Oxidase"", Analytical Chemistry, vol. 67, No. 7, 1995, pp. 1240-1244.;;Csoregi, E., et al., ""Design, Characterization, and One-Point in Vivo Calibration of a Subcutaneously Implanted Glucose Electrode"", Analytical Chemistry, vol. 66 No. 19, 1994, pp. 3131-3138.;;Csoregi, E., et al., ""On-Line Glucose Monitoring by Using Microdialysis Sampling and Amperometric Detection Based on 'Wired' Glucose Oxidase in Carbon Paste"", Mikrochimica Acta, vol. 121, 1995, pp. 31-40.;;D'Arrigo, G., et al., ""Porous-Si Based Bio Reactors for Glucose Monitoring and Drugs Production"", Proceedings of SPIE: Microfluids, BioMEMS, and Medical Microsystems, vol. 4982, 2003, pp. 178-184.;;Dai, W. S., et al., ""Hydrogel Membranes with Mesh Size Asymmetry Based on the Gradient Crosslinking of Poly(vinyl alcohol),"" Journal of Membrane Science, vol. 156, 1999, pp. 67-79.;;Davies, M. L., et al., ""Polymer Membranes in Clinical Sensor Applications"", Biomaterials, vol. 13 No. 14, 1992, pp. 971-978.;;Davis, G., ""Electrochemical Techniques for the Development of Amperometric Biosensors"", Biosensors, vol. 1, 1985, pp. 161-178.;;Degani, Y., et al., ""Direct Electrical Communication Between Chemically Modified Enzymes and Metal Electrodes. 1. Electron Transfer from Glucose Oxidase to Metal Electrodes via Electron Relays, Bound Covalently to the Enzyme"", The Journal of Physical Chemistry, vol. 91, No. 6, 1987, pp. 1285-1289. .;;Degani, Y., et al., ""Direct Electrical Communication Between Chemically Modified Enzymes and Metal Electrodes. 2. Methods for Bonding Electron-Transfer Relays to Glucose Oxidase and D-Amino-Acid Oxidase"", Journal of the American Chemical Society, vol. 110, No. 8, 1988, pp.2615-2620.;;Degani, Y., et al., ""Electrical Communication Between Redox Centers of Glucose Oxidase and Electrodes via Electrostatically and Covalently Bound Redox Polymers"", Journal of the American Chemical Society, vol. 111, 1989, pp. 2357-2358.;;Denisevich, P., et al., ""Unidirectional Current Flow and Charge State Trapping at Redox Polymer Interfaces on Bilayer Electrodes: Principles, Experimental Demonstration, and Theory"", Journal of the American Chemical Society, vol. 103, 1981, pp. 4727-4737.;;Dicks, J. M., et al., ""Ferrocene Modified Polypyrrole with Immobilised Glucose Oxidase and its Application in Amperometric Glucose Microbiosensors"", Annales de Biologie Clinique, vol. 47, 1989, pp. 607-619.;;Dixon, B. M., et al., ""Characterization In Vitro and In Vivo of the Oxygen Dependence of an Enzyme/Polymer Biosensors for Monitoring Brain Glucose"", Journal of Neuroscience Methods, vol. 119, 2002, pp. 135-142.;;Eighth Annual Diabetes Technology Meeting Abstracts, Nov. 13-15, 2008, pp. A1-A182.;;El-Khatib, F. H, et al., ""Adaptive Closed-Loop Control Provides Blood-Glucose Regulation Using Subcutaneous Insulin and Glucagon Infusion in Diabetic Swine"", Journal of Diabetes Science and Technology, vol. 1, No. 2, 2007, pp. 181-192.;;Ellis, C. D., et al., ""Selectivity and Directed Charge Transfer through an Electroactive Metallopolymer Film"", Journal of the American Chemical Society, vol. 103, No. 25, 1981, pp. 7480-7483.;;El-Sa'Ad, L., et al., ""Moisture Absorption by Epoxy Resins: The Reverse Thermal Effect"", Journal of Materials Science, vol. 25, No. 8, 1990, pp. 3577-3582.;;Engstrom, R. C., ""Electrochemical Pretreatment of Glassy Carbon Electrodes"", Analytical Chemistry, vol. 54, No. 13, 1982, pp. 2310-2314.;;Engstrom, R. C., et al., ""Characterization of Electrochemically Pretreated Glassy Carbon Electrodes"", Analytical Chemistry, vol. 56, No. 2, 1984, pp. 136-141.;;Ernst, H., et al., ""Reliable Glucose Monitoring Through the Use of Microsystem Technology"", Analytical and Bioanalytical Chemistry, vol. 373, 2002, pp. 758-761.;;Fabietti, P. G., et al. ""Clinical Validation of a New Control-Oriented Model of Insulin and Glucose Dynamics in Subjects with Type 1 Diabetes"", Diabetes Technology & Therapeutics, vol. 9 No. 4, 2007, pp. 327-338.;;Fare, T. L., et al., ""Functional Characterization of a Conducting Polymer-Based Immunoassay System"", Biosensors & Bioelectronics, vol. 13, No. 3-4, 1998, pp. 459-470.;;Feldman, B., et al., ""A Continuous Glucose Sensor Based on Wired Enzyme(TM) Technology-Results from a 3-Day Trial in Patients with Type 1 Diabetes"", Diabetes Technology & Therapeutics, vol. 5, No. 5, 2003, pp. 769-779.;;Feldman, B., et al., ""Correlation Glucose Concentrations in Interstitial Fluid and Venous Blood During Periods of Rapid Continuous Glucose Change"", Abbot Diabetes Care, Inv. Freestyle Navigator Continuous Glucose Monitor Pamplet, 2004.;;Feldman, B., et al., ""Electron Transfer Kinetics at Redox Polymer/Solution Interfaces Using Microelectrodes and Twin Electrode Thin Layer Cells"", Journal of ElectroAnalytical Chemistry, vol. 194, 1985, pp. 63-81.;;Fischer, H., et al., ""Intramolecular Electron Transfer Medicated by 4,4'-Bypyridine and Related Bridging Groups"", Journal of the American Chemical Society, vol. 98, No. 18, 1976, pp. 5512-5517.;;Flentge, F., et al., ""An Enzyme-Reactor for Electrochemical Monitoring of Choline and Acetylcholine: Applications in High-Performance Liquid Chromatography, Bran Tissue, Microdialysis and Cerebrospinal Fluid,"" Analytical Biochemistry, vol. 204, 1992, pp. 305-310.;;Foulds, N. C., et al., ""Enzyme Entrapment in Electrically Conducting Polymers: Immobilisation of Glucose Oxidase in Polypyrrole and its Application in Amperometric Glucose Sensors"", Journal of the Chemical Society, Faraday Transactions 1, vol. 82, 1986, pp. 1259-1264.;;Foulds, N. C., et al , ""Immobilization of Glucose Oxidase in Ferrocene-Modified Pyrrole Polymers"", Analytical Chemistry, vol. 60, No. 22, 1988, pp. 2473-2478.;;Frew, J. E., et al., ""Electron-Transfer Biosensors"", Philosophical Transactions of the Royal Society of London, vol. 316, 1987, pp. 95-106.;;Frohnauer, M. K., et al., ""Graphical Human Insulin Time-Activity Profiles Using Standardized Definitions"", Diabetes Technology & Therapeutics, vol. 3, No. 3, 2001, pp. 419-429.;;Frost, M. C., et al., ""Implantable Chemical Sensors for Real-Time Clinical Monitoring: Progress and Challenges"", Current Opinion in Chemical Biology, vol. 6, 2002, pp. 633-641.;;Garg, S. K., et al., ""Correlation of Fingerstick Blood Glucose Measurements with GlucoWatch Biographer Glucose Results in Young Subjects with Type 1 Diabetes"", Diabetes Care, vol. 22, No. 10, 1999, pp. 1708-1714.;;Garg, S. K., et al., ""Improved Glucose Excursions Using an Implantable Real-Time Continuous Glucose Sensor in Adults with 7 Type 1 Diabetes"", Diabetes Care, vol. 27, No. 3, 2004, pp. 734-738.",EXPIRED
201,US,B2,US 8880137 B2,174-247-204-358-27X,2014-11-04,2014,US 42005703 A,2003-04-18,US 42005703 A;;US 66719900 A;;US 7067798 A,1998-04-30,Analyte monitoring device and methods of use,"An analyte monitor includes a sensor, a sensor control unit, and a display unit. The sensor has, for example, a substrate, a recessed channel formed in the substrate, and conductive material disposed in the recessed channel to form a working electrode. The sensor control unit typically has a housing adapted for placement on skin and is adapted to receive a portion of an electrochemical sensor. The sensor control unit also includes two or more conductive contacts disposed on the housing and configured for coupling to two or more contact pads on the sensor. A transmitter is disposed in the housing and coupled to the plurality of conductive contacts for transmitting data obtained using the sensor. The display unit has a receiver for receiving data transmitted by the transmitter of the sensor control unit and a display coupled to the receiver for displaying an indication of a level of an analyte. The analyte monitor may also be part of a drug delivery system to alter the level of the analyte based on the data obtained using the sensor.",SAY JAMES;;TOMASCO MICHAEL F;;HELLER ADAM;;GAL YORAM;;ARIA BEHRAD;;HELLER EPHRAIM;;PLANTE PHILLIP JOHN;;VREEKE MARK S;;FRIEDMAN KEITH A;;COLMAN FREDRIC C;;ABBOTT DIABETES CARE INC,SAY JAMES;;TOMASCO MICHAEL F;;HELLER ADAM;;GAL YORAM;;ARIA BEHRAD;;HELLER EPHRAIM;;PLANTE PHILLIP JOHN;;VREEKE MARK S;;FRIEDMAN KEITH A;;COLMAN FREDRIC C,E. HELLER & CO (1998-07-02);;ABBOTT DIABETES CARE INC (2000-03-13),https://lens.org/174-247-204-358-27X,Granted Patent,yes,0,14,211,221,0,A61B5/14532;;A61B5/14532;;A61B5/0002;;A61B5/0002;;A61B5/002;;A61B5/01;;A61B5/14503;;A61B5/1451;;A61B5/14546;;A61B5/14546;;A61B5/1473;;A61B5/1473;;A61B5/1486;;A61B5/1486;;A61B5/14865;;A61B5/1495;;A61B5/4839;;A61B5/72;;A61B5/7278;;A61B5/7282;;A61B5/7405;;A61B5/743;;A61B5/7445;;A61B5/7445;;A61B5/7455;;A61B2560/0252;;A61B2560/0252;;A61M5/1723;;C12Q1/54;;G16H10/40;;G16H10/40;;G16H20/17;;G16H20/17;;H01L23/3107;;H01L23/3107;;H01L23/49548;;H01L23/49548;;H01L2924/0002;;H01L2924/0002;;H01L2924/19041;;H01L2924/19041;;H01L2924/3011;;H01L2924/3011;;Y10S128/903;;Y10S128/903;;Y10T29/49;;Y10T29/49;;Y10T29/49124;;Y10T29/49124,A61B5/05;;G01N27/30;;A61B5/00;;A61B5/145;;A61B5/1468;;A61B5/1473;;A61B5/1477;;A61B5/1486;;A61B5/1495;;G01N27/416;;G06F19/00;;H01L23/31;;H01L23/495,600/345;;600/347;;600/365;;128/903,99,88,062-360-289-025-864;;010-601-725-111-91X;;101-292-518-663-191;;014-700-576-603-812;;033-562-815-299-181;;058-476-824-396-350;;000-125-755-474-124;;015-985-399-299-132;;081-249-097-078-543;;089-612-747-111-646;;082-114-500-909-975;;004-239-090-971-580;;026-894-457-160-450;;077-128-610-778-669;;009-725-244-669-882;;007-500-825-916-378;;037-755-689-613-42X;;012-449-714-188-064;;031-517-704-996-130;;131-299-284-996-064;;049-133-049-742-708;;000-272-178-768-076;;070-797-683-833-124;;032-860-147-271-886;;132-460-374-211-421;;052-364-430-129-757;;037-898-018-686-909;;130-044-667-529-69X;;017-934-465-161-477;;101-660-130-379-529;;056-662-192-844-472;;131-420-472-995-124;;000-292-848-642-076;;037-547-642-717-655;;011-361-512-574-415;;006-033-609-366-053;;045-087-287-424-000;;112-172-675-119-141;;012-348-107-238-223;;057-907-035-573-356;;056-088-679-719-231;;158-841-328-840-967;;096-846-866-019-020;;046-051-917-287-322;;132-477-256-994-251;;126-256-551-957-406;;107-031-219-451-407;;070-035-450-644-84X;;073-842-915-397-35X;;002-244-337-345-21X;;068-386-284-377-434;;084-058-419-754-426;;011-920-220-103-986;;186-568-798-241-628;;083-932-858-886-510;;017-237-987-892-02X;;077-944-356-331-559;;015-613-189-270-414;;041-852-924-917-140;;052-850-283-559-75X;;047-861-542-219-382;;062-540-858-075-06X;;054-358-164-375-163;;031-531-088-033-656;;051-006-667-298-94X;;047-733-435-485-371;;003-067-671-137-047;;007-135-567-040-648;;006-536-656-748-868;;077-626-976-841-740;;035-535-925-014-211;;072-940-861-593-031;;024-011-256-425-251;;025-030-453-190-842;;030-775-076-635-419;;061-539-442-167-302;;008-149-576-479-541;;014-861-759-005-556;;035-211-086-138-107;;138-961-462-563-877;;115-233-158-409-162;;101-078-880-152-485;;007-757-545-982-964;;065-365-061-588-814;;116-750-608-164-513;;176-190-698-353-230;;063-392-112-944-585;;017-293-343-302-991,10.1021/ja00391a001;;2889225;;10.1098/rstb.1987.0021;;10.1109/51.294001;;10.1016/0265-928x(87)80018-4;;3333622;;10.1021/ac00017a008;;1789439;;8277748;;10.1016/0141-5425(93)90058-7;;236018;;10.1016/0005-2795(75)90259-7;;505005;;10.1126/science.505005;;6721151;;10.1021/ac00268a018;;6733082;;10.1021/bi00305a016;;4500021;;10.1007/978-1-4684-3288-6_18;;14021529;;10.1111/j.1749-6632.1962.tb13623.x;;3196517;;10.2337/diacare.10.5.622;;3677983;;7978306;;10.1021/ac00091a022;;7733469;;10.1021/ac00103a015;;10.1007/bf01248238;;10.1016/0265-928x(85)80002-x;;10.1021/j100290a001;;10.1021/ja00216a040;;10.1021/ja00188a091;;10.1021/ja00406a011;;2624333;;10.1021/ac00250a038;;10.1021/ac00266a005;;10.1021/ja00415a014;;10.1016/0022-0728(85)87006-6;;10.1021/ja00434a018;;3245585;;10.1021/ac00173a008;;2889234;;10.1098/rstb.1987.0020;;10.1016/0003-2670(91)85072-z;;10.1021/ac00202a007;;2305956;;10.1021/j100168a046;;10.1021/ja00191a084;;10.1021/ac00170a003;;3239784;;4356378;;10.1016/0925-4005(93)85356-f;;10.1021/j100188a007;;10.1021/ar00173a002;;10.1021/ac00236a033;;10.1021/ac00244a019;;10.1271/bbb1961.49.541;;10.1021/ja00415a004;;10.1021/ac00245a028;;10.1016/0925-4005(91)80225-9;;3842604;;10.1016/0265-928x(85)80005-5;;10.1149/1.2095533;;10.1021/ja00087a065;;1590584;;10.1021/ac00033a009;;10.1039/ft9969204131;;10.1016/0956-5663(91)85005-h;;2049169;;10.1016/0302-4598(90)80030-m;;10.1055/s-2007-1001749;;7875647;;10.1039/ft9938900361;;10.1021/ac00047a003;;1463213;;2712293;;10.1021/ac00176a006;;10.1016/0304-4165(85)90250-8;;3967047;;10.1016/0956-5663(92)85030-e;;1632948;;7926347;;10.1007/s001250050155;;10.1007/bf00403381;;10.1007/bf00400921;;1373393;;6130453;;10.1016/0024-3205(82)90736-6;;10.1016/0005-2744(76)90084-x;;182278;;10.1021/ac00071a031;;8297033;;8092486;;10.1021/ac00087a008;;10.1007/bf00580834;;567324;;10.1016/0022-0728(89)87165-7;;3812989;;10.1016/0003-2697(86)90315-5;;10.1016/0022-0728(95)04020-o;;10.1021/ja00047a065;;7763951;;10.1016/0167-7799(93)90016-3;;10.1007/bf00265097;;2666212;;10.1016/0265-928x(89)80026-4;;2719726;;1759711;;10.1021/ac00020a014;;10.1007/bf00404077;;8359584;;1457093;;10.1016/0956-5663(92)85010-8;;1751159;;10.1021/ja00540a026;;10.1021/ac00030a001;;10.1021/ac00030a718;;1580356;;2673892;;10.1007/bf00285330;;10.1016/0925-4005(93)85391-m;;10.1021/ja00392a010;;10.1021/ac00210a004;;2889233;;10.1098/rstb.1987.0019;;10.1016/0368-1874(83)80336-0;;10.1007/bf00250158;;6341145;;10.1021/ac00260a039;;10.1002/elan.1140080608;;7875646;;10.1055/s-2007-1001748,"Abruña, H. D. et al., ""Rectifying Interfaces Using Two-Layer Films of Electrochemically Polymerized Vinylpyridine and Vinylbipyridine Complexes of Ruthenium and Iron on Electrodes,"" J. Am. Chem. Soc. 103(1):1-5 (Jan. 14, 1981).;;Albery, W. J. et al., ""Amperometric enzyme electrodes. Part II. Conducting salts as electrode materials for the oxidation of glucose oxidase,"" J. Electroanal. Chem. Interfacial Electrochem., 194(2) (1 page-Abstract only) (1985).;;Albery, W. J. et al., ""Amperometric Enzyme Electrodes,"" Phil. Trans. R. Soc. Lond. B316:107-119 (1987).;;Alcock, S. J. et al., ""Continuous Analyte Monitoring to Aid Clinical Practice,"" IEEE Engineering in Medicine and Biology, 319-325 (1994).;;Anderson, L. B. et al., ""Thin-Layer Electrochemistry: Steady-State Methods of Studying Rate Processes,"" J. Electroanal. Chem., 10:295-395 (1965).;;Bartlett, P. N. et al., ""Covalent Binding of Electron Relays to Glucose Oxidation,"" J. Chem. Soc. Chem. Commun., 1603-1604 (1987).;;Bartlett, P. N. et al., ""Modification of glucose oxidase by tetrathiafulvalene,"" J. Chem. Soc., Chem. Commun., 16 (1 page-Abstract only) (1990).;;Bartlett, P. N. et al., ""Strategies for the Development of Amperometric Enzyme Electrodes,"" Biosensors, 3:359-379 (1987/88).;;Bindra, D.S. et al., ""Design and in Vitro Studies of a Needle-Type Glucose Sensor for Subcutaneous Monitoring"", Anal. Chem., 63(17):1692-1696 (Sep. 1, 1991).;;Bobbioni-Harsch, E. et al., ""Lifespan of subcutaneous glucose sensors and their performances during dynamic glycaemia changes in rats,"" J. Biomed. Eng. 15:457-463 (1993).;;Brandt, J. et al., ""Covalent attachment of proteins to polysaccharide carriers by means of benzoquinone,"" Biochim. Biophys. Acta. 386(l) (1 page Abstract only) (1975).;;Brownlee, M. et al., ""A Glucose-Controlled Insulin-Delivery System: Semisynthetic Insulin Bound to Lectin"", Science, 206(4423):1190-1191 (Dec. 7, 1979).;;Cass, A.E.G. et al., ""Ferricinum Ion As An Electron Acceptor for Oxido-Reductases,"" J. Electroanal. Chem., 190:117-127 (1985).;;Cass, A.E.G. et al., ""Ferrocene-Mediated Enzyme Electrode for Amperometric Determination of Glucose"", Anal. Chem., 56(4):667-671 (Apr. 1984).;;Castner, J. F. et al., ""Mass Transport and Reaction Kinetic Parameters Determined Electrochemically for Immobilized Glucose Oxidase,"" Biochemisty, 23(10):2203-2210 (1984).;;Claremont, D.J. et al., ""Biosensors for Continuous In Vivo Glucose Monitoring"", IEEE Engineering in Medicine and Biology Society 10th Annual International Conference, New Orleans, Louisiana, 3 pgs. (Nov. 4-7, 1988).;;Clark, L.C. et al., ""Differential Anodic Enzyme Polarography for the Measurement of Glucose"", Oxygen Transport to Tissue: Instrumentation, Methods, and Physiology, 127-132 (1973).;;Clark, L.C., Jr. et al., ""Electrode Systems for Continuous Monitoring in Cardiovascular Surgery,"" Annals New York Academy of Sciences, pp. 29-45 (1962).;;Clark, L.C. et al., ""Long-term Stability of Electroenzymatic Glucose Sensors Implanted in Mice,"" Trans. Am. Soc. Artif. Intern. Organs, XXXIV:259-265 (1988).;;Clarke, W. L., et al., ""Evaluating Clinical Accuracy of Systems for Self-Monitoring of Blood Glucose,"" Diabetes Care, 10(5):622-628 (Sep.-Oct. 1987).;;Csöregi, E. et al., ""Design, Characterization, and One-Point in Vivo Calibration of a Subcutaneously Implanted Glucose Electrode,"" Anal. Chem. 66(19):3131-3138 (Oct. 1, 1994).;;Csöregi, E. et al., ""Design and Optimization of a Selective Subcutaneously Implantable Glucose Electrode Based on ""Wired"" Glucose Oxidase,"" Anal. Chem. 67(7):1240-1244 (Apr. 1, 1995).;;Csöregi, E. et al., ""On-Line Glucose Monitoring by Using Microdialysis Sampling and Amperometric Detection Based on ""Wired"" Glucose Oxidase in Carbon Paste,"" Mikrochim. Acta. 121:31-40 (1995).;;Davis, G., ""Electrochemical Techniques for the Development of Amperometric Biosensors"" Biosensors, 1:161-178 (1985).;;Degani, Y. et al., ""Direct Electrical Communication between Chemically Modified Enzymes and Metal Electrodes. 1. Electron Transfer from Glucose Oxidase to Metal Electrodes via Electron Relays, Bound Covalently to the Enzyme,"" J. Phys. Chem., 91(6):1285-1289 (1987).;;Degani, Y. et al., ""Direct Electrical Communication between Chemically Modified Enzymes and Metal Electrodes. 2. Methods for Bonding Electron-Transfer Relays to Glucose Oxidase and D-Amino-Acid Oxidase,"" J. Am. Chem. Soc., 110(8):2615-2620 (1988).;;Degani, Y. et al., ""Electrical Communication between Redox Centers of Glucose Oxidase and Electrodes via Electrostatically and Covalently Bound Redox Polymers,"" J. Am. Chem. Soc., 111:2357-2358 (1989).;;Denisevich, P. et al., ""Unidirectional Current Flow and Charge State Trapping at Redox Polymer Interfaces on Bilayer Electrodes: Principles, Experimental Demonstration, and Theory,"" J Am. Chem. Soc., 103(1 6):4727-4737 (1981).;;Dicks, J. M., ""Ferrocene modified polypyrrole with immobilised glucose oxidase and its application in amperometric glucose microbiosensors,"" Ann. Biol. clin., 47:607-619 (1989).;;Engstrom, R.C., ""Electrochemical Pretreatment of Glassy Carbon Electrodes"", Anal. Chem., 54(13):2310-2314 (Nov. 1982).;;Engstrom, R.C. et al., ""Characterization of Electrochemically Pretreated Glassy Carbon Electrodes"", Anal. Chem., 56(2):136-141 (Feb. 1984).;;Ellis, C. D., ""Selectivity and Directed Charge Transfer through an Electroactive Metallopolymer Film,"" J. Am. Chem. Soc., 103(25):7480-7483 (1981).;;Feldman, B.J. et al., ""Electron Transfer Kinetics at Redox Polymer/Solution Interfaces Using Microelectrodes and Twin Electrode Thin Layer Cells"", J. Electroanal Chem., 194(1):63-81 (Oct. 10, 1985).;;Fischer, H. et al., ""Intramolecular Electron Transfer Mediated by 4,4'-Bipyridine and Related Bridging Groups"", J. Am. Chem. Soc., 98(18):5512-5517 (Sep. 1, 1976).;;Foulds, N.C. et al., ""Enzyme Entrapment in Electrically Conducting Polymers,"" J. Chem. Soc., Faraday Trans I., 82:1259-1264 (1986).;;Foulds, N.C. et al., ""Immobilization of Glucose Oxidase in Ferrocene-Modified Pyrrole Polymers,"" Anal. Chem., 60(22):2473-2478 (Nov. 15, 1988).;;Frew, J.E. et al., ""Electron-Transfer Biosensors"", Phil Trans. R. Soc. Lond., B316:95-106 (1987).;;Gorton, L. et al., ""Selective detection in flow analysis based on the combination of immobilized enzymes and chemically modified electrodes,"" Analytica Chimica Acta., 250:203-248 (1991).;;Gregg, B. A. et al., ""Cross-Linked Redox Gels Containing Glucose Oxidase for Amperometric Biosensor Applications,"" Analytical Chemistry, 62(3):258-263 (Feb. 1, 1990).;;Gregg, B. A. et al., ""Redox Polymer Films Containing Enzymes. 1. A Redox-Conducting Epoxy Cement: Synthesis, Characterization, and Electrocatalytic Oxidation of Hydroquinone,"" J. Phys. Chem., 95(15):5970-5975 (1991).;;Hale, P.D. et al., ""A New Class of Amperometric Biosensor Incorporating a Polymeric Electron-Transfer Mediator,"" J. Am. Chem. Soc., 111(9):3482-3484 (1989).;;Harrison, D.J. et al., ""Characterization of Perfluorosulfonic Acid Polymer Coated Enzyme Electrodes and a Miniaturized Integrated Potentiostat for Glucose Analysis in Whole Blood"", Anal. Chem., 60(19):2002-2007 (Oct. 1, 1988).;;Hawkridge, F. M. et al., ""Indirect Coulometric Titration of Biological Electron Transport Components,"" Analytical Chemistry, 45(7):1021-1027 (Jun. 1973).;;Heller, A., ""Amperometric biosensors based on three-dimensional hydrogel-forming epoxy networks,"" Sensors and Actuators B, 13-14:180-183 (1993).;;Heller, A., ""Electrical Connection of Enzyme Redox Centers to Electrodes,"" J. Phys. Chem,, 96(9):3579-3587 (1992).;;Heller, A., ""Electrical Wiring of Redox Enzymes,"" Acc. Chem. Res., 23(5):129-134 (1990).;;Ianniello, R.M. et al. ""Immobilized Enzyme Chemically Modified Electrode as an Amperometric Sensor"", Anal. Chem., 53(13):2090-2095 (Nov. 1981).;;Ianniello, R.M. et al., ""Differential Pulse Voltammetric Study of Direct Electron Transfer in Glucose Oxidase Chemically Modified Graphite Electrodes"", Anal. Chem., 54:(7):1098-110I (Jun. 1981).;;Ikeda, T. et al., ""Glucose oxidase-immobilized benzoquinone-carbon paste electrode as a glucose sensor,"" Agric. Biol. Chem., 49(2) (1 page-Abstract only) (1985).;;Ikeda, T. et al., ""Kinetics of Outer-Sphere Electron Transfers Between Metal Complexes in Solutions and Polymeric Films on Modified Electrodes"", J. Am. Chem. Soc., 103(25):7422-7425 (Dec. 16, 1981).;;Johnson, J. M. et al., ""Potential-Dependent Enzymatic Activity in an Enzyme Thin-Layer Cell,"" Anal. Chem. 54:1377-1383 (1982).;;Johnson, K.W., ""Reproducible Electrodeposition of Biomolecules for the Fabrication of Miniature Electroenzymatic Biosensors"", Sensors and Actuators B Chemical, B5:85-89 (1991).;;Jönsson, G. et al., ""An Amperometric Glucose Sensor Made by Modification of a Graphite Electrode Surface With Immobilized Glucose Oxidase and Adsorbed Mediator"", Biosensors, 1:355-368 (1985).;;Josowicz, M. et al., ""Electrochemical Pretreatment of Thin Film Platinum Electrodes"", J. Elecrochem. Soc., 135(1):112-115 (Jan. 1988).;;Katakis, I. et al., ""Electrostatic Control of the Electron Transfer Enabling Binding of Recombinant Glucose Oxidase and Redox Polyelectrolytes,"" J. Am. Chem. Soc., 116(8):3617-3618 (1994).;;Katakis, I. et al., ""L-alpha-Glycerophosphate and L-Lactate Electrodes Based on the Electrochemical ""Wiring"" of Oxidases,"" Analytical Chemistry, 64(9):1008-1013 (May 1, 1992).;;Kenausis, G. et al., ""'Wiring' of glucose oxidase and lactate oxidase within a hydrogel made with poly(vinyl pyridine) complexed with [Os(4,4'-dimethoxy-2,2'-bipyridine)2C1]+/2+,"" J. Chem. Soc., Faraday Trans., 92(20):4131-4136 (1996).;;Koudelka, M. et al., ""In-Vivo Behaviour of Hypodermically Implanted Microfabricated Glucose Sensors"", Biosensors & Bioelectronics, 6(1):31-36 (1991).;;Kulys, J. et al., ""Mediatorless peroxidase electrode and preparation of bienzyme sensors,"" Bioelectrochemistry and Bioenergetics, 24:305-311 (1990).;;Lager, W. et al., ""Implantable Electrocatalytic Glucose Sensor,"" Horm. Metab. Res., 26:526-530 (Nov. 1994).;;Lindner, E. et al. ""Flexible (Kapton-Based) Microsensor Arrays of High Stability for Cardiovascular Applications"", J. Chem. Soc.Faraday Trans., 89(2):361-367 (Jan. 21, 1993).;;Maidan, R. et al., ""Elimination of Electrooxidizable Interferant-Produced Currents in Amperometric Biosensors,"" Analytical Chemistry, 64(23):2889-2896 (Dec. 1, 1992).;;Mastrototaro, J.J. et al., ""An Electroenzymatic Glucose Sensor Fabricated on a Flexible Substrate"", Sensors and Biosensors B Chemical, B5:139-144 (1991).;;McNeil, C. J. et al., ""Thermostable Reduced Nicotinamide Adenine Dinucleotide Oxidase: Application to Amperometric Enzyme Assay,"" Anal. Chem., 61(1):25-29 (Jan. 1, 1989).;;Miyawaki, O. et al., ""Electrochemical and Glucose Oxidase Coenzyme Activity of Flavin Adenine Dinucleotide Covalently Attached to Glassy Carbon at the Adenine Amino Group"", Biochimica et Biophysica Acta, 838:60-68 (1985).;;Moatti-Sirat, D. et al., ""Evaluating in vitro and in vivo the inteference of ascorbate and acetaminophen on glucose detection by a needle-type glucose sensor,"" Biosensors & Bioelectronics, 7(5):345-352 (1992).;;Moatti-Sirat, D. et al., ""Reduction of acetaminophen interference in glucose sensors by a composite Nafion membrane: demonstration in rats and man,"" Diabetologia, 37(6) (1 page-Abstract only) (Jun. 1994).;;Moatti-Sirat, D. et al., ""Towards continuous glucose monitoring: in vivo evaluation of a miniaturized glucose sensor implanted for several days in rat subcutaneous tissue,"" Diabetologia, 35(3) (1 page-Abstract only) (Mar. 1992).;;Nagy, G. et al., ""A New Type of Enzyme Electrode: The Ascorbic Acid Eliminator Electrode,"" Life Sciences, 31(23):2611-2616 (1982).;;Nakamura, S. et al., ""Effect of Periodate Oxidation on the Structure and Properties of Glucose Oxidase,"" Biochimica et Biophysica Acta., 445:294-308 (1976).;;Narazimhan, K. et al., ""p-Benzoquinone activation of metal oxide electrodes for attachment of enzymes,"" Enzyme Microb. Technol., 7(6) (1 page-Abstract only) (1985).;;Ohara, T. J. et al., ""Glucose Electrodes Based on Cross-Linked [Os(bpy)2CI]+/2+ Complexed Poly(1-vinylimadazole) Films,"" Analytical Chemistry, 65(23):3512-3516 (Dec. 1, 1993).;;Ohara, T. J., ""Osmium Bipyridyl Redox Polymers Used in Enzyme Electrodes,"" Platinum Metals Rev., 39(2):54-62 (Apr. 1995).;;Ohara, T. J. et al., """"Wired"" Enzyme Electrodes for Amperometric Determination of Glucose or Lactate in the Presence of Interfering Substances,"" Analytical Chemistry, 66(15):2451-2457 (Aug. 1, 1994).;;Olievier, C. N. et al., ""In vivo Measurement of Carbon Dioxide Tension with a Miniature Electrode,"" Pflugers Arch. 373:269-272 (1978).;;Paddock, R. et al., ""Electrocatalytic reduction of hydrogen peroxide via direct electron transfer from pyrolytic graphite electrodes to irreversibly adsorbed cytochrome c peroxidase,"" J. Electroanal. Chem., 260:487-494 (1989).;;Palleschi, G. et al., ""A Study of Interferences in Glucose Measurements in Blood by Hydrogen Peroxide Based Glucose Probes"", Anal. Biochem., 159:114-121 (1986).;;Pankratov, I. et al., ""Sol-gel derived renewable-surface biosensors,"" Journal of Electroanalytical Chemistry, 393:35-41 (1995).;;Pathak, C. P. et al., ""Rapid Photopolymerization of Immunoprotective Gels in Contact with Cells and Tissue,"" J. Am. Chem. Soc., 114(21):8311-8312 (1992).;;Pickup, J., ""Developing glucose sensors for in vivo use,"" Tibtech, 11: 285-289 (Jul. 1993).;;Pickup, J. C. et al., ""In vivo molecular sensing in diabetes mellitus: an implantable glucose sensor with direct electron transfer,"" Diabetologia, 32(3):213-217 (1989).;;Pickup, J. et al., ""Potentially-implantable, amperometric glucose sensors with mediated electron transfer: improving the operating stability,"" Biosensors, 4(2) (1 page-Abstract only) (1989).;;Pishko, M.V. et al., ""Amperometric Glucose Microelectrodes Prepared Through Immobilization of Glucose Oxidase in Redox Hydrogels"", Anal. Chem., 63(20):2268-2272 (Oct. 15, 1991).;;Poitout, V. et al., ""A glucose monitoring system for on line estimation in man of blood glucose concentration using a miniaturized glucose sensor implanted in the subcutaneous tissue and a wearable control unit,"" Diabetolgia, 36(7) (1 page-Abstract only) (Jul. 1993).;;Poitout, V. et al., ""Calibration in dogs of a subcutaneous miniaturized glucose sensor using a glucose meter for blood glucose determination,"" Biosensors & Bioelectronics, 7:587-592 (1992).;;Poitout, V. et al., ""In vitro and in vivo evaluation in dogs of a miniaturized glucose sensor,"" ASAIO Transactions, 37(3) (1 page-Abstract only) (Jul.-Sep. 1991).;;Pollak, A. et al., ""Enzyme Immobilization by Condensation Copolymerization into Cross-Linked Polyacrylamide Gels,"" J. Am. Chem. Soc., 102(20):6324-6336 (1980).;;Reach, G. et al., ""Can Continuous Glucose Monitoring Be Used for the Treatment of Diabetes?"" Analytical Chemistry, 64(6):381-386 (Mar. 15, 1992).;;Rebrin, K. et al., ""Automated Feedback Control of Subcutaneous Glucose Concentration in Diabetic Dogs"", Diabetologia, 32(8):573-576 (Aug. 1989).;;Sakakida, M. et al., ""Ferrocene-mediate needle-type glucose sensor covered with newly designed biocompatible membrane,"" Sensors and Actuators B, 13-14:319-322 (1993).;;Samuels, G. J. et al., ""An Electrode-Supported Oxidation Catalyst Based on Ruthenium (IV). pH ""Encapsulation"" in a Polymer Film,"" J. Am. Chem. Soc., 103(2):307-312 (1981).;;Sasso, S.V. et al., ""Electropolymerized 1,2-Diaminobenzene as a Means to Prevent Interferences and Fouling and to Stabilize Immobilized Enzyme in Electrochemical Biosensors"", Anal. Chem., 62(11):1111-1117 (Jun. 1, 1990).;;Scheller, F. et al., ""Enzyme electrodes and their application,"" Phil. Trans. R. Soc. Lond., B:316:85-94 (1987).;;Schmehl, R.H. et al., ""The Effect of Redox Site Concentration on the Rate of Mediated Oxidation of Solution Substrates by a Redox Copolymer Film"", J. Electroanal. Chem., 152:97-109 (Aug. 25, 1983).;;Shichiri, M. et al., ""Glycaemic Control in Pancreatetomized Dogs with a Wearable Artificial Endocrine Pancreas"", Diabetologia, 24(3):179-184 (Mar. 1983).;;Sittampalam, G. et al., ""Surface-Modified Electrochemical Detector for Liquid Chromatography"", Anal. Chem., 55(9):1608-1610 (Aug. 1983).;;Soegijoko, S. et al., Horm. Metabl. Res., Suppl. Ser, 12 (1 page-Abstract only) (1982).;;Sprules, S. D. et al., ""Evaluation of a New Disposable Screen-Printed Sensor Strip for the Measurement of NADH and Its Modification to Produce a Lactate Biosensor Employing Microliter Volumes,"" Electroanalysis, 8(6):539-543 (1996).;;Sternberg, F. et al., ""Calibration Problems of Subcutaneous Glucosensors when Applied ""In-Situ"" in Man,"" Horm. metabl. Res, 26:524-525 (1994).",EXPIRED
202,US,B2,US 8738109 B2,183-887-029-287-890,2014-05-27,2014,US 39728109 A,2009-03-03,US 39728109 A;;US 42005703 A;;US 66719900 A;;US 7067798 A,1998-04-30,Analyte monitoring device and methods of use,"An analyte monitor includes a sensor, a sensor control unit, and a display unit. The sensor has, for example, a substrate, a recessed channel formed in the substrate, and conductive material disposed in the recessed channel to form a working electrode. The sensor control unit typically has a housing adapted for placement on skin and is adapted to receive a portion of an electrochemical sensor. The sensor control unit also includes two or more conductive contacts disposed on the housing and configured for coupling to two or more contact pads on the sensor. A transmitter is disposed in the housing and coupled to the plurality of conductive contacts for transmitting data obtained using the sensor. The display unit has a receiver for receiving data transmitted by the transmitter of the sensor control unit and a display coupled to the receiver for displaying an indication of a level of an analyte. The analyte monitor may also be part of a drug delivery system to alter the level of the analyte based on the data obtained using the sensor.",SAY JAMES;;TOMASCO MICHAEL F;;HELLER ADAM;;GAL YORAM;;ARIA BEHRAD;;HELLER EPHRAIM;;PLANTE PHILLIP JOHN;;VREEKE MARK S;;FRIEDMAN KEITH A;;COLMAN FREDRIC C;;ABBOTT DIABETES CARE INC,SAY JAMES;;TOMASCO MICHAEL F;;HELLER ADAM;;GAL YORAM;;ARIA BEHRAD;;HELLER EPHRAIM;;PLANTE PHILLIP JOHN;;VREEKE MARK S;;FRIEDMAN KEITH A;;COLMAN FREDRIC C,E. HELLER & CO (1998-07-02);;ABBOTT DIABETES CARE INC (2000-03-13),https://lens.org/183-887-029-287-890,Granted Patent,yes,114,0,211,221,0,A61B5/14532;;A61B5/14532;;A61B5/0002;;A61B5/0002;;A61B5/002;;A61B5/01;;A61B5/14503;;A61B5/1451;;A61B5/14546;;A61B5/14546;;A61B5/1473;;A61B5/1473;;A61B5/1486;;A61B5/1486;;A61B5/14865;;A61B5/1495;;A61B5/4839;;A61B5/72;;A61B5/7278;;A61B5/7282;;A61B5/7405;;A61B5/743;;A61B5/7445;;A61B5/7445;;A61B5/7455;;A61B2560/0252;;A61B2560/0252;;A61M5/1723;;C12Q1/54;;G16H10/40;;G16H10/40;;G16H20/17;;G16H20/17;;H01L23/3107;;H01L23/3107;;H01L23/49548;;H01L23/49548;;H01L2924/0002;;H01L2924/0002;;H01L2924/19041;;H01L2924/19041;;H01L2924/3011;;H01L2924/3011;;Y10S128/903;;Y10S128/903;;Y10T29/49;;Y10T29/49;;Y10T29/49124;;Y10T29/49124,A61B5/04;;G01N27/30;;A61B5/00;;A61B5/145;;A61B5/1477;;A61B5/1495;;G01N27/416;;G06F19/00;;H01L23/31;;H01L23/495,600/345;;600/347,99,76,136-791-935-548-81X;;062-360-289-025-864;;010-601-725-111-91X;;101-292-518-663-191;;056-703-879-057-297;;030-155-762-644-019;;004-149-141-436-651;;016-731-054-793-457;;080-559-561-995-335;;044-807-213-528-815;;027-538-525-436-179;;015-020-161-517-40X;;025-919-454-564-785;;014-700-576-603-812;;004-851-060-590-788;;075-958-432-122-199;;052-356-140-149-389;;035-090-282-884-790;;033-562-815-299-181;;018-803-926-589-211;;008-505-762-041-402;;016-601-143-530-813;;019-502-772-562-215;;058-476-824-396-350;;006-498-707-073-30X;;054-091-551-638-293;;010-531-147-771-746;;054-827-198-877-419;;122-658-944-077-000;;017-261-560-469-37X;;000-125-755-474-124;;113-381-664-783-802;;082-626-907-191-554;;017-950-014-792-456;;090-348-305-613-628;;015-985-399-299-132;;171-049-047-164-618;;016-819-089-891-758;;081-249-097-078-543;;089-612-747-111-646;;031-706-897-890-035;;094-198-536-559-723;;003-690-143-043-420;;007-943-354-378-456;;082-114-500-909-975;;004-239-090-971-580;;026-894-457-160-450;;077-128-610-778-669;;022-466-506-956-898;;008-424-592-956-946;;007-500-825-916-378;;009-725-244-669-882;;037-755-689-613-42X;;153-411-506-517-475;;038-134-360-685-692;;012-449-714-188-064;;031-517-704-996-130;;131-299-284-996-064;;049-133-049-742-708;;000-272-178-768-076;;070-797-683-833-124;;043-870-224-178-49X;;025-574-914-238-550;;052-364-430-129-757;;004-434-167-910-115;;032-860-147-271-886;;132-460-374-211-421;;098-172-374-375-47X;;109-358-955-476-095;;014-988-634-483-130;;061-786-187-274-992;;037-898-018-686-909;;130-044-667-529-69X;;134-265-642-839-645;;065-221-074-461-027;;017-934-465-161-477,10.1016/s0956-5663(02)00099-4;;12392956;;10.1021/ja00391a001;;2889225;;10.1098/rstb.1987.0021;;10.1109/51.294001;;10.1016/0022-0728(65)85063-x;;2245876;;10.2337/diabetes.39.12.1519;;10.2337/diab.39.12.1519;;10.1016/s0956-5663(03)00220-3;;14611755;;18615658;;10.1002/bit.260430310;;9366023;;10.1016/s0956-5663(97)00025-0;;9451795;;10.1016/s0956-5663(97)00083-3;;10.1016/0956-5663(93)80028-n;;8311939;;8651496;;10.1021/ac960030d;;10.1080/03091900210156797;;12487712;;10.1016/0265-928x(87)80018-4;;3333622;;10.1109/19.816143;;10.1007/bf01015979;;10.1089/15209150252924058;;12017416;;18473691;;10.1089/dia.2007.0281;;10.1021/ac00017a008;;1789439;;2817408;;10.1021/ac00197a022;;10.1016/0925-4005(95)01730-5;;10.1016/0010-4825(90)90013-f;;2257734;;2868172;;8277748;;10.1016/0141-5425(93)90058-7;;11469630;;10.1089/15209150050214104;;10624783;;10.1016/s0168-8227(99)00113-8;;10.1089/15209150050214113;;11469631;;10.1007/bf00401374;;1478372;;10.2337/diacare.20.1.64;;9028696;;10.1109/tbme.1986.325807;;3957374;;236018;;10.1016/0005-2795(75)90259-7;;10.1089/hum.1998.9.6-879;;9581910;;11762520;;10.1089/15209150152607196;;10.2337/diabetes.48.3.445;;10078542;;10.1016/0265-928x(87)80012-3;;505005;;10.1126/science.505005;;10.1021/ac0498516;;15253640;;10.1109/10.284922;;8026845;;6721151;;10.1021/ac00268a018;;6733082;;10.1021/bi00305a016;;10.1515/cclm.2002.135;;12392305;;10.1016/j.ecl.2003.12.001;;15053902;;12052350;;10.1016/s0956-5663(01)00304-9;;12052349;;10.1016/s0956-5663(01)00306-2;;4500021;;10.1007/978-1-4684-3288-6_18;;14021529;;10.1111/j.1749-6632.1962.tb13623.x;;3196517;;10.2337/diacare.10.5.622;;3677983;;10.2337/diacare.8.6.529;;4075939;;10.1002/elan.1140061103;;7733469;;10.1021/ac00103a015;;7978306;;10.1021/ac00091a022;;10.1007/bf01248238;;10.1016/s0376-7388(98)00330-5;;10.1016/0142-9612(92)90147-g;;1472593;;10.1016/0265-928x(85)80002-x;;10.1021/j100290a001;;10.1021/ja00216a040;;10.1021/ja00188a091;;10.1021/ja00406a011;;2624333;;12323417;;10.1016/s0165-0270(02)00170-x;;10.1177/193229680700100208;;pmc2771467;;19888405;;10.1021/ja00415a014;;10.1007/bf00575392;;10.1021/ac00250a038;;10.1021/ac00266a005;;10.1007/s00216-002-1284-0;;12194035;;10.1089/dia.2006.0030;;17705688;;9642777;;10.1016/s0956-5663(97)00091-2;;10.1089/152091503322526978;;14633342;;10.1016/0022-0728(85)87006-6;;10.1021/ja00434a018;;10.1016/0003-2697(92)90243-z;;1443528;;10.1039/f19868201259;;3245585;;10.1021/ac00173a008,"Japanese Patent Application No. 2007-270411, Office Action mailed Aug. 17, 2010.;;Japanese Patent Application No. 2007-270411, Office Action mailed Jun. 21, 2011.;;U.S. Appl. No. 12/614,974, Office Action mailed Apr. 12, 2011.;;U.S. Appl. No. 12/825,202 Office Action mailed Jun. 8, 2011.;;U.S. Appl. No. 12/902,138 Office Action mailed Jun. 7, 2011.;;""Poretics Polycarbonate Membrane"", Osmonics Filtration and Separation Group, 2002.;;Abel, P. U., et al., ""Biosensors for In Vivo Glucose Measurement: Can We Cross the Experimental Stage"", Biosensors and Bioelectronics, vol. 17, 2002, pp. 1059-1070.;;Abruna, H. D., et al., ""Rectifying Interfaces Using Two-Layer Films of Electrochemically Polymerized Vinylpyridine and Vinylbipyridine Complexes of Ruthenium and Iron on Electrodes"", Journal of the American Chemical Society, vol. 103, No. 1, 1981, pp. 1-5.;;Albery, W. J., et al., ""Amperometric Enzyme Electrodes Part II: Conducting Salts as Electrode Materials for the Oxidation of Glucose Oxidase"", Journal of ElectroAnalytical Chemistry, vol. 194, 1985, pp. 223-235.;;Albery, W. J., et al., ""Amperometric Enzyme Electrodes"", Philosophical Transactions of The Royal Society of London, vol. 316, 1987, pp. 107-119.;;Alcock, S. J., et al., ""Continuous Analyte Monitoring to Aid Clinical Practice"", IEEE Engineering in Medicine and Biology Magazine, 1994, pp. 319-325.;;Anderson, L. B., et al., ""Thin-Layer Electrochemistry: Steady-State Methods of Studying Rate Processes"", Journal of ElectroAnalytical Chemistry, vol. 10, 1965, pp. 295-305.;;Armour, J. C., et al., ""Application of Chronic Intravascular Blood Glucose Sensor in Dogs"", Diabetes, vol. 39, 1990, pp. 1519-1526.;;Asberg, P., et al., ""Hydrogels of a Conducting Conjugated Polymer as 3-D Enzyme Electrode"", Biosensors & Bioelectronics, vol. 19, 2003, pp. 199-207.;;Atanasov, P., et al., ""Biosensor for Continuous Glucose Monitoring"", Biotechnology and Bioengineering, vol. 43, 1994, pp. 262-266.;;Atanasov, P., et al., ""Implantation of a Refillable Glucose Monitoring-Telemetry Device"", Biosensors & Bioelectronics, vol. 12, No. 7, 1997, pp. 669-680.;;Aussedat, B., et al., ""A User-Friendly Method for Calibrating a Subcutaneous Glucose Sensor-Based Hypoglycaemic Alarm"", Biosensors & Bioelectronics, vol. 12, No. 11, 1997, pp. 1061-1071.;;Baker, D. A., et al., ""Dynamic Concentration Challenges for Biosensor Characterization"", Biosensors & Bioelectronics, vol. 8, 1993, pp. 433-441.;;Baker, D. A., et al., ""Dynamic Delay and Maximal Dynamic Error in Continuous Biosensors"", Analytical Chemistry, vol. 68, No. 8, 1996, pp. 1292-1297.;;Bani Amer, M. M., ""An Accurate Amperometric Glucose Sensor Based Glucometer with Eliminated Cross-Sensitivity"", Journal of Medical Engineering & Technology, vol. 26, No. 5, 2002, pp. 208-213.;;Bard, A. J., et al., Electrochemical Methods, 1980, pp. 173-175.;;Bartlett, P. N., et al., ""Covalent Binding of Electron Relays to Glucose Oxidase"", Journal of the Chemical Society, Chemical Communications, 1987, pp. 1603-1604.;;Bartlett, P. N., et al., ""Modifications of Glucose Oxidase by Tetrathiafulvalene"", Journal of the Chemical Society, Chemical Communications, 1990, pp. 1135-1136.;;Bartlett, P. N., et al., ""Strategies for the Development of Amperometric Enzyme Electrodes"", Biosensors, vol. 3, 1987/88, pp. 359-379.;;Beach, R. D., et al., ""Subminiature Implantable Potentiostat and Modified Commercial Telemetry Device for Remote Glucose Monitoring"", IEEE Transactions on Instrumentation and Measurement, vol. 28, No. 6, 1999, pp. 1239-1245.;;Beech, W. A., ""AX.25 Link Access Protocol for Amateur packet Radio"", Tucson Amateur Packet Radio Corporation, 1998, pp. 1-133.;;Bellucci, F., et al., ""Electrochemical Behaviour of Graphite-Epoxy Composite Materials (GECM) in Aqueous Salt Solutions"", Journal of Applied Electrochemistry, vol. 16, 1986, pp. 15-22.;;Bennion, N., et al., ""Alternate Site Glucose Testing: A Crossover Design"", Diabetes Technology & Therapeutics, vol. 4, No. 1, 2002, pp. 25-33.;;Biermann, E., et al., ""How Would Patients Behave if They Were Continually Informed of Their Blood Glucose Levels? A Simulation Study Using a 'Virtual' Patient"", Diabetes Technology & Therapeutics, vol. 10, No. 3, 2008, pp. 178-187.;;Bindra, D. S., et al., ""Design and in Vitro Studies of a Needle-Type Glucose Sensor for Subcutaneous Monitoring"", Analytical Chemistry, vol. 63, No. 17, 1991, pp. 1692-1696.;;Bindra, D. S., et al., ""Pulsed Amperometric Detection of Glucose in Biological Fluids at a Surface-Modified Gold Electrode"", Analytical Chemistry, vol. 61, No. 22, 1989, pp. 2566-2570.;;Bisenberger, M., et al., ""A Triple-Step Potential Waveform at Enzyme Multisensors with Thick-Film Gold Electrodes for Detection of Glucose and Sucrose"", Sensors and Actuators B, vol. 28, 1995, pp. 181-189.;;Bland, J. M., et al., ""A Note on the Use of the Intraclass Correlation Coefficient in the Evaluation of Agreement Between Two Methods of Measurement"", Computers in Biology and Medicine, vol. 20, No. 5, 1990, pp. 337-340.;;Bland, J. M., et al., ""Statistical Methods for Assessing Agreement Between Two Methods of Clinical Measurement"", The Lancet, 1986, pp. 307-310.;;Blank, T. B., et al., ""Clinical Results From a Non-Invasive Blood Glucose Monitor"", Optical Diagnostics and Sensing of Biological Fluids and Glucose and Cholesterol Monitoring II, Proceedings of SPIE, vol. 4624, 2002, pp. 1-10.;;Bobbioni-Harsch, E., et al., ""Lifespan of Subcutaneous Glucose Sensors and Their Performances During Dynamic Glycaemia Changes in Rats"", Journal of Biomedical Engineering, vol. 15, 1993, pp. 457-463.;;Bode, B. W., ""Clinical Utility of the Continuous Glucose Monitoring System"", Diabetes Technology & Therapeutics, vol. 2, Sup. 1, 2000, pp. S35-S41.;;Bode, B. W., et al., ""Continuous Glucose Monitoring Used to Adjust Diabetes Therapy Improves Glycosylated Hemoglobin: A Pilot Study"", Diabetes Research and Clinical Practice, vol. 46, 1999, pp. 183-190.;;Bode, B. W., et al., ""Using the Continuous Glucose Monitoring System to Improve the Management of Type 1 Diabetes"", Diabetes Technology & Therapeutics, vol. 2, Sup. 1, 2000, pp. S43-S48.;;Boedeker Plastics, Inc., ""Polyethylene Specifications"", Web Page of Boedeker.com, 2007, pp. 1-3.;;Bolinder, J., et al., ""Microdialysis Measurement of the Absolute Glucose Concentration in Subcutaneous Adipose Tissue Allowing Glucose Monitoring in Diabetic Patients"", Diabetologia, vol. 35, 1992, pp. 1177-1180.;;Bolinder, J., et al., ""Self-Monitoring of Blood Glucose in Type I Diabetic Patients: Comparison with Continuous Microdialysis Measurements of Glucose in Subcutaneous Adipose Tissue During Ordinary Life Conditions"", Diabetes Care, vol. 20, No. 1, 1997, pp. 64-70.;;Bott, A. W., ""A Comparison of Cyclic Voltammetry and Cyclic Staircase Voltammetry"", Current Separations, vol. 16, No. 1, 1997, pp. 23-26.;;Bott, A. W., ""Electrochemical Methods for the Determination of Glucose"", Current Separations, vol. 17, No. 1, 1998, pp. 25-31.;;Bowman, L., et al., ""The Packaging of Implantable Integrated Sensors"", IEEE Transactions on Biomedical Engineering, vol. 33, No. 2, 1986, pp. 248-255.;;Brandt, J., et al., ""Covalent Attachment of Proteins to Polysaccharide Carriers by Means of Benzoquinone"", Biochimica et Biophysica Acta, vol. 386, 1975, pp. 196-202.;;Brauker, J., et al., ""Sustained Expression of High Levels of Human Factor IX from Human Cells Implanted Within an Immunoisolation Device into Athymic Rodents"", Human Gene Therapy, vol. 9, No. 6, 1998, pp. 879-888.;;Bremer, T. M., et al., ""Benchmark Data from the Literature for Evaluation of New Glucose Sensing Technologies"", Diabetes Technology & Therapeutics, vol. 3, No. 3, 2001, pp. 409-418.;;Bremer, T., et al., ""Is Blood Glucose Predictable from Previous Values?"", Diabetes, vol. 48, 1999, pp. 445-451.;;Brooks, S. L., et al., ""Development of an On-Line Glucose Sensor for Fermentation Monitoring"", Biosensors, vol. 3, 1987/88, pp. 45-56.;;Brownlee, M., et al., ""A Glucose-Controlled Insulin-Delivery System: Semisynthetic Insulin Bound to Lectin"", Science, vol. 206, 1979, 1190-1191.;;Cai, Q., et al., ""A Wireless, Remove Query Glucose Biosensor Based on a pH-Sensitive Polymer"", Analytical Chemistry, vol. 76, No. 14, 2004, pp. 4038-4043.;;Candas, B., et al., ""An Adaptive Plasma Glucose Controller Based on a Nonlinear Insulin/Glucose Model"", IEEE Transactions on Biomedical Engineering, vol. 41, No. 2, 1994, pp. 116-124.;;Cass, A. E., et al., ""Ferricinum Ion as an Electron Acceptor for Oxido-Reductases"", Journal of ElectroAnalytical Chemistry, vol. 190, 1985, pp. 117-127.;;Cass, A. E., et al., ""Ferrocene-Medicated Enzyme Electrode for Amperometric Determination of Glucose"", Analytical Chemistry, vol. 56, No. 4, 1984, 667-671.;;Castner, J. F., et al., ""Mass Transport and Reaction Kinetic Parameters Determined Electrochemically for Immobilized Glucose Oxidase"", Biochemistry, vol. 23, No. 10, 1984, 2203-2210.;;Chen, J. C., et al., ""A Comparison of MAC Protocols for Wireless Local Networks Based on battery Power Consumption"", IEEE, 1998, pp. 150-157.;;Chen, T., et al., ""Defining the Period of Recovery of the Glucose Concentration After Its Local Perturbation by the Implantation of a Miniature Sensor"", Clinical Chemistry and Laboratory Medicine, vol. 40, No. 8, 2002, pp. 486-489.;;Chia, C. W., et al., ""Glucose Sensors: Toward Closed Loop Insulin Delivery"", Endocrinology and Metabolism Clinics of North America, vol. 33, 2004, pp. 175-195.;;Choleau, C., et al., ""Calibration of a Subcutaneous Amperometric Glucose Sensor Implanted for 7 Days in Diabetic Patients Part 2: Superiority of the One-Point Calibration Method"", Biosensors and Bioelectronics, vol. 17, 2002, pp. 647-654.;;Choleau, C., et al., ""Calibration of a Subcutaneous Amperometric Glucose Sensor Part 1: Effect of Measurement Uncertainties on the Determination of Sensor Sensitivity and Background Current"", Biosensors and Bioelectronics, vol. 17, 2002, pp. 641-646.;;Claremont, D. J., et al., ""Biosensors for Continuous In Vivo Glucose Monitoring"", Proceedings of the Annual International Conference of the IEEE Engineering in Medicine and Biology Society, vol. 10, 1988.;;Clark Jr., L. C., et al., ""Differential Anodic Enzyme Polarography for the Measurement of Glucose"", Oxygen Transport to Tissue: Instrumentation, Methods, and Physiology, 1973, pp. 127-133.;;Clark Jr., L. C., et al., ""Electrode Systems for Continuous Monitoring in Cardiovascular Surgery"", Annals New York Academy of Sciences, 1962, pp. 29-45.;;Clark Jr., L. C., et al., ""Long-term Stability of Electroenzymatic Glucose Sensors Implanted in Mice"", American Society of Artificial Internal Organs Transactions, vol. XXXIV, 1988, pp. 259-265.;;Clarke, W. L., et al., ""Evaluating Clinical Accuracy of Systems for Self-Monitoring of Blood Glucose"", Diabetes Care, vol. 10, No. 5, 1987, pp. 622-628.;;Complaint, ""Abbott Diabetes Care, Inc. v. Dexcom, Inc."", filed Aug. 11, 2005.;;Complaint, Amended, ""Abbott Diabetes Care, Inc. v. Dexcom, Inc."", filed Jun. 27, 2006.;;Cox, D. J., et al., ""Accuracy of Perceiving Blood Glucose in IDDM"", Diabetes Care, vol. 8, No. 6, 1985, pp. 529-536.;;Csoregi, E., et al., ""Amperometric Microbiosensors for Detection of Hydrogen Peroxide and Glucose Based on Peroxidase-Modified Carbon Fibers"", Electroanalysis, vol. 6, 1994, pp. 925-933.;;Csoregi, E., et al., ""Design and Optimization of a Selective Subcutaneously Implantable Glucose Electrode Based on 'Wired' Glucose Oxidase"", Analytical Chemistry, vol. 67, No. 7, 1995, pp. 1240-1244.;;Csoregi, E., et al., ""Design, Characterization, and One-Point in Vivo Calibration of a Subcutaneously Implanted Glucose Electrode"", Analytical Chemistry, vol. 66, No. 19, 1994, pp. 3131-3138.;;Csoregi, E., et al., ""On-Line Glucose Monitoring by Using Microdialysis Sampling and Amperometric Detection Based on 'Wired' Glucose Oxidase in Carbon Paste"", Mikrochimica Acta, vol. 121, 1995, pp. 31-40.;;D'Arrigo, G., et al., ""Porous-Si Based Bio Reactors for Glucose Monitoring and Drugs Production"", Proceedings of SPIE: Microfluids, BioMEMS, and Medical Microsystems, vol. 4982, 2003, pp. 178-184.;;Dai, W. S., et al., ""Hydrogel Membranes with Mesh Size Asymmetry Based on the Gradient Crosslinking of Poly(vinyl alcohol),"" Journal of Membrane Science, vol. 156, 1999, pp. 67-79.;;Davies, M. L., et al., ""Polymer Membranes in Clinical Sensor Applications"", Biomaterials, vol. 13, No. 14, 1992, pp. 971-978.;;Davis, G., ""Electrochemical Techniques for the Development of Amperometric Biosensors"", Biosensors, vol. 1, 1985, pp. 161-178.;;Degani, Y., et al., ""Direct Electrical Communication Between Chemically Modified Enzymes and Metal Electrodes. 1. Electron Transfer from Glucose Oxidase to Metal Electrodes via Electron Relays, Bound Covalently to the Enzyme"", The Journal of Physical Chemistry, vol. 91, No. 6, 1987, pp. 1285-1289.;;Degani, Y., et al., ""Direct Electrical Communication Between Chemically Modified Enzymes and Metal Electrodes. 2. Methods for Bonding Electron-Transfer Relays to Glucose Oxidase and D-Amino-Acid Oxidase"", Journal of the American Chemical Society, vol. 110, No. 8, 1988, pp. 2615-2620.;;Degani, Y., et al., ""Electrical Communication Between Redox Centers of Glucose Oxidase and Electrodes via Electrostatically and Covalently Bound Redox Polymers"", Journal of the American Chemical Society, vol. 111, 1989, pp. 2357-2358.;;Denisevich, P., et al., ""Unidirectional Current Flow and Charge State Trapping at Redox Polymer Interfaces on Bilayer Electrodes: Principles, Experimental Demonstration, and Theory"", Journal of the American Chemical Society, vol. 103, 1981, pp. 4727-4737.;;Dicks, J. M., et al., ""Ferrocene Modified Polypyrrole with Immobilised Glucose Oxidase and its Application in Amperometric Glucose Microbiosensors"", Annales de Biologie Clinique, vol. 47, 1989, pp. 607-619.;;Dixon, B. M., et al., ""Characterization In Vitro and In Vivo of the Oxygen Dependence of an Enzyme/Polymer Biosensors for Monitoring Brain Glucose"", Journal of Neuroscience Methods, vol. 199, 2002, pp. 135-142.;;Eighth Annual Diabetes Technology Meeting Abstracts, Nov. 13-15, 2008, pp. A1-A182.;;El-Khatib, F. H, et al., ""Adaptive Closed-Loop Control Provides Blood-Glucose Regulation Using Subcutaneous Insulin and Glucagon Infusion in Diabetic Swine"", Journal of Diabetes Science and Technology, vol. 1, No. 2, 2007, pp. 181-192.;;Ellis, C. D., et al., ""Selectivity and Directed Charge Transfer through an Electroactive Metallopolymer Film"", Journal of the American Chemical Society, vol. 103, No. 25, 1981, pp. 7480-7483.;;El-Sa'ad, L., et al., ""Moisture Absorption by Epoxy Resins: The Reverse Thermal Effect"", Journal of Materials Science, vol. 25, No. 8, 1990, pp. 3577-3582.;;Engstrom, R. C., ""Electrochemical Pretreatment of Glassy Carbon Electrodes"", Analytical Chemistry, vol. 54, No. 13, 1982, pp. 2310-2314.;;Engstrom, R. C., et al., ""Characterization of Electrochemically Pretreated Glassy Carbon Electrodes"", Analytical Chemistry, vol. 56, No. 2, 1984, pp. 136-141.;;Ernst, H., et al., ""Reliable Glucose Monitoring Through the Use of Microsystem Technology"", Analytical and Bioanalytical Chemistry, vol. 373, 2002, pp. 758-761.;;Fabietti, P. G., et al. ""Clinical Validation of a New Control-Oriented Model of Insulin and Glucose Dynamics in Subjects with Type 1 Diabetes"", Diabetes Technology & Therapeutics, vol. 9, No. 4, 2007, pp. 327-338.;;Fare, T. L., et al., ""Functional Characterization of a Conducting Polymer-Based Immunoassay System"", Biosensors & Bioelectronics, vol. 13, No. 3-4, 1998, pp. 459-470.;;Feldman, B., et al., ""A Continuous Glucose Sensor Based on Wired Enzyme(TM) Technology-Results from a 3-Day Trial in Patients with Type 1 Diabetes"", Diabetes Technology & Therapeutics, vol. 5, No. 5, 2003, pp. 769-779.;;Feldman, B., et al., ""Correlation of Glucose Concentrations in Interstitial Fluid and Venous Blood During Periods of Rapid Glucose Change"", Abbott Diabetes Care, Inc. Freestyle Navigator Continuous Glucose Monitor Pamphlet, 2004.;;Feldman, B., et al., ""Electron Transfer Kinetics at Redox Polymer/Solution Interfaces Using Microelectrodes and Twin Electrode Thin Layer Cells"", Journal of ElectroAnalytical Chemistry, vol. 194, 1985, pp. 63-81.;;Fischer, H., et al., ""Intramolecular Electron Transfer Medicated by 4,4'-Bypyridine and Related Bridging Groups"", Journal of the American Chemical Society, vol. 98, No. 18, 1976, pp. 5512-5517.;;Flentge, F., et al., ""An Enzyme-Reactor for Electrochemical Monitoring of Choline and Acetylcholine: Applications in High-Performance Liquid Chromatography, Bran Tissue, Microdialysis and Cerebrospinal Fluid,"" Analytical Biochemistry, vol. 204, 1992, pp. 305-310.;;Foulds, N. C., et al., ""Enzyme Entrapment in Electrically Conducting Polymers: Immobilisation of Glucose Oxidase in Polypyrrole and its Application in Amperometric Glucose Sensors"", Journal of the Chemical Society, Faraday Transactions 1, vol. 82, 1986, pp. 1259-1264.;;Foulds, N. C., et al , ""Immobilization of Glucose Oxidase in Ferrocene-Modified Pyrrole Polymers"", Analytical Chemistry, vol. 60, No. 22, 1988, pp. 2473-2478.",EXPIRED
203,US,A1,US 2010/0280346 A1,177-872-291-870-628,2010-11-04,2010,US 83746310 A,2010-07-15,US 83746310 A;;US 69082607 A;;US 42005703 A;;US 66719900 A;;US 7067798 A,1998-04-30,Analyte Monitoring Device and Methods of Use,"An analyte monitor includes a sensor, a sensor control unit, and a display unit. The sensor has, for example, a substrate, a recessed channel formed in the substrate, and conductive material disposed in the recessed channel to form a working electrode. The sensor control unit typically has a housing adapted for placement on skin and is adapted to receive a portion of an electrochemical sensor. The sensor control unit also includes two or more conductive contacts disposed on the housing and configured for coupling to two or more contact pads on the sensor. A transmitter is disposed in the housing and coupled to the plurality of conductive contacts for transmitting data obtained using the sensor. The display unit has a receiver for receiving data transmitted by the transmitter of the sensor control unit and a display coupled to the receiver for displaying an indication of a level of an analyte. The analyte monitor may also be part of a drug delivery system to alter the level of the analyte based on the data obtained using the sensor.",ABBOTT DIABETES CARE INC,SAY JAMES;;TOMASCO MICHAEL F;;HELLER ADAM;;GAL YORAM;;ARIA BEHRAD;;HELLER EPHRAIM;;PLANTE PHILLIP JOHN;;VREEKE MARK S;;FRIEDMAN KEITH A;;COLMAN FREDRIC C,,https://lens.org/177-872-291-870-628,Patent Application,yes,1,46,211,221,0,A61B5/14532;;A61B5/14532;;A61B5/0002;;A61B5/0002;;A61B5/002;;A61B5/01;;A61B5/14503;;A61B5/1451;;A61B5/14546;;A61B5/14546;;A61B5/1473;;A61B5/1473;;A61B5/1486;;A61B5/1486;;A61B5/14865;;A61B5/1495;;A61B5/4839;;A61B5/72;;A61B5/7278;;A61B5/7282;;A61B5/7405;;A61B5/743;;A61B5/7445;;A61B5/7445;;A61B5/7455;;A61B2560/0252;;A61B2560/0252;;A61M5/1723;;C12Q1/54;;G16H10/40;;G16H10/40;;G16H20/17;;G16H20/17;;H01L23/3107;;H01L23/3107;;H01L23/49548;;H01L23/49548;;H01L2924/0002;;H01L2924/0002;;H01L2924/19041;;H01L2924/19041;;H01L2924/3011;;H01L2924/3011;;Y10S128/903;;Y10S128/903;;Y10T29/49;;Y10T29/49;;Y10T29/49124;;Y10T29/49124,A61B5/05;;G01N27/30;;A61B5/00;;A61B5/145;;A61B5/1477;;A61B5/1495;;G01N27/416;;G06F19/00;;H01L23/31;;H01L23/495,600/345,0,0,,,,DISCONTINUED
204,US,A1,US 2009/0182213 A1,028-570-701-327-913,2009-07-16,2009,US 40578609 A,2009-03-17,US 40578609 A;;US 42005703 A;;US 66719900 A;;US 7067798 A,1998-04-30,Analyte Monitoring Device and Methods of Use,"An analyte monitor includes a sensor, a sensor control unit, and a display unit. The sensor has, for example, a substrate, a recessed channel formed in the substrate, and conductive material disposed in the recessed channel to form a working electrode. The sensor control unit typically has a housing adapted for placement on skin and is adapted to receive a portion of an electrochemical sensor. The sensor control unit also includes two or more conductive contacts disposed on the housing and configured for coupling to two or more contact pads on the sensor. A transmitter is disposed in the housing and coupled to the plurality of conductive contacts for transmitting data obtained using the sensor. The display unit has a receiver for receiving data transmitted by the transmitter of the sensor control unit and a display coupled to the receiver for displaying an indication of a level of an analyte. The analyte monitor may also be part of a drug delivery system to alter the level of the analyte based on the data obtained using the sensor.",ABBOTT DIABETES CARE INC,SAY JAMES;;TOMASCO MICHAEL F;;HELLER ADAM;;GAL YORAM;;ARIA BEHRAD;;HELLER EPHRAIM;;PLANTE PHILLIP JOHN;;VREEKE MARK S;;FRIEDMAN KEITH A;;COLMAN FREDRIC C,,https://lens.org/028-570-701-327-913,Patent Application,yes,1,56,211,221,0,A61B5/14532;;A61B5/14532;;A61B5/0002;;A61B5/0002;;A61B5/002;;A61B5/01;;A61B5/14503;;A61B5/1451;;A61B5/14546;;A61B5/14546;;A61B5/1473;;A61B5/1473;;A61B5/1486;;A61B5/1486;;A61B5/14865;;A61B5/1495;;A61B5/4839;;A61B5/72;;A61B5/7278;;A61B5/7282;;A61B5/7405;;A61B5/743;;A61B5/7445;;A61B5/7445;;A61B5/7455;;A61B2560/0252;;A61B2560/0252;;A61M5/1723;;C12Q1/54;;G16H10/40;;G16H10/40;;G16H20/17;;G16H20/17;;H01L23/3107;;H01L23/3107;;H01L23/49548;;H01L23/49548;;H01L2924/0002;;H01L2924/0002;;H01L2924/19041;;H01L2924/19041;;H01L2924/3011;;H01L2924/3011;;Y10S128/903;;Y10S128/903;;Y10T29/49;;Y10T29/49;;Y10T29/49124;;Y10T29/49124,A61B5/1468;;G01N27/30;;A61B5/00;;A61B5/145;;A61B5/1477;;A61B5/1495;;G01N27/416;;G06F19/00;;H01L23/31;;H01L23/495,600/345,0,0,,,,DISCONTINUED
205,US,A1,US 2010/0056889 A1,023-569-944-051-27X,2010-03-04,2010,US 61497409 A,2009-11-09,US 61497409 A;;US 42005703 A;;US 66719900 A;;US 7067798 A,1998-04-30,Analyte Monitoring Device And Methods Of Use,"An analyte monitor includes a sensor, a sensor control unit, and a display unit. The sensor has, for example, a substrate, a recessed channel formed in the substrate, and conductive material disposed in the recessed channel to form a working electrode. The sensor control unit typically has a housing adapted for placement on skin and is adapted to receive a portion of an electrochemical sensor. The sensor control unit also includes two or more conductive contacts disposed on the housing and configured for coupling to two or more contact pads on the sensor. A transmitter is disposed in the housing and coupled to the plurality of conductive contacts for transmitting data obtained using the sensor. The display unit has a receiver for receiving data transmitted by the transmitter of the sensor control unit and a display coupled to the receiver for displaying an indication of a level of an analyte. The analyte monitor may also be part of a drug delivery system to alter the level of the analyte based on the data obtained using the sensor.",SAY JAMES;;TOMASCO MICHAEL F;;HELLER ADAM;;GAL YORAM;;ARIA BEHRAD;;HELLER EPHRAIM;;PLANTE PHILLIP JOHN;;VREEKE MARK S;;FRIEDMAN KEITH A;;COLMAN FREDRIC C,SAY JAMES;;TOMASCO MICHAEL F;;HELLER ADAM;;GAL YORAM;;ARIA BEHRAD;;HELLER EPHRAIM;;PLANTE PHILLIP JOHN;;VREEKE MARK S;;FRIEDMAN KEITH A;;COLMAN FREDRIC C,E. HELLER & CO (1998-07-02);;ABBOTT DIABETES CARE INC (2000-03-13),https://lens.org/023-569-944-051-27X,Patent Application,yes,63,1,211,221,0,A61B5/14532;;A61B5/14532;;A61B5/0002;;A61B5/0002;;A61B5/002;;A61B5/01;;A61B5/14503;;A61B5/1451;;A61B5/14546;;A61B5/14546;;A61B5/1473;;A61B5/1473;;A61B5/1486;;A61B5/1486;;A61B5/14865;;A61B5/1495;;A61B5/4839;;A61B5/72;;A61B5/7278;;A61B5/7282;;A61B5/7405;;A61B5/743;;A61B5/7445;;A61B5/7445;;A61B5/7455;;A61B2560/0252;;A61B2560/0252;;A61M5/1723;;C12Q1/54;;G16H10/40;;G16H10/40;;G16H20/17;;G16H20/17;;H01L23/3107;;H01L23/3107;;H01L23/49548;;H01L23/49548;;H01L2924/0002;;H01L2924/0002;;H01L2924/19041;;H01L2924/19041;;H01L2924/3011;;H01L2924/3011;;Y10S128/903;;Y10S128/903;;Y10T29/49;;Y10T29/49;;Y10T29/49124;;Y10T29/49124,A61B5/05;;G01N27/30;;A61B5/00;;A61B5/145;;A61B5/1477;;A61B5/1495;;G01N27/416;;G06F19/00;;H01L23/31;;H01L23/495,600/345,0,0,,,,EXPIRED
206,US,A1,US 2009/0187090 A1,025-595-881-777-947,2009-07-23,2009,US 41448709 A,2009-03-30,US 41448709 A;;US 42005703 A;;US 66719900 A;;US 7067798 A,1998-04-30,Analyte Monitoring Device and Methods of Use,"An analyte monitor includes a sensor, a sensor control unit, and a display unit. The sensor has, for example, a substrate, a recessed channel formed in the substrate, and conductive material disposed in the recessed channel to form a working electrode. The sensor control unit typically has a housing adapted for placement on skin and is adapted to receive a portion of an electrochemical sensor. The sensor control unit also includes two or more conductive contacts disposed on the housing and configured for coupling to two or more contact pads on the sensor. A transmitter is disposed in the housing and coupled to the plurality of conductive contacts for transmitting data obtained using the sensor. The display unit has a receiver for receiving data transmitted by the transmitter of the sensor control unit and a display coupled to the receiver for displaying an indication of a level of an analyte. The analyte monitor may also be part of a drug delivery system to alter the level of the analyte based on the data obtained using the sensor.",ABBOTT DIABETES CARE INC,SAY JAMES;;TOMASCO MICHAEL F;;HELLER ADAM;;GAL YORAM;;ARIA BEHRAD;;HELLER EPHRAIM;;PLANTE PHILLIP JOHN;;VREEKE MARK S;;FRIEDMAN KEITH A;;COLMAN FREDRIC C,E. HELLER & CO (1998-07-02);;ABBOTT DIABETES CARE INC (2000-03-13),https://lens.org/025-595-881-777-947,Patent Application,yes,100,109,211,221,0,A61B5/14532;;A61B5/14532;;A61B5/0002;;A61B5/0002;;A61B5/002;;A61B5/01;;A61B5/14503;;A61B5/1451;;A61B5/14546;;A61B5/14546;;A61B5/1473;;A61B5/1473;;A61B5/1486;;A61B5/1486;;A61B5/14865;;A61B5/1495;;A61B5/4839;;A61B5/72;;A61B5/7278;;A61B5/7282;;A61B5/7405;;A61B5/743;;A61B5/7445;;A61B5/7445;;A61B5/7455;;A61B2560/0252;;A61B2560/0252;;A61M5/1723;;C12Q1/54;;G16H10/40;;G16H10/40;;G16H20/17;;G16H20/17;;H01L23/3107;;H01L23/3107;;H01L23/49548;;H01L23/49548;;H01L2924/0002;;H01L2924/0002;;H01L2924/19041;;H01L2924/19041;;H01L2924/3011;;H01L2924/3011;;Y10S128/903;;Y10S128/903;;Y10T29/49;;Y10T29/49;;Y10T29/49124;;Y10T29/49124,A61B5/1468;;G01N27/30;;A61B5/00;;A61B5/145;;A61B5/1477;;A61B5/1495;;G01N27/416;;G06F19/00;;H01L23/31;;H01L23/495,600/345,0,0,,,,EXPIRED
207,US,B2,US 8175673 B2,043-199-334-235-362,2012-05-08,2012,US 61506909 A,2009-11-09,US 61506909 A;;US 42005703 A;;US 66719900 A;;US 7067798 A,1998-04-30,Analyte monitoring device and methods of use,"An analyte monitor includes a sensor, a sensor control unit, and a display unit. The sensor has, for example, a substrate, a recessed channel formed in the substrate, and conductive material disposed in the recessed channel to form a working electrode. The sensor control unit typically has a housing adapted for placement on skin and is adapted to receive a portion of an electrochemical sensor. The sensor control unit also includes two or more conductive contacts disposed on the housing and configured for coupling to two or more contact pads on the sensor. A transmitter is disposed in the housing and coupled to the plurality of conductive contacts for transmitting data obtained using the sensor. The display unit has a receiver for receiving data transmitted by the transmitter of the sensor control unit and a display coupled to the receiver for displaying an indication of a level of an analyte. The analyte monitor may also be part of a drug delivery system to alter the level of the analyte based on the data obtained using the sensor.",SAY JAMES;;TOMASCO MICHAEL F;;HELLER ADAM;;GAL YORAM;;ARIA BEHRAD;;HELLER EPHRAIM;;PLANTE PHILLIP JOHN;;VREEKE MARK S;;FRIEDMAN KEITH A;;COLMAN FREDRIC C;;ABBOTT DIABETES CARE INC,SAY JAMES;;TOMASCO MICHAEL F;;HELLER ADAM;;GAL YORAM;;ARIA BEHRAD;;HELLER EPHRAIM;;PLANTE PHILLIP JOHN;;VREEKE MARK S;;FRIEDMAN KEITH A;;COLMAN FREDRIC C,,https://lens.org/043-199-334-235-362,Granted Patent,yes,117,5,211,221,0,A61B5/14532;;A61B5/14532;;A61B5/0002;;A61B5/0002;;A61B5/002;;A61B5/01;;A61B5/14503;;A61B5/1451;;A61B5/14546;;A61B5/14546;;A61B5/1473;;A61B5/1473;;A61B5/1486;;A61B5/1486;;A61B5/14865;;A61B5/1495;;A61B5/4839;;A61B5/72;;A61B5/7278;;A61B5/7282;;A61B5/7405;;A61B5/743;;A61B5/7445;;A61B5/7445;;A61B5/7455;;A61B2560/0252;;A61B2560/0252;;A61M5/1723;;C12Q1/54;;G16H10/40;;G16H10/40;;G16H20/17;;G16H20/17;;H01L23/3107;;H01L23/3107;;H01L23/49548;;H01L23/49548;;H01L2924/0002;;H01L2924/0002;;H01L2924/19041;;H01L2924/19041;;H01L2924/3011;;H01L2924/3011;;Y10S128/903;;Y10S128/903;;Y10T29/49;;Y10T29/49;;Y10T29/49124;;Y10T29/49124,A61B5/05;;G01N27/30;;A61B5/00;;A61B5/145;;A61B5/1477;;A61B5/1495;;G01N27/416;;G06F19/00;;H01L23/31;;H01L23/495,600/345;;600/309;;600/365,99,82,136-791-935-548-81X;;062-360-289-025-864;;010-601-725-111-91X;;101-292-518-663-191;;056-703-879-057-297;;030-155-762-644-019;;004-149-141-436-651;;016-731-054-793-457;;080-559-561-995-335;;044-807-213-528-815;;027-538-525-436-179;;015-020-161-517-40X;;025-919-454-564-785;;014-700-576-603-812;;004-851-060-590-788;;075-958-432-122-199;;052-356-140-149-389;;035-090-282-884-790;;033-562-815-299-181;;018-803-926-589-211;;008-505-762-041-402;;016-601-143-530-813;;019-502-772-562-215;;058-476-824-396-350;;006-498-707-073-30X;;054-091-551-638-293;;010-531-147-771-746;;054-827-198-877-419;;122-658-944-077-000;;017-261-560-469-37X;;000-125-755-474-124;;113-381-664-783-802;;082-626-907-191-554;;017-950-014-792-456;;090-348-305-613-628;;015-985-399-299-132;;171-049-047-164-618;;016-819-089-891-758;;081-249-097-078-543;;081-249-097-078-543;;089-612-747-111-646;;031-706-897-890-035;;094-198-536-559-723;;003-690-143-043-420;;007-943-354-378-456;;082-114-500-909-975;;004-239-090-971-580;;026-894-457-160-450;;077-128-610-778-669;;022-466-506-956-898;;008-424-592-956-946;;007-500-825-916-378;;009-725-244-669-882;;037-755-689-613-42X;;153-411-506-517-475;;038-134-360-685-692;;012-449-714-188-064;;031-517-704-996-130;;131-299-284-996-064;;049-133-049-742-708;;000-272-178-768-076;;070-797-683-833-124;;043-870-224-178-49X;;025-574-914-238-550;;052-364-430-129-757;;004-434-167-910-115;;032-860-147-271-886;;132-460-374-211-421;;098-172-374-375-47X;;109-358-955-476-095;;014-988-634-483-130;;061-786-187-274-992;;037-898-018-686-909;;130-044-667-529-69X;;134-265-642-839-645;;065-221-074-461-027;;017-934-465-161-477;;101-660-130-379-529;;028-236-706-290-220;;087-333-189-994-274;;059-082-211-027-266;;057-977-752-782-568,10.1016/s0956-5663(02)00099-4;;12392956;;10.1021/ja00391a001;;2889225;;10.1098/rstb.1987.0021;;10.1109/51.294001;;10.1016/0022-0728(65)85063-x;;2245876;;10.2337/diabetes.39.12.1519;;10.2337/diab.39.12.1519;;10.1016/s0956-5663(03)00220-3;;14611755;;18615658;;10.1002/bit.260430310;;9366023;;10.1016/s0956-5663(97)00025-0;;9451795;;10.1016/s0956-5663(97)00083-3;;10.1016/0956-5663(93)80028-n;;8311939;;8651496;;10.1021/ac960030d;;10.1080/03091900210156797;;12487712;;10.1016/0265-928x(87)80018-4;;3333622;;10.1109/19.816143;;10.1007/bf01015979;;10.1089/15209150252924058;;12017416;;18473691;;10.1089/dia.2007.0281;;10.1021/ac00017a008;;1789439;;2817408;;10.1021/ac00197a022;;10.1016/0925-4005(95)01730-5;;10.1016/0010-4825(90)90013-f;;2257734;;2868172;;8277748;;10.1016/0141-5425(93)90058-7;;11469630;;10.1089/15209150050214104;;10624783;;10.1016/s0168-8227(99)00113-8;;10.1089/15209150050214113;;11469631;;10.1007/bf00401374;;1478372;;10.2337/diacare.20.1.64;;9028696;;10.1109/tbme.1986.325807;;3957374;;236018;;10.1016/0005-2795(75)90259-7;;10.1089/hum.1998.9.6-879;;9581910;;11762520;;10.1089/15209150152607196;;10.2337/diabetes.48.3.445;;10078542;;10.1016/0265-928x(87)80012-3;;505005;;10.1126/science.505005;;10.1021/ac0498516;;15253640;;10.1109/10.284922;;8026845;;6721151;;10.1021/ac00268a018;;6721151;;10.1021/ac00268a018;;6733082;;10.1021/bi00305a016;;10.1515/cclm.2002.135;;12392305;;10.1016/j.ecl.2003.12.001;;15053902;;12052350;;10.1016/s0956-5663(01)00304-9;;12052349;;10.1016/s0956-5663(01)00306-2;;4500021;;10.1007/978-1-4684-3288-6_18;;14021529;;10.1111/j.1749-6632.1962.tb13623.x;;3196517;;10.2337/diacare.10.5.622;;3677983;;10.2337/diacare.8.6.529;;4075939;;10.1002/elan.1140061103;;7733469;;10.1021/ac00103a015;;7978306;;10.1021/ac00091a022;;10.1007/bf01248238;;10.1016/s0376-7388(98)00330-5;;10.1016/0142-9612(92)90147-g;;1472593;;10.1016/0265-928x(85)80002-x;;10.1021/j100290a001;;10.1021/ja00216a040;;10.1021/ja00188a091;;10.1021/ja00406a011;;2624333;;12323417;;10.1016/s0165-0270(02)00170-x;;10.1177/193229680700100208;;pmc2771467;;19888405;;10.1021/ja00415a014;;10.1007/bf00575392;;10.1021/ac00250a038;;10.1021/ac00266a005;;10.1007/s00216-002-1284-0;;12194035;;10.1089/dia.2006.0030;;17705688;;9642777;;10.1016/s0956-5663(97)00091-2;;10.1089/152091503322526978;;14633342;;10.1016/0022-0728(85)87006-6;;10.1021/ja00434a018;;10.1016/0003-2697(92)90243-z;;1443528;;10.1039/f19868201259;;3245585;;10.1021/ac00173a008;;2889234;;10.1098/rstb.1987.0020;;11762521;;10.1089/15209150152607204;;12413548;;10.1016/s1367-5931(02)00371-x;;10526740;;10.2337/diacare.22.10.1708;;14988294;;10.2337/diacare.27.3.734,"""Poretics Polycarbonate Membrane"", Osmonics Filtration and Separation Group, 2002.;;Abel, P. U., et al., ""Biosensors for In Vivo Glucose Measurement: Can We Cross the Experimental Stage"", Biosensors and Bioelectronics, vol. 17, 2002, pp. 1059-1070.;;Abruna, H. D., et al., ""Rectifying Interfaces Using Two-Layer Films of Electrochemically Polymerized Vinylpyridine and Vinylbipyridine Complexes of Ruthenium and Iron on Electrodes"", Journal of the American Chemical Society, vol. 103, No. 1, 1981, pp. 1-5.;;Albery, W. J., et al., ""Amperometric Enzyme Electrodes Part II: Conducting Salts as Electrode Materials for the Oxidation of Glucose Oxidase"", Journal of ElectroAnalytical Chemistry, vol. 194, 1985, pp. 223-235.;;Albery, W. J., et al., ""Amperometric Enzyme Electrodes"", Philosophical Transactions of The Royal Society of London, vol. 316, 1987, pp. 107-119;;Alcock, S. J., et al., ""Continuous Analyte Monitoring to Aid Clinical Practice"", IEEE Engineering in Medicine and Biology Magazine, 1994, pp. 319-325.;;Anderson, L. B., et al., ""Thin-Layer Electrochemistry: Steady-State Methods of Studying Rate Processes"", Journal of ElectroAnalytical Chemistry, vol. 10, 1965, pp. 295-305.;;Armour, J. C., et al., ""Application of Chronic Intravascular Blood Glucose Sensor in Dogs"", Diabetes, vol. 39, 1990, pp. 1519-1526.;;Asberg, P., et al., ""Hydrogels of a Conducting Conjugated Polymer as 3-D Enzyme Electrode"", Biosensors & Bioelectronics, vol. 19, 2003, pp. 199-207.;;Atanasov, P., et al., ""Biosensor for Continuous Glucose Monitoring"", Biotechnology and Bioengineering, vol. 43, 1994, pp. 262-266.;;Atanasov, P., et al., ""Implantation of a Refillable Glucose Monitoring-Telemetry Device"", Biosensors & Bioelectronics, vol. 12, No. 7, 1997, pp. 669-680.;;Aussedat, B., et al., ""A User-Friendly Method for Calibrating a Subcutaneous Glucose Sensor-Based Hypoglycaemic Alarm"", Biosensors & Bioelectronics, vol. 12, No. 11, 1997, pp. 1061-1071.;;Baker, D. A., et al., ""Dynamic Concentration Challenges for Biosensor Characterization"", Biosensors & Bioelectronics, vol. 8, 1993, pp. 433-441.;;Baker, D. A., et al., ""Dynamic Delay and Maximal Dynamic Error in Continuous Biosensors"", Analytical Chemistry, vol. 68, No. 8, 1996, pp. 1292-1297.;;Bani Amer, M. M., ""An Accurate Amperometric Glucose Based Glucometer with Eliminated Cross-Sensitivity"", Journal of Medical Engineering & Technology, vol. 26, No. 5, 2002, pp. 208-213.;;Bard, A. J., et al., Electrochemical Methods, 1980, pp. 173-175.;;Bartlett, P. N., et al., ""Covalent Binding of Electron Relays to Glucose Oxidase"", Journal of the Chemical Society, Chemical Communications, 1987, pp. 1603-1604.;;Bartlett, P. N., et al., ""Modification of Glucose Oxidase by Tetrathiafulvalene"", Journal of the Chemical Society, Chemical Communications, 1990, pp. 1135-1136.;;Bartlett, P. N., et al., ""Strategies for the Development of Amperometric Enzyme Electrodes"", Biosensors, vol. 3, 1987/1988, pp. 359-379.;;Beach, R. D., et al., ""Subminiature Implantable Potentiostat and Modified Commercial Telemetry Device for Remote Glucose Monitoring"", IEEE Transactions on Instrumentation and Measurement, vol. 28, No. 6, 1999, pp. 1239-1245.;;Beech, W. A., ""AX.25 Link Access Protocol for Amateur packet Radio"", Tucson Amateur Packet Radio Corporation, 1998, pp. 1-133.;;Bellucci, F., et al., ""Electrochemical Behaviour of Graphite-Epoxy Composite Materials (GECM) in Aqueous Salt Solutions"", Journal of Applied Electrochemistry, vol. 16, 1986, pp. 15-22.;;Bennion, N., et al., ""Alternate Site Glucose Testing: A Crossover Design"", Diabetes Technology & Therapeutics, vol. 4, No. 1, 2002, pp. 25-33.;;Biermann, E., et al., ""How Would Patients Behave if They Were Continually Informed of Their Blood Glucose Levels? A Simulation Study Using a 'Virtual' Patient"", Diabetes Technology & Therapeutics, vol. 10, No. 3, 2008, pp. 178-187.;;Bindra, D. S., et al., ""Design and in Vitro Studies of a Needle-Type Glucose Sensor for Subcutaneous Monitoring"", Analytical Chemistry, vol. 63, No. 17, 1991, pp. 1692-1696.;;Bindra, D. S., et al., ""Pulsed Amperometric Detection of Glucose in Biological Fluids at a Surface-Modified Gold Electrode"", Analytical Chemistry, vol. 61, No. 22, 1989, pp. 2566-2570.;;Bisenberger, M., et al., ""A Triple-Step Potential Waveform at Enzyme Multisensors with Thick-Film Gold Electrodes for Detection of Glucose and Sucrose"", Sensors and Actuators B, vol. 28, 1995, pp. 181-189.;;Bland, J. M., et al., ""A Note on the Use of the Intraclass Correlation Coefficient in the Evaluation of Agreement Between Two Methods of Measurement"", Computers in Biology and Medicine, vol. 20, No. 5, 1990, pp. 337-340.;;Bland, J. M., et al., ""Statistical Methods for Assessing Agreement Between Two Methods of Clinical Measurement"", The Lancet, 1986, pp. 307-310.;;Blank, T. B., et al., ""Clinical Results From a Non-Invasive Blood Glucose Monitor"", Optical Diagnostics and Sensing of Biological Fluids and Glucose and Cholesterol Monitoring II, Proceedings of SPIE, vol. 4624, 2002, pp. 1-10.;;Bobbioni-Harsch, E., et al., ""Lifespan of Subcutaneous Glucose Sensors and Their Performances During Dynamic Glycaemia Changes in Rats"", Journal of Biomedical Engineering, vol. 15, 1993, pp. 457-463.;;Bode, B. W., ""Clinical Utility of the Continuous Glucose Monitoring System"", Diabetes Technology & Therapeutics, vol. 2, Sup. 1, 2000, pp. S35-S41.;;Bode, B. W., et al., ""Continuous Glucose Monitoring Used to Adjust Diabetes Therapy Improves Glycosylated Hemoglobin: A Pilot Study"", Diabetes Research and Clinical Practice, vol. 46, 1999, pp. 183-190.;;Bode, B. W., et al., ""Using the Continuous Glucose Monitoring System to Improve the Management of Type I Diabetes"", Diuabetes Technology & Therapeutics, vol. 2, Sup. 1, 2000, pp. S43-S48.;;Boedeker Plastics, Inc., ""Polyethylene Specifications"", Web Page of Boedeker.com, 2007, pp. 1-3.;;Bolinder, J., et al., ""Microdialysis Measurement of the Absolute Glucose Concentration in Subcutaneous Adipose Tissue Allowing Glucose Monitoring in Diabetic Patients"", Diabetologia, vol. 35, 1992m, pp. 1177-1180.;;Bolinder, J., et al., ""Self-Monitoring of Blood Glucose in Type I Diabetic Patients: Comparison with Continuous Microdialysis Measurements of Glucose in Subcutaneous Adipose Tissue During Ordinary Life Conditions"", Diabetes Care, vol. 20, No. 1, 1997, pp. 64-70.;;Bott, A. W., ""A Comparison of Cyclic Voltammetry and Cyclic Staircase Voltammetry"", Current Separations, vol. 16, No. 1, 1997, pp. 23-26.;;Bott, A. W., ""Electrochemical Methods for the Determination of Glucose"", Current Separations, vol. 17, No. 1, 1998, pp. 25-31.;;Bowman, L., et al., ""The Packaging of Implantable Integrated Sensors"", IEEE Transactions on Biomedical Engineering, vol. 33, No. 2, 1986, pp. 248-255.;;Brandt, J., et al., ""Covalent Attachment of Proteins to Polysaccharide Carriers by Means of Benzoquinone"", Biochimica et Biophysica Acta, vol. 386, 1975, pp. 196-202.;;Brauker, J., et al., ""Sustained Expression of High Levels of Human Factor IX from Human Cells Implanted Within an Immunoisolation Device into Athymic Rodents"", Human Gene Therapy, Therapy, vol. 9, No. 6, 1998, pp. 879-888.;;Bremer, T. M., et al., ""Benchmark Data from the Literature for Evaluation of New Glucose Sensing Technologies"", Diabetes Technology & Therapeutics, vol. 3, No. 3, 2001, pp. 409-418.;;Bremer, T., et al., ""Is Blood Glucose Predictable from Previous Values?"", Diabetes, vol. 48, 1999, pp. 445-451.;;Brooks, S. L., et al., ""Development of an On-Line Glucose Sensor for Fermentation Monitoring"", Biosensors, vol. 3, 1987/88, pp. 45-56.;;Brownlee, M., et al., ""A Glucose-Controlled Insulin-Delivery System: Semisynthetic Insulin Bound to Lectin"", Science, vol. 206, 1979, 1190-1191.;;Cai, Q., et al., ""A Wireless, Remove Query Glucose Biosensor Based on a pH-Sensitive Polymer"", Analytical Chemistry, vol. 76, No. 14, 2004, pp. 4038-4043.;;Candas, B., et al., ""An Adaptive Plasma Glucose Controller Based on a Nonlinear Insulin/Glucose Model"", IEEE Transactions on Biomedical Engineering, vol. 41, No. 2, 1994, pp. 116-124.;;Cass, A. E., et al., ""Ferriocene-Medicated Enzyme Electrode for Amperometric Determination of Glucose"", Analytical Chemistry, vol. 56, No. 4, 1984, 667-671.;;Cass, a. E., et al., ""Ferrocene-Medicated Enzyme Electrode for Amperometric Determination of Glucose"", Analytical Chemistry, vol. 56, No. 4, 1984, 667-671.;;Castner, J. F., et al., ""Mass Transport and Reaction Kinetic Parameters Determined Electrochemically for Immobilized Glucose Oxidase"", Biochemistry, vol. 23 No. 10, 1984, 2203-2210.;;Chen, J. C., et al., ""A Comparison of MAC Protocols for Wireless Local Networks Based on battery Power Consumption"",IEEE, 1998, pp. 150-157.;;Chen, T., et al., ""Defining the Period of Recovery of the Glucose Concentration After Its Local Perturbation by the Implantation of a Miniature Sensor"", Clinical Chemistry and Laboratory Medicine, vol. 40, No. 8, 2002, pp. 486-489.;;Chia, C. W., et al., ""Glucose Sensors: Toward Closed Loop Insulin Delivery"", Endocrinology and Metabolism Clinics of North America, vol. 33, 2004, pp. 175-195.;;Choleau, C., et al., ""Calibration of a Subcutaneous Amperometric Glucose Sensor Implanted for 7 Days in Diabetic Patients Part 2: Superiority of the One-Point Calibration Method"", Biosensors and Bioelectronics, vol. 17, 2002, pp. 647-654.;;Choleau, C., et al., ""Calibration of a Subcutaneous Amperometric Glucose Sensor Part 1: Effect of Measurement Uncertainties on the Determination of Sensor Sensitivity and Background Current"", Biosensors and Bioelectronics, vol. 17, 2002, pp. 641-646.;;Claremont, D. J., et al., ""Biosensors for Continuous In Vivo Glucose Monitoring"", Proceedings of the Annual International Conference of the IEEE Engineering in Medicine and Biology Society, vol. 10, 1988.;;Clark Jr., L. C., et al., ""Differential Anodic Enzyme Polarography for the Measurement of Glucose"", Oxygen Transport to Tissue: Instrumentation, Methods, and Physiology, 1973, pp. 127-133.;;Clark Jr., L. C., et al., ""Electrode Systems for Continuous Monitoring in Cardiovascular Surgery"", Annals New York Academy of Sciences, 1962, pp. 29-45.;;Clark Jr., L. C., et al., ""Long-term Stability of Electroenzymatic Glucose Sensors Implanted in Mice"", American Society of Artificial Internal Organs Transactions, vol. XXXIV, 1988, pp. 259-265.;;Clarke, W. L., et al., ""Evaluating Clinical Accuracy of Systems for Self-Monitoring of Blood Glucose"", Diabetes Care, vol. 10, No. 5, 1987, pp. 622-628.;;Complaint, ""Abbott Diabetes Care, Inc. v. Dexcom, Inc."", filed Aug. 11, 2005.;;Complaint, Amended, ""Abbott Diabetes Care, Inc. v. Dexcom, Inc."", filed Jun. 27, 2006.;;Cox, D. J., et al., ""Accuracy of Perceiving Blood Glucose in IDDM"", Diabetes Care, vol. 8, No. 6, 1985, pp. 529-536.;;Csoregi, E., et al., ""Amperometric Microbiosensors for Detection of Hydrogen Peroxide and Glucose Based on Peroxidase-Modified Carbon Fibers"", Electroanalysis, vol. 6, 1994, pp. 925-933.;;Csoregi, E., et al., ""Design and Optimization of a Selective Subcutaneously Implantable Glucose Electrode Based on 'Wired' Glucose Oxidase"", Analytical Chemistry, vol. 67, No. 7, 1995, pp. 1240-1244.;;Csoregi, E., et al., ""Design, Characterization, and One-Point in Vivo Calibration of a Subcutaneously Implanted Glucose Electrode"", Analytical Chemistry, vol. 66 No. 19, 1994, pp. 3131-3138.;;Csoregi, E., et al., ""On-Line Glucose Monitoring by Using Microdialysis Sampling and Amperometric Detection Based on 'Wired' Glucose Oxidase in Carbon Paster"", Mikrochimica Acta, vol. 121, 1995, pp. 31-40.;;D'Arrigo, G., et al., ""Porous-Si Based Bio Reactors for Glucose Monitoring and Drugs Production"", Proceedings of SPIE: Microfluids, BioMEMS, and Medical Microsystems, vol. 4982, 2003, pp. 178-184.;;Dai, W. S., et al., ""Hydrogel Membranes with Mesh Size Asymmetry Based on the Gradient Crosslinking of Poly(vinyl alcohol),"" Journal of Membrane Science, vol. 156, 1999, pp. 67-79.;;Davies, M. L., et al., ""Polymer Membranes in Clinical Sensor Applications"", Biomaterials, vol. 13, No. 14, 1992, pp. 971-978.;;Davis, G., ""Electrochemical Techniques for the Development of Amperometric Biosensors"", Biosensors, vol. 1, 1985, pp. 161-178.;;Degani, Y., et al., ""Direct Electrical Communication Between Chemically Modified Enzymes and Metal Electrodes. 1. Electron Transfer from Glucose Oxidase to Metal Electrodes via Electron Relays, Bound Covalently to the Enzyme"", The Journal of Physical Chemistry, vol. 91,. No. 6, 1987, pp. 1285-1289.;;Degani, Y., et al., ""Direct Electrical Communication Between Chemically Modified Enzymes and Metal Electrodes. 2. Methods for Bonding Electron-Transfer Relays to Glucose Oxidase and D-Amino-Acid Oxidase"", Journal of the American Chemical Society, vol. 110, No. 8, 1988, pp. 2615-2620.;;Degani, Y., et al., ""Electrical Communication Between Redox Centers of Glucose Oxidase and Electrodes via Electrostatically and Covalently Bound Redox Polymers"", Journal of the American Chemical Society, vol. 111, 1989, pp. 2357-2358.;;Denisevich, P., et al., ""Unidirectional Current Flow and Charge State Trapping at Redox Polymer Interfaces on Bilayer Electrodes: Principles, Experimental Demonstration, and Theory"", Journal of the American Chemical Society, vol. 103, 1981, pp. 4727-4737.;;Dicks, J. M., et al., ""Ferrocene Modified Polypyrrole with Immobilised Glucose Oxidase and its Application in Amperometric Glucose Microbiosensors"", Annales de Biologie Clinique, vol. 47, 1989, pp. 607-619.;;Dixon, B. M., et al., ""Characterization in Vitro and in Vivo of the Oxygen Dependence of an Enzyme/Polymer Biosensors for Monitoring Brain Glucose"", Journal of Neuroscience Methods, vol. 119, 2002, pp. 135-142.;;Eighth Annual Diabetes Technology Meeting Abstracts, Nov. 13-15, 2008, pp. Al-A182.;;El-Khatib, F. H, et al., ""Adaptive Closed-Loop Control Provides Blood-Glucose Regulation Using Subcutaneous Insulin and Glucagon Infusion in Diabetic Swine"", Journal of Diabetes Science and Technology, vol. 1, No. 2, 2007, pp. 181-192.;;Ellis, C. D., et al., ""Selectivity and Directed Charge Transfer through an Electroactive Metallopolymer Film"", Journal of the American Chemical Society, vol. 103, No. 25, 1981, pp.7480-7483.;;El-SA'AD, L., et al., ""Moisture Absorption by Epoxy Resins: Rhe Reverse Thermal Effect"", Journal of Materials Science, vol. 25, No. 8, 1990, pp. 3577-3582.;;Engstrom, R. C., ""Electrochemical Pretreatment of Glassy Carbon Electrodes"", Analytical Chemistry, vol. 54, No. 13, 1982, pp. 2310-2314.;;Engstrom, R. C., et al., ""Characterization of Electrochemically Pretreated Glassy Carbon Electrodes"", Analytical Chemistry, vol. 56, No. 2, 1984, pp. 136-141.;;Ernst, H., et al., ""Reliable Glucose Monitoring Through the Use of Microsystem Technology"", Analytical and Bioanalytical Chemistry, vol. 373, 2002, pp. 758-761.;;Fabietti, P. G., et al. ""Clinical Validation of a New Conrol-Oriented Model of Insulin and Glucose Dynamics in Subjects with Type 1 Diabetes"", Diabetes Technology & Therapeutics, vol. 9, No. 4, 2007, pp. 327-328.;;Fare, T. L., et al., ""Functional Characterization of a Conducting Polymer-Based Immunoassay System"", Biosensors & Bioelectronics, vol. 13, No. 3-4, 1998, pp. 459-470.;;Feldman, B., et al., ""A Continuous Glucose Sensor Based on Wired Enzyme(TM) Technology-Results from a 3-Day Trial in Patients with Type 1 Diabetes"", Diabetes Technology & Therapeutics, vol. 5, No. 5, 2003, pp. 769-779.;;Feldman, B., et al., ""Correlation of Glucose Concentrations in Interstitial Fluid and Venous Blood During Periods of Rapid Glucose Change"", Abbott Diabetes Care, Inc. Freestyle Navigator Continuous Glucose Monitor Pamphlet, 2004.;;Feldman, B., et al., ""Electron Transfer Kinetics at Redox Polymer/Solution Interfaces Using Microelectrodes and Twin Electrode Thin Layer Cells"", Journal of ElectroAnalytical Chemistry, vol. 194, 1985, pp. 63-81.;;Fischer, H., et al., ""Intramolecular Electron Transfer Medicated by 4,4'-Bypyridine and Related Bridging Groups"", Journal of the American Chemical Society, vol. 98, No. 18, 1976, pp. 5512-5517.;;Flentge, F., et al., ""An Enzyme-Reactor for Electrochemical Monitoring of Choline and Acetylcholine: Applications in High-Performance Liquid Chromatography, Bran Tissue, Microdialysis and Cerebrospinal Fluid,"" Analytical Biochemistry, vol. 204, 1992, pp. 305-310.;;Foulds, N. C., et al., ""Enzyme Entrapment in Electrically Conducting Polymers: Immobilisation of Glucose Oxidase in Polypyrrole and its Application in Amperometric Glucose Sensors"", Journal of the Chemical Society, Faraday Transactions 1, vol. 82, 1986, pp. 1259-1264.;;Foulds, N. C., et al , ""Immobilization of Glucose Oxidase in Ferrocene-Modified Pyrrole Polymers"", Analytical Chemistry, vol. 60, No. 22, 1988, pp. 2473-2478.;;Frew, J. E., et al., ""Electron-Transfer Biosensors"", Philosophical Transactions of the Royal Society of London, vol. 316, 1987, pp. 95-106.;;Frohnauer, M. K., et al., ""Graphical Human Insulin Time-Activity Profiles Using Standardized Definitions"", Diabetes Technology & Therapeutics, vol. 3, No. 3, 2001, pp. 419-429.;;Frost, M. C., et al., ""Implantable Chemical Sensors for Real-Time Clinical Monitoring: Progress and Challenges"", Current Opinion in Chemical Biology, vol. 6, 2002, pp. 633-641.;;Garg, S. K., et al., ""Correlation of Fingerstick Blood Glucose Measurements with GlucoWatch Biographer Glucose Results in Young Subjects with Type 1 Diabetes"", Diabetes Care, vol. 22, No. 10, 1999, pp. 1708-1714.;;Garg, S. K., et al., ""Improved Glucose Excursions Using an Implantable Real-Time Continuous Glucose Sensor in Adults with Type 1 Diabetes"", Diabetes Care, vol. 27, No. 3, 2004, pp. 734-738.",EXPIRED
208,WO,A2,WO 2004/089294 A2,131-052-462-390-918,2004-10-21,2004,US 2004/0010278 W,2004-04-02,US 46067803 P;;US 47249403 P;;US 53203003 P;;US 54898604 P,2003-04-04,"COMPOSITIONS, METHODS AND KITS RELATING TO HER-2 CLEAVAGE","The present invention relates to compositions, methods and kits based on the ADAM-mediated cleavage of Her-2. The present invention also relates to treatments for cancer, and in particular, breast cancer, by modulating the ADAM&shy;mediated cleavage of Her-2. Further, the invention relates to compositions, methods and kits based on the surprising synergistic effect between inhibition of Her-2 cleavage by an ADAM and certain cytostatic (e.g., Herceptin) and cytotoxic (e.g., Taxol) compounds in, among other things, inhibiting tumor cell proliferation and inducing cell death. Additionally, the invention relates to novel variants of ADAM15, designated ADAM15 variant I and ADAM 15 variant 2, now identified and isolated.",INCYTE CORP;;FRIEDMAN STEVEN M;;SCHERLE PEGGY A;;LIU XIANGDONG;;BURN TIMOTHY C;;HUBER REID;;LIU PHILLIP C C;;HOLLIS GREGORY F;;VADDI KRISHNA;;FRIDMAN JORDAN S,FRIEDMAN STEVEN M;;SCHERLE PEGGY A;;LIU XIANGDONG;;BURN TIMOTHY C;;HUBER REID;;LIU PHILLIP C C;;HOLLIS GREGORY F;;VADDI KRISHNA;;FRIDMAN JORDAN S,,https://lens.org/131-052-462-390-918,Patent Application,yes,5,10,10,10,0,A61K31/19;;A61K31/19;;A61K31/395;;A61K31/395;;A61P35/00;;A61P35/04,A61K/;;A61K31/19;;A61K39/395,,7,4,090-927-413-030-362;;026-281-375-851-686;;028-732-734-943-455;;062-225-493-305-044,11406546;;10.1016/s0093-7754(01)90276-3;;10.1053/sonc.2001.28544;;11706390;;9704716;;10.1200/jco.1998.16.8.2659;;12171558;;10.2174/0929867023369402,"MOLINA ET AL., CANCER RES., vol. 61, 2001, pages 4744 - 4749;;BASELGA ET AL., SEMINARS IN ONCOLOGY, vol. 28, no. 16, 2001, pages 4 - 11;;BASELGA ET AL., ANNALS OF ONCOLOGY, vol. 12, no. 1, 2001, pages S35 - S41;;PEGRAM ET AL., JOURNAL OF CLINICAL ONCOLOGY, vol. 16, no. 8, 1998, pages 2659 - 2671;;HARLOW ET AL.: ""Antibodies, A Laboratory Manual"", 1988, COLD SPRING HARBOR;;MURI ET AL.: ""Hydroxamic acids as pharmacological agents"", CURR. MED. CHEM., vol. 9, no. 17, September 2002 (2002-09-01), pages 1631 - 53;;See also references of EP 1613269A4",PENDING
209,EP,B1,EP 2305108 B1,122-465-007-173-582,2016-10-19,2016,EP 10012961 A,1999-01-21,EP 99903239 A;;US 7067798 A,1998-04-30,Analyte monitoring device,,ABBOTT DIABETES CARE INC,SAY JAMES;;TOMASCO MICHAEL F;;HELLER ADAM;;GAL YORAM;;ARIA BEHRAD;;HELLER EPHRAIM;;PLANTE PHILLIP JOHN;;VREEKE MARK S;;FRIEDMAN KEITH A;;COLMAN FREDRIC C,,https://lens.org/122-465-007-173-582,Granted Patent,yes,4,4,211,221,0,A61B5/14532;;A61B5/14532;;A61B5/0002;;A61B5/0002;;A61B5/002;;A61B5/01;;A61B5/14503;;A61B5/1451;;A61B5/14546;;A61B5/14546;;A61B5/1473;;A61B5/1473;;A61B5/1486;;A61B5/1486;;A61B5/14865;;A61B5/1495;;A61B5/4839;;A61B5/72;;A61B5/7278;;A61B5/7282;;A61B5/7405;;A61B5/743;;A61B5/7445;;A61B5/7445;;A61B5/7455;;A61B2560/0252;;A61B2560/0252;;A61M5/1723;;C12Q1/54;;G16H10/40;;G16H10/40;;G16H20/17;;G16H20/17;;H01L23/3107;;H01L23/3107;;H01L23/49548;;H01L23/49548;;H01L2924/0002;;H01L2924/0002;;H01L2924/19041;;H01L2924/19041;;H01L2924/3011;;H01L2924/3011;;Y10S128/903;;Y10S128/903;;Y10T29/49;;Y10T29/49;;Y10T29/49124;;Y10T29/49124,A61B5/00;;G01N27/30;;A61B5/145;;A61B5/1468;;A61B5/1477;;A61B5/1495;;G01N27/416;;G06F19/00;;H01L23/31;;H01L23/495,,0,0,,,,EXPIRED
210,US,A1,US 2009/0177060 A1,126-556-616-574-137,2009-07-09,2009,US 40584309 A,2009-03-17,US 40584309 A;;US 42005703 A;;US 66719900 A;;US 7067798 A,1998-04-30,Analyte Monitoring Device and Methods of Use,"An analyte monitor includes a sensor, a sensor control unit, and a display unit. The sensor has, for example, a substrate, a recessed channel formed in the substrate, and conductive material disposed in the recessed channel to form a working electrode. The sensor control unit typically has a housing adapted for placement on skin and is adapted to receive a portion of an electrochemical sensor. The sensor control unit also includes two or more conductive contacts disposed on the housing and configured for coupling to two or more contact pads on the sensor. A transmitter is disposed in the housing and coupled to the plurality of conductive contacts for transmitting data obtained using the sensor. The display unit has a receiver for receiving data transmitted by the transmitter of the sensor control unit and a display coupled to the receiver for displaying an indication of a level of an analyte. The analyte monitor may also be part of a drug delivery system to alter the level of the analyte based on the data obtained using the sensor.",ABBOTT DIABETES CARE INC,SAY JAMES;;TOMASCO MICHAEL F;;HELLER ADAM;;GAL YORAM;;ARIA BEHRAD;;HELLER EPHRAIM;;PLANTE PHILLIP JOHN;;VREEKE MARK S;;FRIEDMAN KEITH A;;COLMAN FREDRIC C,,https://lens.org/126-556-616-574-137,Patent Application,yes,5,95,211,221,0,A61B5/14532;;A61B5/14532;;A61B5/0002;;A61B5/0002;;A61B5/002;;A61B5/01;;A61B5/14503;;A61B5/1451;;A61B5/14546;;A61B5/14546;;A61B5/1473;;A61B5/1473;;A61B5/1486;;A61B5/1486;;A61B5/14865;;A61B5/1495;;A61B5/4839;;A61B5/72;;A61B5/7278;;A61B5/7282;;A61B5/7405;;A61B5/743;;A61B5/7445;;A61B5/7445;;A61B5/7455;;A61B2560/0252;;A61B2560/0252;;A61M5/1723;;C12Q1/54;;G16H10/40;;G16H10/40;;G16H20/17;;G16H20/17;;H01L23/3107;;H01L23/3107;;H01L23/49548;;H01L23/49548;;H01L2924/0002;;H01L2924/0002;;H01L2924/19041;;H01L2924/19041;;H01L2924/3011;;H01L2924/3011;;Y10S128/903;;Y10S128/903;;Y10T29/49;;Y10T29/49;;Y10T29/49124;;Y10T29/49124,A61B5/1468;;G01N27/30;;A61B5/00;;A61B5/145;;A61B5/1477;;A61B5/1495;;G01N27/416;;G06F19/00;;H01L23/31;;H01L23/495,600/345,0,0,,,,DISCONTINUED
211,US,B2,US 8226558 B2,145-816-856-408-960,2012-07-24,2012,US 89159210 A,2010-09-27,US 89159210 A;;US 39388309 A;;US 42005703 A;;US 66719900 A;;US 7067798 A,1998-04-30,Analyte monitoring device and methods of use,"An analyte monitor includes a sensor, a sensor control unit, and a display unit. The sensor has, for example, a substrate, a recessed channel formed in the substrate, and conductive material disposed in the recessed channel to form a working electrode. The sensor control unit typically has a housing adapted for placement on skin and is adapted to receive a portion of an electrochemical sensor. The sensor control unit also includes two or more conductive contacts disposed on the housing and configured for coupling to two or more contact pads on the sensor. A transmitter is disposed in the housing and coupled to the plurality of conductive contacts for transmitting data obtained using the sensor. The display unit has a receiver for receiving data transmitted by the transmitter of the sensor control unit and a display coupled to the receiver for displaying an indication of a level of an analyte. The analyte monitor may also be part of a drug delivery system to alter the level of the analyte based on the data obtained using the sensor.",SAY JAMES;;TOMASCO MICHAEL F;;HELLER ADAM;;GAL YORAM;;ARIA BEHRAD;;HELLER EPHRAIM;;PLANTE PHILLIP JOHN;;VREEKE MARK S;;FRIEDMAN KEITH A;;COLMAN FREDRIC C;;ABBOTT DIABETES CARE INC,SAY JAMES;;TOMASCO MICHAEL F;;HELLER ADAM;;GAL YORAM;;ARIA BEHRAD;;HELLER EPHRAIM;;PLANTE PHILLIP JOHN;;VREEKE MARK S;;FRIEDMAN KEITH A;;COLMAN FREDRIC C,ABOTT DIABETES CARE INC (2000-03-13);;E. HELLER & CO (1998-07-02),https://lens.org/145-816-856-408-960,Granted Patent,yes,99,18,211,221,0,A61B5/14532;;A61B5/14532;;A61B5/0002;;A61B5/0002;;A61B5/002;;A61B5/01;;A61B5/14503;;A61B5/1451;;A61B5/14546;;A61B5/14546;;A61B5/1473;;A61B5/1473;;A61B5/1486;;A61B5/1486;;A61B5/14865;;A61B5/1495;;A61B5/4839;;A61B5/72;;A61B5/7278;;A61B5/7282;;A61B5/7405;;A61B5/743;;A61B5/7445;;A61B5/7445;;A61B5/7455;;A61B2560/0252;;A61B2560/0252;;A61M5/1723;;C12Q1/54;;G16H10/40;;G16H10/40;;G16H20/17;;G16H20/17;;H01L23/3107;;H01L23/3107;;H01L23/49548;;H01L23/49548;;H01L2924/0002;;H01L2924/0002;;H01L2924/19041;;H01L2924/19041;;H01L2924/3011;;H01L2924/3011;;Y10S128/903;;Y10S128/903;;Y10T29/49;;Y10T29/49;;Y10T29/49124;;Y10T29/49124,A61B5/00;;G01N27/30;;A61B5/05;;A61B5/145;;A61B5/1477;;A61B5/1495;;G01N27/416;;G06F19/00;;H01L23/31;;H01L23/495,600/365;;600/347,99,4,129-974-218-261-531;;115-480-299-312-274;;017-843-532-202-598;;124-660-118-050-67X,2714056;;10.1088/0143-0815/10/1/001;;10.1039/ac9963300271;;8797377;;10.1021/ac950630x;;10.1016/0250-6874(89)87015-5,"Kusano, H., ""Glucose Enzyme Electrode with Percutaneous Interface Which Operates Independently of Dissolved Oxygen"", Clinical Physics and Phsiological Measurement, vol. 10, No. 1, 1989, pp. 1-9.;;Park, T., et al., ""Sol-Gel-based Amperometric Glucose Biosensor Incorporating an Osmium Redox Polymer as Mediator"", Analytical Communications, vol. 33, 1996, pp. 271-273.;;""Poretics Polycarbonate Membrane"", Osmonics Filtration and Separation Group, 2002.;;Stedman's Medical Dictionary, 26th Edition, 1995, pp. 665.;;Jobst, G., et al., ""Thin-Film Microbiosensors for Glucose-Lactate Monitoring"", Analytical Chemistry, vol. 68, No. 18, 1996, pp. 3173-3179.;;Canadian Patent Application No. 2,433,144, Examiner's Report mailed Nov. 2, 2010.;;European Patent Application No. 06 839 640.7, Extended European Search Report mailed Oct. 21, 2010.;;European Patent Application No. 99 903 239.4, Invitation Pursuant to Article 94(3) and Rule 71(1) EPC mailed Dec. 15, 2010.;;PCT Application No. PCT/US2010/040117, International Search Report and Written Opinion of the International Searching Authority mailed Sep. 1, 2010.;;PCT Application No. PCT/US2010/040118, International Search Report and Written Opinion of the International Searching Authority mailed Sep. 17, 2010.;;PCT Application No. PCT/US2010/040119, International Search Report and Written Opinion of the International Searching Authority mailed Sep. 17, 2010.;;European Patent Application No. 10012409.8, Extended European Search Report mailed Mar. 15, 2011.;;European Patent Application No. 10012414.8, Extended European Search Report mailed Mar. 15, 2011.;;European Patent Application No. 10012960.0, Extended European Search Report mailed Mar. 2, 2011.;;European Patent Application No. 10012961.8, Extended European Search Report mailed Mar. 2, 2011.;;U.S. Appl. No. 11/265,787, Office Action mailed Aug. 4, 2010.;;U.S. Appl. No. 11/681,730, Office Action mailed Oct. 15, 2010.;;U.S. Appl. No. 11/683,371, Office Action mailed Jun. 24, 2010.;;U.S. Appl. No. 11/683,371, Office Action mailed Aug. 13, 2010.;;U.S. Appl. No. 11/683,371, Office Action mailed Mar. 8, 2011.;;U.S. Appl. No. 11/683,396, Office Action mailed Jan. 18, 2011.;;U.S. Appl. No. 11/683,408, Office Action mailed Jul. 12, 2010.;;U.S. Appl. No. 11/683,408, Notice of Allowance mailed Oct. 19, 2010.;;U.S. Appl. No. 11/695,608, Office Action mailed Jul. 22, 2010.;;U.S. Appl. No. 11/695,608, Office Action mailed Mar. 29, 2011.;;U.S. Appl. No. 11/734,782, Office Action mailed Jul. 19, 2010.;;U.S. Appl. No. 11/766,686, Office Action mailed Jun. 25, 2010.;;U.S. Appl. No. 11/766,708, Office Action mailed Jul. 9, 2010.;;U.S. Appl. No. 11/766,708, Office Action mailed Mar. 3, 2011.;;U.S. Appl. No. 11/928,574, Office Action mailed Jul. 21, 2010.;;U.S. Appl. No. 11/928,668, Office Action mailed Dec. 23, 2010.;;U.S. Appl. No. 11/928,795, Office Action mailed Sep. 15, 2010.;;U.S. Appl. No. 11/941,078, Office Action mailed Dec. 22, 2010.;;U.S. Appl. No. 12/109,049, Office Action mailed Mar. 4, 2011.;;U.S. Appl. No. 12/371,539, Office Action mailed Mar. 7, 2011.;;U.S. Appl. No. 12/397,281, Office Action mailed Oct. 15, 2010.;;U.S. Appl. No. 12/397,293, Office Action mailed Dec. 1, 2010.;;U.S. Appl. No. 12/397,301, Office Action mailed Dec. 1, 2010.;;U.S. Appl. No. 12/405,515, Office Action mailed Sep. 23, 2010.;;U.S. Appl. No. 12/405,568, Office Action mailed Jan. 25, 2011.;;U.S. Appl. No. 12/405,643, Office Action mailed Mar. 30, 2011.;;U.S. Appl. No. 12/405,690, Office Action mailed Mar. 10, 2011.;;U.S. Appl. No. 12/405,739, Office Action mailed Mar. 15, 2011.;;U.S. Appl. No. 12/405,843, Office Action mailed Mar. 24, 2011.;;U.S. Appl. No. 12/406,800, Office Action mailed Jul. 20, 2010.;;U.S. Appl. No. 12/414,456, Office Action mailed Sep. 17, 2010.;;U.S. Appl. No. 12/414,474, Office Action mailed Mar. 15, 2011.;;U.S. Appl. No. 12/414,487, Office Action mailed Mar. 3, 2011.;;U.S. Appl. No. 12/414,531, Office Action mailed Mar. 22, 2011.;;U.S. Appl. No. 12/468,775, Office Action mailed Feb. 4, 2011.;;U.S. Appl. No. 12/468,782, Office Action mailed Feb. 18, 2011.;;U.S. Appl. No. 12/468,787, Office Action mailed Mar. 7, 2011.;;U.S. Appl. No. 12/533,680, Office Action mailed Mar. 3, 2011.;;U.S. Appl. No. 12/643,974, Office Action mailed Oct. 1, 2010.;;U.S. Appl. No. 12/643,975, Office Action mailed Feb. 18, 2011.;;U.S. Appl. No. 12/643,980, Office Action mailed Oct. 29, 2010.;;U.S. Appl. No. 12/643,982, Office Action mailed Oct. 28, 2010.;;U.S. Appl. No. 12/643,986, Office Action mailed Oct. 29, 2010.;;U.S. Appl. No. 12/717,937, Office Action mailed Sep. 22, 2010.;;U.S. Appl. No. 12/779,941, Office Action mailed Jan. 25, 2011.;;U.S. Appl. No. 12/779,944, Office Action mailed Jan. 25, 2011.;;U.S. Appl. No. 12/825,180, Office Action mailed Mar. 4, 2011.;;U.S. Appl. No. 12/846,803, Office Action mailed Sep. 22, 2010.;;U.S. Appl. No. 12/846,803, Office Action mailed Feb. 17, 2011.;;U.S. Appl. No. 12/852,436, Office Action mailed Sep. 29, 2010.;;U.S. Appl. No. 12/852,436, Notice of Allowance mailed Oct. 21, 2010.;;U.S. Appl. No. 12/852,439, Notice of Allowance mailed Oct. 14, 2010.;;U.S. Appl. No. 12/855,682, Office Action mailed Sep. 22, 2010.;;U.S. Patent Reexamination Application No. 90/007,903, Decision on Appeal mailed Jan. 18, 2011.;;U.S. Patent Reexamination Application No. 90/007,910, Decision on Appeal mailed Jan. 18, 2011.;;U.S. Patent Reexamination Application No. 90/009,104 & 90/009,328, Notice of Intent to Issue Reexamination Certificate mailed Nov. 20, 2009.;;U.S. Patent Reexamination Application No. 90/009,390, Office Action mailed Nov. 26, 2010.;;U.S. Patent Reexamination Application No. 90/009,390, Office Action mailed Aug. 23, 2010.;;U.S. Patent Reexamination Application No. 90/009,497, Notice of Intent to Issue Reexamination Certificate mailed Aug. 23, 2010.;;U.S. Patent Reexamination Application No. 90/009,763, Request for Reexamination of U.S. Patent No. 6,134,461 filed Jun. 18, 2010.;;U.S. Patent Reexamination Application No. 90/011,317, Request for Reexamination of U.S. Patent No. 6,484,046 filed Nov. 5, 2010.;;U.S. Patent Reexamination Application No. 90/011,317, Replacement Request for Reexamination of U.S. Patent No. 6,484,046 filed Jan. 14, 2011.;;U.S. Patent Reexamination Application No. 90/011,346, Request for Reexamination of U.S. Patent No. 6,103,033 filed Nov. 19, 2010.;;European Patent Application No. 09 010 614.7, Extended European Search Report mailed Jan. 14, 2011.;;Koudelka, M., et al., ""Planar Amperometric Enzyme-Based Glucose Microelectrode"", Sensors and Actuators, vol. 18, 1989, pp. 157-165.;;U.S. Appl. No. 10/783,675, Office Action mailed Dec. 14, 2010.;;U.S. Appl. No. 10/783,675, Office Action mailed Jun. 2, 2011.;;U.S. Appl. No. 11/681,730, Office Action mailed Apr. 27, 2011.;;U.S. Appl. No. 11/742,507, Office Action mailed Apr. 13, 2011.;;U.S. Appl. No. 11/742,507, Office Action mailed Jun. 12, 2009.;;U.S. Appl. No. 11/928,795, Office Action mailed May 12, 2011.;;U.S. Appl. No. 11/941,078, Office Action mailed Apr. 22, 2011.;;U.S. Appl. No. 11/941,078, Office Action mailed Mar. 18, 2010.;;U.S. Appl. No. 12/249,644, Office Action mailed Apr. 15, 2011.;;U.S. Appl. No. 12/397,281, Office Action mailed May 12, 2011.;;U.S. Appl. No. 12/397,293, Office Action mailed Aug. 5, 2011.;;U.S. Appl. No. 12/405,515, Office Action mailed Apr. 29, 2011.;;U.S. Appl. No. 12/406,746, Office Action mailed Apr. 5, 2011.;;U.S. Appl. No. 12/406,746, Office Action mailed Jul. 23, 2010.;;U.S. Appl. No. 12/406,800, Office Action mailed Apr. 20, 2011.;;U.S. Appl. No. 12/414,456, Office Action mailed Apr. 29, 2011.;;U.S. Appl. No. 12/414,542, Office Action mailed Apr. 13, 2011.;;U.S. Appl. No. 12/414,558, Office Action mailed Apr. 4, 2011.;;U.S. Appl. No. 12/422,269, Office Action mailed Apr. 14, 2011.",EXPIRED
212,US,A1,US 2010/0292554 A1,156-356-075-759-738,2010-11-18,2010,US 84681310 A,2010-07-29,US 84681310 A;;US 69082607 A;;US 42005703 A;;US 66719900 A;;US 7067798 A,1998-04-30,Analyte Monitoring Device and Methods of Use,"An analyte monitor includes a sensor, a sensor control unit, and a display unit. The sensor has, for example, a substrate, a recessed channel formed in the substrate, and conductive material disposed in the recessed channel to form a working electrode. The sensor control unit typically has a housing adapted for placement on skin and is adapted to receive a portion of an electrochemical sensor. The sensor control unit also includes two or more conductive contacts disposed on the housing and configured for coupling to two or more contact pads on the sensor. A transmitter is disposed in the housing and coupled to the plurality of conductive contacts for transmitting data obtained using the sensor. The display unit has a receiver for receiving data transmitted by the transmitter of the sensor control unit and a display coupled to the receiver for displaying an indication of a level of an analyte. The analyte monitor may also be part of a drug delivery system to alter the level of the analyte based on the data obtained using the sensor.",ABBOTT DIABETES CARE INC,SAY JAMES;;TOMASCO MICHAEL F;;HELLER ADAM;;GAL YORAM;;ARIA BEHRAD;;HELLER EPHRAIM;;PLANTE PHILLIP JOHN;;VREEKE MARK S;;FRIEDMAN KEITH A;;COLMAN FREDRIC C,,https://lens.org/156-356-075-759-738,Patent Application,yes,1,0,211,221,0,A61B5/14532;;A61B5/14532;;A61B5/0002;;A61B5/0002;;A61B5/002;;A61B5/01;;A61B5/14503;;A61B5/1451;;A61B5/14546;;A61B5/14546;;A61B5/1473;;A61B5/1473;;A61B5/1486;;A61B5/1486;;A61B5/14865;;A61B5/1495;;A61B5/4839;;A61B5/72;;A61B5/7278;;A61B5/7282;;A61B5/7405;;A61B5/743;;A61B5/7445;;A61B5/7445;;A61B5/7455;;A61B2560/0252;;A61B2560/0252;;A61M5/1723;;C12Q1/54;;G16H10/40;;G16H10/40;;G16H20/17;;G16H20/17;;H01L23/3107;;H01L23/3107;;H01L23/49548;;H01L23/49548;;H01L2924/0002;;H01L2924/0002;;H01L2924/19041;;H01L2924/19041;;H01L2924/3011;;H01L2924/3011;;Y10S128/903;;Y10S128/903;;Y10T29/49;;Y10T29/49;;Y10T29/49124;;Y10T29/49124,A61B5/05;;G01N27/30;;A61B5/00;;A61B5/145;;A61B5/1477;;A61B5/1495;;G01N27/416;;G06F19/00;;H01L23/31;;H01L23/495,600/347,0,0,,,,DISCONTINUED
213,US,B2,US 8346336 B2,171-341-143-312-818,2013-01-01,2013,US 40680009 A,2009-03-18,US 40680009 A;;US 42005703 A;;US 66719900 A;;US 7067798 A,1998-04-30,Analyte monitoring device and methods of use,"An analyte monitor includes a sensor, a sensor control unit, and a display unit. The sensor has, for example, a substrate, a recessed channel formed in the substrate, and conductive material disposed in the recessed channel to form a working electrode. The sensor control unit typically has a housing adapted for placement on skin and is adapted to receive a portion of an electrochemical sensor. The sensor control unit also includes two or more conductive contacts disposed on the housing and configured for coupling to two or more contact pads on the sensor. A transmitter is disposed in the housing and coupled to the plurality of conductive contacts for transmitting data obtained using the sensor. The display unit has a receiver for receiving data transmitted by the transmitter of the sensor control unit and a display coupled to the receiver for displaying an indication of a level of an analyte. The analyte monitor may also be part of a drug delivery system to alter the level of the analyte based on the data obtained using the sensor.",ABBOTT DIABETES CARE INC;;SAY JAMES;;TOMASCO MICHAEL F;;HELLER ADAM;;GAL YORAM;;ARIA BEHRAD;;HELLER EPHRAIM;;PLANTE PHILLIP JOHN;;VREEKE MARK S;;FRIEDMAN KEITH A;;COLMAN FREDRIC C,SAY JAMES;;TOMASCO MICHAEL F;;HELLER ADAM;;GAL YORAM;;ARIA BEHRAD;;HELLER EPHRAIM;;PLANTE PHILLIP JOHN;;VREEKE MARK S;;FRIEDMAN KEITH A;;COLMAN FREDRIC C,E. HELLER & CO (1998-07-02);;ABBOTT DIABETES CARE INC (2000-03-13),https://lens.org/171-341-143-312-818,Granted Patent,yes,115,0,211,221,0,A61B5/14532;;A61B5/14532;;A61B5/0002;;A61B5/0002;;A61B5/002;;A61B5/01;;A61B5/14503;;A61B5/1451;;A61B5/14546;;A61B5/14546;;A61B5/1473;;A61B5/1473;;A61B5/1486;;A61B5/1486;;A61B5/14865;;A61B5/1495;;A61B5/4839;;A61B5/72;;A61B5/7278;;A61B5/7282;;A61B5/7405;;A61B5/743;;A61B5/7445;;A61B5/7445;;A61B5/7455;;A61B2560/0252;;A61B2560/0252;;A61M5/1723;;C12Q1/54;;G16H10/40;;G16H10/40;;G16H20/17;;G16H20/17;;H01L23/3107;;H01L23/3107;;H01L23/49548;;H01L23/49548;;H01L2924/0002;;H01L2924/0002;;H01L2924/19041;;H01L2924/19041;;H01L2924/3011;;H01L2924/3011;;Y10S128/903;;Y10S128/903;;Y10T29/49;;Y10T29/49;;Y10T29/49124;;Y10T29/49124,A61B5/05;;G01N27/30;;A61B5/00;;A61B5/145;;A61B5/1477;;A61B5/1495;;G01N27/416;;G06F19/00;;H01L23/31;;H01L23/495,600/345;;600/347;;600/365,99,82,136-791-935-548-81X;;062-360-289-025-864;;010-601-725-111-91X;;101-292-518-663-191;;056-703-879-057-297;;030-155-762-644-019;;004-149-141-436-651;;016-731-054-793-457;;080-559-561-995-335;;044-807-213-528-815;;027-538-525-436-179;;015-020-161-517-40X;;025-919-454-564-785;;014-700-576-603-812;;004-851-060-590-788;;075-958-432-122-199;;052-356-140-149-389;;035-090-282-884-790;;033-562-815-299-181;;018-803-926-589-211;;008-505-762-041-402;;016-601-143-530-813;;019-502-772-562-215;;058-476-824-396-350;;006-498-707-073-30X;;054-091-551-638-293;;010-531-147-771-746;;054-827-198-877-419;;122-658-944-077-000;;017-261-560-469-37X;;000-125-755-474-124;;113-381-664-783-802;;082-626-907-191-554;;017-950-014-792-456;;090-348-305-613-628;;015-985-399-299-132;;171-049-047-164-618;;016-819-089-891-758;;081-249-097-078-543;;089-612-747-111-646;;031-706-897-890-035;;094-198-536-559-723;;003-690-143-043-420;;007-943-354-378-456;;082-114-500-909-975;;004-239-090-971-580;;026-894-457-160-450;;077-128-610-778-669;;022-466-506-956-898;;008-424-592-956-946;;007-500-825-916-378;;009-725-244-669-882;;037-755-689-613-42X;;153-411-506-517-475;;038-134-360-685-692;;012-449-714-188-064;;031-517-704-996-130;;131-299-284-996-064;;049-133-049-742-708;;000-272-178-768-076;;070-797-683-833-124;;043-870-224-178-49X;;025-574-914-238-550;;052-364-430-129-757;;004-434-167-910-115;;032-860-147-271-886;;132-460-374-211-421;;098-172-374-375-47X;;109-358-955-476-095;;014-988-634-483-130;;061-786-187-274-992;;037-898-018-686-909;;130-044-667-529-69X;;134-265-642-839-645;;065-221-074-461-027;;017-934-465-161-477;;101-660-130-379-529;;028-236-706-290-220;;087-333-189-994-274;;059-082-211-027-266;;057-977-752-782-568;;022-511-780-866-588,10.1016/s0956-5663(02)00099-4;;12392956;;10.1021/ja00391a001;;2889225;;10.1098/rstb.1987.0021;;10.1109/51.294001;;10.1016/0022-0728(65)85063-x;;2245876;;10.2337/diabetes.39.12.1519;;10.2337/diab.39.12.1519;;10.1016/s0956-5663(03)00220-3;;14611755;;18615658;;10.1002/bit.260430310;;9366023;;10.1016/s0956-5663(97)00025-0;;9451795;;10.1016/s0956-5663(97)00083-3;;10.1016/0956-5663(93)80028-n;;8311939;;8651496;;10.1021/ac960030d;;10.1080/03091900210156797;;12487712;;10.1016/0265-928x(87)80018-4;;3333622;;10.1109/19.816143;;10.1007/bf01015979;;10.1089/15209150252924058;;12017416;;18473691;;10.1089/dia.2007.0281;;10.1021/ac00017a008;;1789439;;2817408;;10.1021/ac00197a022;;10.1016/0925-4005(95)01730-5;;10.1016/0010-4825(90)90013-f;;2257734;;2868172;;8277748;;10.1016/0141-5425(93)90058-7;;11469630;;10.1089/15209150050214104;;10624783;;10.1016/s0168-8227(99)00113-8;;10.1089/15209150050214113;;11469631;;10.1007/bf00401374;;1478372;;10.2337/diacare.20.1.64;;9028696;;10.1109/tbme.1986.325807;;3957374;;236018;;10.1016/0005-2795(75)90259-7;;10.1089/hum.1998.9.6-879;;9581910;;11762520;;10.1089/15209150152607196;;10.2337/diabetes.48.3.445;;10078542;;10.1016/0265-928x(87)80012-3;;505005;;10.1126/science.505005;;10.1021/ac0498516;;15253640;;10.1109/10.284922;;8026845;;6721151;;10.1021/ac00268a018;;6733082;;10.1021/bi00305a016;;10.1515/cclm.2002.135;;12392305;;10.1016/j.ecl.2003.12.001;;15053902;;12052350;;10.1016/s0956-5663(01)00304-9;;12052349;;10.1016/s0956-5663(01)00306-2;;4500021;;10.1007/978-1-4684-3288-6_18;;14021529;;10.1111/j.1749-6632.1962.tb13623.x;;3196517;;10.2337/diacare.10.5.622;;3677983;;10.2337/diacare.8.6.529;;4075939;;10.1002/elan.1140061103;;7733469;;10.1021/ac00103a015;;7978306;;10.1021/ac00091a022;;10.1007/bf01248238;;10.1016/s0376-7388(98)00330-5;;10.1016/0142-9612(92)90147-g;;1472593;;10.1016/0265-928x(85)80002-x;;10.1021/j100290a001;;10.1021/ja00216a040;;10.1021/ja00188a091;;10.1021/ja00406a011;;2624333;;12323417;;10.1016/s0165-0270(02)00170-x;;10.1177/193229680700100208;;pmc2771467;;19888405;;10.1021/ja00415a014;;10.1007/bf00575392;;10.1021/ac00250a038;;10.1021/ac00266a005;;10.1007/s00216-002-1284-0;;12194035;;10.1089/dia.2006.0030;;17705688;;9642777;;10.1016/s0956-5663(97)00091-2;;10.1089/152091503322526978;;14633342;;10.1016/0022-0728(85)87006-6;;10.1021/ja00434a018;;10.1016/0003-2697(92)90243-z;;1443528;;10.1039/f19868201259;;3245585;;10.1021/ac00173a008;;2889234;;10.1098/rstb.1987.0020;;11762521;;10.1089/15209150152607204;;12413548;;10.1016/s1367-5931(02)00371-x;;10526740;;10.2337/diacare.22.10.1708;;14988294;;10.2337/diacare.27.3.734;;10.1111/j.1749-6632.1997.tb52216.x;;9616733,"Abel, P. U., et al., ""Biosensors for In Vivo Glucose Measurement: Can We Cross the Experimental Stage"", Biosensors and Bioelectronics, vol. 17, 2002, pp. 1059-1070.;;Abruna, H. D., et al., ""Rectifying Interfaces Using Two-Layer Films of Electrochemically Polymerized Vinylpyridine and Vinylbipyridine Complexes of Ruthenium and Iron on Electrodes"", Journal of the American Chemical Society, vol. 103, No. 1, 1981, pp. 1-5.;;Albery, W. J., et al., ""Amperometric Enzyme Electrodes Part II: Conducting Salts as Electrode Materials for the Oxidation of Glucose Oxidase"", Journal of ElectroAnalytical Chemistry, vol. 194, 1985, pp. 223-235.;;Albery, W. J., et al., ""Amperometric Enzyme Electrodes"",Philosophical Transactions of The Royal Society of London, vol. 316, 1987, pp. 107-119.;;Alcock, S. J., et al., ""Continuous Analyte Monitoring to Aid Clinical Practice"", IEEE Engineering in Medicine and Biology Magazine, 1994, pp. 319-325.;;Anderson, L. B., et al., ""Thin-Layer Electrochemistry: Steady-State Methods of Studying Rate Processes"", Journal of ElectroAnalytical Chemistry, vol. 10, 1965, pp. 295-305.;;Armour, J. C., et al., ""Application of Chronic Intravascular Blood Glucose Sensor in Dogs"", Diabetes, vol. 39, 1990, pp. 1519-1526.;;Asberg, P., et al., ""Hydrogels of a Conducting Conjugated Polymer as 3-D Enzyme Electrode"", Biosensors & Bioelectronics, vol. 19, 2003, pp. 199-207.;;Atanasov, P., et al., ""Biosensor for Continuous Glucose Bioengineering, Biotechnology and Monitoring"", vol. 43, 1994, pp. 262-266.;;Atanasov, P., et al., ""Implantation of a Refillable Glucose Monitoring-Telemetry Device"", Biosensors & Bioelectronics, vol. 12, No. 7, 1997, pp. 669-680.;;Aussedat, B., et al., ""A User-Friendly Method for Calibrating a Subcutaneous Glucose Sensor-Based Hypoglycaemic Alarm"", Biosensors & Bioelectronics, vol. 12, No. 11, 1997, pp. 1061-1071.;;Baker, D. A., et al., ""Dynamic Concentration Challenges for Biosensor Characterization"", Biosensors & Bioelectronics, vol. 8, 1993, pp. 433-441.;;Baker, D. A., et al., ""Dynamic Delay and Maximal Dynamic Error in Continuous Biosensors"", Analytical Chemistry, vol. 68, No. 8, 1996, pp. 1292-1297.;;Bani Amer, M. M., ""An Accurate Amperometric Glucose Sensor Based Glucometer with Eliminated Cross-Sensitivity"", Journal of Medical Engineering & Technology, vol. 26, No. 5, 2002, pp. 208-213.;;Bard, A. J., et al., Electrochemical Methods, 1980, pp. 173-175.;;Bartlett, P. N., et al., ""Covalent Binding of Electron Relays to Glucose Oxidase"", Journal of the Chemical Society, Chemical Communications, 1987, pp. 1603-1604.;;Bartlett, P. N., et al., ""Modification of Glucose Oxidase by Tetrathiafulvalene"", Journal of the Chemical Society, Chemical Communications, 1990, pp. 1135-1136.;;Bartlett, P. N., et al., ""Strategies for the Development of Amperometric Enzyme Electrodes"", Biosensors, vol. 3, 1987/88, pp. 359-379.;;Beach, R. D., et al., ""Subminiature Implantable Potentiostat and Modified Commercial Telemetry Device for Remote Glucose Monitoring"", IEEE Transactions on Instrumentation and Measurement, vol. 28, No. 6, 1999, pp. 1239-1245.;;Beech, W. A., ""AX.25 Link Access Protocol for Amateur packet Radio"", Tucson Amateur Packet Radio Corporation, 1998, pp. 1-133.;;Bellucci, F., et al., ""Electrochemical Behaviour of Graphite-Epoxy Composite Materials (GECM) in Aqueous Salt Solutions"", Journal of Applied Electrochemistry, vol. 16, 1986, pp. 15-22.;;Bennion, N., et al., ""Alternate Site Glucose Testing: A Crossover Design"", Diabetes Technology & Therapeutics, vol. 4, No. 1, 2002, pp. 25-33.;;Biermann, E., et al., ""How Would Patients Behave if They Were Continually Informed of Their Blood Glucose Levels? A Simulation Study Using a 'Virtual' Patient"", Diabetes Technology & Therapeutics, vol. 10, No. 3, 2008, pp. 178-187.;;Bindra, D. S., et al., ""Design and in Vitro Studies of a Needle-Type Glucose Sensor for Subcutaneous Monitoring"", Analytical Chemistry, vol. 63, No. 17, 1991, pp. 1692-1696.;;Bindra, D. S., et al., ""Pulsed Amperometric Detection of Glucose in Biological Fluids at a Surface-Modified Gold Electrode"", Analytical Chemistry, vol. 61, No. 22, 1989, pp. 2566-2570.;;Bisenberger, M., et al., ""A Triple-Step Potential Waveform at Enzyme Multisensors with Thick-Film Gold Electrodes for Detection of Glucose and Sucrose"", Sensors and Actuators B, vol. 28, 1995, pp. 181-189.;;Bland, J. M., et al., ""A Note on the Use of the Intraclass Correlation Coefficient in the Evaluation of Agreement Between Two Methods of Measurement"", Computers in Biology and Medicine, vol. 20, No. 5, 1990, pp. 337-340.;;Bland, J. M., et al., ""Statistical Methods for Assessing Agreement Between Two Methods of Clinical Measurement"", The Lancet, 1986, pp. 307-310.;;Blank, T. B., et al., ""Clinical Results From a Non-Invasive Blood Glucose Monitor"", Optical Diagnostics and Sensing of Biological Fluids and Glucose and Cholesterol Monitoring II, Proceedings of SPIE, vol. 4624, 2002, pp. 1-10.;;Bobbioni-Harsch, E., et al., ""Lifespan of Subcutaneous Glucose Sensors and Their Performances During Dynamic Glycaemia Changes in Rats"", Journal of Biomedical Engineering, vol. 15, 1993, pp. 457-463.;;Bode, B. W., ""Clinical Utility of the Continuous Glucose Monitoring System"", Diabetes Technology & Therapeutics, vol. 2, Sup. 1, 2000, pp. S35-S41.;;Bode, B. W., et al., ""Continuous Glucose Monitoring Used to Adjust Diabetes Therapy Improves Glycosylated Hemoglobin: A Pilot Study"", Diabetes Research and Clinical Practice, vol. 46, 1999, pp. 183-190.;;Bode, B. W., et al., ""Using the Continuous Glucose Monitoring System to Improve the Management of Type I Diabetes"", Diabetes Technology & Therapeutics, vol. 2, Sup. 1, 2000, pp. S43-S48.;;Boedeker Plastics, Inc., ""Polyethylene Specifications"", Web Page of Boedeker.com, 2007, pp. 1-3.;;Bolinder, J., et al., ""Microdialysis Measurement of the Absolute Glucose Concentration in Subcutaneous Adipose Tissue Allowing Glucose Monitoring in Diabetic Patients"", Diabetologia, vol. 35, 1992, pp. 1177-1180.;;Bolinder, J., et al., ""Self-Monitoring of Blood Glucose in Type I Diabetic Patients: Comparison with Continuous Microdialysis Measurements of Glucose in Subcutaneous Adipose Tissue During Ordinary Life Conditions"", Diabetes Care, vol. 20, No. 1, 1997, pp. 64-70.;;Bott, A. W., ""A Comparison of Cyclic Voltammetry and Cyclic Staircase Voltammetry"", Current Separations, vol. 16, No. 1, 1997, pp. 23-26.;;Bott, A. W., ""Electrochemical Methods for the Determination of Glucose"", Current Separations, vol. 17, No. 1, 1998, pp. 25-31.;;Bowman, L., et al., ""The Packaging of Implantable Integrated Sensors"", IEEE Transactions on Biomedical Engineering, vol. 33, No. 2, 1986, pp. 248-255.;;Brandt, J., et al., ""Covalent Attachment of Proteins to Polysaccharide Carriers by Means of Benzoquinone"", Biochimica et Biophysica Acta, vol. 386, 1975, pp. 196-202.;;Brauker, J., et al., ""Sustained Expression of High Levels of Human Factor IX from Human Cells Implanted Within an Immunoisolation Device into Athymic Rodents"", Human Gene Therapy, vol. 9, No. 6, 1998, pp. 879-888.;;Bremer, T. M., et al., ""Benchmark Data from the Literature for Evaluation of New Glucose Sensing Technologies"", Diabetes Technology & Therapeutics, vol. 3, No. 3, 2001, pp. 409-418.;;Bremer, T., et al., ""Is Blood Glucose Predictable from Previous Values?"", Diabetes, vol. 48, 1999, pp. 445-451.;;Brooks, S. L., et al., ""Development of an On-Line Glucose Sensor for Fermentation Monitoring"", Biosensors, vol. 3, 1987/88, pp. 45-56.;;Brownlee, M., et al., ""A Glucose-Controlled Insulin-Delivery System: Semisynthetic Insulin Bound to Lectin"", Science, vol. 206, 1979, 1190-1191.;;Cai, Q., et al., ""A Wireless, Remove Query Glucose Biosensor Based on a pH-Sensitive Polymer"", Analytical Chemistry, vol. 76, No. 14, 2004, pp. 4038-4043.;;Candas, B., et al., ""An Adaptive Plasma Glucose Controller Based on a Nonlinear Insulin/Glucose Model"", IEEE Transactions on Biomedical Engineering, vol. 41, No. 2, 1994, pp. 116-124.;;Cass, A. E., et al., ""Ferricinum Ion As an Electron Acceptor for Oxido-Reductases"", Journal of ElectroAnalytical Chemistry, vol. 190, 1985, pp. 117-127.;;Cass, A. E., et al., ""Ferrocene-Medicated Enzyme Electrode for Amperometric Determination of Glucose"", Analytical Chemistry, vol. 56, No. 4, 1984, 667-671.;;Castner, J. F., et al., ""Mass Transport and Reaction Kinetic Parameters Determined Electrochemically for Immobilized Glucose Oxidase"", Biochemistry, vol. 23 No. 10, 1984, 2203-2210.;;Chen, J. C., et al., ""A Comparison of MAC Protocols for Wireless Local Networks Based on battery Power Consumption"", IEEE, 1998, pp. 150-157.;;Chen, T., et al., ""Defining the Period of Recovery of the Glucose Concentration After Its Local Perturbation by the Implantation of a Miniature Sensor"", Clinical Chemistry and Laboratory Medicine, vol. 40, No. 8, 2002, pp. 486-489.;;Chia, C. W., et al., ""Glucose Sensors: Toward Closed Loop Insulin Delivery"", Endocrinology and Metabolism Clinics of North America, vol. 33, 2004, pp. 175-195.;;Choleau, C., et al., ""Calibration of a Subcutaneous Amperometric Glucose Sensor Implanted for 7 Days in Diabetic Patients Part 2: Superiority of the One-Point Calibration Method"", Biosensors and Bioelectronics, vol. 17, 2002, pp. 647-654.;;Choleau, C., et al., ""Calibration of a Subcutaneous Amperometric Glucose Sensor Part 1: Effect of Measurement Uncertainties on the Determination of Sensor Sensitivity and Background Current"", Biosensors and Bioelectronics, vol. 17, 2002, pp. 641-646.;;Claremont, D. J., et al., ""Biosensors for Continuous In Vivo Glucose Monitoring"", Proceedings of the Annual International Conference of the IEEE Engineering in Medicine and Biology Society, vol. 10, 1988.;;Clark Jr., L. C., et al., ""Differential Anodic Enzyme Polarography for the Measurement of Glucose"", Oxygen Transport to Tissue: Instrumentation, Methods, and Physiology, 1973, pp. 127-133.;;Clark Jr., L. C., et al., ""Electrode Systems for Continuous Monitoring in Cardiovascular Surgery"", Annals New York Academy of Sciences, 1962, pp. 29-45.;;Clark Jr., L. C., et al., ""Long-term Stability of Electroenzymatic Glucose Sensors Implanted in Mice"", American Society of Artificial Internal Organs Transactions, vol. XXXIV, 1988, pp. 259-265.;;Clarke, W. L., et al., ""Evaluating Clinical Accuracy of Systems for Self-Monitoring of Blood Glucose"", Diabetes Care, vol. 10, No. 5, 1987, pp. 622-628.;;Complaint, ""Abbott Diabetes Care, Inc. v. Dexcom, Inc."", filed Aug. 11, 2005.;;Complaint, Amended, ""Abbott Diabetes Care, Inc. v. Dexcom, Inc."", filed Jun. 27, 2006.;;Cox, D. J., et al., ""Accuracy of Perceiving Blood Glucose in IDDM"", Diabetes Care, vol. 8, No. 6, 1985, pp. 529-536.;;Csoregi, E., et al., ""Amperometric Microbiosensors for Detection of Hydrogen Peroxide and Glucose Based on Peroxidase-Modified Carbon Fibers"", Electroanalysis, vol. 6, 1994, pp. 925-933.;;Csoregi, E., et al., ""Design and Optimization of a Selective Subcutaneously Implantable Glucose Electrode Based on 'Wired' Glucose Oxidase"", Analytical Chemistry, vol. 67, No. 7, 1995, pp. 1240-1244.;;Csoregi, E., et al., ""Design, Characterization, and One-Point in Vivo Calibration of a Subcutaneously Implanted Glucose Electrode"", Analytical Chemistry, vol. 66 No. 19, 1994, pp. 3131-3138.;;Csoregi, E., et al., ""On-Line Glucose Monitoring by Using Microdialysis Sampling and Amperometric Detection Based on 'Wired' Glucose Oxidase in Carbon Paste"", Mikrochimica Acta, vol. 121, 1995, pp. 31-40.;;D'Arrigo, G., et al., ""Porous-Si Based Bio Reactors for Glucose Monitoring and Drugs Production"", Proceedings of SPIE: Microfluids, BioMEMS, and Medical Microsystems, vol. 4982, 2003, pp. 178-184.;;Dai, W. S., et al., ""Hydrogel Membranes with Mesh Size Asymmetry Based on the Gradient Crosslinking of Poly(vinyl alcohol),"" Journal of Membrane Science, vol. 156, 1999, pp. 67-79.;;Davies, M. L., et al., ""Polymer Membranes in Clinical Sensor Applications"", Biomaterials, vol. 13, No. 14, 1992, pp. 971-978.;;Davis, G., ""Electrochemical Techniques for the Development of Amperometric Biosensors"", Biosensors, vol. 1, 1985, pp. 161-178.;;Degani, Y., et al., ""Direct Electrical Communication Between Chemically Modified Enzymes and Metal Electrodes. 1. Electron Transfer from Glucose Oxidase to Metal Electrodes via Electron Relays, Bound Covalently to the Enzyme"", The Journal of Physical Chemistry, vol. 91, No. 6, 1987, pp. 1285-1289.;;Degani, Y., et al., ""Direct Electrical Communication Between Chemically Modified Enzymes and Metal Electrodes. 2. Methods for Bonding Electron-Transfer Relays to Glucose Oxidase and D-Amino-Acid Oxidase"", Journal of the American Chemical Society, vol. 110, No. 8, 1988, pp. 2615-2620.;;Degani, Y., et al., ""Electrical Communication Between Redox Centers of Glucose Oxidase and Electrodes via Electrostatically and Covalently Bound Redox Polymers"", Journal of the American Chemical Society, vol. 111, 1989, pp. 2357-2358.;;Denisevich, P., et al., ""Unidirectional Current Flow and Charge State Trapping at Redox Polymer Interfaces on Bilayer Electrodes: Principles, Experimental Demonstration, and Theory"", Journal of the American Chemical Society, vol. 103, 1981, pp. 4727-4737.;;Dicks, J. M., et al., ""Ferrocene Modified Polypyrrole with Immobilised Glucose Oxidase and its Application in Amperometric Glucose Microbiosensors"", Annales de Biologie Clinique, vol. 47,1989, pp. 607-619.;;Dixon, B. M., et al., ""Characterization In Vitro and In Vivo of the Oxygen Dependence of an Enzyme/Polymer Biosensors for Monitoring Brain Glucose"", Journal of Neuroscience Methods, vol. 119, 2002, pp. 135-142.;;Eight Annual Diabetes Technology Meeting Abstracts, Nov. 13-15, 2008, pp. A1-A182.;;El-Khatib, F. H, et al., ""Adaptive Closed-Loop Control Provides Blood-Glucose Regulation Using Subcutaneous Insulin and Glucagon Infusion in Diabetic Swine"", Journal of Diabetes Science and Technology, vol. 1, No. 2, 2007, pp. 181-192.;;Ellis, C. D., et al., ""Selectivity and Directed Charge Transfer through an Electroactive Metallopolymer Film"", Journal of the American Chemical Society, vol. 103, No. 25, 1981, pp. 7480-7483.;;El-Sa'ad, L., et al., ""Moisture Absorption by Epoxy Resins: The Reverse Thermal Effect"", Journal of Materials Science, vol. 25, No. 8, 1990, pp. 3577-3582.;;Engstrom, R. C., ""Electrochemical Pretreatment of Glassy Carbon Electrodes"", Analytical Chemistry, vol. 54, No. 13, 1982, pp. 2310-2314.;;Engstrom, R. C., et al., ""Characterization of Electrochemically Pretreated Glassy Carbon Electrodes"", Analytical Chemistry, vol. 56, No. 2, 1984, pp. 136-141.;;Ernst, H., et al., ""Reliable Glucose Monitoring Through the Use of Microsystem Technology"", Analytical and Bioanalytical Chemistry, vol. 373, 2002, pp. 758-761.;;Fabietti, P. G., et al. ""Clinical Validation of a New Control-Oriented Model of Insulin and Glucose Dynamics in Subjects with Type 1 Diabetes"", Diabetes Technology & Therapeutics, vol. 9, No. 4, 2007, pp. 327-338.;;Fare, T. L., et al., ""Functional Characterization of a Conducting Polymer-Based Immunoassay System"", Biosensors & Bioelectronics, vol. 13, No. 3-4, 1998, pp. 459-470.;;Feldman, B., et al., ""A Continuous Glucose Sensor Based on Wired Enzyme(TM) Technology-Results from a 3-Day Trial in Patients with Type 1 Diabetes"", Diabetes Technology & Therapeutics, vol. 5, No. 5, 2003, pp. 769-779.;;Feldman, B., et al., ""Correlation of Glucose Concentrations in Interstitial Fluid and Venous Blood During Periods of Rapid Glucose Change"", Abbott Diabetes Care, Inc. Freestyle Navigator Continuous Glucose Monitor Pamphlet, 2004.;;Feldman, B., et al., ""Electron Transfer Kinetics at Redox Polymer/Solution Interfaces Using Microelectrodes and Twin Electrode Thin Layer Cells"", Journal of ElectroAnalytical Chemistry, vol. 194, 1985, pp. 63-81.;;Fischer, H., et al., ""Intramolecular Electron Transfer Medicated by 4,4'-Bypyridine and Related Bridging Groups"", Journal of the American Chemical Society, vol. 98, No. 18, 1976, pp. 5512-5517.;;Flentge, F., et al., ""An Enzyme-Reactor for Electrochemical Monitoring of Choline and Acetylcholine: Applications in High-Performance Liquid Chromatography, Bran Tissue, Microdialysis and Cerebrospinal Fluid,"" Analytical Biochemistry, vol. 204, 1992, pp. 305-310.;;Foulds, N. C., et al., ""Enzyme Entrapment in Electrically Conducting Polymers: Immobilisation of Glucose Oxidase in Polypyrrole and its Application in Amperometric Glucose Sensors"", Journal of the Chemical Society, Faraday Transactions 1, vol. 82, 1986, pp. 1259-1264.;;Foulds, N. C., et al , ""Immobilization of Glucose Oxidase in Ferrocene-Modified Pyrrole Polymers"", Analytical Chemistry, vol. 60, No. 22, 1988, pp. 2473-2478.;;Frew, J. E., et al., ""Electron-Transfer Biosensors"", Philosophical Transactions of the Royal Society of London, vol. 316, 1987, pp. 95-106.;;Frohnauer, M. K., et al., ""Graphical Human Insulin Time-Activity Profiles Using Standardized Definitions"", Diabetes Technology & Therapeutics, vol. 3, No. 3, 2001, pp. 419-429.;;Frost, M. C., et al., ""Implantable Chemical Sensors for Real-Time Clinical Monitoring: Progress and Challenges"", Current Opinion in Chemical Biology, vol. 6, 2002, pp. 633-641.;;Garg, S. K., et al., ""Correlation of Fingerstick Blood Glucose Measurements with GlucoWatch Biographer Glucose Results in Young Subjects with Type 1 Diabetes"", Diabetes Care, vol. 22, No. 10, 1999, pp. 1708-1714.;;Garg, S. K., et al., ""Improved Glucose Excursions Using an Implantable Real-Time Continuous Glucose Sensor in Adults with Type 1 Diabetes"", Diabetes Care, vol. 27, No. 3, 2004, pp. 734-738.;;Geller, R. L., et al., ""Use of an Immunoisolation Device for Cell Transplantation and Tumor Immunotherapy"", Annals of the New York Academy of Sciences, vol. 831, 1997, pp. 438-451.",EXPIRED
214,US,A1,US 2010/0160748 A1,179-740-852-708-021,2010-06-24,2010,US 71793710 A,2010-03-04,US 71793710 A;;US 69082607 A;;US 42005703 A;;US 66719900 A;;US 7067798 A,1998-04-30,Analyte Monitoring Device and Methods of Use,"An analyte monitor includes a sensor, a sensor control unit, and a display unit. The sensor has, for example, a substrate, a recessed channel formed in the substrate, and conductive material disposed in the recessed channel to form a working electrode. The sensor control unit typically has a housing adapted for placement on skin and is adapted to receive a portion of an electrochemical sensor. The sensor control unit also includes two or more conductive contacts disposed on the housing and configured for coupling to two or more contact pads on the sensor. A transmitter is disposed in the housing and coupled to the plurality of conductive contacts for transmitting data obtained using the sensor. The display unit has a receiver for receiving data transmitted by the transmitter of the sensor control unit and a display coupled to the receiver for displaying an indication of a level of an analyte. The analyte monitor may also be part of a drug delivery system to alter the level of the analyte based on the data obtained using the sensor.",ABBOTT DIABETES CARE INC,SAY JAMES;;TOMASCO MICHAEL F;;HELLER ADAM;;GAL YORAM;;ARIA BEHRAD;;HELLER EPHRAIM;;PLANTE PHILLIP JOHN;;VREEKE MARK S;;FRIEDMAN KEITH A;;COLMAN FREDRIC C,,https://lens.org/179-740-852-708-021,Patent Application,yes,3,0,211,221,0,A61B5/14532;;A61B5/14532;;A61B5/0002;;A61B5/0002;;A61B5/002;;A61B5/01;;A61B5/14503;;A61B5/1451;;A61B5/14546;;A61B5/14546;;A61B5/1473;;A61B5/1473;;A61B5/1486;;A61B5/1486;;A61B5/14865;;A61B5/1495;;A61B5/4839;;A61B5/72;;A61B5/7278;;A61B5/7282;;A61B5/7405;;A61B5/743;;A61B5/7445;;A61B5/7445;;A61B5/7455;;A61B2560/0252;;A61B2560/0252;;A61M5/1723;;C12Q1/54;;G16H10/40;;G16H10/40;;G16H20/17;;G16H20/17;;H01L23/3107;;H01L23/3107;;H01L23/49548;;H01L23/49548;;H01L2924/0002;;H01L2924/0002;;H01L2924/19041;;H01L2924/19041;;H01L2924/3011;;H01L2924/3011;;Y10S128/903;;Y10S128/903;;Y10T29/49;;Y10T29/49;;Y10T29/49124;;Y10T29/49124,A61B5/145;;G01N27/30;;A61B5/00;;A61B5/1477;;A61B5/1495;;G01N27/416;;G06F19/00;;H01L23/31;;H01L23/495,600/309,0,0,,,,DISCONTINUED
215,US,A1,US 2007/0149873 A1,176-338-612-469-354,2007-06-28,2007,US 68337107 A,2007-03-07,US 68337107 A;;US 42005703 A;;US 66719900 A;;US 7067798 A,1998-04-30,Analyte Monitoring Device and Methods of Use,"An analyte monitor includes a sensor, a sensor control unit, and a display unit. The sensor has, for example, a substrate, a recessed channel formed in the substrate, and conductive material disposed in the recessed channel to form a working electrode. The sensor control unit typically has a housing adapted for placement on skin and is adapted to receive a portion of an electrochemical sensor. The sensor control unit also includes two or more conductive contacts disposed on the housing and configured for coupling to two or more contact pads on the sensor. A transmitter is disposed in the housing and coupled to the plurality of conductive contacts for transmitting data obtained using the sensor. The display unit has a receiver for receiving data transmitted by the transmitter of the sensor control unit and a display coupled to the receiver for displaying an indication of a level of an analyte. The analyte monitor may also be part of a drug delivery system to alter the level of the analyte based on the data obtained using the sensor.",ABBOTT DIABETES CARE INC,SAY JAMES;;TOMASCO MICHAEL F;;HELLER ADAM;;GAL YORAM;;ARIA BEHRAD;;HELLER EPHRAIM;;PLANTE PHILLIP J;;VREEKE MARK S;;FRIEDMAN KEITH A;;COLMAN FREDRIC C,E. HELLER & CO (1998-07-02);;ABBOTT DIABETES CARE INC (2000-03-13),https://lens.org/176-338-612-469-354,Patent Application,yes,99,59,211,221,0,A61B5/14532;;A61B5/14532;;A61B5/0002;;A61B5/0002;;A61B5/002;;A61B5/01;;A61B5/14503;;A61B5/1451;;A61B5/14546;;A61B5/14546;;A61B5/1473;;A61B5/1473;;A61B5/1486;;A61B5/1486;;A61B5/14865;;A61B5/1495;;A61B5/4839;;A61B5/72;;A61B5/7278;;A61B5/7282;;A61B5/7405;;A61B5/743;;A61B5/7445;;A61B5/7445;;A61B5/7455;;A61B2560/0252;;A61B2560/0252;;A61M5/1723;;C12Q1/54;;G16H10/40;;G16H10/40;;G16H20/17;;G16H20/17;;H01L23/3107;;H01L23/3107;;H01L23/49548;;H01L23/49548;;H01L2924/0002;;H01L2924/0002;;H01L2924/19041;;H01L2924/19041;;H01L2924/3011;;H01L2924/3011;;Y10S128/903;;Y10S128/903;;Y10T29/49;;Y10T29/49;;Y10T29/49124;;Y10T29/49124,A61B5/05;;G01N27/30;;A61B5/00;;A61B5/145;;A61B5/1477;;A61B5/1495;;G01N27/416;;G06F19/00;;H01L23/31;;H01L23/495,600/345;;600/347;;600/365,0,0,,,,EXPIRED
216,US,B2,US 8226555 B2,168-728-807-021-561,2012-07-24,2012,US 40674609 A,2009-03-18,US 40674609 A;;US 42005703 A;;US 66719900 A;;US 7067798 A,1998-04-30,Analyte monitoring device and methods of use,"An analyte monitor includes a sensor, a sensor control unit, and a display unit. The sensor has, for example, a substrate, a recessed channel formed in the substrate, and conductive material disposed in the recessed channel to form a working electrode. The sensor control unit typically has a housing adapted for placement on skin and is adapted to receive a portion of an electrochemical sensor. The sensor control unit also includes two or more conductive contacts disposed on the housing and configured for coupling to two or more contact pads on the sensor. A transmitter is disposed in the housing and coupled to the plurality of conductive contacts for transmitting data obtained using the sensor. The display unit has a receiver for receiving data transmitted by the transmitter of the sensor control unit and a display coupled to the receiver for displaying an indication of a level of an analyte. The analyte monitor may also be part of a drug delivery system to alter the level of the analyte based on the data obtained using the sensor.",SAY JAMES;;TOMASCO MICHAEL F;;HELLER ADAM;;GAL YORAM;;ARIA BEHRAD;;HELLER EPHRAIM;;PLANTE PHILLIP JOHN;;VREEKE MARK S;;FRIEDMAN KEITH A;;COLMAN FREDRIC C;;ABBOTT DIABETES CARE INC,SAY JAMES;;TOMASCO MICHAEL F;;HELLER ADAM;;GAL YORAM;;ARIA BEHRAD;;HELLER EPHRAIM;;PLANTE PHILLIP JOHN;;VREEKE MARK S;;FRIEDMAN KEITH A;;COLMAN FREDRIC C,,https://lens.org/168-728-807-021-561,Granted Patent,yes,107,7,211,221,0,A61B5/14532;;A61B5/14532;;A61B5/0002;;A61B5/0002;;A61B5/002;;A61B5/01;;A61B5/14503;;A61B5/1451;;A61B5/14546;;A61B5/14546;;A61B5/1473;;A61B5/1473;;A61B5/1486;;A61B5/1486;;A61B5/14865;;A61B5/1495;;A61B5/4839;;A61B5/72;;A61B5/7278;;A61B5/7282;;A61B5/7405;;A61B5/743;;A61B5/7445;;A61B5/7445;;A61B5/7455;;A61B2560/0252;;A61B2560/0252;;A61M5/1723;;C12Q1/54;;G16H10/40;;G16H10/40;;G16H20/17;;G16H20/17;;H01L23/3107;;H01L23/3107;;H01L23/49548;;H01L23/49548;;H01L2924/0002;;H01L2924/0002;;H01L2924/19041;;H01L2924/19041;;H01L2924/3011;;H01L2924/3011;;Y10S128/903;;Y10S128/903;;Y10T29/49;;Y10T29/49;;Y10T29/49124;;Y10T29/49124,A61B5/00;;G01N27/30;;A61B5/05;;A61B5/145;;A61B5/1477;;A61B5/1495;;G01N27/416;;G06F19/00;;H01L23/31;;H01L23/495,600/365;;600/345;;600/347;;600/309,99,78,136-791-935-548-81X;;062-360-289-025-864;;056-703-879-057-297;;030-155-762-644-019;;004-149-141-436-651;;016-731-054-793-457;;080-559-561-995-335;;044-807-213-528-815;;027-538-525-436-179;;015-020-161-517-40X;;025-919-454-564-785;;014-700-576-603-812;;004-851-060-590-788;;075-958-432-122-199;;052-356-140-149-389;;035-090-282-884-790;;033-562-815-299-181;;018-803-926-589-211;;008-505-762-041-402;;016-601-143-530-813;;019-502-772-562-215;;058-476-824-396-350;;006-498-707-073-30X;;054-091-551-638-293;;010-531-147-771-746;;054-827-198-877-419;;122-658-944-077-000;;017-261-560-469-37X;;000-125-755-474-124;;113-381-664-783-802;;082-626-907-191-554;;017-950-014-792-456;;090-348-305-613-628;;015-985-399-299-132;;171-049-047-164-618;;016-819-089-891-758;;081-249-097-078-543;;089-612-747-111-646;;031-706-897-890-035;;094-198-536-559-723;;003-690-143-043-420;;007-943-354-378-456;;082-114-500-909-975;;004-239-090-971-580;;026-894-457-160-450;;077-128-610-778-669;;022-466-506-956-898;;008-424-592-956-946;;007-500-825-916-378;;009-725-244-669-882;;037-755-689-613-42X;;153-411-506-517-475;;038-134-360-685-692;;012-449-714-188-064;;031-517-704-996-130;;131-299-284-996-064;;049-133-049-742-708;;000-272-178-768-076;;070-797-683-833-124;;043-870-224-178-49X;;025-574-914-238-550;;052-364-430-129-757;;004-434-167-910-115;;032-860-147-271-886;;132-460-374-211-421;;098-172-374-375-47X;;109-358-955-476-095;;014-988-634-483-130;;061-786-187-274-992;;037-898-018-686-909;;130-044-667-529-69X;;134-265-642-839-645;;065-221-074-461-027;;017-934-465-161-477;;101-660-130-379-529;;028-236-706-290-220;;087-333-189-994-274;;059-082-211-027-266,10.1016/s0956-5663(02)00099-4;;12392956;;10.1021/ja00391a001;;10.1016/0022-0728(65)85063-x;;2245876;;10.2337/diabetes.39.12.1519;;10.2337/diab.39.12.1519;;10.1016/s0956-5663(03)00220-3;;14611755;;18615658;;10.1002/bit.260430310;;9366023;;10.1016/s0956-5663(97)00025-0;;9451795;;10.1016/s0956-5663(97)00083-3;;10.1016/0956-5663(93)80028-n;;8311939;;8651496;;10.1021/ac960030d;;10.1080/03091900210156797;;12487712;;10.1016/0265-928x(87)80018-4;;3333622;;10.1109/19.816143;;10.1007/bf01015979;;10.1089/15209150252924058;;12017416;;18473691;;10.1089/dia.2007.0281;;10.1021/ac00017a008;;1789439;;2817408;;10.1021/ac00197a022;;10.1016/0925-4005(95)01730-5;;10.1016/0010-4825(90)90013-f;;2257734;;2868172;;8277748;;10.1016/0141-5425(93)90058-7;;11469630;;10.1089/15209150050214104;;10624783;;10.1016/s0168-8227(99)00113-8;;10.1089/15209150050214113;;11469631;;10.1007/bf00401374;;1478372;;10.2337/diacare.20.1.64;;9028696;;10.1109/tbme.1986.325807;;3957374;;236018;;10.1016/0005-2795(75)90259-7;;10.1089/hum.1998.9.6-879;;9581910;;11762520;;10.1089/15209150152607196;;10.2337/diabetes.48.3.445;;10078542;;10.1016/0265-928x(87)80012-3;;505005;;10.1126/science.505005;;10.1021/ac0498516;;15253640;;10.1109/10.284922;;8026845;;6721151;;10.1021/ac00268a018;;6733082;;10.1021/bi00305a016;;10.1515/cclm.2002.135;;12392305;;10.1016/j.ecl.2003.12.001;;15053902;;12052350;;10.1016/s0956-5663(01)00304-9;;12052349;;10.1016/s0956-5663(01)00306-2;;4500021;;10.1007/978-1-4684-3288-6_18;;14021529;;10.1111/j.1749-6632.1962.tb13623.x;;3196517;;10.2337/diacare.10.5.622;;3677983;;10.2337/diacare.8.6.529;;4075939;;10.1002/elan.1140061103;;7733469;;10.1021/ac00103a015;;7978306;;10.1021/ac00091a022;;10.1007/bf01248238;;10.1016/s0376-7388(98)00330-5;;10.1016/0142-9612(92)90147-g;;1472593;;10.1016/0265-928x(85)80002-x;;10.1021/j100290a001;;10.1021/ja00216a040;;10.1021/ja00188a091;;10.1021/ja00406a011;;2624333;;12323417;;10.1016/s0165-0270(02)00170-x;;10.1177/193229680700100208;;pmc2771467;;19888405;;10.1021/ja00415a014;;10.1007/bf00575392;;10.1021/ac00250a038;;10.1021/ac00266a005;;10.1007/s00216-002-1284-0;;12194035;;10.1089/dia.2006.0030;;17705688;;9642777;;10.1016/s0956-5663(97)00091-2;;10.1089/152091503322526978;;14633342;;10.1016/0022-0728(85)87006-6;;10.1021/ja00434a018;;10.1016/0003-2697(92)90243-z;;1443528;;10.1039/f19868201259;;3245585;;10.1021/ac00173a008;;2889234;;10.1098/rstb.1987.0020;;11762521;;10.1089/15209150152607204;;12413548;;10.1016/s1367-5931(02)00371-x;;10526740;;10.2337/diacare.22.10.1708,"U.S. Appl. No. 12/852,436, Notice of Allowance mailed Oct. 21, 2010.;;U.S. Appl. No. 12/852,436, Office Action mailed Sep. 29, 2010.;;""Poretics Polycarbonate Membrane"", Osmonics Filtration and Separation Group, 2002.;;Abel, P. U., et al., ""Biosensors for in Vivo Glucose Measurement: Can We Cross the Experimental Stage"", Biosensors and Bioelectronics, vol. 17, 2002, pp. 1059-1070.;;Abruna, H. D., et al., ""Rectifying Interfaces Using Two-Layer Films of Electrochemically Polymerized Vinylpyridine and Vinylbipyridine Complexes of Ruthenium and Iron on Electrodes"", Journal of the American Chemical Society, vol. 103, No. 1, 1981, pp. 1-5.;;Albery, W. J., et al., ""Amperometric Enzyme Electrodes Part II: Conducting Salts as Electrode Materials for the Oxidation of Glucose Oxidase"", Journal of ElectroAnalytical Chemistry, vol. 194, 1985, pp. 223-235.;;Alcock, S. J., et al., ""Continuons Analyte Monitoring to Aid Clinical Practice"", IEEE Engineering in Medicine and Biology Magazine, 1994, pp. 319-325.;;Anderson, L. B., et al., ""Thin-Layer Electrochemistry: Steady-State Methods of Studying Rate Processes"", Journal of ElectroAnalytical Chemistry, vol. 10, 1965, pp. 295-305.;;Armour, J. C., et al., ""Application of Chronic Intravascular Blood Glucose Sensor in Dogs"", Diabetes, vol. 39, 1990, pp. 1519-1526.;;Asberg, P., et al., ""Hydrogels of a Conducting Conjugated Polymer as 3-D Enzyme Electrode"", Biosensors & Bioelectronics, vol. 19, 2003, pp. 199-207.;;Atanasov, P., et al., ""Biosensor for Continuous Glucose Monitoring"", Biotechnology and Bioengineering, vol. 43, 1994, pp. 262-266.;;Atanasov, P., et al., ""Implantation of a Refillable Glucose Monitoring-Telemetry Device"", Biosensors & Bioelectronics, vol. 12, No. 7, 1997, pp. 669-680.;;Aussedat, B., et al., ""A Sensor-Based Hypoglycaemic 1061-1071. User-Friendly Method for Calibrating a Subcutaneous Glucose Alarm"", Biosensors & Bioelectronics, vol. 12, No. 11, 1997, pp. 1061-1071.;;Baker, D. A., et al., ""Dynamic Concentration Challenges for Biosensor Characterization"", Biosensors & Bioelectronics, vol. 8, 1993, pp. 433-441.;;Baker, D. A., et al., ""Dynamic Delay and Maximal Dynamic Error in Continuous Biosensors"", Analytical Chemistry, vol. 68, No. 8, 1996, pp. 1292-1297.;;Bani Amer, M. M. ""An Accurate Amperometric Glucose Sensor Based Glucometer with Eliminated Cross-Sensitivity"", Journal of Medical Engineering & Technology, vol. 26, No. 5, 2002, pp. 203-213.;;Bard, A. J., et al., Electrochemical Methods, 1980, pp. 173-175.;;Bartlett, P.N., et al., ""Covalent Binding of Electron Relays to Glucose Oxidase"", Journal of the Chemical Society, Chemical Communications, 1987, pp. 1603-1604.;;Bartlett, P.N., et al., ""Modification of Glucose Oxidase by Tetrathiafulvalene"", Journal of the Chemical Society, Chemical Communications, 1990, pp. 1135-1136.;;Bartlett, P. N., et al., ""Strategies for the Development of Amperometric Enzyme Electrodes"", Biosensors, vol. 3, 1987/88, pp. 359-379.;;Beach, R. D., et al., ""Subminiature Implantable Potentiostat and Modified Commercial Telemetry Device for Remote Glucose Monitoring"", IEEE Transactions on Instrumentation and Measurement, vol. 28, No. 6, 1999, pp. 1239-1245.;;Beech, W. A., ""AX.25 Link Access Protocol for Amateur packet Radio"", Tucson Amateur Packet Radio Corporation, 1998, pp. 1-133.;;Bellucci, F., et al., ""Electrochemical Behaviour of Graphite-Epoxy Composite Materials (GECM) in Aqueous Salt Solutions"",Journal of Applied Electrochemistry, vol. 16, 1986, pp. 15-22.;;Bennion, N., et al., ""Alternate Site Glucose Testing: A Crossover Design"", Diabetes Technology & Therapeutics, vol. 4, No. 1, 2002, pp. 25-33.;;Biermann, E., et al., ""How Would Patients Behave if They Were Continually Informed of Their Blood Glucose Levels? A Simulation Study Using a 'Virtual' Patient"", Diabetes Technology & Therapeutics, vol. 10, No. 3, 2008, pp. 178-187.;;Bindra, D. S., et al., ""Design and in Vitro Studies of a Needle-Type Glucose Sensor for Subcutaneous Monitoring"", Analytical Chemistry, vol. 63, No. 17, 1991, pp. 1692-1696.;;Bindra, D. S., et al., ""Pulsed Amperometric Detection of Glucose in Biological Fluids at a Surface-Modified Gold Electrode"", Analytical Chemistry, vol. 61, No. 22, 1989, pp. 2566-2570.;;Bisenberger, M., et al., ""A Triple-Step Potential Waveform at Enzyme Multisensors with Thick-Film Gold Electrodes for Detection of Glucose and Sucrose"", Sensors and Actuators B, vol. 28, 1995, pp. 181-189.;;Bland, J. M., et al., ""A Note on the Use of the Intraclass Correlation Coefficient in the Evaluation of Agreement Between Two Methods of Measurement"", Computers in Biology and Medicine, vol. 20, No. 5, 1990, pp. 337-340.;;Bland, J. M., et al., ""Statistical Methods for Assessing Agreement Between Two Methods of Clinical Measurement"", The Lancet, 1986, pp. 307-310.;;Blank, T. B., et al., ""Clinical Results From a Non-Invasive Blood Glucose Monitor"", Optical Diagnostics and Sensing of Biological Fluids and Glucose and Cholesterol Monitoring II, Proceedings of SPIE, vol. 4624, 2002, pp. 1-10.;;Bobbioni-Harsch, E., et al., ""Lifespan of Subcutaneous Glucose Sensors and Their Performances During Dynamic Glycaemia Changes in Rats"", Journal of Biomedical Engineering, vol. 15, 1993, pp. 457-463.;;Bode, B. W., ""Clinical Utility of the Continuous Glucose Monitoring System"", Diabetes Technology & Therapeutics, vol. 2, Sup. 1, 2000, pp. S35-S41.;;Bode, B. W., et al., ""Continuous Glucose Monitoring Used to Adjust Diabetes Therapy Improves Glycosylated Hemoglobin: A Pilot Study"", Diabetes Research and Clinical Practice, vol. 46, 1999, pp. 183-190.;;Bode, B. W., et al., ""Using the Continuous Glucose Monitoring System to Improve the Management of Type I Diabetes"", Diabetes Technology & Therapeutics, vol. 2, Sup. 1, 2000, pp. S43-S48.;;Boedeker Plastics, Inc., ""Polyethylene Specifications"", Web Page of Boedeker.com, 2007, pp. 1-3.;;Bolinder, J., et al., ""Microdialysis Measurement of the Absolute Glucose Concentration in Subcutaneous Adipose Tissue Allowing Glucose Monitoring in Diabetic in Diabetic Patients"", Diabetologia, vol. 35, 1992, pp. 1177-1180.;;Bolinder, J., et al., ""Self-Monitoring of Blood Glucose in Type I Diabetic Patients: Comparison with Continuous Microdialysis Measurements of Glucose in Subcutaneous Adipose Tissue During Ordinary Life Conditions"", Diabetes Care, vol. 20, No. 1, 1997, pp. 64-70.;;Bott, A. W., ""A Comparison of Cyclic Voltammetry and Cyclic Staircase Voltammetry"", Current Separations, vol. 16, No. 1, 1997, pp. 23-26.;;Bott, A. W., ""Electrochemical Methods for the Determination of Glucose"", Current Separations, vol. 17, No. 1, 1998, pp. 25-31.;;Bowman, L., et al., ""The Packaging of Implantable Integrated Sensors"", IEEE Transactions on Biomedical Engineering, vol. 33, No. 2, 1986, pp. 248-255.;;Brandt, J., et al., ""Covalent Attachment of Proteins to Polysaccharide Carriers by Means of Benzoquinone"", Biochimica et Biophysica Acta, vol. 386, 1975, pp. 196-202.;;Brauker, J., et al., ""Sustained Expression of High Levels of Human Factor IX from Human Cells Implanted Within an Immunoisolation Device into Athymic Rodents"", Human Gene Therapy, vol. 9, No. 6, 1998, pp. 879-888.;;Bremer, T. M., et al., ""Benchmark Data from the Literature for Evaluation of New Glucose Sensing Technologies"", Diabetes Technology & Therapeutics, vol. 3, No. 3, 2001, pp. 409-418.;;Bremer, T., et al., ""Is Blood Glucose Predictable from Previous Values?"", Diabetes, vol. 48, 1999, pp. 445-451.;;Brooks, S. L., et al., ""Development of an On-Line Glucose Sensor for Fermentation Monitoring"", Biosensors, vol. 3, 1987/88, pp. 45-56.;;Brownlee, M., et al., ""A Glucose-Controlled Insulin-Delivery System: Semisynthetic Insulin Bound to Lectin"", Science, vol. 206, 1979, 1190-1191.;;Cai, Q., et al., ""A Wireless, Remove Query Glucose Biosensor Based on a pH-Sensitive Polymer"", Analytical Chemistry, vol. 76, No. 14, 2004, pp. 4038-4043.;;Candas, B., et al., ""An Adaptive Plasma Glucose Controller Based on a Nonlinear Insulin/Glucose Model"", IEEE Transactions on Biomedical Engineering, vol. 41, No. 2, 1994, pp. 116-124.;;Cass, A. E., et al., ""Ferricinum Ion As An Electron Acceptoror for Oxido-Reductases"", Journal of ElectroAnalytical Chemistry, vol. 190, 1985, pp. 117-127.;;Cass, A. E., et al., ""Ferrocene-Medicated Enzyme Electrode for Amperometric Determination of Glucose"", Analytical Chemistry, vol. 56, No. 4, 1984, 667-671.;;Castner, J. F., et al., ""Mass Transport and Reaction Kinetic Parameters Determined Electrochemically for Immobilized Glucose Oxidase"", Biochemistry, vol. 23 No. 10, 1984, 2203-2210.;;Chen, J. C., et al., ""A Comparison of MAC Protocols for Wireless Local Networks Based on battery Power Consumption"", IEEE, 1998, pp. 150-157.;;Chen, T., et al., ""Defining the Period of Recovery of the Glucose Concentration After Its Local Perturbation by the Implantation of a Miniature Sensor"", Clinical Chemistry and Laboratory Medicine, vol. 40, No. 8, 2002, pp. 486-489.;;Chia, C. W., et al., ""Glucose Sensors: Toward Closed Loop Insulin Delivery"", Endocrinology and Metabolism Clinics of North America, vol. 33, 2004, pp. 175-195.;;Choleau, C., et al., ""Calibration of a Subcutaneous Amperometric Glucose Sensor Implanted for 7 Days in Diabetic Patients Part 2: Superiority of the One-Point Calibration Method"", Biosensors and Bioelectronics, vol. 17, 2002, pp. 647-654.;;Choleau, C., et al., ""Calibration of a Subcutaneous Amperometric Glucose Sensor Part 1: Effect of Measurement Uncertainties on the Determination of Sensor Sensitivity and Background Current"", Biosensors and Bioelectronics, vol. 17, 2002, pp. 641-646.;;Claremont, D. J., et al., ""Biosensors for Continuous in Vivo Glucose Monitoring"", Proceedings of the Annual International Conference of the IEEE Engineering in Medicine and Biology Society, vol. 10, 1988.;;Clark Jr., L. C., et al., ""Differential Anodic Enzyme Polarography for the Measurement of Glucose"", Oxygen Transport to Tissue: Instrumentation, Methods, and Physiology, 1973, pp. 127-133.;;Clark Jr., L. C., et al., ""Electrode Systems for Continuous Monitoring in Cardiovascular Surgery"", Annals New York Academy of Sciences, 1962, pp. 29-45.;;Clark Jr., L. C., et al., ""Long-term Stability of Electroenzymatic Glucose Sensors Implanted in Mice"", American Society of Artificial Internal Organs Transactions, vol. XXXIV, 1988, pp. 259-265.;;Clarke, W. L., et al., ""Evaluating Clinical Accuracy of Systems for Self-Monitoring of Blood Glucose"", Diabetes Care, vol. 10, No. 5, 1987, pp. 622-628.;;Complaint, ""Abbott Diabetes Care, Inc. v. Dexcom, Inc."", filed Aug. 11, 2005.;;Complaint, Amended, ""Abbott Diabetes Care, Inc. v. Dexcom, Inc."", filed Jun. 27, 2006.;;Cox, D. J., et al., ""Accuracy of Perceiving Blood Glucose in IDDM"", Diabetes Care, vol. 8, No. 6, 1985, pp. 529-536.;;Csoregi, E., et al., ""Amperometric Microbiosensors for Detection of Hydrogen Peroxide and Glucose Based on 'Wired' Carbon Fibers"", Electroanalysis, vol. 6, 1994, pp. 925-933.;;Csoregi, E., et al., ""Design and Optimization of a Selective Subcutaneously Implantable Glucose Electrode Based on 'Wired' Glucose Oxidase"", Analytical Chemistry, vol. 67, No. 7, 1995, pp. 1240-1244.;;Csoregi, E., et al., ""Design, Characterization, and One-Point in Vivo Calibration of a Subcutaneously Implanted Glucose Electrode"", Analytical Chemistry, vol. 66 No. 19, 1994, pp. 3131-3138.;;Csoregi, E., et al., ""On-Line Glucose Monitoring by Using Amperometric Detection Based on 'Wired' Glucose Oxidase in Carbon Pasts"", Mikrochimica Acta, vol. 121, 1995, pp. 31-40.;;D'Arrigo, G., et al., ""Porous-Si Based Bio Reactors for Glucose Monitoring and Drugs Production"", Proceedings of SPIE: Microfluids, BioMEMS, and Medical Microsystems, vol. 4982, 2003, pp. 178-184.;;Dai, W. S., et al., ""Hydrogel Membranes with Mesh Size Asymmetry Based on the Gradient Crosslinking of Poly(vinyl alcohol),"" Journal of Membrane Science, vol. 156, 1999, pp. 67-79.;;Davies, M. L., et al., ""Polymer Membranes in Clinical Sensor Applications"", Biomaterials, vol. No. 14, 1992, pp. 971-978.;;Davis, G., ""Electrochemical Techniques for the Development of Amperometric Biosensors"", Biosensors, vol. 1, 1985, pp. 161-178.;;Degani, Y., et al., ""Direct Electrical Communication Between Chemically Modified Enzymes and Metal Electrodes. 1. Electron Electron Transfer from Glucose Oxidase to Metal Electrodes via Electron Relays, Bound Covalently to the Enzyme"",The Journal of Physical Chemistry, vol. 91, No. 6, 1987, pp. 1285-1289.;;Degani, Y., et al., ""Direct Electrical Communication Between Chemically Modified Enzymes and Metal Electrodes. 2. Methods for Bonding Electron-Transfer Relays to Glucose Oxidase and D-Amino-Acid Oxidase"", Journal of the American Chemical Society, vol. 110, No. 8, 1988, pp. 2615-2620.;;Degani, Y., et al., ""Electrical Communication Between Redox Centers of Glucose Oxidase and Electrodes via Electrostatically and Covalently Bound Redox Polymers"", Journal of the American Chemical Society, vol. 111, 1989, pp. 2357-2358.;;Denisevich, P., et al., ""Unidirectional Current Flow and Charge State Trapping at Redox Polymer Interfaces on Bilayer Electrodes: Principles, Experimental Demonstration, and Theory"", Journal of the American Chemical Society, vol. 103, 1981, pp. 4727-4737.;;Dicks, J. M., et al., ""Ferrocene Modified Polypyrrole with Immobilised Glucose Oxidase and its Application in Amperometric Glucose Microbiosensors"", Annales de Biologie Clinique, vol. 47, 1989, pp. 607-619.;;Dixon, B. M., et al., ""Characterization In Vitro and In Vivo of the Oxygen Dependence of an Enzyme/Polymer Biosensors for Monitoring Brain Glucose"", Journal of Neuroscience Methods, vol. 119, 2002, pp. 135-142.;;Eighth Annual Diabetes Technology Meeting Abstracts, Nov. 13-15, 2008, pp. A1-A182.;;El-Khatib, F. H, et al., ""Adaptive Closed-Loop Control Provides Blood-Glucose Regulation Using Subcutaneous Insulin and Glucagon Infusion in Diabetic Swine"", Journal of Diabetes Science and Technology, vol. 1, No. 2, 2007, pp. 181-192.;;Ellis, C. D., et al., ""Selectivity and Directed Charge Transfer through an Electroactive Metallopolymer Film"", Journal of the American Chemical Society, vol. 103, No. 25, 1981, pp. 7480-7483.;;El-Sa'Ad, L., et al., ""Moisture Absorption by Epoxy Resins: The Reverse Thermal Effect"", Journal of Materials Science, vol. 25, No. 8, 1990, pp. 3577-3582.;;Engstrom, R. C., ""Electrochemical Pretreatment of Glassy Carbon Electrodes"", Analytical Chemistry, vol. 54, No. 13, 1982, pp. 2310-2314.;;Engstrom, R. C., et al., ""Characterization of Electrochemically Pretreated Glassy Carbon Electrodes"", Analytical Chemistry, vol. 56, No. 2, 1984, pp. 136-141.;;Ernst, H., et al., ""Reliable Glucose Monitoring Through the Use of Microsystem Technology"", Analytical and Bioanalytical Chemistry, vol. 373, 2002, pp. 758-761.;;Fabietti, P. G., et al. ""Clinical Validation of a New Control-Oriented Model of Insulin and Glucose Dynamics in Subjects with Type 1 Diabetes"",Diabetes Technology & Therapeutics, vol. 9, No. 2007, pp. 327-338.;;Fare, T. L., et al., ""Functional Characterization of a Conducting Polymer-Based Immunoassay System"", Biosensors & Bioelectronics, vol. 13, No. 3-4, 1998, pp. 459-470.;;Feldman, B., et al., ""A Continuous Glucose Sensor Based on Wired Enzyme(TM) Technology-Results from a 3-Day Trial in Patients with Type 1 Diabetes"",Diabetes Technology & Therapeutics, vol. 5, No. 5, 2003, pp. 769-779.;;Feldman, B., et al., ""Correlation of Glucose Concentrations in Interstitial Fluid and Venous Blood During Periods of Rapid Glucose Change"", Abbott Diabetes Care, Inc. Freestyle Navigator Continuous Glucose Monitor Pamphlet, 2004.;;Feldman, B., et al., ""Electron Transfer Kinetics at Redox Polymer/Solution Interfaces Using Microelectrodes and Twin Electrode Thin Layer Cells"", Journal of ElectroAnalytical Chemistry, vol. 194, 1985, pp. 63-81.;;Fischer, H., et al., ""Intramolecular Electron Transfer Medicated by 4,4'-Bypyridine and Related Bridging Groups"", Journal of the American Chemical Society, vol. 98, No. 18, 1976, pp. 5512-5517.;;Flentge, F., et al., ""An Enzyme-Reactor for Electrochemical Monitoring of Choline and Acetylcholine: Applications in High-Performance Liquid Chromatography, Bran Tissue, Microdialysis and Cerebrospinal Fluid,"" Analytical Biochemistry, vol. 204, 1992, pp. 305-310.;;Foulds, N. C., et al., ""Enzyme Entrapment in Electrically Conducting Polymers: Immobilisation of Glucose Oxidase in Polypyrrole and its Application in Amperometric Glucose Sensors"", Journal of the Chemical Society, Faraday Transactions 1, vol. 82, 1986, pp. 1259-1264.;;Foulds, N. C., et al , ""Immobilization of Glucose Oxidase in Ferrocene-Modified Pyrrole Polymers"", Analytical Chemistry, vol. 60, No. 22, 1988, pp. 2473-2478.;;Frew, J. E., et al., ""Electron-Transfer Biosensors"", Philosophical Transactions of The Royal Society of London, vol. 316, 1987, pp. 95-106.;;Frohnauer, M. K., et al., ""Graphical Human Insulin Time-Activity Profiles Using Standardized Definitions"", Diabetes Technology & Therapeutics, vol. 3, No. 3, 2001, pp. 419-429.;;Frost, M. C., et al., ""Implantable Chemical Sensors for Real-Time Clinical Monitoring: Progress and Challenges"", Current Opinion in Chemical Biology, vol. 6, 2002, pp. 633-641.;;Garg, S. K., et al., ""Correlation of Fingerstick Blood Glucose Measurements with GlucoWatch 1 Diabetes Biographer Glucose Results in Young Subjects with Types 1 Diabetes"", Diabetes Care, vol. 22, No. 10, 1999, pp. 1708-1714.",EXPIRED
217,US,A1,US 2009/0192372 A1,186-797-108-420-135,2009-07-30,2009,US 41795209 A,2009-04-03,US 41795209 A;;US 42005703 A;;US 66719900 A;;US 7067798 A,1998-04-30,Analyte Monitoring Device and Methods of Use,"An analyte monitor includes a sensor, a sensor control unit, and a display unit. The sensor has, for example, a substrate, a recessed channel formed in the substrate, and conductive material disposed in the recessed channel to form a working electrode. The sensor control unit typically has a housing adapted for placement on skin and is adapted to receive a portion of an electrochemical sensor. The sensor control unit also includes two or more conductive contacts disposed on the housing and configured for coupling to two or more contact pads on the sensor. A transmitter is disposed in the housing and coupled to the plurality of conductive contacts for transmitting data obtained using the sensor. The display unit has a receiver for receiving data transmitted by the transmitter of the sensor control unit and a display coupled to the receiver for displaying an indication of a level of an analyte. The analyte monitor may also be part of a drug delivery system to alter the level of the analyte based on the data obtained using the sensor.",ABBOTT DIABETES CARE INC,SAY JAMES;;TOMASCO MICHAEL F;;HELLER ADAM;;GAL YORAM;;ARIA BEHRAD;;HELLER EPHRAIM;;PLANTE PHILLIP JOHN;;VREEKE MARK S;;FRIEDMAN KEITH A;;COLMAN FREDRIC C,,https://lens.org/186-797-108-420-135,Patent Application,yes,1,57,211,221,0,A61B5/14532;;A61B5/14532;;A61B5/0002;;A61B5/0002;;A61B5/002;;A61B5/01;;A61B5/14503;;A61B5/1451;;A61B5/14546;;A61B5/14546;;A61B5/1473;;A61B5/1473;;A61B5/1486;;A61B5/1486;;A61B5/14865;;A61B5/1495;;A61B5/4839;;A61B5/72;;A61B5/7278;;A61B5/7282;;A61B5/7405;;A61B5/743;;A61B5/7445;;A61B5/7445;;A61B5/7455;;A61B2560/0252;;A61B2560/0252;;A61M5/1723;;C12Q1/54;;G16H10/40;;G16H10/40;;G16H20/17;;G16H20/17;;H01L23/3107;;H01L23/3107;;H01L23/49548;;H01L23/49548;;H01L2924/0002;;H01L2924/0002;;H01L2924/19041;;H01L2924/19041;;H01L2924/3011;;H01L2924/3011;;Y10S128/903;;Y10S128/903;;Y10T29/49;;Y10T29/49;;Y10T29/49124;;Y10T29/49124,A61B5/1468;;G01N27/30;;A61B5/00;;A61B5/145;;A61B5/1477;;A61B5/1495;;G01N27/416;;G06F19/00;;H01L23/31;;H01L23/495,600/345,0,0,,,,DISCONTINUED
218,US,A1,US 2010/0106001 A1,017-534-295-910-582,2010-04-29,2010,US 64397509 A,2009-12-21,US 64397509 A;;US 42005703 A;;US 66719900 A;;US 7067798 A,1998-04-30,Analyte Monitoring Device and Methods of Use,"An analyte monitor includes a sensor, a sensor control unit, and a display unit. The sensor has, for example, a substrate, a recessed channel formed in the substrate, and conductive material disposed in the recessed channel to form a working electrode. The sensor control unit typically has a housing adapted for placement on skin and is adapted to receive a portion of an electrochemical sensor. The sensor control unit also includes two or more conductive contacts disposed on the housing and configured for coupling to two or more contact pads on the sensor. A transmitter is disposed in the housing and coupled to the plurality of conductive contacts for transmitting data obtained using the sensor. The display unit has a receiver for receiving data transmitted by the transmitter of the sensor control unit and a display coupled to the receiver for displaying an indication of a level of an analyte. The analyte monitor may also be part of a drug delivery system to alter the level of the analyte based on the data obtained using the sensor.",ABBOTT DIABETES CARE INC,SAY JAMES;;TOMASCO MICHAEL F;;HELLER ADAM;;GAL YORAM;;ARIA BEHRAD;;HELLER EPHRAIM;;PLANTE PHILLIP JOHN;;VREEKE MARK S;;FRIEDMAN KEITH A;;COLMAN FREDERIC C,E. HELLER & CO (1998-07-02);;ABBOTT DIABETES CARE INC (2000-03-13),https://lens.org/017-534-295-910-582,Patent Application,yes,58,48,211,221,0,A61B5/14532;;A61B5/14532;;A61B5/0002;;A61B5/0002;;A61B5/002;;A61B5/01;;A61B5/14503;;A61B5/1451;;A61B5/14546;;A61B5/14546;;A61B5/1473;;A61B5/1473;;A61B5/1486;;A61B5/1486;;A61B5/14865;;A61B5/1495;;A61B5/4839;;A61B5/72;;A61B5/7278;;A61B5/7282;;A61B5/7405;;A61B5/743;;A61B5/7445;;A61B5/7445;;A61B5/7455;;A61B2560/0252;;A61B2560/0252;;A61M5/1723;;C12Q1/54;;G16H10/40;;G16H10/40;;G16H20/17;;G16H20/17;;H01L23/3107;;H01L23/3107;;H01L23/49548;;H01L23/49548;;H01L2924/0002;;H01L2924/0002;;H01L2924/19041;;H01L2924/19041;;H01L2924/3011;;H01L2924/3011;;Y10S128/903;;Y10S128/903;;Y10T29/49;;Y10T29/49;;Y10T29/49124;;Y10T29/49124,A61B5/145;;G01N27/30;;A61B5/00;;A61B5/1477;;A61B5/1495;;G01N27/416;;G06F19/00;;H01L23/31;;H01L23/495,600/365,0,0,,,,EXPIRED
219,US,A1,US 2007/0161879 A1,015-340-586-180-374,2007-07-12,2007,US 68339607 A,2007-03-07,US 68339607 A;;US 42005703 A;;US 66719900 A;;US 7067798 A,1998-04-30,Analyte Monitoring Device and Methods of Use,"An analyte monitor includes a sensor, a sensor control unit, and a display unit. The sensor has, for example, a substrate, a recessed channel formed in the substrate, and conductive material disposed in the recessed channel to form a working electrode. The sensor control unit typically has a housing adapted for placement on skin and is adapted to receive a portion of an electrochemical sensor. The sensor control unit also includes two or more conductive contacts disposed on the housing and configured for coupling to two or more contact pads on the sensor. A transmitter is disposed in the housing and coupled to the plurality of conductive contacts for transmitting data obtained using the sensor. The display unit has a receiver for receiving data transmitted by the transmitter of the sensor control unit and a display coupled to the receiver for displaying an indication of a level of an analyte. The analyte monitor may also be part of a drug delivery system to alter the level of the analyte based on the data obtained using the sensor.",ABBOTT DIABETES CARE INC,SAY JAMES;;TOMASCO MICHAEL F;;HELLER ADAM;;GAL YORAM;;ARIA BEHRAD;;HELLER EPHRAIM;;PLANTE PHILLIP J;;VREEKE MARK S;;FRIEDMAN KEITH A;;COLMAN FREDRIC C,E. HELLER & CO (1998-07-02);;ABBOTT DIABETES CARE INC (2000-03-13),https://lens.org/015-340-586-180-374,Patent Application,yes,99,39,211,221,0,A61B5/14532;;A61B5/14532;;A61B5/0002;;A61B5/0002;;A61B5/002;;A61B5/01;;A61B5/14503;;A61B5/1451;;A61B5/14546;;A61B5/14546;;A61B5/1473;;A61B5/1473;;A61B5/1486;;A61B5/1486;;A61B5/14865;;A61B5/1495;;A61B5/4839;;A61B5/72;;A61B5/7278;;A61B5/7282;;A61B5/7405;;A61B5/743;;A61B5/7445;;A61B5/7445;;A61B5/7455;;A61B2560/0252;;A61B2560/0252;;A61M5/1723;;C12Q1/54;;G16H10/40;;G16H10/40;;G16H20/17;;G16H20/17;;H01L23/3107;;H01L23/3107;;H01L23/49548;;H01L23/49548;;H01L2924/0002;;H01L2924/0002;;H01L2924/19041;;H01L2924/19041;;H01L2924/3011;;H01L2924/3011;;Y10S128/903;;Y10S128/903;;Y10T29/49;;Y10T29/49;;Y10T29/49124;;Y10T29/49124,A61B5/05;;G01N27/30;;A61B5/00;;A61B5/145;;A61B5/1477;;A61B5/1495;;G01N27/416;;G06F19/00;;H01L23/31;;H01L23/495,600/345;;600/347;;600/365,0,0,,,,EXPIRED
220,EP,A4,EP 1613269 A4,041-388-979-372-188,2009-11-11,2009,EP 04758815 A,2004-04-02,US 2004/0010278 W;;US 46067803 P;;US 47249403 P;;US 53203003 P;;US 54898604 P,2003-04-04,"COMPOSITIONS, METHODS AND KITS RELATING TO HER-2 CLEAVAGE",,INCYTE CORP,FRIEDMAN STEVEN M;;SCHERLE PEGGY A;;LIU XIANGDONG;;BURN TIMOTHY C;;HUBER REID;;LIU PHILLIP C C;;HOLLIS GREGORY F;;VADDI KRISHNA;;FRIDMAN JORDAN S,"INCYTE HOLDINGS CORPORATION (2015-12-09);;INCYTE CORPORATION (2015-02-11);;INCYTE HOLDINGS CORPORATION, US (2016-09-27);;INCYTE HOLDINGS CORPORATION, WILMINGTON, US (2016-02-24)",https://lens.org/041-388-979-372-188,Search Report,no,1,0,10,10,0,A61K31/395;;A61K31/19;;A61P35/00;;A61P35/04;;A61K31/395;;A61K31/19,A61K39/395;;A61K/;;A61K31/19,,3,2,100-874-294-784-309;;051-826-302-349-824,9816289;;11961506;;10.1016/s0147-0272(02)70005-6,"JA LOW, MD JOHNSON, EA BONE, AND RB DICKSON: ""The matrix metalloproteinase inhibitor batimastat (BB-94) retards human breast cancer solid tumor growth but not ascites formation in nude mice"", CLINICAL CANCER RESEARCH, vol. 2, July 1996 (1996-07-01), pages 1207 - 1214, XP002542088;;SLEDGE ET AL: ""Angiogenesis and Antiangiogenic Therapy"", CURRENT PROBLEMS IN CANCER, MOSBY, ST LOUIS, MO, US, vol. 26, no. 1, 1 January 2002 (2002-01-01), pages 6 - 59, XP005139279, ISSN: 0147-0272;;See also references of WO 2004089294A2",ACTIVE
221,US,A1,US 2009/0198175 A1,068-005-649-533-70X,2009-08-06,2009,US 42226909 A,2009-04-11,US 42226909 A;;US 4140405 A;;US 42005703 A;;US 66719900 A;;US 7067798 A,1998-04-30,Analyte Monitoring Device and Methods of Use,"An analyte monitor includes a sensor, a sensor control unit, and a display unit. The sensor has, for example, a substrate, a recessed channel formed in the substrate, and conductive material disposed in the recessed channel to form a working electrode. The sensor control unit typically has a housing adapted for placement on skin and is adapted to receive a portion of an electrochemical sensor. The sensor control unit also includes two or more conductive contacts disposed on the housing and configured for coupling to two or more contact pads on the sensor. A transmitter is disposed in the housing and coupled to the plurality of conductive contacts for transmitting data obtained using the sensor. The display unit has a receiver for receiving data transmitted by the transmitter of the sensor control unit and a display coupled to the receiver for displaying an indication of a level of an analyte. The analyte monitor may also be part of a drug delivery system to alter the level of the analyte based on the data obtained using the sensor.",ABBOTT DIABETES CARE INC,SAY JAMES;;TOMASCO MICHAEL F;;HELLER ADAM;;GAL YORAM;;ARIA BEHRAD;;HELLER EPHRAIM;;PLANTE PHILLIP JOHN;;VREEKE MARK S;;FRIEDMAN KEITH A;;COLMAN FREDRIC C,E. HELLER & CO (1998-07-02);;ABBOTT DIABETES CARE INC (2000-03-13),https://lens.org/068-005-649-533-70X,Patent Application,yes,99,58,211,221,0,A61B5/14532;;A61B5/14532;;A61B5/0002;;A61B5/0002;;A61B5/002;;A61B5/01;;A61B5/14503;;A61B5/1451;;A61B5/14546;;A61B5/14546;;A61B5/1473;;A61B5/1473;;A61B5/1486;;A61B5/1486;;A61B5/14865;;A61B5/1495;;A61B5/4839;;A61B5/72;;A61B5/7278;;A61B5/7282;;A61B5/7405;;A61B5/743;;A61B5/7445;;A61B5/7445;;A61B5/7455;;A61B2560/0252;;A61B2560/0252;;A61M5/1723;;C12Q1/54;;G16H10/40;;G16H10/40;;G16H20/17;;G16H20/17;;H01L23/3107;;H01L23/3107;;H01L23/49548;;H01L23/49548;;H01L2924/0002;;H01L2924/0002;;H01L2924/19041;;H01L2924/19041;;H01L2924/3011;;H01L2924/3011;;Y10S128/903;;Y10S128/903;;Y10T29/49;;Y10T29/49;;Y10T29/49124;;Y10T29/49124,A61B5/1468;;G01N27/30;;A61B5/00;;A61B5/145;;A61B5/1477;;A61B5/1495;;A61M37/00;;G01N27/416;;G06F19/00;;H01L23/31;;H01L23/495,604/66;;600/345;;600/347,0,0,,,,EXPIRED
222,US,A1,US 2010/0324396 A1,087-063-695-949-540,2010-12-23,2010,US 86968110 A,2010-08-26,US 86968110 A;;US 69082607 A;;US 42005703 A;;US 66719900 A;;US 7067798 A,1998-04-30,Analyte Monitoring Device and Methods of Use,"An analyte monitor includes a sensor, a sensor control unit, and a display unit. The sensor has, for example, a substrate, a recessed channel formed in the substrate, and conductive material disposed in the recessed channel to form a working electrode. The sensor control unit typically has a housing adapted for placement on skin and is adapted to receive a portion of an electrochemical sensor. The sensor control unit also includes two or more conductive contacts disposed on the housing and configured for coupling to two or more contact pads on the sensor. A transmitter is disposed in the housing and coupled to the plurality of conductive contacts for transmitting data obtained using the sensor. The display unit has a receiver for receiving data transmitted by the transmitter of the sensor control unit and a display coupled to the receiver for displaying an indication of a level of an analyte. The analyte monitor may also be part of a drug delivery system to alter the level of the analyte based on the data obtained using the sensor.",ABBOTT DIABETES CARE INC,SAY JAMES;;TOMASCO MICHAEL F;;HELLER ADAM;;GAL YORAM;;ARIA BEHRAD;;HELLER EPHRAIM;;PLANTE PHILLIP JOHN;;VREEKE MARK S;;FRIEDMAN KEITH A;;COLMAN FREDRIC C,,https://lens.org/087-063-695-949-540,Patent Application,yes,1,0,211,221,0,A61B5/14532;;A61B5/14532;;A61B5/0002;;A61B5/0002;;A61B5/002;;A61B5/01;;A61B5/14503;;A61B5/1451;;A61B5/14546;;A61B5/14546;;A61B5/1473;;A61B5/1473;;A61B5/1486;;A61B5/1486;;A61B5/14865;;A61B5/1495;;A61B5/4839;;A61B5/72;;A61B5/7278;;A61B5/7282;;A61B5/7405;;A61B5/743;;A61B5/7445;;A61B5/7445;;A61B5/7455;;A61B2560/0252;;A61B2560/0252;;A61M5/1723;;C12Q1/54;;G16H10/40;;G16H10/40;;G16H20/17;;G16H20/17;;H01L23/3107;;H01L23/3107;;H01L23/49548;;H01L23/49548;;H01L2924/0002;;H01L2924/0002;;H01L2924/19041;;H01L2924/19041;;H01L2924/3011;;H01L2924/3011;;Y10S128/903;;Y10S128/903;;Y10T29/49;;Y10T29/49;;Y10T29/49124;;Y10T29/49124,A61B5/05;;G01N27/30;;A61B5/00;;A61B5/145;;A61B5/1477;;A61B5/1495;;G01N27/416;;G06F19/00;;H01L23/31;;H01L23/495,600/347,0,0,,,,DISCONTINUED
223,US,A1,US 2008/0262329 A1,071-544-416-432-757,2008-10-23,2008,US 13593708 A,2008-06-09,US 13593708 A;;US 42005703 A;;US 66719900 A;;US 7067798 A,1998-04-30,Analyte Monitoring Device and Methods of Use,"An analyte monitor includes a sensor, a sensor control unit, and a display unit. The sensor has, for example, a substrate, a recessed channel formed in the substrate, and conductive material disposed in the recessed channel to form a working electrode. The sensor control unit typically has a housing adapted for placement on skin and is adapted to receive a portion of an electrochemical sensor. The sensor control unit also includes two or more conductive contacts disposed on the housing and configured for coupling to two or more contact pads on the sensor. A transmitter is disposed in the housing and coupled to the plurality of conductive contacts for transmitting data obtained using the sensor. The display unit has a receiver for receiving data transmitted by the transmitter of the sensor control unit and a display coupled to the receiver for displaying an indication of a level of an analyte. The analyte monitor may also be part of a drug delivery system to alter the level of the analyte based on the data obtained using the sensor.",ABBOTT DIABETES CARE INC,SAY JAMES;;TOMASCO MICHAEL F;;HELLER ADAM;;GAL YORAM;;ARIA BEHRAD;;HELLER EPHRAIM;;PLANTE PHILLIP JOHN;;VREEKE MARK S;;FRIEDMAN KEITH A;;COLMAN FREDRIC C,E. HELLER & CO (1998-07-02);;ABBOTT DIABETES CARE INC (2000-03-13),https://lens.org/071-544-416-432-757,Patent Application,yes,99,23,211,221,0,A61B5/14532;;A61B5/14532;;A61B5/0002;;A61B5/0002;;A61B5/002;;A61B5/01;;A61B5/14503;;A61B5/1451;;A61B5/14546;;A61B5/14546;;A61B5/1473;;A61B5/1473;;A61B5/1486;;A61B5/1486;;A61B5/14865;;A61B5/1495;;A61B5/4839;;A61B5/72;;A61B5/7278;;A61B5/7282;;A61B5/7405;;A61B5/743;;A61B5/7445;;A61B5/7445;;A61B5/7455;;A61B2560/0252;;A61B2560/0252;;A61M5/1723;;C12Q1/54;;G16H10/40;;G16H10/40;;G16H20/17;;G16H20/17;;H01L23/3107;;H01L23/3107;;H01L23/49548;;H01L23/49548;;H01L2924/0002;;H01L2924/0002;;H01L2924/19041;;H01L2924/19041;;H01L2924/3011;;H01L2924/3011;;Y10S128/903;;Y10S128/903;;Y10T29/49;;Y10T29/49;;Y10T29/49124;;Y10T29/49124,A61B5/1468;;G01N27/30;;A61B5/00;;A61B5/145;;A61B5/1477;;A61B5/1495;;G01N27/416;;G06F19/00;;H01L23/31;;H01L23/495,600/345;;600/309,0,0,,,,EXPIRED
224,US,A1,US 2008/0091096 A1,078-095-618-088-847,2008-04-17,2008,US 94107807 A,2007-11-16,US 94107807 A;;US 42005703 A;;US 66719900 A;;US 7067798 A,1998-04-30,Analyte Monitoring Device and Methods of Use,"An analyte monitor includes a sensor, a sensor control unit, and a display unit. The sensor has, for example, a substrate, a recessed channel formed in the substrate, and conductive material disposed in the recessed channel to form a working electrode. The sensor control unit typically has a housing adapted for placement on skin and is adapted to receive a portion of an electrochemical sensor. The sensor control unit also includes two or more conductive contacts disposed on the housing and configured for coupling to two or more contact pads on the sensor. A transmitter is disposed in the housing and coupled to the plurality of conductive contacts for transmitting data obtained using the sensor. The display unit has a receiver for receiving data transmitted by the transmitter of the sensor control unit and a display coupled to the receiver for displaying an indication of a level of an analyte. The analyte monitor may also be part of a drug delivery system to alter the level of the analyte based on the data obtained using the sensor.",ABBOTT DIABETES CARE INC,SAY JAMES;;TOMASCO MICHAEL F;;HELLER ADAM;;GAL YORAM;;ARIA BEHRAD;;HELLER EPHRAIM;;PLANTE PHILLIP J;;VREEKE MARK S;;FRIEDMAN KEITH A;;COLMAN FREDRIC C,E. HELLER & CO (1998-07-02);;ABBOTT DIABETES CARE INC (2000-03-13),https://lens.org/078-095-618-088-847,Patent Application,yes,99,12,211,221,0,A61B5/14532;;A61B5/14532;;A61B5/0002;;A61B5/0002;;A61B5/002;;A61B5/01;;A61B5/14503;;A61B5/1451;;A61B5/14546;;A61B5/14546;;A61B5/1473;;A61B5/1473;;A61B5/1486;;A61B5/1486;;A61B5/14865;;A61B5/1495;;A61B5/4839;;A61B5/72;;A61B5/7278;;A61B5/7282;;A61B5/7405;;A61B5/743;;A61B5/7445;;A61B5/7445;;A61B5/7455;;A61B2560/0252;;A61B2560/0252;;A61M5/1723;;C12Q1/54;;G16H10/40;;G16H10/40;;G16H20/17;;G16H20/17;;H01L23/3107;;H01L23/3107;;H01L23/49548;;H01L23/49548;;H01L2924/0002;;H01L2924/0002;;H01L2924/19041;;H01L2924/19041;;H01L2924/3011;;H01L2924/3011;;Y10S128/903;;Y10S128/903;;Y10T29/49;;Y10T29/49;;Y10T29/49124;;Y10T29/49124,A61B5/145;;G01N27/30;;A61B5/00;;A61B5/1477;;A61B5/1495;;G01N27/416;;G06F19/00;;H01L23/31;;H01L23/495,600/365,0,0,,,,EXPIRED
225,US,A1,US 2008/0167543 A1,109-027-245-612-113,2008-07-10,2008,US 5248908 A,2008-03-20,US 5248908 A;;US 42005703 A;;US 66719900 A;;US 7067798 A,1998-04-30,Analyte Monitoring Device And Methods Of Use,"An analyte monitor includes a sensor, a sensor control unit, and a display unit. The sensor has, for example, a substrate, a recessed channel formed in the substrate, and conductive material disposed in the recessed channel to form a working electrode. The sensor control unit typically has a housing adapted for placement on skin and is adapted to receive a portion of an electrochemical sensor. The sensor control unit also includes two or more conductive contacts disposed on the housing and configured for coupling to two or more contact pads on the sensor. A transmitter is disposed in the housing and coupled to the plurality of conductive contacts for transmitting data obtained using the sensor. The display unit has a receiver for receiving data transmitted by the transmitter of the sensor control unit and a display coupled to the receiver for displaying an indication of a level of an analyte. The analyte monitor may also be part of a drug delivery system to alter the level of the analyte based on the data obtained using the sensor.",ABBOTT DIABETES CARE INC,SAY JAMES;;TOMASCO MICHAEL F;;HELLER ADAM;;GAL YORAM;;ARIA BEHRAD;;HELLER EPHRAIM;;PLANTE PHILLIP JOHN;;VREEKE MARK S;;FRIEDMAN KEITH A;;COLMAN FREDRIC C,,https://lens.org/109-027-245-612-113,Patent Application,yes,99,200,211,221,0,A61B5/14532;;A61B5/14532;;A61B5/0002;;A61B5/0002;;A61B5/002;;A61B5/01;;A61B5/14503;;A61B5/1451;;A61B5/14546;;A61B5/14546;;A61B5/1473;;A61B5/1473;;A61B5/1486;;A61B5/1486;;A61B5/14865;;A61B5/1495;;A61B5/4839;;A61B5/72;;A61B5/7278;;A61B5/7282;;A61B5/7405;;A61B5/743;;A61B5/7445;;A61B5/7445;;A61B5/7455;;A61B2560/0252;;A61B2560/0252;;A61M5/1723;;C12Q1/54;;G16H10/40;;G16H10/40;;G16H20/17;;G16H20/17;;H01L23/3107;;H01L23/3107;;H01L23/49548;;H01L23/49548;;H01L2924/0002;;H01L2924/0002;;H01L2924/19041;;H01L2924/19041;;H01L2924/3011;;H01L2924/3011;;Y10S128/903;;Y10S128/903;;Y10T29/49;;Y10T29/49;;Y10T29/49124;;Y10T29/49124,A61B5/05;;G01N27/30;;A61B5/00;;A61B5/145;;A61B5/1477;;A61B5/1495;;G01N27/416;;G06F19/00;;H01L23/31;;H01L23/495,600/345;;702/19,0,0,,,,DISCONTINUED
226,US,B2,US 9011331 B2,118-027-788-882-853,2015-04-21,2015,US 2742304 A,2004-12-29,US 2742304 A;;US 42005703 A;;US 66719900 A;;US 7067798 A,1998-04-30,Analyte monitoring device and methods of use,"An analyte monitor includes a sensor, a sensor control unit, and a display unit. The sensor has, for example, a substrate, a recessed channel formed in the substrate, and conductive material disposed in the recessed channel to form a working electrode. The sensor control unit typically has a housing adapted for placement on skin and is adapted to receive a portion of an electrochemical sensor. The sensor control unit also includes two or more conductive contacts disposed on the housing and configured for coupling to two or more contact pads on the sensor. A transmitter is disposed in the housing and coupled to the plurality of conductive contacts for transmitting data obtained using the sensor. The display unit has a receiver for receiving data transmitted by the transmitter of the sensor control unit and a display coupled to the receiver for displaying an indication of a level of an analyte. The analyte monitor may also be part of a drug delivery system to alter the level of the analyte based on the data obtained using the sensor.",SAY JAMES;;TOMASCO MICHAEL F;;HELLER ADAM;;GAL YORAM;;ARIA BEHRAD;;HELLER EPHRAIM;;PLANTE PHILLIP JOHN;;VREEKE MARK S;;FRIEDMAN KEITH A;;COLMAN FREDRIC C;;ABBOTT DIABETES CARE INC,SAY JAMES;;TOMASCO MICHAEL F;;HELLER ADAM;;GAL YORAM;;ARIA BEHRAD;;HELLER EPHRAIM;;PLANTE PHILLIP JOHN;;VREEKE MARK S;;FRIEDMAN KEITH A;;COLMAN FREDRIC C,ABBOTT DIABETES CARE INC (2000-03-13);;E. HELLER & COMPANY (1998-07-02),https://lens.org/118-027-788-882-853,Granted Patent,yes,106,6,211,221,0,A61B5/14532;;A61B5/14532;;A61B5/0002;;A61B5/0002;;A61B5/002;;A61B5/01;;A61B5/14503;;A61B5/1451;;A61B5/14546;;A61B5/14546;;A61B5/1473;;A61B5/1473;;A61B5/1486;;A61B5/1486;;A61B5/14865;;A61B5/1495;;A61B5/4839;;A61B5/72;;A61B5/7278;;A61B5/7282;;A61B5/7405;;A61B5/743;;A61B5/7445;;A61B5/7445;;A61B5/7455;;A61B2560/0252;;A61B2560/0252;;A61M5/1723;;C12Q1/54;;G16H10/40;;G16H10/40;;G16H20/17;;G16H20/17;;H01L23/3107;;H01L23/3107;;H01L23/49548;;H01L23/49548;;H01L2924/0002;;H01L2924/0002;;H01L2924/19041;;H01L2924/19041;;H01L2924/3011;;H01L2924/3011;;Y10S128/903;;Y10S128/903;;Y10T29/49;;Y10T29/49;;Y10T29/49124;;Y10T29/49124,A61B5/00;;G01N27/30;;A61B5/05;;A61B5/145;;A61B5/1473;;A61B5/1477;;A61B5/1486;;A61B5/1495;;G01N27/416;;G06F19/00;;H01L23/31;;H01L23/495,600/365;;600/347;;600/345;;600/309;;128/903,99,25,075-958-432-122-199;;035-090-282-884-790;;016-819-089-891-758;;038-134-360-685-692;;025-574-914-238-550;;109-358-955-476-095;;173-901-776-852-06X;;098-973-607-166-581;;029-493-512-369-495;;035-856-257-818-78X;;054-580-942-789-395;;024-691-508-279-134;;017-843-532-202-598;;034-958-263-939-044;;124-660-118-050-67X;;129-974-218-261-531;;074-053-786-843-062;;013-438-201-644-557;;062-066-135-131-958;;115-480-299-312-274;;165-290-677-293-493;;034-397-061-963-129;;000-878-682-341-828;;114-397-952-341-999;;080-674-869-523-362,10.1007/bf01015979;;18473691;;10.1089/dia.2007.0281;;10.1109/10.284922;;8026845;;10.1016/0142-9612(92)90147-g;;1472593;;10.1177/193229680700100208;;pmc2771467;;19888405;;10.1089/dia.2006.0030;;17705688;;10.1142/9789810248628_0003;;10.2337/diacare.26.3.582;;12610005;;4064281;;10.1093/clinchem/31.12.1931;;10.1016/0003-2670(93)85008-8;;10.1016/s0967-0661(97)00046-4;;10.1016/s0967-0661(97)00053-1;;8797377;;10.1021/ac950630x;;1789455;;10.1021/ac00024a029;;10.1016/0250-6874(89)87015-5;;2714056;;10.1088/0143-0815/10/1/001;;10.1016/s0169-7439(98)00146-4;;18473688;;10.1089/dia.2007.0293;;10.1016/0142-9612(92)90148-h;;1472594;;10.1039/ac9963300271;;10.1016/0013-4686(81)90029-3;;10.1089/dia.2007.0273;;18473693;;5469118;;10.2337/diab.19.9.644;;10.1093/clinchem/26.1.0089;;7356580;;8850596,"U.S. Appl. No. 09/447,227, Shults.;;U.S. Appl. No. 11/737,671, Wolpert, et al.;;U.S. Appl. No. 11/766,747, Say, et al.;;U.S. Appl. No. 11/849,200, Peyser, et al.;;U.S. Appl. No. 11/928,574, Heller, et al.;;U.S. Appl. No. 11/928,668, Heller, et al.;;U.S. Appl. No. 11/928,743, Heller, et al.;;U.S. Appl. No. 11/928,795, Heller, et al.;;U.S. Appl. No. 11/928,891, Heller, et al.;;U.S. Appl. No. 11/928,968, Heller, et al.;;U.S. Appl. No. 11/941,078, Say, et al.;;""Poretics Polycarbonate Membrane"", Osmonics Filtration and Separation Group, 2002.;;Bellucci, F., et al., ""Electrochemical Behaviour of Graphite-Epoxy Composite Materials (GECM) in Aqueous Salt Solutions"", Journal of Applied Electrochemistry, vol. 16, 1986, pp. 15-22.;;Biermann, E., et al., ""How Would Patients Behave if They Were Continually Informed of Their Blood Glucose Levels? A Simulation Study Using a 'Virtual' Patient"", Diabetes Technology & Therapeutics, vol. 10, No. 3, 2008, pp. 178-187.;;Candas, B., et al., ""An Adaptive Plasma Glucose Controller Based on a Nonlinear Insulin/Glucose Model"", IEEE Transactions on Biomedical Engineering, vol. 41, No. 2, 1994, pp. 116-124.;;Davies, M. L., et al., ""Polymer Membranes in Clinical Sensor Applications"", Biomaterials, vol. 13, No. 14, 1992, pp. 971-978.;;Eighth Annual Diabetes Technology Meeting Abstracts, Nov. 13-15, 2008, pp. A1-A182.;;El-Khatib, F. H, et al., ""Adaptive Closed-Loop Control Provides Blood-Glucose Regulation Using Subcutaneous Insulin and Glucagon Infusion in Diabetic Swine"", Journal of Diabetes Science and Technology, vol. 1, No. 2, 2007, pp. 181-192.;;Fabietti, P. G., et al. ""Clinical Validation of a New Control-Oriented Model of Insulin and Glucose Dynamics in Subjects with Type 1 Diabetes"", Diabetes Technology & Therapeutics, vol. 9, No. 4, 2007, pp. 327-338.;;Gough, D. A., et al., ""The Implantable Glucose Sensor: An Example of Bioengineering Design."", Introduction to Bioengineering, Chapter 3, 2001, pp. 57-66.;;Guerci, B., et al., ""Clinical Performance of CGMS in Type 1 Diabetic Patients Treated by Continuous Subcutaneous Insulin Infusion Using Insulin Analogs"", Diabetes Care, vol. 26, 2003, pp. 582-589.;;Hicks, J. M., ""In Situ Monitoring"", Clinical Chemistry, vol. 31, No. 12, 1985, pp. 1931-1935.;;Hu, Y., et al., ""A Needle-Type Enzyme-Based Lactate Sensor for In Vivo Monitoring"", Analytica Chimica Acta, vol. 281, 1993, pp. 503-511.;;Isermann, R., ""Supervision, Fault-Detection and Fault-Diagnosis Methods-An Introduction"", Control Engineering Practice, vol. 5, No. 5, 1997, pp. 639-652.;;Isermann, R., et al., ""Trends in the Application of Model-Based Fault Detection and Diagnosis of Technical Processes"", Control Engineering Practice, vol. 5, No. 5, 1997, pp. 709-719.;;Jobst, G., et al., ""Thin-Film Microbiosensors for Glucose-Lactate Monitoring"", Analytical Chemistry, vol. 68, No. 18, 1996, pp. 3173-3179.;;Kamath, A., et al., ""Calibration of a Continuous Glucose Monitor: Effect of Glucose Rate of Change"", Eighth Annual Diabetes Technology Meeting Abstracts, Nov. 13-15, 2008, pp. A88.;;Kawagoe, J. L., et al., ""Enzyme-Modified Organic Conducting Salt Microelectrode"", Analytical Chemistry, vol. 63, No. 24, 1991, pp. 2961-2965.;;Koudelka, M., et al., ""Planar Amperometric Enzyme-Based Glucose Microelectrode"", Sensors and Actuators, vol. 18, 1989, pp. 157-165.;;Kusano, H., ""Glucose Enzyme Electrode with Percutaneous Interface Which Operates Independently of Dissolved Oxygen"", Clinical Physics and Physiological Measurement, vol. 10, No. 1, 1989, pp. 1-9.;;Lewis, R. J., ed., ""2-hydroxyethyl methacrylate"", Hawley's Condensed Chemical Dictionary, Twelfth Edition, 1993, pp. 596.;;Lohn, A., et al., ""A Knowledge-Based System for Real-Time Validation of Calibrations and Measurements"", Chemometrics and Intelligent Laboratory Systems, vol. 46, 1999, pp. 57-66.;;Mazze, R. S., et al., ""Characterizing Glucose Exposure for Individuals with Normal Glucose Tolerance Using Continuous Glucose Monitoring and Ambulatory Glucose Profile Analysis"", Diabetes Technology & Therapeutics, vol. 10, No. 3, 2008, pp. 149-159.;;Murphy, S. M., et al., ""Polymer Membranes in Clinical Sensor Applications"", Biomaterials, vol. 13, No. 14, 1992, pp. 979-990.;;Park, T., et al., ""Sol-Gel-based Amperometric Glucose Biosensor Incorporating an Osmium Redox Polymer as Mediator"", Analytical Communications, vol. 33, 1996, pp. 271-273.;;Prabhu, V. G., et al., ""Electrochemical Studies of Hydrogen Peroxide at a Platinum Disc Electrode"", Electrochimica Acta, vol. 26, No. 6, 1981, pp. 725-729.;;Rigla, M, et al., ""Real-Time Continuous Glucose Monitoring Together with Telemedical Assistance Improves Glycemic Control and Glucose Stability in Pump-Treated Patients"", Diabetes Technology & Therapeutics, vol. 10, No. 3, 2008, pp. 194-199.;;Service, F. J., et al., ""Mean Amplitude of Glycemic Excursions, a Measure of Diabetic Instability"", Diabetes, vol. 19, No. 9, 1970, pp. 644-655.;;Sokol, L., et al., ""Immobilized-Enzyme Rate-Determination Method for Glucose Analysis"", Clinical Chemistry, vol. 26, No. 1, 1980, pp. 89-92.;;Stedman's Medical Dictionary, 26th Edition, 1995, pp. 665.;;Yang, S., et al., ""A Glucose Biosensor Based on an Oxygen Electrode: In-Vitro Performances in Model Buffer Solution and in Blood Plasma"", Biomedical Instrumentation & Technology, vol. 30, No. 1, 1996, pp. 55-61.;;Canadian Patent Application No. 2,433,144, Examiner's Report mailed Nov. 2, 2010.;;Canadian Patent Application No. 2,433,144, Examiner's Report mailed Sep. 8, 2008.;;Chinese Patent Application No. 01822786.4, Office Action mailed Feb. 2, 2007.;;Chinese Patent Application No. 01822786.4, Office Action mailed Sep. 21, 2007.;;European Patent Application No. 01994499.0, Examination Report mailed Dec. 7, 2006.;;European Patent Application No. 01994499.0, Examination Report mailed Feb. 10, 2009.;;European Patent Application No. 01994499.0, Examination Report mailed Oct. 11, 2007.;;European Patent Application No. 06839640.7, Extended European Search Report mailed Oct. 21, 2010.;;European Patent Application No. 09010614.7, Extended European Search Report mailed Mar. 2, 2010.;;European Patent Application No. 10012409.8, Extended European Search Report mailed Mar. 15, 2011.;;European Patent Application No. 10012414.8, Extended European Search Report mailed Mar. 15, 2011.;;European Patent Application No. 10012960.0, Extended European Search Report mailed Mar. 2, 2011.;;European Patent Application No. 10012961.8, Extended European Search Report mailed Mar. 2, 2011.;;European Patent Application No. 99903239.4, Examination Report mailed Apr. 14, 2008.;;European Patent Application No. 99903239.4, Examination Report mailed Dec. 20, 2004.;;European Patent Application No. 99903239.4, Examination Report mailed Oct. 7, 2005.;;European Patent Application No. 99903239.4, Invitation Pursuant to Article 94(3) and Rule 71(1) EPC mailed Dec. 15, 2010.;;Japanese Patent Application No. 2000-546653, Office Action mailed Dec. 15, 2009.;;Japanese Patent Application No. 2000-546653, Office Action mailed Jan. 6, 2009.;;Japanese Patent Application No. 2002-558875, Office Action mailed Sep. 26, 2006.;;Japanese Patent Application No. 2007-270411, Office Action mailed Aug. 17, 2010.;;Japanese Patent Application No. 2007-270411, Office Action mailed Jun. 21, 2011.;;PCT Application No. PCT/US1999/001229, International Preliminary Examination Report mailed Aug. 1, 2000.;;PCT Application No. PCT/US1999/001229, International Search Report mailed May 6, 1999.;;PCT Application No. PCT/US1999/001229, Written Opinion of the International Preliminary Examining Authority mailed Feb. 7, 2000.;;PCT Application No. PCT/US2001/050832, International Preliminary Examination Report mailed Nov. 4, 2003.;;PCT Application No. PCT/US2006/060400, International Search Report and Written Opinion of the International Searching Authority mailed Oct. 16, 2007.;;PCT Application No. PCT/US2008/074469, International Preliminary Report on Patentability and Written Opinion of the International Searching Authority mailed Mar. 11, 2010.;;PCT Application No. PCT/US2008/074469, International Search Report and Written Opinion of the International Searching Authority mailed Nov. 3, 2008.;;PCT Application No. PCT/US2010/040117, International Preliminary Report on Patentability and Written Opinion of the International Searching Authority mailed Jan. 12, 2012.;;PCT Application No. PCT/US2010/040117, International Search Report and Written Opinion of the International Searching Authority mailed Sep. 1, 2010.;;PCT Application No. PCT/US2010/040118, International Preliminary Report on Patentability and Written Opinion of the International Searching Authority mailed Jan. 12, 2012.;;PCT Application No. PCT/US2010/040118, International Search Report and Written Opinion of the International Searching Authority mailed Sep. 17, 2010.;;PCT Application No. PCT/US2010/040119, International Preliminary Report on Patentability and Written Opinion of the International Searching Authority mailed Jan. 12, 2012.;;PCT Application No. PCT/US2010/040119, International Search Report and Written Opinion of the International Searching Authority mailed Sep. 17, 2010.;;U.S. Appl. No. 09/070,677, Notice of Allowance mailed Aug. 1, 2000.;;U.S. Appl. No. 09/070,677, Notice of Allowance mailed Jun. 6, 2000.;;U.S. Appl. No. 09/070,677, Office Action mailed Apr. 27, 1999.;;U.S. Appl. No. 09/070,677, Office Action mailed Nov. 15, 1999.;;U.S. Appl. No. 09/667,199, Notice of Allowance mailed Nov. 25, 2002.;;U.S. Appl. No. 09/667,199, Office Action mailed Jul. 24, 2002.;;U.S. Appl. No. 09/753,746, Notice of Allowance mailed Oct. 9, 2002.;;U.S. Appl. No. 09/753,746, Office Action mailed Jul. 3, 2002.;;U.S. Appl. No. 10/336,195, Office Action mailed Apr. 29, 2005.;;U.S. Appl. No. 10/336,195, Office Action mailed Dec. 28, 2007.;;U.S. Appl. No. 10/336,195, Office Action mailed Feb. 6, 2006.;;U.S. Appl. No. 10/336,195, Office Action mailed Jul. 16, 2008.;;U.S. Appl. No. 10/336,195, Office Action mailed Jun. 17, 2004.;;U.S. Appl. No. 10/336,195, Office Action mailed Mar. 25, 2009.;;U.S. Appl. No. 10/336,195, Office Action mailed Nov. 10, 2009.;;U.S. Appl. No. 10/336,195, Office Action mailed Oct. 26, 2006.;;U.S. Appl. No. 10/420,057, Advisory Action mailed Jan. 27, 2009.;;U.S. Appl. No. 10/420,057, Office Action mailed Apr. 4, 2006.;;U.S. Appl. No. 10/420,057, Office Action mailed Aug. 21, 2008.;;U.S. Appl. No. 10/420,057, Office Action mailed Jul. 25, 2007.;;U.S. Appl. No. 10/420,057, Office Action mailed Jun. 1, 2005.;;U.S. Appl. No. 10/420,057, Office Action mailed Jun. 24, 2010.;;U.S. Appl. No. 10/420,057, Office Action mailed Nov. 23, 2007.",INACTIVE
227,US,A1,US 2014/0051957 A1,119-022-045-231-244,2014-02-20,2014,US 201314027197 A,2013-09-14,US 201314027197 A;;US 42005703 A;;US 66719900 A;;US 7067798 A,1998-04-30,Analyte Monitoring Device and Methods of Use,"An analyte monitor includes a sensor, a sensor control unit, and a display unit. The sensor has, for example, a substrate, a recessed channel formed in the substrate, and conductive material disposed in the recessed channel to form a working electrode. The sensor control unit typically has a housing adapted for placement on skin and is adapted to receive a portion of an electrochemical sensor. The sensor control unit also includes two or more conductive contacts disposed on the housing and configured for coupling to two or more contact pads on the sensor. A transmitter is disposed in the housing and coupled to the plurality of conductive contacts for transmitting data obtained using the sensor. The display unit has a receiver for receiving data transmitted by the transmitter of the sensor control unit and a display coupled to the receiver for displaying an indication of a level of an analyte. The analyte monitor may also be part of a drug delivery system to alter the level of the analyte based on the data obtained using the sensor.",ABBOTT DIABETES CARE INC,SAY JAMES;;TOMASCO MICHAEL F;;HELLER ADAM;;GAL YORAM;;ARIA BEHRAD;;HELLER EPHRAIM;;PLANTE PHILLIP JOHN;;VREEKE MARK S;;FRIEDMAN KEITH A;;COLMAN FREDRIC C,E. HELLER & CO (1998-07-02);;ABBOTT DIABETES CARE INC (2000-03-13),https://lens.org/119-022-045-231-244,Patent Application,yes,1,2,211,221,0,A61B5/14532;;A61B5/14532;;A61B5/0002;;A61B5/0002;;A61B5/002;;A61B5/01;;A61B5/14503;;A61B5/1451;;A61B5/14546;;A61B5/14546;;A61B5/1473;;A61B5/1473;;A61B5/1486;;A61B5/1486;;A61B5/14865;;A61B5/1495;;A61B5/4839;;A61B5/72;;A61B5/7278;;A61B5/7282;;A61B5/7405;;A61B5/743;;A61B5/7445;;A61B5/7445;;A61B5/7455;;A61B2560/0252;;A61B2560/0252;;A61M5/1723;;C12Q1/54;;G16H10/40;;G16H10/40;;G16H20/17;;G16H20/17;;H01L23/3107;;H01L23/3107;;H01L23/49548;;H01L23/49548;;H01L2924/0002;;H01L2924/0002;;H01L2924/19041;;H01L2924/19041;;H01L2924/3011;;H01L2924/3011;;Y10S128/903;;Y10S128/903;;Y10T29/49;;Y10T29/49;;Y10T29/49124;;Y10T29/49124,A61B5/145;;G01N27/30;;A61B5/00;;A61B5/1477;;A61B5/1495;;G01N27/416;;G06F19/00;;H01L23/31;;H01L23/495,600/347;;600/345;;702/19,0,0,,,,DISCONTINUED
228,US,B2,US 8231532 B2,133-854-835-802-522,2012-07-31,2012,US 74245307 A,2007-04-30,US 74245307 A;;US 42005703 A;;US 66719900 A;;US 7067798 A,1998-04-30,Analyte monitoring device and methods of use,"An analyte monitor includes a sensor, a sensor control unit, and a display unit. The sensor has, for example, a substrate, a recessed channel formed in the substrate, and conductive material disposed in the recessed channel to form a working electrode. The sensor control unit typically has a housing adapted for placement on skin and is adapted to receive a portion of an electrochemical sensor. The sensor control unit also includes two or more conductive contacts disposed on the housing and configured for coupling to two or more contact pads on the sensor. A transmitter is disposed in the housing and coupled to the plurality of conductive contacts for transmitting data obtained using the sensor. The display unit has a receiver for receiving data transmitted by the transmitter of the sensor control unit and a display coupled to the receiver for displaying an indication of a level of an analyte. The analyte monitor may also be part of a drug delivery system to alter the level of the analyte based on the data obtained using the sensor.",SAY JAMES;;TOMASCO MICHAEL F;;HELLER ADAM;;GAL YORAM;;BEHRAD ARIA;;HELLER EPHRAIM;;PLANTE PHILLIP JOHN;;VREEKE MARK S;;FRIEDMAN KEITH A;;COLMAN FREDRIC C;;ABBOTT DIABETES CARE INC,SAY JAMES;;TOMASCO MICHAEL F;;HELLER ADAM;;GAL YORAM;;BEHRAD ARIA;;HELLER EPHRAIM;;PLANTE PHILLIP JOHN;;VREEKE MARK S;;FRIEDMAN KEITH A;;COLMAN FREDRIC C,,https://lens.org/133-854-835-802-522,Granted Patent,yes,99,12,211,221,0,A61B5/14532;;A61B5/14532;;A61B5/0002;;A61B5/0002;;A61B5/002;;A61B5/01;;A61B5/14503;;A61B5/1451;;A61B5/14546;;A61B5/14546;;A61B5/1473;;A61B5/1473;;A61B5/1486;;A61B5/1486;;A61B5/14865;;A61B5/1495;;A61B5/4839;;A61B5/72;;A61B5/7278;;A61B5/7282;;A61B5/7405;;A61B5/743;;A61B5/7445;;A61B5/7445;;A61B5/7455;;A61B2560/0252;;A61B2560/0252;;A61M5/1723;;C12Q1/54;;G16H10/40;;G16H10/40;;G16H20/17;;G16H20/17;;H01L23/3107;;H01L23/3107;;H01L23/49548;;H01L23/49548;;H01L2924/0002;;H01L2924/0002;;H01L2924/19041;;H01L2924/19041;;H01L2924/3011;;H01L2924/3011;;Y10S128/903;;Y10S128/903;;Y10T29/49;;Y10T29/49;;Y10T29/49124;;Y10T29/49124,A61B5/00;;G01N27/30;;A61B5/05;;A61B5/145;;A61B5/1477;;A61B5/1495;;G01N27/416;;G06F19/00;;H01L23/31;;H01L23/495,600/365;;600/347,99,71,136-791-935-548-81X;;062-360-289-025-864;;010-601-725-111-91X;;101-292-518-663-191;;056-703-879-057-297;;030-155-762-644-019;;004-149-141-436-651;;016-731-054-793-457;;080-559-561-995-335;;044-807-213-528-815;;027-538-525-436-179;;015-020-161-517-40X;;025-919-454-564-785;;014-700-576-603-812;;004-851-060-590-788;;075-958-432-122-199;;052-356-140-149-389;;035-090-282-884-790;;033-562-815-299-181;;018-803-926-589-211;;008-505-762-041-402;;016-601-143-530-813;;019-502-772-562-215;;058-476-824-396-350;;006-498-707-073-30X;;054-091-551-638-293;;010-531-147-771-746;;054-827-198-877-419;;122-658-944-077-000;;017-261-560-469-37X;;000-125-755-474-124;;113-381-664-783-802;;082-626-907-191-554;;017-950-014-792-456;;090-348-305-613-628;;015-985-399-299-132;;171-049-047-164-618;;016-819-089-891-758;;081-249-097-078-543;;089-612-747-111-646;;031-706-897-890-035;;094-198-536-559-723;;003-690-143-043-420;;007-943-354-378-456;;082-114-500-909-975;;004-239-090-971-580;;026-894-457-160-450;;077-128-610-778-669;;022-466-506-956-898;;008-424-592-956-946;;007-500-825-916-378;;009-725-244-669-882;;037-755-689-613-42X;;153-411-506-517-475;;038-134-360-685-692;;012-449-714-188-064;;031-517-704-996-130;;131-299-284-996-064;;049-133-049-742-708;;000-272-178-768-076;;070-797-683-833-124;;043-870-224-178-49X;;025-574-914-238-550;;052-364-430-129-757;;004-434-167-910-115;;032-860-147-271-886;;132-460-374-211-421;;098-172-374-375-47X;;109-358-955-476-095;;014-988-634-483-130;;061-786-187-274-992,10.1016/s0956-5663(02)00099-4;;12392956;;10.1021/ja00391a001;;2889225;;10.1098/rstb.1987.0021;;10.1109/51.294001;;10.1016/0022-0728(65)85063-x;;2245876;;10.2337/diabetes.39.12.1519;;10.2337/diab.39.12.1519;;10.1016/s0956-5663(03)00220-3;;14611755;;18615658;;10.1002/bit.260430310;;9366023;;10.1016/s0956-5663(97)00025-0;;9451795;;10.1016/s0956-5663(97)00083-3;;10.1016/0956-5663(93)80028-n;;8311939;;8651496;;10.1021/ac960030d;;10.1080/03091900210156797;;12487712;;10.1016/0265-928x(87)80018-4;;3333622;;10.1109/19.816143;;10.1007/bf01015979;;10.1089/15209150252924058;;12017416;;18473691;;10.1089/dia.2007.0281;;10.1021/ac00017a008;;1789439;;2817408;;10.1021/ac00197a022;;10.1016/0925-4005(95)01730-5;;10.1016/0010-4825(90)90013-f;;2257734;;2868172;;8277748;;10.1016/0141-5425(93)90058-7;;11469630;;10.1089/15209150050214104;;10624783;;10.1016/s0168-8227(99)00113-8;;10.1089/15209150050214113;;11469631;;10.1007/bf00401374;;1478372;;10.2337/diacare.20.1.64;;9028696;;10.1109/tbme.1986.325807;;3957374;;236018;;10.1016/0005-2795(75)90259-7;;10.1089/hum.1998.9.6-879;;9581910;;11762520;;10.1089/15209150152607196;;10.2337/diabetes.48.3.445;;10078542;;10.1016/0265-928x(87)80012-3;;505005;;10.1126/science.505005;;10.1021/ac0498516;;15253640;;10.1109/10.284922;;8026845;;6721151;;10.1021/ac00268a018;;6733082;;10.1021/bi00305a016;;10.1515/cclm.2002.135;;12392305;;10.1016/j.ecl.2003.12.001;;15053902;;12052350;;10.1016/s0956-5663(01)00304-9;;12052349;;10.1016/s0956-5663(01)00306-2;;4500021;;10.1007/978-1-4684-3288-6_18;;14021529;;10.1111/j.1749-6632.1962.tb13623.x;;3196517;;10.2337/diacare.10.5.622;;3677983;;10.2337/diacare.8.6.529;;4075939;;10.1002/elan.1140061103;;7733469;;10.1021/ac00103a015;;7978306;;10.1021/ac00091a022;;10.1007/bf01248238;;10.1016/s0376-7388(98)00330-5;;10.1016/0142-9612(92)90147-g;;1472593;;10.1016/0265-928x(85)80002-x;;10.1021/j100290a001;;10.1021/ja00216a040;;10.1021/ja00188a091;;10.1021/ja00406a011;;2624333;;12323417;;10.1016/s0165-0270(02)00170-x;;10.1177/193229680700100208;;pmc2771467;;19888405;;10.1021/ja00415a014;;10.1007/bf00575392;;10.1021/ac00250a038;;10.1021/ac00266a005;;10.1007/s00216-002-1284-0;;12194035;;10.1089/dia.2006.0030;;17705688;;9642777;;10.1016/s0956-5663(97)00091-2;;10.1089/152091503322526978;;14633342,"U.S. Appl. No. 09/447,227, Shults.;;U.S. Appl. No. 11/737,671, Wolpert, et al.;;U.S. Appl. No. 11/766,747, Say, et al.;;U.S. Appl. No. 11/849,200, Peyser, et al.;;U.S. Appl. No. 11/928,574, Heller, et al.;;U.S. Appl. No. 11/928,668, Heller, et al.;;U.S. Appl. No. 11/928,743, Heller, et al.;;U.S. Appl. No. 11/928,795, Heller, et al.;;U.S. Appl. No. 11/928,891, Heller, et al.;;U.S. Appl. No. 11/928,968, Heller, et al.;;U.S. Appl. No. 11/941,078, Say, et al.;;Abel, P. U., et al., ""Biosensors for In Vivo Glucose Measurement: Can We Cross the Experimental Stage"", Biosensors and Bioelectronics, vol. 17, 2002, pp. 1059-1070.;;Abruna, H. D., et al., ""Rectifying Interfaces Using Two-Layer Films of Electrochemically Polymerized Vinylpyridine and Vinylbipyridine Complexes of Ruthenium and Iron on Electrodes"", Journal of the American Chemical Society, vol. 103, No. 1, 1981, pp. 1-5.;;Albery, W. J., et al., ""Amperometric Enzyme Electrodes Part II: Conducting Salts as Electrode Materials for the Oxidation of Glucose Oxidase"", Journal of ElectroAnalytical Chemistry, vol. 194, 1985, pp. 223-235.;;Albery, W. J., et al., ""Amperometric Enzyme Electrodes"", Philosophical Transactions of the Royal Society of London, vol. 316, 1987, pp. 107-119.;;Alcock, S. J., et al., ""Continuous Analyte Monitoring to Aid Clinical Practice"", IEEE Engineering in Medicine and Biology Magazine, 1994, pp. 319-325.;;Anderson, L. B., et al., ""Thin-Layer Electrochemistry: Steady-State Methods of Studying Rate Processes"", Journal of ElectroAnalytical Chemistry, vol. 10, 1965, pp. 295-305.;;Armour, J. C., et al., ""Application of Chronic Intravascular Blood Glucose Sensor in Dogs"", Diabetes, vol. 39, 1990, pp. 1519-1526.;;Asberg, P., et al., ""Hydrogels of a Conducting Conjugated Polymer as 3-D Enzyme Electrode"", Biosensors & Bioelectronics, vol. 19, 2003, pp. 199-207.;;Atanasov, P., et al., ""Biosensor for Continuous Glucose Monitoring"", Biotechnology and Bioengineering, vol. 43, 1994, pp. 262-266.;;Atanasov, P., et al., ""Implantation of a Refillable Glucose Monitoring-Telemetry Device"", Biosensors & Bioelectronics, vol. 12, No. 7, 1997, pp. 669-680.;;Aussedat, B., et al., ""A User-Friendly Method for Calibrating a Subcutaneous Glucose Sensor-Based Hypoglycaemic Alarm"", Biosensors & Bioelectronics, vol. 12, No. 11, 1997, pp. 1061-1071.;;Baker, D. A., et al., ""Dynamic Concentration Challenges for Biosensor Characterization"", Biosensors & Bioelectronics, vol. 8, 1993, pp. 433-441.;;Baker, D. A., et al., ""Dynamic Delay and Maximal Dynamic Error in Continuous Biosensors"", Analytical Chemistry, vol. 68, No. 8, 1996, pp. 1292-1297.;;Bani Amer, M. M., ""An Accurate Amperometric Glucose Sensor Based Glucometer with Eliminated Cross-Sensitivity"", Journal of Medical Engineering & Technology, vol. 26, No. 5, 2002, pp. 208-213.;;Bard, A. J., et al., Electrochemical Methods, 1980, pp. 173-175.;;Bartlett, P. N., et al., ""Covalent Binding of Electron Relays to Glucose Oxidase"", Journal of the Chemical Society, Chemical Communications, 1987, pp. 1603-1604.;;Bartlett, P. N., et al., ""Modification of Glucose Oxidase by Tetrathiafulvalene"", Journal of the Chemical Society, Chemical Communications, 1990, pp. 1135-1136.;;Bartlett, P. N., et al., ""Strategies for the Development of Amperometric Enzyme Electrodes"", Biosensors, vol. 3, 1987/88, pp. 359-379.;;Beach, R. D., et al., ""Subminiature Implantable Potentiostat and Modified Commercial Telemetry Device for Remote Glucose Monitoring"", IEEE Transactions on Instrumentation and Measurement, vol. 28, No. 6, 1999, pp. 1239-1245.;;Beech, W. A., ""AX.25 Link Access Protocol for Amateur packet Radio"", Tucson Amateur Packet Radio Corporation, 1998, pp. 1-133.;;Bellucci, F., et al., ""Electrochemical Behaviour of Graphite-Epoxy Composite Materials (GECM) in Aqueous Salt Solutions"", Journal of Applied Electrochemistry, vol. 16, 1986, pp. 15-22.;;Bennion, N., et al., ""Alternate Site Glucose Testing: A Technology Crossover Design"", Diabetes & Therapeutics, vol. 4, No. 1, 2002, pp. 25-33.;;Biermann, E., et al., ""How Would Patients Behave if They Were Continually Informed of Their Blood Glucose Levels? A Simulation Study Using a 'Virtual' Patient"", Diabetes Technology & Therapeutics, vol. 10, No. 3, 2008, pp. 178-187.;;Bindra, D. S., et al., ""Design and in Vitro Studies of a Needle-Type Glucose Sensor for Subcutaneous Monitoring"", Analytical Chemistry, vol. 63, No. 17, 1991, pp. 1692-1696.;;Bindra, D. S., et al., ""Pulsed Amperometric Detection of Glucose in Biological Fluids at a Surface-Modified Gold Electrode"", Analytical Chemistry, vol. 61, No. 22, 1989, pp. 2566-2570.;;Bisenberger, M., et al., ""A Triple-Step Potential Waveform at Enzyme Multisensors with Thick-Film Gold Electrodes for Detection of Glucose and Sucrose"", Sensors and Actuators B, vol. 28, 1995, pp. 181-189.;;Bland, J. M., et al., ""A Note on the Use of the Intraclass Correlation Coefficient in the Evaluation of Agreement Between Two Methods of Measurement"", Computers in Biology and Medicine, vol. 20, No. 5, 1990, pp. 337-340.;;Bland, J. M., et al., ""Statistical Methods for Assessing Agreement Between Two Methods of Clinical Measurement"", The Lancet, 1986, pp. 307-310.;;Blank, T. B., et al., ""Clinical Results From a Non-Invasive Blood Glucose Monitor"", Optical Diagnostics and Sensing of Biological Fluids and Glucose and Cholesterol Monitoring II, Proceedings of SPIE, vol. 4624, 2002, pp. 1-10.;;Bobbioni-Harsch, E., et al., ""Lifespan of Subcutaneous Glucose Sensors and Their Performances During Dynamic Glycaemia Changes in Rats"", Journal of Biomedical Engineering, vol. 15, 1993, pp. 457-463.;;Bode, B. W., ""Clinical Utility of the Continuous Glucose Monitoring System"", Diabetes Technology & Therapeutics, vol. 2, Sup. 1, 2000, pp. S35-S41.;;Bode, B. W., et al., ""Continuous Glucose Monitoring Used to Adjust Diabetes Therapy Improves Glycosylated Hemoglobin: A Pilot Study"", Diabetes Research and Clinical Practice, vol. 46, 1999, pp. 183-190.;;Bode, B. W., et al., ""Using the Continuous Glucose Monitoring System to Improve the Management of Type I Diabetes"", Diabetes Technology & Therapeutics, vol. 2, Sup. 1, 2000, pp. S43-S48.;;Boedeker Plastics, Inc., ""Polyethylene Specifications"", Web Page of Boedeker.com, 2007, pp. 1-3.;;Bolinder, J., et al., ""Microdialysis Measurement of the Absolute Glucose Concentration in Subcutaneous Adipose Tissue Allowing Glucose Monitoring in Diabetic Patients"", Diabetologia, vol. 35, 1992, pp. 1177-1180.;;Bolinder, J., et al., ""Self-Monitoring of Blood Glucose in Type I Diabetic Patients: Comparison with Continuous Microdialysis Measurements of Glucose in Subcutaneous Adipose Tissue During Ordinary Life Conditions"", Diabetes Care, vol. 20, No. 1, 1997, pp. 64-70.;;Bott, A. W., ""A Comparison of Cyclic Voltammetry and Cyclic Staircase Voltammetry"", Current Separations, vol. 16, No. 1, 1997, pp. 23-26.;;Bott, A. W., ""Electrochemical Methods for the Determination of Glucose"", Current Separations, vol. 17, No. 1, 1998, pp. 25-31.;;Bowman, L., et al., ""The Packaging of Implantable Integrated Sensors"", IEEE Transactions on Biomedical Engineering, vol. 33, No. 2, 1986, pp. 248-255.;;Brandt, J., et al., ""Covalent Attachment of Proteins to Polysaccharide Carriers by Means of Benzoquinone"", Biochimica et Biophysica Acta, vol. 386, 1975, pp. 196-202.;;Brauker, J., et al., ""Sustained Expression of High Levels of Human Factor IX from Human Cells Implanted Within an Immunoisolation Device into Athymic Therapy"", Human Gene Therapy, vol. 9, No. 6, 1998, pp. 879-888.;;Bremer, T. M., et al., ""Benchmark Data from the Literature for Evaluation of New Glucose Sensing Technologies"", Diabetes Technology & Therapeutics, vol. 3, No. 3, 2001, pp. 409-418.;;Bremer, T., et al., ""Is Blood Glucose Predictable from Previous Values?"", Diabetes, vol. 48, 1999, pp. 445-451.;;Brooks, S. L., et al., ""Development of an On-Line Glucose Sensor for Fermentation Monitoring"", Biosensors, vol. 3, 1987/88, pp. 45-56.;;Brownlee, M., et al., ""A Glucose-Controlled Insulin-Delivery System: Semisynthetic Insulin Bound to Lectin"", Science, vol. 206, 1979, 1190-1191.;;Cai, Q., et al., ""A Wireless, Remove Query Glucose Biosensor Based on a pH-Sensitive Polymer"", Analytical Chemistry, vol. 76, No. 14, 2004, pp. 4038-4043.;;Candas, B., et al., ""An Adaptive Plasma Glucose Controller Based on a Nonlinear Insulin/Glucose Model"", IEEE Transactions on Biomedical Engineering, vol. 41, No. 2, 1994, pp. 116-124.;;Cass, A. E., et al., ""Ferricinum Ion As an Electron Acceptor for Oxido-Reductases"", Journal of ElectroAnalytical Chemistry, vol. 190, 1985, pp. 117-127.;;Cass, A. E., et al., ""Ferrocene-Medicated Enzyme Electrode for Amperometric Determination of Glucose"", Analytical Chemistry, vol. 56, No. 4, 1984, 667-671.;;Castner, J. F., et al., ""Mass Transport and Reaction Kinetic Parameters Determined Electrochemically for Immobilized Glucose Oxidase"", Biochemistry, vol. 23, No. 10, 1984, 2203-2210.;;Chen, J. C., et al., ""A Comparison of MAC Protocols for Wireless Local Networks Based on battery Power Consumption"", IEEE, 1998, pp. 150-157.;;Chen, T., et al., ""Defining the Period of Recovery of the Glucose Concentration After Its Local Perturbation by the Implantation of a Miniature Sensor"", Clinical Chemistry and Laboratory Medicine, vol. 40, No. 8, 2002, pp. 486-489.;;Chia, C. W., et al., ""Glucose Sensors: Toward Closed Loop Insulin Delivery"", Endocrinology and Metabolism Clinics of North America, vol. 33, 2004, pp. 175-195.;;Choleau, C., et al., ""Calibration of a Subcutaneous Amperometric Glucose Sensor Implanted for 7 Days in Diabetic Patients Part 2: Superiority of the One-Point Calibration Method"", Biosensors and Bioelectronics, vol. 17, 2002, pp. 647-654.;;Choleau, C., et al., ""Calibration of a Subcutaneous Amperometric Glucose Sensor Part 1: Effect of Measurement Uncertainties on the Determination of Sensor Sensitivity and Background Current"", Biosensors and Bioelectronics, vol. 17, 2002, pp. 641-646.;;Claremont, D. J., et al., ""Biosensors for Continuous In Vivo Glucose Monitoring"", Proceedings of the Annual International Conference of the IEEE Engineering in Medicine and Biology Society, vol. 10, 1988.;;Clark Jr., L. C., et al., ""Differential Anodic Enzyme Polarography for the Measurement of Glucose"", Oxygen Transport to Tissue: Instrumentation, Methods, and Physiology, 1973, pp. 127-133.;;Clark Jr., L. C., et al., ""Electrode Systems for Continuous Monitoring in Cardiovascular Surgery"", Annals New York Academy of Sciences, 1962, pp. 29-45.;;Clark Jr., L. C., et al., ""Long-term Stability of Electroenzymatic Glucose Sensors Implanted in Mice"", American Society of Artificial Internal Organs Transactions, vol. XXXIV, 1988, pp. 259-265.;;Clarke, W. L., et al., ""Evaluating Clinical Accuracy of Systems for Self-Monitoring of Blood Glucose"", Diabetes Care, vol. 10, No. 5, 1987, pp. 622-628.;;Complaint, ""Abbott Diabetes Care, Inc. v. Dexcom, Inc."", filed Aug. 11, 2005.;;Complaint, Amended, ""Abbott Diabetes Care, Inc. v. Dexcom, Inc."", filed Jun. 27, 2006.;;Cox, D. J., et al., ""Accuracy of Perceiving Blood Glucose in IDDM"", Diabetes Care, vol. 8, No. 6, 1985, pp. 529-536.;;Csoregi, E., et al., ""Amperometric Microbiosensors for Detection of Hydrogen Peroxide and Glucose Based on Peroxidase-Modified Carbon Fibers"", Electroanalysis, vol. 6, 1994, pp. 925-933.;;Csoregi, E., et al., ""Design and Optimization of a Selective Subcutaneously Implantable Glucose Electrode Based on 'Wired' Glucose Oxidase"", Analytical Chemistry, vol. 67, No. 7, 1995, pp. 1240-1244.;;Csoregi, E., et al., ""Design, Characterization, and One-Point in Vivo Calibration of a Subcutaneously Implanted Glucose Electrode"", Analytical Chemistry, vol. 66 No. 19, 1994, pp. 3131-3138.;;Csoregi, E., et al., ""On-Line Glucose Monitoring by Using Microdialysis Sampling and Amperometric Detection Based on 'Wired' Glucose Oxidase in Carbon Paste"", Mikrochimica Acta, vol. 121, 1995, pp. 31-40.;;D'Arrigo, G., et al., ""Porous-Si Based Bio Reactors for Glucose Monitoring and Drugs Production"", Proceedings of SPIE: Microfluids, BioMEMS, and Medical Microsystems, vol. 4982, 2003, pp. 178-184.;;Dai, W. S., et al., ""Hydrogel Membranes with Mesh Size Asymmetry Based on the Gradient Crosslinking of Poly(vinyl alcohol),"" Journal of Membrane Science, vol. 156, 1999, pp. 67-79.;;Davies, M. L., et al., ""Polymer Membranes in Clinical Sensor Applications"", Biomaterials, vol. 13, No. 14, 1992, pp. 971-978.;;Davis, G., ""Electrochemical Techniques for the Development of Amperometric Biosensors"", Biosensors, vol. 1, 1985, pp. 161-178.;;Degani, Y., et al., ""Direct Electrical Communication Between Chemically Modified Enzymes and Metal Electrodes. 1. Electron Transfer from Glucose Oxidase to Metal Electrodes via Electron Relays, Bound Covalently to the Enzyme"", The Journal of Physical Chemistry, vol. 91, No. 6, 1987, pp. 1285-1289.;;Degani, Y., et al., ""Direct Electrical Communication Between Chemically Modified Enzymes and Metal Electrodes. 2. Methods for Bonding Electron-Transfer Relays to Glucose Oxidase and D-Amino-Acid Oxidase"", Journal of the American Chemical Society, vol. 110, No. 8, 1988, pp. 2615-2620.;;Degani, Y., et al., ""Electrical Communication Between Redox Centers of Glucose Oxidase and Electrodes via Electrostatically and Covalently Bound Redox Polymers"", Journal of the American Chemical Society, vol. 111, 1989, pp. 2357-2358.;;Denisevich, P., et al., ""Unidirectional Current Flow and Charge State Trapping at Redox Polymer Interfaces on Bilayer Electrodes: Principles, Experimental Demonstration, and Theory"", Journal of the American Chemical Society, vol. 103, 1981, pp. 4727-4737.;;Dicks, J. M., et al., ""Ferrocene Modified Polypyrrole with Immobilised Glucose Oxidase and its Application in Amperometric Glucose Microbiosensors"", Annales de Biologie Clinique, vol. 47, 1989, pp. 607-619.;;Dixon, B. M., et al., ""Characterization In Vitro and In Vivo of the Oxygen Dependence of an Enzyme/Polymer Biosensors for Monitoring Brain Glucose"", Journal of Neuroscience Methods, vol. 119, 2002, pp. 135-142.;;Eighth Annual Diabetes Technology Meeting Abstracts, Nov. 13-15, 2008, pp. A1-A182.;;El-Khatib, F. H, et al., ""Adaptive Closed-Loop Control Provides Blood-Glucose Regulation Using Subcutaneous Insulin and Glucagon Infusion in Diabetic Swine"", Journal of Diabetes Science and Technology, vol. 1, No. 2, 2007, pp. 181-192.;;Ellis, C. D., et al., ""Selectivity and Directed Charge Transfer through an Electroactive Metallopolymer Film"", Journal of the American Chemical Society, vol. 103, No. 25, 1981, pp.7480-7483.;;El-Sa'Ad, L., et al., ""Moisture Absorption by Epoxy Resins: The Reverse Thermal Effect"", Journal of Materials Science, vol. 25, No. 8, 1990, pp. 3577-3582.;;Engstrom, R. C., ""Electrochemical Pretreatment of Glassy Carbon Electrodes"", Analytical Chemistry, vol. 54, No. 13, 1982, pp. 2310-2314.;;Engstrom, R. C., et al., ""Characterization of Electrochemically Pretreated Glassy Carbon Electrodes"", Analytical Chemistry, vol. 56, No. 2, 1984, pp. 136-141.;;Ernst, H., et al., ""Reliable Glucose Monitoring Through the Use of Microsystem Technology"", Analytical and Bioanalytical Chemistry, vol. 373, 2002, pp. 758-761.;;Fabietti, P. G., et al. ""Clinical Validation of a New Control-Oriented Model of Insulin and Glucose Dynamics in Subjects with Type 1 Diabetes"", Diabetes Technology & Therapeutics, vol. 9 No. 4, 2007, pp. 327-338.;;Fare, T. L., et al., ""Functional Characterization of a Conducting Polymer-Based Immunoassay System"", Biosensors & Bioelectronics, vol. 13, No. 3-4, 1998, pp. 459-470.;;Feldman, B., et al., ""A Continuous Glucose Sensor Based on Wired Enzyme(TM) Technology-Results from a 3-Day Trial in Patients with Type 1 Diabetes"", Diabetes Technology & Therapeutics, vol. 5, No. 5, 2003, pp. 769-779.;;Feldman, B., et al., ""Correlation of Glucose Concentrations in Interstitial Fluid and Venous Blood During Periods of Rapid Glucose Change"", Abbott Diabetes Care, Inc. Freestyle Navigator Continuous Glucose Monitor Pamphlet, 2004.",EXPIRED
229,US,A1,US 2009/0192373 A1,136-048-884-290-01X,2009-07-30,2009,US 41797509 A,2009-04-03,US 41797509 A;;US 42005703 A;;US 66719900 A;;US 7067798 A,1998-04-30,Analyte Monitoring Device and Methods of Use,"An analyte monitor includes a sensor, a sensor control unit, and a display unit. The sensor has, for example, a substrate, a recessed channel formed in the substrate, and conductive material disposed in the recessed channel to form a working electrode. The sensor control unit typically has a housing adapted for placement on skin and is adapted to receive a portion of an electrochemical sensor. The sensor control unit also includes two or more conductive contacts disposed on the housing and configured for coupling to two or more contact pads on the sensor. A transmitter is disposed in the housing and coupled to the plurality of conductive contacts for transmitting data obtained using the sensor. The display unit has a receiver for receiving data transmitted by the transmitter of the sensor control unit and a display coupled to the receiver for displaying an indication of a level of an analyte. The analyte monitor may also be part of a drug delivery system to alter the level of the analyte based on the data obtained using the sensor.",ABBOTT DIABETES CARE INC,SAY JAMES;;TOMASCO MICHAEL F;;HELLER ADAM;;GAL YORAM;;ARIA BEHRAD;;HELLER EPHRAIM;;PLANTE PHILLIP JOHN;;VREEKE MARK S;;FRIEDMAN KEITH A;;COLMAN FREDRIC C,,https://lens.org/136-048-884-290-01X,Patent Application,yes,1,57,211,221,0,A61B5/14532;;A61B5/14532;;A61B5/0002;;A61B5/0002;;A61B5/002;;A61B5/01;;A61B5/14503;;A61B5/1451;;A61B5/14546;;A61B5/14546;;A61B5/1473;;A61B5/1473;;A61B5/1486;;A61B5/1486;;A61B5/14865;;A61B5/1495;;A61B5/4839;;A61B5/72;;A61B5/7278;;A61B5/7282;;A61B5/7405;;A61B5/743;;A61B5/7445;;A61B5/7445;;A61B5/7455;;A61B2560/0252;;A61B2560/0252;;A61M5/1723;;C12Q1/54;;G16H10/40;;G16H10/40;;G16H20/17;;G16H20/17;;H01L23/3107;;H01L23/3107;;H01L23/49548;;H01L23/49548;;H01L2924/0002;;H01L2924/0002;;H01L2924/19041;;H01L2924/19041;;H01L2924/3011;;H01L2924/3011;;Y10S128/903;;Y10S128/903;;Y10T29/49;;Y10T29/49;;Y10T29/49124;;Y10T29/49124,A61B5/1468;;G01N27/30;;A61B5/00;;A61B5/145;;A61B5/1477;;A61B5/1495;;G01N27/416;;G06F19/00;;H01L23/31;;H01L23/495,600/345,0,0,,,,DISCONTINUED
230,US,B2,US 8235896 B2,140-705-965-904-564,2012-08-07,2012,US 64398009 A,2009-12-21,US 64398009 A;;US 42005703 A;;US 66719900 A;;US 7067798 A,1998-04-30,Analyte monitoring device and methods of use,"An analyte monitor includes a sensor, a sensor control unit, and a display unit. The sensor has, for example, a substrate, a recessed channel formed in the substrate, and conductive material disposed in the recessed channel to form a working electrode. The sensor control unit typically has a housing adapted for placement on skin and is adapted to receive a portion of an electrochemical sensor. The sensor control unit also includes two or more conductive contacts disposed on the housing and configured for coupling to two or more contact pads on the sensor. A transmitter is disposed in the housing and coupled to the plurality of conductive contacts for transmitting data obtained using the sensor. The display unit has a receiver for receiving data transmitted by the transmitter of the sensor control unit and a display coupled to the receiver for displaying an indication of a level of an analyte. The analyte monitor may also be part of a drug delivery system to alter the level of the analyte based on the data obtained using the sensor.",SAY JAMES;;TOMASCO MICHAEL F;;HELLER ADAM;;GAL YORAM;;ARIA BEHRAD;;HELLER EPHRAIM;;PLANTE PHILLIP JOHN;;VREEKE MARK S;;FRIEDMAN KEITH A;;COLMAN FREDRIC C;;ABBOTT DIABETES CARE INC,SAY JAMES;;TOMASCO MICHAEL F;;HELLER ADAM;;GAL YORAM;;ARIA BEHRAD;;HELLER EPHRAIM;;PLANTE PHILLIP JOHN;;VREEKE MARK S;;FRIEDMAN KEITH A;;COLMAN FREDRIC C,,https://lens.org/140-705-965-904-564,Granted Patent,yes,116,0,211,221,0,A61B5/14532;;A61B5/14532;;A61B5/0002;;A61B5/0002;;A61B5/002;;A61B5/01;;A61B5/14503;;A61B5/1451;;A61B5/14546;;A61B5/14546;;A61B5/1473;;A61B5/1473;;A61B5/1486;;A61B5/1486;;A61B5/14865;;A61B5/1495;;A61B5/4839;;A61B5/72;;A61B5/7278;;A61B5/7282;;A61B5/7405;;A61B5/743;;A61B5/7445;;A61B5/7445;;A61B5/7455;;A61B2560/0252;;A61B2560/0252;;A61M5/1723;;C12Q1/54;;G16H10/40;;G16H10/40;;G16H20/17;;G16H20/17;;H01L23/3107;;H01L23/3107;;H01L23/49548;;H01L23/49548;;H01L2924/0002;;H01L2924/0002;;H01L2924/19041;;H01L2924/19041;;H01L2924/3011;;H01L2924/3011;;Y10S128/903;;Y10S128/903;;Y10T29/49;;Y10T29/49;;Y10T29/49124;;Y10T29/49124,A61B5/00;;G01N27/30;;A61B5/145;;A61B5/1477;;A61B5/1495;;G01N27/416;;G01N33/49;;G06F19/00;;H01L23/31;;H01L23/495,600/365;;600/309;;422/68.1,99,84,136-791-935-548-81X;;062-360-289-025-864;;010-601-725-111-91X;;101-292-518-663-191;;056-703-879-057-297;;030-155-762-644-019;;004-149-141-436-651;;016-731-054-793-457;;080-559-561-995-335;;044-807-213-528-815;;027-538-525-436-179;;015-020-161-517-40X;;025-919-454-564-785;;014-700-576-603-812;;004-851-060-590-788;;075-958-432-122-199;;052-356-140-149-389;;035-090-282-884-790;;033-562-815-299-181;;018-803-926-589-211;;008-505-762-041-402;;016-601-143-530-813;;019-502-772-562-215;;058-476-824-396-350;;006-498-707-073-30X;;054-091-551-638-293;;010-531-147-771-746;;054-827-198-877-419;;122-658-944-077-000;;017-261-560-469-37X;;000-125-755-474-124;;113-381-664-783-802;;082-626-907-191-554;;017-950-014-792-456;;090-348-305-613-628;;015-985-399-299-132;;171-049-047-164-618;;016-819-089-891-758;;081-249-097-078-543;;089-612-747-111-646;;031-706-897-890-035;;094-198-536-559-723;;003-690-143-043-420;;007-943-354-378-456;;082-114-500-909-975;;004-239-090-971-580;;026-894-457-160-450;;077-128-610-778-669;;022-466-506-956-898;;008-424-592-956-946;;007-500-825-916-378;;009-725-244-669-882;;037-755-689-613-42X;;153-411-506-517-475;;038-134-360-685-692;;012-449-714-188-064;;031-517-704-996-130;;131-299-284-996-064;;049-133-049-742-708;;000-272-178-768-076;;070-797-683-833-124;;043-870-224-178-49X;;025-574-914-238-550;;052-364-430-129-757;;004-434-167-910-115;;032-860-147-271-886;;132-460-374-211-421;;098-172-374-375-47X;;109-358-955-476-095;;014-988-634-483-130;;061-786-187-274-992;;037-898-018-686-909;;130-044-667-529-69X;;134-265-642-839-645;;065-221-074-461-027;;017-934-465-161-477;;101-660-130-379-529;;028-236-706-290-220;;087-333-189-994-274;;059-082-211-027-266;;057-977-752-782-568;;022-511-780-866-588;;017-782-200-698-498;;031-911-801-211-572,10.1016/s0956-5663(02)00099-4;;12392956;;10.1021/ja00391a001;;2889225;;10.1098/rstb.1987.0021;;10.1109/51.294001;;10.1016/0022-0728(65)85063-x;;2245876;;10.2337/diabetes.39.12.1519;;10.2337/diab.39.12.1519;;10.1016/s0956-5663(03)00220-3;;14611755;;18615658;;10.1002/bit.260430310;;9366023;;10.1016/s0956-5663(97)00025-0;;9451795;;10.1016/s0956-5663(97)00083-3;;10.1016/0956-5663(93)80028-n;;8311939;;8651496;;10.1021/ac960030d;;10.1080/03091900210156797;;12487712;;10.1016/0265-928x(87)80018-4;;3333622;;10.1109/19.816143;;10.1007/bf01015979;;10.1089/15209150252924058;;12017416;;18473691;;10.1089/dia.2007.0281;;10.1021/ac00017a008;;1789439;;2817408;;10.1021/ac00197a022;;10.1016/0925-4005(95)01730-5;;10.1016/0010-4825(90)90013-f;;2257734;;2868172;;8277748;;10.1016/0141-5425(93)90058-7;;11469630;;10.1089/15209150050214104;;10624783;;10.1016/s0168-8227(99)00113-8;;10.1089/15209150050214113;;11469631;;10.1007/bf00401374;;1478372;;10.2337/diacare.20.1.64;;9028696;;10.1109/tbme.1986.325807;;3957374;;236018;;10.1016/0005-2795(75)90259-7;;10.1089/hum.1998.9.6-879;;9581910;;11762520;;10.1089/15209150152607196;;10.2337/diabetes.48.3.445;;10078542;;10.1016/0265-928x(87)80012-3;;505005;;10.1126/science.505005;;10.1021/ac0498516;;15253640;;10.1109/10.284922;;8026845;;6721151;;10.1021/ac00268a018;;6733082;;10.1021/bi00305a016;;10.1515/cclm.2002.135;;12392305;;10.1016/j.ecl.2003.12.001;;15053902;;12052350;;10.1016/s0956-5663(01)00304-9;;12052349;;10.1016/s0956-5663(01)00306-2;;4500021;;10.1007/978-1-4684-3288-6_18;;14021529;;10.1111/j.1749-6632.1962.tb13623.x;;3196517;;10.2337/diacare.10.5.622;;3677983;;10.2337/diacare.8.6.529;;4075939;;10.1002/elan.1140061103;;7733469;;10.1021/ac00103a015;;7978306;;10.1021/ac00091a022;;10.1007/bf01248238;;10.1016/s0376-7388(98)00330-5;;10.1016/0142-9612(92)90147-g;;1472593;;10.1016/0265-928x(85)80002-x;;10.1021/j100290a001;;10.1021/ja00216a040;;10.1021/ja00188a091;;10.1021/ja00406a011;;2624333;;12323417;;10.1016/s0165-0270(02)00170-x;;10.1177/193229680700100208;;pmc2771467;;19888405;;10.1021/ja00415a014;;10.1007/bf00575392;;10.1021/ac00250a038;;10.1021/ac00266a005;;10.1007/s00216-002-1284-0;;12194035;;10.1089/dia.2006.0030;;17705688;;9642777;;10.1016/s0956-5663(97)00091-2;;10.1089/152091503322526978;;14633342;;10.1016/0022-0728(85)87006-6;;10.1021/ja00434a018;;10.1016/0003-2697(92)90243-z;;1443528;;10.1039/f19868201259;;3245585;;10.1021/ac00173a008;;2889234;;10.1098/rstb.1987.0020;;11762521;;10.1089/15209150152607204;;12413548;;10.1016/s1367-5931(02)00371-x;;10526740;;10.2337/diacare.22.10.1708;;14988294;;10.2337/diacare.27.3.734;;10.1111/j.1749-6632.1997.tb52216.x;;9616733;;10868819;;10.2337/diacare.23.2.143;;10.1002/1097-4636(200101)54:1<69::aid-jbm8>3.0.co;2-q;;11077404;;10.1002/1097-4636(200101)54:1<69::aid-jbm8>3.3.co;2-h,"Abel, P. U., et al., ""Biosensors for in Vivo Glucose Measurement: Can We Cross the Experimental Stage"", Biosensors and Bioelectronics, vol. 17, 2002, pp. 1059-1070.;;Abruna, H. D., et al., ""Rectifying Interfaces Using Two-Layer Films of Electrochemically Polymerized Vinylpyridine and Vinylbipyridine Complexes of Ruthenium and Iron on Electrodes"", Journal of the American Chemical Society, vol. 103, No. 1, 1981, pp. 1-5.;;Albery, W. J., et al., ""Amperometric Enzyme Electrodes Part II: Conducting Salts as Electrode Materials for the Oxidation of Glucose Oxidase"", Journal of ElectroAnalytical Chemistry, vol. 194, 1985, pp. 223-235.;;Albery, W. J., et al., ""Amperometric Enzyme Electrodes"", Philosophical Transactions of The Royal Society of London, vol. 316, 1987, pp. 107-119.;;Alcock, S. J., et al., ""Continuous Analyte Monitoring to Aid Clinical Practice"", IEEE Engineering in Medicine and Biology Magazine, 1994, pp. 319-325.;;Anderson, L. B., et al., ""Thin-Layer Electrochemistry: Steady-State Methods of Studying Rate Processes"", Journal of ElectroAnalytical Chemistry, vol. 10, 1965, pp. 295-305.;;Armour, J. C., et al., ""Application of Chronic Intravascular Blood Glucose Sensor in Dogs"", Diabetes, vol. 39, 1990, pp. 1519-1526.;;Asberg, P., et al., ""Hydrogels of a Conducting Conjugated Polymer as 3-D Enzyme Electrode"", Biosensors & Bioelectronics, vol. 19, 2003, pp. 199-207.;;Atanasov, P., et al., ""Biosensor for Continuous Glucose Monitoring"", Biotechnology and Bioengineering, vol. 43, 1994, pp. 262-266.;;Atanasov, P., et al., ""Implantation of a Refillable Glucose Monitoring-Telemetry Device"", Biosensors & Bioelectronics, vol. 12, No. 7, 1997, pp. 669-680.;;Aussedat, B., et al., ""A User-Friendly Method for Calibrating a Subcutaneous Glucose Sensor-Based Hypoglycaemic Alarm"", Biosensors & Bioelectronics, vol. 12, No. 11, 1997, pp. 1061-1071.;;Baker, D. A., et al., ""Dynamic Concentration Challenges for Biosensor Characterization"", Biosensors & Bioelectronics, vol. 8, 1993, pp. 433-441.;;Baker, D. A., et al., ""Dynamic Delay and Maximal Dynamic Error in Continuous Biosensors"", Analytical Chemistry, vol. 68, No. 8, 1996, pp. 1292-1297.;;Bani Amer, M. M., ""An Accurate Amperometric Glucose Sensor Based Glucometer with Eliminated Cross-Sensitivity"", Journal of Medical Engineering & Technology, vol. 26, No. 5, 2002, pp. 208-213.;;Bard, A. J., et al., Electrochemical Methods, 1980, pp. 173-175.;;Bartlett, P. N., et al., ""Covalent Binding of Electron Relays to Glucose Oxidase"", Journal of the Chemical Society, Chemical Communications, 1987, pp. 1603-1604.;;Bartlett, P. N., et al., ""Modification of Glucose Oxidase by Tetrathiafulvalene"", Journal of the Chemical Society, Chemical Communications, 1990, pp. 1135-1136.;;Bartlett, P. N., et al., ""Strategies for the Development of Amperometric Enzyme Electrodes"", Biosensors, vol. 3, 1987/88, pp. 359-379.;;Beach, R. D., et al., ""Subminiature Implantable Potentiostat and Modified Commercial Telemetry Device for Remote Glucose Monitoring"", IEEE Transactions on Instrumentation and Measurement, vol. 28, No. 6, pp. 1239-1245.;;Beech, W. A., ""AX.25 Link Access Protocol for Amateur packet Radio"", Tucson Amateur Packet Radio Corporation, 1998, pp. 1-133.;;Bellucci, F., et al., ""Electrochemical Behaviour of Graphite-Epoxy Composite Materials (GECM) in Aqueous Salt Solutions"", Journal of Applied Electrochemistry, vol. 16, 1986, pp. 15-22.;;Bennion, N., et al., ""Alternate Site Glucose Testing: A Crossover Design"", Diabetes Technology & Therapeutics, vol. 4, No. 1, 2002, pp. 25-33.;;Biermann, E., et al., ""How Would Patients Behave if They Were Continually Informed of Their Blood Glucose Levels? A Simulation Study Using a 'Virtual' Patient"", Diabetes Technology & Therapeutics, vol. 10, No. 3, 2008, pp. 178-187.;;Bindra, D. S., et al., ""Design and in Vitro Studies of a Needle-Type Glucose Sensor for Subcutaneous Monitoring"", Analytical Chemistry, vol. 63, No. 17, 1991, pp. 1692-1696.;;Bindra, D. S., et al., ""Pulsed Amperometric Detection of Glucose in Biological Fluids at a Surface-Modified Gold Electrode"", Analytical Chemistry, vol. 61, No. 22, 1989, pp. 2566-2570.;;Bisenberger, M., et al., ""A Triple-Step Potential Waveform at Enzyme Multisensors with Thick-Film Gold Electrodes for Detection of Glucose and Sucrose"", Sensors and Actuators B,vol. 28, 1995, pp. 181-189.;;Bland, J. M., et al., ""A Note on the Use of the Intraclass Correlation Coefficient in the Evaluation of Agreement Between Two Methods of Measurement"", Computers in Biology and Medicine, vol. 20, No. 5, 1990, pp. 337-340.;;Bland, J. M., et al., ""Statistical Methods for Assessing Agreement Between Two Methods of Clinical Measurement"", The Lancet, 1986, pp. 307-310.;;Blank, T. B., et al., ""Clinical Results From a Non-Invasive Blood Glucose Monitor"", Optical Diagnostics and Sensing of Biological Fluids and Glucose and Cholesterol Monitoring II, Proceedings of SPIE, vol. 4624, 2002, pp. 1-10.;;Bobbioni-Harsch, E., et al., ""Lifespan of Subcutaneous Glucose Sensors and Their Performances During Dynamic Glycaemia Changes in Rats"", Journal of Biomedical Engineering, vol. 15, 1993, pp. 457-463.;;Bode, B. W., ""Clinical Utility of the Continuous Glucose Monitoring System"", Diabetes Technology & Therapeutics, vol. 2, Sup. 1, 2000, pp. S35-S41.;;Bode, B. W., et al., ""Continuous Glucose Monitoring Used to Adjust Diabetes Therapy Improves Glycosylated Hemoglobin: A Pilot Study"", Diabetes Research and Clinical Practice, vol. 46, 1999, pp. 183-190.;;Bode, B. W., et al., ""Using the Continuous Glucose Monitoring System to Improve the Management of Type I Diabetes"", Diabetes Technology & Therapeutics, vol. 2, Sup. 1, 2000, pp. S43-S48.;;Boedeker Plastics, Inc., ""Polyethylene Specifications"", Web Page of Boedeker.com, 2007, pp. 1-3.;;Bolinder, J., et al., ""Microdialysis Measurement of the Absolute Glucose Concentration in Subcutaneous Adipose Tissue Allowing Glucose Monitoring in Diabetic Patients"", Diabetologia, vol. 35, 1992, pp. 1177-1180.;;Bolinder, J., et al., ""Self-Monitoring of Blood Glucose in Type I Diabetic Patients: Comparison with Continuous Microdialysis Measurements of Glucose in Subcutaneous Adipose Tissue During Ordinary Life Conditions"", Diabetes Care, vol. 20, No. 1, 1997, pp. 64-70.;;Bott, A. W., ""A Comparison of Cyclic Voltammetry and Cyclic Staircase Voltammetry"", Current Separations, vol. 16, No. 1, 1997, pp. 23-26.;;Bott, A. W., ""Electrochemical Methods for the Determination of Glucose"", Current Separations, vol. 17, No. 1, 1998, pp. 25-31.;;Bowman, L., et al., ""The Packaging of Implantable Integrated Sensors"", IEEE Transactions on Biomedical Engineering, vol. 33, No. 2, 1986, pp. 248-255.;;Brandt, J., et al., ""Covalent Attachment of Proteins to Polysaccharide Carriers by Means of Benzoquinone"", Biochimica et Biophysica Acta, vol. 386, 1975, pp. 196-202.;;Brauker, J., et al., ""Sustained Expression of High Levels of Human Factor IX from Human Cells Implanted Within an Immunoisolation Device into Athymic Rodents"", Human Gene Therapy, vol. 9, No. 6, 1998, pp. 879-888.;;Bremer, T. M., et al., ""Benchmark Data from the Literature for Evaluation of New Glucose Sensing Technologies"", Diabetes Technology & Therapeutics, vol. 3, No. 3, 2001, pp. 409-418.;;Bremer, T., et al., ""Is Blood Glucose Predictable from Previous Values?"", Diabetes, vol. 48, 1999, pp. 445-451.;;Brooks, S. L., et al., ""Development of an On-Line Glucose Sensor for Fermentation Monitoring"", Biosensors, vol. 3, 1987/88, pp. 45-56.;;Brownlee, M., et al., ""A Glucose-Controlled Insulin-Delivery System: Semisynthetic Insulin Bound to Lectin"", Science, vol. 206, 1979, 1190-1191.;;Cai, Q., et al., ""A Wireless, Remove Query Glucose Biosensor Based on a pH-Sensitive Polymer"", Analytical Chemistry, vol. 76, No. 14, 2004, pp. 4038-4043.;;Candas, B., et al., ""An Adaptive Plasma Glucose Controller Based on a Nonlinear Insulin/Glucose Model"", IEEE Transactions on Biomedical Engineering, vol. 41, No. 2, 1994, pp. 116-124.;;Cass, A. E., et al., ""Ferricinum Ion As An Electron Acceptor for Oxido-Reductases"", Journal of ElectroAnalytical Chemistry, vol. 190, 1985, pp. 117-127.;;Cass, A. E., et al., ""Ferrocene-Medicated Enzyme Electrode for Amperometric Determination of Glucose"", Analytical Chemistry, vol. 56, No. 4, 1984, 667-671.;;Castner, J. F., et al., ""Mass Transport and Reaction Kinetic Parameters Determined Glucose Oxidase"", Biochemistry, vol. 23 No. 10, 1984, 2203-2210.;;Chen, J. C., et al., ""A Comparison of MAC Protocols for Wireless Local Networks Based on battery Power Consumption"", IEEE, 1998, pp. 150-157.;;Chen, T., et al., ""Defining the Period of Recovery of the Glucose Concentration After Its Local Perturbation by the Implantation of a Miniature Sensor"", Clinical Chemistry and Laboratory Medicine, vol. 40, No. 8, 2002, pp. 486-489.;;Chia, C. W., et al., ""Glucose Sensors: Toward Closed Loop Insulin Delivery"", Endocrinology and Metabolism Clinics of North America, vol. 33, 2004, pp. 175-195.;;Choleau, C., et al., ""Calibration of a Subcutaneous Amperometric Glucose Sensor Implanted for 7 Days in Diabetic Patients Part 2: Superiority of the One-Point Calibration Method"", Biosensors and Bioelectronics, vol. 17, 2002, pp. 647-654.;;Choleau, C., et al., ""Calibration of a Subcutaneous Amperometric Glucose Sensor Part 1: Effect of Measurement Uncertainties on the Determination of Sensor Sensitivity and Background Current"", Biosensors and Bioelectronics, vol. 17, 2002, pp. 641-646.;;Claremont, D. J., et al., ""Biosensors for Continuous in Vivo Glucose Monitoring"", Proceedings of the Annual International Conference of the IEEE Engineering in Medicine and.Biology Society, vol. 10, 1988.;;Clark Jr., L. C., et al., ""Differential Anodic Enzyme Polarography for the Measurement of Glucose"", Oxygen Transport to Tissue: Instrumentation, Methods, and Physiology, 1973, pp. 127-133.;;Clark Jr., L. C., et al., ""Electrode Systems for Continuous Monitoring in Cardiovascular Surgery"", Annals New York Academy of Sciences, 1962, pp. 29-45.;;Clark Jr., L. C., et al., ""Long-term Stability of Electroenzymatic Glucose Sensors Implanted in Mice"", American Society of Artificial Internal Organs Transactions, vol. XXXIV, 1988, pp. 259-265.;;Clarke, W. L., et al., ""Evaluating Clinical Accuracy of Systems for Self-Monitoring of Blood Glucose"", Diabetes Care, vol. 10, No. 5, 1987, pp. 622-628.;;Cox, D. J., et al., ""Accuracy of Perceiving Blood Glucose in IDDM"", Diabetes Care, vol. 8, No. 6, 1985, pp. 529-536.;;Csoregi, E., et al., ""Amperometric Microbiosensors for Detection of Hydrogen Peroxide and Glucose Based on Peroxidase-Modified Carbon Fibers"", Electroanalysis, vol. 6, 1994, pp. 925-933.;;Csoregi, E., et al., ""Design and Optimization of a Selective Subcutaneously Implantable Glucose Electrode Based on 'Wired' Glucose Oxidase"", Analytical Chemistry, vol. 67, No. 7, 1995, pp. 1240-1244.;;Csoregi, E., et al., ""Design, Characterization, and One-Point in Vivo Calibration of a Subcutaneously Implanted Glucose Electrode"", Analytical Chemistry, vol. 66 No. 19, 1994, pp. 3131-3138.;;Csoregi, E., et al., ""On-Line Glucose Monitoring by Using Microdialysis Sampling and Amperometric Detection Based on 'Wired' Glucose Oxidase in Carbon Paste"", Mikrochimica Acta, vol. 121, 1995, pp. 31-40.;;D'Arrigo, G., et al., ""Porous-Si Based Bio Reactors for Glucose Monitoring and Drugs Production"", Proceedings of SPIE: Microfluids, BioMEMS, and Medical Microsystems, vol. 4982, 2003, pp. 178-184.;;Dai, W. S., et al., ""Hydrogel Membranes with Mesh Size Asymmetry Based on the Gradient Crosslinking of Poly(vinyl alcohol),"" Journal of Membrane Science, vol. 156, 1999, pp. 67-79.;;Davies, M. L., et al., ""Polymer Membranes in Clinical Sensor Applications"", Biomaterials, vol. 13, No. 14, 1992, pp. 971-978.;;Davis, G., ""Electrochemical Techniques for the Development of Amperometric Biosensors"", Biosensors, vol. 1, 1985, pp. 161-178.;;Degani, Y., et al., ""Direct Electrical Communication Between Chemically Modified Enzymes and Metal Electrodes. 1. Electron Transfer from Glucose Oxidase to Metal Electrodes via Electron Relays, Bound Covalently to the Enzyme"", The Journal of Physical Chemistry, vol. 91, No. 6, 1987, pp. 1285-1289.;;Degani, Y., et al., ""Direct Electrical Communication Between Chemically Modified Enzymes and Metal Electrodes. 2. Methods for Bonding Electron-Transfer Relays to Glucose Oxidase and D-Amino-Acid Oxidase"", Journal of the American Chemical Society, vol. 110, No. 8, 1988, pp. 2615-2620.;;Degani, Y., et al., ""Electrical Communication Between Redox Centers of Glucose Oxidase and Electrodes via Electrostatically and Covalently Bound Redox Polymers"", Journal of the American Chemical Society, vol. 111, 1989, pp. 2357-2358.;;Denisevich, P., et al., ""Unidirectional Current Flow and Charge State Trapping at Redox Polymer Interfaces on Bilayer Electrodes: Principles, Experimental Demonstration, and Theory"", Journal of the American Chemical Society, vol. 103, 1981, pp. 4727-4737.;;Dicks, J. M., et al., ""Ferrocene Modified Polypyrrole with Immobilised Glucose Oxidase and its Application in Amperometric Glucose Microbiosensors"", Annales de Biologie Clinique, vol. 47, 1989, pp. 607-619.;;Dixon, B. M., et al., ""Characterization In Vitro and In Vivo of the Oxygen Dependence of an Enzyme/Polymer Biosensors for Monitoring Brain Glucose"", Journal of Neuroscience Methods, vol. 119, 2002, pp. 135-142.;;Eighth Annual Diabetes Technology Meeting Abstracts, Nov. 13-15, 2008, pp. Al-A182.;;El-Khatib, F. H, et al., ""Adaptive Closed-Loop Control Provides Blood-Glucose Regulation Using Subcutaneous Insulin and Glucagon Infusion in Diabetic Swine"", Journal of Diabetes Science and Technology, vol. 1, No. 2, 2007, pp. 181-192.;;Ellis, C. D., et al., ""Selectivity and Directed Charge Transfer through an Electroactive Metallopolymer Film"", Journal of the American Chemical Society, vol. 103, No. 25, 1981, pp. 7480-7483.;;El-Sa'Ad, L., et al., ""Moisture Absorption by Epoxy Resins: The Reverse Thermal Effect"", Journal of Materials Science, vol. 25, No. 8, 1990, pp. 3577-3582.;;Engstrom, R. C., ""Electrochemical Pretreatment of Glassy Carbon Electrodes"", Analytical Chemistry, vol. 54, No. 13, 1982, pp. 2310-2314.;;Engstrom, R. C., et al., ""Characterization of Electrochemically Pretreated Glassy Carbon Electrodes"", Analytical Chemistry, vol. 56, No. 2, 1984, pp. 136-141.;;Ernst, H., et al., ""Reliable Glucose Monitoring Through the Use of Microsystem Technology"", Analytical and Bioanalytical Chemistry, vol. 373, 2002, pp. 758-761.;;Fabietti, P. G., et al. ""Clinical Validation of a New Control-Oriented Model of Insulin and Glucose Dynamics in Subjects with Type 1 Diabetes"", Diabetes Technology & Therapeutics, vol.9, No. 4, 2007, pp. 327-338.;;Fare, T. L., et al., ""Functional Characterization of a Conducting Polymer-Based Immunoassay System"", Biosensors & Bioelectronics, vol. 13, No. 3-4, 1998, pp. 459-470.;;Feldman, B., et al., ""A Continuous Glucose Sensor Based on Wired Enzyme(TM) Technology-Results from a 3-Day Trial in Patients with Type 1 Diabetes"", Diabetes Technology & Therapeutics, vol. 5, No. 5, 2003, pp. 769-779.;;Feldman, B., et al., ""Correlation of Glucose Concentrations in Interstitial Fluid and Venous Blood During Periods of Rapid Glucose Change"", Abbott Diabetes Care, Inc. Freestyle Navigator Continuous Glucose Monitor Pamphlet, 2004.;;Feldman, B., et al., ""Electron Transfer Kinetics at Redox Polymer/Solution Interfaces Using Microelectrodes and Twin Electrode Thin Layer Cells"", Journal of ElectroAnalytical Chemistry, vol. 194, 1985, pp. 63-81.;;Fischer, H., et al., ""Intramolecular Electron Transfer Medicated by 4,4'-Bypyridine and Related Bridging Groups"", Journal of the American Chemical Society, vol. 98, No. 18, 1976, pp. 5512-5517.;;Flentge, F., et al., ""An Enzyme-Reactor for Electrochemical Monitoring of Choline and Acetylcholine: Applications in High-Performance Liquid Chromatography, Bran Tissue, Microdialysis and Cerebrospinal Fluid,"" Analytical Biochemistry, vol. 204, 1992, pp. 305-310.;;Foulds, N. C., et al., ""Enzyme Entrapment in Electrically Conducting Polymers: Immobilisation of Glucose Oxidase in Polypyrrole and its Application in Amperometric Glucose Sensors"", Journal of the Chemical Society, Faraday Transactions 1, vol. 82, 1986, pp. 1259-1264.;;Foulds, N. C., et al , ""Immobilization of Glucose Oxidase in Ferrocene-Modified Pyrrole Polymers"", Analytical Chemistry, vol. 60, No. 22, 1988, pp. 2473-2478.;;Frew, J. E., et al., ""Electron-Transfer Biosensors"", Philosophical Transactions of the Royal Society of London, vol. 316, 1987, pp. 95-106.;;Frohnauer, M. K., et al., ""Graphical Human Insulin Time-Activity Profiles Using Standardized Definitions"", Diabetes Technology & Therapeutics, vol. 3, No. 3, 2001, pp. 419-429.;;Frost, M. C., et al., ""Implantable Chemical Sensors for Real-Time Clinical Monitoring: Progress and Challenges"", Current Opinion in Chemical Biology, vol. 6, 2002, pp. 633-641.;;Garg, S. K., et al., ""Correlation of Fingerstick Blood Glucose Measurements with GlucoWatch Biographer Glucose Results in Young Subjects with Type 1 Diabetes"", Diabetes Care, vol. 22, No. 10, 1999, pp. 1708-1714.;;Garg, S. K., et al., ""Improved Glucose Excursions Using an Implantable Real-Time Continuous Glucose Sensor in Adults with Type 1 Diabetes"", Diabetes Care, vol. 27, No. 3, 2004, pp. 734-738.;;Geller, R. L., et al., ""Use of an Immunoisolation Device for Cell Transplantation and Tumor Immunotherapy"", Annals of the New York Academy of Sciences, vol. 831, 1997, pp. 438-451.;;Gerritsen, M., ""Problems Associated with Subcutaneously Implanted Glucose Sensors"", Diabetes Care, vol. 23, No. 2, 2000, pp. 143-145.;;Gerritsen, M., et al., ""Influence of Inflammatory Cells and Serum on the Performance of Implantable Glucose Sensors"", Journal of Biomedical materials Research, vol. 54, 2001, pp. 69-75.",EXPIRED
231,US,A1,US 2007/0208247 A1,172-646-091-708-098,2007-09-06,2007,US 74245307 A,2007-04-30,US 74245307 A;;US 42005703 A;;US 66719900 A;;US 7067798 A,1998-04-30,Analyte Monitoring Device and Methods of Use,"An analyte monitor includes a sensor, a sensor control unit, and a display unit. The sensor has, for example, a substrate, a recessed channel formed in the substrate, and conductive material disposed in the recessed channel to form a working electrode. The sensor control unit typically has a housing adapted for placement on skin and is adapted to receive a portion of an electrochemical sensor. The sensor control unit also includes two or more conductive contacts disposed on the housing and configured for coupling to two or more contact pads on the sensor. A transmitter is disposed in the housing and coupled to the plurality of conductive contacts for transmitting data obtained using the sensor. The display unit has a receiver for receiving data transmitted by the transmitter of the sensor control unit and a display coupled to the receiver for displaying an indication of a level of an analyte. The analyte monitor may also be part of a drug delivery system to alter the level of the analyte based on the data obtained using the sensor.",ABBOTT DIABETES CARE INC,SAY JAMES;;TOMASCO MICHAEL F;;HELLER ADAM;;GAL YORAM;;BEHRAD ARIA;;HELLER EPHRAIM;;PLANTE PHILLIP J;;VREEKE MARK S;;FRIEDMAN KEITH A;;COLMAN FREDRIC C,,https://lens.org/172-646-091-708-098,Patent Application,yes,99,37,211,221,0,A61B5/14532;;A61B5/14532;;A61B5/0002;;A61B5/0002;;A61B5/002;;A61B5/01;;A61B5/14503;;A61B5/1451;;A61B5/14546;;A61B5/14546;;A61B5/1473;;A61B5/1473;;A61B5/1486;;A61B5/1486;;A61B5/14865;;A61B5/1495;;A61B5/4839;;A61B5/72;;A61B5/7278;;A61B5/7282;;A61B5/7405;;A61B5/743;;A61B5/7445;;A61B5/7445;;A61B5/7455;;A61B2560/0252;;A61B2560/0252;;A61M5/1723;;C12Q1/54;;G16H10/40;;G16H10/40;;G16H20/17;;G16H20/17;;H01L23/3107;;H01L23/3107;;H01L23/49548;;H01L23/49548;;H01L2924/0002;;H01L2924/0002;;H01L2924/19041;;H01L2924/19041;;H01L2924/3011;;H01L2924/3011;;Y10S128/903;;Y10S128/903;;Y10T29/49;;Y10T29/49;;Y10T29/49124;;Y10T29/49124,A61B5/00;;G01N27/30;;A61B5/145;;A61B5/1477;;A61B5/1495;;G01N27/416;;G06F19/00;;H01L23/31;;H01L23/495,600/365,0,0,,,,EXPIRED
232,US,A1,US 2009/0177063 A1,169-040-999-493-715,2009-07-09,2009,US 40595809 A,2009-03-17,US 40595809 A;;US 42005703 A;;US 66719900 A;;US 7067798 A,1998-04-30,Analyte Monitoring Device and Methods of Use,"An analyte monitor includes a sensor, a sensor control unit, and a display unit. The sensor has, for example, a substrate, a recessed channel formed in the substrate, and conductive material disposed in the recessed channel to form a working electrode. The sensor control unit typically has a housing adapted for placement on skin and is adapted to receive a portion of an electrochemical sensor. The sensor control unit also includes two or more conductive contacts disposed on the housing and configured for coupling to two or more contact pads on the sensor. A transmitter is disposed in the housing and coupled to the plurality of conductive contacts for transmitting data obtained using the sensor. The display unit has a receiver for receiving data transmitted by the transmitter of the sensor control unit and a display coupled to the receiver for displaying an indication of a level of an analyte. The analyte monitor may also be part of a drug delivery system to alter the level of the analyte based on the data obtained using the sensor.",ABBOTT DIABETES CARE INC,SAY JAMES;;TOMASCO MICHAEL F;;HELLER ADAM;;GAL YORAM;;ARIA BEHRAD;;HELLER EPHRAIM;;PLANTE PHILLIP JOHN;;VREEKE MARK S;;FRIEDMAN KEITH A;;COLMAN FREDRIC C,E. HELLER & CO (1998-07-02);;ABBOTT DIABETES CARE INC (2000-03-13),https://lens.org/169-040-999-493-715,Patent Application,yes,3,57,211,221,0,A61B5/14532;;A61B5/14532;;A61B5/0002;;A61B5/0002;;A61B5/002;;A61B5/01;;A61B5/14503;;A61B5/1451;;A61B5/14546;;A61B5/14546;;A61B5/1473;;A61B5/1473;;A61B5/1486;;A61B5/1486;;A61B5/14865;;A61B5/1495;;A61B5/4839;;A61B5/72;;A61B5/7278;;A61B5/7282;;A61B5/7405;;A61B5/743;;A61B5/7445;;A61B5/7445;;A61B5/7455;;A61B2560/0252;;A61B2560/0252;;A61M5/1723;;C12Q1/54;;G16H10/40;;G16H10/40;;G16H20/17;;G16H20/17;;H01L23/3107;;H01L23/3107;;H01L23/49548;;H01L23/49548;;H01L2924/0002;;H01L2924/0002;;H01L2924/19041;;H01L2924/19041;;H01L2924/3011;;H01L2924/3011;;Y10S128/903;;Y10S128/903;;Y10T29/49;;Y10T29/49;;Y10T29/49124;;Y10T29/49124,A61B5/1468;;G01N27/30;;A61B5/00;;A61B5/145;;A61B5/1477;;A61B5/1495;;G01N27/416;;G06F19/00;;H01L23/31;;H01L23/495,600/345,0,0,,,,DISCONTINUED
233,US,B2,US 8597189 B2,199-220-800-110-315,2013-12-03,2013,US 39730109 A,2009-03-03,US 39730109 A;;US 69082607 A;;US 42005703 A;;US 66719900 A;;US 7067798 A,1998-04-30,Analyte monitoring device and methods of use,"An analyte monitor includes a sensor, a sensor control unit, and a display unit. The sensor has, for example, a substrate, a recessed channel formed in the substrate, and conductive material disposed in the recessed channel to form a working electrode. The sensor control unit typically has a housing adapted for placement on skin and is adapted to receive a portion of an electrochemical sensor. The sensor control unit also includes two or more conductive contacts disposed on the housing and configured for coupling to two or more contact pads on the sensor. A transmitter is disposed in the housing and coupled to the plurality of conductive contacts for transmitting data obtained using the sensor. The display unit has a receiver for receiving data transmitted by the transmitter of the sensor control unit and a display coupled to the receiver for displaying an indication of a level of an analyte. The analyte monitor may also be part of a drug delivery system to alter the level of the analyte based on the data obtained using the sensor.",SAY JAMES;;TOMASCO MICHAEL F;;HELLER ADAM;;GAL YORAM;;ARIA BEHRAD;;HELLER EPHRAIM;;PLANTE PHILLIP JOHN;;VREEKE MARK S;;FRIEDMAN KEITH A;;COLMAN FREDRIC C;;ABBOTT DIABETES CARE INC,SAY JAMES;;TOMASCO MICHAEL F;;HELLER ADAM;;GAL YORAM;;ARIA BEHRAD;;HELLER EPHRAIM;;PLANTE PHILLIP JOHN;;VREEKE MARK S;;FRIEDMAN KEITH A;;COLMAN FREDRIC C,E. HELLER & CO (1998-07-02);;ABBOTT DIABETES CARE INC (2000-03-13),https://lens.org/199-220-800-110-315,Granted Patent,yes,99,0,211,221,0,A61B5/14532;;A61B5/14532;;A61B5/0002;;A61B5/0002;;A61B5/002;;A61B5/01;;A61B5/14503;;A61B5/1451;;A61B5/14546;;A61B5/14546;;A61B5/1473;;A61B5/1473;;A61B5/1486;;A61B5/1486;;A61B5/14865;;A61B5/1495;;A61B5/4839;;A61B5/72;;A61B5/7278;;A61B5/7282;;A61B5/7405;;A61B5/743;;A61B5/7445;;A61B5/7445;;A61B5/7455;;A61B2560/0252;;A61B2560/0252;;A61M5/1723;;C12Q1/54;;G16H10/40;;G16H10/40;;G16H20/17;;G16H20/17;;H01L23/3107;;H01L23/3107;;H01L23/49548;;H01L23/49548;;H01L2924/0002;;H01L2924/0002;;H01L2924/19041;;H01L2924/19041;;H01L2924/3011;;H01L2924/3011;;Y10S128/903;;Y10S128/903;;Y10T29/49;;Y10T29/49;;Y10T29/49124;;Y10T29/49124,A61B5/00;;G01N27/30;;A61B5/05;;A61B5/145;;A61B5/1477;;A61B5/1495;;G01N27/416;;G06F19/00;;H01L23/31;;H01L23/495,600/365;;600/347,99,5,173-901-776-852-06X;;017-843-532-202-598;;124-660-118-050-67X;;129-974-218-261-531;;115-480-299-312-274,10.1142/9789810248628_0003;;8797377;;10.1021/ac950630x;;10.1016/0250-6874(89)87015-5;;2714056;;10.1088/0143-0815/10/1/001;;10.1039/ac9963300271,"""Poretics Polycarbonate Membrane"", Osmonics Filtration and Separation Group, 2002.;;Gough, D. A., et al., ""The Implantable Glucose Sensor: An Example of Bioengineering Design."", Introduction to Bioengineering, Chapter 3, 2001, pp. 57-66.;;Jobst, G., et al., ""Thin-Film Microbiosensors for Glucose-Lactate Monitoring"", Analytical Chemistry, vol. 68, No. 18, 1996, pp. 3173-3179.;;Koudelka, M., et al., ""Planar Amperometric Enzyme-Based Glucose Microelectrode"", Sensors and Actuators, vol. 18, 1989, pp. 157-165.;;Kusano, H., ""Glucose Enzyme Electrode with Percutaneous Interface Which Operates Independently of Dissolved Oxygen"", Clinical Physics and Physiological Measurement, vol. 10, No. 1, 1989, pp. 1-9.;;Park, T., et al., ""Sol-Gel-based Amperometric Glucose Biosensor Incorporating an Osmium Redox Polymer as Mediator"", Analytical Communications, vol. 33, 1996, pp. 271-273.;;Stedman's Medical Dictionary, 26th Edition, 1995, pp. 665.;;Canadian Patent Application No. 2,433,144, Examiner's Report mailed Nov. 2, 2010.;;European Patent Application No. 06839640.7, Extended European Search Report mailed Oct. 21, 2010.;;European Patent Application No. 10012409.8, Extended European Search Report mailed Mar. 15, 2011.;;European Patent Application No. 10012414.8, Extended European Search Report mailed Mar. 15, 2011.;;European Patent Application No. 10012960.0, Extended European Search Report mailed Mar. 2, 2011.;;European Patent Application No. 10012961.8, Extended European Search Report mailed Mar. 2, 2011.;;European Patent Application No. 99903239.4, Invitation Pursuant to Article 94(3) and Rule 71(1) EPC mailed Dec. 15, 2010.;;Japanese Patent Application No. 2007-270411, Office Action mailed Aug. 17, 2010.;;Japanese Patent Application No. 2007-270411, Office Action mailed Jun. 21, 2011.;;PCT Application No. PCT/US2008/074469, International Preliminary Report on Patentability and Written Opinion of the International Searching Authority mailed Mar. 11, 2010.;;PCT Application No. PCT/US2010/040117, International Preliminary Report on Patentability and Written Opinion of the International Searching Authority mailed Jan. 12, 2012.;;PCT Application No. PCT/US2010/040117, International Search Report and Written Opinion of the International Searching Authority mailed Sep. 1, 2010.;;PCT Application No. PCT/US2010/040118, International Preliminary Report on Patentability and Written Opinion of the International Searching Authority mailed Jan. 12, 2012.;;PCT Application No. PCT/US2010/040118, International Search Report and Written Opinion of the International Searching Authority mailed Sep. 17, 2010.;;PCT Application No. PCT/US2010/040119, International Preliminary Report on Patentability and Written Opinion of the International Searching Authority mailed Jan. 12, 2012.;;PCT Application No. PCT/US2010/040119, International Search Report and Written Opinion of the International Searching Authority mailed Sep. 17, 2010.;;U.S. Appl. No. 10/783,675, Office Action mailed Dec. 14, 2010.;;U.S. Appl. No. 10/783,675, Office Action mailed Jun. 2, 2011.;;U.S. Appl. No. 11/265,787, Office Action mailed Aug. 4, 2010.;;U.S. Appl. No. 11/681,730, Office Action mailed Apr. 27, 2011.;;U.S. Appl. No. 11/681,730, Office Action mailed Dec. 15, 2011.;;U.S. Appl. No. 11/681,730, Office Action mailed Oct. 15, 2010.;;U.S. Appl. No. 11/683,371, Office Action mailed Aug. 13, 2010.;;U.S. Appl. No. 11/683,371, Office Action mailed Mar. 8, 2011.;;U.S. Appl. No. 11/683,396, Office Action mailed Jan. 18, 2011.;;U.S. Appl. No. 11/683,396, Office Action mailed Sep. 8, 2011.;;U.S. Appl. No. 11/683,408, Notice of Allowance mailed Oct. 19, 2010.;;U.S. Appl. No. 11/683,408, Office Action mailed Jul. 12, 2010.;;U.S. Appl. No. 11/690,826, Office Action mailed Aug. 9, 2011.;;U.S. Appl. No. 11/695,607, Office Action mailed Mar. 2, 2011.;;U.S. Appl. No. 11/695,608, Office Action mailed Jul. 22, 2010.;;U.S. Appl. No. 11/695,608, Office Action mailed Mar. 29, 2011.;;U.S. Appl. No. 11/734,782, Office Action mailed Jul. 19, 2010.;;U.S. Appl. No. 11/742,453, Office Action mailed Oct. 28, 2011.;;U.S. Appl. No. 11/742,507, Office Action mailed Apr. 13, 2011.;;U.S. Appl. No. 11/742,507, Office Action mailed Jun. 12, 2009.;;U.S. Appl. No. 11/766,708, Office Action mailed Mar. 3, 2011.;;U.S. Appl. No. 11/928,574, Office Action mailed Jul. 21, 2010.;;U.S. Appl. No. 11/928,668, Office Action mailed Dec. 23, 2010.;;U.S. Appl. No. 11/928,795, Office Action mailed May 12, 2011.;;U.S. Appl. No. 11/928,795, Office Action mailed Sep. 15, 2010.;;U.S. Appl. No. 11/941,078, Office Action mailed Apr. 22, 2011.;;U.S. Appl. No. 11/941,078, Office Action mailed Dec. 22, 2010.;;U.S. Appl. No. 11/941,078, Office Action mailed Dec. 22, 2011.;;U.S. Appl. No. 12/109,049, Office Action mailed Mar. 4, 2011.;;U.S. Appl. No. 12/135,937, Office Action mailed Dec. 19, 2011.;;U.S. Appl. No. 12/249,644, Notice of Allowance mailed Mar. 14, 2012.;;U.S. Appl. No. 12/249,644, Office Action mailed Apr. 15, 2011.;;U.S. Appl. No. 12/249,644, Office Action mailed Nov. 17, 2011.;;U.S. Appl. No. 12/371,539, Office Action mailed Mar. 7, 2011.;;U.S. Appl. No. 12/371,539, Office Action mailed Sep. 26, 2011.;;U.S. Appl. No. 12/397,281, Office Action mailed May 12, 2011.;;U.S. Appl. No. 12/397,281, Office Action mailed Oct. 15, 2010.;;U.S. Appl. No. 12/397,293, Office Action mailed Aug. 5, 2011.;;U.S. Appl. No. 12/397,293, Office Action mailed Dec. 1, 2010.;;U.S. Appl. No. 12/397,301, Office Action mailed Dec. 1, 2010.;;U.S. Appl. No. 12/405,515, Office Action mailed Apr. 29, 2011.;;U.S. Appl. No. 12/405,515, Office Action mailed Nov. 22, 2011.;;U.S. Appl. No. 12/405,515, Office Action mailed Sep. 23, 2010.;;U.S. Appl. No. 12/405,568, Office Action mailed Jan. 25, 2011.;;U.S. Appl. No. 12/405,568, Office Action mailed Sep. 16, 2011.;;U.S. Appl. No. 12/405,643, Advisory Action mailed Mar. 9, 2012.;;U.S. Appl. No. 12/405,643, Office Action mailed Mar. 30, 2011.;;U.S. Appl. No. 12/405,643, Office Action mailed Nov. 14, 2011.;;U.S. Appl. No. 12/405,690, Office Action mailed Mar. 10, 2011.;;U.S. Appl. No. 12/405,739, Office Action mailed Mar. 15, 2011.;;U.S. Appl. No. 12/405,843, Office Action mailed Mar. 24, 2011.;;U.S. Appl. No. 12/405,987, Office Action mailed Nov. 16, 2010.;;U.S. Appl. No. 12/406,746, Office Action mailed Apr. 5, 2011.;;U.S. Appl. No. 12/406,746, Office Action mailed Jul. 23, 2010.;;U.S. Appl. No. 12/406,746, Office Action mailed Sep. 1, 2011.;;U.S. Appl. No. 12/406,800, Office Action mailed Apr. 20, 2011.;;U.S. Appl. No. 12/406,800, Office Action mailed Jul. 20, 2010.;;U.S. Appl. No. 12/406,800, Office Action mailed Nov. 29, 2011.;;U.S. Appl. No. 12/414,456, Notice of Allowance mailed Dec. 19, 2011.;;U.S. Appl. No. 12/414,456, Office Action mailed Apr. 29, 2011.;;U.S. Appl. No. 12/414,456, Office Action mailed Sep. 17, 2010.;;U.S. Appl. No. 12/414,474, Office Action mailed Mar. 15, 2011.;;U.S. Appl. No. 12/414,487, Notice of Allowance mailed Dec. 20, 2011.;;U.S. Appl. No. 12/414,487, Office Action mailed Mar. 3, 2011.;;U.S. Appl. No. 12/414,487, Office Action mailed Oct. 31, 2011.;;U.S. Appl. No. 12/414,531, Office Action mailed Mar. 22, 2011.;;U.S. Appl. No. 12/414,542, Office Action mailed Apr. 13, 2011.;;U.S. Appl. No. 12/414,542, Office Action mailed Nov. 14, 2011.;;U.S. Appl. No. 12/414,558, Office Action mailed Apr. 4, 2011.;;U.S. Appl. No. 12/422,269, Office Action mailed Apr. 14, 2011.;;U.S. Appl. No. 12/422,269, Office Action mailed Nov. 18, 2011.;;U.S. Appl. No. 12/468,775, Office Action mailed Feb. 4, 2011.;;U.S. Appl. No. 12/468,782, Office Action mailed Feb. 18, 2011.;;U.S. Appl. No. 12/468,787, Office Action mailed Mar. 7, 2011.;;U.S. Appl. No. 12/495,798, Office Action mailed Dec. 1, 2011.;;U.S. Appl. No. 12/495,798, Office Action mailed Jun. 30, 2011.",EXPIRED
234,US,A1,US 2003/0187338 A1,192-288-996-240-248,2003-10-02,2003,US 42005703 A,2003-04-18,US 42005703 A;;US 66719900 A;;US 7067798 A,1998-04-30,Analyte monitoring device and methods of use,"
   An analyte monitor includes a sensor, a sensor control unit, and a display unit. The sensor has, for example, a substrate, a recessed channel formed in the substrate, and conductive material disposed in the recessed channel to form a working electrode. The sensor control unit typically has a housing adapted for placement on skin and is adapted to receive a portion of an electrochemical sensor. The sensor control unit also includes two or more conductive contacts disposed on the housing and configured for coupling to two or more contact pads on the sensor. A transmitter is disposed in the housing and coupled to the plurality of conductive contacts for transmitting data obtained using the sensor. The display unit has a receiver for receiving data transmitted by the transmitter of the sensor control unit and a display coupled to the receiver for displaying an indication of a level of an analyte. The analyte monitor may also be part of a drug delivery system to alter the level of the analyte based on the data obtained using the sensor. 
",THERASENSE INC,SAY JAMES;;TOMASCO MICHAEL F;;HELLER ADAM;;GAL YORAM;;ARIA BEHRAD;;HELLER EPHRAIM;;PLANTE PHILLIP JOHN;;VREEKE MARK S;;FRIEDMAN KEITH A;;COLMAN FREDRIC C,E. HELLER & CO (1998-07-02);;ABBOTT DIABETES CARE INC (2000-03-13),https://lens.org/192-288-996-240-248,Patent Application,yes,100,691,211,221,0,A61B5/14532;;A61B5/14532;;A61B5/0002;;A61B5/0002;;A61B5/002;;A61B5/01;;A61B5/14503;;A61B5/1451;;A61B5/14546;;A61B5/14546;;A61B5/1473;;A61B5/1473;;A61B5/1486;;A61B5/1486;;A61B5/14865;;A61B5/1495;;A61B5/4839;;A61B5/72;;A61B5/7278;;A61B5/7282;;A61B5/7405;;A61B5/743;;A61B5/7445;;A61B5/7445;;A61B5/7455;;A61B2560/0252;;A61B2560/0252;;A61M5/1723;;C12Q1/54;;G16H10/40;;G16H10/40;;G16H20/17;;G16H20/17;;H01L23/3107;;H01L23/3107;;H01L23/49548;;H01L23/49548;;H01L2924/0002;;H01L2924/0002;;H01L2924/19041;;H01L2924/19041;;H01L2924/3011;;H01L2924/3011;;Y10S128/903;;Y10S128/903;;Y10T29/49;;Y10T29/49;;Y10T29/49124;;Y10T29/49124,G01N27/30;;A61B5/00;;A61B5/145;;A61B5/1477;;A61B5/1495;;G01N27/416;;G06F19/00;;H01L23/31;;H01L23/495,600/345;;600/365;;128/903,0,0,,,,EXPIRED
235,US,B2,US 7885699 B2,023-344-323-928-676,2011-02-08,2011,US 85243910 A,2010-08-06,US 85243910 A;;US 69082607 A;;US 42005703 A;;US 66719900 A;;US 7067798 A,1998-04-30,Analyte monitoring device and methods of use,"An analyte monitor includes a sensor, a sensor control unit, and a display unit. The sensor has, for example, a substrate, a recessed channel formed in the substrate, and conductive material disposed in the recessed channel to form a working electrode. The sensor control unit typically has a housing adapted for placement on skin and is adapted to receive a portion of an electrochemical sensor. The sensor control unit also includes two or more conductive contacts disposed on the housing and configured for coupling to two or more contact pads on the sensor. A transmitter is disposed in the housing and coupled to the plurality of conductive contacts for transmitting data obtained using the sensor. The display unit has a receiver for receiving data transmitted by the transmitter of the sensor control unit and a display coupled to the receiver for displaying an indication of a level of an analyte. The analyte monitor may also be part of a drug delivery system to alter the level of the analyte based on the data obtained using the sensor.",ABBOTT DIABETES CARE INC,SAY JAMES;;TOMASCO MICHAEL F;;HELLER ADAM;;GAL YORAM;;ARIA BEHRAD;;HELLER EPHRAIM;;PLANTE PHILLIP JOHN;;VREEKE MARK S;;FRIEDMAN KEITH A;;COLMAN FREDRIC C,E. HELLER & CO (1998-07-02);;ABBOTT DIABETES CARE INC (2000-03-13),https://lens.org/023-344-323-928-676,Granted Patent,yes,100,25,211,221,0,A61B5/14532;;A61B5/14532;;A61B5/0002;;A61B5/0002;;A61B5/002;;A61B5/01;;A61B5/14503;;A61B5/1451;;A61B5/14546;;A61B5/14546;;A61B5/1473;;A61B5/1473;;A61B5/1486;;A61B5/1486;;A61B5/14865;;A61B5/1495;;A61B5/4839;;A61B5/72;;A61B5/7278;;A61B5/7282;;A61B5/7405;;A61B5/743;;A61B5/7445;;A61B5/7445;;A61B5/7455;;A61B2560/0252;;A61B2560/0252;;A61M5/1723;;C12Q1/54;;G16H10/40;;G16H10/40;;G16H20/17;;G16H20/17;;H01L23/3107;;H01L23/3107;;H01L23/49548;;H01L23/49548;;H01L2924/0002;;H01L2924/0002;;H01L2924/19041;;H01L2924/19041;;H01L2924/3011;;H01L2924/3011;;Y10S128/903;;Y10S128/903;;Y10T29/49;;Y10T29/49;;Y10T29/49124;;Y10T29/49124,A61B5/00;;G01N27/30;;A61B5/145;;A61B5/1477;;A61B5/1495;;G01N27/416;;G06F19/00;;H01L23/31;;H01L23/495,600/347;;600/365,99,82,136-791-935-548-81X;;062-360-289-025-864;;010-601-725-111-91X;;101-292-518-663-191;;056-703-879-057-297;;030-155-762-644-019;;004-149-141-436-651;;016-731-054-793-457;;080-559-561-995-335;;044-807-213-528-815;;027-538-525-436-179;;015-020-161-517-40X;;025-919-454-564-785;;014-700-576-603-812;;004-851-060-590-788;;075-958-432-122-199;;052-356-140-149-389;;035-090-282-884-790;;033-562-815-299-181;;018-803-926-589-211;;008-505-762-041-402;;016-601-143-530-813;;019-502-772-562-215;;058-476-824-396-350;;006-498-707-073-30X;;054-091-551-638-293;;010-531-147-771-746;;054-827-198-877-419;;122-658-944-077-000;;017-261-560-469-37X;;000-125-755-474-124;;113-381-664-783-802;;082-626-907-191-554;;017-950-014-792-456;;090-348-305-613-628;;015-985-399-299-132;;171-049-047-164-618;;016-819-089-891-758;;081-249-097-078-543;;089-612-747-111-646;;031-706-897-890-035;;094-198-536-559-723;;003-690-143-043-420;;007-943-354-378-456;;082-114-500-909-975;;004-239-090-971-580;;026-894-457-160-450;;077-128-610-778-669;;022-466-506-956-898;;008-424-592-956-946;;007-500-825-916-378;;009-725-244-669-882;;037-755-689-613-42X;;153-411-506-517-475;;038-134-360-685-692;;012-449-714-188-064;;031-517-704-996-130;;131-299-284-996-064;;049-133-049-742-708;;000-272-178-768-076;;070-797-683-833-124;;043-870-224-178-49X;;025-574-914-238-550;;052-364-430-129-757;;004-434-167-910-115;;032-860-147-271-886;;132-460-374-211-421;;098-172-374-375-47X;;109-358-955-476-095;;014-988-634-483-130;;061-786-187-274-992;;037-898-018-686-909;;130-044-667-529-69X;;134-265-642-839-645;;065-221-074-461-027;;017-934-465-161-477;;101-660-130-379-529;;028-236-706-290-220;;087-333-189-994-274;;059-082-211-027-266;;057-977-752-782-568;;022-511-780-866-588,10.1016/s0956-5663(02)00099-4;;12392956;;10.1021/ja00391a001;;2889225;;10.1098/rstb.1987.0021;;10.1109/51.294001;;10.1016/0022-0728(65)85063-x;;2245876;;10.2337/diabetes.39.12.1519;;10.2337/diab.39.12.1519;;10.1016/s0956-5663(03)00220-3;;14611755;;18615658;;10.1002/bit.260430310;;9366023;;10.1016/s0956-5663(97)00025-0;;9451795;;10.1016/s0956-5663(97)00083-3;;10.1016/0956-5663(93)80028-n;;8311939;;8651496;;10.1021/ac960030d;;10.1080/03091900210156797;;12487712;;10.1016/0265-928x(87)80018-4;;3333622;;10.1109/19.816143;;10.1007/bf01015979;;10.1089/15209150252924058;;12017416;;18473691;;10.1089/dia.2007.0281;;10.1021/ac00017a008;;1789439;;2817408;;10.1021/ac00197a022;;10.1016/0925-4005(95)01730-5;;10.1016/0010-4825(90)90013-f;;2257734;;2868172;;8277748;;10.1016/0141-5425(93)90058-7;;11469630;;10.1089/15209150050214104;;10624783;;10.1016/s0168-8227(99)00113-8;;10.1089/15209150050214113;;11469631;;10.1007/bf00401374;;1478372;;10.2337/diacare.20.1.64;;9028696;;10.1109/tbme.1986.325807;;3957374;;236018;;10.1016/0005-2795(75)90259-7;;10.1089/hum.1998.9.6-879;;9581910;;11762520;;10.1089/15209150152607196;;10.2337/diabetes.48.3.445;;10078542;;10.1016/0265-928x(87)80012-3;;505005;;10.1126/science.505005;;10.1021/ac0498516;;15253640;;10.1109/10.284922;;8026845;;6721151;;10.1021/ac00268a018;;6733082;;10.1021/bi00305a016;;10.1515/cclm.2002.135;;12392305;;10.1016/j.ecl.2003.12.001;;15053902;;12052350;;10.1016/s0956-5663(01)00304-9;;12052349;;10.1016/s0956-5663(01)00306-2;;4500021;;10.1007/978-1-4684-3288-6_18;;14021529;;10.1111/j.1749-6632.1962.tb13623.x;;3196517;;10.2337/diacare.10.5.622;;3677983;;10.2337/diacare.8.6.529;;4075939;;10.1002/elan.1140061103;;7733469;;10.1021/ac00103a015;;7978306;;10.1021/ac00091a022;;10.1007/bf01248238;;10.1016/s0376-7388(98)00330-5;;10.1016/0142-9612(92)90147-g;;1472593;;10.1016/0265-928x(85)80002-x;;10.1021/j100290a001;;10.1021/ja00216a040;;10.1021/ja00188a091;;10.1021/ja00406a011;;2624333;;12323417;;10.1016/s0165-0270(02)00170-x;;10.1177/193229680700100208;;pmc2771467;;19888405;;10.1021/ja00415a014;;10.1007/bf00575392;;10.1021/ac00250a038;;10.1021/ac00266a005;;10.1007/s00216-002-1284-0;;12194035;;10.1089/dia.2006.0030;;17705688;;9642777;;10.1016/s0956-5663(97)00091-2;;10.1089/152091503322526978;;14633342;;10.1016/0022-0728(85)87006-6;;10.1021/ja00434a018;;10.1016/0003-2697(92)90243-z;;1443528;;10.1039/f19868201259;;3245585;;10.1021/ac00173a008;;2889234;;10.1098/rstb.1987.0020;;11762521;;10.1089/15209150152607204;;12413548;;10.1016/s1367-5931(02)00371-x;;10526740;;10.2337/diacare.22.10.1708;;14988294;;10.2337/diacare.27.3.734;;10.1111/j.1749-6632.1997.tb52216.x;;9616733,"Abel, P. U., et al., ""Biosensors for In Vivo Glucose Measurement: Can We Cross the Experimental Stage"", Biosensors and Bioelectronics, vol. 17, 2002, pp. 1059-1070.;;Abruna, H. D., et al., ""Rectifying Interfaces Using Two-Layer Films of Electrochemically Polymerized Vinylpyridine and Vinylbipyridine Complexes of Ruthenium and Iron on Electrodes"", Journal of the American Chemical Society, vol. 103, No. 1, 1981, pp. 1-5.;;Albery, W. J., et al., ""Amperometric Enzyme Electrodes Part II: Conducting Salts as Electrode Materials for the Oxidation of Glucose Oxidase"", Journal of ElectroAnalytical Chemistry, vol. 194, 1985, pp. 223-235.;;Albery, W. J., et al., ""Amperometric Enzyme Electrodes"", Philosophical Transactions of The Royal Society of London, vol. 316, 1987, pp. 107-119.;;Alcock, S. J., et al., ""Continuous Analyte Monitoring to Aid Clinical Practice"", IEEE Engineering in Medicine and Biology Magazine, 1994, pp. 319-325.;;Anderson, L. B., et al., ""Thin-Layer Electrochemistry: Steady-State Methods of Studying Rate Processes"", Journal of ElectroAnalytical Chemistry, vol. 10, 1965, pp. 295-305.;;Armour, J. C., et al., ""Application of Chronic Intravascular Blood Glucose Sensor in Dogs"", Diabetes, vol. 39, 1990, pp. 1519-1526.;;Asberg, P., et al., ""Hydrogels of a Conducting Conjugated Polymer as 3-D Enzyme Electrode"", Biosensors & Bioelectronics, vol. 19, 2003, pp. 199-207.;;Atanasov, P., et al., ""Biosensor for Continuous Glucose Monitoring"", Biotechnology and Bioengineering, vol. 43, 1994, pp. 262-266.;;Atanasov, P., et al., ""Implantation of a Refillable Glucose Monitoring-Telemetry Device"", Biosensors & Bioelectronics, vol. 12, No. 7, 1997, pp. 669-680.;;Aussedat, B., et al., ""A User-Friendly Method for Calibrating a Subcutaneous Glucose Sensor-Based Hypoglycaemic Alarm"", Biosensors & Bioelectronics, vol. 12, No. 11, 1997, pp. 1061-1071.;;Baker, D. A., et al., ""Dynamic Concentration Challenges for Biosensor Characterization"", Biosensors & Bioelectronics, vol. 8, 1993, pp. 433-441.;;Baker, D. A., et al., ""Dynamic Delay and Maximal Dynamic Error in Continuous Biosensors"", Analytical Chemistry, vol. 68, No. 8, 1996, pp. 1292-1297.;;Bani Amer, M. M., ""An Accurate Amperometric Glucose Sensor Based Glucometer with Eliminated Cross-Sensitivity"", Journal of Medical Engineering & Technology, vol. 26, No. 5, 2002, pp. 208-213.;;Bard, A. J., et al., Electrochemical Methods, 1980, pp. 173-175.;;Bartlett, P. N., et al., ""Covalent Binding of Electron Relays to Glucose Oxidase"", Journal of the Chemical Society, Chemical Communications, 1987, pp. 1603-1604.;;Bartlett, P. N., et al., ""Modification of Glucose Oxidase by Tetrathiafulvalene"", Journal of the Chemical Society, Chemical Communications, 1990, pp. 1135-1136.;;Bartlett, P. N., et al., ""Strategies for the Development of Amperometric Enzyme Electrodes"", Biosensors, vol. 3, 1987/88, pp. 359-379.;;Beach, R. D., et al., ""Subminiature Implantable Potentiostat and Modified Commercial Telemetry Device for Remote Glucose Monitoring"", IEEE Transactions on Instrumentation and Measurement, vol. 28, No. 6, 1999, pp. 1239-1245.;;Beech, W. A., ""AX.25 Link Access Protocol for Amateur packet Radio"", Tucson Amateur Packet Radio Corporation, 1998, pp. 1-133.;;Bellucci, F., et al., ""Electrochemical Behaviour of Graphite-Epoxy Composite Materials (GECM) in Aqueous Salt Solutions"", Journal of Applied Electrochemistry, vol. 16, 1986, pp. 15-22.;;Bennion, N., et al., ""Alternate Site Glucose Testing: A Crossover Design"", Diabetes Technology & Therapeutics, vol. 4, No. 1, 2002, pp. 25-33.;;Biermann, E., et al., ""How Would Patients Behave if They Were Continually Informed of Their Blood Glucose Levels? A Simulation Study Using a 'Virtual' Patient"", Diabetes Technology & Therapeutics, vol. 10, No. 3, 2008, pp. 178-187.;;Bindra, D. S., et al., ""Design and in Vitro Studies of a Needle-Type Glucose Sensor for Subcutaneous Monitoring"", Analytical Chemistry, vol. 63, No. 17, 1991, pp. 1692-1696.;;Bindra, D. S., et al., ""Pulsed Amperometric Detection of Glucose in Biological Fluids at a Surface-Modified Gold Electrode"", Analytical Chemistry, vol. 61, No. 22, 1989, pp. 2566-2570.;;Bisenberger, M., et al., ""A Triple-Step Potential Waveform at Enzyme Multisensors with Thick-Film Gold Electrodes for Detection of Glucose and Sucrose"", Sensors and Actuators B, vol. 28, 1995, pp. 181-189.;;Bland, J. M., et al., ""A Note on the Use of the Intraclass Correlation Coefficient in the Evaluation of Agreement Between Two Methods of Measurement"", Computers in Biology and Medicine, vol. 20 No. 5, 1990, pp. 337-340.;;Bland, J. M., et al., ""Statistical Methods for Assessing Agreement Between Two Methods of Clinical Measurement"", The Lancet, 1986, pp. 307-310.;;Blank, T. B., et al., ""Clinical Results From a Non-Invasive Blood Glucose Monitor"", Optical Diagnostics and Sensing of Biological Fluids and Glucose and Cholesterol Monitoring II, Proceedings of SPIE, vol. 4624, 2002, pp. 1-10.;;Bobbioni-Harsch, E., et al., ""Lifespan of Subcutaneous Glucose Sensors and Their Performances During Dynamic Glycaemia Changes in Rats"", Journal of Biomedical Engineering, vol. 15, 1993, pp. 457-463.;;Bode, B. W., ""Clinical Utility of the Continuous Glucose Monitoring System"", Diabetes Technology & Therapeutics, vol. 2, Sup. 1, 2000, pp. S35-S41.;;Bode, B. W., et al., ""Continuous Glucose Monitoring Used to Adjust Diabetes Therapy Improves Glycosylated Hemoglobin: A Pilot Study"", Diabetes Research and Clinical Practice, vol. 46, 1999, pp. 183-190.;;Bode, B. W., et al., ""Using The Continuous Glucose Monitoring System to Improve the Management of Type I Diabetes"", Diabetes Technology & Therapeutics, vol. 2, Sup. 1, 2000, pp. S43-S48.;;Boedeker Plastics, Inc., ""Polyethylene Specifications"", Web Page of Boedeker.com, 2007, pp. 1-3.;;Bolinder, J., et al., ""Microdialysis Measurement of the Absolute Glucose Concentration in Subcutaneous Adipose Tissue Allowing Glucose Monitoring in Diabetic Patients"", Diabetologia, vol. 35, 1992, pp. 1177-1180.;;Bolinder, J., et al., ""Self-Monitoring of Blood Glucose in Type I Diabetic Patients: Comparison with Continuous Microdialysis Measurements of Glucose in Subcutaneous Adipose Tissue During Ordinary Life Conditions"", Diabetes Care, vol. 20, No. 1, 1997, pp. 64-70.;;Bott, A. W., ""A Comparison of Cyclic Voltammctry and Cyclic Staircase Voltammetry"", Current Separations, vol. 16, No. 1, 1997, pp. 23-26.;;Bott, A. W., ""Electrochemical Methods for the Determination of Glucose"", Current Separations, vol. 17, No. 1, 1998, pp. 25-31.;;Bowman, L., et al., ""The Packaging of Implantable Integrated Sensors"", IEEE Transactions on Biomedical Engineering, vol. 33, No. 2, 1986, pp. 248-255.;;Brandt, J., et al., ""Covalent Attachment of Proteins to Polysaccharide Carriers by Means of Benzoquinone"", Biochimica et Biophysica Acta, vol. 386, 1975, pp. 196-202.;;Brauker, J., et al., ""Sustained Expression of High Levels of Human Factor IX from Human Cells Implanted Within an Immunoisolation Device into Athymic Rodents"", Human Gene Therapy, vol. 9, No. 6, 1998, pp. 879-888.;;Bremer, T. M., et al., ""Benchmark Data from the Literature for Evaluation of New Glucose Sensing Technologies"", Diabetes Technology & Therapeutics, vol. 3, No. 3, 2001, pp. 409-418.;;Bremer, T., et al., ""Is Blood Glucose Predictable from Previous Values?"", Diabetes, vol. 48, 1999, pp. 445-451.;;Brooks, S. L., et al., ""Development of an On-Line Glucose Sensor for Fermentation Monitoring"", Biosensors, vol. 3, 1987/88, pp. 45-56.;;Brownlee, M., et al., ""A Glucose-Controlled Insulin-Delivery System: Semisynthetic Insulin Bound to Lectin"", Science, vol. 206, 1979, 1190-1191.;;Cai, Q., et al., ""A Wireless, Remove Query Glucose Biosensor Based on a pH-Sensitive Polymer"", Analytical Chemistry, vol. 76, No. 14, 2004, pp. 4038-4043.;;Candas, B., et al., ""An Adaptive Plasma Glucose Controller Based on a Nonlinear Insulin/Glucose Model"", IEEE Transactions on Biomedical Engineering, vol. 41, No. 2, 1994, pp. 116-124.;;Cass, A. E., et al., ""Ferricinum Ion As An Electron Acceptor for Oxido-Reductases"", Journal of ElectroAnalytical Chemistry, vol. 190, 1985, pp. 117-127.;;Cass, A. E., et al., ""Ferrocene-Medicated Enzyme Electrode for Amperometric Determination of Glucose"", Analytical Chemistry, vol. 56, No. 4, 1984, 667-671.;;Castner, J. F., et al., ""Mass Transport and Reaction Kinetic Parameters Determined Electrochemically for Immobilized Glucose Oxidase"", Biochemistry, vol. 23 No. 10, 1984, 2203-2210.;;Chen, J. C., et al., ""A Comparison of MAC Protocols for Wireless Local Networks Based on battery Power Consumption"", IEEE, 1998, pp. 150-157.;;Chen, T., et al., ""Defining the Period of Recovery of the Glucose Concentration After Its Local Perturbation by the Implantation of a Miniature Sensor"", Clinical Chemistry and Laboratory Medicine, vol. 40, No. 8, 2002, pp. 486-489.;;Chia, C. W., et al., ""Glucose Sensors: Toward Closed Loop Insulin Delivery"", Endocrinology and Metabolism Clinics of North America, vol. 33, 2004, pp. 175-195.;;Choleau, C., et al., ""Calibration of a Subcutaneous Amperometric Glucose Sensor Implanted for 7 Days in Diabetic Patients Part 2: Superiority of the One-Point Calibration Method"", Biosensors and Bioelectronics, vol. 17, 2002, pp. 647-654.;;Choleau, C., et al., ""Calibration of a Subcutaneous Amperometric Glucose Sensor Part 1: Effect of Measurement Uncertainties on the Determination of Sensor Sensitivity and Background Current"", Biosensors and Bioelectronics, vol. 17, 2002, pp. 641-646.;;Claremont, D. J., et al., ""Biosensors for Continuous In Vivo Glucose Monitoring"", Proceedings of the Annual International Conference of the IEEE Engineering in Medicine and Biology Society, vol. 10, 1988.;;Clark Jr., L. C., et al., ""Differential Anodic Enzyme Polarography for the Measurement of Glucose"", Oxygen Transport to Tissue: Instrumentation, Methods, and Physiology, 1973, pp. 127-133.;;Clark Jr., L. C., et al., ""Electrode Systems for Continuous Monitoring in Cardiovascular Surgery"", Annals New York Academy of Sciences, 1962, pp. 29-45.;;Clark Jr., L. C., et al., ""Long-term Stability of Electroenzymatic Glucose Sensors Implanted in Mice"", American Society of Artificial Internal Organs Transactions, vol. XXXIV, 1988, pp. 259-265.;;Clarke, W. L., et al., ""Evaluating Clinical Accuracy of Systems for Self-Monitoring of Blood Glucose"", Diabetes Care, vol. 10, No. 5, 1987, pp. 622-628.;;Complaint, ""Abbott Diabetes Care, Inc. v. Dexcom, Inc."", filed Aug. 11, 2005.;;Complaint, Amended, ""Abbott Diabetes Care, Inc. v. Dexcom, Inc."", filed Jun. 27, 2006.;;Cox, D. J., et al., ""Accuracy of Perceiving Blood Glucose in IDDM"", Diabetes Care, vol. 8, No. 6, 1985, pp. 529-536.;;Csoregi, E., et al., ""Amperometric Microbiosensors for Detection of Hydrogen Peroxide and Glucose Based on Peroxidase-Modified Carbon Fibers"", Electroanalysis, vol. 6 1994, pp. 925-933.;;Csoregi, E., et al., ""Design and Optimization of a Selective Subcutaneously Implantable Glucose Electrode Based on 'Wired' Glucose Oxidase"", Analytical Chemistry, vol. 67, No. 7, 1995, pp. 1240-1244.;;Csoregi, E., et al., ""Design, Characterization, and One-Point in Vivo Calibration of a Subcutaneously Implanted Glucose Electrode"", Analytical Chemistry, vol. 66 No. 19, 1994, pp. 3131-3138.;;Csoregi, E., et al., ""On-Line Glucose Monitoring by Using Microdialysis Sampling and Amperometric Detection Based on 'Wired' Glucose Oxidase in Carbon Paste"", Mikrochimica Acta, vol. 121, 1995, pp. 31-40.;;D'Arrigo, G., et al., ""Porous-Si Based Bio Reactors for Glucose Monitoring and Drugs Production"", Proceedings of SPIE: Microfluids, BioMEMS, and Medical Microsystems, vol. 4982, 2003, pp. 178-184.;;Dai, W. S., et al., ""Hydrogel Membranes with Mesh Size Asymmetry Based on the Gradient Crosslinking of Poly(vinyl alcohol),"" Journal of Membrane Science, vol. 156, 1999, pp. 67-79.;;Davies, M. L., et al., ""Polymer Membranes in Clinical Sensor Applications"", Biomaterials, vol. 13, No. 14, 1992, pp. 971-978.;;Davis, G., ""Electrochemical Techniques for the Development of Amperometric Biosensors"", Biosensors, vol. 1, 1985, pp. 161-178.;;Degani, Y., et al., ""Direct Electrical Communication Between Chemically Modified Enzymes and Metal Electrodes. 1. Electron Transfer from Glucose Oxidase to Metal Electrodes via Electron Relays, Bound Covalently to the Enzyme"", The Journal of Physical Chemistry, vol. 91, No. 6, 1987, pp. 1285-1289.;;Degani, Y., et al., ""Direct Electrical Communication Between Chemically Modified Enzymes and Metal Electrodes. 2. Methods for Bonding Electron-Transfer Relays to Glucose Oxidase and D-Amino-Acid Oxidase"", Journal of the American Chemical Society, vol. 110, No. 8, 1988, pp. 2615-2620.;;Degani, Y., et al., ""Electrical Communication Between Redox Centers of Glucose Oxidase and Electrodes via Electrostatically and Covalently Bound Redox Polymers"", Journal of the American Chemical Society, vol. 111, 1989, pp. 2357-2358.;;Denisevich, P., et al., ""Unidirectional Current Flow and Charge State Trapping at Redox Polymer Interfaces on Bilayer Electrodes: Principles, Experimental Demonstration, and Theory"", Journal of the American Chemical Society, vol. 103, 1981, pp. 4727-4737.;;Dicks, J. M., et al., ""Ferrocene Modified Polypyrrole with Immobilised Glucose Oxidase and its Application in Amperometric Glucose Microbiosensors"", Annales de Biologie Clinique, vol. 47, 1989, pp. 607-619.;;Dixon, B. M., et al., ""Characterization In Vitro and In Vivo of the Oxygen Dependence of an Enzyme/Polymer Biosensors for Monitoring Brain Glucose"", Journal of Neuroscience Methods, vol. 119, 2002, pp. 135-142.;;Eighth Annual Diabetes Technology Meeting Abstracts, Nov. 13-15, 2008, pp. A1-A182.;;El-Khatib, F. H, et al., ""Adaptive Closed-Loop Control Provides Blood-Glucose Regulation Using Subcutaneous Insulin and Glucagon Infusion in Diabetic Swine"", Journal of Diabetes Science and Technology, vol. 1, No. 2, 2007, pp. 181-192.;;Ellis, C. D., et al., ""Selectivity and Directed Charge Transfer through an Electroactive Metallopolymer Film"", Journal of the American Chemical Society, vol. 103, No. 25, 1981, pp. 7480-7483.;;El-Sa'Ad, L., et al., ""Moisture Absorption by Epoxy Resins: The Reverse Thermal Effect"", Journal of Materials Science, vol. 25, No. 8, 1990, pp. 3577-3582.;;Engstrom, R. C., ""Electrochemical Pretreatment of Glassy Carbon Electrodes"", Analytical Chemistry, vol. 54, No. 13, 1982, pp. 2310-2314.;;Engstrom, R. C., et al., ""Characterization of Electrochemically Pretreated Glassy Carbon Electrodes"", Analytical Chemistry, vol. 56, No. 2, 1984, pp. 136-141.;;Ernst, H., et al., ""Reliable Glucose Monitoring Through the Use of Microsystem Technology"", Analytical and Bioanalytical Chemistry, vol. 373, 2002, pp. 758-761.;;Fabietti, P. G., et al. ""Clinical Validation of a New Control-Oriented Model of Insulin and Glucose Dynamics in Subjects with Type 1 Diabetes"", Diabetes Technology & Therapeutics, vol. 9, No. 4, 2007, pp. 327-338.;;Fare, T. L., et al., ""Functional Characterization of a Conducting Polymer-Based Immunoassay System"", Biosensors & Bioelectronics, vol. 13, No. 3-4, 1998, pp. 459-470.;;Feldman, B., et al., ""A Continuous Glucose Sensor Based on Wired Enzyme(TM) Technology-Results from a 3-Day Trial in Patients with Type 1 Diabetes"",Diabetes Technology & Therapeutics, vol. 5, No. 5, 2003, pp. 769-779.;;Feldman, B., et al., ""Correlation of Glucose Concentrations in Interstitial Fluid and Venous Blood During Periods of Rapid Glucose Change"" Abbott Diabetes Care, Inc. Freestyle Navigator Continuous Glucose Monitor Pamphlet, 2004.;;Feldman, B., et al., ""Electron Transfer Kinetics at Redox Polymer/Solution Interfaces Using Microelectrodes and Twin Electrode Thin Layer Cells"", Journal of ElectroAnalytical Chemistry, vol. 194, 1985, pp. 63-81.;;Fischer, H., et al., ""Intramolecular Electron Transfer Medicated by 4,4'-Bypyridine and Related Bridging Groups"", Journal of the American Chemical Society, vol. 98, No. 18, 1976, pp. 5512-5517.;;Flentge, F., et al., ""An Enzyme-Reactor for Electrochemical Monitoring of Choline and Acetylcholine: Applications in High-Performance Liquid Chromatography, Bran Tissue, Microdialysis and Cerebrospinal Fluid,"" Analytical Biochemistry, vol. 204, 1992, pp. 305-310.;;Foulds, N. C., et al., ""Enzyme Entrapment in Electrically Conducting Polymers: Immobilisation of Glucose Oxidase in Polypyrrole and its Application in Amperometric Glucose Sensors"", Journal of the Chemical Society, Faraday Transactions 1, vol. 82, 1986, pp. 1259-1264.;;Foulds, N. C., et al., ""Immobilization of Glucose Oxidase in Ferrocene-Modified Pyrrole Polymers"", Analytical Chemistry, vol. 60, No. 22, 1988, pp. 2473-2478.;;Frew, J. E., et al., ""Electron-Transfer Biosensors"", Philosophical Transactions of The Royal Society of London, vol. 316, 1987, pp. 95-106.;;Frohnauer, M. K., et al., ""Graphical Human Insulin Time-Activity Profiles Using Standardized Definitions"", Diabetes Technology & Therapeutics, vol. 3, No. 3, 2001, pp. 419-429.;;Frost, M. C., et al., ""Implantable Chemical Sensors for Real-Time Clinical Monitoring: Progress and Challenges"", Current Opinion in Chemical Biology, vol. 6, 2002, pp. 633-641.;;Garg, S. K., et al., ""Correlation of Fingerstick Blood Glucose Measurements with GlucoWatch Biographer Glucose Results in Young Subjects with Type 1 Diabetes"", Diabetes Care, vol. 22, No. 10, 1999, pp. 1708-1714.;;Garg, S. K., et al., ""Improved Glucose Excursions Using an Implantable Real-Time Continuous Glucose Sensor in Adults withType 1 Diabetes"", Diabetes Care, vol. 27, No. 3, 2004, pp. 734-738.;;Geller, R. L., et al., ""Use of an Immunoisolation Device for Cell Transplantation and Tumor Immunotherapy"", Annals of the New York Academy of Sciences, vol. 831, 1997, pp. 438-451.",EXPIRED
236,US,A1,US 2009/0093696 A1,031-328-725-557-505,2009-04-09,2009,US 24561808 A,2008-10-03,US 24561808 A;;US 42005703 A;;US 66719900 A;;US 7067798 A,1998-04-30,Analyte Monitoring Device and Methods of Use,"An analyte monitor includes a sensor, a sensor control unit, and a display unit. The sensor has, for example, a substrate, a recessed channel formed in the substrate, and conductive material disposed in the recessed channel to form a working electrode. The sensor control unit typically has a housing adapted for placement on skin and is adapted to receive a portion of an electrochemical sensor. The sensor control unit also includes two or more conductive contacts disposed on the housing and configured for coupling to two or more contact pads on the sensor. A transmitter is disposed in the housing and coupled to the plurality of conductive contacts for transmitting data obtained using the sensor. The display unit has a receiver for receiving data transmitted by the transmitter of the sensor control unit and a display coupled to the receiver for displaying an indication of a level of an analyte. The analyte monitor may also be part of a drug delivery system to alter the level of the analyte based on the data obtained using the sensor.",ABBOTT DIABETES CARE INC,SAY JAMES;;TOMASCO MICHAEL F;;HELLER ADAM;;GAL YORAM;;ARIA BEHRAD;;HELLER EPHRAIM;;PLANTE PHILLIP JOHN;;VREEKE MARK S;;FRIEDMAN KEITH A;;COLMAN FREDRIC C,,https://lens.org/031-328-725-557-505,Patent Application,yes,1,23,211,221,0,A61B5/14532;;A61B5/14532;;A61B5/0002;;A61B5/0002;;A61B5/002;;A61B5/01;;A61B5/14503;;A61B5/1451;;A61B5/14546;;A61B5/14546;;A61B5/1473;;A61B5/1473;;A61B5/1486;;A61B5/1486;;A61B5/14865;;A61B5/1495;;A61B5/4839;;A61B5/72;;A61B5/7278;;A61B5/7282;;A61B5/7405;;A61B5/743;;A61B5/7445;;A61B5/7445;;A61B5/7455;;A61B2560/0252;;A61B2560/0252;;A61M5/1723;;C12Q1/54;;G16H10/40;;G16H10/40;;G16H20/17;;G16H20/17;;H01L23/3107;;H01L23/3107;;H01L23/49548;;H01L23/49548;;H01L2924/0002;;H01L2924/0002;;H01L2924/19041;;H01L2924/19041;;H01L2924/3011;;H01L2924/3011;;Y10S128/903;;Y10S128/903;;Y10T29/49;;Y10T29/49;;Y10T29/49124;;Y10T29/49124,A61B5/1473;;G01N27/30;;A61B5/00;;A61B5/145;;A61B5/1477;;A61B5/1495;;G01N27/416;;G06F19/00;;H01L23/31;;H01L23/495,600/347;;600/345;;600/365,0,0,,,,DISCONTINUED
237,US,A1,US 2010/0168659 A1,028-027-517-572-930,2010-07-01,2010,US 64397809 A,2009-12-21,US 64397809 A;;US 42005703 A;;US 66719900 A;;US 7067798 A,1998-04-30,Analyte Monitoring Device and Methods of Use,"An analyte monitor includes a sensor, a sensor control unit, and a display unit. The sensor has, for example, a substrate, a recessed channel formed in the substrate, and conductive material disposed in the recessed channel to form a working electrode. The sensor control unit typically has a housing adapted for placement on skin and is adapted to receive a portion of an electrochemical sensor. The sensor control unit also includes two or more conductive contacts disposed on the housing and configured for coupling to two or more contact pads on the sensor. A transmitter is disposed in the housing and coupled to the plurality of conductive contacts for transmitting data obtained using the sensor. The display unit has a receiver for receiving data transmitted by the transmitter of the sensor control unit and a display coupled to the receiver for displaying an indication of a level of an analyte. The analyte monitor may also be part of a drug delivery system to alter the level of the analyte based on the data obtained using the sensor.",ABBOTT DIABETES CARE INC,SAY JAMES;;TOMASCO MICHAEL F;;HELLER ADAM;;GAL YORAM;;ARIA BEHRAD;;HELLER EPHRAIM;;PLANTE PHILLIP JOHN;;VREEKE MARK S;;FRIEDMAN KEITH A;;COLMAN FREDRIC C,E. HELLER & CO (1998-07-02);;ABBOTT DIABETES CARE INC (2000-03-13),https://lens.org/028-027-517-572-930,Patent Application,yes,99,49,211,221,0,A61B5/14532;;A61B5/14532;;A61B5/0002;;A61B5/0002;;A61B5/002;;A61B5/01;;A61B5/14503;;A61B5/1451;;A61B5/14546;;A61B5/14546;;A61B5/1473;;A61B5/1473;;A61B5/1486;;A61B5/1486;;A61B5/14865;;A61B5/1495;;A61B5/4839;;A61B5/72;;A61B5/7278;;A61B5/7282;;A61B5/7405;;A61B5/743;;A61B5/7445;;A61B5/7445;;A61B5/7455;;A61B2560/0252;;A61B2560/0252;;A61M5/1723;;C12Q1/54;;G16H10/40;;G16H10/40;;G16H20/17;;G16H20/17;;H01L23/3107;;H01L23/3107;;H01L23/49548;;H01L23/49548;;H01L2924/0002;;H01L2924/0002;;H01L2924/19041;;H01L2924/19041;;H01L2924/3011;;H01L2924/3011;;Y10S128/903;;Y10S128/903;;Y10T29/49;;Y10T29/49;;Y10T29/49124;;Y10T29/49124,A61M37/00;;G01N27/30;;A61B5/00;;A61B5/145;;A61B5/1477;;A61B5/1495;;G01N27/416;;G06F19/00;;H01L23/31;;H01L23/495,604/66,0,0,,,,EXPIRED
238,US,A1,US 2009/0198115 A1,039-225-703-422-49X,2009-08-06,2009,US 40546909 A,2009-03-17,US 40546909 A;;US 42005703 A;;US 66719900 A;;US 7067798 A,1998-04-30,Analyte Monitoring Device and Methods of Use,"An analyte monitor includes a sensor, a sensor control unit, and a display unit. The sensor has, for example, a substrate, a recessed channel formed in the substrate, and conductive material disposed in the recessed channel to form a working electrode. The sensor control unit typically has a housing adapted for placement on skin and is adapted to receive a portion of an electrochemical sensor. The sensor control unit also includes two or more conductive contacts disposed on the housing and configured for coupling to two or more contact pads on the sensor. A transmitter is disposed in the housing and coupled to the plurality of conductive contacts for transmitting data obtained using the sensor. The display unit has a receiver for receiving data transmitted by the transmitter of the sensor control unit and a display coupled to the receiver for displaying an indication of a level of an analyte. The analyte monitor may also be part of a drug delivery system to alter the level of the analyte based on the data obtained using the sensor.",ABBOTT DIABETES CARE INC,SAY JAMES;;TOMASCO MICHAEL F;;HELLER ADAM;;GAL YORAM;;ARIA BEHRAD;;HELLER EPHRAIM;;PLANTE PHILLIP JOHN;;VREEKE MARK S;;FRIEDMAN KEITH A;;COLMAN FREDRIC C,,https://lens.org/039-225-703-422-49X,Patent Application,yes,1,57,211,221,0,A61B5/14532;;A61B5/14532;;A61B5/0002;;A61B5/0002;;A61B5/002;;A61B5/01;;A61B5/14503;;A61B5/1451;;A61B5/14546;;A61B5/14546;;A61B5/1473;;A61B5/1473;;A61B5/1486;;A61B5/1486;;A61B5/14865;;A61B5/1495;;A61B5/4839;;A61B5/72;;A61B5/7278;;A61B5/7282;;A61B5/7405;;A61B5/743;;A61B5/7445;;A61B5/7445;;A61B5/7455;;A61B2560/0252;;A61B2560/0252;;A61M5/1723;;C12Q1/54;;G16H10/40;;G16H10/40;;G16H20/17;;G16H20/17;;H01L23/3107;;H01L23/3107;;H01L23/49548;;H01L23/49548;;H01L2924/0002;;H01L2924/0002;;H01L2924/19041;;H01L2924/19041;;H01L2924/3011;;H01L2924/3011;;Y10S128/903;;Y10S128/903;;Y10T29/49;;Y10T29/49;;Y10T29/49124;;Y10T29/49124,A61B5/1468;;G01N27/30;;A61B5/00;;A61B5/145;;A61B5/1477;;A61B5/1495;;G01N27/416;;G06F19/00;;H01L23/31;;H01L23/495,600/345,0,0,,,,DISCONTINUED
239,US,B2,US 8273022 B2,044-592-756-649-706,2012-09-25,2012,US 37153909 A,2009-02-13,US 37153909 A;;US 42005703 A;;US 66719900 A;;US 7067798 A,1998-04-30,Analyte monitoring device and methods of use,"An analyte monitor includes a sensor, a sensor control unit, and a display unit. The sensor has, for example, a substrate, a recessed channel formed in the substrate, and conductive material disposed in the recessed channel to form a working electrode. The sensor control unit typically has a housing adapted for placement on skin and is adapted to receive a portion of an electrochemical sensor. The sensor control unit also includes two or more conductive contacts disposed on the housing and configured for coupling to two or more contact pads on the sensor. A transmitter is disposed in the housing and coupled to the plurality of conductive contacts for transmitting data obtained using the sensor. The display unit has a receiver for receiving data transmitted by the transmitter of the sensor control unit and a display coupled to the receiver for displaying an indication of a level of an analyte. The analyte monitor may also be part of a drug delivery system to alter the level of the analyte based on the data obtained using the sensor.",SAY JAMES;;TOMASCO MICHAEL F;;HELLER ADAM;;GAL YORAM;;ARIA BEHRAD;;HELLER EPHRAIM;;PLANTE PHILLIP JOHN;;VREEKE MARK S;;FRIEDMAN KEITH A;;COLMAN FREDRIC C;;ABBOTT DIABETES CARE INC,SAY JAMES;;TOMASCO MICHAEL F;;HELLER ADAM;;GAL YORAM;;ARIA BEHRAD;;HELLER EPHRAIM;;PLANTE PHILLIP JOHN;;VREEKE MARK S;;FRIEDMAN KEITH A;;COLMAN FREDRIC C,E. HELLER & CO (1998-07-02);;ABBOTT DIABETES CARE INC (2000-03-13),https://lens.org/044-592-756-649-706,Granted Patent,yes,110,14,211,221,0,A61B5/14532;;A61B5/14532;;A61B5/0002;;A61B5/0002;;A61B5/002;;A61B5/01;;A61B5/14503;;A61B5/1451;;A61B5/14546;;A61B5/14546;;A61B5/1473;;A61B5/1473;;A61B5/1486;;A61B5/1486;;A61B5/14865;;A61B5/1495;;A61B5/4839;;A61B5/72;;A61B5/7278;;A61B5/7282;;A61B5/7405;;A61B5/743;;A61B5/7445;;A61B5/7445;;A61B5/7455;;A61B2560/0252;;A61B2560/0252;;A61M5/1723;;C12Q1/54;;G16H10/40;;G16H10/40;;G16H20/17;;G16H20/17;;H01L23/3107;;H01L23/3107;;H01L23/49548;;H01L23/49548;;H01L2924/0002;;H01L2924/0002;;H01L2924/19041;;H01L2924/19041;;H01L2924/3011;;H01L2924/3011;;Y10S128/903;;Y10S128/903;;Y10T29/49;;Y10T29/49;;Y10T29/49124;;Y10T29/49124,A61B5/00;;G01N27/30;;A61B5/145;;A61B5/1477;;A61B5/1495;;G01N27/416;;G01N33/66;;G06F19/00;;H01L23/31;;H01L23/495,600/365;;422/68.1,99,81,136-791-935-548-81X;;062-360-289-025-864;;010-601-725-111-91X;;101-292-518-663-191;;056-703-879-057-297;;030-155-762-644-019;;004-149-141-436-651;;016-731-054-793-457;;080-559-561-995-335;;044-807-213-528-815;;027-538-525-436-179;;015-020-161-517-40X;;025-919-454-564-785;;014-700-576-603-812;;004-851-060-590-788;;075-958-432-122-199;;052-356-140-149-389;;035-090-282-884-790;;033-562-815-299-181;;018-803-926-589-211;;008-505-762-041-402;;016-601-143-530-813;;019-502-772-562-215;;058-476-824-396-350;;006-498-707-073-30X;;054-091-551-638-293;;010-531-147-771-746;;054-827-198-877-419;;122-658-944-077-000;;017-261-560-469-37X;;000-125-755-474-124;;113-381-664-783-802;;082-626-907-191-554;;017-950-014-792-456;;090-348-305-613-628;;015-985-399-299-132;;171-049-047-164-618;;016-819-089-891-758;;081-249-097-078-543;;089-612-747-111-646;;031-706-897-890-035;;094-198-536-559-723;;003-690-143-043-420;;007-943-354-378-456;;082-114-500-909-975;;004-239-090-971-580;;026-894-457-160-450;;077-128-610-778-669;;022-466-506-956-898;;008-424-592-956-946;;007-500-825-916-378;;009-725-244-669-882;;037-755-689-613-42X;;153-411-506-517-475;;038-134-360-685-692;;012-449-714-188-064;;031-517-704-996-130;;131-299-284-996-064;;049-133-049-742-708;;000-272-178-768-076;;070-797-683-833-124;;043-870-224-178-49X;;025-574-914-238-550;;052-364-430-129-757;;004-434-167-910-115;;032-860-147-271-886;;132-460-374-211-421;;098-172-374-375-47X;;109-358-955-476-095;;014-988-634-483-130;;061-786-187-274-992;;037-898-018-686-909;;130-044-667-529-69X;;134-265-642-839-645;;065-221-074-461-027;;017-934-465-161-477;;101-660-130-379-529;;028-236-706-290-220;;087-333-189-994-274;;059-082-211-027-266;;057-977-752-782-568,10.1016/s0956-5663(02)00099-4;;12392956;;10.1021/ja00391a001;;2889225;;10.1098/rstb.1987.0021;;10.1109/51.294001;;10.1016/0022-0728(65)85063-x;;2245876;;10.2337/diabetes.39.12.1519;;10.2337/diab.39.12.1519;;10.1016/s0956-5663(03)00220-3;;14611755;;18615658;;10.1002/bit.260430310;;9366023;;10.1016/s0956-5663(97)00025-0;;9451795;;10.1016/s0956-5663(97)00083-3;;10.1016/0956-5663(93)80028-n;;8311939;;8651496;;10.1021/ac960030d;;10.1080/03091900210156797;;12487712;;10.1016/0265-928x(87)80018-4;;3333622;;10.1109/19.816143;;10.1007/bf01015979;;10.1089/15209150252924058;;12017416;;18473691;;10.1089/dia.2007.0281;;10.1021/ac00017a008;;1789439;;2817408;;10.1021/ac00197a022;;10.1016/0925-4005(95)01730-5;;10.1016/0010-4825(90)90013-f;;2257734;;2868172;;8277748;;10.1016/0141-5425(93)90058-7;;11469630;;10.1089/15209150050214104;;10624783;;10.1016/s0168-8227(99)00113-8;;10.1089/15209150050214113;;11469631;;10.1007/bf00401374;;1478372;;10.2337/diacare.20.1.64;;9028696;;10.1109/tbme.1986.325807;;3957374;;236018;;10.1016/0005-2795(75)90259-7;;10.1089/hum.1998.9.6-879;;9581910;;11762520;;10.1089/15209150152607196;;10.2337/diabetes.48.3.445;;10078542;;10.1016/0265-928x(87)80012-3;;505005;;10.1126/science.505005;;10.1021/ac0498516;;15253640;;10.1109/10.284922;;8026845;;6721151;;10.1021/ac00268a018;;6733082;;10.1021/bi00305a016;;10.1515/cclm.2002.135;;12392305;;10.1016/j.ecl.2003.12.001;;15053902;;12052350;;10.1016/s0956-5663(01)00304-9;;12052349;;10.1016/s0956-5663(01)00306-2;;4500021;;10.1007/978-1-4684-3288-6_18;;14021529;;10.1111/j.1749-6632.1962.tb13623.x;;3196517;;10.2337/diacare.10.5.622;;3677983;;10.2337/diacare.8.6.529;;4075939;;10.1002/elan.1140061103;;7733469;;10.1021/ac00103a015;;7978306;;10.1021/ac00091a022;;10.1007/bf01248238;;10.1016/s0376-7388(98)00330-5;;10.1016/0142-9612(92)90147-g;;1472593;;10.1016/0265-928x(85)80002-x;;10.1021/j100290a001;;10.1021/ja00216a040;;10.1021/ja00188a091;;10.1021/ja00406a011;;2624333;;12323417;;10.1016/s0165-0270(02)00170-x;;10.1177/193229680700100208;;pmc2771467;;19888405;;10.1021/ja00415a014;;10.1007/bf00575392;;10.1021/ac00250a038;;10.1021/ac00266a005;;10.1007/s00216-002-1284-0;;12194035;;10.1089/dia.2006.0030;;17705688;;9642777;;10.1016/s0956-5663(97)00091-2;;10.1089/152091503322526978;;14633342;;10.1016/0022-0728(85)87006-6;;10.1021/ja00434a018;;10.1016/0003-2697(92)90243-z;;1443528;;10.1039/f19868201259;;3245585;;10.1021/ac00173a008;;2889234;;10.1098/rstb.1987.0020;;11762521;;10.1089/15209150152607204;;12413548;;10.1016/s1367-5931(02)00371-x;;10526740;;10.2337/diacare.22.10.1708;;14988294;;10.2337/diacare.27.3.734,"""Poretics Polycarbonate Membrane"", Osmonics Filtration and Separation Group, 2002.;;Abel, P. U., et al., ""Biosensors for In Vivo Glucose Measurement: Can We Cross the Experimental Stage"", Biosensors and Bioelectronics, vol. 17, 2002, pp. 1059-1070.;;Abruna, H. D., et al., ""Rectifying Interfaces Using Two-Layer Films of Electrochemically Polymerized Vinylpyridine and Vinylbipyridine Complexes of Ruthenium and Iron on Electrodes"", Journal of the American Chemical Society, vol. 103, No. 1, 1981, pp. 1-5.;;Albery, W. J., et al., ""Amperometric Enzyme Electrodes Part II: Conducting Salts as Electrode Materials for the Oxidation of Glucose Oxidase"", Journal of ElectroAnalytical Chemistry, vol. 194, 1985, pp. 223-235.;;Albery, W. J., et al., ""Amperometric Enzyme Electrodes"", Philosophical Transactions of The Royal Society of London, vol. 316, 1987, pp. 107-119.;;Alcock, S. J., et al., ""Continuous Analyte Monitoring to Aid Clinical Practice"", IEEE Engineering in Medicine and Biology Magazine, 1994, pp. 319-325.;;Anderson, L. B., et al., ""Thin-Layer Electrochemistry: Steady-State Methods of Studying Rate Processes"", Journal of ElectroAnalytical Chemistry, vol. 10, 1965, pp. 295-305.;;Armour, J. C., et al., ""Application of Chronic Intravascular Blood Glucose Sensor in Dogs"", Diabetes, vol. 39, 1990, pp. 1519-1526.;;Asberg, P., et al., ""Hydrogels of a Conducting Conjugated Polymer as 3-D Enzyme Electrode"", Biosensors & Bioelectronics, vol. 19, 2003, pp. 199-207.;;Atanasov, P., et al., ""Biosensor for Continuous Glucose Monitoring"", Biotechnology and Bioengineering, vol. 43, 1994, pp. 262-266.;;Atanasov, P., et al., ""Implantation of a Refillable Glucose Monitoring-Telemetry Device"", Biosensors & Bioelectronics, vol. 12, No. 7, 1997, pp. 669-680.;;Aussedat, B., et al., ""A User-Friendly Method for Calibrating a Subcutaneous Glucose Sensor-Based Hypoglycaemic Alarm"", Biosensors & Bioelectronics, vol. 12, No. 11, 1997, pp. 1061-1071.;;Baker, D. A., et al., ""Dynamic Concentration Challenges for Biosensor Characterization"", Biosensors & Bioelectronics, vol. 8, 1993, pp. 433-441.;;Baker, D. A., et al., ""Dynamic Delay and Maximal Dynamic Error in Continuous Biosensors"", Analytical Chemistry, vol. 68, No. 8, 1996, pp. 1292-1297.;;Bani Amer, M. M., ""An Accurate Amperometric Glucose Sensor Based Glucometer with Eliminated Cross-Sensitivity"", Journal of Medical Engineering & Technology, vol. 26, No. 5, 2002, pp. 208-213.;;Bard, A. J., et al., Electrochemical Methods, 1980, pp. 173-175.;;Bartlett, P. N., et al., ""Covalent Binding of Electron Relays to Glucose Oxidase"", Journal of the Chemical Society, Chemical Communications, 1987, pp. 1603-1604.;;Bartlett, P. N., et al., ""Modification of Glucose Oxidase by Tetrathiafulvalene"", Journal of the Chemical Society, Chemical Communications, 1990, pp. 1135-1136.;;Bartlett, P. N., et al., ""Strategies for the Development of Amperometric Enzyme Electrodes"", Biosensors, vol. 3, 1987/1988, pp. 359-379.;;Beach, R. D., et al., ""Subminiature Implantable Potentiostat and Modified Commercial Telemetry Device for Remote Glucose Monitoring"", IEEE Transactions on Instrumentation and Measurement, vol. 28, No. 6, 1999, pp. 1239-1245.;;Beech, W. A., ""AX.25 Link Access Protocol for Amateur packet Radio"", Tucson Amateur Packet Radio Corporation, 1998, pp. 1-133.;;Bellucci, F., et al., ""Electrochemical Behaviour of Graphite-Epoxy Composite Materials (GECM) in Aqueous Salt Solutions"", Journal of Applied Electrochemistry, vol. 16, 1986, pp. 15-22.;;Bennion, N., et al., ""Alternate Site Glucose Testing: A Crossover Design"", Diabetes Technology & Therapeutics, vol. 4, No. 1, 2002, pp. 25-33.;;Biermann, E., et al., ""How Would Patients Behave if They Were Continually Informed of Their Blood Glucose Levels? A Simulation Study Using a 'Virtual' Patient"", Diabetes Technology & Therapeutics, vol. 10, No. 3, 2008, pp. 178-187.;;Bindra, D. S., et al., ""Design and in Vitro Studies of a Needle-Type Glucose Sensor for Subcutaneous Monitoring"", Analytical Chemistry, vol. 63, No. 17, 1991, pp. 1692-1696.;;Bindra, D. S., et al., ""Pulsed Amperometric Detection of Glucose in Biological Fluids at a Surface-Modified Gold Electrode"", Analytical Chemistry, vol. 61, No. 22, 1989, pp. 2566-2570.;;Bisenberger, M., et al., ""A Triple-Step Potential Waveform at Enzyme Multisensors with Thick-Film Gold Electrodes for Detection of Glucose and Sucrose"", Sensors and Actuators B, vol. 28, 1995, pp. 181-189.;;Bland, J. M., et al., ""A Note on the Use of the Intraclass Correlation Coefficient in the Evaluation of Agreement Between Two Methods of Measurement"", Computers in Biology and Medicine, vol. 20, No. 5, 1990, pp. 337-340.;;Bland, J. M., et al., ""Statistical Methods for Assessing Agreement Between Two Methods of Clinical Measurement"", The Lancet, 1986, pp. 307-310.;;Blank, T. B., et al., ""Clinical Results From a Non-Invasive Blood Glucose Monitor"", Optical Diagnostics and Sensing of Biological Fluids and Glucose and Cholesterol Monitoring II, Proceedings of SPIE, vol. 4624, 2002, pp. 1-10.;;Bobbioni-Harsch, E., et al., ""Lifespan of Subcutaneous Glucose Sensors and Their Performances During Dynamic Glycaemia Changes in Rats"", Journal of Biomedical Engineering, vol. 15, 1993, pp. 457-463.;;Bode, B. W., ""Clinical Utility of the Continuous Glucose Monitoring System"", Diabetes Technology & Therapeutics, vol. 2, Sup. 1, 2000, pp. S35-S41.;;Bode, B. W., et al., ""Continuous Glucose Monitoring Used to Adjust Diabetes Therapy Improves Glycosylated Hemoglobin: A Pilot Study"", Diabetes Research and Clinical Practice, vol. 46, 1999, pp. 183-190.;;Bode, B. W., et al., ""Using the Continuous Glucose Monitoring System to Improve the Management of Type I Diabetes"", Diabetes Technology & Therapeutics, vol. 2, Sup. 1, 2000, pp. S43-S48.;;Boedeker Plastics, Inc., ""Polyethylene Specifications"", Web Page of Boedeker.com, 2007, pp. 1-3.;;Bolinder, J., et al., ""Microdialysis Measurement of the Absolute Glucose Concentration inSubcutaneous Adipose Tissue Allowing Glucose Monitoring in Diabetic Patients"", Diabetologia, vol. 35, 1992, pp. 1177-1180.;;Bolinder, J., et al., ""Self-Monitoring of Blood Glucose in Type I Diabetic Patients: Comparison with Continuous Microdialysis Measurements of Glucose in Subcutaneous Adipose Tissue During Ordinary Life Conditions"", Diabetes Care, vol. 20, No. 1, 1997, pp. 64-70.;;Bott, A. W., ""A Comparison of Cyclic Voltammetry and Cyclic Staircase Voltammetry"", Current Separations, vol. 16, No. 1, 1997, pp. 23-26.;;Bott, A. W., ""Electrochemical Methods for the Determination of Glucose"", Current Separations, vol. 17, No. 1, 1998, pp. 25-31.;;Bowman, L., et al., ""The Packaging of Implantable Integrated Sensors"", IEEE Transactions on Biomedical Engineering, vol. 33, No. 2, 1986, pp. 248-255.;;Brandt, J., et al., ""Covalent Attachment of Proteins to Polysaccharide Carriers by Means of Benzoquinone"", Biochimica et Biophysica Acta, vol. 386, 1975, pp. 196-202.;;Brauker, J., et al., ""Sustained Expression of High Levels of Human Factor IX from Human Cells Implanted Within an Immunoisolation Device into Athymic Rodents"", Human Gene Therapy, vol. 9, No. 6, 1998, pp. 879-888.;;Bremer, T. M., et al., ""Benchmark Data from the Literature for Evaluation of New Glucose Sensing Technologies"", Diabetes Technology & Therapeutics, vol. 3, No. 3, 2001, pp. 409-418.;;Bremer, T., et al., ""Is Blood Glucose Predictable from Previous Values?"", Diabetes, vol. 48, 1999, pp. 445-451.;;Brooks, S. L., et al., ""Development of an On-Line Glucose Sensor for Fermentation Monitoring"", Biosensors, vol. 3, 1987/1988, pp. 45-56.;;Brownlee, M., et al., ""A Glucose-Controlled Insulin-Delivery System: Semisynthetic Insulin Bound to Lectin"", Science, vol. 206, 1979, 1190-1191.;;Cai, Q., et al., ""A Wireless, Remove Query Glucose Biosensor Based on a pH-Sensitive Polymer"", Analytical Chemistry, vol. 76, No. 14, 2004, pp. 4038-4043.;;Candas, B., et al., ""An Adaptive Plasma Glucose Controller Based on a Nonlinear Insulin/Glucose Model"", IEEE Transactions on Biomedical Engineering, vol. 41, No. 2, 1994, pp. 116-124.;;Cass, A. E., et al., ""Ferricinum Ion As an Electron Acceptor for Oxido-Reductases"", Journal of ElectroAnalytical Chemistry, vol. 190, 1985, pp. 117-127.;;Cass, A. E., et al., ""Ferrocene-Medicated Enzyme Electrode for Amperometric Determination of Glucose"", Analytical Chemistry, vol. 56, No. 4, 1984, 667-671.;;Castner, J. F., et al., ""Mass Transport and Reaction Kinetic Parameters Determined Electrochemically for Immobilized Glucose Oxidase"", Biochemistry, vol. 23 No. 10, 1984, 2203-2210.;;Chen, J. C., et al., ""A Comparison of MAC Protocols for Wireless Local Networks Based on battery Power Consumption"", IEEE, 1998, pp. 150-157.;;Chen, T., et al., ""Defining the Period of Recovery of the Glucose Concentration After Its Local Perturbation by the Implantation of a Miniature Sensor"", Clinical Chemistry and Laboratory Medicine, vol. 40, No. 8, 2002, pp. 486-489.;;Chia, C. W., et al., ""Glucose Sensors: Toward Closed Loop Insulin Delivery"", Endocrinology and Metabolism Clinics of North America, vol. 33, 2004, .pp. 175-195.;;Choleau, C., et al., ""Calibration of a Subcutaneous Amperometric Glucose Sensor Implanted for 7 Days in Diabetic Patients Part 2: Superiority of the One-Point Calibration Method"", Biosensors and Bioelectronics, vol. 17, 2002, pp. 647-654.;;Choleau, C., et al., ""Calibration of a Subcutaneous Amperometric Glucose Sensor Part 1: Effect of Measurement Uncertainties on the Determination of Sensor Sensitivity and Background Current"", Biosensors and Bioelectronics, vol. 17, 2002, pp. 641-646.;;Claremont, D. J., et al., ""Biosensors for Continuous In Vivo Glucose Monitoring"", Proceedings of the Annual International Conference of the IEEE Engineering in Medicine and Biology Society, vol. 10, 1988.;;Clark Jr., L. C., et al., ""Differential Anodic Enzyme Polarography for the Measurement of Glucose"", Oxygen Transport to Tissue: Instrumentation, Methods, and Physiology, 1973, pp. 127-133.;;Clark Jr., L. C., et al., ""Electrode Systems for Continuous Monitoring in Cardiovascular Surgery"", Annals New York Academy of Sciences, 1962, pp. 29-45.;;Clark Jr., L. C., et al., ""Long-term Stability of Electroenzymatic Glucose Sensors Implanted in Mice"", American Society of Artificial Internal Organs Transactions, vol. XXXIV, 1988, pp. 259-265.;;Clarke, W. L., et al., ""Evaluating Clinical Accuracy of Systems for Self-Monitoring of Blood Glucose"", Diabetes Care, vol. 10, No. 5, 1987, pp. 622-628.;;Complaint, ""Abbott Diabetes Care, Inc. v. Dexcom, Inc."", filed Aug. 11, 2005.;;Complaint, Amended, ""Abbott Diabetes Care, Inc. v. Dexcom, Inc."", filed Jun. 27, 2006.;;Cox, D. J., et al., ""Accuracy of Perceiving Blood Glucose in IDDM"", Diabetes Care, vol. 8, No. 6, 1985, pp. 529-536.;;Csoregi, E., et al., ""Amperometric Microbiosensors for Detection of Hydrogen Peroxide and Glucose Based on Peroxidase-Modified Carbon Fibers"", Electroanalysis, vol. 6, 1994, pp. 925-933.;;Csoregi, E., et al., ""Design and Optimization of a Selective Subcutaneously Implantable Glucose Electrode Based on 'Wired' Glucose Oxidase"", Analytical Chemistry, vol. 67, No. 7, 1995, pp. 1240-1244.;;Csoregi, E., et al., ""Design, Characterization, and One-Point in Vivo Calibration of a Subcutaneously Implanted Glucose Electrode"", Analytical Chemistry, vol. 66 No. 19, 1994, pp. 3131-3138.;;Csoregi, E., et al., ""On-Line Glucose Monitoring by Using Microdialysis Sampling and Amperometric Detection Based on 'Wired' Glucose Oxidase in Carbon Paste"", Mikrochimica Acta, vol. 121, 1995, pp. 31-40.;;D'Arrigo, G., et al., ""Porous-Si Based Bio Reactors for Glucose Monitoring and Drugs Production"", Proceedings of SPIE: Microfluids, BioMEMS, and Medical Microsystems, vol. 4982, 2003, pp. 178-184.;;Dai, W. S., et al., ""Hydrogel Membranes with Mesh Size Asymmetry Based on the Gradient Crosslinking of Poly(vinyl alcohol),"" Journal of Membrane Science, vol. 156, 1999, pp. 67-79.;;Davies, M. L., et al., ""Polymer Membranes in Clinical Sensor Applications"", Biomaterials, vol. 13, No. 14, 1992, pp. 971-978.;;Davis, G., ""Electrochemical Techniques for the Development of Amperometric Biosensors"", Biosensors, vol. 1, 1985, pp. 161-178.;;Degani, Y., et al., ""Direct Electrical Communication Between Chemically Modified Enzymes and Metal Electrodes. 1. Electron Transfer from Glucose Oxidase to Metal Electrodes via Electron Relays, Bound Covalently to the Enzyme"", The Journal of Physical Chemistry, vol. 91, No. 6, 1987, pp. 1285-1289.;;Degani, Y., et al., ""Direct Electrical Communication Between Chemically Modified Enzymes and Metal Electrodes. 2. Methods for Bonding Electron-Transfer Relays to Glucose Oxidase and D-Amino-Acid Oxidase"", Journal of the American Chemical Society, vol. 110, No. 8, 1988, pp. 2615-2620.;;Degani, Y., et al., ""Electrical Communication Between Redox Centers of Glucose Oxidase and Electrodes via Electrostatically and Covalently Bound Redox Polymers"", Journal of the American Chemical Society, vol. 111, 1989, pp. 2357-2358.;;Denisevich, P., et al., ""Unidirectional Current Flow and Charge State Trapping at Redox Polymer Interfaces on Bilayer Electrodes: Principles, Experimental Demonstration, and Theory"", Journal of the American Chemical Society, vol. 103, 1981, pp. 4727-4737.;;Dicks, J. M., et al., ""Ferrocene Modified Polypyrrole with Immobilised Glucose Oxidase and its Application in Amperometric Glucose Microbiosensors"", Annales de Biologie Clinique, vol. 47, 1989, pp. 607-619.;;Dixon, B. M., et al., ""Characterization In Vitro and In Vivo of the Oxygen Dependence of an Enzyme/Polymer Biosensors for Monitoring Brain Glucose"", Journal of Neuroscience Methods, vol. 119, 2002, pp. 135-142.;;Eighth Annual Diabetes Technology Meeting Abstracts, Nov. 13-15, 2008, pp. A1-A182.;;El-Khatib, F. H, et al., ""Adaptive Closed-Loop Control Provides Blood-Glucose Regulation Using Subcutaneous Insulin and Glucagon Infusion in Diabetic Swine"", Journal of Diabetes Science and Technology, vol. 1, No. 2, 2007, pp. 181-192.;;Ellis, C. D., et al., ""Selectivity and Directed Charge Transfer through an Electroactive Metallopolymer Film"", Journal of the American Chemical Society, vol. 103, No. 25, 1981, pp. 7480-7483.;;El-Sa'Ad, L., et al., ""Moisture Absorption by Epoxy Resins: The Reverse Thermal Effect"", Journal of Materials Science, vol. 25, No. 8, 1990, pp. 3577-3582.;;Engstrom, R. C., ""Electrochemical Pretreatment of Glassy Carbon Electrodes"", Analytical Chemistry, vol. 54, No. 13, 1982, pp. 2310-2314.;;Engstrom, R. C., et al., ""Characterization of Electrochemically Pretreated Glassy Carbon Electrodes"", Analytical Chemistry, vol. 56, No. 2, 1984, pp. 136-141.;;Ernst, H., et al., ""Reliable Glucose Monitoring Through the Use of Microsystem Technology"", Analytical and Bioanalytical Chemistry, vol. 373, 2002, pp. 758-761.;;Fabietti, P. G., et al. ""Clinical Validation of a New Control-Oriented Model of Insulin and Glucose Dynamics in Subjects with Type 1 Diabetes"", Diabetes Technology & Therapeutics, vol. 9 No. 4, 2007, pp. 327-338.;;Fare, T. L., et al., ""Functional Characterization of a Conducting Polymer-Based Immunoassay System"", Biosensors & Bioelectronics, vol. 13, No. 3-4, 1998, pp. 459-470.;;Feldman, B., et al., ""A Continuous Glucose Sensor Based on Wired Enzyme(TM) Technology-Results from a 3-Day Trial in Patients with Type 1 Diabetes"", Diabetes Technology & Therapeutics, vol. 5, No. 5, 2003, pp. 769-779.;;Feldman, B., et al., ""Correlation of Glucose Concentrations in Interstitial Fluid and Venous Blood During Periods of Rapid Glucose Change"", Abbott Diabetes Care, Inc. Freestyle Navigator Continuous Glucose Monitor Pamphlet, 2004.;;Feldman, B., et al., ""Electron Transfer Kinetics at Redox Polymer/Solution Interfaces Using Microelectrodes and Twin Electrode Thin Layer Cells"", Journal of ElectroAnalytical Chemistry, vol. 194, 1985, pp. 63-81.;;Fischer, H., et al., ""Intramolecular Electron Transfer Medicated by 4,4'-Bypyridine and Related Bridging Groups"", Journal of the American Chemical Society, vol. 98, No. 18, 1976, pp. 5512-5517.;;Flentge, F., et al., ""An Enzyme-Reactor for Electrochemical Monitoring of Choline and Acetylcholine: Applications in High-Performance Liquid Chromatography, Bran Tissue, Microdialysis and Cerebrospinal Fluid,"" Analytical Biochemistry, vol. 204, 1992, pp. 305-310.;;Foulds, N. C., et al., ""Enzyme Entrapment in Electrically Conducting Polymers: Immobilisation of Glucose Oxidase in Polypyrrole and its Application in Amperometric Glucose Sensors"", Journal of the Chemical Society, Faraday Transactions 1, vol. 82, 1986, pp. 1259-1264.;;Foulds, N. C., et al , ""Immobilization of Glucose Oxidase in Ferrocene-Modified Pyrrole Polymers"", Analytical Chemistry, vol. 60, No. 22, 1988, pp. 2473-2478.;;Frew, J. E., et al., ""Electron-Transfer Biosensors"", Philosophical Transactions of The Royal Society of London, vol. 316, 1987, pp. 95-106.;;Frohnauer, M. K., et al., ""Graphical Human Insulin Time-Activity Profiles Using Standardized Definitions"", Diabetes Technology & Therapeutics, vol. 3, No. 3, 2001, pp. 419-429.;;Frost, M. C., et al., ""Implantable Chemical Sensors for Real-Time Clinical Monitoring: Progress and Challenges"", Current Opinion in Chemical Biology, vol. 6, 2002, pp. 633-641.;;Garg, S. K., et al., ""Correlation of Fingerstick Blood Glucose Measurements with GlucoWatch Biographer Glucose Results in Young Subjects with Type 1 Diabetes"", Diabetes Care, vol. 22, No. 10, 1999, pp. 1708-1714.;;Garg, S. K., et al., ""Improved Glucose Excursions Using an Implantable Real-Time Continuous Glucose Sensor in Adults with Type 1 Diabetes"", Diabetes Care, vol. 27, No. 3, 2004, pp. 734-738.",EXPIRED
240,US,A1,US 2009/0177065 A1,071-650-997-608-35X,2009-07-09,2009,US 40601209 A,2009-03-17,US 40601209 A;;US 42005703 A;;US 66719900 A;;US 7067798 A,1998-04-30,Analyte Monitoring Device and Methods of Use,"An analyte monitor includes a sensor, a sensor control unit, and a display unit. The sensor has, for example, a substrate, a recessed channel formed in the substrate, and conductive material disposed in the recessed channel to form a working electrode. The sensor control unit typically has a housing adapted for placement on skin and is adapted to receive a portion of an electrochemical sensor. The sensor control unit also includes two or more conductive contacts disposed on the housing and configured for coupling to two or more contact pads on the sensor. A transmitter is disposed in the housing and coupled to the plurality of conductive contacts for transmitting data obtained using the sensor. The display unit has a receiver for receiving data transmitted by the transmitter of the sensor control unit and a display coupled to the receiver for displaying an indication of a level of an analyte. The analyte monitor may also be part of a drug delivery system to alter the level of the analyte based on the data obtained using the sensor.",ABBOTT DIABETES CARE INC,SAY JAMES;;TOMASCO MICHAEL F;;HELLER ADAM;;GAL YORAM;;ARIA BEHRAD;;HELLER EPHRAIM;;PLANTE PHILLIP JOHN;;VREEKE MARK S;;FRIEDMAN KEITH A;;COLMAN FREDRIC C,,https://lens.org/071-650-997-608-35X,Patent Application,yes,0,59,211,221,0,A61B5/14532;;A61B5/14532;;A61B5/0002;;A61B5/0002;;A61B5/002;;A61B5/01;;A61B5/14503;;A61B5/1451;;A61B5/14546;;A61B5/14546;;A61B5/1473;;A61B5/1473;;A61B5/1486;;A61B5/1486;;A61B5/14865;;A61B5/1495;;A61B5/4839;;A61B5/72;;A61B5/7278;;A61B5/7282;;A61B5/7405;;A61B5/743;;A61B5/7445;;A61B5/7445;;A61B5/7455;;A61B2560/0252;;A61B2560/0252;;A61M5/1723;;C12Q1/54;;G16H10/40;;G16H10/40;;G16H20/17;;G16H20/17;;H01L23/3107;;H01L23/3107;;H01L23/49548;;H01L23/49548;;H01L2924/0002;;H01L2924/0002;;H01L2924/19041;;H01L2924/19041;;H01L2924/3011;;H01L2924/3011;;Y10S128/903;;Y10S128/903;;Y10T29/49;;Y10T29/49;;Y10T29/49124;;Y10T29/49124,A61B5/1468;;G01N27/30;;A61B5/00;;A61B5/145;;A61B5/1477;;A61B5/1495;;G01N27/416;;G06F19/00;;H01L23/31;;H01L23/495,600/345,0,0,,,,DISCONTINUED
241,US,A1,US 2010/0256471 A1,096-980-000-056-848,2010-10-07,2010,US 81812810 A,2010-06-17,US 81812810 A;;US 69082607 A;;US 42005703 A;;US 66719900 A;;US 7067798 A,1998-04-30,Analyte Monitoring Device and Methods of Use,"An analyte monitor includes a sensor, a sensor control unit, and a display unit. The sensor has, for example, a substrate, a recessed channel formed in the substrate, and conductive material disposed in the recessed channel to form a working electrode. The sensor control unit typically has a housing adapted for placement on skin and is adapted to receive a portion of an electrochemical sensor. The sensor control unit also includes two or more conductive contacts disposed on the housing and configured for coupling to two or more contact pads on the sensor. A transmitter is disposed in the housing and coupled to the plurality of conductive contacts for transmitting data obtained using the sensor. The display unit has a receiver for receiving data transmitted by the transmitter of the sensor control unit and a display coupled to the receiver for displaying an indication of a level of an analyte. The analyte monitor may also be part of a drug delivery system to alter the level of the analyte based on the data obtained using the sensor.",ABBOTT DIABETES CARE INC,SAY JAMES;;TOMASCO MICHAEL F;;HELLER ADAM;;GAL YORAM;;ARIA BEHRAD;;HELLER EPHRAIM;;PLANTE PHILLIP JOHN;;VREEKE MARK S;;FRIEDMAN KEITH A;;COLMAN FREDRIC C,,https://lens.org/096-980-000-056-848,Patent Application,yes,0,14,211,221,0,A61B5/14532;;A61B5/14532;;A61B5/0002;;A61B5/0002;;A61B5/002;;A61B5/01;;A61B5/14503;;A61B5/1451;;A61B5/14546;;A61B5/14546;;A61B5/1473;;A61B5/1473;;A61B5/1486;;A61B5/1486;;A61B5/14865;;A61B5/1495;;A61B5/4839;;A61B5/72;;A61B5/7278;;A61B5/7282;;A61B5/7405;;A61B5/743;;A61B5/7445;;A61B5/7445;;A61B5/7455;;A61B2560/0252;;A61B2560/0252;;A61M5/1723;;C12Q1/54;;G16H10/40;;G16H10/40;;G16H20/17;;G16H20/17;;H01L23/3107;;H01L23/3107;;H01L23/49548;;H01L23/49548;;H01L2924/0002;;H01L2924/0002;;H01L2924/19041;;H01L2924/19041;;H01L2924/3011;;H01L2924/3011;;Y10S128/903;;Y10S128/903;;Y10T29/49;;Y10T29/49;;Y10T29/49124;;Y10T29/49124,A61B5/1468;;G01N27/30;;A61B5/00;;A61B5/145;;A61B5/1477;;A61B5/1495;;G01N27/416;;G06F19/00;;H01L23/31;;H01L23/495,600/345,0,0,,,,DISCONTINUED
242,US,A1,US 2007/0191700 A1,159-792-023-744-171,2007-08-16,2007,US 73478207 A,2007-04-12,US 73478207 A;;US 72224603 A;;US 42005703 A;;US 66719900 A;;US 7067798 A,1998-04-30,Analyte Monitoring Device and Methods of Use,"An analyte monitor includes a sensor, a sensor control unit, and a display unit. The sensor has, for example, a substrate, a recessed channel formed in the substrate, and conductive material disposed in the recessed channel to form a working electrode. The sensor control unit typically has a housing adapted for placement on skin and is adapted to receive a portion of an electrochemical sensor. The sensor control unit also includes two or more conductive contacts disposed on the housing and configured for coupling to two or more contact pads on the sensor. A transmitter is disposed in the housing and coupled to the plurality of conductive contacts for transmitting data obtained using the sensor. The display unit has a receiver for receiving data transmitted by the transmitter of the sensor control unit and a display coupled to the receiver for displaying an indication of a level of an analyte. The analyte monitor may also be part of a drug delivery system to alter the level of the analyte based on the data obtained using the sensor.",ABBOTT DIABETES CARE INC,SAY JAMES;;TOMASCO MICHAEL F;;HELLER ADAM;;GAL YORAM;;ARIA BEHRAD;;HELLER EPHRAIM;;PLANTE PHILLIP J;;VREEKE MARK S;;FRIEDMAN KEITH A;;COLMAN FREDRIC C,E. HELLER & CO (1998-07-02);;ABBOTT DIABETES CARE INC (2000-03-13),https://lens.org/159-792-023-744-171,Patent Application,yes,99,64,2,221,0,A61B5/14865;;A61B5/14865;;A61B5/14532;;A61B5/14532;;A61B5/14546;;A61B5/14546;;A61B5/1495;;A61B5/1495;;A61B5/7445;;A61B5/7445;;A61M5/1723;;A61M5/1723,A61B5/05,600/345;;600/347,0,0,,,,EXPIRED
243,US,A1,US 2009/0163789 A1,155-495-141-949-729,2009-06-25,2009,US 39728109 A,2009-03-03,US 39728109 A;;US 42005703 A;;US 66719900 A;;US 7067798 A,1998-04-30,Analyte Monitoring Device and Methods of Use,"An analyte monitor includes a sensor, a sensor control unit, and a display unit. The sensor has, for example, a substrate, a recessed channel formed in the substrate, and conductive material disposed in the recessed channel to form a working electrode. The sensor control unit typically has a housing adapted for placement on skin and is adapted to receive a portion of an electrochemical sensor. The sensor control unit also includes two or more conductive contacts disposed on the housing and configured for coupling to two or more contact pads on the sensor. A transmitter is disposed in the housing and coupled to the plurality of conductive contacts for transmitting data obtained using the sensor. The display unit has a receiver for receiving data transmitted by the transmitter of the sensor control unit and a display coupled to the receiver for displaying an indication of a level of an analyte. The analyte monitor may also be part of a drug delivery system to alter the level of the analyte based on the data obtained using the sensor.",ABBOTT DIABETES CARE INC,SAY JAMES;;TOMASCO MICHAEL F;;HELLER ADAM;;GAL YORAM;;ARIA BEHRAD;;HELLER EPHRAIM;;PLANTE PHILLIP JOHN;;VREEKE MARK S;;FRIEDMAN KEITH A;;COLMAN FREDRIC C,E. HELLER & CO (1998-07-02);;ABBOTT DIABETES CARE INC (2000-03-13),https://lens.org/155-495-141-949-729,Patent Application,yes,99,83,211,221,0,A61B5/14532;;A61B5/14532;;A61B5/0002;;A61B5/0002;;A61B5/002;;A61B5/01;;A61B5/14503;;A61B5/1451;;A61B5/14546;;A61B5/14546;;A61B5/1473;;A61B5/1473;;A61B5/1486;;A61B5/1486;;A61B5/14865;;A61B5/1495;;A61B5/4839;;A61B5/72;;A61B5/7278;;A61B5/7282;;A61B5/7405;;A61B5/743;;A61B5/7445;;A61B5/7445;;A61B5/7455;;A61B2560/0252;;A61B2560/0252;;A61M5/1723;;C12Q1/54;;G16H10/40;;G16H10/40;;G16H20/17;;G16H20/17;;H01L23/3107;;H01L23/3107;;H01L23/49548;;H01L23/49548;;H01L2924/0002;;H01L2924/0002;;H01L2924/19041;;H01L2924/19041;;H01L2924/3011;;H01L2924/3011;;Y10S128/903;;Y10S128/903;;Y10T29/49;;Y10T29/49;;Y10T29/49124;;Y10T29/49124,A61B5/1468;;G01N27/30;;A61B5/00;;A61B5/145;;A61B5/1477;;A61B5/1495;;G01N27/416;;G06F19/00;;H01L23/31;;H01L23/495,600/345,0,0,,,,EXPIRED
244,US,B2,US 8177716 B2,155-033-478-822-84X,2012-05-15,2012,US 64397409 A,2009-12-21,US 64397409 A;;US 42005703 A;;US 66719900 A;;US 7067798 A,1998-04-30,Analyte monitoring device and methods of use,"An analyte monitor includes a sensor, a sensor control unit, and a display unit. The sensor has, for example, a substrate, a recessed channel formed in the substrate, and conductive material disposed in the recessed channel to form a working electrode. The sensor control unit typically has a housing adapted for placement on skin and is adapted to receive a portion of an electrochemical sensor. The sensor control unit also includes two or more conductive contacts disposed on the housing and configured for coupling to two or more contact pads on the sensor. A transmitter is disposed in the housing and coupled to the plurality of conductive contacts for transmitting data obtained using the sensor. The display unit has a receiver for receiving data transmitted by the transmitter of the sensor control unit and a display coupled to the receiver for displaying an indication of a level of an analyte. The analyte monitor may also be part of a drug delivery system to alter the level of the analyte based on the data obtained using the sensor.",SAY JAMES;;TOMASCO MICHAEL F;;HELLER ADAM;;GAL YORAM;;ARIA BEHRAD;;HELLER EPHRAIM;;PLANTE PHILLIP JOHN;;VREEKE MARK S;;FRIEDMAN KEITH A;;COLMAN FREDRIC C;;ABBOTT DIABETES CARE INC,SAY JAMES;;TOMASCO MICHAEL F;;HELLER ADAM;;GAL YORAM;;ARIA BEHRAD;;HELLER EPHRAIM;;PLANTE PHILLIP JOHN;;VREEKE MARK S;;FRIEDMAN KEITH A;;COLMAN FREDRIC C,,https://lens.org/155-033-478-822-84X,Granted Patent,yes,119,17,211,221,0,A61B5/14532;;A61B5/14532;;A61B5/0002;;A61B5/0002;;A61B5/002;;A61B5/01;;A61B5/14503;;A61B5/1451;;A61B5/14546;;A61B5/14546;;A61B5/1473;;A61B5/1473;;A61B5/1486;;A61B5/1486;;A61B5/14865;;A61B5/1495;;A61B5/4839;;A61B5/72;;A61B5/7278;;A61B5/7282;;A61B5/7405;;A61B5/743;;A61B5/7445;;A61B5/7445;;A61B5/7455;;A61B2560/0252;;A61B2560/0252;;A61M5/1723;;C12Q1/54;;G16H10/40;;G16H10/40;;G16H20/17;;G16H20/17;;H01L23/3107;;H01L23/3107;;H01L23/49548;;H01L23/49548;;H01L2924/0002;;H01L2924/0002;;H01L2924/19041;;H01L2924/19041;;H01L2924/3011;;H01L2924/3011;;Y10S128/903;;Y10S128/903;;Y10T29/49;;Y10T29/49;;Y10T29/49124;;Y10T29/49124,A61B5/00;;G01N27/30;;A61B5/05;;A61B5/145;;A61B5/1477;;A61B5/1495;;G01N27/416;;G06F19/00;;H01L23/31;;H01L23/495,600/365;;600/345;;600/347,99,81,136-791-935-548-81X;;062-360-289-025-864;;010-601-725-111-91X;;101-292-518-663-191;;056-703-879-057-297;;030-155-762-644-019;;004-149-141-436-651;;016-731-054-793-457;;080-559-561-995-335;;044-807-213-528-815;;027-538-525-436-179;;015-020-161-517-40X;;025-919-454-564-785;;014-700-576-603-812;;004-851-060-590-788;;075-958-432-122-199;;052-356-140-149-389;;035-090-282-884-790;;033-562-815-299-181;;018-803-926-589-211;;008-505-762-041-402;;016-601-143-530-813;;019-502-772-562-215;;058-476-824-396-350;;006-498-707-073-30X;;054-091-551-638-293;;010-531-147-771-746;;054-827-198-877-419;;122-658-944-077-000;;017-261-560-469-37X;;000-125-755-474-124;;113-381-664-783-802;;082-626-907-191-554;;017-950-014-792-456;;090-348-305-613-628;;015-985-399-299-132;;171-049-047-164-618;;016-819-089-891-758;;081-249-097-078-543;;089-612-747-111-646;;031-706-897-890-035;;094-198-536-559-723;;003-690-143-043-420;;007-943-354-378-456;;082-114-500-909-975;;004-239-090-971-580;;026-894-457-160-450;;077-128-610-778-669;;022-466-506-956-898;;008-424-592-956-946;;007-500-825-916-378;;009-725-244-669-882;;037-755-689-613-42X;;153-411-506-517-475;;038-134-360-685-692;;012-449-714-188-064;;031-517-704-996-130;;131-299-284-996-064;;049-133-049-742-708;;000-272-178-768-076;;070-797-683-833-124;;043-870-224-178-49X;;025-574-914-238-550;;052-364-430-129-757;;004-434-167-910-115;;032-860-147-271-886;;132-460-374-211-421;;098-172-374-375-47X;;109-358-955-476-095;;014-988-634-483-130;;061-786-187-274-992;;037-898-018-686-909;;130-044-667-529-69X;;134-265-642-839-645;;065-221-074-461-027;;017-934-465-161-477;;101-660-130-379-529;;028-236-706-290-220;;087-333-189-994-274;;059-082-211-027-266;;057-977-752-782-568,10.1016/s0956-5663(02)00099-4;;12392956;;10.1021/ja00391a001;;2889225;;10.1098/rstb.1987.0021;;10.1109/51.294001;;10.1016/0022-0728(65)85063-x;;2245876;;10.2337/diabetes.39.12.1519;;10.2337/diab.39.12.1519;;10.1016/s0956-5663(03)00220-3;;14611755;;18615658;;10.1002/bit.260430310;;9366023;;10.1016/s0956-5663(97)00025-0;;9451795;;10.1016/s0956-5663(97)00083-3;;10.1016/0956-5663(93)80028-n;;8311939;;8651496;;10.1021/ac960030d;;10.1080/03091900210156797;;12487712;;10.1016/0265-928x(87)80018-4;;3333622;;10.1109/19.816143;;10.1007/bf01015979;;10.1089/15209150252924058;;12017416;;18473691;;10.1089/dia.2007.0281;;10.1021/ac00017a008;;1789439;;2817408;;10.1021/ac00197a022;;10.1016/0925-4005(95)01730-5;;10.1016/0010-4825(90)90013-f;;2257734;;2868172;;8277748;;10.1016/0141-5425(93)90058-7;;11469630;;10.1089/15209150050214104;;10624783;;10.1016/s0168-8227(99)00113-8;;10.1089/15209150050214113;;11469631;;10.1007/bf00401374;;1478372;;10.2337/diacare.20.1.64;;9028696;;10.1109/tbme.1986.325807;;3957374;;236018;;10.1016/0005-2795(75)90259-7;;10.1089/hum.1998.9.6-879;;9581910;;11762520;;10.1089/15209150152607196;;10.2337/diabetes.48.3.445;;10078542;;10.1016/0265-928x(87)80012-3;;505005;;10.1126/science.505005;;10.1021/ac0498516;;15253640;;10.1109/10.284922;;8026845;;6721151;;10.1021/ac00268a018;;6733082;;10.1021/bi00305a016;;10.1515/cclm.2002.135;;12392305;;10.1016/j.ecl.2003.12.001;;15053902;;12052350;;10.1016/s0956-5663(01)00304-9;;12052349;;10.1016/s0956-5663(01)00306-2;;4500021;;10.1007/978-1-4684-3288-6_18;;14021529;;10.1111/j.1749-6632.1962.tb13623.x;;3196517;;10.2337/diacare.10.5.622;;3677983;;10.2337/diacare.8.6.529;;4075939;;10.1002/elan.1140061103;;7733469;;10.1021/ac00103a015;;7978306;;10.1021/ac00091a022;;10.1007/bf01248238;;10.1016/s0376-7388(98)00330-5;;10.1016/0142-9612(92)90147-g;;1472593;;10.1016/0265-928x(85)80002-x;;10.1021/j100290a001;;10.1021/ja00216a040;;10.1021/ja00188a091;;10.1021/ja00406a011;;2624333;;12323417;;10.1016/s0165-0270(02)00170-x;;10.1177/193229680700100208;;pmc2771467;;19888405;;10.1021/ja00415a014;;10.1007/bf00575392;;10.1021/ac00250a038;;10.1021/ac00266a005;;10.1007/s00216-002-1284-0;;12194035;;10.1089/dia.2006.0030;;17705688;;9642777;;10.1016/s0956-5663(97)00091-2;;10.1089/152091503322526978;;14633342;;10.1016/0022-0728(85)87006-6;;10.1021/ja00434a018;;10.1016/0003-2697(92)90243-z;;1443528;;10.1039/f19868201259;;3245585;;10.1021/ac00173a008;;2889234;;10.1098/rstb.1987.0020;;11762521;;10.1089/15209150152607204;;12413548;;10.1016/s1367-5931(02)00371-x;;10526740;;10.2337/diacare.22.10.1708;;14988294;;10.2337/diacare.27.3.734,"""Poretics Polycarbonate Membrane"", Osmonics Filtration and Separation Group, 2002.;;Abel, P. U., et al., ""Biosensors for In Vivo Glucose Measurement: Can We Cross the Experimental Stage"", Biosensors and Bioelectronics, vol. 17, 2002, pp. 1059-1070.;;Abruna, H. D., et al., ""Rectifying Interfaces Using Two-Layer Films of Electrochemically Polymerized Vinylpyridine and Vinylbipyridine Complexes of Ruthenium and Iron on Electrodes"", Journal of the American Chemical Society, vol. 103, No. 1, 1981, pp. 1-5.;;Albery, W. J., et al., ""Amperometric Enzyme Electrodes Part II: Conducting Salts as electrode Materials for the Oxidation of Glucose Oxidase"", Journal of ElectroAnalytical Chemistry, vol. 194, 1985, pp. 223-235.;;Albery, W. J., et al., ""Amperometric Enzyme Electrodes"", Philosophical Transactions of The Royal Society of London, vol. 316, 1987, pp. 107-119.;;Alcock, S. J., et al., ""Continuous Analyte Monitoring to Aid Clinical Practice"", IEEE Engineering in Medicine and Biology Magazine, 1994, pp. 319-325.;;Anderson, L. B., et al., ""Thin-Layer Electrochemistry: Steady-State Methods of Studying Rate Processes"", Journal of ElectroAnalytical Chemistry, vol. 10, 1965, pp. 295-305.;;Armour, J. C., et al., ""Application of Chronic Intravascular Blood Glucose Sensor in Dogs"", Diabetes, vol. 39, 1990, pp. 1519-1526.;;Asberg, P., et al., ""Hydrogels of a Conducting Conjugated Polymer as 3-D Enzyme Electrode"", Biosensors & Bioelectronics, vol. 19, 2003, pp. 199-207.;;Atanasov, P., et al., ""Biosensor for Continuous Glucose Monitoring"", Biotechnology and Bioengineering, vol. 43, 1994, pp. 262-266.;;Atanasov, P., et al., ""Implantation of a Refillable Glucose Monitoring-Telemetry Device"", Biosensors & Bioelectronics, vol. 12, No. 7, 1997, pp. 669-680.;;Aussedat, B., et al., ""A User-Friendly Method for Calibrating a Subcutaneous Glucose Sensor-Based Hypoglycaemic Alarm"", Biosensors & Bioelectronics, vol. 12, No. 11, 1997, pp. 1061-1071.;;Baker, D. A., et al., ""Dynamic Concentration Challenges for Biosensor Characterization"", Biosensors & Bioelectronics, vol. 8, 1993, pp. 433-441.;;Baker, D. A., et al., ""Dynamic Delay and Maximal Dynamic Error in Continuous Biosensors"", Analytical Chemistry, vol. 68, No. 8, 1996, pp. 1292-1297.;;Bani Amer, M. M., ""An Accurate Amperometric Glucose Sensor Based Glucometer with Eliminated Cross-Sensitivity"", Journal of Medical Engineering & Technology, vol. 26, No. 5, 2002, pp. 208-213.;;Bard, A. J., et al., Electrochemical Methods, 1980, pp. 173-175.;;Bartlett, P. N., et al., ""Covalent Binding of Electron Relays to Glucose Oxidase"", Journal of the Chemical Society, Chemical Communications, 1987, pp. 1603-1604.;;Bartlett, P. N., et al., ""Modification of Glucose Oxidase by Tetrathiafulvalene"", Journal of the Chemical Society, Chemical Communications, 1990, pp. 1135-1136.;;Bartlett, P. N., et al., ""Strategies for the Development of Amperometric Enzyme Electrodes"", Biosensors, vol. 3, 1987/88, pp. 359-379.;;Beach, R. D., et al., ""Subminiature Implantable Petentiostat and Modified Commercial Telemetry Device for Remote Glucose Monitoring"", IEEE Transactions on Instrumentation and Measurement, vol. 28, No. 6, 1999, pp. 1239-1245.;;Beech, W. A., ""AX.25 Link Access Protocol for Amateur packet Radio"", Tucson Amateur Packet Radio Corporation, 1998, pp. 1-133.;;Bellucci, F., et al., ""Electrochemical Behaviour of Graphite-Epoxy Composite Materials (GECM) in Aqueous Salt Solutions"", Journal of Applied Electrochemistry, vol. 16, 1986, pp. 15-22.;;Bennion, N., et al., ""Alternate Site Glucose Testing: A Crossover Design"", Diabetes Technology & Therapeutics, vol. 4, No. 1, 2002, pp. 25-33.;;Biermann, E., et al., ""How Would Patients Behave if They Were Continually Informed of Their Blood Glucose Levels? A Simulation Study Using a 'Virtual' Patient"", Diabetes Technology & Therapeutics, vol. 10, No. 3, 2008, pp. 178-187.;;Bindra, D. S., et al., ""Design and in Vitro Studies of a Needle-Type Glucose Sensor for Subcutaneous Monitoring"", Analytical Chemistry, vol. 63, No. 17, 1991, pp. 1692-1696.;;Bindra, D. S., et al., ""Pulsed Amperometric Detection of Glucose in Biological Fluids at a Surface-Modified Gold Electrode"", Analytical Chemistry, vol. 61, No. 22, 1989, pp. 2566-2570.;;Bisenberger, M., et al., ""A Triple-Step Potential Waveform at Enzyme Multisensors with Thick-Film Gold Electrodes for Detection of Glucose and Sucrose"", Sensors and Actuators B, vol. 28, 1995, pp. 181-189.;;Bland, J. M., et al., ""A Note on the Use of the Intraclass Correlation Coefficient in the Evaluation of Agreement Between Two Methods of Measurement"", Computers in Biology and Medicine, vol. 20, No. 5, 1990, pp. 337-340.;;Bland, J. M., et al., ""Statistical Methods for Assessing Agreement Between Two Methods of Clinical Measurement"", The Lancet, 1986, pp. 307-310.;;Blank, T. B., et al., ""Clinical Results From a Non-Invasive Blood Glucose Monitor"", Optical Diagnostics and Sensing of Biological Fluids and Glucose and Cholesterol Monitoring II, Proceedings of SPIE, vol. 4624, 2002, pp. 1-10.;;Bobbioni-Harsch, E., et al., ""Lifespan of Subcutaneous Glucose Sensors and Their Performances During Dynamic Glycaemia Changes in Rats"", Journal of Biomedical Engineering, vol. 15, 1993, pp. 457-463.;;Bode, B. W., ""Clinical Utility of the Continuous Glucose Monitoring System"", Diabetes Technology & Therapeutics, vol. 2, Sup. 1, 2000, pp. S35-S41.;;Bode, B. W., et al., ""Continuous Glucose Monitoring Used to Adjust Diabetes Therapy Improves Glycosylated Hemoglobin: A Pilot Study"", Diabetes Research and Clinical Practice, vol. 46, 1999, pp. 183-190.;;Bode, B. W., et al., ""Using the Continuous Glucose Monitoring System to Improve the Management of Type I Diabetes"", Diabetes Technology & Therapeutics, vol. 2, Sup. 1, 2000, pp. S43-S48.;;Boedeker Plastics, Inc., ""Polyethylene Specifications"", Web Page of Boedeker.com, 2007, pp. 1-3.;;Bolinder, J., et al., ""Microdialysis Measurement of the Absolute Glucose Concentration in Subcutaneous Adipose Tissue Allowing Glucose Monitoring om Diabetic Patients"", Diabetologia, vol. 35, 1992, pp. 1177-1180.;;Bolinder, J., et al., ""Self-Monitoring of Blood Glucose in Type I Diabetic Patients: Comparison with Continuous Microdialysis Measurements of Glucose in Subcutaneous Adipose Tissue During Ordinary Life Conditions"", Diabetes Care, vol. 20, No. 1, 1997, pp. 64-70.;;Bott, A. W., ""A Comparison of Cyclic Voltammetry and Cyclic Staircase Voltammetry"", Current Separations, vol. 16, No. 1, 1997, pp. 23-26.;;Bott, A. W., ""Electrochemical Methods for the Determination of Glucose"",Current Separations, vol. 17, No. 1, 1998, pp. 25-31.;;Bowman, L., et al., ""The Packaging of Implantable Sensors"", IEEE Transactions on Biomedical Engineering, vol. 33, No. 2, 1986, pp. 248-255.;;Brandt, J., et al., ""Covalent Attachment of Proteins to Polysaccharide Carriers by Means of Benzoquinone"", Biochimica et Biophysica Acta, vol. 386, 1975, pp. 196-202.;;Brauker, J., et al., ""Sustained Expression of High Levels Cells of Human Factor IX from Human Cells Implanted Within an Immunoisolation Device into Athymic Rodents"", Human Gene Therapy, vol. 9, No. 6, 1998, pp. 879-888.;;Bremer, T. M., et al., ""Benchmark Data from the Literature for Evaluation of New Glucose Sensing Technologies"", Diabetes Technology & Therapeutics, vol. 3, No. 3, 2001, pp. 409-418.;;Bremer, T., et al., ""Is Blood Glucose Predictable from Previous Values?"", Diabetes, vol. 48, 1999, pp. 445-451.;;Brooks, S. L., et al., ""Development of an On-Line Glucose Sensor for Fermentation Monitoring"", Biosensors, vol. 3, 1987/88, pp. 45-56.;;Brownlee, M., et al., ""A Glucose-Controlled Insulin-Delivery System: Semisynthetic Insulin Bound to Lectin"", Science, vol. 206, 1979, 1190-1191.;;Cai, Q., et al., ""A Wireless, Remove Query Glucose Biosensor Based on a pH-Sensitive Polymer"", Analytical Chemistry, vol. 76, No. 14, 2004, pp. 4038-4043.;;Candas, B., et al., ""An Adaptive Plasma Glucose Controller Based on a Nonlinear Insulin/Glucose Model"", IEEE Transactions on Biomedical Engineering, vol. 41, No. 2, 1994, pp. 116-124.;;Cass, A. E., et al., ""Ferricinum Ion as an Electron Acceptor for Oxido-Reductases"", Journal of ElectroAnalytical Chemistry, vol. 190, 1985, pp. 117-127.;;Cass, A. E., et al., ""Ferrocene-Medicated Enzyme Electrode for Amperometric Determination of Glucose"", Analytical Chemistry, vol. 56, No. 4, 1984, 667-671.;;Castner, J. F., et al., ""Mass Transport and Reaction Kinetic Parameters Determined Electrochemically for Immobilized Glucose Oxidase"", Biochemistry, vol. 23 No. 10, 1984, 2203-2210.;;Chen, J. C., et al., ""A Comparison of MAC Protocols for Wireless Local Networks Based on battery Power Consumption"", IEEE, 1998, pp. 150-157.;;Chen, T., et al., ""Defining the Period of Recovery of the Glucose Concentration After Its Local Perturbation by the Implantation of a Miniature Sensor"", Clinical Chemistry and Laboratory Medicine, vol. 40, No. 8, 2002, pp. 486-489.;;Chia, C. W., et al., ""Glucose Sensors: Toward Closed Loop Insulin Delivery"", Endocrinology and Metabolism Clinics of North America, vol. 33, 2004, pp. 175-195.;;Choleau, C., et al., ""Calibration of a Subcutaneous Amperometric Glucose Sensor Implanted for 7 Days in Diabetic Patients Part 2: Superiority of the One-Point Calibration Method"", Biosensors and Bioelectronics, vol. 17, 2002, pp. 647-654.;;Choleau, C., et al., ""Calibration of a Subcutaneous Amperometric Glucose Sensor Part 1: Effect of Measurement Uncertainties on the Determination of Sensor Sensitivity and Background Current"", Biosensors and Bioelectronics, vol. 17, 2002, pp. 641-646.;;Claremont, D. J., et al., ""Biosensors for Continuous in Vivo Glucose Monitoring"", Proceedings of the Annual International Conference of the IEEE Engineering in Medicine and Biology Society, vol. 10, 1988.;;Clark Jr., L. C., et al., ""Differential Anodic Enzyme Polarography for the Measurement of Glucose"", Oxygen Transport to Tissue: Instrumentation, Methods, and Physiology, 1973, pp. 127-133.;;Clark Jr., L. C., et al., ""Electrode Systems for Continuous Monitoring in Cardiovascular Surgery"", Annals New York Academy of Sciences, 1962, pp. 29-45.;;Clark Jr., L. C., et al., ""Long-term Stability of Electroenzymatic Glucose Sensors Implanted in Mice"", American Society of Artificial Internal Organs Transactions, vol. XXXIV, 1988, pp. 259-265.;;Clarke, W. L., et al., ""Evaluating Clinical Accuracy of Systems for Self-Monitoring of Blood Glucose"", Diabetes Care, vol. 10, No. 5, 1987, pp. 622-628.;;Complaint, ""Abbott Diabetes Care, Inc. v. Dexcom, Inc."", filed Aug. 11, 2005.;;Complaint, Amended, ""Abbott Diabetes Care, Inc. v. Dexcom, Inc."", filed Jun. 27, 2006.;;Cox, D. J., et al., ""Accuracy of Perceiving Blood Glucose in IDDM"", Diabetes Care, vol. 8, No. 6, 1985, pp. 529-536.;;Csoregi, E., et al., ""Amperometric Microbiosensors for Detection of Hydrogen Peroxide and Glucose Based on Peroxidase-Modified Carbon Fibers"", Electroanalysis, vol. 6, 1994, pp. 925-933.;;Csoregi, E., et al., ""Design and Optimization of a Selective Subcutaneously Implantable Glucose Electrode Based on 'Wired' Glucose Oxidase"", Analytical Chemistry, vol. 67, No. 7, 1995, pp. 1240-1244.;;Csoregi, E., et al., ""Design, Characterization, and One-Point in Vivo Calibration of a Subcutaneously Implanted Glucose Electrode"", Analytical Chemistry, vol. 66 No. 19, 1994, pp. 3131-3138.;;Csoregi, E., et al., ""On-Line Glucose Monitoring by Using Microdialysis Sampling and Amperometric Detection Based on 'Wired' Glucose Oxidase in Carbon Paste"", Mikrochimica Acta, vol. 121, 1995, pp. 31-40.;;D'Arrigo, G., et al., ""Porous-Si Based Bio Reactors for Glucose Monitoring and Drugs Production"", Proceedings of SPIE: Microfluids, BioMEMS, and Medical Microsystems, vol. 4982, 2003, pp. 178-184.;;Dai, W. S., et al., ""Hydrogel Membranes with Mesh Size Asymmetry Based on the Gradient Crosslinking of Poly(vinyl alcohol),"" Journal of Membrane Science, vol. 156, 1999, pp. 67-79.;;Davies, M. L., et al., ""Polymer Membranes in Clinical Sensor Applications"", Biomaterials, vol. 13, No. 14, 1992, pp. 971-978.;;Davis, G., ""Electrochemical Techniques for the Development of Amperometric Biosensors"", Biosensors, vol. 1, 1985, pp. 161-178.;;Degani, Y., et al., ""Direct Electrical Communication Between Chemically Modified Enzymes and Metal Electrodes. 1. Electron Transfer from Glucose Oxidase to Metal Electrodes via Electron Relays, Bound Covalently to the Enzyme"", The Journal of Physical Chemistry, vol. 91, No. 6, 1987, pp. 1285-1289.;;Degani, Y., et al., ""Direct Electrical Communication Between Chemically Modified Enzymes and Metal Electrodes. 2. Methods for Bonding Electron-Transfer Relays to Glucose Oxidase and D-Amino-Acid Oxidase"", Journal of the American Chemical Society, vol. 110, No. 8, 1988, pp. 2615-2620.;;Degani, Y., et al., ""Electrical Communication Between Redox Centers of Glucose Oxidase and Electrodes via Electrostatically and Covalently Bound Redox Polymers"", Journal of the American Chemical Society, vol. 111, 1989, pp. 2357-2358.;;Denisevich, P., et al., ""Unidirectional Current Flow and Charge State Trapping at Redox Polymer Interfaces on Bilayer Electrodes: Principles, Experimental Demonstration, and Theory"", Journal of the American Chemical Society, vol. 103, 1981, pp. 4727-4737.;;Dicks, J. M., et al., ""Ferrocene Modified Polypyrrole with Immobilised Glucose Oxidase and its Application in Amperometric Glucose Microbiosensors"", Annales de Biologie Clinique, vol. 47, 1989, pp. 607-619.;;Dixon, B. M., et al., ""Characterization in Vitro and in Vivo of the Oxygen Dependence of an Enzyme/Polymer Biosensors for Monitoring Brain Glucose"", Journal of Neuroscience Methods, vol. 119, 2002, pp. 135-142.;;Eighth Annual Diabetes Technology Meeting Abstracts, Nov. 13-15, 2008, pp. A1-A182.;;El-Khatib, F. H, et al., ""Adaptive Closed-Loop Control Provides Blood-Glucose Regulation Using Subcutaneous Insulin and Glucagon Infusion in Diabetic Swine"", Journal of Diabetes Science and Technology, vol. 1, No. 2, 2007, pp. 181-192.;;Ellis, C. D., et al., ""Selectivity and Directed Charge Transfer through an Electroactive Metallopolymer Film"", Journal of the American Chemical Society, vol. 103, No. 25, 1981, pp. 7480-7483.;;El-Sa'Ad, L., et al., ""Moisture Absorption by Epoxy Resins: The Reverse Thermal Effect"", Journal of Materials Science, vol. 25, No. 8, 1990, pp. 3577-3582.;;Engstrom, R. C., ""Electrochemical Pretreatment of Glassy Carbon Electrodes"", Analytical Chemistry, vol. 54, No. 13, 1982, pp. 2310-2314.;;Engstrom, R. C., et al., ""Characterization of Electrochemically Pretreated Glassy Carbon Electrodes"", Analytical Chemistry, vol. 56, No. 2, 1984, pp. 136-141.;;Ernst, H., et al., ""Reliable Glucose Monitoring Through the Use of Microsystem Technology"", Analytical and Bioanalytical Chemistry, vol. 373, 2002, pp. 758-761.;;Fabietti, P. G., et al. ""Clinical Validation of a New Control-Oriented Model of Insulin and Glucose Dynamics in Subjects with Type 1 Diabetes"", Diabetes Technology & Therapeutics, vol. 9, No. 4, 2007, pp. 327-338.;;Fare, T. L., et al., ""Functional Characterization of a Conducting Polymer-Based Immunoassay System"", Biosensors & Bioelectronics, vol. 13, No. 3-4, 1998, pp. 459-470.;;Feldman, B., et al., ""A Continuous Glucose Sensor Based on Wired Enzyme(TM) Technology-Results from a 3-Day Trial in Patients with Type 1 Diabetes"", Diabetes Technology & Therapeutics, vol. 5, No. 5, 2003, pp. 769-779.;;Feldman, B., et al., ""Correlation of Glucose Concentrations in Interstitial Fluid and Venous Blood During Periods of Rapid Continuous Glucose Change"", Abbott Diabetes Care, Inc. Freestyle Navigator Continuous Glucose Monitor Pamphlet, 2004.;;Feldman, B., et al., ""Electron Transfer Kinetics at Redox Polymer/Solution Interfaces Using Microelectrodes and Twin Electrode Thin Layer Cells"", Journal of ElectroAnalytical Chemistry, vol. 194, 1985, pp. 63-81.;;Fischer, H., et al., ""Intramolecular Electron Transfer Medicated by 4,4'-Bypyridine and Related Bridging Groups"", Journal of the American Chemical Society, vol. 98, No. 18, 1976, pp. 5512-5517.;;Flentge, F., et al., ""An Enzyme-Reactor for Electrochemical Monitoring of Choline and Acetylcholine: Applications in High-Performance Liquid Chromatography, Bran Tissue, Microdialysis and Cerebrospinal Fluid,"" Analytical Biochemistry, vol. 204, 1992, pp. 305-310.;;Foulds, N. C., et al., ""Enzyme Entrapment in Electrically Conducting Polymers: Immobilisation of Glucose Oxidase in Polypyrrole and its Application in Amperometric Glucose Sensors"", Journal of the Chemical Society, Faraday Transactions 1, vol. 82, 1986, pp. 1259-1264.;;Foulds, N. C., et al., ""Immobilization of Glucose Oxidase in Ferrocene-Modified Pyrrole Polymers"", Analytical Chemistry, vol. 60, No. 22, 1988, pp. 2473-2478.;;Frew, J. E., et al., ""Electron-Transfer Biosensors"", Philosophical Transactions of the Royal Society of London, vol. 316, 1987, pp. 95-106.;;Frohnauer, M. K., et al., ""Graphical Human Insulin Time-Activity Profiles Using Standardized Definitions"", Diabetes Technology & Therapeutics, vol. 3, No. 3, 2001, pp. 419-429.;;Frost, M. C., et al., ""Implantable Chemical Sensors for Real-Time Clinical Monitoring: Progress and Challenges"", Current Opinion in Chemical Biology, vol. 6, 2002, pp. 633-641.;;Garg, S. K., et al., ""Correlation of Fingerstick Blood Glucose Measurements with GlucoWatch Biographer Glucose Results in Young Subjects with Type 1 Diabetes"", Diabetes Care, vol. 22,;;Garg, S. K., et al., ""Improved Glucose Excursions Using an Implantable Real-Time Continuous Glucose Sensor in Adults with Type 1 Diabetes"", Diabetes Care, vol. 27, No. 3, 2004, pp. 734-738.",EXPIRED
245,US,A1,US 2007/0213610 A1,146-121-867-271-096,2007-09-13,2007,US 68173007 A,2007-03-02,US 68173007 A;;US 42005703 A;;US 66719900 A;;US 7067798 A,1998-04-30,Analyte Monitoring Device and Methods of Use,"An analyte monitor includes a sensor, a sensor control unit, and a display unit. The sensor has, for example, a substrate, a recessed channel formed in the substrate, and conductive material disposed in the recessed channel to form a working electrode. The sensor control unit typically has a housing adapted for placement on skin and is adapted to receive a portion of an electrochemical sensor. The sensor control unit also includes two or more conductive contacts disposed on the housing and configured for coupling to two or more contact pads on the sensor. A transmitter is disposed in the housing and coupled to the plurality of conductive contacts for transmitting data obtained using the sensor. The display unit has a receiver for receiving data transmitted by the transmitter of the sensor control unit and a display coupled to the receiver for displaying an indication of a level of an analyte. The analyte monitor may also be part of a drug delivery system to alter the level of the analyte based on the data obtained using the sensor.",ABBOTT DIABETES CARE INC,SAY JAMES;;TOMASCO MICHAEL F;;HELLER ADAM;;GAL YORAM;;ARIA BEHRAD;;HELLER EPHRAIM;;PLANTE PHILLIP J;;VREEKE MARK S;;FRIEDMAN KEITH A;;COLMAN FREDRIC C,E. HELLER & CO (1998-07-02);;ABBOTT DIABETES CARE INC (2000-03-13),https://lens.org/146-121-867-271-096,Patent Application,yes,99,134,211,221,0,A61B5/14532;;A61B5/14532;;A61B5/0002;;A61B5/0002;;A61B5/002;;A61B5/01;;A61B5/14503;;A61B5/1451;;A61B5/14546;;A61B5/14546;;A61B5/1473;;A61B5/1473;;A61B5/1486;;A61B5/1486;;A61B5/14865;;A61B5/1495;;A61B5/4839;;A61B5/72;;A61B5/7278;;A61B5/7282;;A61B5/7405;;A61B5/743;;A61B5/7445;;A61B5/7445;;A61B5/7455;;A61B2560/0252;;A61B2560/0252;;A61M5/1723;;C12Q1/54;;G16H10/40;;G16H10/40;;G16H20/17;;G16H20/17;;H01L23/3107;;H01L23/3107;;H01L23/49548;;H01L23/49548;;H01L2924/0002;;H01L2924/0002;;H01L2924/19041;;H01L2924/19041;;H01L2924/3011;;H01L2924/3011;;Y10S128/903;;Y10S128/903;;Y10T29/49;;Y10T29/49;;Y10T29/49124;;Y10T29/49124,A61B5/05;;G01N27/30;;A61B5/00;;A61B5/145;;A61B5/1477;;A61B5/1495;;G01N27/416;;G06F19/00;;H01L23/31;;H01L23/495,600/365;;600/345,0,0,,,,EXPIRED
246,US,B2,US 8372005 B2,170-691-308-660-313,2013-02-12,2013,US 64398209 A,2009-12-21,US 64398209 A;;US 42005703 A;;US 66719900 A;;US 7067798 A,1998-04-30,Analyte monitoring device and methods of use,"An analyte monitor includes a sensor, a sensor control unit, and a display unit. The sensor has, for example, a substrate, a recessed channel formed in the substrate, and conductive material disposed in the recessed channel to form a working electrode. The sensor control unit typically has a housing adapted for placement on skin and is adapted to receive a portion of an electrochemical sensor. The sensor control unit also includes two or more conductive contacts disposed on the housing and configured for coupling to two or more contact pads on the sensor. A transmitter is disposed in the housing and coupled to the plurality of conductive contacts for transmitting data obtained using the sensor. The display unit has a receiver for receiving data transmitted by the transmitter of the sensor control unit and a display coupled to the receiver for displaying an indication of a level of an analyte. The analyte monitor may also be part of a drug delivery system to alter the level of the analyte based on the data obtained using the sensor.",ABBOTT DIABETES CARE INC;;SAY JAMES;;TOMASCO MICHAEL F;;HELLER ADAM;;GAL YORAM;;ARIA BEHRAD;;HELLER EPHRAIM;;PLANTE PHILLIP JOHN;;VREEKE MARK S;;FRIEDMAN KEITH A;;COLMAN FREDRIC C,SAY JAMES;;TOMASCO MICHAEL F;;HELLER ADAM;;GAL YORAM;;ARIA BEHRAD;;HELLER EPHRAIM;;PLANTE PHILLIP JOHN;;VREEKE MARK S;;FRIEDMAN KEITH A;;COLMAN FREDRIC C,E. HELLER & CO (1998-07-02);;ABBOTT DIABETES CARE INC (2000-03-13),https://lens.org/170-691-308-660-313,Granted Patent,yes,117,24,211,221,0,A61B5/14532;;A61B5/14532;;A61B5/0002;;A61B5/0002;;A61B5/002;;A61B5/01;;A61B5/14503;;A61B5/1451;;A61B5/14546;;A61B5/14546;;A61B5/1473;;A61B5/1473;;A61B5/1486;;A61B5/1486;;A61B5/14865;;A61B5/1495;;A61B5/4839;;A61B5/72;;A61B5/7278;;A61B5/7282;;A61B5/7405;;A61B5/743;;A61B5/7445;;A61B5/7445;;A61B5/7455;;A61B2560/0252;;A61B2560/0252;;A61M5/1723;;C12Q1/54;;G16H10/40;;G16H10/40;;G16H20/17;;G16H20/17;;H01L23/3107;;H01L23/3107;;H01L23/49548;;H01L23/49548;;H01L2924/0002;;H01L2924/0002;;H01L2924/19041;;H01L2924/19041;;H01L2924/3011;;H01L2924/3011;;Y10S128/903;;Y10S128/903;;Y10T29/49;;Y10T29/49;;Y10T29/49124;;Y10T29/49124,A61B5/00;;G01N27/30;;A61B5/05;;A61B5/145;;A61B5/1477;;A61B5/1495;;G01N27/416;;G06F19/00;;H01L23/31;;H01L23/495,600/365;;600/347,99,81,136-791-935-548-81X;;062-360-289-025-864;;010-601-725-111-91X;;101-292-518-663-191;;056-703-879-057-297;;030-155-762-644-019;;004-149-141-436-651;;016-731-054-793-457;;080-559-561-995-335;;044-807-213-528-815;;027-538-525-436-179;;015-020-161-517-40X;;025-919-454-564-785;;014-700-576-603-812;;004-851-060-590-788;;075-958-432-122-199;;052-356-140-149-389;;035-090-282-884-790;;033-562-815-299-181;;018-803-926-589-211;;008-505-762-041-402;;016-601-143-530-813;;019-502-772-562-215;;058-476-824-396-350;;006-498-707-073-30X;;054-091-551-638-293;;010-531-147-771-746;;054-827-198-877-419;;122-658-944-077-000;;017-261-560-469-37X;;000-125-755-474-124;;113-381-664-783-802;;082-626-907-191-554;;017-950-014-792-456;;090-348-305-613-628;;015-985-399-299-132;;171-049-047-164-618;;016-819-089-891-758;;081-249-097-078-543;;089-612-747-111-646;;031-706-897-890-035;;094-198-536-559-723;;003-690-143-043-420;;007-943-354-378-456;;082-114-500-909-975;;004-239-090-971-580;;026-894-457-160-450;;077-128-610-778-669;;022-466-506-956-898;;008-424-592-956-946;;007-500-825-916-378;;009-725-244-669-882;;037-755-689-613-42X;;153-411-506-517-475;;038-134-360-685-692;;012-449-714-188-064;;031-517-704-996-130;;131-299-284-996-064;;049-133-049-742-708;;000-272-178-768-076;;070-797-683-833-124;;043-870-224-178-49X;;025-574-914-238-550;;052-364-430-129-757;;004-434-167-910-115;;032-860-147-271-886;;132-460-374-211-421;;098-172-374-375-47X;;109-358-955-476-095;;014-988-634-483-130;;061-786-187-274-992;;037-898-018-686-909;;130-044-667-529-69X;;134-265-642-839-645;;065-221-074-461-027;;017-934-465-161-477;;101-660-130-379-529;;028-236-706-290-220;;087-333-189-994-274;;059-082-211-027-266;;057-977-752-782-568,10.1016/s0956-5663(02)00099-4;;12392956;;10.1021/ja00391a001;;2889225;;10.1098/rstb.1987.0021;;10.1109/51.294001;;10.1016/0022-0728(65)85063-x;;2245876;;10.2337/diabetes.39.12.1519;;10.2337/diab.39.12.1519;;10.1016/s0956-5663(03)00220-3;;14611755;;18615658;;10.1002/bit.260430310;;9366023;;10.1016/s0956-5663(97)00025-0;;9451795;;10.1016/s0956-5663(97)00083-3;;10.1016/0956-5663(93)80028-n;;8311939;;8651496;;10.1021/ac960030d;;10.1080/03091900210156797;;12487712;;10.1016/0265-928x(87)80018-4;;3333622;;10.1109/19.816143;;10.1007/bf01015979;;10.1089/15209150252924058;;12017416;;18473691;;10.1089/dia.2007.0281;;10.1021/ac00017a008;;1789439;;2817408;;10.1021/ac00197a022;;10.1016/0925-4005(95)01730-5;;10.1016/0010-4825(90)90013-f;;2257734;;2868172;;8277748;;10.1016/0141-5425(93)90058-7;;11469630;;10.1089/15209150050214104;;10624783;;10.1016/s0168-8227(99)00113-8;;10.1089/15209150050214113;;11469631;;10.1007/bf00401374;;1478372;;10.2337/diacare.20.1.64;;9028696;;10.1109/tbme.1986.325807;;3957374;;236018;;10.1016/0005-2795(75)90259-7;;10.1089/hum.1998.9.6-879;;9581910;;11762520;;10.1089/15209150152607196;;10.2337/diabetes.48.3.445;;10078542;;10.1016/0265-928x(87)80012-3;;505005;;10.1126/science.505005;;10.1021/ac0498516;;15253640;;10.1109/10.284922;;8026845;;6721151;;10.1021/ac00268a018;;6733082;;10.1021/bi00305a016;;10.1515/cclm.2002.135;;12392305;;10.1016/j.ecl.2003.12.001;;15053902;;12052350;;10.1016/s0956-5663(01)00304-9;;12052349;;10.1016/s0956-5663(01)00306-2;;4500021;;10.1007/978-1-4684-3288-6_18;;14021529;;10.1111/j.1749-6632.1962.tb13623.x;;3196517;;10.2337/diacare.10.5.622;;3677983;;10.2337/diacare.8.6.529;;4075939;;10.1002/elan.1140061103;;7733469;;10.1021/ac00103a015;;7978306;;10.1021/ac00091a022;;10.1007/bf01248238;;10.1016/s0376-7388(98)00330-5;;10.1016/0142-9612(92)90147-g;;1472593;;10.1016/0265-928x(85)80002-x;;10.1021/j100290a001;;10.1021/ja00216a040;;10.1021/ja00188a091;;10.1021/ja00406a011;;2624333;;12323417;;10.1016/s0165-0270(02)00170-x;;10.1177/193229680700100208;;pmc2771467;;19888405;;10.1021/ja00415a014;;10.1007/bf00575392;;10.1021/ac00250a038;;10.1021/ac00266a005;;10.1007/s00216-002-1284-0;;12194035;;10.1089/dia.2006.0030;;17705688;;9642777;;10.1016/s0956-5663(97)00091-2;;10.1089/152091503322526978;;14633342;;10.1016/0022-0728(85)87006-6;;10.1021/ja00434a018;;10.1016/0003-2697(92)90243-z;;1443528;;10.1039/f19868201259;;3245585;;10.1021/ac00173a008;;2889234;;10.1098/rstb.1987.0020;;11762521;;10.1089/15209150152607204;;12413548;;10.1016/s1367-5931(02)00371-x;;10526740;;10.2337/diacare.22.10.1708;;14988294;;10.2337/diacare.27.3.734,"""Poretics Polycarbonate Membrane"", Osmonics Filtration and Separation Group, 2002.;;Abel, P. U., et al., ""Biosensors for In Vivo Glucose Measurement: Can We Cross the Experimental Stage"", Biosensors and Bioelectronics, vol. 17, 2002, pp. 1059-1070.;;Abruna, H. D., et al., ""Rectifying Interfaces Using Two-Layer Films of Electrochemically Polymerized Vinylpyridine and Vinylbipyridine Complexes of Ruthenium and Iron on Electrodes"", Journal of the American Chemical Society, vol. 103, No. 1, 1981, pp. 1-5.;;Albery, W. J., et al., ""Amperometric Enzyme Electrodes Part II: Conducting Salts as Electrode Materials for the Oxidation of Glucose Oxidase"", Journal of ElectroAnalytical Chemistry, vol. 194, 1985, pp. 223-235.;;Albery, W. J., et al., ""Amperometric Enzyme Electrodes"", Philosophical Transactions of The Royal Society of London, vol. 316, 1987, pp. 107-119.;;Alcock, S. J., et al., ""Continuous Analyte Monitoring to Aid Clinical Practice"", IEEE Engineering in Medicine and Biology Magazine, 1994, pp. 319-325.;;Anderson, L. B., et al., ""Thin-Layer Electrochemistry: Steady-State Methods of Studying Rate Processes"", Journal of ElectroAnalytical Chemistry, vol. 10, 1965, pp. 295-305.;;Armour, J. C., et al., ""Application of Chronic Intravascular Blood Glucose Sensor in Dogs"", Diabetes, vol. 39, 1990, pp. 1519-1526.;;Asberg, P., et al., ""Hydrogels of a Conducting Conjugated Polymer as 3-D Enzyme Electrode"", Biosensors & Bioelectronics, vol. 19, 2003, pp. 199-207.;;Atanasov, P., et al., ""Biosensor for Continuous Glucose Monitoring"", Biotechnology and Bioengineering, vol. 43, 1994, pp. 262-266.;;Atanasov, P., et al., ""Implantation of a Refillable Glucose Monitoring-Telemetry Device"", Biosensors & Bioelectronics, vol. 12, No. 7, 1997, pp. 669-680.;;Aussedat, B., et al., ""A User-Friendly Method for Calibrating a Subcutaneous Glucose Sensor-Based Hypoglycaemic Alarm"", Biosensors & Bioelectronics, vol. 12, No. 11, 1997, pp. 1061-1071.;;Baker, D. A., et al., ""Dynamic Concentration Challenges for Biosensor Characterization"", Biosensors & Bioelectronics, vol. 8, 1993, pp. 433-441.;;Baker, D. A., et al., ""Dynamic Delay and Maximal Dynamic Error in Continuous Biosensors"", Analytical Chemistry, vol. 68, No. 8, 1996, pp. 1292-1297.;;Bani Amer, M. M., ""An Accurate Amperometric Glucose Sensor Based Glucometer with Eliminated Cross-Sensitivity"", Journal of Medical Engineering & Technology, vol. 26, No. 5, 2002, pp. 208-213.;;Bard, A. J., et al., Electrochemical Methods, 1980, pp. 173-175.;;Bartlett, P. N., et al., ""Covalent Binding of Electron Relays to Glucose Oxidase"", Journal of the Chemical Society, Chemical Communications, 1987, pp. 1603-1604.;;Bartlett, P. N., et al., ""Modification of Glucose Oxidase by Tetrathiafulvalene"", Journal of the Chemical Society, Chemical Communications, 1990, pp. 1135-1136.;;Bartlett, P. N., et al., ""Strategies for the Development of Amperometric Enzyme Electrodes"", Biosensors, vol. 3, 1987/88, pp. 359-379.;;Beach, R. D., et al., ""Subminiature Implantable Potentiostat and Modified Commercial Telemetry Device for Remote Glucose Monitoring"", IEEE Transactions on Instrumentation and Measurement, vol. 28, No. 6, 1999, pp. 1239-1245.;;Beech, W. A., ""AX.25 Link Access Protocol for Amateur packet Radio"", Tucson Amateur Packet Radio Corporation, 1998, pp. 1-133.;;Bellucci, F., et al., ""Electrochemical Behaviour of Graphite-Epoxy Composite Materials (GECM) in Aqueous Salt Solutions"", Journal of Applied Electrochemistry, vol. 16, 1986, pp. 15-22.;;Bennion, N., et al., ""Alternate Site Glucose Testing: A Crossover Design"", Diabetes Technology & Therapeutics, vol. 4, No. 1, 2002, pp. 25-33.;;Biermann, E., et al., ""How Would Patients Behave if They Were Continually Informed of Their Blood Glucose Levels? A Simulation Study Using a 'Virtual' Patient"", Diabetes Technology & Therapeutics, vol. 10, No. 3, 2008, pp. 178-187.;;Bindra, D. S., et al., ""Design and in Vitro Studies of a Needle-Type Glucose Sensor for Subcutaneous Monitoring"", Analytical Chemistry, vol. 63, No. 17, 1991, pp. 1692-1696.;;Bindra, D. S., et al., ""Pulsed Amperometric Detection of Glucose in Biological Fluids at a Surface-Modified Gold Electrode"", Analytical Chemistry, vol. 61, No. 22, 1989, pp. 2566-2570.;;Bisenberger, M., et al., ""A Triple-Step Potential Waveform at Enzyme Multisensors with Thick-Film Gold Electrodes for Detection of Glucose and Sucrose"", Sensors and Actuators B, vol. 28, 1995, pp. 181-189.;;Bland, J. M., et al., ""A Note on the Use of the Intraclass Correlation Coefficient in the Evaluation of Agreement Between Two Methods of Measurement"", Computers in Biology and Medicine, vol. 20, No. 5, 1990, pp. 337-340.;;Bland, J. M., et al., ""Statistical Methods for Assessing Agreement Between Two Methods of Clinical Measurement"", The Lancet, 1986, pp. 307-310.;;Blank, T. B., et al., ""Clinical Results From a Non-Invasive Blood Glucose Monitor"", Optical Diagnostics and Sensing of Biological Fluids and Glucose and Cholesterol Monitoring II, Proceedings of SPIE, vol. 4624, 2002, pp. 1-10.;;Bobbioni-Harsch, E., et al., ""Lifespan of Subcutaneous Glucose Sensors and Their Performances During Dynamic Glycaemia Changes in Rats"", Journal of Biomedical Engineering, vol. 15, 1993, pp. 457-463.;;Bode, B. W., ""Clinical Utility of the Continuous Glucose Monitoring System"", Diabetes Technology & Therapeutics, vol. 2, Sup. 1, 2000, pp. S35-S41.;;Bode, B. W., et al., ""Continuous Glucose Monitoring Used to Adjust Diabetes Therapy Improves Glycosylated Hemoglobin: A Pilot Study"", Diabetes Research and Clinical Practice, vol. 46, 1999, pp. 183-190.;;Bode, B. W., et al., ""Using the Continuous Glucose Monitoring System to Improve the Management of Type I Diabetes"", Diabetes Technology & Therapeutics, vol. 2, Sup. 1, 2000, pp. S43-S48.;;Boedeker Plastics, Inc., ""Polyethylene Specifications"", Web Page of Boedeker.com, 2007, pp. 1-3.;;Bolinder, J., et al., ""Microdialysis Measurement of the Absolute Glucose Concentration in Subcutaneous Adipose Tissue Allowing Glucose Monitoring in Diabetic Patients"", Diabetologia, vol. 35, 1992, pp. 1177-1180.;;Bolinder, J., et al., ""Self-Monitoring of Blood Glucose in Type I Diabetic Patients: Comparison with Continuous Microdialysis Measurements of Glucose in Subcutaneous Adipose Tissue During Ordinary Life Conditions"", Diabetes Care, vol. 20, No. 1, 1997, pp. 64-70.;;Bott, A. W., ""A Comparison of Cyclic Voltammetry and Cyclic Staircase Voltammetry"",Current Separations, vol. 16, No. 1, 1997, pp. 23-26.;;Bott, A. W., ""Electrochemical Methods for the Determination of Glucose"", Current Separations, vol. 17, No. 1, 1998, pp. 25-31.;;Bowman, L., et al., ""The Packaging of Implantable Integrated Sensors"", IEEE Transactions on Biomedical Engineering, vol. 33, No. 2, 1986, pp. 248-255.;;Brandt, J., et al., ""Covalent Attachment of Proteins to Polysaccharide Carriers by Means of Benzoquinone"", Biochimica et Biophysica Acta, vol. 386, 1975, pp. 196-202.;;Brauker, J., et al., ""Sustained Expression of High Levels of Human Factor IX from Human Cells Implanted Within an Immunoisolation Device into Athymic Rodents"", Human Gene Therapy, vol. 9, No. 6, 1998, pp. 879-888.;;Bremer, T. M., et al., ""Benchmark Data from the Literature for Evaluation of New Glucose Sensing Technologies"", Diabetes Technology & Therapeutics, vol. 3, No. 3, 2001, pp. 409-418.;;Bremer, T., et al., ""Is Blood Glucose Predictable from Previous Values?"", Diabetes, vol. 48, 1999, pp. 445-451.;;Brooks, S. L., et al., ""Development of an On-Line Glucose Sensor for Fermentation Monitoring"", Biosensors, vol. 3, 1987/88, pp. 45-56.;;Brownlee, M., et al., ""A Glucose-Controlled Insulin-Delivery System: Semisynthetic Insulin Bound to Lectin"", Science, vol. 206, 1979, 1190-1191.;;Cai, Q., et al., ""A Wireless, Remove Query Glucose Biosensor Based on a pH-Sensitive Polymer"", Analytical Chemistry, vol. 76, No. 14, 2004, pp. 4038-4043.;;Candas, B., et al., ""An Adaptive Plasma Glucose Controller Based on a Nonlinear Insulin/Glucose Model"", IEEE Transactions on Biomedical Engineering, vol. 41, No. 2, 1994, pp. 116-124.;;Cass, A. E., et al., ""Ferricinum Ion as an Electron Acceptor for Oxido-Reductases"", Journal of ElectroAnalytical Chemistry, vol. 190, 1985, pp. 117-127.;;Cass, A. E., et al., ""Ferrocene-Medicated Enzyme Electrode for Amperometric Determination of Glucose"", Analytical Chemistry, vol. 56, No. 4, 1984, 667-671.;;Castner, J. F., et al., ""Mass Transport and Reaction Kinetic Parameters Determined Electrochemically for Immobilized Glucose Oxidase"", Biochemistry, vol. 23 No. 10, 1984, 2203-2210.;;Chen, J. C., et al., ""A Comparison of MAC Protocols for Wireless Local Networks Based on battery Power Consumption"", IEEE, 1998, pp. 150-157.;;Chen, T., et al., ""Defining the Period of Recovery of the Glucose Concentration After Its Local Perturbation by the Implantation of a Miniature Sensor"", Clinical Chemistry and Laboratory Medicine, vol. 40, No. 8, 2002, pp. 486-489.;;Chia, C. W., et al., ""Glucose Sensors: Toward Closed Loop Insulin Delivery"", Endocrinology and Metabolism Clinics of North America, vol. 33, 2004, pp. 175-195.;;Choleau, C., et al., ""Calibration of a Subcutaneous Amperometric Glucose Sensor Implanted for 7 Days in Diabetic Patients Part 2: Superiority of the One-Point Calibration Method"", Biosensors and Bioelectronics, vol. 17, 2002, pp. 647-654.;;Choleau, C., et al., ""Calibration of a Subcutaneous Amperometric Glucose Sensor Part 1: Effect of Measurement Uncertainties on the Determination of Sensor Sensitivity and Background Current"", Biosensors and Bioelectronics, vol. 17, 2002, pp. 641-646.;;Claremont, D. J., et al., ""Biosensors for Continuous In Vivo Glucose Monitoring"", Proceedings of the Annual International Conference of the IEEE Engineering in Medicine and Biology Society, vol. 10, 1988.;;Clark Jr., L. C., et al., ""Differential Anodic Enzyme Polarography for the Measurement of Glucose"", Oxygen Transport to Tissue: Instrumentation, Methods, and Physiology, 1973, pp. 127-133.;;Clark Jr., L. C., et al., ""Electrode Systems for Continuous Monitoring in Cardiovascular Surgery"", Annals New York Academy of Sciences, 1962, pp. 29-45.;;Clark Jr., L. C., et al., ""Long-term Stability of Electroenzymatic Glucose Sensors Implanted in Mice"", American Society of Artificial Internal Organs Transactions, vol. XXXIV, 1988, pp. 259-265.;;Clarke, W. L., et al., ""Evaluating Clinical Accuracy of Systems for Self-Monitoring of Blood Glucose"", Diabetes Care, vol. 10, No. 5, 1987, pp. 622-628.;;Complaint, ""Abbott Diabetes Care, Inc. v. Dexcom, Inc."", filed Aug. 11, 2005.;;Complaint, Amended, ""Abbott Diabetes Care, Inc. v. Dexcom, Inc."", filed Jun. 27, 2006.;;Cox, D. J., et al., ""Accuracy of Perceiving Blood Glucose in IDDM"", Diabetes Care, vol. 8, No. 6, 1985, pp. 529-536.;;Csoregi, E., et al., ""Amperometric Microbiosensors for Detection of Hydrogen Peroxide and Glucose Based on Peroxidase-Modified Carbon Fibers"", Electroanalysis, vol. 6, 1994, pp. 925-933.;;Csoregi, E., et al., ""Design and Optimization of a Selective Subcutaneously Implantable Glucose Electrode Based on 'Wired' Glucose Oxidase"", Analytical Chemistry, vol. 67, No. 7, 1995, pp. 1240-1244.;;Csoregi, E., et al., ""Design, Characterization, and One-Point in Vivo Calibration of a Subcutaneously Implanted Glucose Electrode"", Analytical Chemistry, vol. 66 No. 19, 1994, pp. 3131-3138.;;Csoregi, E., et al., ""On-Line Glucose Monitoring by Using Microdialysis Sampling and Amperometric Detection Based on 'Wired' Glucose Oxidase in Carbon Paste"", Mikrochimica Acta, vol. 121, 1995, pp. 31-40.;;D'Arrigo, G., et al., ""Porous-Si Based Bio Reactors for Glucose Monitoring and Drugs Production"", Proceedings of SPIE: Microfluids, BioMEMS, and Medical Microsystems, vol. 4982, 2003, pp. 178-184.;;Dai, W. S., et al., ""Hydrogel Membranes with Mesh Size Asymmetry Based on the Gradient Crosslinking of Poly(vinyl alcohol),"" Journal of Membrane Science, vol. 156, 1999, pp. 67-79.;;Davies, M. L., et al., ""Polymer Membranes in Clinical Sensor Applications"", Biomaterials, vol. 13, No. 14, 1992, pp. 971-978.;;Davis, G., ""Electrochemical Techniques for the Development of Amperometric Biosensors"", Biosensors, vol. 1, 1985, pp. 161-178.;;Degani, Y., et al., ""Direct Electrical Communication Between Chemically Modified Enzymes and Metal Electrodes. 1. Electron Transfer from Glucose Oxidase to Metal Electrodes via Electron Relays, Bound Covalently to the Enzyme"", The Journal of Physical Chemistry, vol. 91, No. 6, 1987, pp. 1285-1289.;;Degani, Y., et al., ""Direct Electrical Communication Between Chemically Modified Enzymes and Metal Electrodes. 2. Methods for Bonding Electron-Transfer Relays to Glucose Oxidase and D-Amino-Acid Oxidase"", Journal of the American Chemical Society, vol. 110, No. 8, 1988, pp. 2615-2620.;;Degani, Y., et al., ""Electrical Communication Between Redox Centers of Glucose Oxidase and Electrodes via Electrostatically and Covalently Bound Redox Polymers"", Journal of the American Chemical Society, vol. 111, 1989, pp. 2357-2358.;;Denisevich, P., et al., ""Unidirectional Current Flow and Charge State Trapping at Redox Polymer Interfaces on Bilayer Electrodes: Principles, Experimental Demonstration, and Theory"", Journal of the American Chemical Society, vol. 103, 1981, pp. 4727-4737.;;Dicks, J. M., et al., ""Ferrocene Modified Polypyrrole with Immobilised Glucose Oxidase and its Application in Amperometric Glucose Microbiosensors"", Annales de Biologie Clinique, vol. 47, 1989, pp. 607-619.;;Dixon, B. M., et al., ""Characterization In Vitro and In Vivo of the Oxygen Dependence of an Enzyme/Polymer Biosensors for Monitoring Brain Glucose"", Journal of Neuroscience Methods, vol. 119, 2002, pp. 135-142.;;Eighth Annual Diabetes Technology Meeting Abstracts, Nov. 13-15, 2008, pp. A1-A182.;;El-Khatib, F. H, et al., ""Adaptive Closed-Loop Control Provides Blood-Glucose Regulation Using Subcutaneous Insulin and Glucagon Infusion in Diabetic Swine"", Journal of Diabetes Science and Technology, vol. 1, No. 2, 2007, pp. 181-192.;;Ellis, C. D., et al., ""Selectivity and Directed Charge Transfer through an Electroactive Metallopolymer Film"", Journal of the American Chemical Society, vol. 103, No. 25, 1981, pp. 7480-7483.;;El-Sa'Ad, L., et al., ""Moisture Absorption by Epoxy Resins: The Reverse Thermal Effect"", Journal of Materials Science, vol. 25, No. 8, 1990, pp. 3577-3582.;;Engstrom, R. C., ""Electrochemical Pretreatment of Glassy Carbon Electrodes"", Analytical Chemistry, vol. 54, No. 13, 1982, pp. 2310-2314.;;Engstrom, R. C., et al., ""Characterization of Electrochemically Pretreated Glassy Carbon Electrodes"", Analytical Chemistry, vol. 56, No. 2, 1984, pp. 136-141.;;Ernst, H., et al., ""Reliable Glucose Monitoring Through the Use of Microsystem Technology"", Analytical and Bioanalytical Chemistry, vol. 373, 2002, pp. 758-761.;;Fabietti, P. G., et al. ""Clinical Validation of a New Control-Oriented Model of Insulin and Glucose Dynamics in Subjects with Type 1 Diabetes"", Diabetes Technology & Therapeutics, vol. 9 No. 4, 2007, pp. 327-338.;;Fare, T. L., et al., ""Functional Characterization of a Conducting Polymer-Based Immunoassay System"", Biosensors & Bioelectronics, vol. 13, No. 3-4, 1998, pp. 459-470.;;Feldman, B., et al., ""A Continuous Glucose Sensor Based on Wired Enzyme(TM) Technology-Results from a 3-Day Trial in Patients with Type 1 Diabetes"", Diabetes Technology & Therapeutics, vol. 5, No. 5, 2003, pp. 769-779.;;Feldman, B., et al., ""Correlation of Glucose Concentrations in Interstitial Fluid and Venous Blood During Periods of Rapid Glucose Change"", Abbott Diabetes Care, Inc. Freestyle Navigator Continuous Glucose Monitor Pamphlet, 2004.;;Feldman, B., et al., ""Electron Transfer Kinetics at Redox Polymer/Solution Interfaces Using Microelectrodes and Twin Electrode Thin Layer Cells"", Journal of ElectroAnalytical Chemistry, vol. 194, 1985, pp. 63-81.;;Fischer, H., et al., ""Intramolecular Electron Transfer Medicated by 4,4'-Bypyridine and Related Bridging Groups"", Journal of the American Chemical Society, vol. 98, No. 18, 1976, pp. 5512-5517.;;Flentge, F., et al., ""An Enzyme-Reactor for Electrochemical Monitoring of Choline and Acetylcholine: Applications in High-Performance Liquid Chromatography, Bran Tissue, Microdialysis and Cerebrospinal Fluid,"" Analytical Biochemistry, vol. 204, 1992, pp. 305-310.;;Foulds, N. C., et al., ""Enzyme Entrapment in Electrically Conducting Polymers: Immobilisation of Glucose Oxidase in Polypyrrole and its Application in Amperometric Glucose Sensors"", Journal of the Chemical Society, Faraday Transactions 1, vol. 82, 1986, pp. 1259-1264.;;Foulds, N. C., et al., ""Immobilization of Glucose Oxidase in Ferrocene-Modified Pyrrole Polymers"", Analytical Chemistry, vol. 60, No. 22, 1988, pp. 2473-2478.;;Frew, J. E., et al., ""Electron-Transfer Biosensors"", Philosophical Transactions of The Royal Society of London, vol. 316, 1987, pp. 95-106.;;Frohnauer, M. K., et al., ""Graphical Human Insulin Time-Activity Profiles Using Standardized Definitions"", Diabetes Technology & Therapeutics, vol. 3, No. 3, 2001, pp. 419-429.;;Frost, M. C., et al., ""Implantable Chemical Sensors for Real-Time Clinical Monitoring: Progress and Challenges"", Current Opinion in Chemical Biology, vol. 6, 2002, pp. 633-641.;;Garg, S. K., et al., ""Correlation of Fingerstick Blood Glucose Measurements with GlucoWatch Biographer Glucose Results in Young Subjects with Type 1 Diabetes"", Diabetes Care, vol. 22, No. 10, 1999, pp. 1708-1714.;;Garg, S. K., et al., ""Improved Glucose Excursions Using an Implantable Real-Time Continuous Glucose Sensor in Adults with Type 1 Diabetes"", Diabetes Care, vol. 27, No. 3, 2004, pp. 734-738.",EXPIRED
247,US,B2,US 8617071 B2,176-625-850-462-774,2013-12-31,2013,US 76670807 A,2007-06-21,US 76670807 A;;US 42005703 A;;US 66719900 A;;US 7067798 A,1998-04-30,Analyte monitoring device and methods of use,"An analyte monitor includes a sensor, a sensor control unit, and a display unit. The sensor has, for example, a substrate, a recessed channel formed in the substrate, and conductive material disposed in the recessed channel to form a working electrode. The sensor control unit typically has a housing adapted for placement on skin and is adapted to receive a portion of an electrochemical sensor. The sensor control unit also includes two or more conductive contacts disposed on the housing and configured for coupling to two or more contact pads on the sensor. A transmitter is disposed in the housing and coupled to the plurality of conductive contacts for transmitting data obtained using the sensor. The display unit has a receiver for receiving data transmitted by the transmitter of the sensor control unit and a display coupled to the receiver for displaying an indication of a level of an analyte. The analyte monitor may also be part of a drug delivery system to alter the level of the analyte based on the data obtained using the sensor.",SAY JAMES;;TOMASCO MICHAEL F;;HELLER ADAM;;GAL YORAM;;ARIA BEHRAD;;HELLER EPHRAIM;;PLANTE PHILLIP JOHN;;VREEKE MARK S;;FRIEDMAN KEITH A;;COLMAN FREDRIC C;;ABBOTT DIABETES CARE INC,SAY JAMES;;TOMASCO MICHAEL F;;HELLER ADAM;;GAL YORAM;;ARIA BEHRAD;;HELLER EPHRAIM;;PLANTE PHILLIP JOHN;;VREEKE MARK S;;FRIEDMAN KEITH A;;COLMAN FREDRIC C,E. HELLER & CO (1998-07-02);;ABBOTT DIABETES CARE INC (2000-03-13),https://lens.org/176-625-850-462-774,Granted Patent,yes,105,18,211,221,0,A61B5/14532;;A61B5/14532;;A61B5/0002;;A61B5/0002;;A61B5/002;;A61B5/01;;A61B5/14503;;A61B5/1451;;A61B5/14546;;A61B5/14546;;A61B5/1473;;A61B5/1473;;A61B5/1486;;A61B5/1486;;A61B5/14865;;A61B5/1495;;A61B5/4839;;A61B5/72;;A61B5/7278;;A61B5/7282;;A61B5/7405;;A61B5/743;;A61B5/7445;;A61B5/7445;;A61B5/7455;;A61B2560/0252;;A61B2560/0252;;A61M5/1723;;C12Q1/54;;G16H10/40;;G16H10/40;;G16H20/17;;G16H20/17;;H01L23/3107;;H01L23/3107;;H01L23/49548;;H01L23/49548;;H01L2924/0002;;H01L2924/0002;;H01L2924/19041;;H01L2924/19041;;H01L2924/3011;;H01L2924/3011;;Y10S128/903;;Y10S128/903;;Y10T29/49;;Y10T29/49;;Y10T29/49124;;Y10T29/49124,A61B5/00;;G01N27/30;;A61B5/05;;A61B5/145;;A61B5/1477;;A61B5/1495;;C12Q1/00;;C12Q1/54;;G01N27/416;;G06F19/00;;H01L23/31;;H01L23/495,600/365;;600/345;;600/347;;422/50,99,71,136-791-935-548-81X;;062-360-289-025-864;;010-601-725-111-91X;;101-292-518-663-191;;056-703-879-057-297;;030-155-762-644-019;;004-149-141-436-651;;016-731-054-793-457;;080-559-561-995-335;;044-807-213-528-815;;027-538-525-436-179;;015-020-161-517-40X;;025-919-454-564-785;;014-700-576-603-812;;004-851-060-590-788;;075-958-432-122-199;;052-356-140-149-389;;035-090-282-884-790;;033-562-815-299-181;;018-803-926-589-211;;008-505-762-041-402;;016-601-143-530-813;;019-502-772-562-215;;058-476-824-396-350;;006-498-707-073-30X;;054-091-551-638-293;;010-531-147-771-746;;054-827-198-877-419;;122-658-944-077-000;;017-261-560-469-37X;;000-125-755-474-124;;113-381-664-783-802;;082-626-907-191-554;;017-950-014-792-456;;090-348-305-613-628;;015-985-399-299-132;;171-049-047-164-618;;016-819-089-891-758;;081-249-097-078-543;;089-612-747-111-646;;031-706-897-890-035;;094-198-536-559-723;;003-690-143-043-420;;007-943-354-378-456;;082-114-500-909-975;;004-239-090-971-580;;026-894-457-160-450;;077-128-610-778-669;;022-466-506-956-898;;008-424-592-956-946;;007-500-825-916-378;;009-725-244-669-882;;037-755-689-613-42X;;153-411-506-517-475;;038-134-360-685-692;;012-449-714-188-064;;031-517-704-996-130;;131-299-284-996-064;;049-133-049-742-708;;000-272-178-768-076;;070-797-683-833-124;;043-870-224-178-49X;;025-574-914-238-550;;052-364-430-129-757;;004-434-167-910-115;;032-860-147-271-886;;132-460-374-211-421;;098-172-374-375-47X;;109-358-955-476-095;;014-988-634-483-130;;061-786-187-274-992,10.1016/s0956-5663(02)00099-4;;12392956;;10.1021/ja00391a001;;2889225;;10.1098/rstb.1987.0021;;10.1109/51.294001;;10.1016/0022-0728(65)85063-x;;2245876;;10.2337/diabetes.39.12.1519;;10.2337/diab.39.12.1519;;10.1016/s0956-5663(03)00220-3;;14611755;;18615658;;10.1002/bit.260430310;;9366023;;10.1016/s0956-5663(97)00025-0;;9451795;;10.1016/s0956-5663(97)00083-3;;10.1016/0956-5663(93)80028-n;;8311939;;8651496;;10.1021/ac960030d;;10.1080/03091900210156797;;12487712;;10.1016/0265-928x(87)80018-4;;3333622;;10.1109/19.816143;;10.1007/bf01015979;;10.1089/15209150252924058;;12017416;;18473691;;10.1089/dia.2007.0281;;10.1021/ac00017a008;;1789439;;2817408;;10.1021/ac00197a022;;10.1016/0925-4005(95)01730-5;;10.1016/0010-4825(90)90013-f;;2257734;;2868172;;8277748;;10.1016/0141-5425(93)90058-7;;11469630;;10.1089/15209150050214104;;10624783;;10.1016/s0168-8227(99)00113-8;;10.1089/15209150050214113;;11469631;;10.1007/bf00401374;;1478372;;10.2337/diacare.20.1.64;;9028696;;10.1109/tbme.1986.325807;;3957374;;236018;;10.1016/0005-2795(75)90259-7;;10.1089/hum.1998.9.6-879;;9581910;;11762520;;10.1089/15209150152607196;;10.2337/diabetes.48.3.445;;10078542;;10.1016/0265-928x(87)80012-3;;505005;;10.1126/science.505005;;10.1021/ac0498516;;15253640;;10.1109/10.284922;;8026845;;6721151;;10.1021/ac00268a018;;6733082;;10.1021/bi00305a016;;10.1515/cclm.2002.135;;12392305;;10.1016/j.ecl.2003.12.001;;15053902;;12052350;;10.1016/s0956-5663(01)00304-9;;12052349;;10.1016/s0956-5663(01)00306-2;;4500021;;10.1007/978-1-4684-3288-6_18;;14021529;;10.1111/j.1749-6632.1962.tb13623.x;;3196517;;10.2337/diacare.10.5.622;;3677983;;10.2337/diacare.8.6.529;;4075939;;10.1002/elan.1140061103;;7733469;;10.1021/ac00103a015;;7978306;;10.1021/ac00091a022;;10.1007/bf01248238;;10.1016/s0376-7388(98)00330-5;;10.1016/0142-9612(92)90147-g;;1472593;;10.1016/0265-928x(85)80002-x;;10.1021/j100290a001;;10.1021/ja00216a040;;10.1021/ja00188a091;;10.1021/ja00406a011;;2624333;;12323417;;10.1016/s0165-0270(02)00170-x;;10.1177/193229680700100208;;pmc2771467;;19888405;;10.1021/ja00415a014;;10.1007/bf00575392;;10.1021/ac00250a038;;10.1021/ac00266a005;;10.1007/s00216-002-1284-0;;12194035;;10.1089/dia.2006.0030;;17705688;;9642777;;10.1016/s0956-5663(97)00091-2;;10.1089/152091503322526978;;14633342,"U.S. Appl. No. 09/447,227, Shults.;;U.S. Appl. No. 11/737,671, Wolpert, et al.;;U.S. Appl. No. 11/766,747, Say, et al.;;U.S. Appl. No. 11/849,200, Peyser, et al.;;U.S. Appl. No. 11/928,574, Heller, et al.;;U.S. Appl. No. 11/928,668, Heller, et al.;;U.S. Appl. No. 11/928,743, Heller, et al.;;U.S. Appl. No. 11/928,795, Heller, et al.;;U.S. Appl. No. 11/928,891, Heller, et al.;;U.S. Appl. No. 11/928,968, Heller, et al.;;U.S. Appl. No. 11/941,078, Say, et al.;;""Poretics Polycarbonate Membrane"", Osmonics Filtration and Separation Group, 2002.;;Abel, P. U., et al., ""Biosensors for In Vivo Glucose Measurement: Can We Cross the Experimental Stage"", Biosensors and Bioelectronics, vol. 17, 2002, pp. 1059-1070.;;Abruna, H. D., et al., ""Rectifying Interfaces Using Two-Layer Films of Electrochemically Polymerized Vinylpyridine and Vinylbipyridine Complexes of Ruthenium and Iron on Electrodes"", Journal of the American Chemical Society, vol. 103, No. 1, 1981, pp. 1-5.;;Albery, W. J., et al., ""Amperometric Enzyme Electrodes Part II: Conducting Salts as Electrode Materials for the Oxidation of Glucose Oxidase"", Journal of ElectroAnalytical Chemistry, vol. 194, 1985, pp. 223-235.;;Albery, W. J., et al., ""Amperometric Enzyme Electrodes"", Philosophical Transactions of the Royal Society of London, vol. 316, 1987, pp. 107-119.;;Alcock, S. J., et al., ""Continuous Analyte Monitoring to Aid Clinical Practice"", IEEE Engineering in Medicine and Biology Magazine, 1994, pp. 319-325.;;Anderson, L. B., et al., ""Thin-Layer Electrochemistry: Steady-State Methods of Studying Rate Processes"", Journal of ElectroAnalytical Chemistry, vol. 10, 1965, pp. 295-305.;;Armour, J. C., et al., ""Application of Chronic Intravascular Blood Glucose Sensor in Dogs"", Diabetes, vol. 39, 1990, pp. 1519-1526.;;Asberg, P., et al., ""Hydrogels of a Conducting Conjugated Polymer as 3-D Enzyme Electrode"", Biosensors & Bioelectronics, vol. 19, 2003, pp. 199-207.;;Atanasov, P., et al., ""Biosensor for Continuous Glucose Monitoring"", Biotechnology and Bioengineering, vol. 43, 1994, pp. 262-266.;;Atanasov, P., et al., ""Implantation of a Refillable Glucose Monitoring-Telemetry Device"", Biosensors & Bioelectronics, vol. 12, No. 7, 1997, pp. 669-680.;;Aussedat, B., et al., ""A User-Friendly Method for Calibrating a Subcutaneous Glucose Sensor-Based Hypoglycaemic Alarm"", Biosensors & Bioelectronics, vol. 12, No. 11, 1997, pp. 1061-1071.;;Baker, D. A., et al., ""Dynamic Concentration Challenges for Biosensor Characterization"", Biosensors & Bioelectronics, vol. 8, 1993, pp. 433-441.;;Baker, D. A., et al., ""Dynamic Delay and Maximal Dynamic Error in Continuous Biosensors"", Analytical Chemistry, vol. 68, No. 8, 1996, pp. 1292-1297.;;Bani Amer, M. M., ""An Accurate Amperometric Glucose Sensor Based Glucometer with Eliminated Cross-Sensitivity"", Journal of Medical Engineering & Technology, vol. 26, No. 5, 2002, pp. 208-213.;;Bard, A. J., et al., Electrochemical Methods, 1980, pp. 173-175.;;Bartlett, P. N., et al., ""Covalent Binding of Electron Relays to Glucose Oxidase"", Journal of the Chemical Society, Chemical Communications, 1987, pp. 1603-1604.;;Bartlett, P. N., et al., ""Modification of Glucose Oxidase by Tetrathiafulvalene"", Journal of the Chemical Society, Chemical Communications, 1990, pp. 1135-1136.;;Bartlett, P. N., et al., ""Strategies for the Development of Amperometric Enzyme Electrodes"", Biosensors, vol. 3, 1987/1988, pp. 359-379.;;Beach, R. D., et al., ""Subminiature Implantable Potentiostat and Modified Commercial Telemetry Device for Remote Glucose Monitoring"", IEEE Transactions on Instrumentation and Measurement, vol. 28, No. 6, 1999, pp. 1239-1245.;;Beech, W. A., ""AX.25 Link Access Protocol for Amateur packet Radio"", Tucson Amateur Packet Radio Corporation, 1998, pp. 1-133.;;Bellucci, F., et al., ""Electrochemical Behaviour of Graphite-Epoxy Composite Materials (GECM) in Aqueous Salt Solutions"", Journal of Applied Electrochemistry, vol. 16, 1986, pp. 15-22.;;Bennion, N., et al., ""Alternate Site Glucose Testing: A Crossover Design"", Diabetes Technology & Therapeutics, vol. 4, No. 1, 2002, pp. 25-33.;;Biermann, E., et al., ""How Would Patients Behave if They Were Continually Informed of Their Blood Glucose Levels? A Simulation Study Using a 'Virtual' Patient"", Diabetes Technology & Therapeutics, vol. 10, No. 3, 2008, pp. 178-187.;;Bindra, D. S., et al., ""Design and in Vitro Studies of a Needle-Type Glucose Sensor for Subcutaneous Monitoring"", Analytical Chemistry, vol. 63, No. 17, 1991, pp. 1692-1696.;;Bindra, D. S., et al., ""Pulsed Amperometric Detection of Glucose in Biological Fluids at a Surface-Modified Gold Electrode"", Analytical Chemistry, vol. 61, No. 22, 1989, pp. 2566-2570.;;Bisenberger, M., et al., ""A Triple-Step Potential Waveform at Enzyme Multisensors with Thick-Film Gold Electrodes for Detection of Glucose and Sucrose"", Sensors and Actuators B, vol. 28, 1995, pp. 181-189.;;Bland, J. M., et al., ""A Note on the Use of the Intraclass Correlation Coefficient in the Evaluation of Agreement Between Two Methods of Measurement"", Computers in Biology and Medicine, vol. 20, No. 5, 1990, pp. 337-340.;;Bland, J. M., et al., ""Statistical Methods for Assessing Agreement Between Two Methods of Clinical Measurement"", The Lancet, 1986, pp. 307-310.;;Blank, T. B., et al., ""Clinical Results From a Non-Invasive Blood Glucose Monitor"", Optical Diagnostics and Sensing of Biological Fluids and Glucose and Cholesterol Monitoring II, Proceedings of SPIE, vol. 4624, 2002, pp. 1-10.;;Bobbioni-Harsch, E., et al., ""Lifespan of Subcutaneous Glucose Sensors and Their Performances During Dynamic Glycaemia Changes in Rats"", Journal of Biomedical Engineering, vol. 15, 1993, pp. 457-463.;;Bode, B. W., ""Clinical Utility of the Continuous Glucose Monitoring System"", Diabetes Technology & Therapeutics, vol. 2, Sup. 1, 2000, pp. S35-S41.;;Bode, B. W., et al., ""Continuous Glucose Monitoring Used to Adjust Diabetes Therapy Improves Glycosylated Hemoglobin: A Pilot Study"", Diabetes Research and Clinical Practice, vol. 46, 1999, pp. 183-190.;;Bode, B. W., et al., ""Using the Continuous Glucose Monitoring System to Improve the Management of Type I Diabetes"", Diabetes Technology & Therapeutics, vol. 2, Sup. 1, 2000, pp. S43-S48.;;Boedeker Plastics, Inc., ""Polyethylene Specifications"", Web Page of Boedeker.com, 2007, pp. 1-3.;;Bolinder, J., et al., ""Microdialysis Measurement of the Absolute Glucose Concentration in Subcutaneous Adipose Tissue Allowing Glucose Monitoring in Diabetic Patients"", Diabetologia, vol. 35, 1992, pp. 1177-1180.;;Bolinder, J., et al., ""Self-Monitoring of Blood Glucose in Type I Diabetic Patients: Comparison with Continuous Microdialysis Measurements of Glucose in Subcutaneous Adipose Tissue During Ordinary Life Conditions"", Diabetes Care, vol. 20, No. 1, 1997, pp. 64-70.;;Bott, A. W., ""A Comparison of Cyclic Voltammetry and Cyclic Staircase Voltammetry"", Current Separations, vol. 16, No. 1, 1997, pp. 23-26.;;Bott, A. W., ""Electrochemical Methods for the Determination of Glucose"", Current Separations, vol. 17, No. 1, 1998, pp. 25-31.;;Bowman, L., et al., ""The Packaging of Implantable Integrated Sensors"", IEEE Transactions on Biomedical Engineering, vol. 33, No. 2, 1986, pp. 248-255.;;Brandt, J., et al., ""Covalent Attachment of Proteins to Polysaccharide Carriers by Means of Benzoquinone"", Biochimica et Biophysica Acta, vol. 386, 1975, pp. 196-202.;;Brauker, J., et al., ""Sustained Expression of High Levels of Human Factor IX from Human Cells Implanted Within an Immunoisolation Device into Athymic Rodents"", Human Gene Therapy, vol. 9, No. 6, 1998, pp. 879-888.;;Bremer, T. M., et al., ""Benchmark Data from the Literature for Evaluation of New Glucose Sensing Technologies"", Diabetes Technology & Therapeutics, vol. 3, No. 3, 2001, pp. 409-418.;;Bremer, T., et al., ""Is Blood Glucose Predictable from Previous Values?"", Diabetes, vol. 48, 1999, pp. 445-451.;;Brooks, S. L., et al., ""Development of an On-Line Glucose Sensor for Fermentation Monitoring"", Biosensors, vol. 3, 1987/1988, pp. 45-56.;;Brownlee, M., et al., ""A Glucose-Controlled Insulin-Delivery System: Semisynthetic Insulin Bound to Lectin"", Science, vol. 206, 1979, 1190-1191.;;Cai, Q., et al., ""A Wireless, Remove Query Glucose Biosensor Based on a pH-Sensitive Polymer"", Analytical Chemistry, vol. 76, No. 14, 2004, pp. 4038-4043.;;Candas, B., et al., ""An Adaptive Plasma Glucose Controller Based on a Nonlinear Insulin/Glucose Model"", IEEE Transactions on Biomedical Engineering, vol. 41, No. 2, 1994, pp. 116-124.;;Cass, A. E., et al., ""Ferricinum Ion As an Electron Acceptor for Oxido-Reductases"", Journal of ElectroAnalytical Chemistry, vol. 190, 1985, pp. 117-127.;;Cass, A. E., et al., ""Ferrocene-Medicated Enzyme Electrode for Amperometric Determination of Glucose"", Analytical Chemistry, vol. 56, No. 4, 1984, 667-671.;;Castner, J. F., et al., ""Mass Transport and Reaction Kinetic Parameters Determined Electrochemically for Immobilized Glucose Oxidase"", Biochemistry, vol. 23 No. 10, 1984, 2203-2210.;;Chen, J. C., et al., ""A Comparison of MAC Protocols for Wireless Local Networks Based on battery Power Consumption"", IEEE, 1998, pp. 150-157.;;Chen, T., et al., ""Defining the Period of Recovery of the Glucose Concentration After Its Local Perturbation by the Implantation of a Miniature Sensor"", Clinical Chemistry and Laboratory Medicine, vol. 40, No. 8, 2002, pp. 486-489.;;Chia, C. W., et al., ""Glucose Sensors: Toward Closed Loop Insulin Delivery"", Endocrinology and Metabolism Clinics of North America, vol. 33, 2004, pp. 175-195.;;Choleau, C., et al., ""Calibration of a Subcutaneous Amperometric Glucose Sensor Implanted for 7 Days in Diabetic Patients Part 2: Superiority of the One-Point Calibration Method"", Biosensors and Bioelectronics, vol. 17, 2002, pp. 647-654.;;Choleau, C., et al., ""Calibration of a Subcutaneous Amperometric Glucose Sensor Part 1: Effect of Measurement Uncertainties on the Determination of Sensor Sensitivity and Background Current"", Biosensors and Bioelectronics, vol. 17, 2002, pp. 641-646.;;Claremont, D. J., et al., ""Biosensors for Continuous In Vivo Glucose Monitoring"", Proceedings of the Annual International Conference of the IEEE Engineering in Medicine and Biology Society, vol. 10, 1988.;;Clark Jr., L. C., et al., ""Differential Anodic Enzyme Polarography for the Measurement of Glucose"", Oxygen Transport to Tissue: Instrumentation, Methods, and Physiology, 1973, pp. 127-133.;;Clark Jr., L. C., et al., ""Electrode Systems for Continuous Monitoring in Cardiovascular Surgery"", Annals New York Academy of Sciences, 1962, pp. 29-45.;;Clark Jr., L. C., et al., ""Long-term Stability of Electroenzymatic Glucose Sensors Implanted in Mice"", American Society of Artificial Internal Organs Transactions, vol. XXXIV, 1988, pp. 259-265.;;Clarke, W. L., et al., ""Evaluating Clinical Accuracy of Systems for Self-Monitoring of Blood Glucose"", Diabetes Care, vol. 10, No. 5, 1987, pp. 622-628.;;Complaint, ""Abbott Diabetes Care, Inc. v. Dexcom, Inc."", filed Aug. 11, 2005.;;Complaint, Amended, ""Abbott Diabetes Care, Inc. v. Dexcom, Inc."", filed Jun. 27, 2006.;;Cox, D. J., et al., ""Accuracy of Perceiving Blood Glucose in IDDM"", Diabetes Care, vol. 8, No. 6, 1985, pp. 529-536.;;Csoregi, E., et al., ""Amperometric Microbiosensors for Detection of Hydrogen Peroxide and Glucose Based on Peroxidase-Modified Carbon Fibers"", Electroanalysis, vol. 6, 1994, pp. 925-933.;;Csoregi, E., et al., ""Design and Optimization of a Selective Subcutaneously Implantable Glucose Electrode Based on 'Wired' Glucose Oxidase"", Analytical Chemistry, vol. 67, No. 7, 1995, pp. 1240-1244.;;Csoregi, E., et al., ""Design, Characterization, and One-Point in Vivo Calibration of a Subcutaneously Implanted Glucose Electrode"", Analytical Chemistry, vol. 66 No. 19, 1994, pp. 3131-3138.;;Csoregi, E., et al., ""On-Line Glucose Monitoring by Using Microdialysis Sampling and Amperometric Detection Based on 'Wired' Glucose Oxidase in Carbon Paste"", Mikrochimica Acta, vol. 121, 1995, pp. 31-40.;;D'Arrigo, G., et al., ""Porous-Si Based Bio Reactors for Glucose Monitoring and Drugs Production"", Proceedings of SPIE: Microfluids, BioMEMS, and Medical Microsystems, vol. 4982, 2003, pp. 178-184.;;Dai, W. S., et al., ""Hydrogel Membranes with Mesh Size Asymmetry Based on the Gradient Crosslinking of Poly(vinyl alcohol),"" Journal of Membrane Science, vol. 156, 1999, pp. 67-79.;;Davies, M. L., et al., ""Polymer Membranes in Clinical Sensor Applications"", Biomaterials, vol. 13, No. 14, 1992, pp. 971-978.;;Davis, G., ""Electrochemical Techniques for the Development of Amperometric Biosensors"", Biosensors, vol. 1, 1985, pp. 161-178.;;Degani, Y., et al., ""Direct Electrical Communication Between Chemically Modified Enzymes and Metal Electrodes. 1. Electron Transfer from Glucose Oxidase to Metal Electrodes via Electron Relays, Bound Covalently to the Enzyme"", The Journal of Physical Chemistry, vol. 91, No. 6, 1987, pp. 1285-1289.;;Degani, Y., et al., ""Direct Electrical Communication Between Chemically Modified Enzymes and Metal Electrodes. 2. Methods for Bonding Electron-Transfer Relays to Glucose Oxidase and D-Amino-Acid Oxidase"", Journal of the American Chemical Society, vol. 110, No. 8, 1988, pp. 2615-2620.;;Degani, Y., et al., ""Electrical Communication Between Redox Centers of Glucose Oxidase and Electrodes via Electrostatically and Covalently Bound Polymers"", Journal of the American Redox Chemical Society, vol. 111, 1989, pp. 2357-2358.;;Denisevich, P., et al., ""Unidirectional Current Flow and Charge State Trapping at Redox Polymer Interfaces on Bilayer Electrodes: Principles, Experimental Demonstration, and Theory"", Journal of the American Chemical Society, vol. 103, 1981, pp. 4727-4737.;;Dicks, J. M., et al., ""Ferrocene Modified Polypyrrole with Immobilised Glucose Oxidase and its Application in Amperometric Glucose Microbiosensors"", Annales de Biologie Clinique, vol. 47, 1989, pp. 607-619.;;Dixon, B. M., et al., ""Characterization In Vitro and In Vivo of the Oxygen Dependence of an Enzyme/Polymer Biosensors for Monitoring Brain Glucose"", Journal of Neuroscience Methods, vol. 119, 2002, pp. 135-142.;;Eighth Annual Diabetes Technology Meeting Abstracts, Nov. 13-15, 2008, pp. A1-A182.;;El-Khatib, F. H, et al., ""Adaptive Closed-Loop Control Provides Blood-Glucose Regulation Using Subcutaneous Insulin and Glucagon Infusion in Diabetic Swine"", Journal of Diabetes Science and Technology, vol. 1, No. 2, 2007, pp. 181-192.;;Ellis, C. D., et al., ""Selectivity and Directed Charge Transfer through an Electroactive Metallopolymer Film"", Journal of the American Chemical Society, vol. 103, No. 25, 1981, pp. 7480-7483.;;El-Sa'Ad, L., et al., ""Moisture Absorption by Epoxy Resins: The Reverse Thermal Effect"", Journal of Materials Science, vol. 25, No. 8, 1990, pp. 3577-3582.;;Engstrom, R. C., ""Electrochemical Pretreatment of Glassy Carbon Electrodes"", Analytical Chemistry, vol. 54, No. 13, 1982, pp. 2310-2314.;;Engstrom, R. C., et al., ""Characterization of Electrochemically Pretreated Glassy Carbon Electrodes"", Analytical Chemistry, vol. 56, No. 2, 1984, pp. 136-141.;;Ernst, H., et al., ""Reliable Glucose Monitoring Through the Use of Microsystem Technology"", Analytical and Bioanalytical Chemistry, vol. 373, 2002, pp. 758-761.;;Fabietti, P. G., et al. ""Clinical Validation of a New Control-Oriented Model of Insulin and Glucose Dynamics in Subjects with Type 1 Diabetes"", Diabetes Technology & Therapeutics, vol. 9, No. 4, 2007, pp. 327-338.;;Fare, T. L., et al., ""Functional Characterization of a Conducting Polymer-Based Immunoassay System"", Biosensors & Bioelectronics, vol. 13, No. 3-4, 1998, pp. 459-470.;;Feldman, B., et al., ""A Continuous Glucose Sensor Based on Wired Enzyme(TM) Technology-Results from a 3-Day Trial in Patients with Type 1 Diabetes"", Diabetes Technology & Therapeutics, vol. 5, No. 5, 2003, pp. 769-779.",EXPIRED
248,US,A1,US 2009/0227940 A1,181-124-107-089-083,2009-09-10,2009,US 46877509 A,2009-05-19,US 46877509 A;;US 69560807 A;;US 42005703 A;;US 66719900 A;;US 7067798 A,1998-04-30,Analyte Monitoring Device and Methods of Use,"An analyte monitor includes a sensor, a sensor control unit, and a display unit. The sensor has, for example, a substrate, a recessed channel formed in the substrate, and conductive material disposed in the recessed channel to form a working electrode. The sensor control unit typically has a housing adapted for placement on skin and is adapted to receive a portion of an electrochemical sensor. The sensor control unit also includes two or more conductive contacts disposed on the housing and configured for coupling to two or more contact pads on the sensor. A transmitter is disposed in the housing and coupled to the plurality of conductive contacts for transmitting data obtained using the sensor. The display unit has a receiver for receiving data transmitted by the transmitter of the sensor control unit and a display coupled to the receiver for displaying an indication of a level of an analyte. The analyte monitor may also be part of a drug delivery system to alter the level of the analyte based on the data obtained using the sensor.",ABBOTT DIABETES CARE INC,SAY JAMES;;TOMASCO MICHAEL F;;HELLER ADAM;;GAL YORAM;;ARIA BEHRAD;;HELLER EPHRAIM;;PLANTE PHILLIP JOHN;;VREEKE MARK S;;FRIEDMAN KEITH A;;COLMAN FREDRIC C,,https://lens.org/181-124-107-089-083,Patent Application,yes,10,59,211,221,0,A61B5/14532;;A61B5/14532;;A61B5/0002;;A61B5/0002;;A61B5/002;;A61B5/01;;A61B5/14503;;A61B5/1451;;A61B5/14546;;A61B5/14546;;A61B5/1473;;A61B5/1473;;A61B5/1486;;A61B5/1486;;A61B5/14865;;A61B5/1495;;A61B5/4839;;A61B5/72;;A61B5/7278;;A61B5/7282;;A61B5/7405;;A61B5/743;;A61B5/7445;;A61B5/7445;;A61B5/7455;;A61B2560/0252;;A61B2560/0252;;A61M5/1723;;C12Q1/54;;G16H10/40;;G16H10/40;;G16H20/17;;G16H20/17;;H01L23/3107;;H01L23/3107;;H01L23/49548;;H01L23/49548;;H01L2924/0002;;H01L2924/0002;;H01L2924/19041;;H01L2924/19041;;H01L2924/3011;;H01L2924/3011;;Y10S128/903;;Y10S128/903;;Y10T29/49;;Y10T29/49;;Y10T29/49124;;Y10T29/49124,A61M37/00;;G01N27/30;;A61B5/00;;A61B5/145;;A61B5/1477;;A61B5/1495;;G01N27/416;;G06F19/00;;H01L23/31;;H01L23/495,604/66,0,0,,,,DISCONTINUED
249,US,A1,US 2009/0187094 A1,007-383-321-645-447,2009-07-23,2009,US 41456509 A,2009-03-30,US 41456509 A;;US 42005703 A;;US 66719900 A;;US 7067798 A,1998-04-30,Analyte Monitoring Device and Methods of Use,"An analyte monitor includes a sensor, a sensor control unit, and a display unit. The sensor has, for example, a substrate, a recessed channel formed in the substrate, and conductive material disposed in the recessed channel to form a working electrode. The sensor control unit typically has a housing adapted for placement on skin and is adapted to receive a portion of an electrochemical sensor. The sensor control unit also includes two or more conductive contacts disposed on the housing and configured for coupling to two or more contact pads on the sensor. A transmitter is disposed in the housing and coupled to the plurality of conductive contacts for transmitting data obtained using the sensor. The display unit has a receiver for receiving data transmitted by the transmitter of the sensor control unit and a display coupled to the receiver for displaying an indication of a level of an analyte. The analyte monitor may also be part of a drug delivery system to alter the level of the analyte based on the data obtained using the sensor.",ABBOTT DIABETES CARE INC,SAY JAMES;;TOMASCO MICHAEL F;;HELLER ADAM;;GAL YORAM;;ARIA BEHRAD;;HELLER EPHRAIM;;PLANTE PHILLIP JOHN;;VREEKE MARK S;;FRIEDMAN KEITH A;;COLMAN FREDRIC C,,https://lens.org/007-383-321-645-447,Patent Application,yes,1,57,211,221,0,A61B5/14532;;A61B5/14532;;A61B5/0002;;A61B5/0002;;A61B5/002;;A61B5/01;;A61B5/14503;;A61B5/1451;;A61B5/14546;;A61B5/14546;;A61B5/1473;;A61B5/1473;;A61B5/1486;;A61B5/1486;;A61B5/14865;;A61B5/1495;;A61B5/4839;;A61B5/72;;A61B5/7278;;A61B5/7282;;A61B5/7405;;A61B5/743;;A61B5/7445;;A61B5/7445;;A61B5/7455;;A61B2560/0252;;A61B2560/0252;;A61M5/1723;;C12Q1/54;;G16H10/40;;G16H10/40;;G16H20/17;;G16H20/17;;H01L23/3107;;H01L23/3107;;H01L23/49548;;H01L23/49548;;H01L2924/0002;;H01L2924/0002;;H01L2924/19041;;H01L2924/19041;;H01L2924/3011;;H01L2924/3011;;Y10S128/903;;Y10S128/903;;Y10T29/49;;Y10T29/49;;Y10T29/49124;;Y10T29/49124,A61B5/1468;;G01N27/30;;A61B5/00;;A61B5/145;;A61B5/1477;;A61B5/1495;;G01N27/416;;G06F19/00;;H01L23/31;;H01L23/495,600/345,0,0,,,,DISCONTINUED
250,US,A1,US 2010/0274111 A1,001-150-426-236-951,2010-10-28,2010,US 82569210 A,2010-06-29,US 82569210 A;;US 39388309 A;;US 42005703 A;;US 66719900 A;;US 7067798 A,1998-04-30,Analyte Monitoring Device and Methods of Use,"An analyte monitor includes a sensor, a sensor control unit, and a display unit. The sensor has, for example, a substrate, a recessed channel formed in the substrate, and conductive material disposed in the recessed channel to form a working electrode. The sensor control unit typically has a housing adapted for placement on skin and is adapted to receive a portion of an electrochemical sensor. The sensor control unit also includes two or more conductive contacts disposed on the housing and configured for coupling to two or more contact pads on the sensor. A transmitter is disposed in the housing and coupled to the plurality of conductive contacts for transmitting data obtained using the sensor. The display unit has a receiver for receiving data transmitted by the transmitter of the sensor control unit and a display coupled to the receiver for displaying an indication of a level of an analyte. The analyte monitor may also be part of a drug delivery system to alter the level of the analyte based on the data obtained using the sensor.",ABBOTT DIABETES CARE INC,SAY JAMES;;TOMASCO MICHAEL F;;HELLER ADAM;;GAL YORAM;;ARIA BEHRAD;;HELLER EPHRAIM;;PLANTE PHILLIP JOHN;;VREEKE MARK S;;FRIEDMAN KEITH A;;COLMAN FREDRIC C,E. HELLER & CO (1998-07-02);;ABBOTT DIABETES CARE INC (2000-03-13),https://lens.org/001-150-426-236-951,Patent Application,no,99,145,211,221,0,A61B5/14532;;A61B5/14532;;A61B5/0002;;A61B5/0002;;A61B5/002;;A61B5/01;;A61B5/14503;;A61B5/1451;;A61B5/14546;;A61B5/14546;;A61B5/1473;;A61B5/1473;;A61B5/1486;;A61B5/1486;;A61B5/14865;;A61B5/1495;;A61B5/4839;;A61B5/72;;A61B5/7278;;A61B5/7282;;A61B5/7405;;A61B5/743;;A61B5/7445;;A61B5/7445;;A61B5/7455;;A61B2560/0252;;A61B2560/0252;;A61M5/1723;;C12Q1/54;;G16H10/40;;G16H10/40;;G16H20/17;;G16H20/17;;H01L23/3107;;H01L23/3107;;H01L23/49548;;H01L23/49548;;H01L2924/0002;;H01L2924/0002;;H01L2924/19041;;H01L2924/19041;;H01L2924/3011;;H01L2924/3011;;Y10S128/903;;Y10S128/903;;Y10T29/49;;Y10T29/49;;Y10T29/49124;;Y10T29/49124,A61B5/1477;;G01N27/30;;A61B5/00;;A61B5/145;;A61B5/1495;;G01N27/416;;G06F19/00;;H01L23/31;;H01L23/495,600/347;;600/345,0,0,,,,EXPIRED
251,US,A1,US 2010/0268046 A1,023-462-605-031-872,2010-10-21,2010,US 82520210 A,2010-06-28,US 82520210 A;;US 39388309 A;;US 42005703 A;;US 66719900 A;;US 7067798 A,1998-04-30,Analyte Monitoring Device and Methods of Use,"An analyte monitor includes a sensor, a sensor control unit, and a display unit. The sensor has, for example, a substrate, a recessed channel formed in the substrate, and conductive material disposed in the recessed channel to form a working electrode. The sensor control unit typically has a housing adapted for placement on skin and is adapted to receive a portion of an electrochemical sensor. The sensor control unit also includes two or more conductive contacts disposed on the housing and configured for coupling to two or more contact pads on the sensor. A transmitter is disposed in the housing and coupled to the plurality of conductive contacts for transmitting data obtained using the sensor. The display unit has a receiver for receiving data transmitted by the transmitter of the sensor control unit and a display coupled to the receiver for displaying an indication of a level of an analyte. The analyte monitor may also be part of a drug delivery system to alter the level of the analyte based on the data obtained using the sensor.",SAY JAMES;;TOMASCO MICHAEL F;;HELLER ADAM;;GAL YORAM;;ARIA BEHRAD;;HELLER EPHRAIM;;PLANTE PHILLIP JOHN;;VREEKE MARK S;;FRIEDMAN KEITH A;;COLMAN FREDRIC C,SAY JAMES;;TOMASCO MICHAEL F;;HELLER ADAM;;GAL YORAM;;ARIA BEHRAD;;HELLER EPHRAIM;;PLANTE PHILLIP JOHN;;VREEKE MARK S;;FRIEDMAN KEITH A;;COLMAN FREDRIC C,E. HELLER & CO (1998-07-02);;ABBOTT DIABETES CARE INC (2000-03-13),https://lens.org/023-462-605-031-872,Patent Application,yes,99,6,211,221,0,A61B5/14532;;A61B5/14532;;A61B5/0002;;A61B5/0002;;A61B5/002;;A61B5/01;;A61B5/14503;;A61B5/1451;;A61B5/14546;;A61B5/14546;;A61B5/1473;;A61B5/1473;;A61B5/1486;;A61B5/1486;;A61B5/14865;;A61B5/1495;;A61B5/4839;;A61B5/72;;A61B5/7278;;A61B5/7282;;A61B5/7405;;A61B5/743;;A61B5/7445;;A61B5/7445;;A61B5/7455;;A61B2560/0252;;A61B2560/0252;;A61M5/1723;;C12Q1/54;;G16H10/40;;G16H10/40;;G16H20/17;;G16H20/17;;H01L23/3107;;H01L23/3107;;H01L23/49548;;H01L23/49548;;H01L2924/0002;;H01L2924/0002;;H01L2924/19041;;H01L2924/19041;;H01L2924/3011;;H01L2924/3011;;Y10S128/903;;Y10S128/903;;Y10T29/49;;Y10T29/49;;Y10T29/49124;;Y10T29/49124,A61B5/1468;;G01N27/30;;A61B5/00;;A61B5/145;;A61B5/1477;;A61B5/1495;;G01N27/416;;G06F19/00;;H01L23/31;;H01L23/495,600/345,0,0,,,,DISCONTINUED
252,US,B2,US 8734346 B2,022-128-705-732-908,2014-05-27,2014,US 74257107 A,2007-04-30,US 74257107 A;;US 42005703 A;;US 66719900 A;;US 7067798 A,1998-04-30,Analyte monitoring device and methods of use,"An analyte monitor includes a sensor, a sensor control unit, and a display unit. The sensor has, for example, a substrate, a recessed channel formed in the substrate, and conductive material disposed in the recessed channel to form a working electrode. The sensor control unit typically has a housing adapted for placement on skin and is adapted to receive a portion of an electrochemical sensor. The sensor control unit also includes two or more conductive contacts disposed on the housing and configured for coupling to two or more contact pads on the sensor. A transmitter is disposed in the housing and coupled to the plurality of conductive contacts for transmitting data obtained using the sensor. The display unit has a receiver for receiving data transmitted by the transmitter of the sensor control unit and a display coupled to the receiver for displaying an indication of a level of an analyte. The analyte monitor may also be part of a drug delivery system to alter the level of the analyte based on the data obtained using the sensor.",SAY JAMES;;TOMASCO MICHAEL F;;HELLER ADAM;;GAL YORAM;;ARIA BEHRAD;;HELLER EPHRAIM;;PLANTE PHILLIP JOHN;;VREEKE MARK S;;FRIEDMAN KEITH A;;COLMAN FREDRIC C;;ABBOTT DIABETES CARE INC,SAY JAMES;;TOMASCO MICHAEL F;;HELLER ADAM;;GAL YORAM;;ARIA BEHRAD;;HELLER EPHRAIM;;PLANTE PHILLIP JOHN;;VREEKE MARK S;;FRIEDMAN KEITH A;;COLMAN FREDRIC C,E. HELLER & CO (1998-07-02);;ABBOTT DIABETES CARE INC (2000-03-13),https://lens.org/022-128-705-732-908,Granted Patent,yes,102,2,211,221,0,A61B5/14532;;A61B5/14532;;A61B5/0002;;A61B5/0002;;A61B5/002;;A61B5/01;;A61B5/14503;;A61B5/1451;;A61B5/14546;;A61B5/14546;;A61B5/1473;;A61B5/1473;;A61B5/1486;;A61B5/1486;;A61B5/14865;;A61B5/1495;;A61B5/4839;;A61B5/72;;A61B5/7278;;A61B5/7282;;A61B5/7405;;A61B5/743;;A61B5/7445;;A61B5/7445;;A61B5/7455;;A61B2560/0252;;A61B2560/0252;;A61M5/1723;;C12Q1/54;;G16H10/40;;G16H10/40;;G16H20/17;;G16H20/17;;H01L23/3107;;H01L23/3107;;H01L23/49548;;H01L23/49548;;H01L2924/0002;;H01L2924/0002;;H01L2924/19041;;H01L2924/19041;;H01L2924/3011;;H01L2924/3011;;Y10S128/903;;Y10S128/903;;Y10T29/49;;Y10T29/49;;Y10T29/49124;;Y10T29/49124,A61B5/00;;G01N27/30;;A61B5/05;;A61B5/145;;A61B5/1477;;A61B5/1495;;G01N27/416;;G06F19/00;;H01L23/31;;H01L23/495,600/365;;600/347;;600/345,99,71,136-791-935-548-81X;;062-360-289-025-864;;010-601-725-111-91X;;101-292-518-663-191;;056-703-879-057-297;;030-155-762-644-019;;004-149-141-436-651;;016-731-054-793-457;;080-559-561-995-335;;044-807-213-528-815;;027-538-525-436-179;;015-020-161-517-40X;;025-919-454-564-785;;014-700-576-603-812;;004-851-060-590-788;;075-958-432-122-199;;052-356-140-149-389;;035-090-282-884-790;;033-562-815-299-181;;018-803-926-589-211;;008-505-762-041-402;;016-601-143-530-813;;019-502-772-562-215;;058-476-824-396-350;;006-498-707-073-30X;;054-091-551-638-293;;010-531-147-771-746;;054-827-198-877-419;;122-658-944-077-000;;017-261-560-469-37X;;000-125-755-474-124;;113-381-664-783-802;;082-626-907-191-554;;017-950-014-792-456;;090-348-305-613-628;;015-985-399-299-132;;171-049-047-164-618;;016-819-089-891-758;;081-249-097-078-543;;089-612-747-111-646;;031-706-897-890-035;;094-198-536-559-723;;003-690-143-043-420;;007-943-354-378-456;;082-114-500-909-975;;004-239-090-971-580;;026-894-457-160-450;;077-128-610-778-669;;022-466-506-956-898;;008-424-592-956-946;;007-500-825-916-378;;009-725-244-669-882;;037-755-689-613-42X;;153-411-506-517-475;;038-134-360-685-692;;012-449-714-188-064;;031-517-704-996-130;;131-299-284-996-064;;049-133-049-742-708;;000-272-178-768-076;;070-797-683-833-124;;043-870-224-178-49X;;025-574-914-238-550;;052-364-430-129-757;;004-434-167-910-115;;032-860-147-271-886;;132-460-374-211-421;;098-172-374-375-47X;;109-358-955-476-095;;014-988-634-483-130;;061-786-187-274-992,10.1016/s0956-5663(02)00099-4;;12392956;;10.1021/ja00391a001;;2889225;;10.1098/rstb.1987.0021;;10.1109/51.294001;;10.1016/0022-0728(65)85063-x;;2245876;;10.2337/diabetes.39.12.1519;;10.2337/diab.39.12.1519;;10.1016/s0956-5663(03)00220-3;;14611755;;18615658;;10.1002/bit.260430310;;9366023;;10.1016/s0956-5663(97)00025-0;;9451795;;10.1016/s0956-5663(97)00083-3;;10.1016/0956-5663(93)80028-n;;8311939;;8651496;;10.1021/ac960030d;;10.1080/03091900210156797;;12487712;;10.1016/0265-928x(87)80018-4;;3333622;;10.1109/19.816143;;10.1007/bf01015979;;10.1089/15209150252924058;;12017416;;18473691;;10.1089/dia.2007.0281;;10.1021/ac00017a008;;1789439;;2817408;;10.1021/ac00197a022;;10.1016/0925-4005(95)01730-5;;10.1016/0010-4825(90)90013-f;;2257734;;2868172;;8277748;;10.1016/0141-5425(93)90058-7;;11469630;;10.1089/15209150050214104;;10624783;;10.1016/s0168-8227(99)00113-8;;10.1089/15209150050214113;;11469631;;10.1007/bf00401374;;1478372;;10.2337/diacare.20.1.64;;9028696;;10.1109/tbme.1986.325807;;3957374;;236018;;10.1016/0005-2795(75)90259-7;;10.1089/hum.1998.9.6-879;;9581910;;11762520;;10.1089/15209150152607196;;10.2337/diabetes.48.3.445;;10078542;;10.1016/0265-928x(87)80012-3;;505005;;10.1126/science.505005;;10.1021/ac0498516;;15253640;;10.1109/10.284922;;8026845;;6721151;;10.1021/ac00268a018;;6733082;;10.1021/bi00305a016;;10.1515/cclm.2002.135;;12392305;;10.1016/j.ecl.2003.12.001;;15053902;;12052350;;10.1016/s0956-5663(01)00304-9;;12052349;;10.1016/s0956-5663(01)00306-2;;4500021;;10.1007/978-1-4684-3288-6_18;;14021529;;10.1111/j.1749-6632.1962.tb13623.x;;3196517;;10.2337/diacare.10.5.622;;3677983;;10.2337/diacare.8.6.529;;4075939;;10.1002/elan.1140061103;;7733469;;10.1021/ac00103a015;;7978306;;10.1021/ac00091a022;;10.1007/bf01248238;;10.1016/s0376-7388(98)00330-5;;10.1016/0142-9612(92)90147-g;;1472593;;10.1016/0265-928x(85)80002-x;;10.1021/j100290a001;;10.1021/ja00216a040;;10.1021/ja00188a091;;10.1021/ja00406a011;;2624333;;12323417;;10.1016/s0165-0270(02)00170-x;;10.1177/193229680700100208;;pmc2771467;;19888405;;10.1021/ja00415a014;;10.1007/bf00575392;;10.1021/ac00250a038;;10.1021/ac00266a005;;10.1007/s00216-002-1284-0;;12194035;;10.1089/dia.2006.0030;;17705688;;9642777;;10.1016/s0956-5663(97)00091-2;;10.1089/152091503322526978;;14633342,"U.S. Appl. No. 09/447,227, Shults.;;U.S. Appl. No. 11/737,671, Wolpert, et al.;;U.S. Appl. No. 11/766,747, Say, et al.;;U.S. Appl. No. 11/849,200, Peyser, et al.;;U.S. Appl. No. 11/928,574, Heller, et al.;;U.S. Appl. No. 11/928,668, Heller, et al.;;U.S. Appl. No. 11/928,743, Heller, et al.;;U.S. Appl. No. 11/928,795, Heller, et al.;;U.S. Appl. No. 11/928,891, Heller, et al.;;U.S. Appl. No. 11/928,968, Heller, et al.;;U.S. Appl. No. 11/941,078, Say, et al.;;""Poretics Polycarbonate Membrane"", Osmonics Filtration and Separation Group, 2002.;;Abel, P. U., et al., ""Biosensors for In Vivo Glucose Measurement: Can We Cross the Experimental Stage"", Biosensors and Bioelectronics, vol. 17, 2002, pp. 1059-1070.;;Abruna, H. D., et al., ""Rectifying Interfaces Using Two-Layer Films of Electrochemically Polymerized Vinylpyridine and Vinylbipyridine Complexes of Ruthenium and Iron on Electrodes"", Journal of the American Chemical Society, vol. 103, No. 1, 1981, pp. 1-5.;;Albery, W. J., et al., ""Amperometric Enzyme Electrodes Part II: Conducting Salts as Electrode Materials for the Oxidation of Glucose Oxidase"", Journal of ElectroAnalytical Chemistry, vol. 194, 1985, pp. 223-235.;;Albery, W. J., et al., ""Amperometric Enzyme Electrodes"", Philosophical Transactions of The Royal Society of London, vol. 316, 1987, pp. 107-119.;;Alcock, S. J., et al., ""Continuous Analyte Monitoring to Aid Clinical Practice"", IEEE Engineering in Medicine and Biology Magazine, 1994, pp. 319-325.;;Anderson, L. B., et al., ""Thin-Layer Electrochemistry: Steady-State Methods of Studying Rate Processes"", Journal of ElectroAnalytical Chemistry, vol. 10, 1965, pp. 295-305.;;Armour, J. C., et al., ""Application of Chronic Intravascular Blood Glucose Sensor in Dogs"", Diabetes, vol. 39, 1990, pp. 1519-1526.;;Asberg, P., et al., ""Hydrogels of a Conducting Conjugated Polymer as 3-D Enzyme Electrode"", Biosensors & Bioelectronics, vol. 19, 2003, pp. 199-207.;;Atanasov, P., et al., ""Biosensor for Continuous Glucose Monitoring"", Biotechnology and Bioengineering, vol. 43, 1994, pp. 262-266.;;Atanasov, P., et al., ""Implantation of a Refillable Glucose Monitoring-Telemetry Device"", Biosensors & Bioelectronics, vol. 12, No. 7, 1997, pp. 669-680.;;Aussedat, B., et al., ""A User-Friendly Method for Calibrating a Subcutaneous Glucose Sensor-Based Hypoglycaemic Alarm"", Biosensors & Bioelectronics, vol. 12, No. 11, 1997, pp. 1061-1071.;;Baker, D. A., et al., ""Dynamic Concentration Challenges for Biosensor Characterization"", Biosensors & Bioelectronics, vol. 8, 1993, pp. 433-441.;;Baker, D. A., et al., ""Dynamic Delay and Maximal Dynamic Error in Continuous Biosensors"", Analytical Chemistry, vol. 68, No. 8, 1996, pp. 1292-1297.;;Bani Amer, M. M., ""An Accurate Amperometric Glucose Sensor Based Glucometer with Eliminated Cross-Sensitivity"", Journal of Medical Engineering & Technology, vol. 26, No. 5, 2002, pp. 208-213.;;Bard, A. J., et al., Electrochemical Methods, 1980, pp. 173-175.;;Bartlett, P. N., et al., ""Covalent Binding of Electron Relays to Glucose Oxidase"", Journal of the Chemical Society, Chemical Communications, 1987, pp. 1603-1604.;;Bartlett, P. N., et al., ""Modification of Glucose Oxidase by Tetrathiafulvalene"", Journal of the Chemical Society, Chemical Communications, 1990, pp. 1135-1136.;;Bartlett, P. N., et al., ""Strategies for the Development of Amperometric Enzyme Electrodes"", Biosensors, vol. 3, 1987/88, pp. 359-379.;;Beach, R. D., et al., ""Subminiature Implantable Potentiostat and Modified Commercial Telemetry Device for Remote Glucose Monitoring"", IEEE Transactions on Instrumentation and Measurement, vol. 28, No. 6, 1999, pp. 1239-1245.;;Beech, W. A., ""AX.25 Link Access Protocol for Amateur packet Radio"", Tucson Amateur Packet Radio Corporation, 1998, pp. 1-133.;;Bellucci, F., et al., ""Electrochemical Behaviour of Graphite-Epoxy Composite Materials (GECM) in Aqueous Salt Solutions"", Journal of Applied Electrochemistry, vol. 16, 1986, pp. 15-22.;;Bennion, N., et al., ""Alternate Site Glucose Testing: A Crossover Design"", Diabetes Technology & Therapeutics, vol. 4, No. 1, 2002, pp. 25-33.;;Biermann, E., et al., ""How Would Patients Behave if They Were Continually Informed of Their Blood Glucose Levels? A Simulation Study Using a 'Virtual' Patient"", Diabetes Technology & Therapeutics, vol. 10, No. 3, 2008, pp. 178-187.;;Bindra, D. S., et al., ""Design and in Vitro Studies of a Needle-Type Glucose Sensor for Subcutaneous Monitoring"", Analytical Chemistry, vol. 63, No. 17, 1991, pp. 1692-1696.;;Bindra, D. S., et al., ""Pulsed Amperometric Detection of Glucose in Biological Fluids at a Surface-Modified Gold Electrode"", Analytical Chemistry, vol. 61, No. 22, 1989, pp. 2566-2570.;;Bisenberger, M., et al., ""A Triple-Step Potential Waveform at Enzyme Multisensors with Thick-Film Gold Electrodes for Detection of Glucose and Sucrose"", Sensors and Actuators B, vol. 28, 1995, pp. 181-189.;;Bland, J. M., et al., ""A Note on the Use of the Intraclass Correlation Coefficient in the Evaluation of Agreement Between Two Methods of Measurement"", Computers in Biology and Medicine, vol. 20, No. 5, 1990, pp. 337-340.;;Bland, J. M., et al., ""Statistical Methods for Assessing Agreement Between Two Methods of Clinical Measurement"", The Lancet, 1986, pp. 307-310.;;Blank, T. B., et al., ""Clinical Results From a Non-Invasive Blood Glucose Monitor"", Optical Diagnostics and Sensing of Biological Fluids and Glucose and Cholesterol Monitoring II, Proceedings of SPIE, vol. 4624, 2002, pp. 1-10.;;Bobbioni-Harsch, E., et al., ""Lifespan of Subcutaneous Glucose Sensors and Their Performances During Dynamic Glycaemia Changes in Rats"", Journal of Biomedical Engineering, vol. 15, 1993, pp. 457-463.;;Bode, B. W., ""Clinical Utility of the Continuous Glucose Monitoring System"", Diabetes Technology & Therapeutics, vol. 2, Sup. 1, 2000, pp. S35-S41.;;Bode, B. W., et al., ""Continuous Glucose Monitoring Used to Adjust Diabetes Therapy Improves Glycosylated Hemoglobin: A Pilot Study"", Diabetes Research and Clinical Practice, vol. 46, 1999, pp. 183-190.;;Bode, B. W., et al., ""Using the Continuous Glucose Monitoring System to Improve the Management of Type I Diabetes"", Diabetes Technology & Therapeutics, vol. 2, Sup. 1, 2000, pp. S43-S48.;;Boedeker Plastics, Inc., ""Polyethylene Specifications"", Web Page of Boedeker.com, 2007, pp. 1-3.;;Bolinder, J., et al., ""Microdialysis Measurement of the Absolute Glucose Concentration in Subcutaneous Adipose Tissue Allowing Glucose Monitoring in Diabetic Patients"", Diabetologia, vol. 35, 1992, pp. 1177-1180.;;Bolinder, J., et al., ""Self-Monitoring of Blood Glucose in Type I Diabetic Patients: Comparison with Continuous Microdialysis Measurements of Glucose in Subcutaneous Adipose Tissue During Ordinary Life Conditions"", Diabetes Care, vol. 20, No. 1, 1997, pp. 64-70.;;Bott, A. W., ""A Comparison of Cyclic Voltammetry and Cyclic Staircase Voltammetry"", Current Separations, vol. 16, No. 1, 1997, pp. 23-26.;;Bott, A. W., ""Electrochemical Methods for the Determination of Glucose"", Current Separations, vol. 17, No. 1, 1998, pp. 25-31.;;Bowman, L., et al., ""The Packaging of Implantable Integrated Sensors"", IEEE Transactions on Biomedical Engineering, vol. 33, No. 2, 1986, pp. 248-255.;;Brandt, J., et al., ""Covalent Attachment of Proteins to Polysaccharide Carriers by Means of Benzoquinone"", Biochimica et Biophysica Acta, vol. 386, 1975, pp. 196-202.;;Brauker, J., et al., ""Sustained Expression of High Levels of Human Factor IX from Human Cells Implanted Within an Immunoisolation Device into Athymic Rodents"", Human Gene Therapy, vol. 9, No. 6, 1998, pp. 879-888.;;Bremer, T. M., et al., ""Benchmark Data from the Literature for Evaluation of New Glucose Sensing Technologies"", Diabetes Technology & Therapeutics, vol. 3, No. 3, 2001, pp. 409-418.;;Bremer, T., et al., ""Is Blood Glucose Predictable from Previous Values?"", Diabetes, vol. 48, 1999, pp. 445-451.;;Brooks, S. L., et al., ""Development of an On-Line Glucose Sensor for Fermentation Monitoring"", Biosensors, vol. 3, 1987/88, pp. 45-56.;;Brownlee, M., et al., ""A Glucose-Controlled Insulin-Delivery System: Semisynthetic Insulin Bound to Lectin"", Science, vol. 206, 1979, 1190-1191.;;Cai, Q., et al., ""A Wireless, Remove Query Glucose Biosensor Based on a pH-Sensitive Polymer"", Analytical Chemistry, vol. 76, No. 14, 2004, pp. 4038-4043.;;Candas, B., et al., ""An Adaptive Plasma Glucose Controller Based on a Nonlinear Insulin/Glucose Model"", IEEE Transactions on Biomedical Engineering, vol. 41, No. 2, 1994, pp. 116-124.;;Cass, A. E., et al., ""Ferricinum Ion As An Electron Acceptor for Oxido-Reductases"", Journal of ElectroAnalytical Chemistry, vol. 190, 1985, pp. 117-127.;;Cass, A. E., et al., ""Ferrocene-Medicated Enzyme Electrode for Amperometric Determination of Glucose"", Analytical Chemistry, vol. 56, No. 4, 1984, 667-671.;;Castner, J. F., et al., ""Mass Transport and Reaction Kinetic Parameters Determined Electrochemically for Immobilized Glucose Oxidase"", Biochemistry, vol. 23 No. 10, 1984, 2203-2210.;;Chen, J. C., et al., ""A Comparison of MAC Protocols for Wireless Local Networks Based on battery Power Consumption"", IEEE, 1998, pp. 150-157.;;Chen, T., et al., ""Defining the Period of Recovery of the Glucose Concentration After Its Local Perturbation by the Implantation of a Miniature Sensor"", Clinical Chemistry and Laboratory Medicine, vol. 40, No. 8, 2002, pp. 486-489.;;Chia, C. W., et al., ""Glucose Sensors: Toward Closed Loop Insulin Delivery"", Endocrinology and Metabolism Clinics of North America, vol. 33, 2004, pp. 175-195.;;Choleau, C., et al., ""Calibration of a Subcutaneous Amperometric Glucose Sensor Implanted for 7 Days in Diabetic Patients Part 2: Superiority of the One-Point Calibration Method"", Biosensors and Bioelectronics, vol. 17, 2002, pp. 647-654.;;Choleau, C., et al., ""Calibration of a Subcutaneous Amperometric Glucose Sensor Part 1: Effect of Measurement Uncertainties on the Determination of Sensor Sensitivity and Background Current"", Biosensors and Bioelectronics, vol. 17, 2002, pp. 641-646.;;Claremont, D. J., et al., ""Biosensors for Continuous In Vivo Glucose Monitoring"", Proceedings of the Annual International Conference of the IEEE Engineering in Medicine and Biology Society, vol. 10, 1988.;;Clark Jr., L. C., et al., ""Differential Anodic Enzyme Polarography for the Measurement of Glucose"", Oxygen Transport to Tissue: Instrumentation, Methods, and Physiology, 1973, pp. 127-133.;;Clark Jr., L. C., et al., ""Electrode Systems for Continuous Monitoring in Cardiovascular Surgery"", Annals New York Academy of Sciences, 1962, pp. 29-45.;;Clark Jr., L. C., et al., ""Long-term Stability of Electroenzymatic Glucose Sensors Implanted in Mice"", American Society of Artificial Internal Organs Transactions, vol. XXXIV, 1988, pp. 259-265.;;Clarke, W. L., et al., ""Evaluating Clinical Accuracy of Systems for Self-Monitoring of Blood Glucose"", Diabetes Care, vol. 10, No. 5, 1987, pp. 622-628.;;Complaint, ""Abbott Diabetes Care, Inc. v. Dexcom, Inc."", filed Aug. 11, 2005.;;Complaint, Amended, ""Abbott Diabetes Care, Inc. v. Dexcom, Inc."", filed Jun. 27, 2006.;;Cox, D. J., et al., ""Accuracy of Perceiving Blood Glucose in IDDM"", Diabetes Care, vol. 8, No. 6, 1985, pp. 529-536.;;Csoregi, E., et al., ""Amperometric Microbiosensors for Detection of Hydrogen Peroxide and Glucose Based on Peroxidase-Modified Carbon Fibers"", Electroanalysis, vol. 6, 1994, pp. 925-933.;;Csoregi, E., et al., ""Design and Optimization of a Selective Subcutaneously Implantable Glucose Electrode Based on 'Wired' Glucose Oxidase"", Analytical Chemistry, vol. 67, No. 7, 1995, pp. 1240-1244.;;Csoregi, E., et al., ""Design, Characterization, and One-Point in Vivo Calibration of a Subcutaneously Implanted Glucose Electrode"", Analytical Chemistry, vol. 66 No. 19, 1994, pp. 3131-3138.;;Csoregi, E., et al., ""On-Line Glucose Monitoring by Using Microdialysis Sampling and Amperometric Detection Based on 'Wired' Glucose Oxidase in Carbon Paste"", Mikrochimica Acta, vol. 121, 1995, pp. 31-40.;;D'Arrigo, G., et al., ""Porous-Si Based Bio Reactors for Glucose Monitoring and Drugs Production"", Proceedings of SPIE: Microfluids, BioMEMS, and Medical Microsystems, vol. 4982, 2003, pp. 178-184.;;Dai, W. S., et al., ""Hydrogel Membranes with Mesh Size Asymmetry Based on the Gradient Crosslinking of Poly(vinyl alcohol),"" Journal of Membrane Science, vol. 156, 1999, pp. 67-79.;;Davies, M. L., et al., ""Polymer Membranes in Clinical Sensor Applications"", Biomaterials, vol. 13, No. 14, 1992, pp. 971-978.;;Davis, G., ""Electrochemical Techniques for the Development of Amperometric Biosensors"", Biosensors, vol. 1, 1985, pp. 161-178.;;Degani, Y., et al., ""Direct Electrical Communication Between Chemically Modified Enzymes and Metal Electrodes. 1. Electron Transfer from Glucose Oxidase to Metal Electrodes via Electron Relays, Bound Covalently to the Enzyme"", The Journal of Physical Chemistry, vol. 91, No. 6, 1987, pp. 1285-1289.;;Degani, Y., et al., ""Direct Electrical Communication Between Chemically Modified Enzymes and Metal Electrodes. 2. Methods for Bonding Electron-Transfer Relays to Glucose Oxidase and D-Amino-Acid Oxidase"", Journal of the American Chemical Society, vol. 110, No. 8, 1988, pp. 2615-2620.;;Degani, Y., et al., ""Electrical Communication Between Redox Centers of Glucose Oxidase and Electrodes via Electrostatically and Covalently Bound Redox Polymers"", Journal of the American Chemical Society, vol. 111, 1989, pp. 2357-2358.;;Denisevich, P., et al., ""Unidirectional Current Flow and Charge State Trapping at Redox Polymer Interfaces on Bilayer Electrodes: Principles, Experimental Demonstration, and Theory"", Journal of the American Chemical Society, vol. 103, 1981, pp. 4727-4737.;;Dicks, J. M., et al., ""Ferrocene Modified Polypyrrole with Immobilised Glucose Oxidase and its Application in Amperometric Glucose Microbiosensors"", Annales de Biologie Clinique, vol. 47, 1989, pp. 607-619.;;Dixon, B. M., et al., ""Characterization In Vitro and In Vivo of the Oxygen Dependence of an Enzyme/Polymer Biosensors for Monitoring Brain Glucose"", Journal of Neuroscience Methods, vol. 119, 2002, pp. 135-142.;;Eighth Annual Diabetes Technology Meeting Abstracts, Nov. 13-15, 2008, pp. A1-A182.;;El-Khatib, F. H, et al., ""Adaptive Closed-Loop Control Provides Blood-Glucose Regulation Using Subcutaneous Insulin and Glucagon Infusion in Diabetic Swine"", Journal of Diabetes Science and Technology, vol. 1, No. 2, 2007, pp. 181-192.;;Ellis, C. D., et al., ""Selectivity and Directed Charge Transfer through an Electroactive Metallopolymer Film"", Journal of the American Chemical Society, vol. 103, No. 25, 1981, pp.7480-7483.;;El-Sa'Ad, L., et al., ""Moisture Absorption by Epoxy Resins: The Reverse Thermal Effect"", Journal of Materials Science, vol. 25, No. 8, 1990, pp. 3577-3582.;;Engstrom, R. C., ""Electrochemical Pretreatment of Glassy Carbon Electrodes"", Analytical Chemistry, vol. 54, No. 13, 1982, pp. 2310-2314.;;Engstrom, R. C., et al., ""Characterization of Electrochemically Pretreated Glassy Carbon Electrodes"", Analytical Chemistry, vol. 56, No. 2, 1984, pp. 136-141.;;Ernst, H., et al., ""Reliable Glucose Monitoring Through the Use of Microsystem Technology"", Analytical and Bioanalytical Chemistry, vol. 373, 2002, pp. 758-761.;;Fabietti, P. G., et al. ""Clinical Validation of a New Control-Oriented Model of Insulin and Glucose Dynamics in Subjects with Type 1 Diabetes"", Diabetes Technology & Therapeutics, vol. 9, No. 4, 2007, pp. 327-338.;;Fare, T. L., et al., ""Functional Characterization of a Conducting Polymer-Based Immunoassay System"", Biosensors & Bioelectronics, vol. 13, No. 3-4, 1998, pp. 459-470.;;Feldman, B., et al., ""A Continuous Glucose Sensor Based on Wired Enzyme(TM) Technology-Results from a 3-Day Trial in Patients with Type 1 Diabetes"", Diabetes Technology & Therapeutics, vol. 5, No. 5, 2003, pp. 769-779.",EXPIRED
253,US,A1,US 2010/0324402 A1,109-356-915-693-221,2010-12-23,2010,US 85567910 A,2010-08-12,US 85567910 A;;US 69082607 A;;US 42005703 A;;US 66719900 A;;US 7067798 A,1998-04-30,Analyte Monitoring Device and Methods of Use,"An analyte monitor includes a sensor, a sensor control unit, and a display unit. The sensor has, for example, a substrate, a recessed channel formed in the substrate, and conductive material disposed in the recessed channel to form a working electrode. The sensor control unit typically has a housing adapted for placement on skin and is adapted to receive a portion of an electrochemical sensor. The sensor control unit also includes two or more conductive contacts disposed on the housing and configured for coupling to two or more contact pads on the sensor. A transmitter is disposed in the housing and coupled to the plurality of conductive contacts for transmitting data obtained using the sensor. The display unit has a receiver for receiving data transmitted by the transmitter of the sensor control unit and a display coupled to the receiver for displaying an indication of a level of an analyte. The analyte monitor may also be part of a drug delivery system to alter the level of the analyte based on the data obtained using the sensor.",ABBOTT DIABETES CARE INC,SAY JAMES;;TOMASCO MICHAEL F;;HELLER ADAM;;GAL YORAM;;ARIA BEHRAD;;HELLER EPHRAIM;;PLANTE PHILLIP JOHN;;VREEKE MARK S;;FRIEDMAN KEITH A;;COLMAN FREDRIC C,,https://lens.org/109-356-915-693-221,Patent Application,yes,1,0,211,221,0,A61B5/14532;;A61B5/14532;;A61B5/0002;;A61B5/0002;;A61B5/002;;A61B5/01;;A61B5/14503;;A61B5/1451;;A61B5/14546;;A61B5/14546;;A61B5/1473;;A61B5/1473;;A61B5/1486;;A61B5/1486;;A61B5/14865;;A61B5/1495;;A61B5/4839;;A61B5/72;;A61B5/7278;;A61B5/7282;;A61B5/7405;;A61B5/743;;A61B5/7445;;A61B5/7445;;A61B5/7455;;A61B2560/0252;;A61B2560/0252;;A61M5/1723;;C12Q1/54;;G16H10/40;;G16H10/40;;G16H20/17;;G16H20/17;;H01L23/3107;;H01L23/3107;;H01L23/49548;;H01L23/49548;;H01L2924/0002;;H01L2924/0002;;H01L2924/19041;;H01L2924/19041;;H01L2924/3011;;H01L2924/3011;;Y10S128/903;;Y10S128/903;;Y10T29/49;;Y10T29/49;;Y10T29/49124;;Y10T29/49124,A61B5/145;;G01N27/30;;A61B5/00;;A61B5/1477;;A61B5/1495;;G01N27/416;;G06F19/00;;H01L23/31;;H01L23/495,600/365,0,0,,,,DISCONTINUED
254,US,A1,US 2004/0106859 A1,111-925-887-471-267,2004-06-03,2004,US 72225103 A,2003-11-24,US 72225103 A;;US 42005703 A;;US 66719900 A;;US 7067798 A,1998-04-30,Analyte monitoring device and methods of use,"
   An analyte monitor includes a sensor, a sensor control unit, and a display unit. The sensor has, for example, a substrate, a recessed channel formed in the substrate, and conductive material disposed in the recessed channel to form a working electrode. The sensor control unit typically has a housing adapted for placement on skin and is adapted to receive a portion of an electrochemical sensor. The sensor control unit also includes two or more conductive contacts disposed on the housing and configured for coupling to two or more contact pads on the sensor. A transmitter is disposed in the housing and coupled to the plurality of conductive contacts for transmitting data obtained using the sensor. The display unit has a receiver for receiving data transmitted by the transmitter of the sensor control unit and a display coupled to the receiver for displaying an indication of a level of an analyte. The analyte monitor may also be part of a drug delivery system to alter the level of the analyte based on the data obtained using the sensor. 
",SAY JAMES;;TOMASCO MICHAEL F.;;HELLER ADAM;;GAL YORAM;;ARIA BEHRAD;;HELLER EPHRAIM;;PLANTE PHILLIP JOHN;;VREEKE MARK S.;;FRIEDMAN KEITH A.;;COLMAN FREDRIC C.,SAY JAMES;;TOMASCO MICHAEL F;;HELLER ADAM;;GAL YORAM;;ARIA BEHRAD;;HELLER EPHRAIM;;PLANTE PHILLIP JOHN;;VREEKE MARK S;;FRIEDMAN KEITH A;;COLMAN FREDRIC C,,https://lens.org/111-925-887-471-267,Patent Application,yes,5,287,211,221,0,A61B5/14532;;A61B5/14532;;A61B5/0002;;A61B5/0002;;A61B5/002;;A61B5/01;;A61B5/14503;;A61B5/1451;;A61B5/14546;;A61B5/14546;;A61B5/1473;;A61B5/1473;;A61B5/1486;;A61B5/1486;;A61B5/14865;;A61B5/1495;;A61B5/4839;;A61B5/72;;A61B5/7278;;A61B5/7282;;A61B5/7405;;A61B5/743;;A61B5/7445;;A61B5/7445;;A61B5/7455;;A61B2560/0252;;A61B2560/0252;;A61M5/1723;;C12Q1/54;;G16H10/40;;G16H10/40;;G16H20/17;;G16H20/17;;H01L23/3107;;H01L23/3107;;H01L23/49548;;H01L23/49548;;H01L2924/0002;;H01L2924/0002;;H01L2924/19041;;H01L2924/19041;;H01L2924/3011;;H01L2924/3011;;Y10S128/903;;Y10S128/903;;Y10T29/49;;Y10T29/49;;Y10T29/49124;;Y10T29/49124,G01N27/30;;A61B5/00;;A61B5/145;;A61B5/1477;;A61B5/1495;;G01N27/416;;G06F19/00;;H01L23/31;;H01L23/495,600/345;;600/365;;128/903,0,0,,,,EXPIRED
255,US,A1,US 2009/0192371 A1,131-898-277-549-762,2009-07-30,2009,US 41789709 A,2009-04-03,US 41789709 A;;US 42005703 A;;US 66719900 A;;US 7067798 A,1998-04-30,Analyte Monitoring Device and Methods of Use,"An analyte monitor includes a sensor, a sensor control unit, and a display unit. The sensor has, for example, a substrate, a recessed channel formed in the substrate, and conductive material disposed in the recessed channel to form a working electrode. The sensor control unit typically has a housing adapted for placement on skin and is adapted to receive a portion of an electrochemical sensor. The sensor control unit also includes two or more conductive contacts disposed on the housing and configured for coupling to two or more contact pads on the sensor. A transmitter is disposed in the housing and coupled to the plurality of conductive contacts for transmitting data obtained using the sensor. The display unit has a receiver for receiving data transmitted by the transmitter of the sensor control unit and a display coupled to the receiver for displaying an indication of a level of an analyte. The analyte monitor may also be part of a drug delivery system to alter the level of the analyte based on the data obtained using the sensor.",ABBOTT DIABETES CARE INC,SAY JAMES;;TOMASCO MICHAEL F;;HELLER ADAM;;GAL YORAM;;ARIA BEHRAD;;HELLER EPHRAIM;;PLANTE PHILLIP JOHN;;VREEKE MARK S;;FRIEDMAN KEITH A;;COLMAN FREDRIC C,,https://lens.org/131-898-277-549-762,Patent Application,yes,1,57,211,221,0,A61B5/14532;;A61B5/14532;;A61B5/0002;;A61B5/0002;;A61B5/002;;A61B5/01;;A61B5/14503;;A61B5/1451;;A61B5/14546;;A61B5/14546;;A61B5/1473;;A61B5/1473;;A61B5/1486;;A61B5/1486;;A61B5/14865;;A61B5/1495;;A61B5/4839;;A61B5/72;;A61B5/7278;;A61B5/7282;;A61B5/7405;;A61B5/743;;A61B5/7445;;A61B5/7445;;A61B5/7455;;A61B2560/0252;;A61B2560/0252;;A61M5/1723;;C12Q1/54;;G16H10/40;;G16H10/40;;G16H20/17;;G16H20/17;;H01L23/3107;;H01L23/3107;;H01L23/49548;;H01L23/49548;;H01L2924/0002;;H01L2924/0002;;H01L2924/19041;;H01L2924/19041;;H01L2924/3011;;H01L2924/3011;;Y10S128/903;;Y10S128/903;;Y10T29/49;;Y10T29/49;;Y10T29/49124;;Y10T29/49124,A61B5/1468;;G01N27/30;;A61B5/00;;A61B5/145;;A61B5/1477;;A61B5/1495;;G01N27/416;;G06F19/00;;H01L23/31;;H01L23/495,600/345,0,0,,,,DISCONTINUED
256,US,A1,US 2009/0292189 A1,147-735-624-076-272,2009-11-26,2009,US 53368009 A,2009-07-31,US 53368009 A;;US 42005703 A;;US 66719900 A;;US 7067798 A,1998-04-30,Analyte Monitoring Device and Methods of Use,"An analyte monitor includes a sensor, a sensor control unit, and a display unit. The sensor has, for example, a substrate, a recessed channel formed in the substrate, and conductive material disposed in the recessed channel to form a working electrode. The sensor control unit typically has a housing adapted for placement on skin and is adapted to receive a portion of an electrochemical sensor. The sensor control unit also includes two or more conductive contacts disposed on the housing and configured for coupling to two or more contact pads on the sensor. A transmitter is disposed in the housing and coupled to the plurality of conductive contacts for transmitting data obtained using the sensor. The display unit has a receiver for receiving data transmitted by the transmitter of the sensor control unit and a display coupled to the receiver for displaying an indication of a level of an analyte. The analyte monitor may also be part of a drug delivery system to alter the level of the analyte based on the data obtained using the sensor.",ABBOTT DIABETES CARE INC,SAY JAMES;;TOMASCO MICHAEL F;;HELLER ADAM;;GAL YORAM;;ARIA BEHRAD;;HELLER EPHRAIM;;PLANTE PHILLIP JOHN;;VREEKE MARK S;;FRIEDMAN KEITH A;;COLMAN FREDRIC C,E. HELLER & CO (1998-07-02);;ABBOTT DIABETES CARE INC (2000-03-13),https://lens.org/147-735-624-076-272,Patent Application,yes,99,4,211,221,0,A61B5/14532;;A61B5/14532;;A61B5/0002;;A61B5/0002;;A61B5/002;;A61B5/01;;A61B5/14503;;A61B5/1451;;A61B5/14546;;A61B5/14546;;A61B5/1473;;A61B5/1473;;A61B5/1486;;A61B5/1486;;A61B5/14865;;A61B5/1495;;A61B5/4839;;A61B5/72;;A61B5/7278;;A61B5/7282;;A61B5/7405;;A61B5/743;;A61B5/7445;;A61B5/7445;;A61B5/7455;;A61B2560/0252;;A61B2560/0252;;A61M5/1723;;C12Q1/54;;G16H10/40;;G16H10/40;;G16H20/17;;G16H20/17;;H01L23/3107;;H01L23/3107;;H01L23/49548;;H01L23/49548;;H01L2924/0002;;H01L2924/0002;;H01L2924/19041;;H01L2924/19041;;H01L2924/3011;;H01L2924/3011;;Y10S128/903;;Y10S128/903;;Y10T29/49;;Y10T29/49;;Y10T29/49124;;Y10T29/49124,A61B5/1473;;G01N27/30;;A61B5/00;;A61B5/145;;A61B5/1477;;A61B5/1495;;G01N27/416;;G06F19/00;;H01L23/31;;H01L23/495,600/347;;600/345,0,0,,,,EXPIRED
257,US,B2,US 8226557 B2,164-498-468-993-81X,2012-07-24,2012,US 64814309 A,2009-12-28,US 64814309 A;;US 42005703 A;;US 66719900 A;;US 7067798 A,1998-04-30,Analyte monitoring device and methods of use,"An analyte monitor includes a sensor, a sensor control unit, and a display unit. The sensor has, for example, a substrate, a recessed channel formed in the substrate, and conductive material disposed in the recessed channel to form a working electrode. The sensor control unit typically has a housing adapted for placement on skin and is adapted to receive a portion of an electrochemical sensor. The sensor control unit also includes two or more conductive contacts disposed on the housing and configured for coupling to two or more contact pads on the sensor. A transmitter is disposed in the housing and coupled to the plurality of conductive contacts for transmitting data obtained using the sensor. The display unit has a receiver for receiving data transmitted by the transmitter of the sensor control unit and a display coupled to the receiver for displaying an indication of a level of an analyte. The analyte monitor may also be part of a drug delivery system to alter the level of the analyte based on the data obtained using the sensor.",SAY JAMES;;TOMASCO MICHAEL F;;HELLER ADAM;;GAL YORAM;;ARIA BEHRAD;;HELLER EPHRAIM;;PLANTE PHILLIP JOHN;;VREEKE MARK S;;FRIEDMAN KEITH A;;COLMAN FREDRIC C;;ABBOTT DIABETES CARE INC,SAY JAMES;;TOMASCO MICHAEL F;;HELLER ADAM;;GAL YORAM;;ARIA BEHRAD;;HELLER EPHRAIM;;PLANTE PHILLIP JOHN;;VREEKE MARK S;;FRIEDMAN KEITH A;;COLMAN FREDRIC C,ABBOTT DIABETES CARE INC (2005-07-25);;THERASENSE INC (2000-03-13);;E. HELLER & COMPANY (1998-07-02),https://lens.org/164-498-468-993-81X,Granted Patent,yes,99,3,211,221,0,A61B5/14532;;A61B5/14532;;A61B5/0002;;A61B5/0002;;A61B5/002;;A61B5/01;;A61B5/14503;;A61B5/1451;;A61B5/14546;;A61B5/14546;;A61B5/1473;;A61B5/1473;;A61B5/1486;;A61B5/1486;;A61B5/14865;;A61B5/1495;;A61B5/4839;;A61B5/72;;A61B5/7278;;A61B5/7282;;A61B5/7405;;A61B5/743;;A61B5/7445;;A61B5/7445;;A61B5/7455;;A61B2560/0252;;A61B2560/0252;;A61M5/1723;;C12Q1/54;;G16H10/40;;G16H10/40;;G16H20/17;;G16H20/17;;H01L23/3107;;H01L23/3107;;H01L23/49548;;H01L23/49548;;H01L2924/0002;;H01L2924/0002;;H01L2924/19041;;H01L2924/19041;;H01L2924/3011;;H01L2924/3011;;Y10S128/903;;Y10S128/903;;Y10T29/49;;Y10T29/49;;Y10T29/49124;;Y10T29/49124,A61B5/00;;G01N27/30;;A61B5/145;;A61B5/1477;;A61B5/1495;;G01N27/416;;G06F19/00;;H01L23/31;;H01L23/495,600/365,99,70,062-360-289-025-864;;010-601-725-111-91X;;101-292-518-663-191;;030-155-762-644-019;;004-149-141-436-651;;016-731-054-793-457;;080-559-561-995-335;;044-807-213-528-815;;027-538-525-436-179;;015-020-161-517-40X;;025-919-454-564-785;;014-700-576-603-812;;004-851-060-590-788;;075-958-432-122-199;;052-356-140-149-389;;035-090-282-884-790;;018-803-926-589-211;;033-562-815-299-181;;008-505-762-041-402;;016-601-143-530-813;;019-502-772-562-215;;058-476-824-396-350;;006-498-707-073-30X;;054-091-551-638-293;;010-531-147-771-746;;054-827-198-877-419;;122-658-944-077-000;;017-261-560-469-37X;;000-125-755-474-124;;113-381-664-783-802;;082-626-907-191-554;;017-950-014-792-456;;090-348-305-613-628;;015-985-399-299-132;;171-049-047-164-618;;016-819-089-891-758;;081-249-097-078-543;;089-612-747-111-646;;031-706-897-890-035;;094-198-536-559-723;;003-690-143-043-420;;007-943-354-378-456;;004-239-090-971-580;;082-114-500-909-975;;026-894-457-160-450;;077-128-610-778-669;;022-466-506-956-898;;037-755-689-613-42X;;007-500-825-916-378;;009-725-244-669-882;;008-424-592-956-946;;037-755-689-613-42X;;153-411-506-517-475;;038-134-360-685-692;;012-449-714-188-064;;031-517-704-996-130;;131-299-284-996-064;;049-133-049-742-708;;000-272-178-768-076;;070-797-683-833-124;;043-870-224-178-49X;;025-574-914-238-550;;052-364-430-129-757;;004-434-167-910-115;;032-860-147-271-886;;132-460-374-211-421;;098-172-374-375-47X;;109-358-955-476-095;;014-988-634-483-130;;061-786-187-274-992,10.1021/ja00391a001;;2889225;;10.1098/rstb.1987.0021;;10.1109/51.294001;;2245876;;10.2337/diabetes.39.12.1519;;10.2337/diab.39.12.1519;;10.1016/s0956-5663(03)00220-3;;14611755;;18615658;;10.1002/bit.260430310;;9366023;;10.1016/s0956-5663(97)00025-0;;9451795;;10.1016/s0956-5663(97)00083-3;;10.1016/0956-5663(93)80028-n;;8311939;;8651496;;10.1021/ac960030d;;10.1080/03091900210156797;;12487712;;10.1016/0265-928x(87)80018-4;;3333622;;10.1109/19.816143;;10.1007/bf01015979;;10.1089/15209150252924058;;12017416;;18473691;;10.1089/dia.2007.0281;;2817408;;10.1021/ac00197a022;;10.1021/ac00017a008;;1789439;;10.1016/0925-4005(95)01730-5;;10.1016/0010-4825(90)90013-f;;2257734;;2868172;;8277748;;10.1016/0141-5425(93)90058-7;;11469630;;10.1089/15209150050214104;;10624783;;10.1016/s0168-8227(99)00113-8;;10.1089/15209150050214113;;11469631;;10.1007/bf00401374;;1478372;;10.2337/diacare.20.1.64;;9028696;;10.1109/tbme.1986.325807;;3957374;;236018;;10.1016/0005-2795(75)90259-7;;10.1089/hum.1998.9.6-879;;9581910;;11762520;;10.1089/15209150152607196;;10.2337/diabetes.48.3.445;;10078542;;10.1016/0265-928x(87)80012-3;;505005;;10.1126/science.505005;;10.1021/ac0498516;;15253640;;10.1109/10.284922;;8026845;;6721151;;10.1021/ac00268a018;;6733082;;10.1021/bi00305a016;;10.1515/cclm.2002.135;;12392305;;10.1016/j.ecl.2003.12.001;;15053902;;12052350;;10.1016/s0956-5663(01)00304-9;;12052349;;10.1016/s0956-5663(01)00306-2;;14021529;;10.1111/j.1749-6632.1962.tb13623.x;;4500021;;10.1007/978-1-4684-3288-6_18;;3196517;;10.2337/diacare.10.5.622;;3677983;;10.2337/diacare.8.6.529;;4075939;;10.1007/bf01248238;;7733469;;10.1021/ac00103a015;;7978306;;10.1021/ac00091a022;;10.1002/elan.1140061103;;10.1007/bf01248238;;10.1016/s0376-7388(98)00330-5;;10.1016/0142-9612(92)90147-g;;1472593;;10.1016/0265-928x(85)80002-x;;10.1021/j100290a001;;10.1021/ja00216a040;;10.1021/ja00188a091;;10.1021/ja00406a011;;2624333;;12323417;;10.1016/s0165-0270(02)00170-x;;10.1177/193229680700100208;;pmc2771467;;19888405;;10.1021/ja00415a014;;10.1007/bf00575392;;10.1021/ac00250a038;;10.1021/ac00266a005;;10.1007/s00216-002-1284-0;;12194035;;10.1089/dia.2006.0030;;17705688;;9642777;;10.1016/s0956-5663(97)00091-2;;10.1089/152091503322526978;;14633342,"U.S. Appl. No. 09/447,227, filed Nov. 22, 1999, Shults, et al.;;Abruna, H. D. et al. ""Rectifying Interfaces Using Two-Layer Films of Electrochemically Polymerized Vinylpyridine and Vinylbipyridine Complexes of Ruthenium and Iron on Electrodes,"" J Am. Chem. Soc., 103(1): 1-5 (Jan. 14, 1981).;;Albery, W. J. et al. ""Amperometric Enzyme Electrodes,"" Phil. Trans. R. Soc. Lond. 8316:107-119(1987).;;Albery, W. J. et al. ""Amperometric Enzyme Electrodes. Part II. Conducting salts as electrode materials for the oxidation of glucose Oxidase,"" J. Eleciroanal. Chem. Interfacial Electrochem., 194(2) (1 page-Abstract only) (1985).;;Alcock, S. J. et al. ""Continuous Analyte Monitoring to Aid Clinical Practice,"" IEEE Engineering in Medicine and Biology, 319-325 (1994).;;Anderson, L. B. et al. ""Thin-Layer Electrochemistry: Steady-State Methods of Studying Rate Processes"" J. Electroanal. Chem., 10:295-395 (1965).;;Armour, et al. Application of Chronic Intravascular Blood Glucose Sensor in Dogs, Diabetes, vol. 39, Dec. 1990.;;Asberg, P., et al., ""Hydrogels of a Conducting Conjugated Polymer as 3-D Enzyme Electrode"" Biosensors & Bioelectronics, vol. 19, 2003, pp. 199-207.;;Atanasov, P., et al., ""Biosensor for Continuous Glucose Monitoring"" Biotechnology and Bioengineering, vol. 43, 1994, pp. 262-266.;;Atanasov, P., et al., ""Implantation of a Refillable Glucose Monitoring-Telemetry Device"" Biosensors & Bioelectronics. vol. 12, No. 7, 1997, pp. 669-680.;;Aussedat, B., et al., ""A User-Friendly Method for Calibrating a Subcutaneous Glucose Sensor-Based Hypoglycaemic Alarm"" Biosensors & Bioelectronics, vol. 12, No. 11, 1997, pp. 1061-1071.;;Baker, D. A., et al., ""Dynamic Concentration Challenges for Biosensor Characterization"" Biosensors & Bioelectronics, vol. 8, 1993, pp. 433-441.;;Baker, D. A., et al., ""Dynamic Delay and Maximal Dynamic Error in Continuous Biosensors"" Analytical Chemistry, vol. 68, No. 8, 1996, pp. 1292-1297.;;Bani Amer, M. M., ""An Accurate Amperometric Glucose Sensor Based Glucometer with Eliminated Cross-Sensitivity"" Journal of Medical Engineering & Technology, vol. 26, No. 5, 2002, pp. 208-213.;;Bard, A. J., et al., Electrochemical Methods, 1980, pp. 173-175.;;Bartlett, P. N., et al. ""Covalent Binding of Electron Relays to Glucose Oxidation,"" J. Chem. Soc. Chem. Commun., 1603-1604 (1987).;;Bartlett, P. N., et al. ""Modification of Glucose Oxidase by Tetrathiafulvalene"" J. Chem. Soc., Chem. Commun., 16 (1 page-Abstract only) (1990).;;Bartlett, P. N., et al. ""Strategies for the Development of Amperometric Enzyme Electrodes"" Biosensors, 3:359-379 (1987/88).;;Beach, R. D., et al., ""Subminiature Implantable Potentiostat and Modified Commercial Telemetry Device for Remote Glucose Monitoring"" IEEE Transactions on Instrumentation and Measurement, vol. 28, No. 6, 1999, pp. 1239-1245.;;Beech, W. A., ""AX.25 Link Access Protocol for Amateur packet Radio"" Tucson Amateur Packet Radio Corporation, 1998, pp. 1-133.;;Bellucci, F., et al. ""Electrochemical Behaviour of Graphite-Epoxy Composite Materials (GECM) in Aqueous Salt Solutions"" Journal of Applied Electrochemistry. vol. 16, 1986, pp. 15-22.;;Bennion, N., et al., ""Alternate Site Glucose Testing: A Crossover Design"" Diabetes Technology & Therapeutics, vol. 4, No. 1, 2002, pp. 25-33.;;Biermann, E., et al. ""How Would Patients Behave if They Were Continually Informed of Their Blood Glucose Levels? A Simulation Study Using a 'Virtual' Patient"", Diabetes Technology & Therapeutics. vol. 10, No. 3, 2008, pp. 178-187.;;Bindra, D. S., et al., ""Pulsed Amperometric Detection of Glucose in Biological Fluids at a Surface-Modified Gold Electrode"" Analytical Chemistry, vol. 61, No. 22, 1989, pp. 2566-2570.;;Bindra, D.S., et al. ""Design and in Vitro Studies of a Needle-Type Glucose Sensor for Subcutaneous Monitoring"" Anal. Chem., 63(17):1692-1696 (Sep. 1, 1991).;;Bisenberger, M., et al., ""A Triple-Step Potential Waveform at Enzyme Multisensors with Thick-Film Gold Electrodes for Detection of Glucose and Sucrose"", Sensors and Actuators B, vol. 28, 1995, pp. 181-189.;;Bland, J. M., et al., ""A Note on the Use of the Intraclass Correlation Coefficient in the Evaluation of Agreement between Two Methods of Measurement"" Computers in Biology and Medicine, vol. 20, No. 5, 1990, pp. 337-340.;;Bland, J. M., et al., ""Statistical Methods for Assessing Agreement between Two Methods of Clinical Measurement"" The Lancet, 1986, pp. 307-310.;;Blank, T. B., et al., ""Clinical Results From a Non-Invasive Blood Glucose Monitor"" Optical Diagnostics and Sensing of Biological Fluids and Glucose and Cholesterol Monitoring II, Proceedings of SPIE, vol. 4624, 2002, pp. 1-10.;;Bobbioni-Harsch, E., et al. ""Lifespan of Subcutaneous Glucose Sensors and Their Performances During Dynamic Glycaemia Changes in Rats"" J. Biomed. Eng. 15:457-463 (1993).;;Bode, B. W., ""Clinical Utility of the Continuous Glucose Monitoring System"", Diabetes Technology & Therapeutics. vol. 2. Sup. 1, 2000, pp. S35-S41.;;Bode, B. W., et al., ""Continuous Glucose Monitoring Used to Adjust Diabetes Therapy Improves Glycosylated Hemoglobin: A Pilot Study"" Diabetes Research and Clinical Practice. vol. 46, 1999, pp. 183-190.;;Bode, B. W., et al., ""Using the Continuous Glucose Monitoring System to Improve the Management of Type I Diabetes"" Diabetes Technology & Therapeutics, vol. 2, Sup. 1, 2000, pp. S43-S48.;;Boedeker Plastics, Inc., ""Polyethylene Specifications"", Web Page of Boedeker.com, 2007, pp. 1-3.;;Bolinder, J., et al., ""Microdialysis Measurement of the Absolute Glucose Concentration in Subcutaneous Adipose Tissue Allowing Glucose Monitoring in Diabetic Patients"" Diabetologia, vol. 35, 1992, pp. 1177-1180.;;Bott, A. W., ""A Comparison of Cyclic Voltammetry and Cyclic Staircase Voltammetry"" Current Separations, vol. 16, No. 1, 1997, pp. 23-26.;;Bott, A. W., ""Electrochemical Methods for the Determination of Glucose"", Current Separations. vol. 17, No. 1, 1998, pp. 25-31.;;Bounder, J., et al., ""Self-Monitoring of Blood Glucose in Type I Diabetic Patients: Comparison with Continuous Microdialysis Measurements of Glucose in Subcutaneous Adipose Tissue during Ordinary Life Conditions"" Diabetes Care. vol. 20, No. 1, 1997, pp. 64-70.;;Bowman, L., et al., ""The Packaging of Implantable Integrated Sensors"" IEEE Transactions on Biomedical Engineering, vol. 33. No. 2, 1986, pp. 248-255.;;Brandt, J., et al. ""Covalent attachment of proteins to polysaccharide carriers by means of benzoquinone"" Biochim Biophys. Acta, 386(1) (1 page Abstract only) (1975).;;Brauker, J., et al., ""Sustained Expression of High Levels of Human Factor IX from Human Cells Implanted Within an Immunoisolation Device into Athymic Rodents"" Human Gene Therapy, vol. 9, No. 6, 1998, pp. 879-888.;;Bremer, T. M., et al., ""Benchmark Data from the Literature for Evaluation of New Glucose Sensing Technologies"" Diabetes Technology & Therapeutics, vol. 3, No. 3, 2001, pp. 409-418.;;Bremer, T., et al., ""Is Blood Glucose Predictable from Previous Values?"" Diabetes. vol. 48, 1999, pp. 445-451.;;Brooks, S. L., et al., ""Development of an On-Line Glucose Sensor for Fermentation Monitoring"" Biosensors, vol. 3, 1987/88, pp. 45-56.;;Brownlee, M., et al. ""A Glucose-Controlled Insulin-Delivery System: Semisynthetic Insulin Bound to Lectin"" Science, 206(4423):1190-1191 (Dec. 7, 1979).;;Cai, Q., et al., ""A Wireless, Remove Query Glucose Biosensor Based on a pH-Sensitive Polymer"" Analytical Chemistry, vol. 76, No. 14, 2004, pp. 4038-4043.;;Canadian Patent Application No. 2,433,144, Examiner's Report mailed Sep. 8, 2008.;;Candas, B., et al. ""An Adaptive Plasma Glucose Controller Based on a Nonlinear Insulin/Glucose Model"", IEEE Transactions on Biomedical Engineering, vol. 41, No. 2, 1994, pp. 116-124.;;Cass, A.E.G., et al. ""Ferricinum Ion as an Electron Acceptor for Oxido-Reductases"" J. Electroanal. Chem., 190:117-127(1985).;;Cass, A.E.G., et al. ""Ferrocene-Mediated Enzyme Electrode for Amperometric Determination of Glucose"" Anal. Chem., 56(4):667-671 (Apr. 1984).;;Castner, J. F., et al. ""Mass Transport and Reaction Kinetic Parameters Determined Electrochemically for Immobilized Glucose Oxidase"" Biochemistry, 23(10):2203-2210 (1984).;;Chen, J. C., et al., ""A Comparison of MAC Protocols for Wireless Local Networks Based on battery Power Consumption"" IEEE 1998, pp. 150-157.;;Chen, T., et al., ""Defining the Period of Recovery of the Glucose Concentration after Its Local Perturbation by the Implantation of a Miniature Sensor"", Clinical Chemistry and Laboratory Medicine, vol. 40, No. 8, 2002, pp. 486-489.;;Chia, C. W., et al., ""Glucose Sensors: Toward Closed Loop Insulin Delivery"" Endocrinology and Metabolism Clinics of North America, vol. 33, 2004, pp. 175-195.;;Chinese Patent Application No. 01822786.4, Office Action mailed Feb. 2, 2007.;;Chinese Patent Application No. 01822786.4, Office Action mailed Sep. 21, 2007.;;Choleau, C., et al., ""Calibration of a Subcutaneous Amperometric Glucose Sensor Implanted for 7 Days in Diabetic Patients Part 2: Superiority of the One-Point Calibration Method"" Biosensors and Bioelectronics. vol. 17, 2002, pp. 647-654.;;Choleau, C., et al., ""Calibration of a Subcutaneous Amperometric Glucose Sensor Part 1: Effect of Measurement Uncertainties on the Determination of Sensor Sensitivity and Background Current"" Biosensors and Bioelectronics, vol. 17, 2002, pp. 641-646.;;Claremont, D.J., et al. ""Biosensors for Continuous In Vivo Glucose Monitoring"" IEEE Engineering in Medicine and Biology Society 10th Annual International Conference, New Orleans, Louisiana, 3 pgs (Nov. 4-7, 1988).;;Clark, L.C. Jr., et al. ""Electrode Systems for Continuous Monitoring in Cardiovascular Surgery"" Annals New York Academy of Sciences, pp. 29-45 (1962).;;Clark, L.C., et al. ""Differential Anodic Enzyme Polarography for the Measurement of Glucose"" Oxygen Transport to Tissue Instrumentation, Methods, and Physiology, 127-132 (1973).;;Clark, L.C., et al. ""Long-term Stability of Electroenzymatic Glucose Sensors Implanted in Mice"" Trans. Am. Soc. Artf. Intern. Organs, XXXI V:259-265 (1988).;;Clarke, W. L., et al. ""Evaluating Clinical Accuracy of Systems for Self-Monitoring of Blood Glucose"" Diabetes Care, 10(5):622-628 (Sep.-Oct. 1987).;;Complaint, ""Abbott Diabetes Care, Inc. v. Dexcom, Inc."" filed Aug. 11, 2005.;;Complaint, Amended, ""Abbott Diabetes Care, Inc. v. Dexcom, Inc."" filed Jun. 27, 2006.;;Cox, D. J., et al., ""Accuracy of Perceiving Blood Glucose in IDDM"" Diabetes Care, vol. 8, No. 6, 1985, pp. 529-536.;;Csöregi, E. et al. ""On-Line Glucose Monitoring by Using Microdialysis Sampling and Ampertripetectio Based on 'Wired' Glucose Oxidase in Carbon Paste"" Mikrochim. Acta. 121:31-40 (1995).;;Csöregi, E., et al. ""Design and Optimization of a Selective Subcutaneously Implantable Glucose ectrode Based on 'Wired' Glucose Oxidase"" Anal. Chem. 67(7):1240-1244 (Apr. 1, 1995).;;Csöregi, E., et al. ""Design, Characterization, and One-Point in Vivo Calibration of a Subcutaneously Implanted Glucose Electrode"" Anal. Chem. 66(19):3 131-3138 (Oct. 1, 1994).;;Csoregi, E., et al., ""Amperometric Microbiosensors for Detection of Hydrogen Peroxide and Glucose Based on Peroxidase-Modified Carbon Fibers"" Electroanalysis, vol. 6, 1994, pp. 925-933.;;Csoregi, E., et al., ""On-Line Glucose Monitoring by Using Microdialysis Sampling and Amperometric Detection Based on 'Wired' Glucose Oxidase in Carbon Paste"" Mikrochimica Acta, vol. 121, 1995, pp. 31-40.;;D'Arrtgo, G., et al., ""Porous-Si Based Bio Reactors for Glucose Monitoring and Drugs Production"" Proceedings of SPIE: Microfluids, BioMEMS, and Medical Microsystems, vol. 4982, 2003, pp. 178-184.;;Dai, W. S., et al., ""Hydrogel Membranes with Mesh Size Asymmetry Based on the Gradient Crosslinking of Poly(vinyl alcohol)"" Journal of Membrane Science, vol. 156, 1999, pp. 67-79.;;Davies, M. L., et al. ""Polymer Membranes in Clinical Sensor Applications"", Biomaterials. vol. 13, No. 14, 1992, pp. 971-978.;;Davis, G. ""Electrochemical Techniques for the Development of Amperometric Biosensors"" Biosensors, 1:161-178 (1985).;;Degani, Y., et al. ""Direct Electrical Communication between Chemically Modified Enzymes and Metal Electrodes. 1. Electron Transfer from Glucose Oxidase to Metal Electrodes via Electron Relays, Bound Covalently to the Enzyme"" J. Phys. Chem., 91(6): 1285-1289 (1987).;;Degani, Y., et al. ""Direct Electrical Communication between Chemically Modified Enzymes and Metal Electrodes. 2. Methods for Bonding Electron-Transfer Relays to Glucose Oxidase and D-Amino-Acid Oxidase"" J. Am. Chem. Soc., 110(8):2615-2620 (1988).;;Degani, Y., et al. ""Electrical Communication between Redox Centers of Glucose Oxidase and Electrodes via Electrostatically and Covalently Bound Redox Polymers"" J. Am. Chem. Soc., 111:2357-2358 (1989).;;Denisevich, P., et al. ""Unidirectional Current Flow and Charge State Trapping at Redox Polymer Interfaces on Bilayer Electrodes: Principles, Experimental Demonstration and Theory,"" J. Am. Chem. Soc., 103(16):4727-4737 (1981).;;Dicks, J. M. ""Ferrocene modified polypyrrole with immobilised glucose oxidase and its application in amperometric glucose microbiosensors"" Ann. Biol. Clin., 47:607-619 (1989).;;Dixon, B. M., et al., ""Characterization In Vitro and In Vivo of the Oxygen Dependence of an Enzyme/Polymer Biosensors for Monitoring Brain Glucose"" Journal of Neuroscience Methods, vol. 119, 2002, pp. 135-142.;;Eighth Annual Diabetes Technology Meeting Abstracts, Nov. 13-15, 2008, pp. A1-A182.;;El-Khatib, F. H, et al., ""Adaptive Closed-Loop Control Provides Blood-Glucose Regulation Using Subcutaneous Insulin and Glucagon Infusion in Diabetic Swine"", Journal of Diabetes Science and Technology, vol. 1, No. 2, 2007, pp. 181-192.;;Ellis, C. D. ""Selectivity and Directed Charge Transfer through an Electroactive Metallopolymer Film"" J. Am. Chem. Soc., 103(25):7480-7483 (1981).;;El-Sa'ad, L., et al., ""Moisture Absorption by Epoxy Resins: The Reverse Thermal Effect"" Journal of Materials Science. vol. 25, No. 8, 1990, pp. 3577-3582.;;Engstrom, R.C. ""Electrochemical Pretreatment of Glassy Carbon Electrodes"" Anal. Chem., 54(13):2310-2314 (Nov. 1982).;;Engstrom, R.C., et al. ""Characterization of Electrochemically Pretreated Glassy Carbon Electrodes"" Anal. Chem., 56(2):136-141 (Feb. 1984).;;Ernst, H., et al., ""Reliable Glucose Monitoring Through the Use of Microsystem Technology"" Analytical and Bioanalytical Chemistry, vol. 373, 2002, pp. 758-761.;;European Patent Application No. 01 994 499.0, Examination Report mailed Dec. 7, 2006.;;European Patent Application No. 01 994 499.0, Examination Report mailed Feb. 10, 2009.;;European Patent Application No. 01 994 499.0, Examination Report mailed Oct. 11, 2007.;;European Patent Application No. 09 010 614.7, Extended European Search Report mailed Mar. 2,2010.;;European Patent Application No. 99 903 239.4, Examination Report mailed Apr. 14, 2008.;;European Patent Application No. 99 903 239.4, Examination Report mailed Dec. 20, 2004.;;European Patent Application No. 99 903 239.4, Examination Report mailed Oct. 7, 2005.;;Fabietti, P. G., et al. ""Clinical Validation of a New Control-Oriented Model of Insulin and Glucose Dynamics in Subjects with Type 1 Diabetes"" Diabetes Technology & Therapeutics, vol. 9, No. 4, 2007, pp. 327-338.;;Fare, T. L., et al., ""Functional Characterization of a Conducting Polymer-Based Immunoassay System"" Biosensors & Bioelectronics, vol. 13, No. 3-4, 1998, pp. 459-470.;;Feldman, B., et al., ""A Continuous Glucose Sensor Based on Wired Enzyme(TM) Technology-Results from a 3-Day Trial in Patients with Type 1 Diabetes"" Diabetes Technology & Therapeutics. vol. 5, No. 5, 2003, pp. 769-779.;;Feldman, B., et al., ""Correlation of Glucose Concentrations in Interstitial Fluid and Venous Blood during Periods of Rapid Glucose Change"" Abbott Diabetes Care, Inc. Freestyle Navigator Continuous Glucose Monitor Pamphlet.",EXPIRED
258,US,A1,US 2012/0263676 A1,059-255-863-548-086,2012-10-18,2012,US 201113336587 A,2011-12-23,US 201113336587 A;;US 81771804 A;;US 46067803 P;;US 47249403 P;;US 53203003 P;;US 54898604 P,2003-04-04,"COMPOSITIONS, METHODS AND KITS RELATING TO HER-2 CLEAVAGE","The present invention relates to compositions, methods and kits based on the ADAM-mediated cleavage of Her-2. The present invention also relates to treatments for cancer, and in particular, breast cancer, by modulating the ADAM-mediated cleavage of Her-2. Further, the invention relates to compositions, methods and kits based on the surprising synergistic effect between inhibition of Her-2 cleavage by an ADAM and certain cytostatic (e.g., Herceptin) and cytotoxic (e.g., Taxol) compounds in, among other things, inhibiting tumor cell proliferation and inducing cell death. Additionally, the invention relates to novel variants of ADAM15, designated ADAM15 variant 1 and ADAM15 variant 2, now identified and isolated.",FRIEDMAN STEVEN M;;SCHERLE PEGGY A;;LIU XIANGDONG;;BURN TIMOTHY C;;HUBER REID;;LIU PHILLIP C C;;HOLLIS GREGORY F;;VADDI KRISHNA;;FRIDMAN JORDAN S;;INCYTE CORP A DELAWARE CORP,FRIEDMAN STEVEN M;;SCHERLE PEGGY A;;LIU XIANGDONG;;BURN TIMOTHY C;;HUBER REID;;LIU PHILLIP C C;;HOLLIS GREGORY F;;VADDI KRISHNA;;FRIDMAN JORDAN S,INCYTE CORPORATION (2015-01-07);;INCYTE HOLDINGS CORPORATION (2015-01-07),https://lens.org/059-255-863-548-086,Patent Application,yes,0,2,10,10,48,A61K31/19;;A61K31/19;;A61K31/395;;A61K31/395;;A61P35/00;;A61P35/04,A61K31/496;;A61K/;;A61K31/19;;A61K31/444;;A61K31/472;;A61K31/495;;A61K31/541;;A61K31/713;;A61K38/20;;A61K38/21;;A61K39/395;;A61P35/00;;A61P35/04,424/85.2;;424/138.1;;424/130.1;;424/85.4;;424/133.1;;514/253.13;;514/255.01;;514/309;;514/227.8;;514/278;;X514 44  A,0,0,,,,ACTIVE
259,US,A1,US 2009/0216101 A1,079-933-317-171-07X,2009-08-27,2009,US 37153909 A,2009-02-13,US 37153909 A;;US 42005703 A;;US 66719900 A;;US 7067798 A,1998-04-30,Analyte Monitoring Device and Methods of Use,"An analyte monitor includes a sensor, a sensor control unit, and a display unit. The sensor has, for example, a substrate, a recessed channel formed in the substrate, and conductive material disposed in the recessed channel to form a working electrode. The sensor control unit typically has a housing adapted for placement on skin and is adapted to receive a portion of an electrochemical sensor. The sensor control unit also includes two or more conductive contacts disposed on the housing and configured for coupling to two or more contact pads on the sensor. A transmitter is disposed in the housing and coupled to the plurality of conductive contacts for transmitting data obtained using the sensor. The display unit has a receiver for receiving data transmitted by the transmitter of the sensor control unit and a display coupled to the receiver for displaying an indication of a level of an analyte. The analyte monitor may also be part of a drug delivery system to alter the level of the analyte based on the data obtained using the sensor.",ABBOTT DIABETES CARE INC,SAY JAMES;;TOMASCO MICHAEL F;;HELLER ADAM;;GAL YORAM;;ARIA BEHRAD;;HELLER EPHRAIM;;PLANTE PHILLIP JOHN;;VREEKE MARK S;;FRIEDMAN KEITH A;;COLMAN FREDRIC C,E. HELLER & CO (1998-07-02);;ABBOTT DIABETES CARE INC (2000-03-13),https://lens.org/079-933-317-171-07X,Patent Application,yes,198,57,211,221,0,A61B5/14532;;A61B5/14532;;A61B5/0002;;A61B5/0002;;A61B5/002;;A61B5/01;;A61B5/14503;;A61B5/1451;;A61B5/14546;;A61B5/14546;;A61B5/1473;;A61B5/1473;;A61B5/1486;;A61B5/1486;;A61B5/14865;;A61B5/1495;;A61B5/4839;;A61B5/72;;A61B5/7278;;A61B5/7282;;A61B5/7405;;A61B5/743;;A61B5/7445;;A61B5/7445;;A61B5/7455;;A61B2560/0252;;A61B2560/0252;;A61M5/1723;;C12Q1/54;;G16H10/40;;G16H10/40;;G16H20/17;;G16H20/17;;H01L23/3107;;H01L23/3107;;H01L23/49548;;H01L23/49548;;H01L2924/0002;;H01L2924/0002;;H01L2924/19041;;H01L2924/19041;;H01L2924/3011;;H01L2924/3011;;Y10S128/903;;Y10S128/903;;Y10T29/49;;Y10T29/49;;Y10T29/49124;;Y10T29/49124,A61B5/1468;;G01N27/30;;A61B5/00;;A61B5/145;;A61B5/1477;;A61B5/1495;;G01N27/416;;G06F19/00;;H01L23/31;;H01L23/495,600/347,0,0,,,,EXPIRED
260,US,B1,US 6565509 B1,096-614-364-675-631,2003-05-20,2003,US 66719900 A,2000-09-21,US 66719900 A;;US 7067798 A,1998-04-30,Analyte monitoring device and methods of use,"
    An analyte monitor includes a sensor, a sensor control unit, and a display unit. The sensor has, for example, a substrate, a recessed channel formed in the substrate, and conductive material disposed in the recessed channel to form a working electrode. The sensor control unit typically has a housing adapted for placement on skin and is adapted to receive a portion of an electrochemical sensor. The sensor control unit also includes two or more conductive contacts disposed on the housing and configured for coupling to two or more contact pads on the sensor. A transmitter is disposed in the housing and coupled to the plurality of conductive contacts for transmitting data obtained using the sensor. The display unit has a receiver for receiving data transmitted by the transmitter of the sensor control unit and a display coupled to the receiver for displaying an indication of a level of an analyte. The analyte monitor may also be part of a drug delivery system to alter the level of the analyte based on the data obtained using the sensor. 
",THERASENSE INC,SAY JAMES;;TOMASCO MICHAEL F;;HELLER ADAM;;GAL YORAM;;ARIA BEHRAD;;HELLER EPHRAIM;;PLANTE PHILLIP JOHN;;VREEKE MARK S;;FRIEDMAN KEITH A;;COLMAN FREDRIC C,E. HELLER & CO (1998-07-02);;ABBOTT DIABETES CARE INC (2000-03-13),https://lens.org/096-614-364-675-631,Granted Patent,yes,101,1350,211,221,0,A61B5/14532;;A61B5/14532;;A61B5/0002;;A61B5/0002;;A61B5/002;;A61B5/01;;A61B5/14503;;A61B5/1451;;A61B5/14546;;A61B5/14546;;A61B5/1473;;A61B5/1473;;A61B5/1486;;A61B5/1486;;A61B5/14865;;A61B5/1495;;A61B5/4839;;A61B5/72;;A61B5/7278;;A61B5/7282;;A61B5/7405;;A61B5/743;;A61B5/7445;;A61B5/7445;;A61B5/7455;;A61B2560/0252;;A61B2560/0252;;A61M5/1723;;C12Q1/54;;G16H10/40;;G16H10/40;;G16H20/17;;G16H20/17;;H01L23/3107;;H01L23/3107;;H01L23/49548;;H01L23/49548;;H01L2924/0002;;H01L2924/0002;;H01L2924/19041;;H01L2924/19041;;H01L2924/3011;;H01L2924/3011;;Y10S128/903;;Y10S128/903;;Y10T29/49;;Y10T29/49;;Y10T29/49124;;Y10T29/49124,G01N27/30;;A61B5/00;;A61B5/145;;A61B5/1477;;A61B5/1495;;G01N27/416;;G06F19/00;;H01L23/31;;H01L23/495,600/365;;600/347;;600/345,99,89,062-360-289-025-864;;010-601-725-111-91X;;101-292-518-663-191;;014-700-576-603-812;;033-562-815-299-181;;058-476-824-396-350;;000-125-755-474-124;;015-985-399-299-132;;081-249-097-078-543;;089-612-747-111-646;;082-114-500-909-975;;004-239-090-971-580;;026-894-457-160-450;;077-128-610-778-669;;009-725-244-669-882;;007-500-825-916-378;;037-755-689-613-42X;;012-449-714-188-064;;031-517-704-996-130;;131-299-284-996-064;;049-133-049-742-708;;000-272-178-768-076;;070-797-683-833-124;;032-860-147-271-886;;132-460-374-211-421;;052-364-430-129-757;;037-898-018-686-909;;130-044-667-529-69X;;065-221-074-461-027;;017-934-465-161-477;;101-660-130-379-529;;056-662-192-844-472;;131-420-472-995-124;;000-292-848-642-076;;037-547-642-717-655;;011-361-512-574-415;;006-033-609-366-053;;045-087-287-424-000;;112-172-675-119-141;;012-348-107-238-223;;057-907-035-573-356;;056-088-679-719-231;;158-841-328-840-967;;096-846-866-019-020;;046-051-917-287-322;;132-477-256-994-251;;126-256-551-957-406;;107-031-219-451-407;;070-035-450-644-84X;;073-842-915-397-35X;;002-244-337-345-21X;;068-386-284-377-434;;084-058-419-754-426;;011-920-220-103-986;;186-568-798-241-628;;083-932-858-886-510;;017-237-987-892-02X;;077-944-356-331-559;;015-613-189-270-414;;041-852-924-917-140;;052-850-283-559-75X;;047-861-542-219-382;;062-540-858-075-06X;;054-358-164-375-163;;031-531-088-033-656;;051-006-667-298-94X;;047-733-435-485-371;;003-067-671-137-047;;007-135-567-040-648;;006-536-656-748-868;;077-626-976-841-740;;035-535-925-014-211;;072-940-861-593-031;;024-011-256-425-251;;025-030-453-190-842;;030-775-076-635-419;;061-539-442-167-302;;008-149-576-479-541;;014-861-759-005-556;;035-211-086-138-107;;138-961-462-563-877;;115-233-158-409-162;;101-078-880-152-485;;007-757-545-982-964;;065-365-061-588-814;;116-750-608-164-513;;176-190-698-353-230;;063-392-112-944-585;;017-293-343-302-991,10.1021/ja00391a001;;2889225;;10.1098/rstb.1987.0021;;10.1109/51.294001;;10.1016/0265-928x(87)80018-4;;3333622;;10.1021/ac00017a008;;1789439;;8277748;;10.1016/0141-5425(93)90058-7;;236018;;10.1016/0005-2795(75)90259-7;;505005;;10.1126/science.505005;;6721151;;10.1021/ac00268a018;;6733082;;10.1021/bi00305a016;;4500021;;10.1007/978-1-4684-3288-6_18;;14021529;;10.1111/j.1749-6632.1962.tb13623.x;;3196517;;10.2337/diacare.10.5.622;;3677983;;7978306;;10.1021/ac00091a022;;7733469;;10.1021/ac00103a015;;10.1007/bf01248238;;10.1016/0265-928x(85)80002-x;;10.1021/j100290a001;;10.1021/ja00216a040;;10.1021/ja00188a091;;10.1021/ja00406a011;;2624333;;10.1021/ac00250a038;;10.1021/ac00266a005;;10.1021/ja00415a014;;10.1016/0022-0728(85)87006-6;;10.1021/ja00434a018;;10.1039/f19868201259;;3245585;;10.1021/ac00173a008;;2889234;;10.1098/rstb.1987.0020;;10.1016/0003-2670(91)85072-z;;10.1021/ac00202a007;;2305956;;10.1021/j100168a046;;10.1021/ja00191a084;;10.1021/ac00170a003;;3239784;;4356378;;10.1016/0925-4005(93)85356-f;;10.1021/j100188a007;;10.1021/ar00173a002;;10.1021/ac00236a033;;10.1021/ac00244a019;;10.1271/bbb1961.49.541;;10.1021/ja00415a004;;10.1021/ac00245a028;;10.1016/0925-4005(91)80225-9;;3842604;;10.1016/0265-928x(85)80005-5;;10.1149/1.2095533;;10.1021/ja00087a065;;1590584;;10.1021/ac00033a009;;10.1039/ft9969204131;;10.1016/0956-5663(91)85005-h;;2049169;;10.1016/0302-4598(90)80030-m;;10.1055/s-2007-1001749;;7875647;;10.1039/ft9938900361;;10.1021/ac00047a003;;1463213;;2712293;;10.1021/ac00176a006;;10.1016/0304-4165(85)90250-8;;3967047;;10.1016/0956-5663(92)85030-e;;1632948;;7926347;;10.1007/s001250050155;;10.1007/bf00403381;;10.1007/bf00400921;;1373393;;6130453;;10.1016/0024-3205(82)90736-6;;10.1016/0005-2744(76)90084-x;;182278;;10.1021/ac00071a031;;8297033;;8092486;;10.1021/ac00087a008;;10.1007/bf00580834;;567324;;10.1016/0022-0728(89)87165-7;;3812989;;10.1016/0003-2697(86)90315-5;;10.1016/0022-0728(95)04020-o;;10.1021/ja00047a065;;7763951;;10.1016/0167-7799(93)90016-3;;10.1007/bf00265097;;2666212;;10.1016/0265-928x(89)80026-4;;2719726;;1759711;;10.1021/ac00020a014;;10.1007/bf00404077;;8359584;;1457093;;10.1016/0956-5663(92)85010-8;;1751159;;10.1021/ja00540a026;;10.1021/ac00030a001;;10.1021/ac00030a718;;1580356;;2673892;;10.1007/bf00285330;;10.1016/0925-4005(93)85391-m;;10.1021/ja00392a010;;10.1021/ac00210a004;;2889233;;10.1098/rstb.1987.0019;;10.1016/0368-1874(83)80336-0;;10.1007/bf00250158;;6341145;;10.1021/ac00260a039;;10.1002/elan.1140080608;;7875646;;10.1055/s-2007-1001748,"Abruña, H. D. et al., ""Rectifying Interfaces Using Two-Layer Films of Electrochemically Polymerized Vinylpyridine and Vinylbipyridine Complexes of Ruthenium and Iron on Electrodes,"" J. Am. Chem. Soc., 103(1):1-5 (Jan. 14, 1981).;;Albery, W. J. et al., ""Amperometric enzyme electrodes. Part II. Conducting salts as electrode materials for the oxidation of glucose oxidase,"" J. Electroanal. Chem. Interfacial Electrochem., 194(2) (1 page-Abstract only) (1985).;;Albery, W. J. et al., ""Amperometric Enzyme Electrodes,"" Phil. Trans. R. Soc. Lond. B316:107-119 (1987).;;Alcock, S. J. et al., ""Continuous Analyte Monitoring to Aid Clinical Practice,"" IEEE Engineering in Medicine and Biology, 319-325 (1994).;;Anderson, L. B. et al., ""Thin-Layer Electrochemistry: Steady-State Methods of Studying Rate Processes,"" J. Electroanal. Chem., 10:295-395 (1965).;;Bartlett, P. N. et al., ""Covalent Binding of Electron Relays to Glucose Oxidation,"" J. Chem. Soc. Chem. Commun., 1603-1604 (1987).;;Bartlett, P. N. et al., ""Modification of glucose oxidase by tetrathiafulvalene,"" J. Chem. Soc., Chem. Commun., 16 (1 page-Abstract only) (1990).;;Bartlett, P. N. et al., ""Strategies for the Development of Amperometric Enzyme Electrodes,"" Biosensors, 3:359-379 (1987/88).;;Bindra, D.S. et al., ""Design and in Vitro Studies of a Needle-Type Glucose Sensor for Subcutaneous Monitoring"", Anal. Chem., 63(17):1692-1696 (Sep. 1, 1991).;;Bobbioni-Harsch, E. et al., ""Lifespan of subcutaneous glucose sensors and their performances during dynamic glycaemia changes in rats,"" J. Biomed. Eng. 15:457-463 (1993).;;Brandt, J. et al., ""Covalent attachment of proteins to polysaccharide carriers by means of benzoquinone,"" Biochim. Biophys. Acta, 386(1) (1 page Abstract only) (1975).;;Brownlee, M. et al., ""A Glucose-Controlled Insulin-Delivery System: Semisynthetic Insulin Bound to Lectin"", Science, 206(4423):1190-1191 (Dec. 7, 1979).;;Cass, A.E.G. et al., ""Ferricinum Ion As An Electron Acceptor for Oxido-Reductases,"" J. Electroanal. Chem., 190:117-127 (1985).;;Cass, A.E.G. et al., ""Ferrocene-Mediated Enzyme Electrode for Amperometric Determination of Glucose"", Anal. Chem., 56(4):667-671 (Apr. 1984).;;Castner, J. F. et al., ""Mass Transport and Reaction Kinetic Parameters Determined Electrochemically for Immobilized Glucose Oxidase,"" Biochemistry, 23(10):2203-2210 (1984).;;Claremont, D.J. et al., ""Biosensors for Continuous In Vivo Glucose Monitoring"", IEEE Engineering in Medicine and Biology Society 10th Annual International Conference, New Orleans, Louisiana, 3 pgs. (Nov. 4-7, 1988).;;Clark, L.C. et al., ""Differential Anodic Enzyme Polarography for the Measurement of Glucose"", Oxygen Transport to Tissue: Instrumentation, Methods, and Physiology, 127-132 (1973).;;Clark, L.C., Jr. et al., ""Electrode Systems for Continuous Monitoring in Cardiovascular Surgery,"" Annals New York Academy of Sciences, pp. 29-45 (1962).;;Clark, L.C. et al., ""Long-term Stability of Electroenzymatic Glucose Sensors Implanted in Mice,"" Trans. Am. Soc. Artif. Intern. Organs, XXXIV:259-265 (1988).;;Clarke, W. L., et al., ""Evaluating Clinical Accuracy of Systems for Self-Monitoring of Blood Glucose,"" Diabetes Care, 10(5):622-628 (Sep.-Oct. 1987).;;Csöregi, E. et al., ""Design, Characterization, and One-Point in Vivo Calibration of a Subcutaneously Implanted Glucose Electrode,"" Anal. Chem. 66(19):3131-3138 (Oct. 1, 1994).;;Csöregi, E. et al., ""Design and Optimization of a Selective Subcutaneously Implantable Glucose Electrode Based on ""Wired"" Glucose Oxidase,"" Anal. Chem. 67(7):1240-1244 (Apr. 1, 1995).;;Csöregi, E. et al., ""On-Line Glucose Monitoring by Using Microdialysis Sampling and Amperometric Detection Based on ""Wired"" Glucose Oxidase in Carbon Paste,"" Mikrochim. Acta. 121:31-40 (1995).;;Davis, G., ""Electrochemical Techniques for the Development of Amperometric Biosensors"", Biosensors, 1:161-178 (1985).;;Degani, Y. et al., ""Direct Electrical Communication between Chemically Modified Enzymes and Metal Electrodes. 1. Electron Transfer from Glucose Oxidase to Metal Electrodes via Electron Relays, Bound Covalently to the Enzyme,"" J. Phys. Chem., 91(6):1285-1289 (1987).;;Degani, Y. et al., ""Direct Electrical Communication between Chemically Modified Enzymes and Metal Electrodes. 2. Methods for Bonding Electron-Transfer Relays to Glucose Oxidase and D-Amino-Acid Oxidase,"" J. Am. Chem. Soc., 110(8):2615-2620 (1988).;;Degani, Y. et al., ""Electrical Communication between Redox Centers of Glucose Oxidase and Electrodes via Electrostatically and Covalently Bound Redox Polymers,"" J. Am. Chem. Soc., 111:2357-2358 (1989).;;Denisevich, P. et al., ""Unidirectional Current Flow and Charge State Trapping at Redox Polymer Interfaces on Bilayer Electrodes: Principles, Experimental Demonstration, and Theory,"" J. Am. Chem. Soc., 103(16):4727-4737 (1981).;;Dicks, J. M., ""Ferrocene modified polypyrrole with immobilised glucose oxidase and its application in amperometric glucose microbiosensors,"" Ann. Biol. clin., 47:607-619 (1989).;;Engstrom, R.C., ""Electrochemical Pretreatment of Glassy Carbon Electrodes"", Anal. Chem., 54(13):2310-2314 (Nov. 1982).;;Engstrom, R.C. et al., ""Characterization of Electrochemically Pretreated Glassy Carbon Electrodes"", Anal. Chem., 56(2):136-141 (Feb. 1984).;;Ellis, C. D., ""Selectivity and Directed Charge Transfer through an Electroactive Metallopolymer Film,"" J. Am. Chem. Soc., 103(25):7480-7483 (1981).;;Feldman, B.J. et al., ""Electron Transfer Kinetics at Redox Polymer/Solution Interfaces Using Microelectrodes and Twin Electrode Thin Layer Cells"", J. Electroanal. Chem., 194(1):63-81 (Oct. 10, 1985).;;Fischer, H. et al., ""Intramolecular Electron Transfer Mediated by 4,4'-Bipyridine and Related Bridging Groups"", J. Am. Chem. Soc., 98(18):5512-5517 (Sep. 1, 1976).;;Foulds, N.C. et al., ""Enzyme Entrapment in Electrically Conducting Polymers,"" J. Chem. Soc., Faraday Trans 1., 82:1259-1264 (1986).;;Foulds, N.C. et al., ""Immobilization of Glucose Oxidase in Ferrocene-Modified Pyrrole Polymers,"" Anal. Chem., 60(22):2473-2478 (Nov. 15, 1988).;;Frew, J.E. et al., ""Electron-Transfer Biosensors"", Phil. Trans. R. Soc. Lond., B316:95-106 (1987).;;Gorton, L. et al., ""Selective detection in flow analysis based on the combination of immobilized enzymes and chemically modified electrodes,"" Analytica Chimica Acta., 250:203-248 (1991).;;Gregg, B. A. et al., ""Cross-Linked Redox Gels Containing Glucose Oxidase for Amperometric Biosensor Applications,"" Analytical Chemistry, 62(3):258-263 (Feb. 1, 1990).;;Gregg, B. A. et al., ""Redox Polymer Films Containing Enzymes. 1. A Redox-Conducting Epoxy Cement: Synthesis, Characterization, and Electrocatalytic Oxidation of Hydroquinone,"" J. Phys. Chem., 95(15):5970-5975 (1991).;;Hale, P.D. et al., ""A New Class of Amperometric Biosensor Incorporating a Polymeric Electron-Transfer Mediator,"" J. Am. Chem. Soc., 111(9):3482-3484 (1989).;;Harrison, D.J. et al., ""Characterization of Perfluorosulfonic Acid Polymer Coated Enzyme Electrodes and a Miniaturized Integrated Potentiostat for Glucose Analysis in Whole Blood"", Anal. Chem., 60(19):2002-2007 (Oct. 1, 1988).;;Hawkridge, F. M. et al., ""Indirect Coulometric Titration of Biological Electron Transport Components,"" Analytical Chemistry, 45(7):1021-1027 (Jun. 1973).;;Heller, A., ""Amperometric biosensors based on three-dimensional hydrogel-forming epoxy networks,"" Sensors and Actuators B, 13-14:180-183 (1993).;;Heller, A., ""Electrical Connection of Enzyme Redox Centers to Electrodes,"" J. Phys. Chem., 96(9):3579-3587 (1992).;;Heller, A., ""Electrical Wiring of Redox Enzymes,"" Acc. Chem. Res., 23(5):129-134 (1990).;;Ianniello, R.M. et al. ""Immobilized Enzyme Chemically Modified Electrode as an Amperometric Sensor"", Anal. Chem., 53(13):2090-2095 (Nov. 1981).;;Ianniello, R.M. et al., ""Differential Pulse Voltammetric Study of Direct Electron Transfer in Glucose Oxidase Chemically Modified Graphite Electrodes"", Anal. Chem., 54(7):1098-1101 (Jun. 1981).;;Ikeda, T. et al., ""Glucose oxidase-immobilized benzoquinone-carbon paste electrode as a glucose sensor,"" Agric. Biol. Chem., 49(2) (1 page-Abstract only) (1985).;;Ikeda, T. et al., ""Kinetics of Outer-Sphere Electron Transfers Between Metal Complexes in Solutions and Polymeric Films on Modified Electrodes"", J. Am. Chem. Soc., 103(25):7422-7425 (Dec. 16, 1981).;;Johnson, J. M. et al., ""Potential-Dependent Enzymatic Activity in an Enzyme Thin-Layer Cell,"" Anal. Chem. 54:1377-1383 (1982).;;Johnson, K. W. et al., ""Reproducible Electrodeposition of Biomolecules for the Fabrication of Miniature Electroenzymatic Biosensors"", Sensors and Actuators B Chemical, B5:85-89 (1991).;;Jönsson, G. et al., ""An Amperometric Glucose Sensor Made by Modification of a Graphite Electrode Surface With Immobilized Glucose Oxidase and Adsorbed Mediator"", Biosensors, 1:355-368 (1985).;;Josowicz, M. et al., ""Electrochemical Pretreatment of Thin Film Platinum Electrodes"", J. Electrochem. Soc., 135(1):112-115 (Jan. 1988).;;Katakis, I. et al., ""Electrostatic Control of the Electron Transfer Enabling Binding of Recombinant Glucose Oxidase and Redox Polyelectrolytes,"" J. Am. Chem. Soc., 116(8):3617-3618 (1994).;;Katakis, I. et al., ""L-alpha-Glycerophosphate and L-Lactate Electrodes Based on the Electrochemical ""Wiring"" of Oxidases,"" Analytical Chemistry, 64(9):1008-1013 (May 1, 1992).;;Kenausis, G. et al., """"Wiring' of glucose oxidase and lactate oxidase within a hydrogel made with poly(vinyl pyridine) complexed with [Os(4,4'-dimethoxy-2,2'-bipyridine)2Cl]+/2+,"" J. Chem. Soc., Faraday Trans., 92(20):4131-4136 (1996).;;Koudelka, M. et al., ""In-Vivo Behaviour of Hypodermically Implanted Microfabricated Glucose Sensors"", Biosensors & Bioelectronics, 6(1):31-36 (1991).;;Kulys, J. et al., ""Mediatorless peroxidase electrode and preparation of bienzyme sensors,"" Bioelectrochemisty and Bioenergetics, 24:305-311 (1990).;;Lager, W. et al., ""Implantable Electrocatalytic Glucose Sensor,"" Horm. Metab. Res., 26:526-530 (Nov. 1994).;;Lindner, E. et al. ""Flexible (Kapton-Based) Microsensor Arrays of High Stability for Cardiovascular Applications"", J. Chem. Soc.Faraday Trans., 89(2):361-367 (Jan. 21, 1993).;;Maidan, R. et al., ""Elimination of Electrooxidizable Interferant-Produced Currents in Amperometric Biosensors,"" Analytical Chemistry, 64(23):2889-2896 (Dec. 1, 1992).;;Mastrototaro, J.J. et al., ""An Electroenzymatic Glucose Sensor Fabricated on a Flexible Substrate"", Sensors and Biosensors B Chemical, B5:139-144 (1991).;;McNeil, C. J. et al., ""Thermostable Reduced Nicotinamide Adenine Dinucleotide Oxidase: Application to Amperometric Enzyme Assay,"" Anal. Chem., 61(1):25-29 (Jan. 1, 1989).;;Miyawaki, O. et al., ""Electrochemical and Glucose Oxidase Coenzyme Activity of Flavin Adenine Dinucleotide Covalently Attached to Glassy Carbon at the Adenine Amino Group"", Biochimica et Biophysica Acta, 838:60-68 (1985).;;Moatti-Sirat, D. et al., ""Evaluating in vitro and in vivo the inteference of ascorbate and acetaminophen on glucose detection by a needle-type glucose sensor,"" Biosensors & Bioelectronics, 7(5):345-352 (1992).;;Moatti-Sirat, D. et al., ""Reduction of acetaminophen interference in glucose sensors by a composite Nafion membrane: demonstration in rats and man,"" Diabetologia, 37(6) (1 page-Abstract only) (Jun. 1994).;;Moatti-Sirat, D. et al., ""Towards continuous glucose monitoring: in vivo evaluation of a miniaturized glucose sensor implanted for several days in rat subcutaneous tissue,"" Diabetologia, 35(3) (1 page-Abstract only) (Mar. 1992).;;Nagy, G. et al., ""A New Type of Enzyme Electrode: The Ascorbic Acid Eliminator Electrode,"" Life Sciences, 31(23):2611-2616 (1982).;;Nakamura, S. et al., ""Effect of Periodate Oxidation on the Structure and Properties of Glucose Oxidase,"" Biochimica et Biophysica Acta., 445:294-308 (1976).;;Narazimhan, K. et al., ""p-Benzoquinone activation of metal oxide electrodes for attachment of enzymes,"" Enzyme Microb. Technol., 7(6) (1 page-Abstract only) (1985).;;Ohara, T. J. et al., ""Glucose Electrodes Based on Cross-Linked [Os(bpy)2CI]+/2+ Complexed Poly(1-vinylimadazole) Films,"" Analytical Chemistry, 65(23):3512-3516 (Dec. 1, 1993).;;Ohara, T. J., ""Osmium Bipyridyl Redox Polymers Used in Enzyme Electrodes,"" Platinum Metals Rev., 39(2):54-62 (Apr. 1995).;;Ohara, T. J. et al., """"Wired"" Enzyme Electrodes for Amperometric Determination of Glucose or Lactate in the Presence of Interfering Substances,"" Analytical Chemistry, 66(15):2451-2457 (Aug. 1, 1994).;;Olievier, C. N. et al., ""In vivo Measurement of Carbon Dioxide Tension with a Miniature Electrode,"" Pflugers Arch. 373:269-272 (1978).;;Paddock, R. et al., ""Electrocatalytic reduction of hydrogen peroxide via direct electron transfer from pyrolytic graphite electrodes to irreversibly adsorbed cytochrome c peroxidase,"" J. Electroanal. Chem., 260:487-494 (1989).;;Palleschi, G. et al., ""A Study of Interferences in Glucose Measurements in Blood by Hydrogen Peroxide Based Glucose Probes"", Anal. Biochem., 159:114-121 (1986).;;Pankratov, I. et al., ""Sol-gel derived renewable-surface biosensors,"" Journal of Electroanalytical Chemistry, 393:35-41 (1995).;;Pathak, C. P. et al., ""Rapid Photopolymerization of Immunoprotective Gels in Contact with Cells and Tissue,"" J. Am. Chem. Soc., 114(21):8311-8312 (1992).;;Pickup, J., ""Developing glucose sensors for in vivo use,"" Tibtech, 11: 285-289 (Jul. 1993).;;Pickup, J. C. et al., ""In vivo molecular sensing in diabetes mellitus: an implantable glucose sensor with direct electron transfer,"" Diabetologia, 32(3):213-217 (1989).;;Pickup, J. et al., ""Potentially-implantable, amperometric glucose sensors with mediated electron transfer: improving the operating stability,"" Biosensors, 4(2) (1 page-Abstract only) (1989).;;Pishko, M. V. et al., ""Amperometric Glucose Microelectrodes Prepared Through Immobilization of Glucose Oxidase in Redox Hydrogels"", Anal. Chem., 63(20):2268-2272 (Oct. 15, 1991).;;Poitout, V. et al., ""A glucose monitoring system for on line estimation in man of blood glucose concentration using a miniaturized glucose sensor implanted in the subcutaneous tissue and a wearable control unit,"" Diabetolgia, 36(7) (1 page-Abstract only) (Jul. 1993).;;Poitout, V. et al., ""Calibration in dogs of a subcutaneous miniaturized glucose sensor using a glucose meter for blood glucose determination,"" Biosensors & Bioelectronics, 7:587-592 (1992).;;Poitout, V. et al., ""In vitro and in vivo evaluation in dogs of a miniaturized glucose sensor,"" ASAIO Transactions, 37(3) (1 page-Abstract only) (Jul.-Sep. 1991).;;Pollak, A. et al., ""Enzyme Immobilization by Condensation Copolymerization into Cross-Linked Polyacrylamide Gels,"" J. Am. Chem. Soc., 102(20):6324-6336 (1980).;;Reach, G. et al., ""Can Continuous Glucose Monitoring Be Used for the Treatment of Diabetes?"" Analytical Chemistry, 64(6):381-386 (Mar. 15, 1992).;;Rebrin, K. et al., ""Automated Feedback Control of Subcutaneous Glucose Concentration in Diabetic Dogs"", Diabetologia, 32(8):573-576 (Aug. 1989).;;Sakakida, M. et al., ""Ferrocene-mediate needle-type glucose sensor covered with newly designed biocompatible membrane,"" Sensors and Actuators B, 13-14:319-322 (1993).;;Samuels, G. J. et al., ""An Electrode-Supported Oxidation Catalyst Based on Ruthenium (IV). pH ""Encapsulation"" in a Polymer Film,"" J. Am. Chem. Soc., 103(2):307-312 (1981).;;Sasso, S.V. et al., ""Electropolymerized 1,2-Diaminobenzene as a Means to Prevent Interferences and Fouling and to Stabilize Immobilized Enzyme in Electrochemical Biosensors"", Anal. Chem., 62(11):1111-1117 (Jun. 1, 1990).;;Scheller, F. et al., ""Enzyme electrodes and their application,"" Phil. Trans. R. Soc. Lond., B 316:85-94 (1987).;;Schmehl, R.H. et al., ""The Effect of Redox Site Concentration on the Rate of Mediated Oxidation of Solution Substrates by a Redox Copolymer Film"", J. Electroanal. Chem., 152:97-109 (Aug. 25, 1983).;;Shichiri, M. et al., ""Glycaemic Control in Pancreatetomized Dogs with a Wearable Artificial Endocrine Pancreas"", Diabetologia, 24(3):179-184 (Mar. 1983).;;Sittampalam, G. et al., ""Surface-Modified Electrochemical Detector for Liquid Chromatography"", Anal. Chem., 55(9):1608-1610 (Aug. 1983).;;Soegijoko, S. et al., Horm. Metabl. Res., Suppl. Ser, 12 (1 page-Abstract only) (1982).;;Sprules, S. D. et al., ""Evaluation of a New Disposable Screen-Printed Sensor Strip for the Measurement of NADH and Its Modification to Produce a Lactate Biosensor Employing Microliter Volumes,"" Electroanalysis, 8(6):539-543 (1996).;;Sternberg, F. et al., ""Calibration Problems of Subcutaneous Glucosensors when Applied ""In-Situ"" in Man,"" Horm. metabl. Res, 26:524-525 (1994).",EXPIRED
261,US,A1,US 2009/0227941 A1,103-752-444-756-56X,2009-09-10,2009,US 46878209 A,2009-05-19,US 46878209 A;;US 69560807 A;;US 42005703 A;;US 66719900 A;;US 7067798 A,1998-04-30,Analyte Monitoring Device and Methods of Use,"An analyte monitor includes a sensor, a sensor control unit, and a display unit. The sensor has, for example, a substrate, a recessed channel formed in the substrate, and conductive material disposed in the recessed channel to form a working electrode. The sensor control unit typically has a housing adapted for placement on skin and is adapted to receive a portion of an electrochemical sensor. The sensor control unit also includes two or more conductive contacts disposed on the housing and configured for coupling to two or more contact pads on the sensor. A transmitter is disposed in the housing and coupled to the plurality of conductive contacts for transmitting data obtained using the sensor. The display unit has a receiver for receiving data transmitted by the transmitter of the sensor control unit and a display coupled to the receiver for displaying an indication of a level of an analyte. The analyte monitor may also be part of a drug delivery system to alter the level of the analyte based on the data obtained using the sensor.",ABBOTT DIABETES CARE INC,SAY JAMES;;TOMASCO MICHAEL F;;HELLER ADAM;;GAL YORAM;;ARIA BEHRAD;;HELLER EPHRAIM;;PLANTE PHILLIP JOHN;;VREEKE MARK S;;FRIEDMAN KEITH A;;COLMAN FREDRIC C,,https://lens.org/103-752-444-756-56X,Patent Application,yes,2,59,211,221,0,A61B5/14532;;A61B5/14532;;A61B5/0002;;A61B5/0002;;A61B5/002;;A61B5/01;;A61B5/14503;;A61B5/1451;;A61B5/14546;;A61B5/14546;;A61B5/1473;;A61B5/1473;;A61B5/1486;;A61B5/1486;;A61B5/14865;;A61B5/1495;;A61B5/4839;;A61B5/72;;A61B5/7278;;A61B5/7282;;A61B5/7405;;A61B5/743;;A61B5/7445;;A61B5/7445;;A61B5/7455;;A61B2560/0252;;A61B2560/0252;;A61M5/1723;;C12Q1/54;;G16H10/40;;G16H10/40;;G16H20/17;;G16H20/17;;H01L23/3107;;H01L23/3107;;H01L23/49548;;H01L23/49548;;H01L2924/0002;;H01L2924/0002;;H01L2924/19041;;H01L2924/19041;;H01L2924/3011;;H01L2924/3011;;Y10S128/903;;Y10S128/903;;Y10T29/49;;Y10T29/49;;Y10T29/49124;;Y10T29/49124,A61M37/00;;G01N27/30;;A61B5/00;;A61B5/145;;A61B5/1477;;A61B5/1495;;G01N27/416;;G06F19/00;;H01L23/31;;H01L23/495,604/66,0,0,,,,DISCONTINUED
262,US,B2,US 9326714 B2,119-877-343-803-291,2016-05-03,2016,US 82569210 A,2010-06-29,US 82569210 A;;US 39388309 A;;US 42005703 A;;US 66719900 A;;US 7067798 A,1998-04-30,Analyte monitoring device and methods of use,"An analyte monitor includes a sensor, a sensor control unit, and a display unit. The sensor has, for example, a substrate, a recessed channel formed in the substrate, and conductive material disposed in the recessed channel to form a working electrode. The sensor control unit typically has a housing adapted for placement on skin and is adapted to receive a portion of an electrochemical sensor. The sensor control unit also includes two or more conductive contacts disposed on the housing and configured for coupling to two or more contact pads on the sensor. A transmitter is disposed in the housing and coupled to the plurality of conductive contacts for transmitting data obtained using the sensor. The display unit has a receiver for receiving data transmitted by the transmitter of the sensor control unit and a display coupled to the receiver for displaying an indication of a level of an analyte. The analyte monitor may also be part of a drug delivery system to alter the level of the analyte based on the data obtained using the sensor.",SAY JAMES;;TOMASCO MICHAEL F;;HELLER ADAM;;GAL YORAM;;ARIA BEHRAD;;HELLER EPHRAIM;;PLANTE PHILLIP JOHN;;VREEKE MARK S;;FRIEDMAN KEITH A;;COLMAN FREDRIC C;;ABBOTT DIABETES CARE INC,SAY JAMES;;TOMASCO MICHAEL F;;HELLER ADAM;;GAL YORAM;;ARIA BEHRAD;;HELLER EPHRAIM;;PLANTE PHILLIP JOHN;;VREEKE MARK S;;FRIEDMAN KEITH A;;COLMAN FREDRIC C,E. HELLER & CO (1998-07-02);;ABBOTT DIABETES CARE INC (2000-03-13),https://lens.org/119-877-343-803-291,Granted Patent,yes,101,3,211,221,0,A61B5/14532;;A61B5/14532;;A61B5/0002;;A61B5/0002;;A61B5/002;;A61B5/01;;A61B5/14503;;A61B5/1451;;A61B5/14546;;A61B5/14546;;A61B5/1473;;A61B5/1473;;A61B5/1486;;A61B5/1486;;A61B5/14865;;A61B5/1495;;A61B5/4839;;A61B5/72;;A61B5/7278;;A61B5/7282;;A61B5/7405;;A61B5/743;;A61B5/7445;;A61B5/7445;;A61B5/7455;;A61B2560/0252;;A61B2560/0252;;A61M5/1723;;C12Q1/54;;G16H10/40;;G16H10/40;;G16H20/17;;G16H20/17;;H01L23/3107;;H01L23/3107;;H01L23/49548;;H01L23/49548;;H01L2924/0002;;H01L2924/0002;;H01L2924/19041;;H01L2924/19041;;H01L2924/3011;;H01L2924/3011;;Y10S128/903;;Y10S128/903;;Y10T29/49;;Y10T29/49;;Y10T29/49124;;Y10T29/49124,A61B5/1486;;G01N27/30;;A61B5/00;;A61B5/01;;A61B5/145;;A61B5/1473;;A61B5/1477;;A61B5/1495;;A61M5/172;;C12Q1/54;;G01N27/416;;G06F19/00;;H01L23/31;;H01L23/495,,99,70,062-360-289-025-864;;010-601-725-111-91X;;101-292-518-663-191;;030-155-762-644-019;;004-149-141-436-651;;016-731-054-793-457;;080-559-561-995-335;;044-807-213-528-815;;027-538-525-436-179;;015-020-161-517-40X;;025-919-454-564-785;;014-700-576-603-812;;004-851-060-590-788;;075-958-432-122-199;;052-356-140-149-389;;035-090-282-884-790;;018-803-926-589-211;;033-562-815-299-181;;008-505-762-041-402;;016-601-143-530-813;;019-502-772-562-215;;058-476-824-396-350;;006-498-707-073-30X;;054-091-551-638-293;;010-531-147-771-746;;054-827-198-877-419;;122-658-944-077-000;;017-261-560-469-37X;;000-125-755-474-124;;113-381-664-783-802;;082-626-907-191-554;;017-950-014-792-456;;090-348-305-613-628;;015-985-399-299-132;;171-049-047-164-618;;016-819-089-891-758;;081-249-097-078-543;;089-612-747-111-646;;031-706-897-890-035;;094-198-536-559-723;;003-690-143-043-420;;007-943-354-378-456;;004-239-090-971-580;;082-114-500-909-975;;026-894-457-160-450;;077-128-610-778-669;;022-466-506-956-898;;037-755-689-613-42X;;007-500-825-916-378;;009-725-244-669-882;;008-424-592-956-946;;037-755-689-613-42X;;153-411-506-517-475;;038-134-360-685-692;;012-449-714-188-064;;031-517-704-996-130;;131-299-284-996-064;;049-133-049-742-708;;000-272-178-768-076;;070-797-683-833-124;;043-870-224-178-49X;;025-574-914-238-550;;052-364-430-129-757;;004-434-167-910-115;;032-860-147-271-886;;132-460-374-211-421;;098-172-374-375-47X;;109-358-955-476-095;;014-988-634-483-130;;061-786-187-274-992,10.1021/ja00391a001;;2889225;;10.1098/rstb.1987.0021;;10.1109/51.294001;;2245876;;10.2337/diabetes.39.12.1519;;10.2337/diab.39.12.1519;;10.1016/s0956-5663(03)00220-3;;14611755;;18615658;;10.1002/bit.260430310;;9366023;;10.1016/s0956-5663(97)00025-0;;9451795;;10.1016/s0956-5663(97)00083-3;;10.1016/0956-5663(93)80028-n;;8311939;;8651496;;10.1021/ac960030d;;10.1080/03091900210156797;;12487712;;10.1016/0265-928x(87)80018-4;;3333622;;10.1109/19.816143;;10.1007/bf01015979;;10.1089/15209150252924058;;12017416;;18473691;;10.1089/dia.2007.0281;;2817408;;10.1021/ac00197a022;;10.1021/ac00017a008;;1789439;;10.1016/0925-4005(95)01730-5;;10.1016/0010-4825(90)90013-f;;2257734;;2868172;;8277748;;10.1016/0141-5425(93)90058-7;;11469630;;10.1089/15209150050214104;;10624783;;10.1016/s0168-8227(99)00113-8;;10.1089/15209150050214113;;11469631;;10.1007/bf00401374;;1478372;;10.2337/diacare.20.1.64;;9028696;;10.1109/tbme.1986.325807;;3957374;;236018;;10.1016/0005-2795(75)90259-7;;10.1089/hum.1998.9.6-879;;9581910;;11762520;;10.1089/15209150152607196;;10.2337/diabetes.48.3.445;;10078542;;10.1016/0265-928x(87)80012-3;;505005;;10.1126/science.505005;;10.1021/ac0498516;;15253640;;10.1109/10.284922;;8026845;;6721151;;10.1021/ac00268a018;;6733082;;10.1021/bi00305a016;;10.1515/cclm.2002.135;;12392305;;10.1016/j.ecl.2003.12.001;;15053902;;12052350;;10.1016/s0956-5663(01)00304-9;;12052349;;10.1016/s0956-5663(01)00306-2;;14021529;;10.1111/j.1749-6632.1962.tb13623.x;;4500021;;10.1007/978-1-4684-3288-6_18;;3196517;;10.2337/diacare.10.5.622;;3677983;;10.2337/diacare.8.6.529;;4075939;;10.1007/bf01248238;;7733469;;10.1021/ac00103a015;;7978306;;10.1021/ac00091a022;;10.1002/elan.1140061103;;10.1007/bf01248238;;10.1016/s0376-7388(98)00330-5;;10.1016/0142-9612(92)90147-g;;1472593;;10.1016/0265-928x(85)80002-x;;10.1021/j100290a001;;10.1021/ja00216a040;;10.1021/ja00188a091;;10.1021/ja00406a011;;2624333;;12323417;;10.1016/s0165-0270(02)00170-x;;10.1177/193229680700100208;;pmc2771467;;19888405;;10.1021/ja00415a014;;10.1007/bf00575392;;10.1021/ac00250a038;;10.1021/ac00266a005;;10.1007/s00216-002-1284-0;;12194035;;10.1089/dia.2006.0030;;17705688;;9642777;;10.1016/s0956-5663(97)00091-2;;10.1089/152091503322526978;;14633342,"U.S. Appl. No. 09/447,227, filed Nov. 22, 1999, Shults, et al.;;Abruna, H. D. et al. ""Rectifying Interfaces Using Two-Layer Films of Electrochemically Polymerized Vinylpyridine and Vinylbipyridine Complexes of Ruthenium and Iron on Electrodes,"" J Am. Chem. Soc., 103(1): 1-5 (Jan. 14, 1981).;;Albery, W. J. et al. ""Amperometric Enzyme Electrodes,"" Phil. Trans. R. Soc. Lond. 8316:107-119(1987).;;Albery, W. J. et al. ""Amperometric Enzyme Electrodes. Part II. Conducting salts as electrode materials for the oxidation of glucose Oxidase,"" J. Eleciroanal. Chem. Interfacial Electrochem., 194(2) (1 page-Abstract only) (1985).;;Alcock, S. J. et al. ""Continuous Analyte Monitoring to Aid Clinical Practice,"" IEEE Engineering in Medicine and Biology, 319-325 (1994).;;Anderson, L. B. et al. ""Thin-Layer Electrochemistry: Steady-State Methods of Studying Rate Processes"" J. Electroanal. Chem., 10:295-395 (1965).;;Armour, et al. Application of Chronic Intravascular Blood Glucose Sensor in Dogs, Diabetes, vol. 39, Dec. 1990.;;Asberg, P., et al., ""Hydrogels of a Conducting Conjugated Polymer as 3-D Enzyme Electrode"" Biosensors & Bioelectronics, vol. 19, 2003, pp. 199-207.;;Atanasov, P., et al., ""Biosensor for Continuous Glucose Monitoring"" Biotechnology and Bioengineering, vol. 43, 1994, pp. 262-266.;;Atanasov, P., et al., ""Implantation of a Refillable Glucose Monitoring-Telemetry Device"" Biosensors & Bioelectronics. vol. 12, No. 7, 1997, pp. 669-680.;;Aussedat, B., et al., ""A User-Friendly Method for Calibrating a Subcutaneous Glucose Sensor-Based Hypoglycaemic Alarm"" Biosensors & Bioelectronics, vol. 12, No. 11, 1997, pp. 1061-1071.;;Baker, D. A., et al., ""Dynamic Concentration Challenges for Biosensor Characterization"" Biosensors & Bioelectronics, vol. 8, 1993, pp. 433-441.;;Baker, D. A., et al., ""Dynamic Delay and Maximal Dynamic Error in Continuous Biosensors"" Analytical Chemistry, vol. 68, No. 8, 1996, pp. 1292-1297.;;Bani Amer, M. M., ""An Accurate Amperometric Glucose Sensor Based Glucometer with Eliminated Cross-Sensitivity"" Journal of Medical Engineering & Technology, vol. 26, No. 5, 2002, pp. 208-213.;;Bard, A. J., et al., Electrochemical Methods, 1980, pp. 173-175.;;Bartlett, P. N., et al. ""Covalent Binding of Electron Relays to Glucose Oxidation,"" J. Chem. Soc. Chem. Commun., 1603-1604 (1987).;;Bartlett, P. N., et al. ""Modification of Glucose Oxidase by Tetrathiafulvalene"" J. Chem. Soc., Chem. Commun., 16 (1 page-Abstract only) (1990).;;Bartlett, P. N., et al. ""Strategies for the Development of Amperometric Enzyme Electrodes"" Biosensors, 3:359-379 (1987/88).;;Beach, R. D., et al., ""Subminiature Implantable Potentiostat and Modified Commercial Telemetry Device for Remote Glucose Monitoring"" IEEE Transactions on Instrumentation and Measurement, vol. 28, No. 6, 1999, pp. 1239-1245.;;Beech, W. A., ""AX.25 Link Access Protocol for Amateur packet Radio"" Tucson Amateur Packet Radio Corporation, 1998, pp. 1-133.;;Bellucci, F., et al. ""Electrochemical Behaviour of Graphite-Epoxy Composite Materials (GECM) in Aqueous Salt Solutions"" Journal of Applied Electrochemistry. vol. 16, 1986, pp. 15-22.;;Bennion, N., et al., ""Alternate Site Glucose Testing: A Crossover Design"" Diabetes Technology & Therapeutics, vol. 4, No. 1, 2002, pp. 25-33.;;Biermann, E., et al. ""How Would Patients Behave if They Were Continually Informed of Their Blood Glucose Levels? A Simulation Study Using a 'Virtual' Patient"", Diabetes Technology & Therapeutics. vol. 10, No. 3, 2008, pp. 178-187.;;Bindra, D. S., et al., ""Pulsed Amperometric Detection of Glucose in Biological Fluids at a Surface-Modified Gold Electrode"" Analytical Chemistry, vol. 61, No. 22, 1989, pp. 2566-2570.;;Bindra, D.S., et al. ""Design and in Vitro Studies of a Needle-Type Glucose Sensor for Subcutaneous Monitoring"" Anal. Chem., 63(17):1692-1696 (Sep. 1, 1991).;;Bisenberger, M., et al., ""A Triple-Step Potential Waveform at Enzyme Multisensors with Thick-Film Gold Electrodes for Detection of Glucose and Sucrose"", Sensors and Actuators B, vol. 28, 1995, pp. 181-189.;;Bland, J. M., et al., ""A Note on the Use of the Intraclass Correlation Coefficient in the Evaluation of Agreement between Two Methods of Measurement"" Computers in Biology and Medicine, vol. 20, No. 5, 1990, pp. 337-340.;;Bland, J. M., et al., ""Statistical Methods for Assessing Agreement between Two Methods of Clinical Measurement"" The Lancet, 1986, pp. 307-310.;;Blank, T. B., et al., ""Clinical Results From a Non-Invasive Blood Glucose Monitor"" Optical Diagnostics and Sensing of Biological Fluids and Glucose and Cholesterol Monitoring II, Proceedings of SPIE, vol. 4624, 2002, pp. 1-10.;;Bobbioni-Harsch, E., et al. ""Lifespan of Subcutaneous Glucose Sensors and Their Performances During Dynamic Glycaemia Changes in Rats"" J. Biomed. Eng. 15:457-463 (1993).;;Bode, B. W., ""Clinical Utility of the Continuous Glucose Monitoring System"", Diabetes Technology & Therapeutics. vol. 2. Sup. 1, 2000, pp. S35-S41.;;Bode, B. W., et al., ""Continuous Glucose Monitoring Used to Adjust Diabetes Therapy Improves Glycosylated Hemoglobin: A Pilot Study"" Diabetes Research and Clinical Practice. vol. 46, 1999, pp. 183-190.;;Bode, B. W., et al., ""Using the Continuous Glucose Monitoring System to Improve the Management of Type I Diabetes"" Diabetes Technology & Therapeutics, vol. 2, Sup. 1, 2000, pp. S43-S48.;;Boedeker Plastics, Inc., ""Polyethylene Specifications"", Web Page of Boedeker.com, 2007, pp. 1-3.;;Bolinder, J., et al., ""Microdialysis Measurement of the Absolute Glucose Concentration in Subcutaneous Adipose Tissue Allowing Glucose Monitoring in Diabetic Patients"" Diabetologia, vol. 35, 1992, pp. 1177-1180.;;Bott, A. W., ""A Comparison of Cyclic Voltammetry and Cyclic Staircase Voltammetry"" Current Separations, vol. 16, No. 1, 1997, pp. 23-26.;;Bott, A. W., ""Electrochemical Methods for the Determination of Glucose"", Current Separations. vol. 17, No. 1, 1998, pp. 25-31.;;Bounder, J., et al., ""Self-Monitoring of Blood Glucose in Type I Diabetic Patients: Comparison with Continuous Microdialysis Measurements of Glucose in Subcutaneous Adipose Tissue during Ordinary Life Conditions"" Diabetes Care. vol. 20, No. 1, 1997, pp. 64-70.;;Bowman, L., et al., ""The Packaging of Implantable Integrated Sensors"" IEEE Transactions on Biomedical Engineering, vol. 33. No. 2, 1986, pp. 248-255.;;Brandt, J., et al. ""Covalent attachment of proteins to polysaccharide carriers by means of benzoquinone"" Biochim. Biophys. Acta, 386(1) (1 page Abstract only) (1975).;;Brauker, J., et al., ""Sustained Expression of High Levels of Human Factor IX from Human Cells Implanted Within an Immunoisolation Device into Athymic Rodents"" Human Gene Therapy, vol. 9, No. 6, 1998, pp. 879-888.;;Bremer, T. M., et al., ""Benchmark Data from the Literature for Evaluation of New Glucose Sensing Technologies"" Diabetes Technology & Therapeutics, vol. 3, No. 3, 2001, pp. 409-418.;;Bremer, T., et al., ""Is Blood Glucose Predictable from Previous Values?"" Diabetes. vol. 48, 1999, pp. 445-451.;;Brooks, S. L., et al., ""Development of an On-Line Glucose Sensor for Fermentation Monitoring"" Biosensors, vol. 3, 1987/88, pp. 45-56.;;Brownlee, M., et al. ""A Glucose-Controlled Insulin-Delivery System: Semisynthetic Insulin Bound to Lectin"" Science, 206(4423):1190-1191 (Dec. 7, 1979).;;Cai, Q., et al., ""A Wireless, Remove Query Glucose Biosensor Based on a pH-Sensitive Polymer"" Analytical Chemistry, vol. 76, No. 14, 2004, pp. 4038-4043.;;Canadian Patent Application No. 2,433,144, Examiner's Report mailed Sep. 8, 2008.;;Candas, B., et al. ""An Adaptive Plasma Glucose Controller Based on a Nonlinear Insulin/Glucose Model"", IEEE Transactions on Biomedical Engineering, vol. 41, No. 2, 1994, pp. 116-124.;;Cass, A.E.G., et al. ""Ferricinum Ion as an Electron Acceptor for Oxido-Reductases"" J. Electroanal. Chem., 190:117-127(1985).;;Cass, A.E.G., et al. ""Ferrocene-Mediated Enzyme Electrode for Amperometric Determination of Glucose"" Anal. Chem., 56(4):667-671 (Apr. 1984).;;Castner, J. F., et al. ""Mass Transport and Reaction Kinetic Parameters Determined Electrochemically for Immobilized Glucose Oxidase"" Biochemistry, 23(10):2203-2210 (1984).;;Chen, J. C., et al., ""A Comparison of MAC Protocols for Wireless Local Networks Based on battery Power Consumption"" IEEE 1998, pp. 150-157.;;Chen, T., et al., ""Defining the Period of Recovery of the Glucose Concentration after Its Local Perturbation by the Implantation of a Miniature Sensor"", Clinical Chemistry and Laboratory Medicine, vol. 40, No. 8, 2002, pp. 486-489.;;Chia, C. W., et al., ""Glucose Sensors: Toward Closed Loop Insulin Delivery"" Endocrinology and Metabolism Clinics of North America, vol. 33, 2004, pp. 175-195.;;Chinese Patent Application No. 01822786.4, Office Action mailed Feb. 2, 2007.;;Chinese Patent Application No. 01822786.4, Office Action mailed Sep. 21, 2007.;;Choleau, C., et al., ""Calibration of a Subcutaneous Amperometric Glucose Sensor Implanted for 7 Days in Diabetic Patients Part 2: Superiority of the One-Point Calibration Method"" Biosensors and Bioelectronics. vol. 17, 2002, pp. 647-654.;;Choleau, C., et al., ""Calibration of a Subcutaneous Amperometric Glucose Sensor Part 1: Effect of Measurement Uncertainties on the Determination of Sensor Sensitivity and Background Current"" Biosensors and Bioelectronics, vol. 17, 2002, pp. 641-646.;;Claremont, D.J., et al. ""Biosensors for Continuous In Vivo Glucose Monitoring"" IEEE Engineering in Medicine and Biology Society 10th Annual International Conference, New Orleans, Louisiana, 3 pgs (Nov. 4-7, 1988).;;Clark, L.C. Jr., et al. ""Electrode Systems for Continuous Monitoring in Cardiovascular Surgery"" Annals New York Academy of Sciences, pp. 29-45 (1962).;;Clark, L.C., et al. ""Differential Anodic Enzyme Polarography for the Measurement of Glucose"" Oxygen Transport to Tissue Instrumentation, Methods, and Physiology, 127-132 (1973).;;Clark, L.C., et al. ""Long-term Stability of Electroenzymatic Glucose Sensors Implanted in Mice"" Trans. Am. Soc. Artf. Intern. Organs, XXXI V:259-265 (1988).;;Clarke, W. L., et al. ""Evaluating Clinical Accuracy of Systems for Self-Monitoring of Blood Glucose"" Diabetes Care, 10(5):622-628 (Sep.-Oct. 1987).;;Complaint, ""Abbott Diabetes Care, Inc. v. Dexcom, Inc."" filed Aug. 11, 2005.;;Complaint, Amended, ""Abbott Diabetes Care, Inc. v. Dexcom, Inc."" filed Jun. 27, 2006.;;Cox, D. J., et al., ""Accuracy of Perceiving Blood Glucose in IDDM"" Diabetes Care, vol. 8, No. 6, 1985, pp. 529-536.;;Csöregi, E. et al. ""On-Line Glucose Monitoring by Using Microdialysis Sampling and Ampertripetectio Based on 'Wired' Glucose Oxidase in Carbon Paste"" Mikrochim. Acta. 121:31-40(1995).;;Csöregi, E., et al. ""Design and Optimization of a Selective Subcutaneously Implantable Glucose ectrode Based on 'Wired' Glucose Oxidase"" Anal. Chem. 67(7):1240-1244 (Apr. 1, 1995).;;Csöregi, E., et al. ""Design, Characterization, and One-Point in Vivo Calibration of a Subcutaneously Implanted Glucose Electrode"" Anal. Chem. 66(19):3 131-3138 (Oct. 1, 1994).;;Csoregi, E., et al., ""Amperometric Microbiosensors for Detection of Hydrogen Peroxide and Glucose Based on Peroxidase-Modified Carbon Fibers"" Electroanalysis, vol. 6, 1994, pp. 925-933.;;Csoregi, E., et al., ""On-Line Glucose Monitoring by Using Microdialysis Sampling and Amperometric Detection Based on 'Wired' Glucose Oxidase in Carbon Paste"" Mikrochimica Acta, vol. 121, 1995, pp. 31-40.;;D'Arrtgo, G., et al., ""Porous-Si Based Bio Reactors for Glucose Monitoring and Drugs Production"" Proceedings of SPIE: Microfluids, BioMEMS, and Medical Microsystems, vol. 4982, 2003, pp. 178-184.;;Dai, W. S., et al., ""Hydrogel Membranes with Mesh Size Asymmetry Based on the Gradient Crosslinking of Poly(vinyl alcohol)"" Journal of Membrane Science, vol. 156, 1999, pp. 67-79.;;Davies, M. L., et al. ""Polymer Membranes in Clinical Sensor Applications"", Biomaterials. vol. 13, No. 14, 1992, pp. 971-978.;;Davis, G. ""Electrochemical Techniques for the Development of Amperometric Biosensors"" Biosensors, 1:161-178 (1985).;;Degani, Y., et al. ""Direct Electrical Communication between Chemically Modified Enzymes and Metal Electrodes. 1. Electron Transfer from Glucose Oxidase to Metal Electrodes via Electron Relays, Bound Covalently to the Enzyme"" J. Phys. Chem., 91(6): 1285-1289 (1987).;;Degani, Y., et al. ""Direct Electrical Communication between Chemically Modified Enzymes and Metal Electrodes. 2. Methods for Bonding Electron-Transfer Relays to Glucose Oxidase and D-Amino-Acid Oxidase"" J. Am. Chem. Soc., 110(8):2615-2620 (1988).;;Degani, Y., et al. ""Electrical Communication between Redox Centers of Glucose Oxidase and Electrodes via Electrostatically and Covalently Bound Redox Polymers"" J. Am. Chem. Soc., 111:2357-2358 (1989).;;Denisevich, P., et al. ""Unidirectional Current Flow and Charge State Trapping at Redox Polymer Interfaces on Bilayer Electrodes: Principles, Experimental Demonstration and Theory,"" J. Am. Chem. Soc., 103(16):4727-4737 (1981).;;Dicks, J. M. ""Ferrocene modified polypyrrole with immobilised glucose oxidase and its application in amperometric glucose microbiosensors"" Ann. Biol. Clin., 47:607-619 (1989).;;Dixon, B. M., et al., ""Characterization In Vitro and In Vivo of the Oxygen Dependence of an Enzyme/Polymer Biosensors for Monitoring Brain Glucose"" Journal of Neuroscience Methods, vol. 119, 2002, pp. 135-142.;;Eighth Annual Diabetes Technology Meeting Abstracts, Nov. 13-15, 2008, pp. A1-A182.;;El-Khatib, F. H, et al., ""Adaptive Closed-Loop Control Provides Blood-Glucose Regulation Using Subcutaneous Insulin and Glucagon Infusion in Diabetic Swine"", Journal of Diabetes Science and Technology, vol. 1, No. 2, 2007, pp. 181-192.;;Ellis, C. D. ""Selectivity and Directed Charge Transfer through an Electroactive Metallopolymer Film"" J. Am. Chem. Soc., 103(25):7480-7483 (1981).;;El-Sa'ad, L., et al., ""Moisture Absorption by Epoxy Resins: The Reverse Thermal Effect"" Journal of Materials Science. vol. 25, No. 8, 1990, pp. 3577-3582.;;Engstrom, R.C. ""Electrochemical Pretreatment of Glassy Carbon Electrodes"" Anal. Chem., 54(13):2310-2314 (Nov. 1982).;;Engstrom, R.C., et al. ""Characterization of Electrochemically Pretreated Glassy Carbon Electrodes"" Anal. Chem., 56(2):136-141 (Feb. 1984).;;Ernst, H., et al., ""Reliable Glucose Monitoring Through the Use of Microsystem Technology"" Analytical and Bioanalytical Chemistry, vol. 373, 2002, pp. 758-761.;;European Patent Application No. 01 994 499.0, Examination Report mailed Dec. 7, 2006.;;European Patent Application No. 01 994 499.0, Examination Report mailed Feb. 10, 2009.;;European Patent Application No. 01 994 499.0, Examination Report mailed Oct. 11, 2007.;;European Patent Application No. 09 010 614.7, Extended European Search Report mailed Mar. 2, 2010.;;European Patent Application No. 99 903 239.4, Examination Report mailed Apr. 14, 2008.;;European Patent Application No. 99 903 239.4, Examination Report mailed Dec. 20, 2004.;;European Patent Application No. 99 903 239.4, Examination Report mailed Oct. 7, 2005.;;Fabietti, P. G., et al. ""Clinical Validation of a New Control-Oriented Model of Insulin and Glucose Dynamics in Subjects with Type 1 Diabetes"" Diabetes Technology & Therapeutics, vol. 9, No. 4, 2007, pp. 327-338.;;Fare, T. L., et al., ""Functional Characterization of a Conducting Polymer-Based Immunoassay System"" Biosensors & Bioelectronics, vol. 13, No. 3-4, 1998, pp. 459-470.;;Feldman, B., et al., ""A Continuous Glucose Sensor Based on Wired Enzyme(TM) Technology-Results from a 3-Day Trial in Patients with Type 1 Diabetes"" Diabetes Technology & Therapeutics. vol. 5, No. 5, 2003, pp. 769-779.;;Feldman, B., et al., ""Correlation of Glucose Concentrations in Interstitial Fluid and Venous Blood during Periods of Rapid Glucose Change"" Abbott Diabetes Care, Inc. Freestyle Navigator Continuous Glucose Monitor Pamphlet.",EXPIRED
263,US,A1,US 2009/0187095 A1,126-677-663-632-492,2009-07-23,2009,US 41457709 A,2009-03-30,US 41457709 A;;US 42005703 A;;US 66719900 A;;US 7067798 A,1998-04-30,Analyte Monitoring Device and Methods of Use,"An analyte monitor includes a sensor, a sensor control unit, and a display unit. The sensor has, for example, a substrate, a recessed channel formed in the substrate, and conductive material disposed in the recessed channel to form a working electrode. The sensor control unit typically has a housing adapted for placement on skin and is adapted to receive a portion of an electrochemical sensor. The sensor control unit also includes two or more conductive contacts disposed on the housing and configured for coupling to two or more contact pads on the sensor. A transmitter is disposed in the housing and coupled to the plurality of conductive contacts for transmitting data obtained using the sensor. The display unit has a receiver for receiving data transmitted by the transmitter of the sensor control unit and a display coupled to the receiver for displaying an indication of a level of an analyte. The analyte monitor may also be part of a drug delivery system to alter the level of the analyte based on the data obtained using the sensor.",ABBOTT DIABETES CARE INC,SAY JAMES;;TOMASCO MICHAEL F;;HELLER ADAM;;GAL YORAM;;ARIA BEHRAD;;HELLER EPHRAIM;;PLANTE PHILLIP JOHN;;VREEKE MARK S;;FRIEDMAN KEITH A;;COLMAN FREDRIC C,,https://lens.org/126-677-663-632-492,Patent Application,yes,1,57,211,221,0,A61B5/14532;;A61B5/14532;;A61B5/0002;;A61B5/0002;;A61B5/002;;A61B5/01;;A61B5/14503;;A61B5/1451;;A61B5/14546;;A61B5/14546;;A61B5/1473;;A61B5/1473;;A61B5/1486;;A61B5/1486;;A61B5/14865;;A61B5/1495;;A61B5/4839;;A61B5/72;;A61B5/7278;;A61B5/7282;;A61B5/7405;;A61B5/743;;A61B5/7445;;A61B5/7445;;A61B5/7455;;A61B2560/0252;;A61B2560/0252;;A61M5/1723;;C12Q1/54;;G16H10/40;;G16H10/40;;G16H20/17;;G16H20/17;;H01L23/3107;;H01L23/3107;;H01L23/49548;;H01L23/49548;;H01L2924/0002;;H01L2924/0002;;H01L2924/19041;;H01L2924/19041;;H01L2924/3011;;H01L2924/3011;;Y10S128/903;;Y10S128/903;;Y10T29/49;;Y10T29/49;;Y10T29/49124;;Y10T29/49124,A61B5/1468;;G01N27/30;;A61B5/00;;A61B5/145;;A61B5/1477;;A61B5/1495;;G01N27/416;;G06F19/00;;H01L23/31;;H01L23/495,600/345,0,0,,,,DISCONTINUED
264,DK,T3,DK 1075209 T3,132-587-278-392-312,2015-01-19,2015,DK 99903239 T,1999-01-21,US 7067798 A;;US 9901229 W,1998-04-30,Analytovervågningsapparat,,ABBOTT DIABETES CARE INC,GAL YORAM;;FRIEDMAN KEITH A;;HELLER ADAM;;HELLER EPHRAIM;;PLANTE PHILLIP J;;VREEKE MARK S;;COLMAN FREDRIC C;;SAY JAMES;;TOMASCO MICHAEL F;;ARIA BEHRAD,,https://lens.org/132-587-278-392-312,Granted Patent,no,0,0,211,221,0,A61B5/14532;;A61B5/14532;;A61B5/0002;;A61B5/0002;;A61B5/002;;A61B5/01;;A61B5/14503;;A61B5/1451;;A61B5/14546;;A61B5/14546;;A61B5/1473;;A61B5/1473;;A61B5/1486;;A61B5/1486;;A61B5/14865;;A61B5/1495;;A61B5/4839;;A61B5/72;;A61B5/7278;;A61B5/7282;;A61B5/7405;;A61B5/743;;A61B5/7445;;A61B5/7445;;A61B5/7455;;A61B2560/0252;;A61B2560/0252;;A61M5/1723;;C12Q1/54;;G16H10/40;;G16H10/40;;G16H20/17;;G16H20/17;;H01L23/3107;;H01L23/3107;;H01L23/49548;;H01L23/49548;;H01L2924/0002;;H01L2924/0002;;H01L2924/19041;;H01L2924/19041;;H01L2924/3011;;H01L2924/3011;;Y10S128/903;;Y10S128/903;;Y10T29/49;;Y10T29/49;;Y10T29/49124;;Y10T29/49124,A61B5/00;;G01N27/30;;A61B5/145;;A61B5/1477;;A61B5/1495;;G01N27/416;;G06F19/00;;H01L23/31;;H01L23/495,,0,0,,,,EXPIRED
265,US,A1,US 2009/0069658 A1,180-504-618-076-194,2009-03-12,2009,US 21012208 A,2008-09-12,US 21012208 A;;US 42005703 A;;US 66719900 A;;US 7067798 A,1998-04-30,Analyte Monitoring Device and Methods of Use,"An analyte monitor includes a sensor, a sensor control unit, and a display unit. The sensor has, for example, a substrate, a recessed channel formed in the substrate, and conductive material disposed in the recessed channel to form a working electrode. The sensor control unit typically has a housing adapted for placement on skin and is adapted to receive a portion of an electrochemical sensor. The sensor control unit also includes two or more conductive contacts disposed on the housing and configured for coupling to two or more contact pads on the sensor. A transmitter is disposed in the housing and coupled to the plurality of conductive contacts for transmitting data obtained using the sensor. The display unit has a receiver for receiving data transmitted by the transmitter of the sensor control unit and a display coupled to the receiver for displaying an indication of a level of an analyte. The analyte monitor may also be part of a drug delivery system to alter the level of the analyte based on the data obtained using the sensor.",ABBOTT DIABETES CARE INC,SAY JAMES;;TOMASCO MICHAEL F;;HELLER ADAM;;GAL YORAM;;ARIA BEHRAD;;HELLER EPHRAIM;;PLANTE PHILLIP JOHN;;VREEKE MARK S;;FRIEDMAN KEITH A;;COLMAN FREDRIC C,,https://lens.org/180-504-618-076-194,Patent Application,yes,1,143,211,221,0,A61B5/14532;;A61B5/14532;;A61B5/0002;;A61B5/0002;;A61B5/002;;A61B5/01;;A61B5/14503;;A61B5/1451;;A61B5/14546;;A61B5/14546;;A61B5/1473;;A61B5/1473;;A61B5/1486;;A61B5/1486;;A61B5/14865;;A61B5/1495;;A61B5/4839;;A61B5/72;;A61B5/7278;;A61B5/7282;;A61B5/7405;;A61B5/743;;A61B5/7445;;A61B5/7445;;A61B5/7455;;A61B2560/0252;;A61B2560/0252;;A61M5/1723;;C12Q1/54;;G16H10/40;;G16H10/40;;G16H20/17;;G16H20/17;;H01L23/3107;;H01L23/3107;;H01L23/49548;;H01L23/49548;;H01L2924/0002;;H01L2924/0002;;H01L2924/19041;;H01L2924/19041;;H01L2924/3011;;H01L2924/3011;;Y10S128/903;;Y10S128/903;;Y10T29/49;;Y10T29/49;;Y10T29/49124;;Y10T29/49124,A61B5/1473;;G01N27/30;;A61B5/00;;A61B5/145;;A61B5/1477;;A61B5/1495;;G01N27/416;;G06F19/00;;H01L23/31;;H01L23/495,600/347;;600/345,0,0,,,,DISCONTINUED
266,US,A1,US 2009/0099432 A1,197-541-624-114-935,2009-04-16,2009,US 27056408 A,2008-11-13,US 27056408 A;;US 42005703 A;;US 66719900 A;;US 7067798 A,1998-04-30,Analyte Monitoring Device and Methods of Use,"An analyte monitor includes a sensor, a sensor control unit, and a display unit. The sensor has, for example, a substrate, a recessed channel formed in the substrate, and conductive material disposed in the recessed channel to form a working electrode. The sensor control unit typically has a housing adapted for placement on skin and is adapted to receive a portion of an electrochemical sensor. The sensor control unit also includes two or more conductive contacts disposed on the housing and configured for coupling to two or more contact pads on the sensor. A transmitter is disposed in the housing and coupled to the plurality of conductive contacts for transmitting data obtained using the sensor. The display unit has a receiver for receiving data transmitted by the transmitter of the sensor control unit and a display coupled to the receiver for displaying an indication of a level of an analyte. The analyte monitor may also be part of a drug delivery system to alter the level of the analyte based on the data obtained using the sensor.",ABBOTT DIABETES CARE INC,SAY JAMES;;TOMASCO MICHAEL F;;HELLER ADAM;;GAL YORAM;;ARIA BEHRAD;;HELLER EPHRAIM;;PLANTE PHILLIP JOHN;;VREEKE MARK S;;FRIEDMAN KEITH A;;COLMAN FREDRIC C,,https://lens.org/197-541-624-114-935,Patent Application,yes,1,24,211,221,0,A61B5/14532;;A61B5/14532;;A61B5/0002;;A61B5/0002;;A61B5/002;;A61B5/01;;A61B5/14503;;A61B5/1451;;A61B5/14546;;A61B5/14546;;A61B5/1473;;A61B5/1473;;A61B5/1486;;A61B5/1486;;A61B5/14865;;A61B5/1495;;A61B5/4839;;A61B5/72;;A61B5/7278;;A61B5/7282;;A61B5/7405;;A61B5/743;;A61B5/7445;;A61B5/7445;;A61B5/7455;;A61B2560/0252;;A61B2560/0252;;A61M5/1723;;C12Q1/54;;G16H10/40;;G16H10/40;;G16H20/17;;G16H20/17;;H01L23/3107;;H01L23/3107;;H01L23/49548;;H01L23/49548;;H01L2924/0002;;H01L2924/0002;;H01L2924/19041;;H01L2924/19041;;H01L2924/3011;;H01L2924/3011;;Y10S128/903;;Y10S128/903;;Y10T29/49;;Y10T29/49;;Y10T29/49124;;Y10T29/49124,A61B5/05;;G01N27/30;;A61B5/00;;A61B5/145;;A61B5/1477;;A61B5/1495;;G01N27/416;;G06F19/00;;H01L23/31;;H01L23/495,600/345,0,0,,,,DISCONTINUED
267,US,A1,US 2009/0209838 A1,015-449-263-524-119,2009-08-20,2009,US 41447409 A,2009-03-30,US 41447409 A;;US 42005703 A;;US 66719900 A;;US 7067798 A,1998-04-30,Analyte Monitoring Device and Methods of Use,"An analyte monitor includes a sensor, a sensor control unit, and a display unit. The sensor has, for example, a substrate, a recessed channel formed in the substrate, and conductive material disposed in the recessed channel to form a working electrode. The sensor control unit typically has a housing adapted for placement on skin and is adapted to receive a portion of an electrochemical sensor. The sensor control unit also includes two or more conductive contacts disposed on the housing and configured for coupling to two or more contact pads on the sensor. A transmitter is disposed in the housing and coupled to the plurality of conductive contacts for transmitting data obtained using the sensor. The display unit has a receiver for receiving data transmitted by the transmitter of the sensor control unit and a display coupled to the receiver for displaying an indication of a level of an analyte. The analyte monitor may also be part of a drug delivery system to alter the level of the analyte based on the data obtained using the sensor.",ABBOTT DIABETES CARE INC,SAY JAMES;;TOMASCO MICHAEL F;;HELLER ADAM;;GAL YORAM;;ARIA BEHRAD;;HELLER EPHRAIM;;PLANTE PHILLIP JOHN;;VREEKE MARK S;;FRIEDMAN KEITH A;;COLMAN FREDRIC C,,https://lens.org/015-449-263-524-119,Patent Application,yes,2,11,211,221,0,A61B5/14532;;A61B5/14532;;A61B5/0002;;A61B5/0002;;A61B5/002;;A61B5/01;;A61B5/14503;;A61B5/1451;;A61B5/14546;;A61B5/14546;;A61B5/1473;;A61B5/1473;;A61B5/1486;;A61B5/1486;;A61B5/14865;;A61B5/1495;;A61B5/4839;;A61B5/72;;A61B5/7278;;A61B5/7282;;A61B5/7405;;A61B5/743;;A61B5/7445;;A61B5/7445;;A61B5/7455;;A61B2560/0252;;A61B2560/0252;;A61M5/1723;;C12Q1/54;;G16H10/40;;G16H10/40;;G16H20/17;;G16H20/17;;H01L23/3107;;H01L23/3107;;H01L23/49548;;H01L23/49548;;H01L2924/0002;;H01L2924/0002;;H01L2924/19041;;H01L2924/19041;;H01L2924/3011;;H01L2924/3011;;Y10S128/903;;Y10S128/903;;Y10T29/49;;Y10T29/49;;Y10T29/49124;;Y10T29/49124,A61B5/1468;;G01N27/30;;A61B5/00;;A61B5/145;;A61B5/1477;;A61B5/1495;;G01N27/416;;G06F19/00;;H01L23/31;;H01L23/495,600/345,0,0,,,,DISCONTINUED
268,US,A1,US 2009/0187091 A1,025-800-860-220-867,2009-07-23,2009,US 41451109 A,2009-03-30,US 41451109 A;;US 42005703 A;;US 66719900 A;;US 7067798 A,1998-04-30,Analyte Monitoring Device and Methods of Use,"An analyte monitor includes a sensor, a sensor control unit, and a display unit. The sensor has, for example, a substrate, a recessed channel formed in the substrate, and conductive material disposed in the recessed channel to form a working electrode. The sensor control unit typically has a housing adapted for placement on skin and is adapted to receive a portion of an electrochemical sensor. The sensor control unit also includes two or more conductive contacts disposed on the housing and configured for coupling to two or more contact pads on the sensor. A transmitter is disposed in the housing and coupled to the plurality of conductive contacts for transmitting data obtained using the sensor. The display unit has a receiver for receiving data transmitted by the transmitter of the sensor control unit and a display coupled to the receiver for displaying an indication of a level of an analyte. The analyte monitor may also be part of a drug delivery system to alter the level of the analyte based on the data obtained using the sensor.",ABBOTT DIABETES CARE INC,SAY JAMES;;TOMASCO MICHAEL F;;HELLER ADAM;;GAL YORAM;;ARIA BEHRAD;;HELLER EPHRAIM;;PLANTE PHILLIP JOHN;;VREEKE MARK S;;FRIEDMAN KEITH A;;COLMAN FREDRIC C,,https://lens.org/025-800-860-220-867,Patent Application,yes,1,110,211,221,0,A61B5/14532;;A61B5/14532;;A61B5/0002;;A61B5/0002;;A61B5/002;;A61B5/01;;A61B5/14503;;A61B5/1451;;A61B5/14546;;A61B5/14546;;A61B5/1473;;A61B5/1473;;A61B5/1486;;A61B5/1486;;A61B5/14865;;A61B5/1495;;A61B5/4839;;A61B5/72;;A61B5/7278;;A61B5/7282;;A61B5/7405;;A61B5/743;;A61B5/7445;;A61B5/7445;;A61B5/7455;;A61B2560/0252;;A61B2560/0252;;A61M5/1723;;C12Q1/54;;G16H10/40;;G16H10/40;;G16H20/17;;G16H20/17;;H01L23/3107;;H01L23/3107;;H01L23/49548;;H01L23/49548;;H01L2924/0002;;H01L2924/0002;;H01L2924/19041;;H01L2924/19041;;H01L2924/3011;;H01L2924/3011;;Y10S128/903;;Y10S128/903;;Y10T29/49;;Y10T29/49;;Y10T29/49124;;Y10T29/49124,A61B5/1468;;G01N27/30;;A61B5/00;;A61B5/145;;A61B5/1477;;A61B5/1495;;G01N27/416;;G06F19/00;;H01L23/31;;H01L23/495,600/345,0,0,,,,DISCONTINUED
269,US,A1,US 2009/0187092 A1,022-188-310-055-062,2009-07-23,2009,US 41453109 A,2009-03-30,US 41453109 A;;US 42005703 A;;US 66719900 A;;US 7067798 A,1998-04-30,Analyte Monitoring Device and Methods of Use,"An analyte monitor includes a sensor, a sensor control unit, and a display unit. The sensor has, for example, a substrate, a recessed channel formed in the substrate, and conductive material disposed in the recessed channel to form a working electrode. The sensor control unit typically has a housing adapted for placement on skin and is adapted to receive a portion of an electrochemical sensor. The sensor control unit also includes two or more conductive contacts disposed on the housing and configured for coupling to two or more contact pads on the sensor. A transmitter is disposed in the housing and coupled to the plurality of conductive contacts for transmitting data obtained using the sensor. The display unit has a receiver for receiving data transmitted by the transmitter of the sensor control unit and a display coupled to the receiver for displaying an indication of a level of an analyte. The analyte monitor may also be part of a drug delivery system to alter the level of the analyte based on the data obtained using the sensor.",ABBOTT DIABETES CARE INC,SAY JAMES;;TOMASCO MICHAEL F;;HELLER ADAM;;GAL YORAM;;ARIA BEHRAD;;HELLER EPHRAIM;;PLANTE PHILLIP JOHN;;VREEKE MARK S;;FRIEDMAN KEITH A;;COLMAN FREDRIC C,,https://lens.org/022-188-310-055-062,Patent Application,yes,6,57,211,221,0,A61B5/14532;;A61B5/14532;;A61B5/0002;;A61B5/0002;;A61B5/002;;A61B5/01;;A61B5/14503;;A61B5/1451;;A61B5/14546;;A61B5/14546;;A61B5/1473;;A61B5/1473;;A61B5/1486;;A61B5/1486;;A61B5/14865;;A61B5/1495;;A61B5/4839;;A61B5/72;;A61B5/7278;;A61B5/7282;;A61B5/7405;;A61B5/743;;A61B5/7445;;A61B5/7445;;A61B5/7455;;A61B2560/0252;;A61B2560/0252;;A61M5/1723;;C12Q1/54;;G16H10/40;;G16H10/40;;G16H20/17;;G16H20/17;;H01L23/3107;;H01L23/3107;;H01L23/49548;;H01L23/49548;;H01L2924/0002;;H01L2924/0002;;H01L2924/19041;;H01L2924/19041;;H01L2924/3011;;H01L2924/3011;;Y10S128/903;;Y10S128/903;;Y10T29/49;;Y10T29/49;;Y10T29/49124;;Y10T29/49124,A61B5/1468;;G01N27/30;;A61B5/00;;A61B5/145;;A61B5/1477;;A61B5/1495;;G01N27/416;;G06F19/00;;H01L23/31;;H01L23/495,600/345,0,0,,,,DISCONTINUED
270,US,A1,US 2009/0203978 A1,043-931-484-500-939,2009-08-13,2009,US 10904908 A,2008-04-24,US 10904908 A;;US 42005703 A;;US 66719900 A;;US 7067798 A,1998-04-30,Analyte Monitoring Device and Methods of Use,"An analyte monitor includes a sensor, a sensor control unit, and a display unit. The sensor has, for example, a substrate, a recessed channel formed in the substrate, and conductive material disposed in the recessed channel to form a working electrode. The sensor control unit typically has a housing adapted for placement on skin and is adapted to receive a portion of an electrochemical sensor. The sensor control unit also includes two or more conductive contacts disposed on the housing and configured for coupling to two or more contact pads on the sensor. A transmitter is disposed in the housing and coupled to the plurality of conductive contacts for transmitting data obtained using the sensor. The display unit has a receiver for receiving data transmitted by the transmitter of the sensor control unit and a display coupled to the receiver for displaying an indication of a level of an analyte. The analyte monitor may also be part of a drug delivery system to alter the level of the analyte based on the data obtained using the sensor.",ABBOTT DIABETES CARE INC,SAY JAMES;;TOMASCO MICHAEL F;;HELLER ADAM;;GAL YORAM;;ARIA BEHRAD;;HELLER EPHRAIM;;PLANTE PHILLIP JOHN;;VREEKE MARK S;;FRIEDMAN KEITH A;;COLMAN FREDRIC C,,https://lens.org/043-931-484-500-939,Patent Application,yes,3,67,211,221,0,A61B5/14532;;A61B5/14532;;A61B5/0002;;A61B5/0002;;A61B5/002;;A61B5/01;;A61B5/14503;;A61B5/1451;;A61B5/14546;;A61B5/14546;;A61B5/1473;;A61B5/1473;;A61B5/1486;;A61B5/1486;;A61B5/14865;;A61B5/1495;;A61B5/4839;;A61B5/72;;A61B5/7278;;A61B5/7282;;A61B5/7405;;A61B5/743;;A61B5/7445;;A61B5/7445;;A61B5/7455;;A61B2560/0252;;A61B2560/0252;;A61M5/1723;;C12Q1/54;;G16H10/40;;G16H10/40;;G16H20/17;;G16H20/17;;H01L23/3107;;H01L23/3107;;H01L23/49548;;H01L23/49548;;H01L2924/0002;;H01L2924/0002;;H01L2924/19041;;H01L2924/19041;;H01L2924/3011;;H01L2924/3011;;Y10S128/903;;Y10S128/903;;Y10T29/49;;Y10T29/49;;Y10T29/49124;;Y10T29/49124,A61B5/1473;;G01N27/30;;A61B5/00;;A61B5/05;;A61B5/145;;A61B5/1477;;A61B5/1495;;G01N27/416;;G06F19/00;;H01L23/31;;H01L23/495,600/347;;600/345,0,0,,,,DISCONTINUED
271,US,B2,US 8473021 B2,054-852-538-290-249,2013-06-25,2013,US 53368009 A,2009-07-31,US 53368009 A;;US 42005703 A;;US 66719900 A;;US 7067798 A,1998-04-30,Analyte monitoring device and methods of use,"An analyte monitor includes a sensor, a sensor control unit, and a display unit. The sensor has, for example, a substrate, a recessed channel formed in the substrate, and conductive material disposed in the recessed channel to form a working electrode. The sensor control unit typically has a housing adapted for placement on skin and is adapted to receive a portion of an electrochemical sensor. The sensor control unit also includes two or more conductive contacts disposed on the housing and configured for coupling to two or more contact pads on the sensor. A transmitter is disposed in the housing and coupled to the plurality of conductive contacts for transmitting data obtained using the sensor. The display unit has a receiver for receiving data transmitted by the transmitter of the sensor control unit and a display coupled to the receiver for displaying an indication of a level of an analyte. The analyte monitor may also be part of a drug delivery system to alter the level of the analyte based on the data obtained using the sensor.",SAY JAMES;;TOMASCO MICHAEL F;;HELLER ADAM;;GAL YORAM;;ARIA BEHRAD;;HELLER EPHRAIM;;PLANTE PHILLIP JOHN;;VREEKE MARK S;;FRIEDMAN KEITH A;;COLMAN FREDRIC C;;ABBOTT DIABETES CARE INC,SAY JAMES;;TOMASCO MICHAEL F;;HELLER ADAM;;GAL YORAM;;ARIA BEHRAD;;HELLER EPHRAIM;;PLANTE PHILLIP JOHN;;VREEKE MARK S;;FRIEDMAN KEITH A;;COLMAN FREDRIC C,E. HELLER & CO (1998-07-02);;ABBOTT DIABETES CARE INC (2000-03-13),https://lens.org/054-852-538-290-249,Granted Patent,yes,107,0,211,221,0,A61B5/14532;;A61B5/14532;;A61B5/0002;;A61B5/0002;;A61B5/002;;A61B5/01;;A61B5/14503;;A61B5/1451;;A61B5/14546;;A61B5/14546;;A61B5/1473;;A61B5/1473;;A61B5/1486;;A61B5/1486;;A61B5/14865;;A61B5/1495;;A61B5/4839;;A61B5/72;;A61B5/7278;;A61B5/7282;;A61B5/7405;;A61B5/743;;A61B5/7445;;A61B5/7445;;A61B5/7455;;A61B2560/0252;;A61B2560/0252;;A61M5/1723;;C12Q1/54;;G16H10/40;;G16H10/40;;G16H20/17;;G16H20/17;;H01L23/3107;;H01L23/3107;;H01L23/49548;;H01L23/49548;;H01L2924/0002;;H01L2924/0002;;H01L2924/19041;;H01L2924/19041;;H01L2924/3011;;H01L2924/3011;;Y10S128/903;;Y10S128/903;;Y10T29/49;;Y10T29/49;;Y10T29/49124;;Y10T29/49124,A61B5/05;;G01N27/30;;A61B5/00;;A61B5/145;;A61B5/1477;;A61B5/1495;;G01N27/416;;G06F19/00;;H01L23/31;;H01L23/495,600/345;;600/347;;600/365,99,2,124-660-118-050-67X;;173-901-776-852-06X,10.1016/0250-6874(89)87015-5;;10.1142/9789810248628_0003,"Koudelka, M., et al., ""Planar Amperometric Enzyme-Based Glucose Microelectrode"", Sensors and Actuators, vol. 18, 1989, pp. 157-165.;;European Patent Application No. 10012409.8, Extended European Search Report mailed Mar. 15, 2011.;;European Patent Application No. 10012414.8, Extended European Search Report mailed Mar. 15, 2011.;;European Patent Application No. 10012960.0, Extended European Search Report mailed Mar. 2, 2011.;;European Patent Application No. 10012961.8, Extended European Search Report mailed Mar. 2, 2011.;;U.S. Appl. No. 10/783,675, Office Action mailed Dec. 14, 2010.;;U.S. Appl. No. 10/783,675, Office Action mailed Jun. 2, 2011.;;U.S. Appl. No. 11/681,730, Office Action mailed Apr. 27, 2011.;;U.S. Appl. No. 11/683,371, Office Action mailed Mar. 8, 2011.;;U.S. Appl. No. 11/683,396, Office Action mailed Jan. 18, 2011.;;U.S. Appl. No. 11/690,826, Office Action mailed Aug. 9, 2011.;;U.S. Appl. No. 11/695,607, Office Action mailed Mar. 2, 2011.;;U.S. Appl. No. 11/695,608, Office Action mailed Mar. 29, 2011.;;U.S. Appl. No. 11/742,507, Office Action mailed Apr. 13, 2011.;;U.S. Appl. No. 11/742,507, Office Action mailed Jun. 12, 2009.;;U.S. Appl. No. 11/766,708, Office Action mailed Mar. 3, 2011.;;U.S. Appl. No. 11/928,795, Office Action mailed May 12, 2011.;;U.S. Appl. No. 11/941,078, Office Action mailed Apr. 22, 2011.;;U.S. Appl. No. 12/109,049, Office Action mailed Mar. 4, 2011.;;U.S. Appl. No. 12/249,644, Office Action mailed Apr. 15, 2011.;;U.S. Appl. No. 12/371,539, Office Action mailed Mar. 7, 2011.;;U.S. Appl. No. 12/397,281, Office Action mailed May 12, 2011.;;U.S. Appl. No. 12/397,293, Office Action mailed Aug. 5, 2011.;;U.S. Appl. No. 12/397,301, Office Action mailed Aug. 22, 2011.;;U.S. Appl. No. 12/405,515, Office Action mailed Apr. 29, 2011.;;U.S. Appl. No. 12/405,568, Office Action mailed Jan. 25, 2011.;;U.S. Appl. No. 12/405,643, Office Action mailed Mar. 30, 2011.;;U.S. Appl. No. 12/405,690, Office Action mailed Mar. 10, 2011.;;U.S. Appl. No. 12/405,739, Office Action mailed Mar. 15, 2011.;;U.S. Appl. No. 12/405,843, Office Action mailed Mar. 24, 2011.;;U.S. Appl. No. 12/406,746, Office Action mailed Apr. 5, 2011.;;U.S. Appl. No. 12/406,746, Office Action mailed Jul. 23, 2010.;;U.S. Appl. No. 12/406,746, Office Action mailed Sep. 1, 2011.;;U.S. Appl. No. 12/406,800, Office Action mailed Apr. 20, 2011.;;U.S. Appl. No. 12/414,456, Office Action mailed Apr. 29, 2011.;;U.S. Appl. No. 12/414,474, Office Action mailed Mar. 15, 2011.;;U.S. Appl. No. 12/414,487, Office Action mailed Mar. 3, 2011.;;U.S. Appl. No. 12/414,531, Office Action mailed Mar. 22, 2011.;;U.S. Appl. No. 12/414,542, Office Action mailed Apr. 13, 2011.;;U.S. Appl. No. 12/414,558, Office Action mailed Apr. 4, 2011.;;U.S. Appl. No. 12/422,269, Office Action mailed Apr. 14, 2011.;;U.S. Appl. No. 12/468,775, Office Action mailed Feb. 4, 2011.;;U.S. Appl. No. 12/468,782, Office Action mailed Feb. 18, 2011.;;U.S. Appl. No. 12/468,787, Office Action mailed Mar. 7, 2011.;;U.S. Appl. No. 12/495,798, Office Action mailed Jun. 30, 2011.;;U.S. Appl. No. 12/495,803, Office Action mailed Jun. 30, 2011.;;U.S. Appl. No. 12/495,807, Office Action mailed Jul. 21, 2011.;;U.S. Appl. No. 12/533,680, Office Action mailed Mar. 3, 2011.;;U.S. Appl. No. 12/614,974, Office Action mailed Apr. 12, 2011.;;U.S. Appl. No. 12/614,990, Office Action mailed Apr. 14, 2011.;;U.S. Appl. No. 12/615,069, Office Action mailed Jun. 9, 2011.;;U.S. Appl. No. 12/615,128, Office Action mailed Aug. 19, 2011.;;U.S. Appl. No. 12/643,974, Office Action mailed May 4, 2011.;;U.S. Appl. No. 12/643,975, Office Action mailed Feb. 18, 2011.;;U.S. Appl. No. 12/643,978, Office Action mailed Apr. 15, 2011.;;U.S. Appl. No. 12/643,980, Office Action mailed Jun. 24, 2011.;;U.S. Appl. No. 12/643,982, Office Action mailed Jun. 17, 2011.;;U.S. Appl. No. 12/643,986, Office Action mailed Jun. 17, 2011.;;U.S. Appl. No. 12/779,941, Office Action mailed Jan. 25, 2011.;;U.S. Appl. No. 12/779,944, Office Action mailed Jan. 25, 2011.;;U.S. Appl. No. 12/779,947, Office Action mailed Apr. 8, 2011.;;U.S. Appl. No. 12/825,180, Office Action mailed Mar. 4, 2011.;;U.S. Appl. No. 12/825,186, Office Action mailed Mar. 31, 2011.;;U.S. Appl. No. 12/825,202 Office Action mailed Jun. 8, 2011.;;U.S. Appl. No. 12/846,803, Office Action mailed Feb. 17, 2011.;;U.S. Appl. No. 12/846,803, Office Action mailed Sep. 22, 2010.;;U.S. Appl. No. 12/902,138 Office Action mailed Jun. 7, 2011.;;U.S. Patent Reexamination Application No. 90/007,903, Decision on Appeal mailed Jan. 18, 2011.;;U.S. Patent Reexamination Application No. 90/007,910, Decision on Appeal mailed Jan. 18, 2011.;;U.S. Patent Reexamination Application No. 90/010,791, Notice of Intent to Issue Reexamination Certificate mailed May 17, 2011.;;U.S. Patent Reexamination Application No. 90/010,791, Office Action mailed Dec. 17, 2010.;;U.S. Patent Reexamination Application No. 90/010,791, Office Action mailed May 28, 2010.;;U.S. Patent Reexamination Application No. 90/011,317, Replacement Request for Reexamination of U.S. Patent No. 6,484,046 filed Jan. 14, 2011.;;U.S. Patent Reexamination Application No. 90/011,730, Request for Reexamination of U.S. Patent No. 6,990,366 filed Jun. 3, 2011.;;Gough, D. A., et al., ""The Implantable Glucose Sensor: An Example of Bioengineering Design"", Introduction to Bioengineering, Chapter 3, 2001, pp. 57-66.;;Japanese Patent Application No. 2007-270411, Office Action mailed Aug. 17, 2010.;;Japanese Patent Application No. 2007-270411, Office Action mailed Jun. 21, 2011.;;PCT Application No. PCT/US2008/074469, International Preliminary Report on Patentability and Written Opinion of the International Searching Authority mailed Mar. 11, 2010.;;PCT Application No. PCT/US2010/040117, International Preliminary Report on Patentability and Written Opinion of the International Searching Authority mailed Jan. 12, 2012.;;PCT Application No. PCT/US2010/040118, International Preliminary Report on Patentability and Written Opinion of the International Searching Authority mailed Jan. 12, 2012.;;PCT Application No. PCT/US2010/040119, International Preliminary Report on Patentability and Written Opinion of the International Searching Authority mailed Jan. 12, 2012.;;U.S. Appl. No. 11/681,730, Office Action mailed Dec. 15, 2011.;;U.S. Appl. No. 11/683,396, Office Action mailed Sep. 8, 2011.;;U.S. Appl. No. 11/742,453, Office Action mailed Oct. 28, 2011.;;U.S. Appl. No. 11/941,078, Office Action mailed Dec. 22, 2011.;;U.S. Appl. No. 12/135,937, Notice of Allowance mailed May 18, 2012.;;U.S. Appl. No. 12/135,937, Office Action mailed Dec. 19, 2011.;;U.S. Appl. No. 12/249,644, Notice of Allowance mailed Mar. 14, 2012.;;U.S. Appl. No. 12/249,644, Office Action mailed Nov. 17, 2011.;;U.S. Appl. No. 12/371,539, Notice of Allowance mailed May 31, 2012.;;U.S. Appl. No. 12/371,539, Office Action mailed Sep. 26, 2011.;;U.S. Appl. No. 12/397,301, Office Action mailed Mar. 16, 2012.;;U.S. Appl. No. 12/405,515, Office Action mailed Jun. 8, 2012.;;U.S. Appl. No. 12/405,515, Office Action mailed Nov. 22, 2011.;;U.S. Appl. No. 12/405,568, Office Action mailed Sep. 16, 2011.;;U.S. Appl. No. 12/405,643, Advisory Action mailed Mar. 9, 2012.;;U.S. Appl. No. 12/405,643, Office Action mailed Jun. 13, 2012.;;U.S. Appl. No. 12/405,643, Office Action mailed Nov. 14, 2011.;;U.S. Appl. No. 12/405,987, Office Action mailed Nov. 16, 2010.",EXPIRED
272,US,A1,US 2009/0177062 A1,073-602-347-213-117,2009-07-09,2009,US 40593009 A,2009-03-17,US 40593009 A;;US 42005703 A;;US 66719900 A;;US 7067798 A,1998-04-30,Analyte Monitoring Device and Methods of Use,"An analyte monitor includes a sensor, a sensor control unit, and a display unit. The sensor has, for example, a substrate, a recessed channel formed in the substrate, and conductive material disposed in the recessed channel to form a working electrode. The sensor control unit typically has a housing adapted for placement on skin and is adapted to receive a portion of an electrochemical sensor. The sensor control unit also includes two or more conductive contacts disposed on the housing and configured for coupling to two or more contact pads on the sensor. A transmitter is disposed in the housing and coupled to the plurality of conductive contacts for transmitting data obtained using the sensor. The display unit has a receiver for receiving data transmitted by the transmitter of the sensor control unit and a display coupled to the receiver for displaying an indication of a level of an analyte. The analyte monitor may also be part of a drug delivery system to alter the level of the analyte based on the data obtained using the sensor.",ABBOTT DIABETES CARE INC,SAY JAMES;;TOMASCO MICHAEL F;;HELLER ADAM;;GAL YORAM;;ARIA BEHRAD;;HELLER EPHRAIM;;PLANTE PHILLIP JOHN;;VREEKE MARK S;;FRIEDMAN KEITH A;;COLMAN FREDRIC C,,https://lens.org/073-602-347-213-117,Patent Application,yes,1,61,211,221,0,A61B5/14532;;A61B5/14532;;A61B5/0002;;A61B5/0002;;A61B5/002;;A61B5/01;;A61B5/14503;;A61B5/1451;;A61B5/14546;;A61B5/14546;;A61B5/1473;;A61B5/1473;;A61B5/1486;;A61B5/1486;;A61B5/14865;;A61B5/1495;;A61B5/4839;;A61B5/72;;A61B5/7278;;A61B5/7282;;A61B5/7405;;A61B5/743;;A61B5/7445;;A61B5/7445;;A61B5/7455;;A61B2560/0252;;A61B2560/0252;;A61M5/1723;;C12Q1/54;;G16H10/40;;G16H10/40;;G16H20/17;;G16H20/17;;H01L23/3107;;H01L23/3107;;H01L23/49548;;H01L23/49548;;H01L2924/0002;;H01L2924/0002;;H01L2924/19041;;H01L2924/19041;;H01L2924/3011;;H01L2924/3011;;Y10S128/903;;Y10S128/903;;Y10T29/49;;Y10T29/49;;Y10T29/49124;;Y10T29/49124,A61B5/1468;;G01N27/30;;A61B5/00;;A61B5/145;;A61B5/1477;;A61B5/1495;;G01N27/416;;G06F19/00;;H01L23/31;;H01L23/495,600/345,0,0,,,,DISCONTINUED
273,US,A1,US 2004/0167801 A1,095-502-350-636-671,2004-08-26,2004,US 78367504 A,2004-02-16,US 78367504 A;;US 42005403 A;;US 66719900 A;;US 7067798 A,1998-04-30,Analyte monitoring device and methods of use,"
   An analyte monitor includes a sensor, a sensor control unit, and a display unit. The sensor has, for example, a substrate, a recessed channel formed in the substrate, and conductive material disposed in the recessed channel to form a working electrode. The sensor control unit typically has a housing adapted for placement on skin and is adapted to receive a portion of an electrochemical sensor. The sensor control unit also includes two or more conductive contacts disposed on the housing and configured for coupling to two or more contact pads on the sensor. A transmitter is disposed in the housing and coupled to the plurality of conductive contacts for transmitting data obtained using the sensor. The display unit has a receiver for receiving data transmitted by the transmitter of the sensor control unit and a display coupled to the receiver for displaying an indication of a level of an analyte. The analyte monitor may also be part of a drug delivery system to alter the level of the analyte based on the data obtained using the sensor. 
",SAY JAMES;;TOMASCO MICHAEL F.;;HELLER ADAM;;GAL YORAM;;ARIA BEHRAD;;HELLER EPHRAIM;;PLANTE PHILLIP JOHN;;VREEKE MARK S.;;FRIEDMAN KEITH A.;;COLMAN FREDRIC C.,SAY JAMES;;TOMASCO MICHAEL F;;HELLER ADAM;;GAL YORAM;;ARIA BEHRAD;;HELLER EPHRAIM;;PLANTE PHILLIP JOHN;;VREEKE MARK S;;FRIEDMAN KEITH A;;COLMAN FREDRIC C,E. HELLER & CO (1998-07-02);;ABBOTT DIABETES CARE INC (2000-03-13),https://lens.org/095-502-350-636-671,Patent Application,yes,96,504,7,7,0,A61B5/14532;;A61B5/14532;;A61B5/0002;;A61B5/0002;;A61B5/14546;;A61B5/14546;;A61B5/7445;;A61B5/7445;;G16H15/00;;G16H15/00;;G16H40/67;;G16H40/67;;H01L23/3107;;H01L23/3107;;H01L23/49548;;H01L23/49548;;H01L24/48;;H01L24/48;;H01L2224/48091;;H01L2224/48091;;H01L2224/48247;;H01L2224/48247;;H01L2924/00014;;H01L2924/00014;;H01L2924/01012;;H01L2924/01012;;H01L2924/12042;;H01L2924/12042;;H01L2924/14;;H01L2924/14;;H01L2924/181;;H01L2924/181;;H01L2924/19041;;H01L2924/19041;;H01L2924/3011;;H01L2924/3011;;Y02A90/10;;Y02A90/10,G01N27/30;;A61B5/00;;A61B5/145;;A61B5/1477;;A61B5/1495;;G01N27/416;;H01L23/31;;H01L23/495,705/2,0,0,,,,EXPIRED
274,US,A1,US 2010/0268048 A1,080-992-264-425-210,2010-10-21,2010,US 82568110 A,2010-06-29,US 82568110 A;;US 39388309 A;;US 42005703 A;;US 66719900 A;;US 7067798 A,1998-04-30,Analyte Monitoring Device and Methods of Use,"An analyte monitor includes a sensor, a sensor control unit, and a display unit. The sensor has, for example, a substrate, a recessed channel formed in the substrate, and conductive material disposed in the recessed channel to form a working electrode. The sensor control unit typically has a housing adapted for placement on skin and is adapted to receive a portion of an electrochemical sensor. The sensor control unit also includes two or more conductive contacts disposed on the housing and configured for coupling to two or more contact pads on the sensor. A transmitter is disposed in the housing and coupled to the plurality of conductive contacts for transmitting data obtained using the sensor. The display unit has a receiver for receiving data transmitted by the transmitter of the sensor control unit and a display coupled to the receiver for displaying an indication of a level of an analyte. The analyte monitor may also be part of a drug delivery system to alter the level of the analyte based on the data obtained using the sensor.",ABBOTT DIABETES CARE INC,SAY JAMES;;TOMASCO MICHAEL F;;HELLER ADAM;;GAL YORAM;;ARIA BEHRAD;;HELLER EPHRAIM;;PLANTE PHILLIP JOHN;;VREEKE MARK S;;FRIEDMAN KEITH A;;COLMAN FREDRIC C,E. HELLER & CO (1998-07-02);;ABBOTT DIABETES CARE INC (2000-03-13),https://lens.org/080-992-264-425-210,Patent Application,yes,62,46,211,221,0,A61B5/14532;;A61B5/14532;;A61B5/0002;;A61B5/0002;;A61B5/002;;A61B5/01;;A61B5/14503;;A61B5/1451;;A61B5/14546;;A61B5/14546;;A61B5/1473;;A61B5/1473;;A61B5/1486;;A61B5/1486;;A61B5/14865;;A61B5/1495;;A61B5/4839;;A61B5/72;;A61B5/7278;;A61B5/7282;;A61B5/7405;;A61B5/743;;A61B5/7445;;A61B5/7445;;A61B5/7455;;A61B2560/0252;;A61B2560/0252;;A61M5/1723;;C12Q1/54;;G16H10/40;;G16H10/40;;G16H20/17;;G16H20/17;;H01L23/3107;;H01L23/3107;;H01L23/49548;;H01L23/49548;;H01L2924/0002;;H01L2924/0002;;H01L2924/19041;;H01L2924/19041;;H01L2924/3011;;H01L2924/3011;;Y10S128/903;;Y10S128/903;;Y10T29/49;;Y10T29/49;;Y10T29/49124;;Y10T29/49124,A61B5/1468;;G01N27/30;;A61B5/00;;A61B5/145;;A61B5/1477;;A61B5/1495;;G01N27/416;;G06F19/00;;H01L23/31;;H01L23/495,600/345,0,0,,,,DISCONTINUED
275,US,A1,US 2010/0222659 A1,104-566-897-543-468,2010-09-02,2010,US 77994710 A,2010-05-13,US 77994710 A;;US 69082607 A;;US 42005703 A;;US 66719900 A;;US 7067798 A,1998-04-30,Analyte Monitoring Device and Methods of Use,"An analyte monitor includes a sensor, a sensor control unit, and a display unit. The sensor has, for example, a substrate, a recessed channel formed in the substrate, and conductive material disposed in the recessed channel to form a working electrode. The sensor control unit typically has a housing adapted for placement on skin and is adapted to receive a portion of an electrochemical sensor. The sensor control unit also includes two or more conductive contacts disposed on the housing and configured for coupling to two or more contact pads on the sensor. A transmitter is disposed in the housing and coupled to the plurality of conductive contacts for transmitting data obtained using the sensor. The display unit has a receiver for receiving data transmitted by the transmitter of the sensor control unit and a display coupled to the receiver for displaying an indication of a level of an analyte. The analyte monitor may also be part of a drug delivery system to alter the level of the analyte based on the data obtained using the sensor.",ABBOTT DIABETES CARE INC,SAY JAMES;;TOMASCO MICHAEL F;;HELLER ADAM;;GAL YORAM;;ARIA BEHRAD;;HELLER EPHRAIM;;PLANTE PHILLIP JOHN;;VREEKE MARK S;;FRIEDMAN KEITH A;;COLMAN FREDRIC C,,https://lens.org/104-566-897-543-468,Patent Application,yes,6,0,211,221,0,A61B5/14532;;A61B5/14532;;A61B5/0002;;A61B5/0002;;A61B5/002;;A61B5/01;;A61B5/14503;;A61B5/1451;;A61B5/14546;;A61B5/14546;;A61B5/1473;;A61B5/1473;;A61B5/1486;;A61B5/1486;;A61B5/14865;;A61B5/1495;;A61B5/4839;;A61B5/72;;A61B5/7278;;A61B5/7282;;A61B5/7405;;A61B5/743;;A61B5/7445;;A61B5/7445;;A61B5/7455;;A61B2560/0252;;A61B2560/0252;;A61M5/1723;;C12Q1/54;;G16H10/40;;G16H10/40;;G16H20/17;;G16H20/17;;H01L23/3107;;H01L23/3107;;H01L23/49548;;H01L23/49548;;H01L2924/0002;;H01L2924/0002;;H01L2924/19041;;H01L2924/19041;;H01L2924/3011;;H01L2924/3011;;Y10S128/903;;Y10S128/903;;Y10T29/49;;Y10T29/49;;Y10T29/49124;;Y10T29/49124,A61B5/145;;G01N27/30;;A61B5/00;;A61B5/1477;;A61B5/1495;;G01N27/416;;G06F19/00;;H01L23/31;;H01L23/495,600/345,0,0,,,,DISCONTINUED
276,US,B2,US 8260392 B2,125-757-548-725-70X,2012-09-04,2012,US 13593708 A,2008-06-09,US 13593708 A;;US 42005703 A;;US 66719900 A;;US 7067798 A,1998-04-30,Analyte monitoring device and methods of use,"An analyte monitor includes a sensor, a sensor control unit, and a display unit. The sensor has, for example, a substrate, a recessed channel formed in the substrate, and conductive material disposed in the recessed channel to form a working electrode. The sensor control unit typically has a housing adapted for placement on skin and is adapted to receive a portion of an electrochemical sensor. The sensor control unit also includes two or more conductive contacts disposed on the housing and configured for coupling to two or more contact pads on the sensor. A transmitter is disposed in the housing and coupled to the plurality of conductive contacts for transmitting data obtained using the sensor. The display unit has a receiver for receiving data transmitted by the transmitter of the sensor control unit and a display coupled to the receiver for displaying an indication of a level of an analyte. The analyte monitor may also be part of a drug delivery system to alter the level of the analyte based on the data obtained using the sensor.",SAY JAMES;;TOMASCO MICHAEL F;;HELLER ADAM;;GAL YORAM;;ARIA BEHRAD;;HELLER EPHRAIM;;PLANTE PHILLIP JOHN;;VREEKE MARK S;;FRIEDMAN KEITH A;;COLMAN FREDRIC C;;ABBOTT DIABETES CARE INC,SAY JAMES;;TOMASCO MICHAEL F;;HELLER ADAM;;GAL YORAM;;ARIA BEHRAD;;HELLER EPHRAIM;;PLANTE PHILLIP JOHN;;VREEKE MARK S;;FRIEDMAN KEITH A;;COLMAN FREDRIC C,E. HELLER & CO (1998-07-02);;ABBOTT DIABETES CARE INC (2000-03-13),https://lens.org/125-757-548-725-70X,Granted Patent,yes,113,13,211,221,0,A61B5/14532;;A61B5/14532;;A61B5/0002;;A61B5/0002;;A61B5/002;;A61B5/01;;A61B5/14503;;A61B5/1451;;A61B5/14546;;A61B5/14546;;A61B5/1473;;A61B5/1473;;A61B5/1486;;A61B5/1486;;A61B5/14865;;A61B5/1495;;A61B5/4839;;A61B5/72;;A61B5/7278;;A61B5/7282;;A61B5/7405;;A61B5/743;;A61B5/7445;;A61B5/7445;;A61B5/7455;;A61B2560/0252;;A61B2560/0252;;A61M5/1723;;C12Q1/54;;G16H10/40;;G16H10/40;;G16H20/17;;G16H20/17;;H01L23/3107;;H01L23/3107;;H01L23/49548;;H01L23/49548;;H01L2924/0002;;H01L2924/0002;;H01L2924/19041;;H01L2924/19041;;H01L2924/3011;;H01L2924/3011;;Y10S128/903;;Y10S128/903;;Y10T29/49;;Y10T29/49;;Y10T29/49124;;Y10T29/49124,A61B5/04;;G01N27/30;;A61B5/00;;A61B5/145;;A61B5/1477;;A61B5/1495;;G01N27/416;;G06F19/00;;H01L23/31;;H01L23/495,600/345;;600/347;;600/365,99,82,136-791-935-548-81X;;062-360-289-025-864;;010-601-725-111-91X;;101-292-518-663-191;;056-703-879-057-297;;030-155-762-644-019;;004-149-141-436-651;;016-731-054-793-457;;080-559-561-995-335;;044-807-213-528-815;;027-538-525-436-179;;015-020-161-517-40X;;025-919-454-564-785;;014-700-576-603-812;;004-851-060-590-788;;075-958-432-122-199;;052-356-140-149-389;;035-090-282-884-790;;033-562-815-299-181;;018-803-926-589-211;;008-505-762-041-402;;016-601-143-530-813;;019-502-772-562-215;;058-476-824-396-350;;006-498-707-073-30X;;054-091-551-638-293;;010-531-147-771-746;;054-827-198-877-419;;122-658-944-077-000;;017-261-560-469-37X;;000-125-755-474-124;;113-381-664-783-802;;082-626-907-191-554;;017-950-014-792-456;;090-348-305-613-628;;015-985-399-299-132;;171-049-047-164-618;;016-819-089-891-758;;081-249-097-078-543;;089-612-747-111-646;;031-706-897-890-035;;094-198-536-559-723;;003-690-143-043-420;;007-943-354-378-456;;082-114-500-909-975;;004-239-090-971-580;;026-894-457-160-450;;077-128-610-778-669;;022-466-506-956-898;;008-424-592-956-946;;007-500-825-916-378;;009-725-244-669-882;;037-755-689-613-42X;;153-411-506-517-475;;038-134-360-685-692;;012-449-714-188-064;;031-517-704-996-130;;131-299-284-996-064;;049-133-049-742-708;;000-272-178-768-076;;070-797-683-833-124;;043-870-224-178-49X;;025-574-914-238-550;;052-364-430-129-757;;004-434-167-910-115;;032-860-147-271-886;;132-460-374-211-421;;098-172-374-375-47X;;109-358-955-476-095;;014-988-634-483-130;;061-786-187-274-992;;037-898-018-686-909;;130-044-667-529-69X;;134-265-642-839-645;;065-221-074-461-027;;017-934-465-161-477;;101-660-130-379-529;;028-236-706-290-220;;087-333-189-994-274;;059-082-211-027-266;;057-977-752-782-568;;022-511-780-866-588,10.1016/s0956-5663(02)00099-4;;12392956;;10.1021/ja00391a001;;2889225;;10.1098/rstb.1987.0021;;10.1109/51.294001;;10.1016/0022-0728(65)85063-x;;2245876;;10.2337/diabetes.39.12.1519;;10.2337/diab.39.12.1519;;10.1016/s0956-5663(03)00220-3;;14611755;;18615658;;10.1002/bit.260430310;;9366023;;10.1016/s0956-5663(97)00025-0;;9451795;;10.1016/s0956-5663(97)00083-3;;10.1016/0956-5663(93)80028-n;;8311939;;8651496;;10.1021/ac960030d;;10.1080/03091900210156797;;12487712;;10.1016/0265-928x(87)80018-4;;3333622;;10.1109/19.816143;;10.1007/bf01015979;;10.1089/15209150252924058;;12017416;;18473691;;10.1089/dia.2007.0281;;10.1021/ac00017a008;;1789439;;2817408;;10.1021/ac00197a022;;10.1016/0925-4005(95)01730-5;;10.1016/0010-4825(90)90013-f;;2257734;;2868172;;8277748;;10.1016/0141-5425(93)90058-7;;11469630;;10.1089/15209150050214104;;10624783;;10.1016/s0168-8227(99)00113-8;;10.1089/15209150050214113;;11469631;;10.1007/bf00401374;;1478372;;10.2337/diacare.20.1.64;;9028696;;10.1109/tbme.1986.325807;;3957374;;236018;;10.1016/0005-2795(75)90259-7;;10.1089/hum.1998.9.6-879;;9581910;;11762520;;10.1089/15209150152607196;;10.2337/diabetes.48.3.445;;10078542;;10.1016/0265-928x(87)80012-3;;505005;;10.1126/science.505005;;10.1021/ac0498516;;15253640;;10.1109/10.284922;;8026845;;6721151;;10.1021/ac00268a018;;6733082;;10.1021/bi00305a016;;10.1515/cclm.2002.135;;12392305;;10.1016/j.ecl.2003.12.001;;15053902;;12052350;;10.1016/s0956-5663(01)00304-9;;12052349;;10.1016/s0956-5663(01)00306-2;;4500021;;10.1007/978-1-4684-3288-6_18;;14021529;;10.1111/j.1749-6632.1962.tb13623.x;;3196517;;10.2337/diacare.10.5.622;;3677983;;10.2337/diacare.8.6.529;;4075939;;10.1002/elan.1140061103;;7733469;;10.1021/ac00103a015;;7978306;;10.1021/ac00091a022;;10.1007/bf01248238;;10.1016/s0376-7388(98)00330-5;;10.1016/0142-9612(92)90147-g;;1472593;;10.1016/0265-928x(85)80002-x;;10.1021/j100290a001;;10.1021/ja00216a040;;10.1021/ja00188a091;;10.1021/ja00406a011;;2624333;;12323417;;10.1016/s0165-0270(02)00170-x;;10.1177/193229680700100208;;pmc2771467;;19888405;;10.1021/ja00415a014;;10.1007/bf00575392;;10.1021/ac00250a038;;10.1021/ac00266a005;;10.1007/s00216-002-1284-0;;12194035;;10.1089/dia.2006.0030;;17705688;;9642777;;10.1016/s0956-5663(97)00091-2;;10.1089/152091503322526978;;14633342;;10.1016/0022-0728(85)87006-6;;10.1021/ja00434a018;;10.1016/0003-2697(92)90243-z;;1443528;;10.1039/f19868201259;;3245585;;10.1021/ac00173a008;;2889234;;10.1098/rstb.1987.0020;;11762521;;10.1089/15209150152607204;;12413548;;10.1016/s1367-5931(02)00371-x;;10526740;;10.2337/diacare.22.10.1708;;14988294;;10.2337/diacare.27.3.734;;10.1111/j.1749-6632.1997.tb52216.x;;9616733,"Abel, P. U., et al., ""Biosensors for In Vivo Glucose Measurement: Can We Cross the Experimental Stage"", Biosensors and Bioelectronics, vol. 17, 2002, pp. 1059-1070.;;Abruna, H. D., et al., ""Rectifying Interfaces Using Two-Layer Films of Electrochemically Polymerized Vinylpyridine and Vinylbipyridine Complexes of Ruthenium and Iron on Electrodes"", Journal of the American Chemical Society, vol. 103, No. 1, 1981, pp. 1-5.;;Albery, W. J., et al., ""Amperometric Enzyme Electrodes Part II: Conducting Salts as Electrode Materials for the Oxidation of Glucose Oxidase"", Journal of ElectroAnalytical Chemistry, vol. 194, 1985, pp. 223-235.;;Albery, W. J., et al., ""Amperometric Enzyme Electrodes"", Philosophical Transactions of the Royal Society of London, vol. 316, 1987, pp. 107-119.;;Alcock, S. J., et al., ""Continuous Analyte Monitoring to Aid Clinical Practice"", IEEE Engineering in Medicine and Biology Magazine, 1994, pp. 319-325.;;Anderson, L. B., et al., ""Thin-Layer Electrochemistry: Steady-State Methods of Studying Rate Processes"", Journal of ElectroAnalytical Chemistry, vol. 10, 1965, pp. 295-305.;;Armour, J. C., et al., ""Application of Chronic Intravascular Blood Glucose Sensor in Dogs"", Diabetes, vol. 39, 1990, pp. 1519-1526.;;Asberg, P., et al., ""Hydrogels of a Conducting Conjugated Polymer as 3-D Enzyme Electrode"", Biosensors & Bioelectronics, vol. 19, 2003, pp. 199-207.;;Atanasov, P., et al., ""Biosensor for Continuous Glucose Monitoring"", Biotechnology and Bioengineering, vol. 43, 1994, pp. 262-266.;;Atanasov, P., et al., ""Implantation of a Refillable Glucose Monitoring-Telemetry Device"", Biosensors & Bioelectronics, vol. 12, No. 7, 1997, pp. 669-680.;;Aussedat, B., et al., ""A User-Friendly Method for Calibrating a Subcutaneous Glucose Sensor-Based Hypoglycaemic Alarm"", Biosensors & Bioelectronics, vol. 12, No. 11, 1997, pp. 1061-1071.;;Baker, D. A., et al., ""Dynamic Concentration Challenges for Biosensor Characterization"", Biosensors & Bioelectronics, vol. 8, 1993, pp. 433-441.;;Baker, D. A., et al., ""Dynamic Delay and Maximal Dynamic Error in Continuous Biosensors"", Analytical Chemistry, vol. 68, No. 8, 1996, pp. 1292-1297.;;Bani Amer, M. M., ""An Accurate Amperometric Glucose Sensor Based Glucometer with Eliminated Cross-Sensitivity"", Journal of Medical Engineering & Technology, vol. 26, No. 5, 2002, pp. 208-213.;;Bard, A. J., et al., Electrochemical Methods, 1980, pp. 173-175.;;Bartlett, P. N., et al., ""Covalent Binding of Electron Relays to Glucose Oxidase"", Journal of the Chemical Society, Chemical Communications, 1987, pp. 1603-1604.;;Bartlett, P. N., et al., ""Modification of Glucose Oxidase by Tetrathiafulvalene"", Journal of the Chemical Society, Chemical Communications, 1990, pp. 1135-1136.;;Bartlett, P. N., et al., ""Strategies for the Development of Amperometric Enzyme Electrodes"", Biosensors, vol. 3, 1987/88, pp. 359-379.;;Beach, R. D., et al., ""Subminiature Implantable Potentiostat and Modified Commercial Telemetry Device for Remote Glucose Monitoring"", IEEE Transactions on Instrumentation and Measurement, vol. 28, No. 6, 1999, pp. 1239-1245.;;Beech, W. A., ""AX.25 Link Access Protocol for Amateur packet Radio"", Tucson Amateur Packet Radio Corporation, 1998, pp. 1-133.;;Bellucci, F., et al., ""Electrochemical Behaviour of Graphite-Epoxy Composite Materials (GECM) in Aqueous Salt Solutions"", Journal of Applied Electrochemistry, vol. 16, 1986, pp. 15-22.;;Bennion, N., et al., ""Alternate Site Glucose Testing: A Crossover Design"", Diabetes Technology & Therapeutics, vol. 4, No. 1, 2002, pp. 25-33.;;Biermann, E., et al., ""How Would Patients Behave if They Were Continually Informed of Their Blood Glucose Levels? A Simulation Study Using a 'Virtual' Patient"", Diabetes Technology & Therapeutics, vol. 10, No. 3, 2008, pp. 178-187.;;Bindra, D. S., et al., ""Design and in Vitro Studies of a Needle-Type Glucose Sensor for Subcutaneous Monitoring"", Analytical Chemistry, vol. 63, No. 17, 1991, pp. 1692-1696.;;Bindra, D. S., et al., ""Pulsed Amperometric Detection of Glucose in Biological Fluids at a Surface-Modified Gold Electrode"", Analytical Chemistry, vol. 61, No. 22, 1989, pp. 2566-2570.;;Bisenberger, M., et al., ""A Triple-Step Potential Waveform at Enzyme Multisensors with Thick-Film Gold Electrodes for Detection of Glucose and Sucrose"", Sensors and Actuators B, vol. 28, 1995, pp. 181-189.;;Bland, J. M., et al., ""A Note on the Use of the Intraclass Correlation Coefficient in the Evaluation of Agreement Between Two Methods of Measurement"", Computers in Biology and Medicine, vol. 20, No. 5, 1990, pp. 337-340.;;Bland, J. M., et al., ""Statistical Methods for Assessing Agreement Between Two Methods of Clinical Measurement"", The Lancet, 1986, pp. 307-310.;;Blank, T. B., et al., ""Clinical Results From a Non-Invasive Blood Glucose Monitor"", Optical Diagnostics and Sensing of Biological Fluids and Glucose and Cholesterol Monitoring II, Proceedings of SPIE, vol. 4624, 2002, pp. 1-10.;;Bobbioni-Harsch, E., et al., ""Lifespan of Subcutaneous Glucose Sensors and Their Performances During Dynamic Glycaemia Changes in Rats"", Journal of Biomedical Engineering,vol. 15, 1993, pp. 457-463.;;Bode, B. W., ""Clinical Utility of the Continuous Glucose Monitoring System"", Diabetes Technology & Therapeutics, vol. 2, Sup. 1, 2000, pp. S35-S41.;;Bode, B. W., et al., ""Continuous Glucose Monitoring Used to Adjust Diabetes Therapy Improves Glycosylated Hemoglobin: A Pilot Study"", Diabetes Research and Clinical Practice, vol. 46, 1999, pp. 183-190.;;Bode, B. W., et al., ""Using the Continuous Glucose Monitoring System to Improve the Management of Type I Diabetes"", Diabetes Technology & Therapeutics, vol. 2, Sup. 1, 2000, pp. S43-S48.;;Boedeker Plastics, Inc., ""Polyethylene Specifications"", Web Page of Boedeker.com, 2007, pp. 1-3.;;Bolinder, J., et al., ""Microdialysis Measurement of the Absolute Glucose Concentration in Subcutaneous Adipose Tissue Allowing Glucose Monitoring in Diabetic Patients"", Diabetologia, vol. 35, 1992, pp. 1177-1180.;;Bolinder, J., et al., ""Self-Monitoring of Blood Glucose in Type I Diabetic Patients: Comparison with Continuous Microdialysis Measurements of Glucose in Subcutaneous Adipose Tissue During Ordinary Life Conditions"", Diabetes Care, vol. 20, No. 1, 1997, pp. 64-70.;;Bott, A. W., ""A Comparison of Cyclic Voltammetry and Cyclic Staircase Voltammetry"", Current Separations, vol. 16, No. 1, 1997, pp. 23-26.;;Bott, A. W., ""Electrochemical Methods for the Determination of Glucose"", Current Separations, vol. 17, No. 1, 1998, pp. 25-31.;;Bowman, L., et al., ""The Packaging of Implantable Integrated Sensors"", IEEE Transactions on Biomedical Engineering, vol. 33, No. 2, 1986, pp. 248-255.;;Brandt, J., et al., ""Covalent Attachment of Proteins to Polysaccharide Carriers by Means of Benzoquinone"", Biochimica et Biophysica Acta, vol. 386, 1975, pp. 196-202.;;Brauker, J., et al., ""Sustained Expression of High Levels of Human Factor IX from Human Cells Implanted Within an Immunoisolation Device into Athymic Rodents"", Human Gene Therapy, vol. 9, No. 6, 1998, pp. 879-888.;;Bremer, T. M., et al., ""Benchmark Data from the Literature for Evaluation of New Glucose Sensing Technologies"", Diabetes Technology & Therapeutics, vol. 3, No. 3, 2001, pp. 409-418.;;Bremer, T., et al., ""Is Blood Glucose Predictable from Previous Values?"", Diabetes, vol. 48, 1999, pp. 445-451.;;Brooks, S. L., et al., ""Development of an On-Line Glucose Sensor for Fermentation Monitoring"", Biosensors, vol. 3, 1987/88, pp. 45-56.;;Brownlee, M., et al., ""A Glucose-Controlled Insulin-Delivery System: Semisynthetic Insulin Bound to Lectin"", Science, vol. 206, 1979, 1190-1191.;;Cai, Q., et al., ""A Wireless, Remove Query Glucose Biosensor Based on a pH-Sensitive Polymer"", Analytical Chemistry, vol. 76, No. 14, 2004, pp. 4038-4043.;;Candas, B., et al., ""An Adaptive Plasma Glucose Controller Based on a Nonlinear Insulin/Glucose Model"", IEEE Transactions on Biomedical Engineering, vol. 41, No. 2, 1994, pp. 116-124.;;Cass, A. E., et al., ""Ferricinum Ion As an Electron Acceptor for Oxido-Reductases"", Journal of ElectroAnalytical Chemistry, vol. 190, 1985, pp. 117-127.;;Cass, A. E., et al., ""Ferrocene-Medicated Enzyme Electrode for Amperometric Determination of Glucose"", Analytical Chemistry, vol. 56, No. 4, 1984, 667-671.;;Castner, J. F., et al., ""Mass Transport and Reaction Kinetic Parameters Determined Electrochemically for Immobilized Glucose Oxidase"", Biochemistry, vol. 23 No. 10, 1984, 2203-2210.;;Chen, J. C., et al., ""A Comparison of MAC Protocols for Wireless Local Networks Based on battery Power Consumption"", IEEE, 1998, pp. 150-157.;;Chen, T., et al., ""Defining the Period of Recovery of the Glucose Concentration After Its Local Perturbation by the Implantation of a Miniature Sensor"", Clinical Chemistry and Laboratory Medicine, vol. 40, No. 8, 2002, pp. 486-489.;;Chia, C. W., et al., ""Glucose Sensors: Toward Closed Loop Insulin Delivery"", Endocrinology and Metabolism Clinics of North America, vol. 33, 2004, pp. 175-195.;;Choleau, C., et al., ""Calibration of a Subcutaneous Amperometric Glucose Sensor Implanted for 7 Days in Diabetic Patients Part 2: Superiority of the One-Point Calibration Method"", Biosensors and Bioelectronics, vol. 17, 2002, pp. 647-654.;;Choleau, C., et al., ""Calibration of a Subcutaneous Amperometric Glucose Sensor Part 1: Effect of Measurement Uncertainties on the Determination of Sensor Sensitivity and Background Current"", Biosensors and Bioelectronics, vol. 17, 2002, pp. 641-646.;;Claremont, D. J., et al., ""Biosensors for Continuous In Vivo Glucose Monitoring"", Proceedings of the Annual International Conference of the IEEE Engineering in Medicine and Biology Society, vol. 10, 1988.;;Clark Jr., L. C., et al., ""Differential Anodic Enzyme Polarography for the Measurement of Glucose"", Oxygen Transport to Tissue: Instrumentation, Methods, and Physiology, 1973, pp. 127-133.;;Clark Jr., L. C., et al., ""Electrode Systems for Continuous Monitoring in Cardiovascular Surgery"", Annals New York Academy of Sciences, 1962, pp. 29-45.;;Clark Jr., L. C., et al., ""Long-term Stability of Electroenzymatic Glucose Sensors Implanted in Mice"", American Society of Artificial Internal Organs Transactions, vol. XXXIV, 1988, pp. 259-265.;;Clarke, W. L., et al., ""Evaluating Clinical Accuracy of Systems for Self-Monitoring of Blood Glucose"", Diabetes Care, vol. 10, No. 5, 1987, pp. 622-628.;;Complaint, ""Abbott Diabetes Care, Inc. v. Dexcom, Inc."", filed Aug. 11, 2005.;;Complaint, Amended, ""Abbott Diabetes Care, Inc. v. Dexcom, Inc."", filed Jun. 27, 2006.;;Cox, D. J., et al., ""Accuracy of Perceiving Blood Glucose in IDDM"", Diabetes Care, vol. 8, No. 6, 1985, pp. 529-536.;;Csoregi, E., et al., ""Amperometric Microbiosensors for Detection of Hydrogen Peroxide and Glucose Based on Peroxidase-Modified Carbon Fibers"", Electroanalysis, vol. 6, 1994, pp. 925-933.;;Csoregi, E., et al., ""Design and Optimization of a Selective Subcutaneously Implantable Glucose Electrode Based on 'Wired' Glucose Oxidase"", Analytical Chemistry, vol. 67, No. 7, 1995, pp. 1240-1244.;;Csoregi, E., et al., ""Design, Characterization, and One-Point in Vivo Calibration of a Subcutaneously Implanted Glucose Electrode"", Analytical Chemistry, vol. 66 No. 19, 1994, pp. 3131-3138.;;Csoregi, E., et al., ""On-Line Glucose Monitoring by Using Microdialysis Sampling and Amperometric Detection Based on 'Wired' Glucose Oxidase in Carbon Paste"", Mikrochimica Acta, vol. 121, 1995, pp. 31-40.;;D'Arrigo, G., et al., ""Porous-Si Based Bio Reactors for Glucose Monitoring and Drugs Production"", Proceedings of SPIE: Microfluids, BioMEMS, and Medical Microsystems, vol. 4982, 2003, pp. 178-184.;;Dai, W. S., et al., ""Hydrogel Membranes with Mesh Size Asymmetry Based on the Gradient Crosslinking of Poly(vinyl alcohol),"" Journal of Membrane Science, vol. 156, 1999, pp. 67-79.;;Davies, M. L., et al., ""Polymer Membranes in Clinical Sensor Applications"", Biomaterials, vol. 13 No. 14, 1992, pp. 971-978.;;Davis, G., ""Electrochemical Techniques for the Development of Amperometric Biosensors"", Biosensors, vol. 1, 1985, pp. 161-178.;;Degani, Y., et al., ""Direct Electrical Communication Between Chemically Modified Enzymes and Metal Electrodes. 1. Electron Transfer from Glucose Oxidase to Metal Electrodes via Electron Relays, Bound Covalently to the Enzyme"", The Journal of Physical Chemistry, vol. 91, No. 6, 1987, pp. 1285-1289.;;Degani, Y., et al., ""Direct Electrical Communication Between Chemically Modified Enzymes and Metal Electrodes. 2. Methods for Bonding Electron-Transfer Relays to Glucose Oxidase and D-Amino-Acid Oxidase"", Journal of the American Chemical Society, vol. 110, No. 8, 1988, pp. 2615-2620.;;Degani, Y., et al., ""Electrical Communication Between Redox Centers of Glucose Oxidase and Electrodes via Electrostatically and Covalently Bound Redox Polymers"", Journal of the American Chemical Society, vol. 111, 1989, pp. 2357-2358.;;Denisevich, P., et al., ""Unidirectional Current Flow and Charge State Trapping at Redox Polymer Interfaces on Bilayer Electrodes: Principles, Experimental Demonstration, and Theory"", Journal of the American Chemical Society, vol. 103, 1981, pp. 4727-4737.;;Dicks, J. M., et al., ""Ferrocene Modified Polypyrrole with Immobilised Glucose Oxidase and its Application in Amperometric Glucose Microbiosensors"", Annales de Biologie Clinique, vol. 47, 1989, pp. 607-619.;;Dixon, B. M., et al., ""Characterization In Vitro and In Vivo of the Oxygen Dependence of an Enzyme/Polymer Biosensors for Monitoring Brain Glucose"", Journal of Neuroscience Methods, vol. 119, 2002, pp. 135-142.;;Eighth Annual Diabetes Technology Meeting Abstracts, Nov. 13-15, 2008, pp. A1-A182.;;El-Khatib, F. H, et al., ""Adaptive Closed-Loop Control Provides Blood-Glucose Regulation Using Subcutaneous Insulin and Glucagon Infusion in Diabetic Swine"", Journal of Diabetes Science and Technology, vol. 1, No. 2, 2007, pp. 181-192.;;Ellis, C. D., et al., ""Selectivity and Directed Charge Transfer through an Electroactive Metallopolymer Film"", Journal of the American Chemical Society, vol. 103, No. 25, 1981, pp. 7480-7483.;;El-Sa'ad, L., et al., ""Moisture Absorption by Epoxy Resins: The Reverse Thermal Effect"", Journal of Materials Science, vol. 25, No. 8, 1990, pp. 3577-3582.;;Engstrom, R. C., ""Electrochemical Pretreatment of Glassy Carbon Electrodes"", Analytical Chemistry, vol. 54, No. 13, 1982, pp. 2310-2314.;;Engstrom, R. C., et al., ""Characterization of Electrochemically Pretreated Glassy Carbon Electrodes"", Analytical Chemistry, vol. 56, No. 2, 1984, pp. 136-141.;;Ernst, H., et al., ""Reliable Glucose Monitoring Through the Use of Microsystem Technology"", Analytical and Bioanalytical Chemistry, vol. 373, 2002, pp. 758-761.;;Fabietti, P. G., et al. ""Clinical Validation of a New Control-Oriented Model of Insulin and Glucose Dynamics in Subjects with Type 1 Diabetes"", Diabetes Technology & Therapeutics, vol. 9 No. 4, 2007, pp. 327-338.;;Fare, T. L., et al., ""Functional Characterization of a Conducting Polymer-Based Immunoassay System"", Biosensors & Bioelectronics, vol. 13, No. 3-4, 1998, pp. 459-470.;;Feldman, B., et al., ""A Continuous Glucose Sensor Based on Wired Enzyme(TM) Technology-Results from a 3-Day Trial in Patients with Type 1 Diabetes"", Diabetes Technology & Therapeutics, vol. 5, No. 5, 2003, pp. 769-779.;;Feldman, B., et al., ""Correlation of Glucose Concentrations in Interstitial Fluid and Venous Blood During Periods of Rapid Glucose Change"", Abbott Diabetes Care, Inc. Freestyle Navigator Continuous Glucose Monitor Pamphlet, 2004.;;Feldman, B., et al., ""Electron Transfer Kinetics at Redox Polymer/Solution Interfaces Using Microelectrodes and Twin Electrode Thin Layer Cells"", Journal of ElectroAnalytical Chemistry, vol. 194, 1985, pp. 63-81.;;Fischer, H., et al., ""Intramolecular Electron Transfer Medicated by 4,4'-Bypyridine and Related Bridging Groups"", Journal of the American Chemical Society, vol. 98, No. 18, 1976, pp. 5512-5517.;;Flentge, F., et al., ""An Enzyme-Reactor for Electrochemical Monitoring of Choline and Acetylcholine: Applications in High-Performance Liquid Chromatography, Bran Tissue, Microdialysis and Cerebrospinal Fluid,"" Analytical Biochemistry, vol. 204, 1992, pp. 305-310.;;Foulds, N. C., et al., ""Enzyme Entrapment in Electrically Conducting Polymers: Immobilisation of Glucose Oxidase in Polypyrrole and its Application in Amperometric Glucose Sensors"", Journal of the Chemical Society, Faraday Transactions 1, vol. 82, 1986, pp. 1259-1264.;;Foulds, N. C., et al , ""Immobilization of Glucose Oxidase in Ferrocene-Modified Pyrrole Polymers"", Analytical Chemistry, vol. 60, No. 22, 1988, pp. 2473-2478.;;Frew, J. E., et al., ""Electron-Transfer Biosensors"", Philosophical Transactions of the Royal Society of London, vol. 316, 1987, pp. 95-106.;;Frohnauer, M. K., et al., ""Graphical Human Insulin Time-Activity Profiles Using Standardized Definitions"", Diabetes Technology & Therapeutics, vol. 3, No. 3, 2001, pp. 419-429.;;Frost, M. C., et al., ""Implantable Chemical Sensors for Real-Time Clinical Monitoring: Progress and Challenges"", Current Opinion in Chemical Biology, vol. 6, 2002, pp. 633-641.;;Garg, S. K., et al., ""Correlation of Fingerstick Blood Glucose Measurements with GlucoWatch Biographer Glucose Results in Young Subjects with Type 1 Diabetes"", Diabetes Care, vol. 22, No. 10, 1999, pp. 1708-1714.;;Garg, S. K., et al., ""Improved Glucose Excursions Using an Implantable Real-Time Continuous Glucose Sensor in Adults with Type 1 Diabetes"", Diabetes Care, vol. 27, No. 3, 2004, pp. 734-738.;;Geller, R. L., et al., ""Use of an Immunoisolation Device for Cell Transplantation and Tumor Immunotherapy"", Annals of the New York Academy of Sciences, vol. 831, 1997, pp. 438-451.",EXPIRED
277,US,A1,US 2009/0069656 A1,147-211-267-180-882,2009-03-12,2009,US 20577908 A,2008-09-05,US 20577908 A;;US 42005703 A;;US 66719900 A;;US 7067798 A,1998-04-30,Analyte Monitoring Device and Methods of Use,"An analyte monitor includes a sensor, a sensor control unit, and a display unit. The sensor has, for example, a substrate, a recessed channel formed in the substrate, and conductive material disposed in the recessed channel to form a working electrode. The sensor control unit typically has a housing adapted for placement on skin and is adapted to receive a portion of an electrochemical sensor. The sensor control unit also includes two or more conductive contacts disposed on the housing and configured for coupling to two or more contact pads on the sensor. A transmitter is disposed in the housing and coupled to the plurality of conductive contacts for transmitting data obtained using the sensor. The display unit has a receiver for receiving data transmitted by the transmitter of the sensor control unit and a display coupled to the receiver for displaying an indication of a level of an analyte. The analyte monitor may also be part of a drug delivery system to alter the level of the analyte based on the data obtained using the sensor.",ABBOTT DIABETES CARE INC,SAY JAMES;;TOMASCO MICHAEL F;;HELLER ADAM;;GAL YORAM;;ARIA BEHRAD;;HELLER EPHRAIM;;PLANTE PHILLIP JOHN;;VREEKE MARK S;;FRIEDMAN KEITH A;;COLMAN FREDRIC C,,https://lens.org/147-211-267-180-882,Patent Application,yes,1,61,211,221,0,A61B5/14532;;A61B5/14532;;A61B5/0002;;A61B5/0002;;A61B5/002;;A61B5/01;;A61B5/14503;;A61B5/1451;;A61B5/14546;;A61B5/14546;;A61B5/1473;;A61B5/1473;;A61B5/1486;;A61B5/1486;;A61B5/14865;;A61B5/1495;;A61B5/4839;;A61B5/72;;A61B5/7278;;A61B5/7282;;A61B5/7405;;A61B5/743;;A61B5/7445;;A61B5/7445;;A61B5/7455;;A61B2560/0252;;A61B2560/0252;;A61M5/1723;;C12Q1/54;;G16H10/40;;G16H10/40;;G16H20/17;;G16H20/17;;H01L23/3107;;H01L23/3107;;H01L23/49548;;H01L23/49548;;H01L2924/0002;;H01L2924/0002;;H01L2924/19041;;H01L2924/19041;;H01L2924/3011;;H01L2924/3011;;Y10S128/903;;Y10S128/903;;Y10T29/49;;Y10T29/49;;Y10T29/49124;;Y10T29/49124,A61B5/1468;;G01N27/30;;A61B5/00;;A61B5/145;;A61B5/1477;;A61B5/1495;;G01N27/416;;G06F19/00;;H01L23/31;;H01L23/495,600/347;;600/365,0,0,,,,DISCONTINUED
278,US,A1,US 2011/0092897 A1,162-917-280-413-001,2011-04-21,2011,US 95933710 A,2010-12-02,US 95933710 A;;US 69082607 A;;US 42005703 A;;US 66719900 A;;US 7067798 A,1998-04-30,Analyte Monitoring Device and Methods of Use,"An analyte monitor includes a sensor, a sensor control unit, and a display unit. The sensor has, for example, a substrate, a recessed channel formed in the substrate, and conductive material disposed in the recessed channel to form a working electrode. The sensor control unit typically has a housing adapted for placement on skin and is adapted to receive a portion of an electrochemical sensor. The sensor control unit also includes two or more conductive contacts disposed on the housing and configured for coupling to two or more contact pads on the sensor. A transmitter is disposed in the housing and coupled to the plurality of conductive contacts for transmitting data obtained using the sensor. The display unit has a receiver for receiving data transmitted by the transmitter of the sensor control unit and a display coupled to the receiver for displaying an indication of a level of an analyte. The analyte monitor may also be part of a drug delivery system to alter the level of the analyte based on the data obtained using the sensor.",ABBOTT DIABETES CARE INC,SAY JAMES;;TOMASCO MICHAEL F;;HELLER ADAM;;GAL YORAM;;ARIA BEHRAD;;HELLER EPHRAIM;;PLANTE PHILLIP JOHN;;VREEKE MARK S;;FRIEDMAN KEITH A;;COLMAN FREDRIC C,,https://lens.org/162-917-280-413-001,Patent Application,yes,8,1,211,221,0,A61B5/14532;;A61B5/14532;;A61B5/0002;;A61B5/0002;;A61B5/002;;A61B5/01;;A61B5/14503;;A61B5/1451;;A61B5/14546;;A61B5/14546;;A61B5/1473;;A61B5/1473;;A61B5/1486;;A61B5/1486;;A61B5/14865;;A61B5/1495;;A61B5/4839;;A61B5/72;;A61B5/7278;;A61B5/7282;;A61B5/7405;;A61B5/743;;A61B5/7445;;A61B5/7445;;A61B5/7455;;A61B2560/0252;;A61B2560/0252;;A61M5/1723;;C12Q1/54;;G16H10/40;;G16H10/40;;G16H20/17;;G16H20/17;;H01L23/3107;;H01L23/3107;;H01L23/49548;;H01L23/49548;;H01L2924/0002;;H01L2924/0002;;H01L2924/19041;;H01L2924/19041;;H01L2924/3011;;H01L2924/3011;;Y10S128/903;;Y10S128/903;;Y10T29/49;;Y10T29/49;;Y10T29/49124;;Y10T29/49124,A61M5/168;;G01N27/30;;A61B5/00;;A61B5/145;;A61B5/1477;;A61B5/1495;;G01N27/416;;G06F19/00;;H01L23/31;;H01L23/495,604/66,0,0,,,,DISCONTINUED
279,US,B2,US 8391945 B2,171-569-976-416-997,2013-03-05,2013,US 40564309 A,2009-03-17,US 40564309 A;;US 42005703 A;;US 66719900 A;;US 7067798 A,1998-04-30,Analyte monitoring device and methods of use,"An analyte monitor includes a sensor, a sensor control unit, and a display unit. The sensor has, for example, a substrate, a recessed channel formed in the substrate, and conductive material disposed in the recessed channel to form a working electrode. The sensor control unit typically has a housing adapted for placement on skin and is adapted to receive a portion of an electrochemical sensor. The sensor control unit also includes two or more conductive contacts disposed on the housing and configured for coupling to two or more contact pads on the sensor. A transmitter is disposed in the housing and coupled to the plurality of conductive contacts for transmitting data obtained using the sensor. The display unit has a receiver for receiving data transmitted by the transmitter of the sensor control unit and a display coupled to the receiver for displaying an indication of a level of an analyte. The analyte monitor may also be part of a drug delivery system to alter the level of the analyte based on the data obtained using the sensor.",SAY JAMES;;TOMASCO MICHAEL F;;HELLER ADAM;;GAL YORAM;;ARIA BEHRAD;;HELLER EPHRAIM;;PLANTE PHILLIP JOHN;;VREEKE MARK S;;FRIEDMAN KEITH A;;COLMAN FREDRIC C;;ABBOTT DIABETES CARE INC,SAY JAMES;;TOMASCO MICHAEL F;;HELLER ADAM;;GAL YORAM;;ARIA BEHRAD;;HELLER EPHRAIM;;PLANTE PHILLIP JOHN;;VREEKE MARK S;;FRIEDMAN KEITH A;;COLMAN FREDRIC C,E. HELLER & CO (1998-07-02);;ABBOTT DIABETES CARE INC (2000-03-13),https://lens.org/171-569-976-416-997,Granted Patent,yes,109,6,211,221,0,A61B5/14532;;A61B5/14532;;A61B5/0002;;A61B5/0002;;A61B5/002;;A61B5/01;;A61B5/14503;;A61B5/1451;;A61B5/14546;;A61B5/14546;;A61B5/1473;;A61B5/1473;;A61B5/1486;;A61B5/1486;;A61B5/14865;;A61B5/1495;;A61B5/4839;;A61B5/72;;A61B5/7278;;A61B5/7282;;A61B5/7405;;A61B5/743;;A61B5/7445;;A61B5/7445;;A61B5/7455;;A61B2560/0252;;A61B2560/0252;;A61M5/1723;;C12Q1/54;;G16H10/40;;G16H10/40;;G16H20/17;;G16H20/17;;H01L23/3107;;H01L23/3107;;H01L23/49548;;H01L23/49548;;H01L2924/0002;;H01L2924/0002;;H01L2924/19041;;H01L2924/19041;;H01L2924/3011;;H01L2924/3011;;Y10S128/903;;Y10S128/903;;Y10T29/49;;Y10T29/49;;Y10T29/49124;;Y10T29/49124,A61B5/05;;G01N27/30;;A61B5/00;;A61B5/145;;A61B5/1477;;A61B5/1495;;G01N27/416;;G06F19/00;;H01L23/31;;H01L23/495,600/345;;600/347,99,81,136-791-935-548-81X;;062-360-289-025-864;;010-601-725-111-91X;;101-292-518-663-191;;056-703-879-057-297;;030-155-762-644-019;;004-149-141-436-651;;016-731-054-793-457;;080-559-561-995-335;;044-807-213-528-815;;027-538-525-436-179;;015-020-161-517-40X;;025-919-454-564-785;;014-700-576-603-812;;004-851-060-590-788;;075-958-432-122-199;;052-356-140-149-389;;035-090-282-884-790;;033-562-815-299-181;;018-803-926-589-211;;008-505-762-041-402;;016-601-143-530-813;;019-502-772-562-215;;058-476-824-396-350;;006-498-707-073-30X;;054-091-551-638-293;;010-531-147-771-746;;054-827-198-877-419;;122-658-944-077-000;;017-261-560-469-37X;;000-125-755-474-124;;113-381-664-783-802;;082-626-907-191-554;;017-950-014-792-456;;090-348-305-613-628;;015-985-399-299-132;;171-049-047-164-618;;016-819-089-891-758;;081-249-097-078-543;;089-612-747-111-646;;031-706-897-890-035;;094-198-536-559-723;;003-690-143-043-420;;007-943-354-378-456;;082-114-500-909-975;;004-239-090-971-580;;026-894-457-160-450;;077-128-610-778-669;;022-466-506-956-898;;008-424-592-956-946;;007-500-825-916-378;;009-725-244-669-882;;037-755-689-613-42X;;153-411-506-517-475;;038-134-360-685-692;;012-449-714-188-064;;031-517-704-996-130;;131-299-284-996-064;;049-133-049-742-708;;000-272-178-768-076;;070-797-683-833-124;;043-870-224-178-49X;;025-574-914-238-550;;052-364-430-129-757;;004-434-167-910-115;;032-860-147-271-886;;132-460-374-211-421;;098-172-374-375-47X;;109-358-955-476-095;;014-988-634-483-130;;061-786-187-274-992;;037-898-018-686-909;;130-044-667-529-69X;;134-265-642-839-645;;065-221-074-461-027;;017-934-465-161-477;;101-660-130-379-529;;028-236-706-290-220;;087-333-189-994-274;;059-082-211-027-266;;057-977-752-782-568,10.1016/s0956-5663(02)00099-4;;12392956;;10.1021/ja00391a001;;2889225;;10.1098/rstb.1987.0021;;10.1109/51.294001;;10.1016/0022-0728(65)85063-x;;2245876;;10.2337/diabetes.39.12.1519;;10.2337/diab.39.12.1519;;10.1016/s0956-5663(03)00220-3;;14611755;;18615658;;10.1002/bit.260430310;;9366023;;10.1016/s0956-5663(97)00025-0;;9451795;;10.1016/s0956-5663(97)00083-3;;10.1016/0956-5663(93)80028-n;;8311939;;8651496;;10.1021/ac960030d;;10.1080/03091900210156797;;12487712;;10.1016/0265-928x(87)80018-4;;3333622;;10.1109/19.816143;;10.1007/bf01015979;;10.1089/15209150252924058;;12017416;;18473691;;10.1089/dia.2007.0281;;10.1021/ac00017a008;;1789439;;2817408;;10.1021/ac00197a022;;10.1016/0925-4005(95)01730-5;;10.1016/0010-4825(90)90013-f;;2257734;;2868172;;8277748;;10.1016/0141-5425(93)90058-7;;11469630;;10.1089/15209150050214104;;10624783;;10.1016/s0168-8227(99)00113-8;;10.1089/15209150050214113;;11469631;;10.1007/bf00401374;;1478372;;10.2337/diacare.20.1.64;;9028696;;10.1109/tbme.1986.325807;;3957374;;236018;;10.1016/0005-2795(75)90259-7;;10.1089/hum.1998.9.6-879;;9581910;;11762520;;10.1089/15209150152607196;;10.2337/diabetes.48.3.445;;10078542;;10.1016/0265-928x(87)80012-3;;505005;;10.1126/science.505005;;10.1021/ac0498516;;15253640;;10.1109/10.284922;;8026845;;6721151;;10.1021/ac00268a018;;6733082;;10.1021/bi00305a016;;10.1515/cclm.2002.135;;12392305;;10.1016/j.ecl.2003.12.001;;15053902;;12052350;;10.1016/s0956-5663(01)00304-9;;12052349;;10.1016/s0956-5663(01)00306-2;;4500021;;10.1007/978-1-4684-3288-6_18;;14021529;;10.1111/j.1749-6632.1962.tb13623.x;;3196517;;10.2337/diacare.10.5.622;;3677983;;10.2337/diacare.8.6.529;;4075939;;10.1002/elan.1140061103;;7733469;;10.1021/ac00103a015;;7978306;;10.1021/ac00091a022;;10.1007/bf01248238;;10.1016/s0376-7388(98)00330-5;;10.1016/0142-9612(92)90147-g;;1472593;;10.1016/0265-928x(85)80002-x;;10.1021/j100290a001;;10.1021/ja00216a040;;10.1021/ja00188a091;;10.1021/ja00406a011;;2624333;;12323417;;10.1016/s0165-0270(02)00170-x;;10.1177/193229680700100208;;pmc2771467;;19888405;;10.1021/ja00415a014;;10.1007/bf00575392;;10.1021/ac00250a038;;10.1021/ac00266a005;;10.1007/s00216-002-1284-0;;12194035;;10.1089/dia.2006.0030;;17705688;;9642777;;10.1016/s0956-5663(97)00091-2;;10.1089/152091503322526978;;14633342;;10.1016/0022-0728(85)87006-6;;10.1021/ja00434a018;;10.1016/0003-2697(92)90243-z;;1443528;;10.1039/f19868201259;;3245585;;10.1021/ac00173a008;;2889234;;10.1098/rstb.1987.0020;;11762521;;10.1089/15209150152607204;;12413548;;10.1016/s1367-5931(02)00371-x;;10526740;;10.2337/diacare.22.10.1708;;14988294;;10.2337/diacare.27.3.734,"""Poretics Polycarbonate Membrane"", Osmonics Filtration and Separation Group, 2002.;;Abel, P. U., et al., ""Biosensors for in Vivo Glucose Measurement: Can We Cross the Experimental Stage"", Biosensors and Bioelectronics, vol. 17, 2002, pp. 1059-1070.;;Abruna, H. D., et al., ""Rectifying Interfaces Using Two-Layer Films of Electrochemically Polymerized Vinylpyridine and Vinylbipyridine Complexes of Ruthenium and Iron on Electrodes"", Journal of the American Chemical Society, vol. 103, No. 1, 1981, pp. 1-5.;;Albery, W. J., et al., ""Amperometric Enzyme Electrodes Part II: Conducting Salts as Electrode Materials for the Oxidation of Glucose Oxidase"", Journal of ElectroAnalytical Chemistry, vol. 194, 1985, pp. 223-235.;;Albery, W. J., et al., ""Amperometric Enzyme Electrodes"", Philosophical Transactions of the Royal Society of London, vol. 316, 1987, pp. 107-119.;;Alcock, S. J., et al., ""Continuous Analyte Monitoring to Aid Clinical Practice"", IEEE Engineering in Medicine and Biology Magazine, 1994, pp. 319-325.;;Anderson, L. B., et al., ""Thin-Layer Electrochemistry: Steady-State Methods of Studying Rate Processes"", Journal of ElectroAnalytical Chemistry, vol. 10, 1965, pp. 295-305.;;Armour, J. C., et al., ""Application of Chronic Intravascular Blood Glucose Sensor in Dogs"", Diabetes, vol. 39, 1990, pp. 1519-1526.;;Asberg, P., et al., ""Hydrogels of a Conducting Conjugated Polymer as 3-D Enzyme Electrode"", Biosensors & Bioelectronics, vol. 19, 2003, pp. 199-207.;;Atanasov, P., et al., ""Biosensor for Continuous Glucose Monitoring"", Biotechnology and Bioengineering, vol. 43, 1994, pp. 262-266.;;Atanasov, P., et al., ""Implantation of a Refillable Glucose Monitoring-Telemetry Device"", Biosensors & Bioelectronics, vol. 12, No. 7, 1997, pp. 669-680.;;Aussedat, B., et al., ""A User-Friendly Method for Calibrating a Subcutaneous Glucose Sensor-Based Hypoglycaemic Alarm"", Biosensors & Bioelectronics, vol. 12, No. 11, 1997, pp. 1061-1071.;;Baker, D. A., et al., ""Dynamic Concentration Challenges for Biosensor Characterization"", Biosensors & Bioelectronics, vol. 8, 1993, pp. 433-441.;;Baker, D. A., et al., ""Dynamic Delay and Maximal Dynamic Error in Continuous Biosensors"", Analytical Chemistry, vol. 68, No. 8, 1996, pp. 1292-1297.;;Bani Amer, M. M., ""An Accurate Amperometric Glucose Sensor Based Glucometer with Eliminated Cross-Sensitivity"", Journal of Medical Engineering & Technology, vol. 26, No. 5, 2002, pp. 208-213.;;Bard, A. J., et al., Electrochemical Methods, 1980, pp. 173-175.;;Bartlett, P. N., et al., ""Covalent Binding of Electron Relays to Glucose Oxidase"", Journal of the Chemical Society, Chemical Communications, 1987, pp. 1603-1604.;;Bartlett, P. N., et al., ""Modification of Glucose Oxidase by Tetrathiafulvalene"", Journal of the Chemical Society, Chemical Communications, 1990, pp. 1135-1136.;;Bartlett, P. N., et al., ""Strategies for the Development of Amperometric Enzyme Electrodes"", Biosensors, vol. 3, 1987/88, pp. 359-379.;;Beach, R. D., et al., ""Subminiature Implantable Potentiostat and Modified Commercial Telemetry Device for Remote Glucose Monitoring"", IEEE Transactions on Instrumentation and Measurement, vol. 28, No. 6, 1999, pp. 1239-1245.;;Beech, W. A., ""Ax.25 Link Access Protocol for Amateur packet Radio"", Tucson Amateur Packet Radio Corporation, 1998, pp. 1-133.;;Bellucci, F., et al., ""Electrochemical Behaviour of Graphite-Epoxy Composite Materials (GECM) in Aqueous Salt Solutions"", Journal of Applied Electrochemistry, vol. 16, 1986, pp. 15-22.;;Bennion, N., et al., ""Alternate Site Glucose Testing: A Crossover Design"", Diabetes Technology & Therapeutics, vol. 4, No. 1, 2002, pp. 25-33.;;Biermann, E., et al., ""How Would Patients Behave if They Were Continually Informed of Their Blood Glucose Levels? A Simulation Study Using a 'Virtual' Patient"", Diabetes Technology & Therapeutics, vol. 10, No. 3, 2008, pp. 178-187.;;Bindra, D. S., et al., ""Design and in Vitro Studies of a Needle-Type Glucose Sensor for Subcutaneous Monitoring"", Analytical Chemistry, vol. 63, No. 17, 1991, pp. 1692-1696.;;Bindra, D. S., et al., ""Pulsed Amperometric Detection of Glucose in Biological Fluids at a Surface-Modified Gold Electrode"", Analytical Chemistry, vol. 61, No. 22, 1989, pp. 2566-2570.;;Bisenberger, M., et al., ""A Triple-Step Potential Waveform at Enzyme Multisensors with Thick-Film Gold Electrodes for Detection of Glucose and Sucrose"", Sensors and Actuators B, vol. 28, 1995, pp. 181-189.;;Bland, J. M., et al., ""A Note on the Use of the Intraclass Correlation Coefficient in the Evaluation of Agreement Between Two Methods of Measurement"", Computers in Biology and Medicine, vol. 20, No. 5, 1990, pp. 337-340.;;Bland, J. M., et al., ""Statistical Methods for Assessing Agreement Between Two Methods of Clinical Measurement"", The Lancet, 1986, pp. 307-310.;;Blank, T. B., et al., ""Clinical Results From a Non-Invasive Blood Glucose Monitor"", Optical Diagnostics and Sensing of Biological Fluids and Glucose and Cholesterol Monitoring II, Proceedings of SPIE,vol. 4624, 2002, pp. 1-10.;;Bobbioni-Harsch, E., et al., ""Lifespan of Subcutaneous Glucose Sensors and Their Performances During Dynamic Glycaemia Changes in Rats"", Journal of Biomedical Engineering, vol. 15, 1993, pp. 457-463.;;Bode, B. W., ""Clinical Utility of the Continuous Glucose Monitoring System"", Diabetes Technology & Therapeutics, vol. 2, Sup. 1, 2000, pp. S35-S41.;;Bode, B. W., et al., ""Continuous Glucose Monitoring Used to Adjust Diabetes Therapy Improves Glycosylated Hemoglobin: A Pilot Study"", Diabetes Research and Clinical Practice, vol. 46, 1999, pp. 183-190.;;Bode, B. W., et al., ""Using the Continuous Glucose Monitoring System to Improve the Management of Type I Diabetes"", Diabetes Technology & Therapeutics, vol. 2, Sup. 1, 2000, pp. S43-S48.;;Boedeker Plastics, Inc., ""Polyethylene Specifications"", 2007, pp. 1-3. Web Page of Boedeker.com, 2007, pp. 1-3.;;Bolinder, J., et al., ""Microdialysis Measurement of the Absolute Glucose Concentration in Subcutaneous Adipose Tissue Allowing Glucose Monitoring in Diabetic Patients"", Diabetologia, vol. 35, 1992, pp. 1177-1180.;;Bolinder, J., et al., ""Self-Monitoring of Blood Glucose in Type I Diabetic Patients: Comparison with Continuous Microdialysis Measurements of Glucose in Subcutaneous Adipose Tissue During Ordinary Life Conditions"", Diabetes Care, vol. 20, No. 1, 1997, pp. 64-70.;;Bott, A. W., ""A Comparison of Cyclic Voltammetry and Cyclic Staircase Voltammetry"", Current Separations, vol. 16, No. 1, 1997, pp. 23-26.;;Bott, A. W., ""Electrochemical Methods for the Determination of Glucose"", Current Separations, vol. 17, No. 1, 1998, pp. 25-31.;;Bowman, L., et al., ""The Packaging of Implantable Integrated Sensors"", IEEE Transactions on Biomedical Engineering, vol. 33, No. 2, 1986, pp. 248-255.;;Brandt, J., et al., ""Covalent Attachment of Proteins to Polysaccharide Carriers by Means of Benzoquinone"", Biochimica et Biophysica Acta, vol. 386, 1975, pp. 196-202.;;Brauker, J., et al., ""Sustained Expression of High Levels of Human Factor IX from Human Cells Implanted Within an Immunoisolation Device into Athymic Rodents"", Human Gene Therapy, vol. 9, No. 6, 1998, pp. 879-888.;;Bremer, T. M., et al., ""Benchmark Data from the Literature for Evaluation of New Glucose Sensing Technologies"", Diabetes Technology & Therapeutics, vol. 3, No. 3, 2001, pp. 409-418.;;Bremer, T., et al., ""Is Blood Glucose Predictable from Previous Values?"", Diabetes, vol. 48, 1999, pp. 445-451.;;Brooks, S. L., et al., ""Development of an On-Line Glucose Sensor for Fermentation Monitoring"", Biosensors, vol. 3, 1987/88, pp. 45-56.;;Brownlee, M., et al., ""A Glucose-Controlled Insulin-Delivery System: Semisynthetic Insulin Bound to Lectin"", Science, vol. 206, 1979, 1190-1191.;;Cai, Q., et al., ""A Wireless, Remove Query Glucose Biosensor Based on a pH-Sensitive Polymer"", Analytical Chemistry, vol. 76, No. 14, 2004, pp. 4038-4043.;;Candas, B., et al., ""An Adaptive Plasma Glucose Controller Based on a Nonlinear Insulin/Glucose Model"", IEEE Transactions on Biomedical Engineering, vol. 41, No. 2, 1994, pp. 116-124;;Cass, A. E., et al., ""Ferricinum Ion As An Electron Acceptor for Oxido-Reductases"", Journal of ElectroAnalytical Chemistry, vol. 190, 1985, pp. 117-127.;;Cass, A. E., et al., ""Ferrocene-Medicated Enzyme Electrode for Amperometric Determination of Glucose"", Analytical Chemistry, vol. 56, No. 4, 1984, 667-671.;;Castner, J. F., et al., ""Mass Transport and Reaction Kinetic Parameters Determined Electrochemically for Immobilized Glucose Oxidase"", Biochemistry, vol. 23 No. 10, 1984, 2203-2210.;;Chen, J. C., et al., ""A Comparison of MAC Protocols for Wireless Local Networks Based on battery Power Consumption"", IEEE, 1998, pp. 150-157.;;Chen, T., et al., ""Defining the Period of Recovery of the Glucose Concentration After Its Local Perturbation by the Implantation of a Miniature Sensor"", Clinical Chemistry and Laboratory Medicine, vol. 40, No. 8, 2002, pp. 486-489.;;Chia, C. W., et al., ""Glucose Sensors: Toward Closed Loop Insulin Delivery"", Endocrinology and Metabolism Clinics of North America, vol. 33, 2004, pp. 175-195.;;Choleau, C., et al., ""Calibration of a Subcutaneous Amperometric Glucose Sensor Implanted for 7 Days in Diabetic Patients Part 2: Superiority of the One-Point Calibration Method"", Biosensors and Bioelectronics, vol. 17, 2002, pp. 647-654.;;Choleau, C., et al., ""Calibration of a Subcutaneous Amperometric Glucose Sensor Part 1: Effect of Measurement Uncertainties on the Determination of Sensor Sensitivity and Background Current"", Biosensors and Bioelectronics, vol. 17, 2002, pp. 641-646.;;Claremont, D. J., et al., ""Biosensors for Continuous in Vivo Glucose Monitoring"", Proceedings of the Annual International Conference of the IEEE Engineering in Medicine and Biology Society, vol. 10, 1988.;;Clark Jr., L. C., et al., ""Differential Anodic Enzyme Polarography for the Measurement of Glucose"", Oxygen Transport to Tissue: Instrumentation, Methods, and Physiology, 1973, pp. 127-133.;;Clark Jr., L. C., et al., ""Electrode Systems for Continuous Monitoring in Cardiovascular Surgery"", Annals New York Academy of Sciences, 1962, pp. 29-45.;;Clark Jr., L. C., et al., ""Long-term Stability of Electroenzymatic Glucose Sensors Implanted in Mice"", American Society of Artificial Internal Organs Transactions, vol. XXXIV, 1988, pp. 259-265.;;Clarke, W. L., et al., ""Evaluating Clinical Accuracy of Systems for Self-Monitoring of Blood Glucose"", Diabetes Care, vol. 10, No. 5, 1987, pp. 622-628.;;Complaint, ""Abbott Diabetes Care, Inc. v. Dexcom, Inc."", filed Aug. 11, 2005.;;Complaint, Amended, ""Abbott Diabetes Care, Inc. v. Dexcom, Inc."", filed Jun. 27, 2006.;;Cox, D. J., et al., ""Accuracy of Perceiving Blood Glucose in IDDM"", Diabetes Care, vol. 8, No. 6, 1985, pp. 529-536.;;Csoregi, E., et al., ""Amperometric Microbiosensors for Detection of Hydrogen Peroxide and Glucose Based on Peroxidase-Modified Carbon Fibers"", Electroanalysis, vol. 6, 1994, pp. 925-933.;;Csoregi, E., et al., ""Design and Optimization of a Selective Subcutaneously Implantable Glucose Electrode Based on 'Wired' Glucose Oxidase"", Analytical Chemistry, vol. 67, No. 7, 1995, pp. 1240-1244.;;Csoregi, E., et al., ""Design, Characterization, and One-Point in Vivo Calibration of a Subcutaneously Inplanted Glucose Electrode"", Analytical Chemistry, vol. 66 No. 19, 1994, pp. 3131-3138.;;Csoregi, E., et al., ""On-Line Glucose Monitoring by Using Microdialysis Sampling and Amperometric Detection Based on 'Wired' Glucose Oxidase in Carbon Paste"", Mikrochimica Acta, vol. 121, 1995, pp. 31-40.;;D'Arrigo, G., et al., ""Porous-Si Based Bio Reactors for Glucose Monitoring and Drugs Production"", Proceedings of SPIE: Microfluids, BioMEMS, and Medical Microsystems, vol. 4982, 2003, pp. 178-184.;;Dai, W. S., et al., ""Hydrogel Membranes with Mesh Size Asymmetry Based on the Gradient Crosslinking of Poly(vinyl alcohol),"" Journal of Membrane Science, vol. 156, 1999, pp. 67-79.;;Davies, M. L., et al., ""Polymer Membranes in Clinical Sensor Applications"", Biomaterials, vol. 13 No. 14, 1992, pp. 971-978.;;Davis, G., ""Electrochemical Techniques for the Development of Amperometric Biosensors"", Biosensors, vol. 1, 1985, pp. 161-178.;;Degani, Y., et al., ""Direct Electrical Communication Between Chemically Modified Enzymes and Metal Electrodes. 1. Electron from Glucose Oxidase to Metal Electrodes via Electron Relays, Bound Covalently to the Enzyme"", The Journal of Physical Chemistry, vol. 91, No. 6, 1987, pp. 1285-1289.;;Degani, Y., et al., ""Direct Electrical Communication Between Chemically Modified Enzymes and Metal Electrodes. 2. Methods for Bonding Electron-Transfer Relays to Glucose Oxidase and D-Amino-Acid Oxidase"", Journal of the American Chemical Society, vol. 110, No. 8, 1988, pp. 2615-2620.;;Degani, Y., et al., ""Electrical Communication Between Redox Centers of Glucose Oxidase and Electrodes via Electrostatically and Covalently Bound Redox Polymers"", Journal of the American Chemical Society, vol. 111, 1989, pp. 2357-2358.;;Denisevich, P., et al., ""Unidirectional Current Flow and Charge State Trapping at Redox Polymer Interfaces on Bilayer Electrodes: Principles, Experimental Demonstration, and Theory"", Journal of the American Chemical Society, vol. 103, 1981, pp. 4727-4737.;;Dicks, J. M., et al., ""Ferrocene Modified Polypyrrole with Immobilised Glucose Oxidase and its Application in Amperometric Glucose Microbiosensors"", Annales de Biologie Clinique, vol. 47, 1989, pp. 607-619.;;Dixon, B. M., et al., ""Characterization in Vitro and in Vivo of the Oxygen Dependence of an Enzyme/Polymer Biosensors for Monitoring Brain Glucose"", Journal of Neuroscience Methods, vol. 119, 2002, pp. 135-142.;;Eighth Annual Diabetes Technology Meeting Abstracts, Nov. 13-15, 2008, pp. A1-A182.;;El-Khatib, F. H, et al., ""Adaptive Closed-Loop Control Provides Blood-Glucose Regulation Using Subcutaneous Insulin and Glucagon Infusion in Diabetic Swine"", Journal of Diabetes Science and Technology, vol. 1, No. 2, 2007, pp. 181-192.;;Ellis, C. D., et al., ""Selectivity and Directed Charge Transfer through an Electroactive Metallopolymer Film"", Journal of the American Chemical Society, vol. 103, No. 25, 1981, pp. 7480-7483.;;El-Sa'Ad, L., et al., ""Moisture Absorption by Epoxy Resins: The Reverse Thermal Effect"", Journal of Materials Science, vol. 25, No. 8, 1990, pp. 3577-3582.;;Engstrom, R. C., ""Electrochemical Pretreatment of Glassy Carbon Electrodes"", Analytical Chemistry, vol. 54, No. 13, 1982, pp. 2310-2314.;;Engstrom, R. C., et al., ""Characterization of Electrochemically Pretreated Glassy Carbon Electrodes"", Analytical Chemistry, vol. 56, No. 2, 1984, pp. 136-141.;;Ernst, H., et al., ""Reliable Glucose Monitoring Through the Use of Microsystem Technology"", Analytical and Bioanalytical Chemistry, vol. 373, 2002, pp. 758-761.;;Fabietti, P. G., et al. ""Clinical Validation of a New Control-Oriented Model of Insulin and Glucose Dynamics in Subjects with Type 1 Diabetes"", Diabetes Technology & Therapeutics, vol. 9 No. 4, 2007, pp. 327-338.;;Fare, T. L., et al., ""Functional Characterization of a Conducting Polymer-Based Immunoassay System"", Biosensors & Bioelectronics, vol. 13, No. 3-4, 1998, pp. 459-470.;;Feldman, B., et al., ""A Continuous Glucose Sensor Based on Wired Enzyme(TM)Technology-Results from a 3-Day Trial in Patients with Type 1 Diabetes"", Diabetes Technology & Therapeutics, vol. 5, No. 5, 2003, pp. 769-779.;;Feldman, B., et al., ""Correlation of Glucose Concentrations in Interstitial Fluid and Venous Blood During Periods of Rapid Glucose Change"", Abbott Diabetes Care, Inc. Freestyle Navigator Continuous Glucose Monitor Pamphlet, 2004.;;Feldman, B., et al., ""Electron Transfer Kinetics at Redox Polymer/Solution Interfaces Using Microelectrodes and Twin Electrode Thin Layer Cells"", Journal of ElectroAnalytical Chemistry, vol. 194, 1985, pp. 63-81.;;Fischer, H., et al., ""Intramolecular Electron Transfer Medicated by 4,4'-Bypyridine and Related Bridging Groups"", Journal of the American Chemical Society, vol. 98, No. 18, 1976, pp. 5512-5517.;;Flentge, F., et al., ""An Enzyme-Reactor for Electrochemical Monitoring of Choline and Acetylcholine: Applications in High-Performance Liquid Chromatography, Bran Tissue, Microdialysis and Cerebrospinal Fluid,"" Analytical Biochemistry, vol. 204, 1992, pp. 305-310.;;Foulds, N. C., et al., ""Enzyme Entrapment in Electrically Conducting Polymers: Immobilisation of Glucose Oxidase in Polypyrrole and its Application in Amperometric Glucose Sensors"", Journal of the Chemical Society, Faraday Transactions 1, vol. 82, 1986, pp. 1259-1264.;;Foulds, N. C., et al , ""Immobilization of Glucose Oxidase in Ferrocene-Modified Pyrrole Polymers"", Analytical Chemistry, vol. 60, No. 22, 1988, pp. 2473-2478.;;Frew, J. E., et al., ""Electron-Transfer Biosensors"", Philosophical Transactions of The Royal Society of London, vol. 316, 1987, pp. 95-106.;;Frohnauer, M. K., et al., ""Graphical Human Insulin Time-Activity Profiles Using Standardized Definitions"", Diabetes Technology & Therapeutics, vol. 3, No. 3, 2001, pp. 419-429.;;Frost, M. C., et al., ""Implantable Chemical Sensors for Real-Time Clinical Monitoring: Progress and Challenges"", Current Opinion in Chemical Biology, vol. 6, 2002, pp. 633-641.;;Garg, S. K., et al., ""Correlation of Fingerstick Blood Glucose Measurements with GlucoWatch Biographer Glucose Results in Young Subjects with Type 1 Diabetes"", Diabetes Care, vol. 22, No. 10, 1999, pp. 1708-1714.;;Garg, S. K., et al., ""Improved Glucose Excursions Using an Implantable Real-Time Continuous Glucose Sensor in Adults with Type 1 Diabetes"", Diabetes Care, vol. 27, No. 3, 2004, pp. 734-738.",EXPIRED
280,EP,A1,EP 2305107 A1,173-932-393-809-226,2011-04-06,2011,EP 10012960 A,1999-01-21,EP 99903239 A;;US 7067798 A,1998-04-30,Analyte monitoring device,"An analyte monitor includes a sensor, a sensor control unit, and a display unit. The sensor has, for example, a substrate, a recessed channel formed in the substrate, and conductive material disposed in the recessed channel to form a working electrode. The sensor control unit typically has a housing adapted for placement on skin and is adapted to receive a portion of an electrochemical sensor. The sensor control unit also includes two or more conductive contacts disposed on the housing and configured for coupling to two or more contact pads on the sensor. A transmitter is disposed in the housing and coupled to the plurality of conductive contacts for transmitting data obtained using the sensor. The display unit has a receiver for receiving data transmitted by the transmitter of the sensor control unit and a display coupled to the receiver for displaying an indication of a level of an analyte. The analyte monitor may also be part of a drug delivery system to alter the level of the analyte based on the data obtained using the sensor.
",ABBOTT DIABETES CARE INC,SAY JAMES;;TOMASCO MICHAEL F;;HELLER ADAM;;GAL YORAM;;ARIA BEHRAD;;HELLER EPHRAIM;;PLANTE PHILLIP JOHN;;VREEKE MARK S;;FRIEDMAN KEITH A;;COLMAN FREDRIC C,,https://lens.org/173-932-393-809-226,Patent Application,yes,17,3,211,221,0,A61B5/14532;;A61B5/14532;;A61B5/0002;;A61B5/0002;;A61B5/002;;A61B5/01;;A61B5/14503;;A61B5/1451;;A61B5/14546;;A61B5/14546;;A61B5/1473;;A61B5/1473;;A61B5/1486;;A61B5/1486;;A61B5/14865;;A61B5/1495;;A61B5/4839;;A61B5/72;;A61B5/7278;;A61B5/7282;;A61B5/7405;;A61B5/743;;A61B5/7445;;A61B5/7445;;A61B5/7455;;A61B2560/0252;;A61B2560/0252;;A61M5/1723;;C12Q1/54;;G16H10/40;;G16H10/40;;G16H20/17;;G16H20/17;;H01L23/3107;;H01L23/3107;;H01L23/49548;;H01L23/49548;;H01L2924/0002;;H01L2924/0002;;H01L2924/19041;;H01L2924/19041;;H01L2924/3011;;H01L2924/3011;;Y10S128/903;;Y10S128/903;;Y10T29/49;;Y10T29/49;;Y10T29/49124;;Y10T29/49124,A61B5/00;;G01N27/30;;A61B5/145;;A61B5/1468;;A61B5/1477;;A61B5/1495;;G01N27/416;;G06F19/00;;H01L23/31;;H01L23/495,,2,2,090-280-737-637-908;;101-236-266-667-666,10.1073/pnas.95.1.294;;9419369;;pmc18205;;10.1152/ajpendo.1995.269.1.e155;;7631771,"SCHMIDTKE ET AL.: ""Measurement and Modeling of the Transient Difference Between Blood and Subcutaneous Glucose Concentrations in the Rat after Injection of Insulin"", PROC. OF THE NAT'L ACAD. OF SCIENCE, vol. 95, 1998, pages 294 - 299, XP001203807, DOI: doi:10.1073/pnas.95.1.294;;QUINN ET AL.: ""Kinetics of Glucose Delivery to Subcutaneous Tissue in Rats Measured with 0.3mm Amperometric Microsensors"", AM. J. PHYSIOL., vol. 269, 1995, pages E155 - E161, XP009039648",EXPIRED
281,US,B2,US 8306598 B2,169-592-239-518-954,2012-11-06,2012,US 61512809 A,2009-11-09,US 61512809 A;;US 42005703 A;;US 66719900 A;;US 7067798 A,1998-04-30,Analyte monitoring device and methods of use,"An analyte monitor includes a sensor, a sensor control unit, and a display unit. The sensor has, for example, a substrate, a recessed channel formed in the substrate, and conductive material disposed in the recessed channel to form a working electrode. The sensor control unit typically has a housing adapted for placement on skin and is adapted to receive a portion of an electrochemical sensor. The sensor control unit also includes two or more conductive contacts disposed on the housing and configured for coupling to two or more contact pads on the sensor. A transmitter is disposed in the housing and coupled to the plurality of conductive contacts for transmitting data obtained using the sensor. The display unit has a receiver for receiving data transmitted by the transmitter of the sensor control unit and a display coupled to the receiver for displaying an indication of a level of an analyte. The analyte monitor may also be part of a drug delivery system to alter the level of the analyte based on the data obtained using the sensor.",SAY JAMES;;TOMASCO MICHAEL F;;HELLER ADAM;;GAL YORAM;;ARIA BEHRAD;;HELLER EPHRAIM;;PLANTE PHILLIP JOHN;;VREEKE MARK S;;FRIEDMAN KEITH A;;COLMAN FREDRIC C;;ABBOTT DIABETES CARE INC,SAY JAMES;;TOMASCO MICHAEL F;;HELLER ADAM;;GAL YORAM;;ARIA BEHRAD;;HELLER EPHRAIM;;PLANTE PHILLIP JOHN;;VREEKE MARK S;;FRIEDMAN KEITH A;;COLMAN FREDRIC C,E. HELLER & CO (1998-07-02);;ABBOTT DIABETES CARE INC (2000-03-13),https://lens.org/169-592-239-518-954,Granted Patent,yes,100,3,211,221,0,A61B5/14532;;A61B5/14532;;A61B5/0002;;A61B5/0002;;A61B5/002;;A61B5/01;;A61B5/14503;;A61B5/1451;;A61B5/14546;;A61B5/14546;;A61B5/1473;;A61B5/1473;;A61B5/1486;;A61B5/1486;;A61B5/14865;;A61B5/1495;;A61B5/4839;;A61B5/72;;A61B5/7278;;A61B5/7282;;A61B5/7405;;A61B5/743;;A61B5/7445;;A61B5/7445;;A61B5/7455;;A61B2560/0252;;A61B2560/0252;;A61M5/1723;;C12Q1/54;;G16H10/40;;G16H10/40;;G16H20/17;;G16H20/17;;H01L23/3107;;H01L23/3107;;H01L23/49548;;H01L23/49548;;H01L2924/0002;;H01L2924/0002;;H01L2924/19041;;H01L2924/19041;;H01L2924/3011;;H01L2924/3011;;Y10S128/903;;Y10S128/903;;Y10T29/49;;Y10T29/49;;Y10T29/49124;;Y10T29/49124,A61B5/05;;G01N27/30;;A61B5/00;;A61B5/145;;A61B5/1477;;A61B5/1495;;G01N27/416;;G06F19/00;;H01L23/31;;H01L23/495,600/345;;600/347;;600/365,99,84,136-791-935-548-81X;;062-360-289-025-864;;010-601-725-111-91X;;101-292-518-663-191;;056-703-879-057-297;;030-155-762-644-019;;004-149-141-436-651;;016-731-054-793-457;;080-559-561-995-335;;044-807-213-528-815;;027-538-525-436-179;;015-020-161-517-40X;;025-919-454-564-785;;014-700-576-603-812;;004-851-060-590-788;;075-958-432-122-199;;052-356-140-149-389;;035-090-282-884-790;;033-562-815-299-181;;018-803-926-589-211;;008-505-762-041-402;;016-601-143-530-813;;019-502-772-562-215;;058-476-824-396-350;;006-498-707-073-30X;;054-091-551-638-293;;010-531-147-771-746;;054-827-198-877-419;;122-658-944-077-000;;017-261-560-469-37X;;000-125-755-474-124;;113-381-664-783-802;;082-626-907-191-554;;017-950-014-792-456;;090-348-305-613-628;;015-985-399-299-132;;171-049-047-164-618;;016-819-089-891-758;;081-249-097-078-543;;089-612-747-111-646;;031-706-897-890-035;;094-198-536-559-723;;003-690-143-043-420;;007-943-354-378-456;;082-114-500-909-975;;004-239-090-971-580;;026-894-457-160-450;;077-128-610-778-669;;022-466-506-956-898;;008-424-592-956-946;;007-500-825-916-378;;009-725-244-669-882;;037-755-689-613-42X;;153-411-506-517-475;;038-134-360-685-692;;012-449-714-188-064;;031-517-704-996-130;;131-299-284-996-064;;049-133-049-742-708;;000-272-178-768-076;;070-797-683-833-124;;043-870-224-178-49X;;025-574-914-238-550;;052-364-430-129-757;;004-434-167-910-115;;032-860-147-271-886;;132-460-374-211-421;;098-172-374-375-47X;;109-358-955-476-095;;014-988-634-483-130;;061-786-187-274-992;;037-898-018-686-909;;130-044-667-529-69X;;134-265-642-839-645;;065-221-074-461-027;;017-934-465-161-477;;101-660-130-379-529;;028-236-706-290-220;;087-333-189-994-274;;059-082-211-027-266;;057-977-752-782-568;;022-511-780-866-588;;017-782-200-698-498;;031-911-801-211-572,10.1016/s0956-5663(02)00099-4;;12392956;;10.1021/ja00391a001;;2889225;;10.1098/rstb.1987.0021;;10.1109/51.294001;;10.1016/0022-0728(65)85063-x;;2245876;;10.2337/diabetes.39.12.1519;;10.2337/diab.39.12.1519;;10.1016/s0956-5663(03)00220-3;;14611755;;18615658;;10.1002/bit.260430310;;9366023;;10.1016/s0956-5663(97)00025-0;;9451795;;10.1016/s0956-5663(97)00083-3;;10.1016/0956-5663(93)80028-n;;8311939;;8651496;;10.1021/ac960030d;;10.1080/03091900210156797;;12487712;;10.1016/0265-928x(87)80018-4;;3333622;;10.1109/19.816143;;10.1007/bf01015979;;10.1089/15209150252924058;;12017416;;18473691;;10.1089/dia.2007.0281;;10.1021/ac00017a008;;1789439;;2817408;;10.1021/ac00197a022;;10.1016/0925-4005(95)01730-5;;10.1016/0010-4825(90)90013-f;;2257734;;2868172;;8277748;;10.1016/0141-5425(93)90058-7;;11469630;;10.1089/15209150050214104;;10624783;;10.1016/s0168-8227(99)00113-8;;10.1089/15209150050214113;;11469631;;10.1007/bf00401374;;1478372;;10.2337/diacare.20.1.64;;9028696;;10.1109/tbme.1986.325807;;3957374;;236018;;10.1016/0005-2795(75)90259-7;;10.1089/hum.1998.9.6-879;;9581910;;11762520;;10.1089/15209150152607196;;10.2337/diabetes.48.3.445;;10078542;;10.1016/0265-928x(87)80012-3;;505005;;10.1126/science.505005;;10.1021/ac0498516;;15253640;;10.1109/10.284922;;8026845;;6721151;;10.1021/ac00268a018;;6733082;;10.1021/bi00305a016;;10.1515/cclm.2002.135;;12392305;;10.1016/j.ecl.2003.12.001;;15053902;;12052350;;10.1016/s0956-5663(01)00304-9;;12052349;;10.1016/s0956-5663(01)00306-2;;4500021;;10.1007/978-1-4684-3288-6_18;;14021529;;10.1111/j.1749-6632.1962.tb13623.x;;3196517;;10.2337/diacare.10.5.622;;3677983;;10.2337/diacare.8.6.529;;4075939;;10.1002/elan.1140061103;;7733469;;10.1021/ac00103a015;;7978306;;10.1021/ac00091a022;;10.1007/bf01248238;;10.1016/s0376-7388(98)00330-5;;10.1016/0142-9612(92)90147-g;;1472593;;10.1016/0265-928x(85)80002-x;;10.1021/j100290a001;;10.1021/ja00216a040;;10.1021/ja00188a091;;10.1021/ja00406a011;;2624333;;12323417;;10.1016/s0165-0270(02)00170-x;;10.1177/193229680700100208;;pmc2771467;;19888405;;10.1021/ja00415a014;;10.1007/bf00575392;;10.1021/ac00250a038;;10.1021/ac00266a005;;10.1007/s00216-002-1284-0;;12194035;;10.1089/dia.2006.0030;;17705688;;9642777;;10.1016/s0956-5663(97)00091-2;;10.1089/152091503322526978;;14633342;;10.1016/0022-0728(85)87006-6;;10.1021/ja00434a018;;10.1016/0003-2697(92)90243-z;;1443528;;10.1039/f19868201259;;3245585;;10.1021/ac00173a008;;2889234;;10.1098/rstb.1987.0020;;11762521;;10.1089/15209150152607204;;12413548;;10.1016/s1367-5931(02)00371-x;;10526740;;10.2337/diacare.22.10.1708;;14988294;;10.2337/diacare.27.3.734;;10.1111/j.1749-6632.1997.tb52216.x;;9616733;;10868819;;10.2337/diacare.23.2.143;;10.1002/1097-4636(200101)54:1<69::aid-jbm8>3.0.co;2-q;;11077404;;10.1002/1097-4636(200101)54:1<69::aid-jbm8>3.3.co;2-h,"Abel, P. U., et al., ""Biosensors for in Vivo Glucose Measurement: Can We Cross the Experimental Stage"", Biosensors and Bioelectronics, vol. 17, 2002, pp. 1059-1070.;;Abruna, H. D., et al., ""Rectifying Interfaces Using Two-Layer Films of Electrochemically Polymerized Vinylpyridine and Vinylbipyridine Complexes of Ruthenium and Iron on Electrodes"", Journal of the American Chemical Society, vol. 103, No. 1, 1981, pp. 1-5.;;Albery, W. J., et al., ""Amperometric Enzyme Electrodes Part II: Conducting Salts as Electrode Materials for the Oxidation of Glucose Oxidase"", Journal of ElectroAnalytical Chemistry, vol. 194, 1985, pp. 223-235.;;Albery, W. J., et al., ""Amperometric Enzyme Electrodes"", Philosophical Transactions of The Royal Society of London, vol. 316, 1987, pp. 107-119.;;Alcock, S. J., et al., ""Continuous Analyte Monitoring to Aid Clinical Practice"", IEEE Engineering in Medicine and Biology Magazine, 1994, pp. 319-325.;;Anderson, L. B., et al., ""Thin-Layer Electrochemistry: Steady-State Methods of Studying Rate Processes"", Journal of ElectroAnalytical Chemistry, vol. 10, 1965, pp. 295-305.;;Armour, J. C., et al., ""Application of Chronic Intravascular Blood Glucose Sensor in Dogs"", Diabetes, vol. 39, 1990, pp. 1519-1526.;;Asberg, P., et al., ""Hydrogels of a Conducting Conjugated Polymer as 3-D Enzyme Electrode"", Biosensors & Bioelectronics, vol. 19, 2003, pp. 199-207.;;Atanasov, P., et al., ""Biosensor for Continuous Glucose Monitoring"", Biotechnology and Bioengineering, vol. 43, 1994, pp. 262-266.;;Atanasov, P., et al., ""Implantation of a Refillable Glucose Monitoring-Telemetry Device"", Biosensors & Bioelectronics, vol. 12, No. 7, 1997, pp. 669-680.;;Aussedat, B., et al., ""A User-Friendly Method for Calibrating a Subcutaneous Glucose Sensor-Based Hypoglycaemic Alarm"", Biosensors & Bioelectronics, vol. 12, No. 11, 1997, pp. 1061-1071.;;Baker, D. A., et al., ""Dynamic Concentration Challenges for Biosensor Characterization"", Biosensors & Bioelectronics, vol. 8, 1993, pp. 433-441.;;Baker, D. A., et al., ""Dynamic Delay and Maximal Dynamic Error in Continuous Biosensors"", Analytical Chemistry, vol. 68, No. 8, 1996, pp. 1292-1297.;;Bani Amer, M. M., ""An Accurate Amperometric Glucose Sensor Based Glucometer with Eliminated Cross-Sensitivity"", Journal of Medical Engineering & Technology, vol. 26, No. 5, 2002, pp. 208-213.;;Bard, A. J., et al., Electrochemical Methods, 1980, pp. 173-175.;;Bartlett, P. N., et al., ""Covalent Binding of Electron Relays to Glucose Oxidase"", Journal of the Chemical Society, Chemical Communications, 1987, pp. 1603-1604.;;Bartlett, P. N., et al., ""Modification of Glucose Oxidase by Tetrathiafulvalene"", Journal of the Chemical Society, Chemical Communications, 1990, pp. 1135-1136.;;Bartlett, P. N., et al., ""Strategies for the Development of Amperometric Enzyme Electrodes"", Biosensors, vol. 3, 1987/88, pp. 359-379.;;Beach, R. D., et al., ""Subminiature Implantable Potentiostat and Modified Commercial Telemetry Device for Remote Glucose Monitoring"", IEEE Transactions on Instrumentation and Measurement, vol. 28, No. 6, 1999, pp. 1239-1245.;;Beech, W. A., ""AX.25 Link Access Protocol for Amateur packet Radio"", Tucson Amateur Packet Radio Corporation, 1998, pp. 1-133.;;Bellucci, F., et al., ""Electrochemical Behaviour of Graphite-Epoxy Composite Materials (GECM) in Aqueous Salt Solutions"", Journal of Applied Electrochemistry, vol. 16, 1986, pp. 15-22.;;Bennion, N., et al., ""Alternate Site Glucose Testing: A Crossover Design"", Diabetes Technology & Therapeutics, vol. 4, No. 1, 2002, pp. 25-33.;;Biermann, E., et al., ""How Would Patients Behave if They Were Continually Informed of Their Blood Glucose Levels? A Simulation Study Using a 'Virtual' Patient"", Diabetes Technology & Therapeutics, vol. 10, No. 3, 2008, pp. 178-187.;;Bindra, D. S., et al., ""Design and in Vitro Studies of a Needle-Type Glucose Sensor for Subcutaneous Monitoring"", Analytical Chemistry, vol. 63, No. 17, 1991, pp. 1692-1696.;;Bindra, D. S., et al., ""Pulsed Amperometric Detection of Glucose in Biological Fluids at a Surface-Modified Gold Electrode"", Analytical Chemistry, vol. 61, No. 22, 1989, pp. 2566-2570.;;Bisenberger, M., et al., ""A Triple-Step Potential Waveform at Enzyme Multisensors with Thick-Film Gold Electrodes for Detection of Glucose and Sucrose"", Sensors and Actuators B, vol. 28, 1995, pp. 181-189.;;Bland, J. M., et al., ""A Note on the Use of the Intraclass Correlation Coefficient in the Evaluation of Agreement Between Two Methods of Measurement"", Computers in Biology and Medicine, vol. 20, No. 5, 1990, pp. 337-340.;;Bland, J. M., et al., ""Statistical Methods for Assessing Agreement Between Two Methods of Clinical Measurement"", The Lancet, 1986, pp. 307-310.;;Blank, T. B., et al., ""Clinical Results From a Non-Invasive Blood Glucose Monitor"", Optical Diagnostics and Sensing of Biological Fluids and Glucose and Cholesterol Monitoring II, Proceedings of SPIE, vol. 4624, 2002, pp. 1-10.;;Bobbioni-Harsch, E., et al., ""Lifespan of Subcutaneous Glucose Sensors and Their Performances During Dynamic Glycaemia Changes in Rats"", Journal of Biomedical Engineering, vol. 15, 1993, pp. 457-463.;;Bode, B. W., ""Clinical Utility of the Continuous Glucose Monitoring System"", Diabetes Technology & Therapeutics, vol. 2, Sup. 1, 2000, pp. S35-S41.;;Bode, B. W., et al., ""Continuous Glucose Monitoring Used to Adjust Diabetes Therapy Improves Glycosylated Hemoglobin: A Pilot Study"", Diabetes Research and Clinical Practice, vol. 46, 1999, pp. 183-190.;;Bode, B. W., et al., ""Using the Continuous Glucose Monitoring System to Improve the Management of Type I Diabetes"", Diabetes Technology & Therapeutics, vol. 2, Sup. 1, 2000, pp. S43-S48.;;Boedeker Plastics, Inc., ""Polyethylene Specifications"", Web Page of Boedeker.com, 2007, pp. 1-3.;;Bolinder, J., et al., ""Microdialysis Measurement of the Absolute Glucose Concentration in Subcutaneous Adipose Tissue Allowing Glucose Monitoring in Diabetic Patients"", Diabetologia, vol. 35, 1992, pp. 1177-1180.;;Bolinder, J., et al., ""Self-Monitoring of Blood Glucose in Type I Diabetic Patients: Comparison with Continuous Microdialysis Measurements of Glucose in Subcutaneous Adipose Tissue During Ordinary Life Conditions"", Diabetes Care, vol. 20, No. 1, 1997, pp. 64-70.;;Bott, A. W., ""A Comparison of Cyclic Voltammetry and Cyclic Staircase Voltammetry"", Current Separations, vol. 16, No. 1, 1997, pp. 23-26.;;Bott, A. W., ""Electrochemical Methods for the Determination of Glucose"", Current Separations, vol. 17, No. 1, 1998, pp. 25-31.;;Bowman, L., et al., ""The Packaging of Implantable Integrated Sensors"", IEEE Transactions on Biomedical Engineering, vol. 33, No. 2, 1986, pp. 248-255.;;Brandt, J., et al., ""Covalent Attachment of Proteins to Polysaccharide Carriers by Means of Benzoquinone"", Biochimica et Biophysica Acta, vol. 386, 1975, pp. 196-202.;;Brauker, J., et al., ""Sustained Expression of High Levels of Human Factor IX from Human Cells Implanted Within an Immunoisolation Device into Athymic Rodents"", Human Gene Therapy, vol. 9, No. 6, 1998, pp. 879-888.;;Bremer, T. M., et al., ""Benchmark Data from the Literature for Evaluation of New Glucose Sensing Technologies"", Diabetes Technology & Therapeutics, vol. 3, No. 3, 2001, pp. 409-418.;;Bremer, T., et al., ""Is Blood Glucose Predictable from Previous Values?"", Diabetes, vol. 48, 1999, pp. 445-451.;;Brooks, S. L., et al., ""Development of an On-Line Glucose Sensor for Fermentation Monitoring"", Biosensors, vol. 3, 1987/88, pp. 45-56.;;Brownlee, M., et al., ""A Glucose-Controlled Insulin-Delivery System: Semisynthetic Insulin Bound to Lectin"", Science, vol. 206, 1979, 1190-1191.;;Cai, Q., et al., ""A Wireless, Remove Query Glucose Biosensor Based on a pH-Sensitive Polymer"", Analytical Chemistry, vol. 76, No. 14, 2004, pp. 4038-4043.;;Candas, B., et al., ""An Adaptive Plasma Glucose Controller Based on a Nonlinear Insulin/Glucose Model"", IEEE Transactions on Biomedical Engineering, vol. 41, No. 2, 1994, pp. 116-124.;;Cass, A. E., et al., ""Ferricinum Ion As an Electron Acceptor for Oxido-Reductases"", Journal of ElectroAnalytical Chemistry, vol. 190, 1985, pp. 117-127.;;Cass, A. E., et al., ""Ferrocene-Medicated Enzyme Electrode for Amperometric Determination of Glucose"", Analytical Chemistry, vol. 56, No. 4, 1984, 667-671.;;Castner, J. F., et al., ""Mass Transport and Reaction Kinetic Parameters Determined Electrochemically for Immobilized Glucose Oxidase"", Biochemistry, vol. 23 No. 10, 1984, 2203-2210.;;Chen, J. C., et al., ""A Comparison of MAC Protocols for Wireless Local Networks Based on battery Power Consumption"", IEEE, 1998, pp. 150-157.;;Chen, T., et al., ""Defining the Period of Recovery of the Glucose Concentration After Its Local Perturbation by the Implantation of a Miniature Sensor"", Clinical Chemistry and Laboratory Medicine, vol. 40, No. 8, 2002, pp. 486-489.;;Chia, C. W., et al., ""Glucose Sensors: Toward Closed Loop Insulin Delivery"", Endocrinology and Metabolism Clinics of North America, vol. 33, 2004, pp. 175-195.;;Choleau, C., et al., ""Calibration of a Subcutaneous Amperometric Glucose Sensor Implanted for 7 Days in Diabetic Patients Part 2: Superiority of the One-Point Calibration Method"", Biosensors and Bioelectronics, vol. 17, 2002, pp. 647-654.;;Choleau, C., et al., ""Calibration of a Subcutaneous Amperometric Glucose Sensor Part 1: Effect of Measurement Uncertainties on the Determination of Sensor Sensitivity and Background Current"", Biosensors and Bioelectronics, vol. 17, 2002, pp. 641-646.;;Claremont, D. J., et al., ""Biosensors for Continuous in Vivo Glucose Monitoring"", Proceedings of the Annual International Conference of the IEEE Engineering in Medicine and Biology Society, vol. 10, 1988.;;Clark Jr., L. C., et al., ""Differential Anodic Enzyme Polarography for the Measurement of Glucose"", Oxygen Transport to Tissue: Instrumentation, Methods, and Physiology, 1973, pp. 127-133.;;Clark Jr., L. C., et al., ""Electrode Systems for Continuous Monitoring in Cardiovascular Surgery"", Annals New York Academy of Sciences, 1962, pp. 29-45.;;Clark Jr., L. C., et al., ""Long-term Stability of Electroenzymatic Glucose Sensors Implanted in Mice"", American Society of Artificial Internal Organs Transactions, vol. XXXIV, 1988, pp. 259-265.;;Clarke, W. L., et al., ""Evaluating Clinical Accuracy of Systems for Self-Monitoring of Blood Glucose"", Diabetes Care, vol. 10, No. 5, 1987, pp. 622-628.;;Cox, D. J., et al., ""Accuracy of Perceiving Blood Glucose in IDDM"", Diabetes Care, vol. 8, No. 6, 1985, pp. 529-536.;;Csoregi, E., et al., ""Amperometric Microbiosensors for Detection of Hydrogen Peroxide and Glucose Based on Peroxidase-Modified Carbon Fibers"", Electroanalysis, vol. 6, 1994, pp. 925-933.;;Csoregi, E., et al., ""Design and Optimization of a Selective Subcutaneously Implantable Glucose Electrode Based on 'Wired' Glucose Oxidase"", Analytical Chemistry, vol. 67, No. 7, 1995, pp. 1240-1244.;;Csoregi, E., et al., ""Design, Characterization, and One-Point in Vivo Calibration of a Subcutaneously Inplanted Glucose Electrode"", Analytical Chemistry, vol. 66, No. 19, 1994, pp. 3131-3138.;;Csoregi, E., et al., ""On-Line Glucose Monitoring by Using Microdialysis Sampling and Amperometric Detection Based on 'Wired' Glucose Oxidase in Carbon Paste"", Mikrochimica Acta, vol. 121, 1995, pp. 31-40.;;D'Arrigo, G., et al., ""Porous-Si Based Bio Reactors for Glucose Monitoring and Drugs Production"", Proceedings of SPIE: Microfluids, BioMEMS, and Medical Microsystems, vol. 4982, 2003, pp. 178-184.;;Dai, W. S., et al., ""Hydrogel Membranes with Mesh Size Asymmetry Based on the Gradient Crosslinking of Poly(vinyl alcohol),"" Journal of Membrane Science, vol. 156, 1999, pp. 67-79.;;Davies, M. L., et al., ""Polymer Membranes in Clinical Sensor Applications"", Biomaterials, vol. 13 No. 14, 1992, pp. 971-978.;;Davis, G., ""Electrochemical Techniques for the Development of Amperometric Biosensors"", Biosensors, vol. 1, 1985, pp. 161-178.;;Degani, Y., et al., ""Direct Electrical Communication Between Chemically Modified Enzymes and Metal Electrodes. 1. Electron Transfer from Glucose Oxidase to Metal Electrodes via Electron Relays, Bound Covalently to the Enzyme"", The Journal of Physical Chemistry, vol. 91, No. 6, 1987, pp. 1285-1289.;;Degani, Y., et al., ""Direct Electrical Communication Between Chemically Modified Enzymes and Metal Electrodes. 2. Methods for Bonding Electron-Transfer Relays to Glucose Oxidase and D-Amino-Acid Oxidase"", Journal of the American Chemical Society, vol. 110, No. 8, 1988, pp. 2615-2620.;;Degani, Y., et al., ""Electrical Communication Between Redox Centers of Glucose Oxidase and Electrodes via Electrostatically and Covalently Bound Redox Polymers"", Journal of the American Chemical Society, vol. 111, 1989, pp. 2357-2358.;;Denisevich, P., et al., ""Unidirectional Current Flow and Charge State Trapping at Redox Polymer Interfaces on Bilayer Electrodes: Principles, Experimental Demonstration, and Theory"", Journal of the American Chemical Society, vol. 103, 1981, pp. 4727-4737.;;Dicks, J. M., et al., ""Ferrocene Modified Polypyrrole with Immobilised Glucose Oxidase and its Application in Amperometric Glucose Microbiosensors"", Annales de Biologie Clinique, vol. 47, 1989, pp. 607-619.;;Dixon, B. M., et al., ""Characterization in Vitro and in Vivo of the Oxygen Dependence of an Enzyme/Polymer Biosensors for Monitoring Brain Glucose"", Journal of Neuroscience Methods, vol. 119, 2002, pp. 135-142.;;Eighth Annual Diabetes Technology Meeting Abstracts, Nov. 13-15, 2008, pp. A1-A182.;;El-Khatib, F. H, et al., ""Adaptive Closed-Loop Control Provides Blood-Glucose Regulation Using Subcutaneous Insulin and Glucagon Infusion in Diabetic Swine"", Journal of Diabetes Science and Technology, vol. 1, No. 2, 2007, pp. 181-192.;;Ellis, C. D., et al., ""Selectivity and Directed Charge Transfer through an Electroactive Metallopolymer Film"", Journal of the American Chemical Society, vol. 103, No. 25, 1981, pp. 7480-7483.;;El-Sa'ad, L., et al., ""Moisture Absorption by Epoxy Resins: The Reverse Thermal Effect"", Journal of Materials Science, vol. 25, No. 8, 1990, pp. 3577-3582.;;Engstrom, R. C., ""Electrochemical Pretreatment of Glassy Carbon Electrodes"", Analytical Chemistry, vol. 54, No. 13, 1982, pp. 2310-2314.;;Engstrom, R. C., et al., ""Characterization of Electrochemically Pretreated Glassy Carbon Electrodes"", Analytical Chemistry, vol. 56, No. 2, 1984, pp. 136-141.;;Ernst, H., et al., ""Reliable Glucose Monitoring Through the Use of Microsystem Technology"", Analytical and Bioanalytical Chemistry, vol. 373, 2002, pp. 758-761.;;Fabietti, P. G., et al. ""Clinical Validation of a New Control-Oriented Model of Insulin and Glucose Dynamics in Subjects with Type 1 Diabetes"", Diabetes Technology & Therapeutics, vol. 9 No. 4, 2007, pp. 327-338.;;Fare, T. L., et al., ""Functional Characterization of a Conducting Polymer-Based Immunoassay System"", Biosensors & Bioelectronics, vol. 13, No. 3-4, 1998, pp. 459-470.;;Feldman, B., et al., ""A Continuous Glucose Sensor Based on Wired Enzyme(TM) Technology-Results from a 3-Day Trial in Patients with Type 1 Diabetes"", Diabetes Technology & Therapeutics, vol. 5, No. 5, 2003, pp. 769-779.;;Feldman, B., et al., ""Correlation of Glucose Concentrations in Interstitial Fluid and Venous Blood During Periods of Rapid Glucose Change"", Abbott Diabetes Care, Inc. Freestyle Navigator Continuous Glucose Monitor Pamphlet, 2004.;;Feldman, B., et al., ""Electron Transfer Kinetics at Redox Polymer/Solution Interfaces Using Microelectrodes and Twin Electrode Thin Layer Cells"", Journal of ElectroAnalytical Chemistry, vol. 194, 1985, pp. 63-81.;;Fischer, H., et al., ""Intramolecular Electron Transfer Medicated by 4,4'-Bypyridine and Related Bridging Groups"", Journal of the American Chemical Society, vol. 98, No. 18, 1976, pp. 5512-5517.;;Flentge, F., et al., ""An Enzyme-Reactor for Electrochemical Monitoring of Choline and Acetylcholine: Applications in High-Performance Liquid Chromatography, Bran Tissue, Microdialysis and Cerebrospinal Fluid,"" Analytical Biochemistry, vol. 204, 1992, pp. 305-310.;;Foulds, N. C., et al., ""Enzyme Entrapment in Electrically Conducting Polymers: Immobilisation of Glucose Oxidase in Polypyrrole and its Application in Amperometric Glucose Sensors"", Journal of the Chemical Society, Faraday Transactions 1, vol. 82, 1986, pp. 1259-1264.;;Foulds, N. C., et al , ""Immobilization of Glucose Oxidase in Ferrocene-Modified Pyrrole Polymers"", Analytical Chemistry, vol. 60, No. 22, 1988, pp. 2473-2478.;;Frew, J. E., et al., ""Electron-Transfer Biosensors"", Philosophical Transactions of The Royal Society of London, vol. 316, 1987, pp. 95-106.;;Frohnauer, M. K., et al., ""Graphical Human Insulin Time-Activity Profiles Using Standardized Definitions"", Diabetes Technology & Therapeutics, vol. 3, No. 3, 2001, pp. 419-429.;;Frost, M. C., et al., ""Implantable Chemical Sensors for Real-Time Clinical Monitoring: Progress and Challenges"", Current Opinion in Chemical Biology, vol. 6, 2002, pp. 633-641.;;Garg, S. K., et al., ""Correlation of Fingerstick Blood Glucose Measurements with GlucoWatch Biographer Glucose Results in Young Subjects with Type 1 Diabetes"", Diabetes Care, vol. 22, No. 10, 1999, pp. 1708-1714.;;Garg, S. K., et al., ""Improved Glucose Excursions Using an Implantable Real-Time Continuous Glucose Sensor in Adults with Type 1 Diabetes"", Diabetes Care, vol. 27, No. 3, 2004, pp. 734-738.;;Geller, R. L., et al., ""Use of an Immunoisolation Device for Cell Transplantation and Tumor Immunotherapy"", Annals of the New York Academy of Sciences, vol. 831, 1997, pp. 438-451.;;Gerritsen, M., ""Problems Associated with Subcutaneously Implanted Glucose Sensors"", Diabetes Care, vol. 23, No. 2, 2000, pp. 143-145.;;Gerritsen, M., et al., ""Influence of Inflammatory Cells and Serum on the Performance of Implantable Glucose Sensors"", Journal of Biomedical materials Research, vol. 54, 2001, pp. 69-75.",EXPIRED
282,US,A1,US 2009/0099435 A1,025-178-568-819-218,2009-04-16,2009,US 27063808 A,2008-11-13,US 27063808 A;;US 42005703 A;;US 66719900 A;;US 7067798 A,1998-04-30,Analyte Monitoring Device and Methods of Use,"An analyte monitor includes a sensor, a sensor control unit, and a display unit. The sensor has, for example, a substrate, a recessed channel formed in the substrate, and conductive material disposed in the recessed channel to form a working electrode. The sensor control unit typically has a housing adapted for placement on skin and is adapted to receive a portion of an electrochemical sensor. The sensor control unit also includes two or more conductive contacts disposed on the housing and configured for coupling to two or more contact pads on the sensor. A transmitter is disposed in the housing and coupled to the plurality of conductive contacts for transmitting data obtained using the sensor. The display unit has a receiver for receiving data transmitted by the transmitter of the sensor control unit and a display coupled to the receiver for displaying an indication of a level of an analyte. The analyte monitor may also be part of a drug delivery system to alter the level of the analyte based on the data obtained using the sensor.",ABBOTT DIABETES CARE INC,SAY JAMES;;TOMASCO MICHAEL F;;HELLER ADAM;;GAL YORAM;;ARIA BEHRAD;;HELLER EPHRAIM;;PLANTE PHILLIP JOHN;;VREEKE MARK S;;FRIEDMAN KEITH A;;COLMAN FREDRIC C,,https://lens.org/025-178-568-819-218,Patent Application,yes,1,74,211,221,0,A61B5/14532;;A61B5/14532;;A61B5/0002;;A61B5/0002;;A61B5/002;;A61B5/01;;A61B5/14503;;A61B5/1451;;A61B5/14546;;A61B5/14546;;A61B5/1473;;A61B5/1473;;A61B5/1486;;A61B5/1486;;A61B5/14865;;A61B5/1495;;A61B5/4839;;A61B5/72;;A61B5/7278;;A61B5/7282;;A61B5/7405;;A61B5/743;;A61B5/7445;;A61B5/7445;;A61B5/7455;;A61B2560/0252;;A61B2560/0252;;A61M5/1723;;C12Q1/54;;G16H10/40;;G16H10/40;;G16H20/17;;G16H20/17;;H01L23/3107;;H01L23/3107;;H01L23/49548;;H01L23/49548;;H01L2924/0002;;H01L2924/0002;;H01L2924/19041;;H01L2924/19041;;H01L2924/3011;;H01L2924/3011;;Y10S128/903;;Y10S128/903;;Y10T29/49;;Y10T29/49;;Y10T29/49124;;Y10T29/49124,A61B5/05;;G01N27/30;;A61B5/00;;A61B5/145;;A61B5/1477;;A61B5/1495;;G01N27/416;;G06F19/00;;H01L23/31;;H01L23/495,600/347;;600/365,0,0,,,,DISCONTINUED
283,US,A1,US 2010/0268050 A1,066-338-774-267-335,2010-10-21,2010,US 82518610 A,2010-06-28,US 82518610 A;;US 39388309 A;;US 42005703 A;;US 66719900 A;;US 7067798 A,1998-04-30,Analyte Monitoring Device and Methods of Use,"An analyte monitor includes a sensor, a sensor control unit, and a display unit. The sensor has, for example, a substrate, a recessed channel formed in the substrate, and conductive material disposed in the recessed channel to form a working electrode. The sensor control unit typically has a housing adapted for placement on skin and is adapted to receive a portion of an electrochemical sensor. The sensor control unit also includes two or more conductive contacts disposed on the housing and configured for coupling to two or more contact pads on the sensor. A transmitter is disposed in the housing and coupled to the plurality of conductive contacts for transmitting data obtained using the sensor. The display unit has a receiver for receiving data transmitted by the transmitter of the sensor control unit and a display coupled to the receiver for displaying an indication of a level of an analyte. The analyte monitor may also be part of a drug delivery system to alter the level of the analyte based on the data obtained using the sensor.",ABBOTT DIABETES CARE INC,SAY JAMES;;TOMASCO MICHAEL F;;HELLER ADAM;;GAL YORAM;;ARIA BEHRAD;;HELLER EPHRAIM;;PLANTE PHILLIP JOHN;;VREEKE MARK S;;FRIEDMAN KEITH A;;COLMAN FREDRIC C,E. HELLER & CO (1998-07-02);;ABBOTT DIABETES CARE INC (2000-03-13),https://lens.org/066-338-774-267-335,Patent Application,yes,151,46,211,221,0,A61B5/14532;;A61B5/14532;;A61B5/0002;;A61B5/0002;;A61B5/002;;A61B5/01;;A61B5/14503;;A61B5/1451;;A61B5/14546;;A61B5/14546;;A61B5/1473;;A61B5/1473;;A61B5/1486;;A61B5/1486;;A61B5/14865;;A61B5/1495;;A61B5/4839;;A61B5/72;;A61B5/7278;;A61B5/7282;;A61B5/7405;;A61B5/743;;A61B5/7445;;A61B5/7445;;A61B5/7455;;A61B2560/0252;;A61B2560/0252;;A61M5/1723;;C12Q1/54;;G16H10/40;;G16H10/40;;G16H20/17;;G16H20/17;;H01L23/3107;;H01L23/3107;;H01L23/49548;;H01L23/49548;;H01L2924/0002;;H01L2924/0002;;H01L2924/19041;;H01L2924/19041;;H01L2924/3011;;H01L2924/3011;;Y10S128/903;;Y10S128/903;;Y10T29/49;;Y10T29/49;;Y10T29/49124;;Y10T29/49124,A61B5/1468;;G01N27/30;;A61B5/00;;A61B5/145;;A61B5/1477;;A61B5/1495;;G01N27/416;;G06F19/00;;H01L23/31;;H01L23/495,600/347,0,0,,,,DISCONTINUED
284,US,B2,US 7003341 B2,066-382-809-723-440,2006-02-21,2006,US 72225103 A,2003-11-24,US 72225103 A;;US 42005703 A;;US 66719900 A;;US 7067798 A,1998-04-30,Analyte monitoring devices and methods of use,"An analyte monitor includes a sensor, a sensor control unit, and a display unit. The sensor has, for example, a substrate, a recessed channel formed in the substrate, and conductive material disposed in the recessed channel to form a working electrode. The sensor control unit typically has a housing adapted for placement on skin and is adapted to receive a portion of an electrochemical sensor. The sensor control unit also includes two or more conductive contacts disposed on the housing and configured for coupling to two or more contact pads on the sensor. A transmitter is disposed in the housing and coupled to the plurality of conductive contacts for transmitting data obtained using the sensor. The display unit has a receiver for receiving data transmitted by the transmitter of the sensor control unit and a display coupled to the receiver for displaying an indication of a level of an analyte. The analyte monitor may also be part of a drug delivery system to alter the level of the analyte based on the data obtained using the sensor.",ABBOTT DIABETES CARE INC,SAY JAMES;;TOMASCO MICHAEL F;;HELLER ADAM;;GAL YORAM;;ARIA BEHRAD;;HELLER EPHRAIM;;PLANTE PHILLIP JOHN;;VREEKE MARK S;;FRIEDMAN KEITH A;;COLMAN FREDRIC C,,https://lens.org/066-382-809-723-440,Granted Patent,yes,5,588,211,221,0,A61B5/14532;;A61B5/14532;;A61B5/0002;;A61B5/0002;;A61B5/002;;A61B5/01;;A61B5/14503;;A61B5/1451;;A61B5/14546;;A61B5/14546;;A61B5/1473;;A61B5/1473;;A61B5/1486;;A61B5/1486;;A61B5/14865;;A61B5/1495;;A61B5/4839;;A61B5/72;;A61B5/7278;;A61B5/7282;;A61B5/7405;;A61B5/743;;A61B5/7445;;A61B5/7445;;A61B5/7455;;A61B2560/0252;;A61B2560/0252;;A61M5/1723;;C12Q1/54;;G16H10/40;;G16H10/40;;G16H20/17;;G16H20/17;;H01L23/3107;;H01L23/3107;;H01L23/49548;;H01L23/49548;;H01L2924/0002;;H01L2924/0002;;H01L2924/19041;;H01L2924/19041;;H01L2924/3011;;H01L2924/3011;;Y10S128/903;;Y10S128/903;;Y10T29/49;;Y10T29/49;;Y10T29/49124;;Y10T29/49124,A61B5/05;;G01N27/30;;A61B5/00;;A61B5/145;;A61B5/1477;;A61B5/1495;;G01N27/416;;G06F19/00;;H01L23/31;;H01L23/495,600/345,0,0,,,,EXPIRED
285,US,A1,US 2010/0268049 A1,085-309-338-221-206,2010-10-21,2010,US 82568710 A,2010-06-29,US 82568710 A;;US 39388309 A;;US 42005703 A;;US 66719900 A;;US 7067798 A,1998-04-30,Analyte Monitoring Device and Methods of Use,"An analyte monitor includes a sensor, a sensor control unit, and a display unit. The sensor has, for example, a substrate, a recessed channel formed in the substrate, and conductive material disposed in the recessed channel to form a working electrode. The sensor control unit typically has a housing adapted for placement on skin and is adapted to receive a portion of an electrochemical sensor. The sensor control unit also includes two or more conductive contacts disposed on the housing and configured for coupling to two or more contact pads on the sensor. A transmitter is disposed in the housing and coupled to the plurality of conductive contacts for transmitting data obtained using the sensor. The display unit has a receiver for receiving data transmitted by the transmitter of the sensor control unit and a display coupled to the receiver for displaying an indication of a level of an analyte. The analyte monitor may also be part of a drug delivery system to alter the level of the analyte based on the data obtained using the sensor.",ABBOTT DIABETES CARE INC,SAY JAMES;;TOMASCO MICHAEL F;;HELLER ADAM;;GAL YORAM;;ARIA BEHRAD;;HELLER EPHRAIM;;PLANTE PHILLIP JOHN;;VREEKE MARK S;;FRIEDMAN KEITH A;;COLMAN FREDRIC C,E. HELLER & CO (1998-07-02);;ABBOTT DIABETES CARE INC (2000-03-13),https://lens.org/085-309-338-221-206,Patent Application,yes,99,46,211,221,0,A61B5/14532;;A61B5/14532;;A61B5/0002;;A61B5/0002;;A61B5/002;;A61B5/01;;A61B5/14503;;A61B5/1451;;A61B5/14546;;A61B5/14546;;A61B5/1473;;A61B5/1473;;A61B5/1486;;A61B5/1486;;A61B5/14865;;A61B5/1495;;A61B5/4839;;A61B5/72;;A61B5/7278;;A61B5/7282;;A61B5/7405;;A61B5/743;;A61B5/7445;;A61B5/7445;;A61B5/7455;;A61B2560/0252;;A61B2560/0252;;A61M5/1723;;C12Q1/54;;G16H10/40;;G16H10/40;;G16H20/17;;G16H20/17;;H01L23/3107;;H01L23/3107;;H01L23/49548;;H01L23/49548;;H01L2924/0002;;H01L2924/0002;;H01L2924/19041;;H01L2924/19041;;H01L2924/3011;;H01L2924/3011;;Y10S128/903;;Y10S128/903;;Y10T29/49;;Y10T29/49;;Y10T29/49124;;Y10T29/49124,A61B5/1468;;G01N27/30;;A61B5/00;;A61B5/145;;A61B5/1477;;A61B5/1495;;G01N27/416;;G06F19/00;;H01L23/31;;H01L23/495,600/345,0,0,,,,DISCONTINUED
286,US,A1,US 2010/0056890 A1,090-883-488-066-835,2010-03-04,2010,US 61499009 A,2009-11-09,US 61499009 A;;US 42005703 A;;US 66719900 A;;US 7067798 A,1998-04-30,Analyte Monitoring Device And Methods Of Use,"An analyte monitor includes a sensor, a sensor control unit, and a display unit. The sensor has, for example, a substrate, a recessed channel formed in the substrate, and conductive material disposed in the recessed channel to form a working electrode. The sensor control unit typically has a housing adapted for placement on skin and is adapted to receive a portion of an electrochemical sensor. The sensor control unit also includes two or more conductive contacts disposed on the housing and configured for coupling to two or more contact pads on the sensor. A transmitter is disposed in the housing and coupled to the plurality of conductive contacts for transmitting data obtained using the sensor. The display unit has a receiver for receiving data transmitted by the transmitter of the sensor control unit and a display coupled to the receiver for displaying an indication of a level of an analyte. The analyte monitor may also be part of a drug delivery system to alter the level of the analyte based on the data obtained using the sensor.",SAY JAMES;;TOMASCO MICHAEL F;;HELLER ADAM;;GAL YORAM;;ARIA BEHRAD;;HELLER EPHRAIM;;PLANTE PHILLIP JOHN;;VREEKE MARK S;;FRIEDMAN KEITH A;;COLMAN FREDRIC C,SAY JAMES;;TOMASCO MICHAEL F;;HELLER ADAM;;GAL YORAM;;ARIA BEHRAD;;HELLER EPHRAIM;;PLANTE PHILLIP JOHN;;VREEKE MARK S;;FRIEDMAN KEITH A;;COLMAN FREDRIC C,E. HELLER & CO (1998-07-02);;ABBOTT DIABETES CARE INC (2000-03-13),https://lens.org/090-883-488-066-835,Patent Application,yes,15,1,211,221,0,A61B5/14532;;A61B5/14532;;A61B5/0002;;A61B5/0002;;A61B5/002;;A61B5/01;;A61B5/14503;;A61B5/1451;;A61B5/14546;;A61B5/14546;;A61B5/1473;;A61B5/1473;;A61B5/1486;;A61B5/1486;;A61B5/14865;;A61B5/1495;;A61B5/4839;;A61B5/72;;A61B5/7278;;A61B5/7282;;A61B5/7405;;A61B5/743;;A61B5/7445;;A61B5/7445;;A61B5/7455;;A61B2560/0252;;A61B2560/0252;;A61M5/1723;;C12Q1/54;;G16H10/40;;G16H10/40;;G16H20/17;;G16H20/17;;H01L23/3107;;H01L23/3107;;H01L23/49548;;H01L23/49548;;H01L2924/0002;;H01L2924/0002;;H01L2924/19041;;H01L2924/19041;;H01L2924/3011;;H01L2924/3011;;Y10S128/903;;Y10S128/903;;Y10T29/49;;Y10T29/49;;Y10T29/49124;;Y10T29/49124,A61B5/05;;G01N27/30;;A61B5/00;;A61B5/145;;A61B5/1477;;A61B5/1495;;G01N27/416;;G06F19/00;;H01L23/31;;H01L23/495,600/345,0,0,,,,EXPIRED
287,US,A1,US 2010/0168658 A1,096-532-031-802-525,2010-07-01,2010,US 64397709 A,2009-12-21,US 64397709 A;;US 42005703 A;;US 66719900 A;;US 7067798 A,1998-04-30,Analyte Monitoring Device and Methods of Use,"An analyte monitor includes a sensor, a sensor control unit, and a display unit. The sensor has, for example, a substrate, a recessed channel formed in the substrate, and conductive material disposed in the recessed channel to form a working electrode. The sensor control unit typically has a housing adapted for placement on skin and is adapted to receive a portion of an electrochemical sensor. The sensor control unit also includes two or more conductive contacts disposed on the housing and configured for coupling to two or more contact pads on the sensor. A transmitter is disposed in the housing and coupled to the plurality of conductive contacts for transmitting data obtained using the sensor. The display unit has a receiver for receiving data transmitted by the transmitter of the sensor control unit and a display coupled to the receiver for displaying an indication of a level of an analyte. The analyte monitor may also be part of a drug delivery system to alter the level of the analyte based on the data obtained using the sensor.",ABBOTT DIABETES CARE INC,SAY JAMES;;TOMASCO MICHAEL F;;HELLER ADAM;;GAL YORAM;;ARIA BEHRAD;;HELLER EPHRAIM;;PLANTE PHILLIP JOHN;;VREEKE MARK S;;FRIEDMAN KEITH A;;COLMAN FREDRIC C,E. HELLER & CO (1998-07-02);;ABBOTT DIABETES CARE INC (2000-03-13),https://lens.org/096-532-031-802-525,Patent Application,yes,99,2,211,221,0,A61B5/14532;;A61B5/14532;;A61B5/0002;;A61B5/0002;;A61B5/002;;A61B5/01;;A61B5/14503;;A61B5/1451;;A61B5/14546;;A61B5/14546;;A61B5/1473;;A61B5/1473;;A61B5/1486;;A61B5/1486;;A61B5/14865;;A61B5/1495;;A61B5/4839;;A61B5/72;;A61B5/7278;;A61B5/7282;;A61B5/7405;;A61B5/743;;A61B5/7445;;A61B5/7445;;A61B5/7455;;A61B2560/0252;;A61B2560/0252;;A61M5/1723;;C12Q1/54;;G16H10/40;;G16H10/40;;G16H20/17;;G16H20/17;;H01L23/3107;;H01L23/3107;;H01L23/49548;;H01L23/49548;;H01L2924/0002;;H01L2924/0002;;H01L2924/19041;;H01L2924/19041;;H01L2924/3011;;H01L2924/3011;;Y10S128/903;;Y10S128/903;;Y10T29/49;;Y10T29/49;;Y10T29/49124;;Y10T29/49124,A61M37/00;;G01N27/30;;A61B5/00;;A61B5/145;;A61B5/1477;;A61B5/1495;;G01N27/416;;G06F19/00;;H01L23/31;;H01L23/495,604/66,0,0,,,,EXPIRED
288,US,A1,US 2009/0163781 A1,117-052-951-162-783,2009-06-25,2009,US 35921309 A,2009-01-23,US 35921309 A;;US 42005703 A;;US 66719900 A;;US 7067798 A,1998-04-30,Analyte Monitoring Device And Methods Of Use,"An analyte monitor includes a sensor, a sensor control unit, and a display unit. The sensor has, for example, a substrate, a recessed channel formed in the substrate, and conductive material disposed in the recessed channel to form a working electrode. The sensor control unit typically has a housing adapted for placement on skin and is adapted to receive a portion of an electrochemical sensor. The sensor control unit also includes two or more conductive contacts disposed on the housing and configured for coupling to two or more contact pads on the sensor. A transmitter is disposed in the housing and coupled to the plurality of conductive contacts for transmitting data obtained using the sensor. The display unit has a receiver for receiving data transmitted by the transmitter of the sensor control unit and a display coupled to the receiver for displaying an indication of a level of an analyte. The analyte monitor may also be part of a drug delivery system to alter the level of the analyte based on the data obtained using the sensor.",ABBOTT DIABETES CARE INC,SAY JAMES;;TOMASCO MICHAEL F;;HELLER ADAM;;GAL YORAM;;ARIA BEHRAD;;HELLER EPHRAIM;;PLANTE PHILLIP JOHN;;VREEKE MARK S;;FRIEDMAN KEITH A;;COLMAN FREDRIC C,,https://lens.org/117-052-951-162-783,Patent Application,yes,1,52,211,221,0,A61B5/14532;;A61B5/14532;;A61B5/0002;;A61B5/0002;;A61B5/002;;A61B5/01;;A61B5/14503;;A61B5/1451;;A61B5/14546;;A61B5/14546;;A61B5/1473;;A61B5/1473;;A61B5/1486;;A61B5/1486;;A61B5/14865;;A61B5/1495;;A61B5/4839;;A61B5/72;;A61B5/7278;;A61B5/7282;;A61B5/7405;;A61B5/743;;A61B5/7445;;A61B5/7445;;A61B5/7455;;A61B2560/0252;;A61B2560/0252;;A61M5/1723;;C12Q1/54;;G16H10/40;;G16H10/40;;G16H20/17;;G16H20/17;;H01L23/3107;;H01L23/3107;;H01L23/49548;;H01L23/49548;;H01L2924/0002;;H01L2924/0002;;H01L2924/19041;;H01L2924/19041;;H01L2924/3011;;H01L2924/3011;;Y10S128/903;;Y10S128/903;;Y10T29/49;;Y10T29/49;;Y10T29/49124;;Y10T29/49124,A61B5/1468;;G01N27/30;;A61B5/00;;A61B5/145;;A61B5/1477;;A61B5/1495;;A61M5/00;;G01N27/416;;G06F19/00;;H01L23/31;;H01L23/495,600/301;;600/347;;604/246,0,0,,,,DISCONTINUED
289,US,A1,US 2010/0292552 A1,105-864-454-704-121,2010-11-18,2010,US 84679510 A,2010-07-29,US 84679510 A;;US 69082607 A;;US 42005703 A;;US 66719900 A;;US 7067798 A,1998-04-30,Analyte Monitoring Device and Methods of Use,"An analyte monitor includes a sensor, a sensor control unit, and a display unit. The sensor has, for example, a substrate, a recessed channel formed in the substrate, and conductive material disposed in the recessed channel to form a working electrode. The sensor control unit typically has a housing adapted for placement on skin and is adapted to receive a portion of an electrochemical sensor. The sensor control unit also includes two or more conductive contacts disposed on the housing and configured for coupling to two or more contact pads on the sensor. A transmitter is disposed in the housing and coupled to the plurality of conductive contacts for transmitting data obtained using the sensor. The display unit has a receiver for receiving data transmitted by the transmitter of the sensor control unit and a display coupled to the receiver for displaying an indication of a level of an analyte. The analyte monitor may also be part of a drug delivery system to alter the level of the analyte based on the data obtained using the sensor.",ABBOTT DIABETES CARE INC,SAY JAMES;;TOMASCO MICHAEL F;;HELLER ADAM;;GAL YORAM;;ARIA BEHRAD;;HELLER EPHRAIM;;PLANTE PHILLIP JOHN;;VREEKE MARK S;;FRIEDMAN KEITH A;;COLMAN FREDRIC C,,https://lens.org/105-864-454-704-121,Patent Application,yes,1,3,211,221,0,A61B5/14532;;A61B5/14532;;A61B5/0002;;A61B5/0002;;A61B5/002;;A61B5/01;;A61B5/14503;;A61B5/1451;;A61B5/14546;;A61B5/14546;;A61B5/1473;;A61B5/1473;;A61B5/1486;;A61B5/1486;;A61B5/14865;;A61B5/1495;;A61B5/4839;;A61B5/72;;A61B5/7278;;A61B5/7282;;A61B5/7405;;A61B5/743;;A61B5/7445;;A61B5/7445;;A61B5/7455;;A61B2560/0252;;A61B2560/0252;;A61M5/1723;;C12Q1/54;;G16H10/40;;G16H10/40;;G16H20/17;;G16H20/17;;H01L23/3107;;H01L23/3107;;H01L23/49548;;H01L23/49548;;H01L2924/0002;;H01L2924/0002;;H01L2924/19041;;H01L2924/19041;;H01L2924/3011;;H01L2924/3011;;Y10S128/903;;Y10S128/903;;Y10T29/49;;Y10T29/49;;Y10T29/49124;;Y10T29/49124,A61B5/05;;G01N27/30;;A61B5/00;;A61B5/145;;A61B5/1477;;A61B5/1495;;G01N27/416;;G06F19/00;;H01L23/31;;H01L23/495,600/347,0,0,,,,DISCONTINUED
290,US,B2,US 8162829 B2,149-568-501-798-520,2012-04-24,2012,US 41445609 A,2009-03-30,US 41445609 A;;US 42005703 A;;US 66719900 A;;US 7067798 A,1998-04-30,Analyte monitoring device and methods of use,"An analyte monitor includes a sensor, a sensor control unit, and a display unit. The sensor has, for example, a substrate, a recessed channel formed in the substrate, and conductive material disposed in the recessed channel to form a working electrode. The sensor control unit typically has a housing adapted for placement on skin and is adapted to receive a portion of an electrochemical sensor. The sensor control unit also includes two or more conductive contacts disposed on the housing and configured for coupling to two or more contact pads on the sensor. A transmitter is disposed in the housing and coupled to the plurality of conductive contacts for transmitting data obtained using the sensor. The display unit has a receiver for receiving data transmitted by the transmitter of the sensor control unit and a display coupled to the receiver for displaying an indication of a level of an analyte. The analyte monitor may also be part of a drug delivery system to alter the level of the analyte based on the data obtained using the sensor.",SAY JAMES;;TOMASCO MICHAEL F;;HELLER ADAM;;GAL YORAM;;ARIA BEHRAD;;HELLER EPHRAIM;;PLANTE PHILLIP JOHN;;VREEKE MARK S;;FRIEDMAN KEITH A;;COLMAN FREDRIC C;;ABBOTT DIABETES CARE INC,SAY JAMES;;TOMASCO MICHAEL F;;HELLER ADAM;;GAL YORAM;;ARIA BEHRAD;;HELLER EPHRAIM;;PLANTE PHILLIP JOHN;;VREEKE MARK S;;FRIEDMAN KEITH A;;COLMAN FREDRIC C,,https://lens.org/149-568-501-798-520,Granted Patent,yes,114,8,211,221,0,A61B5/14532;;A61B5/14532;;A61B5/0002;;A61B5/0002;;A61B5/002;;A61B5/01;;A61B5/14503;;A61B5/1451;;A61B5/14546;;A61B5/14546;;A61B5/1473;;A61B5/1473;;A61B5/1486;;A61B5/1486;;A61B5/14865;;A61B5/1495;;A61B5/4839;;A61B5/72;;A61B5/7278;;A61B5/7282;;A61B5/7405;;A61B5/743;;A61B5/7445;;A61B5/7445;;A61B5/7455;;A61B2560/0252;;A61B2560/0252;;A61M5/1723;;C12Q1/54;;G16H10/40;;G16H10/40;;G16H20/17;;G16H20/17;;H01L23/3107;;H01L23/3107;;H01L23/49548;;H01L23/49548;;H01L2924/0002;;H01L2924/0002;;H01L2924/19041;;H01L2924/19041;;H01L2924/3011;;H01L2924/3011;;Y10S128/903;;Y10S128/903;;Y10T29/49;;Y10T29/49;;Y10T29/49124;;Y10T29/49124,A61B5/00;;G01N27/30;;A61B5/05;;A61B5/145;;A61B5/1477;;A61B5/1495;;G01N27/416;;G06F19/00;;H01L23/31;;H01L23/495,600/365;;600/347,99,81,136-791-935-548-81X;;062-360-289-025-864;;010-601-725-111-91X;;101-292-518-663-191;;056-703-879-057-297;;030-155-762-644-019;;004-149-141-436-651;;016-731-054-793-457;;080-559-561-995-335;;044-807-213-528-815;;027-538-525-436-179;;015-020-161-517-40X;;025-919-454-564-785;;014-700-576-603-812;;004-851-060-590-788;;075-958-432-122-199;;052-356-140-149-389;;035-090-282-884-790;;033-562-815-299-181;;018-803-926-589-211;;008-505-762-041-402;;016-601-143-530-813;;019-502-772-562-215;;058-476-824-396-350;;006-498-707-073-30X;;054-091-551-638-293;;010-531-147-771-746;;054-827-198-877-419;;122-658-944-077-000;;017-261-560-469-37X;;000-125-755-474-124;;113-381-664-783-802;;082-626-907-191-554;;017-950-014-792-456;;090-348-305-613-628;;015-985-399-299-132;;171-049-047-164-618;;016-819-089-891-758;;081-249-097-078-543;;089-612-747-111-646;;031-706-897-890-035;;094-198-536-559-723;;003-690-143-043-420;;007-943-354-378-456;;082-114-500-909-975;;004-239-090-971-580;;026-894-457-160-450;;077-128-610-778-669;;022-466-506-956-898;;008-424-592-956-946;;007-500-825-916-378;;009-725-244-669-882;;037-755-689-613-42X;;153-411-506-517-475;;038-134-360-685-692;;012-449-714-188-064;;031-517-704-996-130;;131-299-284-996-064;;049-133-049-742-708;;000-272-178-768-076;;070-797-683-833-124;;043-870-224-178-49X;;025-574-914-238-550;;052-364-430-129-757;;004-434-167-910-115;;032-860-147-271-886;;132-460-374-211-421;;098-172-374-375-47X;;109-358-955-476-095;;014-988-634-483-130;;061-786-187-274-992;;037-898-018-686-909;;130-044-667-529-69X;;134-265-642-839-645;;065-221-074-461-027;;017-934-465-161-477;;101-660-130-379-529;;028-236-706-290-220;;087-333-189-994-274;;059-082-211-027-266;;057-977-752-782-568,10.1016/s0956-5663(02)00099-4;;12392956;;10.1021/ja00391a001;;2889225;;10.1098/rstb.1987.0021;;10.1109/51.294001;;10.1016/0022-0728(65)85063-x;;2245876;;10.2337/diabetes.39.12.1519;;10.2337/diab.39.12.1519;;10.1016/s0956-5663(03)00220-3;;14611755;;18615658;;10.1002/bit.260430310;;9366023;;10.1016/s0956-5663(97)00025-0;;9451795;;10.1016/s0956-5663(97)00083-3;;10.1016/0956-5663(93)80028-n;;8311939;;8651496;;10.1021/ac960030d;;10.1080/03091900210156797;;12487712;;10.1016/0265-928x(87)80018-4;;3333622;;10.1109/19.816143;;10.1007/bf01015979;;10.1089/15209150252924058;;12017416;;18473691;;10.1089/dia.2007.0281;;10.1021/ac00017a008;;1789439;;2817408;;10.1021/ac00197a022;;10.1016/0925-4005(95)01730-5;;10.1016/0010-4825(90)90013-f;;2257734;;2868172;;8277748;;10.1016/0141-5425(93)90058-7;;11469630;;10.1089/15209150050214104;;10624783;;10.1016/s0168-8227(99)00113-8;;10.1089/15209150050214113;;11469631;;10.1007/bf00401374;;1478372;;10.2337/diacare.20.1.64;;9028696;;10.1109/tbme.1986.325807;;3957374;;236018;;10.1016/0005-2795(75)90259-7;;10.1089/hum.1998.9.6-879;;9581910;;11762520;;10.1089/15209150152607196;;10.2337/diabetes.48.3.445;;10078542;;10.1016/0265-928x(87)80012-3;;505005;;10.1126/science.505005;;10.1021/ac0498516;;15253640;;10.1109/10.284922;;8026845;;6721151;;10.1021/ac00268a018;;6733082;;10.1021/bi00305a016;;10.1515/cclm.2002.135;;12392305;;10.1016/j.ecl.2003.12.001;;15053902;;12052350;;10.1016/s0956-5663(01)00304-9;;12052349;;10.1016/s0956-5663(01)00306-2;;4500021;;10.1007/978-1-4684-3288-6_18;;14021529;;10.1111/j.1749-6632.1962.tb13623.x;;3196517;;10.2337/diacare.10.5.622;;3677983;;10.2337/diacare.8.6.529;;4075939;;10.1002/elan.1140061103;;7733469;;10.1021/ac00103a015;;7978306;;10.1021/ac00091a022;;10.1007/bf01248238;;10.1016/s0376-7388(98)00330-5;;10.1016/0142-9612(92)90147-g;;1472593;;10.1016/0265-928x(85)80002-x;;10.1021/j100290a001;;10.1021/ja00216a040;;10.1021/ja00188a091;;10.1021/ja00406a011;;2624333;;12323417;;10.1016/s0165-0270(02)00170-x;;10.1177/193229680700100208;;pmc2771467;;19888405;;10.1021/ja00415a014;;10.1007/bf00575392;;10.1021/ac00250a038;;10.1021/ac00266a005;;10.1007/s00216-002-1284-0;;12194035;;10.1089/dia.2006.0030;;17705688;;9642777;;10.1016/s0956-5663(97)00091-2;;10.1089/152091503322526978;;14633342;;10.1016/0022-0728(85)87006-6;;10.1021/ja00434a018;;10.1016/0003-2697(92)90243-z;;1443528;;10.1039/f19868201259;;3245585;;10.1021/ac00173a008;;2889234;;10.1098/rstb.1987.0020;;11762521;;10.1089/15209150152607204;;12413548;;10.1016/s1367-5931(02)00371-x;;10526740;;10.2337/diacare.22.10.1708;;14988294;;10.2337/diacare.27.3.734,"""Poretics Polycarbonate Membrane"", Osmonics Filtration and Separation Group, 2002.;;Abel, P. U., et al., ""Biosensors for In Vivo Glucose Measurement: Can We Cross the Experimental Stage"", Biosensors and Bioelectronics, vol. 17, 2002, pp. 1059-1070.;;Abruna, H. D., et al., ""Rectifying Interfaces Using Two-Layer Films of Electrochemically Polymerized Vinylpyridine and Vinylbipyridine Complexes of Ruthenium and Iron on Electrodes"", Journal of the American Chemical Society, vol. 103, No. 1, 1981, pp. 1-5.;;Albery, W. J., et al., ""Amperometric Enzyme Electrodes Part II: Conducting Salts as Electrode Materials for the Oxidation of Glucose Oxidase"", Journal of ElectroAnalytical Chemistry, vol. 194, 1985, pp. 223-235.;;Albery, W. J., et al., ""Amperometric Enzyme Electrodes"", Philosophical Transactions of the Royal Society of London, vol. 316, 1987, pp. 107-119.;;Alcock, S. J., et al., ""Continuous Analyte Monitoring to Aid Clinical Practice"", IEEE Engineering in Medicine and Biology Magazine, 1994, pp. 319-325.;;Anderson, L. B., et al., ""Thin-Layer Electrochemistry: Steady-State Methods of Studying Rate Processes"", Journal of ElectroAnalytical Chemistry, vol. 10, 1965, pp. 295-305.;;Armour, J. C., et al., ""Application of Chronic Intravascular Blood Glucose Sensor in Dogs"", Diabetes, vol. 39, 1990, pp. 1519-1526.;;Asberg, P., et al., ""Hydrogels of a Conducting Conjugated Polymer as 3-D Enzyme Electrode"", Biosensors & Bioelectronics, vol. 19, 2003, pp. 199-207.;;Atanasov, P., et al., ""Biosensor for Continuous Glucose Monitoring"", Biotechnology and Bioengineering, vol. 43, 1994, pp. 262-266.;;Atanasov, P., et al., ""Implantation of a Refillable Glucose Monitoring-Telemetry Device"", Biosensors & Bioelectronics, vol. 12, No. 7, 1997, pp. 669-680.;;Aussedat, B., et al., ""A User-Friendly Method for Calibrating a Subcutaneous Glucose Sensor-Based Hypoglycaemic Alarm"", Biosensors & Bioelectronics, vol. 12, No. 11, 1997, pp. 1061-1071.;;Baker, D. A., et al., ""Dynamic Concentration Challenges for Biosensor Characterization"", Biosensors & Bioelectronics, vol. 8, 1993, pp. 433-441.;;Baker, D. A., et al., ""Dynamic Delay and Maximal Dynamic Error in Continuous Biosensors"", Analytical Chemistry, vol. 68, No. 8, 1996, pp. 1292-1297.;;Bani Amer, M. M., ""An Accurate Amperometric Glucose Sensor Based Glucometer with Eliminated Cross-Sensitivity"", Journal of Medical Engineering & Technology, vol. 26, No. 5, 2002, pp. 208-213.;;Bard, A. J., et al., Electrochemical Methods, 1980, pp. 173-175.;;Bartlett, P. N., et al., ""Covalent Binding of Electron Relays to Glucose Oxidase"", Journal of the Chemical Society, Chemical Communications, 1987, pp. 1603-1604.;;Bartlett, P. N., et al., ""Modification of Glucose Oxidase by Tetrathiafulvalene"", Journal of the Chemical Society, Chemical Communications, 1990, pp. 1135-1136.;;Bartlett, P. N., et al., ""Strategies for the Development of Amperometric Enzyme Electrodes"", Biosensors, vol. 3, 1987/88, pp. 359-379.;;Beach, R. D., et al., ""Subminiature Implantable Potentiostat and Modified Commercial Telemetry Device for Remote Glucose Monitoring"", IEEE Transactions on Instrumentation and Measurement, vol. 28, No. 6, 1999, pp. 1239-1245.;;Beech, W. A., ""AX.25 Link Access Protocol for Amateur packet Radio"", Tucson Amateur Packet Radio Corporation, 1998, pp. 1-133.;;Bellucci, F., et al., ""Electrochemical Behaviour of Graphite-Epoxy Composite Materials (GECM) in Aqueous Salt Solutions"", Journal of Applied Electrochemistry, vol. 16, 1986, pp. 15-22.;;Bennion, N., et al., ""Alternate Site Glucose Testing: A Crossover Design"", Diabetes Technology & Therapeutics, vol. 4, No. 1, 2002, pp. 25-33.;;Biermann, E., et al., ""How Would Patients Behave if They Were Continually Informed of Their Blood Glucose Levels? A Simulation Study Using a 'Virtual' Patient"", Diabetes Technology & Therapeutics, vol. 10, No. 3, 2008, pp. 178-187.;;Bindra, D. S., et al., ""Design and in Vitro Studies of a Needle-Type Glucose Sensor for Subcutaneous Monitoring"", Analytical Chemistry, vol. 63, No. 17, 1991, pp. 1692-1696.;;Bindra, D. S., et al., ""Pulsed Amperometric Detection of Glucose in Biological Fluids at a Surface-Modified Gold Electrode"", Analytical Chemistry, vol. 61, No. 22, 1989, pp. 2566-2570.;;Bisenberger, M., et al., ""A Triple-Step Potential Waveform at Enzyme Multisensors with Thick-Film Gold Electrodes for Detection of Glucose and Sucrose"", Sensors and Actuators B, vol. 28, 1995, pp. 181-189.;;Bland, J. M., et al., ""A Note on the Use of the Intraclass Correlation Coefficient in the Evaluation of Agreement Between Two Methods of Measurement"", Computers in Biology and Medicine, vol. 20, No. 5, 1990, pp. 337-340.;;Bland, J. M., et al., ""Statistical Methods for Assessing Agreement Between Two Methods of Clinical Measurement"", The Lancet, 1986, pp. 307-310.;;Blank, T. B., et al., ""Clinical Results From a Non-Invasive Blood Glucose Monitor"", Optical Diagnostics and Sensing of Biological Fluids and Glucose and Cholesterol Monitoring II, Proceedings of SPIE, vol. 4624, 2002, pp. 1-10.;;Bobbioni-Harsch, E., et al., ""Lifespan of Subcutaneous Glucose Sensors and Their Performances During Dynamic Glycaemia Changes in Rats"", Journal of Biomedical Engineering, vol. 15, 1993, pp. 457-463.;;Bode, B. W., ""Clinical Utility of the Continuous Glucose Monitoring System"", Diabetes Technology & Therapeutics, vol. 2, Sup. 1, 2000, pp. S35-S41.;;Bode, B. W., et al., ""Continuous Glucose Monitoring Used to Adjust Diabetes Therapy Improves Glycosylated Hemoglobin: A Pilot Study"", Diabetes Research and Clinical Practice, vol. 46, 1999, pp. 183-190.;;Bode, B. W., et al., ""Using the Continuous Glucose Monitoring System to Improve the Management of Type I Diabetes"", Diabetes Technology & Therapeutics, vol. 2, Sup. 1, 2000, pp. S43-S48.;;Boedeker Plastics, Inc., ""Polyethylene Specifications"", Web Page of Boedeker.com, 2007, pp. 1-3.;;Bolinder, J., et al., ""Microdialysis Measurement of the Absolute Glucose Concentration in Subcutaneous Adipose Tissue Allowing Glucose Monitoring in Diabetic Patients"", Diabetologia, vol. 35, 1992, pp. 1177-1180.;;Bolinder, J., et al., ""Self-Monitoring of Blood Glucose in Type I Diabetic Patients: Comparison with Continuous Microdialysis Measurements of Glucose in Subcutaneous Adipose Tissue During Ordinary Life Conditions"", Diabetes Care, vol. 20, No. 1, 1997, pp. 64-70.;;Bott, A. W., ""A Comparison of Cyclic Voltammetry and Cyclic Staircase Voltammetry"", Current Separations, vol. 16, No. 1, 1997, pp. 23-26.;;Bott, A. W., ""Electrochemical Methods for the Determination of Glucose"", Current Separations, vol. 17, No. 1, 1998, pp. 25-31.;;Bowman, L., et al., ""The Packaging of Implantable Integrated Sensors"", IEEE Transactions on Biomedical Engineering, vol. 33, No. 2, 1986, pp. 248-255.;;Brandt, J., et al., ""Covalent Attachment of Proteins to Polysaccharide Carriers by Means of Benzoquinone"", Biochimica et Biophysica Acta, vol. 386, 1975, pp. 196-202.;;Brauker, J., et al., ""Sustained Expression of High Levels of Human Factor IX from Human Cells Implanted Within an Immunoisolation Device into Athymic Rodents"", Human Gene Therapy, vol. 9, No. 6, 1998, pp. 879-888.;;Bremer, T. M., et al., ""Benchmark Data from the Literature for Evaluation of New Glucose Sensing Technologies"", Diabetes Technology & Therapeutics, vol. 3, No. 3, 2001, pp. 409-418.;;Bremer, T., et al., ""Is Blood Glucose Predictable from Previous Values?"", Diabetes, vol. 48, 1999, pp. 445-451.;;Brooks, S. L., et al., ""Development of an On-Line Glucose Sensor for Fermentation Monitoring"", Biosensors, vol. 3, 1987/88, pp. 45-56.;;Brownlee, M., et al., ""A Glucose-Controlled Insulin-Delivery System: Semisynthetic Insulin Bound to Lectin"", Science, vol. 206, 1979, 1190-1191.;;Cai, Q., et al., ""A Wireless, Remove Query Glucose Biosensor Based on a pH-Sensitive Polymer"", Analytical Chemistry, vol. 76, No. 14, 2004, pp. 4038-4043.;;Candas, B., et al., ""An Adaptive Plasma Glucose Controller Based on a Nonlinear Insulin/Glucose Model"", IEEE Transactions on Biomedical Engineering, vol. 41, No. 2, 1994, pp. 116-124.;;Cass, A. E., et al., ""Ferricinum Ion as an Electron Acceptor for Oxido-Reductases"", Journal of ElectroAnalytical Chemistry, vol. 190, 1985, pp. 117-127.;;Cass, A. E., et al., ""Ferrocene-Medicated Enzyme Electrode for Amperometric Determination of Glucose"", Analytical Chemistry, vol. 56, No. 4, 1984, 667-671.;;Castner, J. F., et al., ""Mass Transport and Reaction Kinetic Parameters Determined Electrochemically for Immobilized Glucose Oxidase"", Biochemistry, vol. 23 No. 10, 1984, 2203-2210.;;Chen, J. C., et al., ""A Comparison of MAC Protocols for Wireless Local Networks Based on battery Power Consumption"", IEEE, 1998, pp. 150-157.;;Chen, T., et al., ""Defining the Period of Recovery of the Glucose Concentration After its Local Perturbation by the Implantation of a Miniature Sensor"", Clinical Chemistry and Laboratory Medicine, vol. 40, No. 8, 2002, pp. 486-489.;;Chia, C. W., et al., ""Glucose Sensors: Toward Closed Loop Insulin Delivery"", Endocrinology and Metabolism Clinics of North America, vol. 33, 2004, pp. 175-195.;;Choleau, C., et al., ""Calibration of a Subcutaneous Amperometric Glucose Sensor Implanted for 7 Days in Diabetic Patients Part 2: Superiority of the One-Point Calibration Method"", Biosensors and Bioelectronics, vol. 17, 2002, pp. 647-654.;;Choleau, C., et al., ""Calibration of a Subcutaneous Amperometric Glucose Sensor Part 1: Effect of Measurement Uncertainties on the Determination of Sensor Sensitivity and Background Current"", Biosensors and Bioelectronics, vol. 17, 2002, pp. 641-646.;;Claremont, D. J., et al., ""Biosensors for Continuous In Vivo Glucose Monitoring"", Proceedings of the Annual International Conference of the IEEE Engineering in Medicine and Biology Society, vol. 10, 1988.;;Clark Jr., L. C., et al., ""Differential Anodic Enzyme Polarography for the Measurement of Glucose"", Oxygen Transport to Tissue: Instrumentation, Methods, and Physiology, 1973, pp. 127-133.;;Clark Jr., L. C., et al., ""Electrode Systems for Continuous Monitoring in Cardiovascular Surgery"", Annals New York Academy of Sciences, 1962, pp. 29-45.;;Clark Jr., L. C., et al., ""Long-term Stability of Electroenzymatic Glucose Sensors Implanted in Mice"", American Society of Artificial Internal Organs Transactions, vol. XXXIV, 1988, pp. 259-265.;;Clarke, W. L., et al., ""Evaluating Clinical Accuracy of Systems for Self-Monitoring of Blood Glucose"", Diabetes Care, vol. 10, No. 5, 1987, pp. 622-628.;;Complaint, ""Abbott Diabetes Care, Inc. v. Dexcom, Inc."", filed Aug. 11, 2005.;;Complaint, Amended, ""Abbott Diabetes Care, Inc. v. Dexcom, Inc."", filed Jun. 27, 2006.;;Cox, D. J., et al., ""Accuracy of Perceiving Blood Glucose in IDDM"", Diabetes Care, vol. 8, No. 6, 1985, pp. 529-536.;;Csoregi, E., et al., ""Amperometric Microbiosensors for Detection of Hydrogen Peroxide and Glucose Based on Peroxidase-Modified Carbon Fibers"", Electroanalysis, vol. 6, 1994, pp. 925-933.;;Csoregi, E., et al., ""Design and Optimization of a Selective Subcutaneously Implantable Glucose Electrode Based on 'Wired' Glucose Oxidase"", Analytical Chemistry, vol. 67, No. 7, 1995, pp. 1240-1244.;;Csoregi, E., et al., ""Design, Characterization, and One-Point in Vivo Calibration of a Subcutaneously Implanted Glucose Electrode"", Analytical Chemistry, vol. 66 No. 19, 1994, pp. 3131-3138.;;Csoregi, E., et al., ""On-Line Glucose Monitoring by Using Microdialysis Sampling and Amperometric Detection Based on 'Wired' Glucose Oxidase in Carbon Paste"", Mikrochimica Acta, vol. 121, 1995, pp. 31-40.;;D'Arrigo, G., et al., ""Porous-Si Based Bio Reactors for Glucose Monitoring and Drugs Production"", Proceedings of SPIE: Microfluids, BioMEMS, and Medical Microsystems, vol. 4982, 2003, pp. 178-184.;;Dai, W. S., et al., ""Hydrogel Membranes with Mesh Size Asymmetry Based on the Gradient Crosslinking of Poly(vinyl alcohol),"" Journal of Membrane Science, vol. 156, 1999, pp. 67-79.;;Davies, M. L., et al., ""Polymer Membranes in Clinical Sensor Applications"", Biomaterials, vol. 13, No. 14, 1992, pp. 971-978.;;Davis, G., ""Electrochemical Techniques for the Development of Amperometric Biosensors"", Biosensors, vol. 1, 1985, pp. 161-178.;;Degani, Y., et al., ""Direct Electrical Communication Between Chemically Modified Enzymes and Metal Electrodes. 1. Electron Transfer from Glucose Oxidase to Metal Electrodes via Electron Relays, Bound Covalently to the Enzyme"", The Journal of Physical Chemistry, vol. 91, No. 6, 1987, pp. 1285-1289.;;Degani, Y., et al., ""Direct Electrical Communication Between Chemically Modified Enzymes and Metal Electrodes. 2. Methods for Bonding Electron-Transfer Relays to Glucose Oxidase and D-Amino-Acid Oxidase"", Journal of the American Chemical Society, vol. 110, No. 8, 1988, pp. 2615-2620.;;Degani, Y., et al., ""Electrical Communication Between Redox Centers of Glucose Oxidase and Electrodes via Electrostatically and Covalently Bound Redox Polymers"", Journal of the American Chemical Society, vol. 111, 1989, pp. 2357-2358.;;Denisevich, P., et al., ""Unidirectional Current Flow and Charge State Trapping at Redox Polymer Interfaces on Bilayer Electrodes: Principles, Experimental Demonstration, and Theory"", Journal of the American Chemical Society, vol. 103, 1981, pp. 4727-4737.;;Dicks, J. M., et al., ""Ferrocene Modified Polypyrrole with Immobilised Glucose Oxidase and its Application in Amperometric Glucose Microbiosensors"", Annales de Biologie Clinique, vol. 47, 1989, pp. 607-619.;;Dixon, B. M., et al., ""Characterization In Vitro and In Vivo of the Oxygen Dependence of an Enzyme/Polymer Biosensors for Monitoring Brain Glucose"", Journal of Neuroscience Methods, vol. 119, 2002, pp. 135-142.;;Eighth Annual Diabetes Technology Meeting Abstracts, Nov. 13-15, 2008, pp. A1-A182.;;El-Khatib, F. H, et al., ""Adaptive Closed-Loop Control Provides Blood-Glucose Regulation Using Subcutaneous Insulin and Glucagon Infusion in Diabetic Swine"", Journal of Diabetes Science and Technology, vol. 1, No. 2, 2007, pp. 181-192.;;Ellis, C. D., et al., ""Selectivity and Directed Charge Transfer through an Electroactive Metallopolymer Film"", Journal of the American Chemical Society, vol. 103, No. 25, 1981, pp. 7480-7483.;;El-Sa'ad, L., et al., ""Moisture Absorption by Epoxy Resins: The Reverse Thermal Effect"", Journal of Materials Science, vol. 25, No. 8, 1990, pp. 3577-3582.;;Engstrom, R. C., ""Electrochemical Pretreatment of Glassy Carbon Electrodes"", Analytical Chemistry, vol. 54, No. 13, 1982, pp. 2310-2314.;;Engstrom, R. C., et al., ""Characterization of Electrochemically Pretreated Glassy Carbon Electrodes"", Analytical Chemistry, vol. 56, No. 2, 1984, pp. 136-141.;;Ernst, H., et al., ""Reliable Glucose Monitoring Through the Use of Microsystem Technology"", Analytical and Bioanalytical Chemistry, vol. 373, 2002, pp. 758-761.;;Fabietti, P. G., et al. ""Clinical Validation of a New Control-Oriented Model of Insulin and Glucose Dynamics in Subjects with Type 1 Diabetes"", Diabetes Technology & Therapeutics, vol. 9 No. 4, 2007, pp. 327-338.;;Fare, T. L., et al., ""Functional Characterization of a Conducting Polymer-Based Immunoassay System"", Biosensors & Bioelectronics, vol. 13, No. 3-4, 1998, pp. 459-470.;;Feldman, B., et al., ""A Continuous Glucose Sensor Based on Wired Enzyme(TM) Technology-Results from a 3-Day Trial in Patients with Type 1 Diabetes"", Diabetes Technology & Therapeutics, vol. 5, No. 5, 2003, pp. 769-779.;;Feldman, B., et al., ""Correlation of Glucose Concentrations in Interstitial Fluid and Venous Blood During Periods of Rapid Glucose Change"", Abbott Diabetes Care, Inc. Freestyle Navigator Continuous Glucose Monitor Pamphlet, 2004.;;Feldman, B., et al., ""Electron Transfer Kinetics at Redox Polymer/Solution Interfaces Using Microelectrodes and Twin Electrode Thin Layer Cells"", Journal of ElectroAnalytical Chemistry, vol. 194, 1985, pp. 63-81.;;Fischer, H., et al., ""Intramolecular Electron Transfer Medicated by 4,4'-Bypyridine and Related Bridging Groups"", Journal of the American Chemical Society, vol. 98, No. 18, 1976, pp. 5512-5517.;;Flentge, F., et al., ""An Enzyme-Reactor for Electrochemical Monitoring of Choline and Acetylcholine: Applications in High-Performance Liquid Chromatography, Bran Tissue, Microdialysis and Cerebrospinal Fluid,"" Analytical Biochemistry, vol. 204, 1992, pp. 305-310.;;Foulds, N. C., et al., ""Enzyme Entrapment in Electrically Conducting Polymers: Immobilisation of Glucose Oxidase in Polypyrrole and its Application in Amperometric Glucose Sensors"", Journal of the Chemical Society, Faraday Transactions 1, vol. 82, 1986, pp. 1259-1264.;;Foulds, N. C., et al , ""Immobilization of Glucose Oxidase in Ferrocene-Modified Pyrrole Polymers"", Analytical Chemistry, vol. 60, No. 22, 1988, pp. 2473-2478.;;Frew, J. E., et al., ""Electron-Transfer Biosensors"", Philosophical Transactions of the Royal Society of London, vol. 316, 1987, pp. 95-106.;;Frohnauer, M. K., et al., ""Graphical Human Insulin Time-Activity Profiles Using Standardized Definitions"", Diabetes Technology & Therapeutics, vol. 3, No. 3, 2001, pp. 419-429.;;Frost, M. C., et al., ""Implantable Chemical Sensors for Real-Time Clinical Monitoring: Progress and Challenges"", Current Opinion in Chemical Biology, vol. 6, 2002, pp. 633-641.;;Garg, S. K., et al., ""Correlation of Fingerstick Blood Glucose Measurements with GlucoWatch Biographer Glucose Results in Young Subjects with Type 1 Diabetes"", Diabetes Care, vol. 22, No. 10, 1999, pp. 1708-1714.;;Garg, S. K., et al., ""Improved Glucose Excursions Using an Implantable Real-Time Continuous Glucose Sensor in Adults with Type 1 Diabetes"", Diabetes Care, vol. 27, No. 3, 2004, pp. 734-738.",EXPIRED
291,US,A1,US 2010/0241388 A1,159-411-579-734-452,2010-09-23,2010,US 79366210 A,2010-06-03,US 79366210 A;;US 69082607 A;;US 42005703 A;;US 66719900 A;;US 7067798 A,1998-04-30,Analyte Monitoring Device And Methods Of Use,"An analyte monitor includes a sensor, a sensor control unit, and a display unit. The sensor has, for example, a substrate, a recessed channel formed in the substrate, and conductive material disposed in the recessed channel to form a working electrode. The sensor control unit typically has a housing adapted for placement on skin and is adapted to receive a portion of an electrochemical sensor. The sensor control unit also includes two or more conductive contacts disposed on the housing and configured for coupling to two or more contact pads on the sensor. A transmitter is disposed in the housing and coupled to the plurality of conductive contacts for transmitting data obtained using the sensor. The display unit has a receiver for receiving data transmitted by the transmitter of the sensor control unit and a display coupled to the receiver for displaying an indication of a level of an analyte. The analyte monitor may also be part of a drug delivery system to alter the level of the analyte based on the data obtained using the sensor.",ABBOTT DIABETES CARE INC,SAY JAMES;;TOMASCO MICHAEL F;;HELLER ADAM;;GAL YORAM;;ARIA BEHRAD;;HELLER EPHRAIM;;PLANTE PHILLIP JOHN;;VREEKE MARK S;;FRIEDMAN KEITH A;;COLMAN FREDRIC C,,https://lens.org/159-411-579-734-452,Patent Application,yes,1,2,211,221,0,A61B5/14532;;A61B5/14532;;A61B5/0002;;A61B5/0002;;A61B5/002;;A61B5/01;;A61B5/14503;;A61B5/1451;;A61B5/14546;;A61B5/14546;;A61B5/1473;;A61B5/1473;;A61B5/1486;;A61B5/1486;;A61B5/14865;;A61B5/1495;;A61B5/4839;;A61B5/72;;A61B5/7278;;A61B5/7282;;A61B5/7405;;A61B5/743;;A61B5/7445;;A61B5/7445;;A61B5/7455;;A61B2560/0252;;A61B2560/0252;;A61M5/1723;;C12Q1/54;;G16H10/40;;G16H10/40;;G16H20/17;;G16H20/17;;H01L23/3107;;H01L23/3107;;H01L23/49548;;H01L23/49548;;H01L2924/0002;;H01L2924/0002;;H01L2924/19041;;H01L2924/19041;;H01L2924/3011;;H01L2924/3011;;Y10S128/903;;Y10S128/903;;Y10T29/49;;Y10T29/49;;Y10T29/49124;;Y10T29/49124,G01N27/30;;A61B5/00;;A61B5/145;;A61B5/1477;;A61B5/1495;;G01N27/416;;G06F19/00;;H01L23/31;;H01L23/495,702/104;;702/182,0,0,,,,DISCONTINUED
292,US,A1,US 2010/0099968 A1,176-228-566-982-394,2010-04-22,2010,US 64398209 A,2009-12-21,US 64398209 A;;US 42005703 A;;US 66719900 A;;US 7067798 A,1998-04-30,Analyte Monitoring Device and Methods of Use,"An analyte monitor includes a sensor, a sensor control unit, and a display unit. The sensor has, for example, a substrate, a recessed channel formed in the substrate, and conductive material disposed in the recessed channel to form a working electrode. The sensor control unit typically has a housing adapted for placement on skin and is adapted to receive a portion of an electrochemical sensor. The sensor control unit also includes two or more conductive contacts disposed on the housing and configured for coupling to two or more contact pads on the sensor. A transmitter is disposed in the housing and coupled to the plurality of conductive contacts for transmitting data obtained using the sensor. The display unit has a receiver for receiving data transmitted by the transmitter of the sensor control unit and a display coupled to the receiver for displaying an indication of a level of an analyte. The analyte monitor may also be part of a drug delivery system to alter the level of the analyte based on the data obtained using the sensor.",ABBOTT DIABETES CARE INC,SAY JAMES;;TOMASCO MICHAEL F;;HELLER ADAM;;GAL YORAM;;ARIA BEHRAD;;HELLER EPHRAIM;;PLANTE PHILLIP JOHN;;VREEKE MARK S;;FRIEDMAN KEITH A;;COLMAN FREDRIC C,E. HELLER & CO (1998-07-02);;ABBOTT DIABETES CARE INC (2000-03-13),https://lens.org/176-228-566-982-394,Patent Application,yes,85,46,211,221,0,A61B5/14532;;A61B5/14532;;A61B5/0002;;A61B5/0002;;A61B5/002;;A61B5/01;;A61B5/14503;;A61B5/1451;;A61B5/14546;;A61B5/14546;;A61B5/1473;;A61B5/1473;;A61B5/1486;;A61B5/1486;;A61B5/14865;;A61B5/1495;;A61B5/4839;;A61B5/72;;A61B5/7278;;A61B5/7282;;A61B5/7405;;A61B5/743;;A61B5/7445;;A61B5/7445;;A61B5/7455;;A61B2560/0252;;A61B2560/0252;;A61M5/1723;;C12Q1/54;;G16H10/40;;G16H10/40;;G16H20/17;;G16H20/17;;H01L23/3107;;H01L23/3107;;H01L23/49548;;H01L23/49548;;H01L2924/0002;;H01L2924/0002;;H01L2924/19041;;H01L2924/19041;;H01L2924/3011;;H01L2924/3011;;Y10S128/903;;Y10S128/903;;Y10T29/49;;Y10T29/49;;Y10T29/49124;;Y10T29/49124,A61B5/1468;;G01N27/30;;A61B5/00;;A61B5/145;;A61B5/1477;;A61B5/1495;;G01N27/416;;G06F19/00;;G08B23/00;;H01L23/31;;H01L23/495,600/345;;340/573.1,0,0,,,,EXPIRED
293,US,A1,US 2004/0247602 A1,199-914-197-907-851,2004-12-09,2004,US 81771804 A,2004-04-02,US 81771804 A;;US 46067803 P;;US 47249403 P;;US 53203003 P;;US 54898604 P,2003-04-04,"Compositions, methods and kits relating to Her-2 cleavage","
   The present invention relates to compositions, methods and kits based on the ADAM-mediated cleavage of Her-2. The present invention also relates to treatments for cancer, and in particular, breast cancer, by modulating the ADAM-mediated cleavage of Her-2. Further, the invention relates to compositions, methods and kits based on the surprising synergistic effect between inhibition of Her-2 cleavage by an ADAM and certain cytostatic (e.g., Herceptin) and cytotoxic (e.g., Taxol) compounds in, among other things, inhibiting tumor cell proliferation and inducing cell death. Additionally, the invention relates to novel variants of ADAM15, designated ADAM15 variant 1 and ADAM15 variant 2, now identified and isolated. 
",FRIEDMAN STEVEN M.;;SCHERLE PEGGY A.;;LIU XIANGDONG;;BURN TIMOTHY C.;;HUBER REID;;LIU PHILLIP C.C.;;HOLLIS GREGORY F.;;VADDI KRISHNA;;FRIDMAN JORDAN S.,FRIEDMAN STEVEN M;;SCHERLE PEGGY A;;LIU XIANGDONG;;BURN TIMOTHY C;;HUBER REID;;LIU PHILLIP C C;;HOLLIS GREGORY F;;VADDI KRISHNA;;FRIDMAN JORDAN S,INCYTE CORPORATION (2015-01-07);;INCYTE HOLDINGS CORPORATION (2015-01-07),https://lens.org/199-914-197-907-851,Patent Application,yes,10,29,10,10,48,A61K31/19;;A61K31/19;;A61K31/395;;A61K31/395;;A61P35/00;;A61P35/04,A61K/;;A61K31/19;;A61K39/395,424/155.1;;514/575,0,0,,,,ACTIVE
294,US,A1,US 2010/0099967 A1,006-280-633-771-591,2010-04-22,2010,US 64397409 A,2009-12-21,US 64397409 A;;US 42005703 A;;US 66719900 A;;US 7067798 A,1998-04-30,Analyte Monitoring Device and Methods of Use,"An analyte monitor includes a sensor, a sensor control unit, and a display unit. The sensor has, for example, a substrate, a recessed channel formed in the substrate, and conductive material disposed in the recessed channel to form a working electrode. The sensor control unit typically has a housing adapted for placement on skin and is adapted to receive a portion of an electrochemical sensor. The sensor control unit also includes two or more conductive contacts disposed on the housing and configured for coupling to two or more contact pads on the sensor. A transmitter is disposed in the housing and coupled to the plurality of conductive contacts for transmitting data obtained using the sensor. The display unit has a receiver for receiving data transmitted by the transmitter of the sensor control unit and a display coupled to the receiver for displaying an indication of a level of an analyte. The analyte monitor may also be part of a drug delivery system to alter the level of the analyte based on the data obtained using the sensor.",ABBOTT DIABETES CARE INC,SAY JAMES;;TOMASCO MICHAEL F;;HELLER ADAM;;GAL YORAM;;ARIA BEHRAD;;HELLER EPHRAIM;;PLANTE PHILLIP JOHN;;VREEKE MARK S;;FRIEDMAN KEITH A;;COLMAN FREDRIC C,,https://lens.org/006-280-633-771-591,Patent Application,yes,20,49,211,221,0,A61B5/14532;;A61B5/14532;;A61B5/0002;;A61B5/0002;;A61B5/002;;A61B5/01;;A61B5/14503;;A61B5/1451;;A61B5/14546;;A61B5/14546;;A61B5/1473;;A61B5/1473;;A61B5/1486;;A61B5/1486;;A61B5/14865;;A61B5/1495;;A61B5/4839;;A61B5/72;;A61B5/7278;;A61B5/7282;;A61B5/7405;;A61B5/743;;A61B5/7445;;A61B5/7445;;A61B5/7455;;A61B2560/0252;;A61B2560/0252;;A61M5/1723;;C12Q1/54;;G16H10/40;;G16H10/40;;G16H20/17;;G16H20/17;;H01L23/3107;;H01L23/3107;;H01L23/49548;;H01L23/49548;;H01L2924/0002;;H01L2924/0002;;H01L2924/19041;;H01L2924/19041;;H01L2924/3011;;H01L2924/3011;;Y10S128/903;;Y10S128/903;;Y10T29/49;;Y10T29/49;;Y10T29/49124;;Y10T29/49124,A61B5/1468;;G01N27/30;;A61B5/00;;A61B5/145;;A61B5/1477;;A61B5/1495;;G01N27/416;;G06F19/00;;H01L23/31;;H01L23/495,600/345,0,0,,,,EXPIRED
295,US,A1,US 2009/0069655 A1,011-771-310-582-873,2009-03-12,2009,US 20574008 A,2008-09-05,US 20574008 A;;US 42005703 A;;US 66719900 A;;US 7067798 A,1998-04-30,Analyte Monitoring Device and Methods of Use,"An analyte monitor includes a sensor, a sensor control unit, and a display unit. The sensor has, for example, a substrate, a recessed channel formed in the substrate, and conductive material disposed in the recessed channel to form a working electrode. The sensor control unit typically has a housing adapted for placement on skin and is adapted to receive a portion of an electrochemical sensor. The sensor control unit also includes two or more conductive contacts disposed on the housing and configured for coupling to two or more contact pads on the sensor. A transmitter is disposed in the housing and coupled to the plurality of conductive contacts for transmitting data obtained using the sensor. The display unit has a receiver for receiving data transmitted by the transmitter of the sensor control unit and a display coupled to the receiver for displaying an indication of a level of an analyte. The analyte monitor may also be part of a drug delivery system to alter the level of the analyte based on the data obtained using the sensor.",ABBOTT DIABETES CARE INC,SAY JAMES;;TOMASCO MICHAEL F;;HELLER ADAM;;GAL YORAM;;ARIA BEHRAD;;HELLER EPHRAIM;;PLANTE PHILLIP JOHN;;VREEKE MARK S;;FRIEDMAN KEITH A;;COLMAN FREDRIC C,,https://lens.org/011-771-310-582-873,Patent Application,yes,1,73,211,221,0,A61B5/14532;;A61B5/14532;;A61B5/0002;;A61B5/0002;;A61B5/002;;A61B5/01;;A61B5/14503;;A61B5/1451;;A61B5/14546;;A61B5/14546;;A61B5/1473;;A61B5/1473;;A61B5/1486;;A61B5/1486;;A61B5/14865;;A61B5/1495;;A61B5/4839;;A61B5/72;;A61B5/7278;;A61B5/7282;;A61B5/7405;;A61B5/743;;A61B5/7445;;A61B5/7445;;A61B5/7455;;A61B2560/0252;;A61B2560/0252;;A61M5/1723;;C12Q1/54;;G16H10/40;;G16H10/40;;G16H20/17;;G16H20/17;;H01L23/3107;;H01L23/3107;;H01L23/49548;;H01L23/49548;;H01L2924/0002;;H01L2924/0002;;H01L2924/19041;;H01L2924/19041;;H01L2924/3011;;H01L2924/3011;;Y10S128/903;;Y10S128/903;;Y10T29/49;;Y10T29/49;;Y10T29/49124;;Y10T29/49124,A61B5/1477;;G01N27/30;;A61B5/00;;A61B5/145;;A61B5/1495;;G01N27/416;;G06F19/00;;H01L23/31;;H01L23/495,600/347,0,0,,,,DISCONTINUED
296,US,A1,US 2009/0228214 A1,015-658-129-092-061,2009-09-10,2009,US 46878709 A,2009-05-19,US 46878709 A;;US 69560807 A;;US 42005703 A;;US 66719900 A;;US 7067798 A,1998-04-30,Analyte Monitoring Device and Methods of Use,"An analyte monitor includes a sensor, a sensor control unit, and a display unit. The sensor has, for example, a substrate, a recessed channel formed in the substrate, and conductive material disposed in the recessed channel to form a working electrode. The sensor control unit typically has a housing adapted for placement on skin and is adapted to receive a portion of an electrochemical sensor. The sensor control unit also includes two or more conductive contacts disposed on the housing and configured for coupling to two or more contact pads on the sensor. A transmitter is disposed in the housing and coupled to the plurality of conductive contacts for transmitting data obtained using the sensor. The display unit has a receiver for receiving data transmitted by the transmitter of the sensor control unit and a display coupled to the receiver for displaying an indication of a level of an analyte. The analyte monitor may also be part of a drug delivery system to alter the level of the analyte based on the data obtained using the sensor.",ABBOTT DIABETES CARE INC,SAY JAMES;;TOMASCO MICHAEL F;;HELLER ADAM;;GAL YORAM;;ARIA BEHRAD;;HELLER EPHRAIM;;PLANTE PHILLIP JOHN;;VREEKE MARK S;;FRIEDMAN KEITH A;;COLMAN FREDRIC C,,https://lens.org/015-658-129-092-061,Patent Application,yes,0,74,211,221,0,A61B5/14532;;A61B5/14532;;A61B5/0002;;A61B5/0002;;A61B5/002;;A61B5/01;;A61B5/14503;;A61B5/1451;;A61B5/14546;;A61B5/14546;;A61B5/1473;;A61B5/1473;;A61B5/1486;;A61B5/1486;;A61B5/14865;;A61B5/1495;;A61B5/4839;;A61B5/72;;A61B5/7278;;A61B5/7282;;A61B5/7405;;A61B5/743;;A61B5/7445;;A61B5/7445;;A61B5/7455;;A61B2560/0252;;A61B2560/0252;;A61M5/1723;;C12Q1/54;;G16H10/40;;G16H10/40;;G16H20/17;;G16H20/17;;H01L23/3107;;H01L23/3107;;H01L23/49548;;H01L23/49548;;H01L2924/0002;;H01L2924/0002;;H01L2924/19041;;H01L2924/19041;;H01L2924/3011;;H01L2924/3011;;Y10S128/903;;Y10S128/903;;Y10T29/49;;Y10T29/49;;Y10T29/49124;;Y10T29/49124,A61B5/1468;;G01N27/30;;A61B5/00;;A61B5/145;;A61B5/1477;;A61B5/1495;;G01N27/416;;G06F19/00;;H01L23/31;;H01L23/495,702/19;;600/347,0,0,,,,DISCONTINUED
297,US,A1,US 2010/0056891 A1,023-270-162-204-271,2010-03-04,2010,US 61512809 A,2009-11-09,US 61512809 A;;US 42005703 A;;US 66719900 A;;US 7067798 A,1998-04-30,Analyte Monitoring Device And Methods Of Use,"An analyte monitor includes a sensor, a sensor control unit, and a display unit. The sensor has, for example, a substrate, a recessed channel formed in the substrate, and conductive material disposed in the recessed channel to form a working electrode. The sensor control unit typically has a housing adapted for placement on skin and is adapted to receive a portion of an electrochemical sensor. The sensor control unit also includes two or more conductive contacts disposed on the housing and configured for coupling to two or more contact pads on the sensor. A transmitter is disposed in the housing and coupled to the plurality of conductive contacts for transmitting data obtained using the sensor. The display unit has a receiver for receiving data transmitted by the transmitter of the sensor control unit and a display coupled to the receiver for displaying an indication of a level of an analyte. The analyte monitor may also be part of a drug delivery system to alter the level of the analyte based on the data obtained using the sensor.",SAY JAMES;;TOMASCO MICHAEL F;;HELLER ADAM;;GAL YORAM;;ARIA BEHRAD;;HELLER EPHRAIM;;PLANTE PHILLIP JOHN;;VREEKE MARK S;;FRIEDMAN KEITH A;;COLMAN FREDRIC C,SAY JAMES;;TOMASCO MICHAEL F;;HELLER ADAM;;GAL YORAM;;ARIA BEHRAD;;HELLER EPHRAIM;;PLANTE PHILLIP JOHN;;VREEKE MARK S;;FRIEDMAN KEITH A;;COLMAN FREDRIC C,E. HELLER & CO (1998-07-02);;ABBOTT DIABETES CARE INC (2000-03-13),https://lens.org/023-270-162-204-271,Patent Application,yes,42,49,211,221,0,A61B5/14532;;A61B5/14532;;A61B5/0002;;A61B5/0002;;A61B5/002;;A61B5/01;;A61B5/14503;;A61B5/1451;;A61B5/14546;;A61B5/14546;;A61B5/1473;;A61B5/1473;;A61B5/1486;;A61B5/1486;;A61B5/14865;;A61B5/1495;;A61B5/4839;;A61B5/72;;A61B5/7278;;A61B5/7282;;A61B5/7405;;A61B5/743;;A61B5/7445;;A61B5/7445;;A61B5/7455;;A61B2560/0252;;A61B2560/0252;;A61M5/1723;;C12Q1/54;;G16H10/40;;G16H10/40;;G16H20/17;;G16H20/17;;H01L23/3107;;H01L23/3107;;H01L23/49548;;H01L23/49548;;H01L2924/0002;;H01L2924/0002;;H01L2924/19041;;H01L2924/19041;;H01L2924/3011;;H01L2924/3011;;Y10S128/903;;Y10S128/903;;Y10T29/49;;Y10T29/49;;Y10T29/49124;;Y10T29/49124,A61B5/05;;G01N27/30;;A61B5/00;;A61B5/145;;A61B5/1477;;A61B5/1495;;G01N27/416;;G06F19/00;;H01L23/31;;H01L23/495,600/345,0,0,,,,EXPIRED
298,US,A1,US 2007/0244380 A1,029-055-833-497-463,2007-10-18,2007,US 76668607 A,2007-06-21,US 76668607 A;;US 42005703 A;;US 66719900 A;;US 7067798 A,1998-04-30,ANALYTE MONITORING DEVICE AND METHODS OF USE,"An analyte monitor includes a sensor, a sensor control unit, and a display unit. The sensor has, for example, a substrate, a recessed channel formed in the substrate, and conductive material disposed in the recessed channel to form a working electrode. The sensor control unit typically has a housing adapted for placement on skin and is adapted to receive a portion of an electrochemical sensor. The sensor control unit also includes two or more conductive contacts disposed on the housing and configured for coupling to two or more contact pads on the sensor. A transmitter is disposed in the housing and coupled to the plurality of conductive contacts for transmitting data obtained using the sensor. The display unit has a receiver for receiving data transmitted by the transmitter of the sensor control unit and a display coupled to the receiver for displaying an indication of a level of an analyte. The analyte monitor may also be part of a drug delivery system to alter the level of the analyte based on the data obtained using the sensor.",ABBOTT DIABETES CARE INC,SAY JAMES;;TOMASCO MICHAEL F;;HELLER ADAM;;GAL YORAM;;ARIA BEHRAD;;HELLER EPHRAIM;;PLANTE PHILLIP J;;VREEKE MARK S;;FRIEDMAN KEITH A;;COLMAN FREDRIC C,E. HELLER & CO (1998-07-02);;ABBOTT DIABETES CARE INC (2000-03-13),https://lens.org/029-055-833-497-463,Patent Application,yes,99,50,211,221,0,A61B5/14532;;A61B5/14532;;A61B5/0002;;A61B5/0002;;A61B5/002;;A61B5/01;;A61B5/14503;;A61B5/1451;;A61B5/14546;;A61B5/14546;;A61B5/1473;;A61B5/1473;;A61B5/1486;;A61B5/1486;;A61B5/14865;;A61B5/1495;;A61B5/4839;;A61B5/72;;A61B5/7278;;A61B5/7282;;A61B5/7405;;A61B5/743;;A61B5/7445;;A61B5/7445;;A61B5/7455;;A61B2560/0252;;A61B2560/0252;;A61M5/1723;;C12Q1/54;;G16H10/40;;G16H10/40;;G16H20/17;;G16H20/17;;H01L23/3107;;H01L23/3107;;H01L23/49548;;H01L23/49548;;H01L2924/0002;;H01L2924/0002;;H01L2924/19041;;H01L2924/19041;;H01L2924/3011;;H01L2924/3011;;Y10S128/903;;Y10S128/903;;Y10T29/49;;Y10T29/49;;Y10T29/49124;;Y10T29/49124,A61B5/00;;G01N27/30;;A61B5/145;;A61B5/1477;;A61B5/1495;;G01N27/416;;G06F19/00;;H01L23/31;;H01L23/495,600/347,0,0,,,,EXPIRED
299,US,A1,US 2010/0312078 A1,033-588-705-641-682,2010-12-09,2010,US 85905410 A,2010-08-18,US 85905410 A;;US 39388309 A;;US 42005703 A;;US 66719900 A;;US 7067798 A,1998-04-30,Analyte Monitoring Device and Methods of Use,"An analyte monitor includes a sensor, a sensor control unit, and a display unit. The sensor has, for example, a substrate, a recessed channel formed in the substrate, and conductive material disposed in the recessed channel to form a working electrode. The sensor control unit typically has a housing adapted for placement on skin and is adapted to receive a portion of an electrochemical sensor. The sensor control unit also includes two or more conductive contacts disposed on the housing and configured for coupling to two or more contact pads on the sensor. A transmitter is disposed in the housing and coupled to the plurality of conductive contacts for transmitting data obtained using the sensor. The display unit has a receiver for receiving data transmitted by the transmitter of the sensor control unit and a display coupled to the receiver for displaying an indication of a level of an analyte. The analyte monitor may also be part of a drug delivery system to alter the level of the analyte based on the data obtained using the sensor.",ABBOTT DIABETES CARE INC,SAY JAMES;;TOMASCO MICHAEL F;;HELLER ADAM;;GAL YORAM;;ARIA BEHRAD;;HELLER EPHRAIM;;PLANTE PHILLIP JOHN;;VREEKE MARK S;;FRIEDMAN KEITH A;;COLMAN FREDRIC C,E. HELLER & CO (1998-07-02);;ABBOTT DIABETES CARE INC (2000-03-13),https://lens.org/033-588-705-641-682,Patent Application,yes,67,3,211,221,0,A61B5/14532;;A61B5/14532;;A61B5/0002;;A61B5/0002;;A61B5/002;;A61B5/01;;A61B5/14503;;A61B5/1451;;A61B5/14546;;A61B5/14546;;A61B5/1473;;A61B5/1473;;A61B5/1486;;A61B5/1486;;A61B5/14865;;A61B5/1495;;A61B5/4839;;A61B5/72;;A61B5/7278;;A61B5/7282;;A61B5/7405;;A61B5/743;;A61B5/7445;;A61B5/7445;;A61B5/7455;;A61B2560/0252;;A61B2560/0252;;A61M5/1723;;C12Q1/54;;G16H10/40;;G16H10/40;;G16H20/17;;G16H20/17;;H01L23/3107;;H01L23/3107;;H01L23/49548;;H01L23/49548;;H01L2924/0002;;H01L2924/0002;;H01L2924/19041;;H01L2924/19041;;H01L2924/3011;;H01L2924/3011;;Y10S128/903;;Y10S128/903;;Y10T29/49;;Y10T29/49;;Y10T29/49124;;Y10T29/49124,A61B5/00;;G01N27/30;;A61B5/145;;A61B5/1477;;A61B5/1495;;G01N27/416;;G06F19/00;;G06F21/00;;H01L23/31;;H01L23/495,600/309;;726/5,0,0,,,,DISCONTINUED
300,EP,A1,EP 1075209 A1,043-951-932-271-817,2001-02-14,2001,EP 99903239 A,1999-01-21,US 9901229 W;;US 7067798 A,1998-04-30,ANALYTE MONITORING DEVICE,,THERASENSE INC,SAY JAMES;;TOMASCO MICHAEL F;;HELLER ADAM;;GAL YORAM;;ARIA BEHRAD;;HELLER EPHRAIM;;PLANTE PHILLIP J;;VREEKE MARK S;;FRIEDMAN KEITH A;;COLMAN FREDRIC C,ABBOTT DIABETES CARE INC. (2008-06-04),https://lens.org/043-951-932-271-817,Patent Application,yes,0,10,211,221,0,A61B5/14532;;A61B5/14532;;A61B5/0002;;A61B5/0002;;A61B5/002;;A61B5/01;;A61B5/14503;;A61B5/1451;;A61B5/14546;;A61B5/14546;;A61B5/1473;;A61B5/1473;;A61B5/1486;;A61B5/1486;;A61B5/14865;;A61B5/1495;;A61B5/4839;;A61B5/72;;A61B5/7278;;A61B5/7282;;A61B5/7405;;A61B5/743;;A61B5/7445;;A61B5/7445;;A61B5/7455;;A61B2560/0252;;A61B2560/0252;;A61M5/1723;;C12Q1/54;;G16H10/40;;G16H10/40;;G16H20/17;;G16H20/17;;H01L23/3107;;H01L23/3107;;H01L23/49548;;H01L23/49548;;H01L2924/0002;;H01L2924/0002;;H01L2924/19041;;H01L2924/19041;;H01L2924/3011;;H01L2924/3011;;Y10S128/903;;Y10S128/903;;Y10T29/49;;Y10T29/49;;Y10T29/49124;;Y10T29/49124,G01N27/30;;A61B5/00;;A61B5/145;;A61B5/1477;;A61B5/1495;;G01N27/416;;G06F19/00;;H01L23/31;;H01L23/495,,1,0,,,See references of WO 9956613A1,EXPIRED
301,US,A1,US 2008/0033271 A1,051-908-190-292-710,2008-02-07,2008,US 76674707 A,2007-06-21,US 76674707 A;;US 42005703 A;;US 66719900 A;;US 7067798 A,1998-04-30,ANALYTE MONITORING DEVICE AND METHODS OF USE,"An analyte monitor includes a sensor, a sensor control unit, and a display unit. The sensor has, for example, a substrate, a recessed channel formed in the substrate, and conductive material disposed in the recessed channel to form a working electrode. The sensor control unit typically has a housing adapted for placement on skin and is adapted to receive a portion of an electrochemical sensor. The sensor control unit also includes two or more conductive contacts disposed on the housing and configured for coupling to two or more contact pads on the sensor. A transmitter is disposed in the housing and coupled to the plurality of conductive contacts for transmitting data obtained using the sensor. The display unit has a receiver for receiving data transmitted by the transmitter of the sensor control unit and a display coupled to the receiver for displaying an indication of a level of an analyte. The analyte monitor may also be part of a drug delivery system to alter the level of the analyte based on the data obtained using the sensor.",ABBOTT DIABETES CARE INC,SAY JAMES;;TOMASCO MICHAEL F;;HELLER ADAM;;GAL YORAM;;ARIA BEHRAD;;HELLER EPHRAIM;;PLANTE PHILLIP J;;VREEKE MARK S;;FRIEDMAN KEITH A;;COLMAN FREDRIC C,ABBOTT DIABETES CARE INC (2005-07-29),https://lens.org/051-908-190-292-710,Patent Application,yes,98,33,211,221,0,A61B5/14532;;A61B5/14532;;A61B5/0002;;A61B5/0002;;A61B5/002;;A61B5/01;;A61B5/14503;;A61B5/1451;;A61B5/14546;;A61B5/14546;;A61B5/1473;;A61B5/1473;;A61B5/1486;;A61B5/1486;;A61B5/14865;;A61B5/1495;;A61B5/4839;;A61B5/72;;A61B5/7278;;A61B5/7282;;A61B5/7405;;A61B5/743;;A61B5/7445;;A61B5/7445;;A61B5/7455;;A61B2560/0252;;A61B2560/0252;;A61M5/1723;;C12Q1/54;;G16H10/40;;G16H10/40;;G16H20/17;;G16H20/17;;H01L23/3107;;H01L23/3107;;H01L23/49548;;H01L23/49548;;H01L2924/0002;;H01L2924/0002;;H01L2924/19041;;H01L2924/19041;;H01L2924/3011;;H01L2924/3011;;Y10S128/903;;Y10S128/903;;Y10T29/49;;Y10T29/49;;Y10T29/49124;;Y10T29/49124,A61B5/1468;;G01N27/30;;A61B5/00;;A61B5/145;;A61B5/1477;;A61B5/1495;;G01N27/416;;G06F19/00;;H01L23/31;;H01L23/495,600/347,0,0,,,,DISCONTINUED
302,US,A1,US 2005/0199494 A1,054-593-339-597-164,2005-09-15,2005,US 2742304 A,2004-12-29,US 2742304 A;;US 42005703 A;;US 66719900 A;;US 7067798 A,1998-04-30,Analyte monitoring device and methods of use,"An analyte monitor includes a sensor, a sensor control unit, and a display unit. The sensor has, for example, a substrate, a recessed channel formed in the substrate, and conductive material disposed in the recessed channel to form a working electrode. The sensor control unit typically has a housing adapted for placement on skin and is adapted to receive a portion of an electrochemical sensor. The sensor control unit also includes two or more conductive contacts disposed on the housing and configured for coupling to two or more contact pads on the sensor. A transmitter is disposed in the housing and coupled to the plurality of conductive contacts for transmitting data obtained using the sensor. The display unit has a receiver for receiving data transmitted by the transmitter of the sensor control unit and a display coupled to the receiver for displaying an indication of a level of an analyte. The analyte monitor may also be part of a drug delivery system to alter the level of the analyte based on the data obtained using the sensor.",SAY JAMES;;TOMASCO MICHAEL F.;;HELLER ADAM;;GAL YORAM;;ARIA BEHRAD;;HELLER EPHRAIM;;PLANTE PHILLIP J.;;VREEKE MARK S.;;FRIEDMAN KEITH A.;;COLMAN FREDRIC C.,SAY JAMES;;TOMASCO MICHAEL F;;HELLER ADAM;;GAL YORAM;;ARIA BEHRAD;;HELLER EPHRAIM;;PLANTE PHILLIP JOHN;;VREEKE MARK S;;FRIEDMAN KEITH A;;COLMAN FREDRIC C,ABBOTT DIABETES CARE INC (2000-03-13);;E. HELLER & COMPANY (1998-07-02),https://lens.org/054-593-339-597-164,Patent Application,yes,100,338,211,221,0,A61B5/14532;;A61B5/14532;;A61B5/0002;;A61B5/0002;;A61B5/002;;A61B5/01;;A61B5/14503;;A61B5/1451;;A61B5/14546;;A61B5/14546;;A61B5/1473;;A61B5/1473;;A61B5/1486;;A61B5/1486;;A61B5/14865;;A61B5/1495;;A61B5/4839;;A61B5/72;;A61B5/7278;;A61B5/7282;;A61B5/7405;;A61B5/743;;A61B5/7445;;A61B5/7445;;A61B5/7455;;A61B2560/0252;;A61B2560/0252;;A61M5/1723;;C12Q1/54;;G16H10/40;;G16H10/40;;G16H20/17;;G16H20/17;;H01L23/3107;;H01L23/3107;;H01L23/49548;;H01L23/49548;;H01L2924/0002;;H01L2924/0002;;H01L2924/19041;;H01L2924/19041;;H01L2924/3011;;H01L2924/3011;;Y10S128/903;;Y10S128/903;;Y10T29/49;;Y10T29/49;;Y10T29/49124;;Y10T29/49124,G01N27/30;;A61B5/00;;A61B5/145;;A61B5/1477;;A61B5/1495;;G01N27/416;;G06F19/00;;H01L23/31;;H01L23/495,204/403.01,0,0,,,,EXPIRED
303,US,A1,US 2009/0177058 A1,071-691-384-733-300,2009-07-09,2009,US 40569009 A,2009-03-17,US 40569009 A;;US 42005703 A;;US 66719900 A;;US 7067798 A,1998-04-30,Analyte Monitoring Device and Methods of Use,"An analyte monitor includes a sensor, a sensor control unit, and a display unit. The sensor has, for example, a substrate, a recessed channel formed in the substrate, and conductive material disposed in the recessed channel to form a working electrode. The sensor control unit typically has a housing adapted for placement on skin and is adapted to receive a portion of an electrochemical sensor. The sensor control unit also includes two or more conductive contacts disposed on the housing and configured for coupling to two or more contact pads on the sensor. A transmitter is disposed in the housing and coupled to the plurality of conductive contacts for transmitting data obtained using the sensor. The display unit has a receiver for receiving data transmitted by the transmitter of the sensor control unit and a display coupled to the receiver for displaying an indication of a level of an analyte. The analyte monitor may also be part of a drug delivery system to alter the level of the analyte based on the data obtained using the sensor.",ABBOTT DIABETES CARE INC,SAY JAMES;;TOMASCO MICHAEL F;;HELLER ADAM;;GAL YORAM;;ARIA BEHRAD;;HELLER EPHRAIM;;PLANTE PHILLIP JOHN;;VREEKE MARK S;;FRIEDMAN KEITH A;;COLMAN FREDRIC C,,https://lens.org/071-691-384-733-300,Patent Application,yes,7,60,211,221,0,A61B5/14532;;A61B5/14532;;A61B5/0002;;A61B5/0002;;A61B5/002;;A61B5/01;;A61B5/14503;;A61B5/1451;;A61B5/14546;;A61B5/14546;;A61B5/1473;;A61B5/1473;;A61B5/1486;;A61B5/1486;;A61B5/14865;;A61B5/1495;;A61B5/4839;;A61B5/72;;A61B5/7278;;A61B5/7282;;A61B5/7405;;A61B5/743;;A61B5/7445;;A61B5/7445;;A61B5/7455;;A61B2560/0252;;A61B2560/0252;;A61M5/1723;;C12Q1/54;;G16H10/40;;G16H10/40;;G16H20/17;;G16H20/17;;H01L23/3107;;H01L23/3107;;H01L23/49548;;H01L23/49548;;H01L2924/0002;;H01L2924/0002;;H01L2924/19041;;H01L2924/19041;;H01L2924/3011;;H01L2924/3011;;Y10S128/903;;Y10S128/903;;Y10T29/49;;Y10T29/49;;Y10T29/49124;;Y10T29/49124,A61B5/1468;;G01N27/30;;A61B5/00;;A61B5/145;;A61B5/1477;;A61B5/1495;;G01N27/416;;G06F19/00;;H01L23/31;;H01L23/495,600/345,0,0,,,,DISCONTINUED
304,US,A1,US 2010/0268047 A1,087-434-712-691-28X,2010-10-21,2010,US 82567210 A,2010-06-29,US 82567210 A;;US 39388309 A;;US 42005703 A;;US 66719900 A;;US 7067798 A,1998-04-30,Analyte Monitoring Device and Methods of Use,"An analyte monitor includes a sensor, a sensor control unit, and a display unit. The sensor has, for example, a substrate, a recessed channel formed in the substrate, and conductive material disposed in the recessed channel to form a working electrode. The sensor control unit typically has a housing adapted for placement on skin and is adapted to receive a portion of an electrochemical sensor. The sensor control unit also includes two or more conductive contacts disposed on the housing and configured for coupling to two or more contact pads on the sensor. A transmitter is disposed in the housing and coupled to the plurality of conductive contacts for transmitting data obtained using the sensor. The display unit has a receiver for receiving data transmitted by the transmitter of the sensor control unit and a display coupled to the receiver for displaying an indication of a level of an analyte. The analyte monitor may also be part of a drug delivery system to alter the level of the analyte based on the data obtained using the sensor.",ABBOTT DIABETES CARE INC,SAY JAMES;;TOMASCO MICHAEL F;;HELLER ADAM;;GAL YORAM;;ARIA BEHRAD;;HELLER EPHRAIM;;PLANTE PHILLIP JOHN;;VREEKE MARK S;;FRIEDMAN KEITH A;;COLMAN FREDRIC C,E. HELLER & CO (1998-07-02);;ABBOTT DIABETES CARE INC (2000-03-13),https://lens.org/087-434-712-691-28X,Patent Application,yes,99,0,211,221,0,A61B5/14532;;A61B5/14532;;A61B5/0002;;A61B5/0002;;A61B5/002;;A61B5/01;;A61B5/14503;;A61B5/1451;;A61B5/14546;;A61B5/14546;;A61B5/1473;;A61B5/1473;;A61B5/1486;;A61B5/1486;;A61B5/14865;;A61B5/1495;;A61B5/4839;;A61B5/72;;A61B5/7278;;A61B5/7282;;A61B5/7405;;A61B5/743;;A61B5/7445;;A61B5/7445;;A61B5/7455;;A61B2560/0252;;A61B2560/0252;;A61M5/1723;;C12Q1/54;;G16H10/40;;G16H10/40;;G16H20/17;;G16H20/17;;H01L23/3107;;H01L23/3107;;H01L23/49548;;H01L23/49548;;H01L2924/0002;;H01L2924/0002;;H01L2924/19041;;H01L2924/19041;;H01L2924/3011;;H01L2924/3011;;Y10S128/903;;Y10S128/903;;Y10T29/49;;Y10T29/49;;Y10T29/49124;;Y10T29/49124,A61B5/1468;;G01N27/30;;A61B5/00;;A61B5/145;;A61B5/1477;;A61B5/1495;;G01N27/416;;G06F19/00;;H01L23/31;;H01L23/495,600/345,0,0,,,,DISCONTINUED
305,US,A1,US 2009/0187093 A1,129-901-314-542-731,2009-07-23,2009,US 41455809 A,2009-03-30,US 41455809 A;;US 42005703 A;;US 66719900 A;;US 7067798 A,1998-04-30,Analyte Monitoring Device and Methods of Use,"An analyte monitor includes a sensor, a sensor control unit, and a display unit. The sensor has, for example, a substrate, a recessed channel formed in the substrate, and conductive material disposed in the recessed channel to form a working electrode. The sensor control unit typically has a housing adapted for placement on skin and is adapted to receive a portion of an electrochemical sensor. The sensor control unit also includes two or more conductive contacts disposed on the housing and configured for coupling to two or more contact pads on the sensor. A transmitter is disposed in the housing and coupled to the plurality of conductive contacts for transmitting data obtained using the sensor. The display unit has a receiver for receiving data transmitted by the transmitter of the sensor control unit and a display coupled to the receiver for displaying an indication of a level of an analyte. The analyte monitor may also be part of a drug delivery system to alter the level of the analyte based on the data obtained using the sensor.",ABBOTT DIABETES CARE INC,SAY JAMES;;TOMASCO MICHAEL F;;HELLER ADAM;;GAL YORAM;;ARIA BEHRAD;;HELLER EPHRAIM;;PLANTE PHILLIP JOHN;;VREEKE MARK S;;FRIEDMAN KEITH A;;COLMAN FREDRIC C,,https://lens.org/129-901-314-542-731,Patent Application,yes,8,57,211,221,0,A61B5/14532;;A61B5/14532;;A61B5/0002;;A61B5/0002;;A61B5/002;;A61B5/01;;A61B5/14503;;A61B5/1451;;A61B5/14546;;A61B5/14546;;A61B5/1473;;A61B5/1473;;A61B5/1486;;A61B5/1486;;A61B5/14865;;A61B5/1495;;A61B5/4839;;A61B5/72;;A61B5/7278;;A61B5/7282;;A61B5/7405;;A61B5/743;;A61B5/7445;;A61B5/7445;;A61B5/7455;;A61B2560/0252;;A61B2560/0252;;A61M5/1723;;C12Q1/54;;G16H10/40;;G16H10/40;;G16H20/17;;G16H20/17;;H01L23/3107;;H01L23/3107;;H01L23/49548;;H01L23/49548;;H01L2924/0002;;H01L2924/0002;;H01L2924/19041;;H01L2924/19041;;H01L2924/3011;;H01L2924/3011;;Y10S128/903;;Y10S128/903;;Y10T29/49;;Y10T29/49;;Y10T29/49124;;Y10T29/49124,A61B5/1468;;G01N27/30;;A61B5/00;;A61B5/145;;A61B5/1477;;A61B5/1495;;G01N27/416;;G06F19/00;;H01L23/31;;H01L23/495,600/345,0,0,,,,DISCONTINUED
306,US,A1,US 2009/0182212 A1,149-997-671-468-853,2009-07-16,2009,US 40551509 A,2009-03-17,US 40551509 A;;US 42005703 A;;US 66719900 A;;US 7067798 A,1998-04-30,Analyte Monitoring Device and Methods of Use,"An analyte monitor includes a sensor, a sensor control unit, and a display unit. The sensor has, for example, a substrate, a recessed channel formed in the substrate, and conductive material disposed in the recessed channel to form a working electrode. The sensor control unit typically has a housing adapted for placement on skin and is adapted to receive a portion of an electrochemical sensor. The sensor control unit also includes two or more conductive contacts disposed on the housing and configured for coupling to two or more contact pads on the sensor. A transmitter is disposed in the housing and coupled to the plurality of conductive contacts for transmitting data obtained using the sensor. The display unit has a receiver for receiving data transmitted by the transmitter of the sensor control unit and a display coupled to the receiver for displaying an indication of a level of an analyte. The analyte monitor may also be part of a drug delivery system to alter the level of the analyte based on the data obtained using the sensor.",ABBOTT DIABETES CARE INC,SAY JAMES;;TOMASCO MICHAEL F;;HELLER ADAM;;GAL YORAM;;ARIA BEHRAD;;HELLER EPHRAIM;;PLANTE PHILLIP JOHN;;VREEKE MARK S;;FRIEDMAN KEITH A;;COLMAN FREDRIC C,E. HELLER & CO (1998-07-02);;ABBOTT DIABETES CARE INC (2000-03-13),https://lens.org/149-997-671-468-853,Patent Application,yes,75,56,211,221,0,A61B5/14532;;A61B5/14532;;A61B5/0002;;A61B5/0002;;A61B5/002;;A61B5/01;;A61B5/14503;;A61B5/1451;;A61B5/14546;;A61B5/14546;;A61B5/1473;;A61B5/1473;;A61B5/1486;;A61B5/1486;;A61B5/14865;;A61B5/1495;;A61B5/4839;;A61B5/72;;A61B5/7278;;A61B5/7282;;A61B5/7405;;A61B5/743;;A61B5/7445;;A61B5/7445;;A61B5/7455;;A61B2560/0252;;A61B2560/0252;;A61M5/1723;;C12Q1/54;;G16H10/40;;G16H10/40;;G16H20/17;;G16H20/17;;H01L23/3107;;H01L23/3107;;H01L23/49548;;H01L23/49548;;H01L2924/0002;;H01L2924/0002;;H01L2924/19041;;H01L2924/19041;;H01L2924/3011;;H01L2924/3011;;Y10S128/903;;Y10S128/903;;Y10T29/49;;Y10T29/49;;Y10T29/49124;;Y10T29/49124,A61B5/1468;;G01N27/30;;A61B5/00;;A61B5/145;;A61B5/1477;;A61B5/1495;;G01N27/416;;G06F19/00;;H01L23/31;;H01L23/495,600/345,0,0,,,,EXPIRED
307,US,A1,US 2009/0187089 A1,153-239-778-549-276,2009-07-23,2009,US 41444209 A,2009-03-30,US 41444209 A;;US 42005703 A;;US 66719900 A;;US 7067798 A,1998-04-30,Analyte Monitoring Device and Methods of Use,"An analyte monitor includes a sensor, a sensor control unit, and a display unit. The sensor has, for example, a substrate, a recessed channel formed in the substrate, and conductive material disposed in the recessed channel to form a working electrode. The sensor control unit typically has a housing adapted for placement on skin and is adapted to receive a portion of an electrochemical sensor. The sensor control unit also includes two or more conductive contacts disposed on the housing and configured for coupling to two or more contact pads on the sensor. A transmitter is disposed in the housing and coupled to the plurality of conductive contacts for transmitting data obtained using the sensor. The display unit has a receiver for receiving data transmitted by the transmitter of the sensor control unit and a display coupled to the receiver for displaying an indication of a level of an analyte. The analyte monitor may also be part of a drug delivery system to alter the level of the analyte based on the data obtained using the sensor.",ABBOTT DIABETES CARE INC,SAY JAMES;;TOMASCO MICHAEL F;;HELLER ADAM;;GAL YORAM;;ARIA BEHRAD;;HELLER EPHRAIM;;PLANTE PHILLIP JOHN;;VREEKE MARK S;;FRIEDMAN KEITH A;;COLMAN FREDRIC C,,https://lens.org/153-239-778-549-276,Patent Application,yes,1,103,211,221,0,A61B5/14532;;A61B5/14532;;A61B5/0002;;A61B5/0002;;A61B5/002;;A61B5/01;;A61B5/14503;;A61B5/1451;;A61B5/14546;;A61B5/14546;;A61B5/1473;;A61B5/1473;;A61B5/1486;;A61B5/1486;;A61B5/14865;;A61B5/1495;;A61B5/4839;;A61B5/72;;A61B5/7278;;A61B5/7282;;A61B5/7405;;A61B5/743;;A61B5/7445;;A61B5/7445;;A61B5/7455;;A61B2560/0252;;A61B2560/0252;;A61M5/1723;;C12Q1/54;;G16H10/40;;G16H10/40;;G16H20/17;;G16H20/17;;H01L23/3107;;H01L23/3107;;H01L23/49548;;H01L23/49548;;H01L2924/0002;;H01L2924/0002;;H01L2924/19041;;H01L2924/19041;;H01L2924/3011;;H01L2924/3011;;Y10S128/903;;Y10S128/903;;Y10T29/49;;Y10T29/49;;Y10T29/49124;;Y10T29/49124,A61B5/1468;;G01N27/30;;A61B5/00;;A61B5/145;;A61B5/1477;;A61B5/1495;;G01N27/416;;G06F19/00;;H01L23/31;;H01L23/495,600/345,0,0,,,,DISCONTINUED
308,US,A1,US 2009/0163788 A1,160-439-485-797-292,2009-06-25,2009,US 36746809 A,2009-02-06,US 36746809 A;;US 42005703 A;;US 66719900 A;;US 7067798 A,1998-04-30,Analyte Monitoring Device and Methods of Use,"An analyte monitor includes a sensor, a sensor control unit, and a display unit. The sensor has, for example, a substrate, a recessed channel formed in the substrate, and conductive material disposed in the recessed channel to form a working electrode. The sensor control unit typically has a housing adapted for placement on skin and is adapted to receive a portion of an electrochemical sensor. The sensor control unit also includes two or more conductive contacts disposed on the housing and configured for coupling to two or more contact pads on the sensor. A transmitter is disposed in the housing and coupled to the plurality of conductive contacts for transmitting data obtained using the sensor. The display unit has a receiver for receiving data transmitted by the transmitter of the sensor control unit and a display coupled to the receiver for displaying an indication of a level of an analyte. The analyte monitor may also be part of a drug delivery system to alter the level of the analyte based on the data obtained using the sensor.",ABBOTT DIABETES CARE INC,SAY JAMES;;TOMASCO MICHAEL F;;HELLER ADAM;;GAL YORAM;;ARIA BEHRAD;;HELLER EPHRAIM;;PLANTE PHILLIP JOHN;;VREEKE MARK S;;FRIEDMAN KEITH A;;COLMAN FREDRIC C,,https://lens.org/160-439-485-797-292,Patent Application,yes,1,12,211,221,0,A61B5/14532;;A61B5/14532;;A61B5/0002;;A61B5/0002;;A61B5/002;;A61B5/01;;A61B5/14503;;A61B5/1451;;A61B5/14546;;A61B5/14546;;A61B5/1473;;A61B5/1473;;A61B5/1486;;A61B5/1486;;A61B5/14865;;A61B5/1495;;A61B5/4839;;A61B5/72;;A61B5/7278;;A61B5/7282;;A61B5/7405;;A61B5/743;;A61B5/7445;;A61B5/7445;;A61B5/7455;;A61B2560/0252;;A61B2560/0252;;A61M5/1723;;C12Q1/54;;G16H10/40;;G16H10/40;;G16H20/17;;G16H20/17;;H01L23/3107;;H01L23/3107;;H01L23/49548;;H01L23/49548;;H01L2924/0002;;H01L2924/0002;;H01L2924/19041;;H01L2924/19041;;H01L2924/3011;;H01L2924/3011;;Y10S128/903;;Y10S128/903;;Y10T29/49;;Y10T29/49;;Y10T29/49124;;Y10T29/49124,A61B5/145;;G01N27/30;;A61B5/00;;A61B5/1477;;A61B5/1495;;G01N27/416;;G06F19/00;;H01L23/31;;H01L23/495,600/345,0,0,,,,DISCONTINUED
309,US,B2,US 7190988 B2,198-061-007-770-164,2007-03-13,2007,US 72225303 A,2003-11-24,US 72225303 A;;US 42005703 A;;US 66719900 A;;US 7067798 A,1998-04-30,Analyte monitoring device and methods of use,"An analyte monitor includes a sensor, a sensor control unit, and a display unit. The sensor has, for example, a substrate, a recessed channel formed in the substrate, and conductive material disposed in the recessed channel to form a working electrode. The sensor control unit typically has a housing adapted for placement on skin and is adapted to receive a portion of an electrochemical sensor. The sensor control unit also includes two or more conductive contacts disposed on the housing and configured for coupling to two or more contact pads on the sensor. A transmitter is disposed in the housing and coupled to the plurality of conductive contacts for transmitting data obtained using the sensor. The display unit has a receiver for receiving data transmitted by the transmitter of the sensor control unit and a display coupled to the receiver for displaying an indication of a level of an analyte. The analyte monitor may also be part of a drug delivery system to alter the level of the analyte based on the data obtained using the sensor.",ABBOTT DIABETES CARE INC,SAY JAMES;;TOMASCO MICHAEL F;;HELLER ADAM;;GAL YORAM;;ARIA BEHRAD;;HELLER EPHRAIM;;PLANTE PHILLIP JOHN;;VREEKE MARK S;;FRIEDMAN KEITH A;;COLMAN FREDRIC C,SYNTHEON NEUROVASCULAR LLC (2021-05-07),https://lens.org/198-061-007-770-164,Granted Patent,yes,2,499,211,221,0,A61B5/14532;;A61B5/14532;;A61B5/0002;;A61B5/0002;;A61B5/002;;A61B5/01;;A61B5/14503;;A61B5/1451;;A61B5/14546;;A61B5/14546;;A61B5/1473;;A61B5/1473;;A61B5/1486;;A61B5/1486;;A61B5/14865;;A61B5/1495;;A61B5/4839;;A61B5/72;;A61B5/7278;;A61B5/7282;;A61B5/7405;;A61B5/743;;A61B5/7445;;A61B5/7445;;A61B5/7455;;A61B2560/0252;;A61B2560/0252;;A61M5/1723;;C12Q1/54;;G16H10/40;;G16H10/40;;G16H20/17;;G16H20/17;;H01L23/3107;;H01L23/3107;;H01L23/49548;;H01L23/49548;;H01L2924/0002;;H01L2924/0002;;H01L2924/19041;;H01L2924/19041;;H01L2924/3011;;H01L2924/3011;;Y10S128/903;;Y10S128/903;;Y10T29/49;;Y10T29/49;;Y10T29/49124;;Y10T29/49124,A61B5/05;;G01N27/30;;A61B5/00;;A61B5/145;;A61B5/1477;;A61B5/1495;;G01N27/26;;G01N27/416;;G06F19/00;;H01L23/31;;H01L23/495,600/345;;600/347;;600/365;;204/401,0,0,,,,EXPIRED
310,US,A1,US 2007/0249920 A1,174-916-387-130-598,2007-10-25,2007,US 76672607 A,2007-06-21,US 76672607 A;;US 42005703 A;;US 66719900 A;;US 7067798 A,1998-04-30,ANALYTE MONITORING DEVICE AND METHODS OF USE,"An analyte monitor includes a sensor, a sensor control unit, and a display unit. The sensor has, for example, a substrate, a recessed channel formed in the substrate, and conductive material disposed in the recessed channel to form a working electrode. The sensor control unit typically has a housing adapted for placement on skin and is adapted to receive a portion of an electrochemical sensor. The sensor control unit also includes two or more conductive contacts disposed on the housing and configured for coupling to two or more contact pads on the sensor. A transmitter is disposed in the housing and coupled to the plurality of conductive contacts for transmitting data obtained using the sensor. The display unit has a receiver for receiving data transmitted by the transmitter of the sensor control unit and a display coupled to the receiver for displaying an indication of a level of an analyte. The analyte monitor may also be part of a drug delivery system to alter the level of the analyte based on the data obtained using the sensor.",ABBOTT DIABETES CARE INC,SAY JAMES;;TOMASCO MICHAEL F;;HELLER ADAM;;GAL YORAM;;ARIA BEHRAD;;HELLER EPHRAIM;;PLANTE PHILLIP J;;VREEKE MARK S;;FRIEDMAN KEITH A;;COLMAN FREDRIC C,E. HELLER & CO (1998-07-02);;ABBOTT DIABETES CARE INC (2000-03-13),https://lens.org/174-916-387-130-598,Patent Application,yes,99,37,211,221,0,A61B5/14532;;A61B5/14532;;A61B5/0002;;A61B5/0002;;A61B5/002;;A61B5/01;;A61B5/14503;;A61B5/1451;;A61B5/14546;;A61B5/14546;;A61B5/1473;;A61B5/1473;;A61B5/1486;;A61B5/1486;;A61B5/14865;;A61B5/1495;;A61B5/4839;;A61B5/72;;A61B5/7278;;A61B5/7282;;A61B5/7405;;A61B5/743;;A61B5/7445;;A61B5/7445;;A61B5/7455;;A61B2560/0252;;A61B2560/0252;;A61M5/1723;;C12Q1/54;;G16H10/40;;G16H10/40;;G16H20/17;;G16H20/17;;H01L23/3107;;H01L23/3107;;H01L23/49548;;H01L23/49548;;H01L2924/0002;;H01L2924/0002;;H01L2924/19041;;H01L2924/19041;;H01L2924/3011;;H01L2924/3011;;Y10S128/903;;Y10S128/903;;Y10T29/49;;Y10T29/49;;Y10T29/49124;;Y10T29/49124,A61B5/05;;G01N27/30;;A61B5/00;;A61B5/145;;A61B5/1477;;A61B5/1495;;G01N27/416;;G06F19/00;;H01L23/31;;H01L23/495,600/345,0,0,,,,DISCONTINUED
311,US,A1,US 2015/0065818 A1,159-642-806-964-708,2015-03-05,2015,US 201414529417 A,2014-10-31,US 201414529417 A;;US 42005703 A;;US 66719900 A;;US 7067798 A,1998-04-30,Analyte Monitoring Device and Methods of Use,"An analyte monitor includes a sensor, a sensor control unit, and a display unit. The sensor has, for example, a substrate, a recessed channel formed in the substrate, and conductive material disposed in the recessed channel to form a working electrode. The sensor control unit typically has a housing adapted for placement on skin and is adapted to receive a portion of an electrochemical sensor. The sensor control unit also includes two or more conductive contacts disposed on the housing and configured for coupling to two or more contact pads on the sensor. A transmitter is disposed in the housing and coupled to the plurality of conductive contacts for transmitting data obtained using the sensor. The display unit has a receiver for receiving data transmitted by the transmitter of the sensor control unit and a display coupled to the receiver for displaying an indication of a level of an analyte. The analyte monitor may also be part of a drug delivery system to alter the level of the analyte based on the data obtained using the sensor.",ABBOTT DIABETES CARE INC,SAY JAMES L;;TOMASCO MICHAEL FRANCIS;;HELLER ADAM;;GAL YORAM;;ARIA BEHRAD;;HELLER EPHRAIM;;PLANTE PHILLIP JOHN;;VREEKE MARK S;;FRIEDMAN KEITH A;;COLMAN FREDRIC C,E. HELLER & CO (1998-07-02);;ABBOTT DIABETES CARE INC (2005-07-25);;THERASENSE INC (2000-03-13),https://lens.org/159-642-806-964-708,Patent Application,yes,0,8,211,221,0,A61B5/14532;;A61B5/14532;;A61B5/0002;;A61B5/0002;;A61B5/002;;A61B5/01;;A61B5/14503;;A61B5/1451;;A61B5/14546;;A61B5/14546;;A61B5/1473;;A61B5/1473;;A61B5/1486;;A61B5/1486;;A61B5/14865;;A61B5/1495;;A61B5/4839;;A61B5/72;;A61B5/7278;;A61B5/7282;;A61B5/7405;;A61B5/743;;A61B5/7445;;A61B5/7445;;A61B5/7455;;A61B2560/0252;;A61B2560/0252;;A61M5/1723;;C12Q1/54;;G16H10/40;;G16H10/40;;G16H20/17;;G16H20/17;;H01L23/3107;;H01L23/3107;;H01L23/49548;;H01L23/49548;;H01L2924/0002;;H01L2924/0002;;H01L2924/19041;;H01L2924/19041;;H01L2924/3011;;H01L2924/3011;;Y10S128/903;;Y10S128/903;;Y10T29/49;;Y10T29/49;;Y10T29/49124;;Y10T29/49124,A61B5/1486;;G01N27/30;;A61B5/00;;A61B5/01;;A61B5/145;;A61B5/1477;;A61B5/1495;;G01N27/416;;G06F19/00;;H01L23/31;;H01L23/495,600/301;;600/309;;600/365;;600/345,0,0,,,,DISCONTINUED
